PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nabarro, D				Nabarro, David			Global child and maternal nutrition-the SUN rises	LANCET			English	Editorial Material									SUN Movement Secretariat, CH-1201 Geneva, Switzerland		Nabarro, D (corresponding author), SUN Movement Secretariat, Villa Pelouse 2nd Floor, CH-1201 Geneva, Switzerland.	david.nabarro@undp.org						Bhutta ZA, 2013, LANCET; Black R., 2013, LANCET; Gillespie S, 2013, LANCET; Ruel M, 2013, LANCET	4	15	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2013	382	9893					666	667		10.1016/S0140-6736(13)61086-7	http://dx.doi.org/10.1016/S0140-6736(13)61086-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	206SI	23746773				2022-12-28	WOS:000323542400007
J	OuYang, B; Xie, SQ; Berardi, MJ; Zhao, XH; Dev, J; Yu, WJ; Sun, B; Chou, JJ				OuYang, Bo; Xie, Shiqi; Berardi, Marcelo J.; Zhao, Xinhao; Dev, Jyoti; Yu, Wenjing; Sun, Bing; Chou, James J.			Unusual architecture of the p7 channel from hepatitis C virus	NATURE			English	Article							ION-CHANNEL; POLYACRYLAMIDE GELS; CHEMICAL-SHIFT; PROTEIN; NMR; SENSITIVITY; AMANTADINE; ALIGNMENT; INHIBITION; MECHANISM	The hepatitis C virus (HCV) has developed a small membrane protein, p7, which remarkably can self-assemble into a large channel complex that selectively conducts cations(1-4). We wanted to examine the structural solution that the viroporin adopts in order to achieve selective cation conduction, because p7 has no homology with any of the known prokaryotic or eukaryotic channel proteins. The activity of p7 can be inhibited by amantadine and rimantadine(2,5), which are potent blockers of the influenza M2 channel(6) and licensed drugs against influenza infections(7). The adamantane derivatives have been used in HCV clinical trials(8), but large variation in drug efficacy among the various HCV genotypes has been difficult to explain without detailed molecular structures. Here we determine the structures of this HCV viroporin as well as its drug-binding site using the latest nuclear magnetic resonance (NMR) technologies. The structure exhibits an unusual mode of hexameric assembly, where the individual p7 monomers, i, not only interact with their immediate neighbours, but also reach farther to associate with the i+2 and i+3 monomers, forming a sophisticated, funnel-like architecture. The structure also points to a mechanism of cation selection: an asparagine/histidine ring that constricts the narrow end of the funnel serves as a broad cation selectivity filter, whereas an arginine/lysine ring that defines the wide end of the funnel may selectively allow cation diffusion into the channel. Our functional investigation using whole-cell channel recording shows that these residues are critical for channel activity. NMR measurements of the channel-drug complex revealed six equivalent hydrophobic pockets between the peripheral and pore-forming helices to which amantadine or rimantadine binds, and compound binding specifically to this position may allosterically inhibit cation conduction by preventing the channel from opening. Our data provide a molecular explanation for p7-mediated cation conductance and its inhibition by adamantane derivatives.	[OuYang, Bo; Berardi, Marcelo J.; Dev, Jyoti; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [OuYang, Bo; Chou, James J.] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [OuYang, Bo; Chou, James J.] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Natl Ctr Prot Sci, Shanghai 200031, Peoples R China; [Xie, Shiqi; Zhao, Xinhao; Yu, Wenjing; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Mol Virus Unit,Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Sun, Bing] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	bsun@sibs.ac.cn; chou@cmcd.hms.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013; Dev, Jyoti/I-4109-2016	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344; Dev, Jyoti/0000-0002-9217-7406; Xie, Shiqi/0000-0002-0516-3621	National Key Project of 973 [2013CB530504]; National Science and Technology Major Project [2012ZX10002-007-003]; NIH [GM094608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094608] Funding Source: NIH RePORTER	National Key Project of 973(National Basic Research Program of China); National Science and Technology Major Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Sounier for helping with making specific methyl-labelled protein, S. Brueschweiler for helping with ITC measurements, G. Bellot, J. Min and W. Shih for providing DNA nanotube liquid crystal, and K. Oxenoid for discussion. This work was supported by the National Key Project of 973 (2013CB530504) and National Science and Technology Major Project (2012ZX10002-007-003) (to B. S.) and NIH grant GM094608 (to J.J.C.).	Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Cook GA, 2011, BBA-BIOMEMBRANES, V1808, P1448, DOI 10.1016/j.bbamem.2010.08.010; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Fischer WB, 2002, BBA-BIOMEMBRANES, V1561, P27, DOI 10.1016/S0304-4157(01)00009-0; Foster TL, 2011, HEPATOLOGY, V54, P79, DOI 10.1002/hep.24371; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Griffin S, 2008, HEPATOLOGY, V48, P1779, DOI 10.1002/hep.22555; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Mihm U, 2006, ANTIVIR THER, V11, P507; Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pielak RM, 2011, STRUCTURE, V19, P1655, DOI 10.1016/j.str.2011.09.003; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; SZYPERSKI T, 1992, J BIOMOL NMR, V2, P323, DOI 10.1007/BF01874811; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Vieyres G, 2013, J VIROL, V87, P1664, DOI 10.1128/JVI.02782-12; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Wu JH, 2004, J AM CHEM SOC, V126, P15018, DOI 10.1021/ja045300l	42	217	217	1	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					521	+		10.1038/nature12283	http://dx.doi.org/10.1038/nature12283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23739335	Green Accepted, Green Submitted			2022-12-28	WOS:000320929400060
J	Ross, BD; Rosin, L; Thomae, AW; Hiatt, MA; Vermaak, D; de la Cruz, AFA; Imhof, A; Mellone, BG; Malik, HS				Ross, Benjamin D.; Rosin, Leah; Thomae, Andreas W.; Hiatt, Mary Alice; Vermaak, Danielle; de la Cruz, Aida Flor A.; Imhof, Axel; Mellone, Barbara G.; Malik, Harmit S.			Stepwise Evolution of Essential Centromere Function in a Drosophila Neogene	SCIENCE			English	Article							GENE; HETEROCHROMATIN; CHROMODOMAIN; MUTATIONS; INSIGHTS; BINDING; MODELS; DOMAIN	Evolutionarily young genes that serve essential functions represent a paradox; they must perform a function that either was not required until after their birth or was redundant with another gene. How young genes rapidly acquire essential function is largely unknown. We traced the evolutionary steps by which the Drosophila gene Umbrea acquired an essential role in chromosome segregation in D. melanogaster since the gene's origin less than 15 million years ago. Umbrea neofunctionalization occurred via loss of an ancestral heterochromatin-localizing domain, followed by alterations that rewired its protein interaction network and led to species-specific centromere localization. Our evolutionary cell biology approach provides temporal and mechanistic detail about how young genes gain essential function. Such innovations may constantly alter the repertoire of centromeric proteins in eukaryotes.	[Ross, Benjamin D.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Ross, Benjamin D.; Hiatt, Mary Alice; Vermaak, Danielle; de la Cruz, Aida Flor A.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Rosin, Leah; Mellone, Barbara G.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Thomae, Andreas W.; Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci, D-08336 Munich, Germany; [Thomae, Andreas W.; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-08336 Munich, Germany; [Hiatt, Mary Alice] Law Firm Fitzpatrick Cella Harper & Scinto, New York, NY 10104 USA; [de la Cruz, Aida Flor A.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Connecticut; University of Munich; University of Munich; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Imhof, Axel/AAU-5313-2021	Malik, Harmit S/0000-0001-6005-0016; Imhof, Axel/0000-0003-2993-8249; Ross, Benjamin/0000-0002-8817-3138; Mellone, Barbara/0000-0002-2785-5119; Thomae, Andreas/0000-0003-3156-9075	NIH [T32HG000035, R01GM074108]; EU [EpiGeneSys 257082]; NSF [1024973]; Mathers Foundation; Div Of Molecular and Cellular Bioscience [1024973] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NSF(National Science Foundation (NSF)); Mathers Foundation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bloom, M. Daugherty, M. Emerman, D. Gottschling, M. Levine, M. Patel, N. Phadnis, K. Peichel, and W. Shou for helpful comments, and Drosophila colleagues for generous sharing of reagents. Supported by NIH Training grant T32HG000035 and an NSF predoctoral fellowship (B. D. R.), an EU network grant (EpiGeneSys 257082, A. I.), NSF award 1024973 (B. G. M.), and a grant from the Mathers Foundation and NIH grant R01GM074108 (H. S. M.). H. S. M. is an HHMI Early Career Scientist. Umbrea DNA sequences have been submitted to GenBank under accession numbers KC660086 to KC660100. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (PRIDE partner repository dataset identifier PXD000163).	Abel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005089; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Force A, 1999, GENETICS, V151, P1531; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Joppich C, 2009, CHROMOSOME RES, V17, P19, DOI 10.1007/s10577-008-9002-1; Levine MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002729; LOHE AR, 1987, J MOL BIOL, V194, P161, DOI 10.1016/0022-2836(87)90365-2; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; OHTA T, 1988, GENETICS, V120, P841; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Zhang DY, 2011, CHROMOSOMA, V120, P97, DOI 10.1007/s00412-010-0294-5; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101	25	63	65	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1211	1214		10.1126/science.1234393	http://dx.doi.org/10.1126/science.1234393			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744945	Green Accepted			2022-12-28	WOS:000319972800044
J	Ferrari, G; Vigano, M				Ferrari, Giulio; Vigano, Maurizia			Bitot's Spot in Vitamin A Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ferrari, Giulio; Vigano, Maurizia] Ist Sci San Raffaele, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ferrari, G (corresponding author), Ist Sci San Raffaele, I-20132 Milan, Italy.	ferrari.giulio@hsr.it	Ferrari, Giulio/AAT-1970-2021; ferrari, giulio/J-9260-2016; ferrari, giulio/AAR-8261-2021	ferrari, giulio/0000-0001-6474-9908; ferrari, giulio/0000-0001-6474-9908					0	5	5	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					E29	E29		10.1056/NEJMicm1205309	http://dx.doi.org/10.1056/NEJMicm1205309			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23718174				2022-12-28	WOS:000319574200011
J	Frank, T; Gody, JC; Nguyen, LBL; Berthet, N; Le Fleche-Mateos, A; Bata, P; Rafai, C; Kazanji, M; Breurec, S				Frank, Thierry; Gody, Jean Chrysostome; Liem Binh Luong Nguyen; Berthet, Nicolas; Le Fleche-Mateos, Anne; Bata, Petula; Rafai, Clotaire; Kazanji, Mirdad; Breurec, Sebastien			First case of Elizabethkingia anophelis meningitis in the Central African Republic	LANCET			English	Editorial Material									[Frank, Thierry; Liem Binh Luong Nguyen; Rafai, Clotaire; Kazanji, Mirdad; Breurec, Sebastien] Inst Pasteur, Unit Med Biol, Bangui, Cent Afr Republ; [Gody, Jean Chrysostome; Bata, Petula] Complexe Pediat, Bangui, Cent Afr Republ; [Berthet, Nicolas] Inst Pasteur, Paris, France; [Berthet, Nicolas] CNRS, UMR 3569, Paris, France; [Le Fleche-Mateos, Anne] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Breurec, S (corresponding author), Inst Pasteur, BP923, Bangui, Cent Afr Republ.	sbreurec@gmail.com	Berthet, Nicolas/J-9373-2012	LE FLECHE MATEOS, ANNE/0000-0001-7497-3153				Bobossi-Serengbe G, 2006, Med Trop (Mars), V66, P182; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Ceyhan M, 2012, INT J PEDIAT, V2011, P215; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; Sivanandan S, 2012, INT J PEDIAT, V2011	5	63	64	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2013	381	9880					1876	1876		10.1016/S0140-6736(13)60318-9	http://dx.doi.org/10.1016/S0140-6736(13)60318-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23706804				2022-12-28	WOS:000319443700034
J	Schreiber, MR				Schreiber, M. R.			One Good Measure	SCIENCE			English	Editorial Material							ACCRETION DISC VISCOSITY; SS-CYGNI; INSTABILITY; OUTBURSTS; MODEL		Univ Valparaiso, Dept Fis & Astron, Valparaiso 2360102, Chile	Universidad de Valparaiso	Schreiber, MR (corresponding author), Univ Valparaiso, Dept Fis & Astron, Av Gran Bretana 1111, Valparaiso 2360102, Chile.	matthias@dfa.uv.cl	Schreiber, Matthias R./AAQ-1185-2020	Schreiber, Matthias R./0000-0003-3903-8009				BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; Hameury JM, 1998, MON NOT R ASTRON SOC, V298, P1048, DOI 10.1046/j.1365-8711.1998.01773.x; Harrison TE, 1999, ASTROPHYS J, V515, pL93, DOI 10.1086/311982; King AR, 2007, MON NOT R ASTRON SOC, V376, P1740, DOI 10.1111/j.1365-2966.2007.11556.x; King AR, 2013, MON NOT R ASTRON SOC, V431, P2655, DOI 10.1093/mnras/stt364; Lasota JP, 2008, NEW ASTRON REV, V51, P752, DOI 10.1016/j.newar.2008.03.003; Miller-Jones JCA, 2013, SCIENCE, V340, P950, DOI [10.1126/science.1237145, 10.1126/science.123.7145]; Schreiber MR, 2007, ASTRON ASTROPHYS, V473, P897, DOI 10.1051/0004-6361:20078146; Schreiber MR, 2002, ASTRON ASTROPHYS, V382, P124, DOI 10.1051/0004-6361:20011627; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337	10	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					932	933		10.1126/science.1238835	http://dx.doi.org/10.1126/science.1238835			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704560				2022-12-28	WOS:000319344100030
J	Aggarwal, N; Shrestha, S				Aggarwal, Naveen; Shrestha, Sarju			Dystrophic Calcinosis Cutis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Aggarwal, Naveen] Queen Elizabeth Hosp, Gateshead, England; [Shrestha, Sarju] Univ Hosp Hartlepool, Hartlepool, England		Aggarwal, N (corresponding author), Queen Elizabeth Hosp, Gateshead, England.	drnaveenaggarwal@yahoo.com							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					E28	E28		10.1056/NEJMicm1211227	http://dx.doi.org/10.1056/NEJMicm1211227			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148TJ	23697531				2022-12-28	WOS:000319270200004
J	Michel, M; Cramer, P				Michel, Margaux; Cramer, Patrick			Transitions for Regulating Early Transcription	CELL			English	Editorial Material							ROLES		[Michel, Margaux; Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Michel, Margaux; Cramer, Patrick] Univ Munich, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de						Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; GILL SC, 1990, BIOPHYS CHEM, V37, P239; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002	10	7	7	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					943	944		10.1016/j.cell.2013.04.050	http://dx.doi.org/10.1016/j.cell.2013.04.050			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706732	Green Published, Bronze			2022-12-28	WOS:000319456800003
J	Fields, E; Chard, J; Murphy, MS; Richardson, M				Fields, Ella; Chard, Jiri; Murphy, M. Stephen; Richardson, Martin		Guideline Dev Grp; Tech Team	Assessment and initial management of feverish illness in children younger than 5 years: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SERIOUS INFECTIONS		[Fields, Ella; Chard, Jiri; Murphy, M. Stephen] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Richardson, Martin] Peterborough & Stamford Hosp Fdn Trust, Peterborough PE3 9GZ, Cambs, England		Chard, J (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	jchard@ncc-wch.org.uk	Roland, Damian/D-9553-2018	Roland, Damian/0000-0001-9334-5144				Advanced Life Support Group, 2005, ADV PAED LIF SUPP PR, V4th; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; De S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f866; Harnden A, 2007, BRIT MED J, V335, P409, DOI 10.1136/bmj.39295.383843.AD; National Institute for Health and Care Excellence, 2013, FEV ILL CHILDR ASS I; National Institute for Health and Clinical Excellence, 2010, BACT MEN MEN SEPT MA; National Institute for Health and Clinical Excellence, 2007, FEV ILL CHILDR ASS I; National Institute for Health and Clinical Excellence, 2007, UR TRACT INF DIAGN T; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538	10	29	30	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2013	346								f2866	10.1136/bmj.f2866	http://dx.doi.org/10.1136/bmj.f2866			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AV	23697671				2022-12-28	WOS:000319574400009
J	Conn, A				Conn, Alasdair			Marathon Day at Massachusetts General	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Conn, A (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,Founders 114, Boston, MA 02114 USA.	aconn@partners.org							0	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					143	144		10.7326/0003-4819-159-2-201307160-00648	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00648			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23698555				2022-12-28	WOS:000322112000021
J	de Oteyza, DG; Gorman, P; Chen, YC; Wickenburg, S; Riss, A; Mowbray, DJ; Etkin, G; Pedramrazi, Z; Tsai, HZ; Rubio, A; Crommie, MF; Fischer, FR				de Oteyza, Dimas G.; Gorman, Patrick; Chen, Yen-Chia; Wickenburg, Sebastian; Riss, Alexander; Mowbray, Duncan J.; Etkin, Grisha; Pedramrazi, Zahra; Tsai, Hsin-Zon; Rubio, Angel; Crommie, Michael F.; Fischer, Felix R.			Direct Imaging of Covalent Bond Structure in Single-Molecule Chemical Reactions	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; CYCLIZATION; ENEDIYNES; RESOLUTION; CATALYSIS; STEPS	Observing the intricate chemical transformation of an individual molecule as it undergoes a complex reaction is a long-standing challenge in molecular imaging. Advances in scanning probe microscopy now provide the tools to visualize not only the frontier orbitals of chemical reaction partners and products, but their internal covalent bond configurations as well. We used noncontact atomic force microscopy to investigate reaction-induced changes in the detailed internal bond structure of individual oligo-(phenylene-1,2-ethynylenes) on a (100) oriented silver surface as they underwent a series of cyclization processes. Our images reveal the complex surface reaction mechanisms underlying thermally induced cyclization cascades of enediynes. Calculations using ab initio density functional theory provide additional support for the proposed reaction pathways.	[de Oteyza, Dimas G.; Chen, Yen-Chia; Wickenburg, Sebastian; Riss, Alexander; Pedramrazi, Zahra; Tsai, Hsin-Zon; Crommie, Michael F.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [de Oteyza, Dimas G.; Rubio, Angel] UPV EHU Mat Phys Ctr, Ctr Fis Mat CSIC, E-20018 San Sebastian, Spain; [Gorman, Patrick; Etkin, Grisha; Fischer, Felix R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chen, Yen-Chia; Wickenburg, Sebastian; Crommie, Michael F.; Fischer, Felix R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Mowbray, Duncan J.; Rubio, Angel] Donostia Int Phys Ctr, E-20018 San Sebastian, Spain; [Mowbray, Duncan J.; Rubio, Angel] Univ Pais Vasco UPV, EHU, Nanobio Spect Grp, E-20018 San Sebastian, Spain; [Mowbray, Duncan J.; Rubio, Angel] Univ Pais Vasco UPV, EHU, ETSF Sci Dev Ctr, Dpto Fis Mat, E-20018 San Sebastian, Spain	University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Centro de Fisica de Materiales (CFM); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Basque Country; European Theoretical Spectroscopy Facility (ETSF); University of Basque Country	Crommie, MF (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	crommie@berkeley.edu; ffischer@berkeley.edu	de Oteyza, Dimas G./H-5955-2013; Riss, Alexander/C-1565-2014; Tsai, Hsin-Zon/J-1682-2016; Mowbray, Duncan John/GSN-9438-2022; Mowbray, Duncan John/A-5531-2010; Rubio, Angel/A-5507-2008	de Oteyza, Dimas G./0000-0001-8060-6819; Riss, Alexander/0000-0002-3212-7925; Tsai, Hsin-Zon/0000-0003-2097-0170; Mowbray, Duncan John/0000-0002-8520-0364; Mowbray, Duncan John/0000-0002-8520-0364; Rubio, Angel/0000-0003-2060-3151	Office of Naval Research BRC Program; Helios Solar Energy Research Center; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy [DE-AC02-05CH11231]; NSF [DMR-1206512]; European Research Council [DYNamo ERC-2010-AdG-267374]; European Union [FP7-PEOPLE-2010-IOF-271909]; Austrian Science Fund (FWF) [J3026-N16]; Spanish "Juan de la Cierva" program [JCI-2010-08156]; Austrian Science Fund (FWF) [J 3026] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1206512] Funding Source: National Science Foundation	Office of Naval Research BRC Program(Office of Naval Research); Helios Solar Energy Research Center; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Spanish "Juan de la Cierva" program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by the Office of Naval Research BRC Program (molecular synthesis, characterization, and STM imaging); the Helios Solar Energy Research Center supported by the Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy under contract DE-AC02-05CH11231 (STM and nc-AFM instrumentation development, AFM operation); NSF grant DMR-1206512 (image analysis); and European Research Council advanced grant DYNamo ERC-2010-AdG-267374 (ab initio calculations). Computing time was provided by the Barcelona Supercomputing Center "Red Espanola de Supercomputacion." D.G.d.O. acknowledges fellowship support by the European Union under FP7-PEOPLE-2010-IOF-271909, A.R. by Austrian Science Fund (FWF) grant J3026-N16, and D.J.M. by the Spanish "Juan de la Cierva" program (JCI-2010-08156). The data presented in the manuscript are tabulated in the main paper and in the supplementary materials. The authors declare no conflicts of interest.	Alabugin IV, 2002, J AM CHEM SOC, V124, P9052, DOI 10.1021/ja026630d; Alabugin IV, 2003, J AM CHEM SOC, V125, P4495, DOI 10.1021/ja029664u; Brooks MA, 1999, J AM CHEM SOC, V121, P5444, DOI 10.1021/ja984472d; Enkovaara J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/25/253202; ERTL G, 1990, ANGEW CHEM INT EDIT, V29, P1219, DOI 10.1002/anie.199012191; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; Giessibl FJ, 2003, REV MOD PHYS, V75, P949, DOI 10.1103/RevModPhys.75.949; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Hanssen KO, 2012, ANGEW CHEM INT EDIT, V51, P12238, DOI 10.1002/anie.201203960; Hla SW, 2000, PHYS REV LETT, V85, P2777, DOI 10.1103/PhysRevLett.85.2777; Hofmann M, 1999, J PHYS CHEM A, V103, P8895, DOI 10.1021/jp9927707; Johnson JP, 2003, J AM CHEM SOC, V125, P14708, DOI 10.1021/ja035695t; JONES RR, 1972, J AM CHEM SOC, V94, P660, DOI 10.1021/ja00757a071; Lee CY, 2007, EUR J ORG CHEM, V2007, P3463, DOI 10.1002/ejoc.200601029; Lewis KD, 2005, J AM CHEM SOC, V127, P9968, DOI 10.1021/ja042703C; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Pavlicek N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086101; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Prall M, 2001, J PHYS CHEM A, V105, P9265, DOI 10.1021/jp0028002; Skoog D.A., 2006, PRINCIPLES INSTRUMEN; SOMORJAI GA, 1994, SURF SCI, V299, P849, DOI 10.1016/0039-6028(94)90702-1; Vavilala C, 2008, J AM CHEM SOC, V130, P13549, DOI 10.1021/ja803413f; WIESENDANGER R, 1998, SCANNING PROBE MICRO	26	398	400	14	431	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1434	1437		10.1126/science.1238187	http://dx.doi.org/10.1126/science.1238187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23722428				2022-12-28	WOS:000320647000037
J	Marcus, CL; Moore, RH; Rosen, CL; Giordani, B; Garetz, SL; Taylor, G; Mitchell, RB; Amin, R; Katz, ES; Arens, R; Paruthi, S; Muzumdar, H; Gozal, D; Thomas, NH; Ware, J; Beebe, D; Snyder, K; Elden, L; Sprecher, RC; Willging, P; Jones, D; Bent, JP; Hoban, T; Chervin, RD; Ellenberg, SS; Redline, S				Marcus, Carole L.; Moore, Renee H.; Rosen, Carol L.; Giordani, Bruno; Garetz, Susan L.; Taylor, Gerry; Mitchell, Ron B.; Amin, Raouf; Katz, Eliot S.; Arens, Raanan; Paruthi, Shalini; Muzumdar, Hiren; Gozal, David; Thomas, Nina Hattiangadi; Ware, Janice; Beebe, Dean; Snyder, Karen; Elden, Lisa; Sprecher, Robert C.; Willging, Paul; Jones, Dwight; Bent, John P.; Hoban, Timothy; Chervin, Ronald D.; Ellenberg, Susan S.; Redline, Susan		Childhood Adenotonsillectomy Trial	A Randomized Trial of Adenotonsillectomy for Childhood Sleep Apnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; CHILDREN; RELIABILITY; COGNITION; OBESE; PEDSQL(TM)-4.0; HYPERACTIVITY; VALIDITY; DEFICITS; VALUES	BACKGROUND Adenotonsillectomy is commonly performed in children with the obstructive sleep apnea syndrome, yet its usefulness in reducing symptoms and improving cognition, behavior, quality of life, and polysomnographic findings has not been rigorously evaluated. We hypothesized that, in children with the obstructive sleep apnea syndrome without prolonged oxyhemoglobin desaturation, early adenotonsillectomy, as compared with watchful waiting with supportive care, would result in improved outcomes. METHODS We randomly assigned 464 children, 5 to 9 years of age, with the obstructive sleep apnea syndrome to early adenotonsillectomy or a strategy of watchful waiting. Polysomnographic, cognitive, behavioral, and health outcomes were assessed at baseline and at 7 months. RESULTS The average baseline value for the primary outcome, the attention and executive-function score on the Developmental Neuropsychological Assessment (with scores ranging from 50 to 150 and higher scores indicating better functioning), was close to the population mean of 100, and the change from baseline to follow-up did not differ significantly according to study group (mean [+/- SD] improvement, 7.1 +/- 13.9 in the early-adenotonsillectomy group and 5.1 +/- 13.4 in the watchful-waiting group; P = 0.16). In contrast, there were significantly greater improvements in behavioral, quality-of-life, and polysomnographic findings and significantly greater reduction in symptoms in the early-adenotonsillectomy group than in the watchful-waiting group. Normalization of polysomnographic findings was observed in a larger proportion of children in the early-adenotonsillectomy group than in the watchful-aiting group (79% vs. 46%). CONCLUSIONS As compared with a strategy of watchful waiting, surgical treatment for the obstructive sleep apnea syndrome in school-age children did not significantly improve attention or executive function as measured by neuropsychological testing but did reduce symptoms and improve secondary outcomes of behavior, quality of life, and polysomnographic findings, thus providing evidence of beneficial effects of early adenotonsillectomy.	[Marcus, Carole L.] Childrens Hosp Philadelphia, Sleep Ctr, Dept Pediat, Philadelphia, PA 19104 USA; [Thomas, Nina Hattiangadi] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA 19104 USA; [Elden, Lisa] Childrens Hosp Philadelphia, Dept Otolaryngol, Philadelphia, PA 19104 USA; [Moore, Renee H.; Ellenberg, Susan S.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Moore, Renee H.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Rosen, Carol L.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Sprecher, Robert C.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Dept Otolaryngol, Cleveland, OH 44106 USA; [Giordani, Bruno] Univ Michigan, Dept Psychiat & Psychol, Ann Arbor, MI 48109 USA; [Giordani, Bruno; Hoban, Timothy; Chervin, Ronald D.] Univ Michigan, Dept Pediat & Neurol, Ann Arbor, MI 48109 USA; [Garetz, Susan L.] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Mitchell, Ron B.] St Louis Univ, Cardinal Glennon Childrens Med Ctr, Dept Otolaryngol, St Louis, MO 63103 USA; [Paruthi, Shalini; Snyder, Karen] St Louis Univ, Cardinal Glennon Childrens Med Ctr, Dept Pediat, St Louis, MO 63103 USA; [Mitchell, Ron B.] Univ Texas SW Med Ctr Dallas, Dept Otolaryngol, Dallas, TX 75390 USA; [Mitchell, Ron B.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Amin, Raouf] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Willging, Paul] Cincinnati Childrens Hosp Med Ctr, Dept Otolaryngol, Cincinnati, OH 45229 USA; [Katz, Eliot S.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Ware, Janice] Boston Childrens Hosp, Dept Med & Psychiat, Boston, MA USA; [Jones, Dwight] Boston Childrens Hosp, Dept Otorhinolaryngol, Boston, MA USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Redline, Susan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Arens, Raanan; Muzumdar, Hiren] Childrens Hosp Montefiore, Dept Pediat, Bronx, NY USA; [Bent, John P.] Childrens Hosp Montefiore, Dept Otolaryngol Head & Neck Surg, Bronx, NY USA; [Bent, John P.] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Gozal, David] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of North Carolina; North Carolina State University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Saint Louis University; Saint Louis University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Chicago	Redline, S (corresponding author), Brigham & Womens Hosp, 221 Longwood Ave, Boston, MA 02115 USA.	sredline@partners.org	Gozal, David/ABH-3805-2020; Paditz, Ekkehart/F-5351-2015; Giordani, Bruno/AAR-1910-2021; Amin, Raouf/AHC-7308-2022; Gozal, David/M-9492-2017	Amin, Raouf/0000-0002-4942-6024; Thomas, Nina/0000-0002-4452-3626; Muzumdar, Hiren/0000-0002-7647-7994; Giordani, Bruno/0000-0001-5921-3455	National Institutes of Health; National Institutes of Health [HL083075, HL083129, UL1 RR024134, UL1 RR024989]; Galleon Pharmaceuticals; Arena Pharmaceuticals; Guidepoint Global; OrbiMed Advisors; Procter Gamble; Zansors; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989, UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL083075, U01HL083129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Galleon Pharmaceuticals; Arena Pharmaceuticals; Guidepoint Global; OrbiMed Advisors; Procter Gamble(Procter & Gamble); Zansors; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (HL083075, HL083129, UL1 RR024134, and UL1 RR024989) from the National Institutes of Health.; Dr. Marcus reports receiving a loan of research equipment from Philips Respironics and Ventus Medical. Dr. Gozal reports receiving consulting fees from Galleon Pharmaceuticals. Dr. Hoban reports receiving payment for expert testimony for cases regarding pediatric neurology. Dr. Chervin reports serving as a board member for Sweet Dreamzzz and Pavad Medical; receiving stock options from Pavad Medical; receiving consulting fees from Arena Pharmaceuticals, Guidepoint Global, OrbiMed Advisors, Procter & Gamble, and Zansors; having patents and patents pending, owned by his institution, for signal-analysis algorithms relevant to diagnosis of sleep disorders and having a patent pending, owned by his institution, for a novel device to treat obstructive sleep apnea (none of these patents are currently licensed); and receiving gifts to his institution for educational purposes from Philips Respironics and Fisher and Paykel. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2011, PROC MI VERS 9 3; Apostolidou MT, 2008, CHEST, V134, P1149, DOI 10.1378/chest.08-1056; Bhattacharjee R, 2010, AM J RESP CRIT CARE, V182, P676, DOI 10.1164/rccm.200912-1930OC; Bhattacharyya N, 2010, OTOLARYNG HEAD NECK, V143, P680, DOI 10.1016/j.otohns.2010.06.918; Brietzke SE, 2006, OTOLARYNG HEAD NECK, V134, P979, DOI 10.1016/j.otohns.2006.02.033; BROUILLETTE RT, 1982, J PEDIATR-US, V100, P31, DOI 10.1016/S0022-3476(82)80231-X; Chervin RD, 2006, PEDIATRICS, V117, pE769, DOI 10.1542/peds.2005-1837; Chervin RD, 2000, SLEEP MED, V1, P21, DOI 10.1016/S1389-9457(99)00009-X; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conners C.K., 2001, CONNERS RATING SCALE; Cortese S, 2009, J AM ACAD CHILD PSY, V48, P894, DOI 10.1097/CHI.0b013e3181ac09c9; Costa DJ, 2009, OTOLARYNG HEAD NECK, V140, P455, DOI 10.1016/j.otohns.2008.12.038; Elliott C, 1990, DIFFERENTIAL ABILITI; Emancipator JL, 2006, ARCH PEDIAT ADOL MED, V160, P203, DOI 10.1001/archpedi.160.2.203; Franco RA, 2000, OTOLARYNG HEAD NECK, V123, P9, DOI 10.1067/mhn.2000.105254; Friedman BC, 2003, SLEEP, V26, P999, DOI 10.1093/sleep/26.8.999; Gioia GA, 2000, BEHAV RATING INVENTO; Gottlieb DJ, 2004, J PEDIATR-US, V145, P458, DOI 10.1016/j.jpeds.2004.05.039; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; GUILLEMINAULT C, 1981, LUNG, V159, P275, DOI 10.1007/BF02713925; Halbower AC, 2006, PLOS MED, V3, P1391, DOI 10.1371/journal.pmed.0030301; Kohler MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007343; Korkman N, 1998, NEPSY DEV NEUROPSYCH; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; MARCUS CL, 1992, AM REV RESPIR DIS, V146, P1235, DOI 10.1164/ajrccm/146.5_Pt_1.1235; Melendres MCS, 2004, PEDIATRICS, V114, P768, DOI 10.1542/peds.2004-0730; Mitchell RB, 2004, OTOLARYNG HEAD NECK, V131, P104, DOI 10.1016/j.otohns.2004.02.024; Mitchell RB, 2007, OTOLARYNG HEAD NECK, V137, P43, DOI 10.1016/j.otohns.2007.03.028; Montgomery-Downs HE, 2006, PEDIATRICS, V117, P741, DOI 10.1542/peds.2005-1067; Montgomery-Downs HE, 2005, EUR RESPIR J, V25, P336, DOI 10.1183/09031936.05.00082904; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; O'Brien LM, 2004, J SLEEP RES, V13, P165, DOI 10.1111/j.1365-2869.2004.00395.x; Redline S, 1999, AM J RESP CRIT CARE, V159, P1527, DOI 10.1164/ajrccm.159.5.9809079; Redline S, 2011, SLEEP, V34, P1509, DOI 10.5665/sleep.1388; Row BW, 2002, PEDIATR RES, V52, P449, DOI 10.1203/01.PDR.0000030718.77598.A4; Tauman R, 2006, J PEDIATR-US, V149, P803, DOI 10.1016/j.jpeds.2006.08.067; Uliel S, 2004, CHEST, V125, P872, DOI 10.1378/chest.125.3.872; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Witmans MB, 2003, AM J RESP CRIT CARE, V168, P1540, DOI 10.1164/ajrccm.168.12.954	40	720	742	7	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2366	2376		10.1056/NEJMoa1215881	http://dx.doi.org/10.1056/NEJMoa1215881			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23692173	Green Accepted			2022-12-28	WOS:000320601700006
J	McAfee, T				McAfee, Tim			Encouraging Smokers to Talk With Their Physicians About Quitting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McAfee, Tim] Ctr Dis Control & Prevent, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	McAfee, T (corresponding author), Ctr Dis Control & Prevent, Off Smoking & Hlth, 4770 Buford Hwy NE,MS F79, Atlanta, GA 30341 USA.	mtt4@cdc.gov	McAfee, Tim/GXG-1246-2022					Augustson Erik, 2012, Morbidity and Mortality Weekly Report, V61, P667; Centers for Disease Control and Prevention, TIPS FORM SMOK; Centers for Disease Control and Prevention, TIPS FORM SMOK HLTH; FIORE MC, 1991, JAMA-J AM MED ASSOC, V266, P3183, DOI 10.1001/jama.266.22.3183; Fiore MC, 2008, TREATING TOBACCO USE; Rigotti NA, 2012, JAMA-J AM MED ASSOC, V308, P1573, DOI 10.1001/jama.2012.13043	6	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2329	2330		10.1001/jama.2013.5975	http://dx.doi.org/10.1001/jama.2013.5975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23700193				2022-12-28	WOS:000320176000020
J	Tinghog, G; Andersson, D; Bonn, C; Bottiger, H; Josephson, C; Lundgren, G; Vastfjall, D; Kirchler, M; Johannesson, M				Tinghog, Gustav; Andersson, David; Bonn, Caroline; Bottiger, Harald; Josephson, Camilla; Lundgren, Gustaf; Vastfjall, Daniel; Kirchler, Michael; Johannesson, Magnus			Intuition and cooperation reconsidered	NATURE			English	Letter									[Tinghog, Gustav; Andersson, David; Josephson, Camilla; Johannesson, Magnus] Linkoping Univ, Dept Management & Engn, Div Econ, SE-58183 Linkoping, Sweden; [Tinghog, Gustav] Linkoping Univ, Dept Med & Hlth Sci, Natl Ctr Prior Setting Hlth Care, SE-58183 Linkoping, Sweden; [Bonn, Caroline; Kirchler, Michael] Univ Innsbruck, Dept Banking & Finance, A-6020 Innsbruck, Austria; [Bottiger, Harald] Klarna AB, SE-11343 Stockholm, Sweden; [Lundgren, Gustaf; Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, SE-11383 Stockholm, Sweden; [Vastfjall, Daniel] Linkoping Univ, Dept Behav Sci & Learning, SE-58183 Linkoping, Sweden; [Vastfjall, Daniel] Decis Res, Eugene, OR 97401 USA; [Kirchler, Michael] Univ Gothenburg, Dept Econ, Ctr Finance, SE-40530 Gothenburg, Sweden	Linkoping University; Linkoping University; University of Innsbruck; Stockholm School of Economics; Linkoping University; University of Gothenburg	Tinghog, G (corresponding author), Linkoping Univ, Dept Management & Engn, Div Econ, SE-58183 Linkoping, Sweden.	magnus.johannesson@hhs.se	Tinghög, Gustav/K-2961-2012; Johannesson, Magnus/E-9680-2011; Västfjäll, Daniel/F-9629-2014	Tinghög, Gustav/0000-0002-8159-1249; Johannesson, Magnus/0000-0001-8759-6393; Vastfjall, Daniel/0000-0003-2873-4500				Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467	2	149	152	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					E1	E2		10.1038/nature12194	http://dx.doi.org/10.1038/nature12194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23739429				2022-12-28	WOS:000319947800001
J	Wallace, DJ; Greenberg, DS; Sawinski, J; Rulla, S; Notaro, G; Kerr, JND				Wallace, Damian J.; Greenberg, David S.; Sawinski, Juergen; Rulla, Stefanie; Notaro, Giuseppe; Kerr, Jason N. D.			Rats maintain an overhead binocular field at the expense of constant fusion	NATURE			English	Article							HEAD MOVEMENTS; EYE; EXPERIENCE; REFLEX; SEE	Fusing left and right eye images into a single view is dependent on precise ocular alignment, which relies on coordinated eye movements. During movements of the head this alignment is maintained by numerous reflexes. Although rodents share with other mammals the key components of eye movement control, the coordination of eye movements in freely moving rodents is unknown. Here we show that movements of the two eyes in freely moving rats differ fundamentally from the precisely controlled eye movements used by other mammals to maintain continuous binocular fusion. The observed eye movements serve to keep the visual fields of the two eyes continuously overlapping above the animal during free movement, but not continuously aligned. Overhead visual stimuli presented to rats freely exploring an open arena evoke an immediate shelter-seeking behaviour, but are ineffective when presented beside the arena. We suggest that continuously overlapping visual fields overhead would be of evolutionary benefit for predator detection by minimizing blind spots.	[Wallace, Damian J.; Greenberg, David S.; Sawinski, Juergen; Rulla, Stefanie; Notaro, Giuseppe; Kerr, Jason N. D.] Max Planck Inst Biol Cybernet, Network Imaging Grp, D-72076 Tubingen, Germany; [Notaro, Giuseppe; Kerr, Jason N. D.] Bernstein Ctr Computat Neurosci Tubingen, D-72076 Tubingen, Germany	Max Planck Society	Kerr, JND (corresponding author), Max Planck Inst Biol Cybernet, Network Imaging Grp, Spemannstr 41, D-72076 Tubingen, Germany.	jason@tuebingen.mpg.de		Greenberg, David/0000-0002-8515-0459; Notaro, Giuseppe/0000-0002-5355-6577; Kerr, Jason/0000-0001-9459-883X	German Federal Ministry of Education and Research (BMBF) [FKZ: 01GQ1002]; Max Planck Society	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank W. Denk, R. Hahnloser, K. Kirchfeld, K. Martin, A. Schwartz and F. Wolf for comments on earlier versions of this manuscript and M. Rictis for help with electronics fabrication. We also thank A. Benali, A. Brauer, U. Czubayko, M.-L. Silva, V. Pawlak, V. Ramachandra and T. Senkova from the Network Imaging Group for data processing, A. Schaefer and M. Kollo for loan of the spherical treadmill, and F. Wolf for advice on the modelling and discussions throughout the project. We thank N. Logothetis for support and C. Sakmann for insights. G.N.'s salary was financed by the German Federal Ministry of Education and Research (BMBF; FKZ: 01GQ1002). The Max Planck Society financed research. We apologize to all authors whom we have not been able to cite because of space restrictions.	Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Artal P, 1998, VISUAL NEUROSCI, V15, P597, DOI 10.1017/S0952523898154020; Berardi N, 1999, J NEUROBIOL, V41, P119, DOI 10.1002/(SICI)1097-4695(199910)41:1<119::AID-NEU15>3.0.CO;2-N; CHELAZZI L, 1989, EUR J NEUROSCI, V1, P639, DOI 10.1111/j.1460-9568.1989.tb00369.x; Dawkins MS, 2002, ANIM BEHAV, V63, P991, DOI [10.1006/anbe.2002.1999, 10.1006/anbe.2002.999]; Dell'Osso LF, 1998, J NEURO-OPHTHALMOL, V18, P112; DONCASTER CP, 1990, J MAMMAL, V71, P188, DOI 10.2307/1382166; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; DUWAER AL, 1981, PERCEPT PSYCHOPHYS, V29, P295, DOI 10.3758/BF03207338; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; Fernandez-Juricic E, 2011, BRAIN BEHAV EVOLUT, V77, P147, DOI 10.1159/000326053; FULLER JH, 1985, VISION RES, V25, P1121, DOI 10.1016/0042-6989(85)90101-4; HESS BJM, 1990, EUR J NEUROSCI, V2, P909, DOI 10.1111/j.1460-9568.1990.tb00003.x; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; HUGHES A, 1977, VISION RES, V17, P927, DOI 10.1016/0042-6989(77)90068-2; LEGG CR, 1990, BEHAV BRAIN RES, V41, P11, DOI 10.1016/0166-4328(90)90049-K; LYLE T K, 1955, Br J Ophthalmol, V39, P474, DOI 10.1136/bjo.39.8.474; MORRIS P, 1979, J ZOOL, V189, P540, DOI 10.1111/j.1469-7998.1979.tb03983.x; Munz M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00191; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Quinn KJ, 1998, J NEUROSCI METH, V80, P201, DOI 10.1016/S0165-0270(98)00005-3; Russell JT, 1932, PEDAGOG SEMIN J GEN, V40, P136; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; Zee DS., 1999, NEUROLOGY EYE MOVEME; Zoccolan D, 2009, P NATL ACAD SCI USA, V106, P8748, DOI 10.1073/pnas.0811583106	27	167	169	0	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					65	69		10.1038/nature12153	http://dx.doi.org/10.1038/nature12153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23708965				2022-12-28	WOS:000319947800033
J	Kupfer, JM				Kupfer, Joel M.			The Morality of Using Mortality as a Financial Incentive Unintended Consequences and Implications for Acute Hospital Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION		[Kupfer, Joel M.] Methodist Med Ctr, Dept Cardiol, Peoria, IL USA; [Kupfer, Joel M.] Univ Illinois, Coll Med Peoria, Peoria, IL 61606 USA	University of Illinois System; University of Illinois Peoria	Kupfer, JM (corresponding author), Univ Illinois, Coll Med Peoria, Dept Cardiol, Methodist Med Ctr, 112 NE Crescent Ave, Peoria, IL 61606 USA.	jmkupfer@comcast.net						Chong CAKY, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001729; Eapen ZJ, 2011, CIRC-CARDIOVASC QUAL, V4, P610, DOI 10.1161/CIRCOUTCOMES.111.961391; Hernandez AF, 2011, CIRCULATION, V124, P712, DOI 10.1161/CIRCULATIONAHA.111.026088; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Kernisan LP, 2009, JAMA-J AM MED ASSOC, V301, P1341, DOI 10.1001/jama.2009.422; Lilford R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2016; Nelson L., 2012, 201202 C BUDG OFF; Vaduganathan M, 2013, JAMA-J AM MED ASSOC, V309, P345, DOI 10.1001/jama.2012.205110	9	19	19	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2213	2214		10.1001/jama.2013.5009	http://dx.doi.org/10.1001/jama.2013.5009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736729				2022-12-28	WOS:000319859200021
J	Kaidi, A; Jackson, SP				Kaidi, Abderrahmane; Jackson, Stephen P.			KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling	NATURE			English	Article							DNA-DAMAGE RESPONSE; HISTONE H3 METHYLATION; DOUBLE-STRAND BREAKS; C-ABL; ACTIVATES ATM; KINASE; PROTEIN; AUTOPHOSPHORYLATION; ACETYLATION; INHIBITION	KAT5 tyrosine phosphorylation, mediated by the tyrosine kinase c-Abl, increases after DNA damage, promoting KAT5 binding to histone H3K9me3, which triggers KAT5-mediated acetylation of the ATM kinase; this promotes the activation of the DNA damage checkpoint and cell survival. The detection of DNA lesions within chromatin represents a critical step in cellular responses to DNA damage. However, the regulatory mechanisms that couple chromatin sensing to DNA-damage signalling in mammalian cells are not well understood. Here we show that tyrosine phosphorylation of the protein acetyltransferase KAT5 (also known as TIP60) increases after DNA damage in a manner that promotes KAT5 binding to the histone mark H3K9me3. This triggers KAT5-mediated acetylation of the ATM kinase, promoting DNA-damage-checkpoint activation and cell survival. We also establish that chromatin alterations can themselves enhance KAT5 tyrosine phosphorylation and ATM-dependent signalling, and identify the proto-oncogene c-Abl as a mediator of this modification. These findings define KAT5 tyrosine phosphorylation as a key event in the sensing of genomic and chromatin perturbations, and highlight a key role for c-Abl in such processes. Sensing genomic and chromatin perturbations When DNA experiences a double-strand break, the enzyme ATM (ataxia telangiectasia mutated) kinase is activated. Binding of the acetyltransferase KAT5 to the modified histone mark H3K9me3 facilitates ATM activation by acetylating the kinase. In this article, Abderrahmane Kaidi and Stephen Jackson show that the c-Abl kinase phosphorylates KAT5 on tyrosine 44 after DNA damage, enhancing its interaction with H3K9me3 and allowing ATM-mediated signalling to initiate the DNA damage checkpoint. These findings may help explain the mechanism of action of the lysine deacetylase inhibitors that are being developed as therapeutic agents, and could therefore inform on how such drugs might be best used against cancer and neurodegenerative diseases.	[Kaidi, Abderrahmane; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England; [Kaidi, Abderrahmane; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Jackson, Stephen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk		Kaidi, Abderrahmane/0000-0001-9411-8912; Jackson, Stephen Philip/0000-0001-9317-7937	Cancer Research UK [C6/A11224]; European Research Council; European Community Seventh Framework Programme [HEALTH-F2-2010-259893]; CRUK [C6946/A14492]; Wellcome Trust [WT092096]; Herchel Smith Fellowship from the University of Cambridge	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); European Community Seventh Framework Programme(European Commission); CRUK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Herchel Smith Fellowship from the University of Cambridge	We thank all members of the Jackson laboratory for help and support, and A. Blackford, S. Britton, K. Dry, J. Forment and J. Travers for critical reading of the manuscript. Research in the Jackson laboratory is funded by Cancer Research UK program grant C6/A11224, the European Research Council and the European Community Seventh Framework Programme grant agreement no. HEALTH-F2-2010-259893 (DDR). Core funding is provided by CRUK (C6946/A14492) and the Wellcome Trust (WT092096). S.P.J. receives his salary from the University of Cambridge, UK, supplemented by CRUK. A.K. is funded by a Herchel Smith Fellowship from the University of Cambridge.	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Buchdunger E, 1996, CANCER RES, V56, P100; Chantalat S, 2011, GENOME RES, V21, P1426, DOI 10.1101/gr.118091.110; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang ZH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-88; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Meltser V, 2011, CELL DEATH DIFFER, V18, P2, DOI 10.1038/cdd.2010.132; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller KM, 2012, BIOCHEM SOC T, V40, P370, DOI 10.1042/BST20110747; Pegoraro G, 2009, AGING-US, V1, P1017, DOI 10.18632/aging.100106; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Podtcheko A, 2006, RADIAT RES, V165, P35, DOI 10.1667/RR3466.1; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	35	134	136	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2013	498	7452								10.1038/nature12201	http://dx.doi.org/10.1038/nature12201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI6RP	23708966	Green Accepted			2022-12-28	WOS:000507637600001
J	Noble, D; Biller-Andorno, N; Sutherland, JM; Anstey, M				Noble, Douglas; Biller-Andorno, Nikola; Sutherland, Jason M.; Anstey, Matthew			Challenges facing Medicaid expansion in the US	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE; NHS		[Noble, Douglas] Weill Cornell Med Coll, New York, NY USA; [Biller-Andorno, Nikola] Harvard Univ, New England Journal Med, Boston, MA 02115 USA; [Sutherland, Jason M.] Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada; [Anstey, Matthew] Kaiser Permanente, Inst Hlth Policy, Oakland, CA USA	Cornell University; Harvard University; University of British Columbia; Kaiser Permanente	Noble, D (corresponding author), Weill Cornell Med Coll, New York, NY USA.	djn2004@med.cornell.edu	Anstey, Matthew/AAG-1853-2019	Biller-Andorno, Nikola/0000-0001-7661-1324				[Anonymous], 2013, AV STAT REF INS; Congressional Budget Office, 2013, EST AFF CAR ACT HLTH; Currie C, 1997, BRIT MED J, V314, P1848, DOI 10.1136/bmj.314.7098.1848; Delamothe T, 2008, BRIT MED J, V336, P1216, DOI 10.1136/bmj.39582.501192.94; Jennings CC, 2010, NEW ENGL J MED, V362, P2244, DOI 10.1056/NEJMp1004761; Naylor CD, 1999, HEALTH AFFAIR, V18, P9, DOI 10.1377/hlthaff.18.3.9; OECD, 2017, OECD REV HLTH SYSTEM, DOI [10.1787/9789264269453-en, DOI 10.1787/146D0DEA-EN, 10.1787/9789264120914-en]; Podger A, 1999, HEALTH AFFAIR, V18, P111, DOI 10.1377/hlthaff.18.3.111; Scotton RB, 2000, MED J AUSTRALIA, V173, P9; US Census Bureau, COMP UN RAT STAT US	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3261	10.1136/bmj.f3261	http://dx.doi.org/10.1136/bmj.f3261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DG	23719638				2022-12-28	WOS:000319948200007
J	Xu, CC; Wang, SY; Thibault, G; Ng, DTW				Xu, Chengchao; Wang, Songyu; Thibault, Guillaume; Ng, Davis T. W.			Futile Protein Folding Cycles in the ER Are Terminated by the Unfolded Protein O-Mannosylation Pathway	SCIENCE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; GREEN FLUORESCENT PROTEIN; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; YEAST; TRANSLOCON; MECHANISMS; CHAPERONES; PRINCIPLES	Newly synthesized polypeptides fold and assemble with assistance from protein chaperones. Full maturation can take multiple attempts, exchanging chaperones at each round. Improperly folded molecules must exit folding cycles and be degraded. In the endoplasmic reticulum (ER), prolonged substrate cycling is detrimental because it expends chaperone and energy resources and increases toxic reactive oxygen species. In budding yeast, we found that unfolded protein O-mannosylation terminated failed folding attempts through the Pmt1/Pmt2 complex. O-mannosylation incapacitated target molecule folding and removed them from folding cycles by reducing engagement with the Kar2 chaperone. In an in vitro protein refolding assay, the modification intrinsically and irreversibly disabled the folding potential of the substrate. Thus, protein folding termination can involve a covalent glycosylation event.	[Xu, Chengchao; Wang, Songyu; Thibault, Guillaume; Ng, Davis T. W.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Xu, Chengchao; Wang, Songyu; Ng, Davis T. W.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ng, Davis T. W.] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore	National University of Singapore; National University of Singapore	Ng, DTW (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	davis@tll.org.sg	Thibault, Guillaume/J-9730-2013	Thibault, Guillaume/0000-0002-7926-4812; Xu, Chengchao/0000-0003-4558-7581	Temasek Trust; Singapore Millennium Foundation; National University of Singapore Graduate Research Scholarship	Temasek Trust; Singapore Millennium Foundation(Singapore Millennium Foundation); National University of Singapore Graduate Research Scholarship(National University of Singapore)	We thank M. DeLisa for providing the P7-GFP construct. We thank W. Xie, S. Vashist, C. Blackman, and M. T. Toh for discussion and technical assistance. This work was supported by funds from the Temasek Trust and grants from the Singapore Millennium Foundation to S.W. (predoctoral fellowship) and G.T. (postdoctoral fellowship). C.X. is a recipient of The National University of Singapore Graduate Research Scholarship. Research funding agencies played no rule in project conception, experimental design and analysis, manuscript preparation, or decision to publish. C.X., S.W., G.T., and D.T.W.N. performed molecular, genetic, and imaging analyses. C.X., S.W., and G.T. performed biochemical and quantitative analyses. D.T.W.N. conceived and supervised the project. C.X., S.W., G.T. and D.T.W.N. wrote the paper.	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goder V, 2011, J CELL SCI, V124, P144, DOI 10.1242/jcs.072181; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Li SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041119; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rodrigo-Brenni MC, 2012, DEV CELL, V23, P896, DOI 10.1016/j.devcel.2012.10.012; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; SWEET DJ, 1992, EMBO J, V11, P423, DOI 10.1002/j.1460-2075.1992.tb05071.x; Thibault G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013193; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9	28	56	60	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					978	981		10.1126/science.1234055	http://dx.doi.org/10.1126/science.1234055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704572				2022-12-28	WOS:000319344100047
J	Tobias, SM; Cattaneo, F				Tobias, S. M.; Cattaneo, F.			Shear-driven dynamo waves at high magnetic Reynolds number	NATURE			English	Article							FLOWS	Astrophysical magnetic fields often display remarkable organization, despite being generated by dynamo action driven by turbulent flows at high conductivity(1,2). An example is the eleven-year solar cycle, which shows spatial coherence over the entire solar surface(3-5). The difficulty in understanding the emergence of this large-scale organization is that whereas at low conductivity (measured by the magnetic Reynolds number, Rm) dynamo fields are well organized, at high Rm their structure is dominated by rapidly varying small-scale fluctuations. This arises because the smallest scales have the highest rate of strain, and can amplify magnetic field most efficiently. Therefore most of the effort to find flows whose large-scale dynamo properties persist at high Rm has been frustrated. Here we report high-resolution simulations of a dynamo that can generate organized fields at high Rm; indeed, the generation mechanism, which involves the interaction between helical flows and shear, only becomes effective at large Rm. The shear does not enhance generation at large scales, as is commonly thought; instead it reduces generation at small scales. The solution consists of propagating dynamo waves, whose existence was postulated more than 60 years ago(6) and which have since been used to model the solar cycle(7).	[Tobias, S. M.] Univ Leeds, Dept Appl Math, Leeds LS2 9JT, W Yorkshire, England; [Cattaneo, F.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Cattaneo, F.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA	University of Leeds; University of Chicago; University of Chicago	Tobias, SM (corresponding author), Univ Leeds, Dept Appl Math, Leeds LS2 9JT, W Yorkshire, England.	smt@maths.leeds.ac.uk		Tobias, Steven/0000-0003-0205-7716	Science and Technology Facilities Council (STFC); Center for Magnetic Self-Organisation (National Science Foundation) at the University of Chicago; STFC [ST/K000853/1, ST/H008802/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H008802/1, ST/K000853/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [0821899] Funding Source: National Science Foundation	Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); Center for Magnetic Self-Organisation (National Science Foundation) at the University of Chicago; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by the Science and Technology Facilities Council (STFC) and by the Center for Magnetic Self-Organisation (sponsored by the National Science Foundation) at the University of Chicago. Computations were performed on the STFC-supported UKMHD consortium cluster (DiRAC) at the University of Leeds.	Cattaneo F, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2145755; Courvoisier A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.034503; Courvoisier A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046308; FINN JM, 1988, PHYS FLUIDS, V31, P2992, DOI 10.1063/1.866956; GALLOWAY DJ, 1992, NATURE, V356, P691, DOI 10.1038/356691a0; Hughes DW, 2013, J FLUID MECH, V717, P395, DOI 10.1017/jfm.2012.584; Kapyla PJ, 2009, ASTROPHYS J, V699, P1059, DOI 10.1088/0004-637X/699/2/1059; MESTEL L, 1999, STELLAR MAGNETISM; Moffatt H. K., 1978, MAGNETIC FIELD GENER; Parker E.N., 1979, COSMICAL MAGNETIC FI; PARKER EN, 1955, ASTROPHYS J, V122, P293, DOI 10.1086/146087; Sridhar S, 2010, J FLUID MECH, V664, P265, DOI 10.1017/S0022112010003745; Steenbeck M, 1966, Z NATURFORSCH PT A, VA 21, P369; Stix M., 2004, SUN INTRO; Tobias SM, 2002, PHILOS T ROY SOC A, V360, P2741, DOI 10.1098/rsta.2002.1090; Tobias S, 2007, SOLAR TACHOCLINE, P319, DOI 10.1017/CBO9780511536243.014; Tobias SM, 2008, J FLUID MECH, V601, P101, DOI 10.1017/S002211200800044X; Yousef TA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.184501	18	53	53	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					463	465		10.1038/nature12177	http://dx.doi.org/10.1038/nature12177			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698444				2022-12-28	WOS:000319254000041
J	Bauman, WA; Spungen, AM; Collins, JF; Raisch, DW; Ho, C; Deitrick, GA; Nemchausky, BA; Goetz, LL; Park, JS; Schwartz, M; Merritt, JL; Jayawardena, V; Sandford, P; Sabharwal, S; Holmes, SA; Nasar, F; Sasaki, R; Punj, V; Zachow, KF; Chua, WC; Thomas, MD; Trincher, RC				Bauman, William A.; Spungen, Ann M.; Collins, Joseph F.; Raisch, Dennis W.; Ho, Chester; Deitrick, George A.; Nemchausky, Bernard A.; Goetz, Lance L.; Park, Jai S.; Schwartz, Michael; Merritt, John L.; Jayawardena, Vidya; Sandford, Paul; Sabharwal, Sunil; Holmes, Sally A.; Nasar, Fahima; Sasaki, Roy; Punj, Vandana; Zachow, Karin F.; Chua, Walter C.; Thomas, MaryKutty D.; Trincher, Rose C.			The Effect of Oxandrolone on the Healing of Chronic Pressure Ulcers in Persons With Spinal Cord Injury A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SURGICAL-PATIENTS; NUTRITIONAL-STATUS; TESTOSTERONE; MALNUTRITION; CYTOKINES; WEIGHT; INFECTION; ARGININE; DISEASE; IMPACT	Background: Anabolic steroids have been reported to improve wound healing. Objective: To determine whether oxandrolone increases the percentage of target pressure ulcers (TPUs) that heal compared with placebo and whether healed ulcers remain closed 8 weeks after treatment. Design: Parallel-group, placebo-controlled, randomized trial conducted from 1 August 2005 to 30 November 2008. Patients, clinical care providers, study personnel, and statisticians were blinded to treatment assignment. (ClinicalTrials.gov: NCT00101361) Setting: 16 inpatient spinal cord injury (SCI) services at Veterans Affairs medical centers. Patients: 1900 prescreened, 779 screened, and 212 randomly assigned inpatients with SCI and stage III or IV TPUs. Intervention: Oxandrolone, 20 mg/d (n = 108), or placebo (n = 104) until the TPU healed or 24 weeks. Measurements: The primary outcome was healed TPUs. The secondary outcome was the percentage of TPUs that remained healed at 8-week follow-up. Results: 24.1% (95% CI, 16.0% to 32.1%) of TPUs in oxandrolone recipients and 29.8% (CI, 21.0% to 38.6%) in placebo recipients healed (difference, -5.7 percentage points [CI, -17.5 to 6.8 percentage points]; P = 0.40). At 8-week follow-up, 16.7% (CI, 9.6% to 23.7%) of oxandrolone recipients and 15.4% (CI, 8.5% to 22.3%) of placebo recipients retained a healed TPU (difference, 1.3 percentage points [CI, -8.8 to 11.2 percentage points]; P = 0.70). No serious adverse events were related to oxandrolone. Liver enzyme levels were elevated in 32.4% (CI, 23.6% to 41.2%) of oxandrolone recipients and 2.9% (CI, 0.0% to 6.1%) of placebo recipients (P < 0.001). Limitations: Selection of severe wounds may have reduced treatment response. Approximately one third of patients did not complete the study in the treatment and placebo groups. The study was terminated after a futility analysis showed a low probability of detecting a significant difference between the groups. Conclusion: Oxandrolone showed no benefit over placebo for improving healing or the percentage of TPUs that remained closed after 8 weeks of treatment.	James J Peters Vet Affairs Med Ctr, Natl Ctr Excellence Med Consequences Spinal Cord, Med Spinal Cord Injury & Res Serv, Bronx, NY 10468 USA; Mt Sinai Sch Med, New York, NY USA; Perry Point Vet Affairs Med Ctr, Vet Affairs Cooperat Studies Program, Coordinating Ctr, Perry Point, MD USA; Univ New Mexico, Vet Affairs Cooperat Study Program, Clin Res Pharm Coordinating Ctr, Albuquerque, NM 87131 USA; Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH USA; Univ Calgary, Calgary, AB, Canada; Vet Affairs North Texas Hlth Care Syst, Dallas, TX USA; Virginia Commonwealth Univ, Richmond, VA USA; St Louis Vet Affairs Med Ctr, Spinal Cord Injury Serv, St Louis, MO 63125 USA; Univ S Florida, James A Haley Vet Hosp, Tampa, FL USA; Univ S Florida, Coll Med, Tampa, FL USA; Hunter H McGuire Vet Affairs Med Ctr, Richmond, VA USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Harvard Univ, Sch Med, Boston, MA USA; Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Vet Affairs Boston Healthcare Syst, Boston, MA 02132 USA; Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA; Stanford Sch Med, Stanford, CA USA; Miami Vet Affairs Healthcare Syst, Spinal Cord Injury Serv, Miami, FL USA; Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA; Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30904 USA; Georgia Hlth Sci Univ, Augusta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; University of New Mexico; University of New Mexico; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Calgary; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Virginia Commonwealth University; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; Hunter Holmes McGuire Veterinary Affairs Medical Center; Tufts University; Harvard University; Harvard Medical School; Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University	Bauman, WA (corresponding author), James J Peters Vet Affairs Med Ctr, Natl Ctr Excellence Med Consequences Spinal Cord, Suite 7A-13,130 West Kingsbridge Rd, Bronx, NY 10468 USA.	william.bauman@va.gov		Ho, Chester/0000-0002-4238-5506	By the Veterans Affairs Clinical Science Research and Development Service, Cooperative Study [535]; Rehabilitation Research and Development, National Center of Excellence for the Medical Consequences of Spinal Cord Injury [B2648C, B4162C, B9212C]; Department of Veterans Affairs, Spinal Cord Injury Services	By the Veterans Affairs Clinical Science Research and Development Service, Cooperative Study; Rehabilitation Research and Development, National Center of Excellence for the Medical Consequences of Spinal Cord Injury; Department of Veterans Affairs, Spinal Cord Injury Services(US Department of Veterans Affairs)	Grant Support: By the Veterans Affairs Clinical Science Research and Development Service, Cooperative Study #535; Rehabilitation Research and Development, National Center of Excellence for the Medical Consequences of Spinal Cord Injury (B2648C, B4162C, and B9212C); and Department of Veterans Affairs, Spinal Cord Injury Services.	ALEXANDER LR, 1995, ARCH PHYS MED REHAB, V76, P819, DOI 10.1016/S0003-9993(95)80545-1; Allman R M, 1999, Adv Wound Care, V12, P22; ALLMAN RM, 1995, JAMA-J AM MED ASSOC, V273, P865, DOI 10.1001/jama.273.11.865; BAUMAN WA, 1994, HORM METAB RES, V26, P152, DOI 10.1055/s-2007-1000798; Beckrich K, 1999, NURS ECON, V17, P263; Berkowitz M, 1998, SPINAL CORD INJURY A; Berlowitz DR, 1997, J AM GERIATR SOC, V45, P30, DOI 10.1111/j.1532-5415.1997.tb00974.x; Bernstein L, 1996, NUTRITION, V12, P255, DOI 10.1016/S0899-9007(96)90852-7; BONNEFOY M, 1995, AGE AGEING, V24, P37, DOI 10.1093/ageing/24.1.37; Brewer S, 2010, J WOUND CARE, V19, P311, DOI 10.12968/jowc.2010.19.7.48905; CARDENAS DD, 1995, ARCH PHYS MED REHAB, V76, P272, DOI 10.1016/S0003-9993(95)80615-6; Cruse JM, 2000, EXP MOL PATHOL, V68, P38, DOI 10.1006/exmp.1999.2292; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; Demling R, 1998, Ostomy Wound Manage, V44, P58; Demling RH, 2000, WOUND REPAIR REGEN, V8, P97, DOI 10.1046/j.1524-475x.2000.00097.x; Demling RH, 1997, J TRAUMA, V43, P47, DOI 10.1097/00005373-199707000-00012; Demling RH, 2001, BURNS, V27, P46, DOI 10.1016/S0305-4179(00)00064-4; Ferrando AA, 2001, CRIT CARE MED, V29, P1936, DOI 10.1097/00003246-200110000-00015; FOX M, 1962, J CLIN ENDOCR METAB, V22, P921, DOI 10.1210/jcem-22-9-921; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hart DW, 2001, ANN SURG, V233, P556, DOI 10.1097/00000658-200104000-00012; HAYDOCK DA, 1987, BRIT J SURG, V74, P320, DOI 10.1002/bjs.1800740432; HAYDOCK DA, 1986, JPEN-PARENTER ENTER, V10, P550, DOI 10.1177/0148607186010006550; Hiller L, 2001, J AM DIET ASSOC, V101, P786, DOI 10.1016/S0002-8223(01)00196-1; Jensen GL, 2010, JPEN-PARENTER ENTER, V34, P156, DOI 10.1177/0148607110361910; Jensen GL, 2009, JPEN-PARENTER ENTER, V33, P710, DOI 10.1177/0148607109344724; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V164, P657, DOI 10.1530/EJE-10-1170; LAN KKG, 1988, BIOMETRICS, V44, P579, DOI 10.2307/2531870; Legendre C, 2008, J VASC SURG, V48, P688, DOI 10.1016/j.jvs.2008.04.012; Liu M H, 1996, Adv Wound Care, V9, P41; Lopez-Hellin J, 2002, CLIN NUTR, V21, P119, DOI 10.1054/clnu.2001.0515; Lowery JC, 1998, MED CARE, V36, P1578, DOI 10.1097/00005650-199811000-00007; Miller JT, 2009, PHARMACOTHERAPY, V29, P213, DOI 10.1592/phco.29.2.213; Pham TN, 2008, J BURN CARE RES, V29, P902, DOI 10.1097/BCR.0b013e31818ba14d; Postma K, 2009, J REHABIL MED, V41, P729, DOI 10.2340/16501977-0410; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Redelings Matthew D, 2005, Adv Skin Wound Care, V18, P367, DOI 10.1097/00129334-200509000-00010; Salva A, 2009, J NUTR HEALTH AGING, V13, P475, DOI 10.1007/s12603-009-0097-7; Segal JL, 1997, ARCH PHYS MED REHAB, V78, P44, DOI 10.1016/S0003-9993(97)90008-3; Sheffield-Moore M, 1999, J CLIN ENDOCR METAB, V84, P2705, DOI 10.1210/jc.84.8.2705; Singh G, 2000, J Spinal Cord Med, V23, P23; Spungen A M, 2001, Adv Skin Wound Care, V14, P139, DOI 10.1097/00129334-200105000-00011; Trautner Barbara W, 2002, J Spinal Cord Med, V25, P277; TSITOURAS PD, 1995, HORM METAB RES, V27, P287, DOI 10.1055/s-2007-979961; Weaver FM, 2000, MED CARE, V38, pS82; Welk B, 2012, J ENDOUROL, V26, P954, DOI 10.1089/end.2012.0063; WINDSOR J A, 1988, Australian and New Zealand Journal of Surgery, V58, P711, DOI 10.1111/j.1445-2197.1988.tb01101.x; WINDSOR JA, 1988, ANN SURG, V207, P290, DOI 10.1097/00000658-198803000-00011; WINDSOR JA, 1988, BRIT J SURG, V75, P135, DOI 10.1002/bjs.1800750215; Zhao JB, 2004, STEROIDS, V69, P357, DOI 10.1016/j.steroids.2004.01.006; Zoico E, 2002, NUTR REV, V60, P39, DOI 10.1301/00296640260085949	51	17	18	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					718	726		10.7326/0003-4819-158-10-201305210-00006	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689765				2022-12-28	WOS:000319666200014
J	Taylor, A; Dangour, AD; Reddy, KS				Taylor, Anna; Dangour, Alan D.; Reddy, K. Srinath			Only collective action will end undernutrition	LANCET			English	Editorial Material									[Taylor, Anna; Dangour, Alan D.] UK Dept Int Dev, London SW1A 2EG, England; [Dangour, Alan D.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Dangour, Alan D.] London Sch Hyg & Trop Med, Leverhulme Ctr Integrat Res Agr & Hlth, London WC1, England; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Taylor, A (corresponding author), UK Dept Int Dev, London SW1A 2EG, England.	a-taylor@dfid.gov.uk		Dangour, Alan/0000-0001-6908-1273; Reddy, K Srinath/0000-0003-3416-3548				Black R., 2013, LANCET; Eastwood R, 2011, POP STUD-J DEMOG, V65, P9, DOI 10.1080/00324728.2010.547946; Horton SSR, 2013, MALNUTRITION GLOBAL; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195	4	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 10	2013	382	9891					490	491		10.1016/S0140-6736(13)61084-3	http://dx.doi.org/10.1016/S0140-6736(13)61084-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201SD	23746777				2022-12-28	WOS:000323162400009
J	Moyer, VA				Moyer, Virginia A.		US Prevent Serv Task Force	Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BRIEF PHYSICIAN ADVICE; UNITED-STATES; RISK DRINKING; OLDER-ADULTS; METAANALYSIS; CONSUMPTION; INJURY; ABUSE	Description: Update of the 2004 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening and behavioral counseling interventions in primary care to reduce alcohol misuse. Methods: The USPSTF reviewed new evidence on the effectiveness of screening for alcohol misuse for improving health outcomes, the accuracy of various screening approaches, the effectiveness of various behavioral counseling interventions for improving intermediate or long-term health outcomes, the harms of screening and behavioral counseling interventions, and influences from the health care system that promote or detract from effective screening and counseling interventions for alcohol misuse. Population: These recommendations apply to adolescents aged 12 to 17 years and adults aged 18 years or older. These recommendations do not apply to persons who are actively seeking evaluation or treatment of alcohol misuse. Recommendation: The USPSTF recommends that clinicians screen adults aged 18 years or older for alcohol misuse and provide persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce alcohol misuse. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening and behavioral counseling interventions in primary care settings to reduce alcohol misuse in adolescents. (I statement)	[Moyer, Virginia A.] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.			Pignone, Michael/0000-0002-6657-7342	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U. S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Society of Addiction Medicine, 1997, PUBL POL STAT SCREEN; At-risk drinking and alcohol dependence: obstetric and gynecologic implications. Committee Opinion No. 496, 2011, OBSTET GYNECOL, V118, P383, DOI DOI 10.1097/AOG.0B013E31822C9906; Centers for Disease Control and Prevention, 1995, MMWR-MORBID MORTAL W, V44, P249; Centers for Disease Control and Prevention [CDC], 2012, 10 LEAD CAUS INJ DEA; Chang G, 1999, ADDICTION, V94, P1499, DOI 10.1046/j.1360-0443.1999.941014996.x; Cherpitel CJ, 2008, J STUD ALCOHOL DRUGS, V69, P535, DOI 10.15288/jsad.2008.69.535; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Fleming MF, 1999, J FAM PRACTICE, V48, P378; Fleming MF, 2008, ALCOHOL CLIN EXP RES, V32, P1600, DOI 10.1111/j.1530-0277.2008.00738.x; Fleming MF, 2010, J STUD ALCOHOL DRUGS, V71, P23, DOI 10.15288/jsad.2010.71.23; Foxcroft DR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009308; Foxcroft DR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009113; Grossberg PM, 2004, ANN FAM MED, V2, P474, DOI 10.1370/afm.122; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Hingson R, 2002, ACCIDENT ANAL PREV, V34, P85, DOI 10.1016/S0001-4575(01)00002-1; Janca A, 1994, ICD 10 SYMPTON CHECK; Johnston L. D., 2012, MONITORING FUTURE NA, VI; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Jonas DE, 2012, COMP EFFECTIVENESS R, V64; Millstein SG, 2003, PEDIATRICS, V111, P114, DOI 10.1542/peds.111.1.114; Moore AA, 2011, ADDICTION, V106, P111, DOI 10.1111/j.1360-0443.2010.03229.x; National Institute on Alcohol Abuse and Alcoholism, 2010, RETH DRINK ALC YOUR; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER, V3, P3, DOI DOI 10.1037/E306662005-004; National Institute on Alcohol Abuse and Alcoholism, 2000, 10 NAT I ALC AB ALC; National Institute on Alcohol Abuse and Alcoholism, 2007, HELP PAT WHO DRINK T; Perrine MW, 1989, SURG GEN WORKSH DRUN; Schaus JF, 2009, J STUD ALCOHOL DRUGS, P131, DOI 10.15288/jsads.2009.s16.131; Stratton K., 1996, FETAL ALCOHOL SYNDRO; Substance Abuse and Mental Health Services Administration, 2011, C PREV RED UND DRINK; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Van Hook S, 2007, J ADOLESCENT HEALTH, V40, P456, DOI 10.1016/j.jadohealth.2006.12.007; Vinson DC, 2010, ANN FAM MED, V8, P484, DOI 10.1370/afm.1175; Williams JF, 2011, PEDIATRICS, V128, pE1330, DOI 10.1542/peds.2011-1754	35	279	283	2	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					210	+		10.7326/0003-4819-159-3-201308060-00652	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-00652			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201RD	23698791				2022-12-28	WOS:000323159800007
J	Kelleher, J; Bhat, R; Salas, AA; Addis, D; Mills, EC; Mallick, H; Tripathi, A; Pruitt, EP; Roane, C; McNair, T; Owen, J; Ambalavanan, N; Carlo, WA				Kelleher, John; Bhat, Ramachandra; Salas, Ariel A.; Addis, Dylan; Mills, Emily C.; Mallick, Himel; Tripathi, Arvind; Pruitt, Elizabeth P.; Roane, Claire; McNair, Tara; Owen, John; Ambalavanan, Namasivayam; Carlo, Waldemar A.			Oronasopharyngeal suction versus wiping of the mouth and nose at birth: a randomised equivalency trial	LANCET			English	Article							EMERGENCY CARDIOVASCULAR CARE; VAGINALLY BORN INFANTS; CARDIOPULMONARY-RESUSCITATION; DELIVERY; TERM; MULTICENTER; LABOR	Background Wiping of the mouth and nose at birth is an alternative method to oronasopharyngeal suction in delivery-room management of neonates, but whether these methods have equivalent effectiveness is unclear. Methods For this randomised equivalency trial, neonates delivered at 35 weeks' gestation or later at the University of Alabama at Birmingham Hospital, Birmingham, AL, USA, between October, 2010, and November, 2011, were eligible. Before birth, neonates were randomly assigned gentle wiping of the face, mouth (implemented by the paediatric or obstetric resident), and nose with a towel (wipe group) or suction with a bulb syringe of the mouth and nostrils (suction group). The primary outcome was the respiratory rate in the first 24 h after birth. We hypothesised that respiratory rates would differ by fewer than 4 breaths per min between groups. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01197807. Findings 506 neonates born at a median of 39 weeks' gestation (IQR 38-40) were randomised. Three parents withdrew consent and 15 non-vigorous neonates with meconium-stained amniotic fluid were excluded. Among the 488 treated neonates, the mean respiratory rates in the first 24 h were 51 (SD 8) breaths per min in the wipe group and 50 (6) breaths per min in the suction group (difference of means 1 breath per min, 95% CI -2 to 0, p<0.001). Interpretation Wiping the nose and mouth has equivalent efficacy to routine use of oronasopharyngeal suction in neonates born at or beyond 35 weeks' gestation.	[Kelleher, John; Bhat, Ramachandra; Salas, Ariel A.; Addis, Dylan; Mills, Emily C.; Roane, Claire; McNair, Tara; Ambalavanan, Namasivayam; Carlo, Waldemar A.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35249 USA; [Mallick, Himel; Tripathi, Arvind; Pruitt, Elizabeth P.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35249 USA; [Owen, John] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35249 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Carlo, WA (corresponding author), Univ Alabama Birmingham, Women & Infants Ctr, Div Neonatol, 176F Suite 9380,619 20th St South, Birmingham, AL 35249 USA.	wcarlo@peds.uab.edu	Mallick, Himel/L-7702-2018; Ambalavanan, Namasivayam/AAI-4088-2020; Ambalavanan, Namasivayam/AAL-3832-2020	Mallick, Himel/0000-0003-4956-2429; Ambalavanan, Namasivayam/0000-0003-0731-9092; Pruitt, Elizabeth/0000-0001-6626-9027; Salas, Ariel/0000-0002-4676-7747; Addis, Dylan/0000-0002-3856-6419				Aguilar AM, 2010, ARCH ARGENT PEDIATR, V108, P31, DOI 10.1590/S0325-00752010000100007; BLAND RD, 1979, AM J OBSTET GYNECOL, V135, P364, DOI 10.1016/0002-9378(79)90706-3; BROWN MJ, 1983, J PHYSIOL-LONDON, V344, P137, DOI 10.1113/jphysiol.1983.sp014929; Carrasco M, 1997, J PEDIATR-US, V130, P832, DOI 10.1016/S0022-3476(97)80031-5; CORDERO L, 1971, J PEDIATR-US, V78, P441, DOI 10.1016/S0022-3476(71)80224-X; ESTOL PC, 1992, J PERINAT MED, V20, P297, DOI 10.1515/jpme.1992.20.4.297; Gungor S, 2006, GYNECOL OBSTET INVES, V61, P9, DOI 10.1159/000087604; Gungor S, 2005, AUST NZ J OBSTET GYN, V45, P453, DOI 10.1111/j.1479-828X.2005.00452.x; Kattwinkel J, 2011, TXB NEONATAL RESUSCI, P37; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Mascha EJ, 2011, ANESTH ANALG, V112, P678, DOI 10.1213/ANE.0b013e318206f872; MORLEY CJ, 1990, ARCH DIS CHILD, V65, P834, DOI 10.1136/adc.65.8.834; Perlman JM, 2010, PEDIATRICS, V126, pE1319, DOI 10.1542/peds.2010-2972B; Vain NE, 2004, LANCET, V364, P597, DOI 10.1016/S0140-6736(04)16852-9; Wiswell TE, 2000, PEDIATRICS, V105, P1, DOI 10.1542/peds.105.1.1; World Health Organization, 2009, PREGN CHILDB POSTP N; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	17	33	33	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					326	330		10.1016/S0140-6736(13)60775-8	http://dx.doi.org/10.1016/S0140-6736(13)60775-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23739521				2022-12-28	WOS:000322544900029
J	Fu, H; Cooray, A; Feruglio, C; Ivison, RJ; Riechers, DA; Gurwell, M; Bussmann, RS; Harris, AI; Altieri, B; Aussel, H; Baker, AJ; Bock, J; Boylan-Kolchin, M; Bridge, C; Calanog, JA; Casey, CM; Cava, A; Chapman, SC; Clements, DL; Conley, A; Cox, P; Farrah, D; Frayer, D; Hopwood, R; Jia, J; Magdis, G; Marsden, G; Martinez-Navajas, P; Negrello, M; Neri, R; Oliver, SJ; Omont, A; Page, MJ; Perez-Fournon, I; Schulz, B; Scott, D; Smith, A; Vaccari, M; Valtchanov, I; Vieira, JD; Viero, M; Wang, L; Wardlow, JL; Zemcov, M				Fu, Hai; Cooray, Asantha; Feruglio, C.; Ivison, R. J.; Riechers, D. A.; Gurwell, M.; Bussmann, R. S.; Harris, A. I.; Altieri, B.; Aussel, H.; Baker, A. J.; Bock, J.; Boylan-Kolchin, M.; Bridge, C.; Calanog, J. A.; Casey, C. M.; Cava, A.; Chapman, S. C.; Clements, D. L.; Conley, A.; Cox, P.; Farrah, D.; Frayer, D.; Hopwood, R.; Jia, J.; Magdis, G.; Marsden, G.; Martinez-Navajas, P.; Negrello, M.; Neri, R.; Oliver, S. J.; Omont, A.; Page, M. J.; Perez-Fournon, I.; Schulz, B.; Scott, D.; Smith, A.; Vaccari, M.; Valtchanov, I.; Vieira, J. D.; Viero, M.; Wang, L.; Wardlow, J. L.; Zemcov, M.			The rapid assembly of an elliptical galaxy of 400 billion solar masses at a redshift of 2.3	NATURE			English	Article							H-2 CONVERSION FACTOR; STAR-FORMATION; SUBMILLIMETER GALAXIES; MOLECULAR GAS; MODEL; CO	Stellar archaeology(1) shows that massive elliptical galaxies formed rapidly about ten billion years ago with star-formation rates of above several hundred solar masses per year. Their progenitors are probably the submillimetre bright galaxies(2) at redshifts z greater than 2. Although the mean molecular gas mass(3) (5 x 10(10) solar masses) of the submillimetre bright galaxies can explain the formation of typical elliptical galaxies, it is inadequate to form elliptical galaxies(4) that already have stellar masses above 2 x 10(11) solar masses at z approximate to 2. Here we report multi-wavelength high-resolution observations of a rare merger of two massive submillimetre bright galaxies at z approximate to 2.3. The system is seen to be forming stars at a rate of 2,000 solar masses per year. The star-formation efficiency is an order of magnitude greater than that of normal galaxies, so the gas reservoir will be exhausted and star formation will be quenched in only around 200 million years. At a projected separation of 19 kiloparsecs, the two massive starbursts are about to merge and form a passive elliptical galaxy with a stellar mass of about 4 x 10(11) solar masses. We conclude that gas-rich major galaxy mergers with intense star formation can form the most massive elliptical galaxies by z approximate to 1.5.	[Fu, Hai; Cooray, Asantha; Boylan-Kolchin, M.; Calanog, J. A.; Jia, J.; Wardlow, J. L.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Feruglio, C.; Cox, P.; Neri, R.] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; [Ivison, R. J.] Royal Observ, UK Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland; [Riechers, D. A.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Gurwell, M.; Bussmann, R. S.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Harris, A. I.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Altieri, B.; Valtchanov, I.] European Space Astron Ctr, Herschel Sci Ctr, Madrid 28691, Spain; [Aussel, H.] Univ Paris Diderot, Lab AIM Paris Saclay, CEA Saclay, CEA,DSM,Irfu,SAp,CNRS, F-91191 Gif Sur Yvette, France; [Baker, A. J.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Bock, J.; Zemcov, M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Bock, J.; Bridge, C.; Vieira, J. D.; Viero, M.] CALTECH, Pasadena, CA 91125 USA; [Casey, C. M.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Cava, A.] Univ Complutense Madrid, Fac Ciencias Fis, Dept Astrofis, E-28040 Madrid, Spain; [Chapman, S. C.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 4R2, Canada; [Clements, D. L.; Hopwood, R.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Astrophys Grp, London SW7 2AZ, England; [Conley, A.] Univ Colorado, Ctr Astrophys & Space Astron UCB 389, Boulder, CO 80309 USA; [Farrah, D.] Virginia Tech, Dept Phys, Blacksburg, VA 24061 USA; [Frayer, D.] Natl Radio Astron Observ, Green Bank, WV 24944 USA; [Magdis, G.] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Marsden, G.; Scott, D.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Martinez-Navajas, P.; Perez-Fournon, I.] Inst Astrofis Canarias, E-38200 Tenerife, Spain; [Martinez-Navajas, P.; Perez-Fournon, I.] Univ La Laguna, Dept Astrofis, E-38205 Tenerife, Spain; [Negrello, M.] Osserv Astron Padova, INAF, I-35122 Padua, Italy; [Oliver, S. J.; Smith, A.; Wang, L.] Univ Sussex, Dept Phys & Astron, Ctr Astron, Brighton BN1 9QH, E Sussex, England; [Omont, A.] Univ Paris 06, CNRS, Inst Astrophys Paris, UMR 7095, F-75014 Paris, France; [Page, M. J.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Schulz, B.] CALTECH, Jet Prop Lab, Infrared Proc & Anal Ctr, Pasadena, CA 91125 USA; [Vaccari, M.] Univ Western Cape, Dept Phys, Astrophys Grp, ZA-7535 Cape Town, South Africa	University of California System; University of California Irvine; University of Edinburgh; Cornell University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University System of Maryland; University of Maryland College Park; European Space Agency; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Rutgers State University New Brunswick; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; University of Hawaii System; Complutense University of Madrid; Dalhousie University; Imperial College London; University of Colorado System; University of Colorado Boulder; Virginia Polytechnic Institute & State University; National Radio Astronomy Observatory (NRAO); University of Oxford; University of British Columbia; Instituto de Astrofisica de Canarias; Universidad de la Laguna; Istituto Nazionale Astrofisica (INAF); University of Padua; University of Sussex; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of the Western Cape	Fu, H (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	haif@uci.edu; acooray@uci.edu	Perez-Fournon, Ismael/AAG-9049-2019; Vaccari, Mattia/R-3431-2016; Magdis, Georgios E/C-7295-2014; Boylan-Kolchin, Michael/A-7200-2011; Cava, Antonio/C-5274-2017; Magdis, Georgios/L-5366-2019; Wardlow, Julie L/C-9903-2015; Baker, Andrew/HHM-6373-2022; Magdis, Georgios/AAX-6804-2021; Ivison, R. J./G-4450-2011; Magdis, Georgios/D-1276-2019	Perez-Fournon, Ismael/0000-0002-2807-6459; Vaccari, Mattia/0000-0002-6748-0577; Magdis, Georgios E/0000-0002-4872-2294; Boylan-Kolchin, Michael/0000-0002-9604-343X; Cava, Antonio/0000-0002-4821-1275; Magdis, Georgios/0000-0002-4872-2294; Wardlow, Julie L/0000-0003-2376-8971; Magdis, Georgios/0000-0002-4872-2294; Ivison, R. J./0000-0001-5118-1313; Magdis, Georgios/0000-0002-4872-2294; Scott, Douglas/0000-0002-6878-9840; Gurwell, Mark/0000-0003-0685-3621; Aussel, Herve/0000-0002-1371-5705; Altieri, Bruno/0000-0003-3936-0284; jia, Jiangyong/0000-0002-5725-3397; Farrah, Duncan/0000-0003-1748-2010; Fu, Hai/0000-0001-9608-6395; Casey, Caitlin/0000-0002-0930-6466; Harris, Andrew/0000-0001-6159-9174; Baker, Andrew/0000-0002-7892-396X; Feruglio, Chiara/0000-0002-4227-6035	CSA (Canada); NAOC (China); CEA (France); CNES (France); CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC (UK); NASA (USA); STFC [ST/I000976/1, ST/K000977/1, ST/I005765/1, ST/L001314/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K000977/1, ST/I000976/1, ST/I005765/1, ST/L001314/1] Funding Source: researchfish; UK Space Agency [ST/G003874/1, ST/J004812/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1140031] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1140019, 1140063, 1139950] Funding Source: National Science Foundation	CSA (Canada); NAOC (China); CEA (France)(French Atomic Energy Commission); CNES (France)(Centre National D'etudes Spatiales); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); ASI (Italy)(Agenzia Spaziale Italiana (ASI)); MCINN (Spain); SNSB (Sweden); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NASA (USA)(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA. This research has made use of data from the HerMES project (http://hermes.sussex.ac.uk/). HerMES is a Herschel Key Programme using Guaranteed Time from the SPIRE instrument team, ESAC scientists and a mission scientist. SPIRE has been developed by a consortium of institutes led by Cardiff University (UK) and including the University of Lethbridge (Canada); NAOC (China); CEA, LAM (France); IFSI, the University of Padua (Italy); IAC (Spain); Stockholm Observatory (Sweden); Imperial College London, RAL, UCL-MSSL, UKATC, the University of Sussex (UK); and Caltech/JPL, IPAC and the University of Colorado (USA). This development has been supported by the following national funding agencies: CSA (Canada); NAOC (China); CEA, CNES and CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC (UK); and NASA (USA). The data presented in this paper will be released through the HeDaM Database in Marseille at http://hedam.oamp.fr/HerMES.	Barger AJ, 1998, NATURE, V394, P248, DOI 10.1038/28338; Behroozi PS, 2010, ASTROPHYS J, V717, P379, DOI 10.1088/0004-637X/717/1/379; Bothwell MS, 2013, MON NOT R ASTRON SOC, V429, P3047, DOI 10.1093/mnras/sts562; Chapman SC, 2005, ASTROPHYS J, V622, P772, DOI 10.1086/428082; da Cunha E, 2008, MON NOT R ASTRON SOC, V388, P1595, DOI 10.1111/j.1365-2966.2008.13535.x; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Damjanov I, 2009, ASTROPHYS J, V695, P101, DOI 10.1088/0004-637X/695/1/101; Dave R, 2010, MON NOT R ASTRON SOC, V404, P1355, DOI 10.1111/j.1365-2966.2010.16395.x; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Elbaz D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117239; Engel H, 2010, ASTROPHYS J, V724, P233, DOI 10.1088/0004-637X/724/1/233; Genzel R, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/69; Genzel R, 2010, MON NOT R ASTRON SOC, V407, P2091, DOI 10.1111/j.1365-2966.2010.16969.x; HAINLINE LJ, 2008, THESIS CALTECH; Ilbert O, 2010, ASTROPHYS J, V709, P644, DOI 10.1088/0004-637X/709/2/644; Ivison RJ, 2011, MON NOT R ASTRON SOC, V412, P1913, DOI 10.1111/j.1365-2966.2010.18028.x; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Magdis GE, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L15; Magnelli B, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220074; Martin DC, 2007, ASTROPHYS J SUPPL S, V173, P342, DOI 10.1086/516639; McCarthy PJ, 2004, ASTROPHYS J, V614, pL9, DOI 10.1086/425306; Murray N, 2010, ASTROPHYS J, V709, P191, DOI 10.1088/0004-637X/709/1/191; Narayanan D, 2012, MON NOT R ASTRON SOC, V426, P1178, DOI 10.1111/j.1365-2966.2012.21893.x; Narayanan D, 2012, MON NOT R ASTRON SOC, V421, P3127, DOI 10.1111/j.1365-2966.2012.20536.x; Oliver SJ, 2012, MON NOT R ASTRON SOC, V424, P1614, DOI 10.1111/j.1365-2966.2012.20912.x; Riechers DA, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/1/L31; Strong AW, 1996, ASTRON ASTROPHYS, V308, pL21; Wardlow JL, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/59	30	106	107	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					338	341		10.1038/nature12184	http://dx.doi.org/10.1038/nature12184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23698363	Green Accepted			2022-12-28	WOS:000320592900034
J	Park, J; Al-Ramahi, I; Tan, QM; Mollema, N; Diaz-Garcia, JR; Gallego-Flores, T; Lu, HC; Lagalwar, S; Duvick, L; Kang, H; Lee, Y; Jafar-Nejad, P; Sayegh, LS; Richman, R; Liu, XY; Gao, Y; Shaw, CA; Arthur, JSC; Orr, HT; Westbrook, TF; Botas, J; Zoghbi, HY				Park, Jeehye; Al-Ramahi, Ismael; Tan, Qiumin; Mollema, Nissa; Diaz-Garcia, Javier R.; Gallego-Flores, Tatiana; Lu, Hsiang-Chih; Lagalwar, Sarita; Duvick, Lisa; Kang, Hyojin; Lee, Yoontae; Jafar-Nejad, Paymaan; Sayegh, Layal S.; Richman, Ronald; Liu, Xiuyun; Gao, Yan; Shaw, Chad A.; Arthur, J. Simon C.; Orr, Harry T.; Westbrook, Thomas F.; Botas, Juan; Zoghbi, Huda Y.			RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1	NATURE			English	Article							POLYGLUTAMINE-INDUCED NEURODEGENERATION; SPINOCEREBELLAR ATAXIA; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; KINASE INHIBITORS; LOCUS DUPLICATION; CAG REPEAT; MODEL	Many neurodegenerative disorders, such as Alzheimer's, Parkinson's and polyglutamine diseases, share a common pathogenic mechanism: the abnormal accumulation of disease-causing proteins, due to either the mutant protein's resistance to degradation or overexpression of the wild-type protein. We have developed a strategy to identify therapeutic entry points for such neurodegenerative disorders by screening for genetic networks that influence the levels of disease-driving proteins. We applied this approach, which integrates parallel cell-based and Drosophila genetic screens, to spinocerebellar ataxia type 1 (SCA1), a disease caused by expansion of a polyglutamine tract in ataxin 1 (ATXN1). Our approach revealed that downregulation of several components of the RAS-MAPK-MSK1 pathway decreases ATXN1 levels and suppresses neurodegeneration in Drosophila and mice. Importantly, pharmacological inhibitors of components of this pathway also decrease ATXN1 levels, suggesting that these components represent new therapeutic targets in mitigating SCA1. Collectively, these data reveal new therapeutic entry points for SCA1 and provide a proof-of-principle for tackling other classes of intractable neurodegenerative diseases.	[Park, Jeehye; Al-Ramahi, Ismael; Tan, Qiumin; Diaz-Garcia, Javier R.; Gallego-Flores, Tatiana; Kang, Hyojin; Lee, Yoontae; Jafar-Nejad, Paymaan; Sayegh, Layal S.; Richman, Ronald; Liu, Xiuyun; Gao, Yan; Shaw, Chad A.; Westbrook, Thomas F.; Botas, Juan; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Park, Jeehye; Al-Ramahi, Ismael; Tan, Qiumin; Diaz-Garcia, Javier R.; Gallego-Flores, Tatiana; Lu, Hsiang-Chih; Kang, Hyojin; Lee, Yoontae; Jafar-Nejad, Paymaan; Sayegh, Layal S.; Richman, Ronald; Liu, Xiuyun; Gao, Yan; Botas, Juan; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Park, Jeehye; Tan, Qiumin; Lee, Yoontae; Richman, Ronald; Liu, Xiuyun; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Mollema, Nissa; Lagalwar, Sarita; Duvick, Lisa; Orr, Harry T.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Mollema, Nissa; Lagalwar, Sarita; Duvick, Lisa; Orr, Harry T.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Lu, Hsiang-Chih; Westbrook, Thomas F.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Arthur, J. Simon C.] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; University of Dundee; Baylor College of Medicine	Orr, HT (corresponding author), Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA.	orrxx002@umn.edu; thomasw@bcm.edu; jbotas@bcm.edu; hzoghbi@bcm.edu	Woo, Jean/K-2625-2014; Al-Ramahi, Ismael/B-4000-2017	Woo, Jean/0000-0001-7593-3081; Al-Ramahi, Ismael/0000-0002-1275-1114; Tan, Qiumin/0000-0003-2266-3238; Zoghbi, Huda/0000-0002-0700-3349; Arthur, Simon/0000-0002-8135-1958; Gallego, Tatiana/0000-0003-0773-0578; Orr, Harry/0000-0001-6118-741X; Shaw, Chad/0000-0001-7267-5398	Howard Hughes Medical Institute Collaborative Innovation Awards grant; NIH Brain Disorders and Development training grant [NIH-NS42179]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS042179, R01NS027699, R01NS042179, T32NS043124] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12016/10, MC_U127081014] Funding Source: researchfish; MRC [MC_UU_12016/10, MC_U127081014] Funding Source: UKRI	Howard Hughes Medical Institute Collaborative Innovation Awards grant; NIH Brain Disorders and Development training grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the members of the Zoghbi, Botas, Orr and Westbrook laboratories for suggestions and discussions, and V. Brandt for editorial input. We also appreciate the help from CCSC and C-BASS cores at The Baylor College of Medicine (BCM) for FACS analysis and the confocal microscopy and mouse behavioural cores of the BCM Intellectual and Developmental Disabilities Research Center (HD024064). Thanks to J. Barrish at Texas Children's Hospital for help with scanning electron microscopy. This work was supported by a Howard Hughes Medical Institute Collaborative Innovation Awards grant and grant NIH-NS42179 (J. B.) I.A.-R. was supported by an NIH Brain Disorders and Development training grant.	Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; EVANS DA, 1990, MILBANK Q, V68, P267, DOI 10.2307/3350099; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Jafar-Nejad P, 2011, P NATL ACAD SCI USA, V108, P2142, DOI 10.1073/pnas.1018748108; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jorgensen ND, 2009, J NEUROCHEM, V110, P675, DOI 10.1111/j.1471-4159.2009.06164.x; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lorenzetti D, 2000, HUM MOL GENET, V9, P779, DOI 10.1093/hmg/9.5.779; MARSDEN CD, 1977, LANCET, V1, P345; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Scarpini E, 2003, LANCET NEUROL, V2, P539, DOI 10.1016/S1474-4422(03)00502-7; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shaharabany M, 2008, FEBS J, V275, P1631, DOI 10.1111/j.1742-4658.2008.06318.x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Teixeira-Castro A, 2011, HUM MOL GENET, V20, P2996, DOI 10.1093/hmg/ddr203; van Ham TJ, 2009, EMBO MOL MED, V1, P360, DOI 10.1002/emmm.200900051; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	49	97	100	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					325	+		10.1038/nature12204	http://dx.doi.org/10.1038/nature12204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23719381	Green Accepted			2022-12-28	WOS:000320592900032
J	Chlan, LL; Weinert, CR; Heiderscheit, A; Tracy, MF; Skaar, DJ; Guttormson, JL; Savik, K				Chlan, Linda L.; Weinert, Craig R.; Heiderscheit, Annie; Tracy, Mary Fran; Skaar, Debra J.; Guttormson, Jill L.; Savik, Kay			Effects of Patient-Directed Music Intervention on Anxiety and Sedative Exposure in Critically Ill Patients Receiving Mechanical Ventilatory Support A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; NEUROMUSCULAR BLOCKING-AGENTS; RELAXATION; ANALGESICS; DECREASES; PROTOCOL; DELIRIUM; THERAPY	Importance Alternatives to sedative medications, such as music, may alleviate the anxiety associated with ventilatory support. Objective To test whether listening to self-initiated patient-directed music (PDM) can reduce anxiety and sedative exposure during ventilatory support in critically ill patients. Design, Setting, and Patients Randomized clinical trial that enrolled 373 patients from 12 intensive care units (ICUs) at 5 hospitals in the Minneapolis-St Paul, Minnesota, area receiving acute mechanical ventilatory support for respiratory failure between September 2006 and March 2011. Of the patients included in the study, 86% were white, 52% were female, and the mean (SD) age was 59 (14) years. The patients had a mean (SD) Acute Physiology, Age and Chronic Health Evaluation III score of 63 (21.6) and a mean (SD) of 5.7 (6.4) study days. Interventions Self-initiated PDM (n=126) with preferred selections tailored by a music therapist whenever desired while receiving ventilatory support, self-initiated use of noise-canceling headphones (NCH; n=122), or usual care (n=125). Main Outcomes and Measures Daily assessments of anxiety (on 100-mm visual analog scale) and 2 aggregate measures of sedative exposure (intensity and frequency). Results Patients in the PDM group listened to music for a mean (SD) of 79.8 (126) (median [range], 12 [0-796]) minutes/day. Patients in the NCH group wore the noise-abating headphones for a mean(SD) of 34.0 (89.6) (median [range], 0 [0-916]) minutes/day. The mixed-models analysis showed that at any time point, patients in the PDM group had an anxiety score that was 19.5 points lower(95% CI, -32.2 to -6.8) than patients in the usual care group (P=.003). By the fifth study day, anxiety was reduced by 36.5% in PDM patients. The treatment x time interaction showed that PDM significantly reduced both measures of sedative exposure. Compared with usual care, the PDM group had reduced sedation intensity by -0.18 (95% CI, -0.36 to -0.004) points/day (P=.05) and had reduced frequency by -0.21 (95% CI, -0.37 to -0.05) points/day (P=.01). The PDM group had reduced sedation frequency by -0.18(95% CI, -0.36 to -0.004) points/day vs the NCH group (P=.04). By the fifth study day, the PDM patients received 2 fewer sedative doses (reduction of 38%) and had a reduction of 36% in sedation intensity. Conclusions and Relevance Among ICU patients receiving acute ventilatory support for respiratory failure, PDM resulted in greater reduction in anxiety compared with usual care, but not compared with NCH. Concurrently, PDM resulted in greater reduction in sedation frequency compared with usual care or NCH, and greater reduction in sedation intensity compared with usual care, but not compared with NCH.	[Chlan, Linda L.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [Weinert, Craig R.] Univ Minnesota, Sch Med, Dept Pulm Allergy Crit Care & Sleep Med, Minneapolis, MN 55455 USA; [Heiderscheit, Annie] Univ Minnesota, Ctr Spiritual & Healing, Minneapolis, MN USA; [Skaar, Debra J.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Savik, Kay] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA; [Weinert, Craig R.; Tracy, Mary Fran] Univ Minnesota, Med Ctr, Fairview, MN USA; [Guttormson, Jill L.] Marquette Univ, Coll Nursing, Milwaukee, WI 53233 USA	University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; Marquette University	Chlan, LL (corresponding author), Ohio State Univ, Coll Nursing, 398 Newton Hall,1585 Neil Ave, Columbus, OH 43210 USA.	chlan.1@osu.edu			National Institutes of Health, National Institute of Nursing Research [R01-NR009295]; National Institutes of Health; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR009295] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was funded by grant R01-NR009295 from the National Institutes of Health, National Institute of Nursing Research (Dr Chlan was the principal investigator of the grant). A portion of Dr Chlan's salary was paid by the National Institutes of Health to her institution for the work performed. Drs Weinert, Heiderscheit, Tracy, Skaar, and Ms Savik had a portion of their salaries paid by the National Institutes of Health to their institutions for work performed on the grant. Dr Guttormson was a paid project coordinator on this study funded by the National Institutes of Health.	Arroliga AC, 2008, CRIT CARE MED, V36, P1083, DOI 10.1097/CCM.0B013E3181653895; BARR J, 1995, CRIT CARE CLIN, V11, P827, DOI 10.1016/S0749-0704(18)30041-1; Chakraborty H, MIXED MODEL APPROACH; Chlan L, 1998, HEART LUNG, V27, P169, DOI 10.1016/S0147-9563(98)90004-8; Chlan L L, 2000, AACN Clin Issues, V11, P128, DOI 10.1097/00044067-200002000-00014; Chlan L L, 1995, Am J Crit Care, V4, P233; Chlan L, 2011, CONTEMP CLIN TRIALS, V32, P544, DOI 10.1016/j.cct.2011.03.005; Chlan L, 2011, NURS RES, V60, pS50, DOI 10.1097/NNR.0b013e318216009c; Chlan L, 2009, MUSIC THER PERSPECT, V27, P42, DOI 10.1093/mtp/27.1.42; Chlan LL, 2004, J ADV NURS, V48, P493, DOI 10.1111/j.1365-2648.2004.03231.x; Conti G, 2002, Minerva Anestesiol, V68, P240; Hwang J, 2005, ACTA ANAESTH SCAND, V49, P1334, DOI 10.1111/j.1399-6576.2005.00842.x; Johnson M M, 1990, Crit Care Nurse, V10, P48; Lee DWH, 2002, GASTROINTEST ENDOSC, V55, P33, DOI 10.1067/mge.2002.120387; Lepage C, 2001, ANESTH ANALG, V93, P912, DOI 10.1097/00000539-200110000-00022; Li DT, 2006, APPL NURS RES, V19, P216, DOI 10.1016/j.apnr.2006.01.003; Maranto C. D., 1993, MUSIC THERAPY HLTH E, P153; MAZZEO AJ, 1995, CRIT CARE CLIN, V11, P937, DOI 10.1016/S0749-0704(18)30047-2; MCCARTNEY JR, 1994, CRIT CARE CLIN, V10, P673, DOI 10.1016/S0749-0704(18)30099-X; Mehta S, 2006, CRIT CARE MED, V34, P374, DOI 10.1097/01.CCM.0000196830.61965.F1; Momeni M, 2006, DRUGS, V66, P2321, DOI 10.2165/00003495-200666180-00005; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Riker RR, 2009, CRIT CARE CLIN, V25, P527, DOI 10.1016/j.ccc.2009.05.004; Sikes P J, 1992, AACN Clin Issues Crit Care Nurs, V3, P379; STOLTZFUS DP, 1995, CRIT CARE CLIN, V11, P903, DOI 10.1016/S0749-0704(18)30045-9; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; THAUT MH, 1993, J MUSIC THER, V30, P210, DOI 10.1093/jmt/30.4.210; TUNG A, 1995, CRIT CARE CLIN, V11, P791, DOI 10.1016/S0749-0704(18)30039-3; Vogelsang J, 1988, J Post Anesth Nurs, V3, P235; Weinert CR, 2007, CRIT CARE MED, V35, P393, DOI 10.1097/01.CCM.0000254339.18639.1D; Wong HLC, 2001, HEART LUNG, V30, P376, DOI 10.1067/mhl.2001.118302	31	137	140	0	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2335	2344		10.1001/jama.2013.5670	http://dx.doi.org/10.1001/jama.2013.5670			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161EV	23689789	Green Accepted			2022-12-28	WOS:000320176000023
J	Blencowe, NS; Strong, S; Hollowood, AD				Blencowe, N. S.; Strong, S.; Hollowood, A. D.			Spontaneous oesophageal rupture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT; PERFORATIONS; OPTIONS		[Blencowe, N. S.; Strong, S.; Hollowood, A. D.] Univ Hosp Bristol NHS Fdn Trust, Div Head & Neck Surg, Bristol, Avon, England; [Blencowe, N. S.; Strong, S.] Univ Bristol, Sch Social & Community Med, Surg Res Ctr, Bristol, Avon, England	University of Bristol; University of Bristol	Blencowe, NS (corresponding author), Univ Hosp Bristol NHS Fdn Trust, Div Head & Neck Surg, Bristol, Avon, England.	natalie.blencowe@bristol.ac.uk			National Institute for Health Research [DRF-2011-04-016] Funding Source: researchfish; Department of Health [DRF-2011-04-016] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Abbott OA., 1985, BR J SURG, V72; BREWER LA, 1986, AM J SURG, V152, P62, DOI 10.1016/0002-9610(86)90144-3; Brinster CJ, 2004, ANN THORAC SURG, V77, P1475, DOI 10.1016/j.athoracsur.2003.08.037; CURCI JJ, 1976, ANN SURG, V183, P401, DOI 10.1097/00000658-197604000-00013; De Lutio Di Castelguidone E, 2005, RADIOL MED, V109, P252; Griffin SM, 2008, BRIT J SURG, V95, P1115, DOI 10.1002/bjs.6294; Gupta NM, 2004, AM J SURG, V187, P58, DOI 10.1016/j.amjsurg.2002.11.004; Higgs S, 2010, BR J SURG S, V97S, P53; HSCIC, HOSP EP STAT; Muckier SA., 1952, SURG GYNECOL OBSTET, V95, P345; Sepesi B, 2010, CURR OPIN GASTROEN, V26, P379, DOI 10.1097/MOG.0b013e32833ae2d7; Smith J L, 1972, Northwest Med, V71, P515; Soreide JA, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-66; Vidarsdottir H, 2010, THORAC CARDIOV SURG, V58, P476, DOI 10.1055/s-0030-1250347	14	14	15	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2013	346								f3095	10.1136/bmj.f3095	http://dx.doi.org/10.1136/bmj.f3095			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DQ	23729218				2022-12-28	WOS:000319949200001
J	Wada-Katsumata, A; Silverman, J; Schal, C				Wada-Katsumata, Ayako; Silverman, Jules; Schal, Coby			Changes in Taste Neurons Support the Emergence of an Adaptive Behavior in Cockroaches	SCIENCE			English	Article							GERMAN-COCKROACH; BLATTELLA-GERMANICA; GLUCOSE AVERSION; BITTER TASTE; DROSOPHILA; DICTYOPTERA; INSECTS	In response to the anthropogenic assault of toxic baits, populations of the German cockroach have rapidly evolved an adaptive behavioral aversion to glucose (a phagostimulant component of baits). We hypothesized that changes in the peripheral gustatory system are responsible for glucose aversion. In both wild-type and glucose-averse (GA) cockroaches, D-fructose and D-glucose stimulated sugar gustatory receptor neurons (GRNs), whereas the deterrent caffeine stimulated bitter-GRNs. In contrast, in GA cockroaches, D-glucose also stimulated bitter-GRNs and suppressed the responses of sugar-GRNs. Thus, D-glucose is processed as both a phagostimulant and deterrent in GA cockroaches, and this newly acquired peripheral taste sensitivity underlies glucose aversion in multiple GA populations. The rapid emergence of this highly adaptive behavior underscores the plasticity of the sensory system to adapt to rapid environmental change.	[Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Schal, C (corresponding author), N Carolina State Univ, Dept Entomol, Campus Box 7613, Raleigh, NC 27695 USA.	coby@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Wada-Katsumata, Ayako/0000-0002-2895-1102	NSF [IOS-1052238]; U.S. Department of Housing and Urban Development [NCHHU0001-11]; Blanton J. Whitmire Endowment at North Carolina State University	NSF(National Science Foundation (NSF)); U.S. Department of Housing and Urban Development; Blanton J. Whitmire Endowment at North Carolina State University	We thank R. Santangelo, V. Knowlton, A. Ernst, J. Mahaffey, R. Anholt, N. Bao, D. Bieman, and D. Mukha for equipment and cockroach collections and T. Tanimura, F. Marion-Poll, A. A. Dahanukar, and three anonymous reviewers for constructive comments. This research was supported in part by NSF (IOS-1052238) and U.S. Department of Housing and Urban Development (NCHHU0001-11) awards to C.S. and by the Blanton J. Whitmire Endowment at North Carolina State University. Data associated with this manuscript have been archived in DRYAD Digital Repository (http://datadryad.org/).	Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; DETHIER VG, 1989, PHYSIOL ENTOMOL, V14, P127, DOI 10.1111/j.1365-3032.1989.tb00944.x; DETHIER VG, 1987, CHEM SENSES, V12, P251, DOI 10.1093/chemse/12.2.251; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Isono K, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00020; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meyerhof W, 2011, FLAVOUR FRAG J, V26, P260, DOI 10.1002/ffj.2041; Newland P, 2009, INSECT TASTE; Onstad D. W., 2008, INSECT RESISTANCE MA; Ramdya P, 2010, TRENDS GENET, V26, P307, DOI 10.1016/j.tig.2010.04.004; ROSS MH, 1995, J INSECT BEHAV, V8, P825, DOI 10.1007/BF02009509; Schaltegger CA, 2011, HANDBOOK ON THE SHADOW ECONOMY, P150; SILVERMAN J, 1995, ENTOMOL EXP APPL, V76, P7, DOI 10.1007/BF02382306; Silverman J, 1999, J ECON ENTOMOL, V92, P886, DOI 10.1093/jee/92.4.886; SILVERMAN J, 1993, J INSECT PHYSIOL, V39, P925, DOI 10.1016/0022-1910(93)90002-9; Tanimura T., 2009, INSECT TASTE, P59; Wada-Katsumata A, 2011, CHEM SENSES, V36, P589, DOI 10.1093/chemse/bjr023; Wada-Katsumata A, 2009, J INSECT PHYSIOL, V55, P742, DOI 10.1016/j.jinsphys.2009.04.014; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001	24	74	78	1	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					972	975		10.1126/science.1234854	http://dx.doi.org/10.1126/science.1234854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704571				2022-12-28	WOS:000319344100045
J	Ben-David, U; Nissenbaum, J; Benvenisty, N				Ben-David, Uri; Nissenbaum, Jonathan; Benvenisty, Nissim			New Balance in Pluripotency: Reprogramming with Lineage Specifiers	CELL			English	Editorial Material							CELLS		[Ben-David, Uri; Nissenbaum, Jonathan; Benvenisty, Nissim] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378				Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	9	10	11	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					939	940		10.1016/j.cell.2013.04.051	http://dx.doi.org/10.1016/j.cell.2013.04.051			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706730	Bronze			2022-12-28	WOS:000319456800001
J	Czeisler, C				Czeisler, Charles			Casting light on sleep deficiency	NATURE			English	Editorial Material									[Czeisler, Charles] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA; [Czeisler, Charles] Brigham & Womens Hosp, Dept Med, Div Sleep Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Czeisler, C (corresponding author), Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA.	charles_czeisler@hms.harvard.edu		Czeisler, Charles Andrew/0000-0002-7408-1849				Colten HR, 2006, SLEEP DISORDERS SLEE; Luckhaupt Sara E., 2012, Morbidity and Mortality Weekly Report, V61, P281; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; National Research Council, 2013, ASS ADV SOL STAT LIG	4	130	133	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S13	S13		10.1038/497S13a	http://dx.doi.org/10.1038/497S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698501				2022-12-28	WOS:000319254000007
J	Nafie, LA				Nafie, Laurence A.			PHYSICAL CHEMISTRY Handedness detected by microwaves	NATURE			English	Editorial Material									Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA	Syracuse University	Nafie, LA (corresponding author), Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA.	lnafie@syr.edu	Nafie, Laurence A./AAI-9221-2020	Nafie, Laurence/0000-0002-3221-4332				Arago F., 1811, MEM I IMP FR SMP, V1, P93; Barron L. D., 2004, MOL LIGHT SCATTERING, V2nd; Barron LD, 2007, NATURE, V446, P505, DOI 10.1038/446505a; BARRON LD, 1986, CHEM PHYS LETT, V123, P423, DOI 10.1016/0009-2614(86)80035-5; Haesler J, 2007, NATURE, V446, P526, DOI 10.1038/nature05653; Nafie LA, 2011, VIBRATIONAL OPTICAL ACTIVITY: PRINCIPLES AND APPLICATIONS, P1, DOI 10.1002/9781119976516; Patterson D, 2013, NATURE, V497, P475, DOI 10.1038/nature12150; Wagniere G.H., 2012, COMPREHENSIVE CHIROP, V1, P3	8	18	18	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					446	448		10.1038/497446b	http://dx.doi.org/10.1038/497446b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698440				2022-12-28	WOS:000319254000036
J	Ren, WC; Cheng, HM				Ren, Wencai; Cheng, Hui-Ming			MATERIALS SCIENCE When two is better than one	NATURE			English	Editorial Material							GRAPHENE NETWORKS; AEROGELS; ULTRALIGHT		[Ren, Wencai; Cheng, Hui-Ming] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Institute of Metal Research, CAS	Ren, WC (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.	cheng@imr.ac.cn	Nicholson, Patrick/I-2048-2019; Cheng, Hui-Ming/B-8682-2012	Nicholson, Patrick/0000-0001-7182-5112; Cheng, Hui-Ming/0000-0002-5387-4241				Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Cao XH, 2011, SMALL, V7, P3163, DOI 10.1002/smll.201100990; Chen ZP, 2013, ADV MATER, V25, P1296, DOI 10.1002/adma.201204196; Chen ZP, 2011, NAT MATER, V10, P424, DOI [10.1038/NMAT3001, 10.1038/nmat3001]; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Hu H, 2013, ADV MATER, V25, P2219, DOI 10.1002/adma.201204530; Kim KH, 2012, NAT NANOTECHNOL, V7, P562, DOI [10.1038/NNANO.2012.118, 10.1038/nnano.2012.118]; Kistler SS, 1931, NATURE, V127, P741, DOI 10.1038/127741a0; Li N, 2012, P NATL ACAD SCI USA, V109, P17360, DOI 10.1073/pnas.1210072109; Nardecchia S, 2013, CHEM SOC REV, V42, P794, DOI 10.1039/c2cs35353a; Qiu L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2251; Saito R, 1998, PHYS PROPERTIES CARB; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Sun HY, 2013, ADV MATER, V25, P2554, DOI 10.1002/adma.201204576	14	32	33	6	418	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					448	449		10.1038/497448a	http://dx.doi.org/10.1038/497448a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698442				2022-12-28	WOS:000319254000037
J	Ho, JK; Batniji, R				Ho, Joyce K.; Batniji, Rajaie			Targets for non-communicable disease: what has happened since the UN summit?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ho, Joyce K.] Stanford NBC News Media & Global Hlth, Stanford, CA USA; [Batniji, Rajaie] Stanford Ctr Innovat Global Hlth, Stanford, CA USA		Ho, JK (corresponding author), Grant Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.	joyceho613@gmail.com						[Anonymous], 2012, DRAFT COMPR GLOB MON; Gulland A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3768; Organization WH, 2016, GLOBAL STATUS REPORT; Stuckler D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5336; WHO, 2012, ZER DRAFT GLOB ACT P; WHO, 2011, 1 WHO DISC PAP COMPR; WHO, 2012, 2 WHO DISC PAP COMPR; WHO, 2012, REP FORM M MEMB STAT	8	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3300	10.1136/bmj.f3300	http://dx.doi.org/10.1136/bmj.f3300			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23693060				2022-12-28	WOS:000319573300015
J	Malhotra, A				Malhotra, Aseem			The dietary advice on added sugar needs emergency surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-ACTIVITY		Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Malhotra, A (corresponding author), Royal Free Hosp, London, England.	aseem_malhotra@hotmail.com						[Anonymous], DIABETOLOGI IN PRESS; [Anonymous], SURG BITT TRUTH; Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873; British Dietetic Association (BDA), FOOD FACT SHEET SUG; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Department of Health, 1991, DIET REF VAL FOOD EN; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Hamer M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6320; Harcombe Z., 2010, OBESITY EPIDEMIC WHA; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Metro, 2013, METRO; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Rayner M, 2004, PUBLIC HEALTH NUTR, V7, P549, DOI 10.1079/PHN2003552; Swinburn B., 2009, 2009 EUR C OB 6 9 MA; U.S. Department Agriculture (USDA), 2006, USDA DAT ADD SUG CON	15	3	3	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3199	10.1136/bmj.f3199	http://dx.doi.org/10.1136/bmj.f3199			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23694809				2022-12-28	WOS:000319573300010
J	Sun, B; Edgar, MP; Bowman, R; Vittert, LE; Welsh, S; Bowman, A; Padgett, MJ				Sun, B.; Edgar, M. P.; Bowman, R.; Vittert, L. E.; Welsh, S.; Bowman, A.; Padgett, M. J.			3D Computational Imaging with Single-Pixel Detectors	SCIENCE			English	Article								Computational imaging enables retrieval of the spatial information of an object with the use of single-pixel detectors. By projecting a series of known random patterns and measuring the backscattered intensity, it is possible to reconstruct a two-dimensional (2D) image. We used several single-pixel detectors in different locations to capture the 3D form of an object. From each detector we derived a 2D image that appeared to be illuminated from a different direction, even though only a single digital projector was used for illumination. From the shading of the images, the surface gradients could be derived and the 3D object reconstructed. We compare our result to that obtained from a stereophotogrammetric system using multiple cameras. Our simplified approach to 3D imaging can readily be extended to nonvisible wavebands.	[Sun, B.; Edgar, M. P.; Bowman, R.; Welsh, S.; Padgett, M. J.] Univ Glasgow, Sch Phys & Astron, Scottish Univ Phys Alliance, Glasgow G12 8QQ, Lanark, Scotland; [Bowman, R.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Vittert, L. E.; Bowman, A.] Univ Glasgow, Sch Math & Stat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Strathclyde; University of Cambridge; University of Glasgow	Sun, B (corresponding author), Univ Glasgow, Sch Phys & Astron, Scottish Univ Phys Alliance, Glasgow G12 8QQ, Lanark, Scotland.	b.sun.1@research.gla.ac.uk	Sun, Baoqing/L-9411-2015; Padgett, Miles J/B-7625-2008; Sun, Baoqing/AAD-3615-2019; Bowman, Richard W/D-7736-2011	Padgett, Miles J/0000-0001-6643-0618; Sun, Baoqing/0000-0001-6319-0102; Bowman, Richard W/0000-0002-1531-8199; Bowman, Adrian/0000-0002-5729-4631; Welsh, Stephen/0000-0002-7757-7751	Royal Society; Wolfson Foundation; UK Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/I012451/1] Funding Source: researchfish; EPSRC [EP/I012451/1] Funding Source: UKRI	Royal Society(Royal Society of London); Wolfson Foundation; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the Royal Society and the Wolfson Foundation (M.J.P.) and by the UK Engineering and Physical Sciences Research Council. B. S. and M. P. E. thank D. Giovannini for useful discussions. All authors contributed equally to this work and to the writing of the manuscript.	Bennink RS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.113601; Bromberg Y, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053840; Brooks MJ, 1989, SHAPE SHADING; Duarte MF, 2008, IEEE SIGNAL PROC MAG, V25, P83, DOI 10.1109/MSP.2007.914730; Ferri F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183602; Ferri F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.253603; Gatti A, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013802; Horn BK, 1986, ROBOT VISION, V1st; HORN BKP, 1977, ARTIF INTELL, V8, P201, DOI 10.1016/0004-3702(77)90020-0; Jack B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.083602; Kharnbay B, 2008, BRIT J ORAL MAX SURG, V46, P27, DOI 10.1016/j.bjoms.2007.04.017; Mermelstein M. S., 1999, THESIS MIT; PITTMAN TB, 1995, PHYS REV A, V52, pR3429, DOI 10.1103/PhysRevA.52.R3429; Ryu J, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2192153; Shapiro JH, 2012, QUANTUM INF PROCESS, V11, P949, DOI 10.1007/s11128-011-0356-5; Shapiro JH, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.061802; STREKALOV DV, 1995, PHYS REV LETT, V74, P3600, DOI 10.1103/PhysRevLett.74.3600; Sun BQ, 2012, OPT EXPRESS, V20, P16892, DOI 10.1364/OE.20.016892; Valencia A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.063601; WOODHAM RJ, 1980, OPT ENG, V19, P139, DOI 10.1117/12.7972479	22	571	623	42	390	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					844	847		10.1126/science.1234454	http://dx.doi.org/10.1126/science.1234454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687044				2022-12-28	WOS:000318997400039
J	Vidic, RD; Brantley, SL; Vandenbossche, JM; Yoxtheimer, D; Abad, JD				Vidic, R. D.; Brantley, S. L.; Vandenbossche, J. M.; Yoxtheimer, D.; Abad, J. D.			Impact of Shale Gas Development on Regional Water Quality	SCIENCE			English	Review							POTENTIAL CONTAMINANT PATHWAYS; HYDRAULICALLY FRACTURED SHALE; METHANE CONTAMINATION; PENNSYLVANIA; MANAGEMENT; WELLS; EXTRACTION; CHALLENGES; DISPOSAL; AQUIFERS	Unconventional natural gas resources offer an opportunity to access a relatively clean fossil fuel that could potentially lead to energy independence for some countries. Horizontal drilling and hydraulic fracturing make the extraction of tightly bound natural gas from shale formations economically feasible. These technologies are not free from environmental risks, however, especially those related to regional water quality, such as gas migration, contaminant transport through induced and natural fractures, wastewater discharge, and accidental spills. We review the current understanding of environmental issues associated with unconventional gas extraction. Improved understanding of the fate and transport of contaminants of concern and increased long-term monitoring and data dissemination will help manage these water-quality risks today and in the future.	[Vidic, R. D.; Vandenbossche, J. M.; Abad, J. D.] Univ Pittsburgh, Dept Civil & Environm Engn, Pittsburgh, PA 15261 USA; [Brantley, S. L.; Yoxtheimer, D.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Brantley, S. L.; Yoxtheimer, D.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Vidic, RD (corresponding author), Univ Pittsburgh, Dept Civil & Environm Engn, Pittsburgh, PA 15261 USA.	vidic@pitt.edu	Brantley, Susan L/ABE-4479-2020; Abad, Jorge D/V-2100-2018	Abad, Jorge D/0000-0003-1571-9846; Vidic, Radisav/0000-0001-7969-6845	NSF [OCE-11-40159]; Directorate For Geosciences [1140159] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	R.D.V., S. L. B., D.Y., and J.D.A. acknowledge funding for the Shale Network from NSF grant OCE-11-40159.	[Anonymous], 2012, REUTERS; [Anonymous], 2009, 20095086 US GEOL SUR; Barbot E, 2013, ENVIRON SCI TECHNOL, V47, P2562, DOI 10.1021/es304638h; Blauch M. E., 2009, SPE E REG M SOC PETR; Bol G., 1991, OILFIELD REV, V3, P35; Bonett A, 1996, OILFIELD REV, V8, P36; Boyer EW, 2012, IMPACT MARCELLUS GAS; Brantley S.L., 2012, EOS T AGU, V93, P328, DOI [DOI 10.1029/2012EO340006, 10.1029/2012EO340006]; Breen K. J., 2007, US GEOL SURVEY SCI I, V2007-5085; Bruner R., 2011, COMP STUDY MISSISSIP; Chapman EC, 2012, ENVIRON SCI TECHNOL, V46, P3545, DOI 10.1021/es204005g; Considine T., 2012, ENV IMPACTS MARCELLU; Davies RJ, 2011, P NATL ACAD SCI USA, V108, pE871, DOI 10.1073/pnas.1113299108; de Pater C. J. J., 2011, GEOMECHANICAL STUDY; DiGiulio D. C., 2011, INVESTIGATI IN PRESS; Dresel P. E., 2010, 10010 OFOG, P48; Drohan PJ, 2012, SOIL SCI SOC AM J, V76, P1696, DOI 10.2136/sssaj2012.0087; Dusseault M. B., 2000, 64733 SOC PETR ENG; Eltschlager K.K., 2001, TECHNICAL MEASURES I; Energy Information Administration, 1993, DOEEIATR0565; Engelder T., 2012, GSA ANN M EXP CHARL; Engelder T, 2012, P NATL ACAD SCI USA, V109, pE3625, DOI 10.1073/pnas.1216133110; Engelder Terry., 2009, FORT WORTH BASIN AUG, P18; Entrekin S, 2011, FRONT ECOL ENVIRON, V9, P503, DOI 10.1890/110053; Etiope G., 2013, MARINE PETROLEUM GEO; Ferrar K. J., 2013, ENV SCI TECHNOLOGY; Fisher K, 2012, SPE PROD OPER, V27, P8, DOI 10.2118/145949-PA; Gonzalo V., 2005, SPE LATIN AM CARIBBE; Gorody A. W., 2012, ENV GEOSCI, V19, P17, DOI [10.1306/eg.12081111013, DOI 10.1306/EG.12081111013]; Gough W. R., 1990, WATER RESOURCES PENN, P384; Gregory KB, 2011, ELEMENTS, V7, P181, DOI 10.2113/gselements.7.3.181; Haluszczak LO, 2013, APPL GEOCHEM, V28, P55, DOI 10.1016/j.apgeochem.2012.10.002; HARRISON SS, 1983, GROUND WATER, V21, P689, DOI 10.1111/j.1745-6584.1983.tb01940.x; Hayes TD., 2009, MARCELLUS SHALE WATE; Holditch S.A., 2007, WORKING DOCUMENT NAT, P52; Hutson S., 2004, GEOL SURV CIRC, V1268, P1; IOGC, 2008, PROT COUNTR RES STAT; Jackson R. B., 2012, RESP FREQ ASK QUEST; Kappell W. M., 2012, 20121162 US GEOL SUR; Kargbo DM, 2010, ENVIRON SCI TECHNOL, V44, P5679, DOI 10.1021/es903811p; Kresse T. M., 2012, 20125273 USGS; Kuijvenhoven C., 2011, SHAL GAS WAT MAN C D; Laughrey CD, 1998, AAPG BULL, V82, P317; Lutz BD, 2013, WATER RESOUR RES, V49, P647, DOI 10.1002/wrcr.20096; Maloney KO, 2012, ENVIRON PRAC, V14, P278, DOI 10.1017/S146604661200035X; Mantell M.E., 2011, EPA HYDR FRACT STUD, V4; MIT, 2011, FUT NAT GAS; Molofsky LJ, 2011, OIL GAS J, V109, P54; Myers T, 2012, GROUND WATER, V50, P872, DOI 10.1111/j.1745-6584.2012.00933.x; National Academy of Science, 2012, IND SEISM POT EN TEC; Nicot JP, 2012, ENVIRON SCI TECHNOL, V46, P3580, DOI 10.1021/es204602t; NYS DEC, 2009, GEN ENV I S IN PRESS; Olmstead SM, 2013, P NATL ACAD SCI USA, V110, P4962, DOI 10.1073/pnas.1213871110; Osborn SG, 2011, P NATL ACAD SCI USA, V108, P8172, DOI 10.1073/pnas.1100682108; Osborn SG, 2010, APPL GEOCHEM, V25, P456, DOI 10.1016/j.apgeochem.2010.01.001; PA DEP, 2010, WAST TREATM REQ 25 P; PA DEP Office of Oil and Gas, 2013, OIL GAS COMPL REP; Pennsylvania Department of Environmental Protection (PA DEP), 2011, OIL GAS WELL DRILL P; Poth C. W., 1962, PENNSYLVANIA GEOLO M, VM47, P1; Rahm BG, 2012, ENVIRON SCI POLICY, V17, P12, DOI 10.1016/j.envsci.2011.12.004; Revesz KM, 2010, APPL GEOCHEM, V25, P1845, DOI 10.1016/j.apgeochem.2010.09.011; Rogers M. J., 2004, 90829 SOC PETR ENG; Rowan E.L., 2011, 20115135 US GEOL SUR; Rozell DJ, 2012, RISK ANAL, V32, P1382, DOI 10.1111/j.1539-6924.2011.01757.x; Saiers JE, 2012, GROUND WATER, V50, P826, DOI 10.1111/j.1745-6584.2012.00990.x; Schon SC, 2011, P NATL ACAD SCI USA, V108, pE664, DOI 10.1073/pnas.1107960108; Soeder D. J., 2009, WATER RESOURCES NATU; States S., 2011, AWWA WQTC PHOEN AZ N; Texas Department of Agriculture, 1985, AGR LAND WAT CONT IN; Tinsley J. M., 1979, 8257 SOC PETR ENG; U. S. Energy Information Administration, 2013, ANN EN OUTL 2013 EAR; US DOE, 2011, COST EFF REC LOW TDS; USEPA, 1987, REP C MAN WAST EXPL; Veil J, 2009, PRODUCED WATER VOLUM; Vidic R. D., 2011, SHALE GAS WATER MANA; Warner NR, 2012, P NATL ACAD SCI USA, V109, P11961, DOI 10.1073/pnas.1121181109; Waxman H., 2011, CHEM USED HYDRAULIC; White J. S., 2006, US GEOLOGICAL SURVEY, V156; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Williams J. A., 2010, 20105224 US GEOL SUR; Wilson JM, 2012, ENVIRON PRAC, V14, P288, DOI 10.1017/S1466046612000427; Wright P. R., 2012, USGS DATA SERIES, V718	82	999	1043	35	1322	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134							1235009	10.1126/science.1235009	http://dx.doi.org/10.1126/science.1235009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687049				2022-12-28	WOS:000318997400034
J	Stagnaro-Green, A; Pearce, EN				Stagnaro-Green, Alex; Pearce, Elizabeth N.			Iodine and pregnancy: a call to action	LANCET			English	Editorial Material							SUPPLEMENTATION; CHILDREN		[Stagnaro-Green, Alex] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Pearce, Elizabeth N.] Boston Univ, Sch Med, Boston, MA 02118 USA	George Washington University; Boston University	Stagnaro-Green, A (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA.	alexsg@gwu.edu		Stagnaro-Green, Alex/0000-0003-2434-3852; Pearce, Elizabeth/0000-0003-3799-0354				Bath SC, 2013, LANCET; Berbel P, 2009, THYROID, V19, P511, DOI 10.1089/thy.2008.0341; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Henrichs J, 2010, J CLIN ENDOCR METAB, V95, P4227, DOI 10.1210/jc.2010-0415; Konig F, 2011, J NUTR, V141, P2049, DOI 10.3945/jn.111.144071; Li M, 2012, NAT REV ENDOCRINOL, V8, P434, DOI 10.1038/nrendo.2012.43; Melse-Boonstra A, 2012, J TRACE ELEM MED BIO, V26, P134, DOI 10.1016/j.jtemb.2012.03.005; Murcia M, 2011, AM J EPIDEMIOL, V173, P804, DOI 10.1093/aje/kwq424; Oken E, 2009, J CLIN ENDOCR METAB, V94, P497, DOI 10.1210/jc.2008-0936; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; Vanderpump MPJ, 2011, LANCET, V377, P2007, DOI 10.1016/S0140-6736(11)60693-4; Velasco I, 2009, J CLIN ENDOCR METAB, V94, P3234, DOI 10.1210/jc.2008-2652; Williams FLR, 2013, J CLIN ENDOCR METAB, V98, P829, DOI 10.1210/jc.2012-3572	13	14	15	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					292	293		10.1016/S0140-6736(13)60717-5	http://dx.doi.org/10.1016/S0140-6736(13)60717-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23706509				2022-12-28	WOS:000322544900007
J	Lameire, NH; Bagga, A; Cruz, D; De Maeseneer, J; Endre, Z; Kellum, JA; Liu, KD; Mehta, RL; Pannu, N; Van Biesen, W; Vanholder, R				Lameire, Norbert H.; Bagga, Arvind; Cruz, Dinna; De Maeseneer, Jan; Endre, Zoltan; Kellum, John A.; Liu, Kathleen D.; Mehta, Ravindra L.; Pannu, Neesh; Van Biesen, Wim; Vanholder, Raymond			Acute kidney injury: an increasing global concern	LANCET			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; GLOMERULAR-FILTRATION-RATE; HEMOLYTIC-UREMIC SYNDROME; QUALITY-OF-LIFE; REPLACEMENT THERAPY; PERITONEAL-DIALYSIS; HYDROXYETHYL STARCH; URINARY BIOMARKERS	Despite an increasing incidence of acute kidney injury in both high-income and low-income countries and growing insight into the causes and mechanisms of disease, few preventive and therapeutic options exist. Even small acute changes in kidney function can result in short-term and long-term complications, including chronic kidney disease, end-stage renal disease, and death. Presence of more than one comorbidity results in high severity of illness scores in all medical settings. Development or progression of chronic kidney disease after one or more episode of acute kidney injury could have striking socioeconomic and public health outcomes for all countries. Concerted international action encompassing many medical disciplines is needed to aid early recognition and management of acute kidney injury.	[Lameire, Norbert H.; Van Biesen, Wim; Vanholder, Raymond] Univ Hosp, Div Renal, B-9000 Ghent, Belgium; [Bagga, Arvind] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Cruz, Dinna] Int Renal Res Inst, Dept Nephrol, Vicenza, Italy; [Endre, Zoltan] Prince Wales Hosp, Dept Nephrol, Randwick, NSW 2031, Australia; [Kellum, John A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Liu, Kathleen D.] Univ Calif San Francisco, San Francisco Med Ctr, Dept Crit Care, San Francisco, CA 94143 USA; [Mehta, Ravindra L.] Univ Calif San Diego, Div Nephrol, San Diego, CA 92103 USA; [Pannu, Neesh] Univ Alberta, Dept Med, Edmonton, AB, Canada	Ghent University; Ghent University Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of Alberta	Lameire, NH (corresponding author), Univ Hosp, Div Renal, Pintelaan 185, B-9000 Ghent, Belgium.	norbert.lameire@ugent.be	Mehta, Ravindra/ACD-4769-2022; Kellum, John/AAP-3072-2020; Kellum, John A/HCH-2944-2022; Endre, Zoltan/A-3331-2009	Mehta, Ravindra/0000-0002-0908-2968; Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Liu, Kathleen/0000-0003-4891-8649; Endre, Zoltan/0000-0002-4782-8695				Adhikari NKJ, 2011, CURR OPIN CRIT CARE, V17, P620, DOI 10.1097/MCC.0b013e32834cd39c; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Amin AP, 2012, ARCH INTERN MED, V172, P246, DOI 10.1001/archinternmed.2011.1202; Andrade L, 2008, SEMIN NEPHROL, V28, P383, DOI 10.1016/j.semnephrol.2008.04.008; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bellomo R, 2012, CRIT CARE MED, V40, P1753, DOI 10.1097/CCM.0b013e318246b9c6; Bentata Y, 2012, J NEPHROL, V25, P764, DOI 10.5301/jn.5000058; Blantz RC, 2011, CONTRIB NEPHROL, V174, P4, DOI 10.1159/000329027; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bouchard J, 2010, NEPHROL DIAL TRANSPL, V25, P102, DOI 10.1093/ndt/gfp392; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Butani L, 2007, CLIN PEDIATR, V46, P505, DOI 10.1177/0009922806298896; Caletti MG, 2006, MEDICINA-BUENOS AIRE, V66, P22; Carter M, 2012, BLOOD PURIFICAT, V33, P149, DOI 10.1159/000334139; Carter Mary, 2007, J Hosp Mark Public Relations, V18, P81; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; Cerda J, 2008, NAT CLIN PRACT NEPHR, V4, P138, DOI 10.1038/ncpneph0722; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Clement J, 2012, EUR J CLIN MICROBIOL, V31, P1, DOI 10.1007/s10096-011-1456-y; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Cohen SD, 2008, CURR OPIN CRIT CARE, V14, P647, DOI 10.1097/MCC.0b013e3283186f43; Cruz DN, 2007, CRIT CARE, V11, DOI 10.1186/cc5965; Dasta JF, 2008, NEPHROL DIAL TRANSPL, V23, P1970, DOI 10.1093/ndt/gfm908; De Maeseneer J, 2010, BRIT J GEN PRACT, V60, P286, DOI 10.3399/bjgp10X483977; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Endre ZH, 2011, AM J PHYSIOL-RENAL, V301, pF697, DOI 10.1152/ajprenal.00448.2010; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Esezobor CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051229; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Fischer MJ, 2005, AM J KIDNEY DIS, V46, P1049, DOI 10.1053/j.ajkd.2005.09.006; Gabriel DP, 2008, KIDNEY INT, V73, pS87, DOI 10.1038/sj.ki.5002608; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; George J, 2011, PERITON DIALYSIS INT, V31, P422, DOI 10.3747/pdi.2009.00231; Goldstein SL, 2012, BLOOD PURIFICAT, V33, P131, DOI 10.1159/000334143; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Jacobs R, 2011, BLOOD PURIFICAT, V32, P262, DOI 10.1159/000330244; James MT, 2011, SEMIN DIALYSIS, V24, P215, DOI 10.1111/j.1525-139X.2011.00836.x; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Johansen KL, 2010, CLIN J AM SOC NEPHRO, V5, P1366, DOI 10.2215/CJN.02570310; Jones AE, 2008, CRIT CARE MED, V36, P2734, DOI 10.1097/CCM.0b013e318186f839; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Joyce VR, 2012, CLIN J AM SOC NEPHRO, V7, P1063, DOI 10.2215/CJN.00450112; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kielstein JT, 2011, CURR PHARM BIOTECHNO, V12, P2015; Klima T, 2012, EUR HEART J, V33, P2071, DOI 10.1093/eurheartj/ehr501; Krishnamurthy S, 2013, INDIAN J PEDIATR, V80, P183, DOI 10.1007/s12098-012-0791-z; Lafrance JP, 2010, NEPHROL DIAL TRANSPL, V25, P2203, DOI 10.1093/ndt/gfq011; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Li PKT, 2013, KIDNEY INT, V83, P372, DOI 10.1038/ki.2012.427; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Macedo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036388; Macedo E, 2012, NAT REV NEPHROL, V8, P57, DOI 10.1038/nrneph.2011.172; Macedo E, 2011, SEMIN DIALYSIS, V24, P132, DOI 10.1111/j.1525-139X.2011.00838.x; Macedo E, 2011, NEPHROL DIAL TRANSPL, V26, P509, DOI 10.1093/ndt/gfq332; Mammen C, 2012, AM J KIDNEY DIS, V59, P523, DOI 10.1053/j.ajkd.2011.10.048; Manns B, 2003, CRIT CARE MED, V31, P449, DOI 10.1097/01.CCM.0000045182.90302.B3; Marik PE, 2011, ANN INTENSIVE CARE, V1, DOI [10.1186/2110-5820-1-1, 10.1186/2110-5820-1-17]; Mathew AJ, 2011, ANN SAUDI MED, V31, P451, DOI 10.4103/0256-4947.84620; Mehra N, 2012, TROP DOCT, V42, P160, DOI 10.1258/td.2012.120023; Mehta P, 2012, INDIAN PEDIATR, V49, P537, DOI 10.1007/s13312-012-0121-6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mishra SK, 2008, SEMIN NEPHROL, V28, P395, DOI 10.1016/j.semnephrol.2008.04.007; Morgera S, 2002, AM J KIDNEY DIS, V40, P275, DOI 10.1053/ajkd.2002.34505; Morsch C, 2011, RENAL FAILURE, V33, P949, DOI 10.3109/0886022X.2011.615966; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Naicker S, 2008, SEMIN NEPHROL, V28, P348, DOI 10.1016/j.semnephrol.2008.04.003; Nejat M, 2012, KIDNEY INT, V81, P1254, DOI 10.1038/ki.2012.23; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; O'Brien KL, 1998, JAMA-J AM MED ASSOC, V279, P1175, DOI 10.1001/jama.279.15.1175; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Perazella MA, 2009, CLIN J AM SOC NEPHRO, V4, P691, DOI 10.2215/CJN.06691208; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Phu NH, 2002, NEW ENGL J MED, V347, P895, DOI 10.1056/NEJMoa020074; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Schwenger V, 2012, CRIT CARE, V16, DOI 10.1186/cc11445; Sever MS, 2012, NEPHROL DIAL TRANSPL, V27, P1, DOI 10.1093/ndt/gfs156; Sever MS, 2004, CLIN NEPHROL, V61, P413; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shaw AD, 2013, CLIN J AM SOC NEPHRO, V8, P497, DOI 10.2215/CJN.10921012; Siew ED, 2012, J AM SOC NEPHROL, V23, P305, DOI 10.1681/ASN.2011030315; Sinha R, 2009, NEPHROL DIAL TRANSPL, V24, P829, DOI 10.1093/ndt/gfn539; Srisawat N, 2010, CRIT CARE, V14, DOI 10.1186/cc8933; Sutherland SM, 2010, AM J KIDNEY DIS, V55, P316, DOI 10.1053/j.ajkd.2009.10.048; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanholder R, 2000, J AM SOC NEPHROL, V11, P1553, DOI 10.1681/ASN.V1181553; Vanholder R, 2011, CRIT CARE, V15, DOI 10.1186/cc9345; Vincent JL, 2012, KIDNEY INT, V81, P1060, DOI 10.1038/ki.2011.389; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Waikar SS, 2009, JAMA-J AM MED ASSOC, V302, P1227, DOI 10.1001/jama.2009.1364; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wlodzimirow KA, 2012, CRIT CARE, V16, DOI 10.1186/cc11808; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	101	571	599	13	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					170	179		10.1016/S0140-6736(13)60647-9	http://dx.doi.org/10.1016/S0140-6736(13)60647-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23727171				2022-12-28	WOS:000322115300032
J	Wakefield, ED; Bodey, TW; Bearhop, S; Blackburn, J; Colhoun, K; Davies, R; Dwyer, RG; Green, JA; Gremillet, D; Jackson, AL; Jessopp, MJ; Kane, A; Langston, RHW; Lescroel, A; Murray, S; Le Nuz, M; Patrick, SC; Peron, C; Soanes, LM; Wanless, S; Votier, SC; Hamer, KC				Wakefield, Ewan D.; Bodey, Thomas W.; Bearhop, Stuart; Blackburn, Jez; Colhoun, Kendrew; Davies, Rachel; Dwyer, Ross G.; Green, Jonathan A.; Gremillet, David; Jackson, Andrew L.; Jessopp, Mark J.; Kane, Adam; Langston, Rowena H. W.; Lescroel, Amelie; Murray, Stuart; Le Nuz, Melanie; Patrick, Samantha C.; Peron, Clara; Soanes, Louise M.; Wanless, Sarah; Votier, Stephen C.; Hamer, Keith C.			Space Partitioning Without Territoriality in Gannets	SCIENCE			English	Article							INTRA-SPECIFIC COMPETITION; FORAGING AREAS; PUBLIC INFORMATION; GPS TRACKING; SEABIRDS; BEHAVIOR; FOOD; COLONIES; NEIGHBORS; EVOLUTION	Colonial breeding is widespread among animals. Some, such as eusocial insects, may use agonistic behavior to partition available foraging habitat into mutually exclusive territories; others, such as breeding seabirds, do not. We found that northern gannets, satellite-tracked from 12 neighboring colonies, nonetheless forage in largely mutually exclusive areas and that these colony-specific home ranges are determined by density-dependent competition. This segregation may be enhanced by individual-level public information transfer, leading to cultural evolution and divergence among colonies.	[Wakefield, Ewan D.; Davies, Rachel; Hamer, Keith C.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Bodey, Thomas W.; Bearhop, Stuart; Dwyer, Ross G.] Univ Exeter, Ctr Ecol & Conservat, Penryn TR10 9EZ, Cornwall, England; [Blackburn, Jez] British Trust Ornithol, The Nunnery IP24 2PU, Thetford, England; [Colhoun, Kendrew] Royal Soc Protect Birds, Belfast BT8 4QT, Antrim, North Ireland; [Green, Jonathan A.; Soanes, Louise M.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3GP, Merseyside, England; [Gremillet, David; Lescroel, Amelie; Peron, Clara] CNRS, CEFE, F-34293 Montpellier 5, France; [Gremillet, David] Univ Cape Town, FitzPatrick Inst, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7701 Rondebosch, South Africa; [Jackson, Andrew L.; Kane, Adam] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin 2, Ireland; [Jessopp, Mark J.] Natl Univ Ireland Univ Coll Cork, Coastal & Marine Res Ctr, Cork, Ireland; [Langston, Rowena H. W.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Lescroel, Amelie] Univ Rennes 1, Museum Natl Hist Nat, UMR 7204, F-35042 Rennes, France; [Murray, Stuart] Easter Craigie Dhu, Dunkeld PH8 0EY, Perth, England; [Le Nuz, Melanie] Ligue Protect Oiseaux, Reserve Nat Sept Iles, F-22560 Pleumeur Bodou, France; [Patrick, Samantha C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Wanless, Sarah] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Votier, Stephen C.] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England	University of Leeds; University of Exeter; British Trust for Ornithology; Royal Society for Protection of Birds; University of Liverpool; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; National Research Foundation - South Africa; University of Cape Town; Trinity College Dublin; University College Cork; Royal Society for Protection of Birds; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite de Rennes; University of Plymouth; UK Centre for Ecology & Hydrology (UKCEH); University of Exeter	Wakefield, ED (corresponding author), Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England.	e.d.wakefield@leeds.ac.uk; t.w.bodey@exeter.ac.uk; s.bearhop@exeter.ac.uk; stephen.votier@plymouth.ac.uk; k.c.hamer@leeds.ac.uk	Jessopp, Mark/AAI-4786-2020; PERON, Clara/E-9840-2015; Green, Jonathan A/B-8799-2011; Jackson, Andrew L/D-3441-2009; Votier, Stephen C/G-2348-2014; Bearhop, Stuart/G-3105-2012; Gremillet, David/W-1946-2018; Kane, Adam/H-6449-2013	Jessopp, Mark/0000-0002-2692-3730; PERON, Clara/0000-0002-6529-4578; Green, Jonathan A/0000-0001-8692-0163; Jackson, Andrew L/0000-0001-7334-0434; Votier, Stephen C/0000-0002-0976-0167; Bearhop, Stuart/0000-0002-5864-0129; Gremillet, David/0000-0002-7711-9398; Kane, Adam/0000-0002-2830-5338; Dwyer, Ross/0000-0003-1136-5489; Bodey, Thomas/0000-0002-5334-9615; Colhoun, Kendrew/0000-0003-4451-695X	Natural Environment Research Council [NE/H007466/1]; UK Department of Energy and Climate Change; Centre for Ecology and Hydrology; Centre National de la Recherche Scientifique; Ligue pour la Protection des Oiseaux; Alderney Commission for Renewable Energy; Beaufort Marine Research Award; European Union; Natural Environment Research Council [NE/H007423/1, CEH010021, NE/H007199/1] Funding Source: researchfish; NERC [NE/H007466/1, NE/H007199/1, NE/H007423/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Department of Energy and Climate Change; Centre for Ecology and Hydrology; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ligue pour la Protection des Oiseaux; Alderney Commission for Renewable Energy; Beaufort Marine Research Award; European Union(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the Natural Environment Research Council (Standard Grant NE/H007466/1 to K. C. H., S. B., and S. C. V.), the UK Department of Energy and Climate Change, the Centre for Ecology and Hydrology, the Centre National de la Recherche Scientifique, the Ligue pour la Protection des Oiseaux, the Alderney Commission for Renewable Energy, the Beaufort Marine Research Award, and the European Union INTERREG projects CHARM III and FAME. We acknowledge use of www.seaturtle.org and their analysis tools. Data reported in this paper are tabulated in the supplementary materials and archived by BirdLife International (www.seabirdtracking.org).	Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Baude M, 2011, P ROY SOC B-BIOL SCI, V278, P2806, DOI 10.1098/rspb.2010.2659; Baylis AMM, 2008, MAR ECOL PROG SER, V361, P279, DOI 10.3354/meps07258; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Burger AE, 1997, COLON WATERBIRD, V20, P55, DOI 10.2307/1521764; CAIRNS DK, 1989, AM NAT, V134, P141, DOI 10.1086/284970; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Dechmann DKN, 2009, P ROY SOC B-BIOL SCI, V276, P2721, DOI 10.1098/rspb.2009.0473; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; FURNESS RW, 1984, NATURE, V311, P655, DOI 10.1038/311655a0; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Hamer KC, 2007, MAR ECOL PROG SER, V338, P295, DOI 10.3354/meps338295; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Nelson B., 2001, ATLANTIC GANNET, V2; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; Silverman ED, 2004, MAR ECOL PROG SER, V277, P25, DOI 10.3354/meps277025; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; WANLESS S, 1993, COLON WATERBIRD, V16, P176, DOI 10.2307/1521435; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; Wittenberger J.F., 1985, Avian Biology, V8, P1	27	214	222	11	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					68	70		10.1126/science.1236077	http://dx.doi.org/10.1126/science.1236077			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23744776	Green Accepted			2022-12-28	WOS:000321291700049
J	O'Malley, J; Skylaki, S; Iwabuchi, KA; Chantzoura, E; Ruetz, T; Johnsson, A; Tomlinson, SR; Linnarsson, S; Kaji, K				O'Malley, James; Skylaki, Stavroula; Iwabuchi, Kumiko A.; Chantzoura, Eleni; Ruetz, Tyson; Johnsson, Anna; Tomlinson, Simon R.; Linnarsson, Sten; Kaji, Keisuke			High-resolution analysis with novel cell-surface markers identifies routes to iPS cells	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SOMATIC-CELLS; REPROGRAMMING FACTORS; PLURIPOTENCY; BIOINFORMATICS; TRANSPOSITION; BIOCONDUCTOR; INDUCTION; PIGGYBAC; MURINE	The generation of induced pluripotent stem (iPS) cells presents a challenge to normal developmental processes. The low efficiency and heterogeneity of most methods have hindered understanding of the precise molecular mechanisms promoting, and roadblocks preventing, efficient reprogramming. Although several intermediate populations have been described(1-7), it has proved difficult to characterize the rare, asynchronous transition from these intermediate stages to iPS cells. The rapid expansion of minor reprogrammed cells in the heterogeneous population can also obscure investigation of relevant transition processes. Understanding the biological mechanisms essential for successful iPS cell generation requires both accurate capture of cells undergoing the reprogramming process and identification of the associated global gene expression changes. Here we demonstrate that in mouse embryonic fibroblasts, reprogramming follows an orderly sequence of stage transitions, marked by changes in the cell-surface markers CD44 and ICAM1, and a Nanog-enhanced green fluorescent protein (Nanog-eGFP) reporter. RNA-sequencing analysis of these populations demonstrates two waves of pluripotency gene upregulation, and unexpectedly, transient upregulation of several epidermis-related genes, demonstrating that reprogramming is not simply the reversal of the normal developmental processes. This novel high-resolution analysis enables the construction of a detailed reprogramming route map, and the improved understanding of the reprogramming process will lead to new reprogramming strategies.	[O'Malley, James; Iwabuchi, Kumiko A.; Chantzoura, Eleni; Ruetz, Tyson; Tomlinson, Simon R.; Kaji, Keisuke] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh BioQuarter, Edinburgh EH16 4UU, Midlothian, Scotland; [Skylaki, Stavroula] Helmholtz Ctr Munich, Stem Cell Dynam Res Unit, D-85764 Neuherberg, Germany; [Johnsson, Anna; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, SE-17177 Stockholm, Sweden	University of Edinburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet	Kaji, K (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh BioQuarter, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	keisuke.kaji@ed.ac.uk	Linnarsson, Sten/HCH-3909-2022	Kaji, Keisuke/0000-0001-5946-8415; Ruetz, Tyson/0000-0002-3568-7717	ERC grant ROADTOIPS [261075]; ERC grant BRAINCELL [261063]; Anne Rowling Regenerative Neurology Clinic; MRC PhD Studentship; Darwin Trust of Edinburgh Scholarship; Medical Research Council [G0700711B] Funding Source: researchfish	ERC grant ROADTOIPS; ERC grant BRAINCELL; Anne Rowling Regenerative Neurology Clinic; MRC PhD Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Darwin Trust of Edinburgh Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Nagy and K. Woltjen for providing the 6c iPS cell line, I. Chambers for providing TNG mice, S. Monard and O. Rodrigues for assistance with flow cytometry, and T. Kunath, T. Burdon, S. Lowell and N. Festuccia for discussions and comments on the manuscript. We also thank L. Robertson for technical assistance, and Biomed unit staff for mouse husbandry. This work was supported by ERC grants ROADTOIPS (no. 261075) and BRAINCELL (no. 261063), and the Anne Rowling Regenerative Neurology Clinic. J.O.'M. and T. R. are funded by an MRC PhD Studentship and a Darwin Trust of Edinburgh Scholarship, respectively.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Ligges U., 2003, J STAT SOFTW, V8, P1, DOI [DOI 10.18637/JSS.V008.I11, 10.18637/jss.v008.i11]; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nemajerova A, 2012, CELL DEATH DIFFER, V19, P1268, DOI 10.1038/cdd.2012.45; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu HL, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-173	38	108	108	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					88	+		10.1038/nature12243	http://dx.doi.org/10.1038/nature12243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23728301	Green Accepted			2022-12-28	WOS:000321285600039
J	Hanna, E; Navarro, FJ; Pattyn, F; Domingues, CM; Fettweis, X; Ivins, ER; Nicholls, RJ; Ritz, C; Smith, B; Tulaczyk, S; Whitehouse, PL; Zwally, HJ				Hanna, Edward; Navarro, Francisco J.; Pattyn, Frank; Domingues, Catia M.; Fettweis, Xavier; Ivins, Erik R.; Nicholls, Robert J.; Ritz, Catherine; Smith, Ben; Tulaczyk, Slawek; Whitehouse, Pippa L.; Zwally, H. Jay			Ice-sheet mass balance and climate change	NATURE			English	Review							SEA-LEVEL RISE; RECONCILED ESTIMATE; RADAR ALTIMETRY; GREENLAND; MODEL; GLACIERS; DYNAMICS; ANTARCTICA; VELOCITY; WATER	Since the 2007 Intergovernmental Panel on Climate Change Fourth Assessment Report, new observations of ice-sheet mass balance and improved computer simulations of ice-sheet response to continuing climate change have been published. Whereas Greenland is losing ice mass at an increasing pace, current Antarctic ice loss is likely to be less than some recently published estimates. It remains unclear whether East Antarctica has been gaining or losing ice mass over the past 20 years, and uncertainties in ice-mass change for West Antarctica and the Antarctic Peninsula remain large. We discuss the past six years of progress and examine the key problems that remain.	[Hanna, Edward] Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; [Navarro, Francisco J.] Univ Politecn Madrid, Dept Matemat Aplicada Tecnol Informac, E-28040 Madrid, Spain; [Pattyn, Frank] Univ Libre Bruxelles, Lab Glaciol, B-1050 Brussels, Belgium; [Domingues, Catia M.] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Aspendale, Vic 3195, Australia; [Fettweis, Xavier] Univ Liege, Dept Geog, B-4000 Liege, Belgium; [Ivins, Erik R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Nicholls, Robert J.] Univ Southampton, Fac Engn & Environm, Southampton SO17 1BJ, Hants, England; [Ritz, Catherine] Univ Grenoble 1, CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; [Smith, Ben] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Tulaczyk, Slawek] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Whitehouse, Pippa L.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Zwally, H. Jay] NASA, Goddard Space Flight Ctr, Cryospher Sci Lab, Greenbelt, MD 20771 USA	University of Sheffield; Universidad Politecnica de Madrid; Universite Libre de Bruxelles; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; University of Liege; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Southampton; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; Durham University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Hanna, E (corresponding author), Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England.	ehanna@sheffield.ac.uk	Pattyn, Frank/AAA-9640-2019; Domingues, Catia M./A-2901-2015; Nicholls, Robert James/ABD-1481-2020; Hanna, Edward/H-2219-2016; Tulaczyk, Slawek/O-7375-2018; Navarro, Francisco/L-2941-2014; Nicholls, Robert James/G-3898-2010; Hanna, Edward/W-5927-2019	Pattyn, Frank/0000-0003-4805-5636; Domingues, Catia M./0000-0001-5100-4595; Nicholls, Robert James/0000-0002-9715-1109; Hanna, Edward/0000-0002-8683-182X; Tulaczyk, Slawek/0000-0002-9711-4332; Navarro, Francisco/0000-0002-5147-0067; Nicholls, Robert James/0000-0002-9715-1109; Hanna, Edward/0000-0002-8683-182X; Whitehouse, Pippa/0000-0002-9092-3444; Fettweis, Xavier/0000-0002-4140-3813; Ritz, Catherine/0000-0003-0785-8571	International Council for Science (ICSU); SCAR; IASC; WCRP; International Glaciological Society (IGS); International Association of Cryospheric Sciences (IACS); Climate and Cryosphere (CliC); Association of Polar Early Career Scientists (APECS); Office of Polar Programs (OPP) [0838947, 0839142] Funding Source: National Science Foundation	International Council for Science (ICSU); SCAR; IASC; WCRP; International Glaciological Society (IGS); International Association of Cryospheric Sciences (IACS); Climate and Cryosphere (CliC); Association of Polar Early Career Scientists (APECS); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The work presented here is based on the Ice-Sheet Mass Balance and Sea Level (ISMASS) workshop that was held in Portland, Oregon, USA, on 14 July 2012. This workshop was jointly organized by the Scientific Committee on Antarctic Research (SCAR), the International Arctic Science Committee (IASC) and the Word Climate Research Programme (WCRP), and was co-sponsored by the International Council for Science (ICSU), SCAR, IASC, WCRP, the International Glaciological Society (IGS) and the International Association of Cryospheric Sciences (IACS), with support from Climate and Cryosphere (CliC) and the Association of Polar Early Career Scientists (APECS).	Amundson JM, 2010, J GLACIOL, V56, P822, DOI 10.3189/002214310794457173; Arendt A., 2012, RANDOLPH GLACIER INV; Arneborg L, 2012, NAT GEOSCI, V5, P876, DOI [10.1038/ngeo1644, 10.1038/NGEO1644]; Arthern RJ, 2010, J GLACIOL, V56, P527, DOI 10.3189/002214310792447699; Bartholomew I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002220; Bassis JN, 2011, J GLACIOL, V57, P3, DOI 10.3189/002214311795306745; Bengtsson L, 2011, SURV GEOPHYS, V32, P459, DOI 10.1007/s10712-011-9120-8; Benn DI, 2007, EARTH-SCI REV, V82, P143, DOI 10.1016/j.earscirev.2007.02.002; Bindschadler RA, 2013, J GLACIOL, V59, P195, DOI 10.3189/2013JoG12J125; BLATTER H, 1995, J GLACIOL, V41, P333, DOI 10.3189/S002214300001621X; Bueler E, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001179; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Cogley J. G., 2012, FUTURE WORLDS CLIMAT, P197; Cogley JG, 2009, ANN GLACIOL, V50, P96, DOI 10.3189/172756409787769744; Cornford SL, 2013, J COMPUT PHYS, V232, P529, DOI 10.1016/j.jcp.2012.08.037; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; Dietrich R, 2010, EARTH PLANET SC LETT, V289, P22, DOI 10.1016/j.epsl.2009.10.021; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; Dyurgerov M. B., 2010, MAT GLYATSIOLOGICHES, V108, P5; Ettema J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038110; Ewert H, 2012, J GEODYN, V59-60, P111, DOI 10.1016/j.jog.2011.06.003; FARRELL WE, 1976, GEOPHYS J ROY ASTR S, V46, P647, DOI 10.1111/j.1365-246X.1976.tb01252.x; Fettweis X, 2013, CRYOSPHERE, V7, P469, DOI 10.5194/tc-7-469-2013; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Gillet-Chaulet F, 2012, CRYOSPHERE, V6, P1561, DOI 10.5194/tc-6-1561-2012; Goelzer H, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045401; Goelzer H., J GLACIOL IN PRESS; Gogineni P., 2012, CRESIS DATA PRODUCTS; Gomez N, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002128; Gomez N, 2010, NAT GEOSCI, V3, P850, DOI 10.1038/NGEO1012; Gouretski V, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027834; GREISCHAR LL, 1980, NATURE, V283, P651, DOI 10.1038/283651a0; Gudmundsson GH, 2012, CRYOSPHERE, V6, P1497, DOI 10.5194/tc-6-1497-2012; Harig C, 2012, P NATL ACAD SCI USA, V109, P19934, DOI 10.1073/pnas.1206785109; Harper J, 2012, NATURE, V491, P240, DOI 10.1038/nature11566; Hindmarsh RCA, 2012, J GLACIOL, V58, P375, DOI 10.3189/2012JoG11J206; Hock R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037020; Horwath M, 2012, GEOPHYS J INT, V189, P863, DOI 10.1111/j.1365-246X.2012.05401.x; Ivins E. R., J GEOPHYS R IN PRESS; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Joughin I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044819; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Kendall RA, 2005, GEOPHYS J INT, V161, P679, DOI 10.1111/j.1365-246X.2005.02553.x; King MA, 2012, NATURE, V491, P586, DOI 10.1038/nature11621; Konikow LF, 2013, NAT GEOSCI, V6, P2, DOI 10.1038/ngeo1659; Larour E, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002140; Lenaerts JTM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050713; Leuliette EW, 2011, OCEANOGRAPHY, V24, P122, DOI 10.5670/oceanog.2011.32; Levermann A, 2012, CRYOSPHERE, V6, P273, DOI 10.5194/tc-6-273-2012; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Little C., NATURE CLIM CHANGE; MacAyeal DR, 2003, J GLACIOL, V49, P22, DOI 10.3189/172756503781830863; Meehl GA, 2012, NAT CLIM CHANGE, V2, P576, DOI 10.1038/NCLIMATE1529; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Morelli A, 2004, GLOBAL PLANET CHANGE, V42, P155, DOI 10.1016/j.gloplacha.2003.12.005; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nghiem SV, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053611; Nicholls RJ, 2011, PHILOS T R SOC A, V369, P161, DOI [10.1098/rsta.2010.0291, 10.1098/rsta.2010.029]; Nick FM, 2013, NATURE, V497, P235, DOI 10.1038/nature12068; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Pattyn F, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000394; Pattyn F., J GLACIOL IN PRESS; Pokhrel YN, 2012, NAT GEOSCI, V5, P389, DOI [10.1038/ngeo1476, 10.1038/NGEO1476]; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Price SF, 2011, P NATL ACAD SCI USA, V108, P8978, DOI 10.1073/pnas.1017313108; Purkey SG, 2010, J CLIMATE, V23, P6336, DOI 10.1175/2010JCLI3682.1; Remy F, 2012, ADV SPACE RES, V50, P998, DOI 10.1016/j.asr.2012.04.003; Rignot E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021947; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Ritz C, 2001, J GEOPHYS RES-ATMOS, V106, P31943, DOI 10.1029/2001JD900232; Roemmich D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047992; Sasgen I., 2012, CRYOSPHERE DISCUSS, V6, P3703, DOI DOI 10.5194/TDC-6-3703-2012; Sasgen I, 2012, EARTH PLANET SC LETT, V333, P293, DOI 10.1016/j.epsl.2012.03.033; Sato T, 2011, TECTONOPHYSICS, V511, P79, DOI 10.1016/j.tecto.2010.05.009; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Schoof C, 2010, NATURE, V468, P803, DOI 10.1038/nature09618; Screen J. A., 2011, GEOPHYS RES LETT, V39; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Simpson MJR, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007776; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sundal AV, 2011, NATURE, V469, P522, DOI 10.1038/nature09740; Tarasov L, 2012, EARTH PLANET SC LETT, V315, P30, DOI 10.1016/j.epsl.2011.09.010; Thomas ID, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049277; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; von Schuckmann K., 2011, OCEAN SCI DISCUSS, V8, P999, DOI DOI 10.5194/OSD-8-999-2011; Wada Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051230; Wahr J, 2000, J GEOPHYS RES-SOL EA, V105, P16279, DOI 10.1029/2000JB900113; Whitehouse PL, 2012, GEOPHYS J INT, V190, P1464, DOI 10.1111/j.1365-246X.2012.05557.x; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016; Winkelmann R, 2012, NATURE, V492, P239, DOI 10.1038/nature11616; Yoshimori M, 2012, J CLIMATE, V25, P1157, DOI 10.1175/2011JCLI4011.1; Zwally H. J., 2012, ISMASS 2012 WORKSH; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007; Zwally HJ, 2011, SURV GEOPHYS, V32, P351, DOI 10.1007/s10712-011-9123-5; Zwally HJ, 2011, J GLACIOL, V57, P88, DOI 10.3189/002214311795306682	100	202	206	7	357	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					51	59		10.1038/nature12238	http://dx.doi.org/10.1038/nature12238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23739423	Green Accepted			2022-12-28	WOS:000319947800031
J	Anderson, DR; Dunbar, MJ; Bohm, ER; Belzile, E; Kahn, SR; Zukor, D; Fisher, W; Gofton, W; Gross, P; Pelet, S; Crowther, M; MacDonald, S; Kim, P; Pleasance, S; Davis, N; Andreou, P; Wells, P; Kovacs, M; Rodger, MA; Ramsay, T; Carrier, M; Vendittoli, PA				Anderson, David R.; Dunbar, Michael J.; Bohm, Eric R.; Belzile, Etienne; Kahn, Susan R.; Zukor, David; Fisher, William; Gofton, Wade; Gross, Peter; Pelet, Stephane; Crowther, Mark; MacDonald, Steven; Kim, Paul; Pleasance, Susan; Davis, Nicki; Andreou, Pantelis; Wells, Philip; Kovacs, Michael; Rodger, Marc A.; Ramsay, Tim; Carrier, Marc; Vendittoli, Pascal-Andre			Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY-EMBOLISM; KNEE ARTHROPLASTY; DOUBLE-BLIND; PROLONGED THROMBOPROPHYLAXIS; REPLACEMENT SURGERY; PREVENTION; ENOXAPARIN; THROMBOSIS; METAANALYSIS; DALTEPARIN	Background: The role of aspirin in thromboprophylaxis after total hip arthroplasty (THA) is controversial. Objective: To compare extended prophylaxis with aspirin and dalteparin for prevention of symptomatic venous thromboembolism (VTE) after THA. Design: Multicenter randomized, controlled trial with a noninferiority design based on a minimal clinically important difference of 2.0%. Randomization was electronically generated; patients were assigned to a treatment group through a Web-based program. Patients, physicians, study coordinators, health care team members, outcome adjudicators, and data analysts were blinded to interventions. (Current Controlled Trials: ISRCTN11902170) Setting: 12 tertiary care orthopedic referral centers in Canada. Patients: 778 patients who had elective unilateral THA between 2007 and 2010. Intervention: After an initial 10 days of dalteparin prophylaxis after elective THA, patients were randomly assigned to 28 days of dalteparin (n = 400) or aspirin (n = 386). Measurements: Symptomatic VTE confirmed by objective testing (primary efficacy outcome) and bleeding. Results: Five of 398 patients (1.3%) randomly assigned to dalte-parin and 1 of 380 (0.3%) randomly assigned to aspirin had VTE (absolute difference, 1.0 percentage point [95% CI, -0.5 to 2.5 percentage points]). Aspirin was noninferior (P < 0.001) but not superior (P = 0.22) to dalteparin. Clinically significant bleeding occurred in 5 patients (1.3%) receiving dalteparin and 2 (0.5%) receiving aspirin. The absolute between-group difference in a composite of all VTE and clinically significant bleeding events was 1.7 percentage points (CI, -0.3 to 3.8 percentage points; P = 0.091) in favor of aspirin. Limitation: The study was halted prematurely because of difficulty with patient recruitment. Conclusion: Extended prophylaxis for 28 days with aspirin was noninferior to and as safe as dalteparin for the prevention of VTE after THA in patients who initially received dalteparin for 10 days. Given its low cost and greater convenience, aspirin may be considered a reasonable alternative for extended thromboprophylaxis after THA.	Dalhousie Univ, Halifax, NS, Canada; Univ Manitoba, Winnipeg, MB, Canada; Univ Laval, Quebec City, PQ, Canada; McGill Univ, Montreal, PQ, Canada; Univ Montreal, Montreal, PQ, Canada; Univ Ottawa, Ottawa, ON, Canada; McMaster Univ, Hamilton, ON, Canada; Univ Western Ontario, London, ON, Canada	Dalhousie University; University of Manitoba; Laval University; McGill University; Universite de Montreal; University of Ottawa; McMaster University; Western University (University of Western Ontario)	Anderson, DR (corresponding author), Capital Hlth, Dept Med, 1276 South Pk St,Room 442,Bethune Bldg,VG Site, Halifax, NS B3H 2Y9, Canada.	david.anderson@cdha.nshealth.ca	Vendittoli, Pascal-Andre/J-9621-2013; MacDonald, Steven J/B-6173-2015; Kovacs, Michael/G-3315-2011; Kim, Paul/GYV-3258-2022	Vendittoli, Pascal-Andre/0000-0003-4652-6238; Kim, Paul/0000-0003-0943-4924; Crowther, Mark/0000-0003-4986-4873; Anderson, David/0000-0003-0845-1722; Rodger, Marc/0000-0001-8166-3487; Ramsay, Tim/0000-0001-8478-8170; Dunbar, MD FRCSC PhD FCAHS, Michael/0000-0003-3629-498X	Canadian Institutes for Health Research [MCT-82948]; Pfizer Pharmaceuticals Canada; Fonds de la Recherche en Sante du Quebec	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer Pharmaceuticals Canada; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	By grant MCT-82948 from the Canadian Institutes for Health Research and by Pfizer Pharmaceuticals Canada. In-kind support was provided by Bayer HealthCare. Dr. Kahn is a recipient of a National Research Scholar Award from the Fonds de la Recherche en Sante du Quebec.	Anderson FA, 2003, CHEST, V124, p349S, DOI 10.1378/chest.124.6_suppl.349S; [Anonymous], 2000, LANCET, V355, P1295; Bergqvist D, 1996, NEW ENGL J MED, V335, P696, DOI 10.1056/NEJM199609053351002; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Comp PC, 2001, J BONE JOINT SURG AM, V83A, P336, DOI 10.2106/00004623-200103000-00004; Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Fraser JD, 2004, RADIOL CLIN N AM, V42, P279, DOI 10.1016/j.rcl.2004.01.001; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldhaber SZ, 2004, LANCET, V363, P1295, DOI 10.1016/S0140-6736(04)16004-2; HIRSH J, 2001, ACP J CLUB, V134, P13; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Hull RD, 2001, ANN INTERN MED, V135, P858, DOI 10.7326/0003-4819-135-10-200111200-00006; Hull RD, 2000, ARCH INTERN MED, V160, P2208, DOI 10.1001/archinte.160.14.2208; Jameson SS, 2011, J BONE JOINT SURG BR, V93B, P1465, DOI 10.1302/0301-620X.93B11.27622; Johanson NA, 2009, J BONE JOINT SURG AM, V91A, P1756, DOI 10.2106/JBJS.I.00511; Lassen MR, 1998, THROMB RES, V89, P281, DOI 10.1016/S0049-3848(98)00018-8; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; O'Donnell M, 2003, ARCH INTERN MED, V163, P1362, DOI 10.1001/archinte.163.11.1362; Planes A, 1996, LANCET, V348, P224, DOI 10.1016/S0140-6736(96)01453-5; Rahme E, 2008, CAN MED ASSOC J, V178, P1545, DOI 10.1503/cmaj.071388; Skedgel C, 2007, J BONE JOINT SURG AM, V89A, P819, DOI 10.2106/JBJS.F.00092; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525; Wolowacz SE, 2009, THROMB HAEMOSTASIS, V101, P77, DOI 10.1160/TH08-07-0493; World Health Organization, 1978, WHO OFFS PUBL, V43; 1994, BMJ, V308, P235	28	133	138	1	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					800	+		10.7326/0003-4819-158-11-201306040-00004	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23732713				2022-12-28	WOS:000320379800003
J	Jerolmack, DJ				Jerolmack, Douglas J.			Pebbles on Mars	SCIENCE			English	Editorial Material							CRATER; FLOW		Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Jerolmack, DJ (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	sediment@sas.upenn.edu						Carr MH, 2012, PHILOS T R SOC A, V370, P2193, DOI 10.1098/rsta.2011.0500; Grant GE, 1997, WATER RESOUR RES, V33, P349, DOI 10.1029/96WR03134; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; Hand E, 2012, NATURE, V484, P153, DOI 10.1038/484153a; Jerolmack D., GEOPHYS RES LETT, V31; Kite ES, 2013, GEOLOGY, V41, P543, DOI 10.1130/G33909.1; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; Mangold N, 2012, ICARUS, V220, P530, DOI 10.1016/j.icarus.2012.05.026; Moore JM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002352; Moore JM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL019002; Paola C., 1992, BASIN RES, V4, P73, DOI [10.1111/j.1365-2117.1992.tb00145.x, DOI 10.1111/J.1365-2117.1992.TB00145.X]; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Stock JD, 2008, GEOL SOC AM BULL, V120, P619, DOI 10.1130/B26208.1; Williams RME, 2013, SCIENCE, V340, P1068, DOI 10.1126/science.1237317; Wordsworth R, 2013, ICARUS, V222, P1, DOI 10.1016/j.icarus.2012.09.036	15	8	8	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1055	1056		10.1126/science.1239343	http://dx.doi.org/10.1126/science.1239343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723224				2022-12-28	WOS:000319664500029
J	De, N; Le, TH				Nguyen De; Thanh Hoa Le			Multiple Palpable Cysts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nguyen De] Hanoi Med Univ, Hanoi, Vietnam; [Thanh Hoa Le] Inst Biotechnol, Hanoi, Vietnam	Hanoi Medical University; Vietnam Academy of Science & Technology (VAST)	De, N (corresponding author), Hanoi Med Univ, Hanoi, Vietnam.		Le, Thanh/GRY-4094-2022	LE, THANH HOA/0000-0003-3841-368X					0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2125	2125		10.1056/NEJMicm1205125	http://dx.doi.org/10.1056/NEJMicm1205125			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23718167				2022-12-28	WOS:000319574200010
J	Aylin, P; Alexandrescu, R; Jen, MH; Mayer, EK; Bottle, A				Aylin, P.; Alexandrescu, R.; Jen, M. H.; Mayer, E. K.; Bottle, A.			Day of week of procedure and 30 day mortality for elective surgery: retrospective analysis of hospital episode statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE UNITS; ADMISSION; OUTCOMES; TIME; ICU	Objectives To assess the association between mortality and the day of elective surgical procedure. Design Retrospective analysis of national hospital administrative data. Setting All acute and specialist English hospitals carrying out elective surgery over three financial years, from 2008-09 to 2010-11. Participants Patients undergoing elective surgery in English public hospitals. Main outcome measure Death in or out of hospital within 30 days of the procedure. Results There were 27 582 deaths within 30 days after 4 133 346 inpatient admissions for elective operating room procedures (overall crude mortality rate 6.7 per 1000). The number of weekday and weekend procedures decreased over the three years (by 4.5% and 26.8%, respectively). The adjusted odds of death were 44% and 82% higher, respectively, if the procedures were carried out on Friday (odds ratio 1.44, 95% confidence interval 1.39 to 1.50) or a weekend (1.82, 1.71 to 1.94) compared with Monday. Conclusions The study suggests a higher risk of death for patients who have elective surgical procedures carried out later in the working week and at the weekend.	[Aylin, P.; Alexandrescu, R.; Jen, M. H.; Bottle, A.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Dr Foster Unit, London W6 8RP, England; [Mayer, E. K.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, London W2 1NY, England	Imperial College London; Imperial College London	Aylin, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Dr Foster Unit, London W6 8RP, England.	p.aylin@imperial.ac.uk	Mayer, Erik K/A-6207-2013; Aylin, Paul/A-1073-2014; Jen, Min-Hua/AAP-4200-2021	Mayer, Erik K/0000-0002-5509-4580; Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743	Dr Foster Intelligence (an independent health service research organisation); National Institute of Health Research; NIHR Biomedical Research Centre; National Institute for Health Research [CL-2008-21-502] Funding Source: researchfish	Dr Foster Intelligence (an independent health service research organisation); National Institute of Health Research(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Dr Foster Unit at Imperial College London is funded by a research grant from Dr Foster Intelligence (an independent health service research organisation). The Dr Foster Unit at Imperial is affiliated with the Imperial Centre for Patient Safety and Service Quality at Imperial College Healthcare NHS Trust, which is funded by the National Institute of Health Research. We are grateful for support from the NIHR Biomedical Research Centre funding scheme.	Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; Barnett MJ, 2002, MED CARE, V40, P530, DOI 10.1097/00005650-200206000-00010; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bhonagiri D, 2011, MED J AUSTRALIA, V194, P287, DOI 10.5694/j.1326-5377.2011.tb02976.x; Bottle A, 2009, QUAL SAF HEALTH CARE, V18, P303, DOI 10.1136/qshc.2007.026096; Bottle A, 2008, HEALTH SERV RES, V43, P10, DOI 10.1111/j.1475-6773.2007.00742.x; Bottle A, 2011, J CLIN EPIDEMIOL, V64, P1426, DOI 10.1016/j.jclinepi.2011.04.004; Cavaliere F, 2008, MINERVA ANESTESIOL, V74, P459; Cram P, 2004, AM J MED, V117, P151, DOI 10.1016/j.amjmed.2004.02.035; Fonarow GC, 2008, CIRC-HEART FAIL, V1, P50, DOI 10.1161/CIRCHEARTFAILURE.107.748376; Grant S, 2012, BMJ-BRIT MED J, V334, pe67; Gridlink, 2011, GRIDL; Hospital Episode Statistics online, LINK ONS HES MORT DA; Kuijsten HAJM, 2010, INTENS CARE MED, V36, P1765, DOI 10.1007/s00134-010-1918-1; Luyt CE, 2007, CRIT CARE MED, V35, P3, DOI 10.1097/01.CCM.0000249832.36518.11; Meynaar IA, 2009, CRIT CARE, V13, DOI 10.1186/cc7904; Mohammed MA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-87; National Confidential Enquiry into Patient Outcome and Death, 2003, EL SURG NHS 2003; National Confidential Enquiry into Patient Outcomes and Death, 2011, KNOW RISK REV PER OP; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; World Health Organization, 2008, BETT KNOWL SAF CAR; Wunsch H, 2004, INTENS CARE MED, V30, P895, DOI 10.1007/s00134-004-2170-3; Zare MM, 2007, ANN SURG, V246, P866, DOI 10.1097/SLA.0b013e3180cc2e60	23	185	186	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2013	346								f2424	10.1136/bmj.f2424	http://dx.doi.org/10.1136/bmj.f2424			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158CZ	23716356	Green Published, hybrid			2022-12-28	WOS:000319947500001
J	Lagha, M; Bothma, JP; Esposito, E; Ng, S; Stefanik, L; Tsui, C; Johnston, J; Chen, K; Gilmour, DS; Zeitlinger, J; Levine, MS				Lagha, Mounia; Bothma, Jacques P.; Esposito, Emilia; Ng, Samuel; Stefanik, Laura; Tsui, Chiahao; Johnston, Jeffrey; Chen, Kai; Gilmour, David S.; Zeitlinger, Julia; Levine, Michael S.			Paused Pol II Coordinates Tissue Morphogenesis in the Drosophila Embryo	CELL			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; SPATIAL RANGE; GAGA FACTOR; IN-VIVO; GASTRULATION; SNAIL; DYNAMICS; ELONGATION; ACTIVATION	Paused RNA polymerase (Pol II) is a pervasive feature of Drosophila embryos and mammalian stem cells, but its role in development is uncertain. Here, we demonstrate that a spectrum of paused Pol II determines the "time to synchrony''-the time required to achieve coordinated gene expression across the cells of a tissue. To determine whether synchronous patterns of gene activation are significant in development, we manipulated the timing of snail expression, which controls the coordinated invagination of similar to 1,000 mesoderm cells during gastrulation. Replacement of the strongly paused snail promoter with moderately paused or nonpaused promoters causes stochastic activation of snail expression and increased variability of mesoderm invagination. Computational modeling of the dorsal-ventral patterning network recapitulates these variable and bistable gastrulation profiles and emphasizes the importance of timing of gene activation in development. We conclude that paused Pol II and transcriptional synchrony are essential for coordinating cell behavior during morphogenesis.	[Lagha, Mounia; Esposito, Emilia; Ng, Samuel; Tsui, Chiahao; Levine, Michael S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bothma, Jacques P.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Stefanik, Laura; Gilmour, David S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA; [Johnston, Jeffrey; Chen, Kai; Zeitlinger, Julia] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stowers Institute for Medical Research	Levine, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu	Lagha, Mounia/T-7351-2018	Lagha, Mounia/0000-0002-7082-1950; Johnston, Jeff/0000-0002-8962-6186; ESPOSITO, EMILIA/0000-0003-3664-8063; Levine, Michael/0000-0001-7629-0081	Human Frontier fellowship; NIH [GM46638, GM47477]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047477, R01GM046638, R37GM046638] Funding Source: NIH RePORTER	Human Frontier fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Alistair Boettiger for sharing his ideas about Snail autoregulation. We also thank Mike Perry and Valerie Hilgers for their insightful discussions, Didier Rocancourt for help with artwork, and Lily Mirels and Eileen Wagner for comments on the manuscript. M.L. is the recipient of a Human Frontier fellowship. This work was funded by grants from the NIH, GM46638 to M.S.L. and GM47477 to D.S.G. M.L. and J.P.B. initiated efforts to create a stochastic pattern of snail activation. They also worked closely to determine activation profiles of both endogenous genes and transgenes containing minimal promoter sequences. J.P.B. conceived the use of esg as a means for identifying sna<SUP>-</SUP>/sna<SUP>-</SUP> mutant embryos. M.L. worked with L.S. and D.S.G. to document the sufficiency of minimal promoter sequences in establishing paused RNA polymerase II via permanganate protection assays. She also worked with E.E., K.C., J.J., and J.Z. to document the spectrum of Pol II binding at different promoters via whole-genome ChIP-seq assays. J.P.B. performed the imaging and developed the segmentation algorithms needed to determine t50 activation profiles. He also performed imaging to count mRNAs and analyzed the models exploring the relationship between timing and levels of gene expression. J.P.B. modeled the dynamics of Snail protein expression. M.L. and E.E. designed and created minigenes and BAC transgenes. M.L. performed the genetic crosses. C.T. injected all the plasmid transgenes, and BestGene injected all the BAC transgenes. S.N. helped M.L. and J.P.B. to collect and stain embryos. M.L., J.P.B., and M.S.L wrote the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Boettiger AN, 2013, CELL REP, V3, P8, DOI 10.1016/j.celrep.2012.12.015; Bothma JP, 2011, CURR BIOL, V21, P1571, DOI 10.1016/j.cub.2011.08.019; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Dunipace L, 2011, DEVELOPMENT, V138, P4075, DOI 10.1242/dev.069146; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fay A, 2011, CURR BIOL, V21, P1624, DOI 10.1016/j.cub.2011.08.036; Gaertner B, 2012, CELL REP, V2, P1670, DOI 10.1016/j.celrep.2012.11.024; Gilchrist DA, 2012, GENE DEV, V26, P933, DOI 10.1101/gad.187781.112; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Guenther MG, 2012, CELL STEM CELL, V10, P484, DOI 10.1016/j.stem.2012.04.016; Hemavathy K, 1997, DEVELOPMENT, V124, P3683; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kanodia JS, 2011, DEVELOPMENT, V138, P4867, DOI 10.1242/dev.071571; Kanodia JS, 2009, P NATL ACAD SCI USA, V106, P21707, DOI 10.1073/pnas.0912395106; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Morachis JM, 2010, GENE DEV, V24, P135, DOI 10.1101/gad.1856710; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Reeves GT, 2012, DEV CELL, V22, P544, DOI 10.1016/j.devcel.2011.12.007; Rushlow CA, 2012, CURR OPIN GENET DEV, V22, P542, DOI 10.1016/j.gde.2012.08.005; Saga Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008201; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; SWEETON D, 1991, DEVELOPMENT, V112, P775; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	46	120	121	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					976	987		10.1016/j.cell.2013.04.045	http://dx.doi.org/10.1016/j.cell.2013.04.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706736	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000319456800007
J	Fekete, T				Fekete, Thomas			Review: Probiotics reduce Clostridium difficile-associated diarrhea in patients receiving antibiotics	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.		Fekete, Thomas/AFI-5367-2022					van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	1	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC10	10.7326/0003-4819-158-10-201305210-02010	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689777				2022-12-28	WOS:000319666200009
J	Whitty, CJM; Chiodini, PL; Lalloo, DG				Whitty, Christopher J. M.; Chiodini, Peter L.; Lalloo, David G.			Investigation and treatment of imported malaria in non-endemic countries	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PLASMODIUM-FALCIPARUM-MALARIA; AFRICAN CHILDREN; VIVAX MALARIA; RANDOMIZED-TRIAL; KENYAN CHILDREN; UNITED-KINGDOM; PRIMAQUINE; PREGNANCY; AREA; SURVEILLANCE		[Whitty, Christopher J. M.; Chiodini, Peter L.] Hosp Trop Dis, London WC1E 6JB, England; [Whitty, Christopher J. M.; Chiodini, Peter L.] London Sch Hyg & Trop Med, PHE Malaria Reference Lab, London WC1, England; [Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool	Whitty, CJM (corresponding author), Hosp Trop Dis, London WC1E 6JB, England.	christopher.whitty@lshtm.ac.uk		Chiodini, Peter/0000-0003-0317-7090; Lalloo, David/0000-0001-7680-2200; Whitty, Christopher/0000-0002-6076-5027	UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme	UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme	PLC is supported by the UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme.	Al-Taiar A, 2006, BMJ-BRIT MED J, V333, P827, DOI 10.1136/bmj.38959.368819.BE; Ali AA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-88; [Anonymous], 2011, COCHRANE DATABASE SY; Baird JK, 2011, ANTIMICROB AGENTS CH, V55, P1827, DOI 10.1128/AAC.01296-10; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Birbeck GL, 2010, LANCET NEUROL, V9, P1173, DOI 10.1016/S1474-4422(10)70270-2; Bottieau E, 2006, AM J TROP MED HYG, V75, P133, DOI 10.4269/ajtmh.2006.75.133; Bunn A, 2004, QJM-INT J MED, V97, P645, DOI 10.1093/qjmed/hch113; Centers for Disease Control and Prevention, MALARIA; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Checkley AM, 2012, BMJ-BRIT MED J, V27, P344; CLYDE DF, 1981, B WORLD HEALTH ORGAN, V59, P391; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Faiz MA, 2005, LANCET, V366, P717; Fernando D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-351; Fhogartaigh CN, 2008, QJM-INT J MED, V101, P649, DOI 10.1093/qjmed/hcn072; Griffith KS, 2007, JAMA-J AM MED ASSOC, V297, P2264, DOI 10.1001/jama.297.20.2264; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Kamya MR, 2012, FUTURE VIROL, V7, P699, DOI 10.2217/FVL.12.59; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kyriacou DN, 1996, ANN EMERG MED, V27, P696, DOI 10.1016/S0196-0644(96)70186-5; Ladhani S, 2010, PEDIATR INFECT DIS J, V29, P434, DOI 10.1097/INF.0b013e3181c4d97c; Leslie T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000283; Lubell Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017439; Mai NTH, 1996, LANCET, V348, P917, DOI 10.1016/S0140-6736(96)01409-2; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mali Sonja, 2012, Morbidity and Mortality Weekly Report, V61, P1; Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141; Marks ME, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-118; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; Naing C, 2010, T ROY SOC TROP MED H, V104, P695, DOI 10.1016/j.trstmh.2010.08.009; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Odolini S, 2012, CLIN MICROBIOL INFEC, V18, P468, DOI 10.1111/j.1469-0691.2011.03596.x; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Public Health England, 2011, MAL 2011; Public Health England, MAL REF LAB MAL RL; Robinson T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023204; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Seringe E, 2011, EMERG INFECT DIS, V17, P807, DOI 10.3201/eid1705.101527; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120; Sutherland CJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-240; Whitty CJM, 2005, BJOG-INT J OBSTET GY, V112, P1189, DOI 10.1111/j.1471-0528.2005.00714.x; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2012, MAN SEV MAL PRACT HD, V3	49	14	14	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f2900	10.1136/bmj.f2900	http://dx.doi.org/10.1136/bmj.f2900			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AK	23693055	Green Accepted			2022-12-28	WOS:000319573300004
J	Carretero-Genevrier, A; Gich, M; Picas, L; Gazquez, J; Drisko, GL; Boissiere, C; Grosso, D; Rodriguez-Carvajal, J; Sanchez, C				Carretero-Genevrier, A.; Gich, M.; Picas, L.; Gazquez, J.; Drisko, G. L.; Boissiere, C.; Grosso, D.; Rodriguez-Carvajal, J.; Sanchez, C.			Soft-Chemistry-Based Routes to Epitaxial alpha-Quartz Thin Films with Tunable Textures	SCIENCE			English	Article							GROWTH; CRYSTALLIZATION; CRISTOBALITE; MICROBALANCE; RESONATOR; MASS	Piezoelectric nanostructured quartz films of high resonance frequencies are needed for microelectronic devices; however, synthesis methods have been frustrated by the inhomogeneous crystal growth, crystal twinning, and loss of nanofeatures upon crystallization. We report the epitaxial growth of nanostructured polycrystalline quartz films on silicon [Si(100)] substrates via the solution deposition and gelation of amorphous silica thin films, followed by thermal treatment. Key to the process is the combined use of either a strontium (Sr2+) or barium (Ba2+) catalyst with an amphiphilic molecular template. The silica nanostructure constructed by cooperative self-assembly permits homogeneous distribution of the cations, which are responsible for the crystallization of quartz. The low mismatch between the silicon and a-quartz cell parameters selects this particular polymorph, inducing epitaxial growth.	[Carretero-Genevrier, A.; Drisko, G. L.; Boissiere, C.; Grosso, D.; Sanchez, C.] UMR UPMC Coll France CNRS 7574, Coll France, Lab Chim Mat Condensee, F-75231 Paris, France; [Gich, M.; Gazquez, J.] CSIC, Inst Ciencia Mat Barcelona ICMAB, Bellaterra 08193, Catalonia, Spain; [Picas, L.] INSERM, U1006, F-13009 Marseille, France; [Rodriguez-Carvajal, J.] Inst Laue Langevin, F-38042 Grenoble 9, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Chimie ParisTech; College de France; Centre National de la Recherche Scientifique (CNRS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut Laue-Langevin (ILL)	Sanchez, C (corresponding author), UMR UPMC Coll France CNRS 7574, Coll France, Lab Chim Mat Condensee, 11 Pl Marcelin Berthelot, F-75231 Paris, France.	clement.sanchez@college-de-france.fr	CARRETERO-GENEVRIER, Adrien/R-1420-2017; Grosso, David/K-9500-2015; SANCHEZ, CLEMENT/B-7097-2014; Gazquez, Jaume/C-5334-2012; Rodriguez-Carvajal, Juan/C-4362-2008; Gich, Martí/H-7179-2012; Picas, Laura/Q-9413-2017	CARRETERO-GENEVRIER, Adrien/0000-0003-0488-9452; Gazquez, Jaume/0000-0002-2561-328X; Rodriguez-Carvajal, Juan/0000-0001-5582-2632; Gich, Martí/0000-0001-9958-0057; Sanchez, Clement/0000-0002-6426-4844; Picas, Laura/0000-0002-5619-5228	COMPHOSOL2 (Fond Unique Interministeriel dans le cadre du 9eme AAP); IMPC; College de France Fondation; Beatriu de Pinos; Foundation Pierre-Gilles de Gennes; Marie Curie Reintegration [PCIG09-GA-2011-294168]; Spanish Government [MAT2012-35324, CONSOLIDER-Nanoselect-CSD2007-00041, RyC-2009-04335]; Spanish Government (JAE-CSIC); Oak Ridge National Laboratory; Scientific User Facility Division, Office of Basic Energy Sciences, U.S. Department of Energy	COMPHOSOL2 (Fond Unique Interministeriel dans le cadre du 9eme AAP); IMPC; College de France Fondation; Beatriu de Pinos; Foundation Pierre-Gilles de Gennes; Marie Curie Reintegration(European Commission); Spanish Government(Spanish GovernmentEuropean Commission); Spanish Government (JAE-CSIC); Oak Ridge National Laboratory(United States Department of Energy (DOE)); Scientific User Facility Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	A.C.-G. acknowledges the financial support from COMPHOSOL2 (Fond Unique Interministeriel dans le cadre du 9eme AAP) and IMPC for use of FEG-SEM facilities. A.C.-G. and G. L. D. acknowledge the College de France Fondation for material and partial financial support. This study was made possible by grants from Beatriu de Pinos and Foundation Pierre-Gilles de Gennes to L. P. and from Marie Curie Reintegration (PCIG09-GA-2011-294168) to M. G. We thank S. Scheuring, D. Montero, and M. Selmane for technical support. The HRTEM microscopy work was conducted in Laboratorio de Microscopias Avanzadas at the Instituto de Nanociencia de Aragon-Universidad de Zaragoza (LMA-INA). The authors acknowledge the LMA-INA for offering access to their instruments and expertise. J.G. is grateful to C. Magen for help at LMA-INA. We thank G. Catalan for valuable discussions concerning PFM and A. Perez del Pino and A. Gomez for their technical assistance in the PFM measurements. This research was partially supported by the Spanish Government (projects MAT2012-35324, CONSOLIDER-Nanoselect-CSD2007-00041, and an RyC-2009-04335 contract to M. G. and a JAE-CSIC contract to J.G.). This research was supported in part by Oak Ridge National Laboratory's Shared Research Equipment (ShaRE) User Facility, which is sponsored by the Scientific User Facility Division, Office of Basic Energy Sciences, U.S. Department of Energy. This work has been accepted as patent deposit number FR1257101.	Altamirano-Juarez DC, 2001, J PHYS CHEM SOLIDS, V62, P1911, DOI 10.1016/S0022-3697(00)00277-8; Berg S, 2003, REV SCI INSTRUM, V74, P3845, DOI 10.1063/1.1588751; Boissiere C, 2011, ADV MATER, V23, P599, DOI 10.1002/adma.201001410; Brinker C.J., 1990, SOL GEL SCI PHYS CHE, DOI [DOI 10.1016/B978-0-08-057103-4.50001-5, 10.1016/C2009-0-22386-5]; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R; Bruhns P, 2000, EUR J MINERAL, V12, P615; Chen MS, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155404; Christman JA, 1998, APPL PHYS LETT, V73, P3851, DOI 10.1063/1.122914; Doling D., 1979, J PHYS CHEM SOLIDS, V40, P121; Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l; Grigoriev D. P., 1965, ONTOGENY MINERALS; Grosso D, 2011, J MATER CHEM, V21, P17033, DOI 10.1039/c1jm12837j; Innocenzi P, 2011, CHEM MATER, V23, P2501, DOI 10.1021/cm200050r; Ito D, 2003, J APPL PHYS, V93, P5563, DOI 10.1063/1.1564862; Iwasaki F, 2002, J CRYST GROWTH, V237, P820, DOI 10.1016/S0022-0248(01)02043-7; Jiang XM, 2012, CHEM COMMUN, V48, P1293, DOI 10.1039/c1cc15713b; Jiang XM, 2011, CHEM COMMUN, V47, P7524, DOI 10.1039/c1cc11115a; Kar S, 2005, SOLID STATE COMMUN, V133, P151, DOI 10.1016/j.ssc.2004.10.026; Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3; KRIM J, 1991, PHYS REV LETT, V66, P181, DOI 10.1103/PhysRevLett.66.181; Kubicek M, 2013, ACS NANO, V7, P3276, DOI 10.1021/nn305987x; Kundu M, 2002, APPL PHYS LETT, V80, P1921, DOI 10.1063/1.1461052; Laschitsch A, 1999, J APPL PHYS, V85, P3759, DOI 10.1063/1.369745; LEFKI K, 1994, J APPL PHYS, V76, P1764, DOI 10.1063/1.357693; Okabayashi M, 2005, CHEM LETT, V34, P58, DOI 10.1246/cl.2005.58; Pol VG, 2003, CHEM MATER, V15, P1111, DOI 10.1021/cm021013+; Rodriguez-Navarro A, 2000, EUR J MINERAL, V12, P609; Sanchez C, 2008, CHEM MATER, V20, P682, DOI 10.1021/cm702100t; SCHUMACHER R, 1990, ANGEW CHEM INT EDIT, V29, P329, DOI 10.1002/anie.199003293; Shumyatsky P, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3554742; SPASSOV L, 1994, REV SCI INSTRUM, V65, P721, DOI 10.1063/1.1145091; Su BL, 2012, HIERARCHICALLY STRUCTURED POROUS MATERIALS: FROM NANOSCIENCE TO CATALYSIS, SEPARATION, OPTICS, ENERGY, AND LIFE SCIENCE, P1; Takahashi N, 2003, CHEM MATER, V15, P2889, DOI 10.1021/cm021712m; Venezia AM, 2001, J SOLID STATE CHEM, V161, P373, DOI 10.1006/jssc.2001.9345; Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zhang Z, 2008, THIN SOLID FILMS, V516, P3741, DOI 10.1016/j.tsf.2007.06.070; Zhao LL, 2007, ADV FUNCT MATER, V17, P1952, DOI 10.1002/adfm.200601104	38	55	55	2	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					827	831		10.1126/science.1232968	http://dx.doi.org/10.1126/science.1232968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687040				2022-12-28	WOS:000318997400035
J	Giovanoli, S; Meyer, U				Giovanoli, Sandra; Meyer, Urs			Response to Comment on "Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice"	SCIENCE			English	Editorial Material							FETAL; BRAIN		[Giovanoli, Sandra; Meyer, Urs] Swiss Fed Inst Technol, Physiol & Behav Lab, Schwerzenbach, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Meyer, U (corresponding author), Swiss Fed Inst Technol, Physiol & Behav Lab, Schwerzenbach, Switzerland.	urmeyer@ethz.ch	Meyer, Urs/C-4602-2016	Meyer, Urs/0000-0001-7244-0345				Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Lazic SE, 2013, SCIENCE, V340, DOI 10.1126/science.1237793; Lukkes JL, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.018.2009; Meyer U, 2008, NEUROSCIENCE, V154, P701, DOI 10.1016/j.neuroscience.2008.04.031; Salminen A, 2008, PEDIATR RES, V63, P280, DOI 10.1203/PDR.0b013e318163a8b2; Zorrilla EP, 1997, DEV PSYCHOBIOL, V30, P141, DOI 10.1002/(SICI)1098-2302(199703)30:2<141::AID-DEV5>3.0.CO;2-Q	8	5	5	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134								10.1126/science.1238060	http://dx.doi.org/10.1126/science.1238060			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687030				2022-12-28	WOS:000318997400022
J	Zhang, Y; Ling, JL; Yuan, CY; Dubruille, R; Emery, P				Zhang, Yong; Ling, Jinli; Yuan, Chunyan; Dubruille, Raphaelle; Emery, Patrick			A Role for Drosophila ATX2 in Activation of PER Translation and Circadian Behavior	SCIENCE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-2; EYE-MOVEMENT SLEEP; TRANSGENIC RNAI; CLOCK; PROTEIN; PERIOD; ABNORMALITIES; MELANOGASTER; MECHANISMS; PACEMAKER	A negative transcriptional feedback loop generates circadian rhythms in Drosophila. PERIOD (PER) is a critical state-variable in this mechanism, and its abundance is tightly regulated. We found that the Drosophila homolog of ATAXIN-2 (ATX2)-an RNA-binding protein implicated in human neurodegenerative diseases-was required for circadian locomotor behavior. ATX2 was necessary for PER accumulation in circadian pacemaker neurons and thus determined period length of circadian behavior. ATX2 was required for the function of TWENTY-FOUR (TYF), a crucial activator of PER translation. ATX2 formed a complex with TYF and promoted its interaction with polyadenylate-binding protein (PABP). Our work uncovers a role for ATX2 in circadian timing and reveals that this protein functions as an activator of PER translation in circadian neurons.	[Zhang, Yong; Ling, Jinli; Yuan, Chunyan; Dubruille, Raphaelle; Emery, Patrick] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Ling, Jinli; Emery, Patrick] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Program Neurosci, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Emery, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	patrick.emery@umassmed.edu			R01 grants [GM66777, GM79182, GM100091]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100091, R01GM066777, R01GM079182] Funding Source: NIH RePORTER	R01 grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Wentworth and D. Szydlik for technical assistance; the Allada lab for communicating results before publication and for fly stocks and plasmids; M. Moore and her lab, as well as M. Ramaswami for helpful discussions and reagents; D. Weaver for critical reading of our manuscript; M. Rosbash for PER and PDF antibodies; N. Sonenberg for PABP antibody; the Vienna Drosophila RNAi Center (VDRC) for Atx2 RNAi lines; R. Stanewsky for fly stocks; the Drosophila Genomics Research Center for the Atx2 cDNA; and the Developmental Studies Hybridoma Bank for PDF antibodies. This work was supported by R01 grants GM66777, GM79182, and GM100091 to P.E.	Boesch SM, 2006, MOVEMENT DISORD, V21, P1751, DOI 10.1002/mds.21036; Bradley S, 2012, GENETICS, V192, P943, DOI 10.1534/genetics.112.143248; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Langer CCH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008928; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; Lim C, 2011, NATURE, V470, P399, DOI 10.1038/nature09728; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rodriguez-Labrada R, 2011, MOVEMENT DISORD, V26, P347, DOI 10.1002/mds.23409; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stanewsky R, 2002, J BIOL RHYTHM, V17, P293, DOI 10.1177/074873002129002609; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Tuin I, 2006, NEUROLOGY, V67, P1966, DOI 10.1212/01.wnl.0000247054.90322.14; Velazquez-Perez L, 2011, NEURODEGENER DIS, V8, P447, DOI 10.1159/000324374; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; Zhang Y, 2013, NEURON, V78, P152, DOI 10.1016/j.neuron.2013.01.035	30	92	96	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					879	882		10.1126/science.1234746	http://dx.doi.org/10.1126/science.1234746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687048	Green Accepted			2022-12-28	WOS:000318997400048
J	Mozaffari-Jovin, S; Wandersleben, T; Santos, KF; Will, CL; Luhrmann, R; Wahl, MC				Mozaffari-Jovin, Sina; Wandersleben, Traudy; Santos, Karine F.; Will, Cindy L.; Luehrmann, Reinhard; Wahl, Markus C.			Inhibition of RNA Helicase Brr2 by the C-Terminal Tail of the Spliceosomal Protein Prp8	SCIENCE			English	Article							SPLICING FACTOR PRP8; RETINITIS-PIGMENTOSA; DESIGN PRINCIPLES; DOMAIN; YEAST; ACTIVATION; ATPASE; MUTATIONS; REQUIRES	The Ski2-like RNA helicase Brr2 is a core component of the spliceosome that must be tightly regulated to ensure correct timing of spliceosome activation. Little is known about mechanisms of regulation of Ski2-like helicases by protein cofactors. Here we show by crystal structure and biochemical analyses that the Prp8 protein, a major regulator of the spliceosome, can insert its C-terminal tail into Brr2's RNA-binding tunnel, thereby intermittently blocking Brr2's RNA-binding, adenosine triphosphatase, and U4/U6 unwinding activities. Inefficient Brr2 repression is the only recognizable phenotype associated with certain retinitis pigmentosa-linked Prp8 mutations that map to its C-terminal tail. Our data show how a Ski2-like RNA helicase can be reversibly inhibited by a protein cofactor that directly competes with RNA substrate binding.	[Mozaffari-Jovin, Sina; Will, Cindy L.; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Wandersleben, Traudy; Santos, Karine F.; Wahl, Markus C.] Free Univ Berlin, Lab Struct Biochem, D-14195 Berlin, Germany	Max Planck Society; Free University of Berlin	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.	reinhard.luehrmann@mpi-bpc.mpg.de; mwahl@zedat.fu-berlin.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307; Mozaffari-Jovin, Sina/0000-0003-4410-0460	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck-Centrum; Leibniz-Institut fur Molekulare Pharmakologie; Deutsche Forschungsgemeinschaft [SFB 860, SFB 740/2]	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck-Centrum; Leibniz-Institut fur Molekulare Pharmakologie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank G. Heyne for excellent technical assistance, P. Fabrizio for help with yeast genetics, G. Weber and B. Loll for crystallographic support, J. D. Beggs for providing the antibody to yPrp8, and K.-L. Boon for helpful discussions. We acknowledge access to beamlines of the BESSY II storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck-Centrum, and the Leibniz-Institut fur Molekulare Pharmakologie. This work was supported by the Deutsche Forschungsgemeinschaft (grants SFB 860 to R. L. and SFB 740/2 to M. C. W.). S.M.J.	Boon KL, 2007, NAT STRUCT MOL BIOL, V14, P1077, DOI 10.1038/nsmb1303; Fourmann JB, 2013, GENE DEV, V27, P413, DOI 10.1101/gad.207779.112; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Kuhn AN, 2000, GENETICS, V155, P1667; Kuhn AN, 2002, P NATL ACAD SCI USA, V99, P9145, DOI 10.1073/pnas.102304299; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Mordes D, 2006, MOL VIS, V12, P1259; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Pena V, 2009, MOL CELL, V35, P454, DOI 10.1016/j.molcel.2009.08.006; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Towns KV, 2010, HUM MUTAT, V31, pE1361, DOI 10.1002/humu.21236; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Weber G, 2011, GENE DEV, V25, P1601, DOI 10.1101/gad.635911; Zhang LD, 2007, PROTEIN SCI, V16, P1024, DOI 10.1110/ps.072872007; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625	20	94	97	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					80	84		10.1126/science.1237515	http://dx.doi.org/10.1126/science.1237515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23704370				2022-12-28	WOS:000321291700053
J	Kanekiyo, M; Wei, CJ; Yassine, HM; McTamney, PM; Boyington, JC; Whittle, JRR; Rao, SS; Kong, WP; Wang, LS; Nabel, GJ				Kanekiyo, Masaru; Wei, Chih-Jen; Yassine, Hadi M.; McTamney, Patrick M.; Boyington, Jeffrey C.; Whittle, James R. R.; Rao, Srinivas S.; Kong, Wing-Pui; Wang, Lingshu; Nabel, Gary J.			Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies	NATURE			English	Article							A VIRUSES; HEMAGGLUTININ; EPITOPE; IMMUNOGENICITY; VACCINATION; RECOGNIZES; INDUCTION; FERRITIN; IMMUNITY; PROTEIN	Influenza viruses pose a significant threat to the public and are a burden on global health systems(1,2). Each year, influenza vaccines must be rapidly produced to match circulating viruses, a process constrained by dated technology and vulnerable to unexpected strains emerging from humans and animal reservoirs. Here we use knowledge of protein structure to design self-assembling nanoparticles that elicit broader and more potent immunity than traditional influenza vaccines. The viral haemagglutinin was genetically fused to ferritin, a protein that naturally forms nanoparticles composed of 24 identical polypeptides(3). Haemagglutinin was inserted at the interface of adjacent subunits so that it spontaneously assembled and generated eight trimeric viral spikes on its surface. Immunization with this influenza nanoparticle vaccine elicited haemagglutination inhibition antibody titres more than tenfold higher than those from the licensed inactivated vaccine. Furthermore, it elicited neutralizing antibodies to two highly conserved vulnerable haemagglutinin structures that are targets of universal vaccines: the stem(4,5) and the receptor binding site on the head(6,7). Antibodies elicited by a 1999 haemagglutinin-nanoparticle vaccine neutralized H1N1 viruses from 1934 to 2007 and protected ferrets from an unmatched 2007 H1N1 virus challenge. This structure-based, self-assembling synthetic nanoparticle vaccine improves the potency and breadth of influenza virus immunity, and it provides a foundation for building broader vaccine protection against emerging influenza viruses and other pathogens.	[Kanekiyo, Masaru; Wei, Chih-Jen; Yassine, Hadi M.; McTamney, Patrick M.; Boyington, Jeffrey C.; Whittle, James R. R.; Rao, Srinivas S.; Kong, Wing-Pui; Wang, Lingshu; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), Sanofi, 640 Mem Dr, Cambridge, MA 02139 USA.	Gary.Nabel@sanofi.com	YASSINE, HADI M./AAW-6475-2020; Wei, Chih/GVT-5734-2022; Kanekiyo, Masaru/Y-9820-2018; Cheng, Yushao/E-6256-2011	YASSINE, HADI M./0000-0001-7592-2788; Kanekiyo, Masaru/0000-0001-5767-1532; 	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005003] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Andersen, A. Taylor, A. Zajac and C. Chiedi for help with the animal studies; U. Baxa, K. Nagashima and A. Harned for electron microscopy studies; X. Chen for technical support; A. Panet, B. Graham, R. Schwartz and members of the Nabel lab for discussions; S. Sun and M. Rossmann for technical and conceptual advice; A. Tislerics, B. Hartman and J. Farrar for manuscript preparation. The MF59 adjuvant was kindly provided by Novartis. This work was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health.	Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Cho KJ, 2009, J MOL BIOL, V390, P83, DOI 10.1016/j.jmb.2009.04.078; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Jaaskelainen A, 2007, SMALL, V3, P1362, DOI 10.1002/smll.200700011; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Kong WP, 2003, J VIROL, V77, P12764, DOI 10.1128/JVI.77.23.12764-12772.2003; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Lee LA, 2006, NANOMED-NANOTECHNOL, V2, P137, DOI 10.1016/j.nano.2006.07.009; Li C.Q., 2006, IND BIOTECHNOL, V2, P143, DOI [DOI 10.1089/IND.2006.2.143, 10.1089/ind.2006.2.143]; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/ERV.12.140, 10.1586/erv.12.140]; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Yamashita I, 2010, BBA-GEN SUBJECTS, V1800, P846, DOI 10.1016/j.bbagen.2010.03.005; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	33	482	545	15	292	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					102	+		10.1038/nature12202	http://dx.doi.org/10.1038/nature12202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23698367	Green Accepted			2022-12-28	WOS:000321285600042
J	Lukens, JR; Vogel, P; Johnson, GR; Kelliher, MA; Iwakura, Y; Lamkanfi, M; Kanneganti, TD				Lukens, John R.; Vogel, Peter; Johnson, Gordon R.; Kelliher, Michelle A.; Iwakura, Yoichiro; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			RIP1-driven autoinflammation targets IL-1 alpha independently of inflammasomes and RIP3	NATURE			English	Article							STERILE INFLAMMATION; MOTH-EATEN; CELL; GENE; ACTIVATION; DISEASE; MICE; IDENTIFICATION; AUTOIMMUNITY; PHOSPHATASES	The protein-tyrosine phosphatase SHP-1 has critical roles in immune signalling, but how mutations in SHP-1 cause inflammatory disease in humans remains poorly defined(1). Mice homozygous for the Tyr208Asn amino acid substitution in the carboxy terminus of SHP-1 (referred to as Ptpn6(spin) mice) spontaneously develop a severe inflammatory syndrome that resembles neutrophilic dermatosis in humans and is characterized by persistent footpad swelling and suppurative inflammation(2,3). Here we report that receptor-interacting protein 1 (RIP1)-regulated interleukin (IL)-1 alpha production by haematopoietic cells critically mediates chronic inflammatory disease in Ptpn6(spin) mice, whereas inflammasome signalling and IL-1 beta-mediated events are dispensable. IL-1 alpha was also crucial for exacerbated inflammatory responses and unremitting tissue damage upon footpad microabrasion of Ptpn6(spin) mice. Notably, pharmacological and genetic blockade of the kinase RIP1 protected against wound-induced inflammation and tissue damage in Ptpn6(spin) mice, whereas RIP3 deletion failed to do so. Moreover, RIP1-mediated inflammatory cytokine production was attenuated by NF-kappa B and ERK inhibition. Together, our results indicate that wound-induced tissue damage and chronic inflammation in Ptpn6(spin) mice are critically dependent on RIP1-mediated IL-1 alpha production, whereas inflammasome signalling and RIP3-mediated necroptosis are dispensable. Thus, we have unravelled a novel inflammatory circuit in which RIP1-mediated IL-1 alpha secretion in response to deregulated SHP-1 activity triggers an inflammatory destructive disease that proceeds independently of inflammasomes and programmed necrosis.	[Lukens, John R.; Johnson, Gordon R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; [Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Iwakura, Yoichiro/E-5457-2011; Kanneganti, Thirumala-Devi/M-9435-2018; Vogel, Peter/N-2490-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Iwakura, Yoichiro/0000-0002-9934-5775; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Vogel, Peter/0000-0002-7535-0545; Lukens, John/0000-0002-6795-0866	European Union [256432]; ERC [281600]; Fund for Scientific Research-Flanders [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00]; National Institutes of Health [AR056296, CA163507, AI101935]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI101935, R01AI075118, R01AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	European Union(European Commission); ERC(European Research Council (ERC)European Commission); Fund for Scientific Research-Flanders(FWO); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank B. A. Buetler, V. M. Dixit and D. R. Green for supply of mutant mice. We thank R. Weinlich for helpful discussions. We thank M. Johnson in the St Jude Small Animal Imaging Center for helping to evaluate embryonic development in fetal liver transplantation studies. M. L. is supported by European Union Marie-Curie grant 256432, ERC grant 281600, and grants G030212N, 1.2.201.10.N.00 and 1.5.122.11.N.00 from the Fund for Scientific Research-Flanders. This work was supported by grants from the National Institutes of Health (grants AR056296, CA163507 and AI101935) and the American Lebanese Syrian Associated Charities (ALSAC) to T.-D.K.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Cao HN, 2002, J HUM GENET, V47, P445, DOI 10.1007/s100380200062; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kranich J, 2011, SEMIN IMMUNOL, V23, P139, DOI 10.1016/j.smim.2011.01.011; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Lukens JR, 2011, DISCOV MED, V11, P65; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; Nesterovitch AB, 2011, AM J PATHOL, V178, P1701, DOI 10.1016/j.ajpath.2010.12.053; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4	27	127	132	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					224	+		10.1038/nature12174	http://dx.doi.org/10.1038/nature12174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23708968	Green Accepted			2022-12-28	WOS:000320283400047
J	Walter, M; Doran, B; Gross, D; Christandl, M				Walter, Michael; Doran, Brent; Gross, David; Christandl, Matthias			Entanglement Polytopes: Multiparticle Entanglement from Single-Particle Information	SCIENCE			English	Article								Entangled many-body states are an essential resource for quantum computing and interferometry. Determining the type of entanglement present in a system usually requires access to an exponential number of parameters. We show that in the case of pure, multiparticle quantum states, features of the global entanglement can already be extracted from local information alone. This is achieved by associating any given class of entanglement with an entanglement polytope-a geometric object that characterizes the single-particle states compatible with that class. Our results, applicable to systems of arbitrary size and statistics, give rise to local witnesses for global pure-state entanglement and can be generalized to states affected by low levels of noise.	[Walter, Michael; Christandl, Matthias] ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland; [Doran, Brent] ETH, Dept Math, CH-8092 Zurich, Switzerland; [Gross, David] Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg	Walter, M (corresponding author), ETH, Inst Theoret Phys, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland.	mwalter@phys.ethz.ch	Christandl, Matthias/L-8830-2014; Walter, Michael/AAH-1608-2021	Christandl, Matthias/0000-0003-2281-3355; Walter, Michael/0000-0002-3073-1408	German Science Foundation [CH 843/2-1]; Swiss National Science Foundation [PP00P2_128455, 20CH21_138799, 200021_138071]; Swiss National Center of Competence in Research Quantum Science and Technology; Excellence Initiative of the German Federal Government [ZUK 43]; Excellence Initiative of the German State Government [ZUK 43]	German Science Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center of Competence in Research Quantum Science and Technology; Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	We thank A. Botero, F. Brandao, P. Burgisser, C. Ikenmeyer, F. Kirwan, F. Mintert, G. Mitchison, A. Osterloh, and P. Vrana for valuable discussions. This work is supported by the German Science Foundation (grant CH 843/2-1), the Swiss National Science Foundation [grants PP00P2_128455, 20CH21_138799 (CHIST-ERA project CQC), and 200021_138071], the Swiss National Center of Competence in Research Quantum Science and Technology, and the Excellence Initiative of the German Federal and State Governments (grant ZUK 43). After completion of this work, we have learned about independent related work by Sawicki, Oszmaniec, and Kus.	Bennett CH, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.012307; BORLAND RE, 1972, J PHYS PT B ATOM M P, V5, P7, DOI 10.1088/0022-3700/5/1/009; Buhrman H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.167902; Christandl M, 2006, COMMUN MATH PHYS, V261, P789, DOI 10.1007/s00220-005-1435-1; Coleman A. J., 2000, REDUCED DENSITY MATR; Daftuar S, 2005, ANN PHYS-NEW YORK, V315, P80, DOI 10.1016/j.aop.2004.09.012; Derksen H., 2002, COMPUTATIONAL INVARI; Doran B, 2007, PURE APPL MATH Q, V3, P61; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; Furuya K, 1998, PHYS REV LETT, V80, P5524, DOI 10.1103/PhysRevLett.80.5524; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Guhne O, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/229; Han YJ, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.042309; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Klyachko, 2004, ARXIVQUANTPH0409113; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Malliavin M. P., 1987, SEM ALG P DUBR MP MA, P177; Monz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130506; Pan JW, 2001, PHYS REV LETT, V86, P4435, DOI 10.1103/PhysRevLett.86.4435; Rauschenbeutel A, 2000, SCIENCE, V288, P2024, DOI 10.1126/science.288.5473.2024; Verstraete F, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052112; Vidal G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.147902	24	98	98	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1205	1208		10.1126/science.1232957	http://dx.doi.org/10.1126/science.1232957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744943	Green Submitted			2022-12-28	WOS:000319972800042
J	Gallo, JJ; Morales, KH; Bogner, HR; Raue, PJ; Zee, J; Bruce, ML; Reynolds, CF				Gallo, Joseph J.; Morales, Knashawn H.; Bogner, Hillary R.; Raue, Patrick J.; Zee, Jarcy; Bruce, Martha L.; Reynolds, Charles F., III			Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; NATIONAL DEATH INDEX; LATE-LIFE DEPRESSION; REDUCING SUICIDAL IDEATION; MYOCARDIAL-INFARCTION; COLLABORATIVE CARE; MAJOR DEPRESSION; ENHANCING RECOVERY; SYMPTOMS; OUTCOMES	Objective To investigate whether an intervention to improve treatment of depression in older adults in primary care modified the increased risk of death associated with depression. Design Long term follow-up of multi-site practice randomized controlled trial (PROSPECT-Prevention of Suicide in Primary Care Elderly: Collaborative Trial). Setting 20 primary care practices in New York City, Philadelphia, and Pittsburgh, USA, randomized to intervention or usual care. Participants 1226 participants identified between May 1999 and August 2001 through a two stage, age stratified (60-74; >= 75 years) depression screening of randomly sampled patients; enrollment included patients who screened positive and a random sample of patients who screened negative. Intervention For two years, a depression care manager worked with primary care physicians in intervention practices to provide algorithm based care for depression, offering psychotherapy, increasing antidepressant dose if indicated, and monitoring symptoms, adverse effects of drugs, and adherence to treatment. This paper reports the long term follow-up. Main outcome measure Mortality risk based on a median follow-up of 98 (range 0.8-116.4) months through 2008. Results In baseline clinical interviews, 396 people were classified as having major depression, 203 had clinically significant minor depression, and 627 did not meet criteria for depression. At follow-up, 405 patients had died. Patients with major depression in usual care were more likely to die than were those without depression (hazard ratio 1.90, 95% confidence interval 1.57 to 2.31). In contrast, patients with major depression in intervention practices were at no greater risk than were people without depression (hazard ratio 1.09, 0.83 to 1.44). Patients with major depression in intervention practices, relative to usual care, were 24% less likely to have died (hazard ratio 0.76, 0.57 to 1.00; P=0.05). Preliminary data on cause of death are provided. No significant effect on mortality was found for minor depression. Conclusions Older adults with major depression in practices provided with additional resources to intensively manage depression had a mortality risk lower than that observed in usual care and similar to older adults without depression.	[Gallo, Joseph J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; [Morales, Knashawn H.; Zee, Jarcy] Univ Penn, Sch Med, Dept Biostat, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Bogner, Hillary R.] Univ Penn, Sch Med, Dept Family Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Raue, Patrick J.; Bruce, Martha L.] Weill Cornell Med Coll, Dept Psychiat, White Plains, NY USA; [Reynolds, Charles F., III] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reynolds, CF (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, WPIC Bellefield Towers,Room 758,3811 OHara St, Pittsburgh, PA 15213 USA.	Reynoldscf@upmc.edu		Zee, Jarcy/0000-0003-0586-1160	National Institute of Mental Health [R01 MH065539]; NIMH [K24 MH070407, K01MH073903, K23 MH67671, P30 MH085943, P30 MH090333, T32 MH065218]; Forest Laboratories; John D Hartford Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065539, P30MH052129, P30MH090333, R01MH059381, K24MH070407, K01MH073903, P30MH052247, P30MH068638, R01MH059366, T32MH065218, K23MH067671, R01MH059380, P30MH085943] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Forest Laboratories; John D Hartford Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the National Institute of Mental Health (R01 MH065539). JJG, KHM, and HRB were supported by NIMH awards K24 MH070407, K01MH073903, and K23 MH67671. MLB and PJR were supported by P30 MH085943, and CFR was supported by P30 MH090333 from NIMH. JZ was supported by NIMH award T32 MH065218. PROSPECT was a collaborative research study funded by the NIMH. The three groups included the Advanced Centers for Intervention and Services Research of Cornell University (PROSPECT Coordinating Center; principal investigator: George S Alexopoulos; co-principal investigators: MLB and Herbert C Schulberg; R01 MH59366, P30 MH68638); University of Pennsylvania (principal investigator Ira Katz; co-principal investigators Thomas Ten Have and Gregory K Brown; R01 MH59380, P30 MH52129); and University of Pittsburgh (principal investigator CFR; co-principal investigator Benoit H Mulsant; R01 MH59381, P30 MH52247). Additional small grants came from Forest Laboratories and the John D Hartford Foundation. The sponsor had no role in the design and conduct of the study; in data collection or management, analysis, and interpretation of the data; or in preparation, review, and approval of the manuscript. All the authors had full access to all the data.	Alexopoulos GS, 2009, AM J PSYCHIAT, V166, P882, DOI 10.1176/appi.ajp.2009.08121779; Alexopoulos GS, 2000, ARCH GEN PSYCHIAT, V57, P285, DOI 10.1001/archpsyc.57.3.285; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bartels SJ, 2004, AM J PSYCHIAT, V161, P1455, DOI 10.1176/appi.ajp.161.8.1455; Beck AT, 1997, BEHAV RES THER, V35, P1039, DOI 10.1016/S0005-7967(97)00073-9; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Blumenthal JA, 2012, JAMA-J AM MED ASSOC, V308, P465, DOI 10.1001/jama.2012.8720; Brown GK, 2001, INT J GERIATR PSYCH, V16, P593, DOI 10.1002/gps.468; BRUCE ML, 1994, AM J PSYCHIAT, V151, P716; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Carney RM, 2004, PSYCHOSOM MED, V66, P466, DOI 10.1097/01.psy.0000133362.75075.a6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Collett D, 1994, MODELLING SURVIVAL D; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Dietrich AJ, 2004, BMJ-BRIT MED J, V329, P602, DOI 10.1136/bmj.38219.481250.55; Doody MM, 2001, ANN EPIDEMIOL, V11, P46, DOI 10.1016/S1047-2797(00)00177-0; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedland KE, 2005, PSYCHOSOM MED, V67, pS42, DOI 10.1097/01.psy.0000162255.55629.9c; GALLO JJ, 1994, J GERONTOL, V49, pP251, DOI 10.1093/geronj/49.6.P251; Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hunkeler EM, 2006, BMJ-BRIT MED J, V332, P259, DOI 10.1136/bmj.38683.710255.BE; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Klein JP, 1992, SURVIVAL ANAL STATE; KNAUPER B, 1994, J PSYCHIATR RES, V28, P147, DOI 10.1016/0022-3956(94)90026-4; Lutgendorf SK, 2011, PSYCHOSOM MED, V73, P724, DOI 10.1097/PSY.0b013e318235be76; Mezuk B, 2013, DEPRESSION LATE LIFE, P270; Mulsant BH, 2001, INT J GERIATR PSYCH, V16, P585, DOI 10.1002/gps.465; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raue PJ, 2001, INT J GERIATR PSYCH, V16, P560, DOI 10.1002/gps.469; Reynolds CF, 2006, NEW ENGL J MED, V354, P1130, DOI 10.1056/NEJMoa052619; Reynolds CF, 2001, INT J GERIATR PSYCH, V16, P602, DOI 10.1002/gps.466; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rozzini R, 2012, J AM GERIATR SOC, V60, P989, DOI 10.1111/j.1532-5415.2012.03930.x; Saab PG, 2009, J PSYCHOSOM RES, V67, P45, DOI 10.1016/j.jpsychores.2009.01.015; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Schulberg HC, 2001, INT J GERIATR PSYCH, V16, P577, DOI 10.1002/gps.470; Schulberg HC, 2007, INT J GERIATR PSYCH, V22, P106, DOI 10.1002/gps.1700; Schulz R, 2002, BIOL PSYCHIAT, V52, P205, DOI 10.1016/S0006-3223(02)01423-3; Sherbourne CD, 2008, MED CARE, V46, P78, DOI 10.1097/MLR.0b013e318148478d; Spitzer RL, 1995, STRUCTURED CLIN INTE; Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Unutzer J, 2002, AM J GERIAT PSYCHIAT, V10, P521, DOI 10.1176/appi.ajgp.10.5.521; Van Melle JP, 2007, BRIT J PSYCHIAT, V190, P460, DOI 10.1192/bjp.bp.106.028647; Wells KB, 2008, HEALTH SERV RES, V43, P1952, DOI 10.1111/j.1475-6773.2008.00871.x	54	104	104	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 5	2013	346								f2570	10.1136/bmj.f2570	http://dx.doi.org/10.1136/bmj.f2570			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YF	23738992	hybrid, Green Published			2022-12-28	WOS:000320229500001
J	Maggard-Gibbons, M; Maglione, M; Livhits, M; Ewing, B; Maher, AR; Hu, JH; Li, ZP; Shekelle, PG				Maggard-Gibbons, Melinda; Maglione, Margaret; Livhits, Masha; Ewing, Brett; Maher, Alicia Ruelaz; Hu, Jianhui; Li, Zhaoping; Shekelle, Paul G.			Bariatric Surgery for Weight Loss and Glycemic Control in Nonmorbidly Obese Adults With Diabetes A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							Y GASTRIC BYPASS; BODY-MASS INDEX; LIFE-STYLE INTERVENTIONS; LONG-TERM EFFECTIVENESS; THAN 35 KG/M(2); SLEEVE GASTRECTOMY; BILIOPANCREATIC DIVERSION; METHODOLOGICAL QUALITY; CARBOHYDRATE DIETS; METABOLIC SYNDROME	Importance Bariatric surgery is beneficial in persons with a body mass index (BMI) of 35 or greater with obesity-related comorbidities. There is interest in using these procedures in persons with lower BMI and diabetes. Objective To assess the association between bariatric surgery vs nonsurgical treatments and weight loss and glycemic control among patients with diabetes or impaired glucose tolerance and BMI of 30 to 35. Evidence Review PubMed, EMBASE, and Cochrane Library databases were searched from January 1985 through September 2012. Of 1291 screened articles, we included 32 surgical studies, 11 systematic reviews on nonsurgical treatments, and 11 large nonsurgical studies published after those reviews. Weight loss, metabolic outcomes, and adverse events were abstracted by 2 independent reviewers. Findings Three randomized clinical trials (RCTs) (N=290; including 1 trial of 150 patients with type 2 diabetes and mean BMI of 37, 1 trial of 80 patients without diabetes [38% with metabolic syndrome] and BMI of 30 to 35, and 1 trial of 60 patients with diabetes and BMI of 30 to 40 [13 patients with BMI <35]) found that surgery was associated with greater weight loss (range, 14.4-24 kg) and glycemic control (range, 0.9-1.43 point improvements in hemoglobin A(1c) levels) during 1 to 2 years of follow-up than nonsurgical treatment. Indirect comparisons of evidence from observational studies of bariatric procedures (n approximate to 600 patients) and meta-analyses of nonsurgical therapies (containing more than 300 RCTs) support this finding at 1 or 2 years of follow-up. However, there are no robust surgical data beyond 5 years of follow-up on outcomes of diabetes, glucose control, or macrovascular and microvascular outcomes. In contrast, some RCT data of nonsurgical therapies show benefits at 10 years of follow-up or more. Surgeon-reported adverse events were low (eg, hospital deaths of 0.3%-1.0%), but data were from select centers and surgeons. Long-term adverse events are unknown. Conclusions and Relevance Current evidence suggests that, when compared with nonsurgical treatments, bariatric surgical procedures in patients with a BMI of 30 to 35 and diabetes are associated with greater short-term weight loss and better intermediate glucose outcomes. Evidence is insufficient to reach conclusions about the appropriate use of bariatric surgery in this population until more data are available about long-term outcomes and complications of surgery.	[Maggard-Gibbons, Melinda; Maglione, Margaret; Ewing, Brett; Maher, Alicia Ruelaz; Hu, Jianhui; Shekelle, Paul G.] Rand Hlth, Santa Monica, CA USA; [Maggard-Gibbons, Melinda; Livhits, Masha] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Maggard-Gibbons, Melinda; Livhits, Masha; Li, Zhaoping; Shekelle, Paul G.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Maggard-Gibbons, Melinda] Olive View UCLA Med Ctr, Dept Surg, Sylmar, CA 91342 USA; [Maher, Alicia Ruelaz] Akasha Ctr Integrat Med, Santa Monica, CA USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Maggard-Gibbons, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, CHS 72-215,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	mmaggard@mednet.ucla.edu			AHRQ [290-2007-10062I]; US Department of Health and Human Services	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Department of Health and Human Services	This project was funded under the contract 290-2007-10062I from the AHRQ and US Department of Health and Human Services.	Abbatini F, 2012, SURG OBES RELAT DIS, V8, P20, DOI 10.1016/j.soard.2011.06.015; Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Agency for Healthcare Research and Quality, 2010, RES PROT COMP EFF BA; Angrisani L, 2004, OBES SURG, V14, P415, DOI 10.1381/096089204322917963; Arterburn DE, 2013, OBES SURG, V23, P93, DOI 10.1007/s11695-012-0802-1; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Boza C, 2011, OBES SURG, V21, P1330, DOI 10.1007/s11695-011-0463-5; Boza C, 2010, OBES SURG, V20, P1011; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Castagneto M, 2012, CURR ATHEROSCLER REP, V14, P624, DOI 10.1007/s11883-012-0284-6; Chiellini C, 2009, DIABETOLOGIA, V52, P1027, DOI 10.1007/s00125-009-1333-8; Choi J, 2010, SURG OBES RELAT DIS, V6, P367, DOI 10.1016/j.soard.2009.09.021; Chopra A, 2012, SURG ENDOSC, V26, P831, DOI 10.1007/s00464-011-1960-2; Cohen Ricardo, 2006, Surg Obes Relat Dis, V2, P401, DOI 10.1016/j.soard.2006.02.011; Cohen RV, 2012, DIABETES CARE, V35, P1420, DOI 10.2337/dc11-2289; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Cummings David E, 2005, Surg Obes Relat Dis, V1, P358, DOI 10.1016/j.soard.2005.03.208; DeMaria EJ, 2010, ANN SURG, V252, P559, DOI [10.1097/SLA.0b013e3181f2aed0, 10.1097/SLA.0b013e3181d03db5]; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Dyson PA, 2008, J HUM NUTR DIET, V21, P530, DOI 10.1111/j.1365-277X.2008.00896.x; Fakhoury WKH, 2010, PHARMACOLOGY, V86, P44, DOI 10.1159/000314690; Finks JF, 2011, ANN SURG, V254, P633, DOI 10.1097/SLA.0b013e318230058c; Forgione PM, 2012, J GASTROINTEST SURG, V16, P51, DOI 10.1007/s11605-011-1740-2; Frenken M, 2011, OBESITY FACTS, V4, P13, DOI 10.1159/000327038; Gianos M, 2012, SURG OBES RELAT DIS, V8, P25, DOI 10.1016/j.soard.2011.08.012; Gill RS, 2010, SURG OBES RELAT DIS, V6, P707, DOI 10.1016/j.soard.2010.07.011; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang CK, 2011, OBES SURG, V21, P1344, DOI 10.1007/s11695-011-0408-z; Ilanne-Parikka P, 2008, DIABETES CARE, V31, P805, DOI 10.2337/dc07-1117; Juhasz-Pocsine K, 2007, NEUROLOGY, V68, P1843, DOI 10.1212/01.wnl.0000262768.40174.33; Kashyap SR, 2010, INT J OBESITY, V34, P462, DOI 10.1038/ijo.2009.254; Kim MK, 2012, DIABETES-METAB RES, V28, P439, DOI 10.1002/dmrr.2297; Kirk JK, 2008, J AM DIET ASSOC, V108, P91, DOI 10.1016/j.jada.2007.10.003; Kodama S, 2009, DIABETES CARE, V32, P959, DOI 10.2337/dc08-1716; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Kral John G, 2005, Surg Obes Relat Dis, V1, P35, DOI 10.1016/j.soard.2004.12.003; Laferrere B, 2007, DIABETES CARE, V30, P1709, DOI 10.2337/dc06-1549; LEAPE LL, 1989, NEW ENGL J MED, V321, P653, DOI 10.1056/NEJM198909073211006; Lee WJ, 2008, J GASTROINTEST SURG, V12, P945, DOI 10.1007/s11605-007-0319-4; Lee WJ, 2011, OBES SURG, V21, P889, DOI 10.1007/s11695-011-0401-6; Lee WJ, 2011, ARCH SURG-CHICAGO, V146, P143, DOI 10.1001/archsurg.2010.326; Lembach H, 2010, OBES SURG, V20, P988; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lin VW, 2012, SURG OBES RELAT DIS; Ludwig DS, 2012, JAMA-J AM MED ASSOC, V308, P981, DOI 10.1001/2012.jama.10156; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Maglione M, 2012, AHRQ PUBLICATION, V12-EHC139-EF; Mingrone G, 2008, NUTR METAB CARDIOVAS, V18, P574, DOI 10.1016/j.numecd.2008.07.004; Mingrone G, 2009, DIABETES METAB, V35, P518, DOI 10.1016/S1262-3636(09)73459-7; Norris SL, 2005, AM J PREV MED, V28, P126, DOI 10.1016/j.amepre.2004.08.006; Norris SL, 2004, AM J MED, V117, P762, DOI 10.1016/j.amjmed.2004.05.024; Noya G, 1998, OBES SURG, V8, P67, DOI 10.1381/096089298765555088; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Padwal R, 2011, J GEN INTERN MED, V26, P1183, DOI 10.1007/s11606-011-1721-x; Parikh M, 2006, Surg Obes Relat Dis, V2, P518, DOI 10.1016/j.soard.2006.07.005; Pfeifer S, 2012, LOS ANGELES TIMES; Pfeifer S., 2011, LOS ANGELES TIMES; Phurrough S, 2010, DEC MEM SURG DIAB CA; Pontiroli AE, 2012, NUTR METAB CARDIOVAS, V22, pE24, DOI 10.1016/j.numecd.2012.05.012; Ramos A, 2010, OBES SURG, V20, P1011; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Scopinaro N, 2007, OBES SURG, V17, P185, DOI 10.1007/s11695-007-9045-y; Scopinaro N, 2011, OBES SURG, V21, P880, DOI 10.1007/s11695-011-0407-0; Serrot FJ, 2011, SURGERY, V150, P684, DOI 10.1016/j.surg.2011.07.069; Shah SS, 2010, SURG OBES RELAT DIS, V6, P332, DOI 10.1016/j.soard.2009.08.009; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sinha MK, 2007, KIDNEY INT, V72, P100, DOI 10.1038/sj.ki.5002194; Sjostrom CD, 1999, OBES RES, V7, P477; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Slater GH, 2004, J GASTROINTEST SURG, V8, P48, DOI 10.1016/j.gassur.2003.09.020; Sultan S, 2009, SURG ENDOSC, V23, P1569, DOI 10.1007/s00464-009-0341-6; Sun ZC, 2013, HEPATO-GASTROENTEROL, V60, P129, DOI 10.5754/hge12545; de Sa VCT, 2011, OBES SURG, V21, P283, DOI 10.1007/s11695-010-0318-5; U.S. Food and Drug Administration, 2011, FDA EXP US BAND SYST; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771; Waugh N, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14360; Zhu LY, 2012, OBES SURG, V22, P1562, DOI 10.1007/s11695-012-0694-0	84	159	163	0	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2250	2261		10.1001/jama.2013.4851	http://dx.doi.org/10.1001/jama.2013.4851			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736734				2022-12-28	WOS:000319859200029
J	Schindler, CS; Jacobsen, EN				Schindler, Corinna S.; Jacobsen, Eric N.			A New Twist on Cooperative Catalysis	SCIENCE			English	Editorial Material							DUAL CATALYSIS		[Schindler, Corinna S.; Jacobsen, Eric N.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Schindler, CS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	cschindl@fas.harvard.edu; jacobsen@chemistry.harvard.edu						Allen AE, 2012, CHEM SCI, V3, P633, DOI 10.1039/c2sc00907b; Huang Y, 2005, J AM CHEM SOC, V127, P15051, DOI 10.1021/ja055545d; Jacobsen E. N., 1999, COMPREHENSIVE ASYM 1, VI-III; Krautwald S, 2013, SCIENCE, V340, P1065, DOI 10.1126/science.1237068; Sammis GM, 2004, J AM CHEM SOC, V126, P9928, DOI 10.1021/ja046653n; Taylor MS, 2004, P NATL ACAD SCI USA, V101, P5368, DOI 10.1073/pnas.0307893101; Zhong C, 2010, EUR J ORG CHEM, V2010, P2999, DOI 10.1002/ejoc.201000004	7	72	72	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1052	1053		10.1126/science.1238769	http://dx.doi.org/10.1126/science.1238769			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723222				2022-12-28	WOS:000319664500027
J	Fleming, N				Fleming, Nic			Tell fans definitive calls are an impossible goal	NATURE			English	Editorial Material												nicfleming106@hotmail.com						COLLINS H, 2011, PUBLIC UNDERSTANDING	1	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					537	537		10.1038/497537a	http://dx.doi.org/10.1038/497537a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	152UF	23719426	Bronze			2022-12-28	WOS:000319556100006
J	Williamson, LM; Devine, DV				Williamson, Lorna M.; Devine, Dana V.			Challenges in the management of the blood supply	LANCET			English	Article							PLATELET TRANSFUSIONS; DONATION; STRATEGIES; TRIAL; RISK; INVENTORY; THERAPY; MONITOR; PATIENT; STORAGE	Although blood suppliers are seeing short-term reductions in blood demand as a result of initiatives in patient blood management, modelling suggests that during the next 5-10 years, blood availability in developed countries will need to increase again to meet the demands of ageing populations. Increasing of the blood supply raises many challenges; new approaches to recruitment and retainment of future generations of blood donors will be needed, and care will be necessary to avoid taking too much blood from these donors. Integrated approaches in blood stock management between transfusion services and hospitals will be important to minimise wastage-eg, by use of supply chain solutions from industry. Cross-disciplinary systems for patient blood management need to be developed to lessen the need for transfusion-eg, by early identification and reversal of anaemia with haematinics or by reversal of the underlying cause. Personalised medicine could be applied to match donors to patients, not only with extended blood typing, but also by using genetically determined storage characteristics of blood components. Growing of red cells or platelets in large quantities from stem cells is a possibility in the future, but challenges of cost, scaling up, and reproducibility remain to be solved.	[Williamson, Lorna M.] Natl Hlth Serv Blood & Transplant, Watford, England; [Devine, Dana V.] Canadian Blood Serv, Vancouver, BC, Canada	NHS Blood & Transplant (NHSBT); Canadian Blood Services	Devine, DV (corresponding author), UBC Ctr Blood Res, Canadian Blood Serv, Vancouver, BC V6T 1Z3, Canada.	dana.devine@blood.ca			TerumoBCT; Macopharma	TerumoBCT; Macopharma	LMW declares that she has no conflicts of interest. DVD receives research funding from TerumoBCT and Macopharma. She is a member of the scientific advisory committee of Fresenius-Kabi Transfusion Technologies and has received speaker fees or travel reimbursement for speaking at various conferences including the International Society for Blood Transfusion, the International Association for Biological Standards, the US FDA Blood Products Advisory Committee, Cellular Therapeutics in Trauma and Clinical Care, and the Fresenius-Kabi Advanced Course on Transfusion Technology as well as a number of visiting professorships.	[Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; [Anonymous], REC CHANG ACC CRIT U; AuBuchon JP, 2011, TRANSFUSION, V51, P2750, DOI 10.1111/j.1537-2995.2011.03443.x; Baart AM, 2012, TRANSFUSION, V52, P2559, DOI 10.1111/j.1537-2995.2012.03655.x; Bercovitz RS, 2012, VOX SANG, V102, P345, DOI 10.1111/j.1423-0410.2011.01559.x; Blake JT, 2013, TRANSFUSION, V53, P1544, DOI 10.1111/j.1537-2995.2012.03947.x; Blake JT, 2009, TRANSFUSION, V49, P396, DOI 10.1111/j.1537-2995.2008.02061.x; Boralessa H, 2009, ANN ROY COLL SURG, V91, P599, DOI 10.1308/003588409X432464; Bryant BJ, 2012, TRANSFUSION, V52, P1566, DOI 10.1111/j.1537-2995.2011.03488.x; Cable RG, 2012, TRANSFUSION, V52, P702, DOI 10.1111/j.1537-2995.2011.03401.x; Cap AP, 2011, J TRAUMA, V70, pS59, DOI 10.1097/TA.0b013e31821a606d; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Chapman J, 2007, TRANSFUSION, V47, p190S, DOI 10.1111/j.1537-2995.2007.01384.x; Cid J, 2012, VOX SANG, V103, P322, DOI 10.1111/j.1423-0410.2012.01614.x; de Kort W, 2011, TRANSFUSION, V51, P2295, DOI 10.1111/j.1537-2995.2011.03190.x; Department of Health the National Blood Transfusion Committee NHS Blood and Transplant, 2012, PAT BLOOD MAN FUT BL; Devine DV, 2010, VOX SANG, V98, pe295, DOI 10.1111/j.1423-0410.2009.1252.x; Drackley A, 2012, TRANSFUSION, V52, P366, DOI 10.1111/j.1537-2995.2011.03280.x; Dumont LJ, 2009, TRANSFUSION, V49, P458, DOI 10.1111/j.1537-2995.2008.02038.x; Eder A, 2010, J CLIN APHERESIS, V25, P331, DOI 10.1002/jca.20257; Eder AF, 2008, TRANSFUSION, V48, P1809, DOI 10.1111/j.1537-2995.2008.01811.x; Eder AF, 2008, JAMA-J AM MED ASSOC, V299, P2279, DOI 10.1001/jama.299.19.2279; Ehling M, 2010, TRANSFUS MED HEMOTH, V37, P131, DOI 10.1159/000314281; Estcourt LJ, 2012, VOX SANG, V103, P284, DOI 10.1111/j.1423-0410.2012.01627.x; Estcourt L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004269.pub3; Fan W, 2012, TRANSFUSION MED, V22, P395, DOI 10.1111/j.1365-3148.2012.01184.x; Fergusson DA, 2012, JAMA-J AM MED ASSOC, V308, P1443, DOI 10.1001/2012.jama.11953; Fontaine MJ, 2012, TRANSFUSION, V50, P1685; Foukaneli T, 2010, REAUDIT USE GROUP O; France CR, 2011, TRANSFUSION, V51, P1796, DOI 10.1111/j.1537-2995.2010.03033.x; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Goldman M, 2007, TRANSFUSION, V47, P1595, DOI 10.1111/j.1537-2995.2007.01329.x; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hohberger C, 2012, BIOLOGICALS, V40, P209, DOI 10.1016/j.biologicals.2011.10.008; Karam O, 2010, CRIT CARE, V14, DOI 10.1186/cc8953; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Kolins J, 2003, TRANSFUSION, V43, P1634, DOI 10.1046/j.1537-2995.2003.00560.x; LaSalle-Williams M, 2011, TRANSFUSION, V51, P1732, DOI 10.1111/j.1537-2995.2010.03045.x; Locatelli F, 2010, NEPHROL DIAL TRANSPL, V25, P2846, DOI 10.1093/ndt/gfq336; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; Moran L, GINGER CURRY COPIOUS; Mountford J, 2010, BRIT J HAEMATOL, V149, P22, DOI 10.1111/j.1365-2141.2010.08079.x; Murphy MF, 2012, TRANSFUSION, V52, P2502, DOI 10.1111/j.1537-2995.2011.03509.x; Nessen SC, 2013, TRANSFUSION, V53, p107S, DOI 10.1111/trf.12044; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pinkerton PH, 2010, CAN MED ASSOC J, V182, P1019, DOI 10.1503/cmaj.081933; Pisoni RL, 2012, AM J KIDNEY DIS, V60, P160, DOI 10.1053/j.ajkd.2012.04.001; Potter M, 2012, REPORT CYTOMEGALOVIR; Prensky M., 2001, HORIZON, V9, P1, DOI [DOI 10.1108/10748120110424816, 10.1108/10748120110424843, DOI 10.1108/10748120110424843]; Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x; Raval JS, 2011, VOX SANG, V100, P418, DOI 10.1111/j.1423-0410.2010.01439.x; Reems JA, 2010, TRANSFUS MED REV, V24, P33, DOI 10.1016/j.tmrv.2009.09.003; Reesink HW, 2013, VOX SANG, V104, P350, DOI 10.1111/vox.12003; Riddington C, 2002, COCHRANE DB SYST REV, V1; Schubert P, 2012, J PROTEOMICS, V76, P329, DOI 10.1016/j.jprot.2012.06.023; Seed CR, 2010, TRANSFUSION, V50, P2722, DOI 10.1111/j.1537-2995.2010.02793.x; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; Stainsby D, 2010, VOX SANG, V98, P431, DOI 10.1111/j.1423-0410.2009.01275.x; Stanger SHW, 2012, TRANSFUS MED REV, V26, P153, DOI 10.1016/j.tmrv.2011.09.001; Stanworth SJ, 2012, BLOOD, V120; Tinegate H, 2013, TRANSFUSION, V53, P483, DOI 10.1111/j.1537-2995.2012.03782.x; Tomasulo P, 2011, TRANSFUSION, V51, P1511, DOI 10.1111/j.1537-2995.2011.03074.x; Tuinman PR, 2011, CLIN EXP IMMUNOL, V165, P278, DOI 10.1111/j.1365-2249.2011.04422.x; UK Blood Transfusion and Tissue Transplantation Services, GUID UK BLOOD TRANSF; UK Departments of Health advisory committee on safety of blood tissues and organs, 2011, DON SEL CRIT REV 201; van der Schoot CE, 2009, VOX SANG, V96, P167, DOI 10.1111/j.1423-0410.2008.01131.x; van Dijk N, 2009, TRANSFUSION, V49, P411, DOI 10.1111/j.1537-2995.2008.01996.x; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Vraets A, 2011, TRANSFUS MED REV, V25, P184, DOI 10.1016/j.tmrv.2011.01.006; Yazer M, 2007, TRANSFUSION, V47, p164S, DOI 10.1111/j.1537-2995.2007.01378.x; Yuan S, 2011, TRANSFUSION, V51, P2438, DOI 10.1111/j.1537-2995.2011.03174.x; Zou SM, 2012, TRANSFUS MED REV, V26, P119, DOI 10.1016/j.tmrv.2011.07.007	75	167	175	1	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2013	381	9880					1866	1875		10.1016/S0140-6736(13)60631-5	http://dx.doi.org/10.1016/S0140-6736(13)60631-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23706803				2022-12-28	WOS:000319443700033
J	Oh, MH; Yu, T; Yu, SH; Lim, B; Ko, KT; Willinger, MG; Seo, DH; Kim, BH; Cho, MG; Park, JH; Kang, K; Sung, YE; Pinna, N; Hyeon, T				Oh, Myoung Hwan; Yu, Taekyung; Yu, Seung-Ho; Lim, Byungkwon; Ko, Kyung-Tae; Willinger, Marc-Georg; Seo, Dong-Hwa; Kim, Byung Hyo; Cho, Min Gee; Park, Jae-Hoon; Kang, Kisuk; Sung, Yung-Eun; Pinna, Nicola; Hyeon, Taeghwan			Galvanic Replacement Reactions in Metal Oxide Nanocrystals	SCIENCE			English	Article							LITHIUM-ION BATTERIES; CATION-EXCHANGE; ANODE MATERIAL; NANOPARTICLES; HYBRID; SILVER; NANOSTRUCTURES; NANOCAPSULES; TEMPERATURE; DISSOLUTION	Galvanic replacement reactions provide a simple and versatile route for producing hollow nanostructures with controllable pore structures and compositions. However, these reactions have previously been limited to the chemical transformation of metallic nanostructures. We demonstrated galvanic replacement reactions in metal oxide nanocrystats as well. When manganese oxide (Mn3O4) nanocrystals were reacted with iron(II) perchlorate, hollow box-shaped nanocrystats of Mn3O4/gamma-Fe2O3 ("nanoboxes") were produced. These nanoboxes ultimately transformed into hollow cagetike nanocrystats of gamma-Fe2O3 ("nanocages"). Because of their nonequihbrium compositions and hollow structures, these nanoboxes and nanocages exhibited good performance as anode materials for lithium ion batteries. The generality of this approach was demonstrated with other metal pairs, including Co3O4/SnO2 and Mn3O4/SnO2.	[Oh, Myoung Hwan; Yu, Seung-Ho; Kim, Byung Hyo; Cho, Min Gee; Sung, Yung-Eun; Hyeon, Taeghwan] Seoul Natl Univ, Inst Basic Sci, Ctr Nanoparticle Res, Seoul 151742, South Korea; [Oh, Myoung Hwan; Yu, Seung-Ho; Kim, Byung Hyo; Cho, Min Gee; Sung, Yung-Eun; Pinna, Nicola; Hyeon, Taeghwan] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151742, South Korea; [Oh, Myoung Hwan; Yu, Seung-Ho; Kim, Byung Hyo; Cho, Min Gee; Sung, Yung-Eun; Pinna, Nicola; Hyeon, Taeghwan] Seoul Natl Univ, World Class Univ WCU Program Chem Convergence Ene, Seoul 151742, South Korea; [Yu, Taekyung] Kyung Hee Univ, Coll Engn, Dept Chem Engn, Yongin 446701, South Korea; [Lim, Byungkwon] Sungkyunkwan Univ, Sch Adv Mat Sci & Engn, Suwon 440746, South Korea; [Ko, Kyung-Tae; Park, Jae-Hoon] Pohang Univ Sci & Technol, Pohang 790784, South Korea; [Ko, Kyung-Tae; Park, Jae-Hoon] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea; [Willinger, Marc-Georg] Max Planck Gesell, Fritz Haber Inst, Dept Inorgan Chem, D-14195 Berlin, Germany; [Seo, Dong-Hwa; Kang, Kisuk] Seoul Natl Univ, Dept Mat Sci & Engn, Res Inst Adv Mat, Seoul 151742, South Korea; [Park, Jae-Hoon] Pohang Univ Sci & Technol, Div Adv Mat Sci, Pohang 790784, South Korea; [Pinna, Nicola] Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal; [Pinna, Nicola] Univ Aveiro, Ctr Res Ceram & Composite Mat, P-3810193 Aveiro, Portugal; [Pinna, Nicola] Humboldt Univ, Inst Chem, D-12489 Berlin, Germany	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Sungkyunkwan University (SKKU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Max Planck Society; Fritz Haber Institute of the Max Planck Society; Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Universidade de Aveiro; Universidade de Aveiro; Humboldt University of Berlin	Pinna, N (corresponding author), Seoul Natl Univ, World Class Univ WCU Program Chem Convergence Ene, Seoul 151742, South Korea.	nicola.pinna@hu-berlin.de; thyeon@snu.ac.kr	Yu, Seung-Ho/GLR-4572-2022; Willinger, Marc Georg G/C-1836-2015; Pinna, Nicola/AAB-2638-2020; Kang, Kisuk/B-5776-2011; Yu, Taekyung/AAK-7417-2020; Ko, Kyung-Tae/AAA-5417-2022; Seo, Dong-Hwa/D-1446-2011; Pinna, Nicola/G-2307-2010; Lee, Junyoung/D-5463-2012	Willinger, Marc Georg G/0000-0002-9996-7953; Pinna, Nicola/0000-0003-1273-803X; Ko, Kyung-Tae/0000-0003-3649-4594; Seo, Dong-Hwa/0000-0002-7200-7186; Lee, Junyoung/0000-0001-6689-2759; Kang, Kisuk/0000-0002-8696-1886; Yu, Seung-Ho/0000-0003-4833-3181; Oh, Myoung Hwan/0000-0002-8338-3881	Research Center Program of the IBS in Korea; WCU Program of the National Research Foundation (NRF) of Korea [R31-10013]; Portuguese Fundacao para a Ciencia e a Tecnologia project for TEM work [PTD/CTM/100468/2008, REDE/1509/RME/2005]; Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning grant; Korea government Ministry of Trade, Industry and Energy [20124010203320]; National Creative Initiative [2009-0081576]; WCU [R31-2009-000-10059]; Max Plank POSTECH/KOREA Research Initiative programs though the NRF of Korea [2011-0031558]; POSTECH; Ministry of Science, ICT and Future Planning	Research Center Program of the IBS in Korea; WCU Program of the National Research Foundation (NRF) of Korea; Portuguese Fundacao para a Ciencia e a Tecnologia project for TEM work; Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning grant(Korea Institute of Energy Technology Evaluation & Planning (KETEP)); Korea government Ministry of Trade, Industry and Energy; National Creative Initiative; WCU; Max Plank POSTECH/KOREA Research Initiative programs though the NRF of Korea; POSTECH; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	We acknowledge financial support by the Research Center Program of the IBS in Korea (T.H. and Y.-E.S.); the WCU (R31-10013) Program of the National Research Foundation (NRF) of Korea (T.H., N.P., and Y.-E.S.); Portuguese Fundacao para a Ciencia e a Tecnologia project (PTD/CTM/100468/2008 and REDE/1509/RME/2005) for TEM work (M.-G.W. and N.P.); a Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning grant funded by the Korea government Ministry of Trade, Industry and Energy (20124010203320) (K.K. and D.-H.S); and National Creative Initiative (2009-0081576), WCU (R31-2009-000-10059), and Max Plank POSTECH/KOREA Research Initiative (2011-0031558) programs though the NRF of Korea (K.-T.K. and J.-H.P.). The Pohang Accelerator Laboratory is supported by POSTECH and the Ministry of Science, ICT and Future Planning.	Cabot A, 2007, J AM CHEM SOC, V129, P10358, DOI 10.1021/ja072574a; Cabot A, 2009, J AM CHEM SOC, V131, P11326, DOI 10.1021/ja903751p; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Fetisov VB, 2007, J SOLID STATE ELECTR, V11, P1205, DOI 10.1007/s10008-007-0269-5; Gonzalez E, 2011, SCIENCE, V334, P1377, DOI 10.1126/science.1212822; Kang JS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035121; Kim HS, 2010, ELECTROCHEM COMMUN, V12, P382, DOI 10.1016/j.elecom.2009.12.040; Kim J, 2009, ELECTROCHIM ACTA, V54, P5914, DOI 10.1016/j.electacta.2009.05.058; Koo B, 2012, NANO LETT, V12, P2429, DOI 10.1021/nl3004286; Li MX, 2012, CHEM COMMUN, V48, P410, DOI 10.1039/c1cc15322f; Macdonald JE, 2010, NAT MATER, V9, P810, DOI [10.1038/NMAT2848, 10.1038/nmat2848]; Metraux GS, 2003, NANO LETT, V3, P519, DOI 10.1021/nl034097+; Moon GD, 2011, NANO TODAY, V6, P186, DOI 10.1016/j.nantod.2011.02.006; Park J, 2009, J AM CHEM SOC, V131, P13943, DOI 10.1021/ja905732q; Peng S, 2007, ANGEW CHEM INT EDIT, V46, P4155, DOI 10.1002/anie.200700677; Peng ZM, 2010, NANO LETT, V10, P1492, DOI 10.1021/nl100559y; Piao Y, 2008, NAT MATER, V7, P242, DOI 10.1038/nmat2118; Skrabalak SE, 2008, ACCOUNTS CHEM RES, V41, P1587, DOI 10.1021/ar800018v; Son DH, 2004, SCIENCE, V306, P1009, DOI 10.1126/science.1103755; Sun YG, 2004, J AM CHEM SOC, V126, P3892, DOI 10.1021/ja039734c; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Villinski JE, 2001, ENVIRON SCI TECHNOL, V35, P1157, DOI 10.1021/es001356d; Wang HL, 2010, J AM CHEM SOC, V132, P13978, DOI 10.1021/ja105296a; Wang ZY, 2012, ADV MATER, V24, P1903, DOI 10.1002/adma.201200469; Wu X, 2012, ANGEW CHEM INT EDIT, V51, P3211, DOI 10.1002/anie.201108098; Xiao F, 2007, J AM CHEM SOC, V129, P10068, DOI 10.1021/ja073032w; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Yu T, 2009, CHEM MATER, V21, P2272, DOI 10.1021/cm900431b; Zhang Q, 2009, NANO TODAY, V4, P494, DOI 10.1016/j.nantod.2009.10.008	29	429	432	23	1157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					964	968		10.1126/science.1234751	http://dx.doi.org/10.1126/science.1234751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704569				2022-12-28	WOS:000319344100043
J	Dyer, C				Dyer, Clare			The long road to ensuring patient safety in NHS hospitals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												claredyer4@gmail.com						Bolsin S., 2011, MED HARM        0727; Darzi A., 2008, HIGH QUALITY CARE AL; Department of Health, 2006, SAF 1 REP PAT CLIN H; Department of Health, 2000, ORG MEM; Francis R., 2013, REP MIDST NHS FDN TR; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Institute for Healthcare Improvement, 2008, ACH VIS EXC QUAL; Kennedy I, 2001, LEARNING BRISTOL REP; NHS Litigation Authority, 2012, 10 YEARS MAT CLAIMS; NHS Litigation Authority, 2012, REP ACC 2011 12; Pasupathy D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3498	11	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2013	346								f3029	10.1136/bmj.f3029	http://dx.doi.org/10.1136/bmj.f3029			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AW	23704127				2022-12-28	WOS:000319574500004
J	Hurley, R				Hurley, Richard			Angelina Jolie's double mastectomy and the question of who owns our genes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						[Anonymous], 2013, US TODAY; Boshoff A, 2013, MAIL ONLINE     0515; Cochran A, 2013, CBS NEWS; Funk Krist, 2013, PATIENTS JOURNEY A J; Jolie A., 2013, NEW YORK TIMES, V14, P2013; Kay B, 2013, NATL POST       0513; Marsden S., 2013, TELEGRAPH; McCarthy M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2446; Powledge TM, 2013, SCI BLOGS JOLIE 0517; Wieczner J, 2014, MARKET WATCH    0521	10	6	6	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2013	346								f3340	10.1136/bmj.f3340	http://dx.doi.org/10.1136/bmj.f3340			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AV	23697674				2022-12-28	WOS:000319574400022
J	Mangin, D				Mangin, Dee			Review: Cranberry products do not reduce urinary tract infections in susceptible populations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Otago, Christchurch, New Zealand	University of Otago	Mangin, D (corresponding author), Univ Otago, Christchurch, New Zealand.		Craig, Jonathan/E-2813-2013	Craig, Jonathan/0000-0002-2548-4035				Buitrago-Lopez A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4488; Epp A, 2010, J OBSTET GYNAECOL CA, V32, P1082, DOI 10.1016/S1701-2163(16)34717-X; Jepson RG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001321.pub4; Mangin D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c657	4	0	0	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC11	10.7326/0003-4819-158-10-201305210-02011	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689778				2022-12-28	WOS:000319666200010
J	Kurdi, AT				Kurdi, Ahmed Toufic			Bullosis diabeticorum	LANCET			English	Editorial Material									Amer Univ Beirut, Med Ctr, Beirut 11072020, Lebanon	American University of Beirut	Kurdi, AT (corresponding author), Amer Univ Beirut, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon.	attkurdi@gmail.com							0	7	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					E31	E31		10.1016/S0140-6736(13)60145-2	http://dx.doi.org/10.1016/S0140-6736(13)60145-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259QF	23706658				2022-12-28	WOS:000327540700003
J	Bhala, N; Emberson, J; Merhi, A; Abramson, S; Arber, N; Baron, JA; Bombardier, C; Cannon, C; Farkouh, ME; FitzGerald, GA; Goss, P; Halls, H; Hawk, E; Hawkey, C; Hennekens, C; Hochberg, M; Holland, LE; Kearney, PM; Laine, L; Lanas, A; Lance, P; Laupacis, A; Oates, J; Patrono, C; Schnitzer, TJ; Solomon, S; Tugwell, P; Wilson, K; Wittes, J; Baigent, C; Adelowo, O; Aisen, P; Al-Quorain, A; Altman, R; Bakris, G; Baumgartner, H; Bresee, C; Carducci, M; Chang, DM; Chou, CT; Clegg, D; Cudkowicz, M; Doody, L; El Miedany, Y; Falandry, C; Farley, J; Ford, L; GarciLosa, M; Gonzalez-Ortiz, M; Haghighi, M; Hala, M; Iwama, T; Jajic, Z; Kerr, D; Kim, HS; Kohne, C; Koo, BK; Martin, B; Meinert, C; Muller, N; Myklebust, G; Neustadt, D; Omdal, R; Ozgocmen, S; Papas, A; Patrignani, P; Pelliccia, F; Roy, V; Schlegelmilch, I; Umar, A; Wahlstrom, O; Wollheim, F; Yocum, S; Zhang, XY; Hall, E; McGettigan, P; Midgley, R; Moore, RA; Philipson, R; Curtis, S; Reicin, A; Bond, J; Moore, A; Essex, M; Fabule, J; Morrison, B; Tive, L; Davies, K; Holland, LE; Merhi, A; Yau, F				Bhala, N.; Emberson, J.; Merhi, A.; Abramson, S.; Arber, N.; Baron, J. A.; Bombardier, C.; Cannon, C.; Farkouh, M. E.; FitzGerald, G. A.; Goss, P.; Halls, H.; Hawk, E.; Hawkey, C.; Hennekens, C.; Hochberg, M.; Holland, L. E.; Kearney, P. M.; Laine, L.; Lanas, A.; Lance, P.; Laupacis, A.; Oates, J.; Patrono, C.; Schnitzer, T. J.; Solomon, S.; Tugwell, P.; Wilson, K.; Wittes, J.; Baigent, C.; Adelowo, O.; Aisen, P.; Al-Quorain, A.; Altman, R.; Bakris, G.; Baumgartner, H.; Bresee, C.; Carducci, M.; Chang, D-M.; Chou, C-T.; Clegg, D.; Cudkowicz, M.; Doody, L.; El Miedany, Y.; Falandry, C.; Farley, J.; Ford, L.; GarciLosa, M.; Gonzalez-Ortiz, M.; Haghighi, M.; Hala, M.; Iwama, T.; Jajic, C.; Kerr, D.; Kim, H-S.; Kohne, C.; Koo, B-K.; Martin, B.; Meinert, C.; Muller, N.; Myklebust, G.; Neustadt, D.; Omdal, R.; Ozgocmen, S.; Papas, A.; Patrignani, P.; Pelliccia, F.; Roy, V.; Schlegelmilch, I.; Umar, A.; Wahlstrom, O.; Wollheim, F.; Yocum, S.; Zhang, X. Y.; Hall, E.; McGettigan, P.; Midgley, R.; Moore, R. A.; Philipson, R.; Curtis, S.; Reicin, A.; Bond, J.; Moore, A.; Essex, M.; Fabule, J.; Morrison, B.; Tive, L.; Davies, K.; Holland, L. E.; Merhi, A.; Yau, F.		Coxib Traditional NSAID Trialists	Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials	LANCET			English	Article							LOW-DOSE ASPIRIN; INHIBITORS PARECOXIB; CARDIOVASCULAR RISK; NAPROXEN; SAFETY; COMPLICATIONS; EFFICACY; PHARMACOLOGY; VALDECOXIB; ROFECOXIB	Background The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-inflammatory drugs (tNSAIDs), are not well characterised, particularly in patients at increased risk of vascular disease. We aimed to provide such information through meta-analyses of randomised trials. Methods We undertook meta-analyses of 280 trials of NSAIDs versus placebo (124 513 participants, 68 342 person-years) and 474 trials of one NSAID versus another NSAID (229 296 participants, 165 456 person-years). The main outcomes were major vascular events (non-fatal myocardial in farction, non-fatal stroke, or vascular death); major coronary events (non-fatal myocardial infarction or coronary death); stroke; mortality; heart failure; and upper gastrointestinal complications (perforation, obstruction, or bleed). Findings Major vascular events were increased by about a third by a coxib (rate ratio [RR] 1.37, 95% CI 1.14-1.66; p=0.0009) or diclofenac (1.41, 1.12-1.78; p=0.0036), chiefly due to an increase in major coronary events (coxibs 1.76, 1.31-2.37; p=0.0001; diclofenac 1.70, 1.19-2.41; p=0.0032). Ibuprofen also significantly increased major coronary events (2.22, 1.10-4.48; p=0.0253), but not major vascular events (1.44, 0.89-2.33). Compared with placebo, of 1000 patients allocated to a coxib or diclofenac for a year, three more had major vascular events, one of which was fatal. Naproxen did not significantly increase major vascular events (0.93, 0.69-1.27). Vascular death was increased significantly by coxibs (1.58, 99% CI 1.00-2.49; p=0.0103) and diclofenac (1.65, 0.95-2.85, p=0.0187), nonsignificantly by ibuprofen (1.90, 0.56-6.41; p=0.17), but not by naproxen (1.08, 0.48-2.47, p=0.80). The proportional effects on major vascular events were independent of baseline characteristics, including vascular risk. Heart failure risk was roughly doubled by all NSAIDs. All NSAID regimens increased upper gastrointestinal complications (coxibs 1.81, 1.17-2.81, p=0.0070; diclofenac 1.89, 1.16-3.09, p=0.0106; ibuprofen 3.97, 2.22-7.10, p<0.0001; and naproxen 4.22, 2.71-6.56, p<0.0001). Interpretation The vascular risks of high-dose diclofenac, and possibly ibuprofen, are comparable to coxibs, whereas high-dose naproxen is associated with less vascular risk than other NSAIDs. Although NSAIDs increase vascular and gastrointestinal risks, the size of these risks can be predicted, which could help guide clinical decision making.	[Baigent, C.] Nuffield Dept Clin Med, Clin Trial Serv Unit, Oxford OX3 7LF, England	University of Oxford	Baigent, C (corresponding author), Nuffield Dept Clin Med, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	cnt@ctsu.ox.ac.uk	Carducci, Michael/R-8164-2019; FALANDRY, Claire/H-6055-2012; Falandry, Claire/AAI-5736-2021; Bannuru, Raveendhara/G-2601-2011; Ozgocmen, Salih/K-4680-2019; Patrignani, Paola/B-4844-2011; Ozgocmen, Salih/K-9588-2015; Umar, Asad/AAI-4560-2020; Miedany, Yasser/GLR-7689-2022; Tugwell, Peter/AFD-8076-2022; Lance, Peter/I-2196-2014; Kearney, Patricia M/AAE-8501-2020; CUDKOWICZ, MERIT/GWM-6585-2022	FALANDRY, Claire/0000-0001-7267-4723; Falandry, Claire/0000-0001-7267-4723; Bannuru, Raveendhara/0000-0002-8069-5783; Ozgocmen, Salih/0000-0002-4860-452X; Patrignani, Paola/0000-0003-1419-2691; Ozgocmen, Salih/0000-0002-4860-452X; Umar, Asad/0000-0002-6239-8494; Tugwell, Peter/0000-0001-5062-0556; Lance, Peter/0000-0003-2944-1881; CUDKOWICZ, MERIT/0000-0002-7075-1681; Bombardier, Claire/0000-0001-5083-2137; Emberson, Jonathan/0000-0001-7792-9422; Bhala, Neeraj/0000-0003-2502-1177; Kearney, Patricia/0000-0001-9599-3540; Patrono, Carlo/0000-0002-6447-2424; Arber, Nadir/0000-0001-5283-6991; Al-Quorain, Abdulaziz/0000-0003-4770-3929; Kerr, Rachel/0000-0002-7240-3269	UK Medical Research Council; British Heart Foundation; MRC [MC_U137686849, G0701732] Funding Source: UKRI; Medical Research Council [G0701732, MC_U137686849] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council and British Heart Foundation.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 2002, J RHEUMATOL, V29, P804; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Capone ML, 2007, J PHARMACOL EXP THER, V322, P453, DOI 10.1124/jpet.107.122283; Capone ML, 2004, CIRCULATION, V109, P1468, DOI 10.1161/01.CIR.0000124715.27937.78; Capone ML, 2005, J AM COLL CARDIOL, V45, P1295, DOI 10.1016/j.jacc.2005.01.045; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; *EARL BREAST CANC, 1990, TREATM EARL BREAST C, V1; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Rodriguez LAG, 2008, J AM COLL CARDIOL, V52, P1628, DOI 10.1016/j.jacc.2008.08.041; Glenny A., 2005, HEALTH TECHNOL ASSES, V9, piii; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Maetzel A, 2001, 23 CAN COORD OFF HLT; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Meek IL, 2013, EUR J CLIN PHARMACOL, V69, P365, DOI 10.1007/s00228-012-1370-y; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Ofman JJ, 2002, J RHEUMATOL, V29, P804; Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(03)00125-9; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Rostom A, 2007, CLIN GASTROENTEROL H, V5, P818, DOI 10.1016/j.cgh.2007.03.011; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; US Food and Drug Administration, AN REC AG ACT REG NO	31	1061	1125	11	148	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					769	779		10.1016/S0140-6736(13)60900-9	http://dx.doi.org/10.1016/S0140-6736(13)60900-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23726390	Green Published			2022-12-28	WOS:000324239200027
J	Luyckx, VA; Bertram, JF; Brenner, BM; Fall, C; Hoy, WE; Ozanne, SE; Vikse, BE				Luyckx, Valerie A.; Bertram, John F.; Brenner, Barry M.; Fall, Caroline; Hoy, Wendy E.; Ozanne, Susan E.; Vikse, Bjorn E.			Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease	LANCET			English	Article							LOW-BIRTH-WEIGHT; IMPAIRED GLUCOSE-TOLERANCE; BLOOD-PRESSURE; NEPHRON NUMBER; PRETERM BIRTH; GLOMERULAR NUMBER; RENAL-FUNCTION; SENSITIVE HYPERTENSION; GROWTH RESTRICTION; SALT SENSITIVITY	Developmental programming of non-communicable diseases is now an established paradigm. With respect to hypertension and chronic kidney disease, adverse events experienced in utero can aff ect development of the fetal kidney and reduce fi nal nephron number. Low birthweight and prematurity are the most consistent clinical surrogates for a low nephron number and are associated with increased risk of hypertension, proteinuria, and kidney disease in later life. Rapid weight gain in childhood or adolescence further compounds these risks. Low birthweight, prematurity, and rapid childhood weight gain should alert clinicians to an individual's lifelong risk of hypertension and kidney disease, prompting education to minimise additional risk factors and ensuring follow-up. Birthweight and prematurity are aff ected substantially by maternal nutrition and health during pregnancy. Optimisation of maternal health and early childhood nutrition could, therefore, attenuate this programming cycle and reduce the global burden of hypertension and kidney disease in the future.	[Luyckx, Valerie A.] Univ Alberta, Div Nephrol, Edmonton, AB T6G 2S2, Canada; [Bertram, John F.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Brenner, Barry M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Fall, Caroline] Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO9 4XY, Hants, England; [Hoy, Wendy E.] Univ Queensland, Sch Med, Ctr Chron Dis, Brisbane, Qld, Australia; [Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Cambridge, England; [Vikse, Bjorn E.] Univ Bergen, Inst Med, Bergen, Norway; [Vikse, Bjorn E.] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway	University of Alberta; Monash University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Southampton; University of Queensland; University of Cambridge; University of Bergen; University of Bergen; Haukeland University Hospital	Luyckx, VA (corresponding author), Univ Alberta, Div Nephrol, Edmonton, AB T6G 2S2, Canada.	vluyckx@ualberta.ca	Bertram, John F/I-2588-2014; Hoy, Wendy E/A-7325-2010; Luyckx, Valerie/J-9747-2019	Bertram, John F/0000-0001-5863-6464; Hoy, Wendy E/0000-0002-8405-1539; Luyckx, Valerie/0000-0001-7066-8135; Fall, Caroline/0000-0003-4402-5552; Ozanne, Susan/0000-0001-8753-5144	Medical Research Council [MC_UU_12012/4, MC_UU_12011/3] Funding Source: researchfish; British Heart Foundation [FS/09/029/27902] Funding Source: Medline; Medical Research Council [MC_UP_A620_1016] Funding Source: Medline; MRC [MC_UU_12011/3, MC_UP_A620_1016, MC_UU_12012/4] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdel-Hakeem AK, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.018; Abitbol CL, 2012, NAT REV NEPHROL, V8, P265, DOI 10.1038/nrneph.2012.38; Abitbol CL, 2009, PEDIATR NEPHROL, V24, P1363, DOI 10.1007/s00467-009-1120-2; Abitbol CL, 2003, PEDIATR NEPHROL, V18, P887, DOI 10.1007/s00467-003-1186-1; Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; Amri R, 1999, DIABETES, V48, P2240, DOI 10.2337/diabetes.48.11.2240; Andersen LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014126; [Anonymous], 2009, WHO GLOBAL DATABASE; Bacchetta J, 2009, KIDNEY INT, V76, P445, DOI 10.1038/ki.2009.201; Bansal N, 2008, J HYPERTENS, V26, P412, DOI 10.1097/HJH.0b013e3282f3168e; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Baum M, 2010, AM J PHYSIOL-RENAL, V298, pF235, DOI 10.1152/ajprenal.00288.2009; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bergvall N, 2007, CIRCULATION, V115, P2931, DOI 10.1161/CIRCULATIONAHA.106.674812; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Boivin A, 2012, CAN MED ASSOC J, V184, P1777, DOI 10.1503/cmaj.120143; Boubred F, 2007, AM J PHYSIOL-RENAL, V293, pF1944, DOI 10.1152/ajprenal.00141.2007; Boubred F, 2009, AM J PHYSIOL-RENAL, V297, pF943, DOI 10.1152/ajprenal.90704.2008; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Collins JW, 2011, MATERN CHILD HLTH J, V15, P438, DOI 10.1007/s10995-010-0603-x; Crowther CA, 2007, NEW ENGL J MED, V357, P1179, DOI 10.1056/NEJMoa071152; Dalziel SR, 2005, LANCET, V365, P1856, DOI 10.1016/S0140-6736(05)66617-2; Davis EM, 2010, BIRTH DEFECTS RES A, V88, P722, DOI 10.1002/bdra.20702; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; de Boer MP, 2008, HYPERTENSION, V51, P928, DOI 10.1161/HYPERTENSIONAHA.107.101881; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Denisenko O, 2011, J DEV ORIG HLTH DIS, V2, P124, DOI 10.1017/S2040174410000632; Fall C, 2009, INDIAN J MED RES, V130, P593; Fall CHD, 2008, DIABETES CARE, V31, P2349, DOI 10.2337/dc08-0911; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Goodyer P, 2007, PEDIATR NEPHROL, V22, P209, DOI 10.1007/s00467-006-0213-4; Gray SP, 2008, AM J PHYSIOL-REG I, V295, pR568, DOI 10.1152/ajpregu.90316.2008; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; Hofmeyr GJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub3; Hoy WE, 2010, J DEV ORIG HLTH DIS, V1, P216, DOI 10.1017/S204017441000022X; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Hoy WE, 2001, KIDNEY INT, V60, P249, DOI 10.1046/j.1523-1755.2001.00793.x; Hoy WE, 2008, CURR OPIN NEPHROL HY, V17, P258, DOI 10.1097/MNH.0b013e3282f9b1a5; Hoy WE, 2011, AM J NEPHROL, V33, P15, DOI 10.1159/000327044; Hoy WE, 2010, MED J AUSTRALIA, V192, P14, DOI 10.5694/j.1326-5377.2010.tb03394.x; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Jain V, 2012, REV ENDOCR METAB DIS, V13, P141, DOI 10.1007/s11154-012-9216-6; Jiwani A, 2012, J MATERN-FETAL NEO M, V25, P600, DOI 10.3109/14767058.2011.587921; Kaczmarczyk M, 2013, PEDIATR NEPHROL, V28, P433, DOI 10.1007/s00467-012-2277-7; Keijzer-Veen MG, 2005, J AM SOC NEPHROL, V16, P2762, DOI 10.1681/ASN.2004090783; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Kemper M J, 2001, Curr Opin Urol, V11, P571; Khalil CA, 2010, DIABETES, V59, P2631, DOI 10.2337/db10-0419; Kwinta P, 2011, PEDIATR NEPHROL, V26, P1095, DOI 10.1007/s00467-011-1840-y; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; Lackland DT, 2000, ARCH INTERN MED, V160, P1472, DOI 10.1001/archinte.160.10.1472; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Li S, 2008, KIDNEY INT, V73, P637, DOI 10.1038/sj.ki.5002747; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luyckx VA, 2012, SCHRIERS DIS KIDNEY, P46; Luyckx VA, 2010, J AM SOC NEPHROL, V21, P898, DOI 10.1681/ASN.2009121248; Luyckx VA, 2009, AM J PHYSIOL-RENAL, V297, pF1697, DOI 10.1152/ajprenal.00462.2009; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; Merlet-Benichou C, 1999, CURR OPIN NEPHROL HY, V8, P39, DOI 10.1097/00041552-199901000-00007; Mohn A, 2007, J CLIN ENDOCR METAB, V92, P1372, DOI 10.1210/jc.2006-1344; Moritz KM, 2008, ADV ANAT EMBRYOL CEL, V196, P1; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; Nehiri T, 2008, DIABETES, V57, P2167, DOI 10.2337/db07-0780; Nelson RG, 1998, AM J EPIDEMIOL, V148, P650, DOI 10.1093/aje/148.7.650; Nevis IF, 2011, CLIN J AM SOC NEPHRO, V6, P2587, DOI 10.2215/CJN.10841210; Norman JE, 2011, P NUTR SOC, V70, P450, DOI 10.1017/S0029665111003077; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x; Puelles VG, 2011, CURR OPIN NEPHROL HY, V20, P7, DOI 10.1097/MNH.0b013e3283410a7d; Quinlan J, 2007, J AM SOC NEPHROL, V18, P1915, DOI 10.1681/ASN.2006101107; Raqib R, 2007, AM J CLIN NUTR, V85, P845, DOI 10.1093/ajcn/85.3.845; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; ROSSING P, 1995, BRIT MED J, V310, P296, DOI 10.1136/bmj.310.6975.296; Salazar F, 2008, HYPERTENSION, V51, P1184, DOI 10.1161/HYPERTENSIONAHA.107.100750; Schreuder MF, 2011, CLIN J AM SOC NEPHRO, V6, P212, DOI 10.2215/CJN.04740510; Schreuder MF, 2009, CLIN J AM SOC NEPHRO, V4, P1774, DOI 10.2215/CJN.02230409; Simonetti GD, 2008, HYPERTENSION, V52, P625, DOI 10.1161/HYPERTENSIONAHA.108.114983; Skelton JA, 2011, PEDIATR CLIN N AM, V58, P1333, DOI 10.1016/j.pcl.2011.09.006; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tarry-Adkins JL, 2011, AM J CLIN NUTR, V94, p1765S, DOI 10.3945/ajcn.110.000620; Tsirpanlis G, 2008, AM J KIDNEY DIS, V51, P131, DOI 10.1053/j.ajkd.2007.07.035; UNICEF, 2004, LOW BIRTHW COUNTR RE; Vikse BE, 2013, LANCET; Vikse BE, 2008, J AM SOC NEPHROL, V19, P151, DOI 10.1681/ASN.2007020252; Wang YF, 2006, ADV CHRONIC KIDNEY D, V13, P336, DOI 10.1053/j.ackd.2006.07.016; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Wlodek ME, 2008, KIDNEY INT, V74, P187, DOI 10.1038/ki.2008.153; Wlodek ME, 2007, J AM SOC NEPHROL, V18, P1688, DOI 10.1681/ASN.2007010015; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2012, WORLD HLTH STAT 2012; Zetterstrom K, 2007, BJOG-INT J OBSTET GY, V114, P319, DOI 10.1111/j.1471-0528.2006.01231.x; Zhang Z, 2008, J AM SOC NEPHROL, V19, P2027, DOI 10.1681/ASN.2007101098	101	334	345	3	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					273	283		10.1016/S0140-6736(13)60311-6	http://dx.doi.org/10.1016/S0140-6736(13)60311-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FL	23727166	Green Accepted			2022-12-28	WOS:000322543700037
J	Taylor, RC; Ryan, MJ				Taylor, R. C.; Ryan, M. J.			Interactions of Multisensory Components Perceptually Rescue Tungara Frog Mating Signals	SCIENCE			English	Article							BEHAVIOR; COMMUNICATION; INFERENCE; SELECTION; CHOICE	Sexual signals are often complex and perceived by multiple senses. How animals integrate signal components across sensory modalities can influence signal evolution. Here we show that two relatively unattractive signals that are perceived acoustically and visually can be combined in a pattern to form a signal that is attractive to female tungara frogs. Such unanticipated perceptual effects suggest that the evolution of complex signals can occur by alteration of the relationships among already-existing traits.	[Taylor, R. C.] Salisbury Univ, Dept Biol, Salisbury, MD 21801 USA; [Ryan, M. J.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Ryan, M. J.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	University System of Maryland; Salisbury University; University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian Tropical Research Institute	Ryan, MJ (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	mryan@utexas.edu			NSF [IBN 0517328, IBN 0078150, IOS 1120031]; Clark Hubbs Regents Professorship	NSF(National Science Foundation (NSF)); Clark Hubbs Regents Professorship	We are grateful to the NSF (grants IBN 0517328, IBN 0078150, and IOS 1120031) and the Clark Hubbs Regents Professorship (M.J.R.) for funding and the Smithsonian Tropical Research Institute for logistical support. We thank E. Balaban for helpful discussion and H. Farris, S. Partan, S. Pika, G. Rosenthal, and three anonymous reviewers for their comments on the manuscript. We thank B. Klein and Moey, Incorporated for design and fabrication of the robotic frogs. We are especially grateful to the interns who assisted in data collection. All research reported here complied with IACUC protocols from Salisbury University, the University of Texas, and the Smithsonian Tropical Research Institute. We obtained all required permits from the Government of Panama. Data will be archived in the Dryad Data Repository at dx.doi.org/10.5061/dryad.pk85.	Agresti A, 2001, STAT MED, V20, P2709, DOI 10.1002/sim.738; Agresti A, 2007, INTRO CATEGORICAL DA, V2nd; Bahrick LE, 2004, CURR DIR PSYCHOL SCI, V13, P99, DOI 10.1111/j.0963-7214.2004.00283.x; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bregman A.S., 1994, AUDITORY SCENE ANAL; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; Farris HE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1417; Gridi-Papp M, 2006, NATURE, V441, P38, DOI 10.1038/441038a; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Marler P, 1997, J NEUROBIOL, V33, P501; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Pauly GB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P708, DOI 10.1086/504613; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; Rowe C, 1996, NATURE, V383, P520, DOI 10.1038/383520a0; Ryan M. J., ANN REV ECO IN PRESS; Ryan MJ, 2011, INTEGR COMP BIOL, V51, P756, DOI 10.1093/icb/icr065; Seeba F, 2010, ANIM BEHAV, V79, P1317, DOI 10.1016/j.anbehav.2010.03.004; Taylor RC, 2008, ANIM BEHAV, V76, P1089, DOI 10.1016/j.anbehav.2008.01.031; Taylor RC, 2007, ANIM BEHAV, V74, P1753, DOI 10.1016/j.anbehav.2007.03.010; Taylor RC, 2011, J EXP BIOL, V214, P815, DOI 10.1242/jeb.043638; Wilczynski W, 1999, ANIM BEHAV, V58, P841, DOI 10.1006/anbe.1999.1208	24	75	75	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					273	274		10.1126/science.1237113	http://dx.doi.org/10.1126/science.1237113			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23744778				2022-12-28	WOS:000321959300042
J	Hunt, KA; Mistry, V; Bockett, NA; Ahmad, T; Ban, M; Barker, JN; Barrett, JC; Blackburn, H; Brand, O; Burren, O; Capon, F; Compston, A; Gough, SCL; Jostins, L; Kong, Y; Lee, JC; Lek, M; MacArthur, DG; Mansfield, JC; Mathew, CG; Mein, CA; Mirza, M; Nutland, S; Onengut-Gumuscu, S; Papouli, E; Parkes, M; Rich, SS; Sawcer, S; Satsangi, J; Simmonds, MJ; Trembath, RC; Walker, NM; Wozniak, E; Todd, JA; Simpson, MA; Plagnol, V; van Heel, DA				Hunt, Karen A.; Mistry, Vanisha; Bockett, Nicholas A.; Ahmad, Tariq; Ban, Maria; Barker, Jonathan N.; Barrett, Jeffrey C.; Blackburn, Hannah; Brand, Oliver; Burren, Oliver; Capon, Francesca; Compston, Alastair; Gough, Stephen C. L.; Jostins, Luke; Kong, Yong; Lee, James C.; Lek, Monkol; MacArthur, Daniel G.; Mansfield, John C.; Mathew, Christopher G.; Mein, Charles A.; Mirza, Muddassar; Nutland, Sarah; Onengut-Gumuscu, Suna; Papouli, Efterpi; Parkes, Miles; Rich, Stephen S.; Sawcer, Steven; Satsangi, Jack; Simmonds, Matthew J.; Trembath, Richard C.; Walker, Neil M.; Wozniak, Eva; Todd, John A.; Simpson, Michael A.; Plagnol, Vincent; van Heel, David A.			Negligible impact of rare autoimmune-locus coding-region variants on missing heritability	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; PSORIASIS SUSCEPTIBILITY LOCI; RHEUMATOID-ARTHRITIS; COMMON VARIANTS; LOW-FREQUENCY; GENES; RISK; ARCHITECTURE; REVEALS	Genome-wide association studies(GWAS) have identified common variants of modest-effect size at hundreds of loci for common autoimmune diseases; however, a substantial fraction of heritability remains unexplained, to which rare variants may contribute(1,2). To discover rare variants and test them for association with a phenotype, most studies re-sequence a small initial sample size and then genotype the discovered variants in a larger sample set(3-5). This approach fails to analyse a large fraction of the rare variants present in the entire sample set. Here we perform simultaneous amplicon-sequencing-based variant discovery and genotyping for coding exons of 25 GWAS risk genes in 41,911 UK residents of white European origin, comprising 24,892 subjects with six autoimmune disease phenotypes and 17,019 controls, and show that rare coding-region variants at known loci have a negligible role in common autoimmune disease susceptibility. These results do not support the rare-variant synthetic genome-wide-association hypothesis(6) (in which unobserved rare causal variants lead to association detected at common tag variants). Many known autoimmune disease risk loci contain multiple, independently associated, common and low-frequency variants, and so genes at these loci are a priori stronger candidates for harbouring rare coding-region variants than other genes. Our data indicate that the missing heritability for common autoimmune diseases may not be attributable to the rare coding-region variant portion of the allelic spectrum, but perhaps, as others have proposed, may be a result of many common-variant loci of weak effect(7-10).	[Hunt, Karen A.; Mistry, Vanisha; Bockett, Nicholas A.; van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England; [Ahmad, Tariq] Peninsula Coll Med & Dent, Exeter EX2 5DW, Devon, England; [Ban, Maria; Compston, Alastair; Sawcer, Steven] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Barker, Jonathan N.; Capon, Francesca; Mathew, Christopher G.; Mirza, Muddassar; Papouli, Efterpi; Simpson, Michael A.] Kings Coll London, Sch Med, Div Genet & Mol Med, Guys Hosp, London SE1 9RT, England; [Barrett, Jeffrey C.; Blackburn, Hannah] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Brand, Oliver; Gough, Stephen C. L.; Simmonds, Matthew J.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Burren, Oliver; Nutland, Sarah; Walker, Neil M.; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; [Jostins, Luke] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Kong, Yong] Yale Univ, WM Keck Fdn Biotechnol Resource Lab, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Lee, James C.; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 0QQ, England; [Lek, Monkol; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Mansfield, John C.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Mein, Charles A.; Wozniak, Eva] Queen Mary Univ London, Barts & London Sch Med & Dent, John Vane Sci Ctr, Genome Ctr, London EC1M 6BQ, England; [Onengut-Gumuscu, Suna; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Trembath, Richard C.] Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 2AT, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England	University of London; Queen Mary University London; University of Exeter; University of Plymouth; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Wellcome Trust Sanger Institute; University of Oxford; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Yale University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Massachusetts General Hospital; Newcastle University - UK; University of London; Queen Mary University London; University of Virginia; University of Edinburgh; University of London; Queen Mary University London; University of London; University College London	van Heel, DA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England.	v.plagnol@ucl.ac.uk; d.vanheel@qmul.ac.uk	Simpson, Michael/F-4737-2011; Mathew, Christopher G/G-3434-2015; Kong, Yong/B-5105-2014; Lee, James/ABD-5920-2020; Todd, John A/A-3542-2010; Capon, Francesca/F-4763-2011	Simpson, Michael/0000-0002-8539-8753; Mathew, Christopher G/0000-0003-4178-1838; Kong, Yong/0000-0002-2881-5274; Lee, James/0000-0001-5711-9385; Todd, John A/0000-0003-2740-8148; Capon, Francesca/0000-0003-2432-5793; Rich, Stephen/0000-0003-3872-7793; van Heel, David/0000-0002-0637-2265; Simmonds, Matt/0000-0003-3154-3510; Burren, Oliver/0000-0002-3388-5760; Mein, Charles/0000-0003-0811-9658; Trembath, Richard/0000-0003-0550-3400; Barrett, Jeffrey/0000-0002-1152-370X; Parkes, Miles/0000-0002-6467-0631; Bockett, Nicholas/0000-0002-7630-7637; Walker, Neil/0000-0001-9796-7688; Barker, Jonathan/0000-0002-9030-183X; Plagnol, Vincent/0000-0002-5597-9215; MacArthur, Daniel/0000-0002-5771-2290	Medical Research Council [MRC G1001158]; Coeliac UK; MRC [G0601387]; National Institutes for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Cambridge NIHR Biomedical Research Centre; Wellcome Trust [076113/C/04/Z, 068545/Z/02, 068181, JDRF 4-2001-1008, WT061858]; NIHR [RP-PG-0310-1002]; UK MRC [G0000934]; British Society for Paediatric Endocrinology and Diabetes; Academy of Medical Sciences (AMS) [AMS-SGCL9-Lee] Funding Source: researchfish; Medical Research Council [G1001158, G0000934, G0800675, G0800759, G0601387, G0600329] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379, NF-SI-0508-10335, NF-SI-0508-10275] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/137, ETM/75] Funding Source: researchfish; MRC [G0600329, G0800759, G0800675, G1001158, G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Coeliac UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); NIHR(National Institute for Health Research (NIHR)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Society for Paediatric Endocrinology and Diabetes; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was primarily funded by the Medical Research Council (MRC G1001158 to D. A. v. H and V. P.), with further funding from Coeliac UK (to D. A. v. H). We thank C. Wijmenga and G. Trynka for sharing ImmunoChip data, and the International Multiple Sclerosis Genomics Consortium for ImmunoChip data and samples. J.N.B. and R. C. T. are supported by MRC grant G0601387. This research was supported by the National Institutes for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The study was supported by the Cambridge NIHR Biomedical Research Centre. We thank E. Gray and D. Jones (Wellcome Trust Sanger Institute) for sample preparation. We acknowledge use of DNA from The UK Blood Services collection of Common Controls (UKBS-CC collection), funded by the Wellcome Trust grant 076113/C/04/Z and by NIHR programme grant to NHS Blood and Transplant (RP-PG-0310-1002). The collection was established as part of the Wellcome Trust Case Control Consortium(WTCCC). We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the UK MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02. We thank nurses and doctors for recruiting autoimmune thyroid disease (AITD) subjects into the AITD National Collection, funded by the Wellcome Trust grant 068181. We acknowledge use of DNA from the Cambridge BioResource. We acknowledge use of DNA from the Juvenile Diabetes Research Foundation (JDRF)/Wellcome Trust Case-Series (GRID), funded by JDRF and the Wellcome Trust (grant references JDRF 4-2001-1008 and WT061858). The subjects were recruited in the UK by D. Dunger and his team with support from the British Society for Paediatric Endocrinology and Diabetes. The samples were prepared and provided by the JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, University of Cambridge, UK. Psoriasis samples used were based on the WTCCC2 GWAS clinical panel, for which we thank D. Burden, C. Griffiths, M. Cork and R. McManus. Finally, we would like to thank all autoimmune disease and control subjects for participating in this study.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Liu DJ, 2012, AM J HUM GENET, V91, P585, DOI 10.1016/j.ajhg.2012.08.008; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	30	142	150	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					232	+		10.1038/nature12170	http://dx.doi.org/10.1038/nature12170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23698362	Green Accepted			2022-12-28	WOS:000320283400049
J	Spence, PJ; Jarra, W; Levy, P; Reid, AJ; Chappell, L; Brugat, T; Sanders, M; Berriman, M; Langhorne, J				Spence, Philip J.; Jarra, William; Levy, Prisca; Reid, Adam J.; Chappell, Lia; Brugat, Thibaut; Sanders, Mandy; Berriman, Matthew; Langhorne, Jean			Vector transmission regulates immune control of Plasmodium virulence	NATURE			English	Article							MOSQUITO-TRANSMISSION; RODENT MALARIA; EXPRESSION ANALYSIS; ANTIGENIC VARIANTS; CHABAUDI-CHABAUDI; MULTIGENE FAMILY; FALCIPARUM; INFECTIONS; DIVERSITY; PARASITES	Defining mechanisms by which Plasmodium virulence is regulated is central to understanding the pathogenesis of human malaria. Serial blood passage of Plasmodium through rodents(1-3), primates(4) or humans(5) increases parasite virulence, suggesting that vector transmission regulates Plasmodium virulence within the mammalian host. In agreement, disease severity can be modified by vector transmission(6-8), which is assumed to 'reset' Plasmodium to its original character(3). However, direct evidence that vector transmission regulates Plasmodium virulence is lacking. Here we use mosquito transmission of serially blood passaged (SBP) Plasmodium chabaudi chabaudi(9) to interrogate regulation of parasite virulence. Analysis of SBP P.c. chabaudi before and after mosquito transmission demonstrates that vector transmission intrinsically modifies the asexual blood-stage parasite, which in turn modifies the elicited mammalian immune response, which in turn attenuates parasite growth and associated pathology. Attenuated parasite virulence associates with modified expression of the pir multi-gene family. Vector transmission of Plasmodium therefore regulates gene expression of probable variant antigens in the erythrocytic cycle, modifies the elicited mammalian immune response, and thus regulates parasite virulence. These results place the mosquito at the centre of our efforts to dissect mechanisms of protective immunity to malaria for the development of an effective vaccine.	[Spence, Philip J.; Jarra, William; Levy, Prisca; Brugat, Thibaut; Langhorne, Jean] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Reid, Adam J.; Chappell, Lia; Sanders, Mandy; Berriman, Matthew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	MRC National Institute for Medical Research; Wellcome Trust Sanger Institute	Langhorne, J (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, Mill Hill, London NW7 1AA, England.	jlangho@nimr.mrc.ac.uk	Berriman, Matthew/A-7618-2011	Berriman, Matthew/0000-0002-9581-0377; Reid, Adam/0000-0002-5926-7768; Chappell, Lia/0000-0002-2317-3524; Langhorne, Jean/0000-0002-2257-9733; Spence, Phil/0000-0002-5506-2773	Medical Research Council [U117584248]; Wellcome Trust [089553, 098051]; Leverhulme Trust; MRC [MC_U117584248] Funding Source: UKRI; Medical Research Council [MC_U117584248] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (U117584248) and the Wellcome Trust (089553 and 098051). P.J.S. is the recipient of a Leverhulme Trust Early Career Fellowship. The authors thank R. Sinden, K. Baker and M. Tunnicliff for provision of Anopheles stephensi, and Biological Services at NIMR. M. Blackman, G. Kassiotis and G. Stockinger are thanked for critical reading of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALGER NE, 1971, J PROTOZOOL, V18, P598, DOI 10.1111/j.1550-7408.1971.tb03382.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BRANNAN LR, 1993, PARASITE IMMUNOL, V15, P135, DOI 10.1111/j.1365-3024.1993.tb00593.x; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cunningham D, 2010, MOL BIOCHEM PARASIT, V170, P65, DOI 10.1016/j.molbiopara.2009.12.010; DEARSLY AL, 1990, PARASITOLOGY, V100, P359, DOI 10.1017/S0031182000078628; del Portillo HA, 2012, CELL MICROBIOL, V14, P343, DOI 10.1111/j.1462-5822.2011.01741.x; GLYNN JR, 1995, T ROY SOC TROP MED H, V89, P281, DOI 10.1016/0035-9203(95)90540-5; HARTLEY EG, 1969, T ROY SOC TROP MED H, V63, P411, DOI 10.1016/0035-9203(69)90023-6; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; KNOWLES G, 1980, PARASITOLOGY, V81, P211, DOI 10.1017/S0031182000055165; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lawton J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-125; Mackinnon MJ, 2005, INT J PARASITOL, V35, P145, DOI 10.1016/j.ijpara.2004.11.011; Mackinnon MJ, 1999, P ROY SOC B-BIOL SCI, V266, P741, DOI 10.1098/rspb.1999.0699; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; MCLEAN SA, 1987, PARASITOLOGY, V94, P443, DOI 10.1017/S0031182000055797; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Spence PJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-407; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; YOELI M, 1975, ANN TROP MED PARASIT, V69, P173, DOI 10.1080/00034983.1975.11686998	31	103	103	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					228	+		10.1038/nature12231	http://dx.doi.org/10.1038/nature12231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23719378	Green Accepted			2022-12-28	WOS:000320283400048
J	Guillot, C; Lecuit, T				Guillot, Charlene; Lecuit, Thomas			Mechanics of Epithelial Tissue Homeostasis and Morphogenesis	SCIENCE			English	Review							CELL POLARITY; E-CADHERIN; ADHERENS JUNCTIONS; SINGLE-CELL; ADHESION; CYTOKINESIS; DROSOPHILA; AXIS; INTERCALATION; ELONGATION	Epithelia are robust tissues that support the structure of embryos and organs and serve as effective barriers against pathogens. Epithelia also chemically separate different physiological environments. These vital functions require tight association between cells through the assembly of junctions that mechanically stabilize the tissue. Remarkably, epithelia are also dynamic and can display a fluid behavior. Cells continuously die or divide, thereby allowing functional tissue homeostasis. Epithelial cells can change shape or intercalate as tissues deform during morphogenesis. We review the mechanical basis of tissue robustness and fluidity, with an emphasis on the pivotal role of junction dynamics. Tissue fluidity emerges from local active stresses acting at cell interfaces and allows the maintenance of epithelial organization during morphogenesis and tissue renewal.	[Guillot, Charlene; Lecuit, Thomas] Aix Marseille Univ, CNRS UMR 7288, IBDM, F-13009 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Aix Marseille Univ, CNRS UMR 7288, IBDM, Campus Luminy,Case 907, F-13009 Marseille, France.	thomas.lecuit@univ-amu.fr		Guillot, Charlene/0000-0001-9214-7509	CNRS; ANR [ANR-11-LABX-0054, ANR-11-IDEX-0001-02]; ERC [323027-Biomecamorph]; ARC [SL220120605305]	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); ARC(Australian Research Council)	We thank members of our group, as well as R. Le Borgne and B. Shraiman, for useful comments, and C. Collinet for contributing movie S2. Supported by CNRS, ANR (Programme Blanc, Archiplast, and Labex INFORM, ANR-11-LABX-0054 under the A*MIDEX program ANR-11-IDEX-0001-02), ERC (grant 323027-Biomecamorph), and ARC (grant SL220120605305).	Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Gomez GA, 2011, TRENDS CELL BIOL, V21, P499, DOI 10.1016/j.tcb.2011.05.006; Gu YP, 2012, CURR OPIN CELL BIOL, V24, P865, DOI 10.1016/j.ceb.2012.09.003; Guillot C, 2013, DEV CELL, V24, P227, DOI 10.1016/j.devcel.2013.01.010; Herszterg S, 2013, DEV CELL, V24, P256, DOI 10.1016/j.devcel.2012.11.019; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Ma D, 2008, P NATL ACAD SCI USA, V105, P18800, DOI 10.1073/pnas.0808868105; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Munro EM, 2002, DEVELOPMENT, V129, P13; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Trichas G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001256; TRINKAUS JP, 1992, J EXP ZOOL, V261, P40, DOI 10.1002/jez.1402610107; Vichas A, 2011, SEMIN CELL DEV BIOL, V22, P858, DOI 10.1016/j.semcdb.2011.09.013; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001	42	363	368	4	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1185	1189		10.1126/science.1235249	http://dx.doi.org/10.1126/science.1235249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744939				2022-12-28	WOS:000319972800036
J	Ammann, AJ				Ammann, Arthur J.			US clinical-research system in need of review	NATURE			English	Editorial Material									[Ammann, Arthur J.] Global Strategies, San Francisco, CA USA; [Ammann, Arthur J.] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco	Ammann, AJ (corresponding author), Global Strategies, San Francisco, CA USA.	arthur.ammann@globalstrategies.org							0	2	2	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					7	7		10.1038/498007a	http://dx.doi.org/10.1038/498007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158DC	23739388	Bronze			2022-12-28	WOS:000319947800005
J	Jacobs, LA; Vaughn, DJ				Jacobs, Linda A.; Vaughn, David J.			Care of the adult cancer survivor	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CHALLENGES											Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; Bender Catherine M, 2008, Oncol Nurs Forum, V35, pE1, DOI 10.1188/08.ONF.E1-E11; Bober SL, 2012, J CLIN ONCOL, V30, P3712, DOI 10.1200/JCO.2012.41.7915; Carver JR, 2007, J CLIN ONCOL, V25, P3991, DOI 10.1200/JCO.2007.10.9777; Chan Fong, 2008, J Cancer Surviv, V2, P169, DOI 10.1007/s11764-008-0057-y; Crane-Okada R, 2012, CANCER NURS, V35, pE1, DOI 10.1097/NCC.0b013e3182280f73; Erikson C, 2007, J ONCOL PRACT, V3, P79, DOI 10.1200/JOP.0723601; HAMILTON AS, 2012, INTEGR CANC THER; Hewitt, 2006, CANC PATIENT CANC SU; Lenihan DJ, 2012, J CLIN ONCOL, V30, P3657, DOI 10.1200/JCO.2012.45.2938; Lustberg MB, 2012, J CLIN ONCOL, V30, P3665, DOI 10.1200/JCO.2012.42.2097; Madeira N, 2011, J PSYCHOSOC ONCOL, V29, P636, DOI 10.1080/07347332.2011.615381; Mao JJ, 2009, J CLIN ONCOL, V27, P933, DOI 10.1200/JCO.2008.18.0679; Paskett ED, 2012, J CLIN ONCOL, V30, P3726, DOI 10.1200/JCO.2012.41.8574; Rechis R, 2011, ESSENTIAL ELEMENTS S; Ruddy KJ, 2012, J CLIN ONCOL, V30, P3705, DOI 10.1200/JCO.2012.42.1966; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; SCHUMACHER JR, 2012, J BEHAV MED; Shulman LN, 2009, J ONCOL PRACT, V5, P119, DOI 10.1200/JOP.0932001; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sleijfer S, 2001, CHEST, V120, P617, DOI 10.1378/chest.120.2.617; Stewart DE, 2001, PSYCHO-ONCOLOGY, V10, P259, DOI 10.1002/pon.499; Stricker CT, 2011, J CANCER SURVIV, V5, P358, DOI 10.1007/s11764-011-0196-4; Sung JS, 2011, RADIOLOGY, V259, P65, DOI 10.1148/radiol.10100991; Syrjala KL, 2012, J CLIN ONCOL, V30, P3746, DOI 10.1200/JCO.2012.42.3038; TEBBI CK, 1989, CANCER, V63, P213, DOI 10.1002/1097-0142(19890101)63:1<213::AID-CNCR2820630134>3.0.CO;2-T; Travis LB, 2008, HEMATOL ONCOL CLIN N, V22, pXI, DOI 10.1016/j.hoc.2008.02.001; Warren JL, 2008, J CLIN ONCOL, V26, P3242, DOI 10.1200/JCO.2007.14.6357; Wood ME, 2012, J CLIN ONCOL, V30, P3734, DOI 10.1200/JCO.2012.41.8681; Zucca AC, 2012, J PAIN SYMPTOM MANAG, V43, P720, DOI 10.1016/j.jpainsymman.2011.04.023	30	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11								10.7326/0003-4819-158-11-201306040-01006	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-01006			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NO	23732730				2022-12-28	WOS:000209755900001
J	Stevens, PE; Levin, A				Stevens, Paul E.; Levin, Adeera		Kidney Dis Improving Global	Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; CYSTATIN C; ALL-CAUSE; ESTIMATED GFR; MORTALITY; RISK; PROGRESSION; ASSOCIATION	Description: The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed clinical practice guidelines in 2012 to provide guidance on the evaluation, management, and treatment of chronic kidney disease (CKD) in adults and children who are not receiving renal replacement therapy. Methods: The KDIGO CKD Guideline Development Work Group defined the scope of the guideline, gathered evidence, determined topics for systematic review, and graded the quality of evidence that had been summarized by an evidence review team. Searches of the English-language literature were conducted through November 2012. Final modification of the guidelines was informed by the KDIGO Board of Directors and a public review process involving registered stakeholders. Recommendations: The full guideline included 110 recommendations. This synopsis focuses on 10 key recommendations pertinent to definition, classification, monitoring, and management of CKD in adults.	East Kent Hosp Univ NHS Fdn Trust, Kent Kidney Care Ctr, Canterbury, Kent, England; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Stevens, PE (corresponding author), Kent & Canterbury Hosp, Kent Kidney Care Ctr, Ethelbert Rd, Canterbury CT1 3NG, Kent, England.	pstevens@nhs.net			Abbott Laboratories; Merck Co	Abbott Laboratories(Abbott Laboratories); Merck Co(Merck & Company)	Dr. Levin: Consultancy (money to institution): Abbott Laboratories, Merck & Co; Grants/grants pending (money to institution): Canadian Institutes of Health Research (CIHR), Kidney Foundation, Merck & Co, Ortho. Dr. Stevens: None disclosed. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOf InterestForms.do?msNum = M13-0034.	Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bedford M, 2012, AM J KIDNEY DIS, V59, P485, DOI 10.1053/j.ajkd.2011.09.010; Burgos-Calderon R, 2010, CURR OPIN NEPHROL HY, V19, P208, DOI 10.1097/MNH.0b013e32833281dc; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Jones-Burton C, 2006, AM J NEPHROL, V26, P268, DOI 10.1159/000093833; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P337; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P1565, DOI 10.2215/CJN.02250409; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Rifkin DE, 2010, NEPHROL DIAL TRANSPL, V25, P1560, DOI 10.1093/ndt/gfp646; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Shastri S, 2011, AM J KIDNEY DIS, V57, P832, DOI 10.1053/j.ajkd.2010.11.021; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3835, DOI 10.1093/ndt/gfs263; Turin TC, 2012, AM J NEPHROL, V36, P41, DOI 10.1159/000339289; TURIN TC, 2013, KIDNEY INT; Uhlig K, 2006, KIDNEY INT, V70, P2058, DOI 10.1038/sj.ki.5001875; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Viazzi F, 2010, J HYPERTENS, V28, P848, DOI 10.1097/HJH.0b013e328336ed09; Waheed S, 2012, AM J KIDNEY DIS, V60, P207, DOI 10.1053/j.ajkd.2012.03.011; WAKASUGI M, 2012, HYPERTENS RES	35	1571	1688	5	101	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					825	+		10.7326/0003-4819-158-11-201306040-00007	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23732715				2022-12-28	WOS:000320379800005
J	Srivastava, R				Srivastava, Ranjana			The art of medicine Free-floating anxiety	LANCET			English	Editorial Material									Dandenong Hosp, Dept Med Oncol, Dandenong, Vic 3175, Australia		Srivastava, R (corresponding author), Dandenong Hosp, Dept Med Oncol, Dandenong, Vic 3175, Australia.	ranjana.srivastava@southernhealth.org.au						Srivastava R., 2012, DYING CHAT COMMUNICA	1	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1808	1809		10.1016/S0140-6736(13)61110-1	http://dx.doi.org/10.1016/S0140-6736(13)61110-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151EO	23717835				2022-12-28	WOS:000319443700014
J	Tesseur, I; Lo, AC; Roberfroid, A; Dietvorst, S; Van Broeck, B; Borgers, M; Gijsen, H; Moechars, D; Mercken, M; Kemp, J; D'Hooge, R; De Strooper, B				Tesseur, Ina; Lo, Adrian C.; Roberfroid, Anouk; Dietvorst, Sofie; Van Broeck, Bianca; Borgers, Marianne; Gijsen, Harrie; Moechars, Diederik; Mercken, Marc; Kemp, John; D'Hooge, Rudi; De Strooper, Bart			Comment on "ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models"	SCIENCE			English	Editorial Material									[Tesseur, Ina; Roberfroid, Anouk; Dietvorst, Sofie; De Strooper, Bart] VIB Ctr Biol Dis, Louvain, Belgium; [Tesseur, Ina; Roberfroid, Anouk; De Strooper, Bart] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Tesseur, Ina; Roberfroid, Anouk; De Strooper, Bart] Univ Ziekenhuizen, Ctr Human Genet, B-3000 Louvain, Belgium; [Tesseur, Ina; Roberfroid, Anouk; De Strooper, Bart] Leuven Inst Neurosci & Dis LIND, B-3000 Louvain, Belgium; [Lo, Adrian C.; D'Hooge, Rudi] Katholieke Univ Leuven, Lab Biol Psychol, B-3000 Louvain, Belgium; [Lo, Adrian C.; D'Hooge, Rudi] Katholieke Univ Leuven, Leuven Inst Neurosci & Dis LIND, B-3000 Louvain, Belgium; [Van Broeck, Bianca; Borgers, Marianne; Gijsen, Harrie; Moechars, Diederik; Mercken, Marc; Kemp, John] Janssen Res & Dev, Dept Neurosci, B-2340 Beerse, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Johnson & Johnson; Janssen Pharmaceuticals	De Strooper, B (corresponding author), VIB Ctr Biol Dis, Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831; Lo, Adrian/0000-0001-9104-5949				Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Eisai Manufacturing Ltd. (EML), 2009, TARGR INF; FDA, 1999, DRUG APPR PACK; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Roses Allen D., 1994, Current Opinion in Biotechnology, V5, P663, DOI 10.1016/0958-1669(94)90091-4	5	101	115	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135							1233937	10.1126/science.1233937	http://dx.doi.org/10.1126/science.1233937			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704554				2022-12-28	WOS:000319344100023
J	Hopkins, BD; Fine, B; Steinbach, N; Dendy, M; Rapp, Z; Shaw, J; Pappas, K; Yu, JS; Hodakoski, C; Mense, S; Klein, J; Pegno, S; Sulis, ML; Goldsteini, H; Amendolara, B; Lei, L; Maurer, M; Bruce, J; Canoll, P; Hibshoosh, H; Parsons, R				Hopkins, Benjamin D.; Fine, Barry; Steinbach, Nicole; Dendy, Meaghan; Rapp, Zachary; Shaw, Jacquelyn; Pappas, Kyrie; Yu, Jennifer S.; Hodakoski, Cindy; Mense, Sarah; Klein, Joshua; Pegno, Sarah; Sulis, Maria-Luisa; Goldsteini, Hannah; Amendolara, Benjamin; Lei, Liang; Maurer, Matthew; Bruce, Jeffrey; Canoll, Peter; Hibshoosh, Hanina; Parsons, Ramon			A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival	SCIENCE			English	Article							TUMOR-SUPPRESSOR; PI3K PATHWAY; PROTEIN; PTEN/MMAC1; ACTIVATION; SYSTEMS; CANCER; DOMAIN; GENE	Phosphatase and tensin homolog on chromosome ten (PTEN) is a tumor suppressor and an antagonist of the phosphoinositide-3 kinase (PI3K) pathway. We identified a 576-amino acid translational variant of PTEN, termed PTEN-Long, that arises from an alternative translation start site 519 base pairs upstream of the ATG initiation sequence, adding 173 N-terminal amino acids to the normal PTEN open reading frame. PTEN-Long is a membrane-permeable lipid phosphatase that is secreted from cells and can enter other cells. As an exogenous agent, PTEN-Long antagonized PI3K signaling and induced tumor cell death in vitro and in vivo. By providing a means to restore a functional tumor-suppressor protein to tumor cells, PTEN-Long may have therapeutic uses.	[Hopkins, Benjamin D.; Steinbach, Nicole; Dendy, Meaghan; Pappas, Kyrie; Hodakoski, Cindy; Mense, Sarah; Parsons, Ramon] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Hopkins, Benjamin D.; Fine, Barry; Steinbach, Nicole; Shaw, Jacquelyn; Pappas, Kyrie; Yu, Jennifer S.; Klein, Joshua; Pegno, Sarah; Sulis, Maria-Luisa; Maurer, Matthew] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Hopkins, Benjamin D.; Fine, Barry; Steinbach, Nicole; Rapp, Zachary; Shaw, Jacquelyn; Pappas, Kyrie; Yu, Jennifer S.; Klein, Joshua; Pegno, Sarah; Sulis, Maria-Luisa; Goldsteini, Hannah; Amendolara, Benjamin; Lei, Liang; Maurer, Matthew; Canoll, Peter; Hibshoosh, Hanina] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Shaw, Jacquelyn; Klein, Joshua; Maurer, Matthew] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Sulis, Maria-Luisa] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Goldsteini, Hannah; Amendolara, Benjamin; Bruce, Jeffrey] Columbia Univ, New York Presbyterian Hosp, Neurol Inst, Dept Neurol Surg, New York, NY 10032 USA; [Lei, Liang; Canoll, Peter; Hibshoosh, Hanina] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University	Parsons, R (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1470 Madison Ave, New York, NY 10029 USA.	ramon.parsons@mssm.edu	Bruce, Jeffrey N/AAC-5307-2022	Parsons, Ramon/0000-0002-6656-3514	NIH [CA082783, R01NS066955, 2T32 CA09503]; NCI [CA097403]; Avon Foundation; OctoberWoman Foundation; NATIONAL CANCER INSTITUTE [T32CA009503, P01CA097403, R01CA082783, R01CA155117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073610, R01NS066955] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Avon Foundation; OctoberWoman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Greene, T. Ludwig, D. Yamashiro, K. Olive, and members of the Parsons laboratory for their assistance. This work was supported by NIH grant CA082783, NCI grant CA097403, NIH grant R01NS066955, the Avon Foundation, and the OctoberWoman Foundation. B. D. H. is supported by NIH grant 2T32 CA09503. Columbia University has applied for patents on PTEN-Long. NM_000314.4 is curated by GenBank. Additional data are present in the supplementary materials.	Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Lei L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020041; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li J, 1998, CANCER RES, V58, P5667; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; SUBRAMANIAN T, 1991, EMBO J, V10, P2311, DOI 10.1002/j.1460-2075.1991.tb07768.x; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486	23	223	257	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					399	402		10.1126/science.1234907	http://dx.doi.org/10.1126/science.1234907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23744781	Green Accepted			2022-12-28	WOS:000322259200050
J	Bell, CH; Healey, E; van Erp, S; Bishop, B; Tang, CX; Gilbert, RJC; Aricescu, AR; Pasterkamp, RJ; Siebold, C				Bell, Christian H.; Healey, Eleanor; van Erp, Susan; Bishop, Benjamin; Tang, Chenxiang; Gilbert, Robert J. C.; Aricescu, A. Radu; Pasterkamp, R. Jeroen; Siebold, Christian			Structure of the Repulsive Guidance Molecule (RGM)-Neogenin Signaling Hub	SCIENCE			English	Article							NEOGENIN; HEMOJUVELIN; RGMA; IRON; MUTATIONS; GROWTH; INHIBITION; RECEPTOR; MEDIATE; DCC	Repulsive guidance molecule family members (RGMs) control fundamental and diverse cellular processes, including motility and adhesion, immune cell regulation, and systemic iron metabolism. However, it is not known how RGMs initiate signaling through their common cell-surface receptor, neogenin (NEO1). Here, we present crystal structures of the NEO1 RGM-binding region and its complex with human RGMB (also called dragon). The RGMB structure reveals a previously unknown protein fold and a functionally important autocatalytic cleavage mechanism and provides a framework to explain numerous disease-linked mutations in RGMs. In the complex, two RGMB ectodomains conformationally stabilize the juxtamembrane regions of two NEO1 receptors in a pH-dependent manner. We demonstrate that all RGM-NEO1 complexes share this architecture, which therefore represents the core of multiple signaling pathways.	[Bell, Christian H.; Healey, Eleanor; Bishop, Benjamin; Tang, Chenxiang; Gilbert, Robert J. C.; Aricescu, A. Radu; Siebold, Christian] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [van Erp, Susan; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, NL-3584 CG Utrecht, Netherlands	University of Oxford; Wellcome Centre for Human Genetics; Utrecht University; Utrecht University Medical Center	Siebold, C (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	christian@strubi.ox.ac.uk	Aricescu, Alexandru/L-3891-2013	van Erp, Susan/0000-0003-0883-2795; Siebold, Christian/0000-0002-6635-3621; Pasterkamp, Jeroen/0000-0003-1631-6440; Healey, Eleanor/0000-0002-3036-8637; Aricescu, Alexandru ARadu/0000-0003-3783-1388; Gilbert, Robert/0000-0001-9336-5604	Wellcome Trust; Human Frontier Science Program; Netherlands Organization for Health Research and Development; Medical Research Council; MRC [G0700232] Funding Source: UKRI; Cancer Research UK [14414] Funding Source: researchfish; Medical Research Council [G0700232] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Human Frontier Science Program(Human Frontier Science Program); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Diamond and European Synchrotron Radiation Facility beamline staff for assistance; T. Walter, K. Harlos, and G. Sutton for technical support; and M. Zebisch, E. Y. Jones, and D. I. Stuart for discussions. Work was funded by the Wellcome Trust (C. S.) and Human Frontier Science Program and the Netherlands Organization for Health Research and Development (R.J.P.). The Division of Structural Biology is supported by a Wellcome Trust Core Grant. R.J.C.G. was a Royal Society University Research Fellow. A. R. A. was a Medical Research Council Career Development Award Fellow. C. S. is a Cancer Research UK Senior Research Fellow. Structure coordinates of eRGMB-NEO1<INF>FN56</INF>-Form 1, eRGMB-NEO1<INF>FN56</INF>-Form 2, eRGMB-NEO1<INF>FN56</INF>-Form 3, NEO1<INF>FN56</INF>-Form 1, NEO1<INF>FN56</INF>-Form 2, and NEO1<INF>FN56</INF>-SOS are deposited in the Protein Data Bank (identification codes 4BQ6, 4BQ7, 4BQ8, 4BQ9, 4BQB, and 4BQC, respectively).	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Landon X., 1977, METHOD ENZYMOL, V47, P145; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lee PL, 2004, BLOOD, V103, P4669, DOI 10.1182/blood-2004-01-0072; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Liu XX, 2009, BIOCHEM BIOPH RES CO, V382, P795, DOI 10.1016/j.bbrc.2009.03.115; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Yang F, 2011, J STRUCT BIOL, V174, P239, DOI 10.1016/j.jsb.2010.10.005; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	28	44	50	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					77	80		10.1126/science.1232322	http://dx.doi.org/10.1126/science.1232322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23744777	Green Accepted			2022-12-28	WOS:000321291700052
J	Kachalia, A; Mello, MM				Kachalia, Allen; Mello, Michelle M.			Breast Cancer Screening Conflicting Guidelines and Medicolegal Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kachalia, Allen] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu		Mello, Michelle/0000-0003-2877-4270				American College of Obstetricians and Gynecologists Practice Bulletin, 2011, OBSTET GYNECOL, V118, P372, DOI DOI 10.1097/AOG.0B013E31822C98E5; [Anonymous], 2008, ACR PRACT GUID PERF; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bovbjerg R. R., 2012, VALUE CLIN PRACTICE; Gandhi TK, 2006, ANN INTERN MED, V145, P488, DOI 10.7326/0003-4819-145-7-200610030-00006; Mello MM, 2001, U PENN LAW REV, V149, P645, DOI 10.2307/3312867; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; 2009, ANN INTERN MED, V151, P716	8	14	14	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2555	2556		10.1001/jama.2013.7100	http://dx.doi.org/10.1001/jama.2013.7100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23722969				2022-12-28	WOS:000320848100022
J	Austin, C; Smith, TM; Bradman, A; Hinde, K; Joannes-Boyau, R; Bishop, D; Hare, DJ; Doble, P; Eskenazi, B; Arora, M				Austin, Christine; Smith, Tanya M.; Bradman, Asa; Hinde, Katie; Joannes-Boyau, Renaud; Bishop, David; Hare, Dominic J.; Doble, Philip; Eskenazi, Brenda; Arora, Manish			Barium distributions in teeth reveal early-life dietary transitions in primates	NATURE			English	Article							TRACE-ELEMENTS; ENAMEL; NEANDERTHAL; DIAGENESIS; CHEMISTRY; SPECTROMETRY; BEHAVIOR; HISTORY; GROWTH	Early-life dietary transitions reflect fundamental aspects of primate evolution and are important determinants of health in contemporary human populations(1,2). Weaning is critical to developmental and reproductive rates; early weaning can have detrimental health effects but enables shorter inter-birth intervals, which influences population growth(3). Uncovering early-life dietary history in fossils is hampered by the absence of prospectively validated biomarkers that are not modified during fossilization(4). Here we show that large dietary shifts in early life manifest as compositional variations in dental tissues. Teeth from human children and captive macaques, with prospectively recorded diet histories, demonstrate that barium (Ba) distributions accurately reflect dietary transitions from the introduction of mother's milk through the weaning process. We also document dietary transitions in a Middle Palaeolithic juvenile Neanderthal, which shows a pattern of exclusive breastfeeding for seven months, followed by seven months of supplementation. After this point, Ba levels in enamel returned to baseline prenatal levels, indicating an abrupt cessation of breastfeeding at 1.2 years of age. Integration of Ba spatial distributions and histological mapping of tooth formation enables novel studies of the evolution of human life history, dietary ontogeny in wild primates, and human health investigations through accurate reconstructions of breastfeeding history.	[Austin, Christine; Arora, Manish] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Austin, Christine; Arora, Manish] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Austin, Christine; Arora, Manish] Westmead Hosp, Westmead Millennium Inst, Inst Dent Res, Sydney, NSW 2145, Australia; [Austin, Christine; Arora, Manish] Univ Sydney, Fac Dent, Sydney, NSW 2145, Australia; [Smith, Tanya M.; Hinde, Katie] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Bradman, Asa; Eskenazi, Brenda] Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth, Berkeley, CA 94720 USA; [Hinde, Katie] Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Joannes-Boyau, Renaud] So Cross Univ, Lismore, NSW 2480, Australia; [Bishop, David; Hare, Dominic J.; Doble, Philip] Univ Technol Sydney, Elemental Bioimaging Facil, Sydney, NSW 2007, Australia; [Hare, Dominic J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia	Icahn School of Medicine at Mount Sinai; Harvard University; Harvard T.H. Chan School of Public Health; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Harvard University; University of California System; University of California Berkeley; Southern Cross University; University of Technology Sydney; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Arora, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA.	marora@hsph.harvard.edu	Hare, Dominic/H-2481-2011; Joannes-Boyau, Renaud/D-6058-2012; Doble, Philip/A-8812-2012; Smith, Tanya/T-2683-2017; Bishop, David P/F-2891-2019; Hare, Dominic/AAM-7725-2020	Hare, Dominic/0000-0002-5922-7643; Joannes-Boyau, Renaud/0000-0002-0452-486X; Doble, Philip/0000-0002-8472-1301; Bishop, David P/0000-0002-6533-4410; Austin, Christine/0000-0002-9966-0492; Smith, Tanya M./0000-0001-8175-8208; Hinde, Katie/0000-0002-0528-866X	US Environmental Protection Agency [RD 83171001, RD 82670901]; US National Institutes of Environmental Health Sciences [PO1 ES009605]; NSF [BCS-0921978]; Max Planck Institute for Evolutionary Anthropology; Australian Research Council [DP120101752, LP100200254]; SCU postdoctoral Fellowship grant; National Institute of Environmental Health Sciences [4R00ES019597-03]; NHMRC [APP1028372]; Agilent Technologies; Kennelec Scientific; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009605, R00ES019597] Funding Source: NIH RePORTER	US Environmental Protection Agency(United States Environmental Protection Agency); US National Institutes of Environmental Health Sciences; NSF(National Science Foundation (NSF)); Max Planck Institute for Evolutionary Anthropology(Max Planck Society); Australian Research Council(Australian Research Council); SCU postdoctoral Fellowship grant; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Agilent Technologies; Kennelec Scientific; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	L. Reynard, N. Tuross and F. Bidlack provided comments on this project. C. Amarasiriwardena and N. Lupoli provided expertise in macaque milk analysis. Fossil samples were provided by M. Toussaint, R. Gruen and M.-H. Moncell. The CHAMACOS study is funded by the US Environmental Protection Agency (RD 83171001 and RD 82670901 to B. E.) and the US National Institutes of Environmental Health Sciences (PO1 ES009605 to B. E.). Support for macaque data collection was provided by NSF BCS-0921978 (K. H.); milk samples were made possible through the ARMMS program (Archive of Rhesus Macaque Milk Samples). Histological study of the Scladina Neanderthal was funded by the Max Planck Institute for Evolutionary Anthropology. R.J.-B. is supported by Australian Research Council Discovery Grant (DP120101752) and SCU postdoctoral Fellowship grant. P. D. was supported by Australian Research Council Project Grant (LP100200254) that draws collaborative funding from Agilent Technologies and Kennelec Scientific. M. A. is supported by a National Institute of Environmental Health Sciences grant 4R00ES019597-03. C. A. and M. A. are supported by NHMRC grant APP1028372.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ATSDR, 2007, TOX PROF BAR; Balter V, 2012, NATURE, V489, P558, DOI 10.1038/nature11349; Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P1116, DOI 10.1289/ehp.6789; EZZO JA, 1992, J ARCHAEOL SCI, V19, P23, DOI 10.1016/0305-4403(92)90004-M; Gillespie B, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-4; Goldberg Michel, 2011, Front Biosci (Elite Ed), V3, P711, DOI 10.2741/e281; Hare D, 2011, J DENT, V39, P397, DOI 10.1016/j.jdent.2011.03.004; Harley K, 2007, MATERN CHILD HLTH J, V11, P119, DOI 10.1007/s10995-006-0152-5; Hinde K, 2009, AM J PHYS ANTHROPOL, V138, P148, DOI 10.1002/ajpa.20911; Hinz EA, 2010, GEOCHIM COSMOCHIM AC, V74, P3213, DOI 10.1016/j.gca.2010.03.011; Humphrey LT, 2008, FOLIA PRIMATOL, V79, P197, DOI 10.1159/000113457; Humphrey LT, 2008, P NATL ACAD SCI USA, V105, P6834, DOI 10.1073/pnas.0711513105; Humphrey LT, 2010, SEMIN CELL DEV BIOL, V21, P453, DOI 10.1016/j.semcdb.2009.11.003; Ip S, 2007, BREASTFEEDING MATERN; Kohn MJ, 2013, J ARCHAEOL SCI, V40, P1689, DOI 10.1016/j.jas.2012.11.012; Kohn MJ, 2013, P NATL ACAD SCI USA, V110, P419, DOI 10.1073/pnas.1209513110; Kohn MJ, 1999, GEOCHIM COSMOCHIM AC, V63, P2737, DOI 10.1016/S0016-7037(99)00208-2; Krachler M, 1999, BIOL TRACE ELEM RES, V68, P121, DOI 10.1007/BF02784401; Lear J, 2012, J ANAL ATOM SPECTROM, V27, P159, DOI 10.1039/c1ja10301f; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; McDade TW, 2005, AM J HUM BIOL, V17, P81, DOI 10.1002/ajhb.20095; Nielsen-Marsh CM, 2009, J ARCHAEOL SCI, V36, P1758, DOI 10.1016/j.jas.2009.04.004; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Porte N, 1997, J RADIOANAL NUCL CH, V224, P103, DOI 10.1007/BF02034620; Sellen DW, 2001, HUM NATURE-INT BIOS, V12, P47, DOI 10.1007/s12110-001-1013-y; Sellen DW, 2001, J NUTR, V131, P2707, DOI 10.1093/jn/131.10.2707; Skinner M, 1997, J ARCHAEOL SCI, V24, P677, DOI 10.1006/jasc.1996.0151; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith TM, 2008, EVOL ANTHROPOL, V17, P213, DOI 10.1002/evan.20176; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Smith TM, 2013, P NATL ACAD SCI USA, V110, P2787, DOI 10.1073/pnas.1218746110; Sponheimer M, 2006, GEOCHIM COSMOCHIM AC, V70, P1644, DOI 10.1016/j.gca.2005.12.022; Zaichick V, 2009, BIOL TRACE ELEM RES, V129, P107, DOI 10.1007/s12011-008-8302-9	34	147	148	1	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					216	+		10.1038/nature12169	http://dx.doi.org/10.1038/nature12169			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23698370	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000320283400045
J	Rodrigues, AR; Tabin, CJ				Rodrigues, Alan R.; Tabin, Clifford J.			Deserts and Waves in Gene Expression	SCIENCE			English	Editorial Material							HOX GENES; COMPLEX; EVOLUTION		[Rodrigues, Alan R.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Rodrigues, Alan R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Rodrigues, AR (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD032443] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; GAUNT SJ, 1988, DEVELOPMENT, V103, P135; Graham A, 1999, CURR BIOL, V9, pR630, DOI 10.1016/S0960-9822(99)80409-6; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nelson CE, 1996, DEVELOPMENT, V122, P1449; PEIFER M, 1987, GENE DEV, V1, P891, DOI 10.1101/gad.1.9.891; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Tarchini B, 2006, NATURE, V443, P985, DOI 10.1038/nature05247; Tschopp P, 2011, ANNU REV GENET, V45, P145, DOI 10.1146/annurev-genet-102209-163429; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049	14	5	5	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1181	1182		10.1126/science.1239867	http://dx.doi.org/10.1126/science.1239867			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744937				2022-12-28	WOS:000319972800033
J	van der Marel, N; van Dishoeck, EF; Bruderer, S; Birnstiel, T; Pinilla, P; Dullemond, CP; van Kempen, TA; Schmalzl, M; Brown, JM; Herczeg, GJ; Mathews, GS; Geers, V				van der Marel, Nienke; van Dishoeck, Ewine F.; Bruderer, Simon; Birnstiel, Til; Pinilla, Paola; Dullemond, Cornelis P.; van Kempen, Tim A.; Schmalzl, Markus; Brown, Joanna M.; Herczeg, Gregory J.; Mathews, Geoffrey S.; Geers, Vincent			A Major Asymmetric Dust Trap in a Transition Disk	SCIENCE			English	Article							PROTOPLANETARY DISKS; YOUNG; GAS	The statistics of discovered exoplanets suggest that planets form efficiently. However, there are fundamental unsolved problems, such as excessive inward drift of particles in protoplanetary disks during planet formation. Recent theories invoke dust traps to overcome this problem. We report the detection of a dust trap in the disk around the star Oph IRS 48 using observations from the Atacama Large Millimeter/submillimeter Array (ALMA). The 0.44-millimeter-wavelength continuum map shows high-contrast crescent-shaped emission on one side of the star, originating from millimeter-sized grains, whereas both the mid-infrared image (micrometer-sized dust) and the gas traced by the carbon monoxide 6-5 rotational line suggest rings centered on the star. The difference in distribution of big grains versus small grains/gas can be modeled with a vortex-shaped dust trap triggered by a companion.	[van der Marel, Nienke; van Dishoeck, Ewine F.; van Kempen, Tim A.; Schmalzl, Markus; Mathews, Geoffrey S.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [van Dishoeck, Ewine F.; Bruderer, Simon] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Birnstiel, Til; Brown, Joanna M.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Pinilla, Paola; Dullemond, Cornelis P.] Heidelberg Univ, Ctr Astron, Inst Theoret Astrophys, D-69120 Heidelberg, Germany; [van Kempen, Tim A.] Joint Atacama Large Millimeter Submillimeter Arra, Santiago, Chile; [Herczeg, Gregory J.] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [Geers, Vincent] Dublin Inst Adv Studies, Dublin 2, Ireland	Leiden University; Leiden University - Excl LUMC; Max Planck Society; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Ruprecht Karls University Heidelberg; Peking University; Dublin Institute for Advanced Studies	van der Marel, N (corresponding author), Leiden Univ, Leiden Observ, POB 9513, NL-2300 RA Leiden, Netherlands.	nmarel@strw.leidenuniv.nl		Dullemond, Cornelis/0000-0002-7078-5910; Pinilla, Paola/0000-0001-8764-1780; Birnstiel, Tilman/0000-0002-1899-8783; van Kempen, Tim/0000-0001-8178-5054				Andrews SM, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/42; Andrews SM, 2005, ASTROPHYS J, V631, P1134, DOI 10.1086/432712; Armitage PJ, 2011, ANNU REV ASTRON ASTR, V49, P195, DOI 10.1146/annurev-astro-081710-102521; BARGE P, 1995, ASTRON ASTROPHYS, V295, pL1; Batalha NM, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/2/24; Birnstiel T, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220847; Brauer F, 2008, ASTRON ASTROPHYS, V480, P859, DOI 10.1051/0004-6361:20077759; Brown JM, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/116; Casassus S, 2013, NATURE, V493, P191, DOI 10.1038/nature11769; de Val-Borro M, 2007, ASTRON ASTROPHYS, V471, P1043, DOI 10.1051/0004-6361:20077169; Dodson-Robinson SE, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/131; Draine BT, 2006, ASTROPHYS J, V636, P1114, DOI 10.1086/498130; Geers VC, 2007, ASTRON ASTROPHYS, V469, pL35, DOI 10.1051/0004-6361:20077524; Jewitt D. C., 2000, Protostars and planets 4, P1201; Klahr HH, 1997, ICARUS, V128, P213, DOI 10.1006/icar.1997.5720; Lesur G, 2009, ASTRON ASTROPHYS, V498, P1, DOI 10.1051/0004-6361/200811577; Lovelace RVE, 1999, ASTROPHYS J, V513, P805, DOI 10.1086/306900; Meheut H, 2013, MON NOT R ASTRON SOC, V430, P1988, DOI 10.1093/mnras/stt022; Pinilla P, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219315; Regaly Z, 2012, MON NOT R ASTRON SOC, V419, P1701, DOI 10.1111/j.1365-2966.2011.19834.x; Whipple F. L., 1972, PLASMA PLANET; Williams JP, 2011, ANNU REV ASTRON ASTR, V49, P67, DOI 10.1146/annurev-astro-081710-102548; Windmark F, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118475; Xie JW, 2010, ASTROPHYS J, V724, P1153, DOI 10.1088/0004-637X/724/2/1153; Zhu ZH, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/6	29	388	388	5	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1199	1202		10.1126/science.1236770	http://dx.doi.org/10.1126/science.1236770			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744942	Green Accepted			2022-12-28	WOS:000319972800040
J	Scully, EP; Klompas, M; Morgan, EA; Miller, AL; Loscalzo, J				Scully, Eileen P.; Klompas, Michael; Morgan, Elizabeth A.; Miller, Amy Leigh; Loscalzo, Joseph			Waiting for the Other Foot to Drop	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-B-VIRUS; POLYARTERITIS-NODOSA; INFECTION; EXACERBATION; THERAPY		[Scully, Eileen P.; Klompas, Michael; Miller, Amy Leigh; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Morgan, Elizabeth A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021; Klompas, Michael/Z-2415-2019	Morgan, Elizabeth/0000-0001-5880-9337	Premier Healthcare Alliance	Premier Healthcare Alliance	Dr. Klompas reports receiving lecture fees from Premier Healthcare Alliance. No other potential conflict of interest relevant to this article was reported.	Deeren DH, 2004, CLIN RHEUMATOL, V23, P172, DOI 10.1007/s10067-003-0857-4; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Dienstag JL, 2010, NEW ENGL J MED, V363, P298; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GANEM D, 2004, NEW ENGL J MED, V351, P351; Guillevin L, 2005, MEDICINE, V84, P313, DOI 10.1097/01.md.0000180792.80212.5e; Han YN, 2008, J GASTROEN HEPATOL, V23, P1728, DOI 10.1111/j.1440-1746.2008.05600.x; Kumar M, 2006, DIGEST DIS SCI, V51, P594, DOI 10.1007/s10620-006-3175-2; Lanini S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-15; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mastroianni CM, 2011, WORLD J GASTROENTERO, V17, P3881, DOI 10.3748/wjg.v17.i34.3881; Orenbuch-Harroch E, 2008, WORLD J GASTROENTERO, V14, P7133, DOI 10.3748/wjg.14.7133; Pagnoux C, 2005, CURR OPIN RHEUMATOL, V17, P41, DOI 10.1097/01.bor.0000145518.91595.2f; Savige J, 2005, BEST PRACT RES CL RH, V19, P263, DOI 10.1016/j.berh.2004.10.003; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Whalley SA, 2001, J EXP MED, V193, P847, DOI 10.1084/jem.193.7.847	16	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2220	2225		10.1056/NEJMcps1210603	http://dx.doi.org/10.1056/NEJMcps1210603			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23738548				2022-12-28	WOS:000319948900011
J	Moore, JN; Simmons, SF				Moore, Joseph N.; Simmons, Stuart F.			More Power from Below	SCIENCE			English	Editorial Material									[Moore, Joseph N.; Simmons, Stuart F.] Univ Utah, Energy & Geosci Inst, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Moore, JN (corresponding author), Univ Utah, Energy & Geosci Inst, 423 Wakara Way,Suite 300, Salt Lake City, UT 84108 USA.							Allis R., 2013, P 38 WORKSH GEOTH RE; Bendall B., 2013, P 38 WORKSH GEOTH RE; Bertani R, P WORLD GEOTH C 2010; Blackwell D., 2011, GRC T GRC1029452, V35, P1545; Goldstein B, 2011, RENEWABLE ENERGY SOURCES AND CLIMATE CHANGE MITIGATION: SPECIAL REPORT OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P401; Hulen J. B., 2002, GEOTHERM RESOUR COUN, V26, P29; Lund J.W., 2004, GHC B, V25, P11; Lund JW, 2011, GEOTHERMICS, V40, P159, DOI 10.1016/j.geothermics.2011.07.004; Tester JW, 2006, ASSESSMENT LED INTER; Thain IA, 2009, GEOTHERMICS, V38, P48, DOI 10.1016/j.geothermics.2008.12.004	10	30	32	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					933	934		10.1126/science.1235640	http://dx.doi.org/10.1126/science.1235640			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704561				2022-12-28	WOS:000319344100031
J	Eicken, H				Eicken, Hajo			Arctic sea ice needs better forecasts	NATURE			English	Editorial Material									Univ Alaska Fairbanks, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Eicken, H (corresponding author), Univ Alaska Fairbanks, Fairbanks, AK 99775 USA.	hajo.eicken@gi.alaska.edu	Eicken, Hajo/M-6901-2016					Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Calder J., 2011, UNDERSTANDING EARTHS, P405; Kauker F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036323; Lindsay R, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053576; Lovecraft AL, 2013, POLAR GEOGR, V36, P105, DOI 10.1080/1088937X.2012.733893; Markus T, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005436; National Research Council, 2012, SEAS DEC PRED ARCT S; Parsons MA, 2009, NATURE, V458, P830, DOI 10.1038/458830a; Rampal P, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005066; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051	10	77	80	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					431	433		10.1038/497431a	http://dx.doi.org/10.1038/497431a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698427	Bronze			2022-12-28	WOS:000319254000023
J	Mathews, JD; Forsythe, AV; Brady, Z; Butler, MW; Goergen, SK; Byrnes, GB; Giles, GG; Wallace, AB; Anderson, PR; Guiver, TA; McGale, P; Cain, TM; Dowty, JG; Bickerstaffe, AC; Darby, SC				Mathews, John D.; Forsythe, Anna V.; Brady, Zoe; Butler, Martin W.; Goergen, Stacy K.; Byrnes, Graham B.; Giles, Graham G.; Wallace, Anthony B.; Anderson, Philip R.; Guiver, Tenniel A.; McGale, Paul; Cain, Timothy M.; Dowty, James G.; Bickerstaffe, Adrian C.; Darby, Sarah C.			Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATOMIC-BOMB SURVIVORS; IONIZING-RADIATION; CT SCANS; ATAXIA-TELANGIECTASIA; LEUKEMIA; TUMORS	Objective To assess the cancer risk in children and adolescents following exposure to low dose ionising radiation from diagnostic computed tomography (CT) scans. Design Population based, cohort, data linkage study in Australia. Cohort members 10.9 million people identified from Australian Medicare records, aged 0-19 years on 1 January 1985 or born between 1 January 1985 and 31 December 2005; all exposures to CT scans funded by Medicare during 1985-2005 were identified for this cohort. Cancers diagnosed in cohort members up to 31 December 2007 were obtained through linkage to national cancer records. Main outcome Cancer incidence rates in individuals exposed to a CT scan more than one year before any cancer diagnosis, compared with cancer incidence rates in unexposed individuals. Results 60 674 cancers were recorded, including 3150 in 680 211 people exposed to a CT scan at least one year before any cancer diagnosis. The mean duration of follow-up after exposure was 9.5 years. Overall cancer incidence was 24% greater for exposed than for unexposed people, after accounting for age, sex, and year of birth (incidence rate ratio (IRR) 1.24 (95% confidence interval 1.20 to 1.29); P<0.001). We saw a dose-response relation, and the IRR increased by 0.16 (0.13 to 0.19) for each additional CT scan. The IRR was greater after exposure at younger ages (P<0.001 for trend). At 1-4, 5-9, 10-14, and 15 or more years since first exposure, IRRs were 1.35 (1.25 to 1.45), 1.25 (1.17 to 1.34), 1.14 (1.06 to 1.22), and 1.24 (1.14 to 1.34), respectively. The IRR increased significantly for many types of solid cancer (digestive organs, melanoma, soft tissue, female genital, urinary tract, brain, and thyroid); leukaemia, myelodysplasia, and some other lymphoid cancers. There was an excess of 608 cancers in people exposed to CT scans (147 brain, 356 other solid, 48 leukaemia or myelodysplasia, and 57 other lymphoid). The absolute excess incidence rate for all cancers combined was 9.38 per 100 000 person years at risk, as of 31 December 2007. The average effective radiation dose per scan was estimated as 4.5 mSv. Conclusions The increased incidence of cancer after CT scan exposure in this cohort was mostly due to irradiation. Because the cancer excess was still continuing at the end of follow-up, the eventual lifetime risk from CT scans cannot yet be determined. Radiation doses from contemporary CT scans are likely to be lower than those in 1985-2005, but some increase in cancer risk is still likely from current scans. Future CT scans should be limited to situations where there is a definite clinical indication, with every scan optimised to provide a diagnostic CT image at the lowest possible radiation dose.	[Mathews, John D.; Forsythe, Anna V.; Brady, Zoe; Dowty, James G.; Bickerstaffe, Adrian C.] Univ Melbourne, Sch Populat & Global Hlth, Carlton, Vic 3053, Australia; [Brady, Zoe] Alfred Hlth, Dept Radiol, Prahran, Vic, Australia; [Butler, Martin W.] Dept Hlth & Ageing, Med Benefits Scheme Analyt Sect, Canberra, ACT, Australia; [Goergen, Stacy K.] Southern Hlth, Dept Diagnost Imaging, Clayton, Vic, Australia; [Goergen, Stacy K.] Monash Univ, Southern Clin Sch, Clayton, Vic, Australia; [Byrnes, Graham B.] Int Agcy Res Canc, Biostat Grp, F-69372 Lyon, France; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Wallace, Anthony B.] Australian Radiat Protect & Nucl Safety Agcy, Diagnost Imaging & Nucl Med Sect, Yallambie, Vic, Australia; [Anderson, Philip R.; Guiver, Tenniel A.] Australian Inst Hlth & Welf, Data Linkage Unit, Canberra, ACT, Australia; [Anderson, Philip R.] Univ Canberra, Fac Hlth, Canberra, ACT 2601, Australia; [McGale, Paul; Darby, Sarah C.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [McGale, Paul; Darby, Sarah C.] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Cain, Timothy M.] Royal Childrens Hosp Melbourne, Parkville, Vic, Australia	University of Melbourne; Monash University; World Health Organization; International Agency for Research on Cancer (IARC); Cancer Council Victoria; University of Canberra; University of Oxford; University of Oxford; Royal Children's Hospital Melbourne	Mathews, JD (corresponding author), Univ Melbourne, Sch Populat & Global Hlth, Carlton, Vic 3053, Australia.	mathewsj@unimelb.edu.au		Dowty, James/0000-0003-2383-0886; Giles, Graham/0000-0003-4946-9099; Brady, Zoe/0000-0001-9991-757X; Byrnes, Graham/0000-0003-3893-7539; Mathews, John/0000-0001-9029-7140; Forsythe, Anna/0000-0002-6677-8478	Australian government via the National Health and Medical Research Council; Cancer Research Campaign UK; Medical Research Council [MC_U137686858] Funding Source: researchfish	Australian government via the National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research Campaign UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Australian government via the National Health and Medical Research Council, and supported by in-kind contributions of people funded by the Cancer Research Campaign UK or employed by other agencies. The funding bodies had no role in study design, data analysis, or reporting; government agencies contributed to data collection and data linkage, but did not control data analysis, interpretation, or writing of the report. The corresponding author had full access to all data in the study, and had ultimate responsibility for data integrity, statistical analysis, and the decision to submit for publication.	[Anonymous], 2000, IARC MONOGR EVAL C 1, V75, P1; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Brady Z, 2012, THESIS ROYAL MELBOUR; Brady Z, 2012, MED J AUSTRALIA, V197, P95, DOI 10.5694/mja11.11124; Brady Z, 2011, J MED IMAG RADIAT ON, V55, P132, DOI 10.1111/j.1754-9485.2011.02242.x; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2012, RADIOLOGY, V265, P330, DOI 10.1148/radiol.12121248; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Einstein AJ, 2012, LANCET, V380, P455, DOI 10.1016/S0140-6736(12)60897-6; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Frush DP, 2003, RADIOLOGY, V229, P289, DOI 10.1148/radiol.2291030373; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Galanski M, 2006, PAEDIATRICCT EXPOSUR; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Huda W, 1997, RADIOLOGY, V203, P417, DOI 10.1148/radiology.203.2.9114097; Huda W, 2008, PEDIATR RADIOL, V38, P415, DOI 10.1007/s00247-007-0732-6; ICRP, 1990, ANN ICRP, V21, P1; Jackson D, 2012, AS OC C RAD; Kim KP, 2012, RADIAT PROT DOSIM, V150, P415, DOI 10.1093/rpd/ncr429; Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735; Lee Y, 2003, CANCER RES, V63, P5428; Linet MS, 2009, PEDIATR RADIOL, V39, pS4, DOI 10.1007/s00247-008-1026-3; McLean Donald, 2003, Australas Radiol, V47, P135, DOI 10.1046/j.0004-8461.2003.01141.x; Moss M, 2006, Australas Radiol, V50, P33, DOI 10.1111/j.1440-1673.2005.01544.x; National Council on Radiation Protection and Measurements, 2012, 171 NCRP; National Research Council (US) Committee on the Biological Effects of Ionizing Radiation, 2006, HLTH RISKS EXP LOW L; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Olsen JH, 2001, JNCI-J NATL CANCER I, V93, P121, DOI 10.1093/jnci/93.2.121; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pearce MS, 2011, J MED IMAG RADIAT ON, V55, P107, DOI 10.1111/j.1754-9485.2011.02240.x; Picano E, 2004, BMJ-BRIT MED J, V329, P849, DOI 10.1136/bmj.329.7470.849; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; PRESTON DL, 1994, RADIAT RES, V137, pS68, DOI 10.2307/3578893; Remedios DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1951; SHIMIZU Y, 1990, RADIAT RES, V121, P120, DOI 10.2307/3577495; Shrimpton P.C., 2003, NRPBW67; Shrimpton PC, 1991, NRPBR249; Singh G, 2005, BRAIN, V128, P7, DOI 10.1093/brain/awh363; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Socio-economic indexes for areas (SEIFA), 2006, SOC EC IND AR SEIFA; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, UNSCEAR 2008 REP GEN; White KS, 1996, PEDIATR RADIOL, V26, P5, DOI 10.1007/BF01403695	50	1214	1265	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f2360	10.1136/bmj.f2360	http://dx.doi.org/10.1136/bmj.f2360			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AK	23694687	Green Published, hybrid			2022-12-28	WOS:000319573300002
J	Fisher, SJ; Giudice, LC				Fisher, Susan J.; Giudice, Linda C.			Robert G. Edwards (1925-2013) Retrospective	SCIENCE			English	Biographical-Item									[Fisher, Susan J.; Giudice, Linda C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Fisher, Susan J.; Giudice, Linda C.] Univ Calif San Francisco, Human Embryon Stem Cell Program, San Francisco, CA 94143 USA; [Giudice, Linda C.] Amer Soc Reprod Med, Birmingham, AL 35216 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fisher, SJ (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	sfisher@cgl.ucsf.edu; giudice@obgyn.ucsf.edu						EDWARDS R, PUBLICATION LIST	1	1	1	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					825	825		10.1126/science.1239644	http://dx.doi.org/10.1126/science.1239644			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687039				2022-12-28	WOS:000318997400033
J	Black, RE; Alderman, H; Bhutta, ZA; Gillespie, S; Haddad, L; Horton, S; Lartey, A; Mannar, V; Ruel, M; Victora, CG; Walker, SP; Webb, P				Black, Robert E.; Alderman, Harold; Bhutta, Zulfiqar A.; Gillespie, Stuart; Haddad, Lawrence; Horton, Susan; Lartey, Anna; Mannar, Venkatesh; Ruel, Marie; Victora, Cesar G.; Walker, Susan P.; Webb, Patrick		Maternal Child Nutr Study Grp	Maternal and child nutrition: building momentum for impact	LANCET			English	Editorial Material							UNDERNUTRITION; HEALTH		[Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan; [Horton, Susan] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Lartey, Anna] Univ Ghana, Legon, Ghana; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, RS, Brazil; [Walker, Susan P.] Univ W Indies, Mona, Jamaica; [Webb, Patrick] Tufts Univ, Medford, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aga Khan University; University of Waterloo; University of Ghana; Universidade Federal de Pelotas; University West Indies Mona Jamaica; Tufts University	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.	rblack@jhsph.edu	Victora, Cesar Gomes/Y-2455-2019; Webb, Patrick/P-3420-2017; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Webb, Patrick/0000-0002-9857-3354; Victora, Cesar G/0000-0002-2465-2180; Ruel, Marie/0000-0002-9506-348X; Black, Robert/0000-0001-9926-7984; Horton, Susan/0000-0002-9243-4767				[Anonymous], 2010, FOOD NUTR BULL, V31, P178; [Anonymous], 2010, SCALING NUTR FRAMEWO; Bhutta ZA, 2013, LANCET; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black R., 2013, LANCET; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Dube L, 2012, P NATL ACAD SCI USA, V109, P12294, DOI 10.1073/pnas.0912951109; Gillespie S, 2013, LANCET; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Horton S, 2013, MUCH HAVE G IN PRESS; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Ruel M, 2013, LANCET; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2012, PROP GLOB TARG MAT I	15	113	114	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					372	375		10.1016/S0140-6736(13)60988-5	http://dx.doi.org/10.1016/S0140-6736(13)60988-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23746778				2022-12-28	WOS:000322638500007
J	Morley, JE; Sinclair, A				Morley, John E.; Sinclair, Alan			Individualising treatment for older people with diabetes	LANCET			English	Editorial Material							MELLITUS; ADULTS		[Morley, John E.] St Louis Univ, Sch Med, Div Geriatr Med & Endocrinol, St Louis, MO 63104 USA; [Sinclair, Alan] Univ Bedfordshire, Bedfordshire & Hertfordshire Postgrad Med Sch, Luton, Beds, England; [Sinclair, Alan] Inst Diabet Older People, Luton, Beds, England	Saint Louis University; University of Bedfordshire	Morley, JE (corresponding author), St Louis Univ, Sch Med, Div Geriatr Med & Endocrinol, St Louis, MO 63104 USA.	morley@slu.edu	Morley, John Edward/K-1570-2019					Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Gooben K., 2012, DIAB OBESITY METAB, V14, P1061; Kirkman MS, 2012, J AM GERIATR SOC, V60, P2342, DOI 10.1111/jgs.12035; Migdal A, 2011, J AM MED DIR ASSOC, V12, P627, DOI 10.1016/j.jamda.2011.02.010; Morley JE, J AM MED DI IN PRESS; Morley JE, 2009, CURR PHARM DESIGN, V15, P3384, DOI 10.2174/138161209789105045; Sinclair A, 2012, J AM MED DIR ASSOC, V13, P497, DOI 10.1016/j.jamda.2012.04.012; Strain WD, 2013, LANCET; Vinik AI, 2011, DIABETIC MED, V28, P643, DOI 10.1111/j.1464-5491.2010.03184.x; Yau CK, 2012, J AM GERIATR SOC, V60, P1215, DOI 10.1111/j.1532-5415.2012.04041.x	10	22	23	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 3	2013	382	9890					378	380		10.1016/S0140-6736(13)61055-7	http://dx.doi.org/10.1016/S0140-6736(13)61055-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23706758				2022-12-28	WOS:000322638500010
J	Bath, SC; Steer, CD; Golding, J; Emmett, P; Rayman, MP				Bath, Sarah C.; Steer, Colin D.; Golding, Jean; Emmett, Pauline; Rayman, Margaret P.			Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC)	LANCET			English	Article							URINARY IODINE; DEFICIENCY; SAMPLES; SUPPLEMENTATION; CHILDHOOD; DIET	Background As a component of thyroid hormones, iodine is essential for fetal brain development. Although the UK has long been considered iodine replete, increasing evidence suggests that it might now be mildly iodine deficient. We assessed whether mild iodine deficiency during early pregnancy was associated with an adverse effect on child cognitive development. Methods We analysed mother-child pairs from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort by measuring urinary iodine concentration (and creatinine to correct for urine volume) in stored samples from 1040 first-trimester pregnant women. We selected women on the basis of a singleton pregnancy and availability of both a urine sample from the first trimester (defined as <= 13 weeks' gestation; median 10 weeks [IQR 9-12]) and a measure of intelligence quotient (IQ) in the off spring at age 8 years. Women's results for iodine-to-creatinine ratio were dichotomised to less than 150 mu g/g or 150 mu g/g or more on the basis of WHO criteria for iodine deficiency or sufficiency in pregnancy. We assessed the association between maternal iodine status and child IQ at age 8 years and reading ability at age 9 years. We included 21 socioeconomic, parental, and child factors as confounders. Findings The group was classified as having mild-to-moderate iodine deficiency on the basis of a median urinary iodine concentration of 91.1 mu g/L (IQR 53.8-143; iodine-to-creatinine ratio 110 mu g/g, IQR 74-170). After adjustment for confounders, children of women with an iodine-to-creatinine ratio of less than 150 mu g/g were more likely to have scores in the lowest quartile for verbal IQ (odds ratio 1.58, 95% CI 1.09-2.30; p=0.02), reading accuracy (1.69, 1.15-2.49; p=0.007), and reading comprehension (1.54, 1.06-2.23; p=0.02) than were those of mothers with ratios of 150 mu g/g or more. When the less than 150 mu g/g group was subdivided, scores worsened ongoing from 150 mu g/g or more, to 50-150 mu g/g, to less than 50 mu g/g. Interpretation Our results show the importance of adequate iodine status during early gestation and emphasise the risk that iodine deficiency can pose to the developing infant, even in a country classified as only mildly iodine deficient. Iodine deficiency in pregnant women in the UK should be treated as an important public health issue that needs attention.	[Bath, Sarah C.; Rayman, Margaret P.] Univ Surrey, Fac Hlth & Med Sci, Dept Nutr Sci, Guildford GU2 7XH, Surrey, England; [Steer, Colin D.; Golding, Jean; Emmett, Pauline] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England	University of Surrey; University of Bristol	Rayman, MP (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Dept Nutr Sci, Guildford GU2 7XH, Surrey, England.	m.rayman@surrey.ac.uk	Emmett, Pauline/AAL-6815-2021	Emmett, Pauline/0000-0003-1076-4779; Golding, Jean/0000-0003-2826-3307; Bath, Sarah/0000-0001-5391-9932	Wassen International; Waterloo Foundation; Commission of the European Communities, Quality of Life and Management of Living Resources, within the 7th Framework Programme Nutrimenthe [FP7-212652]; US National Oceanographic and Atmospheric Administration; Wellcome Trust [092731]; Medical Research Council [G9815508] Funding Source: researchfish	Wassen International; Waterloo Foundation; Commission of the European Communities, Quality of Life and Management of Living Resources, within the 7th Framework Programme Nutrimenthe; US National Oceanographic and Atmospheric Administration; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A PhD studentship for SCB, funded by Wassen International and the Waterloo Foundation, enabled the costs of this investigation to be covered. PE was funded by Commission of the European Communities, Quality of Life and Management of Living Resources, within the 7th Framework Programme Nutrimenthe (reference FP7-212652). CDS was funded by the US National Oceanographic and Atmospheric Administration. We thank Christine Sieniawska (Trace Element Unit, Southampton University Hospital NHS Trust, UK) for analysis of urine samples, and Alex Richardson for introducing the Surrey and Bristol groups. We thank all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. The UK Medical Research Council, the Wellcome Trust (grant number 092731), and the University of Bristol provide core support for ALSPAC. MPR is the guarantor for the contents of this paper.	Andersen S, 2008, BRIT J NUTR, V99, P813, DOI 10.1017/S0007114507842292; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 2007, ASS IOD DEF DIS MON; Bath S., 2008, Journal of Human Nutrition and Dietetics, V21, P379, DOI 10.1111/j.1365-277X.2008.00881_9.x; Bath S, 2010, P NUTR SOC, V69, pE483, DOI 10.1017/S0029665110003460; Bath S, 2010, P NUTR SOC, V69; Bowen E, 2005, BJOG-INT J OBSTET GY, V112, P1083, DOI 10.1111/j.1471-0528.2005.00653.x; Caldwell B.M., 1979, HOME OBSERVATION MEA; Department of Health, 1991, DIET REF VAL FOOD EN; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; *I MED FOOD NUTR B, 2001, DIET REF INT VIT A V; Jones G, 2006, J ECON GROWTH, V11, P71, DOI 10.1007/s10887-006-7407-2; Jones G, EC GROWTH; Knudsen N, 2000, EUR J CLIN NUTR, V54, P361, DOI 10.1038/sj.ejcn.1600935; Konig F, 2011, J NUTR, V141, P2049, DOI 10.3945/jn.111.144071; Lazarus JH, 2008, LANCET, V372, P888, DOI 10.1016/S0140-6736(08)61390-2; Melse-Boonstra A, 2012, J TRACE ELEM MED BIO, V26, P134, DOI 10.1016/j.jtemb.2012.03.005; Neale M. D., 1997, NEALE ANAL READING A; NHS Choices, 2009, YOUR HLTH PREGN VIT; Nunes T, 2003, SCI STUD READ, V7, P289, DOI 10.1207/S1532799XSSR0703_6; Pearce EN, 2010, J CLIN ENDOCR METAB, V95, P3207, DOI 10.1210/jc.2010-0014; Pearce EN, 2009, THYROID, V19, P919, DOI 10.1089/thy.2009.0120; Phillips DIW, 1997, J EPIDEMIOL COMMUN H, V51, P391, DOI 10.1136/jech.51.4.391; Rasmussen LB, 1999, EUR J CLIN NUTR, V53, P401, DOI 10.1038/sj.ejcn.1600762; Rayman MP, 2008, P NUTR SOC, V67, DOI DOI 10.1017/S0029665108000736; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Rose M, 2001, J ENVIRON MONITOR, V3, P361, DOI 10.1039/b105695f; Spierto FW, 1997, CLIN CHIM ACTA, V264, P227, DOI 10.1016/S0009-8981(97)00080-6; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Vanderpump MPJ, 2011, LANCET, V377, P2007, DOI 10.1016/S0140-6736(11)60693-4; Wechsler D., 1992, WISC IIIUK WECHSLER; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751; Zimmermann M, 2004, EUR J CLIN NUTR, V58, P979, DOI 10.1038/sj.ejcn.1601933; Zimmermann MB, 2007, THYROID, V17, P829, DOI 10.1089/thy.2007.0108; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	36	463	491	13	142	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					331	337		10.1016/S0140-6736(13)60436-5	http://dx.doi.org/10.1016/S0140-6736(13)60436-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23706508				2022-12-28	WOS:000322544900030
J	Cotton, D				Cotton, Deborah			Boston Medicine, Before and After	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Cotton, D (corresponding author), Amer Coll Physicians, Philadelphia, PA 19106 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					145	+		10.7326/0003-4819-159-2-201307160-00650	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00650			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V38KJ	23698621				2022-12-28	WOS:000209342000001
J	Eckardt, KU; Coresh, J; Devuyst, O; Johnson, RJ; Kottgen, A; Levey, AS; Levin, A				Eckardt, Kai-Uwe; Coresh, Josef; Devuyst, Olivier; Johnson, Richard J.; Koettgen, Anna; Levey, Andrew S.; Levin, Adeera			Evolving importance of kidney disease: from subspecialty to global health burden	LANCET			English	Article							GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; SERUM CREATININE; FUNCTION DECLINE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CONSENSUS CONFERENCE; POSITION STATEMENT; WORKING GROUP; RISK	In the past decade, kidney disease diagnosed with objective measures of kidney damage and function has been recognised as a major public health burden. The population prevalence of chronic kidney disease exceeds 10%, and is more than 50% in high-risk subpopulations. Independent of age, sex, ethnic group, and comorbidity, strong, graded, and consistent associations exist between clinical prognosis and two hallmarks of chronic kidney disease: reduced glomerular filtration rate and increased urinary albumin excretion. Furthermore, an acute reduction in glomerular filtration rate is a risk factor for adverse clinical outcomes and the development and progression of chronic kidney disease. An increasing amount of evidence suggests that the kidneys are not only target organs of many diseases but also can strikingly aggravate or start systemic pathophysiological processes through their complex functions and effects on body homoeostasis. Risk of kidney disease has a notable genetic component, and identified genes have provided new insights into relevant abnormalities in renal structure and function and essential homoeostatic processes. Collaboration across general and specialised health-care professionals is needed to fully address the challenge of prevention of acute and chronic kidney disease and improve outcomes.	[Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Coresh, Josef; Koettgen, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Johnson, Richard J.] Univ Colorado, Div Renal Dis & Hypertens, Denver, CO 80202 USA; [Koettgen, Anna] Freiburg Univ Hosp, Div Renal, Freiburg, Germany; [Levey, Andrew S.] Tufts Med Ctr, Boston, MA USA; [Levin, Adeera] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC, Canada	University of Erlangen Nuremberg; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Colorado System; University of Colorado Denver; University of Freiburg; Tufts Medical Center; University of British Columbia	Eckardt, KU (corresponding author), Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Ulmenweg 18, D-91054 Erlangen, Germany.	kai-uwe.eckardt@uk-erlangen.de		Devuyst, Olivier/0000-0003-3744-4767				Ahuja N, 2012, AM J PHYSIOL-RENAL, V303, pF864, DOI 10.1152/ajprenal.00025.2012; Bagshaw SM, 2010, NEPHROL DIAL TRANSPL, V25, P1406, DOI 10.1093/ndt/gfq066; Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Benigni A, 2010, LANCET, V375, P1310, DOI 10.1016/S0140-6736(10)60237-1; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; CARMELLI D, 1994, J HYPERTENS, V12, P323; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Charytan DM, 2007, KIDNEY INT, V71, P938, DOI 10.1038/sj.ki.5002159; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chawla LS, 2012, NAT REV NEPHROL, V8, P68, DOI 10.1038/nrneph.2011.216; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Devuyst O, 2008, NAT GENET, V40, P495, DOI 10.1038/ng0508-495; Devuyst O, 2012, NEPHROL DIAL TRANSPL, V27, P67, DOI 10.1093/ndt/gfr764; Devuyst O, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-28; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eckardt KU, 2012, NEPHROL DIAL TRANSPL, V27, P1454, DOI 10.1093/ndt/gfr456; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferre S, 2012, KIDNEY INT, V82, P1157, DOI 10.1038/ki.2012.179; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gansevoort RT, 2013, LANCET; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Glassock RJ, 2012, CURR OPIN NEPHROL HY, V21, P235, DOI 10.1097/MNH.0b013e3283522ea8; Gleadle JM, 2009, NEPHROLOGY, V14, P86, DOI 10.1111/j.1440-1797.2008.01064.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P3349; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Helmchen LA, 2004, ANN HUM BIOL, V31, P174, DOI 10.1080/03014460410001663434; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P452, DOI 10.1053/j.ajkd.2009.11.016; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Jha V, 2013, LANCET; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johnson RJ, 2010, J AM SOC NEPHROL, V21, P2036, DOI 10.1681/ASN.2010050506; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Kiberd BA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014251.87778.01; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Krop JS, 1999, ARCH INTERN MED, V159, P1777, DOI 10.1001/archinte.159.15.1777; Kuro-O M, 2012, CURR OPIN NEPHROL HY, V21, P362, DOI 10.1097/MNH.0b013e32835422ad; Lafrance JP, 2010, NEPHROL DIAL TRANSPL, V25, P2203, DOI 10.1093/ndt/gfq011; Lameire NH, 2013, LANCET; Lash JP, 2009, CLIN J AM SOC NEPHRO, V4, P1302, DOI 10.2215/CJN.00070109; Lee M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4249; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Lie ML, 2012, J IMMUNOL, V189, P2843, DOI 10.4049/jimmunol.1103254; Lifton R. P., 2005, HARVEY LECT, V100, P71; Lipkowitz MS, 2013, KIDNEY INT, V83, P114, DOI 10.1038/ki.2012.263; Luyckx VA, 2013, LANCET; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Miller WG, 2009, CLIN CHEM LAB MED, V47, P1017, DOI 10.1515/CCLM.2009.264; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Nakayama T, 2010, AM J PHYSIOL-RENAL, V298, pF712, DOI 10.1152/ajprenal.00433.2009; Noris M, 2010, SEMIN NEPHROL, V30, P395, DOI 10.1016/j.semnephrol.2010.06.006; O'Seaghdha CM, 2012, AM J KIDNEY DIS, V59, P19, DOI 10.1053/j.ajkd.2011.08.030; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Palmer SC, 2011, AM J KIDNEY DIS, V58, P335, DOI 10.1053/j.ajkd.2011.06.006; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Peralta CA, 2011, J AM SOC NEPHROL, V22, P1327, DOI 10.1681/ASN.2010090960; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Remuzzi G, 2013, LANCET; Rodriguez-Iturbe B, 2010, HYPERTENS RES, V33, P975, DOI 10.1038/hr.2010.148; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Santin S, 2011, CLIN J AM SOC NEPHRO, V6, P1139, DOI 10.2215/CJN.05260610; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schrier RW, 2008, SEMIN NEPHROL, V28, P289, DOI 10.1016/j.semnephrol.2008.03.009; Shah NK, 2012, PHARMACOTHERAPY, V32, P80, DOI 10.1002/PHAR.1010; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Singh P, 2010, CURR OPIN NEPHROL HY, V19, P59, DOI 10.1097/MNH.0b013e3283331ffd; Smith KD, 2009, CURR OPIN NEPHROL HY, V18, P189, DOI 10.1097/MNH.0b013e32832a1d5f; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Stockand JD, 2010, KIDNEY INT, V78, P849, DOI 10.1038/ki.2010.276; Teteris SA, 2011, KIDNEY INT, V80, P140, DOI 10.1038/ki.2011.129; Toussaint ND, 2012, NEPHROLOGY, V17, P433, DOI 10.1111/j.1440-1797.2012.01618.x; Turin TC, 2012, J AM SOC NEPHROL, V23, P1569, DOI 10.1681/ASN.2012020164; Turner JM, 2012, KIDNEY INT, V81, P351, DOI 10.1038/ki.2011.380; *US REN DAT SYST, 2004, ATL END STAG REN DIS; Vanholder R, 2012, J AM SOC NEPHROL, V23, P1291, DOI 10.1681/ASN.2011111094; Viasus D, 2011, NEPHROL DIAL TRANSPL, V26, P2899, DOI 10.1093/ndt/gfq798; Wadei HM, 2012, NAT REV NEPHROL, V8, P602, DOI 10.1038/nrneph.2012.191; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Winkelmayer WC, 2006, CLIN J AM SOC NEPHRO, V1, P796, DOI 10.2215/CJN.00150106	121	709	758	6	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					158	169		10.1016/S0140-6736(13)60439-0	http://dx.doi.org/10.1016/S0140-6736(13)60439-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23727165	Green Accepted			2022-12-28	WOS:000322115300031
J	Vikse, BE				Vikse, Bjorn Egil			Pre-eclampsia and the risk of kidney disease	LANCET			English	Editorial Material							HYPERTENSIVE DISORDERS; PREGNANCY; BIOPSY		[Vikse, Bjorn Egil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Vikse, Bjorn Egil] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Vikse, Bjorn Egil] Haugesund Hosp, Dept Med, N-5504 Haugesund, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Vikse, BE (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	bjorn.vikse@med.uib.no						Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; Garovic VD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.007; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; McDonald SD, 2010, AM J KIDNEY DIS, V55, P1026, DOI 10.1053/j.ajkd.2009.12.036; Nanjundan P, 2011, J OBSTET GYNAECOL, V31, P384, DOI 10.3109/01443615.2011.566389; Prakash J, 2010, RENAL FAILURE, V32, P309, DOI 10.3109/08860221003606265; Rasmussen S, 2007, HYPERTENSION, V49, P806, DOI 10.1161/01.HYP.0000259924.74947.aa; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P777, DOI 10.1016/0002-9378(90)91009-2; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Vikse BE, 2006, J AM SOC NEPHROL, V17, P837, DOI 10.1681/ASN.2005050492; Vikse BE, 2010, NEPHROL DIAL TRANSPL, V25, P3289, DOI 10.1093/ndt/gfq169; Wang IK, 2013, CAN MED ASSOC J, V185, P207, DOI 10.1503/cmaj.120230	15	35	37	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					104	106		10.1016/S0140-6736(13)60741-2	http://dx.doi.org/10.1016/S0140-6736(13)60741-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23727168				2022-12-28	WOS:000322115300005
J	Zhu, H; Wang, D; Kelvin, DJ; Li, L; Zheng, Z; Yoon, SW; Wong, SS; Farooqui, A; Wang, J; Banner, D; Chen, R; Zheng, R; Zhou, J; Zhang, Y; Hong, W; Dong, W; Cai, Q; Roehrl, MHA; Huang, SSH; Kelvin, AA; Yao, T; Zhou, B; Chen, X; Leung, GM; Poon, LLM; Webster, RG; Webby, RJ; Peiris, JSM; Guan, Y; Shu, Y				Zhu, H.; Wang, D.; Kelvin, D. J.; Li, L.; Zheng, Z.; Yoon, S. -W.; Wong, S. -S.; Farooqui, A.; Wang, J.; Banner, D.; Chen, R.; Zheng, R.; Zhou, J.; Zhang, Y.; Hong, W.; Dong, W.; Cai, Q.; Roehrl, M. H. A.; Huang, S. S. H.; Kelvin, A. A.; Yao, T.; Zhou, B.; Chen, X.; Leung, G. M.; Poon, L. L. M.; Webster, R. G.; Webby, R. J.; Peiris, J. S. M.; Guan, Y.; Shu, Y.			Infectivity, Transmission, and Pathology of Human-Isolated H7N9 Influenza Virus in Ferrets and Pigs	SCIENCE			English	Article							PATHOGENESIS; EVOLUTION	The emergence of the H7N9 influenza virus in humans in Eastern China has raised concerns that a new influenza pandemic could occur. Here, we used a ferret model to evaluate the infectivity and transmissibility of A/Shanghai/2/2013 (SH2), a human H7N9 virus isolate. This virus replicated in the upper and lower respiratory tracts of the ferrets and was shed at high titers for 6 to 7 days, with ferrets showing relatively mild clinical signs. SH2 was efficiently transmitted between ferrets via direct contact, but less efficiently by airborne exposure. Pigs were productively infected by SH2 and shed virus for 6 days but were unable to transmit the virus to naive pigs or ferrets. Under appropriate conditions, human-to-human transmission of the H7N9 virus may be possible.	[Zhu, H.; Li, L.; Zheng, Z.; Wang, J.; Chen, R.; Zheng, R.; Zhou, J.; Zhang, Y.; Hong, W.; Cai, Q.; Yao, T.; Guan, Y.] Shantou Univ, Joint Influenza Res Ctr SUMC HKU, Shantou, Peoples R China; [Zhu, H.; Zhou, J.; Zhou, B.; Chen, X.; Poon, L. L. M.; Peiris, J. S. M.; Guan, Y.] Shenzhen Third Peoples Hosp, State Key Lab Emerging Infect Dis, HKU Shenzhen Branch, Shenzhen, Peoples R China; [Zhu, H.; Wang, J.; Zhou, J.; Leung, G. M.; Poon, L. L. M.; Peiris, J. S. M.; Guan, Y.] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Kelvin, D. J.; Farooqui, A.; Dong, W.; Kelvin, A. A.] Shantou Univ Med Coll, Joint Vaccine Res Ctr SUMC UHN, Shantou, Peoples R China; [Kelvin, D. J.; Banner, D.; Roehrl, M. H. A.; Huang, S. S. H.; Kelvin, A. A.] Univ Hlth Network, Toronto, ON, Canada; [Kelvin, D. J.; Roehrl, M. H. A.; Huang, S. S. H.] Univ Toronto, Toronto, ON, Canada; [Yoon, S. -W.; Wong, S. -S.; Webster, R. G.; Webby, R. J.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Wang, D.] Natl Hlth & Family Planning Commiss, Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, Beijing, Peoples R China	Shantou University; University of Hong Kong; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; St Jude Children's Research Hospital; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Guan, Y (corresponding author), Shantou Univ, Joint Influenza Res Ctr SUMC HKU, Shantou, Peoples R China.	yguan@hku.hk; yshu@cnic.org.cn	Zhu, Huachen/A-8252-2017; yoon, sun-woo/V-6285-2019; Webby, Richard J/N-5657-2018; Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Roehrl, Michael/AAU-8506-2020; LI, Loong/E-3107-2015	Zhu, Huachen/0000-0003-2711-0501; Poon, Leo Lit Man/0000-0002-9101-7953; Roehrl, Michael/0000-0003-4892-1098; LI, Loong/0000-0003-1670-4523; Bucalic, Leon/0000-0002-5913-0841; Leung, Gabriel/0000-0002-2503-6283; Guan, Yi/0000-0001-6057-9243; Farooqui, Amber/0000-0002-6031-9561	NIH (National Institute of Allergy and Infectious Diseases) [HSN266200700005C]; Li Ka Shing Foundation; Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR [AoE/M-12/06]; Shenzhen Peacock Plan High-End Talents Program [KQTD201203]; Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology [KJYJ-2013-01-01-01]	NIH (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Li Ka Shing Foundation; Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR; Shenzhen Peacock Plan High-End Talents Program; Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology	We gratefully acknowledge our colleagues from the Joint Influenza Research Center (SUMC/HKU) and the State Key Laboratory of Emerging Infectious Diseases for their excellent technical assistance and D. K. Smith for editorial assistance. This study was supported by the NIH (National Institute of Allergy and Infectious Diseases contract HSN266200700005C), Li Ka Shing Foundation, the Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR (grant AoE/M-12/06), Shenzhen Peacock Plan High-End Talents Program (KQTD201203), and Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology (no. KJYJ-2013-01-01-01 to Y.S.). The sequences generated by this study were deposited in GenBank under accession nos. KF0211594 to KF0211601; other data can be found in the supplementary materials.	Bodewes R, 2011, AM J PATHOL, V179, P30, DOI 10.1016/j.ajpath.2011.03.026; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07	16	248	277	4	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					183	186		10.1126/science.1239844	http://dx.doi.org/10.1126/science.1239844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23704376	Bronze			2022-12-28	WOS:000321965300045
J	Mehine, M; Kaasinen, E; Makinen, N; Katainen, R; Kampjarvi, K; Pitkanen, E; Heinonen, HR; Butzow, R; Kilpivaara, O; Kuosmanen, A; Ristolainen, H; Gentile, M; Sjoberg, J; Vahteristo, P; Aaltonen, LA				Mehine, Miika; Kaasinen, Eevi; Makinen, Netta; Katainen, Riku; Kampjarvi, Kati; Pitkanen, Esa; Heinonen, Hanna-Riikka; Butzow, Ralf; Kilpivaara, Outi; Kuosmanen, Anna; Ristolainen, Heikki; Gentile, Massimiliano; Sjoberg, Jari; Vahteristo, Pia; Aaltonen, Lauri A.			Characterization of Uterine Leiomyomas by Whole-Genome Sequencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE; CANCER; REARRANGEMENTS; EXPRESSION; CHROMOTHRIPSIS; T(12/14); COMPLEX; TUMORS; CUX1; PATHOGENESIS	BACKGROUND Uterine leiomyomas are benign but affect the health of millions of women. A better understanding of the molecular mechanisms involved may provide clues to the prevention and treatment of these lesions. METHODS We performed whole-genome sequencing and gene-expression profiling of 38 uterine leiomyomas and the corresponding myometrium from 30 women. RESULTS Identical variants observed in some separate tumor nodules suggested that these nodules have a common origin. Complex chromosomal rearrangements resembling chromothripsis were a common feature of leiomyomas. These rearrangements are best explained by a single event of multiple chromosomal breaks and random reassembly. The rearrangements created tissue-specific changes consistent with a role in the initiation of leiomyoma, such as translocations of the HMGA2 and RAD51B loci and aberrations at the COL4A5-COL4A6 locus, and occurred in the presence of normal TP53 alleles. In some cases, separate events had occurred more than once in single tumor-cell lineages. CONCLUSIONS Chromosome shattering and reassembly resembling chromothripsis (a single genomic event that results in focal losses and rearrangements in multiple genomic regions) is a major cause of chromosomal abnormalities in uterine leiomyomas; we propose that tumorigenesis occurs when tissue-specific tumor-promoting changes are formed through these events. Chromothripsis has previously been associated with aggressive cancer; its common occurrence in leiomyomas suggests that it also has a role in the genesis and progression of benign tumors. We observed that multiple separate tumors could be seeded from a single lineage of uterine leiomyoma cells.	[Mehine, Miika; Kaasinen, Eevi; Makinen, Netta; Katainen, Riku; Kampjarvi, Kati; Pitkanen, Esa; Heinonen, Hanna-Riikka; Kilpivaara, Outi; Kuosmanen, Anna; Ristolainen, Heikki; Vahteristo, Pia; Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Genome Scale Biol Res Program, Helsinki 00014, Finland; [Butzow, Ralf] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki 00014, Finland; [Butzow, Ralf] Univ Helsinki, HUSLAB, FIN-00014 Helsinki, Finland; [Sjoberg, Jari] Univ Helsinki, Dept Obstet & Gynecol, Helsinki 00014, Finland; Univ Helsinki, Cent Hosp, Helsinki 00014, Finland; [Gentile, Massimiliano] CSC IT Ctr Sci, Espoo, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Aaltonen, LA (corresponding author), Univ Helsinki, Dept Med Genet, Biomedicum Helsinki, POB 63,Haartmaninkatu 3, Helsinki 00014, Finland.	lauri.aaltonen@helsinki.fi	Katainen, Riku/GYR-0921-2022; Gentile, Massimo/R-3270-2016; Heinonen, Hanna-Riikka/C-6059-2015; Aaltonen, Lauri/A-5375-2010; Pitkanen, Esa/H-2435-2018	Gentile, Massimo/0000-0002-5256-0726; Heinonen, Hanna-Riikka/0000-0002-4069-2334; Aaltonen, Lauri/0000-0001-6839-4286; Pitkanen, Esa/0000-0002-9818-6370; Makinen, Netta/0000-0003-0104-7794; Kuosmanen, Anna/0000-0002-7002-0803; Kaasinen, Eevi/0000-0002-1333-8049; Katainen, Riku/0000-0003-4575-4239	Academy of Finland Center of Excellence program; Academy of Finland [250345, 260370, 137680]; Sigrid Juselius Foundation; Cancer Society of Finland; Jane and Aatos Erkko Foundation	Academy of Finland Center of Excellence program(Academy of Finland); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Jane and Aatos Erkko Foundation	Funded by the Academy of Finland Center of Excellence program and others.; Supported by grants from the Academy of Finland (250345, 260370, and 137680), the Sigrid Juselius Foundation, the Cancer Society of Finland, and the Jane and Aatos Erkko Foundation.	Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Cuevas EP, 2007, J HEPATOL, V46, P1089, DOI 10.1016/j.jhep.2007.01.031; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Garcia-Torres R, 2000, NEPHROLOGIE, V21, P9; Hodge JC, 2012, HUM MOL GENET, V21, P2312, DOI 10.1093/hmg/dds051; Ingraham SE, 1999, CANCER GENET CYTOGEN, V115, P56, DOI 10.1016/S0165-4608(99)00070-9; Jacoby VL, 2009, OBSTET GYNECOL, V114, P1041, DOI 10.1097/AOG.0b013e3181b9d222; Jerez A, 2012, BLOOD, V119, P6109, DOI 10.1182/blood-2011-12-397620; Kazmierczak B, 1998, GENE CHROMOSOME CANC, V23, P279, DOI 10.1002/(SICI)1098-2264(199812)23:4<279::AID-GCC1>3.0.CO;2-1; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Lehtonen HJ, 2011, FAM CANCER, V10, P397, DOI 10.1007/s10689-011-9428-z; Lehtonen R, 2004, AM J PATHOL, V164, P17, DOI 10.1016/S0002-9440(10)63091-X; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Ligon AH, 2002, CANCER GENET CYTOGEN, V137, P133, DOI 10.1016/S0165-4608(02)00547-2; Ligon AH, 2000, GENE CHROMOSOME CANC, V28, P235, DOI 10.1002/1098-2264(200007)28:3<235::AID-GCC1>3.3.CO;2-Z; Litovkin K. V., 2008, Experimental Oncology, V30, P106; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nibert M, 1990, GENE CHROMOSOME CANC, V2, P3; NILBERT M, 1990, HUM GENET, V85, P605; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; PANDIS N, 1991, INT J GYNECOL CANCER, V1, P163, DOI 10.1046/j.1525-1438.1991.01040163.x; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Sandberg AA, 2005, CANCER GENET CYTOGEN, V158, P1, DOI 10.1016/j.cancergencyto.2004.08.025; Schoenmakers EFPM, 1999, CANCER RES, V59, P19; Schoenmakers EFPM, 2013, GENE CHROMOSOME CANC, V52, P11, DOI 10.1002/gcc.22001; Sornberger KS, 1999, CANCER GENET CYTOGEN, V114, P9, DOI 10.1016/S0165-4608(99)00054-0; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Vadnais C, 2012, NUCLEIC ACIDS RES, V40, P4483, DOI 10.1093/nar/gks041; Vanharanta S, 2006, HUM MOL GENET, V15, P97, DOI 10.1093/hmg/ddi431; Wu CX, 2012, GENE CHROMOSOME CANC, V51, P1144, DOI 10.1002/gcc.21999; Yang ZM, 2009, BIOCHEM BIOPH RES CO, V386, P146, DOI 10.1016/j.bbrc.2009.05.139; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	43	208	217	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					43	53		10.1056/NEJMoa1302736	http://dx.doi.org/10.1056/NEJMoa1302736			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23738515				2022-12-28	WOS:000321263500009
J	Passelegue, FX; Schubnel, A; Nielsen, S; Bhat, HS; Madariaga, R				Passelegue, Francois X.; Schubnel, Alexandre; Nielsen, Stefan; Bhat, Harsha S.; Madariaga, Raul			From Sub-Rayleigh to Supershear Ruptures During Stick-Slip Experiments on Crustal Rocks	SCIENCE			English	Article							GROUND MOTION; KUNLUNSHAN-EARTHQUAKE; SHEAR CRACKS; FAULT; PROPAGATION; MECHANISM; FRICTION; VELOCITY	Supershear earthquake ruptures propagate faster than the shear wave velocity. Although there is evidence that this occurs in nature, it has not been experimentally demonstrated with the use of crustal rocks. We performed stick-slip experiments with Westerly granite under controlled upper-crustal stress conditions. Supershear ruptures systematically occur when the normal stress exceeds 43 megapascals (MPa) with resulting stress drops on the order of 3 to 25 MPa, comparable to the stress drops inferred by seismology for crustal earthquakes. In our experiments, the sub-Rayleigh-to-supershear transition length is a few centimeters at most, suggesting that the rupture of asperities along a fault may propagate locally at supershear velocities. In turn, these sudden accelerations and decelerations could play an important role in the generation of high-frequency radiation and the overall rupture-energy budget.	[Passelegue, Francois X.; Schubnel, Alexandre; Madariaga, Raul] Ecole Normale Super, CNRS UMR 8538, Geol Lab, F-75005 Paris, France; [Nielsen, Stefan] Ist Nazl Geofis & Vulcanol, I-00143 Rome, Italy; [Bhat, Harsha S.] Inst Phys Globe Paris, F-75238 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Istituto Nazionale Geofisica e Vulcanologia (INGV); UDICE-French Research Universities; Universite Paris Cite	Passelegue, FX (corresponding author), Ecole Normale Super, CNRS UMR 8538, Geol Lab, F-75005 Paris, France.	passelegue@geologie.ens.fr	Madariaga, Raul/D-5304-2011; Nielsen, Stefan B/F-6210-2011; Bhat, Harsha/B-1489-2008	Nielsen, Stefan B/0000-0002-9214-2932; Bhat, Dr. Shijaatt Hussain/0000-0002-8735-6792; Bhat, Harsha/0000-0003-0361-1854	French Ministry of Foreign affairs program GALILEO [26019WJ]; Italian Ministry of Foreign affairs program GALILEO [26019WJ]; Institut National des Sciences de l'Univers	French Ministry of Foreign affairs program GALILEO; Italian Ministry of Foreign affairs program GALILEO; Institut National des Sciences de l'Univers	We thank Y. Pinquier for technical support and two reviewers and the associate editor for their constructive remarks, which helped to enhance this paper. F. X. P., A. S., and S.N. acknowledge support from the French and Italian Ministry of Foreign affairs program GALILEO, project no. 26019WJ. This work was supported by the Institut National des Sciences de l'Univers. Data are available in the supplementary materials.	ANDREWS DJ, 1976, J GEOPHYS RES, V81, P5679, DOI 10.1029/JB081i032p05679; ARCHULETA RJ, 1984, J GEOPHYS RES, V89, P4559, DOI 10.1029/JB089iB06p04559; Ben-David O, 2010, SCIENCE, V330, P211, DOI 10.1126/science.1194777; Bizzarri A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006819; Bouchon M, 2003, SCIENCE, V301, P824, DOI 10.1126/science.1086832; Bouchon M, 2001, GEOPHYS RES LETT, V28, P2723, DOI 10.1029/2001GL013112; BRACE WF, 1966, SCIENCE, V153, P990, DOI 10.1126/science.153.3739.990; Brantut N, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005551; BURRIDGE R, 1973, GEOPHYS J ROY ASTR S, V35, P439, DOI 10.1111/j.1365-246X.1973.tb00608.x; Candela T, 2012, J STRUCT GEOL, V45, P85, DOI 10.1016/j.jsg.2012.06.003; Di Toro G, 2006, SCIENCE, V311, P647, DOI 10.1126/science.1121012; Doan ML, 2009, NAT GEOSCI, V2, P709, DOI 10.1038/NGEO640; Dunham EM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021793; Ellsworth WL, 2004, EARTHQ SPECTRA, V20, P597, DOI 10.1193/1.1778172; JOHNSON TL, 1976, J GEOPHYS RES, V81, P881, DOI 10.1029/JB081i005p00881; Liu PC, 2006, B SEISMOL SOC AM, V96, pS143, DOI 10.1785/0120050826; MADARIAGA R, 1983, ANN GEOPHYS, V1, P17; Mello M, 2010, TECTONOPHYSICS, V493, P297, DOI 10.1016/j.tecto.2010.07.003; Nielsen S, 2010, GEOPHYS J INT, V180, P697, DOI 10.1111/j.1365-246X.2009.04444.x; Ohnaka M, 1999, J GEOPHYS RES-SOL EA, V104, P817, DOI 10.1029/1998JB900007; OKUBO PG, 1984, J GEOPHYS RES, V89, P5817, DOI 10.1029/JB089iB07p05817; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Robinson DP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004137; Schubnel A, 2011, EARTH PLANET SC LETT, V308, P424, DOI 10.1016/j.epsl.2011.06.013; SIBSON RH, 1985, NATURE, V316, P248, DOI 10.1038/316248a0; Wang D, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053622; WONG TF, 1982, J GEOPHYS RES, V87, P990, DOI 10.1029/JB087iB02p00990; WU FT, 1972, B SEISMOL SOC AM, V62, P1621; Xia KW, 2004, SCIENCE, V303, P1859, DOI 10.1126/science.1094022	29	89	90	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1208	1211		10.1126/science.1235637	http://dx.doi.org/10.1126/science.1235637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744944				2022-12-28	WOS:000319972800043
J	Brandt, AM				Brandt, Allan M.			How AIDS Invented Global Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brandt, Allan M.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA; [Brandt, Allan M.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	Harvard University; Harvard University; Harvard Medical School	Brandt, AM (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.							Brandt AM, 2000, AM J PUBLIC HEALTH, V90, P707, DOI 10.2105/AJPH.90.5.707; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Killen J, 2012, LANCET, V380, P314, DOI 10.1016/S0140-6736(12)60635-7; MANN JM, 1988, J ROY STAT SOC A STA, V151, P131, DOI 10.2307/2982189; Rosenberg CE, 1986, MILBANK Q         S1, V64, P55	5	56	57	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2149	2152		10.1056/NEJMp1305297	http://dx.doi.org/10.1056/NEJMp1305297			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DN	23738542				2022-12-28	WOS:000319948900001
J	Ito, T; Nishie, W; Fujita, Y; Abe, R; Shimizu, H				Ito, Takamasa; Nishie, Wataru; Fujita, Yasuyuki; Abe, Riichiro; Shimizu, Hiroshi			Infantile eczema caused by formula milk	LANCET			English	Editorial Material							MULTIPLE CARBOXYLASE DEFICIENCY; BIOTIN DEFICIENCY		[Ito, Takamasa; Nishie, Wataru; Fujita, Yasuyuki; Abe, Riichiro; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan	Hokkaido University	Nishie, W (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	nishie@med.hokudai.ac.jp	Fujita, Yasuyuki/A-5464-2012	Fujita, Yasuyuki/0000-0001-7934-9261				Baumgartner ER, 1997, INT J VITAM NUTR RES, V67, P377; Fujimoto W, 2005, J DERMATOL, V32, P256, DOI 10.1111/j.1346-8138.2005.tb00758.x; MOCK DM, 1991, SEMIN DERMATOL, V10, P296; Seymons K, 2004, PEDIATR DERMATOL, V21, P231, DOI 10.1111/j.0736-8046.2004.21308.x	4	1	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1958	1958		10.1016/S0140-6736(13)60684-4	http://dx.doi.org/10.1016/S0140-6736(13)60684-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23725733				2022-12-28	WOS:000320319500037
J	McClatchy, S; McGann, D; Gotwals, R; Baskett, A; Churchill, G				McClatchy, Susan; McGann, Deborah; Gotwals, Robert; Baskett, Amanda; Churchill, Gary			Students as Collaborators in Systems Biology Research	SCIENCE			English	Editorial Material									[McClatchy, Susan; Churchill, Gary] Jackson Lab, Ctr Genome Dynam, Bar Harbor, ME 04609 USA; [McGann, Deborah] Maine Sch Sci & Math, Limestone, ME 04750 USA; [Gotwals, Robert] North Carolina Sch Sci & Math, Durham, NC 27705 USA; [Baskett, Amanda] Rockdale Magnet Sch Sci & Technol, Conyers, GA 30012 USA	Jackson Laboratory; University of North Carolina	Churchill, G (corresponding author), Jackson Lab, Ctr Genome Dynam, 600 Main St, Bar Harbor, ME 04609 USA.	gary.churchill@jax.org	Churchill, Gary/AAY-7496-2020	Churchill, Gary/0000-0001-9190-9284	NIGMS NIH HHS [P50GM076468, P50 GM076468] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Feng MJ, 2009, HYPERTENSION, V54, P802, DOI 10.1161/HYPERTENSIONAHA.109.134569; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; Von Smith R., 2009, NCSSSMST J, V15, P10	4	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1061	1062		10.1126/science.1229906	http://dx.doi.org/10.1126/science.1229906			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23723228	Green Accepted			2022-12-28	WOS:000319664500033
J	Williams, RME; Grotzinger, JP; Dietrich, WE; Gupta, S; Sumner, DY; Wiens, RC; Mangold, N; Malin, MC; Edgett, KS; Maurice, S; Forni, O; Gasnault, O; Ollila, A; Newsom, HE; Dromart, G; Palucis, MC; Yingst, RA; Anderson, RB; Herkenhoff, KE; Le Mouelic, S; Goetz, W; Madsen, MB; Koefoed, A; Jensen, JK; Bridges, JC; Schwenzer, SP; Lewis, KW; Stack, KM; Rubin, D; Kah, LC; Bell, JF; Farmer, JD; Sullivan, R; Van Beek, T; Blaney, DL; Pariser, O; Deen, RG				Williams, R. M. E.; Grotzinger, J. P.; Dietrich, W. E.; Gupta, S.; Sumner, D. Y.; Wiens, R. C.; Mangold, N.; Malin, M. C.; Edgett, K. S.; Maurice, S.; Forni, O.; Gasnault, O.; Ollila, A.; Newsom, H. E.; Dromart, G.; Palucis, M. C.; Yingst, R. A.; Anderson, R. B.; Herkenhoff, K. E.; Le Mouelic, S.; Goetz, W.; Madsen, M. B.; Koefoed, A.; Jensen, J. K.; Bridges, J. C.; Schwenzer, S. P.; Lewis, K. W.; Stack, K. M.; Rubin, D.; Kah, L. C.; Bell, J. F., III; Farmer, J. D.; Sullivan, R.; Van Beek, T.; Blaney, D. L.; Pariser, O.; Deen, R. G.		MSL Sci Team	Martian Fluvial Conglomerates at Gale Crater	SCIENCE			English	Article							CHEMCAM INSTRUMENT SUITE; MERIDIANI-PLANUM; MARS; SYSTEM; WATER; UNIT	Observations by the Mars Science Laboratory Mast Camera (Mastcam) in Gale crater reveal isolated outcrops of cemented pebbles (2 to 40 millimeters in diameter) and sand grains with textures typical of fluvial sedimentary conglomerates. Rounded pebbles in the conglomerates indicate substantial fluvial abrasion. ChemCam emission spectra at one outcrop show a predominantly feldspathic composition, consistent with minimal aqueous alteration of sediments. Sediment was mobilized in ancient water flows that likely exceeded the threshold conditions (depth 0.03 to 0,9 meter, average velocity 0.20 to 0.75 meter per second) required to transport the pebbles. Climate conditions at the time sediment was transported must have differed substantially from the cold, hyper-arid modern environment to permit aqueous flows across several kilometers,	[Williams, R. M. E.; Yingst, R. A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Grotzinger, J. P.; Stack, K. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Dietrich, W. E.; Palucis, M. C.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Sumner, D. Y.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Wiens, R. C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Mangold, N.; Le Mouelic, S.] CNRS, LPGN, UMR6112, F-44322 Nantes, France; [Mangold, N.; Le Mouelic, S.] Univ Nantes, F-44322 Nantes, France; [Malin, M. C.; Edgett, K. S.; Van Beek, T.] Malin Space Sci Syst, San Diego, CA 92121 USA; [Maurice, S.; Forni, O.; Gasnault, O.] Univ Toulouse, CNRS, IRAP, F-31400 Toulouse, France; [Ollila, A.; Newsom, H. E.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Dromart, G.] Univ Lyon, Lab Geol Lyon, F-69364 Lyon, France; [Anderson, R. B.; Herkenhoff, K. E.] US Geol Survey, Flagstaff, AZ 86001 USA; [Goetz, W.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Madsen, M. B.; Koefoed, A.; Jensen, J. K.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Bridges, J. C.] Univ Leicester, Dept Phys & Astron, Space Res Ctr, Leicester LE1 7RH, Leics, England; [Schwenzer, S. P.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Lewis, K. W.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Rubin, D.] US Geol Survey, Santa Cruz, CA 95060 USA; [Kah, L. C.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Bell, J. F., III; Farmer, J. D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Sullivan, R.] Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; [Blaney, D. L.; Pariser, O.; Deen, R. G.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; University of California System; University of California Berkeley; Imperial College London; University of California System; University of California Davis; United States Department of Energy (DOE); Los Alamos National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Le Mans Universite; Nantes Universite; Universite d'Angers; Nantes Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of New Mexico; Ecole Normale Superieure de Lyon (ENS de LYON); United States Department of the Interior; United States Geological Survey; Max Planck Society; University of Copenhagen; Niels Bohr Institute; University of Leicester; Open University - UK; Princeton University; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; Arizona State University; Arizona State University-Tempe; Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Williams, RME (corresponding author), Planetary Sci Inst, Tucson, AZ 85719 USA.	williams@psi.edu	Muller, Jan-Peter/Q-8886-2019; Rodriguez-Manfredi, Jose/AAG-9826-2021; Malakhov, Alexey Vladimirovich/F-7953-2017; Madsen, Morten Bo/D-2082-2011; Gasnault, Olivier/F-4327-2010; Gómez, Felipe/L-7315-2014; Schwenzer, Susanne P/H-6992-2019; Zorzano, María-Paz/F-2184-2015; Avalos, Juan Jose Blanco/AAB-9447-2021; Franz, Heather B/F-3508-2012; Harri, Ari-Matti/C-7142-2012; Floyd, Melissa/D-4626-2012; Farmer, Jack D/B-9343-2019; FABRE, Cécile/B-5827-2012; Benna, Mehdi/F-3489-2012; Teinturier, Samuel/AAS-8663-2020; Steele, Andrew/A-3573-2013; Balic-Zunic, Tonci/A-6362-2013; Kah, Linda C/J-3754-2019; Hayes, Alexander G/P-2024-2014; Sullivan, Robert/AAR-8193-2020; Blaney, Diana/M-1756-2019; Rodriguez-Manfredi, Jose/L-8001-2014; Navarro-González, Rafael/D-1748-2009; Dworkin, Jason P./C-9417-2012; szopa, cyril/C-6865-2015; Sumner, Dawn Y/E-8744-2011; Prats, Benito/F-9467-2019; Lemmon, Mark T/E-9983-2010; Stipp, Susan L.S./B-8494-2019; Stack Morgan, Kathryn/AGY-7985-2022; Blanco, Juan Jose/E-3627-2014; Ramos, Miguel/K-2230-2014; Romeral Planello, Julio Jose/T-1788-2017; Sirven, Jean-Baptiste/H-5782-2013; Vicenzi, Edward/T-9430-2017	Muller, Jan-Peter/0000-0002-5077-3736; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Madsen, Morten Bo/0000-0001-8909-5111; Gasnault, Olivier/0000-0002-6979-9012; Gómez, Felipe/0000-0001-9977-7060; Schwenzer, Susanne P/0000-0002-9608-0759; Zorzano, María-Paz/0000-0002-4492-9650; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Harri, Ari-Matti/0000-0001-8541-2802; FABRE, Cécile/0000-0001-8627-4050; Teinturier, Samuel/0000-0003-1755-9524; Steele, Andrew/0000-0001-9643-2841; Balic-Zunic, Tonci/0000-0003-1687-1233; Kah, Linda C/0000-0001-7172-2033; Hayes, Alexander G/0000-0001-6397-2630; Blaney, Diana/0000-0002-4267-7939; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Navarro-González, Rafael/0000-0002-6078-7621; Dworkin, Jason P./0000-0002-3961-8997; szopa, cyril/0000-0002-0090-4056; Sumner, Dawn Y/0000-0002-7343-2061; Prats, Benito/0000-0003-3869-3351; Lemmon, Mark T/0000-0002-4504-5136; Stipp, Susan L.S./0000-0001-7009-643X; Blanco, Juan Jose/0000-0002-8666-0696; Ramos, Miguel/0000-0003-3648-6818; Le Mouelic, Stephane/0000-0001-5260-1367; BERGER, Gilles/0000-0003-4806-5594; Buch, Arnaud/0000-0002-2097-7252; Romeral Planello, Julio Jose/0000-0002-2205-067X; Gupta, Sanjeev/0000-0001-6415-1332; Sirven, Jean-Baptiste/0000-0002-5523-6809; Williams, Rebecca/0000-0003-1571-6952; Ewing, Ryan/0000-0001-6337-610X; Forni, Olivier/0000-0001-6772-9689; Richardson, Mark/0000-0001-9633-4141; Jensen, Jacob K/0000-0003-0502-2383; Vicenzi, Edward/0000-0003-2085-6546; Edgett, Kenneth/0000-0001-7197-5751; Mitrofanov, Igor/0000-0001-7204-2101; Wilson, Sharon/0000-0001-8872-8546; Newcombe, Megan Eve/0000-0002-8450-768X; Rubin, David/0000-0003-1169-1452; Pla-Garcia, Jorge/0000-0002-8047-3937; Rice, Melissa/0000-0002-8370-4139; Beegle, Luther/0000-0002-4944-4353	NASA under the Mars Program Office [1449884, 1273887]; Centre National d'Etudes Spatiales; UK Space Agency; Danish Council for Independent Research/Natural Sciences (FNU) [12-127126, 11-107019]; TICRA Foundation; Deutsche Forschungsgemeinschaft [GO 2288/1-1]; Science and Technology Facilities Council [ST/J005193/1, 1195655] Funding Source: researchfish; UK Space Agency [ST/J005169/1, ST/J005339/1] Funding Source: researchfish	NASA under the Mars Program Office; Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); UK Space Agency; Danish Council for Independent Research/Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); TICRA Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	We thank K. Tanaka and L. Kestay (USGS-Flagstaff) and four anonymous referees for constructive reviews of this manuscript. This research was carried out for the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA under the Mars Program Office, including JPL contracts 1449884 (R.M.E.W.) and 1273887 (Malin Space Science Systems). Work in France was carried out with funding from the Centre National d'Etudes Spatiales. Work in the UK was funded by the UK Space Agency. Work in Denmark was funded by the Danish Council for Independent Research/Natural Sciences (FNU grants 12-127126 and 11-107019) and the TICRA Foundation. Work in Germany was partly funded by Deutsche Forschungsgemeinschaft grant GO 2288/1-1. Data in this manuscript arc available from the NASA Planetary Data System. This is PSI contribution 603.	Anderson R. B., 2010, MARS, V5, P76, DOI [DOI 10.1555/MARS.2010.0004, 10.1555/mars.2010.0004]; Anderson R. S., 2010, GEOMORPHOLOGY MECHAN; [Anonymous], 1983, GEOL SOC AM BULL, V94, P1035; Bunte K, 2001, RMRSGTR74 USDA; Chow V.T., 1959, OPEN CHANNEL HYDRAUL; Davies N. S., 1977, MEMOIR, V5, P61; Fabre C, 2011, SPECTROCHIM ACTA B, V66, P280, DOI 10.1016/j.sab.2011.03.012; Folk R. L, 1980, PETROLOGY SEDIMENTAR; GARVIN JB, 1981, MOON PLANETS, V24, P355, DOI 10.1007/BF00897109; Grotzinger J, 2006, GEOLOGY, V34, P1085, DOI 10.1130/G22985A.1; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Haberle RM, 2001, J GEOPHYS RES-PLANET, V106, P23317, DOI 10.1029/2000JE001360; Heller PL, 2001, GEOLOGY, V29, P971, DOI 10.1130/0091-7613(2001)029<0971:PODFAW>2.0.CO;2; Jerolmack DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002544; KOMAR PD, 1980, ICARUS, V42, P317, DOI 10.1016/0019-1035(80)90097-4; Krumbein W.C., 1963, STRATIGRAPHY SEDIMEN; Lewin J, 2002, EARTH SURF PROC LAND, V27, P145, DOI 10.1002/esp.306; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; Matijevic JR, 1997, SCIENCE, V278, P1765, DOI 10.1126/science.278.5344.1765; Maurice S, 2012, SPACE SCI REV, V170, P95, DOI 10.1007/s11214-012-9912-2; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; MILLS HH, 1979, J SEDIMENT PETROL, V49, P295; Moore JM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002352; Parker G, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000549; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Smith PH, 1997, SCIENCE, V278, P1758, DOI 10.1126/science.278.5344.1758; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; WHITING PJ, 1988, GEOLOGY, V16, P105, DOI 10.1130/0091-7613(1988)016<0105:BSIHS>2.3.CO;2; Wiens R. C., 2013, 44 LUN PLAN SCI C; Wiens RC, 2012, SPACE SCI REV, V170, P167, DOI 10.1007/s11214-012-9902-4; Yingst RA, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003179; Yingst RA, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2005JE002582	35	281	284	5	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1068	1072		10.1126/science.1237317	http://dx.doi.org/10.1126/science.1237317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723230				2022-12-28	WOS:000319664500037
J	Archibald, RF; Kaspi, VM; Ng, CY; Gourgouliatos, KN; Tsang, D; Scholz, P; Beardmore, AP; Gehrels, N; Kennea, JA				Archibald, R. F.; Kaspi, V. M.; Ng, C. -Y.; Gourgouliatos, K. N.; Tsang, D.; Scholz, P.; Beardmore, A. P.; Gehrels, N.; Kennea, J. A.			An anti-glitch in a magnetar	NATURE			English	Article							X-RAY PULSAR; VARIABLE SPIN-DOWN; NEUTRON-STARS; 1E 2259+586; SGR 1900+14; ROTATION; MAGNETOSPHERES; SUPERFLUIDITY; BURSTS	Magnetars are neutron stars with X-ray and soft gamma-ray outbursts thought to be powered by intense internal magnetic fields(1). Like conventional neutron stars in the form of radio pulsars, magnetars exhibit 'glitches' during which angular momentum is believed to be transferred between the solid outer crust and the superfluid component of the inner crust(2-4). The several hundred observed glitches in radio pulsars(5,6) and magnetars(7) have involved a sudden spin-up (increase in the angular velocity) of the star, presumably because the interior superfluid was rotating faster than the crust. Here we report X-ray timing observations of the magnetar 1E 2259+586 (ref. 8), which exhibited a clear 'anti-glitch'-a sudden spin-down. We show that this event, like some previous magnetar spin-up glitches(9), was accompanied by multiple X-ray radiative changes and a significant spin-down rate change. Such behaviour is not predicted by models of neutron star spin-down and, if of internal origin, is suggestive of differential rotation in the magnetar, supporting the need for a rethinking of glitch theory for all neutron stars(10,11).	[Archibald, R. F.; Kaspi, V. M.; Ng, C. -Y.; Gourgouliatos, K. N.; Tsang, D.; Scholz, P.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Ng, C. -Y.] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Beardmore, A. P.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Gehrels, N.] NASA, Astrophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Kennea, J. A.] Penn State Univ, Dept Astron & Astrophys, Davey Lab 525, University Pk, PA 16802 USA	McGill University; University of Hong Kong; University of Leicester; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kaspi, VM (corresponding author), McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.	vkaspi@physics.mcgill.ca	Ng, Chi Yung/A-7639-2013; Kennea, Jamie/AAF-2090-2019	Ng, Chi Yung/0000-0002-5847-2612; Kennea, Jamie/0000-0002-6745-4790; Tsang, David/0000-0002-1612-2585; Beardmore, Andrew/0000-0001-5186-5950; Archibald, Robert/0000-0002-4017-8837; Gourgouliatos, Konstantinos N./0000-0002-1659-1250	Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research; Fonds de Recherche Nature et Technologies Quebec; Canada Research Chairs Program; Lorne Trottier Chair in Astrophysics and Cosmology; Centre de Recherche en Astrophysique du Quebec; UK Space Agency [ST/J000841/1] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Fonds de Recherche Nature et Technologies Quebec; Canada Research Chairs Program(Canada Research Chairs); Lorne Trottier Chair in Astrophysics and Cosmology; Centre de Recherche en Astrophysique du Quebec; UK Space Agency	V.M.K. acknowledges support from the Natural Sciences and Engineering Research Council of Canada Discovery Grant and the John C. Polanyi Award, from the Canadian Institute for Advanced Research, from Fonds de Recherche Nature et Technologies Quebec, from the Canada Research Chairs Program, and from the Lorne Trottier Chair in Astrophysics and Cosmology. D.T. was supported by the Lorne Trottier Chair in Astrophysics and Cosmology and the Canadian Institute for Advanced Research. K.N.G. was supported by the Centre de Recherche en Astrophysique du Quebec. We thank H. Medlin and J. Gelfand for help with the EVLA observation. We thank D. Eichler, B. Link, M. Lyutikov and C. Thompson for useful discussions. We acknowledge the use of public data from the Swift data archive.	ANDERSON PW, 1975, NATURE, V256, P25, DOI 10.1038/256025a0; Andersson N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.241103; Beloborodov AM, 2009, ASTROPHYS J, V703, P1044, DOI 10.1088/0004-637X/703/1/1044; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Dib R, 2008, ASTROPHYS J, V673, P1044, DOI 10.1086/524653; Espinoza CM, 2011, MON NOT R ASTRON SOC, V414, P1679, DOI 10.1111/j.1365-2966.2011.18503.x; FAHLMAN GG, 1981, NATURE, V293, P202, DOI 10.1038/293202a0; Foley S., 2012, GRB COORD NETW, V13280, P1; Gavriil FP, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/138; Gavriil FP, 2004, ASTROPHYS J, V607, P959, DOI 10.1086/383564; Granot J, 2006, ASTROPHYS J, V638, P391, DOI 10.1086/497680; Harding AK, 1999, ASTROPHYS J, V525, pL125, DOI 10.1086/312339; Hobbs GB, 2006, MON NOT R ASTRON SOC, V369, P655, DOI 10.1111/j.1365-2966.2006.10302.x; Icdem B, 2012, MON NOT R ASTRON SOC, V419, P3109, DOI 10.1111/j.1365-2966.2011.19953.x; International Consortium Of Scientists, 2011, CASA COMMON ASTRONOM, P7013; Kaspi VM, 2003, ASTROPHYS J, V588, pL93, DOI 10.1086/375683; LINK B, 1992, NATURE, V359, P616, DOI 10.1038/359616a0; Livingstone MA, 2010, ASTROPHYS J, V710, P1710, DOI 10.1088/0004-637X/710/2/1710; Parfrey K, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/1/L12; PINES D, 1985, NATURE, V316, P27, DOI 10.1038/316027a0; Ruderman M, 1998, ASTROPHYS J, V492, P267, DOI 10.1086/305026; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Thompson C, 1998, PHYS REV D, V57, P3219, DOI 10.1103/PhysRevD.57.3219; Thompson C, 2000, ASTROPHYS J, V543, P340, DOI 10.1086/317072; Woods PM, 1999, ASTROPHYS J, V524, pL55, DOI 10.1086/312297	26	89	93	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					591	593		10.1038/nature12159	http://dx.doi.org/10.1038/nature12159			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23719460	Green Submitted			2022-12-28	WOS:000319556100037
J	Peterson, DC; Martin-Gill, C; Guyette, FX; Tobias, AZ; McCarthy, CE; Harrington, ST; Delbridge, TR; Yealy, DM				Peterson, Drew C.; Martin-Gill, Christian; Guyette, Francis X.; Tobias, Adam Z.; McCarthy, Catherine E.; Harrington, Scott T.; Delbridge, Theodore R.; Yealy, Donald M.			Outcomes of Medical Emergencies on Commercial Airline Flights	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIRCRAFT; AIR; DIVERSIONS; EXPERIENCE	BACKGROUND Worldwide, 2.75 billion passengers fly on commercial airlines annually. When in-flight medical emergencies occur, access to care is limited. We describe in-flight medical emergencies and the outcomes of these events. METHODS We reviewed records of in-flight medical emergency calls from five domestic and international airlines to a physician-directed medical communications center from January 1, 2008, through October 31, 2010. We characterized the most common medical problems and the type of on-board assistance rendered. We determined the incidence of and factors associated with unscheduled aircraft diversion, transport to a hospital, and hospital admission, and we determined the incidence of death. RESULTS There were 11,920 in-flight medical emergencies resulting in calls to the center (1 medical emergency per 604 flights). The most common problems were syncope or presyncope (37.4% of cases), respiratory symptoms (12.1%), and nausea or vomiting (9.5%). Physician passengers provided medical assistance in 48.1% of in-flight medical emergencies, and aircraft diversion occurred in 7.3%. Of 10,914 patients for whom postflight follow-up data were available, 25.8% were transported to a hospital by emergency-medical-service personnel, 8.6% were admitted, and 0.3% died. The most common triggers for admission were possible stroke (odds ratio, 3.36; 95% confidence interval [CI], 1.88 to 6.03), respiratory symptoms (odds ratio, 2.13; 95% CI, 1.48 to 3.06), and cardiac symptoms (odds ratio, 1.95; 95% CI, 1.37 to 2.77). CONCLUSIONS Most in-flight medical emergencies were related to syncope, respiratory symptoms, or gastrointestinal symptoms, and a physician was frequently the responding medical volunteer. Few in-flight medical emergencies resulted in diversion of aircraft or death; one fourth of passengers who had an in-flight medical emergency underwent additional evaluation in a hospital.	[Peterson, Drew C.; Martin-Gill, Christian; Guyette, Francis X.; Tobias, Adam Z.; McCarthy, Catherine E.; Harrington, Scott T.; Yealy, Donald M.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Delbridge, Theodore R.] E Carolina Univ, Brody Sch Med, Dept Emergency Med, Greenville, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; East Carolina University	Martin-Gill, C (corresponding author), Iroquois Bldg,Suite 400A,3600 Forbes Ave, Pittsburgh, PA 15261 USA.	martingillc2@upmc.edu	, Francis/AAE-1586-2022	Guyette, Francis/0000-0002-9151-4896	National Institutes of Health [UL1 RR024153, UL1 TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the National Institutes of Health (UL1 RR024153 and UL1 TR000005).; Funded by the National Institutes of Health.	[Anonymous], 2012, PASS NUMB REACH 2 75; [Anonymous], 2006, POL AC 121 33B EM ME; [Anonymous], 2009, OBSTET GYNECOL, V114, P954; Baltsezak S, 2008, J TRAVEL MED, V15, P391, DOI 10.1111/j.1708-8305.2008.00233.x; Brown AM, 2010, PREHOSP EMERG CARE, V14, P235, DOI 10.3109/10903120903572319; CUMMINS RO, 1989, JAMA-J AM MED ASSOC, V261, P1295, DOI 10.1001/jama.261.9.1295; DeJohn CA, 2000, EVALUATION IN FLIGHT; Delaune EF, 2003, AVIAT SPACE ENVIR MD, V74, P62; HORDINSKY JR, 1989, AVIAT SPACE ENVIR MD, V60, P1211; Hung KKC, 2010, ARCH INTERN MED, V170, P1401, DOI 10.1001/archinternmed.2010.267; Moore BR, 2005, PEDIATR EMERG CARE, V21, P725, DOI 10.1097/01.pec.0000186424.84764.94; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; RODENBERG H, 1987, ANN EMERG MED, V16, P1373, DOI 10.1016/S0196-0644(87)80422-5; Sand M, 2009, CRIT CARE, V13, DOI 10.1186/cc7690; Shepherd B, 2006, J ROY SOC MED, V99, P628, DOI 10.1258/jrsm.99.12.628; Szmajer M, 2001, RESUSCITATION, V50, P147, DOI 10.1016/S0300-9572(01)00347-1; TranStats: Research and Innovative Technology Administration Bureau of Transportation Statistics, LOAD FACT PASS MIL P	17	144	145	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2075	2083		10.1056/NEJMoa1212052	http://dx.doi.org/10.1056/NEJMoa1212052			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23718164	Bronze, Green Accepted			2022-12-28	WOS:000319574200005
J	Nie, JF; Zhu, YM; Liu, JZ; Fang, XY				Nie, J. F.; Zhu, Y. M.; Liu, J. Z.; Fang, X. Y.			Periodic Segregation of Solute Atoms in Fully Coherent Twin Boundaries	SCIENCE			English	Article							MAXIMUM STRENGTH; INTERFACES; COPPER; PHASE	The formability and mechanical properties of many engineering alloys are intimately related to the formation and growth of twins. Understanding the structure and chemistry of twin boundaries at the atomic scale is crucial if we are to properly tailor twins to achieve a new range of desired properties. We report an unusual phenomenon in magnesium alloys that until now was thought unlikely: the equilibrium segregation of solute atoms into patterns within fully coherent terraces of deformation twin boundaries. This ordered segregation provides a pinning effect for twin boundaries, leading to a concomitant but unusual situation in which annealing strengthens rather than weakens these alloys. The findings point to a platform for engineering nano-twinned structures through solute atoms. This may lead to new alloy compositions and thermomechanical processes.	[Nie, J. F.; Zhu, Y. M.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia; [Liu, J. Z.] Monash Univ, Dept Mech & Aerosp Engn, Clayton, Vic 3800, Australia; [Fang, X. Y.] Monash Univ, Monash Ctr Electron Microscopy, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	Nie, JF (corresponding author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.	jianfeng.nie@monash.edu	LIU, zhe/HGD-6875-2022; Liu, Zhe/B-5916-2008; Zhu, Yuman/AAE-3557-2021	Liu, Zhe/0000-0002-5282-7945; Zhu, Yuman/0000-0002-7204-4008; Nie, Jian-Feng/0000-0002-2768-2414	Australian Research Council	Australian Research Council(Australian Research Council)	The authors are grateful fur the support of the Australian Research Council and for access to the facilities of the Monash Centre for Electron Microscopy and the National Computational Infrastructure at Australian National. University. Further information on the alloys, experimental procedures, and computation details can be found in the supplementary materials.	Agnew SR, 2010, SCRIPTA MATER, V63, P671, DOI 10.1016/j.scriptamat.2010.06.029; Buban JP, 2006, SCIENCE, V311, P212, DOI 10.1126/science.1119839; CHRISTIAN JW, 1995, PROG MATER SCI, V39, P1, DOI 10.1016/0079-6425(94)00007-7; Dillon SJ, 2007, ACTA MATER, V55, P6208, DOI 10.1016/j.actamat.2007.07.029; Hantzsche K, 2010, SCRIPTA MATER, V63, P725, DOI 10.1016/j.scriptamat.2009.12.033; Harmer MP, 2011, SCIENCE, V332, P182, DOI 10.1126/science.1204204; Harmer MP, 2010, J AM CERAM SOC, V93, P301, DOI 10.1111/j.1551-2916.2009.03545.x; Li B, 2009, ACTA MATER, V57, P1734, DOI 10.1016/j.actamat.2008.12.016; Li B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.035503; Li XY, 2010, NATURE, V464, P877, DOI 10.1038/nature08929; Lu K, 2012, SCRIPTA MATER, V66, P835, DOI 10.1016/j.scriptamat.2012.02.024; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; Luo J, 2011, SCIENCE, V333, P1730, DOI 10.1126/science.1208774; Muller DA, 2009, NAT MATER, V8, P263, DOI [10.1038/nmat2380, 10.1038/NMAT2380]; PENNYCOOK SJ, 1992, ACTA METALL MATER, V40, pS149, DOI 10.1016/0956-7151(92)90275-J; Pollock TM, 2010, SCIENCE, V328, P986, DOI 10.1126/science.1182848; Randle V, 2004, ACTA MATER, V52, P4067, DOI 10.1016/j.actamat.2004.05.031; Robson JD, 2011, ACTA MATER, V59, P1945, DOI 10.1016/j.actamat.2010.11.060; Wang J, 2011, ACTA MATER, V59, P3990, DOI 10.1016/j.actamat.2011.03.024; Wang J, 2009, ACTA MATER, V57, P5521, DOI 10.1016/j.actamat.2009.07.047; Wang ZC, 2011, NATURE, V479, P380, DOI 10.1038/nature10593; Ye J, 2011, SCRIPTA MATER, V64, P292, DOI 10.1016/j.scriptamat.2010.09.047; Yu Q, 2012, NANO LETT, V12, P887, DOI 10.1021/nl203937t; Yu Q, 2010, NATURE, V463, P335, DOI 10.1038/nature08692	26	533	552	34	659	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					957	960		10.1126/science.1229369	http://dx.doi.org/10.1126/science.1229369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704567				2022-12-28	WOS:000319344100041
J	DeWeerdt, S				DeWeerdt, Sarah			MOOD DISORDERS The dark night	NATURE			English	Editorial Material							SLEEP-DEPRIVATION; DEPRESSION; INSOMNIA; BRAIN; SYMPTOMS											Colombo C, 1999, PSYCHIAT RES, V86, P267, DOI 10.1016/S0165-1781(99)00036-0; Gillin JC, 2001, DEPRESS ANXIETY, V14, P37, DOI 10.1002/da.1045; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Landsness EC, 2011, J PSYCHIATR RES, V45, P1019, DOI 10.1016/j.jpsychires.2011.02.003; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Szklo-Coxe M, 2010, AM J EPIDEMIOL, V171, P709, DOI 10.1093/aje/kwp454; Troxel WM, 2012, J CLIN PSYCHIAT, V73, P478, DOI 10.4088/JCP.11m07184; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007	9	11	11	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S14	S15		10.1038/497S14a	http://dx.doi.org/10.1038/497S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698502	Bronze			2022-12-28	WOS:000319254000008
J	Scheer, HS; Weibel, L				Scheer, Helene Sophie; Weibel, Lisa			Sudden Purpuriform Rash in an Infant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE HEMORRHAGIC EDEMA; SKIN		[Scheer, Helene Sophie; Weibel, Lisa] Univ Childrens Hosp Zurich, Dept Dermatol, CH-8032 Zurich, Switzerland; [Weibel, Lisa] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; University Zurich Hospital	Weibel, L (corresponding author), Univ Childrens Hosp Zurich, Dept Dermatol, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	lisa.weibel@kispi.uzh.ch		Scheer, Helene Sophie/0000-0001-9124-573X; Weibel, Lisa/0000-0002-8696-8164				Chalmers E, 2011, ARCH DIS CHILD, V96, P1066, DOI 10.1136/adc.2010.199919; Fiore E, 2008, J AM ACAD DERMATOL, V59, P684, DOI 10.1016/j.jaad.2008.06.005; Intong LRA, 2011, HARPERS TXB PEDIAT D, P781; Karremann M, 2009, CLIN PEDIATR, V48, P323, DOI 10.1177/0009922808323113; Kos L, 2006, PEDIATR DERMATOL, V23, P311, DOI 10.1111/j.1525-1470.2006.00266.x; Lai-Cheong JE, 2007, CLIN EXP DERMATOL, V32, P467, DOI 10.1111/j.1365-2230.2007.02355.x; LEGRAIN V, 1991, J AM ACAD DERMATOL, V24, P17, DOI 10.1016/0190-9622(91)70002-J; Snow IM, 1913, J AMER MED ASSOC, V61, P18, DOI 10.1001/jama.1913.04350010020008	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2159	2160		10.1001/jama.2013.4794	http://dx.doi.org/10.1001/jama.2013.4794			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23695485				2022-12-28	WOS:000319229600032
J	Crowther, M				Crowther, Mark			Review: Blood transfusions are associated with higher mortality than no or restricted transfusions in MI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Crowther, Mark] McMaster Univ, Hamilton, ON, Canada; [Crowther, Mark] St Josephs Hosp, Hamilton, ON, Canada	McMaster University; McGill University; McMaster University	Crowther, M (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694				Carson JL, 2013, JAMA INTERN MED, V173, P139, DOI 10.1001/jamainternmed.2013.2855; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555	2	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC13	10.7326/0003-4819-158-10-201305210-02013	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689780				2022-12-28	WOS:000319666200012
J	Gillespie, S; Haddad, L; Mannar, V; Menon, P; Nisbett, N				Gillespie, Stuart; Haddad, Lawrence; Mannar, Venkatesh; Menon, Purnima; Nisbett, Nicholas		Maternal Child Nutr Study Grp	The politics of reducing malnutrition: building commitment and accelerating progress	LANCET			English	Article							HOMESTEAD FOOD-PRODUCTION; CHILD UNDERNUTRITION; FEEDING PRACTICES; YOUNG-CHILDREN; POLICY FORMULATION; NUTRITION AGENDA; IRON-DEFICIENCY; HEALTH; IMPACT; DELIVERY	In the past 5 years, political discourse about the challenge of undernutrition has increased substantially at national and international levels and has led to stated commitments from many national governments, international organisations, and donors. The Scaling Up Nutrition movement has both driven, and been driven by, this developing momentum. Harmonisation has increased among stakeholders, with regard to their understanding of the main causes of malnutrition and to the various options for addressing it. The main challenges are to enhance and expand the quality and coverage of nutrition-specific interventions, and to maximise the nutrition sensitivity of more distal interventions, such as agriculture, social protection, and water and sanitation. But a crucial third level of action exists, which relates to the environments and processes that underpin and shape political and policy processes. We focus on this neglected level. We address several fundamental questions: how can enabling environments and processes be cultivated, sustained, and ultimately translated into results on the ground? How has high-level political momentum been generated? What needs to happen to turn this momentum into results? How can we ensure that high-quality, well-resourced interventions for nutrition are available to those who need them, and that agriculture, social protection, and water and sanitation systems and programmes are proactively reoriented to support nutrition goals? We use a six-cell framework to discuss the ways in which three domains (knowledge and evidence, politics and governance, and capacity and resources) are pivotal to create and sustain political momentum, and to translate momentum into results in high-burden countries.	[Gillespie, Stuart] Int Food Policy Res Inst, Washington, DC 20006 USA; [Haddad, Lawrence; Nisbett, Nicholas] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; [Mannar, Venkatesh] Micronutrient Initiat, Ottawa, ON, Canada; [Menon, Purnima] Int Food Policy Res Inst, New Delhi, India	CGIAR; International Food Policy Research Institute (IFPRI); University of Sussex; CGIAR; International Food Policy Research Institute (IFPRI)	Gillespie, S (corresponding author), Int Food Policy Res Inst, Washington, DC 20006 USA.	s.gillespie@cgiar.org		Nisbett, Nicholas/0000-0002-9558-2263	Bill & Melinda Gates Foundation; Transform Nutrition Research Programme Consortium with UK aid from the UK Government; UK Aid; Irish Aid; Department for International Development (DFID) [201448] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Transform Nutrition Research Programme Consortium with UK aid from the UK Government; UK Aid(CGIAR); Irish Aid(CGIAR); Department for International Development (DFID)	Funding for the preparation of the Series was provided to the Johns Hopkins Bloomberg School of Public Health through a grant from the Bill & Melinda Gates Foundation. The sponsor had no role in the analysis and interpretation of the evidence or in writing the paper and the decision to submit for publication. We thank the contributors for their specified contributions, and the Bill & Melinda Gates Foundation for financial support for the preparation of this paper. SG received some funding from the Transform Nutrition Research Programme Consortium with UK aid from the UK Government. The development of the Nutrition Commitment Index was made possible by support from UK Aid and Irish Aid. The views expressed in this paper do not necessarily reflect the UK Government's official policies. Representatives of the Bill & Melinda Gates Foundation and the UK Department for International Development took part in series preparation meetings. Neither donor had a role in conceptualisation, data collection, analysis, or drafting of the paper.	Adair LS, 2013, LANCET; [Anonymous], 2013, SCAL HLTH INN; Benford RD, 2000, ANNU REV SOCIOL, V26, P611, DOI 10.1146/annurev.soc.26.1.611; Benson T.D., 2008, IMPROVING NUTR DEV P; Berg M, 2009, EVERY CHILD COUNTS U; Berlan D, 2012, HEALTH POLICY PLANN, V27, P271, DOI 10.1093/heapol/czr036; Bhutta ZA, 2013, LANCET; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Black R., 2013, LANCET; Bloom DE, 2011, DEMOGRAPHICS DEV POL; Bloom G, 2013, TRANSFORMING HLTH MA; Bonvecchio A, 2007, J NUTR, V137, P440, DOI 10.1093/jn/137.2.440; Bossert TJ, 2011, SOC SCI MED, V72, P39, DOI 10.1016/j.socscimed.2010.10.019; Brinkerhoff DW, 2011, PUBLIC ADMIN DEVELOP, V31, P2, DOI 10.1002/pad.584; Brown, 2011, CONSCIOUS LEADERSHIP; Brown KH, 2010, GLOB PUBLIC HEALTH, V5, pS1, DOI 10.1080/17441692.2010.526126; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI94, DOI 10.1093/heapol/czi056; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Campbell AA, 2011, PUBLIC HEALTH NUTR, V14, P1627, DOI 10.1017/S1368980011000693; Cash RA, 2011, ONE MANY SCALING HLT; Clark T.W., 2002, POLICY PROCESS PRACT; Cooley L., 2006, SCALING VISION LARGE, V1; Dangour AD, 2012, FOOD NUTR BULL, V33, P92, DOI 10.1177/156482651203300202; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Development Initiatives, 2011, NUTR ADV LANDSC EUR; Di Ciommo M, 2013, AID FINANCING LANDSC; Dolan C, 2012, SYNTHESIS LESSONS GO; Fiedler JL, 2008, HEALTH POLICY PLANN, V23, P408, DOI 10.1093/heapol/czn018; Fiedler JL, 2014, HEALTH POLICY PLANN, V29, P12, DOI 10.1093/heapol/czs129; FIELD JO, 1987, FOOD POLICY, V12, P15, DOI 10.1016/0306-9192(87)90044-3; Fixsen D., 2005, IMPLEMENTATION RES S; Foster-Fishman P, 2007, AM J COMMUN PSYCHOL, V39, P196; Free C, 2013, PLOS MED, V10; Frongillo EA, 2007, DELIVERING IMPACT SY; G-8, 2012, CAMP DAV ACC REP ACT; Garrett JL, 2010, WORKING MULTISECTORA; Gaventa J, 2012, WORLD DEV, V40, P2399, DOI 10.1016/j.worlddev.2012.05.014; Gillespie S, 2003, COMBATING UNDERNUTRI; GILLESPIE S, 1996, NUTR IMPROVES; Gilligan DO, 2009, J DEV STUD, V45, P1684, DOI 10.1080/00220380902935907; Ha DTP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-62; Habicht J-P., 2009, METHODOLOGIES EVALUA; Haddad L, 2003, WORLD BANK ECON REV, V17, P107, DOI 10.1093/wber/lhg012; Haddad L, FOOD POLICY IN PRESS; Haddad L., 2012, ACCELERATING REDUCTI; Haddad L, 2013, EUR J DEV RES, V25, P13, DOI 10.1057/ejdr.2012.45; Haddad L, 2010, IDS BULL-I DEV STUD, V41, P6, DOI 10.1111/j.1759-5436.2010.00177.x; Hall A., 2011, IMPACT EFFECTIVENESS; Hampshire RD, 2004, PUBLIC HEALTH NUTR, V7, P1047, DOI 10.1079/PHN2004641; Harding A, 2009, PARTNERSHIPS PRIVATE; Harriss J, 2009, IDS BULL-I DEV STUD, V40, P9, DOI 10.1111/j.1759-5436.2009.00053.x; Hausmann Ricardo, 2008, 177 CID HARV U; Hawkes C., 2012, Reshaping agriculture for nutrition and health: an IFPRI 2020 book, P73; Headey D, 2011, PRONUTRITION EC GROW; Headey DD, 2013, WORLD DEV, V42, P76, DOI 10.1016/j.worlddev.2012.07.002; Heaver R., 2005, STRENGTHENING COUNTR; Heikens GT, 2008, LANCET, V371, P3; Hill R, 2011, FOOD NUTR BULL, V32, pS92, DOI 10.1177/15648265110322S206; Hoddinott J, 2013, EC RATIONALE INVESTI; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Hoey L, 2011, FOOD NUTR BULL, V32, pS82, DOI 10.1177/15648265110322S205; Hoey L, 2011, FOOD NUTR BULL, V32, pS70, DOI 10.1177/15648265110322S204; Horton S., 2008, HUNGER MALNUTRITION; Hughes R, 2011, COMPETENCY FRAMEWORK; IFPRI Welthungerhilfe Concern Worldwide, 2012, CHALL HUNG ENS SUST; International Baby Food Action Network, 2012, SCAL NUTR IN IBFANS; Jennings S., 2011, TIMES BITTER FLOOD T; Jordan T., 2011, INTEGRAL REV, V7, P47; Khan NC, 2007, ASIA PAC J CLIN NUTR, V16, P274; Khandelwal S, 2012, PUBLIC HEALTH NUTR, V15, P2020, DOI 10.1017/S1368980011003016; Kingdon JohnW., 1995, AGENDAS ALTERNATIVES, V2nd ed.; Lapping K, 2012, HEALTH POLICY PLANN, V27, P32, DOI 10.1093/heapol/czr013; Leroy JL, 2008, J NUTR, V138, P628, DOI 10.1093/jn/138.3.628; Levitt EJ, 2009, FOOD POLICY, V34, P156, DOI 10.1016/j.foodpol.2008.07.004; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Loechl CU, 2009, MATERN CHILD NUTR, V5, P33, DOI 10.1111/j.1740-8709.2008.00154.x; Maluccio JA, 2009, ECON J, V119, P734, DOI 10.1111/j.1468-0297.2009.02220.x; Mander H, 2012, IDS BULL-I DEV STUD, V43, P15, DOI 10.1111/j.1759-5436.2012.00342.x; Marsh DR, 2008, J NUTR, V138, P630, DOI 10.1093/jn/138.3.630; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Masset E, 2013, INCOME GROWTH NUTR S; Masset E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8222; Masset E, 2011, FOOD POLICY, V36, pS102, DOI 10.1016/j.foodpol.2010.11.007; McCannon CJ, 2007, JAMA-J AM MED ASSOC, V298, P1937, DOI 10.1001/jama.298.16.1937; McDonald C., 2010, SCALING NUTR WHAT WI; McGregor A, 2012, BELLAGIO INITIATIVE; Mejia Acosta A, 2012, FIGHTING MAT CHILD M; Mills A, 2003, J INT DEV, V15, P1; Mintrom M, 1997, AM J POLIT SCI, V41, P738, DOI 10.2307/2111674; Molyneux S, 2012, HEALTH POLICY PLANN, V27, P541, DOI 10.1093/heapol/czr083; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Mubiru A, 2010, DOMESTIC RESOURCE MO; Mutuma S, 2012, AID NUTR CAN INVESTM; Natalicchio M, 2009, CARROTS STICKS POLIT; National Development Planning Commission Government of Ghana UNDP Ghana, 2010, GHAN MILL DEV GOALS; Nelson J, 2006, BUSINESS PARTNER OVE; Olney DK, 2012, J NUTR, V142, p178S, DOI 10.3945/jn.110.137182; Olney DK, 2009, FOOD NUTR BULL, V30, P355, DOI 10.1177/156482650903000407; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Paul KH, 2012, MATERN CHILD NUTR, V8, P225, DOI 10.1111/j.1740-8709.2010.00265.x; Pelletier D., 2001, Nutrition and health in developing countries, P523; Pelletier D, 2003, COMBATING UNDERNUTRI; Pelletier DL, 2013, ADV NUTR, V4, P92, DOI 10.3945/an.112.003160; Pelletier DL, 2012, HEALTH POLICY PLANN, V27, P19, DOI 10.1093/heapol/czr011; Pelto GH, 2004, J NUTR, V134, P357, DOI 10.1093/jn/134.2.357; Pelto GH, 2013, MATERN CHILD NUTR, V9, P35, DOI 10.1111/j.1740-8709.2012.00451.x; Pelto GH, 2011, MATERN CHILD NUTR, V7, P66, DOI 10.1111/j.1740-8709.2011.00351.x; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Porter MichaelE., 2011, HARVARD BUS REV; Potter C, 2004, HEALTH POLICY PLANN, V19, P336, DOI 10.1093/heapol/czh038; Prahalad C. K., 2010, WHART SCH PUB; Puett C, 2013, HEALTH POLICY PLANN, V28, P386, DOI 10.1093/heapol/czs070; Rao V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8131; Rasheed S, 2011, FOOD NUTR BULL, V32, P192, DOI 10.1177/156482651103200302; Ravallion M., 2010, MASHUP INDICES DEV; Reardon T., 2010, Trade, food, diet and health: perspectives and policy options, P111; Reich MR, 2012, POLITICAL EC ANAL FO; Ruel M, 2013, LANCET; Sablah M., 2011, SCN News, P40; Save the Children UK, 2013, SUP BAB OV BARR BREA; Scaling Up Nutrition, 2012, BUS NETW; Segre J, 2015, MATERN CHILD NUTR, V11, P16, DOI 10.1111/mcn.12022; Shekar M, 2008, LANCET, V371, P1751, DOI 10.1016/S0140-6736(08)60757-6; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Short, 2009, USING MOBILE PHONES; Spratt S, 2012, AID NUTR USING INNOV; STEPS Centre, 2010, INN SUST DEV NEW MAN; Stoltzfus RJ, 2008, J NUTR, V138, P2542, DOI 10.3945/jn.108.094888; Subramanyam MA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000424; Suchdev PS, 2012, AM J CLIN NUTR, V95, P1223, DOI 10.3945/ajcn.111.030072; Suchdev PS, 2010, FOOD NUTR BULL, V31, pS168, DOI 10.1177/15648265100312S209; Sun J, 2011, MATERN CHILD NUTR, V7, P96, DOI 10.1111/j.1740-8709.2011.00353.x; SUNRAY, 2012, SUST NUTR RES AFR YE; Swain B, 2009, IDS BULL-I DEV STUD, V40, P95, DOI 10.1111/j.1759-5436.2009.00064.x; Swaminathan MS, 2009, IDS BULL-I DEV STUD, V40, P103, DOI 10.1111/j.1759-5436.2009.00065.x; The New York Academy of Sciences, 2013, GLOB RES AG NUTR SCI; The World Food Prize, 2011, 2011 WORLD FOOD PRIZ; Thorne-Lyman AL, 2010, J NUTR, V140, p182S, DOI 10.3945/jn.109.110809; Torero M., 2012, HUNGER MALNUTRITION; UNICEF, 2012, COUNTD 2015 MAT NEWB; United Nations System Standing Committee on Nutrition (UNSCN), 2010, SCAL NUTR FRAM ACT; Ved R, 2012, 1208 IFPRI; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; White H, 2009, J DEV EFFECT, V1, P271, DOI 10.1080/19439340903114628; WHO, 2013, NUTR LANDSC INF SYST; Williams B., 2010, SYSTEMS CONCEPTS ACT; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2004, WORLD DEV REP 2004 M, DOI [10.1596/0-8213-5468-x, DOI 10.1596/0-8213-5468-X]	150	250	250	3	56	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2013	382	9891					552	569		10.1016/S0140-6736(13)60842-9	http://dx.doi.org/10.1016/S0140-6736(13)60842-9			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201SD	23746781				2022-12-28	WOS:000323162400034
J	Lam, MTY; Cho, H; Lesch, HP; Gosselin, D; Heinz, S; Tanaka-Oishi, Y; Benner, C; Kaikkonen, MU; Kim, AS; Kosaka, M; Lee, CY; Watt, A; Grossman, TR; Rosenfeld, MG; Evans, RM; Glass, CK				Lam, Michael T. Y.; Cho, Han; Lesch, Hanna P.; Gosselin, David; Heinz, Sven; Tanaka-Oishi, Yumiko; Benner, Christopher; Kaikkonen, Minna U.; Kim, Aneeza S.; Kosaka, Mika; Lee, Cindy Y.; Watt, Andy; Grossman, Tamar R.; Rosenfeld, Michael G.; Evans, Ronald M.; Glass, Christopher K.			Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription	NATURE			English	Article							ALPHA; OLIGONUCLEOTIDES; COREPRESSOR; METABOLISM; INITIATION; RECEPTORS; DOMAINS; CELLS	Rev-Erb-alpha and Rev-Erb-beta are nuclear receptors that regulate the expression of genes involved in the control of circadian rhythm(1,2), metabolism(3,4) and inflammatory responses(5). Rev-Erbs function as transcriptional repressors by recruiting nuclear receptor co-repressor (NCoR)-HDAC3 complexes to Rev-Erb response elements in enhancers and promoters of target genes(6-8), but the molecular basis for cell-specific programs of repressionis not known. Here we present evidence that in mouse macrophages Rev-Erbs regulate target gene expression by inhibiting the functions of distal enhancers that are selected by macrophage-lineage-determining factors, thereby establishing a macrophage-specific program of repression. Remarkably, the repressive functions of Rev-Erbs are associated with their ability to inhibit the transcription of enhancer-derived RNAs (eRNAs). Furthermore, targeted degradation of eRNAs at two enhancers subject to negative regulation by Rev-Erbs resulted in reduced expression of nearby messenger RNAs, suggesting a direct role of these eRNAs in enhancer function. By precisely defining eRNA start sites using a modified form of global run-on sequencing that quantifies nascent 5' ends, we show that transfer of full enhancer activity to a target promoter requires both the sequences mediating transcription-factor binding and the specific sequences encoding the eRNA transcript. These studies provide evidence for a direct role of eRNAs in contributing to enhancer functions and suggest that Rev-Erbs act to suppress gene expression at a distance by repressing eRNA transcription.	[Lam, Michael T. Y.; Lesch, Hanna P.; Gosselin, David; Heinz, Sven; Tanaka-Oishi, Yumiko; Benner, Christopher; Kaikkonen, Minna U.; Kosaka, Mika; Lee, Cindy Y.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Cho, Han; Evans, Ronald M.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Kim, Aneeza S.; Watt, Andy; Grossman, Tamar R.] Isis Pharmaceut Inc, Carlsbad, CA 92010 USA; [Rosenfeld, Michael G.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.; Evans, Ronald M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California San Diego; Salk Institute; Isis Pharmaceuticals Inc; University of California System; University of California San Diego; Howard Hughes Medical Institute	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Kaikkonen, Minna U/AAK-3612-2020; Evans, Ronald/AAF-4001-2019; Glass, Christopher/AAI-3933-2021	Kaikkonen, Minna U/0000-0001-6294-0979; Evans, Ronald/0000-0002-9986-5965; Glass, Christopher/0000-0003-4344-3592; Benner, Christopher/0000-0002-4618-0719; Heinz, Sven/0000-0002-4665-1007; Lesch, Hanna P./0000-0002-2463-5567	National Institutes of Health [CA17390, U19DK62434, DK091183, DK063491, CA014195, DK057978, HL088093, HL105278, CA52599]; University of California, San Diego Medical Scientist Training Program [T32 GM007198-37]; University of California, San Diego Genetics Training Program [T32 GM008666]; National Institute of General Medical Sciences; LeDucq Foundation Fellowship; Finnish Cultural Foundation; Instumentarium Foundation; Paulo Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Maud Kuistila Memorial Foundation; Fulbright Center; Leona M. and Harry B. Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Glenn Foundation for Medical Research; Ellison Medical Foundation; Ipsen/Biomeasure; NATIONAL CANCER INSTITUTE [R01CA052599, P30CA014195, R01CA173903] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R37DK057978, U19DK062434, R01DK091183, R01DK018477, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198, T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Medical Scientist Training Program; University of California, San Diego Genetics Training Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); LeDucq Foundation Fellowship(Leducq Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Instumentarium Foundation; Paulo Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Maud Kuistila Memorial Foundation; Fulbright Center; Leona M. and Harry B. Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Glenn Foundation for Medical Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Ipsen/Biomeasure(Ipsen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Bautista for assistance with figure preparation. These studies were supported by National Institutes of Health grants CA17390, U19DK62434, DK091183, DK063491, CA014195, DK057978, HL088093, HL105278 and CA52599. M. G. R. and R. M. E. are Investigators of the Howard Hughes Medical Institute. M.T.Y.L. is supported by the University of California, San Diego Medical Scientist Training Program T32 GM007198-37, and Genetics Training Program T32 GM008666, National Institute of General Medical Sciences. M. U. K. was supported by a LeDucq Foundation Fellowship. H. P. L. was supported by the Finnish Cultural Foundation, Instumentarium Foundation, The Paulo Foundation, Paavo Nurmi Foundation, Finnish Foundation for Cardiovascular Research, The Maud Kuistila Memorial Foundation and The Fulbright Center. These studies were also supported by grants from the Leona M. and Harry B. Helmsley Charitable Trust, Samuel Waxman Cancer Research Foundation, the Glenn Foundation for Medical Research, the Ellison Medical Foundation and Ipsen/Biomeasure.	Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schanke J T, 1997, Methods Mol Biol, V67, P203; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Seth Punit P, 2008, Nucleic Acids Symp Ser (Oxf), P553, DOI 10.1093/nass/nrn280; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zamir I, 1996, MOL CELL BIOL, V16, P5458	30	397	407	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					511	+		10.1038/nature12209	http://dx.doi.org/10.1038/nature12209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23728303	Green Accepted			2022-12-28	WOS:000320929400058
J	Civril, F; Deimling, T; Mann, CCD; Ablasser, A; Moldt, M; Witte, G; Hornung, V; Hopfner, KP				Civril, Filiz; Deimling, Tobias; Mann, Carina C. de Oliveira; Ablasser, Andrea; Moldt, Manuela; Witte, Gregor; Hornung, Veit; Hopfner, Karl-Peter			Structural mechanism of cytosolic DNA sensing by cGAS	NATURE			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; I INTERFERON; RECOGNITION RECEPTORS; 2ND-MESSENGER; INFLAMMASOME; SURVEILLANCE; HELICASE; ADAPTER	Cytosolic DNA arising from intracellular bacterial or viral infections is a powerful pathogen-associated molecular pattern (PAMP) that leads to innate immune host defence by the production of type I interferon and inflammatory cytokines. Recognition of cytosolic DNA by the recently discovered cyclic-GMP-AMP (cGAMP) synthase (cGAS) induces the production of cGAMP to activate the stimulator of interferon genes (STING). Here we report the crystal structure of cGAS alone and in complex with DNA, ATP and GTP along with functional studies. Our results explain the broad DNA sensing specificity of cGAS, show how cGAS catalyses dinucleotide formation and indicate activation by a DNA-induced structural switch. cGAS possesses a remarkable structural similarity to the antiviral cytosolic double-stranded RNA sensor 2'-5'oligoadenylate synthase (OAS1), but contains a unique zinc thumb that recognizes B-form double-stranded DNA. Our results mechanistically unify dsRNA and dsDNA innate immune sensing by OAS1 and cGAS nucleotidyl transferases.	[Civril, Filiz; Deimling, Tobias; Mann, Carina C. de Oliveira; Moldt, Manuela; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Civril, Filiz; Deimling, Tobias; Mann, Carina C. de Oliveira; Moldt, Manuela; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Ablasser, Andrea; Hornung, Veit] Univ Bonn, Univ Hosp, Unit Clin Biochem, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Munich; University of Munich; University of Bonn; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Dept Biochem, Marchioninistr 15, D-81377 Munich, Germany.	hopfner@genzentrum.lmu.de	Witte, Gregor/B-4635-2011; Hornung, Veit/C-3565-2012; Hopfner, Karl-Peter/B-6864-2014	Witte, Gregor/0000-0003-0313-0962; Hornung, Veit/0000-0002-4150-194X; Hopfner, Karl-Peter/0000-0002-4528-8357; de Oliveira Mann, Carina/0000-0002-1852-9880	National Institutes of Health [U19AI083025]; European Research Council [322869]; Center for Integrated Protein Science Munich (CIPSM); DFG [3717/2-1, SFB670]; ERC [243046];  [GRK1721]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Center for Integrated Protein Science Munich (CIPSM); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Butryn for comments on the manuscript. We thank the Max-Planck-Crystallization facility for initial crystal screening and the Swiss Light Source, European Synchrotron Radiation Facility and the German electron synchrotron Petra III for beam time and on-site assistance. This work was funded by the National Institutes of Health (U19AI083025), the European Research Council Advanced Grant 322869, and the Center for Integrated Protein Science Munich (CIPSM) to K.-P. H., by DFG grant 3717/2-1 to G. W., by GRK1721 to K.-P. H. and G. W., by DFG grant SFB670 and ERC grant 243046 to V. H.; C.C.O.M. is supported by GRK1721.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A., 2013, NATURE, DOI 10.1038/nature12640.; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Krug Anne, 2008, V183, P129; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Rathinam VAK, 2011, CURR OPIN VIROL, V1, P455, DOI 10.1016/j.coviro.2011.11.004; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Stagno J, 2007, J MOL BIOL, V366, P882, DOI 10.1016/j.jmb.2006.11.065; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	42	432	465	8	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					332	+		10.1038/nature12305	http://dx.doi.org/10.1038/nature12305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23722159	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000320592900033
J	Tinetti, ME; Basch, E				Tinetti, Mary E.; Basch, Ethan			Patients' Responsibility to Participate in Decision Making and Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tinetti, Mary E.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Tinetti, Mary E.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Basch, Ethan] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Basch, Ethan] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	Yale University; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	mary.tinetti@yale.edu						American Medical Association, OP 10 02 PAT RESP; Billingham V, 1998, QUOT SALZB GLOB SEM, V356; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Harris J, 2005, J MED ETHICS, V31, P242, DOI 10.1136/jme.2005.011973; Institute of Medicine, PARTN PAT DRIV SHAR; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; Lewis DK, 2003, BMJ-BRIT MED J, V327, P841, DOI 10.1136/bmj.327.7419.841; National Research Council, 2001, CROSS QUAL CHASM NEW	8	36	36	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2331	2332		10.1001/jama.2013.5592	http://dx.doi.org/10.1001/jama.2013.5592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23700165				2022-12-28	WOS:000320176000021
J	Tripathi, S; Li, HY; Poulos, TL				Tripathi, Sarvind; Li, Huiying; Poulos, Thomas L.			Structural Basis for Effector Control and Redox Partner Recognition in Cytochrome P450	SCIENCE			English	Article							ELECTRON-TRANSFER COMPLEX; CRYSTAL-STRUCTURE; PSEUDOMONAS-PUTIDA; PUTIDAREDOXIN REDUCTASE; METHYLENE HYDROXYLATION; MONOOXYGENASE SYSTEM; P450CAM; P-450CAM; ACTIVATION; RESOLUTION	Cytochromes P450 catalyze a variety of monooxygenase reactions that require electron transfer from redox partners. Although the structure of many P450s and a small handful of redox partners are known, there is very little structural information available on redox complexes, thus leaving a gap in our understanding on the control of P450-redox partner interactions. We have solved the crystal structure of oxidized and reduced P450cam complexed with its redox partner, putidaredoxin (Pdx), to 2.2 and 2.09 angstroms, respectively. It was anticipated that Pdx would favor closed substrate-bound P450cam, which differs substantially from the open conformer, but instead we found that Pdx favors the open state. These new structures indicate that the effector role of Pdx is to shift P450cam toward the open conformation, which enables the establishment of a water-mediated H-bonded network, which is required for proton-coupled electron transfer.	[Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	poulos@uci.edu	Tripathi, sarvind/F-6959-2015; Tripathi, Sarvind/Y-5229-2019	Tripathi, sarvind/0000-0002-6959-0577; Tripathi, Sarvind/0000-0002-6959-0577	NIH [GM33688]; DOE Office of Biological and Environmental Research; National Institute of General Medical Sciences (NIGMS) [P41GM103393]; National Center for Research Resources (NCRR) [P41RR001209]; Office of Science, Office of Basic Energy Sciences, of the DOE [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM033688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Science, Office of Basic Energy Sciences, of the DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM33688. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U. S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIH, the National Institute of General Medical Sciences (NIGMS) (including P41GM103393), and the National Center for Research Resources (NCRR) (P41RR001209). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, NCRR, or NIH. We also acknowledge the Advanced Light Source supported by the Director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract DE-AC02-05CH11231. We thank C. Goulding and A. Borovik for invaluable discussions and advice, D. Goodin for the low Cys P450cam expression plasmid, and Y. Meharenna for assistance in developing cross-linking protocols.	GERBER NC, 1994, J BIOL CHEM, V269, P4260; GUNSALUS IC, 1973, ANN NY ACAD SCI, V212, P107, DOI 10.1111/j.1749-6632.1973.tb47590.x; Guo ML, 2004, P NATL ACAD SCI USA, V101, P5940, DOI 10.1073/pnas.0306708101; KATAGIRI M, 1968, J BIOL CHEM, V243, P3543; KOGA H, 1993, FEBS LETT, V331, P109, DOI 10.1016/0014-5793(93)80307-G; Kuznetsov VY, 2005, J BIOL CHEM, V280, P16135, DOI 10.1074/jbc.M500771200; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; LIPSCOMB JD, 1976, J BIOL CHEM, V251, P1116; Nagano S, 2003, BIOCHEMISTRY-US, V42, P14507, DOI 10.1021/bi035410p; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; NAKAMURA K, 1994, BBA-PROTEIN STRUCT M, V1207, P40, DOI 10.1016/0167-4838(94)90049-3; Pochapsky SS, 2003, BIOCHEMISTRY-US, V42, P5649, DOI 10.1021/bi034263s; Pochapsky TC, 1996, BIOCHIMIE, V78, P723, DOI 10.1016/S0300-9084(97)82530-8; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2003, J MOL BIOL, V333, P377, DOI 10.1016/j.jmb.2003.08.028; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Sevrioukova IF, 2010, J BIOL CHEM, V285, P13616, DOI 10.1074/jbc.M110.104968; Shimada H, 2001, J INORG BIOCHEM, V83, P255, DOI 10.1016/S0162-0134(00)00173-2; SHIRO Y, 1989, J AM CHEM SOC, V111, P7707, DOI 10.1021/ja00202a007; SLIGAR SG, 1974, P NATL ACAD SCI USA, V71, P3906, DOI 10.1073/pnas.71.10.3906; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tosha T, 2003, J BIOL CHEM, V278, P39809, DOI 10.1074/jbc.M304265200; TYSON CA, 1972, J BIOL CHEM, V247, P5777; Unno M, 1997, J AM CHEM SOC, V119, P6614, DOI 10.1021/ja963785a; Unno M, 2002, J BIOL CHEM, V277, P2547, DOI 10.1074/jbc.M108917200; Zhang W, 2008, J MOL BIOL, V384, P349, DOI 10.1016/j.jmb.2008.09.037	28	127	129	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1227	1230		10.1126/science.1235797	http://dx.doi.org/10.1126/science.1235797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744947				2022-12-28	WOS:000319972800049
J	Ni, XJ; Gebo, DL; Dagosto, M; Meng, J; Tafforeau, P; Flynn, JJ; Beard, KC				Ni, Xijun; Gebo, Daniel L.; Dagosto, Marian; Meng, Jin; Tafforeau, Paul; Flynn, John J.; Beard, K. Christopher			The oldest known primate skeleton and early haplorhine evolution	NATURE			English	Article							EARLY EOCENE; MIDDLE EOCENE; LOCOMOTOR ADAPTATIONS; OMOMYIDAE; REMAINS; MORPHOLOGY; DIVERSITY; DENTITION; REVISION; ELEMENTS	Reconstructing the earliest phases of primate evolution has been impeded by gaps in the fossil record, so that disagreements persist regarding the palaeobiology and phylogenetic relationships of the earliest primates. Here we report the discovery of a nearly complete and partly articulated skeleton of a primitive haplorhine primate from the early Eocene of China, about 55 million years ago, the oldest fossil primate of this quality ever recovered. Coupled with detailed morphological examination using propagation phase contrast X-ray synchrotron microtomography, our phylogenetic analysis based on total available evidence indicates that this fossil is the most basal known member of the tarsiiform clade. In addition to providing further support for an early dichotomy between the strepsirrhine and haplorhine clades, this new primate further constrains the age of divergence between tarsiiforms and anthropoids. It also strengthens the hypothesis that the earliest primates were probably diurnal, arboreal and primarily insectivorous mammals the size of modern pygmy mouse lemurs.	[Ni, Xijun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China; [Ni, Xijun; Meng, Jin; Flynn, John J.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Ni, Xijun; Meng, Jin; Flynn, John J.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Gebo, Daniel L.] No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA; [Dagosto, Marian] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Beard, K. Christopher] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Northern Illinois University; Northwestern University; Feinberg School of Medicine; European Synchrotron Radiation Facility (ESRF)	Ni, XJ (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, 142 Xi Zhi Men Wai St, Beijing 100044, Peoples R China.	nixijun@ivpp.ac.cn	Beard, K. Christopher/AAQ-4438-2021	Beard, K. Christopher/0000-0002-6279-9837; Tafforeau, Paul/0000-0002-5962-1683	Strategic Priority Research Program of Chinese Academy of Sciences (CAS) [XDB03020501]; National Basic Research Program of China [2012CB821904]; CAS 100-talent Program; National Natural Science Foundation of China [40672009, 40872032]; US National Science Foundation [BCS 0820602]; ESRF [ec347]; Postdoctoral Research Fellowship Program of the American Museum of Natural History (AMNH); Division Of Behavioral and Cognitive Sci [1157142] Funding Source: National Science Foundation	Strategic Priority Research Program of Chinese Academy of Sciences (CAS); National Basic Research Program of China(National Basic Research Program of China); CAS 100-talent Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation(National Science Foundation (NSF)); ESRF; Postdoctoral Research Fellowship Program of the American Museum of Natural History (AMNH); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This project has been supported by the Strategic Priority Research Program of Chinese Academy of Sciences (CAS, XDB03020501), the National Basic Research Program of China (2012CB821904), the CAS 100-talent Program, the National Natural Science Foundation of China (40672009, 40872032), the US National Science Foundation (BCS 0820602), the ESRF (proposal ec347), and the Postdoctoral Research Fellowship Program of the American Museum of Natural History (AMNH). We are grateful to C. Li, Y. Wang, E. Delson, A. L. Rosenberger, E. Seiffert, M. T. Silcox and J. I. Bloch for helpful discussions. We thank C. Li and Q. Li for their assistance in the field, and C. Nemoz, T. Brochard and all the ID17 beamline team for their help during the synchrotron experiment. We thank the staff of the following museums for access to specimens: AMNH, Field Museum of Natural History, Chicago; Smithsonian Institution, Washington, D. C.; Carnegie Museum of Natural History, Pittsburgh; Royal Belgium Institute of Natural Sciences, Brussels.	Anemone RL, 2000, J HUM EVOL, V38, P607, DOI 10.1006/jhev.1999.0371; Beard KC, 2008, P NATL ACAD SCI USA, V105, P3815, DOI 10.1073/pnas.0710180105; BEARD KC, 1993, MAMMAL PHYLOGENY : PLACENTALS, P129; Beard KC, 2004, J HUM EVOL, V46, P401, DOI 10.1016/j.jhevol.2004.01.002; Beard KC, 1996, SCIENCE, V272, P82, DOI 10.1126/science.272.5258.82; COVERT HH, 1993, J HUM EVOL, V25, P351, DOI 10.1006/jhev.1993.1054; Covert HH, 2002, CAM S BIO EVOL ANTHR, V33, P13; Dagosto M, 1999, ANN CARNEGIE MUS, V68, P175; DAGOSTO M, 1988, J HUM EVOL, V17, P35, DOI 10.1016/0047-2484(88)90048-6; Dagosto M, 1993, POSTCRANIAL ADAPTATI, P150; Dagosto Marian, 1994, P567; Dagosto Marian, 2008, P315, DOI 10.1007/978-1-4020-6997-0_13; FLEAGLE JG, 1982, AM J PHYS ANTHROPOL, V59, P175, DOI 10.1002/ajpa.1330590207; FLEAGLE JG, 1995, AM J PHYS ANTHROPOL, V97, P235, DOI 10.1002/ajpa.1330970303; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1, DOI 10.1016/B978-0-12-378632-6.00001-X; Gebo DL, 2008, DEV PRIMATOL-PROG PR, P229, DOI 10.1007/978-0-387-73896-3_16; Gebo DL, 2012, EVOL ANTHROPOL, V21, P224, DOI 10.1002/evan.21336; Gebo DL, 2012, J HUM EVOL, V63, P205, DOI 10.1016/j.jhevol.2012.03.010; Gebo Daniel L., 1994, P203; Gebo DL, 2008, J HUM EVOL, V55, P999, DOI 10.1016/j.jhevol.2008.03.002; GEBO DL, 1987, AM J PRIMATOL, V13, P271, DOI 10.1002/ajp.1350130305; Gebo DL, 2000, NATURE, V404, P276, DOI 10.1038/35005066; Gebo DL, 2001, AM J PHYS ANTHROPOL, V116, P83, DOI 10.1002/ajpa.1105; GINGERICH PD, 1977, FOLIA PRIMATOL, V28, P144, DOI 10.1159/000155804; Godinot M, 1998, FOLIA PRIMATOL, V69, P218, DOI 10.1159/000052715; Gregory W. K., 1920, Memoirs from the American Museum of Natural History New York NS, V3, P49; Jouffroy F.K., 1979, P143; Kay RF, 2000, AM J PHYS ANTHROPOL, V113, P235, DOI 10.1002/1096-8644(200010)113:2<235::AID-AJPA7>3.0.CO;2-9; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; Ni XJ, 2010, P ROY SOC B-BIOL SCI, V277, P247, DOI 10.1098/rspb.2009.0173; Ni XJ, 2004, NATURE, V427, P65, DOI 10.1038/nature02126; Rasoloarison RM, 2000, INT J PRIMATOL, V21, P963, DOI 10.1023/A:1005511129475; ROSE KD, 1985, AM J PHYS ANTHROPOL, V66, P73, DOI 10.1002/ajpa.1330660107; Rose KD, 2011, AM J PHYS ANTHROPOL, V146, P281, DOI 10.1002/ajpa.21579; Rose KD, 2009, J HUM EVOL, V56, P366, DOI 10.1016/j.jhevol.2009.01.008; Rose Kenneth D., 1994, Evolutionary Anthropology, V3, P159, DOI 10.1002/evan.1360030505; Rossie JB, 2006, P NATL ACAD SCI USA, V103, P4381, DOI 10.1073/pnas.0509424103; Seiffert ER, 2009, NATURE, V461, P1118, DOI 10.1038/nature08429; Simons EL, 1972, PRIMATE EVOLUTION IN; Szalay F.S., 1979, EVOLUTIONARY HIST PR; SZALAY FS, 1980, FOLIA PRIMATOL, V34, P1, DOI 10.1159/000155946; Wang YQ, 2010, SCI CHINA EARTH SCI, V53, P1918, DOI 10.1007/s11430-010-4095-8; White JL, 2004, AM J PRIMATOL, V64, P293, DOI 10.1002/ajp.20079	43	115	121	2	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					60	64		10.1038/nature12200	http://dx.doi.org/10.1038/nature12200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23739424				2022-12-28	WOS:000319947800032
J	Vickers, AJ; Altman, DG				Vickers, Andrew J.; Altman, Douglas G.			Statistics Notes: Missing outcomes in randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England	Memorial Sloan Kettering Cancer Center; University of Oxford	Vickers, AJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA.	vickersa@mskcc.org		Vickers, Andrew/0000-0003-1525-6503				Altman DG, 2007, BRIT MED J, V334, P424, DOI 10.1136/bmj.38977.682025.2C; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Molnar Frank J, 2009, Open Med, V3, pe31; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	7	26	26	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2013	346								f3438	10.1136/bmj.f3438	http://dx.doi.org/10.1136/bmj.f3438			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YI	23744649	Bronze			2022-12-28	WOS:000320229900001
J	Sen, P; Biswas, T				Sen, Parijat; Biswas, Tamoghna			Arsenic: the largest mass poisoning of a population in history	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRINKING-WATER; CANCER; INDIA; CONTAMINATION; MORTALITY; EXPOSURE; BLADDER; HEALTH; BENGAL; STATE		[Sen, Parijat] DNGM Res Fdn, Kolkata, India		Sen, P (corresponding author), DNGM Res Fdn, Kolkata, India.	parijatsenstation@gmail.com		Sen, Parijat/0000-0002-5764-358X				Ahamed S, 2006, SCI TOTAL ENVIRON, V370, P310, DOI 10.1016/j.scitotenv.2006.06.015; Chakraborti D, 2002, TALANTA, V58, P3, DOI 10.1016/S0039-9140(02)00270-9; Chakraborti D, 2009, MOL NUTR FOOD RES, V53, P542, DOI 10.1002/mnfr.200700517; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; DATTA DV, 1979, GUT, V20, P378, DOI 10.1136/gut.20.5.378; Garai R, 1984, J Indian Med Assoc, V82, P34; Government of India, 2013, HIGHLIGHTS OF THE BU; Halder D, 2012, ENVIRON SCI TECHNOL, V46, P4142, DOI 10.1021/es204298a; Mazumder D. G., 2013, GLOB ADV RES J MED M, V2, P47; Mazumder D N, 1998, J Indian Med Assoc, V96, P4; Mazumder DNG, 2008, INDIAN J MED RES, V128, P436; Ministry of Drinking Water and Sanitation, 2013, SHRI BHARATSINH SOLA; Ministry of Water Resources, 2009, ARSENIC CONTAMINATED; Ministry of Water Resources, 2009, CONTAMINATION OF WAT; Nutt WH, 1913, LANCET, V2, P282; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Sarkar A, 2006, EPIDEMIOLOGY, V17, pS210, DOI 10.1097/00001648-200611001-00537; Sengupta AK, ARSENIC CRISIS IN IN; Smith AH, 1998, AM J EPIDEMIOL, V147, P660, DOI 10.1093/oxfordjournals.aje.a009507; TSENG WP, 1968, J NATL CANCER I, V40, P453; World Health Organization, 2000, PR 2000 55 RESEARCHE; World Health Organization, 2012, MILLENNIUM DEVELOPME	22	11	11	3	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 5	2013	346								f3625	10.1136/bmj.f3625	http://dx.doi.org/10.1136/bmj.f3625			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YF	23741031				2022-12-28	WOS:000320229500004
J	Anderson, S; Coulter, D				Anderson, Stewart; Coulter, Douglas			Neuronal Birth to Cortical Circuitry	SCIENCE			English	Editorial Material							CEREBRAL-CORTEX; GABAERGIC INTERNEURONS; CHANDELIER CELLS; SUBTYPE; ORIGINS		[Anderson, Stewart] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Coulter, Douglas] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Pediat Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia	Anderson, S (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	andersons3@email.chop.edu; coulterd@email.chop.edu		Coulter, Douglas/0000-0002-1486-119X				Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; ANDERSON SA, 1995, NEUROSCIENCE, V67, P7, DOI 10.1016/0306-4522(95)00051-J; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Inan M, 2013, J NEUROSCI, V33, P1907, DOI 10.1523/JNEUROSCI.4049-12.2013; Inan M, 2012, CEREB CORTEX, V22, P820, DOI 10.1093/cercor/bhr148; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Urban A, 2012, PROG BRAIN RES, V196, P163, DOI [10.1016/B9780-444-59426-6.00009-4, 10.1016/B978-0-444-59426-6.00009-4]; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529	16	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1058	1059		10.1126/science.1235778	http://dx.doi.org/10.1126/science.1235778			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723226				2022-12-28	WOS:000319664500031
J	Messier, V; Zenklusen, D; Michnick, SW				Messier, Vincent; Zenklusen, Daniel; Michnick, Stephen W.			A Nutrient-Responsive Pathway that Determines M Phase Timing through Control of B-Cyclin mRNA Stability	CELL			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; COTRANSCRIPTIONAL RECRUITMENT; ARGININE METHYLTRANSFERASE; POSITIVE FEEDBACK; PROTEIN-KINASES; NUCLEAR EXPORT; MITOTIC EXIT; POLO-KINASE; S-PHASE	The rate of cell-cycle progression must be tuned in response to nutrient levels to ensure that sufficient materials are synthesized to generate viable daughters. We report that accumulation of the yeast M phase B-cyclin CLB2 mRNA depends on assembly and activation of the heterogeneous nuclear RNA-binding protein (hnRNP) arginine methyltransferase Hmt1, which is promoted by the kinase Dbf2 and countered by the PP2A phosphatase Pph22. Activated Hmt1 methylates hnRNPs, which in turn stabilize CLB2 transcripts. Dbf2 activation of Hmt1 is highly cooperative, producing a sharp increase in CLB2, whereas Pph22 dephosphorylation is graded such that small changes in PP2A activity can cause large shifts in Dbf2-mediated Hmt1 activity. Starvation and rapamycin inhibition of TOR activate Pph22, causing a depletion of CLB2 and delay of M phase. We propose a general model wherein changes to Pph22 activity modulate cyclin mRNA stability to tune cell-cycle progression to environmental conditions.	[Messier, Vincent; Zenklusen, Daniel; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca	Zenklusen, Daniel/C-4503-2008	Zenklusen, Daniel/0000-0002-0067-0093	CIHR [MOP-GMX-152556, MOP-GMX- 231013, MOP-BMB-232642]; NSERC of Canada [194582]; Canadian Foundation for Innovation	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank Anne McBride for strains; Tatjana Trcek and Robert H. Singer (Albert Einstein College of Medicine) for CBL2 and ACT1 FISH probes, strains, and sharing data prior to publication; Raymond J. Deshaies and Tiffany K. J. Chang for providing us with Dbf2-expressing insect cell lines; Damien D'Amours for the gift of D754 strain and Tub1 immunostaining reagents; and Tatjana Trcek, Robert H. Singer, and Damien D'Amours for valuable discussions and comments. The authors acknowledge support from CIHR grants MOP-GMX-152556 and MOP-GMX-231013 and NSERC of Canada grant 194582 (to S.W.M.) and CIHR grant MOP-BMB-232642 and the Canadian Foundation for Innovation (to D.Z.). D.Z. holds a FRSQ Chercheur Boursier Junior I.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chen YC, 2010, MOL CELL BIOL, V30, P5245, DOI 10.1128/MCB.00359-10; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Enyenihi AH, 2003, GENETICS, V163, P47; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hotz M, 2012, CELL, V148, P958, DOI 10.1016/j.cell.2012.01.041; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kerr SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018302; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Lord PW, 2002, BIOINFORMATICS, V18, P1402, DOI 10.1093/bioinformatics/18.10.1402; Luo GZ, 2011, J BIOL CHEM, V286, P8759, DOI 10.1074/jbc.M110.196030; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Pestov DG, 2012, MOL CELL BIOL, V32, P2135, DOI 10.1128/MCB.06763-11; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TOYN JH, 1994, EMBO J, V13, P1103, DOI 10.1002/j.1460-2075.1994.tb06359.x; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	38	29	29	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1080	1093		10.1016/j.cell.2013.04.035	http://dx.doi.org/10.1016/j.cell.2013.04.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706744	Bronze			2022-12-28	WOS:000319456800015
J	Peplow, M				Peplow, Mark			THE ANATOMY OF SLEEP	NATURE			English	Editorial Material																			0	10	10	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S2	S3		10.1038/497S2a	http://dx.doi.org/10.1038/497S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698505	Bronze			2022-12-28	WOS:000319254000002
J	Carey, TS				Carey, Timothy S.			Corticosteroid injection worsened recovery and recurrence of tennis elbow; physiotherapy had no effect	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ N Carolina, Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Carey, TS (corresponding author), Univ N Carolina, Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA.		Coombes, Brooke/D-3456-2015; Bisset, Leanne/AAS-8947-2021	Coombes, Brooke/0000-0002-6163-1047; Bisset, Leanne/0000-0001-8807-7093					0	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC8	10.7326/0003-4819-158-10-201305210-02008	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689787				2022-12-28	WOS:000319666200007
J	Spence, D				Spence, Des			Stop protecting the NHS budget	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Hunter DJ, 2010, BRIT MED J, V341, pc4354; Lowrie A, 2013, NY TIMES; Office for National Statistics, 2007, HLTH STAT Q, P34; Rowlingson K., 2011, DOES INCOME INEQUALI	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2013	346								f3061	10.1136/bmj.f3061	http://dx.doi.org/10.1136/bmj.f3061			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AA	23690460				2022-12-28	WOS:000319572300001
J	Solberg, K				Solberg, Kristin			Running a school of life	LANCET			English	Editorial Material												kristin.solberg@aftenposten.no						Afghan Public Health Institute Ministry of Public Health (Afghanistan) Central Statistics Organization (Afghanistan) ICF Macro Indian Institute of Health Management Research and World Health Organization Regional Office for the Eastern Mediterranean, 2011, AFGH MORT SURV 2010; [Anonymous], LEV TRENDS CHILD MOR; Bartlett LA, 2005, LANCET, V365, P864, DOI 10.1016/S0140-6736(05)71044-8	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1712	1713		10.1016/S0140-6736(13)61065-X	http://dx.doi.org/10.1016/S0140-6736(13)61065-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23691549				2022-12-28	WOS:000319112800020
J	Prandoni, P				Prandoni, Paolo			Peripherally inserted catheters: all that glitters is not gold	LANCET			English	Editorial Material							RISK-FACTORS; THROMBOSIS; PREVENTION; CANCER		[Prandoni, Paolo] Univ Hosp Padua, Dept Cardiothorac & Vasc Sci, Div Internal Med 2, I-35128 Padua, Italy; [Prandoni, Paolo] Univ Hosp Padua, Thromboembolism Unit, I-35128 Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova	Prandoni, P (corresponding author), Univ Hosp Padua, Dept Cardiothorac & Vasc Sci, Div Internal Med 2, I-35128 Padua, Italy.	paoloprandoni@tin.it						Akl EA, 2011, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD006468.PUB3; [Anonymous], 1994, BMJ, V308, P235; Bonizzoli M, 2011, INTENS CARE MED, V37, P284, DOI 10.1007/s00134-010-2043-x; Chopra V, 2013, LANCET; Chopra V, 2013, J HOSP MED, V8, P309, DOI 10.1002/jhm.2031; Debourdeau P, 2013, J THROMB HAEMOST, V11, P71, DOI 10.1111/jth.12071; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Lee AYY, 2006, J CLIN ONCOL, V24, P1404, DOI 10.1200/JCO.2005.03.5600; Linnemann B, 2012, VASA, V41, P319, DOI 10.1024/0301-1526/a000217; Lobo BL, 2009, J HOSP MED, V4, P417, DOI 10.1002/jhm.442; Prandoni P, 2005, LANCET ONCOL, V6, P401, DOI 10.1016/S1470-2045(05)70207-2; Saber W, 2011, J THROMB HAEMOST, V9, P312, DOI 10.1111/j.1538-7836.2010.04126.x; Schiffer CA, 2013, J CLIN ONCOL, V31, P1357, DOI 10.1200/JCO.2012.45.5733; Verso M, 2003, J CLIN ONCOL, V21, P3665, DOI 10.1200/JCO.2003.08.008; Warkentin TE, 2012, NEW ENGL J MED, V367, P2039, DOI 10.1056/NEJMe1211480	15	3	3	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					288	290		10.1016/S0140-6736(13)60901-0	http://dx.doi.org/10.1016/S0140-6736(13)60901-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23697826				2022-12-28	WOS:000322544900005
J	Hirst, J; Jeffery, H				Hirst, Jane; Jeffery, Heather			Education, audit, and outreach to prevent maternal mortality	LANCET			English	Editorial Material									[Hirst, Jane] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Hirst, Jane; Jeffery, Heather] Univ Sydney, Sch Publ Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia; [Jeffery, Heather] Royal Prince Alfred Hosp, Dept Neonatol, Camperdown, NSW 2050, Australia	University of Oxford; University of Sydney; University of Sydney	Hirst, J (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	jane.hirst@obs-gyn.ox.ac.uk	Hirst, Jane Elizabeth/L-8863-2019; Hirst, Jane/AAM-9891-2020	Hirst, Jane/0000-0002-0176-2651				[Anonymous], 2012, AHRC2122 UN; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Dumont A, 2006, B WORLD HEALTH ORGAN, V84, P218, DOI 10.2471/BLT.05.023903; Dumont A, 2013, LANCET; HILL DA, 1992, MED TEACH, V14, P37, DOI 10.3109/01421599209044013; Jeffery HE, 2004, MED EDUC, V38, P435, DOI 10.1046/j.1365-2923.2004.01785.x; Pattinson RC, 2005, COCHRANE DB SYST REV, V4; Peterson HB, 2012, OBSTET GYNECOL, V120, P636, DOI 10.1097/AOG.0b013e3182632cc1; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	12	1	1	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					108	110		10.1016/S0140-6736(13)60906-X	http://dx.doi.org/10.1016/S0140-6736(13)60906-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187JY	23721754				2022-12-28	WOS:000322115300007
J	Clark, JN; Beitra, L; Xiong, G; Higginbotham, A; Fritz, DM; Lemke, HT; Zhu, D; Chollet, M; Williams, GJ; Messerschmidt, M; Abbey, B; Harder, RJ; Korsunsky, AM; Wark, JS; Robinson, IK				Clark, J. N.; Beitra, L.; Xiong, G.; Higginbotham, A.; Fritz, D. M.; Lemke, H. T.; Zhu, D.; Chollet, M.; Williams, G. J.; Messerschmidt, M.; Abbey, B.; Harder, R. J.; Korsunsky, A. M.; Wark, J. S.; Robinson, I. K.			Ultrafast Three-Dimensional Imaging of Lattice Dynamics in Individual Gold Nanocrystals	SCIENCE			English	Article							X-RAY-DIFFRACTION; TIME; LASER; NANOPARTICLES; VIBRATIONS; PARTICLES; MOTION; FIELD	Key insights into the behavior of materials can be gained by observing their structure as they undergo lattice distortion. Laser pulses on the femtosecond time scale can be used to induce disorder in a "pump-probe" experiment with the ensuing transients being probed stroboscopically with femtosecond pulses of visible light, x-rays, or electrons. Here we report three-dimensional imaging of the generation and subsequent evolution of coherent acoustic phonons on the picosecond time scale within a single gold nanocrystal by means of an x-ray free-electron laser, providing insights into the physics of this phenomenon. Our results allow comparison and confirmation of predictive models based on continuum elasticity theory and molecular dynamics simulations.	[Clark, J. N.; Beitra, L.; Xiong, G.; Robinson, I. K.] UCL, London Ctr Nanotechnol, London WC1E 6BT, England; [Higginbotham, A.; Wark, J. S.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Fritz, D. M.; Lemke, H. T.; Zhu, D.; Chollet, M.; Williams, G. J.; Messerschmidt, M.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Abbey, B.] La Trobe Univ, Dept Phys, ARC Ctr Excellence Coherent Xray Sci, Bundoora, Vic 3086, Australia; [Harder, R. J.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Korsunsky, A. M.] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Korsunsky, A. M.; Robinson, I. K.] Res Complex Harwell, Didcot OX11 0DE, Oxon, England	University of London; University College London; University of Oxford; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; La Trobe University; United States Department of Energy (DOE); Argonne National Laboratory; University of Oxford	Clark, JN (corresponding author), UCL, London Ctr Nanotechnol, Mortimer St, London WC1E 6BT, England.	jesse.clark@ucl.ac.uk	Korsunsky, Alexander M./E-2030-2012; Lemke, Henrik Till T/N-7419-2016; Abbey, Brian/D-3274-2011; Zhu, Diling/D-1302-2013; Messerschmidt, Marc/F-3796-2010; Messerschmidt, Marc/Y-8929-2019; Robinson, Ian/A-4906-2010	Korsunsky, Alexander M./0000-0002-3558-5198; Lemke, Henrik Till T/0000-0003-1577-8643; Abbey, Brian/0000-0001-6504-0503; Messerschmidt, Marc/0000-0002-8641-3302; Messerschmidt, Marc/0000-0002-8641-3302; /0000-0001-5211-9933; Robinson, Ian/0000-0003-4897-5221	European Research Council; Engineering and Physical Sciences Research Council (EPSRC) [EP/I022562/1]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H022597/1]; Atomic Weapons Establishment; UK EPSRC [EP/H035877/1]; EPSRC [EP/I020691/1]; Australian Research Council Centre of Excellence for Coherent X-ray Science; BBSRC [BB/H022597/1] Funding Source: UKRI; EPSRC [EP/E034055/1, EP/J017256/1, EP/I022562/1, EP/H003215/1, EP/G035059/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H022597/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G035059/1, EP/I022562/1, EP/J017256/1, EP/E034055/1, EP/I020691/1, EP/H003215/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Atomic Weapons Establishment; UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Australian Research Council Centre of Excellence for Coherent X-ray Science(Australian Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by FP7 advanced grant from the European Research Council. I. K. R is appreciative of support from the Engineering and Physical Sciences Research Council (EPSRC) under grant EP/I022562/1 and from the Biotechnology and Biological Sciences Research Council (BBSRC) under grant BB/H022597/1. A. H. was supported by Atomic Weapons Establishment. J.S.W. is grateful for support from the UK EPSRC under grant EP/H035877/1. A. M. K. is grateful for support from the EPSRC under grant EP/I020691/1. B. A. acknowledges the support of the Australian Research Council Centre of Excellence for Coherent X-ray Science. The experimental work was carried out at the Linac Coherent Light Source, a National User Facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. We acknowledge S. Boutet for insightful discussion.	ALLEN PB, 1987, PHYS REV LETT, V59, P1460, DOI 10.1103/PhysRevLett.59.1460; Cavalleri A, 2006, NATURE, V442, P664, DOI 10.1038/nature05041; Chen J, 2011, P NATL ACAD SCI USA, V108, P18887, DOI 10.1073/pnas.1115237108; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Ernstorfer R, 2009, SCIENCE, V323, P1033, DOI 10.1126/science.1162697; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Hanay MS, 2012, NAT NANOTECHNOL, V7, P602, DOI [10.1038/nnano.2012.119, 10.1038/NNANO.2012.119]; Hart P, 2012, PROC SPIE, V8504, DOI 10.1117/12.930924; Hartland GV, 2003, J PHYS CHEM B, V107, P7472, DOI 10.1021/jp0276092; Hartland GV, 2002, J CHEM PHYS, V116, P8048, DOI 10.1063/1.1469021; Ichiyanagi K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.024110; Lindenberg AM, 2000, PHYS REV LETT, V84, P111, DOI 10.1103/PhysRevLett.84.111; Maier SA, 2001, ADV MATER, V13, P1501, DOI 10.1002/1521-4095(200110)13:19<1501::AID-ADMA1501>3.0.CO;2-Z; McCulloch AJ, 2011, NAT PHYS, V7, P785, DOI 10.1038/nphys2052; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Newton MC, 2010, NAT MATER, V9, P120, DOI [10.1038/nmat2607, 10.1038/NMAT2607]; Pelton M, 2009, NAT NANOTECHNOL, V4, P492, DOI [10.1038/NNANO.2009.192, 10.1038/nnano.2009.192]; Pfeifer MA, 2006, NATURE, V442, P63, DOI 10.1038/nature04867; Plech A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195423; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; Ruan CY, 2007, NANO LETT, V7, P1290, DOI 10.1021/nl070269h; Siders CW, 1999, SCIENCE, V286, P1340, DOI 10.1126/science.286.5443.1340; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; Turner M, 2008, NATURE, V454, P981, DOI 10.1038/nature07194; van Dijk MA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.267406	27	199	202	14	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					56	59		10.1126/science.1236034	http://dx.doi.org/10.1126/science.1236034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23704372	Green Submitted			2022-12-28	WOS:000321291700045
J	Abreu, AP; Dauber, A; Macedo, DB; Noel, SD; Brito, VN; Gill, JC; Cukier, P; Thompson, IR; Navarro, VM; Gagliardi, PC; Rodrigues, T; Kochi, C; Longui, CA; Beckers, D; de Zegher, F; Montenegro, LR; Mendonca, BB; Carroll, RS; Hirschhorn, JN; Latronico, AC; Kaiser, UB				Abreu, Ana Paula; Dauber, Andrew; Macedo, Delanie B.; Noel, Sekoni D.; Brito, Vinicius N.; Gill, John C.; Cukier, Priscilla; Thompson, Iain R.; Navarro, Victor M.; Gagliardi, Priscila C.; Rodrigues, Tania; Kochi, Cristiane; Longui, Carlos Alberto; Beckers, Dominique; de Zegher, Francis; Montenegro, Luciana R.; Mendonca, Berenice B.; Carroll, Rona S.; Hirschhorn, Joel N.; Latronico, Ana Claudia; Kaiser, Ursula B.			Central Precocious Puberty Caused by Mutations in the Imprinted Gene MKRN3	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRADER-WILLI-SYNDROME; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; NEUROBIOLOGICAL MECHANISMS; ARCUATE NUCLEUS; CHINESE GIRLS; NEUROKININ B; ASSOCIATION; EXPRESSION; GROWTH; MOUSE	BACKGROUND The onset of puberty is first detected as an increase in pulsatile secretion of gonadotropin-releasing hormone (GnRH). Early activation of the hypothalamic-pituitary-gonadal axis results in central precocious puberty. The timing of pubertal development is driven in part by genetic factors, but only a few, rare molecular defects associated with central precocious puberty have been identified. METHODS We performed whole-exome sequencing in 40 members of 15 families with central precocious puberty. Candidate variants were confirmed with Sanger sequencing. We also performed quantitative real-time polymerase-chain-reaction assays to determine levels of messenger RNA (mRNA) in the hypothalami of mice at different ages. RESULTS We identified four novel heterozygous mutations in MKRN3, the gene encoding makorin RING-finger protein 3, in 5 of the 15 families; both sexes were affected. The mutations included three frameshift mutations, predicted to encode truncated proteins, and one missense mutation, predicted to disrupt protein function. MKRN3 is a paternally expressed, imprinted gene located in the Prader-Willi syndrome critical region (chromosome 15q11-q13). All affected persons inherited the mutations from their fathers, a finding that indicates perfect segregation with the mode of inheritance expected for an imprinted gene. Levels of Mkrn3 mRNA were high in the arcuate nucleus of prepubertal mice, decreased immediately before puberty, and remained low after puberty. CONCLUSIONS Deficiency of MKRN3 causes central precocious puberty in humans.	[Abreu, Ana Paula; Noel, Sekoni D.; Gill, John C.; Thompson, Iain R.; Navarro, Victor M.; Carroll, Rona S.; Kaiser, Ursula B.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Abreu, Ana Paula; Noel, Sekoni D.; Gill, John C.; Thompson, Iain R.; Navarro, Victor M.; Carroll, Rona S.; Kaiser, Ursula B.] Harvard Univ, Sch Med, Boston, MA USA; [Dauber, Andrew; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Hirschhorn, Joel N.] Boston Childrens Hosp, Div Genet, Boston, MA USA; [Dauber, Andrew; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Abreu, Ana Paula; Macedo, Delanie B.; Brito, Vinicius N.; Cukier, Priscilla; Montenegro, Luciana R.; Mendonca, Berenice B.; Latronico, Ana Claudia] Univ Sao Paulo, Fac Med, Hosp Clin,Lab Hormonios & Genet Mol,LIM42, Disciplina Endocrinol,Unidade Endocrinol Desenvol, BR-05403900 Sao Paulo, Brazil; [Kochi, Cristiane; Longui, Carlos Alberto] Fac Ciencias Med Santa Casa Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Rodrigues, Tania] Univ Fed Minas Gerais, Hosp Clin, Div Pediat Endocrinol, Belo Horizonte, MG, Brazil; [Gagliardi, Priscila C.] Nemours Childrens Clin, Div Endocrinol Diabet & Metab, Jacksonville, FL USA; [Beckers, Dominique; de Zegher, Francis] Univ Hosp Gasthuisberg, Dept Pediat, B-3000 Louvain, Belgium	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidade de Sao Paulo; Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Minas Gerais; KU Leuven; University Hospital Leuven	Latronico, AC (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Disciplina Endocrinol & Metabol, Av Dr Eneas de Carvalho Aguiar,255-7 Andar,Sala 7, BR-05403900 Sao Paulo, Brazil.	anacl@usp.br	Brito, Vinicius Nahime/AAA-2013-2020; Mendonca, Berenice B/J-6917-2015; Longui, Carlos A/B-8112-2013; Latronico, Ana Claudia/AAC-5112-2019; Mendonca, Berenice/AAS-3742-2021; Latronico, Ana Claudia/E-1198-2012; BRITO, VINICIUS N/B-3776-2013	Mendonca, Berenice B/0000-0003-1762-1084; Latronico, Ana Claudia/0000-0001-6782-693X; Mendonca, Berenice/0000-0003-1762-1084; Latronico, Ana Claudia/0000-0001-6782-693X; BRITO, VINICIUS N/0000-0003-4140-6296; Brito, Vinicius Nahime/0000-0002-1052-2246; /0000-0002-5505-0852	National Institutes of Health [1K23HD073351]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [3806-11-1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [1F05HD072773-01, U54HD28138, R21HD066495]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302825/2011-8, 305743/2011-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2005/04726-0]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028138, F05HD072773, R00HD071970, K99HD071970, P30HD018655, K23HD073351] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and others.; Supported by grants from the National Institutes of Health (1K23HD073351, to Dr. Dauber), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (3806-11-1, to Dr. Abreu), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1F05HD072773-01, to Dr. Abreu; U54HD28138, as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; and R21HD066495, to Dr. Kaiser), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (302825/2011-8, to Dr. Latronico; and 305743/2011-2, to Dr. Mendoca), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2005/04726-0, to Dr. Latronico).	[Anonymous], 2013, EX VAR SERV; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; Bohne A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-721; Buettner VI, 2005, MAMM GENOME, V16, P219, DOI 10.1007/s00335-004-2452-7; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Dauber A, 2013, J PEDIATR-US, V162, P202, DOI 10.1016/j.jpeds.2012.07.055; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Vries L, 2004, J CLIN ENDOCR METAB, V89, P1794, DOI 10.1210/jc.2003-030361; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; FISCHBEIN S, 1977, ANN HUM BIOL, V4, P417, DOI 10.1080/03014467700002401; Friedman DS, 2008, OPHTHALMOLOGY, V115, P1786, DOI 10.1016/j.ophtha.2008.04.006; Gajdos ZKZ, 2009, CURR OPIN ENDOCRINOL, V16, P16, DOI 10.1097/MED.0b013e328320253c; Gill JC, 2012, ENDOCRINOLOGY, V153, P4883, DOI 10.1210/en.2012-1529; Gill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011911; Golub MS, 2008, PEDIATRICS, V121, pS218, DOI 10.1542/peds.2007-1813G; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Greulich W.W., 1971, RADIOGRAPHIC ATLAS S; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Kanber D, 2009, EUR J HUM GENET, V17, P582, DOI 10.1038/ejhg.2008.232; Luan X, 2007, NEUROENDOCRINOLOGY, V86, P77, DOI 10.1159/000107511; Freitas KCM, 2007, FERTIL STERIL, V87, P627, DOI 10.1016/j.fertnstert.2006.07.1519; NAKAYAMA Y, 1990, J CLIN ENDOCR METAB, V70, P1233, DOI 10.1210/jcem-70-5-1233; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; NEELY EK, 1995, J PEDIATR-US, V127, P40, DOI 10.1016/S0022-3476(95)70254-7; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Palmert MR, 2001, J CLIN ENDOCR METAB, V86, P2364, DOI 10.1210/jc.86.6.2364; Parent AS, 2008, HORM RES, V69, P114, DOI 10.1159/000111815; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Plant TM, 2004, HUM REPROD UPDATE, V10, P67, DOI 10.1093/humupd/dmh001; San Lucas FA, 2012, BIOINFORMATICS, V28, P421, DOI 10.1093/bioinformatics/btr667; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Semple RK, 2010, CLIN ENDOCRINOL, V72, P427, DOI 10.1111/j.1365-2265.2009.03687.x; Silveira LG, 2010, J CLIN ENDOCR METAB, V95, P2276, DOI 10.1210/jc.2009-2421; SKLAD M, 1977, ACTA GENET MED GEMEL, V26, P221, DOI 10.1017/S0001566000009703; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; Zhao Y, 2010, NEUROSCI LETT, V486, P188, DOI 10.1016/j.neulet.2010.09.049; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	39	285	301	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2467	2475		10.1056/NEJMoa1302160	http://dx.doi.org/10.1056/NEJMoa1302160			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23738509	Green Accepted			2022-12-28	WOS:000320926900007
J	Turner, L; Lavstsen, T; Berger, SS; Wang, CW; Petersen, JEV; Avril, M; Brazier, AJ; Freeth, J; Jespersen, JS; Nielsen, MA; Magistrado, P; Lusingu, J; Smith, JD; Higgins, MK; Theander, TG				Turner, Louise; Lavstsen, Thomas; Berger, Sanne S.; Wang, Christian W.; Petersen, Jens E. V.; Avril, Marion; Brazier, Andrew J.; Freeth, Jim; Jespersen, Jakob S.; Nielsen, Morten A.; Magistrado, Pamela; Lusingu, John; Smith, Joseph D.; Higgins, Matthew K.; Theander, Thor G.			Severe malaria is associated with parasite binding to endothelial protein C receptor	NATURE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; FALCIPARUM-INFECTED ERYTHROCYTES; VAR GENES; DROTRECOGIN-ALPHA; EXPRESSION; ACQUISITION; ANTIBODIES; ADHESION; SUBSET	Sequestration of Plasmodium falciparum-infected erythrocytes in host blood vessels is a key triggering event in the pathogenesis of severe childhood malaria, which is responsible for about one million deaths every year(1). Sequestration is mediated by specific interactions between members of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family and receptors on the endothelial lining(2). Severe childhood malaria is associated with expression of specific PfEMP1 subtypes containing domain cassettes (DCs) 8 and 13 (ref. 3), but the endothelial receptor for parasites expressing these proteins was unknown(4,5). Here we identify endothelial protein C receptor (EPCR), which mediates the cytoprotective effects of activated protein C-6, as the endothelial receptor for DC8 and DC13 PfEMP1. We show that EPCR binding is mediated through the amino-terminal cysteine-rich interdomain region (CIDRa1) of DC8 and group A PfEMP1 subfamilies, and that CIDRa1 interferes with protein C binding to EPCR. This PfEMP1 adhesive property links P. falciparum cytoadhesion to a host receptor involved in anticoagulation and endothelial cytoprotective pathways, and has implications for understanding malaria pathology and the development of new malaria interventions.	[Turner, Louise; Lavstsen, Thomas; Berger, Sanne S.; Wang, Christian W.; Petersen, Jens E. V.; Jespersen, Jakob S.; Nielsen, Morten A.; Theander, Thor G.] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Turner, Louise; Lavstsen, Thomas; Berger, Sanne S.; Wang, Christian W.; Petersen, Jens E. V.; Jespersen, Jakob S.; Nielsen, Morten A.; Theander, Thor G.] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Avril, Marion; Brazier, Andrew J.; Smith, Joseph D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Freeth, Jim] Retrogenix, Whaley Bridge SK23 7LY, High Peak, England; [Magistrado, Pamela; Lusingu, John] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania; [Smith, Joseph D.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Copenhagen; Rigshospitalet; University of Copenhagen; Center for Infectious Disease Research; National Institute of Medical Research; University of Washington; University of Washington Seattle; University of Oxford	Lavstsen, T (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	lturner@sund.ku.dk; thomasl@sund.ku.dk	Lusingu, John P. A./GSJ-3228-2022; Theander, Thor/F-6714-2015	Theander, Thor/0000-0002-3509-7514; Berger, Sanne Schou/0000-0002-1440-4909; Turner, Louise/0000-0003-4494-2289; Lusingu, John P. A./0000-0002-9407-0602; Higgins, Matthew/0000-0002-2870-1955; Petersen, Jens Emil Vang/0000-0001-5567-465X; Wang, Christian/0000-0003-3140-6989; Nielsen, Morten Agertoug/0000-0003-2668-4992; Schmidt Jespersen, Jakob/0000-0002-4930-5900; Lavstsen, Thomas/0000-0002-3044-4249	University of Copenhagen Program of Excellence; Lundbeck Foundation; Danish International Development Agency; Augustinus Fonden; Malaria Capacity Development Consortium; Danish Medical Research Council; National Institutes of Health [R01 AI47953, U19 AI089688]; Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089688, R01AI047953] Funding Source: NIH RePORTER; Lundbeck Foundation [R108-2012-10328] Funding Source: researchfish; Medical Research Council [G0901062] Funding Source: researchfish; MRC [G0901062] Funding Source: UKRI	University of Copenhagen Program of Excellence; Lundbeck Foundation(Lundbeckfonden); Danish International Development Agency; Augustinus Fonden; Malaria Capacity Development Consortium; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Salanti for supplying the full-length VAR2CSA protein and S. Lucking Nielsen for technical assistance. The work was supported by the University of Copenhagen Program of Excellence, Lundbeck Foundation, Danish International Development Agency, Augustinus Fonden, Malaria Capacity Development Consortium and The Danish Medical Research Council, as well as the National Institutes of Health (R01 AI47953 and U19 AI089688 to J.D.S.). M. K. H. was funded by a research grant from the Medical Research Council.	Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Dennis J, 2012, BLOOD, V119, P2392, DOI 10.1182/blood-2011-10-383448; Fukudome K, 1996, J BIOL CHEM, V271, P17491, DOI 10.1074/jbc.271.29.17491; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Gleeson EM, 2012, CELL MOL LIFE SCI, V69, P717, DOI 10.1007/s00018-011-0825-0; Kendrick BJL, 2006, ANAESTHESIA, V61, P899, DOI 10.1111/j.1365-2044.2006.04752.x; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Pintao MC, 2011, J THROMB HAEMOST, V9, P969, DOI 10.1111/j.1538-7836.2011.04256.x; Rankin LG, 2007, ANAESTH INTENS CARE, V35, P428, DOI 10.1177/0310057X0703500320; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Robak O, 2010, ANAESTH INTENS CARE, V38, P751, DOI 10.1177/0310057X1003800421; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Schuepbach RA, 2009, THROMB HAEMOSTASIS, V101, P724, DOI 10.1160/TH08-10-0632; Simmonds RE, 1999, BLOOD, V94, P632, DOI 10.1182/blood.V94.2.632.414k24_632_641; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; Turner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029025; Wang CW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-129; Xu J, 2000, J BIOL CHEM, V275, P6038, DOI 10.1074/jbc.275.8.6038	30	359	363	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					502	+		10.1038/nature12216	http://dx.doi.org/10.1038/nature12216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23739325	Green Accepted			2022-12-28	WOS:000320929400056
J	Tharakaraman, K; Raman, R; Viswanathan, K; Stebbins, NW; Jayaraman, A; Krishnan, A; Sasisekharan, V; Sasisekharan, R				Tharakaraman, Kannan; Raman, Rahul; Viswanathan, Karthik; Stebbins, Nathan W.; Jayaraman, Akila; Krishnan, Arvind; Sasisekharan, V.; Sasisekharan, Ram			Structural Determinants for Naturally Evolving H5N1 Hemagglutinin to Switch Its Receptor Specificity	CELL			English	Article							INFLUENZA-A VIRUSES; AVIAN INFLUENZA; BINDING PROPERTIES; MAMMALIAN HOST; HUMAN AIRWAY; TRANSMISSION; FERRETS; PATHOGENESIS; ADAPTATION; MUTATIONS	Of the factors governing human-to-human transmission of t he highly pathogenic avian-adapted H5N1 virus, the most critical is the acquisition of mutations on the viral hemagglutinin (HA) to "quantitatively switch" its binding from avian to human glycan receptors. Here, we describe a structural framework that outlines a necessary set of H5 HA receptor-binding site (RBS) features required for the H5 HA to quantitatively switch its preference to human receptors. We show here that the same RBS HA mutations that lead to aerosol transmission of A/Vietnam/1203/04 and A/Indonesia/5/05 viruses, when introduced in currently circulating H5N1, do not lead to a quantitative switch in receptor preference. We demonstrate that HAs from circulating clades require as few as a single base pair mutation to quantitatively switch their binding to human receptors. The mutations identified by this study can be used to monitor the emergence of strains having human-to-human transmission potential.	[Tharakaraman, Kannan; Raman, Rahul; Viswanathan, Karthik; Stebbins, Nathan W.; Jayaraman, Akila; Krishnan, Arvind; Sasisekharan, V.; Sasisekharan, Ram] MIT, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Infect Dis Interdisciplinary Res Grp, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Sasisekharan, R (corresponding author), MIT, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Infect Dis Interdisciplinary Res Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu		Krishnan, Arvind/0000-0002-7489-9229	National Institutes of Health [R37 GM057073-13]; National-Research-Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National-Research-Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health (R37 GM057073-13) and the National-Research-Foundation-supported Interdisciplinary Research group in Infectious Diseases of SMART (Singapore-MIT Alliance for Research and Technology).	Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ge SQ, 2011, CRIT REV MICROBIOL, V37, P157, DOI 10.3109/1040841X.2010.536523; Guan Y, 2009, REV SCI TECH OIE, V28, P39, DOI 10.20506/rst.28.1.1868; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mansfield KG, 2007, AM J PATHOL, V171, P1089, DOI 10.2353/ajpath.2007.070695; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Neumann G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002932; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Soundararajan V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00200; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Viswanathan K., 2010, PLOS ONE, V5; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	32	69	72	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1475	1485		10.1016/j.cell.2013.05.035	http://dx.doi.org/10.1016/j.cell.2013.05.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23746829	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000320722000016
J	Crawford, NW; Graham, SM				Crawford, Nigel W.; Graham, Steve M.			EV71 vaccine: protection from a previously neglected disease	LANCET			English	Editorial Material									[Crawford, Nigel W.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Crawford, NW (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.	nigel.crawford@mcri.edu.au		Graham, Stephen/0000-0003-3525-2294				Burchett HED, 2012, HEALTH POLICY PLANN, V27, pII62, DOI 10.1093/heapol/czr049; Chinese CDC, 2008, NATIONAL INCIDENCE A; Donauer S, 2013, VACCINE, V31, P2692, DOI 10.1016/j.vaccine.2013.03.072; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lin TY, 2003, PEDIATR INFECT DIS J, V22, P889, DOI 10.1097/01.inf.0000091294.63706.f3; Marshall HS, 2013, PEDIATR INFECT DIS J, V32, P530, DOI 10.1097/INF.0b013e31827e92b7; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Seiff A, 2012, LANCET, V380, P205, DOI 10.1016/S0140-6736(12)61200-8; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Zhu F-C, 2013, LANCET; Zhu FC, 2013, LANCET, V381, P1037, DOI 10.1016/S0140-6736(12)61764-4	13	13	16	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2013	381	9882					1968	1970		10.1016/S0140-6736(13)61124-1	http://dx.doi.org/10.1016/S0140-6736(13)61124-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171JY	23726163				2022-12-28	WOS:000320924400009
J	Britton, J; McNeill, A				Britton, John; McNeill, Ann			Nicotine regulation and tobacco harm reduction in the UK	LANCET			English	Editorial Material							CIGARETTES; SMOKING		[Britton, John] Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England; [McNeill, Ann] Kings Coll London, Inst Psychiat, UK Ctr Tobacco Control Studies, London WC2R 2LS, England	University of Nottingham; University of London; King's College London	Britton, J (corresponding author), Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England.	j.britton@virgin.net		McNeill, Ann/0000-0002-6223-4000				Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Gartner CE, 2007, LANCET, V369, P2010, DOI 10.1016/S0140-6736(07)60677-1; Medicines and Healthcare Products Regulatory Agency (MHRA), 2005, REP COMM SAF MED WOR; Moore D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1024; *ROYAL COLL PHYS T, 2007, HARM RED NIC ADD; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; Scientific Committee on Emerging and Newly Identified Health Risks, 2008, HLTH EFF SMOK TOB PR; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; West R, 2013, MONTHL TRACK KEY PER	10	5	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1879	1880		10.1016/S0140-6736(13)61122-8	http://dx.doi.org/10.1016/S0140-6736(13)61122-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163EV	23725716				2022-12-28	WOS:000320319500005
J	Bar-Peled, L; Chantranupong, L; Cherniack, AD; Chen, WW; Ottina, KA; Grabiner, BC; Spear, ED; Carter, SL; Meyerson, M; Sabatini, DM				Bar-Peled, Liron; Chantranupong, Lynne; Cherniack, Andrew D.; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Spear, Eric D.; Carter, Scott L.; Meyerson, Matthew; Sabatini, David M.			A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1	SCIENCE			English	Article							HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME 3P21.3; PTEN-DEFICIENT; SENSITIVITY; INHIBITION; ACTIVATION; RAGULATOR; AUTOPHAGY; TARGET; CANCER	The mTOR complex 1 (mTORC1) pathway promotes cell growth in response to many cues, including amino acids, which act through the Rag guanosine triphosphatases (GTPases) to promote mTORC1 translocation to the lysosomal surface, its site of activation. Although progress has been made in identifying positive regulators of the Rags, it is unknown if negative factors also exist. Here, we identify GATOR as a complex that interacts with the Rags and is composed of two subcomplexes we call GATOR1 and -2. Inhibition of GATOR1 subunits (DEPDC5, Nprl2, and Nprl3) makes mTORC1 signaling resistant to amino acid deprivation. In contrast, inhibition of GATOR2 subunits (Mios, WDR24, WDR59, Seh1L, and Sec13) suppresses mTORC1 signaling, and epistasis analysis shows that GATOR2 negatively regulates DEPDC5. GATOR1 has GTPase-activating protein (GAP) activity for RagA and RagB, and its components are mutated in human cancer. In cancer cells with inactivating mutations in GATOR1, mTORC1 is hyperactive and insensitive to amino acid starvation, and such cells are hypersensitive to rapamycin, an mTORC1 inhibitor. Thus, we identify a key negative regulator of the Rag GTPases and reveal that, like other mTORC1 regulators, Rag function can be deregulated in cancer.	[Bar-Peled, Liron; Chantranupong, Lynne; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Chantranupong, Lynne; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Chantranupong, Lynne; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Cherniack, Andrew D.; Carter, Scott L.; Meyerson, Matthew; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Spear, Eric D.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Cherniack, Andrew D./AAY-8132-2020	Cherniack, Andrew D./0000-0003-0470-0111; Meyerson, Matthew/0000-0002-9133-8108; /0000-0002-1446-7256; Chen, Walter/0000-0002-7752-9581	NIH [CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; National Cancer Institute (NIH) [U24CA143867]; David H. Koch Graduate Fellowship Fund; NSF; Harvard-MIT Health, Sciences, and Technology IDEA2 program; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA103866, P30CA014051, U24CA143867, F31CA180271, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); David H. Koch Graduate Fellowship Fund; NSF(National Science Foundation (NSF)); Harvard-MIT Health, Sciences, and Technology IDEA2 program; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Sabatini lab fur helpful suggestions, E. Spooner fur the mass spectrometric analysis of samples, and N. Kory for technical assistance. This work was supported by grants from the NIH (CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D.M.S. and the National Cancer Institute (NIH) (U24CA143867) to M.M. and awards from the David H. Koch Graduate Fellowship Fund to L.B.-P.; the NSF Graduate Research Fellowship Program to L.C.; the Harvard-MIT Health, Sciences, and Technology IDEA<SUP>2</SUP> program to W.W.C.; and the American Cancer Society to B.C.G. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Dokudovskaya S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006478; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Iida T, 2004, DEVELOPMENT, V131, P1029, DOI 10.1242/dev.01001; Ji L, 2002, CANCER RES, V62, P2715; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leksa NC, 2010, NUCLEUS-PHILA, V1, P314, DOI 10.4161/nucl.1.4.11798; Lerman MI, 2000, CANCER RES, V60, P6116; Li F, 2004, CANCER RES, V64, P6438, DOI 10.1158/0008-5472.CAN-03-3869; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Seng TJ, 2005, GENE CHROMOSOME CANC, V43, P181, DOI 10.1002/gcc.20181; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	26	662	715	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1100	1106		10.1126/science.1232044	http://dx.doi.org/10.1126/science.1232044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723238	Green Submitted, Green Accepted			2022-12-28	WOS:000319664500046
J	Galetti, M; Guevara, R; Cortes, MC; Fadini, R; Von Matter, S; Leite, AB; Labecca, F; Ribeiro, T; Carvalho, CS; Collevatti, RG; Pires, MM; Guimaraes, PR; Brancalion, PH; Ribeiro, MC; Jordano, P				Galetti, Mauro; Guevara, Roger; Cortes, Marina C.; Fadini, Rodrigo; Von Matter, Sandro; Leite, Abraao B.; Labecca, Fabio; Ribeiro, Thiago; Carvalho, Carolina S.; Collevatti, Rosane G.; Pires, Mathias M.; Guimaraes, Paulo R., Jr.; Brancalion, Pedro H.; Ribeiro, Milton C.; Jordano, Pedro			Functional Extinction of Birds Drives Rapid Evolutionary Changes in Seed Size	SCIENCE			English	Article							PALM EUTERPE-EDULIS; AVIAN FRUGIVORES; GERMINATION; PREDATORS; DISPERSAL; SURVIVAL; DENSITY; TREE	Local extinctions have cascading effects on ecosystem functions, yet little is known about the potential for the rapid evolutionary change of species in human-modified scenarios. We show that the functional extinction of large-gape seed dispersers in the Brazilian Atlantic forest is associated with the consistent reduction of the seed size of a keystone palm species. Among 22 palm populations, areas deprived of large avian frugivores for several decades present smaller seeds than nondefaunated forests, with negative consequences for palm regeneration. Coalescence and phenotypic selection models indicate that seed size reduction most Likely occurred within the past 100 years, associated with human-driven fragmentation. The fast-paced defaunation of large vertebrates is most Likely causing unprecedented changes in the evolutionary trajectories and community composition of tropical forests.	[Galetti, Mauro; Cortes, Marina C.; Leite, Abraao B.; Labecca, Fabio; Ribeiro, Thiago; Ribeiro, Milton C.] Univ Estadual Paulista, Dept Ecol, BR-13506900 Sao Paulo, Brazil; [Guevara, Roger] AC Red Biol Evolut, Inst Ecol, Xalapa 91070, Veracruz, Mexico; [Fadini, Rodrigo] Univ Fed Oeste Para, Inst Biodiversidade & Florestas, BR-68035110 Santarem, Para, Brazil; [Von Matter, Sandro] Univ Fed Rural Estado Rio de Janeiro, Dept Biol Anim, BR-23897000 Rio De Janeiro, Brazil; [Carvalho, Carolina S.; Collevatti, Rosane G.] Univ Fed Goias, Lab Genet & Biodiversidade, BR-74001970 Goiania, Go, Brazil; [Pires, Mathias M.; Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Dept Ecol, BR-0550890 Sao Paulo, Brazil; [Brancalion, Pedro H.] Univ Sao Paulo, Esco Super Agr Luiz de Queiroz, Dept Ciencias Florestais, BR-13418900 Sao Paulo, Brazil; [Jordano, Pedro] CSIC, EBD, Integrat Ecol Grp, E-41092 Seville, Spain	Universidade Estadual Paulista; Instituto de Ecologia - Mexico; Universidade Federal do Oeste do Para; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade de Sao Paulo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Galetti, M (corresponding author), Univ Estadual Paulista, Dept Ecol, BR-13506900 Sao Paulo, Brazil.	mgaletti@rc.unesp.br	Guimarães-Junior, Paulo R/M-1298-2016; Carvalho, Carolina/E-9746-2013; Brancalion, Pedro/D-6995-2012; Galetti, Mauro/M-8751-2013; Collevatti, Rosane/D-8673-2013; Von Matter, Sandro/M-7151-2013; Guevara, Roger/F-3287-2010; Guimaraes, Paulo R./E-1915-2016; Leite, Abraão/AAE-2362-2020; Jordano, Pedro/A-5162-2008; Côrtes, Marina Corrêa/I-2155-2012; Fadini, Rodrigo/C-7574-2013; Galetti, Mauro/C-5275-2008; Pires, Mathias/I-4489-2012	Carvalho, Carolina/0000-0002-0063-2185; Brancalion, Pedro/0000-0001-8245-4062; Galetti, Mauro/0000-0002-8187-8696; Collevatti, Rosane/0000-0002-3733-7059; Von Matter, Sandro/0000-0002-0412-3820; Guevara, Roger/0000-0003-0768-3580; Guimaraes, Paulo R./0000-0001-9161-8305; Jordano, Pedro/0000-0003-2142-9116; Côrtes, Marina Corrêa/0000-0003-3389-5050; Fadini, Rodrigo/0000-0002-6873-1438; Galetti, Mauro/0000-0002-8187-8696; Pires, Mathias/0000-0003-2500-4748	Fundacao de Amparo do Estado de Sao Paulo (BIOTA - FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq), (Excellence Grant-Junta Andalucia); Programa Iberoamericano de Ciencia y Tecnologia para el Desarollo (CYTED)	Fundacao de Amparo do Estado de Sao Paulo (BIOTA - FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq), (Excellence Grant-Junta Andalucia); Programa Iberoamericano de Ciencia y Tecnologia para el Desarollo (CYTED)	We thank the Fundacao de Amparo do Estado de Sao Paulo (BIOTA - FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq), (Excellence Grant-Junta Andalucia (to P.J.); and Programa lberoamericano de Ciencia y Tecnologia para el Desarollo (CYTED) for funding support. We thank J. Bascompte, R. Dirzo, D. Hansen, D. Levey, E. Bruna, D. Lapola, D. McCauley, M. A. Pizo, and three reviewers for useful comments and suggestions; T. A. Ferreira, E. Cazetta,	Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Dean W., 1976, RIO CLARO BRAZILIAN; Falconer DS, 1996, INTRO QUANTITATIVE G; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Holbrook KM, 2009, ECOLOGY, V90, P1449, DOI 10.1890/08-1332.1; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Leite AD, 2012, J TROP ECOL, V28, P615, DOI 10.1017/S0266467412000594; LEVEY DJ, 1987, AM NAT, V129, P471, DOI 10.1086/284652; Marengo JA, 2010, CLIMATIC CHANGE, V98, P509, DOI 10.1007/s10584-009-9743-7; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Matos DMS, 1999, ECOLOGY, V80, P2635, DOI 10.2307/177246; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pizo MA, 2001, ACTA OECOL, V22, P229, DOI 10.1016/S1146-609X(01)01108-0; Pizo MA, 2006, ACTA OECOL, V29, P311, DOI 10.1016/j.actao.2005.11.011; Roels SAB, 2011, EVOLUTION, V65, P2541, DOI 10.1111/j.1558-5646.2011.01326.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209	22	452	473	10	412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1086	1090		10.1126/science.1233774	http://dx.doi.org/10.1126/science.1233774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723235				2022-12-28	WOS:000319664500042
J	Freynhagen, R; Geisslinger, G; Schug, SA				Freynhagen, Rainer; Geisslinger, Gerd; Schug, Stephan A.			Opioids for chronic non-cancer pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIANS ASIPP GUIDELINES; NEUROPATHIC PAIN; CONTROLLED-RELEASE; CONTROLLED-TRIALS; AMERICAN SOCIETY; ACTING OPIOIDS; UNITED-STATES; MANAGEMENT; RISK; DEPENDENCE		[Freynhagen, Rainer] Benedictus Hosp Tutzing, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, D-82327 Tutzing, Germany; [Freynhagen, Rainer] Tech Univ Munich, Dept Anaesthesiol, D-80290 Munich, Germany; [Geisslinger, Gerd] Goethe Univ Frankfurt, Univ Hosp, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany; [Schug, Stephan A.] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Pharmacol Pharm & Anaesthesiol Unit, Perth, WA 6847, Australia	Technical University of Munich; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Royal Perth Hospital; University of Western Australia	Freynhagen, R (corresponding author), Benedictus Hosp Tutzing, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, Bahnhofstr 5, D-82327 Tutzing, Germany.	r.freynhagen@krankenhaus-tutzing.de	Schug, Stephan/G-1432-2010	Schug, Stephan/0000-0002-0302-2315; Freynhagen, Rainer/0000-0002-3759-1508				Anastassopoulos KP, 2012, J MANAGE CARE PHARM, V18, P615, DOI 10.18553/jmcp.2012.18.8.615; Annemans L, 2011, CLIN DRUG INVEST, V31, P73, DOI 10.2165/11536290-000000000-00000; Avouac J, 2007, OSTEOARTHR CARTILAGE, V15, P957, DOI 10.1016/j.joca.2007.02.006; Beaulieu AD, 2008, PAIN RES MANAG, V13, P103, DOI 10.1155/2008/903784; Birnbaum HG, 2011, PAIN MED, V12, P657, DOI 10.1111/j.1526-4637.2011.01075.x; Bjordal JM, 2004, BMJ-BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Boscarino JA, 2011, J ADDICT DIS, V30, P185, DOI 10.1080/10550887.2011.581961; Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55; British Pain Society, 2010, OPIOIDS FOR PERSISTE; Camilleri M, 2011, AM J GASTROENTEROL, V106, P835, DOI 10.1038/ajg.2011.30; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Edlund MJ, 2007, PAIN, V129, P355, DOI 10.1016/j.pain.2007.02.014; Eisenberg E, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006146; Elliott Jennifer A, 2011, J Opioid Manag, V7, P145; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Freynhagen R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3002; Hollingshead J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651828.CD003726.pub3; Katz Nathaniel P, 2010, J Pain Palliat Care Pharmacother, V24, P141, DOI 10.3109/15360281003799098; Leider HL, 2011, AM J MANAG CARE, V17, P32; Li L, 2013, PAIN PHYSICIAN, V16, P77; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS1; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS67; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P91; Mercadante S, 2013, EXPERT OPIN INV DRUG, V22, P161, DOI 10.1517/13543784.2013.752460; Mercadante S, 2012, DRUGS, V72, P2327, DOI 10.2165/11642230-000000000-00000; Modesto-Lowe V, 2010, J GEN INTERN MED, V25, P305, DOI 10.1007/s11606-009-1225-0; National Institute for Health and Clinical Excellence, 2010, NEUROPATHIC PAIN THE, V96; National Opioid Use Guideline Group Canadian guideline for safe and effective use of opioids for chronic non cancer pain National Opioid Use Guideline Group (NOUGG), 2010, CANADIAN GUIDELINE F; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Nuesch E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003115.pub3; O'Donnell JB, 2009, J INT MED RES, V37, P1789, DOI 10.1177/147323000903700615; Obradovic M, 2012, CLIN THER, V34, P926, DOI 10.1016/j.clinthera.2012.02.011; Office of National Drug Control Policy, PRESCRIPTION DRUG AB; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Scharnagel R, 2013, SCHMERZ, V27, P7, DOI 10.1007/s00482-012-1278-6; Skurtveit S, 2011, PAIN, V152, P1555, DOI 10.1016/j.pain.2011.02.045; Soyka M, 2011, WORLD J BIOL PSYCHIA, V12, P160, DOI 10.3109/15622975.2011.561872; Tompkins DA, 2011, CURR PAIN HEADACHE R, V15, P129, DOI 10.1007/s11916-010-0171-1; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Webster LR, 2005, PAIN MED, V6, P432, DOI 10.1111/j.1526-4637.2005.00072.x; Webster Lynn, 2011, J Opioid Manag, V7, P235; Webster LR, 2008, PAIN MED, V9, P425, DOI 10.1111/j.1526-4637.2007.00343.x	45	21	21	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f2937	10.1136/bmj.f2937	http://dx.doi.org/10.1136/bmj.f2937			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DG	23719636				2022-12-28	WOS:000319948200005
J	McCartney, M				McCartney, Margaret			Profits from pregnancy: how trusted organisations sell out women to commercial interests	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2013	346								f3448	10.1136/bmj.f3448	http://dx.doi.org/10.1136/bmj.f3448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158CZ	23716358				2022-12-28	WOS:000319947500018
J	Landreth, GE; Cramer, PE; Lakner, MM; Cirrito, JR; Wesson, DW; Brunden, KR; Wilson, DA				Landreth, Gary E.; Cramer, Paige E.; Lakner, Mitchell M.; Cirrito, John R.; Wesson, Daniel W.; Brunden, Kurt R.; Wilson, Donald A.			Response to Comments on "ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models"	SCIENCE			English	Editorial Material							PROTEIN/PRESENILIN 1 MICE; ALZHEIMERS-DISEASE; NUCLEAR RECEPTORS; MEMORY; ACTIVATION; PHAGOCYTOSIS		[Landreth, Gary E.; Cramer, Paige E.; Lakner, Mitchell M.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Alzheimer Res Lab, Cleveland, OH 44106 USA; [Cirrito, John R.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, Dept Neurol,Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Wesson, Daniel W.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Brunden, Kurt R.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Wilson, Donald A.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA; [Wilson, Donald A.] NYU, Sch Med, Orangeburg, NY 10962 USA	Case Western Reserve University; Washington University (WUSTL); Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine; Nathan Kline Institute for Psychiatric Research; New York University	Landreth, GE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Alzheimer Res Lab, Cleveland, OH 44106 USA.	gel2@case.edu	Wesson, Daniel/AAJ-6719-2020	Wesson, Daniel/0000-0002-3192-3866; Wilson, Donald/0000-0001-8918-2151	NIA NIH HHS [P50 AG005681, AG030482-03S1, K01 AG029524, R01-AG037693, R01 AG030482, R01 AG037693, P50-AG005681] Funding Source: Medline; NIDCD NIH HHS [DC003906, R01 DC003906] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005681, R01AG037693, K01AG029524, R01AG030482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chua HC, 2000, CLIN NEUROL NEUROSUR, V102, P6, DOI 10.1016/S0303-8467(99)00074-8; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; FDA, 2003, PACKAGE INSERT TARGR; FDA, 1999, DRUG APPROVAL PACKAG; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; GIRI AK, 1993, MUTAT RES, V296, P199, DOI 10.1016/0165-1110(93)90011-B; Howell SR, 2001, DRUG METAB DISPOS, V29, P990; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Mandrekar-Colucci S, 2011, EXPERT OPIN THER TAR, V15, P1085, DOI 10.1517/14728222.2011.594043; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melnikova T, 2013, J NEUROSCI, V33, P3765, DOI 10.1523/JNEUROSCI.4251-12.2013; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Saijo K, 2013, GLIA, V61, P104, DOI 10.1002/glia.22423; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505	21	63	63	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135							1234114	10.1126/science.1234114	http://dx.doi.org/10.1126/science.1234114			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704556	Green Accepted			2022-12-28	WOS:000319344100025
J	Begley, CG				Begley, C. Glenn			Six red flags for suspect work	NATURE			English	Editorial Material									TetraLog Pharmaceut, Malvern, PA USA		Begley, CG (corresponding author), TetraLog Pharmaceut, Malvern, PA USA.	cgbegley@tetralogicpharma.com						Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rossner M., 2006, SCIENTIST; Vaux DL, 2012, NATURE, V492, P180, DOI 10.1038/492180a	4	134	135	7	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					433	434		10.1038/497433a	http://dx.doi.org/10.1038/497433a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698428	Bronze			2022-12-28	WOS:000319254000024
J	Haimovich, G; Medina, DA; Causse, SZ; Garber, M; Millan-Zambrano, G; Barkai, O; Chavez, S; Perez-Ortin, JE; Darzacq, X; Choder, M				Haimovich, Gal; Medina, Daniel A.; Causse, Sebastien Z.; Garber, Manuel; Millan-Zambrano, Gonzalo; Barkai, Oren; Chavez, Sebastian; Perez-Ortin, Jose E.; Darzacq, Xavier; Choder, Mordechai			Gene Expression Is Circular: Factors for mRNA Degradation Also Foster mRNA Synthesis	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; POLYMERASE-II; GENOME-WIDE; IN-VIVO; TRANSCRIPTION ELONGATION; YEAST; DECAY; COMPLEX; TRANSLATION; CYTOPLASM	Maintaining proper mRNA levels is a key aspect in the regulation of gene expression. The balance between mRNA synthesis and decay determines these levels. We demonstrate that most yeast mRNAs are degraded by the cytoplasmic 50-to-30 pathway (the "decaysome''), as proposed previously. Unexpectedly, the level of these mRNAs is highly robust to perturbations in this major pathway because defects in various decaysome components lead to transcription downregulation. Moreover, these components shuttle between the cytoplasm and the nucleus, in a manner dependent on proper mRNA degradation. In the nucleus, they associate with chromatin-preferentially similar to 30 bp upstream of transcription start-sites-and directly stimulate transcription initiation and elongation. The nuclear role of the decaysome in transcription is linked to its cytoplasmic role in mRNA decay; linkage, in turn, seems to depend on proper shuttling of its components. The gene expression process is therefore circular, whereby the hitherto first and last stages are interconnected.	[Haimovich, Gal; Barkai, Oren; Choder, Mordechai] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel; [Medina, Daniel A.; Perez-Ortin, Jose E.] Univ Valencia, Dept Bioquim & Biol Mol, Fac Biol, E-46100 Valencia, Spain; [Medina, Daniel A.; Perez-Ortin, Jose E.] Univ Valencia, ERI Biotecmed, E-46100 Valencia, Spain; [Causse, Sebastien Z.; Darzacq, Xavier] Ecole Normale Super, CNRS, UMR 8197, IBENS,Inst Biol, F-75005 Paris, France; [Garber, Manuel] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Millan-Zambrano, Gonzalo; Chavez, Sebastian] Univ Seville, Fac Biol, Dept Genet, E-41012 Seville, Spain	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Valencia; University of Valencia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Massachusetts System; University of Massachusetts Worcester; University of Sevilla	Choder, M (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel.	choder@technion.ac.il	Chavez, Sebastian S/F-7574-2011; Pérez-Ortín, José E./K-8582-2014; Millan-Zambrano, Gonzalo/AAA-5562-2020; Haimovich, Gal/H-3316-2019; Causse, Sebastien Zwe/AAZ-7365-2021; Medina, Daniel A./AAC-8572-2019; Chávez, Sebastián/GXF-7069-2022; IBIS, GENICA/O-1906-2015	Chavez, Sebastian S/0000-0002-8064-4839; Pérez-Ortín, José E./0000-0002-1992-513X; Millan-Zambrano, Gonzalo/0000-0002-4530-6359; Haimovich, Gal/0000-0002-3360-5108; Medina, Daniel/0000-0002-8183-0043; Causse, Sebastien/0000-0003-3246-3491; Darzacq, Xavier/0000-0003-2537-8395	Israel Science Foundation [1283/07]; Ministry of Health, and Rappaport Foundation [ANR JC 0118-01]; la Ligue; Spanish MCINN; European Union ERDF [BFU2010-21975-C03-01, BFU2010-21975-C03-02]; Regional Valencian Government [GV PROMETEO/2011/088]; Junta de Andalucia [P07-CVI02623, P08-CVI-03508]; MICINN GV; EU; DARPA [D12AP00004]; Center for Excellence in Genome Science from the NHGRI [1P50HG006193]; Gruss-Lipper family postdoctoral fellowship; GV; FPU MICINN; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Ministry of Health, and Rappaport Foundation; la Ligue; Spanish MCINN(Spanish Government); European Union ERDF(European Commission); Regional Valencian Government; Junta de Andalucia(Junta de Andalucia); MICINN GV; EU(European Commission); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Center for Excellence in Genome Science from the NHGRI; Gruss-Lipper family postdoctoral fellowship; GV; FPU MICINN(Spanish Government); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Roy Parker, Tatjana Trcek-Pulisic, Daniel Larson, and Robert Singer for critically reading the manuscript. Roy Parker, Wolf Heyer, Karsten Weis, Tien-Hsien Chang, Arlen Johnson, Shay Ben-Aroya, and Daniel Kornitzer generously shared strains and plasmids. We thank Laboratorio de Chips de DNA (S.C.S.I.E., Universitat de Valencia) for the GRO and the 3'/5' macroarrays and Daniel Larson for sharing algorithms. This work was supported by Israel Science Foundation (1283/07), Ministry of Health, and Rappaport Foundation (to M.C.), ANR JC 0118-01 and la Ligue (to X.D.), the Spanish MCINN and European Union ERDF (BFU2010-21975-C03-01 and BFU2010-21975-C03-02) to J.E.P.-O. and S.C., respectively, and the Regional Valencian Government (GV PROMETEO/2011/088) (to J.E.P.-O.) and from Junta de Andalucia (JA grants P07-CVI02623 and P08-CVI-03508) to S.C., MICINN GV and JA grants involve EDRF resources from the EU. DARPA D12AP00004 and Center for Excellence in Genome Science from the NHGRI 1P50HG006193 to M.G. G.H. is currently a recipient of the Gruss-Lipper family postdoctoral fellowship. D.A.M. is a recipient of a Santiago Grisolia fellowship from GV. G.M.-Z. is a recipient of a FPU MICINN fellowship. G.H. and M.C. conceived the main hypothesis. G.H. constructed strains and plasmids and performed and analyzed the transcription, decay and tethering experiments, shuttling assays, proliferation assays, and PBs analysis. S.Z.C. and X.D. designed, performed and analyzed the FISH experiments. D.A.M. and J.E.P.-O. designed, performed, and analyzed the GRO, RPCC and thiolutin shut-off experiments. G.H. and O.B. designed, performed, and analyzed the ChIP-TAP. G.Z.M and S.C. contributed to design 5'/3' GRO and RPCC experiments. G.Z.M. and S.C. designed, performed, and analyzed the Pol II and phosphoser-2 ChIP of GAL1 in glucose and galactose. M.G. and M.C. analyzed the ChIP-exo data. G.H. and M.C. wrote the manuscript. J.E.P.-O. and S.C. critically read and edited the manuscript. M.C. coordinated the project.	Alberola TM, 2004, INT MICROBIOL, V7, P199; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Badis G, 2004, MOL CELL, V15, P5, DOI 10.1016/j.molcel.2004.06.028; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Dahan N, 2013, BBA-GENE REGUL MECH, V1829, P169, DOI 10.1016/j.bbagrm.2012.08.004; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Esberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020829; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garcia-Martinez J, 2011, METHODS MOL BIOL, V734, P25, DOI 10.1007/978-1-61779-086-7_2; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Gomez-Herreros F, 2012, NUCLEIC ACIDS RES, V40, P6508, DOI 10.1093/nar/gks340; Haimovich G, 2013, BBA-GENE REGUL MECH, V1829, P643, DOI 10.1016/j.bbagrm.2013.01.004; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Morillo-Huesca M, 2006, FEBS J, V273, P756, DOI 10.1111/j.1742-4658.2005.05108.x; Muhlrad D, 2005, EMBO J, V24, P1033, DOI 10.1038/sj.emboj.7600560; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Page AM, 1998, NUCLEIC ACIDS RES, V26, P3707, DOI 10.1093/nar/26.16.3707; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pelechano V, 2008, YEAST, V25, P85, DOI 10.1002/yea.1548; Pelechano V, 2010, YEAST, V27, P413, DOI 10.1002/yea.1768; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Perez-Ortin JE, 2013, J MOL BIOL, V425, P3750, DOI 10.1016/j.jmb.2013.02.029; Perez-Ortin JE, 2012, BBA-GENE REGUL MECH, V1819, P604, DOI 10.1016/j.bbagrm.2011.12.002; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Solinger JA, 1999, MOL CELL BIOL, V19, P5930; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Thompson NL, 2002, CURR OPIN STRUC BIOL, V12, P634, DOI 10.1016/S0959-440X(02)00368-8; Titz B, 2006, NUCLEIC ACIDS RES, V34, P955, DOI 10.1093/nar/gkj493; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	57	224	225	7	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1000	1011		10.1016/j.cell.2013.05.012	http://dx.doi.org/10.1016/j.cell.2013.05.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706738	Green Submitted, Bronze			2022-12-28	WOS:000319456800009
J	Libby, P				Libby, Peter			Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROMOTES COLLAGEN ACCUMULATION; OPTICAL COHERENCE TOMOGRAPHY; TISSUE FACTOR EXPRESSION; FIBROUS-CAP THICKNESS; ATHEROSCLEROTIC PLAQUES; MYOCARDIAL-INFARCTION; MATRIX METALLOPROTEINASES; CARDIOVASCULAR EVENTS; MONOCLONAL-ANTIBODY; CULPRIT LESIONS		Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Libby, P (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X				ACCORD Stud Group, 2010, NEW ENGL J MED, V1362, P1748; Aikawa M, 1999, CIRCULATION, V100, P1215, DOI 10.1161/01.CIR.100.11.1215; Aikawa M, 1998, CIRCULATION, V97, P2433, DOI 10.1161/01.CIR.97.24.2433; Aikawa M, 2001, CIRCULATION, V103, P276; AIM- HIGH Investigators, 2012, NEW ENGL J MED, V367, P189; AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; [Anonymous], TREATM HDL RED INC V; Arbab-Zadeh A, 2012, CIRCULATION, V125, P1147, DOI 10.1161/CIRCULATIONAHA.111.047431; ARMSTRONG ML, 1972, CIRC RES, V30, P675, DOI 10.1161/01.RES.30.6.675; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Braunwald E, 2013, JACC-CARDIOVASC IMAG, V6, P288, DOI 10.1016/j.jcmg.2013.01.003; Chatzizisis YS, 2011, CIRCULATION, V123, P621, DOI 10.1161/CIRCULATIONAHA.110.970038; CLARKSON TB, 1994, JAMA-J AM MED ASSOC, V271, P289, DOI 10.1001/jama.271.4.289; Crea F, 2013, J AM COLL CARDIOL, V61, P1, DOI 10.1016/j.jacc.2012.07.064; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Fukumoto Y, 2004, CIRCULATION, V110, P1953, DOI 10.1161/01.CIR.0000143174.41810.10; Fukumoto Y, 2001, CIRCULATION, V103, P993; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Hattori K, 2012, JACC-CARDIOVASC IMAG, V5, P169, DOI 10.1016/j.jcmg.2011.11.012; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Hoffmann U, 2006, J AM COLL CARDIOL, V47, P1655, DOI 10.1016/j.jacc.2006.01.041; Holmes DR, 2013, JACC-CARDIOVASC IMAG, V6, P290, DOI 10.1016/j.jcmg.2013.01.005; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Koskinas KC, ARTERIOSCLER THROMB, V2; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Libby P, 2008, J INTERN MED, V263, P517, DOI 10.1111/j.1365-2796.2008.01965.x; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Libby P, 2003, NAT MED, V9, P146, DOI 10.1038/nm0103-146b; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Mach F, 1997, CIRCULATION, V96, P396; Maldonado N, 2012, AM J PHYSIOL-HEART C, V303, pH619, DOI 10.1152/ajpheart.00036.2012; Morishige K, 2010, CIRCULATION, V122, P1707, DOI 10.1161/CIRCULATIONAHA.109.891804; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Nakamura T, 2008, J CARDIOVASC PHARM, V51, P365, DOI 10.1097/FJC.0b013e318165dcad; Narula J, 2008, NAT CLIN PRACT CARD, V5, pS2, DOI 10.1038/ncpcardio1247; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Nidorf SM, 2013, J AM COLL CARDIOL, V61, P404, DOI 10.1016/j.jacc.2012.10.027; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Ohayon J, 2008, AM J PHYSIOL-HEART C, V295, pH717, DOI 10.1152/ajpheart.00005.2008; Ozaki Y, 2011, EUR HEART J, V32, P2814, DOI 10.1093/eurheartj/ehr189; Quillard T, 2011, ARTERIOSCL THROM VAS, V31, P2464, DOI 10.1161/ATVBAHA.111.231563; Rajavashisth TB, 1999, J BIOL CHEM, V274, P11924, DOI 10.1074/jbc.274.17.11924; REKHTER MD, 1993, AM J PATHOL, V143, P1634; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2009, J THROMB HAEMOST, V7, P332, DOI 10.1111/j.1538-7836.2009.03404.x; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Schoenhagen P, 2003, ARTERIOSCL THROM VAS, V23, P1895, DOI 10.1161/01.ATV.0000084811.73196.1C; Schonbeck U, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000129505.34151.23; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; SHAH PK, 1995, CIRCULATION, V92, P1565; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Stone GW, 2011, NEW ENGL J MED, V365, P2040; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Sugiyama S, 2004, ARTERIOSCL THROM VAS, V24, P1309, DOI 10.1161/01.ATV.0000131784.50633.4f; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Takarada S, 2009, ATHEROSCLEROSIS, V202, P491, DOI 10.1016/j.atherosclerosis.2008.05.014; Tang TY, 2009, J AM COLL CARDIOL, V53, P2039, DOI 10.1016/j.jacc.2009.03.018; Watanabe K, 2005, J AM COLL CARDIOL, V46, P2022, DOI 10.1016/j.jacc.2005.04.070; White H, 2010, AM HEART J, V160, P655, DOI 10.1016/j.ahj.2010.07.006; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839; Yonetsu T, 2011, EUR HEART J, V32, P1251, DOI 10.1093/eurheartj/ehq518; Zhao XQ, 2011, JACC-CARDIOVASC IMAG, V4, P977, DOI 10.1016/j.jcmg.2011.06.013	79	710	761	9	133	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					2004	2013		10.1056/NEJMra1216063	http://dx.doi.org/10.1056/NEJMra1216063			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148TJ	23697515				2022-12-28	WOS:000319270200002
J	Gornall, J				Gornall, Jonathan			DSM-5: a fatal diagnosis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						American Psychiatric Association, DSM 5 FIELD TRIALS; American Psychiatric Association, DSM HIST MAN; American Psychological Association, 2012, TRANS ICD 10 CM WHAT; [Anonymous], 2012, OP LETT COMM CALLS S; [Anonymous], 2013, HIGHLIGHTS CHANGES D; [Anonymous], 2007, BBC; Brauser D., 2013, MEDSCAPE; Frances A., 2012, PSYCHOL TODAY; Frances A., DSM5 DISTRESS; Frances A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1580; Gellene D., 2008, LOS ANGELES TIMES; Greenberg, 2013, BOOK WOE DSM UNMAKIN; Harris Gardiner, 2008, NY TIMES; Insel T., 2013, NIMH DIRECTORS BLOG; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Kendler KS, GRIEF EXCLUSION CRIT; Kirk S., 1999, MAKING US CRAZY DSM; Naughton Philippe, 2006, TIMES; Pereira J, 2008, WALL STREET J; Rensberger B., 1973, NY TIMES; Watts G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1020; Whoriskey P, 2012, WASHINGTON POST; World Health Organization, INT CLASS DIS INF SH	23	12	14	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2013	346								f3256	10.1136/bmj.f3256	http://dx.doi.org/10.1136/bmj.f3256			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AV	23697831				2022-12-28	WOS:000319574400021
J	Marcum, ZA; Sevick, MA; Handler, SM				Marcum, Zachary A.; Sevick, Mary Ann; Handler, Steven M.			Medication Nonadherence A Diagnosable and Treatable Medical Condition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADHERENCE		[Marcum, Zachary A.; Handler, Steven M.] Univ Pittsburgh, Sch Med, Div Geriatr Med, Pittsburgh, PA 15213 USA; [Handler, Steven M.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15213 USA; [Sevick, Mary Ann] Univ Pittsburgh, Sch Med, Dept Gen Internal Med, Pittsburgh, PA 15213 USA; [Sevick, Mary Ann] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Marcum, ZA (corresponding author), Univ Pittsburgh, Sch Med, Div Geriatr Med, 3471 5th Ave,Ste 500, Pittsburgh, PA 15213 USA.	zam12@pitt.edu	Sevick, Mary/V-6503-2019	Handler, Steven/0000-0002-3940-3224	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K24NR012226, R01NR010135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K07AG033174, P30AG024827] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS018721, R01HS018721] Funding Source: Medline; NIA NIH HHS [K07 AG033174, P30 AG024827, P30AG024827, K07AG033174] Funding Source: Medline; NIDDK NIH HHS [R01 DK100492, R01-DK100492] Funding Source: Medline; NINR NIH HHS [K24-NR012226, 2R01-NR010135, K24 NR012226, R01 NR010135] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Anderson Kitty, 2008, Consult Pharm, V23, P459, DOI 10.4140/TCP.n.2008.459; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; McHorney CA, 2009, CURR MED RES OPIN, V25, P215, DOI 10.1185/03007990802619425 ; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538	7	124	124	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2105	2106		10.1001/jama.2013.4638	http://dx.doi.org/10.1001/jama.2013.4638			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23695479	Green Accepted			2022-12-28	WOS:000319229600024
J	Wake, S; Kitchiner, D				Wake, Sarah; Kitchiner, Deborah			Post-traumatic stress disorder after intensive care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wake, Sarah] Univ Wales Hosp, Cardiff CF14 4XW, S Glam, Wales; [Kitchiner, Deborah] CBT Cardiff, Cardiff, S Glam, Wales	Cardiff University	Wake, S (corresponding author), Univ Wales Hosp, Cardiff CF14 4XW, S Glam, Wales.	sarah.wake@doctors.org.uk							0	10	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2013	346								f3232	10.1136/bmj.f3232	http://dx.doi.org/10.1136/bmj.f3232			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AV	23697673	Bronze			2022-12-28	WOS:000319574400020
J	Davies, E				Davies, Edward			Can Big Pharma put patients first?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Avorn J, 2013, JAMA-J AM MED ASSOC, V309, P1349, DOI 10.1001/jama.2013.623; Roehr B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4568; Silverman E, 2013, PHARMALOT	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3285	10.1136/bmj.f3285	http://dx.doi.org/10.1136/bmj.f3285			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23694747				2022-12-28	WOS:000319573300012
J	Kao, D; Bartelson, BB; Khatri, V; Dart, R; Mehler, PS; Katz, D; Krantz, MJ				Kao, David; Bartelson, Becki Bucher; Khatri, Vaishali; Dart, Richard; Mehler, Philip S.; Katz, David; Krantz, Mori J.			Trends in Reporting Methadone-Associated Cardiac Arrhythmia, 1997-2011 An Analysis of Registry Data	ANNALS OF INTERNAL MEDICINE			English	Article							TORSADE-DE-POINTES; DATA-MINING ALGORITHMS; PHARMACOVIGILANCE DATABASES; QT PROLONGATION; LONG QT; OVERDOSE; INTERVAL; MAINTENANCE; RISK; SERTINDOLE	Background: Long-acting opioids are a leading cause of accidental death in the United States, and methadone is associated with greater mortality rates. Whether this increase is related to the proarrhythmic properties of methadone is unclear. Objective: To describe methadone-associated arrhythmia events reported in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Design: Description of national adverse event registry data before and after publication of a 2002 report describing an association between methadone and arrhythmia. Setting: FAERS, November 1997 and June 2011. Patients: Adults with QTc prolongation or torsade de pointes and ventricular arrhythmia or cardiac arrest. Measurements: FAERS reports before and after the 2002 report. Results: 1646 cases of ventricular arrhythmia or cardiac arrest and 379 cases of QTc prolongation or torsade de pointes were associated with methadone. Monthly reports of QTc prolongation or torsade de pointes increased from a mean of 0.3 (95% CI, 0.1 to 0.5) before the 2002 publication to a mean of 3.5 (CI, 2.5 to 4.8) after it. After 2000, methadone was the second-most common primary suspect in cases of QTc prolongation or torsade de pointes after dofetilide (a known proarrhythmic drug) and was associated with disproportionate reporting similar to that of antiarrhythmic agents known to promote torsade de pointes. Antiretroviral drugs for HIV were the most common coadministered drugs. Limitation: Reports to FAERs are voluntary and selective, and incidence rates cannot be determined from spontaneously reported data. Conclusion: Since 2002, reports to FAERS of methadone-associated arrhythmia have increased substantially and are disproportionately represented relative to other events with the drug. Coadministration of methadone with antiretrovirals in patients with HIV may pose particular risk.	Univ Colorado, Sch Med, Aurora, CO 80045 USA; Colorado Prevent Ctr Community Hlth, Aurora, CO USA; Rocky Mt Poison & Drug Ctr, Denver, CO 80204 USA; Denver Hlth, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Krantz, MJ (corresponding author), Denver Hlth Med Ctr, 777 Bannock St,MC 0960, Denver, CO 80204 USA.	mori.krantz@dhha.org	Kao, David P/K-3288-2013	Kao, David P/0000-0002-2832-9348; Dart, Richard/0000-0001-5989-9354	Colorado Clinical and Translational Sciences Institute; National Institutes of Health [2 T32 HL007822-12]; Leaffer family; University of Colorado Center for Women's Health Research; Agency for Healthcare Research and Quality [1 P01 HS021138-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS021138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007822] Funding Source: NIH RePORTER	Colorado Clinical and Translational Sciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leaffer family; University of Colorado Center for Women's Health Research; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: Data management and statistical analysis was supported by the Colorado Clinical and Translational Sciences Institute. Dr. Kao is supported by the National Institutes of Health (grant 2 T32 HL007822-12), a grant from the Leaffer family, and the University of Colorado Center for Women's Health Research. Dr. Krantz is partially supported by the Agency for Healthcare Research and Quality (grant 1 P01 HS021138-01).	Alvarez Y, 2010, DRUG SAFETY, V33, P475, DOI 10.2165/11534410-000000000-00000; [Anonymous], 2010, BET SOT HCI PACK INS; [Anonymous], DRUGS FDA DAT FIL; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Castillo R, 2002, ANN PHARMACOTHER, V36, P1006; Chugh SS, 2008, AM J MED, V121, P66, DOI 10.1016/j.amjmed.2007.10.009; Cruciani RA, 2008, J PAIN SYMPTOM MANAG, V36, P545, DOI 10.1016/j.jpainsymman.2007.11.003; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; Falconer M, 2007, Ir Med J, V100, P631; Florian J, 2012, CLIN PHARMACOL THER, V91, P666, DOI 10.1038/clpt.2011.273; Food And Drug Administration Public Health Service U S Department Of Health And Human Services, 2011, J Pain Palliat Care Pharmacother, V25, P80, DOI 10.3109/15360288.2010.549553; Gourevitch MN, 2009, ANN INTERN MED, V150, P417, DOI 10.7326/0003-4819-150-6-200903170-00111; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Hauben M, 2007, DRUG SAFETY, V30, P143, DOI 10.2165/00002018-200730020-00004; Hillebrand J, 2001, J SUBST ABUSE TREAT, V21, P155, DOI 10.1016/S0740-5472(01)00198-2; Johnson K, 2012, BIOINFORMATICS, V28, P3123, DOI 10.1093/bioinformatics/bts576; Kao DP, 2012, PHARMACOTHERAPY, V32, P767, DOI 10.1002/j.1875-9114.2012.01118.x; Katchman AN, 2002, J PHARMACOL EXP THER, V303, P688, DOI 10.1124/jpet.102.038240; Kocheril AG, 1997, PACE, V20, P2810, DOI 10.1111/j.1540-8159.1997.tb05439.x; Krantz MJ, 2005, J ADDICT DIS, V24, P53, DOI 10.1300/J069v24n01_05; Krantz MJ, 2002, ANN INTERN MED, V137, P501, DOI 10.7326/0003-4819-137-6-200209170-00010; Krantz MJ, 2007, J ADDICT DIS, V26, P79, DOI 10.1300/J069v26n04_10; Krantz MJ, 2009, ANN INTERN MED, V150, P387, DOI 10.7326/0003-4819-150-6-200903170-00103; Martin JA, 2011, J ADDICT DIS, V30, P283, DOI 10.1080/10550887.2011.610710; McAdams M, 2008, PHARMACOEPIDEM DR S, V17, P229, DOI 10.1002/pds.1535; Moore N, 2003, PHARMACOEPIDEM DR S, V12, P271, DOI 10.1002/pds.848; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Paulozzi Leonard J., 2012, Morbidity and Mortality Weekly Report, V61, P493; Paulozzi LJ, 2009, ADDICTION, V104, P1541, DOI 10.1111/j.1360-0443.2009.02650.x; Pearson RK, 2009, INT J MED INFORM, V78, pE97, DOI 10.1016/j.ijmedinf.2009.01.001; Reinsch N, 2009, HIV CLIN TRIALS, V10, P261, DOI 10.1310/hct1004-261; Riera Andres Ricardo Perez, 2008, Cardiol J, V15, P209; Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics, 2010, JOINT M AN LIF SUPP; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; Roxane Laboratories, 2006, DOL HYDR PACK INS; Sani Mahmoud U, 2005, J Natl Med Assoc, V97, P1657; Starrels JL, 2011, J GEN INTERN MED, V26, P958, DOI 10.1007/s11606-011-1648-2; Tseng ZH, 2012, J AM COLL CARDIOL, V59, P1891, DOI 10.1016/j.jacc.2012.02.024; U.S. Food and Drug Administration, 2012, MEDWATCH ONL VOL REP; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2012, FD ADV EV REP SYST A; Viskin S, 2005, HEART RHYTHM, V2, P569, DOI 10.1016/j.hrthm.2005.02.011; Von Korff M, 2011, ANN INTERN MED, V155, P325, DOI 10.7326/0003-4819-155-5-201109060-00011; Waller P, 2003, PHARMACOEPIDEM DR S, V12, P283, DOI 10.1002/pds.849; Warner Margaret, 2011, NCHS Data Brief, P1; Wedam EF, 2007, ARCH INTERN MED, V167, P2469, DOI 10.1001/archinte.167.22.2469; World Health Organization, WHO MOD LISTS ESS ME	46	39	39	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					735	+		10.7326/0003-4819-158-10-201305210-00008	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689766	Green Accepted			2022-12-28	WOS:000319666200016
J	Lazic, SE				Lazic, Stanley E.			Comment on "Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice"	SCIENCE			English	Editorial Material									Novartis Inst Biomed Res, Basel, Switzerland	Novartis	Lazic, SE (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	stan.lazic@cantab.net						BOX G.E.P., 2005, STAT EXPT DESIGN INN; Casella G., 2008, STAT DESIGN; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; International Conference on Harmonisation, 2000, S5R2 INT C HARM, VS5; Janky DG, 2000, AM STAT, V54, P269, DOI 10.2307/2685778; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lazic SE, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-37; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; Mead R, 2012, CA ST PR MA, P1, DOI 10.1017/CBO9781139020879; OECD, 2007, TEST 225 SED WAT LUM, DOI 10.1787/9789264067356-en	10	7	10	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134								10.1126/science.1237793	http://dx.doi.org/10.1126/science.1237793			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687029				2022-12-28	WOS:000318997400021
J	Lima, S; Guo, MS; Chaba, R; Gross, CA; Sauer, RT				Lima, Santiago; Guo, Monica S.; Chaba, Rachna; Gross, Carol A.; Sauer, Robert T.			Dual Molecular Signals Mediate the Bacterial Response to Outer-Membrane Stress	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; LIPOPOLYSACCHARIDE EXPORT; CRYSTAL-STRUCTURE; PEPTIDE SIGNALS; ENVELOPE; PROTEIN; SIGMA(E); DEGS; COMPLEX; RSEB	In Gram-negative bacteria, outer-membrane integrity is essential for survival and is monitored by the sigma(E) stress-response system, which initiates damage-repair pathways. One activating signal is unassembled outer-membrane proteins. Using biochemical and genetic experiments in Escherichia coli, we found that off-pathway intermediates in lipopolysaccharide transport and assembly provided an additional required signal. These distinct signals, arising from disruptions in the transport and assembly of the major outer-membrane components, jointly determined the rate of proteolytic destruction of a negative regulator of the sigma(E) transcription factor, thereby modulating the expression of stress-response genes. This dual-signal system permits a rapid response to dysfunction in outer-membrane biogenesis, while buffering responses to transient fluctuations in individual components, and may represent a broad strategy for bacteria to monitor their interface with the environment.	[Lima, Santiago; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Guo, Monica S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Chaba, Rachna; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399; Guo, Monica/0000-0002-6720-2323	NIH [AI-16892, GM-36278, AI-084442]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892, F32AI084442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036278, R01GM036278] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Cezairliyan, S. Chng, D. Kahne, C. Raetz, and D. Six for discussions and strains. Supported by NIH grants AI-16892 and GM-36278. S. L. was supported by an NIH postdoctoral fellowship (AI-084442). The data reported in this paper are presented in the main text and supplementary materials.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x; AMES GF, 1974, J BACTERIOL, V117, P406, DOI 10.1128/JB.117.2.406-416.1974; AUSTIN EA, 1990, J BACTERIOL, V172, P5312, DOI 10.1128/jb.172.9.5312-5325.1990; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Cezairliyan BO, 2009, MOL MICROBIOL, V72, P368, DOI 10.1111/j.1365-2958.2009.06654.x; Chaba R, 2011, P NATL ACAD SCI USA, V108, P2106, DOI 10.1073/pnas.1019277108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4	25	123	128	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					837	841		10.1126/science.1235358	http://dx.doi.org/10.1126/science.1235358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687042	Green Submitted, Green Accepted			2022-12-28	WOS:000318997400037
J	Remuzzi, G; Benigni, A; Finkelstein, FO; Grunfeld, JP; Joly, D; Katz, I; Liu, ZH; Miyata, T; Perico, N; Rodriguez-Iturbe, B; Antiga, L; Schaefer, F; Schieppati, A; Schrier, RW; Tonelli, M				Remuzzi, Giuseppe; Benigni, Ariela; Finkelstein, Fredric O.; Grunfeld, Jean-Pierre; Joly, Dominique; Katz, Ivor; Liu, Zhi-Hong; Miyata, Toshio; Perico, Norberto; Rodriguez-Iturbe, Bernardo; Antiga, Luca; Schaefer, Franz; Schieppati, Arrigo; Schrier, Robert W.; Tonelli, Marcello			Kidney failure: aims for the next 10 years and barriers to success	LANCET			English	Article							ACUTE PERITONEAL-DIALYSIS; MESENCHYMAL STEM-CELLS; RENAL-DISEASE; CARDIOVASCULAR-DISEASE; DEVELOPING-COUNTRIES; COST-EFFECTIVENESS; PROGENITOR CELLS; DRUG DISCOVERY; BRAIN-DRAIN; HEALTH	Although in some parts of the world acute and chronic kidney diseases are preventable or treatable disorders, in many other regions these diseases are left without any care. The nephrology community needs to commit itself to reduction of this divide between high-income and low-income regions. Moreover, new and exciting developments in fields such as pharmacology, genetic, or bioengineering, can give a boost, in the next decade, to a new era of diagnosis and treatment of kidney diseases, which should be made available to more patients.	[Remuzzi, Giuseppe; Benigni, Ariela; Perico, Norberto; Schieppati, Arrigo] Ist Ric Farmacol Mario Negri, IRCCS, I-24126 Bergamo, Italy; [Finkelstein, Fredric O.] Yale Univ, New Haven, CT USA; [Grunfeld, Jean-Pierre; Joly, Dominique] Hop Necker Enfants Malad, Paris, France; [Katz, Ivor] St George Hosp, Dept Renal Med, Sydney, Vic, Australia; [Liu, Zhi-Hong] Nanjing Univ Med, Jinling Hosp, Nanjing, Jiangsu, Peoples R China; [Miyata, Toshio] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Rodriguez-Iturbe, Bernardo] Univ Hosp, Maracaibo, Venezuela; [Rodriguez-Iturbe, Bernardo] Univ Zulia, Maracaibo 4011, Venezuela; [Antiga, Luca] Orobix Srl, Bergamo, Italy; [Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Pediat Nephrol Div, D-69115 Heidelberg, Germany; [Schrier, Robert W.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; St George Hospital; Tohoku University; Ruprecht Karls University Heidelberg; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alberta	Remuzzi, G (corresponding author), Ist Ric Farmacol Mario Negri, IRCCS, Ctr Anna Maria Astori, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Ariela, Benigni/ABH-3492-2020; Tonelli, Marcello/B-3028-2009; Perico, Norberto/ABH-3222-2020; Liu, Zhihong/ABB-6918-2021; Miyata, Toshio/A-4872-2010; Remuzzi, Giuseppe/V-9766-2017	Ariela, Benigni/0000-0002-4721-5485; Tonelli, Marcello/0000-0002-0846-3187; Perico, Norberto/0000-0002-3147-4327; Liu, Zhihong/0000-0001-6093-0726; Remuzzi, Giuseppe/0000-0002-6194-3446				Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Baxter K, 2011, GENET TEST MOL BIOMA, V15, P465, DOI 10.1089/gtmb.2011.1522; Bayliss EA, 2011, CLIN J AM SOC NEPHRO, V6, P704, DOI 10.2215/CJN.06610810; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Benigni A, 2011, AM J PATHOL, V179, P628, DOI 10.1016/j.ajpath.2011.04.003; Benigni A, 2010, LANCET, V375, P1310, DOI 10.1016/S0140-6736(10)60237-1; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Boulware LE, 2003, JAMA-J AM MED ASSOC, V290, P3101, DOI 10.1001/jama.290.23.3101; Braun MM, 2010, NAT REV DRUG DISCOV, V9, P519, DOI 10.1038/nrd3160; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Callegari JG, 2012, KIDNEY INT, V81, P331, DOI 10.1038/ki.2011.408; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Chionh CY, 2010, NEPHROL DIAL TRANSPL, V25, P3155, DOI 10.1093/ndt/gfq178; Cravedi P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001357; de Jong PE, 2006, J AM SOC NEPHROL, V17, P2120, DOI 10.1681/ASN.2006010097; Devins GM, 2003, AM J KIDNEY DIS, V42, P693, DOI 10.1016/S0272-6386(03)00835-7; Dodani S, 2005, J ROY SOC MED, V98, P487, DOI 10.1258/jrsm.98.11.487; Eggers PW, 2011, CURR OPIN NEPHROL HY, V20, P241, DOI 10.1097/MNH.0b013e3283454319; Eggers PW, 2004, J AM SOC NEPHROL, V15, P2477, DOI 10.1097/01.ASN.0000138546.53152.A7; El-Ghoul B, 2009, J AM GERIATR SOC, V57, P2217, DOI 10.1111/j.1532-5415.2009.02561.x; Epping-Jordan JE, 2005, KIDNEY INT, V68, pS86, DOI 10.1111/j.1523-1755.2005.09816.x; Fabian J, 2009, NAT REV NEPHROL, V5, P591, DOI 10.1038/nrneph.2009.141; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; George J, 2011, PERITON DIALYSIS INT, V31, P422, DOI 10.3747/pdi.2009.00231; Guindon GE, 2010, CAN MED ASSOC J, V182, pE362, DOI 10.1503/cmaj.081165; Halim N, 2011, HEALTH POLICY PLANN, V26, P242, DOI 10.1093/heapol/czq040; Hallan SI, 2010, J NEPHROL, V23, P147; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; He JC, 2012, KIDNEY INT, V81, P22, DOI 10.1038/ki.2011.314; Hoerger TJ, 2012, J AM SOC NEPHROL, V23, P2035, DOI 10.1681/ASN.2012040347; Hossain MP, 2009, AM J KIDNEY DIS, V53, P166, DOI 10.1053/j.ajkd.2007.10.047; Imai E, 2007, CLIN J AM SOC NEPHRO, V2, P1360, DOI 10.2215/CJN.00980207; International Society of Nephrology, GLOB OUTR PROGR; Iredale R., TACKLING ROOTS BRAIN; JHA V, 1992, Q J MED, V83, P497; Karara AH, 2010, J CLIN PHARMACOL, V50, P380, DOI 10.1177/0091270009344987; Katz IJ, 2006, BLOOD PURIFICAT, V24, P115, DOI 10.1159/000089447; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Keller BJ, 2012, KIDNEY INT, V81, P14, DOI 10.1038/ki.2011.359; Kilonzo KG, 2012, PERITON DIALYSIS INT, V32, P261, DOI 10.3747/pdi.2012.00083; Kimmelman J, 2007, J LAW MED ETHICS, V35, P727, DOI 10.1111/j.1748-720X.2007.00194.x; Klein JD, 2010, HEALTH AFFAIR, V29, P388, DOI 10.1377/hlthaff.2009.0736; Kretzler M, 2010, SEMIN NEPHROL, V30, P439, DOI 10.1016/j.semnephrol.2010.07.001; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Li JH, 2007, STEM CELLS, V25, P697, DOI 10.1634/stemcells.2006-0133; Luyckx VA, 2013, LANCET; Luyckx VA, 2010, J AM SOC NEPHROL, V21, P898, DOI 10.1681/ASN.2009121248; Macconi D, 2009, AM J PATHOL, V174, P797, DOI 10.2353/ajpath.2009.080227; Manns Braden, 2010, BMJ, V341, pc5869, DOI 10.1136/bmj.c5869; Martineau T, 2004, HEALTH POLICY, V70, P1, DOI 10.1016/j.healthpol.2004.01.006; Miyata T, 2011, NAT REV NEPHROL, V7, P469, DOI 10.1038/nrneph.2011.84; Mohammadi NK, 2011, IRAN J PUBLIC HEALTH, V40, P129; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Mudur G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3143; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Najar M Saleem, 2008, Indian J Nephrol, V18, P159, DOI 10.4103/0971-4065.45291; Norback D, 2009, CURR OPIN ALLERGY CL, V9, P55, DOI 10.1097/ACI.0b013e32831f8f08; Perico N, 2005, KIDNEY INT, V68, pS95, DOI 10.1111/j.1523-1755.2005.09716.x; Perico N, 2009, NEPHROL DIAL TRANSPL, V24, P1355, DOI 10.1093/ndt/gfp039; Plata R, 1998, NEPHROL DIAL TRANSPL, V13, P3034, DOI 10.1093/ndt/13.12.3034; Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976; Prakash J, 2010, RENAL FAILURE, V32, P309, DOI 10.3109/08860221003606265; Raffle AE, 2007, SCREENING EVIDENCE P, P288; RAVNSKOV U, 1979, ACTA MED SCAND, V205, P575; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P556, DOI 10.1093/ndt/gfm839; Rodriguez-Iturbe B, 2010, EXPERT OPIN PHARMACO, V11, P2687, DOI 10.1517/14656561003796570; Ronco C, 2012, PEDIATR NEPHROL, V27, P1203, DOI 10.1007/s00467-012-2179-8; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Rucker D, 2011, KIDNEY INT, V79, P210, DOI 10.1038/ki.2010.376; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Senior PA, 2008, AM J KIDNEY DIS, V51, P425, DOI 10.1053/j.ajkd.2007.11.012; Sharma SK, 2010, AM J KIDNEY DIS, V56, P915, DOI 10.1053/j.ajkd.2010.06.022; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Szczech LA, 2007, AIDS, V21, P1003, DOI 10.1097/QAD.0b013e3280d3587f; Tang KC, 2005, 6 GLOB C HLTH PROM, P10; Thanamayooran S, 2005, NEPHROL DIAL TRANSPL, V20, P2385, DOI 10.1093/ndt/gfi024; Thompson JEB, 2007, JOGNN-J OBST GYN NEO, V36, P523, DOI [10.1111/j.1552-6909.2007.00184.x, 10.1111/J.1552-6909.2007.00184.x]; Thorsteinsdottir H, 2010, NAT BIOTECHNOL, V28, P407, DOI 10.1038/nbt0510-407; US FDA, CDER APPR TIM PRIOR; Vijayan A, 2012, AM J KIDNEY DIS, V59, P569, DOI 10.1053/j.ajkd.2011.11.035; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; WHO, WORLD HLTH STAT 2011; Wilson JMG, 1968, PUBLIC HLTH PAPERS; World Health Organization, GLOB STAT REP NONC D; Wu IW, 2009, NEPHROL DIAL TRANSPL, V24, P3426, DOI 10.1093/ndt/gfp259; Xinaris C, 2013, CELL TRANSPLANT, V22, P423, DOI 10.3727/096368912X653246; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Yeates K, 2012, PERITON DIALYSIS INT, V32, P238, DOI 10.3747/pdi.2012.00073; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023	101	44	50	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					353	362		10.1016/S0140-6736(13)60438-9	http://dx.doi.org/10.1016/S0140-6736(13)60438-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FT	23727164				2022-12-28	WOS:000322544900033
J	Donovan, L; Hartling, L; Muise, M; Guthrie, A; Vandermeer, B; Dryden, DM				Donovan, Lois; Hartling, Lisa; Muise, Melanie; Guthrie, Alyssa; Vandermeer, Ben; Dryden, Donna M.			Screening Tests for Gestational Diabetes: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							FASTING PLASMA-GLUCOSE; HIGH-RISK POPULATION; CHALLENGE TEST; TOLERANCE TEST; DIAGNOSTIC-CRITERIA; MELLITUS; PREGNANCY; HYPERGLYCEMIA; SENSITIVITY; PREVALENCE	Background: A 50-g oral glucose challenge test (OGCT) is a widely accepted screening method for gestational diabetes mellitus (GDM), but other options are being considered. Purpose: To systematically review the test characteristics of various screening methods for GDM across a range of recommended diagnostic glucose thresholds. Data Sources: 15 electronic databases from 1995 to May 2012, reference lists, Web sites of relevant organizations, and gray literature. Study Selection: Two reviewers independently identified English-language prospective studies that compared any screening test for GDM with any reference standard. Data Extraction: One reviewer extracted and a second reviewer verified data from 51 cohort studies. Two reviewers independently assessed methodological quality. Data Synthesis: The sensitivity, specificity, and positive and negative likelihood ratios for the OGCT at a threshold of 7.8 mmol/L (140 mg/dL) were 70% to 88%, 69% to 89%, 2.6 to 6.5, and 0.16 to 0.33, respectively. At a threshold of 7.2 mmol/L (130 mg/dL), the test characteristics were 88% to 99%, 66% to 77%, 2.7 to 4.2, and 0.02 to 0.14, respectively. For a fasting plasma glucose threshold of 4.7 mmol/L (85 mg/dL), they were 87%, 52%, 1.8, and 0.25, respectively. Glycated hemoglobin level had poorer test characteristics than fasting plasma glucose level or the OGCT. No studies compared the OGCT with International Association of the Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria. Limitations: The lack of a gold standard for confirming GDM limits comparisons. Few data exist for screening tests before 24 weeks' gestation. Conclusion: The OGCT and fasting plasma glucose level (at a threshold of 4.7 mmol/L [85 mg/dL]) by 24 weeks' gestation are good at identifying women who do not have GDM. The OGCT is better at identifying women who have GDM. The OGCT has not been validated for the IADPSG diagnostic criteria.	Univ Calgary, Calgary, AB, Canada; Univ Alberta, Edmonton, AB, Canada	University of Calgary; University of Alberta	Donovan, L (corresponding author), Richmond Rd Diagnost & Treatment Ctr, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.	lois.donovan@albertahealthservices.ca			Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.	Agarwal MM, 2006, DIABETIC MED, V23, P1319, DOI 10.1111/j.1464-5491.2006.01987.x; Agarwal MM, 2005, ACTA OBSTET GYN SCAN, V84, P1159, DOI 10.1111/j.0001-6349.2005.00650.x; Agarwal MM, 2001, DIABETES RES CLIN PR, V51, P67, DOI 10.1016/S0168-8227(00)00206-0; Agarwal MM, 2000, DIABETIC MED, V17, P720, DOI 10.1046/j.1464-5491.2000.00371.x; Agarwal MM, 2005, EUR J OBSTET GYN R B, V120, P39, DOI 10.1016/j.ejogrb.2004.07.034; Agarwal MM, 2008, GYNECOL OBSTET INVES, V66, P178, DOI 10.1159/000140602; Agarwal MM, 2011, GYNECOL OBSTET INVES, V71, P207, DOI 10.1159/000318705; Ayach Wilson, 2006, Sao Paulo Med. J., V124, P4, DOI 10.1590/S1516-31802006000100002; Balaji V, 2012, DIABETES TECHNOL THE, V14, P131, DOI 10.1089/dia.2011.0060; BERKUS MD, 1995, OBSTET GYNECOL, V85, P423, DOI 10.1016/0029-7844(94)00410-F; Bobrowski R A, 1996, J Matern Fetal Med, V5, P317; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Brustman L E, 1995, J Assoc Acad Minor Phys, V6, P70; Buhling KJ, 2004, EUR J OBSTET GYN R B, V113, P145, DOI 10.1016/j.ejogrb.2003.06.013; Cetin M, 1997, INT J GYNECOL OBSTET, V56, P257, DOI 10.1016/S0020-7292(96)02831-7; Chastang N, 2003, DIABETES METAB, V29, P139, DOI 10.1016/S1262-3636(07)70020-4; Chevalier N, 2011, DIABETES METAB, V37, P419, DOI 10.1016/j.diabet.2011.01.004; Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x; de los Monteros AE, 1999, ACTA OBSTET GYN SCAN, V78, P294, DOI 10.1034/j.1600-0412.1999.780404.x; Deerochanawong C, 1996, DIABETOLOGIA, V39, P1070; Eslamian L., 2008, Acta Medica Iranica, V46, P43; Farrar D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007122.pub2; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gandevani SB, 2011, J OBSTET GYNAECOL RE, V37, P534, DOI 10.1111/j.1447-0756.2010.01400.x; Hill JC, 2005, ACTA OBSTET GYN SCAN, V84, P159, DOI 10.1111/j.0001-6349.2005.00670.x; Hillier TA, 2008, ANN INTERN MED, V148, P766, DOI 10.7326/0003-4819-148-10-200805200-00009; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jakobi P, 2003, J PERINAT MED, V31, P140, DOI 10.1515/JPM.2003.019; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P1383, DOI 10.1067/S0002-9378(03)00601-X; Kashi Z, 2007, INT J ENDOCRINOL MET, V5, P1; Kauffman RP, 2006, AM J OBSTET GYNECOL, V194, P1576, DOI 10.1016/j.ajog.2006.01.010; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Maegawa Y, 2003, DIABETES RES CLIN PR, V62, P47, DOI 10.1016/S0168-8227(03)00146-3; Meltzer SJ, 2010, BJOG-INT J OBSTET GY, V117, P407, DOI 10.1111/j.1471-0528.2009.02475.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moses RG, 2011, MED J AUSTRALIA, V194, P338, DOI 10.5694/j.1326-5377.2011.tb03001.x; National Institutes of Health, 2013, CONS DEV C STAT; Naylor CD, 1997, NEW ENGL J MED, V337, P1591, DOI 10.1056/NEJM199711273372204; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165; Ostlund I, 2003, ACTA OBSTET GYN SCAN, V82, P103, DOI 10.1034/j.1600-0412.2003.00001.x; Perea-Carrasco R, 2002, J ROY SOC MED, V95, P435, DOI 10.1258/jrsm.95.9.435; Perucchini D, 1999, BMJ-BRIT MED J, V319, P812, DOI 10.1136/bmj.319.7213.812; Poyhonen-Alho MK, 2005, EUR J OBSTET GYN R B, V121, P34, DOI 10.1016/j.ejogrb.2004.10.008; Rajput R, 2012, DIABETES RES CLIN PR, V98, P104, DOI 10.1016/j.diabres.2012.02.018; Rasmussen SS, 2008, DIABETES RES CLIN PR, V80, P146, DOI 10.1016/j.diabres.2007.11.003; Reichelt AJ, 1998, DIABETES CARE, V21, P1246, DOI 10.2337/diacare.21.8.1246; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rey E, 2004, CLIN BIOCHEM, V37, P780, DOI 10.1016/j.clinbiochem.2004.05.018; Rust O, 1998, J Perinatol, V18, P49; Sacks DA, 2003, OBSTET GYNECOL, V101, P1197, DOI 10.1016/S0029-7844(03)00049-8; SACKS DA, 1995, AM J OBSTET GYNECOL, V172, P607, DOI 10.1016/0002-9378(95)90580-4; Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641; SERMER M, 1995, AM J OBSTET GYNECOL, V173, P146, DOI 10.1016/0002-9378(95)90183-3; Sermer M, 1998, DIABETES CARE, V21, pB33; Siribaddana S. H., 1998, Ceylon Medical Journal, V43, P88; Soheilykhah S, 2011, GYNECOL ENDOCRINOL, V27, P785, DOI 10.3109/09513590.2010.540598; Soonthornpun S, 2003, INT J GYNECOL OBSTET, V81, P169, DOI 10.1016/S0020-7292(03)00031-6; Tieu J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007222.pub2; Uncu G., 1995, Clinical and Experimental Obstetrics and Gynecology, V22, P230; van Leeuwen M, 2012, BJOG-INT J OBSTET GY, V119, P393, DOI 10.1111/j.1471-0528.2011.03254.x; van Leeuwen M, 2010, BJOG-INT J OBSTET GY, V117, P69, DOI 10.1111/j.1471-0528.2009.02425.x; van Leeuwen M, 2007, DIABETES CARE, V30, P2779, DOI 10.2337/dc07-0571; van Leeuwen M, 2011, EUR J OBSTET GYN R B, V154, P130, DOI 10.1016/j.ejogrb.2010.11.002; Virally M, 2010, DIABETES METAB, V36, P549, DOI 10.1016/j.diabet.2010.11.008; Weerakieti S, 2006, GYNECOL ENDOCRINOL, V22, P362, DOI 10.1080/09513590600818919; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wijeyaratne C. N., 2006, CEYLON MEDICAL JOURNAL, V51, P53; Yachi Y, 2011, DIABETES RES CLIN PR, V92, P293, DOI 10.1016/j.diabres.2011.02.012; Yogev Y, 2004, OBSTET GYNECOL, V103, P1241, DOI 10.1097/01.AOG.0000124781.98059.fe	71	83	84	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					115	W44		10.7326/0003-4819-159-2-201307160-00657	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00657			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23712349				2022-12-28	WOS:000322112000017
J	Rowley, DB; Forte, AM; Moucha, R; Mitrovica, JX; Simmons, NA; Grand, SP				Rowley, David B.; Forte, Alessandro M.; Moucha, Robert; Mitrovica, Jerry X.; Simmons, Nathan A.; Grand, Stephen P.			Dynamic Topography Change of the Eastern United States Since 3 Million Years Ago	SCIENCE			English	Article							SEA-LEVEL FLUCTUATIONS; NEW-JERSEY; PLIOCENE; RECORD; COREHOLES; DRIVEN	Sedimentary rocks from Virginia through Florida record marine flooding during the mid-Pliocene. Several wave-cut scarps that at the time of deposition would have been horizontal are now draped over a warped surface with a maximum variation of 60 meters. We modeled dynamic topography by using mantle convection simulations that predict the amplitude and broad spatial distribution of this distortion. The results imply that dynamic topography and, to a lesser extent, glacial isostatic adjustment account for the current architecture of the coastal plain and proximal shelf. This confounds attempts to use regional stratigraphic relations as references for longer-term sea-level determinations. Inferences of Pliocene global sea-level heights or stability of Antarctic ice sheets therefore cannot be deciphered in the absence of an appropriate mantle dynamic reference frame.	[Rowley, David B.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Forte, Alessandro M.] Univ Quebec, GEOTOP, Montreal, PQ H3C 3P8, Canada; [Moucha, Robert] Syracuse Univ, Dept Earth Sci, Heroy Geol Lab 204, Syracuse, NY 13244 USA; [Mitrovica, Jerry X.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Simmons, Nathan A.] Lawrence Livermore Natl Lab, Atmospher Earth & Energy Div, Livermore, CA 94551 USA; [Grand, Stephen P.] Univ Texas Austin, Jackson Sch Geol Sci, Austin, TX 78712 USA	University of Chicago; University of Quebec; University of Quebec Montreal; Syracuse University; Harvard University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Texas System; University of Texas Austin	Rowley, DB (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	drowley@uchicago.edu	Grand, Stephen/B-4238-2011; Simmons, Nathan Alan/J-9022-2014	Simmons, Nathan/0000-0002-1560-059X; Rowley, David/0000-0001-9767-9029; Forte, Alessandro/0000-0002-3530-0455	Canadian Institute for Advanced Research (CIFAR); Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Program; U.S. Department of Energy [DE-AC52-07NA27344]; NSF [EAR0309189, OCE-1202632]; Harvard University; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Harvard University; U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	D.B.R., A. M. F., and J.X.M. thank the Canadian Institute for Advanced Research (CIFAR) for research support and a postdoctoral fellowship to R. M. and members of the Earth Systems Evolution Program of CIFAR for discussions and encouragement. We also acknowledge funding from Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair Program (A. M. F.), the U.S. Department of Energy under contract DE-AC52-07NA27344 (N.A.S.), NSF grants EAR0309189 (S. P. G.) and OCE-1202632 (J.X.M.), and Harvard University (J.X.M.). Work by N.A.S. is performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. Data are available online in the supplementary materials. D. B. R. was responsible for the geology and data integration and thanks T. Komacek for help compiling Pliocene marine localities along the Coastal Plain; A. M. F. and R. M. were responsible for the dynamic topography calculations; J.X.M. for glacial isostatic adjustment calculations; and N.A.S. and S. P. G., for the global seismic tomography, which, working together with A. M. F., yielded the buoyancy field that underlies the dynamic topography calculations.	Adams PN, 2010, GEOLOGY, V38, P531, DOI 10.1130/G30592.1; Browning JV, 2008, BASIN RES, V20, P227, DOI 10.1111/j.1365-2117.2008.00360.x; Conrad CP, 2004, GEOLOGY, V32, P177, DOI 10.1130/G20137.1; Dillon W.P., 1988, ATLANTIC CONTINENTAL, P291, DOI DOI 10.1130/DNAG-GNA-I2.291; Dowsett H, 2010, STRATIGRAPHY, V7, P123; DOWSETT HJ, 1990, GEOLOGY, V18, P435, DOI 10.1130/0091-7613(1990)018<0435:HESLDT>2.3.CO;2; Drake C. L., 1959, PHYSICS CHEMISTRY EA, V3, P110; Emery K.O., 1984, GEOLOGY ATLANTIC OCE; Forte A. M., 2007, GEOPHYS RES LETT, V34, P5; Forte A. M., 2007, TREATISE GEOPHYS, P805; Forte AM, 2010, EARTH PLANET SC LETT, V295, P329, DOI 10.1016/j.epsl.2010.03.017; Fox D, 2010, SCIENCE, V328, P1630, DOI 10.1126/science.328.5986.1630; Groot J. J., 1999, PLIOCENE QUATERNARY, V58; Haq BU, 2005, GEOARABIA, V10, P127; Hill DJ, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P517; Kominz MA, 2008, BASIN RES, V20, P211, DOI 10.1111/j.1365-2117.2008.00354.x; KRANTZ DE, 1991, QUATERNARY SCI REV, V10, P163, DOI 10.1016/0277-3791(91)90016-N; MCKENZIE D, 1978, EARTH PLANET SC LETT, V40, P25, DOI 10.1016/0012-821X(78)90071-7; Miller K. G., 2008, ENCY PALEOCLIMATOLOG, P879; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Moucha R., 2006, EOS T AM GEOPHYS UN, V87, pT53D; Moucha R, 2008, EARTH PLANET SC LETT, V271, P101, DOI 10.1016/j.epsl.2008.03.056; Moucha R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039778; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; OAKS RQ, 1974, POST MIOCENE STRATIG, P53; Pazzaglia F. J, 2000, GEOMORPHOLOGY GLOBAL, P284; PAZZAGLIA FJ, 1994, J GEOPHYS RES-SOL EA, V99, P12143, DOI 10.1029/93JB03130; Poag C.W., 1989, GEOMORPHOLOGY, V2, P119, DOI [10.1016/0169-555X(89)90009-3, DOI 10.1016/0169-555X(89)90009-3]; POPPE LJ, 1995, MAR PETROL GEOL, V12, P677, DOI 10.1016/0264-8172(95)98092-J; Raymo ME, 2006, SCIENCE, V313, P492, DOI 10.1126/science.1123296; Raymo ME, 2011, NAT GEOSCI, V4, P328, DOI [10.1038/ngeo1118, 10.1038/NGEO1118]; Simmons NA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028009; Simmons NA, 2009, GEOPHYS J INT, V177, P1284, DOI 10.1111/j.1365-246X.2009.04133.x; SLEEP NH, 1971, GEOPHYS J ROY ASTR S, V24, P325, DOI 10.1111/j.1365-246X.1971.tb02182.x; Soller D.R., 1988, 1466A US GEOL SURV, DOI [10.3133/pp1466A, DOI 10.3133/PP1466A]; Spasojevic S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033511; Stanford SD, 2001, J GEOL, V109, P265, DOI 10.1086/319242; Ward LW, 1991, GEOLOGY CAROLINAS, P274; Watts A. B., 1979, Deep Drilling Results in the Atlantic Ocean: Continental Margins and Paleoenvironment. Second Maurice Ewing Symposium, P218, DOI 10.1029/ME003p0218; Watts A.B., 1984, MAR PETROL GEOL, V1, P319, DOI DOI 10.1016/0264-8172(84)90134-X; WINKER CD, 1977, GEOLOGY, V5, P123, DOI 10.1130/0091-7613(1977)5<123:COTDSO>2.0.CO;2	41	135	136	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1560	1563		10.1126/science.1229180	http://dx.doi.org/10.1126/science.1229180			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23686342				2022-12-28	WOS:000321007000038
J	Hudson, KL; Guttmacher, AE; Collins, FS				Hudson, Kathy L.; Guttmacher, Alan E.; Collins, Francis S.			In Support of SUPPORT - A View from the NIH	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEVERE RETINOPATHY; INFANTS		[Hudson, Kathy L.; Guttmacher, Alan E.; Collins, Francis S.] Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA	Hudson, KL (corresponding author), Natl Inst Hlth, Bethesda, MD USA.							Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Chow LC, 2003, PEDIATRICS, V111, P339, DOI 10.1542/peds.111.2.339; Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106	4	39	39	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2349	2351		10.1056/NEJMp1306986	http://dx.doi.org/10.1056/NEJMp1306986			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167AE	23738511	Green Published, Bronze			2022-12-28	WOS:000320601700003
J	Whorton, MR; MacKinnon, R				Whorton, Matthew R.; MacKinnon, Roderick			X-ray structure of the mammalian GIRK2-beta gamma G-protein complex	NATURE			English	Article							BETA-GAMMA-SUBUNITS; SODIUM-DEPENDENT ACTIVATION; RECTIFYING K+ CHANNELS; CRYSTAL-STRUCTURE; POTASSIUM CHANNELS; RECEPTORS; BINDING; SYSTEM; PIP2; RGS9	G-protein-gated inward rectifier K+ (GIRK) channels allow neurotransmitters, through G-protein-coupled receptor stimulation, to control cellular electrical excitability. In cardiac and neuronal cells this control regulates heart rate and neural circuit activity, respectively. Here we present the 3.5 angstrom resolution crystal structure of the mammalian GIRK2 channel in complex with beta gamma G-protein subunits, the central signalling complex that links G-protein-coupled receptor stimulation to K+ channel activity. Short-range atomic and long-range electrostatic interactions stabilize four beta gamma G-protein subunits at the interfaces between four K+ channel subunits, inducing a pre-open state of the channel. The pre-open state exhibits a conformation that is intermediate between the closed conformation and the open conformation of the constitutively active mutant. The resultant structural picture is compatible with 'membrane delimited' activation of GIRK channels by G proteins and the characteristic burst kinetics of channel gating. The structures also permit a conceptual understanding of how the signalling lipid phosphatidylinositol-4,5-bisphosphate (PIP2) and intracellular Na+ ions participate in multi-ligand regulation of GIRK channels.	[Whorton, Matthew R.; MacKinnon, Roderick] Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; [Whorton, Matthew R.; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			National Center for Research Resources of the National Institutes of Health (NIH) [1S10RR022321-01, 1S10RR027037-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022321, S10RR027037] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank P. Hoff and members of D. Gadsby's laboratory (Rockefeller University) for assistance with oocyte preparation; Y. Hsiung for assistance with insect cell culture; R. Sanishvili, N. Venugopalan, and S. Corcoran (GM/CA, Advanced Photon Source, Argonne National laboratory) for assistance at the synchrotron; and members of the MacKinnon laboratory. The use of the Rigaku/MSC microMax007HF and Formulator robot in the Rockefeller University Structural Biology Resource Center was made possible by Grant Numbers 1S10RR022321-01 and 1S10RR027037-01, respectively, from the National Center for Research Resources of the National Institutes of Health (NIH). R. M. is an investigator in the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albsoul-Younes AM, 2001, J BIOL CHEM, V276, P12712, DOI 10.1074/jbc.M011231200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LOEWI O., 1926, PFLUGER S ARCH GES PHYSIOL, V214, P678, DOI 10.1007/BF01741946; Loewi O, 1921, PFLUG ARCH GES PHYS, V189, P239, DOI 10.1007/BF01738910; Loewi O., 1999, NOBLE LECT PHYSL MED; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P5873, DOI 10.1073/pnas.87.15.5873; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Qi Z, 2006, FEBS LETT, V580, P3879, DOI 10.1016/j.febslet.2006.06.016; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhao Q, 2003, MOL PHARMACOL, V64, P1085, DOI 10.1124/mol.64.5.1085	61	214	217	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					190	+		10.1038/nature12241	http://dx.doi.org/10.1038/nature12241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23739333	Green Accepted			2022-12-28	WOS:000320283400039
J	de Lemos, JA				de Lemos, James A.			Increasingly Sensitive Assays for Cardiac Troponins A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; PROGNOSTIC VALUE; EARLY-DIAGNOSIS; ARTERY-DISEASE; GENERAL-POPULATION; CIRCULATING TROPONIN; PRACTICE GUIDELINES; UNSTABLE ANGINA	Cardiac troponins are the preferred biomarkers for diagnosis of myocardial infarction because of their high sensitivity and specificity for myocardial injury. However, acute and chronic conditions distinct from acute coronary syndromes (ACS) commonly lead to small elevations in troponin levels, with few data available regarding management of care for patients with such conditions. Recently developed highly sensitive troponin assays will likely lead to a substantial increase in the proportion of detectable troponin levels attributable to non-ACS conditions. Novel algorithms with highly sensitive assays, incorporating baseline troponin values and changes in values over 1 to 2 hours, may allow rapid exclusion of myocardial infarction and help to address specificity concerns but must be validated in appropriate target populations. Enhanced detection of very low troponin levels with highly sensitive assays has made feasible several potential new indications for troponin testing, including in the ambulatory setting, where assessment for low-level chronic myocardial injury may enhance risk stratification for heart failure and cardiac death.	[de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Med, Div Cardiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	de Lemos, JA (corresponding author), Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021		Roche Diagnostics; Abbott Diagnostics	Roche Diagnostics; Abbott Diagnostics(Abbott Laboratories)	Dr de Lemos has received grant support as the principal investigator for investigator-initiated grants from Roche Diagnostics and Abbott Diagnostics.	Alcalai R, 2007, ARCH INTERN MED, V167, P276, DOI 10.1001/archinte.167.3.276; Ammann P, 2003, J AM COLL CARDIOL, V41, P2004, DOI 10.1016/S0735-1097(03)00421-2; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Apple FS, 1999, CLIN CHIM ACTA, V284, P151, DOI 10.1016/S0009-8981(99)00077-7; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Baker P, 2014, EMERG MED J, V31, P374, DOI 10.1136/emermed-2012-201465; Bavry AA, 2004, AM J CARDIOL, V93, P830, DOI 10.1016/j.amjcard.2003.12.019; Bhuiya Farida A, 2010, NCHS Data Brief, P1; Body R, 2011, J AM COLL CARDIOL, V58, P1333, DOI 10.1016/j.jacc.2011.06.026; Bonaca M, 2010, J AM COLL CARDIOL, V55, P2118, DOI 10.1016/j.jacc.2010.01.044; de Lemos JA, 2011, CLIN CHEM, V57, P826, DOI 10.1373/clinchem.2011.163758; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2012, J AM COLL CARDIOL, V60, P2539, DOI 10.1016/j.jacc.2012.08.1006; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327; Eggers KM, 2008, AM HEART J, V156, P588, DOI 10.1016/j.ahj.2008.04.022; Giannitsis E, 2000, CIRCULATION, V102, P211, DOI 10.1161/01.CIR.102.2.211; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; Hlatky, 2009, CIRCULATION, V119, pE606, DOI 10.1161/CIRCULATIONAHA.109.192590; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Januzzi JL, 2010, CIRCULATION, V121, P1227, DOI 10.1161/CIRCULATIONAHA.109.893826; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Korley FK, 2013, J AM COLL CARDIOL, V61, P1753, DOI 10.1016/j.jacc.2012.09.069; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Leistner DM, 2012, CLIN CHEM, V58, P200, DOI 10.1373/clinchem.2011.174292; Lindahl B, 1997, J AM COLL CARDIOL, V29, P43, DOI 10.1016/S0735-1097(96)00447-0; Lindahl B, 2001, J AM COLL CARDIOL, V38, P979, DOI 10.1016/S0735-1097(01)01501-7; Mahler Simon A, 2011, Crit Pathw Cardiol, V10, P128, DOI 10.1097/HPC.0b013e3182315a85; Mingels A, 2009, CLIN CHEM, V55, P101, DOI 10.1373/clinchem.2008.106427; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Napoli Anthony M, 2012, Crit Pathw Cardiol, V11, P26, DOI 10.1097/HPC.0b013e3182457bee; Neeland IJ, 2013, J AM COLL CARDIOL, V61, P187, DOI 10.1016/j.jacc.2012.10.012; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Reichlin T, 2012, ARCH INTERN MED, V172, P1211, DOI 10.1001/archinternmed.2012.3698; Reichlin T, 2011, CIRCULATION, V124, P136, DOI 10.1161/CIRCULATIONAHA.111.023937; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; REMPPIS A, 1995, J MOL CELL CARDIOL, V27, P793, DOI 10.1016/0022-2828(95)90086-1; Rubin J, 2012, J AM COLL CARDIOL, V59, P484, DOI 10.1016/j.jacc.2011.10.875; Sabatine MS, 2009, EUR HEART J, V30, P162, DOI 10.1093/eurheartj/ehn504; Sato Y, 2001, CIRCULATION, V103, P369; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Than M, 2012, J AM COLL CARDIOL, V59, P2091, DOI 10.1016/j.jacc.2012.02.035; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Turer AT, 2011, J AM COLL CARDIOL, V57, P2398, DOI 10.1016/j.jacc.2010.11.066; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437; Wong GC, 2002, CIRCULATION, V106, P202, DOI 10.1161/01.CIR.0000021921.14653.28	56	131	133	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2262	2269		10.1001/jama.2013.5809	http://dx.doi.org/10.1001/jama.2013.5809			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736735				2022-12-28	WOS:000319859200030
J	Peljto, AL; Zhang, YZ; Fingerlin, TE; Ma, SF; Garcia, JGN; Richards, TJ; Silveira, LJ; Lindell, KO; Steele, MP; Loyd, JE; Gibson, KF; Seibold, MA; Brown, KK; Talbert, JL; Markin, C; Kossen, K; Seiwert, SD; Murphy, E; Noth, I; Schwarz, MI; Kaminski, N; Schwartz, DA				Peljto, Anna L.; Zhang, Yingze; Fingerlin, Tasha E.; Ma, Shwu-Fan; Garcia, Joe G. N.; Richards, Thomas J.; Silveira, Lori J.; Lindell, Kathleen O.; Steele, Mark P.; Loyd, James E.; Gibson, Kevin F.; Seibold, Max A.; Brown, Kevin K.; Talbert, Janet L.; Markin, Cheryl; Kossen, Karl; Seiwert, Scott D.; Murphy, Elissa; Noth, Imre; Schwarz, Marvin I.; Kaminski, Naftali; Schwartz, David A.			Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FORCED VITAL CAPACITY; DISEASE EXTENT; PROTEINS; VARIANT; SYSTEM; INDEX; MODEL	Importance Current prediction models of mortality in idiopathic pulmonary fibrosis (IPF), which are based on clinical and physiological parameters, have modest value in predicting which patients will progress. In addition to the potential for improving prognostic models, identifying genetic and molecular features that are associated with IPF mortality may provide insight into the underlying mechanisms of disease and inform clinical trials. Objective To determine whether the MUC5B promoter polymorphism (rs35705950), previously reported to be associated with the development of pulmonary fibrosis, is associated with survival in IPF. Design, Setting, and Participants Retrospective study of survival in 2 independent cohorts of patients with IPF: the INSPIRE cohort, consisting of patients enrolled in the interferon-gamma 1b trial (n=438; December 15, 2003-May 2, 2009; 81 centers in 7 European countries, the United States, and Canada), and the Chicago cohort, consisting of IPF participants recruited from the Interstitial Lung Disease Clinic at the University of Chicago (n= 148; 2007-2010). The INSPIRE cohort was used to model the association of the MUC5B genotype with survival, accounting for the effect of matrix metalloproteinase 7 (MMP-7) blood concentration and other demographic and clinical covariates. The Chicago cohort was used for replication of findings. Main Outcomes and Measures The primary end point was all-cause mortality. Results Thenumbers of patients in the GG, GT, and TT genotype groups were 148(34%), 259 (59%), and 31 (7%), respectively, in the INSPIRE cohort and 41 (28%), 98 (66%), and 9 (6%), respectively, in the Chicago cohort. The median follow-up period was 1.6 years for INSPIRE and 2.1 years for Chicago. During follow-up, there were 73 deaths (36 GG, 35 GT, and 2 TT) among INSPIRE patients and 64 deaths (26 GG, 36 GT, and 2 TT) among Chicago patients. The unadjusted 2-year cumulative incidence of death was lower among patients carrying 1 or more copies of the IPF risk allele (T) in both the INSPIRE cohort (0.25 [95% CI, 0.17-0.32] for GG, 0.17 [95% CI, 0.11-0.23] for GT, and 0.03 [95% CI, 0.00-0.09] for TT) and the Chicago cohort (0.50 [95% CI, 0.31-0.63] for GG, 0.22 [95% CI, 0.13-0.31] for GT, and 0.11 [95% CI, 0.00-0.28] for TT). In the INSPIRE cohort, the TT and GT genotypes (risk for IPF) were associated with improved survival compared with GG (hazardratios, 0.23[95% CI, 0.10-0.52] and 0.48[95% CI, 0.31-0.72], respectively; P <.001). This finding was replicated in the Chicago cohort (hazard ratios, 0.15[95% CI, 0.05-0.49] and 0.39[95% CI, 0.21-0.70], respectively; P<.002). The observed association of MUC5B with survival was independent of age, sex, forced vital capacity, diffusing capacity of carbon monoxide, MMP-7, and treatment status. The addition of the MUC5B genotype to the survival models significantly improved the predictive accuracy of the model in both the INSPIRE cohort (C = 0.71 [95% CI, 0.64-0.75] vs C = 0.68 [95% CI, 0.61-0.73]; P <.001) and the Chicago cohort (C = 0.73 [95% CI, 0.62-0.78] vs C = 0.69 [95% CI, 0.59-0.75]; P =. 01). Conclusions and Relevance Among patients with IPF, a common risk polymorphism in MUC5B was significantly associated with improved survival. Further research is necessary to refine the risk estimates and to determine the clinical implications of these findings.	[Peljto, Anna L.; Fingerlin, Tasha E.] Univ Colorado, Sch Publ Hlth, Dept Epidemiol, Denver, CO 80202 USA; [Zhang, Yingze; Fingerlin, Tasha E.] Univ Colorado, Sch Publ Hlth, Dept Biostat, Denver, CO 80202 USA; [Murphy, Elissa; Schwarz, Marvin I.; Schwartz, David A.] Univ Colorado, Sch Med, Dept Med, Denver, CO USA; [Silveira, Lori J.] Natl Jewish Hlth, Dept Biostat, Denver, CO USA; [Seibold, Max A.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Brown, Kevin K.; Talbert, Janet L.; Schwartz, David A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Ma, Shwu-Fan; Noth, Imre] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Garcia, Joe G. N.] Univ Illinois, Dept Med, Inst Personalized Resp Med, Chicago, IL USA; [Richards, Thomas J.; Lindell, Kathleen O.; Gibson, Kevin F.; Kaminski, Naftali] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Steele, Mark P.; Loyd, James E.; Markin, Cheryl] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Kossen, Karl; Seiwert, Scott D.] InterMune, Brisbane, CA USA	Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; National Jewish Health; National Jewish Health; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Schwartz, DA (corresponding author), Univ Colorado, 12631 E 17th Ave,B178, Aurora, CO 80045 USA.	david.schwartz@ucdenver.edu	Lindell, Kathleen Oare/GQQ-6372-2022; Brown, Kevin/ABF-2544-2020	Kaminski, Naftali/0000-0001-5917-4601; Loyd, James/0000-0002-5042-7390	National Heart, Lung, and Blood Institute [R01-HL095393, R01-HL097163, R01-HL095397, P50-HL0894932, P01-HL092870, RC1-HL09961, RC2-HL101715]; Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research (University of Pittsburgh School of Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095393, RC2HL101715, RC1HL099619, R01HL097163, F32HL009961, P01HL092870, P50HL084932, R01HL095397] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research (University of Pittsburgh School of Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Heart, Lung, and Blood Institute (grants R01-HL095393, R01-HL097163, R01-HL095397, P50-HL0894932, P01-HL092870, RC1-HL09961, and RC2-HL101715) and the Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research (University of Pittsburgh School of Medicine).	Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Cosgrove GP., 2012, AM J RESP CRIT CARE, V185, pA6865, DOI DOI 10.1164/AJRCCM-C0NFERENCE.2012.185.1_; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P1382, DOI 10.1164/rccm.201105-0840OC; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Raghu G, 2012, LANCET, V380, P699, DOI 10.1016/S0140-6736(12)61256-2; Richards TJ, 2012, AM J RESP CRIT CARE, V185, P67, DOI 10.1164/rccm.201101-0058OC; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Stock CJ, 2013, THORAX, V68, P436, DOI 10.1136/thoraxjnl-2012-201786; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P1109, DOI 10.1164/ajrccm.162.3.9910080; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Zappala CJ, 2010, EUR RESPIR J, V35, P830, DOI 10.1183/09031936.00155108; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504	29	301	310	1	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2232	2239		10.1001/jama.2013.5827	http://dx.doi.org/10.1001/jama.2013.5827			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23695349	Green Accepted, Bronze			2022-12-28	WOS:000319859200027
J	Tosh, W				Tosh, William			It can be tough for families when patients choose to die at home	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Russells Hall Hosp, Dept Anaesthesia, Dudley DY1 2HQ, W Midlands, England	Russells Hall Hospital	Tosh, W (corresponding author), Russells Hall Hosp, Dept Anaesthesia, Dudley DY1 2HQ, W Midlands, England.	w.tosh@doctors.org.uk							0	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3397	10.1136/bmj.f3397	http://dx.doi.org/10.1136/bmj.f3397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DG	23719642				2022-12-28	WOS:000319948200010
J	Goodnough, LT; Levy, JH; Murphy, MF				Goodnough, Lawrence T.; Levy, Jerrold H.; Murphy, Michael F.			Concepts of blood transfusion in adults	LANCET			English	Article							FRESH-FROZEN PLASMA; CLINICAL-PRACTICE GUIDELINE; PROPHYLACTIC PLATELET TRANSFUSIONS; CARDIAC-SURGERY; CELL TRANSFUSION; CARDIOVASCULAR-ANESTHESIOLOGISTS; THORACIC-SURGEONS; HEMATOLOGICAL MALIGNANCIES; CONSENSUS CONFERENCE; PRACTICE PARAMETER	Recent progress has been made in the identification and implementation of best transfusion practices on the basis of evidence-based clinical trials, published clinical practice guidelines, and process improvements for blood use and clinical patient outcomes. However, substantial variability persists in transfusion outcomes for patients in some clinical settings-eg, patients undergoing cardiothoracic surgery. This variability could be the result of insufficient understanding of published guidelines; different recommendations of medical societies, including the specification of a haemoglobin concentration threshold to use as a transfusion trigger; the value of haemoglobin as a surrogate indicator for transfusion benefit, even though only changes in concentration and not absolute red cell mass of haemoglobin can be identified; and disagreement about the validity of the level 1 evidence for clinical practice guidelines. Nevertheless, institutional experience and national databases suggest that a restrictive blood transfusion approach is being increasingly implemented as best practice.	[Goodnough, Lawrence T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Goodnough, Lawrence T.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Levy, Jerrold H.] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC USA; [Murphy, Michael F.] Oxford Univ Hosp, NHS Blood & Transplant, Oxford, England; [Murphy, Michael F.] Univ Oxford, Oxford, England	Stanford University; Stanford University; Duke University; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Goodnough, LT (corresponding author), Stanford Univ, Med Ctr, Transfus Serv, 300 Pasteur Dr, Stanford, CA 94305 USA.	ltgoodno@stanford.edu						Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Adams ES, 2011, PEDIATRICS, V127, pE1112, DOI 10.1542/peds.2010-3252; Adams RC., 1942, SURG GYNECOL OBSTET, V3, P603; Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198; Australasian Society of Blood Transfusion, CLINICAL PRACTICE GU; Bennett-Guerrero E, 2010, JAMA-J AM MED ASSOC, V304, P1568, DOI 10.1001/jama.2010.1406; BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P551; BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700; Bittencourt R, 2012, REV BRAS ANESTESIOL, V62, P402, DOI 10.1016/S0034-7094(12)70140-X; Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x; British Committee for Standards in Haematology (BCSH), GUIDELINE ON THE ADM; Cameron B, 2007, TRANSFUSION, V47, P206, DOI 10.1111/j.1537-2995.2007.01090.x; Carlier M, 2011, TRANSFUS CLIN BIOL, V18, P140, DOI 10.1016/j.tracli.2011.02.024; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Carson JL, 2002, TRANSFUS MED REV, V16, P187, DOI 10.1053/tmrv.2002.33461; Carson JL, 2002, TRANSFUSION, V42, P812, DOI 10.1046/j.1537-2995.2002.00123.x; Carson JL, 2012, COCHRANE DB SYST REV, V18, P4, DOI DOI 10.1002/14651858.CD002042.PUB3; Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x; Como JJ, 2004, TRANSFUSION, V44, P809, DOI 10.1111/j.1537-2995.2004.03409.x; CONTRERAS M, 1992, TRANSFUSION MED, V2, P57; Contreras M, 1998, TRANSFUSION, V38, P796, DOI 10.1046/j.1537-2995.1998.38898375520.x; COOPER ES, 1994, JAMA-J AM MED ASSOC, V271, P777, DOI 10.1001/jama.1994.03510340067036; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Cotton BA, 2009, J TRAUMA, V67, P1004, DOI 10.1097/TA.0b013e3181bcb2a8; Estcourt LJ, 2012, VOX SANG, V103, P284, DOI 10.1111/j.1423-0410.2012.01627.x; Estcourt L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004269.pub3; Estcourt LJ, 2011, BRIT J HAEMATOL, V154, P425, DOI 10.1111/j.1365-2141.2010.08483.x; Expert Working Group, 1997, CAN MED ASSOC J SUPP, V156, P1; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; FINCH CA, 1972, NEW ENGL J MED, V286, P407, DOI 10.1056/NEJM197202242860806; Frank SM, 2012, ANESTHESIOLOGY, V117, P99, DOI 10.1097/ALN.0b013e318255e550; Gammon HM, 2011, TRANSFUSION, V51, P2500, DOI 10.1111/j.1537-2995.2011.03406.x; Goodnough LT, 2013, CURR OPIN ANESTHESIO, V26, P208, DOI 10.1097/ACO.0b013e32835d6f8f; Goodnough Lawrence Tim, 2012, Ann Thorac Surg, V94, P709, DOI 10.1016/j.athoracsur.2012.04.016; Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3; Goodnough LT, 1999, NEW ENGL J MED, V340, P525, DOI 10.1056/NEJM199902183400706; Goodnough LT, 1996, ARCH PATHOL LAB MED, V120, P802; Goodnough LT, 2001, NEW ENGL J MED, V345, P1272, DOI 10.1056/NEJM200110253451711; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; GOODNOUGH LT, 1995, ANN THORAC SURG, V60, P473, DOI 10.1016/0003-4975(95)98960-3; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Haspel RL, 2012, TRANSFUSION, V52, P227, DOI 10.1111/j.1537-2995.2011.03191.x; Healthcare Cost and Utilization Project, HCUP FACTS AND FIGUR; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hessel EA, 2010, ANESTH ANALG, V111, P1555, DOI 10.1213/ANE.0b013e3181fbb386; Hogue CW, 1998, TRANSFUSION, V38, P924, DOI 10.1046/j.1537-2995.1998.381098440856.x; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Hutton B, 2005, CAN J ANAESTH, V52, P581, DOI 10.1007/BF03015766; Inaba K, 2010, J AM COLL SURGEONS, V210, P957, DOI 10.1016/j.jamcollsurg.2010.01.031; Innes G, 1998, J Emerg Med, V16, P129; Jackman RP, 2012, TRANSFUSION, V52, P2533, DOI 10.1111/j.1537-2995.2012.03618.x; Joshi GP, 2005, ANESTH ANALG, V101, P601, DOI 10.1213/01.ANE.0000159171.26521.31; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kelsey P, 2003, BRIT J HAEMATOL, V122, P10; Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group, 2012, KIDNEY INT SUPPL, V2, P279, DOI DOI 10.1038/kisup.2012.37; Levy JH, 2012, ANESTH ANALG, V114, P261, DOI 10.1213/ANE.0b013e31822e1853; Li GX, 2011, TRANSFUSION, V51, P338, DOI 10.1111/j.1537-2995.2010.02816.x; Likosky DS, 2010, ANESTH ANALG, V111, P316, DOI 10.1213/ANE.0b013e3181e329f1; Lin YL, 2012, TRANSFUSION, V52, P567, DOI 10.1111/j.1537-2995.2011.03330.x; Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P132, DOI 10.2450/2009.0005-09; Madjdpour C, 2006, CRIT CARE MED, V34, pS102, DOI 10.1097/01.CCM.0000214317.26717.73; Moore FA, 2008, J TRAUMA, V64, P1010, DOI 10.1097/TA.0b013e31816a2417; Morton J, 2010, AM J MED QUAL, V25, P289, DOI 10.1177/1062860610366159; Mudumbai SC, 2011, TRANSFUSION, V51, P2148, DOI 10.1111/j.1537-2995.2011.03134.x; Murphy MF, 2011, VOX SANG, V100, P46, DOI 10.1111/j.1423-0410.2010.01366.x; Murphy MF, 2001, BRIT J HAEMATOL, V113, P24; MURPHY MF, 1992, TRANSFUSION MED, V2, P311, DOI 10.1111/j.1365-3148.1992.tb00175.x; Napolitano LM, 2009, J TRAUMA, V67, P1439, DOI 10.1097/TA.0b013e3181ba7074; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; National Blood Authority Australia,, PATIENT BLOOD MANAGE; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; Parrillo JE, 2001, CRIT CARE MED, V29, pS139, DOI 10.1097/00003246-200109001-00001; Pattakos G, 2012, ARCH INTERN MED, V172, P1154, DOI 10.1001/archinternmed.2012.2449; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; Roback JD, 2010, TRANSFUSION, V50, P1227, DOI 10.1111/j.1537-2995.2010.02632.x; Rodgers GM, 2012, J NATL COMPR CANC NE, V10, P628, DOI 10.6004/jnccn.2012.0064; Rogers MAM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-37; Sack K., 2013, THE NEW YORK TIMES; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schiffer CA, 2001, J CLIN ONCOL, V19, P1519, DOI 10.1200/JCO.2001.19.5.1519; Segal JB, 2005, TRANSFUSION, V45, P1413, DOI 10.1111/j.1537-2995.2005.00546.x; Shander A, 2011, TRANSFUS MED REV, V25, P232, DOI 10.1016/j.tmrv.2011.02.001; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Shander AS, 2010, JAMA-J AM MED ASSOC, V304, P1610, DOI 10.1001/jama.2010.1483; Simon TL, 1998, ARCH PATHOL LAB MED, V122, P130; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; Snyder-Ramos SA, 2008, TRANSFUSION, V48, P1284, DOI 10.1111/j.1537-2995.2008.01666.x; SPENCE RK, 1992, AM SURGEON, V58, P92; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stanworth SJ, 2013, NEW ENGL J MED, V368, P1771, DOI 10.1056/NEJMoa1212772; Stanworth SJ, 2011, TRANSFUSION, V51, P62, DOI 10.1111/j.1537-2995.2010.02798.x; Stanworth SJ, 2004, BRIT J HAEMATOL, V126, P139, DOI 10.1111/j.1365-2141.2004.04973.x; Starr D., 1998, BLOOD AN EPIC HISTOR; Stehling LC, 1996, ANESTHESIOLOGY, V84, P732; Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009; US Department of Health and Human Services, 2007, 2007 NATIONAL BLOOD; US Food and Drug Administration Center for Biologics Evaluation and Research, FATALITIES REPORTED; Vamvakas EC, 2013, TRANSFUSION, V53, P888, DOI 10.1111/j.1537-2995.2012.03825.x; VANWOERKENS ECSM, 1992, ANESTH ANALG, V75, P818; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Wandt H, 2012, LANCET, V380, P1309, DOI 10.1016/S0140-6736(12)60689-8; WELCH HG, 1992, ANN INTERN MED, V116, P393, DOI 10.7326/0003-4819-116-5-393; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Yang L, 2012, TRANSFUSION, V52, P1673, DOI 10.1111/j.1537-2995.2011.03515.x	109	169	170	2	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2013	381	9880					1845	1854		10.1016/S0140-6736(13)60650-9	http://dx.doi.org/10.1016/S0140-6736(13)60650-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23706801				2022-12-28	WOS:000319443700031
J	Spahn, DR; Goodnough, LT				Spahn, Donat R.; Goodnough, Lawrence T.			Alternatives to blood transfusion	LANCET			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; RANDOMIZED-CLINICAL-TRIAL; CORONARY-ARTERY-BYPASS; IRON-DEFICIENCY ANEMIA; PHASE-III TRIAL; DARBEPOETIN-ALPHA; STIMULATING AGENTS; EPOETIN-ALPHA; DOUBLE-BLIND; FACTOR-XIII	The use of alternatives to allogeneic blood continues to rest on the principles that blood transfusions have inherent risks, associated costs, and affect the blood inventory available for health-care delivery. Increasing evidence exists of a fall in the use of blood because of associated costs and adverse outcomes, and suggests that the challenge for the use of alternatives to blood components will similarly be driven by costs and patient outcomes. Additionally, the risk-benefit profiles of alternatives to blood transfusion such as autologous blood procurement, erythropoiesis-stimulating agents, and haemostatic agents are under investigation. Nevertheless, the inherent risks of blood, along with the continued rise in blood costs are likely to favour the continued development and use of alternatives to blood transfusion. We summarise the current roles of alternatives to blood in the management of medical and surgical anaemias.	[Spahn, Donat R.] Univ Zurich, Inst Anaesthesiol, CH-8091 Zurich, Switzerland; [Spahn, Donat R.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Goodnough, Lawrence T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Goodnough, Lawrence T.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	University of Zurich; University of Zurich; University Zurich Hospital; Stanford University; Stanford University	Spahn, DR (corresponding author), Univ Zurich, Inst Anaesthesiol, CH-8091 Zurich, Switzerland.	donat.spahn@usz.ch			Swiss National Science Foundation (Bern, Switzerland); Swiss Society of Anaesthesiology and Reanimation (Bern, Switzerland); Swiss Foundation for Anesthesia Research (Zurich, Switzerland); Bundesprogramm Chancengleichheit (Bern, Switzerland); CSL Behring (Bern, Switzerland); Vifor SA (Villars-sur-Glane, Switzerland)	Swiss National Science Foundation (Bern, Switzerland)(Swiss National Science Foundation (SNSF)); Swiss Society of Anaesthesiology and Reanimation (Bern, Switzerland); Swiss Foundation for Anesthesia Research (Zurich, Switzerland); Bundesprogramm Chancengleichheit (Bern, Switzerland); CSL Behring (Bern, Switzerland); Vifor SA (Villars-sur-Glane, Switzerland)	DRS's academic department is receiving grant support from the Swiss National Science Foundation (Bern, Switzerland), the Swiss Society of Anaesthesiology and Reanimation (Bern, Switzerland), the Swiss Foundation for Anesthesia Research (Zurich, Switzerland), Bundesprogramm Chancengleichheit (Bern, Switzerland), CSL Behring (Bern, Switzerland), and Vifor SA (Villars-sur-Glane, Switzerland). In the past 5 years, DRS has received honoraria or travel support for consulting or lecturing from the following companies: AMGEN GmbH (Munich, Germany), Baxter AG (Volketswil, Switzerland), Baxter S. p. A. (Rome, Italy), CSL Behring GmbH (Hattersheim am Main, Germany and Bern, Switzerland), Ethicon Biosurgery (Sommerville, NJ, USA), Janssen-Cilag AG (Baar, Switzerland), Janssen-Cilag EMEA (Beerse, Belgium), Novo Nordisk A/S, (Bagsvard, Denmark), Octapharma AG (Lachen, Switzerland), Organon AG (Pfaffikon, Switzerland), Oxygen Biotherapeutics (Costa Mesa, CA, USA), Pentapharm GmbH (now tem Innovations GmbH; Munich, Germany), ratiopharm Arzneimittel Vertriebs-GmbH (Vienna, Austria), Roche Pharma (Switzerland) AG (Reinach, Switzerland), Vifor Pharma Deutschland GmbH (Munich, Germany), Vifor Pharma Osterreich GmbH (Vienna, Austria), Vifor (International) AG (St Gallen, Switzerland). LTG is a consultant for Amgen (Thousand Oaks, CA, USA), Luitpold (Shirley, NY, USA), Vifor (Glattbrugg, Switzerland), CSL Behring (King of Prussia, PA, USA), Hemocue (Cypress, CA, USA), and Octapharma (Hoboken, NJ, USA).	Afshari A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub2; BELL K, 1992, TRANSFUSION MED, V2, P295, DOI 10.1111/j.1365-3148.1992.tb00173.x; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Billote DB, 2002, J BONE JOINT SURG AM, V84A, P1299, DOI 10.2106/00004623-200208000-00003; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Brecher ME, 2001, TRANSFUSION, V41, P1459, DOI 10.1046/j.1537-2995.2001.41121459.x; Bregman DB, 2013, AM J HEMATOL, V88, P97, DOI 10.1002/ajh.23354; Busch MP, 2003, JAMA-J AM MED ASSOC, V289, P959, DOI 10.1001/jama.289.8.959; Carless PA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001888.pub2; Carless PA, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001884.PUB2; Carson Jeffrey L, 2012, Cochrane Database Syst Rev, pCD002042, DOI 10.1002/14651858.CD002042.pub3; Cortet M, 2012, BRIT J ANAESTH, V108, P984, DOI 10.1093/bja/aes096; Crescenzi G, 2008, ANESTHESIOLOGY, V109, P1063, DOI 10.1097/ALN.0b013e31818db18b; D'Ambra MN, 1997, ANN THORAC SURG, V64, P1686, DOI 10.1016/S0003-4975(97)00839-4; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Franchini M, 2010, BLOOD TRANSFUS-ITALY, V8, P149, DOI [10.2450/2010-0149-09, 10.2450/2010.0149-09]; Frank SM, 2013, ANESTH ANALG, V116, P975, DOI 10.1213/ANE.0b013e31828843e6; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gerlach R, 2002, STROKE, V33, P1618, DOI 10.1161/01.STR.0000017219.83330.FF; Godje O, 2006, THORAC CARDIOV SURG, V54, P26, DOI 10.1055/s-2005-872853; Gorlinger K, 2011, ANESTHESIOLOGY, V115, P1179, DOI 10.1097/ALN.0b013e31823497dd; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Goodnough LT, 2013, CURR OPIN ANESTHESIO, V26, P208, DOI 10.1097/ACO.0b013e32835d6f8f; Goodnough LT, 2013, ANESTH ANALG, V116, P15, DOI 10.1213/ANE.0b013e318273f4ae; Goodnough LT, 2012, TRANSFUSION, V52, P1584, DOI 10.1111/j.1537-2995.2011.03495.x; Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3; Goodnough LT, 2011, BLOOD, V117, P6091, DOI 10.1182/blood-2010-11-316075; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Goodnough LT, 2010, AM J HEMATOL, V85, P835, DOI 10.1002/ajh.21870; Goodnough LT, 1999, NEW ENGL J MED, V340, P525, DOI 10.1056/NEJM199902183400706; Goodnough LT, 2003, TRANSFUSION, V43, P668, DOI 10.1046/j.1537-2995.2003.00367.x; Goodnough LT, 1997, NEW ENGL J MED, V336, P933, DOI 10.1056/NEJM199703273361307; Goodnough LT., CRIT CARE M IN PRESS; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; GUYATT GH, 1990, AM J MED, V88, P205, DOI 10.1016/0002-9343(90)90143-2; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hadland BK, 2009, J CLIN ONCOL, V27, P4217, DOI 10.1200/JCO.2008.21.6945; Hanke AA, 2010, ANAESTHESIA, V65, P688, DOI 10.1111/j.1365-2044.2010.06367.x; Hedenus M, 2003, BRIT J HAEMATOL, V122, P394, DOI 10.1046/j.1365-2141.2003.04448.x; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; Henry DH, 2007, ONCOLOGIST, V12, P231, DOI 10.1634/theoncologist.12-2-231; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hutton B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5798; Inbal A, 2012, BLOOD, V119, P5111, DOI 10.1182/blood-2011-10-386045; Innerhofer P, 2013, INJURY, V44, P209, DOI 10.1016/j.injury.2012.08.047; Isbister JP, 2011, TRANSFUS MED REV, V25, P89, DOI 10.1016/j.tmrv.2010.11.001; Karlsson M, 2009, THROMB HAEMOSTASIS, V102, P137, DOI 10.1160/TH08-09-0587; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group, 2012, KIDNEY INT SUPPL, V2, P279, DOI DOI 10.1038/kisup.2012.37; Korte WC, 2009, ANESTHESIOLOGY, V110, P239, DOI 10.1097/ALN.0b013e318194b21e; Kotze A, 2012, BRIT J ANAESTH, V108, P943, DOI 10.1093/bja/aes135; Kozek-Langenecker S, 2011, CRIT CARE, V15, DOI 10.1186/cc10583; Kozek-Langenecker S, 2011, CRIT CARE, V15, DOI 10.1186/cc10488; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Levy JH, 2013, TRANSFUSION, V53, P1120, DOI 10.1111/j.1537-2995.2012.03865.x; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Logan AC, 2011, ANN INTERN MED, V154, P516, DOI 10.7326/0003-4819-154-8-201104190-00002; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Na HS, 2011, TRANSFUSION, V51, P118, DOI 10.1111/j.1537-2995.2010.02783.x; Nasso G, 2009, ANN THORAC SURG, V88, P1520, DOI 10.1016/j.athoracsur.2009.07.014; Nemeth Elizabeta, 2010, Adv Hematol, V2010, P750643, DOI 10.1155/2010/750643; Overgaard J, 2007, EJC SUPPL, V5, P7, DOI 10.1016/S1359-6349(07)70099-X; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Rahe-Meyer N, 2013, ANESTHESIOLOGY, V118, P40, DOI 10.1097/ALN.0b013e3182715d4d; Raje D, 2007, DIS COLON RECTUM, V50, P1211, DOI 10.1007/s10350-007-0249-y; Reiter RA, 2003, BLOOD, V102, P4594, DOI 10.1182/blood-2002-11-3566; Rizzo JD, 2010, J ONCOL PRACT, V6, P317, DOI 10.1200/JOP.2010.000132; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Schochl H, 2011, CRIT CARE, V15, DOI 10.1186/cc10078; Shander A, 2012, BRIT J ANAESTH, V109, P55, DOI 10.1093/bja/aes139; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Singla NK, 2011, J AM COLL SURGEONS, V213, P722, DOI 10.1016/j.jamcollsurg.2011.08.019; Smith RE, 2008, J CLIN ONCOL, V26, P1040, DOI 10.1200/JCO.2007.14.2885; Solomon SB, 2013, BLOOD, V121, P1663, DOI 10.1182/blood-2012-10-462945; Sowade O, 1997, BLOOD, V89, P411, DOI 10.1182/blood.V89.2.411; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Spotnitz WD, 2012, TRANSFUSION, V52, P2243, DOI 10.1111/j.1537-2995.2012.03707.x; Steinlechner B, 2011, ANN THORAC SURG, V91, P1420, DOI 10.1016/j.athoracsur.2011.01.052; Stowell CP, 2009, SPINE, V34, P2479, DOI 10.1097/BRS.0b013e3181bd163f; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; Swift S, 2010, BLOOD, V115, P4254, DOI 10.1182/blood-2009-10-248674; Tanno Toshihiko, 2010, Adv Hematol, V2010, P358283, DOI 10.1155/2010/358283; Thomas G, 2008, GYNECOL ONCOL, V108, P317, DOI 10.1016/j.ygyno.2007.10.011; Unger EF, 2010, NEW ENGL J MED, V362, P189, DOI 10.1056/NEJMp0912328; Untch M, 2011, ANN ONCOL, V22, P1988, DOI 10.1093/annonc/mdq709; Vamvakas EC, 2009, BLOOD, V113, P3406, DOI 10.1182/blood-2008-10-167643; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Virmani S, 2010, ANN CARD ANAESTH, V13, P34, DOI 10.4103/0971-9784.58832; Weber CF, 2012, ANESTHESIOLOGY, V117, P531, DOI 10.1097/ALN.0b013e318264c644; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Weltert L, 2013, TRANSFUSION, V53, P790, DOI 10.1111/j.1537-2995.2012.03836.x; Weltert L, 2010, J THORAC CARDIOV SUR, V139, P621, DOI 10.1016/j.jtcvs.2009.10.012; Wright JR, 2007, J CLIN ONCOL, V25, P1027, DOI 10.1200/JCO.2006.07.1514; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004; Yoo YC, 2011, ANESTHESIOLOGY, V115, P929, DOI 10.1097/ALN.0b013e318232004b	105	162	168	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2013	381	9880					1855	1865		10.1016/S0140-6736(13)60808-9	http://dx.doi.org/10.1016/S0140-6736(13)60808-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23706802	Green Published			2022-12-28	WOS:000319443700032
J	Fisher, SE; Ridley, M				Fisher, Simon E.; Ridley, Matt			Culture, Genes, and the Human Revolution	SCIENCE			English	Editorial Material							FOXP2; SPEECH; EVOLUTION		[Fisher, Simon E.] Max Planck Inst Psycholinguist, Dept Language & Genet, NL-6525 XD Nijmegen, Netherlands; [Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Ridley, Matt] House Lords, London SW1A 0PW, England	Max Planck Society; Radboud University Nijmegen	Fisher, SE (corresponding author), Max Planck Inst Psycholinguist, Dept Language & Genet, Wundtlaan 1, NL-6525 XD Nijmegen, Netherlands.	simon.fisher@mpi.nl	Fisher, Simon E./E-9130-2012	Fisher, Simon E./0000-0002-3132-1996				[Anonymous], 1997, GUNS GERMS STEEL; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Klein R., 2002, DAWN HUMAN CULTURE; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Maricic T, 2013, MOL BIOL EVOL, V30, P844, DOI 10.1093/molbev/mss271; McBrearty S, 2007, RETHINKING HUMAN REV, P133; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Richerson P.J., 2004, NOT GENES ALONE; Somel M, 2013, NAT REV NEUROSCI, V14, P112, DOI 10.1038/nrn3372; Vallender EJ, 2008, TRENDS NEUROSCI, V31, P637, DOI 10.1016/j.tins.2008.08.010; Wrangham RW, 2009, CATCHING FIRE COOKIN	15	38	39	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					929	930		10.1126/science.1236171	http://dx.doi.org/10.1126/science.1236171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149TK	23704558				2022-12-28	WOS:000319344100028
J	Veeraraghavalu, K; Zhang, C; Miller, S; Hefendehl, JK; Rajapaksha, TW; Ulrich, J; Jucker, M; Holtzman, DM; Tanzi, RE; Vassar, R; Sisodia, SS				Veeraraghavalu, Karthikeyan; Zhang, Can; Miller, Sean; Hefendehl, Jasmin K.; Rajapaksha, Tharinda W.; Ulrich, Jason; Jucker, Mathias; Holtzman, David M.; Tanzi, Rudolph E.; Vassar, Robert; Sisodia, Sangram S.			Comment on "ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models"	SCIENCE			English	Editorial Material							FAMILIAL ALZHEIMERS-DISEASE; TRANSGENIC MICE		[Veeraraghavalu, Karthikeyan; Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Zhang, Can; Miller, Sean; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Massachusetts Gen Inst Neurodegenerat Dis, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA 02129 USA; [Zhang, Can; Miller, Sean; Tanzi, Rudolph E.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Hefendehl, Jasmin K.; Jucker, Mathias] Univ Tubingen, German Ctr Neurodegenerat Dis, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; [Rajapaksha, Tharinda W.; Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Ulrich, Jason; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO 63110 USA; [Holtzman, David M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA	University of Chicago; Harvard University; Massachusetts General Hospital; Harvard University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Jucker, M (corresponding author), Univ Tubingen, German Ctr Neurodegenerat Dis, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Otfried Muller Str 27, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de; holtzman@neuro.wustl.edu; tanzi@helix.mgh.harvard.edu; r-vassar@northwestern.edu; ssisodia@bsd.uchicago.edu	Tanzi, Rudolph/AAE-9622-2019; Hefendehl, Jasmin/AAM-1598-2020	Tanzi, Rudolph/0000-0002-7032-1454; 				Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009	9	133	147	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135							1235505	10.1126/science.1235505	http://dx.doi.org/10.1126/science.1235505			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704555				2022-12-28	WOS:000319344100024
J	Uehata, T; Iwasaki, H; Vandenbon, A; Matsushita, K; Hernandez-Cuellar, E; Kuniyoshi, K; Satoh, T; Mino, T; Suzuki, Y; Standley, DM; Tsujimura, T; Rakugi, H; Isaka, Y; Takeuchi, O; Akira, S				Uehata, Takuya; Iwasaki, Hidenori; Vandenbon, Alexis; Matsushita, Kazufumi; Hernandez-Cuellar, Eduardo; Kuniyoshi, Kanako; Satoh, Takashi; Mino, Takashi; Suzuki, Yutaka; Standley, Daron M.; Tsujimura, Tohru; Rakugi, Hiromi; Isaka, Yoshitaka; Takeuchi, Osamu; Akira, Shizuo			Malt1-Induced Cleavage of Regnase-1 in CD4(+) Helper T Cells Regulates Immune Activation	CELL			English	Article							MESSENGER-RNA; TRANSCRIPTION FACTORS; C-REL; ROLES; GENES; MALT1; MICRORNAS; STABILITY; ALPHA	Regnase-1 (also known as Zc3h12a and MCPIP1) is an RNase that destabilizes a set of mRNAs, including Il6 and Il12b, through cleavage of their 3' UTRs. Although Regnase-1 inactivation leads to development of an autoimmune disease characterized by T cell activation and hyperimmunoglobulinemia in mice, the mechanism of Regnase-1-mediated immune regulation has remained unclear. We show that Regnase-1 is essential for preventing aberrant effector CD4(+) T cell generation cell autonomously. Moreover, in T cells, Regnase-1 regulates the mRNAs of a set of genes, including c-Rel, Ox40, and Il2, through cleavage of their 30 UTRs. Interestingly, T cell receptor (TCR) stimulation leads to cleavage of Regnase-1 at R111 by Malt1/paracaspase, freeing T cells from Regnase-1-mediated suppression. Furthermore, Malt1 protease activity is critical for controlling the mRNA stability of T cell effector genes. Collectively, these results indicate that dynamic control of Regnase-1 expression in T cells is critical for controlling T cell activation.	[Uehata, Takuya; Iwasaki, Hidenori; Matsushita, Kazufumi; Hernandez-Cuellar, Eduardo; Kuniyoshi, Kanako; Satoh, Takashi; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Lab Host Def, Suita, Osaka 5650871, Japan; [Vandenbon, Alexis; Standley, Daron M.] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Lab Syst Immunol, Suita, Osaka 5650871, Japan; [Kuniyoshi, Kanako; Satoh, Takashi; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Uehata, Takuya; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Iwasaki, Hidenori] Japan Tobacco, Cent Pharmaceut Res Inst, Takatsuki, Osaka 5691125, Japan; [Mino, Takashi; Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 6068507, Japan; [Takeuchi, Osamu] JST, CREST, Sakyo Ku, Kyoto 6068507, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom, Kashiwa, Chiba 2778562, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Japan Tobacco Inc.; Kyoto University; Japan Science & Technology Agency (JST); University of Tokyo; Hyogo College of Medicine	Akira, S (corresponding author), Osaka Univ, Lab Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Vandenbon, Alexis/A-8430-2017; Mino, Takashi/GRO-0332-2022; Standley, Daron/D-2343-2009; Vandenbon, Alexis/N-4428-2019; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; Mino, Takashi/0000-0002-9562-008X; Rakugi, Hiromi/0000-0001-6508-4338	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS); JSPS; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25860355, 22689016] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of our laboratory, E. Kamada and M. Kageyama for secretarial assistance, and Y. Fujiwara, M. Kumagai, K. Nojima, and N. Umano for technical assistance. We also thank I. Taniuchi for CD4-Cre mice, S.W. Morris and S. Yamasaki for Bcl10<SUP>-</SUP>/-mice, V.M. Dixit and N. Kayagaki for Malt1<SUP>-</SUP>/-mice, S. Gerondakis and T. Kurosaki for c-Rel<SUP>-</SUP>/-mice, and L.M. McAllister-Lucas for the Flag-API2-Malt1 plasmids. This work was supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the funding program for World-Leading Innovative R&D on Science and Technology (FIRST Program) and the Grant-in- Aid for Specially Promoted Research. This work was also supported by the JSPS Grant-in-Aid for Young Scientists (A) (OT) and a grant-in-aid for Scientific Research on Innovative Areas "Genome Science'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	35	232	242	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1036	1049		10.1016/j.cell.2013.04.034	http://dx.doi.org/10.1016/j.cell.2013.04.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706741	Bronze			2022-12-28	WOS:000319456800012
J	Watts, G				Watts, Geoff			Harry Keen Obituary	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1714	1714		10.1016/S0140-6736(13)61066-1	http://dx.doi.org/10.1016/S0140-6736(13)61066-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TA	23691550	Bronze			2022-12-28	WOS:000319112800021
J	Vilcinskas, A; Stoecker, K; Schmidtberg, H; Rohrich, CR; Vogel, H				Vilcinskas, Andreas; Stoecker, Kilian; Schmidtberg, Henrike; Roehrich, Christian R.; Vogel, Heiko			Invasive Harlequin Ladybird Carries Biological Weapons Against Native Competitors	SCIENCE			English	Article							HARMONIA-AXYRIDIS	Invasive species that proliferate after colonizing new habitats have a negative environmental and economic impact. The reason why some species become successful invaders, whereas others, even closely related species, remain noninvasive is often unclear. The harlequin ladybird Harmonia axyridis, introduced for biological pest control, has become an invader that is outcompeting indigenous ladybird species in many countries. Here, we show that Harmonia carries abundant spores of obligate parasitic microsporidia closely related to Nosema thompsoni. These microsporidia, while not harming the carrier Harmonia, are lethal pathogens for the native ladybird Coccinella septempunctata. We propose that intraguild predation, representing a major selective force among competing ladybird species, causes the infection and ultimate death of native ladybirds when they feed on microsporidia-contaminated Harmonia eggs or larvae.	[Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35392 Giessen, Germany; [Stoecker, Kilian] Bundeswehr Inst Microbiol, D-80937 Munich, Germany; [Vilcinskas, Andreas; Stoecker, Kilian; Schmidtberg, Henrike; Roehrich, Christian R.] Fraunhofer Inst Mol Biol & Appl Ecol, D-35394 Giessen, Germany; [Vogel, Heiko] Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Justus Liebig University Giessen; Bundeswehr Institute of Microbiology (IMB); Fraunhofer Gesellschaft; Max Planck Society	Vilcinskas, A (corresponding author), Univ Giessen, Inst Phytopathol & Appl Zool, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	andreas.vilcinskas@agrar.uni-giessen.de			excellence initiative of the Hessian Ministry of Science and Art via the LOEWE research focus "Insect Biotechnology"	excellence initiative of the Hessian Ministry of Science and Art via the LOEWE research focus "Insect Biotechnology"	We acknowledge project funding provided by the excellence initiative of the Hessian Ministry of Science and Art via the LOEWE research focus "Insect Biotechnology." We thank J. Rolff for critical reading and R. M. Twyman for editing of the manuscript.	Alpert P, 2006, BIOL INVASIONS, V8, P1523, DOI 10.1007/s10530-005-5844-z; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Gardiner MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023576; Kajita Y, 2010, OECOLOGIA, V163, P313, DOI 10.1007/s00442-009-1551-2; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Rohrich CR, 2012, BIOL LETTERS, V8, P308, DOI 10.1098/rsbl.2011.0760; Roy H, 2008, BIOCONTROL, V53, P1, DOI 10.1007/s10526-007-9127-8; Roy HE, 2008, BIOCONTROL, V53, P265, DOI 10.1007/s10526-007-9122-0; Vilcinskas A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2113; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Weiss Louis M., 1999, P129	12	116	124	5	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					862	863		10.1126/science.1234032	http://dx.doi.org/10.1126/science.1234032			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687046				2022-12-28	WOS:000318997400043
J	Dumont, A; Fournier, P; Abrahamowicz, M; Traore, M; Haddad, S; Fraser, WD				Dumont, Alexandre; Fournier, Pierre; Abrahamowicz, Michal; Traore, Mamadou; Haddad, Slim; Fraser, William D.		QUARITE Res Grp	Quality of care, risk management, and technology in obstetrics to reduce hospital-based maternal mortality in Senegal and Mali (QUARITE): a cluster-randomised trial	LANCET			English	Article							DEATH REVIEWS	Background Maternal mortality is higher in west Africa than in most industrialised countries, so the development and validation of effective interventions is essential. We did a trial to assess the effect of a multifaceted intervention to promote maternity death reviews and onsite training in emergency obstetric care in referral hospitals with high maternal mortality rates in Senegal and Mali. Methods We did a pragmatic cluster-randomised controlled trial, with hospitals as the units of randomisation and patients as the unit of analysis. 46 public first-level and second-level referral hospitals with more than 800 deliveries a year were enrolled, stratified by country and hospital type, and randomly assigned to either the intervention group (n=23) or the control group with no external intervention (n=23). All women who delivered in each of the participating facilities during the baseline and post-intervention periods were included. The intervention, implemented over a period of 2 years at the hospital level, consisted of an initial interactive workshop and quarterly educational clinically-oriented and evidence-based outreach visits focused on maternal death reviews and best practices implementation. The primary outcome was reduction of risk of hospital-based mortality. Analysis was by intention-to-treat and relied on the generalised estimating equations extension of the logistic regression model to account for clustering of women within hospitals. This study is registered with ClinicalTrials.gov, number ISRCTN46950658. Findings 191 167 patients who delivered in the participating hospitals were analysed (95 931 in the intervention groups and 95 236 in the control groups). Overall, mortality reduction in intervention hospitals was significantly higher than in control hospitals (odds ratio [OR] 0.85, 95% CI 0.73-0.98, p=0.0299), but this effect was limited to capital and district hospitals, which mainly acted as first-level referral hospitals in this trial. There was no effect in second-level referral (regional) hospitals outside the capitals (OR 1.02, 95% CI 0.79-1.31, p=0.89). No hospitals were lost to follow-up. Concrete actions were implemented comprehensively to improve quality of care in intervention hospitals. Interpretation Regular visits by a trained external facilitator and onsite training can provide health-care professionals with the knowledge and confidence to make quality improvement suggestions during audit sessions. Maternal death reviews, combined with best practices implementation, are effective in reducing hospital-based mortality in first-level referral hospitals. Further studies are needed to determine whether the benefits of the intervention are generalisable to second-level referral hospitals.	[Dumont, Alexandre] Univ Paris 05, IRD, UMR 216, Sorbonne Paris Cite, F-75006 Paris, France; [Dumont, Alexandre; Fraser, William D.] Univ Montreal, CHU St Justine, Res Ctr, Montreal, PQ, Canada; [Fournier, Pierre; Haddad, Slim] Univ Montreal, CHUM CRCHUM, Res Ctr, Montreal, PQ, Canada; [Abrahamowicz, Michal] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Traore, Mamadou] URFOSAME, Referral Hlth Ctr Commune 5, Bamako, Mali; [Fraser, William D.] Univ Montreal, Dept Obstet & Gynaecol, Montreal, PQ, Canada	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; McGill University; Universite de Montreal	Dumont, A (corresponding author), Univ Paris 05, IRD, UMR 216, 4 Ave Observ, F-75006 Paris, France.	alexandre.dumont@ird.fr	Dumont, Alexandre/I-9429-2016; Trajman, Anete/C-7679-2016	Dumont, Alexandre/0000-0003-3826-0193; Trajman, Anete/0000-0002-4000-4984; Abrahamowicz, Michal/0000-0002-3172-3952	Canadian Institutes of Health Research; QUARITE trial under Randomized Controlled Trials committee	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); QUARITE trial under Randomized Controlled Trials committee	Canadian Institutes of Health Research.; We thank all the medical and administrative staff of the 46 participating centres for their valuable contribution in this trial. We wish to thank the Canadian Institutes of Health Research (CIHR), which fully funded the QUARITE trial under the auspices of the Randomized Controlled Trials committee. The CIHR also provided a 2-year salary grant to AD for the development of this project in the context of the Randomized Controlled Trials Mentoring Program. Statistical analyses were also supported by the CIHR, grant 81275. We also thank the Fonds de Recherche en Sante du Quebec for providing a research fellowship and operating grant to support this research project. MA is a James McGill Professor at McGill University. WDF receives salary support from CIHR through a Canada Research Chair. The trial has been funded by the CIHR, grant number 200602MCT-157547-RFA-CFCF-100169.	Briand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047352; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dumont A, 2006, B WORLD HEALTH ORGAN, V84, P218, DOI 10.2471/BLT.05.023903; Dumont A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-61; Dumont A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-85; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Kaye DK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-65; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Kongnyuy E J, 2008, Women Birth, V21, P149, DOI 10.1016/j.wombi.2008.08.002; KRITCHEVSKY SB, 1991, JAMA-J AM MED ASSOC, V266, P1817, DOI 10.1001/jama.266.13.1817; Liu XN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-566; MARTEY JO, 1993, INT J GYNECOL OBSTET, V42, P237, DOI 10.1016/0020-7292(93)90217-K; MBARUKU G, 1995, HEALTH POLICY PLANN, V10, P71, DOI 10.1093/heapol/10.1.71; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Santos C, 2006, INT J GYNECOL OBSTET, V94, P190, DOI 10.1016/j.ijgo.2006.05.024; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Society of Obstetricians and Gynaecologists of Canada, 2007, ALARM INT PROGR MAN; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; van Lonkhuijzen L, 2010, BJOG-INT J OBSTET GY, V117, P777, DOI 10.1111/j.1471-0528.2010.02561.x; Witter S, 2010, HEALTH POLICY PLANN, V25, P384, DOI 10.1093/heapol/czq013; World Health Organization, 2004, NUMB REV MAT DEATHS; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	27	89	89	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					146	157		10.1016/S0140-6736(13)60593-0	http://dx.doi.org/10.1016/S0140-6736(13)60593-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23721752				2022-12-28	WOS:000322115300030
J	Montesi, LGJ				Montesi, Laurent G. J.			Solving the Mascon Mystery	SCIENCE			English	Editorial Material							BASINS; MARS		Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Montesi, LGJ (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	montesi@geology.umd.edu	Montesi, Laurent G. J./C-5216-2009	Montesi, Laurent G. J./0000-0002-3519-1412				Andrews-Hanna JC, 2013, ICARUS, V222, P159, DOI 10.1016/j.icarus.2012.10.031; Melosh HJ, 2013, SCIENCE, V340, P1552, DOI [10.1126/science.1235768, 10.1126/science.1238663]; Montesi LGJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001974; MULLER PM, 1968, SCIENCE, V161, P680, DOI 10.1126/science.161.3842.680; Neumann GA, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002262; Neumann GA, 1996, J GEOPHYS RES-PLANET, V101, P16841, DOI 10.1029/96JE01246; Nimmo F, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018847; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; SOLOMON SC, 1980, REV GEOPHYS, V18, P107, DOI 10.1029/RG018i001p00107; Wieczorek MA, 1999, ICARUS, V139, P246, DOI 10.1006/icar.1999.6102	10	8	10	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1535	1536		10.1126/science.1238099	http://dx.doi.org/10.1126/science.1238099			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23722423				2022-12-28	WOS:000321007000028
J	Morens, DM; Taubenberger, JK; Fauci, AS				Morens, David M.; Taubenberger, Jeffery K.; Fauci, Anthony S.			Pandemic Influenza Viruses - Hoping for the Road Not Taken	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Morens, David M.; Fauci, Anthony S.] Natl Inst Allergy & Infect Dis, Natl Inst Hlth, Off Director, Bethesda, MD USA; [Taubenberger, Jeffery K.] Natl Inst Allergy & Infect Dis, Natl Inst Hlth, Viral Pathogenesis & Evolut Sect, Lab Infect Dis, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), Natl Inst Allergy & Infect Dis, Natl Inst Hlth, Off Director, Bethesda, MD USA.		Taubenberger, Jeffery/AAQ-1407-2021		Intramural NIH HHS [ZIA AI000986-06] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2012, NATURE, V486, P335; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Morens DM, 2013, CLIN INFECT DIS, V56, P1213, DOI 10.1093/cid/cit051; Morens DM, 2011, REV MED VIROL, V21, P262, DOI 10.1002/rmv.689; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819	5	50	53	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2345	2348		10.1056/NEJMp1307009	http://dx.doi.org/10.1056/NEJMp1307009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167AE	23738514	Green Accepted			2022-12-28	WOS:000320601700001
J	Efron, B				Efron, Bradley			Bayes' Theorem in the 21st Century	SCIENCE			English	Editorial Material									Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University	Efron, B (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.	brad@stat.stanford.edu			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB002784] Funding Source: NIH RePORTER; NIBIB NIH HHS [R37 EB002784] Funding Source: Medline; Direct For Mathematical & Physical Scien [1208787] Funding Source: National Science Foundation	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger J, 2006, BAYESIAN ANAL, V1, P385, DOI 10.1214/06-BA115; Efron B, 2010, I MATH STAT MONOGRAP; Efron B, 2013, B AM MATH SOC, V50, P129, DOI 10.1090/S0273-0979-2012-01374-5; Robbins H, 1956, P 3 BERK S MATH STAT, V1, P157; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Wang S, 2013, SCIENCE, V339, P758, DOI 10.1126/science.1232290	7	106	112	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1177	1178		10.1126/science.1236536	http://dx.doi.org/10.1126/science.1236536			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744934				2022-12-28	WOS:000319972800030
J	Kempermann, G				Kempermann, Gerd			What the Bomb Said About the Brain	SCIENCE			English	Editorial Material							ADULT NEUROGENESIS; NEURONS		[Kempermann, Gerd] Tech Univ Dresden, DZNE, D-01307 Dresden, Germany; [Kempermann, Gerd] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Technische Universitat Dresden	Kempermann, G (corresponding author), Tech Univ Dresden, DZNE, Fetscherstr 105, D-01307 Dresden, Germany.	gerd.kempermann@dzne.de	Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061				Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Appleby PA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001063; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002	11	7	7	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1180	1181		10.1126/science.1240681	http://dx.doi.org/10.1126/science.1240681			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744936				2022-12-28	WOS:000319972800032
J	Bass, JK; Annan, J; Murray, SM; Kaysen, D; Griffiths, S; Cetinoglu, T; Wachter, K; Murray, LK; Bolton, PA				Bass, Judith K.; Annan, Jeannie; Murray, Sarah McIvor; Kaysen, Debra; Griffiths, Shelly; Cetinoglu, Talita; Wachter, Karin; Murray, Laura K.; Bolton, Paul A.			Controlled Trial of Psychotherapy for Congolese Survivors of Sexual Violence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COGNITIVE-PROCESSING THERAPY; POSTTRAUMATIC-STRESS-DISORDER; HOPKINS SYMPTOM CHECKLIST-25; ANXIETY DISORDERS; BEHAVIORAL THERAPY; PTSD CHECKLIST; MENTAL-HEALTH; EXPOSURE; EFFICACY; VICTIMS	BACKGROUND Survivors of sexual violence have high rates of depression, anxiety, and post-traumatic stress disorder (PTSD). Although treatment for symptoms related to sexual violence has been shown to be effective in high-income countries, evidence is lacking in low-income, conflict-affected countries. METHODS In this trial in the Democratic Republic of Congo, we randomly assigned 16 villages to provide cognitive processing therapy (1 individual session and 11 group sessions) or individual support to female sexual-violence survivors with high levels of PTSD symptoms and combined depression and anxiety symptoms. One village was excluded owing to concern about the competency of the psychosocial assistant, resulting in 7 villages that provided therapy (157 women) and 8 villages that provided individual support (248 women). Assessments of combined depression and anxiety symptoms (average score on the Hopkins Symptom Checklist [range, 0 to 3, with higher scores indicating worse symptoms]), PTSD symptoms (average score on the PTSD Checklist [range, 0 to 3, with higher scores indicating worse symptoms]), and functional impairment (average score across 20 tasks [range, 0 to 4, with higher scores indicating greater impairment]) were performed at baseline, at the end of treatment, and 6 months after treatment ended. RESULTS A total of 65% of participants in the therapy group and 52% of participants in the individual-support group completed all three assessments. Mean scores for combined depression and anxiety improved in the individual-support group (2.2 at baseline, 1.7 at the end of treatment, and 1.5 at 6 months after treatment), but improvements were significantly greater in the therapy group (2.0 at baseline, 0.8 at the end of treatment, and 0.7 at 6 months after treatment) (P<0.001 for all comparisons). Similar patterns were observed for PTSD and functional impairment. At 6 months after treatment, 9% of participants in the therapy group and 42% of participants in the individual-support group met criteria for probable depression or anxiety (P<0.001), with similar results for PTSD. CONCLUSIONS In this study of sexual-violence survivors in a low-income, conflict-affected country, group psychotherapy reduced PTSD symptoms and combined depression and anxiety symptoms and improved functioning.	[Bass, Judith K.; Murray, Sarah McIvor; Murray, Laura K.; Bolton, Paul A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21210 USA; [Bolton, Paul A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21210 USA; [Annan, Jeannie] Int Rescue Comm, Res & Evaluat Unit, New York, NY USA; [Kaysen, Debra] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Kaysen, Debra] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Griffiths, Shelly] Univ Washington, Harborview Ctr Sexual Assault & Traumat Stress, Seattle, WA 98195 USA; [Cetinoglu, Talita] Int Rescue Comm, Kinshasa, DEM REP CONGO; [Wachter, Karin] Univ Texas Austin, Sch Social Work, Austin, TX 78712 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Austin	Bass, JK (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 624 N Broadway,Room 861, Baltimore, MD 21210 USA.	jbass@jhsph.edu	Kaysen, Debra/AAR-2585-2020	Bass, Judith/0000-0002-5192-628X; Kaysen, Debra/0000-0001-7961-2787; Murray, Sarah/0000-0002-4976-9713; Wachter, Karin/0000-0002-4809-0047; Cetinoglu, Talita/0000-0001-9208-4560	U.S. Agency for International Development Victims of Torture Fund; World Bank	U.S. Agency for International Development Victims of Torture Fund(United States Agency for International Development (USAID)); World Bank(The World Bank India)	Funded by the U.S. Agency for International Development Victims of Torture Fund and the World Bank; ClinicalTrials.gov number, NCT01385163.	Bass JK, 2008, TROP MED INT HEALTH, V13, P1534, DOI 10.1111/j.1365-3156.2008.02160.x; Bolton P, 2002, SOC PSYCH PSYCH EPID, V37, P537, DOI 10.1007/s00127-002-0580-5; Booth BM, 2011, J TRAUMA STRESS, V24, P287, DOI 10.1002/jts.20643; Campbell R, 2009, TRAUMA VIOLENCE ABUS, V10, P225, DOI 10.1177/1524838009334456; Chard K. M., 2008, COGNITIVE PROCESSING; Chard KM, 2005, J CONSULT CLIN PSYCH, V73, P965, DOI 10.1037/0022-006X.73.5.965; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; Chivers-Wilson Kaitlin A, 2006, Mcgill J Med, V9, P111; Cloitre M, 2010, AM J PSYCHIAT, V167, P915, DOI 10.1176/appi.ajp.2010.09081247; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Dorrepaal E, 2010, CHILD ABUSE NEGLECT, V34, P284, DOI 10.1016/j.chiabu.2009.07.003; Foa E., 2010, EFFECTIVE TREATMENTS; Forbes D, 2010, J TRAUMA STRESS, V23, P537, DOI 10.1002/jts.20565; Greene MC, WORLD PSYCH IN PRESS; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Murray LK, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-30; Nishith P, 2005, J AFFECT DISORDERS, V86, P259, DOI 10.1016/j.jad.2005.02.013; Olatunji BO, 2010, PSYCHIAT CLIN N AM, V33, P557, DOI 10.1016/j.psc.2010.04.002; Ougrin D, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-200; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; RESICK PA, 1993, J INTERPERS VIOLENCE, V8, P223, DOI 10.1177/088626093008002005; RESICK PA, 1992, J CONSULT CLIN PSYCH, V60, P748, DOI 10.1037/0022-006X.60.5.748; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Resick PA, 2012, J CONSULT CLIN PSYCH, V80, P201, DOI 10.1037/a0026602; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sholomskas DE, 2005, J CONSULT CLIN PSYCH, V73, P106, DOI 10.1037/0022-006X.73.1.106; Stewart RE, 2009, J CONSULT CLIN PSYCH, V77, P595, DOI 10.1037/a0016032; Thoennes, 2006, EXTENT NATURE CONSEQ; Tsutsumi A, 2008, SOC SCI MED, V66, P1841, DOI 10.1016/j.socscimed.2007.12.025; Ventevogel P, 2007, SOC PSYCH PSYCH EPID, V42, P328, DOI 10.1007/s00127-007-0161-8; Verdeli Helen, 2003, World Psychiatry, V2, P114; Vickerman KA, 2009, CLIN PSYCHOL REV, V29, P431, DOI 10.1016/j.cpr.2009.04.004; Weathers FW, 1991, PTSD CHECKLIST CIVIL; WINOKUR A, 1984, BRIT J PSYCHIAT, V144, P395, DOI 10.1192/bjp.144.4.395	40	248	249	3	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2182	2191		10.1056/NEJMoa1211853	http://dx.doi.org/10.1056/NEJMoa1211853			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DN	23738545				2022-12-28	WOS:000319948900006
J	Hawkes, N				Hawkes, Nigel			The government's drug pricing policy is falling apart messily	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Collins M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1363; Hawkes N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2933; Kmietowicz K., 2010, BRIT MED J, V340, pc2832; O'Dowd A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2965	4	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 5	2013	346								f3634	10.1136/bmj.f3634	http://dx.doi.org/10.1136/bmj.f3634			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YF	23741032				2022-12-28	WOS:000320229500005
J	Hochman, ME; Chen, AY; Serota, M				Hochman, Michael E.; Chen, Alex Y.; Serota, Martin			A View From the Safety Net	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hochman, Michael E.; Chen, Alex Y.; Serota, Martin] AltaMed Hlth Serv Corp, Commerce, CA USA; [Chen, Alex Y.] Childrens Hosp, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles	Hochman, ME (corresponding author), AltaMed Hlth Serv Corp, Commerce, CA USA.	mhochman@la.altamed.org						Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Brook RH, 2010, JAMA-J AM MED ASSOC, V304, P1831, DOI 10.1001/jama.2010.1555; Katz MH, 2010, JAMA-J AM MED ASSOC, V304, P679, DOI 10.1001/jama.2010.1126; Wells R, 2009, J HEALTH CARE POOR U, V20, P507, DOI 10.1353/hpu.0.0151	4	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2221	2222		10.1001/jama.2013.3443	http://dx.doi.org/10.1001/jama.2013.3443			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736732				2022-12-28	WOS:000319859200025
J	DesRoches, CM; Audet, AM; Painter, M; Donelan, K				DesRoches, Catherine M.; Audet, Anne-Marie; Painter, Michael; Donelan, Karen			Meeting Meaningful Use Criteria and Managing Patient Populations A National Survey of Practicing Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTRONIC HEALTH RECORD; CARE; INCENTIVES; SYSTEMS	Background: Meaningful use, as defined by the Centers for Medicare & Medicaid Services, will require the aggregation of patient data to enable population assessment. Little is known about the proportion of physicians who are able to meet meaningful use criteria or their use of electronic health records (EHRs) to manage patient populations. Objective: To evaluate physicians' reports of EHR adoption and ease of use and their ability to use EHRs for patient panel management. Design: National mailed survey of practicing physicians (response rate of 60%). Setting: Late 2011 and early 2012. Participants: 1820 primary care physicians and specialists in office-based practices. Measurements: Proportion of physicians who have a basic EHR and meet meaningful use criteria and ease of use of computerized systems designed for patient population management tasks. Results: A total of 43.5% of physicians reported having a basic EHR, and 9.8% met meaningful use criteria. Computerized systems for managing patient populations were not widespread; fewer than one half of respondents reported the presence of computerized systems for any of the patient population management tasks included in the survey. Physicians with such functionalities reported that these systems varied in ease of use. Physicians with an EHR that met meaningful use criteria were significantly more likely than those not meeting the standard to rate panel management tasks as easy. Limitation: Ease-of-use measures are subjective. Conclusion: Few physicians could meet meaningful use criteria in early 2012 and using computerized systems for the panel management tasks was difficult. Results support the growing evidence that using the basic data input capabilities of an EHR does not translate into the greater opportunity that these technologies promise.	[DesRoches, Catherine M.] Mathemat Policy Res, Cambridge, MA 02139 USA; Commonwealth Fund, New York, NY USA; Robert Wood Johnson Fdn, Princeton, NJ 08540 USA; Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA	Mathematica; Commonwealth Fund; Robert Wood Johnson Foundation (RWJF); Harvard University; Massachusetts General Hospital	DesRoches, CM (corresponding author), Mathemat Policy Res, 955 Massachusetts Ave,Suite 800, Cambridge, MA 02139 USA.	cdesroches@mathematica-mpr.com	Donelan, Karen/R-6162-2019; DesRoches, Catherine/ABC-9869-2020	DesRoches, Catherine/0000-0001-5373-855X	Robert Wood Johnson Foundation [68812]; Commonwealth Fund [20110087]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Commonwealth Fund	By the Robert Wood Johnson Foundation (grant 68812) and the Commonwealth Fund (grant 20110087).	Blumenthal D, 2011, NEW ENGL J MED, V365, P2426, DOI 10.1056/NEJMsr1112158; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Bruen BK, 2011, HEALTH AFFAIR, V30, P472, DOI 10.1377/hlthaff.2010.0932; Burt CW, 2005, HEALTH AFFAIR, V24, P1334, DOI 10.1377/hlthaff.24.5.1334; *CENT MED MED SERV, 2012, COMB MED MED PAYM ST, P33245; Centers for Medicare and Medicaid Services, 2010, MED MED EHR INC PROG; Decker SL, 2012, HEALTH AFFAIR, V31, P1108, DOI 10.1377/hlthaff.2011.1121; DesRoches C. M., 2013, HLTH INFORM TECHNOLO; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Dinakarpandian D, 2007, ANN ALLERG ASTHMA IM, V99, P2, DOI 10.1016/S1081-1206(10)60613-8; Edwards PJ, 2008, INT J HUM-COMPUT ST, V66, P718, DOI 10.1016/j.ijhcs.2008.06.002; FIEGL C, 2012, EHR CERTIFICATION LA, P33245; Friedberg MW, 2009, ANN INTERN MED, V151, P456, DOI 10.7326/0003-4819-151-7-200910060-00006; Gill JM, 2012, J AM BOARD FAM MED, V25, P283, DOI 10.3122/jabfm.2012.03.110217; GUERRA A, 2011, INFORMATIONWEEK, P33245; Hogan SO, 2010, HEALTH AFFAIR, V29, P601, DOI 10.1377/hlthaff.2009.1023; Hsiao CJ, 2012, HEALTH AFFAIR, V31, P1100, DOI 10.1377/hlthaff.2011.1315; Jha AK, 2006, HEALTH AFFAIR, V25, pW496, DOI 10.1377/hlthaff.25.w496; Menachemi Nir, 2006, Qual Manag Health Care, V15, P150; *OFF NAT COORD HLT, MEAN US STAG 2, P33245; *SAS INS, 2012, BAS SAS 9 3 PROC GUI, P33245; Wright A, 2012, J AM MED INFORM ASSN, V19, P555, DOI 10.1136/amiajnl-2011-000521	22	46	46	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					791	+		10.7326/0003-4819-158-11-201306040-00003	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164AA	23732712				2022-12-28	WOS:000320379800002
J	Lumsden, MA; Gebbie, A; Holland, C				Lumsden, Mary Ann; Gebbie, Ailsa; Holland, Cathrine			Managing unscheduled bleeding in non-pregnant premenopausal women	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ENDOMETRIAL POLYPS; UTERINE; PREVALENCE; PATHOLOGY; CYCLE		[Lumsden, Mary Ann] Univ Glasgow, Dept Reprod & Maternal Med, Glasgow G4 0SF, Lanark, Scotland; [Gebbie, Ailsa] NHS Lothian Sexual & Reprod Hlth Serv, Edinburgh, Midlothian, Scotland; [Holland, Cathrine] Cent Manchester Univ Hosp Fdn Trust, Dept Gynaecol Oncol, Manchester, Lancs, England	University of Glasgow; University of Manchester	Lumsden, MA (corresponding author), Univ Glasgow, Dept Reprod & Maternal Med, Glasgow G4 0SF, Lanark, Scotland.	maryann.lumsden@glasgow.ac.uk						AAGL Advancing Minimally Invasive, 2012, J MINIM INVAS GYN, V19, P3, DOI 10.1016/j.jmig.2011.09.003; ABDELALEEM H, 2007, COCHRANE DB SYST REV, V4; [Anonymous], 2004, SEL PRACT REC CONTR; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; Cancer Research UK, 2009, CANCERSTATS CANC STA; Critchley HO, 2001, HLTH TECHNOLOGY ASSE, V8, p[iii, 1]; Donnez J, 2012, NEW ENGL J MED, V366, P409, DOI 10.1056/NEJMoa1103182; Dreisler E, 2009, ULTRASOUND OBST GYN, V33, P102, DOI 10.1002/uog.6259; Endrikat J, 2003, GYNECOL ENDOCRINOL, V17, P107, DOI 10.1080/713603216; ESHRE Capri Workshop Grp, 2007, HUM REPROD UPDATE, V13, P421; Faculty of Sexual and Reproductive Healthcare, 2007, INTR CONTR; Faculty of Sexual & Reproductive Healthcare (FSRH), 2020, ESSENTIAL SERVICES S; Farquhar C, 2003, ACTA OBSTET GYN SCAN, V82, P493, DOI 10.1034/j.1600-0412.2003.00191.x; Gallo MF, 2011, COCHRANE DB SYST REV, V1; Gupta JK, 2012, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD005073; HARLOW BL, 1986, J NATL CANCER I, V76, P399; Henderson HJ, 2009, J FAM PLAN REPROD H, V35, P49, DOI 10.1783/147118909787072315; Hickey M, 2000, BEST PRACT RES CL OB, V14, P937, DOI 10.1053/beog.2000.0136; Hickey M, 2012, COCHRANE DB SYST REV, V9; Kjerulff KH, 1996, J REPROD MED, V41, P483; Lee SC, 2010, OBSTET GYNECOL, V116, P1197, DOI 10.1097/AOG.0b013e3181f74864; Lumsden MA, 2009, OBSTET GYNAECOL REPR, V20, P82; National Collaborating Centre for Patients's and Children's Health, 2005, LONG ACT REV CONTR C; National Institute for Health and Care Excellence, 2007, HEAV MENSTR BLEED IN; National Institute for Health and Care Excellence, 2005, REF SUSP CANC; Oddsson K, 2005, HUM REPROD, V20, P557, DOI 10.1093/humrep/deh604; *OFF NAT STAT, 2005, CANC STAT REG REG CA; Orbo A, 2008, GYNECOL ONCOL, V111, P68, DOI 10.1016/j.ygyno.2008.06.014; Public Health England, 2010, CLIN PRACT GUID ASS; Public Health England, 2010, GUID NHS CERV, P15; Rosenthal AN, 2001, BRIT J OBSTET GYNAEC, V108, P103, DOI 10.1111/j.1471-0528.2001.00008.x; Sahu Banchhita, 2007, Archives of Gynecology and Obstetrics, V276, P471, DOI 10.1007/s00404-007-0362-0; Szarewski A, 2009, J FAM PLAN REPROD H, V35, P71, DOI 10.1783/147118909787931933; TRELOAR AE, 1967, INT J FERTIL, V12, P77; Warner P, 2001, BRIT MED J, V323, P24, DOI 10.1136/bmj.323.7303.24	35	6	8	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2013	346								f3251	10.1136/bmj.f3251	http://dx.doi.org/10.1136/bmj.f3251			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YD	23737266				2022-12-28	WOS:000320229300009
J	McNamara, JM; Fawcett, TW; Houston, AI				McNamara, John M.; Fawcett, Tim W.; Houston, Alasdair I.			An Adaptive Response to Uncertainty Generates Positive and Negative Contrast Effects	SCIENCE			English	Article							DECISIONS; BEHAVIOR; REWARD; RISK	Successive contrast effects, in which behavior is dependent on whether conditions are currently better or worse than they were before, are a striking illustration of the fact that animals evaluate the world in relative terms. Existing explanations for these effects are based on descriptive models of psychological and physiological processes, but little attention has been paid to the factors promoting their evolution. Using a simple and general optimality model, we show that contrast effects can result from an adaptive response to uncertainty in a changing, unpredictable world. A wide range of patterns of environmental change will select for sensitivity to past conditions, generating positive and negative contrast effects. Our analysis reveals the importance of incorporating uncertainty and environmental stochasticity into models of adaptive behavior.	[McNamara, John M.] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England; [Fawcett, Tim W.; Houston, Alasdair I.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol; University of Bristol	Fawcett, TW (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	tim.fawcett@cantab.net	Fawcett, Tim/A-5439-2010	Fawcett, Tim/0000-0001-6337-901X	European Research Council [250209]	European Research Council(European Research Council (ERC)European Commission)	We thank A. Higginson, A. Radford, D. Mallpress, and P. Trimmer for discussion and the European Research Council for funding (Advanced Grant 250209 to A.I.H.). J.M.M. and A.I.H. conceived the project, J.M.M. built the model, and T.W.F. analyzed the model and wrote the paper with input from the other authors.	Amsel A., 1992, FRUSTRATION THEORY; Bentosela M, 2009, J COMP PSYCHOL, V123, P125, DOI 10.1037/a0013340; CAPALDI EJ, 1967, J EXP PSYCHOL, V75, P226, DOI 10.1037/h0024986; COUVILLON PA, 1984, J COMP PSYCHOL, V98, P100, DOI 10.1037/0735-7036.98.1.100; Crespi LP, 1942, AM J PSYCHOL, V55, P467, DOI 10.2307/1417120; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Freidin E, 2009, ANIM BEHAV, V77, P857, DOI 10.1016/j.anbehav.2008.12.010; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Higginson AD, 2012, AM NAT, V180, P589, DOI 10.1086/667885; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Houston AI, 1999, MODELS ADAPTIVE BEHA; HUBER J, 1982, J CONSUM RES, V9, P90, DOI 10.1086/208899; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KOBRE KR, 1972, J EXP CHILD PSYCHOL, V14, P81, DOI 10.1016/0022-0965(72)90033-1; MCHOSE JH, 1975, ANIM LEARN BEHAV, V3, P239, DOI 10.3758/BF03213438; MCNAMARA J, 1980, J THEOR BIOL, V85, P673, DOI 10.1016/0022-5193(80)90265-9; McNamara J. M., 2011, ECOL LETT, V14, P58; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Morgan KV, 2012, BEHAV PROCESS, V89, P115, DOI 10.1016/j.beproc.2011.08.017; Mustaca AE, 2000, LEARN MOTIV, V31, P272, DOI 10.1006/lmot.2000.1055; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; PAPINI MR, 1988, ANIM LEARN BEHAV, V16, P53, DOI 10.3758/BF03209043; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Tversky A., 1991, SUBJECTIVE WELL BEIN, P101; ZEAMAN D, 1949, J EXP PSYCHOL, V39, P466, DOI 10.1037/h0060477	27	45	45	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1084	1086		10.1126/science.1230599	http://dx.doi.org/10.1126/science.1230599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23723234				2022-12-28	WOS:000319664500041
J	Willcox, ML; Mant, J; O'Dempsey, T				Willcox, Merlin L.; Mant, Jill; O'Dempsey, Tim			Imported malaria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE FALCIPARUM-MALARIA; RAPID DIAGNOSTIC-TESTS; RETURNING TRAVELERS; RANDOMIZED-TRIAL; CHILDREN; ARTESUNATE; QUININE		[Willcox, Merlin L.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2EP, England; [Mant, Jill] Luton Hosp, Dept Paediat, Luton, Beds, England; [O'Dempsey, Tim] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Oxford; Liverpool School of Tropical Medicine; University of Liverpool	Willcox, ML (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2EP, England.	merlin.willcox@phc.ox.ac.uk	Willcox, Merlin/I-6255-2019	Willcox, Merlin/0000-0002-5227-3444; O'Dempsey, Tim/0000-0002-9596-9687				Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; [Anonymous], 2007, MAIL ONLINE     0110; Batwala V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-349; Bottieau E, 2007, EUR J CLIN MICROBIOL, V26, P181, DOI 10.1007/s10096-007-0264-x; British Medical Association, 2013, BRIT NATL FORMULARY, V65, p[422, 428]; Centers for Disease Control and Prevention, 2012, DOM REF HLTH GUID MA; Checkley AM, 2012, BRIT MED J, V344; D'Acremont V, 2002, AM J TROP MED HYG, V66, P481, DOI 10.4269/ajtmh.2002.66.481; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dubos F, 2010, DIAGN MICR INFEC DIS, V66, P169, DOI 10.1016/j.diagmicrobio.2009.08.018; Faiz MA, 2005, LANCET, V366, P717; Green ST, 2009, J INFECTION, V58, P172, DOI 10.1016/j.jinf.2008.12.001; Health Protection Agency, 2012, IMP MAL CAS DEATHS U; Kiang KM, 2013, ARCH DIS CHILDHOOD-E, V98, P7, DOI 10.1136/archdischild-2011-301530; Ladhani S, 2003, PEDIATR INFECT DIS J, V22, P814, DOI 10.1097/01.inf.0000086401.13592.79; Ladhani S, 2007, LANCET INFECT DIS, V7, P349, DOI 10.1016/S1473-3099(07)70110-X; Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003; Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012; Rossi IA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-377; SVENSON JE, 1995, ARCH INTERN MED, V155, P861, DOI 10.1001/archinte.155.8.861; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, GUID TREATM MAL, V2nd	22	2	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2013	346								f3214	10.1136/bmj.f3214	http://dx.doi.org/10.1136/bmj.f3214			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DM	23723453				2022-12-28	WOS:000319948800005
J	Lacetera, N; Macis, M; Slonim, R				Lacetera, Nicola; Macis, Mario; Slonim, Robert			Economic Rewards to Motivate Blood Donations	SCIENCE			English	Editorial Material							PROSOCIAL BEHAVIOR; DONOR RECRUITMENT; FIELD EXPERIMENTS; INCENTIVES		[Lacetera, Nicola] Univ Toronto, Mississauga, ON L5L 1C6, Canada; [Macis, Mario] Johns Hopkins Univ, Baltimore, MD 21202 USA; [Macis, Mario; Slonim, Robert] Inst Study Lab IZA, D-53113 Bonn, Germany; [Slonim, Robert] Univ Sydney, Sydney, NSW 2006, Australia	University of Toronto; University Toronto Mississauga; Johns Hopkins University; IZA Institute Labor Economics; University of Sydney	Lacetera, N (corresponding author), Univ Toronto, Mississauga, ON L5L 1C6, Canada.	nicola.lacetera@utoronto.ca	Macis, Mario/H-4214-2013	Macis, Mario/0000-0001-6635-2752; Lacetera, Nicola/0000-0002-3191-8792; Slonim, Robert/0000-0002-9513-4970				Ala F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001309; Arrow J. J., 1972, PHILOS PUBLIC AFF, V1, P343; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Chmielewski D, 2012, TRANSFUSION, V52, P1889, DOI 10.1111/j.1537-2995.2011.03545.x; Costa-i-Font J., 2012, 3527 CESIFO GROUP; Eastlund T, 1998, TRANSFUSION, V38, P874, DOI 10.1046/j.1537-2995.1998.38998409009.x; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; FERRARI JR, 1985, J SOC PSYCHOL, V125, P791, DOI 10.1080/00224545.1985.9713559; Glynn SA, 2003, TRANSFUSION, V43, P7, DOI 10.1046/j.1537-2995.2003.00252.x; Gneezy U., 2012, J ECON PERSPECT, V25, P1; Goette L., 2008, 3580 IZA I STUD LAB; Goette L, 2009, TRANSFUSION, V49, P524, DOI 10.1111/j.1537-2995.2008.02007.x; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; Iajya V., 2012, 18630 NBER; Kamenica E, 2012, ANNU REV ECON, V4, P427, DOI 10.1146/annurev-economics-080511-110909; Kessler JB, 2012, AM ECON REV, V102, P2018, DOI 10.1257/aer.102.5.2018; Lacetera Niclola, 2011, 17636 NBER; Lacetera N, 2013, J LAW ECON ORGAN, V29, P1384, DOI 10.1093/jleo/ews019; Lacetera N, 2012, AM ECON J-ECON POLIC, V4, P186, DOI 10.1257/pol.4.1.186; Lacetera N, 2010, J ECON BEHAV ORGAN, V76, P225, DOI 10.1016/j.jebo.2010.08.007; Lacetera N, 2010, J ECON PSYCHOL, V31, P738, DOI 10.1016/j.joep.2010.05.007; List JA, 2008, SCIENCE, V322, P672; Mellstrom C, 2008, J EUR ECON ASSOC, V6, P845, DOI 10.1162/JEEA.2008.6.4.845; Reich P, 2006, TRANSFUSION, V46, P1090, DOI 10.1111/j.1537-2995.2006.00856.x; Roth AE, 2007, J ECON PERSPECT, V21, P37, DOI 10.1257/jep.21.3.37; Sanchez AM, 2001, TRANSFUSION, V41, P172, DOI 10.1046/j.1537-2995.2001.41020172.x; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P21, DOI 10.1186/1478-4505-4-21; SOLOW RM, 1971, YALE LAW J, V80, P1696, DOI 10.2307/795132; Titmuss, 1971, GIFT RELATIONSHIP; Vaillant G. E., 1977, ADAPTATION LIFE; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2009, REP GLOB CONS 100 VO	32	83	85	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					927	928		10.1126/science.1232280	http://dx.doi.org/10.1126/science.1232280			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149TK	23704557				2022-12-28	WOS:000319344100027
J	Burn, J				Burn, John			Should we sequence everyone's genome? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK	Burn, J (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	john.burn@newcastle.ac.uk		Burn, John/0000-0002-9823-2322	Cancer Research UK [15934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10282] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))		Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Chief Medical Officer, 2010, 2009 ANN REP CHIEF M; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	5	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3133	10.1136/bmj.f3133	http://dx.doi.org/10.1136/bmj.f3133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23694691				2022-12-28	WOS:000319573300008
J	Daskivich, TJ; Fan, KH; Koyama, T; Albertsen, PC; Goodman, M; Hamilton, AS; Hoffman, RM; Stanford, JL; Stroup, AM; Litwin, MS; Penson, DF				Daskivich, Timothy J.; Fan, Kang-Hsien; Koyama, Tatsuki; Albertsen, Peter C.; Goodman, Michael; Hamilton, Ann S.; Hoffman, Richard M.; Stanford, Janet L.; Stroup, Antoinette M.; Litwin, Mark S.; Penson, David F.			Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population-Based Cohort of Men With Prostate Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							RADICAL PROSTATECTOMY; RADIATION-THERAPY; LIFE EXPECTANCY; SUBDISTRIBUTION; VALIDATION; OUTCOMES	Background: Accurate estimation of life expectancy is essential to offering appropriate care to men with early-stage prostate cancer, but mortality risks associated with comorbidity are poorly defined. Objective: To determine the effect of age, comorbidity, and tumor risk on other-cause and prostate cancer-specific mortality in men with early-stage disease. Design: Prospective cohort study. Setting: A nationally representative, population-based cohort. Patients: 3183 men with nonmetastatic prostate cancer at diagnosis. Measurements: Baseline self-reported comorbidity (scored as a count of 12 major comorbid conditions), tumor characteristics, initial treatment, and overall and disease-specific mortality through 14 years of follow-up. Survival analyses that accounted for competing risks were performed. Results: Fourteen-year cumulative other-cause mortality rates were 24%, 33%, 46%, and 57% for men with 0, 1, 2, and 3 or more comorbid conditions, respectively. For men diagnosed at age 65 years, subhazard ratios for other-cause mortality among those with 1, 2, or 3 or more comorbid conditions (vs. none) were 1.2 (95% CI, 1.0 to 1.4), 1.7 (CI, 1.4 to 2.0), and 2.4 (CI, 2.0 to 2.8), respectively. Among men with 3 or more comorbid conditions, 10-year other-cause mortality rates were 26%, 40%, and 71% for those aged 60 years or younger, 61 to 74 years, and 75 years or older at diagnosis, respectively. Prostate cancer-specific mortality was minimal in patients with low-risk (3%) and intermediate-risk (7%) disease but appreciable in those with high-risk disease (18%) and did not vary by number of comorbid conditions (10% to 11% in all groups). Limitation: Comorbid conditions were self-reported. Conclusion: Older men with multiple major comorbid conditions are at high risk for other-cause mortality within 10 years of diagnosis and should consider this information when deciding between conservative management and aggressive treatment for low-or intermediate-risk prostate cancer.	Univ Calif Los Angeles, Los Angeles, CA USA; Univ So Calif, Los Angeles, CA 90089 USA; Vanderbilt Univ, Nashville, TN 37203 USA; Vet Affairs Tennessee Valley Geriatr Res Educ & C, Nashville, TN USA; Univ Connecticut, Farmington, CT 06030 USA; Emory Univ, Atlanta, GA 30322 USA; Univ New Mexico, Albuquerque, NM 87131 USA; New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; Univ Utah, Salt Lake City, UT 84108 USA	University of California System; University of California Los Angeles; University of Southern California; Vanderbilt University; Geriatric Research Education & Clinical Center; University of Connecticut; Emory University; University of New Mexico; Fred Hutchinson Cancer Center; Utah System of Higher Education; University of Utah	Penson, DF (corresponding author), Vanderbilt Univ, Med Ctr, 2525 West End Ave,Suite 600, Nashville, TN 37203 USA.			Litwin, Mark/0000-0002-2318-344X; Penson, David/0000-0002-2580-2697; Fan, Kang-hsien/0000-0003-0121-3959; Hoffman, Richard/0000-0002-4714-7726	National Cancer Institute of the National Institutes of Health [R01CA114524]; Robert Wood Johnson Clinical Scholars Foundation; American Cancer Society; American Urological Association; NATIONAL CANCER INSTITUTE [R01CA114524] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert Wood Johnson Clinical Scholars Foundation; American Cancer Society(American Cancer Society); American Urological Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By grant R01CA114524 from the National Cancer Institute of the National Institutes of Health. Dr. Daskivich is supported by grants from the Robert Wood Johnson Clinical Scholars Foundation, American Cancer Society, and American Urological Association.	Albertsen PC, 2011, J CLIN ONCOL, V29, P1335, DOI 10.1200/JCO.2010.31.2330; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Boorjian SA, 2008, J UROLOGY, V179, P1354, DOI 10.1016/j.juro.2007.11.061; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cowen ME, 2006, J UROLOGY, V175, P99, DOI 10.1016/S0022-5347(05)00018-2; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Daskivich TJ, 2011, CANCER-AM CANCER SOC, V117, P4642, DOI 10.1002/cncr.26104; Daskivich TJ, 2011, CANCER-AM CANCER SOC, V117, P2058, DOI 10.1002/cncr.25751; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fowler JE, 1996, J UROLOGY, V156, P1714, DOI 10.1016/S0022-5347(01)65489-2; Grambauer N, 2010, STAT MED, V29, P875, DOI 10.1002/sim.3786; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gray RJ, 2011, CMPRSK SUBDISTRIBUTI; Klabunde CN, 2005, MED CARE, V43, P391, DOI 10.1097/01.mlr.0000156851.80900.d1; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Tewari A, 2004, J UROLOGY, V171, P1513, DOI 10.1097/01.ju.0000117975.40782.95; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Walz J, 2008, BJU INT, V102, P33, DOI 10.1111/j.1464-410X.2008.07614.x; Walz J, 2007, J CLIN ONCOL, V25, P3576, DOI 10.1200/JCO.2006.10.3820; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683	25	121	124	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					709	+		10.7326/0003-4819-158-10-201305210-00005	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689764	Green Accepted			2022-12-28	WOS:000319666200013
J	Pinstrup-Andersen, P				Pinstrup-Andersen, Per			Nutrition-sensitive food systems: from rhetoric to action	LANCET			English	Editorial Material									Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Pinstrup-Andersen, P (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	pp94@cornell.edu						Bhutta ZA, 2013, LANCET; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Gillespie S, 2013, LANCET; Herforth A., 2012, PRIORITIZING NUTR AG; Masset E., 2011, SYSTEMATIC REV AGR I; Monteiro CA, 2009, PUBLIC HEALTH NUTR, V12, P729, DOI 10.1017/S1368980009005291; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Pinstrup-Andersen P., 2012, CTR FOOD SECURITY EN, P51; Pinstrup-Anderson P., 2011, FOOD POLICY DEV COUN; Ruel M, 2013, LANCET	10	70	71	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					375	376		10.1016/S0140-6736(13)61053-3	http://dx.doi.org/10.1016/S0140-6736(13)61053-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23746779				2022-12-28	WOS:000322638500008
J	Chopra, V; Anand, S; Hickner, A; Buist, M; Rogers, MAM; Saint, S; Flanders, SA				Chopra, Vineet; Anand, Sarah; Hickner, Andy; Buist, Michael; Rogers, Mary A. M.; Saint, Sanjay; Flanders, Scott A.			Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis	LANCET			English	Article							DEEP-VEIN THROMBOSIS; LINE-ASSOCIATED THROMBOSIS; RETROSPECTIVE ANALYSIS; HOSPITALIZED-PATIENTS; CANCER-PATIENTS; HEMATOLOGICAL MALIGNANCIES; INTRAVENOUS THERAPY; PICC; COMPLICATIONS; PATTERNS	Background Peripherally inserted central catheters (PICCs) are associated with an increased risk of venous thromboembolism. However, the size of this risk relative to that associated with other central venous catheters (CVCs) is unknown. We did a systematic review and meta-analysis to compare the risk of venous thromboembolism associated with PICCs versus that associated with other CVCs. Methods We searched several databases, including Medline, Embase, Biosis, Cochrane Central Register of Controlled Trials, Conference Papers Index, and Scopus. Additional studies were identified through hand searches of bibliographies and internet searches, and we contacted study authors to obtain unpublished data. All human studies published in full text, abstract, or poster form were eligible for inclusion. All studies were of adult patients aged at least 18 years who underwent insertion of a PICC. Studies were assessed with the Newcastle-Ottawa risk of bias scale. In studies without a comparison group, the pooled frequency of venous thromboembolism was calculated for patients receiving PICCs. In studies comparing PICCs with other CVCs, summary odds ratios (ORs) were calculated with a random effects meta-analysis. Findings Of the 533 citations identified, 64 studies (12 with a comparison group and 52 without) including 29 503 patients met the eligibility criteria. In the non-comparison studies, the weighted frequency of PICC-related deep vein thrombosis was highest in patients who were critically ill (13.91%, 95% CI 7.68-20.14) and those with cancer (6.67%, 4.69-8.64). Our meta-analysis of 11 studies comparing the risk of deep vein thrombosis related to PICCs with that related to CVCs showed that PICCs were associated with an increased risk of deep vein thrombosis (OR 2.55, 1.54-4.23, p<0.0001) but not pulmonary embolism (no events). With the baseline PICC-related deep vein thrombosis rate of 2.7% and pooled OR of 2.55, the number needed to harm relative to CVCs was 26 (95% CI 13-71). Interpretation PICCs are associated with a higher risk of deep vein thrombosis than are CVCs, especially in patients who are critically ill or those with a malignancy. The decision to insert PICCs should be guided by weighing of the risk of thrombosis against the benefit provided by these devices.	[Chopra, Vineet; Anand, Sarah; Hickner, Andy; Buist, Michael; Rogers, Mary A. M.; Saint, Sanjay; Flanders, Scott A.] Univ Michigan Hlth Syst, Dept Internal Med, Div Gen Internal Med, Ann Arbor, MI 48109 USA; [Chopra, Vineet; Hickner, Andy; Saint, Sanjay] Ann Arbor Vet Affairs Med Ctr, Patient Safety Enhancement Program, Ann Arbor, MI USA; [Chopra, Vineet; Hickner, Andy; Saint, Sanjay] Ann Arbor Vet Affairs Med Ctr, Hosp Outcomes Program Excellence, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Chopra, V (corresponding author), Univ Michigan Hlth Syst, 2800 Plymouth Rd,Bldg 16 440E, Ann Arbor, MI 48109 USA.	vineetc@umich.edu	Saint, Sanjay/AAF-5126-2019	Chopra, Vineet/0000-0001-8670-9376; Hickner, Andy/0000-0003-1922-3813; Rogers, Mary/0000-0001-5519-3223	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS022835] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Abdullah JJ, 2005, BRIT J RADIOL, V78, P596, DOI 10.1259/bjr/32639616; Ahn DH., 2011, J CLIN ONCOL, V29; Akl EA, 2007, COCHRANE DB SYST REV, V3; Al Raiy B, 2010, AM J INFECT CONTROL, V38, P149, DOI 10.1016/j.ajic.2009.06.008; Alhimyary A, 1996, Nutr Clin Pract, V11, P199, DOI 10.1177/0115426596011005199; Allen AW, 2000, J VASC INTERV RADIOL, V11, P1309, DOI 10.1016/S1051-0443(07)61307-4; Aw A, 2012, THROMB RES, V130, P323, DOI 10.1016/j.thromres.2012.02.048; BAI YG, 2010, CHIN J CLIN NUTR, V18, P16; Baxi S, 2008, JOINT 48 INT C ANT A; BEGG CB, 1988, J ROY STAT SOC A STA, V151, P419, DOI 10.2307/2982993; Bonizzoli M, 2011, INTENS CARE MED, V37, P284, DOI 10.1007/s00134-010-2043-x; BOTTINO J, 1979, CANCER, V43, P1937, DOI 10.1002/1097-0142(197905)43:5<1937::AID-CNCR2820430554>3.0.CO;2-T; Brewer C., 2012, BR J NURS, V21, pS14; Brewer C., 2012, BR J NURS, V21, pS16; Brewer Carol, 2012, Br J Nurs, V21, pS16; Burg T, 2005, AM J OBSTET GYNECOL, V193, pS81, DOI 10.1016/j.ajog.2005.10.551; Cape A, 2007, AM J OBSTET GYNECOL, V197, pS119, DOI 10.1016/j.ajog.2007.10.411; Catalano O, 2011, ACTA RADIOL, V52, P148, DOI 10.1258/ar.2010.100294; Chakravarthy SB, 2005, CHEST, V128, p193S, DOI 10.1378/chest.128.4_MeetingAbstracts.193S-b; Chemaly RF, 2002, CLIN INFECT DIS, V34, P1179, DOI 10.1086/339808; Chopra V, 2012, JAMA-J AM MED ASSOC, V308, P1527, DOI 10.1001/jama.2012.12704; Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010; Chu SY, 2004, CHIN J RADIOL, V29, P61; Clemence B., 2011, J ASS VASC ACCESS, V16, P199; Cortelezza A, 2003, LEUKEMIA LYMPHOMA, V44, P1495, DOI 10.1080/1042819031000103980; Cowl CT, 2000, CLIN NUTR, V19, P237, DOI 10.1054/clnu.2000.0103; Curbelo-Irizarry A, 2006, 44 ANN M INF DIS SOC; DeLemos C, 2011, CRIT CARE NURSE, V31, P70, DOI 10.4037/ccn2011911; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Derudas D, 2009, HAEMATOLOGICA, V94, P24; Durrani Q, 2009, CRIT CARE MED, V37, pA365; Evans RS, 2013, CHEST, V143, P627, DOI 10.1378/chest.12-0923; Evans RS, 2010, CHEST, V138, P803, DOI 10.1378/chest.10-0154; Fearonce G, 2010, J BURN CARE RES, V31, P31, DOI 10.1097/BCR.0b013e3181cb8eaa; Fletcher JJ, 2011, NEUROCRIT CARE, V15, P454, DOI 10.1007/s12028-011-9554-3; Forauer AR, 2000, J VASC INTERV RADIOL, V11, P1315, DOI 10.1016/S1051-0443(07)61308-6; Gleason J., 1999, STATA TECH B, V52, P16; GRAHAM DR, 1991, AM J MED, V91, pS95, DOI 10.1016/0002-9343(91)90351-W; Grant JD, 2008, J INVEST MED, V56, P131; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P783, DOI 10.1093/oxfordjournals.aje.a117326; Grove JR, 2000, J VASC INTERV RADIOL, V11, P837, DOI 10.1016/S1051-0443(07)61797-7; Guyatt GH, 2012, CHEST, V141, p48S, DOI 10.1378/chest.11-2286; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Moraza-Dulanto MI, 2012, ENFERM CLIN, V22, P135, DOI 10.1016/j.enfcli.2012.04.002; King MM, 2006, SOUTH MED J, V99, P1073, DOI 10.1097/01.smj.0000240707.22171.12; Kirkpatrick A, 2007, AM J MED, V120, P901, DOI 10.1016/j.amjmed.2007.05.010; Kucher N, 2011, NEW ENGL J MED, V364, P861, DOI 10.1056/NEJMcp1008740; Lee AYY, 2006, J CLIN ONCOL, V24, P1404, DOI 10.1200/JCO.2005.03.5600; Lee JA, 2012, VASC ENDOVASC SURG, V46, P139, DOI 10.1177/1538574411432145; Liem TK, 2012, J VASC SURG, V55, P761, DOI 10.1016/j.jvs.2011.10.005; Lin L, 2004, BLOOD, V104, p107B, DOI 10.1182/blood.V104.11.4082.4082; Lobo BL, 2009, J HOSP MED, V4, P417, DOI 10.1002/jhm.442; LOUGHRAN SC, 1995, JPEN-PARENTER ENTER, V19, P133, DOI 10.1177/0148607195019002133; LOUPUS D, 2008, J ASS VASC ACCESS, V13, P82; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marnejon T, 2012, J VASC ACCESS, V13, P231, DOI 10.5301/jva.5000039; MERRELL SW, 1994, WESTERN J MED, V160, P25; Meyer BM, 2011, J ASS VASC ACCESS, V16, P144, DOI [10.2309/java.16-3-3, DOI 10.2309/JAVA.16-3-3]; Meyer BM, 2012, J INFUS MURS, V35, P34, DOI 10.1097/NAN.0b013e31823bc8fd; Mitchell MD, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.07.007; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mollee P, 2011, J HOSP INFECT, V78, P26, DOI 10.1016/j.jhin.2011.01.018; Mukherjee S, 2001, BRIT J CANCER, V85, P66; Munoz FJ, 2008, CHEST, V133, P143, DOI 10.1378/chest.07-1432; Nash EF, 2009, J VASC INTERV RADIOL, V20, P347, DOI 10.1016/j.jvir.2008.11.018; Nifong TP, 2011, CHEST, V140, P48, DOI 10.1378/chest.10-2637; NUNOO RHO, 2011, J AM COLL SURGEONS, V213, pS23; Ogura JM, 2003, AM J OBSTET GYNECOL, V188, P1223, DOI 10.1067/mob.2003.332; Ong B, 2006, Australas Radiol, V50, P451, DOI 10.1111/j.1440-1673.2006.01623.x; Paauw JD, 2008, JPEN-PARENTER ENTER, V32, P443, DOI 10.1177/0148607108319801; PARI C, 2011, J VASC ACCESS, V12, P81; Paz-Fumagalli R, 1997, J Spinal Cord Med, V20, P341; Periard D, 2008, J THROMB HAEMOST, V6, P1281, DOI 10.1111/j.1538-7836.2008.03053.x; Pikwer A, 2012, ANAESTHESIA, V67, P65, DOI 10.1111/j.1365-2044.2011.06911.x; Pittiruti M, 2009, INTENS CARE MED, V35, P262; Pittiruti M., 2012, J ASS VASCULAR ACCES, V16, P205; Romagnoli E, 2010, THROMB RES, V125, pS170, DOI 10.1016/S0049-3848(10)70066-9; Ros M, 2005, EJC SUPPL, V3, P442; SANSIVERO G, 2011, J VASC ACCESS, V12, P81, DOI DOI 10.5301/JVA.2011.6368; Seeley MA, 2007, J INFUS MURS, V30, P280; Shea CD, 2006, AM J GASTROENTEROL, V101, pS460, DOI 10.14309/00000434-200609001-01180; Simcock L., 2008, J ASS VASC ACCESS, V13, P191, DOI [10.2309/java.13-4-6, DOI 10.2309/JAVA.13-4-6]; Smith JR, 1998, AM J SURG, V176, P208, DOI 10.1016/S0002-9610(98)00121-4; Snelling R, 2001, J Intraven Nurs, V24, P38; Sperry BW, 2012, J VASC ACCESS, V13, P91, DOI 10.5301/jva.5000014; Strahilevitz J, 2001, LEUKEMIA LYMPHOMA, V40, P365, DOI 10.3109/10428190109057936; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tejedor SC, 2012, INFECT CONT HOSP EP, V33, P50, DOI 10.1086/663645; Tesselaar M., 2001, European Journal of Cancer, V37, pS354, DOI 10.1016/S0959-8049(01)81809-8; Tran H, 2010, LEUKEMIA LYMPHOMA, V51, P1473, DOI 10.3109/10428194.2010.481065; Trerotola SO, 2010, RADIOLOGY, V256, P312, DOI 10.1148/radiol.10091860; Vidal V, 2008, J RADIOL, V89, P495, DOI 10.1016/S0221-0363(08)71453-7; Walshe LJ, 2002, J CLIN ONCOL, V20, P3276, DOI 10.1200/JCO.2002.11.135; Wells G.A., 2000, VIS COMMUN Q; Wilson TJ, 2012, INTENS CARE MED, V38, P272, DOI 10.1007/s00134-011-2418-7; Wilson TJ, 2012, CLIN NEUROL NEUROSUR; Worley TA, 2007, CHEST, V132, p492S; Worth LJ, 2009, SUPPORT CARE CANCER, V17, P811, DOI 10.1007/s00520-008-0561-7; Xing L, 2012, CHIN J CLIN ONCOL, V38, P1223; Yue Zhi-Ying, 2010, Hu Li Za Zhi, V57, P79; Zhu MW, 2008, CHIN J CLIN NUTR, V16, P160	101	361	393	10	142	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					311	325		10.1016/S0140-6736(13)60592-9	http://dx.doi.org/10.1016/S0140-6736(13)60592-9			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23697825				2022-12-28	WOS:000322544900028
J	Luyckx, VA; Naicker, S; McKee, M				Luyckx, Valerie A.; Naicker, Saraladevi; McKee, Martin			Equity and economics of kidney disease in sub-Saharan Africa	LANCET			English	Editorial Material							DIALYSIS; BURDEN		[Luyckx, Valerie A.; McKee, Martin] London Sch Hyg & Trop Med, London WC1, England; [Luyckx, Valerie A.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Naicker, Saraladevi] Univ Witwatersrand, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Alberta; University of Witwatersrand	Luyckx, VA (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	vluyckx@ualberta.ca	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Luyckx, Valerie/J-9747-2019	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Luyckx, Valerie/0000-0001-7066-8135; Naicker, Saraladevi/0000-0002-7058-9725				Abu-Aisha H, 2010, PERITON DIALYSIS INT, V30, P23, DOI 10.3747/pdi.2008.00226; Arogundade FA, 2011, AFR HEALTH SCI, V11, P594; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dreyer G., 2012, BR J RENAL MED, V17, P24; Fresenius Medical Care, 2012, ESRD PAT 2011 GLOB P; Garcia GG, 2012, SAUDI J KIDNEY DIS T, V23, P215; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Naicker S, 2010, CLIN NEPHROL, V74, pS13; Pozo ME, 2012, TRANSPL INT, V25, P652, DOI 10.1111/j.1432-2277.2012.01468.x; Tantivess S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f462; The World Bank, GNI PER CAP ATL METH; WHO, 2011, WORLD GLOB EXP ATL	14	26	26	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					103	104		10.1016/S0140-6736(13)60817-X	http://dx.doi.org/10.1016/S0140-6736(13)60817-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187JY	23727172				2022-12-28	WOS:000322115300004
J	Oberlander, J; Morrison, M				Oberlander, Jonathan; Morrison, Marisa			Failure to Launch? The Independent Payment Advisory Board's Uncertain Prospects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oberlander, Jonathan; Morrison, Marisa] Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.							Aaron HJ, 2011, NEW ENGL J MED, V364, P2377, DOI 10.1056/NEJMp1105144; Ebeler J, 2011, INDEPENDPENT PAYMENT; Jost TS, 2010, NEW ENGL J MED, V363, P103, DOI 10.1056/NEJMp1005402; Newman D., 2010, INDEPENDENT PAYMENT; Orszag PR, 2010, NEW ENGL J MED, V363, P601, DOI 10.1056/NEJMp1006571	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					105	107		10.1056/NEJMp1306051	http://dx.doi.org/10.1056/NEJMp1306051			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180BH	23718154				2022-12-28	WOS:000321567300005
J	Wenzel, S; Ford, L; Pearlman, D; Spector, S; Sher, L; Skobieranda, F; Wang, L; Kirkesseli, S; Rocklin, R; Bock, B; Hamilton, J; Ming, JE; Radin, A; Stahl, N; Yancopoulos, GD; Graham, N; Pirozzi, G				Wenzel, Sally; Ford, Linda; Pearlman, David; Spector, Sheldon; Sher, Lawrence; Skobieranda, Franck; Wang, Lin; Kirkesseli, Stephane; Rocklin, Ross; Bock, Brian; Hamilton, Jennifer; Ming, Jeffrey E.; Radin, Allen; Stahl, Neil; Yancopoulos, George D.; Graham, Neil; Pirozzi, Gianluca			Dupilumab in Persistent Asthma with Elevated Eosinophil Levels	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IL-4; MEPOLIZUMAB; RECEPTOR; LYMPHOCYTES; ADULTS	BACKGROUND Moderate-to-severe asthma remains poorly treated. We evaluated the efficacy and safety of dupilumab (SAR231893/REGN668), a fully human monoclonal antibody to the alpha subunit of the interleukin-4 receptor, in patients with persistent, moderate-to-severe asthma and elevated eosinophil levels. METHODS We enrolled patients with persistent, moderate-to-severe asthma and a blood eosinophil count of at least 300 cells per microliter or a sputum eosinophil level of at least 3% who used medium-dose to high-dose inhaled glucocorticoids plus long-acting beta-agonists (LABAs). We administered dupilumab (300 mg) or placebo subcutaneously once weekly. Patients were instructed to discontinue LABAs at week 4 and to taper and discontinue inhaled glucocorticoids during weeks 6 through 9. Patients received the study drug for 12 weeks or until a protocol-defined asthma exacerbation occurred. The primary end point was the occurrence of an asthma exacerbation; secondary end points included a range of measures of asthma control. Effects on various type 2 helper T-cell (Th2)-associated biomarkers and safety and tolerability were also evaluated. RESULTS A total of 52 patients were assigned to the dupilumab group, and 52 patients were assigned to the placebo group. Baseline characteristics were similar in the two groups. Three patients had an asthma exacerbation with dupilumab (6%) versus 23 with placebo (44%), corresponding to an 87% reduction with dupilumab (odds ratio, 0.08; 95% confidence interval, 0.02 to 0.28; P<0.001). Significant improvements were observed for most measures of lung function and asthma control. Dupilumab reduced biomarkers associated with Th2-driven inflammation. Injection-site reactions, nasopharyngitis, nausea, and headache occurred more frequently with dupilumab than with placebo. CONCLUSIONS In patients with persistent, moderate-to-severe asthma and elevated eosinophil levels who used inhaled glucocorticoids and LABAs, dupilumab therapy, as compared with placebo, was associated with fewer asthma exacerbations when LABAs and inhaled glucocorticoids were withdrawn, with improved lung function and reduced levels of Th2-associated inflammatory markers.	[Wenzel, Sally] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Ford, Linda] Ctr Asthma & Allergy, Bellevue, NE USA; [Pearlman, David] Colorado Allergy Ctr, Denver, CO USA; [Pearlman, David] Colorado Asthma Ctr, Denver, CO USA; [Spector, Sheldon] Calif Allergy & Asthma Med Grp, Los Angeles, CA USA; [Sher, Lawrence] Peninsula Res Associates, Rolling Hills Estates, CA USA; [Skobieranda, Franck; Wang, Lin; Kirkesseli, Stephane; Rocklin, Ross; Bock, Brian; Ming, Jeffrey E.; Pirozzi, Gianluca] Sanofi, Res & Dev, Bridgewater, NJ USA; [Hamilton, Jennifer; Radin, Allen; Stahl, Neil; Yancopoulos, George D.; Graham, Neil] Regeneron Pharmaceut, Tarrytown, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sanofi-Aventis; Regeneron	Wenzel, S (corresponding author), 3459 5th Ave,NW 628 Montefiore, Pittsburgh, PA 15213 USA.	wenzelse@upmc.edu		Wenzel, Sally/0000-0002-4242-0164	Sanofi; Regeneron Pharmaceuticals; Amgen; Merck; Array BioPharma; Genentech; GlaxoSmithKline; Actelion; Gilead; Teva; Boehringer Ingelheim; Cephalon; Cerecor; Circassia; Cytos Biotechnology; Forest Laboratories; Hoffmann-La Roche; Johnson Johnson; Meda; MedImmune; Novartis; Pfizer; Rigel; Shionogi; Sunovion; Vectura; AstraZeneca; Hycor; KaloBios; Mylan; Revalesio; Roxane Laboratories; Boston Scientific	Sanofi; Regeneron Pharmaceuticals(Regeneron); Amgen(Amgen); Merck(Merck & Company); Array BioPharma(Pfizer); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Actelion; Gilead(Gilead Sciences); Teva(Teva Pharmaceutical Industries); Boehringer Ingelheim(Boehringer Ingelheim); Cephalon; Cerecor; Circassia; Cytos Biotechnology; Forest Laboratories; Hoffmann-La Roche(Hoffmann-La Roche); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Meda; MedImmune(AstraZenecaMedimmune); Novartis(Novartis); Pfizer(Pfizer); Rigel; Shionogi; Sunovion; Vectura; AstraZeneca(AstraZeneca); Hycor; KaloBios; Mylan; Revalesio; Roxane Laboratories; Boston Scientific(Boston Scientific)	Funded by Sanofi and Regeneron Pharmaceuticals; ClinicalTrials.gov number, NCT01312961.); Supported by Sanofi and Regeneron Pharmaceuticals.; Dr. Wenzel reports receiving grant support through her institution and travel support from Sanofi; grant support and consulting fees through her institution from Amgen; grant support and consulting fees through her institution from Merck; grant support through her institution from Array BioPharma, Genentech, and GlaxoSmithKline; and consulting fees from Regeneron Pharmaceuticals and, through her institution, from Actelion, Gilead, and Teva. Dr. Ford reports receiving grant support through her institution from Amgen, Array BioPharma, Boehringer Ingelheim, Cephalon, Cerecor, Circassia, Cytos Biotechnology, Forest Laboratories, Genentech, GlaxoSmithKline, Hoffmann-La Roche, Johnson & Johnson, Meda, MedImmune, Merck, Novartis, Pfizer, Rigel, Sanofi, Shionogi, Sunovion, Teva, and Vectura. Dr. Pearlman reports receiving grant support through his institution from GlaxoSmithKline, Meda, Merck, Novartis, Sanofi, Sunovion, and Teva. Dr. Spector reports receiving grant support through his institution and speaking fees from AstraZeneca; receiving grant support through his institution from GlaxoSmithKline and holding stock or stock options in the company; receiving grant support through his institution and consulting fees from Vectura; receiving grant support through his institution from Amgen, Array BioPharma, Forest Laboratories, Genentech, Hycor, Johnson & Johnson, KaloBios, Mylan, Revalesio, Rigel, Roxane Laboratories, Sanofi, and Teva; receiving speaking fees from Boston Scientific; receiving fees for expert testimony on behalf of a plumbing service company in cases regarding mold; and holding stock or stock options in Merck. Dr. Sher reports receiving grant support from Sanofi. Drs. Skobieranda, Wang, Kirkesseli, Bock, Ming, and Pirozzi report being full-time employees and shareholders of Sanofi. Dr. Rocklin reports having been a full-time employee of Sanofi during the conduct of the trial and now being an employee of Covance. Drs. Hamilton, Radin, Stahl, Yancopoulos, and Graham report being full-time employees and shareholders of Regeneron Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Andrew DP, 1998, J IMMUNOL, V161, P5027; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Borish LC, 2001, J ALLERGY CLIN IMMUN, V107, P963, DOI 10.1067/mai.2001.115624; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chibana K, 2008, CLIN EXP ALLERGY, V38, P936, DOI 10.1111/j.1365-2222.2008.02969.x; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Fish SC, 2005, J IMMUNOL, V174, P7716, DOI 10.4049/jimmunol.174.12.7716; Gavett SH, 1997, AM J PHYSIOL-LUNG C, V272, pL253, DOI 10.1152/ajplung.1997.272.2.L253; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hopkins C, 2009, CLIN OTOLARYNGOL, V34, P447, DOI 10.1111/j.1749-4486.2009.01995.x; Izuhara K., 2002, Current Drug Targets - Inflammation and Allergy, V1, P263, DOI 10.2174/1568010023344661; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Kay AB, 2006, CHEM IMMUNOL ALLERGY, V91, P59; Kupczyk M, 2012, J INTERN MED, V272, P121, DOI 10.1111/j.1365-2796.2012.02558.x; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Piper E, 2013, EUR RESPIR J, V41, P330, DOI 10.1183/09031936.00223411; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zahran Hatice S., 2011, Morbidity and Mortality Weekly Report, V60, P547	26	904	947	0	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2455	2466		10.1056/NEJMoa1304048	http://dx.doi.org/10.1056/NEJMoa1304048			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23688323				2022-12-28	WOS:000320926900006
J	Ahmari, SE; Spellman, T; Douglass, NL; Kheirbek, MA; Simpson, HB; Deisseroth, K; Gordon, JA; Hen, R				Ahmari, Susanne E.; Spellman, Timothy; Douglass, Neria L.; Kheirbek, Mazen A.; Simpson, H. Blair; Deisseroth, Karl; Gordon, Joshua A.; Hen, Rene			Repeated Cortico-Striatal Stimulation Generates Persistent OCD-Like Behavior	SCIENCE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; DEEP BRAIN-STIMULATION; NEUROBIOLOGY; CIRCUITRY; NEURONS	Although cortico-striato-thalamo-cortical (CSTC) circuit dysregulation is correlated with obsessive compulsive disorder (OCD), causation cannot be tested in humans. We used optogenetics in mice to simulate CSTC hyperactivation observed in OCD patients. Whereas acute orbitofrontal cortex (OFC)-ventromedial striatum (VMS) stimulation did not produce repetitive behaviors, repeated hyperactivation over multiple days generated a progressive increase in grooming, a mouse behavior related to OCD. Increased grooming persisted for 2 weeks after stimulation cessation. The grooming increase was temporally coupled with a progressive increase in light-evoked firing of postsynaptic VMS cells. Both increased grooming and evoked firing were reversed by chronic fluoxetine, a first-line OCD treatment. Brief but repeated episodes of abnormal circuit activity may thus set the stage for the development of persistent psychopathology.	[Ahmari, Susanne E.; Douglass, Neria L.; Kheirbek, Mazen A.; Simpson, H. Blair; Gordon, Joshua A.; Hen, Rene] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Ahmari, Susanne E.; Douglass, Neria L.; Kheirbek, Mazen A.; Gordon, Joshua A.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Ahmari, Susanne E.; Simpson, H. Blair] New York State Psychiat Inst & Hosp, Div Clin Therapeut, New York, NY 10032 USA; [Ahmari, Susanne E.; Simpson, H. Blair] New York State Psychiat Inst & Hosp, Anxiety Disorders Clin, New York, NY 10032 USA; [Ahmari, Susanne E.; Simpson, H. Blair] New York State Psychiat Inst & Hosp, OCD Res Program, New York, NY 10032 USA; [Spellman, Timothy] Columbia Univ Coll Phys & Surg, Dept Physiol, New York, NY 10032 USA; [Deisseroth, Karl] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA	Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; Columbia University; Stanford University; Stanford University	Ahmari, SE (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA.	sea2103@columbia.edu	Ahmari, Susanne E./J-5812-2013; Kheirbek, Mazen A/J-3656-2015	Ahmari, Susanne E./0000-0003-4576-076X; Kheirbek, Mazen A/0000-0001-9157-7363	National Institute of Mental Health (NIMH) [K08MH087718]; Louis V. Gerstner, Jr., Scholars Program; Irving Institute for Clinical and Translational Research; Gray Matters Foundation; Leon Levy Foundation; Brain and Behavior Research Foundation NARSAD Young Investigator Award; NIMH [K01MH099371]; Sackler Institute; NARSAD; Howard Hughes Medical Institute, NIH, California Institute for Regenerative Medicine; Defense Advance Research Projects Agency The Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program; NIH [R01 MH096274]; Hope for Depression Research Foundation; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096274, K01MH099371, K08MH087718, K24MH091555] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Louis V. Gerstner, Jr., Scholars Program; Irving Institute for Clinical and Translational Research; Gray Matters Foundation; Leon Levy Foundation; Brain and Behavior Research Foundation NARSAD Young Investigator Award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sackler Institute; NARSAD(NARSAD); Howard Hughes Medical Institute, NIH, California Institute for Regenerative Medicine(Howard Hughes Medical Institute); Defense Advance Research Projects Agency The Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Depression Research Foundation; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. B. Simpson and C. Kellendonk for critical discussions and reading of the manuscript and D. Flicker and M. Cloidt for behavioral scoring assistance. S. E. A. is supported by National Institute of Mental Health (NIMH) K08MH087718; the Louis V. Gerstner, Jr., Scholars Program; the Irving Institute for Clinical and Translational Research; the Gray Matters Foundation; the Leon Levy Foundation; and a Brain and Behavior Research Foundation NARSAD Young Investigator Award. M. A. K. is supported by NIMH K01MH099371, the Sackler Institute, and a NARSAD Young Investigator Award. K. D. is supported by the Howard Hughes Medical Institute, NIH, California Institute for Regenerative Medicine, and the Defense Advance Research Projects Agency The Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program. J.G. is supported by NIH R01 MH096274, the Hope for Depression Research Foundation, and the International Mental Health Research Organization. R. H. is supported by the Hope for Depression Research Foundation.	Abelson JL, 2005, BIOL PSYCHIAT, V57, P510, DOI 10.1016/j.biopsych.2004.11.042; Abler B, 2012, J NEUROSCI, V32, P1329, DOI 10.1523/JNEUROSCI.5826-11.2012; Ahmari SE, 2012, NEUROPSYCHOPHARMACOL, V37, P1216, DOI 10.1038/npp.2011.308; Antzoulatos EG, 2011, NEURON, V71, P243, DOI 10.1016/j.neuron.2011.05.040; BAXTER LR, 1988, AM J PSYCHIAT, V145, P1560; Bourne SK, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00029; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; de Koning PP, 2011, CURR PSYCHIAT REP, V13, P274, DOI 10.1007/s11920-011-0200-8; Dzirasa K, 2010, J NEUROSCI, V30, P6387, DOI 10.1523/JNEUROSCI.0764-10.2010; Gorski JA, 2002, J NEUROSCI, V22, P6309; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P1, DOI 10.1038/npp.2009.146; INSEL TR, 1992, PSYCHIAT CLIN N AM, V15, P813; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koran LM, 2007, AM J PSYCHIAT, V164, P5; Leckman JE, 2010, DEPRESS ANXIETY, V27, P507, DOI 10.1002/da.20669; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; McCabe C, 2010, BIOL PSYCHIAT, V67, P439, DOI 10.1016/j.biopsych.2009.11.001; Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1; Pittenger C, 2011, PHARMACOL THERAPEUT, V132, P314, DOI 10.1016/j.pharmthera.2011.09.006; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Rosenberg DR, 1998, BIOL PSYCHIAT, V43, P623, DOI 10.1016/S0006-3223(97)00443-5; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Ting JT, 2011, CURR OPIN NEUROBIOL, V21, P842, DOI 10.1016/j.conb.2011.04.010; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104	32	288	293	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1234	1239		10.1126/science.1234733	http://dx.doi.org/10.1126/science.1234733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744948	Green Accepted			2022-12-28	WOS:000319972800051
J	Wood, SF; Mador, JK				Wood, Susan F.; Mador, Jillian K.			Uncapping Conflict of Interest?	SCIENCE			English	Editorial Material									[Wood, Susan F.; Mador, Jillian K.] George Washington Univ, Washington, DC 20006 USA	George Washington University	Wood, SF (corresponding author), George Washington Univ, Washington, DC 20006 USA.	sfwood@gwu.edu						Ackerley N., 2009, FIN CONFL OF INT DIS; Ackerley Nyssa, 2007, MEASURING CONFLICT I; American Association of Colleges of Pharmacy AACP Institutional Members, 2012, AACP I MEMB; [Anonymous], 2001, SCI AAAS AUTH FORM S, P20013; [Anonymous], 2012, CONSUMER REPORTS; Association of American Medical Colleges, 2012, AAMC; Association of Schools of Public Health, 2012, MEMB SCH; CDER, 2012, 2011 NOV NEW DRUGS; *CTR SCI PUBL INT, 2005, CONFL INT COX 2 PAN; European Medicines Agency, EUR EXP LIST; FDA, 2011, ANN REP FDA AC VAC P; FDA, PERC FDA ADV COMM ME; FDA, 2012, GUID PUBL FDA ADV CO; Fontanarosa PB, 2010, JAMA-J AM MED ASSOC, V304, P1496, DOI 10.1001/jama.2010.1429; Hamburg MA, 2010, COMMUNICATION; Harris Gardiner, 2005, NY TIMES; Lenzer J, 2012, WASH MON        0109; Lo B, 2009, CONFLICT INTEREST ME; Lurie P, 2006, JAMA-J AM MED ASSOC, V295, P1921, DOI 10.1001/jama.295.16.1921; Science Board to the FDA, 2007, FDA SCI MISS RISK; Wood S. F., 2008, PUBLIC HLTH REP, V43, P409; Zinner DE, 2009, HEALTH AFFAIR, V28, P1814, DOI 10.1377/hlthaff.28.6.1814; Zuckerman Diana M., 2006, FDA ADVISORY COMMITT	23	9	9	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1172	1173		10.1126/science.1231955	http://dx.doi.org/10.1126/science.1231955			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158LP	23744930				2022-12-28	WOS:000319972800026
J	Leuppi, JD; Schuetz, P; Bingisser, R; Bodmer, M; Briel, M; Drescher, T; Duerring, U; Henzen, C; Leibbrandt, Y; Maier, S; Miedinger, D; Muller, B; Scherr, A; Schindler, C; Stoeckli, R; Viatte, S; von Garnier, C; Tamm, M; Rutishauser, J				Leuppi, Joerg D.; Schuetz, Philipp; Bingisser, Roland; Bodmer, Michael; Briel, Matthias; Drescher, Tilman; Duerring, Ursula; Henzen, Christoph; Leibbrandt, Yolanda; Maier, Sabrina; Miedinger, David; Mueller, Beat; Scherr, Andreas; Schindler, Christian; Stoeckli, Rolf; Viatte, Sebastien; von Garnier, Christophe; Tamm, Michael; Rutishauser, Jonas			Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease The REDUCE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SYSTEMIC GLUCOCORTICOIDS; ORAL PREDNISONE; COPD; PREVALENCE; MORTALITY	Importance International guidelines advocate a 7- to 14-day course of systemic glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease (COPD). However, the optimal dose and duration are unknown. Objective To investigate whether a short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation is noninferior to conventional (14 days) treatment in clinical outcome and whether it decreases the exposure to steroids. Design, Setting, and Patients REDUCE (Reduction in the Use of Corticosteroids in Exacerbated COPD), a randomized, noninferiority multicenter trial in 5 Swiss teaching hospitals, enrolling 314 patients presenting to the emergency department with acute COPD exacerbation, past or present smokers (>= 20 pack-years) without a history of asthma, from March 2006 through February 2011. Interventions Treatment with 40 mg of prednisone daily for either 5 or 14 days in a placebo-controlled, double-blind fashion. The predefined noninferiority criterion was an absolute increase in exacerbations of at most 15%, translating to a critical hazard ratio of 1.515 for a reference event rate of 50%. Main Outcome and Measure Time to next exacerbation within 180 days. Results Of 314 randomized patients, 289 (92%) of whom were admitted to the hospital, 311 were included in the intention-to-treat analysis and 296 in the per-protocol analysis. Hazard ratios for the short-term vs conventional treatment group were 0.95 (90% CI, 0.70 to 1.29; P=.006 for noninferiority) in the intention-to-treat analysis and 0.93 (90% CI, 0.68 to 1.26; P=.005 for noninferiority) in the per-protocol analysis, meeting our noninferiority criterion. In the short-term group, 56 patients (35.9%) reached the primary end point; 57 (36.8%) in the conventional group. Estimates of reexacerbation rates within 180 days were 37.2% (95% CI, 29.5% to 44.9%) in the short-term; 38.4% (95% CI, 30.6% to 46.3%) in the conventional, with a difference of -1.2% (95% CI, -12.2% to 9.8%) between the short-term and the conventional. Among patients with a reexacerbation, the median time to event was 43.5 days (interquartile range [IQR], 13 to 118) in the short-term and 29 days (IQR, 16 to 85) in the conventional. There was no difference between groups in time to death, the combined end point of exacerbation, death, or both and recovery of lung function. In the conventional group, mean cumulative prednisone dose was significantly higher (793 mg [95% CI, 710 to 876 mg] vs 379 mg [95% CI, 311 to 446 mg], P<.001), but treatment-associated adverse reactions, including hyperglycemia and hypertension, did not occur more frequently. Conclusions and Relevance In patients presenting to the emergency department with acute exacerbations of COPD, 5-day treatment with systemic glucocorticoids was noninferior to 14-day treatment with regard to reexacerbation within 6 months of follow-up but significantly reduced glucocorticoid exposure. These findings support the use of a 5-day glucocorticoid treatment in acute exacerbations of COPD.	[Leuppi, Joerg D.; Drescher, Tilman; Maier, Sabrina; Miedinger, David; Scherr, Andreas] Univ Basel Hosp, Clin Internal Med, Basel, Switzerland; [Bingisser, Roland; Bodmer, Michael] Univ Basel Hosp, Interdisciplinary Emergency Dept, Basel, Switzerland; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland; [Drescher, Tilman; Duerring, Ursula; Stoeckli, Rolf] Univ Basel Hosp, Clin Endocrinol Diabetol & Metab, Basel, Switzerland; [Scherr, Andreas; Tamm, Michael] Univ Basel Hosp, Clin Pneumol, Basel, Switzerland; [Schuetz, Philipp; Mueller, Beat] Kantonsspital, Med Univ Clin, Aarau, Switzerland; [Henzen, Christoph] Kantonsspital, Dept Internal Med, Luzern, Switzerland; [Rutishauser, Jonas] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland; [Schindler, Christian] Univ Basel, Swiss Trop & Publ Hlth Inst, CH-4003 Basel, Switzerland; [Viatte, Sebastien] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England; [von Garnier, Christophe] Inselspital Bern, Univ Hosp Bern, Resp Med Clin, Bern, Switzerland; [Leibbrandt, Yolanda; Viatte, Sebastien; Rutishauser, Jonas] Hosp Ctr Biel Bienne, Clin Internal Med, Dept Med, Biel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); Lucerne Cantonal Hospital; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; University of Manchester; University of Bern; University Hospital of Bern	Rutishauser, J (corresponding author), Ctr Hosp, Clin Internal Med, Dept Med, Vogelsang 84, CH-2501 Biel, Switzerland.	j.rutishauser@unibas.ch	Schindler, Christian/D-3472-2015; Reid, David W/B-3263-2011; schuetz, philipp/C-8475-2013; Briel, Matthias/AAT-9284-2021; Bodmer, Michael/K-1873-2013; Leuppi, Jörg/W-6798-2019; Viatte, Sebastien/B-4253-2015; Mueller, Beat/G-2662-2012	schuetz, philipp/0000-0001-6400-4949; Viatte, Sebastien/0000-0001-6471-3358; Briel, Matthias/0000-0002-2070-5230; Bingisser, Roland/0000-0001-8223-9792; von Garnier, Christophe/0000-0003-3585-9176	Department of Medicine, University Hospital Basel; Clinic of Internal Medicine, Hospital Center of Biel-Bienne; Freie Akademische Gesellschaft; Fonds fur Lehre und Forschung; AstraZeneca; Viollier Laboratory; Gottfried und Julia Bangerter-Rhyner-Stiftung fur Medizinische Forschung	Department of Medicine, University Hospital Basel; Clinic of Internal Medicine, Hospital Center of Biel-Bienne; Freie Akademische Gesellschaft; Fonds fur Lehre und Forschung; AstraZeneca(AstraZeneca); Viollier Laboratory; Gottfried und Julia Bangerter-Rhyner-Stiftung fur Medizinische Forschung	The REDUCE trial was an investigator-initiated study supported by the Department of Medicine, University Hospital Basel; the Clinic of Internal Medicine, Hospital Center of Biel-Bienne; Freie Akademische Gesellschaft; Fonds fur Lehre und Forschung; AstraZeneca; Viollier Laboratory; Gottfried und Julia Bangerter-Rhyner-Stiftung fur Medizinische Forschung.	Aaron SD, 2003, NEW ENGL J MED, V348, P2618, DOI 10.1056/NEJMoa023161; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bridevaux PO, 2010, EUR RESPIR J, V36, P1259, DOI 10.1183/09031936.00004110; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0; Evans AT, 2002, LANCET, V359, P1648, DOI 10.1016/S0140-6736(02)08597-5; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Jochmann A, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13567; Jochmann A, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13053; Lindenauer PK, 2010, JAMA-J AM MED ASSOC, V303, P2359, DOI 10.1001/jama.2010.796; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Sayiner A, 2001, CHEST, V119, P726, DOI 10.1378/chest.119.3.726; Schuetz P, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13109; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Thompson WH, 1996, AM J RESP CRIT CARE, V154, P407, DOI 10.1164/ajrccm.154.2.8756814; Walters JAE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006897.pub2; Wouters EFM, 2004, LANCET, V364, P883, DOI 10.1016/S0140-6736(04)16984-5	25	244	256	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2223	2231		10.1001/jama.2013.5023	http://dx.doi.org/10.1001/jama.2013.5023			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23695200	Green Published			2022-12-28	WOS:000319859200026
J	Hughes, MCB; Williams, GM; Baker, P; Green, AC				Hughes, Maria Celia B.; Williams, Gail M.; Baker, Peter; Green, Adele C.			Sunscreen and Prevention of Skin Aging A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SUN EXPOSURE; BASAL-CELL; CANCER; MECHANISMS; SUPPLEMENTATION; PROTECTION; SMOKING; SCORE	Background: Sunscreen use and dietary antioxidants are advocated as preventives of skin aging, but supporting evidence is lacking. Objective: To determine whether regular use of sunscreen compared with discretionary use or beta-carotene supplements compared with placebo retard skin aging, measured by degree of photoaging. Design: Randomized, controlled, community-based intervention. (Australian New Zealand Clinical Trials Registry: ACTRN12610000086066). Setting: Nambour, Australia (latitude 26 degrees S). Patients: 903 adults younger than 55 years out of 1621 adults randomly selected from a community register. Intervention: Random assignment into 4 groups: daily use of broad-spectrum sunscreen and 30 mg of beta-carotene, daily use of sunscreen and placebo, discretionary use of sunscreen and 30 mg of beta-carotene, and discretionary use of sunscreen and placebo. Measurements: Change in microtopography between 1992 and 1996 in the sunscreen and beta-carotene groups compared with controls, graded by assessors blinded to treatment allocation. Results: The daily sunscreen group showed no detectable increase in skin aging after 4.5 years. Skin aging from baseline to the end of the trial was 24% less in the daily sunscreen group than in the discretionary sunscreen group (relative odds, 0.76 [95% CI, 0.59 to 0.98]). beta-Carotene supplementation had no overall effect on skin aging, although contrasting associations were seen in subgroups with different severity of aging at baseline. Limitation: Some outcome data were missing, and power to detect moderate treatment effects was modest. Conclusion: Regular sunscreen use retards skin aging in healthy, middle-aged men and women. No overall effect of beta-carotene on skin aging was identified, and further study is required to definitively exclude potential benefit or potential harm.	Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4072, Australia; Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	QIMR Berghofer Medical Research Institute; University of Queensland; University of Manchester	Green, AC (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Locked Bag 2000, Brisbane, Qld 4029, Australia.		Hughes, Maria Celia/S-3444-2019; Green, Adele C/P-2736-2014; Baker, Peter J/J-2055-2012; Hughes, Maria Celia/R-6139-2019; Williams, Gail/S-8833-2019; Green, Adele C/B-5324-2011	Hughes, Maria Celia/0000-0001-8007-4816; Green, Adele C/0000-0002-2753-4841; Baker, Peter J/0000-0002-1241-7263; Williams, Gail/0000-0002-4822-5263; 	National Health and Medical Research Council of Australia (NHMRC) [922608]; Ross Cosmetics; Roche Vitamins and Fine Chemicals	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ross Cosmetics; Roche Vitamins and Fine Chemicals	By the National Health and Medical Research Council of Australia (NHMRC #922608), Ross Cosmetics, and Roche Vitamins and Fine Chemicals.	ADHOUTE H, 1992, PHOTODERMATOL PHOTO, V9, P99; Antoniou C, 2010, AM J CLIN DERMATOL, V11, P95, DOI 10.2165/11530210-000000000-00000; Barrett Jennifer, 2006, Newsweek, V147, P76; Battistutta D, 2006, PHOTODERMATOL PHOTO, V22, P39, DOI 10.1111/j.1600-0781.2006.00194.x; Baumann L, 2005, J INVEST DERMATOL, V125, pXII, DOI 10.1111/j.0022-202X.2005.23810.x; Beagley J, 1980, CHANGES SKIN CONDITI; BOYD AS, 1995, J AM ACAD DERMATOL, V33, P941, DOI 10.1016/0190-9622(95)90284-8; Brandt FS, 2011, SEMIN CUTAN MED SURG, V30, P141, DOI 10.1016/j.sder.2011.05.006; Cho S, 2010, DERMATOLOGY, V221, P160, DOI 10.1159/000305548; Darlington S, 2003, ARCH DERMATOL, V139, P451, DOI 10.1001/archderm.139.4.451; DERIGAL J, 1989, J INVEST DERMATOL, V93, P621, DOI 10.1111/1523-1747.ep12319741; Diffey BL, 2001, PHOTOCHEM PHOTOBIOL, V74, P61, DOI 10.1562/0031-8655(2001)074<0061:SAUPAM>2.0.CO;2; Enders CK., 2010, APPL MISSING DATA AN, P265; ERNSTER VL, 1995, AM J PUBLIC HEALTH, V85, P78, DOI 10.2105/AJPH.85.1.78; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Foote JA, 2001, INT J CANCER, V95, P7, DOI 10.1002/1097-0215(20010120)95:1<7::AID-IJC1001>3.0.CO;2-X; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; GREEN A, 1994, CONTROL CLIN TRIALS, V15, P512, DOI 10.1016/0197-2456(94)90008-6; Green AC, 2011, DERMATOLOGY, V222, P74, DOI 10.1159/000322623; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; GRIFFITHS CEM, 1992, BRIT J DERMATOL, V127, P37, DOI 10.1111/j.1365-2133.1992.tb16986.x; Hirst NG, 2012, VALUE HEALTH, V15, P261, DOI 10.1016/j.jval.2011.10.009; HOLMAN CDJ, 1984, BRIT J DERMATOL, V110, P129, DOI 10.1111/j.1365-2133.1984.tb07458.x; Hughes MC, 2011, DERMATOLOGY, V223, P140, DOI 10.1159/000332425; Hughes MC, 2012, PHOTODERMATOL PHOTO, V28, P153, DOI 10.1111/j.1600-0781.2012.00661.x; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; KADUNCE DP, 1991, ANN INTERN MED, V114, P840, DOI 10.7326/0003-4819-114-10-840; Kligman AM, 1999, FITZPATRICKS DERMATO, P1717; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; Liu W, 2012, PHOTODERMATOL PHOTO, V28, P120, DOI 10.1111/j.1600-0781.2012.00650.x; Lucas RM, 2009, CANCER EPIDEM BIOMAR, V18, P2887, DOI 10.1158/1055-9965.EPI-09-0191; MARKS R, 1992, BRIT J DERMATOL, V127, P7, DOI 10.1111/j.1365-2133.1992.tb16981.x; Martires KJ, 2009, ARCH DERMATOL, V145, P1375, DOI 10.1001/archdermatol.2009.303; MONTAGNA W, 1989, J AM ACAD DERMATOL, V21, P907, DOI 10.1016/S0190-9622(89)70276-0; Parsons NR, 2009, COMPUT STAT DATA AN, V53, P632, DOI 10.1016/j.csda.2008.08.004; Purba MB, 2001, AGE AGEING, V30, P227, DOI 10.1093/ageing/30.3.227; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Sambandan DR, 2011, J AM ACAD DERMATOL, V64, P748, DOI 10.1016/j.jaad.2010.01.005; Stern RS, 2004, NEW ENGL J MED, V350, P1526, DOI 10.1056/NEJMcp023168; Suppa M, 2011, BRIT J DERMATOL, V165, P1011, DOI 10.1111/j.1365-2133.2011.10536.x; Trautinger F, 2001, CLIN EXP DERMATOL, V26, P573, DOI 10.1046/j.1365-2230.2001.00893.x; Uitto J., 2008, J DRUGS DERMATOL, V7, P12; Wolff K, 1999, FITZPATRICKS DERMATO, V5th, P1697; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	45	106	108	1	44	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					781	+		10.7326/0003-4819-158-11-201306040-00002	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00002			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23732711				2022-12-28	WOS:000320379800001
J	Canfin, P; Eide, EB; Natalegawa, M; Ndiaye, M; Nkoana-Mashabane, M; Patriota, A; Towichakchaikul, S				Canfin, Pascal; Eide, Espen Barth; Natalegawa, Marty; Ndiaye, Mankeur; Nkoana-Mashabane, Maite; Patriota, Antonio; Towichakchaikul, Surapong		Foreign Policy Global Hlth Grp	Our common vision for the positioning and role of health to advance the UN development agenda beyond 2015	LANCET			English	Editorial Material									[Canfin, Pascal] Govt France, Delegate Dev, Paris, France		Canfin, P (corresponding author), Govt France, Delegate Dev, Paris, France.							Foreign Ministers of Brazil France Indonesia Norway Senegal South Africa and Thailand (Oslo), 2007, LANCET, V369, P1373	1	12	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1885	1886		10.1016/S0140-6736(13)60952-6	http://dx.doi.org/10.1016/S0140-6736(13)60952-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23726158				2022-12-28	WOS:000320319500009
J	Hurwitz, B; Charon, R				Hurwitz, Brian; Charon, Rita			A narrative future for health care	LANCET			English	Editorial Material							MEDICINE		[Hurwitz, Brian] Kings Coll London, Ctr Humanities & Hlth, London WC2R 2LS, England; [Charon, Rita] Columbia Univ, Coll Phys & Surg, Program Narrat Med, New York, NY USA	University of London; King's College London; Columbia University	Hurwitz, B (corresponding author), Kings Coll London, Ctr Humanities & Hlth, London WC2R 2LS, England.	brian.hurwitz@kcl.ac.uk			NHLBI NIH HHS [R25 HL108014] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL108014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brody H., 1987, STORIES SICKNESS; CHARON R, 1995, ANN INTERN MED, V122, P599, DOI 10.7326/0003-4819-122-8-199504150-00008; Charon R, 2006, NARRATIVE MEDICINE; Frank AW., 2013, WOUNDED STORYTELLER; Greenhalgh P, 1998, NARRATIVE BASED MEDI; Hunter Kathryn M., 1991, DOCTORS STORIES THE; Hurwitz B, 2000, LANCET, V356, P2086, DOI 10.1016/S0140-6736(00)03412-7; Kendall M., 2004, NARRATIVE RES HLTH I, P52; Kleinman A, 1988, THE ILLNESS NARRATIV; Launer J., 2002, NARRATIVE BASED PRIM; Mishler E. G., 1984, THE DISCOURSE OF MED	11	30	31	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1886	1887		10.1016/S0140-6736(13)61129-0	http://dx.doi.org/10.1016/S0140-6736(13)61129-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163EV	23725717	Green Accepted			2022-12-28	WOS:000320319500010
J	Zeitlin, C; Hassler, DM; Cucinotta, FA; Ehresmann, B; Wimmer-Schweingruber, RF; Brinza, DE; Kang, S; Weigle, G; Bottcher, S; Bohm, E; Burmeister, S; Guo, J; Kohler, J; Martin, C; Posner, A; Rafkin, S; Reitz, G				Zeitlin, C.; Hassler, D. M.; Cucinotta, F. A.; Ehresmann, B.; Wimmer-Schweingruber, R. F.; Brinza, D. E.; Kang, S.; Weigle, G.; Boettcher, S.; Boehm, E.; Burmeister, S.; Guo, J.; Koehler, J.; Martin, C.; Posner, A.; Rafkin, S.; Reitz, G.			Measurements of Energetic Particle Radiation in Transit to Mars on the Mars Science Laboratory	SCIENCE			English	Article							SPACE EXPLORATION; TRANSPORT	The Mars Science Laboratory spacecraft, containing the Curiosity rover, was launched to Mars on 26 November 2011, and for most of the 253-day, 560-minion-kilometer cruise to Mars, the Radiation Assessment Detector made detailed measurements of the energetic particle radiation environment inside the spacecraft. These data provide insights into the radiation hazards that would be associated with a human mission to Mars. We report measurements of the radiation dose, dose equivalent, and linear energy transfer spectra. The dose equivalent for even the shortest round-trip with current propulsion systems and comparable shielding is found to be 0.66 +/- 0.12 sievert.	[Zeitlin, C.; Hassler, D. M.; Ehresmann, B.; Rafkin, S.] SW Res Inst, Boulder, CO USA; [Cucinotta, F. A.; Guo, J.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Wimmer-Schweingruber, R. F.; Boettcher, S.; Boehm, E.; Burmeister, S.; Koehler, J.; Martin, C.] Univ Kiel, Kiel, Germany; [Brinza, D. E.; Kang, S.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Weigle, G.] SW Res Inst, San Antonio, TX USA; [Posner, A.] NASA Headquarters, Washington, DC USA; [Reitz, G.] German Aerosp Ctr DLR, Cologne, Germany	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Kiel; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Southwest Research Institute; National Aeronautics & Space Administration (NASA); Helmholtz Association; German Aerospace Centre (DLR)	Zeitlin, C (corresponding author), SW Res Inst, Boulder, CO USA.	zeitlin@boulder.swri.edu	Cucinotta, Francis/AAZ-5941-2020; Guo, Jingnan/ABB-3749-2021; Wimmer-Schweingruber, Robert/AAQ-5794-2021; Reitz, Guenther/ABC-8921-2021	Guo, Jingnan/0000-0002-8707-076X; Wimmer-Schweingruber, Robert/0000-0002-7388-173X; Posner, Arik/0000-0003-1572-8734	NASA (Human Exploration and Operations Mission Directorate) under Jet Propulsion Laboratory (JPL) [1273039]; German Aerospace Center (DLR); DLR's Space Administration [50QM0501, 50 QM1201]; NASA	NASA (Human Exploration and Operations Mission Directorate) under Jet Propulsion Laboratory (JPL); German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); DLR's Space Administration; NASA(National Aeronautics & Space Administration (NASA))	The RAD is supported by NASA (Human Exploration and Operations Mission Directorate) under Jet Propulsion Laboratory (JPL) subcontract 1273039 to the Southwest Research Institute and in Germany by the German Aerospace Center (DLR) and DLR's Space Administration, grant numbers 50QM0501 and 50 QM1201, to the Christian Albrechts University, Kid. Part of this research was carried out at JPL, California Institute of Technology, under a contact with NASA. We appreciate discussions with P. O'Neill and M. Kim at NASA's JSC and with S. Blattnig, F. Badavi, T. Slaba, and C. Mertens of NASA's Langley Research Center. We extend thanks to I. Simmonds, I. Grotzinger, I. Crisp, A. Vasvada, H. Mortensen, and the Operations Product Generation Subsystem team at NASA-JPL. We also thank M. Meyer, E. Stolper, G. Allen, C. Moore, and V. Friedensen at NASA headquarters and H. Witte at DLR in Germany for their support of the RAD over the years. The data used in this paper are archived in the NASA Planetary Data System's Planetary Plasma Interactions Node at the University of California, Los Angeles. The archival volume includes the full binary raw data files, detailed descriptions of the structures therein, and higher-level data products in human-readable form. The PPI node is hosted at http://ppi.pds.nasa.gov/.	Aghara SK, 2009, NUCL INSTRUM METH B, V267, P1115, DOI 10.1016/j.nimb.2009.01.136; [Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 1996, RADIATION HAZARDS TO; [Anonymous], 2006, NCRP REPORT NO 153; [Anonymous], 1993, ICRU REPORT 51; [Anonymous], 2000, NCRP REPORT NO 132; [Anonymous], 2006, HEALTH RISKS FROM EX; BADHWAR GD, 1992, NUCL TRACKS RAD MEAS, V20, P403; Cucinotta F. A., 2011, NASA TECHNICAL PAPER; Cucinotta F. A., 2013, NASA TECHNICAL PAPER; Cucinotta FA, 2006, RADIAT MEAS, V41, P1235, DOI 10.1016/j.radmeas.2006.03.012; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2011, RADIAT RES, V176, P102, DOI 10.1667/RR2540.1; Drake B. G., 2010, AER C 2010 IEEE, P1, DOI [DOI 10.1109/AERO.2010.5446736, 10.1109/AERO.2010.5446736]; Hassler DM, 2012, SPACE SCI REV, V170, P503, DOI 10.1007/s11214-012-9913-1; Kohler J, 2011, NUCL INSTRUM METH B, V269, P2641, DOI 10.1016/j.nimb.2011.07.021; Koontz SL, 2005, NSREC: 2005 IEEE Radiation Effects Data Workshop, Workshop Record, P110; McKenna-Lawlor S, 2012, PLANET SPACE SCI, V63-64, P123, DOI 10.1016/j.pss.2011.06.017; Mrigakshi AI, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017611; Norman RB, 2012, ADV SPACE RES, V50, P146, DOI 10.1016/j.asr.2012.03.023; O'Neill PM, 2010, IEEE T NUCL SCI, V57, P3148, DOI 10.1109/TNS.2010.2083688; Onsager TG, 1996, P SOC PHOTO-OPT INS, V2812, P281, DOI 10.1117/12.254075; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; Posner A, 2005, ADV SPACE RES, V36, P1426, DOI 10.1016/j.asr.2004.11.040; Posner A, 2007, SPACE WEATHER, V5, DOI 10.1029/2006SW000268; Sato T, 2011, RADIAT ENVIRON BIOPH, V50, P115, DOI 10.1007/s00411-010-0330-0; Schwadron NA, 2010, SPACE WEATHER, V8, DOI 10.1029/2010SW000567; Slaba TC, 2010, J COMPUT PHYS, V229, P9397, DOI 10.1016/j.jcp.2010.09.010; Usoskin IG, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011250; Wilson J., 1995, NASA TECHNICAL PAPER; Wilson J. W., 1997, NASA TECHNICAL PAPER	31	368	382	8	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1080	1084		10.1126/science.1235989	http://dx.doi.org/10.1126/science.1235989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723233				2022-12-28	WOS:000319664500040
J	Gupta, K; Trautner, BW				Gupta, Kalpana; Trautner, Barbara W.			Diagnosis and management of recurrent urinary tract infections in non-pregnant women	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ESCHERICHIA-COLI STRAINS; ASYMPTOMATIC BACTERIURIA; UNCOMPLICATED CYSTITIS; PREMENOPAUSAL WOMEN; RISK-FACTORS; DOUBLE-BLIND; YOUNG-WOMEN; PREVENTION; NITROFURANTOIN; PROPHYLAXIS		[Gupta, Kalpana] VA Boston Healthcare Syst, Dept Med, Boston, MA 02132 USA; [Gupta, Kalpana] Boston Univ, Sch Med, Boston, MA 02132 USA; [Gupta, Kalpana] Vet Hlth Adm, Off Publ Hlth, Natl Ctr Occupat Hlth & Infect Control, Gainesville, FL 32608 USA; [Trautner, Barbara W.] Baylor Coll Med, Michael E DeBakey Vet Affairs VA Med Ctr, Hlth Serv Res & Dev HSR&D Ctr Excellence, Houston, TX 77030 USA; [Trautner, Barbara W.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; Baylor College of Medicine	Gupta, K (corresponding author), VA Boston Healthcare Syst, Dept Med, Boston, MA 02132 USA.	Kalpana.Gupta@va.gov			Department of Veterans Affairs; VHA National Center for Patient Safety; VA HSRD IIR [09-104]; NIH [DK092293]; VA HSR&D Houston Center of Excellence [HFP-090-20]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK092293] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); VHA National Center for Patient Safety; VA HSRD IIR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA HSR&D Houston Center of Excellence; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	KG is supported by the Department of Veterans Affairs and in part by the VHA National Center for Patient Safety. BWT is funded by VA HSR&D IIR 09-104 and NIH DK092293; her work was also partly supported by the VA HSR&D Houston Center of Excellence (HFP-090-20). The views expressed reflect those of the authors and not necessarily those of the Department of Veterans Affairs (VA)/Baylor College of Medicine.	Albert X, 2004, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD001209.pub2, DOI 10.1002/14651858.CD001209.PUB2]; Amna MA, 2013, INFECTION, V41, P473, DOI 10.1007/s15010-012-0347-1; Arya LA, 2012, BJU INT, V110, P247, DOI 10.1111/j.1464-410X.2011.10766.x; Beerepoot MAJ, 2012, ARCH INTERN MED, V172, P704, DOI 10.1001/archinternmed.2012.777; Cai T, 2012, CLIN INFECT DIS, V55, P771, DOI 10.1093/cid/cis534; Dason S, 2011, CUAJ-CAN UROL ASSOC, V5, P316, DOI 10.5489/cuaj.11214; Ejrnaes K, 2006, J CLIN MICROBIOL, V44, P1776, DOI 10.1128/JCM.44.5.1776-1781.2006; Ejrnaes K, 2011, VIRULENCE, V2, P528, DOI 10.4161/viru.2.6.18189; Eriksen BC, 1999, AM J OBSTET GYNECOL, V180, P1072, DOI 10.1016/S0002-9378(99)70597-1; Fihn SD, 2003, NEW ENGL J MED, V349, P259, DOI 10.1056/NEJMcp030027; Foxman B, 2002, AM J MED, V113, p5S; Gorter KJ, 2010, FAM PRACT, V27, P379, DOI 10.1093/fampra/cmq026; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; HANSSON S, 1989, BRIT MED J, V298, P853, DOI 10.1136/bmj.298.6677.853; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; HOLMBERG L, 1980, AM J MED, V69, P733, DOI 10.1016/0002-9343(80)90443-X; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; Jepson Ruth G, 2012, Cochrane Database Syst Rev, V10, pCD001321, DOI 10.1002/14651858.CD001321.pub5; Lawrentschuk N, 2006, INT J UROL, V13, P350, DOI 10.1111/j.1442-2042.2006.01316.x; LINDBERG U, 1978, J PEDIATR-US, V92, P194, DOI 10.1016/S0022-3476(78)80003-1; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Madani Y, 2012, PRIM CARE RESP J, V21, P337, DOI 10.4104/pcrj.2012.00059; Melekos MD, 1997, J UROLOGY, V157, P935, DOI 10.1016/S0022-5347(01)65087-0; NICKEL JC, 1991, CAN J SURG, V34, P591; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Perrotta C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005131.pub2; RAZ R, 1993, NEW ENGL J MED, V329, P753, DOI 10.1056/NEJM199309093291102; Raz R, 2003, CLIN INFECT DIS, V36, P1362, DOI 10.1086/374341; Raz R, 2000, CLIN INFECT DIS, V30, P152, DOI 10.1086/313596; RUSSO TA, 1995, J INFECT DIS, V172, P440, DOI 10.1093/infdis/172.2.440; Schaeffer AJ, 1999, J UROLOGY, V161, P207, DOI 10.1016/S0022-5347(01)62099-8; Scholes D, 2000, J INFECT DIS, V182, P1177, DOI 10.1086/315827; Scholes D, 2010, J UROLOGY, V184, P564, DOI 10.1016/j.juro.2010.03.139; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; Smith HS, 1997, CLIN INFECT DIS, V25, P63, DOI 10.1086/514502; Smithson A, 2005, CLIN DIAGN LAB IMMUN, V12, P1358, DOI 10.1128/CDLI.12.12.1358-1363.2005; STAMM WE, 1991, REV INFECT DIS, V13, P77; STAPLETON A, 1990, JAMA-J AM MED ASSOC, V264, P703, DOI 10.1001/jama.264.6.703; Stapleton A, 1999, LANCET, V353, P7, DOI 10.1016/S0140-6736(05)74875-3; Stapleton AE, 2011, CLIN INFECT DIS, V52, P1212, DOI 10.1093/cid/cir183; Stern JA, 2004, J UROLOGY, V171, P768, DOI 10.1097/01.ju.0000107261.64927.b3; van Haarst EP, 2001, UROLOGY, V57, P1068, DOI 10.1016/S0090-4295(01)00971-2; Wang CH, 2012, ARCH INTERN MED, V172, P988, DOI 10.1001/archinternmed.2012.3004	46	48	51	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3140	10.1136/bmj.f3140	http://dx.doi.org/10.1136/bmj.f3140			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DG	23719637	Green Published			2022-12-28	WOS:000319948200006
J	Morange, M				Morange, Michel			Francois Jacob (1920-2013) OBITUARY	NATURE			English	Biographical-Item									Ecole Normale Super, Cavailles Ctr CIRPHLES, USR Hist & Philosophy Sci 3308, F-75231 Paris, France	PSL Research University Paris (ComUE); Ecole Normale Superieure (ENS)	Morange, M (corresponding author), Ecole Normale Super, Cavailles Ctr CIRPHLES, USR Hist & Philosophy Sci 3308, 24 Rue Lhomond, F-75231 Paris, France.	morange@biologie.ens.fr						JACOB F, PUBLICATION LIST	1	2	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					440	440		10.1038/497440a	http://dx.doi.org/10.1038/497440a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698437	Bronze			2022-12-28	WOS:000319254000032
J	Brinker, CJ; Clem, PG				Brinker, C. Jeffrey; Clem, Paul G.			Quartz on Silicon	SCIENCE			English	Editorial Material							FILMS; CHEMISTRY		[Brinker, C. Jeffrey] Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA; [Brinker, C. Jeffrey; Clem, Paul G.] Sandia Natl Labs, Self Assembled Mat Dept, Albuquerque, NM 87185 USA; [Brinker, C. Jeffrey; Clem, Paul G.] Sandia Natl Labs, Elect Opt & Nano Mat Dept, Albuquerque, NM 87185 USA	University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Brinker, CJ (corresponding author), Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA.	cjbrink@sandia.gov; pgclem@sandia.gov						BENES E, 1995, SENSOR ACTUAT A-PHYS, V48, P1, DOI 10.1016/0924-4247(95)00846-2; Brinker C.J., 1990, SOL GEL SCI PHYS CHE, DOI [DOI 10.1016/B978-0-08-057103-4.50001-5, 10.1016/C2009-0-22386-5]; Carretero-Genevrier A, 2013, SCIENCE, V340, P827, DOI 10.1126/science.1232968; Curie J., 1880, B SOC MIN FRANCE, V3, P90, DOI DOI 10.3406/BULMI.1880.1564; Doshi DA, 2000, SCIENCE, V290, P107, DOI 10.1126/science.290.5489.107; FYFE WS, 1962, AM MINERAL, V47, P83; Gotze J, 2009, MINERAL MAG, V73, P645, DOI 10.1180/minmag.2009.073.4.645; HOUE M, 1995, J PHYS D APPL PHYS, V28, P1747, DOI 10.1088/0022-3727/28/9/001; Jiang XM, 2011, CHEM COMMUN, V47, P7524, DOI 10.1039/c1cc11115a; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; MASON WP, 1981, J ACOUST SOC AM, V70, P1561, DOI 10.1121/1.387221; Schwartz RW, 1999, J AM CERAM SOC, V82, P2359, DOI 10.1111/j.1151-2916.1999.tb02091.x; Southin JEA, 2001, J PHYS D APPL PHYS, V34, P1456, DOI 10.1088/0022-3727/34/10/303; TUTTLE BA, 1993, J AM CERAM SOC, V76, P1537, DOI 10.1111/j.1151-2916.1993.tb03936.x; Wang J, 2006, ULTRASONICS, V44, pE869, DOI 10.1016/j.ultras.2006.05.033	15	9	9	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					818	819		10.1126/science.1236752	http://dx.doi.org/10.1126/science.1236752			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687034				2022-12-28	WOS:000318997400028
J	Ruel, MT; Alderman, H				Ruel, Marie T.; Alderman, Harold		Maternal Child Nutr Study Grp	Nutrition-sensitive interventions and programmes: how can they help to accelerate progress in improving maternal and child nutrition?	LANCET			English	Article							SEVERELY MALNOURISHED CHILDREN; CONDITIONAL CASH TRANSFERS; IN-KIND TRANSFERS; PSYCHOSOCIAL STIMULATION; DEVELOPING-COUNTRIES; YOUNG-CHILDREN; AGRICULTURAL-DEVELOPMENT; INCOME COUNTRIES; FOOD; GROWTH	Acceleration of progress in nutrition will require effective, large-scale nutrition-sensitive programmes that address key underlying determinants of nutrition and enhance the coverage and effectiveness of nutrition-specific interventions. We reviewed evidence of nutritional effects of programmes in four sectors-agriculture, social safety nets, early child development, and schooling. The need for investments to boost agricultural production, keep prices low, and increase incomes is undisputable; targeted agricultural programmes can complement these investments by supporting livelihoods, enhancing access to diverse diets in poor populations, and fostering women's empowerment. However, evidence of the nutritional effect of agricultural programmes is inconclusive-except for vitamin A from biofortification of orange sweet potatoes-largely because of poor quality evaluations. Social safety nets currently provide cash or food transfers to a billion poor people and victims of shocks (eg, natural disasters). Individual studies show some effects on younger children exposed for longer durations, but weaknesses in nutrition goals and actions, and poor service quality probably explain the scarcity of overall nutritional benefits. Combined early child development and nutrition interventions show promising additive or synergistic effects on child development-and in some cases nutrition-and could lead to substantial gains in cost, efficiency, and effectiveness, but these programmes have yet to be tested at scale. Parental schooling is strongly associated with child nutrition, and the effectiveness of emerging school nutrition education programmes needs to be tested. Many of the programmes reviewed were not originally designed to improve nutrition yet have great potential to do so. Ways to enhance programme nutrition-sensitivity include: improve targeting; use conditions to stimulate participation; strengthen nutrition goals and actions; and optimise women's nutrition, time, physical and mental health, and empowerment. Nutrition-sensitive programmes can help scale up nutrition-specific interventions and create a stimulating environment in which young children can grow and develop to their full potential.	[Ruel, Marie T.; Alderman, Harold] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20006 USA	CGIAR; International Food Policy Research Institute (IFPRI)	Ruel, MT (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20006 USA.	m.ruel@cgiar.org		Ruel, Marie/0000-0002-9506-348X	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Funding for the preparation of the Series was provided to the Johns Hopkins Bloomberg School of Public Health through a grant from the Bill & Melinda Gates Foundation. The sponsor has no role in the analysis and interpretation of the evidence or in writing the paper and the decision to submit for publication. We thank John Hoddinott, senior research fellow at IFPRI, who reviewed an early version of the paper, and to four anonymous reviewers for their insightful comments.	Aboud FE, 2011, PEDIATRICS, V127, pE1191, DOI 10.1542/peds.2010-2160; Adato M, 2000, FINAL REPORT; Adato M., 2010, CONDITIONAL CASH TRA; Adelman S, 2008, IFPRI FOOD POLICY RE; Afridi F, 2010, J DEV ECON, V92, P152, DOI 10.1016/j.jdeveco.2009.02.002; Akresh R, 2012, WORLD BANK POLICY RE; Alderman H, 2010, J DEV ORIG HLTH DIS, V1, P19, DOI 10.1017/S2040174409990158; Alderman H, 2012, WORLD BANK RES OBSER, V27, P204, DOI 10.1093/wbro/lkr005; Alderman H, 2010, J NUTR, V140, p148S, DOI 10.3945/jn.109.110825; Alderman H, 2009, FOOD NUTR BULL, V30, P265, DOI 10.1177/156482650903000308; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Arimond M, 2011, COMBATING MICRONUTRIENT DEFICIENCIES: FOOD-BASED APPROACHES, P41, DOI 10.1079/9781845937140.0041; Attanasio O, 2012, ECON J, V122, P92, DOI 10.1111/j.1468-0297.2011.02473.x; Barber SL, 2010, J DEV EFFECT, V2, P51, DOI 10.1080/19439341003592630; Barro R, 2010, NBER WORKING PAPER 1; Begum J M, 1994, Indian J Med Sci, V48, P61; Behrman JR, 2005, OXFORD B ECON STAT, V67, P547, DOI 10.1111/j.1468-0084.2005.00131.x; Bentley ME, 2011, J NUTR, V141, P502, DOI 10.3945/jn.110.130005; Berti PR, 2004, PUBLIC HEALTH NUTR, V7, P599, DOI 10.1079/PHN2003595; Bhutta ZA, 2013, LANCET; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black MM, 2009, AM J CLIN NUTR, V89, p951S, DOI 10.3945/ajcn.2008.26692E; Black R., 2013, LANCET; Block SA, 2007, OXFORD ECON PAP, V59, P330, DOI 10.1093/oep/gpm001; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Bundy D, 2012, PUBLIC HEALTH NUTR; Bushamuka V, FOOD NUTR BULL, V26, P17; Carvalho LMJ, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.15618; Chaparro CM, 2010, MATERN CHILD NUTR, V6, P1, DOI 10.1111/j.1740-8709.2009.00224.x; Chou SY, 2010, AM ECON J-APPL ECON, V2, P33, DOI 10.1257/app.2.1.33; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Coote C, 2011, 2020 CONFERENCE NOTE; Davis B, 2012, J DEV EFFECT, V4, P1, DOI 10.1080/19439342.2012.659024; De Brauw A, 2013, WORLD DEV; Demographic Health Surveys, MEASURE DHS STAT COM; DFID, 2011, CASH TRANSFER EVIDEN; Doak C, 2002, PUBLIC HEALTH NUTR, V5, P275, DOI 10.1079/PHN2001304; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; FAO, 2005, NUTRITION EDUCATION; FAO, 2010, THE STATE OF FOOD AN; FAO WFP & IFAD, 2012, THE STATE OF FOOD IN; Fernald LCH, 2012, THE OXFORD HANDBOOK; Gaarder MM, 2010, J DEV EFFECT, V2, P6, DOI 10.1080/19439341003646188; Gardner JMM, 2005, AM J CLIN NUTR, V82, P399, DOI 10.1093/ajcn/82.2.399; Garrett J, WORKING MULTISECTORA; Gelli A, 2010, PCD WORKING PAPER 21; Gereffi G, 2009, J HUNGER ENVIRON NUT, V4, P357, DOI 10.1080/19320240903321276; Giles J, 2010, POLICY RESEARCH WORK; Gillespie S, 2013, LANCET; Girard AW, 2012, PAEDIATR PERINAT EP, V26, P205, DOI 10.1111/j.1365-3016.2012.01282.x; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; Grant MJ, 2010, POPUL DEV REV, V36, P71, DOI 10.1111/j.1728-4457.2010.00318.x; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Grellety E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044549; Grosh M, 2008, FOR PROTECTION AND P; Haas JD, 2005, J NUTR, V135, P2823, DOI 10.1093/jn/135.12.2823; Haddad L, 2003, WORLD BANK ECON REV, V17, P107, DOI 10.1093/wber/lhg012; Hawkes C, 2011, VALUE CHAINS FOR NUT; Hawkes C, 2012, CURRENT AND PLANNED; Hawkes C, 2009, J HUNGER ENVIRON NUT, V4, P336, DOI 10.1080/19320240903321243; Helen Keller International, 2004, HOMESTEAD FOOD PRODU, V2, P1; Helen Keller International, 2004, NEP NUTR B, V2, P1; Helen Keller International Asian Vegetable and Research Development Centre, 1993, HOM GARD BANGL EV RE; Herforth A, 2012, PRIORITIZING NUTRITI; Hoddinott J, 2012, AGRICULTURE HEALTH A; Hoddinott J, 2011, IFPRI DISCUSSION PAP; Hoddinott J. F., 2013, COPENHAGEN CONSENSUS; Hoorweg J, 2000, ECOL FOOD NUTR, V39, P395, DOI 10.1080/03670244.2000.9991627; Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; Hotz C, 2012, BRIT J NUTR, V108, P163, DOI 10.1017/S0007114511005174; Huybregts L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001313; IFPRI, 2012, 2011 GLOBAL FOOD POL; Kadiyala, 2012, IFPRI DISCUSSION PAP; Kagenimana V, 1999, RESEARCH REPORT 3; Kassa H, 2003, LIVEST RES RURAL DEV, V15, P6; Kazianga H, 2009, WORLD BANK POLICY RE; Kristjansson EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004676.pub2; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Leroy JL, 2013, J NUTR, V143, P378, DOI 10.3945/jn.112.167627; Leroy JL, 2009, J DEV EFFECT, V1, P103, DOI 10.1080/19439340902924043; Leroy JL, 2010, J NUTR, V140, P612, DOI 10.3945/jn.109.116285; Leroy JL, 2013, THE MICRONUTRIENT IM; Low JW, 2007, J NUTR, V137, P1320; Manley J, 2012, HOW EFFECTIVE ARE CA; Masset E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8222; Maxwell D, 2010, FOOD POLICY, V35, P91, DOI 10.1016/j.foodpol.2009.10.002; Mazur R, 2011, 2020 CONFERENCE NOTE; Menon P, 2007, J NUTR, V137, P1023, DOI 10.1093/jn/137.4.1023; Mullins G, 1996, HUM ECOL, V24, P231, DOI 10.1007/BF02169128; Nahar B, 2012, EUR J CLIN NUTR, V66, P701, DOI 10.1038/ejcn.2012.13; Nahar B, 2009, EUR J CLIN NUTR, V63, P725, DOI 10.1038/ejcn.2008.44; Nederveen L, GLOBAL MAPPING OF IN; Nelson J, 2009, CLIMATE CHANGE AND GLOBAL POVERTY: A BILLION LIVES IN THE BALANCE, P223; Neufed LM, 2011, J NUTR, V141, P2076, DOI 10.3945/jn.110.134957; Nielsen H, 1997, INTEGRATED FARMING I; OECD/FAO, 2012, OECD FAO AGRICULTURA, DOI 10.1787/agr_outlook-2012-en; Olney DK, 2009, FOOD NUTR BULL, V30, P355, DOI 10.1177/156482650903000407; Osei AK, 2010, J NUTR, V140, P1146, DOI 10.3945/jn.109.114751; Petry N, 2012, J NUTR, V142, P492, DOI 10.3945/jn.111.149286; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Pinstrup A., 2011, ROLE GOVT GLOBAL NAT; Pinstrup-Andersen P, 2011, THE FOOD SYSTEM AND; Pinstrup-Andersen P, 2010, THE AFRICAN FOOD SYS; Pinstrup-Andersen P, 2013, GUIDING FOOD SYSTEM; Pinstrup-Andersen P, 2013, EUR J DEV RES, V25, P5, DOI 10.1057/ejdr.2012.44; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Ruel MT, 2008, LANCET, V371, P588, DOI 10.1016/S0140-6736(08)60271-8; Ruel MT, 2001, FOOD POLICY REVIEW 5; Saltzman A, 2013, GLOB FOOD SECUR-AGR, V2, P9, DOI 10.1016/j.gfs.2012.12.003; Scaling Up Nutrition, 2011, SCALING UP NUTRITION; Schady N.R., 2009, WORLD BANK POLICY RE; Schady N, 2008, ECON LETT, V101, P246, DOI 10.1016/j.econlet.2008.08.015; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Shekar M, 2013, MODULE A INTRODUCTIO; Skoufias E, 2001, FOOD CONSUMPTION AND; SOLON F, 1979, AM J CLIN NUTR, V32, P1445, DOI 10.1093/ajcn/32.7.1445; Sumberg J, 2011, FOOD POLICY, V36, P341, DOI 10.1016/j.foodpol.2011.03.001; Surkan PJ, 2011, B WORLD HEALTH ORGAN, V89, P607, DOI 10.2471/BLT.11.088187; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Vazir S, 2013, MATERN CHILD NUTR, V9, P99, DOI 10.1111/j.1740-8709.2012.00413.x; Verstraeten R, 2012, AM J CLIN NUTR, V96, P415, DOI 10.3945/ajcn.112.035378; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Walker SP, 2011, PEDIATRICS, V127, P849, DOI 10.1542/peds.2010-2231; Webb P, 2010, J NUTR, V140, p143S, DOI 10.3945/jn.109.110536; WHO, 2012, GLOBAL DATABASE ON C; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2009, GLOBAL ECONOMIC PROSPECTS: COMMODITIES AT THE CROSSROADS, P1, DOI 10.1596/978-0-8213-7799-4; World Bank, 2012, MANAGING RISK PROMOT; World Bank, EDUCATION STATISTICS; World Bank, WORLD DEVELOPMENT RE; World Bank, 2007, FROM AGRICULTURE TO; World Bank, 2013, IMPROVING NUTRITION; World Food Programme, 2012, GLOBAL FOOD AID FLOW; Yamano T, 2005, AM J AGR ECON, V87, P273, DOI 10.1111/j.1467-8276.2005.00721.x; Yousafzai AK, 2012, PAKISTAN EARLY CHILD	138	875	882	12	232	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2013	382	9891					536	551		10.1016/S0140-6736(13)60843-0	http://dx.doi.org/10.1016/S0140-6736(13)60843-0			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201SD	23746780				2022-12-28	WOS:000323162400033
J	Stack, AM				Stack, Anne M.			April 15, 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Stack, Anne M.] Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Stack, AM (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.	anne.stack@childrens.harvard.edu							0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					146	147		10.7326/0003-4819-159-2-201307160-00658	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00658			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23712290				2022-12-28	WOS:000322112000022
J	Campbell, SW; D'Orazi, V; Yong, D; Constantino, TN; Lattanzio, JC; Stancliffe, RJ; Angelou, GC; Wylie-de Boer, EC; Grundahl, F				Campbell, Simon W.; D'Orazi, Valentina; Yong, David; Constantino, Thomas N.; Lattanzio, John C.; Stancliffe, Richard J.; Angelou, George C.; Wylie-de Boer, Elizabeth C.; Grundahl, Frank			Sodium content as a predictor of the advanced evolution of globular cluster stars	NATURE			English	Article							HORIZONTAL-BRANCH STARS; METAL-POOR STARS; GIANT STARS; LIGHT-ELEMENTS; HELIUM CONTENT; RED GIANT; NGC-6752; ABUNDANCES; SCALE	The asymptotic giant branch (AGB) phase is the final stage of nuclear burning for low-mass stars. Although Milky Way globular clusters are now known to harbour (at least) two generations of stars(1,2), they still provide relatively homogeneous samples of stars that are used to constrain stellar evolution theory(3-5). It is predicted by stellar models that the majority of cluster stars with masses around the current turn-off mass (that is, the mass of the stars that are currently leaving the main sequence phase) will evolve through the AGB phase(6,7). Here we report that all of the second-generation stars in the globular cluster NGC 6752-70 per cent of the cluster population-fail to reach the AGB phase. Through spectroscopic abundance measurements, we found that every AGB star in our sample has a low sodium abundance, indicating that they are exclusively first-generation stars. This implies that many clusters cannot reliably be used for star counts to test stellar evolution timescales if the AGB population is included. We have no clear explanation for this observation.	[Campbell, Simon W.; D'Orazi, Valentina; Constantino, Thomas N.; Lattanzio, John C.; Angelou, George C.] Monash Univ, Sch Math Sci, Monash Ctr Astrophys, Melbourne, Vic 3800, Australia; [D'Orazi, Valentina] Macquarie Univ, Dept Phys & Astron, Sydney, NSW 2109, Australia; [Yong, David; Stancliffe, Richard J.; Wylie-de Boer, Elizabeth C.] Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Stancliffe, Richard J.] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Grundahl, Frank] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, DK-8000 Aarhus C, Denmark	Monash University; Macquarie University; Australian National University; University of Bonn; Aarhus University	Campbell, SW (corresponding author), Monash Univ, Sch Math Sci, Monash Ctr Astrophys, Melbourne, Vic 3800, Australia.	simon.campbell@monash.edu	D'Orazi, Valentina/N-5230-2015	D'Orazi, Valentina/0000-0002-2662-3762; Stancliffe, Richard/0000-0002-6972-9655; Angelou, George/0000-0003-4463-1907; Yong, David/0000-0002-6502-1406; Constantino, Thomas/0000-0002-0758-4446; Lattanzio, John/0000-0003-2952-859X; Campbell, Simon/0000-0001-5298-0694	Australian Research Council [DP1095368]; Alexander von Humboldt Foundation; Danish National Research Foundation; ASTERISK project; European Research Council [267864]; ESO telescopes at the La Silla Paranal Observatory [089.D-0038]	Australian Research Council(Australian Research Council); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK project; European Research Council(European Research Council (ERC)European Commission); ESO telescopes at the La Silla Paranal Observatory	We thank Y. Momany of the European Southern Observatory (ESO, Chile) for providing his UBV photometric data set, which is mentioned in Supplementary Information section 2. S. W. C. acknowledges support from the Australian Research Council's Discovery Projects funding scheme (project DP1095368). R.J.S. is the recipient of a Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation. F. G. acknowledges funding for the Stellar Astrophysics Centre provided by The Danish National Research Foundation. The research was supported by the ASTERISK project funded by the European Research Council (grant agreement no. 267864). This work was based on observations made with ESO telescopes at the La Silla Paranal Observatory under programme ID 089.D-0038 (principal investigator S. W. C.) and made extensive use of the SIMBAD, Vizier, 2MASS and NASA ADS databases.	Alonso A, 1999, ASTRON ASTROPHYS SUP, V140, P261, DOI 10.1051/aas:1999521; BOOTHROYD AI, 1993, ASTROPHYS J, V416, P762, DOI 10.1086/173275; BUONANNO R, 1985, ASTRON ASTROPHYS, V145, P97; Campbell SW, 2008, ASTRON ASTROPHYS, V490, P769, DOI 10.1051/0004-6361:200809597; CAMPBELL SW, 2010, MEM SOC ASTRON ITAL, V81, P1004; Carretta E, 2007, ASTRON ASTROPHYS, V464, P927, DOI 10.1051/0004-6361:20065208; Carretta E, 2009, ASTRON ASTROPHYS, V505, P139, DOI 10.1051/0004-6361/200912097; Cassisi S, 2003, ASTROPHYS J, V588, P862, DOI 10.1086/374218; Cassisi S, 2001, ASTRON ASTROPHYS, V366, P578, DOI 10.1051/0004-6361:20000293; Clem JL, 2004, ASTRON J, V127, P1227, DOI 10.1086/381295; Gratton RG, 2012, ASTRON ASTROPHYS REV, V20, P1, DOI 10.1007/s00159-012-0050-3; Gratton RG, 1999, ASTRON ASTROPHYS, V350, P955; Gratton RG, 1996, ASTRON ASTROPHYS, V314, P191; Grundahl F, 1999, ASTROPHYS J, V524, P242, DOI 10.1086/307807; IBEN I, 1969, NATURE, V224, P1006, DOI 10.1038/2241006a0; Kippenhahn R., 1990, STELLAR STRUCTURE EV; Kurucz R. L., 1993, ATLAS9 STELLAR ATMOS; Landsman JB, 1996, ASTROPHYS J, V472, pL93, DOI 10.1086/310368; Marigo P, 2009, ASTRON ASTROPHYS, V508, P1539, DOI 10.1051/0004-6361/200912598; Momany Y, 2002, ASTROPHYS J, V576, pL65, DOI 10.1086/343125; NORRIS J, 1981, ASTROPHYS J, V244, P205, DOI 10.1086/158698; RENZINI A, 1988, ANNU REV ASTRON ASTR, V26, P199; Sandquist EL, 2004, ASTROPHYS J, V611, P323, DOI 10.1086/422134; SMITH GH, 1992, MON NOT R ASTRON SOC, V256, P449, DOI 10.1093/mnras/256.3.449; Villanova S, 2009, ASTRON ASTROPHYS, V499, P755, DOI 10.1051/0004-6361/200811493; Yong D, 2008, ASTROPHYS J, V684, P1159, DOI 10.1086/590658	28	67	67	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					198	200		10.1038/nature12191	http://dx.doi.org/10.1038/nature12191			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23719375	Green Submitted			2022-12-28	WOS:000320283400040
J	Han, H; Irimia, M; Ross, PJ; Sung, HK; Alipanahi, B; David, L; Golipour, A; Gabut, M; Michael, IP; Nachman, EN; Wang, E; Trcka, D; Thompson, T; O'Hanlon, D; Slobodeniuc, V; Barbosa-Morais, NL; Burge, CB; Moffat, J; Frey, BJ; Nagy, A; Ellis, J; Wrana, JL; Blencowe, BJ				Han, Hong; Irimia, Manuel; Ross, P. Joel; Sung, Hoon-Ki; Alipanahi, Babak; David, Laurent; Golipour, Azadeh; Gabut, Mathieu; Michael, Iacovos P.; Nachman, Emil N.; Wang, Eric; Trcka, Dan; Thompson, Tadeo; O'Hanlon, Dave; Slobodeniuc, Valentina; Barbosa-Morais, Nuno L.; Burge, Christopher B.; Moffat, Jason; Frey, Brendan J.; Nagy, Andras; Ellis, James; Wrana, Jeffrey L.; Blencowe, Benjamin J.			MBNL proteins repress ES-cell-specific alternative splicing and reprogramming	NATURE			English	Article							PLURIPOTENT STEM-CELLS; LARGE GENE LISTS; TRANSCRIPTIONAL NETWORK; MUSCLEBLIND PROTEINS; SELF-RENEWAL; DIFFERENTIATION; FIBROBLASTS; INTEGRATION; REGULATORS; PATHWAYS	Previous investigations of the core gene regulatory circuitry that controls the pluripotency of embryonic stem (ES) cells have largely focused on the roles of transcription, chromatin and non-coding RNA regulators(1-3). Alternative splicing represents a widely acting mode of gene regulation(4-8), yet its role in regulating ES-cell pluripotency and differentiation is poorly understood. Here we identify the muscleblind-like RNA binding proteins, MBNL1 and MBNL2, as conserved and direct negative regulators of a large program of cassette exon alternative splicing events that are differentially regulated between ES cells and other cell types. Knockdown of MBNL proteins in differentiated cells causes switching to an ES-cell-like alternative splicing pattern for approximately half of these events, whereas overexpression of MBNL proteins in ES cells promotes differentiated-cell-like alternative splicing patterns. Among the MBNL-regulated events is an ES-cell-specific alternative splicing switch in the forkhead family transcription factor FOXP1 that controls pluripotency(9). Consistent with a central and negative regulatory role for MBNL proteins in pluripotency, their knockdown significantly enhances the expression of key pluripotency genes and the formation of induced pluripotent stem cells during somatic cell reprogramming.	[Han, Hong; Irimia, Manuel; Gabut, Mathieu; Nachman, Emil N.; O'Hanlon, Dave; Slobodeniuc, Valentina; Barbosa-Morais, Nuno L.; Moffat, Jason; Frey, Brendan J.; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Han, Hong; Irimia, Manuel; Gabut, Mathieu; Nachman, Emil N.; O'Hanlon, Dave; Slobodeniuc, Valentina; Barbosa-Morais, Nuno L.; Moffat, Jason; Frey, Brendan J.; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Han, Hong; Golipour, Azadeh; Nachman, Emil N.; Moffat, Jason; Ellis, James; Wrana, Jeffrey L.; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ross, P. Joel; Thompson, Tadeo; Ellis, James] Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Sung, Hoon-Ki; Michael, Iacovos P.; Nagy, Andras] Mt Sinai Hosp, Ctr Stem Cells & Tissue Engn, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Alipanahi, Babak; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [David, Laurent; Golipour, Azadeh; Trcka, Dan; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Wang, Eric; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Barbosa-Morais, Nuno L.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Nagy, Andras] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Massachusetts Institute of Technology (MIT); Universidade de Lisboa; University of Toronto	Blencowe, BJ (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca	GABUT, Mathieu/M-7624-2017; Burge, Christopher B./AAH-2177-2020; Moffat, Jason/AAC-1110-2020; Wrana, Jeffrey/F-8857-2013; Ross, Joel/K-3361-2019; Sung, Hoon-Ki/A-1922-2016; Hoon, Dave SB/C-7146-2018; Irimia, Manuel/E-3040-2010; Nagy, Andras/G-6465-2013; Barbosa-Morais, Nuno L/I-2743-2013; Michael, Iacovos P/C-8695-2016; Ellis, James/F-4789-2011	GABUT, Mathieu/0000-0001-7343-5361; Moffat, Jason/0000-0002-5663-8586; Ross, Joel/0000-0001-7105-7117; Sung, Hoon-Ki/0000-0001-6677-9385; Hoon, Dave SB/0000-0003-1915-3683; Irimia, Manuel/0000-0002-2179-2567; Nagy, Andras/0000-0003-4311-0413; Barbosa-Morais, Nuno L/0000-0002-1215-0538; Michael, Iacovos P/0000-0001-7674-1233; Ellis, James/0000-0002-4400-0091; Alipanahi, Babak/0000-0001-8216-7178; Han, Hong/0000-0001-8977-9679; David, Laurent/0000-0003-3594-0353	Canadian Institutes of Health Research (CIHR); Ontario Research Fund; Canadian Stem Cell Network; National Institutes of Health [R33MH087908]; University of Toronto; Ontario Stem Cell Initiative; Human Frontiers Science Program Organization; Marie Curie Actions; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087908] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canadian Stem Cell Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toronto(University of Toronto); Ontario Stem Cell Initiative; Human Frontiers Science Program Organization(Human Frontier Science Program); Marie Curie Actions(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank U. Braunschweig, J. Ellis, S. Gueroussov and B. Raj for comments on the manuscript. We acknowledge D. Torti in the Donnelly Sequencing Centre for sequencing samples; L. Lee for assisting with the splicing code analysis; J. Garner (Hospital for Sick Children Embryonic Stem Cell Facility) for preparing feeder cells; A. Piekna for morphological examination of human iPSC colonies; M. Narimatsu for assisting with chimaerism analysis; and P. Mero for assisting with cell imaging. This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (to B. J. B., J. L. W., A.N., J. E. and B. J. F.), the Ontario Research Fund (to J. L. W., B. J. B., A.N. and others), the Canadian Stem Cell Network (to A.N. and B. J. B.), and by a grant from the National Institutes of Health (R33MH087908) to J. E. H. H. was supported by a University of Toronto Open Fellowship. P. J. R., M. I. and N.L.B.-M. were supported by postdoctoral fellowships from the Ontario Stem Cell Initiative, Human Frontiers Science Program Organization, and the Marie Curie Actions, respectively.	Bao XC, 2013, CURR OPIN CELL BIOL, V25, P208, DOI 10.1016/j.ceb.2012.12.004; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Fernandez-Costa JM, 2011, BIOL REV, V86, P947, DOI 10.1111/j.1469-185X.2011.00180.x; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Hotta A, 2009, NAT PROTOC, V4, P1828, DOI 10.1038/nprot.2009.201; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irimia M, 2012, CURR OPIN CELL BIOL, V24, P323, DOI 10.1016/j.ceb.2012.03.005; Irimia M, 2009, BIOESSAYS, V31, P40, DOI 10.1002/bies.080092; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Mayshar Y, 2008, STEM CELLS, V26, P767, DOI 10.1634/stemcells.2007-1037; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xiong HY, 2011, BIOINFORMATICS, V27, P2554, DOI 10.1093/bioinformatics/btr444; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	38	205	210	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					241	+		10.1038/nature12270	http://dx.doi.org/10.1038/nature12270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23739326	Green Accepted, Green Submitted			2022-12-28	WOS:000320283400051
J	Kato, H; Jiang, JS; Zhou, BR; Rozendaal, M; Feng, HQ; Ghirlando, R; Xiao, TS; Straight, AF; Bai, YW				Kato, Hidenori; Jiang, Jiansheng; Zhou, Bing-Rui; Rozendaal, Marieke; Feng, Hanqiao; Ghirlando, Rodolfo; Xiao, T. Sam; Straight, Aaron F.; Bai, Yawen			A Conserved Mechanism for Centromeric Nucleosome Recognition by Centromere Protein CENP-C	SCIENCE			English	Article							A NUCLEOSOMES; FUNCTIONAL DISSECTION; KINETOCHORE PROTEIN; CHROMATIN; COMPLEX; DNA; DOMAIN; NMR	Chromosome segregation during mitosis requires assembly of the kinetochore complex at the centromere. Kinetochore assembly depends on specific recognition of the histone variant CENP-A in the centromeric nucteosome by centromere protein C (CENP-C). We have defined the determinants of this recognition mechanism and discovered that CENP-C binds a hydrophobic region in the CENP-A tail and docks onto the acidic patch of histone H2A and H2B. We further found that the more broadly conserved CENP-C motif uses the same mechanism for CENP-A nucteosome recognition. Our findings reveal a conserved mechanism for protein recruitment to centromeres and a histone recognition mode whereby a disordered peptide binds the histone tail through hydrophobic interactions facilitated by nucleosome docking.	[Kato, Hidenori; Zhou, Bing-Rui; Feng, Hanqiao; Bai, Yawen] NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA; [Jiang, Jiansheng; Xiao, T. Sam] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Rozendaal, Marieke; Straight, Aaron F.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bai, YW (corresponding author), NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA.	yawen@helix.nih.gov	Xiao, Tsan Sam/A-8590-2010; Xiao, Tsan/I-7616-2013	Xiao, Tsan Sam/0000-0001-9688-475X; Xiao, Tsan/0000-0001-9688-475X; Zhou, Bing-Rui/0000-0002-5375-7977; Straight, Aaron/0000-0001-5885-7881; Jiang, Jiansheng/0000-0003-0964-5481	National Cancer Institute; National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; NIH [R01 GM074728]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZIABC010808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074728] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source (APS) (23-ID beamline) for technical support; C. Carroll for initial participation of the project; J. Barrowman for manuscript editing; A. Kelly, C. Wu, and C. Klee for comments; H. Kurumizaka and K. Morikawa for human histone plasmids and advice for CENP-A nucleosome reconstitution; and S. Tan for the 601 DNA prasmid. Supported by the intramural programs of the National Cancer Institute (H.K., H.F., B.-R.Z, and Y.B.); the National Institute of Allergy and Infectious Diseases (J.J. and T.S.X.); the National Institute of Diabetes and Digestive and Kidney Diseases (R.G.); NIH grant R01 GM074728 (M.R. and A.F.S.); and National Cancer Institute grant Y1-CO-1020, National Institute of General Medical Sciences grant Y1-GM-1104, and U.S. Department of Energy grant DE-AC02-06CH11357 (APS). The structure PDB ID is 4INM.	Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bock LJ, 2012, NAT CELL BIOL, V14, P614, DOI 10.1038/ncb2495; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Khorasanizadeh S, 2011, CURR OPIN STRUC BIOL, V21, P744, DOI 10.1016/j.sbi.2011.10.001; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Song K, 2002, EXP CELL RES, V275, P81, DOI 10.1006/excr.2002.5495; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Trazzi S, 2002, J STRUCT BIOL, V140, P39, DOI 10.1016/S1047-8477(02)00506-3; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004	28	221	222	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1110	1113		10.1126/science.1235532	http://dx.doi.org/10.1126/science.1235532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723239	Green Accepted			2022-12-28	WOS:000319664500048
J	Florez, JC; Shepard, JAO; Kradin, RL				Florez, Jose C.; Shepard, Jo-Anne O.; Kradin, Richard L.			Case 17-2013: A 56-Year-Old Woman with Poorly Controlled Diabetes Mellitus and Fatigue	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CUSHINGS-SYNDROME; EXPERIENCE; DIAGNOSIS		[Florez, Jose C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kradin, Richard L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Florez, Jose C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shepard, Jo-Anne O.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kradin, Richard L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Florez, JC (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.				Pfizer; Eli Lilly; Novartis; AGFA	Pfizer(Pfizer); Eli Lilly(Eli Lilly); Novartis(Novartis); AGFA	Dr. Florez reports receiving consulting fees from Pfizer, Eli Lilly, and Novartis. Dr. Shepard reports receiving consulting fees through her institution from AGFA and serving as an expert witness on behalf of physicians in legal cases involving chest imaging. Dr. Kradin reports serving as an expert witness on behalf of patients in cases involving asbestos and lung disease. No other potential conflict of interest relevant to this article was reported.	BELSKY JL, 1985, J CLIN ENDOCR METAB, V60, P496, DOI 10.1210/jcem-60-3-496; Boscaro M, 2009, J CLIN ENDOCR METAB, V94, P3121, DOI 10.1210/jc.2009-0612; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Gale EAM, 2005, DIABETOLOGIA, V48, P2195, DOI 10.1007/s00125-005-1954-5; Greeley SAW, 2011, CURR DIABETES REP, V11, P519, DOI 10.1007/s11892-011-0234-7; Ilias I, 2005, J CLIN ENDOCR METAB, V90, P4955, DOI 10.1210/jc.2004-2527; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Porterfield JR, 2008, WORLD J SURG, V32, P659, DOI 10.1007/s00268-007-9387-6; Rolandsson O, 2010, DIABETOLOGIA, V53, P1250, DOI 10.1007/s00125-010-1713-0; Terzolo M, 2012, J CLIN ENDOCR METAB, V97, P3467, DOI 10.1210/jc.2012-1323	13	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2126	2136		10.1056/NEJMcpc1215971	http://dx.doi.org/10.1056/NEJMcpc1215971			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23697472				2022-12-28	WOS:000319574200012
J	Mulcahy, A; Harris, K; Finegold, K; Kellermann, A; Edelman, L; Sommers, BD				Mulcahy, Andrew; Harris, Katherine; Finegold, Kenneth; Kellermann, Arthur; Edelman, Laurel; Sommers, Benjamin D.			Insurance Coverage of Emergency Care for Young Adults under Health Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; ACT; ECONOMICS; POLICIES; ACCESS	BACKGROUND The Affordable Care Act (ACA) established nationwide eligibility for young adults 19 to 25 years of age to retain coverage under their parents' private health plans. We conducted a study to determine how the implementation of this provision changed rates of insurance coverage for young adults seeking medical care for major emergencies. METHODS We evaluated more than 480,000 nondiscretionary visits made to emergency departments from 2009 through 2011, as recorded in a large, geographically diverse data set of hospital claims, to estimate how the ACA provision affected private insurance coverage of such visits by young adults (19 to 25 years of age). To adjust for underlying trends in insurance coverage, we compared changes in the target age group with changes among adults 26 to 31 years of age, who were unaffected by the provision (control group). RESULTS After the ACA provision took effect, private coverage of nondiscretionary visits to emergency departments by young adults increased by 3.1 percentage points (95% confidence interval [CI], 2.3 to 3.9; relative increase, 5.2%; P<0.001), as compared with similar visits in the control group. The percentage of visits by uninsured young adults also fell significantly (-1.7 percentage points; 95% CI, -2.8 to -0.7; relative decrease, 9.1%; P<0.001). The rates of nondiscretionary visits that were covered by Medicaid or other nonprivate insurers remained relatively steady throughout the study period. The coverage expansion led to an estimated 22,072 visits to emergency departments by newly insured young adults and $147 million in associated costs that were covered by private insurance plans during a 1-year period. CONCLUSIONS Enactment of the dependent-coverage provision was associated with a significant increase in the proportion of young adults who were protected from the financial consequences of a serious medical emergency.	[Mulcahy, Andrew; Harris, Katherine; Kellermann, Arthur] RAND, Arlington, VA USA; [Finegold, Kenneth; Sommers, Benjamin D.] Off Assistant Secretary Planning & Evaluat, Dept Hlth & Human Serv, Washington, DC USA; [Edelman, Laurel] IMS Hlth, Plymouth Meeting, PA USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	RAND Corporation; Harvard University; Harvard T.H. Chan School of Public Health	Mulcahy, A (corresponding author), 1200 S Hayes St, Arlington, VA 22202 USA.	amulcahy@rand.org			Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services [HHSP23320095649WC]	Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services	Funded by the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services.; Supported by a contract with the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services (HHSP23320095649WC).	[Anonymous], 2009, NAT EM DEP SAMPL; [Anonymous], 2009, ANN SURV DAT FISC YE; Antwi YA, 2012, EFFECTS FEDERAL POLI; Bureau of Labor Statistics, LAB FORC STAT CURR P; Callahan ST, 2005, PEDIATRICS, V116, P88, DOI 10.1542/peds.2004-1449; Cantor JC, 2012, HEALTH SERV RES, V47, P1773, DOI 10.1111/j.1475-6773.2012.01458.x; DeNavas-Walt C., 2012, INCOME POVERTY HLTH; DeNavas-Walt C., 2009, INCOME POVERTY HLTH; Hadley J, 2008, HEALTH AFFAIR, V27, pW399, DOI 10.1377/hlthaff.27.5.w399; Hsia RY, 2011, JAMA-J AM MED ASSOC, V305, P1978, DOI 10.1001/jama.2011.620; Institute of Medicine Committee on the Consequences of Uninsurance, 2002, HLTH INS IS FAM MATT; Institute of Medicine (US) Committee on the Consequences of Uninsurance, 2001, COV MATT INS HLTH CA; Levine PB, 2011, AM ECON J-ECON POLIC, V3, P129, DOI 10.1257/pol.3.1.129; MANNING WG, 1987, AM ECON REV, V77, P251; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Monheit AC, 2011, HEALTH SERV RES, V46, P251, DOI 10.1111/j.1475-6773.2010.01200.x; National Conference of State Legislatures, COV YOUNG AD THEIR P; Nicholson JL, 2009, RITE PASSAGE WHY YOU; PAULY MV, 1968, AM ECON REV, V58, P531; Sommers BD, 2011, 2 5 MILLION YOUNG AD; Sommers BD, 2012, NUMBER YOUNG ADULTS; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552; Sommers BD, 2012, JAMA-J AM MED ASSOC, V307, P913, DOI 10.1001/jama.307.9.913; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112	24	67	67	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2105	2112		10.1056/NEJMsa1212779	http://dx.doi.org/10.1056/NEJMsa1212779			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AT	23718165	Green Published			2022-12-28	WOS:000319574200008
J	Zimmermann, G; Papke, B; Ismail, S; Vartak, N; Chandra, A; Hoffmann, M; Hahn, SA; Triola, G; Wittinghofer, A; Bastiaens, PIH; Waldmann, H				Zimmermann, Gunther; Papke, Bjoern; Ismail, Shehab; Vartak, Nachiket; Chandra, Anchal; Hoffmann, Maike; Hahn, Stephan A.; Triola, Gemma; Wittinghofer, Alfred; Bastiaens, Philippe I. H.; Waldmann, Herbert			Small molecule inhibition of the KRAS-PDE delta interaction impairs oncogenic KRAS signalling	NATURE			English	Article							K-RAS; PROTEIN PRENYLATION; CANCER-THERAPY; ACTIVATION; DISCOVERY; MEMBRANE; LIGANDS; BIND; FLIM; ERK	The KRAS oncogene product is considered a major target in anticancer drug discovery(1-3). However, direct interference with KRAS signalling has not yet led to clinically useful drugs(3-8). Correct localization and signalling by farnesylated KRAS is regulated by the prenyl-binding protein PDE delta, which sustains the spatial organization of KRAS by facilitating its diffusion in the cytoplasm(9-11). Here we report that interfering with binding of mammalian PDEd to KRAS by means of small molecules provides a novel opportunity to suppress oncogenic RAS signalling by altering its localization to endomembranes. Biochemical screening and subsequent structure-based hit optimization yielded inhibitors of the KRAS-PDE delta interaction that selectively bind to the prenyl-binding pocket of PDE delta with nanomolar affinity, inhibit oncogenic RAS signalling and suppress in vitro and in vivo proliferation of human pancreatic ductal adenocarcinoma cells that are dependent on oncogenic KRAS. Our findings may inspire novel drug discovery efforts aimed at the development of drugs targeting oncogenic RAS.	[Zimmermann, Gunther; Triola, Gemma; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Chem Biol, D-44227 Dortmund, Germany; [Papke, Bjoern; Vartak, Nachiket; Chandra, Anchal; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany; [Ismail, Shehab; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Struct Biol Grp, D-44227 Dortmund, Germany; [Hoffmann, Maike; Hahn, Stephan A.] Ruhr Univ Bochum, Dept Mol Gastrointestinal Oncol, D-44801 Bochum, Germany; [Bastiaens, Philippe I. H.; Waldmann, Herbert] TU Dortmund, Fac Chem, D-44227 Dortmund, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Ruhr University Bochum; Dortmund University of Technology	Waldmann, H (corresponding author), Max Planck Inst Mol Physiol, Dept Chem Biol, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de; philippe.bastiaens@mpi-dortmund.mpg.de; herbert.waldmann@mpi-dortmund.mpg.de	Waldmann, Herbert/B-7406-2017; Hahn, Stephan A./AAV-6062-2021; Triola, Gemma/E-2235-2017; Hahn, Stephan/E-3880-2010; Chandra, Anchal/AAT-5644-2021; Vartak, Nachiket/A-2979-2009	Waldmann, Herbert/0000-0002-9606-7247; Hahn, Stephan A./0000-0003-0855-9741; Triola, Gemma/0000-0003-4177-8989; Hahn, Stephan/0000-0003-0855-9741; Chandra, Anchal/0000-0003-4096-4771; Vartak, Nachiket/0000-0002-2966-4631; Vartak, Nachiket/0000-0001-8813-4799; Ismail, Shehab/0000-0002-4150-1077; Papke, Bjoern/0000-0001-8156-7508	European Research Council under the European Union [268309, 268782]; Fonds der Chemischen Industrie	European Research Council under the European Union(European Research Council (ERC)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement no. 268309 to H. W., and no. 268782 to A.W. The Compound Management und Screening Center (COMAS), Dortmund, Germany, is acknowledged for carrying out high-throughput screening and data analysis. G.Z. acknowledges the Fonds der Chemischen Industrie for a Kekule Scholarship. We thank K. Michel for help with western blot analysis. We are grateful to C. Degenhart, A. Wolf, S. Baumann and A. Choidas for help with screening assay development and for the determination of solubility, membrane permeability and stability of deltarasin.	Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; BERROZPE G, 1994, INT J CANCER, V58, P185, DOI 10.1002/ijc.2910580207; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; Chandra A, 2012, NAT CELL BIOL, V14, P329, DOI 10.1038/ncb2462; Chen YX, 2010, ANGEW CHEM INT EDIT, V49, P6090, DOI 10.1002/anie.201001884; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Grecco HE, 2010, NAT METHODS, V7, P467, DOI [10.1038/NMETH.1458, 10.1038/nmeth.1458]; Grecco HE, 2009, OPT EXPRESS, V17, P6493, DOI 10.1364/OE.17.006493; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Monovich LG, 2009, J MED CHEM, V52, P3523, DOI 10.1021/jm801394m; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835	26	442	459	3	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					638	642		10.1038/nature12205	http://dx.doi.org/10.1038/nature12205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23698361				2022-12-28	WOS:000319556100048
J	Fitz, NF; Cronican, AA; Lefterov, I; Koldamova, R				Fitz, Nicholas F.; Cronican, Andrea A.; Lefterov, Iliya; Koldamova, Radosveta			Comment on "ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models"	SCIENCE			English	Editorial Material							ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; MICE; PATHOGENESIS; ABCA1		[Fitz, Nicholas F.; Cronican, Andrea A.; Lefterov, Iliya; Koldamova, Radosveta] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lefterov, I (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, 100 Technol Dr,BRIDG Bldg, Pittsburgh, PA 15219 USA.	iliyal@pitt.edu; radak@pitt.edu	Lefterov, Iliya/B-4767-2008	Koldamova, Radosveta/0000-0002-6761-0984; Hefendehl, Jasmin/0000-0001-8994-2536; Lefterov, Iliya/0000-0002-0249-0280; Fitz, Nicholas/0000-0001-6938-6536	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037919, R01AG037481, F32AG034031] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG037481, R01 AG037919, R01AG037919, R01AG037481, F32 AG034031, F32AG034031] Funding Source: Medline; NIEHS NIH HHS [R21 ES021243, R21ES021243] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Fitz NF, 2012, J NEUROSCI, V32, P13125, DOI 10.1523/JNEUROSCI.1937-12.2012; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koldamova R, 2007, CURR ALZHEIMER RES, V4, P171, DOI 10.2174/156720507780362227; Koldamova R, 2010, BBA-MOL CELL BIOL L, V1801, P824, DOI 10.1016/j.bbalip.2010.02.010; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Lefterov I, 2009, ASN NEURO, V1, DOI 10.1042/AN20090015; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2	14	140	155	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135							1235809	10.1126/science.1235809	http://dx.doi.org/10.1126/science.1235809			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704552	Green Accepted			2022-12-28	WOS:000319344100021
J	Goonetilleke, N; McMichael, AJ				Goonetilleke, Nilu; McMichael, Andrew J.			Antigen Processing Takes a New Direction	SCIENCE			English	Editorial Material							I HEAVY-CHAINS; VACCINE; IMMUNODOMINANCE; ESCAPE; US2; SIV		[Goonetilleke, Nilu; McMichael, Andrew J.] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Goonetilleke, N (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	andrew.mcmichael@ndm.ox.ac.uk			NIAID NIH HHS [U01 AI067854] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Basta S, 2002, J IMMUNOL, V168, P5403, DOI 10.4049/jimmunol.168.11.5403; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Rehm A, 2002, J VIROL, V76, P5043, DOI 10.1128/JVI.76.10.5043-5050.2002; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	12	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					937	938		10.1126/science.1239649	http://dx.doi.org/10.1126/science.1239649			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704564				2022-12-28	WOS:000319344100034
J	Dolgin, E				Dolgin, Elie			DEPRIVATION A wake-up call	NATURE			English	Editorial Material							SLEEP RESTRICTION; DURATION											Broussard JL, 2012, ANN INTERN MED, V157, P549, DOI 10.7326/0003-4819-157-8-201210160-00005; Goel N, 2010, NEUROLOGY, V75, P1509, DOI 10.1212/WNL.0b013e3181f9615d; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Haack M, 2013, J SLEEP RES, V22, P295, DOI 10.1111/jsr.12011; Luckhaupt Sara E., 2012, Morbidity and Mortality Weekly Report, V61, P281; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Prather AA, 2012, SLEEP, V35, P1063, DOI 10.5665/sleep.1990; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	10	15	15	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S6	S7		10.1038/497S6a	http://dx.doi.org/10.1038/497S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698507				2022-12-28	WOS:000319254000004
J	Rey, FA				Rey, Felix A.			DENGUE VIRUS Two hosts, two structures	NATURE			English	Editorial Material							WEST-NILE-VIRUS; ENVELOPE GLYCOPROTEIN; CRYSTAL-STRUCTURE; ANTIBODIES; EPITOPES		[Rey, Felix A.] Inst Pasteur, Unite Virol Struct, F-75724 Paris 15, France; [Rey, Felix A.] CNRS, UMR 3569, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Rey, FA (corresponding author), Inst Pasteur, Unite Virol Struct, F-75724 Paris 15, France.	rey@pasteur.fr	Rey, Felix/B-6497-2012	Rey, Felix/0000-0002-9953-7988				Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Fibriansah G., 2013, J VIROL; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Morens D. M., 2013, ECOHEALTH; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Simmons CP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001752; World Health Organization, 2012, DENG SEV DENG; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	20	23	26	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					443	444		10.1038/497443a	http://dx.doi.org/10.1038/497443a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698439				2022-12-28	WOS:000319254000034
J	Gautschi, OP; Schaller, K				Gautschi, Oliver P.; Schaller, Karl			Surgery or conservative therapy for cerebral haemorrhage?	LANCET			English	Editorial Material							INTRACEREBRAL HEMORRHAGE		[Gautschi, Oliver P.; Schaller, Karl] Univ Geneva, Fac Med, Med Ctr, Dept Neurosurg, CH-1211 Geneva 14, Switzerland	University of Geneva	Gautschi, OP (corresponding author), Univ Geneva, Fac Med, Med Ctr, Dept Neurosurg, CH-1211 Geneva 14, Switzerland.	oliver.gautschi@hcuge.ch						Biffi A, 2011, LANCET NEUROL, V10, P702, DOI 10.1016/S1474-4422(11)70148-X; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; Hanley D., 2013, MINIMALLY INVASIVE S; Hanley DF, 2013, CLOT LYSIS EVALUATIN; Martini SR, 2012, NEUROLOGY, V79, P2275, DOI 10.1212/WNL.0b013e318276896f; Mendelow AD, 2005, LANCET, V365, P387; Mendelow AD, 2013, LANCET	7	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 3	2013	382	9890					377	378		10.1016/S0140-6736(13)61087-9	http://dx.doi.org/10.1016/S0140-6736(13)61087-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23726394	hybrid			2022-12-28	WOS:000322638500009
J	Gansevoort, RT; Correa-Rotter, R; Hemmelgarn, BR; Jafar, TH; Heerspink, HJL; Mann, JF; Matsushita, K; Wen, CP				Gansevoort, Ron T.; Correa-Rotter, Ricardo; Hemmelgarn, Brenda R.; Jafar, Tazeen H.; Heerspink, Hiddo J. Lambers; Mann, Johannes F.; Matsushita, Kunihiro; Wen, Chi Pang			Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention	LANCET			English	Article							STAGE RENAL-DISEASE; GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; ELEVATION MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR HYPERTROPHY; COMMUNITY-BASED POPULATION; ACUTE CORONARY SYNDROME; BLOOD-PRESSURE CONTROL; VITAMIN-D THERAPY; ATHEROSCLEROSIS RISK	Since the first description of the association between chronic kidney disease and heart disease, many epidemiological studies have confirmed and extended this finding. As chronic kidney disease progresses, kidney-specific risk factors for cardiovascular events and disease come into play. As a result, the risk for cardiovascular disease is notably increased in individuals with chronic kidney disease. When adjusted for traditional cardiovascular risk factors, impaired kidney function and raised concentrations of albumin in urine increase the risk of cardiovascular disease by two to four times. Yet, cardiovascular disease is frequently underdiagnosed and undertreated in patients with chronic kidney disease. This group of patients should, therefore, be acknowledged as having high cardiovascular risk that needs particular medical attention at an individual level. This view should be incorporated in the development of guidelines and when defining research priorities. Here, we discuss the epidemiology and pathophysiological mechanisms of cardiovascular risk in patients with chronic kidney disease, and discuss methods of prevention.	[Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Correa-Rotter, Ricardo] Natl Med Sci & Nutr Inst Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City, DF, Mexico; [Hemmelgarn, Brenda R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Jafar, Tazeen H.] Duke NUS Grad Med Sch, Programme Hlth Serv & Syst Res, Singapore, Singapore; [Heerspink, Hiddo J. Lambers] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, NL-9700 RB Groningen, Netherlands; [Mann, Johannes F.] Munich Gen Hosp, Dept Nephrol, Munich, Germany; [Mann, Johannes F.] Univ Erlangen Nurnberg, Dept Med, Clin 4, Nurnberg, Germany; [Matsushita, Kunihiro] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wen, Chi Pang] China Med Univ Hosp, Taichung, Taiwan; [Wen, Chi Pang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan	University of Groningen; University of Calgary; National University of Singapore; University of Groningen; University of Erlangen Nuremberg; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan	Gansevoort, RT (corresponding author), Univ Med Ctr Groningen, Dept Nephrol, POB 30-001, NL-9700 RB Groningen, Netherlands.	r.t.gansevoort@umcg.nl	Matsushita, Kunihiro/B-1021-2018; Matsushita, Kunihiro/AAJ-5817-2020; Heerspink, Hiddo J Lambers/K-3358-2014; Mann, Johannes/AAI-8803-2020	Matsushita, Kunihiro/0000-0002-7179-718X; Matsushita, Kunihiro/0000-0002-7179-718X; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; 	Roy and Vi Baay Chair in Kidney Research; Ministry of health, Singapore; Netherlands Organisation of Scientific Research; European commission [241544]; US National Institutes of Health; National Kidney Foundation; Taiwan Department of Health Clinical Trial and Research Centre of Excellence [DOH 102-TD-B-111-004]	Roy and Vi Baay Chair in Kidney Research; Ministry of health, Singapore(Ministry of Health-Singapore); Netherlands Organisation of Scientific Research(Netherlands Organization for Scientific Research (NWO)); European commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; Taiwan Department of Health Clinical Trial and Research Centre of Excellence	BRH is supported by the Roy and Vi Baay Chair in Kidney Research, THJ by a grant from the Ministry of health, Singapore, JHLH by a VENI grant from the Netherlands Organisation of Scientific Research, JFM by the European commission (grant 241544, SysKid), KM by grants from the US National Institutes of Health and grants to the CKD Prognosis Consortium from the National Kidney Foundation and its sponsors, and CPW by the Taiwan Department of Health Clinical Trial and Research Centre of Excellence (DOH 102-TD-B-111-004). The quotation from Bright at the start of the paper was retrieved with the help of G Eknoyan, Baylor College of Medicine, Houston, TX, USA.	Abdel-Latif A, 2010, CATHETER CARDIO INTE, V76, P942, DOI 10.1002/ccd.22562; Abramson JL, 2003, KIDNEY INT, V64, P610, DOI 10.1046/j.1523-1755.2003.00109.x; Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Andrade JM, 2009, AM J ROENTGENOL, V193, pW25, DOI 10.2214/AJR.08.1389; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Ashrith G, 2010, AM J CARDIOL, V106, P348, DOI 10.1016/j.amjcard.2010.03.037; Asim M, 2011, NEPHRON CLIN PRACT, V119, pC333, DOI 10.1159/000331071; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Astor BC, 2006, AM HEART J, V151, P492, DOI 10.1016/j.ahj.2005.03.055; Baber U, 2009, AM J CARDIOL, V103, P1513, DOI 10.1016/j.amjcard.2009.01.364; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bakris GL, 2012, CONTRIB NEPHROL, V178, P100, DOI 10.1159/000337821; Bleyer AJ, 2000, KIDNEY INT, V57, P2072, DOI 10.1046/j.1523-1755.2000.00056.x; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Bright R., 1836, GUYS HOSP REP, P338; Cardinal H, 2010, NEPHROL THER, V6, P162, DOI 10.1016/j.nephro.2009.10.003; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Charytan DM, 2007, KIDNEY INT, V71, P938, DOI 10.1038/sj.ki.5002159; Cheng TYD, 2008, AM J KIDNEY DIS, V52, P1051, DOI 10.1053/j.ajkd.2008.05.030; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chowdhury T, 2013, AM J KIDNEY DIS, V61, P646, DOI 10.1053/j.ajkd.2012.11.030; Cianciaruso B, 2009, AM J KIDNEY DIS, V54, P1052, DOI 10.1053/j.ajkd.2009.07.021; Crews DC, 2011, ADV CHRONIC KIDNEY D, V18, P249, DOI 10.1053/j.ackd.2011.06.004; Dasmahapatra P, 2011, ANN EPIDEMIOL, V21, P311, DOI 10.1016/j.annepidem.2011.01.007; de Galan BE, 2009, J AM SOC NEPHROL, V20, P883, DOI 10.1681/ASN.2008070667; de Jong PE, 2008, CLIN J AM SOC NEPHRO, V3, P616, DOI 10.2215/CJN.04381007; de Zeeuw D, 2011, ADV CHRONIC KIDNEY D, V18, P222, DOI 10.1053/j.ackd.2011.06.005; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Drechsler C, 2009, KIDNEY INT, V76, P567, DOI 10.1038/ki.2009.200; Eckardt K. U., 2013, LANCET; Eknoyan G, 2011, NEFROLOGIA, V31, P397, DOI 10.3265/Nefrologia.pre2011.May.10963; Esnault VLM, 2005, J AM SOC NEPHROL, V16, P474, DOI 10.1681/ASN.2004060505; Fouque D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001892.pub3; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Franco OH, 2005, HYPERTENSION, V46, P280, DOI 10.1161/01.HYP.0000173433.67426.9b; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gerstein HC, 2000, LANCET, V355, P253; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Green D, 2011, AM J KIDNEY DIS, V57, P921, DOI 10.1053/j.ajkd.2011.02.376; Halbesma N, 2009, J AM SOC NEPHROL, V20, P1797, DOI 10.1681/ASN.2008060649; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hallan SI, 2011, KIDNEY INT, V80, P516, DOI 10.1038/ki.2011.157; HARLOS J, 1994, AM J NEPHROL, V14, P436, DOI 10.1159/000168761; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; HEEG JE, 1989, KIDNEY INT, V36, P272, DOI 10.1038/ki.1989.190; Heiwe S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003236.pub2; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Holtkamp FA, 2011, EUR HEART J, V32, P1493, DOI 10.1093/eurheartj/ehr017; Iwanaga Y, 2010, CIRC J, V74, P1274, DOI 10.1253/circj.CJ-10-0444; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Ketteler M, 2006, HYPERTENSION, V47, P1027, DOI 10.1161/01.HYP.0000219635.51844.da; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT S, V5, P337, DOI DOI 10.1038/KISUP.2012.46; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kielstein JT, 2005, AM J KIDNEY DIS, V46, P186, DOI 10.1053/j.ajkd.2005.05.009; Kokubo Y, 2009, STROKE, V40, P2674, DOI 10.1161/STROKEAHA.109.550707; Kottgen A, 2007, J AM SOC NEPHROL, V18, P1307, DOI 10.1681/ASN.2006101159; Krane V, 2011, NAT REV NEPHROL, V6, P1573; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Lambers Heerspink HJ, 2012, KIDNEY INT, V82, P330, DOI 10.1038/ki.2012.74; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levin A, 2000, AM J KIDNEY DIS, V36, pS24, DOI 10.1053/ajkd.2000.19928; Levin A, 1996, AM J KIDNEY DIS, V27, P347, DOI 10.1016/S0272-6386(96)90357-1; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Loukine L, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/612968; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McCullough PA, 2011, CONTRIB NEPHROL, V171, P68, DOI 10.1159/000327230; Melamed ML, 2012, CLIN J AM SOC NEPHRO, V7, P358, DOI 10.2215/CJN.04040411; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P1565, DOI 10.2215/CJN.02250409; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Ochodnicky P, 2006, J CARDIOVASC PHARM, V47, pS151, DOI 10.1097/00005344-200606001-00009; Packham DK, 2012, AM J KIDNEY DIS, V59, P75, DOI 10.1053/j.ajkd.2011.09.017; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Palmer SC, 2012, ANN INTERN MED, V156, P445, DOI 10.7326/0003-4819-156-6-201203200-00007; Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3; Parikh NI, 2006, ARCH INTERN MED, V166, P1884, DOI 10.1001/archinte.166.17.1884; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pohl MA, 2005, J AM SOC NEPHROL, V16, P3027, DOI 10.1681/ASN.2004110919; Postorino M, 2009, J AM COLL CARDIOL, V53, P1265, DOI 10.1016/j.jacc.2008.12.040; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Robinson ES, 2010, AM J EPIDEMIOL, V171, P515, DOI 10.1093/aje/kwp442; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Ruggenenti P, 2011, J NEPHROL, V24, P274, DOI 10.5301/JN.2011.7763; Saltzman AJ, 2011, JACC-CARDIOVASC INTE, V4, P1011, DOI 10.1016/j.jcin.2011.06.012; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Seddon M, 2010, J RENAL CARE, V36, P118, DOI 10.1111/j.1755-6686.2010.00157.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Slagman MCJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4366; Stack AG, 2005, AM J KIDNEY DIS, V45, P690, DOI 10.1053/j.ajkd.2004.12.013; Szummer K, 2010, J INTERN MED, V268, P40, DOI 10.1111/j.1365-2796.2009.02204.x; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Tonelli M, 2005, CIRCULATION, V112, P171, DOI 10.1161/CIRCULATIONAHA.104.517565; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3182, DOI 10.1093/ndt/gfs052; Upadhyay A, 2011, ANN INTERN MED, V154, P541, DOI 10.7326/0003-4819-154-8-201104190-00335; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vegter S, 2012, J AM SOC NEPHROL, V23, P165, DOI 10.1681/ASN.2011040430; Vogt L, 2008, J AM SOC NEPHROL, V19, P999, DOI 10.1681/ASN.2007060693; Wang AYM, 2012, SEMIN DIALYSIS, V25, P388, DOI 10.1111/j.1525-139X.2012.01099.x; Wattanakit K, 2007, J AM SOC NEPHROL, V18, P629, DOI 10.1681/ASN.2005111204; Weigert AL, 1998, AM J MED SCI, V316, P94, DOI 10.1097/00000441-199808000-00005; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Zoccali C, 2002, KIDNEY INT, V62, P339, DOI 10.1046/j.1523-1755.2002.00437.x	115	1201	1246	26	163	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					339	352		10.1016/S0140-6736(13)60595-4	http://dx.doi.org/10.1016/S0140-6736(13)60595-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23727170				2022-12-28	WOS:000322544900032
J	Arias, CA; Bosquiazzo, LM; Bruna, JA; Fabrica, MC; Mascotti, C; Bertin, MS; Castaldi, JL; Mendoza, SJ; Partida, LY; Zyla, A; Castilla, L; Di Gerolano, E; Espinoza, M; Koch, G; Tulian, M; Melis, M; Miriam, M; Palermo, M; Pappalardo, J; Quinones, M; Cabrera, F; Campos, S; Curioni, MA; Fernandez, J; Grasselli, C; Abarzua, F; Araya, G; Caro, M; Gonzalez, C; Vera, C; Araneda, M; De la Cuadra, S; Kusanovic, JP; Ortiz, JA; Silva, K; Bofa, WK; Djokoto, RM; Konney, TO; Larbi, YO; Quashie, E; Kriplani, A; Kumar, S; Mittal, S; Gupta, U; Puri, M; Raghunandan, C; Trivedi, SS; Batra, S; Kumar, A; Manaktala, U; Prasad, S; Goel, N; Guleria, K; Radhakrishnan, G; Suneja, A; Vaid, NB; Beck, M; D'Souza, A; Sebastian, A; Thomas, AE; Thomas, E; Vijayaselvi, R; Butt, F; Kaliti, S; Nyaboga, EO; Owiti, MJ; Wameyo, A; Akram, S; Junejo, A; Khatoon, J; Siddiqui, S; Zafar, S; Abbasi, F; Aijaz, S; Firdous, A; Khuwaja, A; Zulfiqar, B; Batool, S; Hashmi, H; Hussaini, S; Naqvi, Z; Tahir, S; Ibrahim, S; Khalil, SE; Kuna, A; Saboni, M; Salman, M; Abubakar, MS; Awad, M; Elbashir, M; Gaffar, N; Hussain, S				Arias, C. A.; Bosquiazzo, L. M.; Bruna, J. A.; Fabrica, M. C.; Mascotti, C.; Bertin, M. S.; Castaldi, J. L.; Mendoza, S. J.; Partida, L. Y.; Zyla, A.; Castilla, L.; Di Gerolano, E.; Espinoza, M.; Koch, G.; Tulian, M.; Melis, M.; Miriam, M.; Palermo, M.; Pappalardo, J.; Quinones, M.; Cabrera, F.; Campos, S.; Curioni, M. A.; Fernandez, J.; Grasselli, C.; Abarzua, F.; Araya, G.; Caro, M.; Gonzalez, C.; Vera, C.; Araneda, M.; De la Cuadra, S.; Kusanovic, J. P.; Ortiz, J. A.; Silva, K.; Bofa, W. K.; Djokoto, R. M.; Konney, T. O.; Larbi, Y. O.; Quashie, E.; Kriplani, A.; Kumar, S.; Mittal, S.; Gupta, U.; Puri, M.; Raghunandan, C.; Trivedi, S. S.; Batra, S.; Kumar, A.; Manaktala, U.; Prasad, S.; Goel, N.; Guleria, K.; Radhakrishnan, G.; Suneja, A.; Vaid, N. B.; Beck, M.; D'Souza, A.; Sebastian, A.; Thomas, A. E.; Thomas, E.; Vijayaselvi, R.; Butt, F.; Kaliti, S.; Nyaboga, E. O.; Owiti, M. J.; Wameyo, A.; Akram, S.; Junejo, A.; Khatoon, J.; Siddiqui, S.; Zafar, S.; Abbasi, F.; Aijaz, S.; Firdous, A.; Khuwaja, A.; Zulfiqar, B.; Batool, S.; Hashmi, H.; Hussaini, S.; Naqvi, Z.; Tahir, S.; Ibrahim, S.; Khalil, S. E.; Kuna, A.; Saboni, M.; Salman, M.; Abubakar, M. S.; Awad, M.; Elbashir, M.; Gaffar, N.; Hussain, S.		CORONIS Collaborative Grp	Caesarean section surgical techniques (CORONIS): a fractional, factorial, unmasked, randomised controlled trial	LANCET			English	Article							UTERINE RUPTURE; CLINICAL-TRIALS; DELIVERY; RATES; LABOR	Background Variations exist in the surgical techniques used for caesarean section and many have not been rigorously assessed in randomised controlled trials. We aimed to assess whether any surgical techniques were associated with improved outcomes for women and babies. Methods CORONIS was a pragmatic international 2x2x2x2x2 non-regular fractional, factorial, unmasked, randomised controlled trial that examined five elements of the caesarean section technique in intervention pairs. CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan. Each site was assigned to three of the five intervention pairs: blunt versus sharp abdominal entry; exteriorisation of the uterus for repair versus intra-abdominal repair; single-layer versus double-layer closure of the uterus; closure versus non-closure of the peritoneum (pelvic and parietal); and chromic catgut versus polyglactin-910 for uterine repair. Pregnant women were eligible if they were to undergo their first or second caesarean section through a planned transverse abdominal incision. Women were randomly assigned by a secure web-based number allocation system to one intervention from each of the three assigned pairs. All investigators, surgeons, and participants were unmasked to treatment allocation. The primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion (>1 unit) up to the 6-week follow-up visit. Women were analysed in the groups into which they were allocated. The CORONIS Trial is registered with Current Controlled Trials: ISRCTN31089967. Findings Between May 20, 2007, and Dec 31, 2010, 15 935 women were recruited. There were no statistically significant differences within any of the intervention pairs for the primary outcome: blunt versus sharp entry risk ratio 1.03 (95% CI 0.91-1.17), exterior versus intra-abdominal repair 0.96 (0.84-1.08), single-layer versus double-layer closure 0.96 (0.85-1.08), closure versus non-closure 1.06 (0.94-1.20), and chromic catgut versus polyglactin-910 0.90 (0.78-1.04). 144 serious adverse events were reported, of which 26 were possibly related to the intervention. Most of the reported serious adverse events were known complications of surgery or complications of the reasons for the caesarean section. Interpretation These findings suggest that any of these surgical techniques is acceptable. However, longer-term follow-up is needed to assess whether the absence of evidence of short-term effects will translate into an absence of long-term effects.	[Arias, C. A.; Bosquiazzo, L. M.; Bruna, J. A.; Fabrica, M. C.; Mascotti, C.] Hosp Dr Jose Maria Cullen, Santa Fe, NM USA; [Bertin, M. S.; Castaldi, J. L.; Mendoza, S. J.; Partida, L. Y.; Zyla, A.] Hosp Interzonal Gen Agudos Dr Jose Penna, Bahia Blanca, Buenos Aires, Argentina; [Di Gerolano, E.; Espinoza, M.; Koch, G.; Tulian, M.] Hosp JB Iturraspe, Santa Fe, NM USA; [Melis, M.; Miriam, M.; Palermo, M.; Pappalardo, J.; Quinones, M.] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Cabrera, F.; Campos, S.; Curioni, M. A.; Fernandez, J.; Grasselli, C.] Hosp Reg Dr Ramon Carrillo, Santiago Del Estero, Argentina; [Abarzua, F.; Araya, G.; Caro, M.; Gonzalez, C.; Vera, C.] Pontificia Univ Catolica Chile Hosp, Santiago, Chile; [Araneda, M.; De la Cuadra, S.; Kusanovic, J. P.; Ortiz, J. A.; Silva, K.] Hosp Dr Sotero del Rio, Santiago, Chile; [Bofa, W. K.; Djokoto, R. M.; Konney, T. O.; Larbi, Y. O.; Quashie, E.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Kriplani, A.; Kumar, S.; Mittal, S.] AIIMS, Ansari Nagar, India; [Gupta, U.; Puri, M.; Raghunandan, C.; Trivedi, S. S.] Lady Hardinge Med Coll & Hosp, New Delhi, India; [Gupta, U.; Puri, M.; Raghunandan, C.; Trivedi, S. S.] Sucheta Kriplani Hosp, New Delhi, India; [Batra, S.; Kumar, A.; Manaktala, U.; Prasad, S.] Maulana Azad Med Coll, New Delhi, India; [Batra, S.; Kumar, A.; Manaktala, U.; Prasad, S.] Lok Nayak Hosp, New Delhi, India; [Goel, N.; Guleria, K.; Radhakrishnan, G.; Suneja, A.; Vaid, N. B.] Univ Coll Med Sci, Shahdara, India; [Goel, N.; Guleria, K.; Radhakrishnan, G.; Suneja, A.; Vaid, N. B.] GTB Hosp, Shahdara, India; [Beck, M.; D'Souza, A.; Sebastian, A.; Thomas, A. E.; Thomas, E.; Vijayaselvi, R.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Butt, F.; Kaliti, S.; Nyaboga, E. O.; Owiti, M. J.; Wameyo, A.] Univ Nairobi, Kenyatta Natl Hosp, Nairobi, Kenya; [Akram, S.; Junejo, A.; Khatoon, J.; Siddiqui, S.; Zafar, S.] Countess Dufferin Hosp, Hyderabad, Andhra Pradesh, India; [Abbasi, F.; Aijaz, S.; Firdous, A.; Khuwaja, A.; Zulfiqar, B.] Fatima Bai Hosp, Karachi, Pakistan; [Batool, S.; Hashmi, H.; Hussaini, S.; Naqvi, Z.; Tahir, S.] Liaquat Natl Hosp, Karachi, Pakistan; [Ibrahim, S.; Khalil, S. E.; Kuna, A.; Saboni, M.; Salman, M.] Omdurman Matern Hosp, Omdurman, Sudan; [Abubakar, M. S.; Awad, M.; Elbashir, M.; Gaffar, N.; Hussain, S.] Soba Univ Hosp, Khartoum, Sudan	Pontificia Universidad Catolica de Chile; Universidad de Chile; Kwame Nkrumah University Science & Technology; All India Institute of Medical Sciences (AIIMS) New Delhi; Lady Hardinge Medical College & Hospital; Lady Hardinge Medical College & Hospital; Maulana Azad Medical College; University of Delhi; University College of Medical Sciences; Christian Medical College & Hospital (CMCH) Vellore; Kenyatta National Hospital; University of Nairobi	Arias, CA (corresponding author), Hosp Dr Jose Maria Cullen, Santa Fe, NM USA.		Kusanovic, Juan Pedro/AAM-5782-2020; Campos, Shirley/AAR-6026-2021; Suneja, Amita/ABF-5230-2020; Kusanovic, Juan Pedro/R-8616-2019	Kusanovic, Juan Pedro/0000-0003-0640-2070; Campos, Shirley/0000-0003-3079-8300; Gray, Shan/0000-0002-2551-2112; Oyarzun, Enrique/0000-0002-0093-0473; sebastian, ajit/0000-0002-0145-6654; Campbell, Oona/0000-0002-9311-0115; Jamieson, Nina/0000-0002-8776-5000	UK Medical Research Council; WHO; MRC [G0500959] Funding Source: UKRI; Medical Research Council [G0500959] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WHO(World Health Organization); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council and WHO.	Bamigboye A. A., 2003, COCHRANE DB SYST REV, V4; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Berghella V, 2005, AM J OBSTET GYNECOL, V193, P1607, DOI 10.1016/j.ajog.2005.03.063; Briand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047352; Brocklehurst P, 2010, BJOG-INT J OBSTET GY, V117, P1366, DOI 10.1111/j.1471-0528.2010.02686.x; Chapman SJ, 1997, OBSTET GYNECOL, V89, P16, DOI 10.1016/S0029-7844(97)84257-3; Chauhan SP, 2003, AM J OBSTET GYNECOL, V189, P408, DOI 10.1067/S0002-9378(03)00675-6; CORONIS Trial Collaborative Group, 2007, BMC Pregnancy Childbirth, V7, P24, DOI 10.1186/1471-2393-7-24; Dodd JM, 2008, COCHRANE DB SYST REV, V3; Doganay M, 2010, INT J GYNECOL OBSTET, V111, P175, DOI 10.1016/j.ijgo.2010.06.009; Gates S, 2004, BJOG-INT J OBSTET GY, V111, P213, DOI 10.1111/j.1471-0528.2004.00059.x; Gibbons L., 2010, WORLD HLTH REPORT 20; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Hofmeyr GJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004662.pub2; Huchon C, 2005, Gynecol Obstet Fertil, V33, P745, DOI 10.1016/j.gyobfe.2005.08.001; Joel-Cohen S., 1977, ABDOMINAL VAGINAL HY; Khadem N, 2008, BJOG-INT J OBSTET GY, V115, P99; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Mee RW, 2009, COMPREHENSIVE GUIDE TO FACTORIAL TWO-LEVEL EXPERIMENTATION, P3, DOI 10.1007/b105081_1; Mocanasu C, 2005, Rev Med Chir Soc Med Nat Iasi, V109, P810; Mozurkewich EL, 2000, AM J OBSTET GYNECOL, V183, P1187, DOI 10.1067/mob.2000.108890; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Roset E, 2003, EUR J OBSTET GYN R B, V108, P40, DOI 10.1016/S0301-2115(02)00366-4; Shahin AY, 2009, INT J GYNECOL OBSTET, V104, P135, DOI 10.1016/j.ijgo.2008.09.012; Sood AK, 2005, J OBSTET GYNAECOLOGY, V55, P231; Tully L, 2002, EUR J OBSTET GYN R B, V102, P120, DOI 10.1016/S0301-2115(01)00589-9; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Walsh CA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.009; Weerawetwat Waraporn, 2004, Journal of the Medical Association of Thailand, V87, P1007	30	71	78	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					234	248		10.1016/S0140-6736(13)60441-9	http://dx.doi.org/10.1016/S0140-6736(13)60441-9			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FL	23721753	Green Accepted			2022-12-28	WOS:000322543700033
J	Kvitsiani, D; Ranade, S; Hangya, B; Taniguchi, H; Huang, JZ; Kepecs, A				Kvitsiani, D.; Ranade, S.; Hangya, B.; Taniguchi, H.; Huang, J. Z.; Kepecs, A.			Distinct behavioural and network correlates of two interneuron types in prefrontal cortex	NATURE			English	Article							GABAERGIC NEURONS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; IN-VIVO; INHIBITION; INFORMATION; COMPUTATION; RESPONSES; FEATURES; SUBTYPES	Neurons in the prefrontal cortex exhibit diverse behavioural correlates(1-4), an observation that has been attributed to cell-type diversity. To link identified neuron types with network and behavioural functions, we recorded from the two largest genetically defined inhibitory interneuron classes, the perisomatically targeting parvalbumin (PV) and the dendritically targeting somatostatin (SOM) neurons(5-8) in anterior cingulate cortex of mice performing a reward foraging task. Here we show that PV and a subtype of SOM neurons form functionally homogeneous populations showing a double dissociation between both their inhibitory effects and behavioural correlates. Out of several events pertaining to behaviour, a subtype of SOM neurons selectively responded at reward approach, whereas PV neurons responded at reward leaving and encoded preceding stay duration. These behavioural correlates of PV and SOM neurons defined a behavioural epoch and a decision variable important for foraging (whether to stay or to leave), a crucial function attributed to the anterior cingulate cortex(9-11). Furthermore, PV neurons could fire in millisecond synchrony, exerting fast and powerful inhibition on principal cell firing, whereas the inhibitory effect of SOM neurons on firing output was weak and more variable, consistent with the idea that they respectively control the outputs of, and inputs to, principal neurons(12-16). These results suggest a connection between the circuit-level function of different interneuron types in regulating the flow of information and the behavioural functions served by the cortical circuits. Moreover, these observations bolster the hope that functional response diversity during behaviour can in part be explained by cell-type diversity.	[Kvitsiani, D.; Ranade, S.; Hangya, B.; Taniguchi, H.; Huang, J. Z.; Kepecs, A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Kepecs, A (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	kepecs@cshl.edu	Core, Vector/CAF-4832-2022; Hangya, Balazs/H-5964-2019	Hangya, Balazs/0000-0003-2709-7407; Kepecs, Adam/0000-0003-0049-8120; Huang, Z. Josh/0000-0003-0592-028X; Ranade, Sachin/0000-0002-5150-5776; Kvitsiani, Duda/0000-0003-3175-1774	Klingenstein Foundation; John Merck Foundation; Sloan Foundation; Whitehall Foundation; National Institute of Neurological Disorders and Stroke (National Institutes of Health) [R01NS075531]; Swartz Foundation; The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Human Frontier Science Program; Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075531] Funding Source: NIH RePORTER	Klingenstein Foundation(Klingenstein Philanthropies); John Merck Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Whitehall Foundation; National Institute of Neurological Disorders and Stroke (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swartz Foundation; The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Human Frontier Science Program(Human Frontier Science Program); Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Klingenstein, John Merck, Sloan and Whitehall Foundations to A. K. and the National Institute of Neurological Disorders and Stroke (National Institutes of Health) grant R01NS075531. B. H. received support from the Swartz Foundation and Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development (2007-2013). D. K. received support from The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship and Human Frontier Science Program(2008-2011). We are grateful to K. Deisseroth, E. Boyden, A. Reid and A. Zador for constructs, B. Burbach and R. Eifert for technical assistance, and to J. Lisman, B. Mensh, S. Shea and A. Zador for comments and discussions.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Hangya B, 2010, J PHYSIOL-LONDON, V588, P4165, DOI 10.1113/jphysiol.2010.194274; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Nikolic D, 2012, EUR J NEUROSCI, V35, P742, DOI 10.1111/j.1460-9568.2011.07987.x; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Van De Werd HJJM, 2010, BRAIN STRUCT FUNCT, V214, P339, DOI 10.1007/s00429-010-0247-z; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	44	280	280	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					363	+		10.1038/nature12176	http://dx.doi.org/10.1038/nature12176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23708967	Green Accepted			2022-12-28	WOS:000320592900040
J	Legendre, CM; Licht, C; Muus, P; Greenbaum, LA; Babu, S; Bedrosian, C; Bingham, C; Cohen, DJ; Delmas, Y; Douglas, K; Eitner, F; Feldkamp, T; Fouque, D; Furman, RR; Gaber, O; Herthelius, M; Hourmant, M; Karpman, D; Lebranchu, Y; Mariat, C; Menne, J; Moulin, B; Nurnberger, J; Ogawa, M; Remuzzi, G; Richard, T; Sberro-Soussan, R; Severino, B; Sheerin, NS; Trivelli, A; Zimmerhackl, LB; Goodship, T; Loirat, C				Legendre, C. M.; Licht, C.; Muus, P.; Greenbaum, L. A.; Babu, S.; Bedrosian, C.; Bingham, C.; Cohen, D. J.; Delmas, Y.; Douglas, K.; Eitner, F.; Feldkamp, T.; Fouque, D.; Furman, R. R.; Gaber, O.; Herthelius, M.; Hourmant, M.; Karpman, D.; Lebranchu, Y.; Mariat, C.; Menne, J.; Moulin, B.; Nuernberger, J.; Ogawa, M.; Remuzzi, G.; Richard, T.; Sberro-Soussan, R.; Severino, B.; Sheerin, N. S.; Trivelli, A.; Zimmerhackl, L. B.; Goodship, T.; Loirat, C.			Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; INSIGHTS; IMPACT	Background Atypical hemolytic-uremic syndrome is a genetic, life-threatening, chronic disease of complement-mediated thrombotic microangiopathy. Plasma exchange or infusion may transiently maintain normal levels of hematologic measures but does not treat the underlying systemic disease. Methods We conducted two prospective phase 2 trials in which patients with atypical hemolytic-uremic syndrome who were 12 years of age or older received eculizumab for 26 weeks and during long-term extension phases. Patients with low platelet counts and renal damage (in trial 1) and those with renal damage but no decrease in the platelet count of more than 25% for at least 8 weeks during plasma exchange or infusion (in trial 2) were recruited. The primary end points included a change in the platelet count (in trial 1) and thrombotic microangiopathy event-free status (no decrease in the platelet count of >25%, no plasma exchange or infusion, and no initiation of dialysis) (in trial 2). Results A total of 37 patients (17 in trial 1 and 20 in trial 2) received eculizumab for a median of 64 and 62 weeks, respectively. Eculizumab resulted in increases in the platelet count; in trial 1, the mean increase in the count from baseline to week 26 was 73x10(9) per liter (P<0.001). In trial 2, 80% of the patients had thrombotic microangiopathy event-free status. Eculizumab was associated with significant improvement in all secondary end points, with continuous, time-dependent increases in the estimated glomerular filtration rate (GFR). In trial 1, dialysis was discontinued in 4 of 5 patients. Earlier intervention with eculizumab was associated with significantly greater improvement in the estimated GFR. Eculizumab was also associated with improvement in health-related quality of life. No cumulative toxicity of therapy or serious infection-related adverse events, including meningococcal infections, were observed through the extension period. Conclusions Eculizumab inhibited complement-mediated thrombotic microangiopathy and was associated with significant time-dependent improvement in renal function in patients with atypical hemolytic-uremic syndrome.	[Legendre, C. M.; Sberro-Soussan, R.] Univ Paris 05, Paris, France; Hop Necker Enfants Malad, AP HP, INSERM, U845, Paris, France; [Licht, C.] Hop Robert Debre, AP HP, F-75019 Paris, France; [Delmas, Y.] Ctr Hosp Univ Bordeaux, Bordeaux, France; [Fouque, D.] Hop Edouard Herriot, Lyon, France; [Fouque, D.] Univ Lyon, Lyon, France; [Hourmant, M.] Ctr Hosp Univ Hotel Dieu Nantes, Nantes, France; [Lebranchu, Y.] Univ Tours, Univ Hosp, Tours, France; [Mariat, C.] Ctr Hosp Univ St Etienne, Hop Nord, St Etienne, France; [Moulin, B.] Hop Univ Strasbourg, Hop Civil, Strasbourg, France; [Licht, C.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Muus, P.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Greenbaum, L. A.] Emory Univ, Atlanta, GA 30322 USA; [Greenbaum, L. A.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Babu, S.] Ft Wayne Med Oncol & Hematol, Ft Wayne, IN USA; [Bedrosian, C.; Ogawa, M.; Severino, B.] Alex Pharmaceut, Cheshire, CT USA; [Bingham, C.] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [Douglas, K.] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Sheerin, N. S.; Goodship, T.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cohen, D. J.] Columbia Univ, Med Ctr, New York, NY USA; [Furman, R. R.] Weill Cornell Med Coll, New York, NY USA; [Gaber, O.] Methodist Hosp, New York, NY USA; [Eitner, F.] Univ Aachen, Rheinisch Westfael Tech Hsch, Aachen, Germany; [Feldkamp, T.] Univ Duisburg Essen, Essen, Germany; [Menne, J.] Univ Clin Med Hsch Hannover, Hannover, Germany; [Nuernberger, J.] Helios Klin, Schwerin, Germany; [Herthelius, M.] Karolinska Univ Hosp, Stockholm, Sweden; [Karpman, D.] Lund Univ, Dept Pediat, Lund, Sweden; [Remuzzi, G.] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [Trivelli, A.] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Richard, T.] Alex Pharma Int, Lausanne, Switzerland	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; CHU Lyon; Nantes Universite; CHU de Nantes; CHU Tours; Universite de Tours; CHU de St Etienne; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Radboud University Nijmegen; Emory University; Children's Healthcare of Atlanta (CHOA); University of Exeter; Beatson Oncology Centre; Newcastle University - UK; Columbia University; Cornell University; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; RWTH Aachen University; University of Duisburg Essen; Helios Kliniken; Karolinska Institutet; Karolinska University Hospital; Lund University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Genoa; IRCCS Istituto Giannina Gaslini	Legendre, CM (corresponding author), Univ Paris 05, Serv Transplantat Adultes, 149 Rue Sevres, F-75743 Paris, France.	christophe.legendre@nck.aphp.fr	Trivelli, Antonella/AAA-7282-2020; Fouque, Denis/C-5338-2014; Feldkamp, Thorsten/F-7352-2011; Muus, P./L-4539-2015; Remuzzi, Giuseppe/V-9766-2017	Fouque, Denis/0000-0002-9707-7199; Karpman, Diana/0000-0001-7220-7658; Aradottir, Sigridur Sunna/0000-0002-6898-3256; MOULIN, Bruno/0000-0001-6772-7165; Remuzzi, Giuseppe/0000-0002-6194-3446	Alexion Pharmaceuticals [C08-002]	Alexion Pharmaceuticals	Funded by Alexion Pharmaceuticals; C08-002 ClinicalTrials.gov numbers, NCT00844545 [adults] and NCT00844844 [adolescents]; C08-003 ClinicalTrials.gov numbers, NCT00838513 [adults] and NCT00844428 [adolescents]	Ariceta G, 2012, AM J KIDNEY DIS, V59, P707, DOI 10.1053/j.ajkd.2011.11.027; Benz K, 2010, CURR OPIN NEPHROL HY, V19, P242, DOI 10.1097/MNH.0b013e3283378f25; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Chatelet V, 2009, AM J TRANSPLANT, V9, P2644, DOI 10.1111/j.1600-6143.2009.02817.x; Electronic Medicines Compendium, 2012, SOL SUMM PROD CHAR; Fernandez-de Larrea C, 2010, TRANSPLANTATION, V89, P903, DOI 10.1097/TP.0b013e3181ccd80d; Fremeaux-Bacchi V, 2013, CLIN J AM SOC NEPHRO, V8, P554, DOI 10.2215/CJN.04760512; Gruppo RA, 2009, NEW ENGL J MED, V360, P544, DOI 10.1056/NEJMc0809959; Heinen S, 2013, MOL IMMUNOL, V54, P84, DOI 10.1016/j.molimm.2012.10.044; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Kelly RJ, 2011, BLOOD, V117, P6786, DOI 10.1182/blood-2011-02-333997; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Le Quintrec M, 2013, AM J TRANSPLANT, V13, P663, DOI 10.1111/ajt.12077; Licht C, 2009, BLOOD, V114, P4538, DOI 10.1182/blood-2009-03-205096; Loirat C, 2008, PEDIATR NEPHROL, V23, P1957, DOI 10.1007/s00467-008-0872-4; Loirat Chantal, 2012, Presse Med, V41, pe115, DOI 10.1016/j.lpm.2011.11.013; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; Loirat C, 2010, SEMIN THROMB HEMOST, V36, P673, DOI 10.1055/s-0030-1262890; Mache CJ, 2009, CLIN J AM SOC NEPHRO, V4, P1312, DOI 10.2215/CJN.01090209; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195; Rother RP, 2007, NAT BIOTECHNOL, V25, P1488, DOI 10.1038/nbt1207-1488c; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Saland JM, 2009, J AM SOC NEPHROL, V20, P940, DOI 10.1681/ASN.2008080906; Scheiring J, 2010, EUR J PEDIATR, V169, P7, DOI 10.1007/s00431-009-1039-4; Wilson C, 2011, AM J KIDNEY DIS, V58, P109, DOI 10.1053/j.ajkd.2011.04.008; Zimmerhackl LB, 2010, NEW ENGL J MED, V362, P1746, DOI 10.1056/NEJMc1001060; Zipfel PF, 2010, CURR OPIN NEPHROL HY, V19, P372, DOI 10.1097/MNH.0b013e32833aff4a; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zuber J, 2012, AM J TRANSPLANT, V12, P3337, DOI 10.1111/j.1600-6143.2012.04252.x; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214; Zuber J, 2011, NAT REV NEPHROL, V7, P23, DOI 10.1038/nrneph.2010.155	35	893	946	1	324	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2169	2181		10.1056/NEJMoa1208981	http://dx.doi.org/10.1056/NEJMoa1208981			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23738544	Green Published			2022-12-28	WOS:000319948900005
J	Pujol, M; Marty, B; Burgess, R; Turner, G; Philippot, P				Pujol, Magali; Marty, Bernard; Burgess, Ray; Turner, Grenville; Philippot, Pascal			Argon isotopic composition of Archaean atmosphere probes early Earth geodynamics	NATURE			English	Article							CONTINENTAL-CRUST; WESTERN-AUSTRALIA; PILBARA CRATON; QUARTZ VEINS; NORTH-POLE; EVOLUTION; GROWTH; XENON; DIFFERENTIATION; HELIUM	Understanding the growth rate of the continental crust through timeis a fundamental issue inEarth sciences(1-8). The isotopic signatures of noble gases in the silicate Earth (mantle, crust) and in the atmosphere afford exceptional insight into the evolution through time of these geochemical reservoirs(9). However, no data for the compositions of these reservoirs exists for the distant past, and temporal exchange rates between Earth's interior and its surface are severely under-constrained owing to a lack of samples preserving the original signature of the atmosphere at the time of their formation. Here, we report the analysis of argon in Archaean (3.5-billion-year-old) hydrothermal quartz. Noble gases are hosted in primary fluid inclusions containing a mixture of Archaean freshwater and hydrothermal fluid. Our analysis reveals Archaean atmospheric argon with a Ar-40/Ar-36 value of 143 +/- 24, lower than the present-day value of 298.6 (for which Ar-40 has been produced by the radioactive decay of the potassium isotope K-40, with a half-life of 1.25 billion years; Ar-36 is primordial in origin). This ratio is consistent with an early development of the felsic crust, which might have had an important role in climate variability during the first half of Earth's history.	[Pujol, Magali; Marty, Bernard] Univ Lorraine, CRPG CNRS, F-54501 Vandoeuvre Les Nancy, France; [Burgess, Ray; Turner, Grenville] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Philippot, Pascal] Univ Paris Diderot, CNRS, Inst Phys Globe Paris, Sorbonne Paris Cite, F-75238 Paris 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Manchester; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Marty, B (corresponding author), Univ Lorraine, CRPG CNRS, 15 Rue Notre Dame Pauvres, F-54501 Vandoeuvre Les Nancy, France.	bmarty@crpg.cnrs-nancy.fr	Burgess, Ray/A-5767-2009; Philippot, Pascal/AAD-4313-2020	Burgess, Ray/0000-0001-7674-8718; 	CNRS; Region Lorraine; ANR (Agence Nationale pour la Recherche); European Research Council under the European Community [267255]; Institut de Physique du Globe de Paris (IPGP); Geological Survey of Western Australia (GSWA); Science and Technology Facilities Council [ST/J001643/1] Funding Source: researchfish; STFC [ST/J001643/1] Funding Source: UKRI	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Lorraine(Region Grand-Est); ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); European Research Council under the European Community(European Research Council (ERC)); Institut de Physique du Globe de Paris (IPGP); Geological Survey of Western Australia (GSWA); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank D. Blagburn and L. Zimmermann for their technical support with the irradiated samples measurements, and M. Derrien and B. Faure for their help with the conception of the degassing model. This project was funded by the CNRS, the Region Lorraine, the ANR (Agence Nationale pour la Recherche) projects "e-Life" and "e-Life2" to P. P. and by the European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013 grant agreement number 267255 to B. M. The drilling programme was supported by funds from the Institut de Physique du Globe de Paris (IPGP) and the CNRS, and by the Geological Survey of Western Australia (GSWA). This is Centre de Recherches Geochimiques et Petrographiques (CRPG) contribution number 2239.	ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; ALLEGRE CJ, 1984, EARTH PLANET SC LETT, V67, P19, DOI 10.1016/0012-821X(84)90035-9; Arevalo R, 2009, EARTH PLANET SC LETT, V278, P361, DOI 10.1016/j.epsl.2008.12.023; ARMSTRONG RL, 1981, PHILOS T R SOC A, V301, P443, DOI 10.1098/rsta.1981.0122; Bender ML, 2008, P NATL ACAD SCI USA, V105, P8232, DOI 10.1073/pnas.0711679105; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; CADOGAN PH, 1977, NATURE, V268, P38, DOI 10.1038/268038a0; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; Condie KC, 2011, GEOL SOC AM BULL, V123, P951, DOI 10.1130/B30344.1; Dhuime B, 2012, SCIENCE, V335, P1334, DOI 10.1126/science.1216066; FANALE FP, 1971, CHEM GEOL, V8, P79, DOI 10.1016/0009-2541(71)90051-9; Foriel J, 2004, EARTH PLANET SC LETT, V228, P451, DOI 10.1016/j.epsl.2004.09.034; FYFE WS, 1978, CHEM GEOL, V23, P89, DOI 10.1016/0009-2541(78)90068-2; Hamano Y., 1978, ADV EARTH PLANETARY, V3, P155; Hawkesworth CJ, 2006, CHEM GEOL, V226, P134, DOI 10.1016/j.chemgeo.2005.09.017; Heber VS, 2007, GEOCHIM COSMOCHIM AC, V71, P1041, DOI 10.1016/j.gca.2006.11.010; HURLEY PM, 1969, SCIENCE, V164, P1229, DOI 10.1126/science.164.3885.1229; HURLEY PM, 1968, GEOCHIM COSMOCHIM AC, V32, P273, DOI 10.1016/0016-7037(68)90015-X; Kasting JF, 2010, NATURE, V464, P687, DOI 10.1038/464687a; Kendrick MA, 2001, CHEM GEOL, V177, P351, DOI 10.1016/S0009-2541(00)00419-8; Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; MCLENNAN SM, 1982, J GEOL, V90, P347, DOI 10.1086/628690; Meshik AP, 2001, PHYS REV C, V64, DOI 10.1103/PhysRevC.64.035205; Ozima M., 2001, NOBLE GAS GEOCHEMIST; Pepin RO, 2006, EARTH PLANET SC LETT, V252, P1, DOI 10.1016/j.epsl.2006.09.014; PORCELLI D, 1995, GEOCHIM COSMOCHIM AC, V59, P4921, DOI 10.1016/0016-7037(95)00336-3; Pujol M, 2011, EARTH PLANET SC LETT, V308, P298, DOI 10.1016/j.epsl.2011.05.053; Pujol M, 2009, GEOCHIM COSMOCHIM AC, V73, P6834, DOI 10.1016/j.gca.2009.08.002; REYMER A, 1984, TECTONICS, V3, P63, DOI 10.1029/TC003i001p00063; RICE CM, 1995, J GEOL SOC LONDON, V152, P229, DOI 10.1144/gsjgs.152.2.0229; SRINIVASAN B, 1976, EARTH PLANET SC LETT, V31, P129, DOI 10.1016/0012-821X(76)90104-7; Tessalina SG, 2010, NAT GEOSCI, V3, P214, DOI 10.1038/NGEO772; THORPE RI, 1992, PRECAMBRIAN RES, V56, P169, DOI 10.1016/0301-9268(92)90100-3; Tolstikhin IN, 1998, CHEM GEOL, V147, P27, DOI 10.1016/S0009-2541(97)00170-8; TURNER G, 1988, GEOCHIM COSMOCHIM AC, V52, P1443, DOI 10.1016/0016-7037(88)90214-1; Van Kranendonk MJ, 2008, PRECAMBRIAN RES, V167, P93, DOI 10.1016/j.precamres.2008.07.003; VEIZER J, 1979, J GEOL, V87, P341, DOI 10.1086/628425; YORK D, 1966, CAN J PHYS, V44, P1079, DOI 10.1139/p66-090	39	73	76	0	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					87	+		10.1038/nature12152	http://dx.doi.org/10.1038/nature12152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23739427	Green Submitted			2022-12-28	WOS:000319947800038
J	Etzioni, R; Gulati, R; Mallinger, L; Mandelblatt, J				Etzioni, Ruth; Gulati, Roman; Mallinger, Leslie; Mandelblatt, Jeanne			Influence of Study Features and Methods on Overdiagnosis Estimates in Breast and Prostate Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; LEAD TIME; MAMMOGRAPHY; OVERDETECTION; MORTALITY; DURATION; LUNG	Knowledge of the likelihood that a screening-detected case of cancer has been overdiagnosed is vitally important to make treatment decisions and develop screening policy. An overdiagnosed case is an excess case detected by screening. Estimates of the frequency of overdiagnosis in breast and prostate cancer screening vary greatly across studies. This article identifies features of overdiagnosis studies that influence results and shows their effect by using published research. First, different ways to define and measure overdiagnosis are considered. Second, contextual features and how they affect overdiagnosis estimates are examined. Third, the effect of estimation approach is discussed. Many studies use excess incidence under screening as a proxy for overdiagnosis. Others use statistical models to make inferences about lead time or natural history and then derive the corresponding fraction of cases that are overdiagnosed. This article concludes with questions that readers of overdiagnosis studies can use to evaluate the validity and relevance of published estimates and recommends that authors of studies quantifying overdiagnosis provide information about these features.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC USA	Fred Hutchinson Cancer Center; Georgetown University	Etzioni, R (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.	retzioni@fhcrc.org	Gulati, Roman/AAE-4298-2019; wang, edwin/G-5372-2010	Gulati, Roman/0000-0002-7592-6567; 	National Cancer Institute [U01CA157224, U01CA088283, U01CA152958]; Centers for Disease Control and Prevention;  [KO5CA96940];  [P01CA154292]; NATIONAL CANCER INSTITUTE [U01CA088283, U01CA152958, P01CA154292, K05CA096940, U01CA157224] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By award numbers U01CA157224 and U01CA088283 and U01CA152958 from the National Cancer Institute and the Centers for Disease Control and Prevention. Additional funding was provided by award numbers KO5CA96940 and P01CA154292.	Bach PB, 2008, THORAX, V63, P298, DOI 10.1136/thx.2007.082990; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; CARTER HB, 1990, J UROLOGY, V143, P742, DOI 10.1016/S0022-5347(17)40078-4; Davidov O, 2004, BIOSTATISTICS, V5, P603, DOI 10.1093/biostatistics/kxh012; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Duffy SW, 2008, BRIT J CANCER, V99, P1176, DOI 10.1038/sj.bjc.6604638; Etzioni R, 1998, AM J EPIDEMIOL, V148, P775; Etzioni R, 2002, J NATL CANCER I, V94, P981; FEUER EJ, 1992, AM J EPIDEMIOL, V136, P1423, DOI 10.1093/oxfordjournals.aje.a116463; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Gulati R, 2011, J CLIN EPIDEMIOL, V64, P1412, DOI 10.1016/j.jclinepi.2011.06.011; Humphrey PA, 1996, J UROLOGY, V155, P816, DOI 10.1016/S0022-5347(01)66316-X; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Olsen AH, 2006, BREAST J, V12, P338, DOI 10.1111/j.1075-122X.2006.00272.x; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; Pashayan N, 2006, BRIT J CANCER, V95, P401, DOI 10.1038/sj.bjc.6603246; Pinsky PF, 2005, J UROLOGY, V173, P746, DOI 10.1097/01.ju.0000152697.25708.71; Pinsky PF, 2001, BIOMETRICS, V57, P389, DOI 10.1111/j.0006-341X.2001.00389.x; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shibata A, 1998, J NATL CANCER I, V90, P1230, DOI 10.1093/jnci/90.16.1230; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; WALTER SD, 1983, AM J EPIDEMIOL, V118, P865, DOI 10.1093/oxfordjournals.aje.a113705; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278; Wever EM, 2010, JNCI-J NATL CANCER I, V102, P352, DOI 10.1093/jnci/djp533; Wu GHM, 2012, INT J CANCER, V131, P1367, DOI 10.1002/ijc.27340; Zappa M, 1998, ANN ONCOL, V9, P1297, DOI 10.1023/A:1008492013196	35	100	104	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					831	+		10.7326/0003-4819-158-11-201306040-00008	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23732716	Green Accepted			2022-12-28	WOS:000320379800006
J	Adams, J				Adams, Jonathan			The fourth age of research	NATURE			English	Editorial Material							IMPACT		[Adams, Jonathan] Thomson Reuters, Res Evaluat, Philadelphia, PA 19130 USA	Clarivate		jonathanzadams@gmail.com	Adams, Jonathan/A-5224-2009	Adams, Jonathan/0000-0002-0325-4431				Adams J, 1998, NATURE, V396, P615, DOI 10.1038/25219; Adams JD, 2005, RES POLICY, V34, P259, DOI 10.1016/j.respol.2005.01.014; Adams J, 2007, SCIENTOMETRICS, V72, P325, DOI 10.1007/s11192-007-1696-x; Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a; Dobbs R., 2012, MCKINSEY Q; GIBBONS M., 1994, NEW PRODUCTION KNOWL; Gurney K., 2005, TRACKING UK INT RES; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793; Schmoch U, 2008, SCIENTOMETRICS, V74, P361, DOI 10.1007/s11192-007-1818-5; Van Raan AFJ, 1998, SCIENTOMETRICS, V42, P423, DOI 10.1007/BF02458380	10	286	298	7	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					557	560		10.1038/497557a	http://dx.doi.org/10.1038/497557a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	152UF	23719446	Bronze			2022-12-28	WOS:000319556100018
J	Zhao, GP; Perilla, JR; Yufenyuy, EL; Meng, X; Chen, B; Ning, JY; Ahn, J; Gronenborn, AM; Schulten, K; Aiken, C; Zhang, PJ				Zhao, Gongpu; Perilla, Juan R.; Yufenyuy, Ernest L.; Meng, Xin; Chen, Bo; Ning, Jiying; Ahn, Jinwoo; Gronenborn, Angela M.; Schulten, Klaus; Aiken, Christopher; Zhang, Peijun			Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics	NATURE			English	Article							PROTEIN; CORE; RECONSTRUCTIONS; DOMAIN	Retroviral capsid proteins are conserved structurally but assemble into different morphologies(1). The mature human immunodeficiency virus-1 (HIV-1) capsid is best described by a 'fullerene cone' model(2,3), in which hexamers of the capsid protein are linked to form a hexagonal surface lattice that is closed by incorporating 12 capsid-protein pentamers. HIV-1 capsid protein contains an amino-terminal domain (NTD) comprising seven alpha-helices and a beta-hairpin(4,5), a carboxy-terminal domain (CTD) comprising four alpha-helices(6,7), and a flexible linker with a 3(10)-helix connecting the two structural domains(8). Structures of the capsid-protein assembly units have been determined by X-ray crystallography(9,10); however, structural information regarding the assembled capsid and the contacts between the assembly units is incomplete. Here we report the cryo-electron microscopy structure of a tubular HIV-1 capsid-protein assembly at 8 angstrom resolution and the three-dimensional structure of a native HIV-1 core by cryo-electron tomography. The structure of the tubular assembly shows, at the three-fold interface(11), a three-helix bundle with critical hydrophobic interactions. Mutagenesis studies confirm that hydrophobic residues in the centre of the three-helix bundle are crucial for capsid assembly and stability, and for viral infectivity. The cryo-electron-microscopy structures enable modelling by large-scale molecular dynamics simulation, resulting in all-atom models for the hexamer-of-hexamer and pentamer-of-hexamer elements as well as for the entire capsid. Incorporation of pentamers results in closer trimer contacts and induces acute surface curvature. The complete atomic HIV-1 capsid model provides a platform for further studies of capsid function and for targeted pharmacological intervention.	[Zhao, Gongpu; Meng, Xin; Ning, Jiying; Ahn, Jinwoo; Gronenborn, Angela M.; Zhang, Peijun] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Zhao, Gongpu; Yufenyuy, Ernest L.; Meng, Xin; Ning, Jiying; Ahn, Jinwoo; Gronenborn, Angela M.; Aiken, Christopher; Zhang, Peijun] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA; [Perilla, Juan R.; Schulten, Klaus] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Perilla, Juan R.; Schulten, Klaus] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Yufenyuy, Ernest L.; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Chen, Bo] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Zhang, Peijun] Univ Pittsburgh, Swanson Sch Engn, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Vanderbilt University; State University System of Florida; University of Central Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, PJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	kschulte@ks.uiuc.edu; chris.aiken@vanderbilt.edu; pez7@pitt.edu	NING, JIYING/L-3899-2016; Chen, Bo/F-3573-2015; Aiken, Christopher/Y-9252-2019; zhao, gongpu/B-8151-2012; Chen, Bo/AID-6923-2022	Chen, Bo/0000-0001-5589-2075; Gronenborn, Angela M/0000-0001-9072-3525; Perilla, Juan/0000-0003-1171-6816	National Institutes of Health [GM082251, GM085043, GM104601]; National Science Foundation [PHY0822613, MCB0744057, OCI 07-25070]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251, R01GM085043, P41GM104601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Schwerdtfeger for access to his software for creating fullerene models, T. Brosenitsch for reading the manuscript, and M. DeLucia and J. Mehrens for technical assistance. This work was supported by the National Institutes of Health (GM082251, GM085043 and GM104601) and the National Science Foundation (PHY0822613, MCB0744057). Large-scale molecular dynamics simulations were performed on the Blue Waters Computer, financed by the National Science Foundation (OCI 07-25070).	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Byeon IJL, 2012, J AM CHEM SOC, V134, P6455, DOI 10.1021/ja300937v; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen B, 2011, BIOPHYS J, V100, P3035, DOI 10.1016/j.bpj.2011.05.025; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Jiang JY, 2011, VIROLOGY, V421, P253, DOI 10.1016/j.virol.2011.09.012; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Meng X, 2011, JOVE-J VIS EXP, V54, pe3041, DOI 3010.3791/3041; Meng X, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002886; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Yeager M, 2011, J MOL BIOL, V410, P534, DOI 10.1016/j.jmb.2011.04.073	28	556	568	4	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					643	646		10.1038/nature12162	http://dx.doi.org/10.1038/nature12162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23719463	Green Accepted			2022-12-28	WOS:000319556100049
J	Patel, K				Patel, Kinesh			Is clinical examination dead?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3442	10.1136/bmj.f3442	http://dx.doi.org/10.1136/bmj.f3442			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DG	23719644				2022-12-28	WOS:000319948200012
J	del Portillo, HA; Chitnis, CE				del Portillo, Hernando A.; Chitnis, Chetan E.			Talking to Each Other to Initiate Sexual Differentiation	CELL			English	Editorial Material							MICROPARTICLES		[del Portillo, Hernando A.] Univ Barcelona, Hosp Clin Barcelona, CRESIB, Barcelona Ctr Int Hlth Res,ICREA, E-08036 Barcelona, Spain; [Chitnis, Chetan E.] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	ICREA; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	del Portillo, HA (corresponding author), Univ Barcelona, Hosp Clin Barcelona, CRESIB, Barcelona Ctr Int Hlth Res,ICREA, E-08036 Barcelona, Spain.	hernandoa.delportillo@cresib.cat; cchitnis@icgeb.res.in	del Portillo, Hernando A/L-2131-2014	del Portillo, Hernando A/0000-0002-5278-3452; Chitnis, Chetan/0000-0002-8773-9865	ICREA Funding Source: Custom	ICREA(ICREA)		Campos FMF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-327; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; Gong J, 2012, CANCER TREAT REV, V38, P226, DOI 10.1016/j.ctrv.2011.06.005; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Mantel PY, 2013, CELL HOST MICROBE, V13, P521, DOI 10.1016/j.chom.2013.04.009; MARTORELLI L., 2011, PS AURELII AUGUSTINI, P6; Nantakomol D, 2011, J INFECT DIS, V203, P700, DOI 10.1093/infdis/jiq104; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Roncales Maria, 2012, J Parasitol Res, V2012, P927148, DOI 10.1155/2012/927148; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567	11	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					945	947		10.1016/j.cell.2013.05.013	http://dx.doi.org/10.1016/j.cell.2013.05.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706733	Bronze			2022-12-28	WOS:000319456800004
J	Stavrou, M; Solomou, S; Spooner, O; Perry, R				Stavrou, Maria; Solomou, Solomis; Spooner, Oliver; Perry, Richard			A young woman presenting with severe headache	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CEREBRAL INFARCTION; ISCHEMIC-STROKE; MIGRAINE; ASSOCIATION; DISEASE; RISK; MRI		[Stavrou, Maria] North Cent Thames Fdn Sch, London WC1E 6BT, England; [Solomou, Solomis] Barts & London Queen Marys Sch Med & Dent, London, England; [Spooner, Oliver] Lister Hosp, Dept Geriatr Med, Stevenage, Herts, England; [Perry, Richard] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; Queen Mary University London; Lister Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Stavrou, M (corresponding author), North Cent Thames Fdn Sch, London WC1E 6BT, England.	zchabz6@ucl.ac.uk	Perry, Richard/AAW-4304-2020	Perry, Richard/0000-0002-4536-9018; Solomou, Solomis/0000-0003-2877-7551				Arboix A, 2003, CEPHALALGIA, V23, P389, DOI 10.1046/j.1468-2982.2003.00534.x; Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Berthet K, 2000, STROKE, V31, P398, DOI 10.1161/01.STR.31.2.398; BLAU JN, 1992, LANCET, V339, P1202, DOI 10.1016/0140-6736(92)91140-4; Bostom AG, 1999, ANN INTERN MED, V131, P352, DOI 10.7326/0003-4819-131-5-199909070-00006; Brickner ME, 1996, AM J MED, V100, P465; Del Sette M, 1998, CEREBROVASC DIS, V8, P327, DOI 10.1159/000015875; Di Tullio MR, 2007, J AM COLL CARDIOL, V49, P797, DOI 10.1016/j.jacc.2006.08.063; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Fiebach J, 2001, NEURORADIOLOGY, V43, P628, DOI 10.1007/s002340100542; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Gupta V, 2006, BRAIN, V129, DOI 10.1093/brain/awh697; Kennedy G, 2008, ADV CLIN NEUROSCI RE, V8, P30; Kittner SJ, 1998, NEUROLOGY, V50, P890, DOI 10.1212/WNL.50.4.890; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Lindsay K. W., 2010, NEUROLOGY NEUROSURGE; National Institute for Health and Clinical Excellence, 2008, STROK DIAGN IN MAN A; Sabreen MA, 2011, STUDENT BMJ, V19, pd2911; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; Schillaci G, 2010, NEUROLOGY, V75, P960, DOI 10.1212/WNL.0b013e3181f25ecd; Schwaag S, 2003, HEADACHE, V43, P90, DOI 10.1046/j.1526-4610.2003.03023.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SURESH CG, 1994, POSTGRAD MED J, V70, P37, DOI 10.1136/pgmj.70.819.37; Verdelho A, 2008, CEPHALALGIA, V28, P346, DOI 10.1111/j.1468-2982.2007.01514.x; Viola S, 2012, NEUROL SCI, V33, pS173, DOI 10.1007/s10072-012-1077-y; Wang SJ., 2010, FRONT NEUROL, V1, P16; Wolf ME, 2011, NEUROLOGY, V76, P1911, DOI 10.1212/WNL.0b013e31821d74d5	27	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2013	346								f2448	10.1136/bmj.f2448	http://dx.doi.org/10.1136/bmj.f2448			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AW	23704126				2022-12-28	WOS:000319574500001
J	Pilling, S; Mayo-Wilson, E; Mavranezouli, I; Kew, K; Taylor, C; Clark, DM				Pilling, Stephen; Mayo-Wilson, Evan; Mavranezouli, Ifigeneia; Kew, Kayleigh; Taylor, Clare; Clark, David M.		Guideline Dev Grp	Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NATURAL COURSE; EPIDEMIOLOGY; PHOBIA; BURDEN; EUROPE; SIZE		[Pilling, Stephen; Mayo-Wilson, Evan; Mavranezouli, Ifigeneia] UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England; [Pilling, Stephen; Mayo-Wilson, Evan; Mavranezouli, Ifigeneia] UCL, Ctr Outcomes Res & Effectiveness, London WC1E 7HB, England; [Pilling, Stephen; Mayo-Wilson, Evan; Mavranezouli, Ifigeneia] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 7HB, England; [Kew, Kayleigh] Univ London, Cochrane Airways Grp, London SW17 0RE, England; [Taylor, Clare] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Clark, David M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University of London; University College London; University of Oxford	Pilling, S (corresponding author), UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England.	s.pilling@ucl.ac.uk	Creswell, Cathy/L-9306-2013; Mayo-Wilson, Evan/J-6289-2019; MAVRANEZOULI, IFIGENEIA/C-2430-2008	Creswell, Cathy/0000-0003-1889-0956; Mayo-Wilson, Evan/0000-0001-6126-2459; MAVRANEZOULI, IFIGENEIA/0000-0001-9095-3566; Clark, David/0000-0002-8173-6022; Kew, Kayleigh/0000-0002-0623-6087	Medical Research Council [G0601874] Funding Source: Medline; Wellcome Trust [069777] Funding Source: Medline; Department of Health [CDF-2010-03-36] Funding Source: Medline; MRC [G0601874] Funding Source: UKRI; National Institute for Health Research [CDF-2010-03-36] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Beesdo-Baum K, 2012, ACTA PSYCHIAT SCAND, V126, P411, DOI 10.1111/j.1600-0447.2012.01886.x; Connor KM, 2001, DEPRESS ANXIETY, V14, P137, DOI 10.1002/da.1055; Fehm L, 2005, EUR NEUROPSYCHOPHARM, V15, P453, DOI 10.1016/j.euroneuro.2005.04.002; Grant BF, 2005, J CLIN PSYCHIAT, V66, P1351, DOI 10.4088/JCP.v66n1102; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; National Institute for Health and Care Excellence, 2013, SOC ANX DIS REC ASS, V159; National Institute for Health and Clinical Excellence, 2011, SERV US EXP AD MENT, V136; National Institute for Health and Clinical Excellence, 2011, COMM MENT HLTH DIS I, V123; Wittchen HU, 2003, ACTA PSYCHIAT SCAND, V108, P4, DOI 10.1034/j.1600-0447.108.s417.1.x; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012	10	23	23	1	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2013	346								f2541	10.1136/bmj.f2541	http://dx.doi.org/10.1136/bmj.f2541			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AV	23697669	Green Accepted			2022-12-28	WOS:000319574400008
J	Wilson, NA; Drozda, J				Wilson, Natalia A.; Drozda, Joseph, Jr.			Value of Unique Device Identification in the Digital Health Infrastructure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wilson, Natalia A.] Arizona State Univ, WP Carey Sch Business, Tempe, AZ 85287 USA; [Drozda, Joseph, Jr.] Mercy, Chesterfield, MO USA	Arizona State University; Arizona State University-Tempe	Wilson, NA (corresponding author), Arizona State Univ, WP Carey Sch Business, POB 874706, Tempe, AZ 85287 USA.	Natalia.wilson@asu.edu							0	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2107	2108		10.1001/jama.2013.5514	http://dx.doi.org/10.1001/jama.2013.5514			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23695480				2022-12-28	WOS:000319229600025
J	McDonald, C				McDonald, Christine			Review: Nutritional supplementation has uncertain effects on patient-important outcomes in COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Austin Hosp Dept Resp & Sleep Med, Heidelberg, Vic, Australia		McDonald, C (corresponding author), Austin Hosp Dept Resp & Sleep Med, Heidelberg, Vic, Australia.		McDonald, Christine Faye/AAU-9083-2021					Ferreira IM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000998.pub2	1	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC5	10.7326/0003-4819-158-10-201305210-02005	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689784				2022-12-28	WOS:000319666200004
J	Glavind, J; Uldbjerg, N				Glavind, Julie; Uldbjerg, Niels			Caesarean section: in good surgical skills we trust	LANCET			English	Editorial Material							PREGNANCY OUTCOMES; PERINATAL HEALTH; GLOBAL SURVEY; DELIVERY		[Glavind, Julie; Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynaecol, DK-8200 Aarhus, Denmark	Aarhus University	Glavind, J (corresponding author), Aarhus Univ Hosp, Dept Obstet & Gynaecol, DK-8200 Aarhus, Denmark.	julie.glavind@dadlnet.dk	Uldbjerg, Niels/O-2038-2016; Glavind, Julie/AAQ-2408-2020	Uldbjerg, Niels/0000-0002-6449-6426; Glavind, Julie/0000-0002-9856-6621				Bamigboye A. A., 2003, COCHRANE DB SYST REV, V4; Brocklehurst P, 2010, BJOG-INT J OBSTET GY, V117, P1366, DOI 10.1111/j.1471-0528.2010.02686.x; Dodd JM, 2008, COCHRANE DB SYST REV, V3; Doganay M, 2010, INT J GYNECOL OBSTET, V111, P175, DOI 10.1016/j.ijgo.2010.06.009; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Figueroa D, 2013, OBSTET GYNECOL, V121, P33, DOI [http://10.1097/AOG.0b013e31827a072c, 10.1097/AOG.0b013e31827a072c]; Lauer JA, 2012, OBSTET GYNECOL, V206; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Mathai M, 2007, COCHRANE DB SYST REV, V1; Shah A, 2009, INT J GYNECOL OBSTET, V107, P191, DOI 10.1016/j.ijgo.2009.08.013; The CORONIS Collaborative Group, 2013, LANCET; Tuuli MG, 2012, OBSTET GYNECOL, V119, P815, DOI 10.1097/AOG.0b013e31824c0e12; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7	13	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					188	189		10.1016/S0140-6736(13)60816-8	http://dx.doi.org/10.1016/S0140-6736(13)60816-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FL	23721755				2022-12-28	WOS:000322543700008
J	Fuchs, VR				Fuchs, Victor R.			The Gross Domestic Product and Health Care Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fuchs, Victor R.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Fuchs, Victor R.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University; Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Dept Econ, Stanford, CA 94305 USA.							[Anonymous], 2013, EC REP PRES; Centers for Medicare and Medicaid Services, 1960, NAT HLTH EXP TYP SER; Chernew ME, 2010, NEW ENGL J MED, V362, P1166, DOI 10.1056/NEJMp1002873; Council of Economic Advisors, 2013, EC REP PRES	4	59	61	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					107	109		10.1056/NEJMp1305298	http://dx.doi.org/10.1056/NEJMp1305298			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180BH	23697470				2022-12-28	WOS:000321567300006
J	Phillips-Cremins, JE; Sauria, MEG; Sanyal, A; Gerasimova, TI; Lajoie, BR; Bell, JSK; Ong, CT; Hookway, TA; Guo, CY; Sun, YH; Bland, MJ; Wagstaff, W; Dalton, S; McDevitt, TC; Sen, RJ; Dekker, J; Taylor, J; Corces, VG				Phillips-Cremins, Jennifer E.; Sauria, Michael E. G.; Sanyal, Amartya; Gerasimova, Tatiana I.; Lajoie, Bryan R.; Bell, Joshua S. K.; Ong, Chin-Tong; Hookway, Tracy A.; Guo, Changying; Sun, Yuhua; Bland, Michael J.; Wagstaff, William; Dalton, Stephen; McDevitt, Todd C.; Sen, Ranjan; Dekker, Job; Taylor, James; Corces, Victor G.			Architectural Protein Subclasses Shape 3D Organization of Genomes during Lineage Commitment	CELL			English	Article							CHROMATIN CONFORMATION; NUCLEAR ARCHITECTURE; GENE-EXPRESSION; CTCF; TRANSCRIPTION; MEDIATOR; BINDING; PLURIPOTENT; PRINCIPLES; PROXIMITY	Understanding the topological configurations of chromatin may reveal valuable insights into how the genome and epigenome act in concert to control cell fate during development. Here, we generate high-resolution architecture maps across seven genomic loci in embryonic stem cells and neural progenitor cells. We observe a hierarchy of 3D interactions that undergo marked reorganization at the submegabase scale during differentiation. Distinct combinations of CCCTC-binding factor (CTCF), Mediator, and cohesin show widespread enrichment in chromatin interactions at different length scales. CTCF/cohesin anchor long-range constitutive interactions that might form the topological basis for invariant subdomains. Conversely, Mediator/cohesin bridge short-range enhancer-promoter interactions within and between larger subdomains. Knockdown of Smc1 or Med12 in embryonic stem cells results in disruption of spatial architecture and downregulation of genes found in cohesin-mediated interactions. We conclude that cell-type-specific chromatin organization occurs at the submegabase scale and that architectural proteins shape the genome in hierarchical length scales.	[Phillips-Cremins, Jennifer E.; Sauria, Michael E. G.; Bell, Joshua S. K.; Ong, Chin-Tong; Bland, Michael J.; Wagstaff, William; Taylor, James; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Sauria, Michael E. G.; Taylor, James] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Gerasimova, Tatiana I.; Guo, Changying; Sen, Ranjan] NIA, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA; [Sun, Yuhua; Dalton, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Phillips-Cremins, Jennifer E.; Sanyal, Amartya; Lajoie, Bryan R.; Dekker, Job] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Phillips-Cremins, Jennifer E.; Sanyal, Amartya; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Georgia; University of Georgia; University System of Georgia; Georgia Institute of Technology; University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.	job.dekker@umassmed.edu; james.taylor@emory.edu; vcorces@emory.edu	Hookway, Tracy/P-7674-2019; SANYAL, AMARTYA/D-7240-2015; chang-ying, guo/F-2770-2018; Sun, Yuhua/J-7547-2013; Taylor, James/F-1026-2011; 孙, 玉华/AAS-2506-2020	Hookway, Tracy/0000-0003-2781-0911; SANYAL, AMARTYA/0000-0002-2109-4478; Taylor, James/0000-0001-5079-840X; 孙, 玉华/0000-0001-7902-9022; Sauria, Michael/0000-0001-5556-9446; Dalton, Stephen/0000-0002-3450-1263; Phillips-Cremins, Jennifer/0000-0002-4702-0450; Ong, Chin-Tong/0000-0002-5450-4760; Corces, Victor/0000-0001-5140-4337	National Institute of General Medical Sciences of the NIH [R01GM035463]; National Human Genome Research Institute of the NIH [R01HG003143]; National Institute of Diabetes and Digestive and Kidney Diseases of the NIH [R01DK065806]; W.M. Keck Foundation Distinguished Young Scholar in Biomedical Research Award [RC2HG005542]; American Recovery and Reinvestment Act (ARRA); NIH NRSA postdoctoral fellowship [5F32NS065603]; NIH [PO1GM85354]; Intramural Research Program of the National Institute on Aging (Baltimore, MD); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005542, R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490, R01GM035463, P01GM085354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS065603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000372, ZIAAG000373] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); W.M. Keck Foundation Distinguished Young Scholar in Biomedical Research Award; American Recovery and Reinvestment Act (ARRA); NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute on Aging (Baltimore, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the NIH under award number R01GM035463 (V.G.C), the National Human Genome Research Institute of the NIH under award number R01HG003143 (J.D.), the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH under award number R01DK065806 (J.T.), a W.M. Keck Foundation Distinguished Young Scholar in Biomedical Research Award (J.D.), and award number RC2HG005542 (J.T.) provided by funds from the American Recovery and Reinvestment Act (ARRA). J.E.P.C. was supported by an NIH NRSA postdoctoral fellowship (5F32NS065603). Funds from NIH grant PO1GM85354 also contributed to this work (S.D.). T.I.G., C.G. and R.S. are supported by the Intramural Research Program of the National Institute on Aging (Baltimore, MD). J.E.P.C. and V.G.C. conceived the project. J.E.P.C. and T.C.M. designed stem cell differentiation experiments. J.E.P.C., A.S., B.R.L., and J.D. designed 5C experiments. J.E.P.C., S.D., and Y.S. designed lentiviral experiments. J.E.P.C., T.I.G., C.G., V.G.C., J.D., and R.S. designed FISH experiments. J.E.P.C., A.S., W.W., J.S.K.B., M.J.B., C.T.O., T.A.H., T.I.G., C.G., and Y.S. performed experiments. M.E.G.S., J.E.P.C., and J.T. developed concepts and code for 5C peak calling pipeline and HMM model. J.E.P.C. performed postpeak calling computational analyses and wrote the paper with input from J.D., M.E.G.S., J.T., and V.G.C.	Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gilbert DM, 2010, COLD SH Q B, V75, P143, DOI 10.1101/sqb.2010.75.011; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Nora EP, 2010, COLD SH Q B, V75, P333, DOI 10.1101/sqb.2010.75.032; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van Berkum NL, 2009, METHODS MOL BIOL, V567, P189, DOI 10.1007/978-1-60327-414-2_13; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	49	769	787	2	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1281	1295		10.1016/j.cell.2013.04.053	http://dx.doi.org/10.1016/j.cell.2013.04.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23706625	Bronze, Green Accepted			2022-12-28	WOS:000319979200013
J	Shekhter, A; Ramshaw, BJ; Liang, RX; Hardy, WN; Bonn, DA; Balakirev, FF; McDonald, RD; Betts, JB; Riggs, SC; Migliori, A				Shekhter, Arkady; Ramshaw, B. J.; Liang, Ruixing; Hardy, W. N.; Bonn, D. A.; Balakirev, Fedor F.; McDonald, Ross D.; Betts, Jon B.; Riggs, Scott C.; Migliori, Albert			Bounding the pseudogap with a line of phase transitions in YBa2Cu3O6+delta	NATURE			English	Article							TEMPERATURE; STATE; ANOMALIES; SYMMETRY; ORDER	Close to optimal doping, the copper oxide superconductors show 'strange metal' behaviour(1,2), suggestive of strong fluctuations associated with a quantum critical point(3-6). Such a critical point requires a line of classical phase transitions terminating at zero temperature near optimal doping inside the superconducting 'dome'. The underdoped region of the temperature-doping phase diagram from which superconductivity emerges is referred to as the 'pseudogap'(7-13) because evidence exists for partial gapping of the conduction electrons, but so far there is no compelling thermodynamic evidence as to whether the pseudogap is a distinct phase or a continuous evolution of physical properties on cooling. Here we report that the pseudogap in YBa2Cu3O6+delta is a distinct phase, bounded by a line of phase transitions. The doping dependence of this line is such that it terminates at zero temperature inside the superconducting dome. From this we conclude that quantum criticality drives the strange metallic behaviour and therefore superconductivity in the copper oxide superconductors.	[Shekhter, Arkady; Ramshaw, B. J.; Balakirev, Fedor F.; McDonald, Ross D.; Betts, Jon B.; Migliori, Albert] Los Alamos Natl Lab, Natl High Magnet Field Lab, Pulsed Field Facil, Los Alamos, NM 87545 USA; [Liang, Ruixing; Hardy, W. N.; Bonn, D. A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Liang, Ruixing; Hardy, W. N.; Bonn, D. A.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Riggs, Scott C.] Stanford Univ, Stanford Inst Mat & Energy Sci, Stanford, CA 94305 USA; [Riggs, Scott C.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Riggs, Scott C.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Riggs, Scott C.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of British Columbia; Canadian Institute for Advanced Research (CIFAR); Stanford University; Stanford University; Stanford University; Stanford University	Shekhter, A (corresponding author), Los Alamos Natl Lab, Natl High Magnet Field Lab, Pulsed Field Facil, POB 1663, Los Alamos, NM 87545 USA.	arkady.shekhter@gmail.com	Balakirev, Fedor/AAY-2860-2020; Hardy, Walter Newbold/AAN-7827-2020; Balakirev, Fedor/AAS-6827-2020; Ramshaw, Brad/AAU-5603-2020; shekhter, arkady/L-7537-2016; McDonald, Ross/H-3783-2013; shekhter, arkady/M-8152-2019; Shekhter, Arkady/H-4941-2015; Ramshaw, Brad/J-3121-2013; Migliori, Albert/F-6961-2015	Balakirev, Fedor/0000-0003-4887-5140; Balakirev, Fedor/0000-0003-4887-5140; shekhter, arkady/0000-0003-1550-3690; McDonald, Ross/0000-0002-0188-1087; Shekhter, Arkady/0000-0003-1550-3690; Ramshaw, Brad/0000-0002-3222-5007; Mcdonald, Ross/0000-0002-5819-4739	National Science Foundation [DMR-0654118]; US Department of Energy; State of Florida; Canadian Institute for Advanced Research; Natural Science and Engineering Research Council	National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); State of Florida; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank E. Abrahams, J. Analytis, P. Bourges, A. Finkel'stein, M. Greven, N. Harrison, K. Modic, C. Varma, I. Vishik and G. Yu for critical reading of the manuscript and informative discussions. Work at Los Alamos National Laboratory (LANL) was supported by National Science Foundation grant DMR-0654118, by the US Department of Energy and by the State of Florida. LANL is operated by LANS LLC. Work at the University of British Columbia was supported by the Canadian Institute for Advanced Research and the Natural Science and Engineering Research Council.	Aji V, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184501; Ando Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267001; Bhatia A. B., 1967, ULTRASONIC ABSORPTIO; Birss R. R., 1964, SYMMETRY MAGNETISM; BISHOP DJ, 1987, PHYS REV B, V36, P2408, DOI 10.1103/PhysRevB.36.2408; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Hussey NE, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/12/123201; Kaminski A, 2002, NATURE, V416, P610, DOI 10.1038/416610a; Kondo T, 2011, NAT PHYS, V7, P21, DOI 10.1038/NPHYS1851; Landau L. D., 1954, DOKL AKAD NAUK SSSR, V96, P469; LEI M, 1993, PHYS REV B, V47, P6154, DOI 10.1103/PhysRevB.47.6154; Leridon B, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/17011; Li Y, 2008, NATURE, V455, P372, DOI 10.1038/nature07251; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Migliori A., 2005, REV SCI INSTRUM, V76; Migliori A., 1997, RESONANT ULTRASOUND; Mook HA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020506; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; van der Marel D, 2003, NATURE, V425, P271, DOI 10.1038/nature01978; Varma CM, 2002, PHYS REP, V361, P267, DOI 10.1016/S0370-1573(01)00060-6; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Varshni YP, 1970, PHYS REV B-SOLID ST, V2, P3952, DOI 10.1103/PhysRevB.2.3952; Vishik IM, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/105008; WALSTEDT RE, 1990, PHYS REV B, V41, P9574, DOI 10.1103/PhysRevB.41.9574	30	143	145	3	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					75	77		10.1038/nature12165	http://dx.doi.org/10.1038/nature12165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23739425	Green Submitted			2022-12-28	WOS:000319947800035
J	Wilczek, F				Wilczek, Frank			The enigmatic electron	NATURE			English	Editorial Material									MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Wilczek, F (corresponding author), MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA.	wilczek@mit.edu						Bohr N, 1913, PHILOS MAG, V26, P1, DOI 10.1080/14786441308634955; Bohr N, 1928, NATURE, V121, P580, DOI 10.1038/121580a0; Das Sarma S., 1996, PERSPECTIVES QUANTUM; Dirac PAM, 1928, P R SOC LOND A-CONTA, V117, P610, DOI 10.1098/rspa.1928.0023; Kirkby D., 2012, PHYS REV D, V86; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360	8	4	4	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					31	32		10.1038/498031a	http://dx.doi.org/10.1038/498031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158DC	23739409	Bronze			2022-12-28	WOS:000319947800015
J	McGuire, AL; Joffe, S; Koenig, BA; Biesecker, BB; McCullough, LB; Blumenthal-Barby, JS; Caulfield, T; Terry, SF; Green, RC				McGuire, Amy L.; Joffe, Steven; Koenig, Barbara A.; Biesecker, Barbara B.; McCullough, Laurence B.; Blumenthal-Barby, Jennifer S.; Caulfield, Timothy; Terry, Sharon F.; Green, Robert C.			Ethics and Genomic Incidental Findings	SCIENCE			English	Editorial Material									[McGuire, Amy L.; McCullough, Laurence B.; Blumenthal-Barby, Jennifer S.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Joffe, Steven] Harvard Univ, Dana Farber Canc Inst, Boston Childrens Hosp, Sch Med,Dept Pediat Oncol,Dept Med, Boston, MA 02215 USA; [Koenig, Barbara A.] Univ Calif San Francisco, Inst Hlth & Aging, Dept Anthropol Hist & Social Med, Dept Social & Behav Sci, San Francisco, CA 94143 USA; [Biesecker, Barbara B.] NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA; [Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Terry, Sharon F.] Genet Alliance, Washington, DC 20008 USA; [Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Green, Robert C.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Baylor College of Medicine; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Alberta; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	amcguire@bcm.edu; steven_joffe@dfci.harvard.edu	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384; Biesecker, Barbara/0000-0001-9665-8963	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA154517, R01-CA154517, R01 CA154517] Funding Source: Medline; NHGRI NIH HHS [R01 HG003178, R01 HG006615, HG006485, HG02213, R01 HG002213, HG006615, R01 HG005092, U01 HG006500, HG006500, R21 HG006612, U01 HG006485, HG003178, HG005092, HG006612-02, U01 HG006492, P20 HG007243, HG006492] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA154517] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006615, R01HG002213, P20HG007243, U01HG006485, R21HG006612, U01HG006500, R01HG005092, U01HG006492, R01HG003178] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ACMG, 2013, GENET MED; Allyse M, 2013, TRENDS BIOTECHNOL, V31, P439, DOI 10.1016/j.tibtech.2013.04.006; Faden R., 1986, HIST THEORY INFORM C; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Green R. C., 2013, GENET MED; Green RC, 2013, GENOMIC AND PERSONALIZED MEDICINE, VOL 1-2, 2ND EDITION, P102, DOI 10.1016/B978-0-12-382227-7.00009-4; McGuire AL, 2013, JAMA-J AM MED ASSOC, V309, P1465, DOI 10.1001/jama.2013.1438; McGuire AL, 2012, J LAW MED ETHICS, V40, P1040, DOI 10.1111/j.1748-720X.2012.00731.x; NHGRI, 2012, CLIN SEQ EXPL RES; Rhodes R, 1998, J MED PHILOS, V23, P10, DOI 10.1076/jmep.23.1.10.2594; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119	11	135	136	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1047	1048		10.1126/science.1240156	http://dx.doi.org/10.1126/science.1240156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23686340	Green Accepted			2022-12-28	WOS:000319664500024
J	Agrawal, S; Brennan, N; Budetti, P				Agrawal, Shantanu; Brennan, Niall; Budetti, Peter			The Sunshine Act - Effects on Physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Agrawal, Shantanu; Budetti, Peter] Ctr Medicare & Medicaid Serv, Ctr Program Integr, Baltimore, MD USA; [Brennan, Niall] Ctr Medicare & Medicaid Serv, Off Informat Prod & Data Analyt, Baltimore, MD USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Agrawal, S (corresponding author), Ctr Medicare & Medicaid Serv, Ctr Program Integr, Baltimore, MD USA.							Accreditation Council for Continuing Medical Education (ACCME), 2011, ANN REPORT; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Lo B, 2009, CONFLICT INTEREST ME; Medicare Payment Advisory Commission (MedPAC), 2009, C MED PAYM POL MARCH; Medicare Payment Advisory Commission (MedPAC), 2008, C REF DEL SYST JUN	5	121	122	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2054	2057		10.1056/NEJMp1303523	http://dx.doi.org/10.1056/NEJMp1303523			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AT	23718163				2022-12-28	WOS:000319574200003
J	Spence, D				Spence, Des			Bad medicine: epilepsy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; SUDDEN UNEXPECTED DEATH; LAMOTRIGINE; TOPIRAMATE; SANAD					destwo@yahoo.co.uk						[Anonymous], 2012, TELEGRAPH; Beghi E, 2003, EPILEPSY RES, V57, P1, DOI 10.1016/j.eplepsyres.2003.09.007; Cohen SA, 2012, J PAEDIATR CHILD H, V48, P490, DOI 10.1111/j.1440-1754.2011.02223.x; Department of Justice, 2004, WARN LAMB PAY 430 MI; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Hixson JD, 2010, CURR TREAT OPTION NE, V12, P434, DOI 10.1007/s11940-010-0083-8; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Meeraus WH, 2013, ARCH DIS CHILD, V98, P195, DOI 10.1136/archdischild-2012-302237; National Institute for Health and Care Excellence, 2012, NICE CLIN GUID; Ryvlin P, 2011, LANCET NEUROL, V10, P961, DOI 10.1016/S1474-4422(11)70193-4; Scottish Intercollegiate Guideline Network Guidelines, 2005, SCOTT INT GUID NETW; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; US Department of Justice Office of Public Affairs, 2011, US SUBS BELG PHARM M; US Department of Justice Office of Public Affairs, 2010, 2 JOHNS JOHNS SUBS P; Wilson D., 2010, NY TIMES	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2013	346								f3396	10.1136/bmj.f3396	http://dx.doi.org/10.1136/bmj.f3396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158CZ	23714678				2022-12-28	WOS:000319947500015
J	Boos, D; Yekezare, M; Diffley, JFX				Boos, Dominik; Yekezare, Mona; Diffley, John F. X.			Identification of a Heteromeric Complex That Promotes DNA Replication Origin Firing in Human Cells	SCIENCE			English	Article							BUDDING YEAST; SLD3; MTBP; PHOSPHORYLATION; MDM2; ACTIVATION; INITIATION; CDK; CHECKPOINT; DAMAGE	Treslin/TICRR (TopBP1-interacting, replication stimulating protein/TopBP1-interacting, checkpoint, and replication regulator), the human ortholog of the yeast Sld3 protein, is an essential DNA replication factor that is regulated by cyclin-dependent kinases and the DNA damage checkpoint. We identified MDM two binding protein (MTBP) as a factor that interacts with Treslin/TICRR throughout the cell cycle. We show that MTBP depletion by means of small interfering RNA inhibits DNA replication by preventing assembly of the CMG (Cdc45-MCM-GINS) holoheticase during origin firing. Although MTBP has been implicated in the function of the p53 tumor suppressor, we found MTBP is required for DNA replication irrespective of a cell's p53 status. We propose that MTBP acts with Treslin/TICRR to integrate signals from cell cycle and DNA damage response pathways to control the initiation of DNA replication in human cells.	[Boos, Dominik; Yekezare, Mona; Diffley, John F. X.] Canc Res UK London Res Inst LRI, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst LRI, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	john.diffley@cancer.org.uk		Boos, Dominik/0000-0003-0018-4375; Diffley, John/0000-0001-5184-7680	Cancer Research UK; European Research Council [249883-EUKDNAREP]; Association for International Cancer Research grant [10-0270]; European Molecular Biology Organization Long Term Fellowship; Cancer Research UK [15669] Funding Source: researchfish; Worldwide Cancer Research [10-0270] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Association for International Cancer Research grant; European Molecular Biology Organization Long Term Fellowship(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	We are grateful to the LRI Protein Analysis and Proteomics facility for mass spectrometry analysis; M. Petronczki and colleagues for help with time lapse experiments; L. Sanchez-Pulido and C. P. Pouting for help with bioinformatics; J. Mendez, H.-P. Nasheuer, F. Grosse, and H. Pospiech for antibodies; and LRI Cell Services for assistance with cell lines. This work was supported by Cancer Research UK, European Research Council grant 249883-EUKDNAREP, Association for International Cancer Research grant 10-0270 (J.F.X.D.), and a European Molecular Biology Organization Long Term Fellowship (D.B).	Agarwal N, 2011, CELL DEATH DIFFER, V18, P1208, DOI 10.1038/cdd.2010.189; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Boyd MT, 2000, CYTOGENET CELL GENET, V90, P64, DOI 10.1159/000015663; Boyd MT, 2000, J BIOL CHEM, V275, P31883, DOI 10.1074/jbc.M004252200; Brady M, 2005, MOL CELL BIOL, V25, P545, DOI 10.1128/MCB.25.2.545-553.2005; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; Iwakuma T, 2008, ONCOGENE, V27, P1813, DOI 10.1038/sj.onc.1210827; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Mantiero D, 2011, EMBO J, V30, P4805, DOI 10.1038/emboj.2011.404; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Odvody J, 2010, ONCOGENE, V29, P3287, DOI 10.1038/onc.2010.82; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Tanaka T, 2011, EMBO J, V30, P2019, DOI 10.1038/emboj.2011.115; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373	26	59	60	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					981	984		10.1126/science.1237448	http://dx.doi.org/10.1126/science.1237448			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704573				2022-12-28	WOS:000319344100048
J	Price, AR; Xu, GL; Siemienski, ZB; Smithson, LA; Borchelt, DR; Golde, TE; Felsenstein, KM				Price, Ashleigh R.; Xu, Guilian; Siemienski, Zoe B.; Smithson, Lisa A.; Borchelt, David R.; Golde, Todd E.; Felsenstein, Kevin M.			Comment on "ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models"	SCIENCE			English	Editorial Material							ALZHEIMERS-DISEASE; TRANSGENIC MICE; DEPOSITION; PROTEIN; IMMUNOTHERAPY; REDUCE		[Price, Ashleigh R.; Xu, Guilian; Siemienski, Zoe B.; Smithson, Lisa A.; Borchelt, David R.; Golde, Todd E.; Felsenstein, Kevin M.] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Dept Neurosci,McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Felsenstein, KM (corresponding author), Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Dept Neurosci,McKnight Brain Inst, 1275 Ctr Dr, Gainesville, FL 32610 USA.	kfelsenstein0@ufl.edu		Visconti, Ashleigh/0000-0002-7371-136X				Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bittner B, 2002, ARZNEIMITTELFORSCH, V52, P684; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Golde TE, 2010, EXP NEUROL, V223, P252, DOI 10.1016/j.expneurol.2009.07.035; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Koldamova R, 2007, CURR ALZHEIMER RES, V4, P171, DOI 10.2174/156720507780362227; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Mandrekar-Colucci S, 2011, EXPERT OPIN THER TAR, V15, P1085, DOI 10.1517/14728222.2011.594043; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Querfeldt C, 2006, EXPERT OPIN PHARMACO, V7, P907, DOI 10.1517/14656566.7.7.907; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Wang A, 2011, J NEUROSCI, V31, P4124, DOI 10.1523/JNEUROSCI.5077-10.2011; Wilcock DM, 2006, J NEUROSCI, V26, P5340, DOI 10.1523/JNEUROSCI.0695-06.2006; Xu GL, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt110	15	115	117	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135							1234089	10.1126/science.1234089	http://dx.doi.org/10.1126/science.1234089			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704553				2022-12-28	WOS:000319344100022
J	Fritsch, R; de Krijger, I; Fritsch, K; George, R; Reason, B; Kumar, MS; Diefenbacher, M; Stamp, G; Downward, J				Fritsch, Ralph; de Krijger, Inge; Fritsch, Kornelia; George, Roger; Reason, Beth; Kumar, Madhu S.; Diefenbacher, Markus; Stamp, Gordon; Downward, Julian			RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms	CELL			English	Article							G-BETA-GAMMA; P110-BETA ISOFORM; BINDING DOMAIN; ACTIVATION; KINASE; ROLES; TRANSFORMATION; P110-GAMMA; P110-ALPHA; MUTATIONS	RAS proteins are important direct activators of p110 alpha, p110 gamma, and p110 delta type I phosphoinositide 3-kinases (PI3Ks), interacting via an amino-terminal RAS-binding domain (RBD). Here, we investigate the regulation of the ubiquitous p110 beta isoform of PI3K, implicated in G-protein-coupled receptor (GPCR) signaling, PTEN-loss-driven cancers, and thrombocyte function. Unexpectedly, RAS is unable to interact with p110 beta, but instead RAC1 and CDC42 from the RHO subfamily of small GTPases bind and activate p110 beta via its RBD. In fibroblasts, GPCRs couple to PI3K through Dock180/Elmo1-mediated RAC activation and subsequent interaction with p110 beta. Cells from mice carrying mutations in the p110b RBD show reduced PI3K activity and defective chemotaxis, and these mice are resistant to experimental lung fibrosis. These findings revise our understanding of the regulation of type I PI3K by showing that both RAS and RHO family GTPases directly regulate distinct ubiquitous PI3K isoforms and that RAC activates p110 beta downstream of GPCRs.	[Fritsch, Ralph; de Krijger, Inge; Reason, Beth; Kumar, Madhu S.; Downward, Julian] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3LY, England; [Fritsch, Kornelia; Stamp, Gordon] Canc Res UK London Res Inst, Expt Histopathol Lab, London WC2A 3LY, England; [George, Roger] Canc Res UK London Res Inst, Prot Purificat Facil, London WC2A 3LY, England; [Diefenbacher, Markus] Canc Res UK London Res Inst, Mammalian Genet Lab, London WC2A 3LY, England; [Downward, Julian] Inst Canc Res, Div Canc Biol, Lung Canc Grp, London SW3 6JB, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	julian.downward@cancer.org.uk	Diefenbacher, Markus Elmar/AAY-8650-2021; Fritsch, Ralph/Q-8836-2019	Diefenbacher, Markus Elmar/0000-0002-7402-7949; Fritsch, Ralph/0000-0001-9639-3213; Downward, Julian/0000-0002-2331-4729	Worldwide Cancer Research [13-0142] Funding Source: Medline; Cancer Research UK [15680] Funding Source: researchfish	Worldwide Cancer Research; Cancer Research UK(Cancer Research UK)		Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Yan JS, 2012, DEV CELL, V22, P92, DOI 10.1016/j.devcel.2011.11.007; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; Yart A, 2002, BBA-MOL CELL BIOL L, V1582, P107, DOI 10.1016/S1388-1981(02)00144-0; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	40	188	195	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1050	1063		10.1016/j.cell.2013.04.031	http://dx.doi.org/10.1016/j.cell.2013.04.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706742	Green Published, hybrid			2022-12-28	WOS:000319456800013
J	Qian, MX; Pang, Y; Liu, CH; Haratake, K; Du, BY; Ji, DY; Wang, GF; Zhu, QQ; Song, W; Yu, YD; Zhang, XX; Huang, HT; Miao, SY; Chen, LB; Zhang, ZH; Liang, YN; Liu, S; Cha, HH; Yang, D; Zhai, YG; Komatsu, T; Tsuruta, F; Li, HT; Cao, C; Li, W; Li, GH; Cheng, YF; Chiba, T; Wang, LF; Goldberg, AL; Shen, Y; Qiu, XB				Qian, Min-Xian; Pang, Ye; Liu, Cui Hua; Haratake, Kousuke; Du, Bo-Yu; Ji, Dan-Yang; Wang, Guang-Fei; Zhu, Qian-Qian; Song, Wei; Yu, Yadong; Zhang, Xiao-Xu; Huang, Hai-Tao; Miao, Shiying; Chen, Lian-Bin; Zhang, Zi-Hui; Liang, Ya-Nan; Liu, Shan; Cha, Hwangho; Yang, Dong; Zhai, Yonggong; Komatsu, Takuo; Tsuruta, Fuminori; Li, Haitao; Cao, Cheng; Li, Wei; Li, Guo-Hong; Cheng, Yifan; Chiba, Tomoki; Wang, Linfang; Goldberg, Alfred L.; Shen, Yan; Qiu, Xiao-Bo			Acetylation-Mediated Proteasomal Degradation of Core Histones during DNA Repair and Spermatogenesis	CELL			English	Article							DOUBLE-STRAND BREAKS; ACTIVATOR PA200; SACCHAROMYCES-CEREVISIAE; CHROMATIN; PROTEINS; TURNOVER; BINDING; YEAST; UBIQUITYLATION; RECOGNITION	Histone acetylation plays critical roles in chromatin remodeling, DNA repair, and epigenetic regulation of gene expression, but the underlying mechanisms are unclear. Proteasomes usually catalyze ATP- and polyubiquitin-dependent proteolysis. Here, we show that the proteasomes containing the activator PA200 catalyze the polyubiquitin-independent degradation of histones. Most proteasomes in mammalian testes ("spermatoproteasomes'') contain a spermatid/sperm-specific alpha subunit alpha 4 s/PSMA8 and/or the catalytic beta subunits of immuno-proteasomes in addition to PA200. Deletion of PA200 in mice abolishes acetylation-dependent degradation of somatic core histones during DNA double-strand breaks and delays core histone disappearance in elongated spermatids. Purified PA200 greatly promotes ATP-independent proteasomal degradation of the acetylated core histones, but not polyubiquitinated proteins. Furthermore, acetylation on histones is required for their binding to the bromodomain-like regions in PA200 and its yeast ortholog, Blm10. Thus, PA200/Blm10 specifically targets the core histones for acetylation-mediated degradation by proteasomes, providing mechanisms by which acetylation regulates histone degradation, DNA repair, and spermatogenesis.	[Qian, Min-Xian; Pang, Ye; Liu, Cui Hua; Ji, Dan-Yang; Wang, Guang-Fei; Zhu, Qian-Qian; Zhang, Xiao-Xu; Chen, Lian-Bin; Zhang, Zi-Hui; Liang, Ya-Nan; Liu, Shan; Cha, Hwangho; Yang, Dong; Zhai, Yonggong; Qiu, Xiao-Bo] Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Qian, Min-Xian; Pang, Ye; Liu, Cui Hua; Ji, Dan-Yang; Wang, Guang-Fei; Zhu, Qian-Qian; Zhang, Xiao-Xu; Chen, Lian-Bin; Zhang, Zi-Hui; Liang, Ya-Nan; Liu, Shan; Cha, Hwangho; Yang, Dong; Zhai, Yonggong; Qiu, Xiao-Bo] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Cui Hua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Li, Wei] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; [Li, Guo-Hong] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Haratake, Kousuke; Komatsu, Takuo; Tsuruta, Fuminori; Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Du, Bo-Yu; Song, Wei; Huang, Hai-Tao; Miao, Shiying; Wang, Linfang; Shen, Yan; Qiu, Xiao-Bo] Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Du, Bo-Yu; Song, Wei; Huang, Hai-Tao; Miao, Shiying; Wang, Linfang; Shen, Yan; Qiu, Xiao-Bo] Chinese Acad Med Sci, Beijing 100005, Peoples R China; [Yu, Yadong; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Li, Haitao] Tsinghua Univ, Sch Life Sci, Ctr Struct Biol, Beijing 100084, Peoples R China; [Li, Haitao] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Cao, Cheng] Beijing Inst Biotechnol, Beijing 100850, Peoples R China; [Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Tsukuba; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; University of California System; University of California San Francisco; Tsinghua University; Tsinghua University; Harvard University; Harvard Medical School	Qiu, XB (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.	xqiu@bnu.edu.cn	Li, Haitao/B-2668-2012; Cao, Cheng/GNP-6156-2022	Li, Haitao/0000-0001-6741-293X; Qian, Minxian/0000-0002-1763-2325; Cheng, Yifan/0000-0001-9535-0369; Qiu, Xiao-Bo/0000-0003-2608-9376	Ministry of Science and Technology of China [2012CB910300]; National Natural Science Foundation of China [30525033, 30730024]; Fundamental Research Funds for the Central Universities of China; National Basic Research Program of China [2012CB518700]; MEX, Japan; NIGMS [5R01 GM51923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Basic Research Program of China(National Basic Research Program of China); MEX, Japan; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Finley for critical comments on the manuscript, Y. Cong, D. Finley, and O.J. Rando for reagents, T. Walz for providing the original EM images of Blm10 and PA28, H. Matsumoto and C. Xiong for technical assistance, as well as O. Gozani, D. Patel, H. Wang, and Z. Wang for assistance in the acetyl-peptide binding assay. T.C. thanks K. Tanaka for support and encouragement. This work was supported by grants from the Ministry of Science and Technology of China (2012CB910300); the National Natural Science Foundation of China (30525033 and 30730024); and the Fundamental Research Funds for the Central Universities of China to X.-B.Q.; a National Basic Research Program of China (2012CB518700) to C.H.L.; grants-in-aid for Scientific Research on Priority Areas, MEX, Japan to T.C.; and a grant from NIGMS (5R01 GM51923) to A.L. G.X.-B.Q. conceived the project. M.-X.Q., C.H.L., D.-Y.J., G.-F.W., and X.-B.Q. contributed to protein purification, characterization of proteasomal subunits and activities, and the studies on mutant mouse materials and yeast mutants. Y.P., M.-X.Q., X.-X.Z., H.C., D.Y., H.L., and X.-B.Q. performed acetylation-related studies. B.-Y.D., W.S., Z.-H.Z., H.-T.H., S.M., and L.W. contributed to purification and characterization of proteasomal subunits. K.H., T.K., F.T., and T.C. constructed PA200-deficient mice. Y.Y. and Y.C. conducted electron microscopic studies. Q.-Q.Z., L.-B.C., Y.-N.L., S.L., Y.Z., W.L., G.-H. L., and C.C. contributed to plasmid construction, antibody production, animal handling, or immunohistochemical studies. A.L.G., Y.S., and X.-B.Q. wrote the manuscript.	Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Chen YS, 2012, J GENET GENOMICS, V39, P575, DOI 10.1016/j.jgg.2012.09.001; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu ZQ, 2007, DEV DYNAM, V236, P2889, DOI 10.1002/dvdy.21302; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; MILLS NC, 1977, BIOL REPROD, V17, P760, DOI 10.1095/biolreprod17.5.760; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shabason JE, 2011, J CELL MOL MED, V15, P2735, DOI 10.1111/j.1582-4934.2011.01296.x; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Toulmay A, 2006, YEAST, V23, P825, DOI 10.1002/yea.1397; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Ustrell V, 2005, METHOD ENZYMOL, V398, P321, DOI 10.1016/S0076-6879(05)98026-9; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26	46	197	223	3	116	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1012	1024		10.1016/j.cell.2013.04.032	http://dx.doi.org/10.1016/j.cell.2013.04.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706739	Bronze, Green Accepted			2022-12-28	WOS:000319456800010
J	Seol, Y; Neuman, KC				Seol, Yeonee; Neuman, Keir C.			SnapShot: Force Spectroscopy and Single-Molecule Manipulation	CELL			English	Editorial Material							OPTICAL TWEEZERS; MAGNETIC TWEEZERS; MICROSCOPY		[Seol, Yeonee; Neuman, Keir C.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Seol, Y (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.		Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001056] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barroso A, 2013, SMALL, V9, P885, DOI 10.1002/smll.201201851; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; Inman J, 2010, OPT LETT, V35, P2949, DOI 10.1364/OL.35.002949; Lionnet Timothee, 2012, Cold Spring Harb Protoc, V2012, P34, DOI 10.1101/pdb.top067488; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218	9	9	9	4	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1168	+		10.1016/j.cell.2013.04.047	http://dx.doi.org/10.1016/j.cell.2013.04.047			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706746	Bronze			2022-12-28	WOS:000319456800024
J	Joppa, LN; McInerny, G; Harper, R; Salido, L; Takeda, K; O'Hara, K; Gavaghan, D; Emmott, S				Joppa, Lucas N.; McInerny, Greg; Harper, Richard; Salido, Lara; Takeda, Kenji; O'Hara, Kenton; Gavaghan, David; Emmott, Stephen			Troubling Trends in Scientific Software Use	SCIENCE			English	Editorial Material							MODELS		[Joppa, Lucas N.; McInerny, Greg; Harper, Richard; Takeda, Kenji; O'Hara, Kenton; Emmott, Stephen] Microsoft Res, Cambridge CB1 2FB, England; [McInerny, Greg; Gavaghan, David] Univ Oxford, Dept Comp Sci, Oxford OX1 3QD, England; [Salido, Lara] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland	Microsoft; University of Oxford; UK Centre for Ecology & Hydrology (UKCEH)	Joppa, LN (corresponding author), Microsoft Res, Cambridge CB1 2FB, England.	lujoppa@microsoft.com		Harper, Richard/0000-0001-8838-2012; gavaghan, david/0000-0001-8311-3200	Engineering and Physical Sciences Research Council [EP/I017909/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish; EPSRC [EP/I017909/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Advisory Committee for CyberInfrastructure National Science Foundation, 2011, TASK FORC SOFTW SCI; Aruliah D. A., 2012, ARXIV12100530V1; Basili VR, 2008, IEEE SOFTWARE, V25, P29, DOI 10.1109/MS.2008.103; Baxter SM, 2006, PLOS COMPUT BIOL, V2, P975, DOI 10.1371/journal.pcbi.0020087; Drummond C., 2009, ICML 09; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; EMMOTT S, 2006, 2020 SCI; HANNAY JE, 2009, SECSE 09, P1, DOI DOI 10.1109/SECSE.2009.5069155; HATTON L, 1994, IEEE T SOFTWARE ENG, V20, P785, DOI 10.1109/32.328993; Hey T., 2009, 4 PARADIGM DATA INTE; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Kelly DF, 2007, IEEE SOFTWARE, V24, P120, DOI 10.1109/MS.2007.155; Mallett S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3999; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Miller G, 2006, SCIENCE, V314, P1856, DOI 10.1126/science.314.5807.1856; Morin A, 2012, SCIENCE, V336, P159, DOI 10.1126/science.1218263; Neylon C, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; SANDERS R, 2008, THESIS QUEENS U; Segal J, 2007, VL/HCC 2007: IEEE SYMPOSIUM ON VISUAL LANGUAGES AND HUMAN-CENTRIC COMPUTING, PROCEEDINGS, P111; Segal J, 2011, J ORGAN END USER COM, V23, P51, DOI 10.4018/joeuc.2011100104; Wilson G, 2008, COMPUT SCI ENG, V10, P5, DOI 10.1109/MCSE.2008.86; Wilson G, 2009, AM SCI, V97, P360, DOI 10.1511/2009.80.360; Wilson GV, 2006, AM SCI, V94, P5, DOI 10.1511/2006.57.3473	27	118	122	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					814	815		10.1126/science.1231535	http://dx.doi.org/10.1126/science.1231535			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145EM	23687031				2022-12-28	WOS:000318997400025
J	Levitin, LV; Bennett, RG; Casey, A; Cowan, B; Saunders, J; Drung, D; Schurig, T; Parpia, JM				Levitin, L. V.; Bennett, R. G.; Casey, A.; Cowan, B.; Saunders, J.; Drung, D.; Schurig, Th.; Parpia, J. M.			Phase Diagram of the Topological Superfluid He-3 Confined in a Nanoscale Slab Geometry	SCIENCE			English	Article							THIN-FILMS	The superfluid phases of helium-3 (He-3) are predicted to be strongly influenced by mesoscopic confinement. However, mapping out the phase diagram in a confined geometry has been experimentally challenging. We confined a sample of He-3 within a nanofluidic cavity of precisely defined geometry, cooled it, and fingerprinted the order parameter using a sensitive nuclear magnetic resonance spectrometer. The measured suppression of the p-wave order parameter arising from surface scattering was consistent with the predictions of quasi-classical theory. Controlled confinement of nanofluidic samples provides a new laboratory for the study of topological superfluids and their surface-and edge-bound excitations.	[Levitin, L. V.; Bennett, R. G.; Casey, A.; Cowan, B.; Saunders, J.] Royal Holloway Univ London, Dept Phys, Egham TW20 0EX, Surrey, England; [Drung, D.; Schurig, Th.] Phys Tech Bundesanstalt, D-10587 Berlin, Germany; [Parpia, J. M.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	University of London; Royal Holloway University London; Physikalisch-Technische Bundesanstalt (PTB); Cornell University	Saunders, J (corresponding author), Royal Holloway Univ London, Dept Phys, Egham TW20 0EX, Surrey, England.	j.saunders@rhul.ac.uk			Engineering and Physical Sciences Research Council [EP/C522877/1, EP/E0541129/1, EP/J022004/1]; NSF [DMR-0806629, DMR-120991]; European Microkelvin Consortium [228464]; EPSRC [EP/J022004/1, EP/E054129/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E054129/1] Funding Source: researchfish; Division Of Materials Research [1202991] Funding Source: National Science Foundation	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF(National Science Foundation (NSF)); European Microkelvin Consortium; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S. Dimov, B. Ilic, and S. S. Verbridge for assistance with cell construction at Cornell Nano Fabrication Facility; S. T. Boogert and A. Bosco for advice and loan of equipment for optical thickness measurement; and M. Eschrig for critically reading the manuscript. This work was supported by Engineering and Physical Sciences Research Council grants EP/C522877/1, EP/E0541129/1, and EP/J022004/1; NSF grants DMR-0806629 and DMR-120991; and European Microkelvin Consortium (FP7 grant agreement 228464). We dedicate this paper to the memory of Professor Robert C. Richardson (1937-2013), who inspired this research.	AHONEN AI, 1976, J LOW TEMP PHYS, V25, P421, DOI 10.1007/BF00655840; AMBEGAOKAR V, 1974, PHYS REV A, V9, P2676, DOI 10.1103/PhysRevA.9.2676; BUCHHOLTZ LJ, 1981, PHYS REV B, V23, P5788, DOI 10.1103/PhysRevB.23.5788; Bunkov Yu. M., 1993, SOV PHYS JETP, V76, P794; Chung SB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.235301; FREEMAN MR, 1988, PHYS REV LETT, V60, P596, DOI 10.1103/PhysRevLett.60.596; HU CR, 1994, PHYS REV LETT, V72, P1526, DOI 10.1103/PhysRevLett.72.1526; KJALDMAN LH, 1978, J LOW TEMP PHYS, V33, P577, DOI 10.1007/BF00115576; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; Levitin LV, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2828113; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Nagato Y, 1998, J LOW TEMP PHYS, V110, P1135, DOI 10.1023/A:1022368301143; Nagato Y, 2000, PHYSICA B, V284, P269, DOI 10.1016/S0921-4526(99)02594-6; Norman MR, 2011, SCIENCE, V332, P196, DOI 10.1126/science.1200181; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.187001; Sauls JA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214509; Schechter AMR, 1998, NATURE, V396, P554, DOI 10.1038/25090; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; SERENE JW, 1983, PHYS REP, V101, P221, DOI 10.1016/0370-1573(83)90051-0; STEEL SC, 1994, J LOW TEMP PHYS, V95, P759, DOI 10.1007/BF00754714; Vollhardt D., 1990, SUPERFLUID PHASES 3H; Volovik G E, 2002, UNIVERSE HELIUM DROP; Volovik G. E., 1992, EXOTIC PROPERTIES SU; Vorontsov AB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.045301; Vorontsov AB, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.064508; Wilczek F, 2009, NAT PHYS, V5, P614, DOI 10.1038/nphys1380; XU J, 1990, PHYS REV LETT, V65, P3005, DOI 10.1103/PhysRevLett.65.3005	30	63	65	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					841	844		10.1126/science.1233621	http://dx.doi.org/10.1126/science.1233621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687043				2022-12-28	WOS:000318997400038
J	Lemma, F; Matji, J				Lemma, Ferew; Matji, Joan			Delivery platforms for sustained nutrition in Ethiopia	LANCET			English	Editorial Material							TARGETED HEALTH INTERVENTIONS; SYSTEMS; INTEGRATION		[Lemma, Ferew] Ethiopian Fed Minist Hlth, Addis Ababa, Ethiopia; [Matji, Joan] UNICEF Ethiopia, Addis Ababa, Ethiopia	Federal Ministry of Health - Ethiopia (FMOH)	Lemma, F (corresponding author), Ethiopian Fed Minist Hlth, POB 1234, Addis Ababa, Ethiopia.	lferew@gmail.com						[Anonymous], 2011, ETHIOPIA DEMOGRAPHIC, P452; ATUN R, 2009, HLTH SYSTEMS CHALLEN, P121; Atun RA, 2008, DO VERTICAL STAND AL; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Ministry of Environment, 2012, INVESTING BOYS GIRLS, P35; REACH Partnership, 2012, REACH PARTN ANN REP; Singh A, 2006, HEALTH POLICY PLANN, V21, P326, DOI 10.1093/heapol/czl008; United Nations Children's Fund, 2013, IMPR CHILD NUTR ACH; Wakabi W, 2008, LANCET, V372, P880, DOI 10.1016/S0140-6736(08)61381-1; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2013, ETH HLTH PROF; World Health Organization, 2007, GLOB FUND STRAT APPR	14	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 10	2013	382	9891					488	489		10.1016/S0140-6736(13)61054-5	http://dx.doi.org/10.1016/S0140-6736(13)61054-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201SD	23746774				2022-12-28	WOS:000323162400008
J	Ilani, T; Alon, A; Grossman, I; Horowitz, B; Kartvelishvily, E; Cohen, SR; Fass, D				Ilani, Tal; Alon, Assaf; Grossman, Iris; Horowitz, Ben; Kartvelishvily, Elena; Cohen, Sidney R.; Fass, Deborah			A Secreted Disulfide Catalyst Controls Extracellular Matrix Composition and Function	SCIENCE			English	Article							QUIESCIN-SULFHYDRYL OXIDASE; GENE-EXPRESSION; QSOX; INVASION	Disulfide bond formation in secretory proteins occurs primarily in the endoplasmic reticulum (ER), where multiple enzyme families catalyze cysteine cross-linking. Quiescin sulfhydryl oxidase 1 (QSOX1) is an atypical disulfide catalyst, localized to the Golgi apparatus or secreted from cells. We examined the physiological function for extracellular catalysis of de novo disulfide bond formation by QSOX1. QSOX1 activity was required for incorporation of laminin into the extracellular matrix (ECM) synthesized by fibroblasts, and ECM produced without QSOX1 was defective in supporting cell-matrix adhesion. We developed an inhibitory monoclonal antibody against QSOX1 that could modulate ECM properties and undermine cell migration.	[Ilani, Tal; Alon, Assaf; Grossman, Iris; Horowitz, Ben; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Kartvelishvily, Elena] Weizmann Inst Sci, Irving & Cherna Moskowitz Ctr Nano & Bionano Imag, IL-76100 Rehovot, Israel; [Cohen, Sidney R.] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Ilani, T (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	tal.ilani@weizmann.ac.il; deborah.fass@weizmann.ac.il	Cohen, Sidney R./J-7153-2012	Cohen, Sidney R./0000-0003-4255-3351; Alon, Assaf/0000-0001-8102-5290; Ilani, Tal/0000-0003-2806-4455	Israel Science Foundation; Israel Cancer Association; Abisch-Frenkel Foundation; Kimmelman Center for Macromolecular Assemblies; European Research Council under the European Union [310649]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Abisch-Frenkel Foundation; Kimmelman Center for Macromolecular Assemblies; European Research Council under the European Union(European Research Council (ERC))	Y. Yarden provided valued advice and guidance throughout this project. We also thank V. Rotter, S. Feigelson, R. Alon, G. Shakhar, N. Friedman, M. Oren, and B. Geiger for reagents and advice. O. Leitner, Z. Landau, and H. Hamawi from the Weizmann Institute Antibody Unit performed technical aspects of antibody production. T. Mehlman provided mass spectrometry service. K. Shakhar provided statistics support. This work was supported by the Israel Science Foundation, Israel Cancer Association, Abisch-Frenkel Foundation, Kimmelman Center for Macromolecular Assemblies, and European Research Council under the European Union's Seventh Framework Programme (ERC grant agreement 310649). T. I., A. A., I. G., and D. F. have applied for a patent concerning the QSOX1 inhibitory antibody and its use in modulating assembly of laminin in the basement membrane.	Alon A, 2012, NATURE, V488, P414, DOI 10.1038/nature11267; Antwi K, 2009, J PROTEOME RES, V8, P4722, DOI 10.1021/pr900414f; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Chakravarthi S, 2007, BIOCHEM J, V404, P403, DOI 10.1042/BJ20061510; Coppock D, 2000, BIOCHEM BIOPH RES CO, V269, P604, DOI 10.1006/bbrc.2000.2324; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Givant-Horwitz V, 2005, CANCER LETT, V223, P1, DOI 10.1016/j.canlet.2004.08.030; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; JANOLINO VG, 1975, J BIOL CHEM, V250, P2532; Katchman BA, 2011, MOL CANCER RES, V9, P1621, DOI 10.1158/1541-7786.MCR-11-0018; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Limor-Waisberg K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-70; Mairet-Coello G, 2005, J COMP NEUROL, V484, P403, DOI 10.1002/cne.20411; OSTROWSKI MC, 1980, BIOCHEMISTRY-US, V19, P2639, DOI 10.1021/bi00553a016; OSTROWSKI MC, 1979, BIOCHEM BIOPH RES CO, V87, P171, DOI 10.1016/0006-291X(79)91662-0; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Portes KF, 2008, J MOL HISTOL, V39, P217, DOI 10.1007/s10735-007-9156-8; Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128; Soloviev M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057327; Tury A, 2006, CELL TISSUE RES, V323, P91, DOI 10.1007/s00441-005-0043-x; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	26	106	111	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					74	76		10.1126/science.1238279	http://dx.doi.org/10.1126/science.1238279			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23704371				2022-12-28	WOS:000321291700051
J	Anderson, CS; Heeley, E; Huang, Y; Wang, J; Stapf, C; Delcourt, C; Lindley, R; Robinson, T; Lavados, P; Neal, B; Hata, J; Arima, H; Parsons, M; Li, Y; Wang, J; Heritier, S; Li, Q; Woodward, M; Simes, RJ; Davis, SM; Chalmers, J				Anderson, Craig S.; Heeley, Emma; Huang, Yining; Wang, Jiguang; Stapf, Christian; Delcourt, Candice; Lindley, Richard; Robinson, Thompson; Lavados, Pablo; Neal, Bruce; Hata, Jun; Arima, Hisatomi; Parsons, Mark; Li, Yuechun; Wang, Jinchao; Heritier, Stephane; Li, Qiang; Woodward, Mark; Simes, R. John; Davis, Stephen M.; Chalmers, John		INTERACT2 Investigators	Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSOCIATION/AMERICAN-STROKE-ASSOCIATION; ACUTE ISCHEMIC-STROKE; CONTROLLED-TRIAL; MANAGEMENT; REDUCTION; GROWTH; HEMATOMA; DETERMINANTS; GUIDELINES; MORTALITY	Background Whether rapid lowering of elevated blood pressure would improve the outcome in patients with intracerebral hemorrhage is not known. Methods We randomly assigned 2839 patients who had had a spontaneous intracerebral hemorrhage within the previous 6 hours and who had elevated systolic blood pressure to receive intensive treatment to lower their blood pressure (with a target systolic level of <140 mm Hg within 1 hour) or guideline-recommended treatment (with a target systolic level of <180 mm Hg) with the use of agents of the physician's choosing. The primary outcome was death or major disability, which was defined as a score of 3 to 6 on the modified Rankin scale (in which a score of 0 indicates no symptoms, a score of 5 indicates severe disability, and a score of 6 indicates death) at 90 days. A prespecified ordinal analysis of the modified Rankin score was also performed. The rate of serious adverse events was compared between the two groups. Results Among the 2794 participants for whom the primary outcome could be determined, 719 of 1382 participants (52.0%) receiving intensive treatment, as compared with 785 of 1412 (55.6%) receiving guideline-recommended treatment, had a primary outcome event (odds ratio with intensive treatment, 0.87; 95% confidence interval [CI], 0.75 to 1.01; P = 0.06). The ordinal analysis showed significantly lower modified Rankin scores with intensive treatment (odds ratio for greater disability, 0.87; 95% CI, 0.77 to 1.00; P = 0.04). Mortality was 11.9% in the group receiving intensive treatment and 12.0% in the group receiving guideline-recommended treatment. Nonfatal serious adverse events occurred in 23.3% and 23.6% of the patients in the two groups, respectively. Conclusions In patients with intracerebral hemorrhage, intensive lowering of blood pressure did not result in a significant reduction in the rate of the primary outcome of death or severe disability. An ordinal analysis of modified Rankin scores indicated improved functional outcomes with intensive lowering of blood pressure.	[Anderson, Craig S.; Heeley, Emma; Delcourt, Candice; Lindley, Richard; Neal, Bruce; Hata, Jun; Arima, Hisatomi; Heritier, Stephane; Li, Qiang; Woodward, Mark; Chalmers, John] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Simes, R. John] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia; [Anderson, Craig S.; Delcourt, Candice] Royal Prince Alfred Hosp, Dept Neurol, Sydney, NSW 2050, Australia; [Parsons, Mark] Univ Newcastle, John Hunter Hosp, Dept Neurol, Newcastle, NSW 2300, Australia; [Davis, Stephen M.] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic 3050, Australia; [Davis, Stephen M.] Univ Melbourne, Melbourne, Vic, Australia; [Huang, Yining] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Jiguang] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hypertens, Shanghai, Peoples R China; [Li, Yuechun] Yutian Cty Hosp, Baotou Cent Hosp, Dept Neurol, Tangshan, Hebei, Peoples R China; [Wang, Jinchao] Yutian Cty Hosp, Dept Neurol, Tangshan, Hebei, Peoples R China; [Stapf, Christian] Hop Paris, Hop Lariboisiere, Dept Neurol, Paris, France; [Stapf, Christian] Univ Paris 04, DHU NeuroVasc Paris Sorbonne, Paris, France; [Robinson, Thompson] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Robinson, Thompson] Univ Leicester, NIHR Biomed Res Unit Cardiovasc Sci, Leicester, Leics, England; [Lavados, Pablo] Univ Desarrollo, Clin Alemana, Dept Med, Serv Neurol, Concepcion, Chile; [Lavados, Pablo] Univ Chile, Santiago, Chile; [Hata, Jun] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Woodward, Mark] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; John Hunter Hospital; University of Newcastle; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Peking University; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Leicester; University of Leicester; Clinica Alemana; Universidad del Desarrollo; Universidad de Chile; Kyushu University; Johns Hopkins University	Anderson, CS (corresponding author), Royal Prince Alfred Hosp, George Inst Global Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	canderson@georgeinstitute.org.au	Woodward, Mark/L-6817-2017; Davis, Stephen M/L-5260-2013; Woodward, Mark/D-8492-2015; Spratt, Neil J/K-4208-2012; Martin, Oscar Ayo/Q-8541-2017; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Werring, David/Q-8435-2019; Scheperjans, Filip/F-7628-2015; De Keyser, Jacques/AAA-8721-2021; Curtze, Sami/AAK-8595-2020; Lindley, Richard/B-8148-2013; De Keyser, Jacques/D-3725-2013; Simes, Robert John/P-1497-2014; Hankey, Graeme J/H-4968-2014; Lavados, Pablo M/E-9918-2016; Zini, Andrea/K-1136-2014; Brouns, Raf/E-1044-2013; De Raedt, Sylvie/AAX-4965-2020; Gregório, Tiago/K-2013-2019; Klijn, C.J.M./E-1700-2016; Urra, Xabier/B-7637-2019; Cordonnier, Charlotte/O-3258-2017; Demchuk, Andrew M/E-1103-2012; Billot, Laurent/Y-1241-2019; Toni, Danilo/K-3151-2016; Parsons, Mark W./G-3750-2014; Azevedo, Elsa I/C-1060-2014	Davis, Stephen M/0000-0003-0962-2300; Spratt, Neil J/0000-0002-9023-6177; Martin, Oscar Ayo/0000-0002-3632-1696; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Werring, David/0000-0003-2074-1861; Scheperjans, Filip/0000-0001-9502-7131; De Keyser, Jacques/0000-0002-3394-7757; Curtze, Sami/0000-0003-1545-8500; Lindley, Richard/0000-0002-0104-5679; De Keyser, Jacques/0000-0002-3394-7757; Hankey, Graeme J/0000-0002-6044-7328; Lavados, Pablo M/0000-0002-9118-9093; Zini, Andrea/0000-0003-1486-4507; Brouns, Raf/0000-0001-6540-5699; De Raedt, Sylvie/0000-0001-8042-2024; Gregório, Tiago/0000-0002-0131-9430; Klijn, C.J.M./0000-0002-8495-4578; Urra, Xabier/0000-0002-4763-5252; Cordonnier, Charlotte/0000-0002-5697-6892; Demchuk, Andrew M/0000-0002-4930-7789; Billot, Laurent/0000-0002-4975-9793; Toni, Danilo/0000-0003-2735-8427; Azevedo, Elsa I/0000-0003-3731-4508; Woodward, Mark/0000-0001-9800-5296; Heeley, Emma/0000-0001-9190-2832; Delcourt, Candice/0000-0003-2257-4286; Abimbola, Seye/0000-0003-1294-3850; Kwan, Joseph/0000-0003-4635-3322; Touze, Emmanuel/0000-0002-7254-2162; Castellanos, Maria del Mar/0000-0003-3116-1352; corea, francesco/0000-0002-5864-9991; Schneider, Hauke/0000-0002-9641-0922; Strbian, Daniel/0000-0001-9095-2344; Haunton, Victoria/0000-0001-6078-5469; Stapf, Christian/0000-0002-3193-1006; Herve, Dominique/0000-0001-6197-6275; Neal, Bruce/0000-0002-0490-7465; Chalmers, John/0000-0002-9931-0580; Anderson, Craig/0000-0002-7248-4863; Timsit, Serge/0000-0003-0346-8576; Robinson, Thompson/0000-0003-2144-2468	National Health and Medical Research Council of Australia; National Health and Medical Research Council (NHMRC) of Australia [571281, 512402, 1004170]; Australian Research Council; High Blood Pressure Research Council of Australia; Osaka Pharmaceuticals; Novartis; Omron Healthcare; Pfizer; Takeda; AD Pharma; Servier; Lundbeck; BMJ; Bristol-Myers Squibb; Boehringer Ingelheim; Sanofi-Aventis; EVER Neuro Pharma	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); High Blood Pressure Research Council of Australia; Osaka Pharmaceuticals; Novartis(Novartis); Omron Healthcare; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); AD Pharma; Servier(Servier); Lundbeck(Lundbeck Corporation); BMJ; Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); EVER Neuro Pharma	Funded by the National Health and Medical Research Council of Australia; INTERACT2 ClinicalTrials.gov number, NCT00716079.; Supported by a program grant (571281), project grants (512402 and 1004170), a Senior Principal Research Fellowship (to Dr. Anderson), and a Principal Research Fellowship (to Dr. Neal) from the National Health and Medical Research Council (NHMRC) of Australia. Drs. Neal, Arima, and Parsons are recipients of Future Fellowships from the Australian Research Council. Dr. Hata is a recipient of a Postgraduate Fellowship from the High Blood Pressure Research Council of Australia.; Dr. Huang reports receiving reimbursement for travel expenses from Osaka Pharmaceuticals; Dr. Jiguang Wang, receiving consulting fees from Novartis, Omron Healthcare, Pfizer, and Takeda, grant support from Novartis, Omron Healthcare, and Pfizer, lecture fees from A&D Pharma, Omron Healthcare, Novartis, Pfizer, and Servier, and reimbursement for travel expenses from Pfizer and Takeda; Dr. Lavados, receiving grant support from Lundbeck, payment for manuscript preparation from BMJ, and payment for advisory board membership from Bristol-Myers Squibb; and Dr. Davis, receiving lecture fees from Boehringer Ingelheim, Sanofi-Aventis, and EVER Neuro Pharma. No other potential conflict of interest relevant to this article was reported.	Anderson C, 2013, INT J STROKE; Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Anderson CS, 2010, STROKE, V41, P307, DOI 10.1161/STROKEAHA.109.561795; Arima H, 2010, HYPERTENSION, V56, P852, DOI 10.1161/HYPERTENSIONAHA.110.154328; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Delcourt C, 2010, INT J STROKE, V5, P110, DOI 10.1111/j.1747-4949.2010.00415.x; Dolan P., 1995, SOCIAL TARIFF EUROQO; Fogelholm R, 1997, STROKE, V28, P1396, DOI 10.1161/01.STR.28.7.1396; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Ohwaki K, 2004, STROKE, V35, P1364, DOI 10.1161/01.STR.0000128795.38283.4b; Okumura K, 2005, J HYPERTENS, V23, P1217, DOI 10.1097/01.hjh.0000170385.76826.4a; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; TEASDALE G, 1974, LANCET, V2, P81; Vemmos KN, 2004, J INTERN MED, V255, P257, DOI 10.1046/j.1365-2796.2003.01291.x; Woodward M, 2005, EPIDEMIOLOGY STUDY D, P587; Zhang YH, 2008, J HYPERTENS, V26, P1446, DOI 10.1097/HJH.0b013e328300a24a	29	915	961	3	121	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2355	2365		10.1056/NEJMoa1214609	http://dx.doi.org/10.1056/NEJMoa1214609			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23713578	Green Published			2022-12-28	WOS:000320601700005
J	Findley, K; Oh, J; Yang, J; Conlan, S; Deming, C; Meyer, JA; Schoenfeld, D; Nomicos, E; Park, M; Kong, HH; Segre, JA				Findley, Keisha; Oh, Julia; Yang, Joy; Conlan, Sean; Deming, Clayton; Meyer, Jennifer A.; Schoenfeld, Deborah; Nomicos, Effie; Park, Morgan; Kong, Heidi H.; Segre, Julia A.		NIH Intramural Sequencing Ctr Comp	Topographic diversity of fungal and bacterial communities in human skin	NATURE			English	Article							RIBOSOMAL-RNA SEQUENCES; HUMAN MICROBIOME; RISK-FACTORS; TINEA-PEDIS; PREVALENCE; ALIGNMENT; ACCURACY; DISEASES; PROJECT; SAMPLES	Traditional culture-based methods have incompletely defined the microbial landscape of common recalcitrant human fungal skin diseases, including athlete's foot and toenail infections. Skin protects humans from invasion by pathogenic microorganisms and provides a home for diverse commensal microbiota(1). Bacterial genomic sequence data have generated novel hypotheses about species and community structures underlying human disorders(2-4). However, microbial diversity is not limited to bacteria; microorganisms such as fungi also have major roles in microbial community stability, human health and disease(5). Genomic methodologies to identify fungal species and communities have been limited compared with those that are available for bacteria(6). Fungal evolution can be reconstructed with phylogenetic markers, including ribosomal RNA gene regions and other highly conserved genes(7). Here we sequenced and analysed fungal communities of 14 skin sites in 10 healthy adults. Eleven core-body and arm sites were dominated by fungi of the genus Malassezia, with only species-level classifications revealing fungal-community composition differences between sites. By contrast, three foot sites-plantar heel, toenail and toe web-showed high fungal diversity. Concurrent analysis of bacterial and fungal communities demonstrated that physiologic attributes and topography of skin differentially shape these two microbial communities. These results provide a framework for future investigation of the contribution of interactions between pathogenic and commensal fungal and bacterial communities to the maintainenace of human health and to disease pathogenesis.	[Findley, Keisha; Oh, Julia; Yang, Joy; Conlan, Sean; Deming, Clayton; Meyer, Jennifer A.; Segre, Julia A.] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Schoenfeld, Deborah; Nomicos, Effie; Kong, Heidi H.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Park, Morgan] NHGRI, NIH Intramural Sequencing Ctr, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kong, HH (corresponding author), NCI, Dermatol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	konghe@mail.nih.gov; jsegre@nhgri.nih.gov	Conlan, Sean/B-4401-2008; Kong, Heidi H/L-4856-2018	Conlan, Sean/0000-0001-6848-3465; Kong, Heidi H/0000-0003-4424-064X; Yang, Joy/0000-0002-3385-9490	US National Institutes of Health (NIH) NHGRI and NCI Intramural Research Programs; NIH [1K99AR059222, 1UH2AR057504-01, 4UH3AR057504-02]; NATIONAL CANCER INSTITUTE [ZIABC010938] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG000180] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) NHGRI and NCI Intramural Research Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. Heitman, A. Amend, Y. Shea, M. Turner, I. Brownell and M. Udey for helpful discussions. We thank J. Fekecs for assistance with the figures. This work was supported by the US National Institutes of Health (NIH) NHGRI and NCI Intramural Research Programs, and in part by NIH grant no. 1K99AR059222 (to H. H. K.). Sequencing was funded by grants from the NIH (1UH2AR057504-01 and 4UH3AR057504-02).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; Bruns TD, 1992, MOL PHYLOGENET EVOL, V1, P231, DOI 10.1016/1055-7903(92)90020-H; Cohen AD, 2005, INT J DERMATOL, V44, P1002, DOI 10.1111/j.1365-4632.2005.02281.x; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gioti A, 2013, MBIO, V4, DOI 10.1128/mBio.00572-12; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Larone DH, 2002, MED IMPORTANT FUNGI; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Marples M. J., 1965, ECOLOGY HUMAN SKIN; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Perea S, 2000, J CLIN MICROBIOL, V38, P3226, DOI 10.1128/JCM.38.9.3226-3230.2000; PERFECT JR, 1992, DRUG SAFETY, V7, P323, DOI 10.2165/00002018-199207050-00003; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	41	666	705	26	369	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					367	+		10.1038/nature12171	http://dx.doi.org/10.1038/nature12171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23698366	Green Accepted			2022-12-28	WOS:000320592900041
J	Lukens, JM; Leaird, DE; Weiner, AM				Lukens, Joseph M.; Leaird, Daniel E.; Weiner, Andrew M.			A temporal cloak at telecommunication data rate	NATURE			English	Article							PRINCIPLES; OPTICS; LIGHT	Through advances in metamaterials-artificially engineered media with exotic properties, including negative refractive index(1-3)-the once fanciful invisibility cloak has now assumed a prominent place in scientific research(4-13). By extending these concepts to the temporal domain(14), investigators have recently described a cloak which hides events in time by creating a temporal gap in a probe beam that is subsequently closed up; any interaction which takes place during this hole in time is not detected(15). However, these results are limited to isolated events that fill a tiny portion of the temporal period, giving a fractional cloaking window of only about 10(-4) per cent at a repetition rate of 41 kilohertz (ref. 15)-which is much too low for applications such as optical communications. Here we demonstrate another technique for temporal cloaking, which operates at telecommunication data rates and, by exploiting temporal self-imaging through the Talbot effect, hides optical data from a receiver. We succeed in cloaking 46 per cent of the entire time axis and conceal pseudorandom digital data at a rate of 12.7 gigabits per second. This potential to cloak real-world messages introduces temporal cloaking into the sphere of practical application, with immediate ramifications in secure communications.	[Lukens, Joseph M.; Leaird, Daniel E.; Weiner, Andrew M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Weiner, AM (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.	amw@purdue.edu		Lukens, Joseph/0000-0001-9650-4462	National Science Foundation [ECCS-1102110]; Naval Postgraduate School under the National Security Science and Engineering Faculty Fellowship programme [N00244-09-1-0068]; Department of Defense through a National Defense Science and Engineering Graduate Fellowship	National Science Foundation(National Science Foundation (NSF)); Naval Postgraduate School under the National Security Science and Engineering Faculty Fellowship programme; Department of Defense through a National Defense Science and Engineering Graduate Fellowship	We thank V. Shalaev and V. Torres-Company for comments and discussions. This project was supported in part by the National Science Foundation (grant number ECCS-1102110) and the Naval Postgraduate School (grant number N00244-09-1-0068) under the National Security Science and Engineering Faculty Fellowship programme. (Any opinions, findings and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the sponsors.) J.M.L. acknowledges financial support from the Department of Defense through a National Defense Science and Engineering Graduate Fellowship.	Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; Bennett CV, 2000, IEEE J QUANTUM ELECT, V36, P649, DOI 10.1109/3.845718; Bennett CV, 2000, IEEE J QUANTUM ELECT, V36, P430, DOI 10.1109/3.831018; Bennett CV, 2001, IEEE J QUANTUM ELECT, V37, P20, DOI 10.1109/3.892720; Chen HY, 2010, NAT MATER, V9, P387, DOI [10.1038/nmat2743, 10.1038/NMAT2743]; Farhat M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235105; Fridman M, 2012, NATURE, V481, P62, DOI 10.1038/nature10695; GUIGAY JP, 1971, OPT ACTA, V18, P677, DOI 10.1080/713818491; JANNSON T, 1981, J OPT SOC AM, V71, P1373, DOI 10.1364/JOSA.71.001373; KOLNER BH, 1994, IEEE J QUANTUM ELECT, V30, P1951, DOI 10.1109/3.301659; KOLNER BH, 1989, OPT LETT, V14, P630, DOI 10.1364/OL.14.000630; Komukai T, 2005, IEEE PHOTONIC TECH L, V17, P1746, DOI 10.1109/LPT.2005.850888; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Li JS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203901; Liu R, 2009, SCIENCE, V323, P366, DOI 10.1126/science.1166949; McCall MW, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/2/024003; Metcalf A. J., IEEE J SEL IN PRESS; PATORSKI K, 1989, PROG OPTICS, V27, P1, DOI 10.1016/S0079-6638(08)70084-2; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Shalaev VM, 2008, SCIENCE, V322, P384, DOI 10.1126/science.1166079; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; Smolyaninov II, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213901; Smolyaninova VN, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053029; Torres-Company V, 2006, OPT EXPRESS, V14, P3171, DOI 10.1364/OE.14.003171; Torres-Company V, 2008, OPT LETT, V33, P1822, DOI 10.1364/OL.33.001822; Torres-Company V, 2011, PROG OPTICS, V56, P1, DOI 10.1016/B978-0-444-53886-4.00001-0; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699	30	84	91	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					205	208		10.1038/nature12224	http://dx.doi.org/10.1038/nature12224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23739327				2022-12-28	WOS:000320283400042
J	Zhu, FC; Meng, FY; Li, JX; Li, XL; Mao, QY; Tao, H; Zhang, YT; Yao, X; Chu, K; Chen, QH; Hu, YM; Wu, X; Liu, P; Zhu, LY; Gao, F; Jin, H; Chen, YJ; Dong, YY; Liang, YC; Shi, NM; Ge, HM; Liu, L; Chen, SG; Ai, X; Zhang, ZY; Ji, YG; Luo, FJ; Chen, XQ; Zhang, Y; Zhu, LW; Liang, ZL; Shen, XL				Zhu, Feng-Cai; Meng, Fan-Yue; Li, Jing-Xin; Li, Xiu-Ling; Mao, Qun-Ying; Tao, Hong; Zhang, Yun-Tao; Yao, Xin; Chu, Kai; Chen, Qing-Hua; Hu, Yue-Mei; Wu, Xing; Liu, Pei; Zhu, Lin-Yang; Gao, Fan; Jin, Hui; Chen, Yi-Juan; Dong, Yu-Ying; Liang, Yong-Chun; Shi, Nian-Min; Ge, Heng-Ming; Liu, Lin; Chen, Sheng-Gen; Ai, Xing; Zhang, Zhen-Yu; Ji, Yu-Guo; Luo, Feng-Ji; Chen, Xiao-Qin; Zhang, Ya; Zhu, Li-Wen; Liang, Zheng-Lun; Shen, Xin-Liang			Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							MOUTH-DISEASE; CLINICAL-FEATURES; PULMONARY-EDEMA; RISK-FACTORS; FOOT; HAND; INFECTION; IMMUNOGENICITY; TAIWAN; EPIDEMIC	Background A vaccine for enterovirus 71 (EV71) is needed to address the high burden of disease associated with infection. We assessed the efficacy, safety, immunogenicity, antibody persistence, and immunological correlates of an inactivated alum-adjuvant EV71 vaccine. Methods We did a randomised, double-blind, placebo-controlled, phase 3 trial. Healthy children aged 6-35 months from four centres in China were randomly assigned (1: 1) to receive vaccine or alum-adjuvant placebo at day 0 and 28, according to a randomisation list (block size 30) generated by an independent statistician. Investigators and participants and their guardians were masked to the assignment. Primary endpoints were EV71-associated hand, foot, and mouth disease (HFMD) and EV71-associated disease during the surveillance period from day 56 to month 14, analysed in the per-protocol population. This study is registered with ClinicalTrials.gov, number NCT01508247. Findings 10 245 participants were enrolled and assigned: 5120 to vaccine versus 5125 to placebo. 4907 (with three cases of EV71-associated HFMD and eight cases of EV71-associated disease) versus 4939 (with 30 cases of EV71-associated HFMD and 41 cases of EV71-associated disease) were included in the primary efficacy analysis. Vaccine effi cacy was 90.0% (95% CI 67.1-96.9) against EV71-associated HFMD (p=0.0001) and 80.4% (95% CI 58.2-90.8) against EV71-associated disease (p<0.0001). Serious adverse events were reported by 62 of 5117 (1.2%) participants in the vaccine group versus 75 of 5123 (1.5%) in the placebo group (p=0.27). Adverse events occurred in 3644 (71.2%) versus 3603 (70.3%; p=0.33). Interpretation EV71 vaccine provides high effi cacy, satisfactory safety, and sustained immunogenicity.	[Zhu, Feng-Cai; Meng, Fan-Yue; Li, Jing-Xin; Tao, Hong; Chu, Kai; Hu, Yue-Mei] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Zhu, Feng-Cai; Li, Jing-Xin] Third Mil Med Univ, Coll Pharm, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China; [Zhu, Feng-Cai; Li, Jing-Xin] Natl Engn Res Ctr Immunol Prod, Chongqing, Peoples R China; [Li, Xiu-Ling; Zhang, Yun-Tao; Chen, Qing-Hua; Shen, Xin-Liang] Beijing Vigoo Biol, Beijing 100024, Peoples R China; [Mao, Qun-Ying; Yao, Xin; Wu, Xing; Gao, Fan; Liang, Zheng-Lun] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China; [Liu, Pei; Jin, Hui; Chen, Yi-Juan; Dong, Yu-Ying] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Zhu, Lin-Yang] Lianyungang City Ctr Dis Control & Prevent, Lianyungang, Jiangsu, Peoples R China; [Liang, Yong-Chun; Chen, Sheng-Gen; Ji, Yu-Guo; Zhu, Li-Wen] Baoying Cty Ctr Dis Control & Prevent, Yangzhou, Jiangsu, Peoples R China; [Shi, Nian-Min; Ai, Xing; Luo, Feng-Ji] Chaoyang Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Ge, Heng-Ming; Zhang, Zhen-Yu; Chen, Xiao-Qin] Donghai Cty Ctr Dis Control & Prevent, Lianyungang, Jiangsu, Peoples R China; [Liu, Lin; Zhang, Ya] Pizhou Cty Ctr Dis Control & Prevent, Xuzhou, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Army Medical University; National Institute of Food & Drug Control - China; Southeast University - China	Zhu, FC (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Jiangsu Rd, Nanjing 210009, Jiangsu, Peoples R China.	jszfc@vip.sina.com; lzhenglun@126.com; hen54@x263.net	Hu, Yue/HGE-1673-2022; JIN, HUI/AAA-8732-2019; li, xiu/GXV-1745-2022; Jin, Hui/GXG-2296-2022		China's 12-5 National Major Infectious Disease Program, Beijing Vigoo Biological	China's 12-5 National Major Infectious Disease Program, Beijing Vigoo Biological	Funding China's 12-5 National Major Infectious Disease Program, Beijing Vigoo Biological.	Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Dominguez A, 2010, VACCINE, V28, P3567, DOI 10.1016/j.vaccine.2010.02.107; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu YF, 2012, J VIROL, V86, P10901, DOI 10.1128/JVI.01808-12; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; KENNETT ML, 1974, B WORLD HEALTH ORGAN, V51, P609; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Legay F, 2007, EMERG INFECT DIS, V13, P1084, DOI 10.3201/eid1307.070295; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Meng FY, 2012, HUM VACC IMMUNOTHER, V8, P669, DOI 10.4161/hv.19521; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Paul Y, 2004, VACCINE, V22, P301, DOI 10.1016/j.vaccine.2003.07.016; Poland GA, 2012, VACCINE, V30, P103, DOI 10.1016/j.vaccine.2011.11.085; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; ROBERTSON SE, 1988, LANCET, V1, P897; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; World Health Organization, 1993, IMM BAS IMM MOD 6 PO; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Zhu FC, 2013, LANCET, V381, P1037, DOI 10.1016/S0140-6736(12)61764-4; Zhu FC, 2012, PEDIATR INFECT DIS J, V31, P1158, DOI 10.1097/INF.0b013e31826eba74	29	290	360	4	174	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 8	2013	381	9882					2024	2032		10.1016/S0140-6736(13)61049-1	http://dx.doi.org/10.1016/S0140-6736(13)61049-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171JY	23726161				2022-12-28	WOS:000320924400031
J	Krautwald, S; Sarlah, D; Schafroth, MA; Carreira, EM				Krautwald, Simon; Sarlah, David; Schafroth, Michael A.; Carreira, Erick M.			Enantio- and Di Aereodivergent Dual Catalysis: alpha-Allylation of Branched Aldehydes	SCIENCE			English	Article							PHOTOREDOX CATALYSIS; ALLYLIC ALKYLATION; TRANSITION-METAL; ALCOHOLS; DIASTEREOSELECTIVITY; ORGANOCATALYSIS; NUCLEOPHILE; DERIVATIVES; EFFICIENT; TERTIARY	An important challenge in asymmetric synthesis is the development of fully stereodivergent strategies to access the full complement of stereoisomers of products bearing multiple stereocenters. In the ideal case, where four products are possible, applying distinct catalysts to the same set of starting materials under identical conditions would in a single step afford any given stereoisomer. Herein, we describe the realization of this concept in a fully stereodivergent dual-catalytic synthesis of gamma,delta-unsaturated aldehydes bearing vicinal quaternary/tertiary stereogenic centers. The reaction is enabled by chiral iridium and amine catalysts, which activate the allylic alcohol and aldehyde substrates, respectively. Each catalyst exerts high local stereocontrol irrespective of the other's inherent preference.	[Krautwald, Simon; Sarlah, David; Schafroth, Michael A.; Carreira, Erick M.] ETH, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Carreira, EM (corresponding author), ETH, CH-8093 Zurich, Switzerland.	carreira@org.chem.ethz.ch		Schafroth, Michael Andreas/0000-0002-5864-6766; Sarlah, David/0000-0002-8736-8953; Carreira, Erick/0000-0003-1472-490X	Swiss National Science Foundation [200020_135224]; Fonds der Chemischen Industrie; Cambridge Crystallographic Data Centre [CCDC 933469]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Cambridge Crystallographic Data Centre	We are grateful to the Swiss National Science Foundation for a grant supporting this work (200020_135224). S.K. thanks the Fonds der Chemischen Industrie for support (Chemiefonds-Stipendium). We thank S. MO her for insightful discussions. Structural parameters for a carbamate derived from (R,R)-3a are available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC 933469.	Afewerki S, 2012, CHEM-EUR J, V18, P2972, DOI 10.1002/chem.201103366; Allen AE, 2012, CHEM SCI, V3, P633, DOI 10.1039/c2sc00907b; Burns NZ, 2011, J AM CHEM SOC, V133, P14578, DOI 10.1021/ja206997e; Chen WY, 2013, J AM CHEM SOC, V135, P2068, DOI 10.1021/ja311363a; Dalko P. I., 2006, ENANTIOSELECTIVE ORG; Defieber C, 2007, ANGEW CHEM INT EDIT, V46, P3139, DOI 10.1002/anie.200700159; DiRocco DA, 2012, J AM CHEM SOC, V134, P8094, DOI 10.1021/ja3030164; Hartwig JF, 2011, TOP ORGANOMETAL CHEM, V34, P169, DOI 10.1007/978-3-642-15334-1_7; HOVEYDA AH, 1993, CHEM REV, V93, P1307, DOI 10.1021/cr00020a002; Huang Y, 2005, J AM CHEM SOC, V127, P15051, DOI 10.1021/ja055545d; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Janssen JP, 1997, TETRAHEDRON LETT, V38, P8025, DOI 10.1016/S0040-4039(97)10220-9; Jiang GX, 2011, ANGEW CHEM INT EDIT, V50, P9471, DOI 10.1002/anie.201103263; Kampen D, 2009, TOP CURR CHEM, V291, P395, DOI 10.1007/128_2009_1; Luparia M, 2011, ANGEW CHEM INT EDIT, V50, P12631, DOI 10.1002/anie.201106321; McCooey SH, 2007, ORG LETT, V9, P599, DOI 10.1021/ol0628006; McInturff EL, 2012, J AM CHEM SOC, V134, P20628, DOI 10.1021/ja311208a; Melchiorre P, 2012, ANGEW CHEM INT EDIT, V51, P9748, DOI 10.1002/anie.201109036; Morgen M, 2010, ORG LETT, V12, P4494, DOI 10.1021/ol101755m; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Nojiri A, 2009, J AM CHEM SOC, V131, P3779, DOI 10.1021/ja900084k; Roggen M, 2011, ANGEW CHEM INT EDIT, V50, P5568, DOI 10.1002/anie.201007716; Sammis GM, 2004, J AM CHEM SOC, V126, P9928, DOI 10.1021/ja046653n; Takeuchi R, 1997, ANGEW CHEM INT EDIT, V36, P263, DOI 10.1002/anie.199702631; Tan JJ, 2012, ANGEW CHEM INT EDIT, V51, P8264, DOI 10.1002/anie.201203092; Tian X, 2011, J AM CHEM SOC, V133, P17934, DOI 10.1021/ja207847p; Uyeda C, 2008, J AM CHEM SOC, V130, P9228, DOI 10.1021/ja803370x; Wang BM, 2007, J AM CHEM SOC, V129, P768, DOI 10.1021/ja0670409; Weix DJ, 2007, J AM CHEM SOC, V129, P7720, DOI 10.1021/ja071455s; Xie JW, 2007, ANGEW CHEM INT EDIT, V46, P389, DOI 10.1002/anie.200603612; Yan XX, 2008, J AM CHEM SOC, V130, P14362, DOI 10.1021/ja804527r; Zhong C, 2010, EUR J ORG CHEM, V2010, P2999, DOI 10.1002/ejoc.201000004	32	570	570	8	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1065	1068		10.1126/science.1237068	http://dx.doi.org/10.1126/science.1237068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723229				2022-12-28	WOS:000319664500036
J	Haruki, H; Pedersen, MG; Gorska, KI; Pojer, F; Johnsson, K				Haruki, Hirohito; Pedersen, Miriam Gronlund; Gorska, Katarzyna Irena; Pojer, Florence; Johnsson, Kai			Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs	SCIENCE			English	Article							PNEUMOCYSTIS-JIROVECII PNEUMONIA; REDUCTASE DEFICIENCY; TRIMETHOPRIM; SULFONAMIDE; PHARMACOKINETICS; SULFAMETHOXAZOLE; SULFASALAZINE; DISCOVERY; PSYCHOSIS; REVEALS	The introduction of sulfa drugs for the chemotherapy of bacterial infections in 1935 revolutionized medicine. Although their mechanism of action is understood, the molecular bases for most of their side effects remain obscure. Here, we report that sulfamethoxazole and other sulfa drugs interfere with tetrahydrobiopterin biosynthesis through inhibition of sepiapterin reductase. Crystal structures of sepiapterin reductase with bound sulfa drugs reveal how structurally diverse sulfa drugs achieve specific inhibition of the enzyme. The effect of sulfa drugs on tetrahydrobiopterin-dependent neurotransmitter biosynthesis in cell-based assays provides a rationale for some of their central nervous system related side effects, particularly in high-dose sutfamethoxazole therapy of Pneumorystis pneumonia. Our findings reveal an unexpected aspect of the pharmacology of sulfa drugs and might translate into their improved medical use.	[Haruki, Hirohito; Pedersen, Miriam Gronlund; Gorska, Katarzyna Irena; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland; [Pojer, Florence] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Johnsson, K (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland.	kai.johnsson@epfl.ch	johnsson, kai/P-4222-2014	johnsson, kai/0000-0002-8002-1981	EPFL; Swiss National Science Foundation; NCCR Chemical Biology	EPFL; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Chemical Biology(Swiss National Science Foundation (SNSF))	The authors thank G. Turcatti, M. Chambon, M. Busquets, and M. Rengifo Gonzalez for technical assistance; the Swiss Light Source for support during x-ray data collection; and G. Lukinavicius, O. Sallin, P. Hauser, and C. Woolf for helpful discussions. This work was supported by EPFL, the Swiss National Science Foundation, and the NCCR Chemical Biology. Coordinates and structure factors for the crystal structures have been deposited in the Protein Data Bank (PDB), and the PDB accession codes are listed in table S8.	Auerbach G, 1997, EMBO J, V16, P7219, DOI 10.1093/emboj/16.24.7219; BIEDLER JL, 1978, CANCER RES, V38, P3751; Blau N, 2011, MOL GENET METAB, V104, pS2, DOI 10.1016/j.ymgme.2011.08.017; Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; BRAUTIGAM M, 1984, J NEUROCHEM, V42, P390, DOI 10.1111/j.1471-4159.1984.tb02690.x; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Cribb AE, 1996, ADVERSE DRUG REACT T, V15, P9; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Friedman J, 2012, ANN NEUROL, V71, P520, DOI 10.1002/ana.22685; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; Helweg-Larsen J, 2009, J ANTIMICROB CHEMOTH, V64, P1282, DOI 10.1093/jac/dkp372; Hong YL, 1996, J EUKARYOT MICROBIOL, V43, pS40, DOI 10.1111/j.1550-7408.1996.tb04976.x; Keefer CS, 1942, NEW ENGL J MED, V226, P266, DOI 10.1056/NEJM194202122260705; Kenakin T., 2009, PHARM PRIMER, P184; Lacombe O, 2011, MOL PHARMACEUT, V8, P651, DOI 10.1021/mp1004614; Lee KY, 2012, J ANTIMICROB CHEMOTH, V67, P2749, DOI 10.1093/jac/dks283; Macartney D. W., 1942, LANCET, V239, P639; Marshall EK, 1939, J PHARMACOL EXP THER, V67, P454; PULLAR T, 1992, ADVERSE DRUG REACT T, V11, P93; Rowland RS, 1996, J PHYS CHEM-US, V100, P7384, DOI 10.1021/jp953141+; SADUSK JOSEPH F., 1941, YALE JOUR BIOL AND MED, V13, P351; SAKAI T, 1995, J NEURAL TRANSM-GEN, V102, P159, DOI 10.1016/0022-3093(95)00013-5; Seeliger D, 2007, PROTEINS, V68, P595, DOI 10.1002/prot.21447; STEVENS RC, 1991, ANTIMICROB AGENTS CH, V35, P1884, DOI 10.1128/AAC.35.9.1884; SUGITA O, 1982, J PHARMACOKINET BIOP, V10, P297, DOI 10.1007/BF01059263; van Dyke H. B., 1943, ANN NY ACAD SCI, V44, P477; Walker LE, 2011, J ANTIMICROB CHEMOTH, V66, P1117, DOI 10.1093/jac/dkr050; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; WOODY RC, 1990, DEV MED CHILD NEUROL, V32, P639	29	67	72	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					987	991		10.1126/science.1232972	http://dx.doi.org/10.1126/science.1232972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704574	Green Published			2022-12-28	WOS:000319344100050
J	Mishra, SK; Hoon, MA				Mishra, Santosh K.; Hoon, Mark A.			The Cells and Circuitry for Itch Responses in Mice	SCIENCE			English	Article							GASTRIN-RELEASING-PEPTIDE; BEHAVIORAL-RESPONSES; RECEPTOR; AFFERENTS; SENSATION; PAIN	Itch is triggered by somatosensory neurons expressing the ion channel TRPV1 (transient receptor potential cation channel subfamily V member 1), but the mechanisms underlying this nociceptive response remain poorly understood. Here, we show that the neuropeptide natriuretic polypeptide b (Nppb) is expressed in a subset of TRPV1 neurons and found that Nppb(-/-) mice selectively lose almost all behavioral responses to itch-inducing agents. Nppb triggered potent scratching when injected intrathecally in wild-type and Nppb(-/-) mice, showing that this neuropeptide evokes itch when released from somatosensory neurons. Itch responses were blocked by toxin-mediated ablation of Nppb-receptor-expressing cells, but a second neuropeptide, gastrin-releasing peptide, still induced strong responses in the toxin-treated animals. Thus, our results define the primary pruriceptive neurons, characterize Nppb as an itch-selective neuropeptide, and reveal the next two stages of this dedicated neuronal pathway.	[Mishra, Santosh K.; Hoon, Mark A.] NIDCR, Mol Genet Unit, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Hoon, MA (corresponding author), NIDCR, Mol Genet Unit, Lab Sensory Biol, NIH, Bldg 49,Room 1A16,49 Convent Dr, Bethesda, MD 20892 USA.	mark.hoon@nih.gov	Mishra, Santosh/S-7516-2017	Mishra, Santosh/0000-0001-8616-2606	NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000721] Funding Source: NIH RePORTER	NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to N. Ryba for encouragement and helpful advice and fur valuable suggestions. The Nppb<SUP>-/-</SUP> mice used for this research project were generated from embryonic stem cells obtained from the National Center for Research Resources (NCRR)-NIH-supported KOMP repository (www.komp.org) and engineered by the Wellcome Trust Sanger Institute and the Mouse Biology Program (www.mousebiology.org). We thank NIDCR Gene Targeting Facility for help generating Nppb mutant mice. The mouse strain STOCK Tg(GRP-EGFP) was obtained (rein the Mutant Mouse Regional Resource Center (MMRRC), a NCRR-NIH-funded strain repository, and was donated to the MMRRC by the National Institute of Neurological Disorders and Stroke-funded GENSAT RAC transgenic project. This research was supported by the intramural research program of the NIH, NIDCR.	Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Davidson S, 2012, J NEUROPHYSIOL, V108, P1711, DOI 10.1152/jn.00206.2012; Fleming MS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-52; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; McNeil B, 2012, NEUROSCI BULL, V28, P100, DOI 10.1007/s12264-012-1202-1; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Misono KS, 2011, FEBS J, V278, P1818, DOI 10.1111/j.1742-4658.2011.08083.x; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Patel KN, 2010, NEURON, V68, P334, DOI 10.1016/j.neuron.2010.10.018; Schmelz M., 1997, J NEUROSCI, V17, P8003; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Wiley RG, 2003, ADV DRUG DELIVER REV, V55, P1043, DOI 10.1016/S0169-409X(03)00102-9	21	312	333	4	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					968	971		10.1126/science.1233765	http://dx.doi.org/10.1126/science.1233765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704570	Green Accepted			2022-12-28	WOS:000319344100044
J	Owens, B				Owens, Brian			OBESITY Heavy sleepers	NATURE			English	Editorial Material																		Broussard JL, 2012, ANN INTERN MED, V157, P549, DOI 10.7326/0003-4819-157-8-201210160-00005; Cizza G, 2010, CLIN TRIALS, V7, P274, DOI 10.1177/1740774510368298; Pamidi S., 2013, AM THOR SOC M 20 MAY; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750	5	6	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					S8	S9		10.1038/497S8a	http://dx.doi.org/10.1038/497S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698508	Bronze			2022-12-28	WOS:000319254000005
J	Patterson, D; Schnell, M; Doyle, JM				Patterson, David; Schnell, Melanie; Doyle, John M.			Enantiomer-specific detection of chiral molecules via microwave spectroscopy	NATURE			English	Article							PARITY VIOLATION; SPECTROMETER; PURIFICATION; SPECTRUM; SAMPLES	Chirality plays a fundamental part in the activity of biological molecules and broad classes of chemical reactions, but detecting and quantifying it remains challenging(1). The spectroscopic methods of choice are usually circular dichroism and vibrational circular dichroism, methods that are forbidden in the electric dipole approximation(2). The resultant weak effects produce weak signals, and thus require high sample densities. In contrast, nonlinear techniques probing electric-dipole-allowed effects have been used for sensitive chiral analyses of liquid samples(3-7). Here we extend this class of approaches by carrying out nonlinear resonant phase-sensitive microwave spectroscopy of gas phase samples in the presence of an adiabatically switched non-resonant orthogonal electric field; we use this technique to map the enantiomer-dependent sign of an electric dipole Rabi frequency onto the phase of emitted microwave radiation. We outline theoretically how this results in a sensitive and species-selective method for determining the chirality of cold gas-phase molecules, and implement it experimentally to distinguish between the S and R enantiomers of 1,2-propanediol and their racemic mixture. This technique produces a large and definitive signature of chirality, and has the potential to determine the chirality of multiple species in a mixture.	[Patterson, David; Doyle, John M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Schnell, Melanie] Ctr Free Elect Laser Sci, D-22607 Hamburg, Germany; [Schnell, Melanie] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany	Harvard University; Max Planck Society	Patterson, D (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	dave@cua.harvard.edu	Schnell, Melanie/D-5329-2014					BALLE TJ, 1981, REV SCI INSTRUM, V52, P33, DOI 10.1063/1.1136443; Brown GG, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2919120; Busch K W., 2006, CHIRAL ANAL; Darquie B, 2010, CHIRALITY, V22, P870, DOI 10.1002/chir.20911; Fischer P, 2005, CHIRALITY, V17, P421, DOI 10.1002/chir.20179; Fischer P, 2000, PHYS REV LETT, V85, P4253, DOI 10.1103/PhysRevLett.85.4253; Gerbasi D, 2004, J CHEM PHYS, V120, P11557, DOI 10.1063/1.1753552; Grabow JU, 2011, PHYS CHEM CHEM PHYS, V13, P21063, DOI 10.1039/c1cp22197c; Guo CN, 2004, ANAL CHEM, V76, P6956, DOI 10.1021/ac049366a; Hiramatsu K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.083901; Hirota E, 2012, P JPN ACAD B-PHYS, V88, P120, DOI 10.2183/pjab.88.120; Jacob A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4738753; Kral P, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.033001; Li Y, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.015403; Lovas FJ, 2009, J MOL SPECTROSC, V257, P82, DOI 10.1016/j.jms.2009.06.013; Mata S, 2012, J MOL SPECTROSC, V280, P91, DOI 10.1016/j.jms.2012.08.004; Pate BH, 2012, J MOL SPECTROSC, V280, P1, DOI 10.1016/j.jms.2012.08.003; Patterson D, 2012, MOL PHYS, V110, P1757, DOI 10.1080/00268976.2012.679632; Quack M, 2002, ANGEW CHEM INT EDIT, V41, P4618, DOI 10.1002/anie.200290005; Quack M, 2008, ANNU REV PHYS CHEM, V59, P741, DOI 10.1146/annurev.physchem.58.032806.104511; Rhee H, 2010, ACCOUNTS CHEM RES, V43, P1527, DOI 10.1021/ar100090q; Schnell M, 2011, FARADAY DISCUSS, V150, P33, DOI 10.1039/c0fd00009d; Thanopulos I, 2003, J CHEM PHYS, V119, P5105, DOI 10.1063/1.1597491; Townes C.H., 2013, MICROWAVE SPECTROSCO; Western C. M., 2010, PGOPHER PROGRAM SIMU	25	303	307	7	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					475	+		10.1038/nature12150	http://dx.doi.org/10.1038/nature12150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698447				2022-12-28	WOS:000319254000044
J	Lim, C; Allada, R				Lim, Chunghun; Allada, Ravi			ATAXIN-2 Activates PERIOD Translation to Sustain Circadian Rhythms in Drosophila	SCIENCE			English	Article							GENE; CLOCK; NEURONS; REPEAT; TYPE-2; EXPANSION; PATHOLOGY; HOMOLOG; PROTEIN; CLONING	Evidence for transcriptional feedback in circadian timekeeping is abundant, yet little is known about the mechanisms underlying translational control. We found that ATAXIN-2 (ATX2), an RNA-associated protein involved in neurodegenerative disease, is a translational activator of the rate-limiting clock component PERIOD (PER) in Drosophila. ATX2 specifically interacted with TWENTY-FOUR (TYF), an activator of PER translation. RNA interference-mediated depletion of Atx2 or the expression of a mutant ATX2 protein that does not associate with polyadenylate-binding protein (PABP) suppressed behavioral rhythms and decreased abundance of PER. Although ATX2 can repress translation, depletion of Atx2 from Drosophila S2 cells inhibited translational activation by RNA-tethered TYF and disrupted the association between TYF and PABP. Thus, ATX2 coordinates an active translation complex important for PER expression and circadian rhythms.	[Lim, Chunghun; Allada, Ravi] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	r-allada@northwestern.edu	Lim, Chunghun/AAB-1253-2020	Lim, Chunghun/0000-0001-8473-9272	National Institute of Neurological Disorders and Stroke [R01NS059042]; Defense Advanced Research Projects Agency (DARPA) [D12AP00023]; DARPA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059042] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Choe, P. Hardin, E. Izaurralde, G. P. McNeil, A. Nakamura, L. Pallanck, M. Ramaswami, M. Rosbash, H. Saumweber, M. C. Siomi, N. Sonenberg, Bloomington Drosophila stock center, and Vienna Drosophila RNAi center for reagents; D. Nanavati (Northwestern Proteomics Core) for assistance and helpful comments on proteomics data; G. Auburger for helpful comments; and P. Emery for communicating results before publication. This work was supported by National Institute of Neurological Disorders and Stroke (R01NS059042) and Defense Advanced Research Projects Agency (DARPA) (D12AP00023). This effort was in part sponsored by DARPA; the content of the information does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred.	Bradley S, 2012, GENETICS, V192, P943, DOI 10.1534/genetics.112.143248; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Lastres-Becker I, 2008, HUM MOL GENET, V17, P1465, DOI 10.1093/hmg/ddn035; Lim C, 2011, NATURE, V470, P399, DOI 10.1038/nature09728; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ross OA, 2011, HUM MOL GENET, V20, P3207, DOI 10.1093/hmg/ddr227; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Satterfield TF, 2002, GENETICS, V162, P1687; Staiger D, 2011, TRENDS PLANT SCI, V16, P517, DOI 10.1016/j.tplants.2011.06.002; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tuin I, 2006, NEUROLOGY, V67, P1966, DOI 10.1212/01.wnl.0000247054.90322.14; Velazquez-Perez L, 2011, NEURODEGENER DIS, V8, P447, DOI 10.1159/000324374; Zheng XZ, 2012, TRENDS NEUROSCI, V35, P574, DOI 10.1016/j.tins.2012.05.007	28	94	98	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					875	879		10.1126/science.1234785	http://dx.doi.org/10.1126/science.1234785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687047				2022-12-28	WOS:000318997400047
J	Kim, JY; Farmer, P; Porter, ME				Kim, Jim Yong; Farmer, Paul; Porter, Michael E.			Redefining global health-care delivery	LANCET			English	Article							ANTIRETROVIRAL THERAPY; HIV; TUBERCULOSIS; PREVENTION; MORTALITY; LESSONS	Initiatives to address the unmet needs of those facing both poverty and serious illness have expanded signifi cantly over the past decade. But many of them are designed in an ad-hoc manner to address one health problem among many; they are too rarely assessed; best practices spread slowly. When assessments of delivery do occur, they are often narrow studies of the cost-eff ectiveness of a single intervention rather than the complex set of them required to deliver value to patients and their families. We propose a framework for global health-care delivery and evaluation by considering eff orts to introduce HIV/AIDS care to resource-poor settings. The framework introduces the notion of care delivery value chains that apply a systems-level analysis to the complex processes and interventions that must occur, across a health-care system and over time, to deliver high-value care for patients with HIV/AIDS and cooccurring conditions, from tuberculosis to malnutrition. To deliver value, vertical or stand-alone projects must be integrated into shared delivery infrastructure so that personnel and facilities are used wisely and economies of scale reaped. Two other integrative processes are necessary for delivering and assessing value in global health: one is the alignment of delivery with local context by incorporating knowledge of both barriers to good outcomes (from poor nutrition to a lack of water and sanitation) and broader social and economic determinants of health and wellbeing (jobs, housing, physical infrastructure). The second is the use of eff ective investments in care delivery to promote equitable economic development, especially for those struggling against poverty and high burdens of disease. We close by reporting our own shared experience of seeking to move towards a science of delivery by harnessing research and training to understand and improve care delivery.	[Kim, Jim Yong] World Bank Grp, Washington, DC USA; [Farmer, Paul] Harvard Univ, Harvard Med Sch, Brigham & Womens Hosp, Partners Hlth, Boston, MA 02115 USA; [Porter, Michael E.] Harvard Univ, Harvard Business Sch, Boston, MA 02115 USA	The World Bank; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System; Harvard University	Farmer, P (corresponding author), Harvard Univ, Sch Med, 641 Huntington Ave, Boston, MA 02115 USA.	paul_farmer@hms.harvard.edu			Pershing Square Foundation	Pershing Square Foundation(Pershing Square Foundation)	We thank Joseph Rhatigan, Rebecca Weintraub, Jennifer F Baron, Sachin Jain, Joia Mukherjee, and the other participants (case writers, administrators, faculty, and students) in the Global Health Delivery Project and the Global Health Eff ectiveness courses at Harvard, Boston, MA, USA. Elizabeth Kersten and Carolyn Daly provided valuable research assistance. We also thank Allan Brandt, Joao Biehl, and students in the Future of Global AIDS Treatment Project, Princeton, NJ, USA, for helpful comments. Haun Saussy and Cassia van der Hoof Holstein helped us to edit this report and to refl ect on all aspects of its content. Finally, we thank The Pershing Square Foundation for its unstinting support of this endeavour; and Wes Edens, Mala Gaonkar, and Bill Helman for making possible the work of the Global Health Delivery Partnership.	[Anonymous], GLOB HLTH DEL CAS ST; Avahan, 2008, IND AIDS IN BUS HIV; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Dong K, 2007, J INFECT DIS, V196, pS491, DOI 10.1086/521111; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Frenk J, 2009, LANCET, V374, P170, DOI 10.1016/S0140-6736(09)60693-0; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Global Health Delivery Project, 2011, AV IND AIDS IN; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Irwin A, 2001, DYING GROWTH GLOBAL; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Kim JY, 2010, GLOB PUBLIC HEALTH, V5, P181, DOI 10.1080/17441690903418993; Kim JY, 2012, COMMUNICATION; Kim JY, 2013, GLOBAL SCI DELIVERY, P53; Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098; Krishna A, 2011, ONE ILLNESS AWAY WHY; Ladipo O, 2012, ONE MILLION MORE OUT; Levy NC, 2005, J URBAN HEALTH, V82, P498, DOI 10.1093/jurban/jti090; Marlink RG, 2009, GROUND BUILDING COMP, V3; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Murray C, 2007, LANCET, V369, P1768, DOI 10.1016/S0140-6736(07)60792-2; Niyigena P, 2012, J ACQ IMMUN DEF SYND, V59, P35; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Petryna A, 2013, PEOPLE COME FIRST CR; Porter M.E., 2006, REDEFINING HLTH CARE; Porter ME, 2006, REDEFINING HLTH CARE, P167; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Rhatigan J, 2009, 09093 HBS; Sepulveda J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, pXIII; US Department of Health and Human Services Centers for Disease Control and Prevention, 2009, ROL STD DET TREATM H; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013; Warwick Z, 2006, INT J STD AIDS, V17, P479, DOI 10.1258/095646206777689189; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001	36	183	187	2	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1060	1069		10.1016/S0140-6736(13)61047-8	http://dx.doi.org/10.1016/S0140-6736(13)61047-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222PB	23697823				2022-12-28	WOS:000324742200026
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for HIV: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							COMBINED ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; COST-EFFECTIVENESS; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; CLINICAL-OUTCOMES; AMERICAN-COLLEGE; UNITED-STATES; RISK; TRANSMISSION	Description: Update of the 2005 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for HIV. Methods: The USPSTF reviewed new evidence on the effectiveness of treatments in HIV-infected persons with CD4 counts greater than 0.200 x 10(9) cells/L; effects of screening, counseling, and anti-retroviral therapy (ART) use on risky behaviors and HIV transmission risk; and long-term cardiovascular harms of ART. Population: These recommendations apply to adolescents, adults, and pregnant women. Recommendation: The USPSTF recommends that clinicians screen adolescents and adults aged 15 to 65 years for HIV infection. Younger adolescents and older adults who are at increased risk should also be screened. (Grade A recommendation) The USPSTF recommends that clinicians screen all pregnant women for HIV, including those who present in labor who are untested and whose HIV status is unknown. (Grade A recommendation)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.			Pignone, Michael/0000-0002-6657-7342				American College of Obstetricians and Gynecologists. ACOG Committee Opinion, 2008, OBSTET GYNECOL 1, V112, P401; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Cavazos-Rehg PA, 2009, CONTRACEPTION, V80, P158, DOI 10.1016/j.contraception.2009.02.014; Centers for Disease Control and Prevention, 2012, DIAGN HIV INF AIDS U; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; Centers for Disease Control and Prevention, 2011, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2011, DIAGN HIV INF AIDS U; Chou R, 2005, SCREENING HUMAN IMMU; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Flynn PM, 2011, PEDIATRICS, V128, P1023, DOI 10.1542/peds.2011-1761; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Garcia-Tejedor A, 2009, ACTA OBSTET GYN SCAN, V88, P882, DOI 10.1080/00016340903062836; Gielen AC, 1997, WOMEN HEALTH, V25, P19, DOI 10.1300/J013v25n03_02; Harris NS, 2007, AM J OBSTET GYNECOL, V197, pS33, DOI 10.1016/j.ajog.2007.03.081; Johnson AS., 2019, ARXIV PREPRINT ARXIV; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kleinman S, 1998, JAMA-J AM MED ASSOC, V280, P1080, DOI 10.1001/jama.280.12.1080; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Lubinski C, 2009, CLIN INFECT DIS, V48, P1335, DOI 10.1086/598169; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Rasmussen LD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-169; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Reust CE, 2011, AM FAM PHYSICIAN, V83, P1443; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Sanders GD, 2010, J GEN INTERN MED, V25, P556, DOI 10.1007/s11606-010-1265-5; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7	44	380	382	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2013	159	1					51	+		10.7326/0003-4819-159-1-201307020-00645	http://dx.doi.org/10.7326/0003-4819-159-1-201307020-00645			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179JJ	23698354				2022-12-28	WOS:000321516200006
J	Hunt, B; Sanchez-Yamagishi, JD; Young, AF; Yankowitz, M; LeRoy, BJ; Watanabe, K; Taniguchi, T; Moon, P; Koshino, M; Jarillo-Herrero, P; Ashoori, RC				Hunt, B.; Sanchez-Yamagishi, J. D.; Young, A. F.; Yankowitz, M.; LeRoy, B. J.; Watanabe, K.; Taniguchi, T.; Moon, P.; Koshino, M.; Jarillo-Herrero, P.; Ashoori, R. C.			Massive Dirac Fermions and Hofstadter Butterfly in a van der Waals Heterostructure	SCIENCE			English	Article							HEXAGONAL BORON-NITRIDE; ENERGY-SPECTRUM; BLOCH ELECTRONS; MAGNETIC-FIELD; GRAPHENE; SUPERLATTICES; STATES	van der Waals heterostructures constitute a new class of artificial materials formed by stacking atomically thin planar crystals. We demonstrated band structure engineering in a van der Waals heterostructure composed of a monolayer graphene flake coupled to a rotationally aligned hexagonal boron nitride substrate. The spatially varying interlayer atomic registry results in both a local breaking of the carbon sublattice symmetry and a long-range moire superlattice potential in the graphene. In our samples, this interplay between short- and long-wavelength effects resulted in a band structure described by isolated superlattice minibands and an unexpectedly large band gap at charge neutrality. This picture is confirmed by our observation of fractional quantum Hall states at +/- 5/3 filling and features associated with the Hofstadter butterfly at ultrahigh magnetic fields.	[Hunt, B.; Sanchez-Yamagishi, J. D.; Young, A. F.; Jarillo-Herrero, P.; Ashoori, R. C.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Yankowitz, M.; LeRoy, B. J.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan; [Moon, P.; Koshino, M.] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Massachusetts Institute of Technology (MIT); University of Arizona; National Institute for Materials Science; Tohoku University	Jarillo-Herrero, P (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	pjarillo@mit.edu; ashoori@mit.edu	Moon, Pilkyung/A-2930-2010; Hunt, Benjamin/C-3395-2017; LeRoy, Brian J/J-9112-2012; WATANABE, Kenji/H-2825-2011; Koshino, Mikito/C-2550-2012; TANIGUCHI, Takashi/H-2718-2011; Young, Andrea F/H-9697-2012; Jarillo-Herrero, Pablo/E-3755-2013	Moon, Pilkyung/0000-0003-3994-4255; Hunt, Benjamin/0000-0002-5008-8042; LeRoy, Brian J/0000-0003-1610-5424; WATANABE, Kenji/0000-0003-3701-8119; Koshino, Mikito/0000-0002-5911-7532; Young, Andrea F/0000-0001-5954-8028; Sanchez-Yamagishi, Javier/0000-0001-9703-6525; Jarillo-Herrero, Pablo/0000-0001-8217-8213	Basic Energy Sciences Program, Office of Science, U.S. Department of Energy (DOE) [FG02-08ER46514]; Gordon and Betty Moore Foundation [GBMF2931]; DOE Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0001819]; NSF [DMR-0845287, EECS-0925152, DMR-0819762, ECS-0335765, DMR-0654118]; ONR GATE MURI; Harvard's CNS; State of Florida; DOE; Pappalardo Fellowship in Physics; Japan Society for the Promotion of Science (JSPS) [24740193, 23840004]; Div Of Electrical, Commun & Cyber Sys [0925152] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [24740193] Funding Source: KAKEN	Basic Energy Sciences Program, Office of Science, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); DOE Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); ONR GATE MURI; Harvard's CNS; State of Florida; DOE(United States Department of Energy (DOE)); Pappalardo Fellowship in Physics; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge helpful discussions with C. Dean, H. Churchill, L. Levitov, and J. Song. B.H. and R.C.A. were funded by the Basic Energy Sciences Program, Office of Science, U.S. Department of Energy (DOE), contract FG02-08ER46514, and by Gordon and Betty Moore Foundation grant GBMF2931. J.D.S.-Y. and P.J.-H. were primarily supported by the DOE Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under grant DE-SC0001819. Early fabrication feasibility studies were supported by NSF Career Award DMR-0845287 and the ONR GATE MURI. M.Y. and B.J.L. were supported by NSF grant EECS-0925152. This work made use of the MRSEC Shared Experimental Facilities supported by NSF under grant DMR-0819762 and of Harvard's CNS, supported by NSF under grant ECS-0335765. Some measurements were performed at the National High Magnetic Field Laboratory, which is supported by NSF Cooperative Agreement DMR-0654118, the State of Florida, and DOE. A.F.Y. acknowledges the support of the Pappalardo Fellowship in Physics. M.K. was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research 24740193; P.M. was supported by JSPS Grant-in-Aid for Research Activity Start-up (grant 23840004).	Albrecht C, 2001, PHYS REV LETT, V86, P147, DOI 10.1103/PhysRevLett.86.147; Amet F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216601; Apalkov VM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.126801; ASHOORI RC, 1992, PHYS REV LETT, V68, P3088, DOI 10.1103/PhysRevLett.68.3088; AZBEL MY, 1964, SOV PHYS JETP-USSR, V19, P634; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Feldman BE, 2012, SCIENCE, V337, P1196, DOI 10.1126/science.1224784; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Giovannetti G, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.073103; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Kindermann M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115415; Koshino M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155304; Kubota Y, 2007, SCIENCE, V317, P932, DOI 10.1126/science.1144216; LURYI S, 1988, APPL PHYS LETT, V52, P501, DOI 10.1063/1.99649; Miller DL, 2010, NAT PHYS, V6, P811, DOI 10.1038/NPHYS1736; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Ponomarenko LA, 2011, NAT PHYS, V7, P958, DOI [10.1038/nphys2114, 10.1038/NPHYS2114]; Sachs B, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195414; Schlosser T, 1996, SEMICOND SCI TECH, V11, P1582, DOI 10.1088/0268-1242/11/11S/022; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]; Shibata N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235426; Toke C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235417; Tsu R, 2011, SUPERLATTICE TO NANOELECTRONICS, 2ND EDITION, P1; WALLACE PR, 1947, PHYS REV, V71, P622, DOI 10.1103/PhysRev.71.622; Wallbank JR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245408; WANNIER GH, 1978, PHYS STATUS SOLIDI B, V88, P757, DOI 10.1002/pssb.2220880243	32	1131	1142	33	836	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1427	1430		10.1126/science.1237240	http://dx.doi.org/10.1126/science.1237240			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23686343	Green Submitted			2022-12-28	WOS:000320647000035
J	Greif, D; Uehlinger, T; Jotzu, G; Tarruell, L; Esslinger, T				Greif, Daniel; Uehlinger, Thomas; Jotzu, Gregor; Tarruell, Leticia; Esslinger, Tilman			Short-Range Quantum Magnetism of Ultracold Fermions in an Optical Lattice	SCIENCE			English	Article							PHYSICS; ATOMS; SIMULATION	Quantum magnetism originates from the exchange coupling between quantum mechanical spins. Here, we report on the observation of nearest-neighbor magnetic correlations emerging in the many-body state of a thermalized Fermi gas in an optical lattice. The key to obtaining short-range magnetic order is a local redistribution of entropy, which allows temperatures below the exchange energy for a subset of lattice bonds. When loading a repulsively interacting gas into either dimerized or anisotropic simple cubic configurations of a tunable-geometry lattice, we observe an excess of singlets as compared with triplets consisting of two opposite spins. For the anisotropic lattice, the transverse spin correlator reveals antiferromagnetic correlations along one spatial axis. Our work facilitates addressing open problems in quantum magnetism through the use of quantum simulation.	[Greif, Daniel; Uehlinger, Thomas; Jotzu, Gregor; Tarruell, Leticia; Esslinger, Tilman] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Tarruell, Leticia] Univ Bordeaux 1, Inst Opt, LP2N, UMR 5298, F-33405 Talence, France; [Tarruell, Leticia] CNRS, F-33405 Talence, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Esslinger, T (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Esslinger, Tilman/M-9022-2016; Tarruell, Leticia/I-8152-2012; Greif, Daniel/M-4480-2017	Esslinger, Tilman/0000-0002-8333-107X; Tarruell, Leticia/0000-0002-0564-1435; Greif, Daniel/0000-0002-0721-7726; Jotzu, Gregor/0000-0003-4421-5874	Swiss National Science Foundation; National Centre of Competence in Research-Quantum Science and Technology (QSIT); Synthetic Quantum Many-Body Systems (European Research Council)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research-Quantum Science and Technology (QSIT); Synthetic Quantum Many-Body Systems (European Research Council)(European Research Council (ERC))	We thank N. Blumer, T. Giamarchi, C. Kollath, H. Moritz, C. Ruegg, M. Sigrist, N. Strohmaier, and S. Uchino for insightful discussions and U. Bissbort for help with the calculation of the Hubbard parameters in the dimerized lattice. We acknowledge the Swiss National Science Foundation, National Centre of Competence in Research-Quantum Science and Technology (QSIT), and Synthetic Quantum Many-Body Systems (European Research Council advanced grant) for funding.	Anderson PW, 2004, J PHYS-CONDENS MAT, V16, pR755, DOI 10.1088/0953-8984/16/24/R02; Auerbach A., 1994, INTERACTING ELECT QU; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Bernier JS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061601; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Diep HT, 2005, FRUSTRATED SPIN SYSTEMS, P1, DOI 10.1142/9789812567819; Esslinger T, 2010, ANNU REV CONDEN MA P, V1, P129, DOI 10.1146/annurev-conmatphys-070909-104059; Fuchs S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.030401; Giamarchi T., 2003, QUANTUM PHYS ONE DIM, V121; Gorelik EV, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.061602; Jordens R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.180401; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Kohl M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.080403; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Ma PN, 2012, NAT PHYS, V8, P601, DOI [10.1038/NPHYS2348, 10.1038/nphys2348]; Mathy CJM, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063412; Meng ZY, 2010, NATURE, V464, P847, DOI 10.1038/nature08942; Nascimbene S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.205301; Sachdev S, 2008, NAT PHYS, V4, P173, DOI 10.1038/nphys894; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Struck J, 2011, SCIENCE, V333, P996, DOI 10.1126/science.1207239; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Trotzky S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.265303; Uehlinger T, 2013, EUR PHYS J-SPEC TOP, V217, P121, DOI 10.1140/epjst/e2013-01761-y	25	296	297	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1307	1310		10.1126/science.1236362	http://dx.doi.org/10.1126/science.1236362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23704375	Green Submitted			2022-12-28	WOS:000320320200038
J	Sato, T; Clevers, H				Sato, Toshiro; Clevers, Hans			Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications	SCIENCE			English	Review							IN-VITRO; EXPRESSION MARKS; WNT RECEPTORS; DIFFERENTIATION; EPITHELIUM; EXPANSION; COLON; HOMEOSTASIS; POPULATION; INHIBITION	Recent examples have highlighted how stem cells have the capability to initiate morphogenesis in vitro; that is, to generate complex structures in culture that closely parallel their in vivo counterparts. Lgr5, the receptor for the Wnt-agonistic R-spondins, marks stem cells in multiple adult organs of mice and humans. In R-spondin-based three-dimensional cultures, these Lgr5 stem cells can grow into ever-expanding epithelial organoids that retain their original organ identity. Single Lgr5 stem cells derived from the intestine can be cultured to build epithelial structures that retain hallmarks of the in vivo epithelium. Here, we review the mechanisms that support this notable example of self-organization and discuss applications of this technology for stem cell research, disease modeling (e. g., for colorectal cancer and cystic fibrosis), and regenerative medicine.	[Sato, Toshiro] Keio Univ, Sch Med, Dept Gastroenterol, Tokyo 1608582, Japan; [Clevers, Hans] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Keio University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Sato, T (corresponding author), Keio Univ, Sch Med, Dept Gastroenterol, Tokyo 1608582, Japan.	t.sato@a7.keio.jp; hclevers@hubrecht.eu	Sato, Toshiro/J-3522-2014	Sato, Toshiro/0000-0001-8353-8137				Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dekkers J. F., 2013, NAT MED; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Fafilek B., 2012, GASTROENTEROLOGY; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Ledford H, 2010, NATURE, V464, P972, DOI 10.1038/464972a; Liu JH, 2012, AM J PHYSIOL-CELL PH, V302, pC1492, DOI 10.1152/ajpcell.00392.2011; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Miyoshi H, 2013, CELL CYCLE, V12, P387, DOI 10.4161/cc.23552; Mizutani T, 2012, BIOCHEM BIOPH RES CO, V419, P238, DOI 10.1016/j.bbrc.2012.01.155; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sodhi CP, 2012, GASTROENTEROLOGY, V143, P708, DOI 10.1053/j.gastro.2012.05.053; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	57	717	753	14	424	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1190	1194		10.1126/science.1234852	http://dx.doi.org/10.1126/science.1234852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744940				2022-12-28	WOS:000319972800037
J	Koff, WC; Burton, DR; Johnson, PR; Walker, BD; King, CR; Nabel, GJ; Ahmed, R; Bhan, MK; Plotkin, SA				Koff, Wayne C.; Burton, Dennis R.; Johnson, Philip R.; Walker, Bruce D.; King, Charles R.; Nabel, Gary J.; Ahmed, Rafi; Bhan, Maharaj K.; Plotkin, Stanley A.			Accelerating Next-Generation Vaccine Development for Global Disease Prevention	SCIENCE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; NEUTRALIZING ANTIBODIES; HUMAN IMMUNOLOGY; HIV-1 VACCINE; MYCOBACTERIUM-TUBERCULOSIS; IMMUNOSTIMULATORY DNA; REVERSE VACCINOLOGY; DENDRITIC CELLS; INNATE IMMUNITY	Vaccines are among the greatest successes in the history of public health. However, past strategies for vaccine development are unlikely to succeed in the future against major global diseases such as AIDS, tuberculosis, and malaria. For such diseases, the correlates of protection are poorly defined and the pathogens evade immune detection and/or exhibit extensive genetic variability. Recent advances have heralded in a new era of vaccine discovery. However, translation of these advances into vaccines remains impeded by lack of understanding of key vaccinology principles in humans. We review these advances toward vaccine discovery and suggest that for accelerating successful vaccine development, new human immunology based clinical research initiatives be implemented with the goal of elucidating and more effectively generating vaccine-induced protective immune responses.	[Koff, Wayne C.; King, Charles R.] Int AIDS Vaccine Initiat IAVI, New York, NY 10004 USA; [Burton, Dennis R.] Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, La Jolla, CA 92037 USA; [Johnson, Philip R.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Burton, Dennis R.; Walker, Bruce D.] Rayon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02129 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Nabel, Gary J.] Sanofi Aventis, Cambridge, MA 02139 USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Bhan, Maharaj K.] Govt India, Dept Biotechnol, New Delhi, India; [Plotkin, Stanley A.] Univ Penn, Philadelphia, PA 19104 USA; [Plotkin, Stanley A.] Vaxconsult, Doylestown, PA 18902 USA; [Burton, Dennis R.; Walker, Bruce D.; Ahmed, Rafi] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA	International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; Scripps Research Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Sanofi-Aventis; Emory University; Department of Biotechnology (DBT) India; University of Pennsylvania; Scripps Research Institute	Koff, WC (corresponding author), Int AIDS Vaccine Initiat IAVI, New York, NY 10004 USA.	wkoff@iavi.org			U.S. Agency for International Development (USAID); Bill & Melinda Gates Foundation (BMGF); International AIDS Vaccine Initiative (IAVI); National Institutes of Health (NIH); Centers for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); National Institute of Allergy and Infectious Diseases (NIAID); NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative (IAVI); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the network of IAVI donors, including, the U.S. Agency for International Development (USAID) and the Bill & Melinda Gates Foundation (BMGF) (W.C.K and C.R.K); the International AIDS Vaccine Initiative (IAVI) and the National Institutes of Health (NIH) (P.R.J.); the Centers for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), with funding from the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH (D.R.B., R.A, and B.D.W). Additionally, S.A.P is a paid scientific advisor and consultant for Sanofi, GlaxoSmithKline, Novartis, Merck, Pfizer, Medimmune, Inovio Pharmaceuticals, Dynavax, and Glycovaxyn, and B.D.W. is a paid scientific advisor and consultant for Merck, Bristol-Myers Squibb, and Globe Immune. The authors also wish to thank S. Glass, L. Gieber, O. Shmaidenko, M. Dees, and B. Hayes for their administrative support.	Bakker AH, 2005, CURR OPIN IMMUNOL, V17, P428, DOI 10.1016/j.coi.2005.06.008; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Boudreau JE, 2009, MOL THER, V17, P1465, DOI 10.1038/mt.2009.95; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Chattopadhyay PK, 2008, IMMUNOLOGY, V125, P441, DOI 10.1111/j.1365-2567.2008.02989.x; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cooper CL, 2008, CLIN INFECT DIS, V46, P1310, DOI 10.1086/533467; D'Argenio DA, 2010, IMMUNITY, V33, P437, DOI 10.1016/j.immuni.2010.10.011; Daum R. S., 2013, VACCINES-BASEL, VSixth, P1161; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Ehreth J, 2003, VACCINE, V21, P4105, DOI 10.1016/S0264-410X(03)00377-3; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; ENDERS JF, 1949, SCIENCE, V109, P85, DOI 10.1126/science.109.2822.85; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Germain RN, 2010, IMMUNITY, V33, P441, DOI 10.1016/j.immuni.2010.09.014; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; HILLEMAN MR, 1968, NEW ENGL J MED, V278, P227, DOI 10.1056/NEJM196802012780501; HILLEMAN MR, 1968, J AMER MED ASSOC, V206, P587, DOI 10.1001/jama.206.3.587; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jenner E, 1801, THE ORIGIN OF THE VA; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Koff WC, 2008, BIOLOGICALS, V36, P277, DOI 10.1016/j.biologicals.2008.04.004; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McMurry J, 2005, TUBERCULOSIS, V85, P95, DOI 10.1016/j.tube.2004.09.005; McNeil C, 2006, J NATL CANCER I, V98, P433, DOI 10.1093/jnci/djj144; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller M. A., 2008, VACCINES, P1594; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pasteur Louis, 1880, COMPTES RENDUS ACAD, V91, P673; PLOTKIN SA, 1969, AM J DIS CHILD, V118, P178, DOI 10.1001/archpedi.1969.02100040180004; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Rosario M, 2010, EUR J IMMUNOL, V40, P1973, DOI 10.1002/eji.201040344; SABIN AB, 1954, J EXP MED, V99, P551, DOI 10.1084/jem.99.6.551; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; SALK JE, 1954, AM J PUBLIC HEALTH, V44, P563, DOI 10.2105/AJPH.44.5.563; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schief W., 2012, RETROVIROLOGY SUPPL, V9; SCHNEERSON R, 1980, J EXP MED, V152, P361, DOI 10.1084/jem.152.2.361; Schulz KR, 2007, CURR PROTOC IMMUNOL; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Siegrist C-A, 2013, VACCINES, P14, DOI DOI 10.1016/B978-1-4557-0090-5.00004-5; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith T., 1886, AM VET REV, V10, P63; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Struck MM, 1996, NAT BIOTECHNOL, V14, P591, DOI 10.1038/nbt0596-591; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; von Herrath MG, 2005, J EXP MED, V202, P1159, DOI 10.1084/jem.20051224; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	87	189	200	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136							1232910	10.1126/science.1232910	http://dx.doi.org/10.1126/science.1232910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723240	Green Accepted			2022-12-28	WOS:000319664500035
J	Spence, D				Spence, Des			Bad medicine: statins	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-HEART-DISEASE; DECLINE					destwo@yahoo.co.uk						Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P649; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3	8	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2013	346								f3566	10.1136/bmj.f3566	http://dx.doi.org/10.1136/bmj.f3566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DQ	23729321				2022-12-28	WOS:000319949200007
J	Wolf, SM; Annas, GJ; Elias, S				Wolf, Susan M.; Annas, George J.; Elias, Sherman			Patient Autonomy and Incidental Findings in Clinical Genomics	SCIENCE			English	Editorial Material									[Wolf, Susan M.] Univ Minnesota, Minneapolis, MN 55455 USA; [Annas, George J.] Boston Univ, Boston, MA 02118 USA; [Elias, Sherman] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA	University of Minnesota System; University of Minnesota Twin Cities; Boston University; Northwestern University; Feinberg School of Medicine	Wolf, SM (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	swolf@umn.edu		Annas, George/0000-0001-5836-7831	NATIONAL CANCER INSTITUTE [R01CA154517] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA154517, 1-R01-CA154517] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American College of Medical Genetics and Genomics (ACMG), 2013, INC FIND CLIN GEN CL; Annas GJ, 2008, BIOETHICS, V22, pII, DOI 10.1111/j.1467-8519.2008.00693.x; ANNAS GEORGE J., 2004, RIGHTS PATIENTS, P128; [Anonymous], POINTS CONS CLIN APP; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Green R. C., 2013, GENET MED; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; NIH Task Force on Genetic Testing, 1997, PROM SAF EFF GEN TES; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]; WILFOND BS, 1995, AM J HUM GENET, V57, P1233; Wolf SM, 2008, J LAW MED ETHICS, V36, P211; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23	13	172	173	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1049	1050		10.1126/science.1239119	http://dx.doi.org/10.1126/science.1239119			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23686341	Green Accepted			2022-12-28	WOS:000319664500025
J	McCandlish, DM; Rajon, E; Shah, P; Ding, Y; Plotkin, JB				McCandlish, David M.; Rajon, Etienne; Shah, Premal; Ding, Yang; Plotkin, Joshua B.			The role of epistasis in protein evolution	NATURE			English	Letter							MUTATION-SELECTION MODELS; MOLECULAR EVOLUTION; SEQUENCES; FITNESS		[McCandlish, David M.; Rajon, Etienne; Shah, Premal; Ding, Yang; Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	McCandlish, DM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jplotkin@sas.upenn.edu	Rajon, Etienne/AAE-3868-2020	Shah, Premal/0000-0002-8424-4218; Rajon, Etienne/0000-0003-0658-8311				Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Choi SC, 2008, PHILOS T R SOC B, V363, P3931, DOI 10.1098/rstb.2008.0167; da Silva J, 2006, GENETICS, V174, P1689, DOI 10.1534/genetics.106.062885; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kryazhimskiy S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001301; Li W. H, 1997, MOL EVOLUTION; Rodrigue N, 2010, P NATL ACAD SCI USA, V107, P4629, DOI 10.1073/pnas.0910915107; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Tamuri AU, 2012, GENETICS, V190, P1101, DOI 10.1534/genetics.111.136432; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	15	32	32	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					E1	E2		10.1038/nature12219	http://dx.doi.org/10.1038/nature12219			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23719465	Green Submitted			2022-12-28	WOS:000319556100001
J	[Anonymous]				[Anonymous]			Blood: a precious resource	LANCET			English	Editorial Material																			0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1789	1789						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151EO	23706786				2022-12-28	WOS:000319443700001
J	Ibanez, M; Cabot, A				Ibanez, Maria; Cabot, Andreu			All Change for Nanocrystals	SCIENCE			English	Editorial Material							CATION-EXCHANGE; NANOPARTICLES; NANORODS		[Ibanez, Maria] Catalonia Energy Res Inst IREC, Barcelona 08930, Spain; Univ Barcelona, Dept Elect, E-08028 Barcelona, Spain	Institut de Recerca en Energia de Catalunya (IREC); University of Barcelona	Ibanez, M (corresponding author), Catalonia Energy Res Inst IREC, Jardi Dones Negre 1, Barcelona 08930, Spain.	acabot@irec.cat	Cabot, Andreu/B-5683-2014; cabot, andreu/B-5523-2019; Ibáñez, Maria/B-2445-2014	cabot, andreu/0000-0002-7533-3251; Ibáñez, Maria/0000-0001-5013-2843				Buck MR, 2012, NAT CHEM, V4, P37, DOI 10.1038/nchem.1195; Chou NH, 2007, J AM CHEM SOC, V129, P7339, DOI 10.1021/ja069032y; Gonzalez E, 2011, SCIENCE, V334, P1377, DOI 10.1126/science.1212822; Ibanez M, 2011, CHEM MATER, V23, P3095, DOI 10.1021/cm2006633; Oh MH, 2013, SCIENCE, V340, P964, DOI 10.1126/science.1234751; Robinson RD, 2007, SCIENCE, V317, P355, DOI 10.1126/science.1142593; Sadtler B, 2009, J AM CHEM SOC, V131, P5285, DOI 10.1021/ja809854q; Saruyama M, 2011, J AM CHEM SOC, V133, P17598, DOI 10.1021/ja2078224; Sines IT, 2011, J AM CHEM SOC, V133, P1294, DOI 10.1021/ja110374d; Son DH, 2004, SCIENCE, V306, P1009, DOI 10.1126/science.1103755; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566	13	32	33	2	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					935	936		10.1126/science.1239221	http://dx.doi.org/10.1126/science.1239221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704562				2022-12-28	WOS:000319344100032
J	Kleizen, B; Braakman, I				Kleizen, Bertrand; Braakman, Ineke			A Sweet Send-Off	SCIENCE			English	Editorial Material							PROTEIN O-MANNOSYLATION; WALKER-WARBURG-SYNDROME; QUALITY CONTROL; GENE POMT1; ROLES		[Kleizen, Bertrand; Braakman, Ineke] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3508 TC Utrecht, Netherlands	Utrecht University	Kleizen, B (corresponding author), Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3508 TC Utrecht, Netherlands.	i.braakman@uu.nl		Kleizen, Bertrand/0000-0002-4640-1796; Braakman, Ineke/0000-0003-1592-4364				Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Goder V, 2011, J CELL SCI, V124, P144, DOI 10.1242/jcs.072181; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Xu CC, 2013, SCIENCE, V340, P978, DOI 10.1126/science.1234055	12	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					930	931		10.1126/science.1239294	http://dx.doi.org/10.1126/science.1239294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704559				2022-12-28	WOS:000319344100029
J	Sly, PD; Gangell, CL; Chen, LP; Ware, RS; Ranganathan, S; Mott, LS; Murray, CP; Stick, SM				Sly, Peter D.; Gangell, Catherine L.; Chen, Linping; Ware, Robert S.; Ranganathan, Sarath; Mott, Lauren S.; Murray, Conor P.; Stick, Stephen M.		AREST CF Investigators	Risk Factors for Bronchiectasis in Children with Cystic Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; LOWER AIRWAY INFLAMMATION; STRUCTURAL LUNG INJURY; PULMONARY INFLAMMATION; YOUNG-CHILDREN; NEUTROPHIL ELASTASE; INFANTS; DISEASE; EXACERBATION; INFECTION	BACKGROUND Bronchiectasis develops early in the course of cystic fibrosis, being detectable in infants as young as 10 weeks of age, and is persistent and progressive. We sought to determine risk factors for the onset of bronchiectasis, using data collected by the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) intensive surveillance program. METHODS We examined data from 127 consecutive infants who received a diagnosis of cystic fibrosis after newborn screening. Chest computed tomography (CT) and bronchoalveolar lavage (BAL) were performed, while the children were in stable clinical condition, at 3 months and 1, 2, and 3 years of age. Longitudinal data were used to determine risk factors associated with the detection of bronchiectasis from 3 months to 3 years of age. RESULTS The point prevalence of bronchiectasis at each visit increased from 29.3% at 3 months of age to 61.5% at 3 years of age. In multivariate analyses, risk factors for bronchiectasis were presentation with meconium ileus (odds ratio, 3.17; 95% confidence interval [CI], 1.51 to 6.66; P = 0.002), respiratory symptoms at the time of CT and BAL (odds ratio, 2.27; 95% CI, 1.24 to 4.14; P = 0.008), free neutrophil elastase activity in BAL fluid (odds ratio, 3.02; 95% CI, 1.70 to 5.35; P<0.001), and gas trapping on expiratory CT (odds ratio, 2.05; 95% CI, 1.17 to 3.59; P = 0.01). Free neutrophil elastase activity in BAL fluid at 3 months of age was associated with persistent bronchiectasis (present on two or more sequential scans), with the odds seven times as high at 12 months of age and four times as high at 3 years of age. CONCLUSIONS Neutrophil elastase activity in BAL fluid in early life was associated with early bronchiectasis in children with cystic fibrosis.	[Sly, Peter D.; Gangell, Catherine L.; Chen, Linping; Ware, Robert S.] Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Ware, Robert S.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Ranganathan, Sarath] Univ Melbourne, Royal Childrens Hosp, Dept Resp Med, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ranganathan, Sarath] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Mott, Lauren S.; Stick, Stephen M.] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia; [Murray, Conor P.] Princess Margaret Hosp Children, Dept Diagnost Imaging, Perth, WA, Australia; [Mott, Lauren S.; Stick, Stephen M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia	University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia	Sly, PD (corresponding author), Royal Childrens Hosp, Queensland Childrens Med Res Inst, Level 4,Fdn Bldg,Herston Rd, Herston, Qld 4029, Australia.	p.sly@uq.edu.au	Ware, Robert S./B-2024-2014; Stick, Stephen/GZG-7584-2022; Sly, Peter D/F-1486-2010; Stick, Stephen/O-5683-2014; Stick, Stephen/AAA-5945-2021	Ware, Robert S./0000-0002-6129-6736; Sly, Peter D/0000-0001-6305-2201; Stick, Stephen/0000-0002-5386-8482; Ranganathan, Sarath/0000-0002-6975-0307	National Health and Medical Research Council of Australia; Cystic Fibrosis Foundation Therapeutics	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation)	Funded by the National Health and Medical Research Council of Australia and Cystic Fibrosis Foundation Therapeutics.	Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Brennan S, 2005, THORAX, V60, P159, DOI 10.1136/thx.2004.026419; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; de Jong PA, 2004, EUR RESPIR J, V23, P93, DOI 10.1183/09031936.03.00006603; de Long PA, 2005, AM J RESP CRIT CARE, V172, P218, DOI 10.1164/rccm.200410-1311OC; Elborn JS, 2012, EUR RESPIR J, V40, P969, DOI 10.1183/09031936.00194611; Gangell C, 2011, CLIN INFECT DIS, V53, P425, DOI 10.1093/cid/cir399; Kapur N, 2011, CHEST, V139, P1445, DOI 10.1378/chest.10-1763; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; Kuraki T, 2002, AM J RESP CRIT CARE, V166, P496, DOI 10.1164/rccm.2103118; Laguna TA, 2012, PEDIATR PULM, V47, P856, DOI 10.1002/ppul.22525; Lands LC, 2007, COCHRANE DB SYST REV, V4; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Long FR, 2004, J PEDIATR-US, V144, P154, DOI 10.1016/j.jpeds.2003.09.026; Martinez TM, 2005, AM J RESP CRIT CARE, V172, P1133, DOI 10.1164/rccm.200412-1665OC; Mott LS, 2012, THORAX, V67, P509, DOI 10.1136/thoraxjnl-2011-200912; Mott LS, 2013, J PEDIAT; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Ranganathan SC, 2011, THORAX, V66, P408, DOI 10.1136/thx.2010.139493; Reeves EP, 2012, J CYST FIBROS, V11, P100, DOI 10.1016/j.jcf.2011.09.010; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Stockley RA, 1999, AM J RESP CRIT CARE, V160, pS49, DOI 10.1164/ajrccm.160.supplement_1.13; Tremblay Guy M, 2003, Curr Opin Investig Drugs, V4, P556; Wainwright CE, 2011, JAMA-J AM MED ASSOC, V306, P163, DOI 10.1001/jama.2011.954	27	408	410	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1963	1970		10.1056/NEJMoa1301725	http://dx.doi.org/10.1056/NEJMoa1301725			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194KD	23692169	Green Published			2022-12-28	WOS:000322630700006
J	Wolff, S; Dillin, A				Wolff, Suzanne; Dillin, Andrew			AGEING Beneficial miscommunication	NATURE			English	Editorial Material							MITOCHONDRIAL; EXPRESSION; YEAST		[Wolff, Suzanne; Dillin, Andrew] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wolff, Suzanne; Dillin, Andrew] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute	Wolff, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dillin@berkeley.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	11	6	6	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					442	443		10.1038/497442a	http://dx.doi.org/10.1038/497442a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698438				2022-12-28	WOS:000319254000033
J	Faccio, D; Leach, J				Faccio, Daniele; Leach, Jonathan			Ghost Imaging in Three Dimensions	SCIENCE			English	Editorial Material									[Faccio, Daniele; Leach, Jonathan] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland	Heriot Watt University	Faccio, D (corresponding author), Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.	d.faccio@hw.ac.uk; j.leach@hw.ac.uk	Faccio, Daniele/K-5794-2018	Faccio, Daniele/0000-0001-8397-334X; Leach, Jonathan/0000-0003-3561-4953				Bennink RS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.113601; Bromberg Y, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053840; Shapiro JH, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.061802; STREKALOV DV, 1995, PHYS REV LETT, V74, P3600, DOI 10.1103/PhysRevLett.74.3600; Sun B, 2013, SCIENCE, V340, P844, DOI 10.1126/science.1234454	7	4	4	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					821	822		10.1126/science.1238415	http://dx.doi.org/10.1126/science.1238415			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687036				2022-12-28	WOS:000318997400030
J	Weiss, RA; Stoye, JP				Weiss, Robin A.; Stoye, Jonathan P.			Our Viral Inheritance	SCIENCE			English	Editorial Material							ENDOGENOUS RETROVIRUSES; HUMAN GENOME; EVOLUTION; GENES		[Weiss, Robin A.] UCL, Div Infect & Immun, London WC1E 6BT, England; [Stoye, Jonathan P.] Natl Inst Med Res, MRC, Div Virol, London NW7 1AA, England	University of London; University College London; MRC National Institute for Medical Research	Weiss, RA (corresponding author), UCL, Div Infect & Immun, Gower St, London WC1E 6BT, England.	rweiss@ucl.ac.uk; jstoye@nimr.mrc.ac.uk		Stoye, Jonathan/0000-0003-3377-323X	Medical Research Council [MC_U117512710] Funding Source: Medline; MRC [MC_U117512710] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Haig D, 2012, CURR BIOL, V22, pR609, DOI 10.1016/j.cub.2012.06.002; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; TING CN, 1992, GENE DEV, V6, P1457, DOI 10.1101/gad.6.8.1457; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599	15	26	26	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					820	821		10.1126/science.1235148	http://dx.doi.org/10.1126/science.1235148			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687035				2022-12-28	WOS:000318997400029
J	Horton, R; Lo, S				Horton, Richard; Lo, Selina			Nutrition: a quintessential sustainable development goal	LANCET			English	Editorial Material									[Horton, Richard; Lo, Selina] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Bhutta ZA, 2013, LANCET; Black R., 2013, LANCET; Gillespie S, 2013, LANCET; Katz J, 2013, LANCET; Maternal and Child Nutrition Study Group, 2013, LANCET; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Ruel M, 2013, LANCET	7	43	46	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 3	2013	382	9890					371	372		10.1016/S0140-6736(13)61100-9	http://dx.doi.org/10.1016/S0140-6736(13)61100-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23746782				2022-12-28	WOS:000322638500006
J	Hartling, L; Dryden, DM; Guthrie, A; Muise, M; Vandermeer, B; Donovan, L				Hartling, Lisa; Dryden, Donna M.; Guthrie, Alyssa; Muise, Melanie; Vandermeer, Ben; Donovan, Lois			Benefits and Harms of Treating Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis for the US Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research	ANNALS OF INTERNAL MEDICINE			English	Review							GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; BIRTH-WEIGHT; WOMEN; INTOLERANCE; DIAGNOSIS; QUALITY; OBESITY; TRIAL; CARE	Background: Outcomes of treating gestational diabetes mellitus (GDM) are not well-established. Purpose: To summarize evidence about the maternal and neonatal benefits and harms of treating GDM. Data Sources: 15 electronic databases from 1995 to May 2012, gray literature, Web sites of relevant organizations, trial registries, and reference lists. Study Selection: English-language randomized, controlled trials (n = 5) and cohort studies (n = 6) of women without known preexisting diabetes. Data Extraction: One reviewer extracted data, and a second reviewer verified them. Two reviewers independently assessed methodological quality and evaluated strength of evidence for primary outcomes by using a Grading of Recommendations Assessment, Development and Evaluation approach. Data Synthesis: All studies compared diet modification, glucose monitoring, and insulin as needed with no treatment. Women who were treated had more prenatal visits than those in control groups. Moderate evidence showed fewer cases of preeclampsia, shoulder dystocia, and macrosomia in the treated group. Evidence was insufficient for maternal weight gain and birth injury. Low evidence showed no difference between groups for neonatal hypoglycemia. Evidence was insufficient for long-term metabolic outcomes among offspring. No difference was found for cesarean delivery (low evidence), induction of labor (insufficient evidence), small-forgestational-age neonates (moderate evidence), or admission to a neonatal intensive care unit (low evidence). Limitations: Evidence is low or insufficient for many outcomes of greatest clinical importance. The strongest evidence supports reductions in intermediate outcomes; however, other factors (for example, maternal weight and gestational weight gain) may impart greater risk than GDM, particularly when glucose levels are modestly elevated. Conclusion: Treating GDM results in less preeclampsia, shoulder dystocia, and macrosomia; however, current evidence does not show an effect on neonatal hypoglycemia or future poor metabolic outcomes. There is little evidence of short-term harm of treating GDM other than an increased demand for services.	Univ Alberta, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; Univ Alberta, Evidence Based Practice Ctr, Edmonton, AB, Canada; Univ Calgary, Calgary, AB, Canada	University of Alberta; University of Alberta; University of Calgary	Hartling, L (corresponding author), ECHA 4-472,11405-87 Ave, Edmonton, AB T6G 1C9, Canada.	hartling@ualberta.ca			Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.	Adams KM, 1998, AM J OBSTET GYNECOL, V178, P1321, DOI 10.1016/S0002-9378(98)70339-4; American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS103; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Bevier WC, 1999, AM J PERINAT, V16, P269, DOI 10.1055/s-2007-993871; Black MH, 2013, DIABETES CARE, V36, P56, DOI 10.2337/dc12-0741; Bonomo M, 2005, DIABETIC MED, V22, P1536, DOI 10.1111/j.1464-5491.2005.01690.x; Bonomo M, 1997, Ann Ist Super Sanita, V33, P393; Chou CY, 2010, J WOMENS HEALTH, V19, P935, DOI 10.1089/jwh.2009.1620; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Daniells S, 2003, DIABETES CARE, V26, P385, DOI 10.2337/diacare.26.2.385; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Falavigna M, 2012, DIABETES RES CLIN PR, V98, P396, DOI 10.1016/j.diabres.2012.09.002; Fassett MJ, 2007, AM J OBSTET GYNECOL, V196, P597, DOI 10.1016/j.ajog.2007.03.017; Feig DS, 1998, AM J OBSTET GYNECOL, V178, P386, DOI 10.1016/S0002-9378(98)80030-6; Garner P, 1997, AM J OBSTET GYNECOL, V177, P190, DOI 10.1016/S0002-9378(97)70461-7; Gillman MW, 2010, DIABETES CARE, V33, P964, DOI 10.2337/dc09-1810; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hillier TA, 2008, ANN INTERN MED, V148, P766, DOI 10.7326/0003-4819-148-10-200805200-00009; Horvath K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1395; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; LANGER O, 1989, AM J OBSTET GYNECOL, V161, P646, DOI 10.1016/0002-9378(89)90371-2; Malcolm JC, 2006, DIABETIC MED, V23, P565, DOI 10.1111/j.1464-5491.2006.01840.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; National Diabetes Data Group, 1995, DIABETES AM; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165; Ostlund I, 2004, EUR J OBSTET GYN R B, V113, P12, DOI 10.1016/j.ejogrb.2003.07.001; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Retnakaran R, 2012, CAN MED ASSOC J, V184, P1353, DOI 10.1503/cmaj.111154; Ryan EA, 2011, DIABETOLOGIA, V54, P480, DOI 10.1007/s00125-010-2005-4; Wells G.A., 2000, VIS COMMUN Q	32	181	187	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					123	W51		10.7326/0003-4819-159-2-201307160-00661	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00661			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23712381				2022-12-28	WOS:000322112000018
J	Hamid, O; Robert, C; Daud, A; Hodi, FS; Hwu, WJ; Kefford, R; Wolchok, JD; Hersey, P; Joseph, RW; Weber, JS; Dronca, R; Gangadhar, TC; Patnaik, A; Zarour, H; Joshua, AM; Gergich, K; Elassaiss-Schaap, J; Algazi, A; Mateus, C; Boasberg, P; Tumeh, PC; Chmielowski, B; Ebbinghaus, SW; Li, XN; Kang, SP; Ribas, A				Hamid, Omid; Robert, Caroline; Daud, Adil; Hodi, F. Stephen; Hwu, Wen-Jen; Kefford, Richard; Wolchok, Jedd D.; Hersey, Peter; Joseph, Richard W.; Weber, Jeffrey S.; Dronca, Roxana; Gangadhar, Tara C.; Patnaik, Amita; Zarour, Hassane; Joshua, Anthony M.; Gergich, Kevin; Elassaiss-Schaap, Jeroen; Algazi, Alain; Mateus, Christine; Boasberg, Peter; Tumeh, Paul C.; Chmielowski, Bartosz; Ebbinghaus, Scot W.; Li, Xiaoyun Nicole; Kang, S. Peter; Ribas, Antoni			Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC MELANOMA; CANCER; IMMUNOTHERAPY; PHASE; BLOCKADE; ANTIBODY; CRITERIA; THERAPY; PD-1	BACKGROUND The programmed death 1 (PD-1) receptor is a negative regulator of T-cell effector mechanisms that limits immune responses against cancer. We tested the anti-PD-1 antibody lambrolizumab (previously known as MK-3475) in patients with advanced melanoma. METHODS We administered lambrolizumab intravenously at a dose of 10 mg per kilogram of body weight every 2 or 3 weeks or 2 mg per kilogram every 3 weeks in patients with advanced melanoma, both those who had received prior treatment with the immune checkpoint inhibitor ipilimumab and those who had not. Tumor responses were assessed every 12 weeks. RESULTS A total of 135 patients with advanced melanoma were treated. Common adverse events attributed to treatment were fatigue, rash, pruritus, and diarrhea; most of the adverse events were low grade. The confirmed response rate across all dose cohorts, evaluated by central radiologic review according to the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, was 38% (95% confidence interval [CI], 25 to 44), with the highest confirmed response rate observed in the cohort that received 10 mg per kilogram every 2 weeks (52%; 95% CI, 38 to 66). The response rate did not differ significantly between patients who had received prior ipilimumab treatment and those who had not (confirmed response rate, 38% [95% CI, 23 to 55] and 37% [95% CI, 26 to 49], respectively). Responses were durable in the majority of patients (median follow-up, 11 months among patients who had a response); 81% of the patients who had a response (42 of 52) were still receiving treatment at the time of analysis in March 2013. The overall median progression-free survival among the 135 patients was longer than 7 months. CONCLUSIONS In patients with advanced melanoma, including those who had had disease progression while they had been receiving ipilimumab, treatment with lambrolizumab resulted in a high rate of sustained tumor regression, with mainly grade 1 or 2 toxic effects.	[Hamid, Omid; Boasberg, Peter] Angeles Clin & Res Inst, Los Angeles, CA USA; [Tumeh, Paul C.; Chmielowski, Bartosz; Ribas, Antoni] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Robert, Caroline; Mateus, Christine] Inst Gustave Roussy, Villejuif, France; [Daud, Adil; Algazi, Alain] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Hwu, Wen-Jen] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kefford, Richard] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia; [Kefford, Richard] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2006, Australia; [Hersey, Peter] Melanoma Inst Australia, Kolling Inst, Newcastle, NSW, Australia; [Hersey, Peter] Newcastle Melanoma Unit, Newcastle, NSW, Australia; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Joseph, Richard W.] Mayo Clin, Jacksonville, FL 32224 USA; [Weber, Jeffrey S.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Dronca, Roxana] Mayo Clin, Rochester, MN USA; [Gangadhar, Tara C.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Patnaik, Amita] South Texas Accelerated Res Therapeut, San Antonio, TX USA; [Zarour, Hassane] Univ Pittsburgh, Pittsburgh, PA USA; [Joshua, Anthony M.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Gergich, Kevin; Elassaiss-Schaap, Jeroen; Ebbinghaus, Scot W.; Li, Xiaoyun Nicole; Kang, S. Peter] Merck Sharp & Dohme Ltd, Whitehouse Stn, NJ USA	Angeles Clinic & Research Institute; University of California System; University of California Los Angeles; UNICANCER; Gustave Roussy; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; University of Sydney; Melanoma Institute Australia; University of Sydney; Melanoma Institute Australia; University of Sydney; Kolling Institute of Medical Research; Memorial Sloan Kettering Cancer Center; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Merck & Company	Ribas, A (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Jonsson Comprehens Canc Ctr, 11-934 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	aribas@mednet.ucla.edu	Li, Xiaoyun/P-8265-2014; Robert, Caroline/G-6157-2018; Kanemura, Takashi/H-5717-2015; Elassaiss-Schaap, Jeroen/Q-5451-2016; Daud, Adil/T-3079-2019	Robert, Caroline/0000-0002-9493-0238; Daud, Adil/0000-0002-6617-8421; Joseph, Richard/0000-0001-6102-4661; Joshua, Anthony/0000-0001-5159-4580; Chmielowski, Bartosz/0000-0002-2374-3320; Kefford, Richard/0000-0001-9251-9229; Weber, Jeffrey/0000-0002-4962-2957	Merck Sharp; Dohme; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI091663] Funding Source: NIH RePORTER	Merck Sharp(Merck & Company); Dohme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Merck Sharp and Dohme.	Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patnaik A, 2012, J CLIN ONCOL, V30; Ribas A, 2003, J CLIN ONCOL, V21, P2415, DOI 10.1200/JCO.2003.06.041; Ribas A, 2013, J CLIN ONCOL, V31, P616, DOI 10.1200/JCO.2012.44.6112; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	16	2586	2828	13	410	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					134	144		10.1056/NEJMoa1305133	http://dx.doi.org/10.1056/NEJMoa1305133			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23724846	Green Accepted, Green Published			2022-12-28	WOS:000321567300009
J	Grady, NK; Heyes, JE; Chowdhury, DR; Zeng, Y; Reiten, MT; Azad, AK; Taylor, AJ; Dalvit, DAR; Chen, HT				Grady, Nathaniel K.; Heyes, Jane E.; Chowdhury, Dibakar Roy; Zeng, Yong; Reiten, Matthew T.; Azad, Abul K.; Taylor, Antoinette J.; Dalvit, Diego A. R.; Chen, Hou-Tong			Terahertz Metamaterials for Linear Polarization Conversion and Anomalous Refraction	SCIENCE			English	Article							ANGULAR-MOMENTUM; FREQUENCIES	Polarization is one of the basic properties of electromagnetic waves conveying valuable information in signal transmission and sensitive measurements. Conventional methods for advanced polarization control impose demanding requirements on material properties and attain only limited performance. We demonstrated ultrathin, broadband, and highly efficient metamaterial-based terahertz polarization converters that are capable of rotating a linear polarization state into its orthogonal one. On the basis of these results, we created metamaterial structures capable of realizing near-perfect anomalous refraction. Our work opens new opportunities for creating high-performance photonic devices and enables emergent metamaterial functionalities for applications in the technologically difficult terahertz-frequency regime.	[Grady, Nathaniel K.; Heyes, Jane E.; Chowdhury, Dibakar Roy; Reiten, Matthew T.; Azad, Abul K.; Taylor, Antoinette J.; Chen, Hou-Tong] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM 87545 USA; [Zeng, Yong; Dalvit, Diego A. R.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Chen, HT (corresponding author), Los Alamos Natl Lab, Ctr Integrated Nanotechnol, MS K771, Los Alamos, NM 87545 USA.	chenht@lanl.gov	ROY CHOWDHURY, DIBAKAR/ABG-9158-2021; Chen, Hou-Tong/C-6860-2009; Grady, Nathaniel K/A-4896-2011; zeng, yong/C-7281-2008	Chen, Hou-Tong/0000-0003-2014-7571; Azad, Abul/0000-0002-7784-7432	Los Alamos National Laboratory Laboratory-Directed Research and Development program; U.S. Department of Energy [DE-AC52-06NA25396]	Los Alamos National Laboratory Laboratory-Directed Research and Development program; U.S. Department of Energy(United States Department of Energy (DOE))	We acknowledge partial support from the Los Alamos National Laboratory Laboratory-Directed Research and Development program. This work was performed in part at the Center for Integrated Nanotechnologies, a U.S. Department of Energy, Office of Basic Energy Sciences user facility. Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security for the National Nuclear Security Administration of the U.S. Department of Energy under contract DE-AC52-06NA25396.	Born M., 1980, PRINCIPLES OPTICS; Chen HT, 2012, OPT EXPRESS, V20, P7165, DOI 10.1364/OE.20.007165; Chen HT, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.073901; Chiang YJ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4774300; Chin JY, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3054161; Euler M, 2010, IET MICROW ANTENNA P, V4, P1764, DOI 10.1049/iet-map.2009.0415; Fickler R, 2012, SCIENCE, V338, P640, DOI 10.1126/science.1227193; Franke-Arnold S, 2008, LASER PHOTONICS REV, V2, P299, DOI 10.1002/lpor.200810007; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Hao JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.063908; Mutlu M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.213905; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Peralta XG, 2009, OPT EXPRESS, V17, P773, DOI 10.1364/OE.17.000773; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; Strikwerda AC, 2009, OPT EXPRESS, V17, P136, DOI 10.1364/OE.17.000136; Sun SL, 2012, NAT MATER, V11, P426, DOI [10.1038/nmat3292, 10.1038/NMAT3292]; Sun WJ, 2011, OPT LETT, V36, P927, DOI 10.1364/OL.36.000927; Tharp JS, 2007, IEEE T ANTENN PROPAG, V55, P2983, DOI 10.1109/TAP.2007.908369; Wang J, 2012, NAT PHOTONICS, V6, P488, DOI [10.1038/nphoton.2012.138, 10.1038/NPHOTON.2012.138]; Wei ZY, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3664774; Ye YQ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3429683; YOUNG L, 1973, IEEE T ANTENN PROPAG, VAP21, P376, DOI 10.1109/TAP.1973.1140503; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1877	27	1333	1368	104	1090	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1304	1307		10.1126/science.1235399	http://dx.doi.org/10.1126/science.1235399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23686344	Green Submitted			2022-12-28	WOS:000320320200037
J	Davies, P				Davies, Peter			Trade secrets: will an EU-US treaty enable US big business to gain a foothold?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com						Cameron D, 2013, WALL STREET JOURNAL; European Commission, 2013, TRADE COUNTRIES AND; Koivusalo M, 2013, OPEN DEMOCRACY; Koivusalo M, 2011, THE PROPOSED EU CANA; Lansley A, 2005, SPEECH; Peterson LE, 2005, FRIEDRICH EBERT STIF; Pollock AM, 2003, LANCET, V362, P1072, DOI 10.1016/S0140-6736(03)14419-4; van Harten Gus, 2010, PUBLIC STATEMENT ON	8	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 5	2013	346								f3574	10.1136/bmj.f3574	http://dx.doi.org/10.1136/bmj.f3574			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YF	23741030				2022-12-28	WOS:000320229500003
J	Dykhuizen, EC; Hargreaves, DC; Miller, EL; Cui, KR; Korshunov, A; Kool, M; Pfister, S; Cho, YJ; Zhao, KJ; Crabtree, GR				Dykhuizen, Emily C.; Hargreaves, Diana C.; Miller, Erik L.; Cui, Kairong; Korshunov, Andrey; Kool, Marcel; Pfister, Stefan; Cho, Yoon-Jae; Zhao, Keji; Crabtree, Gerald R.			BAF complexes facilitate decatenation of DNA by topoisomerase II alpha	NATURE			English	Article							CHROMATIN REMODELING COMPLEX; GENETIC LANDSCAPE; GENOME; ESBAF; BETA; PLURIPOTENCY; RESOLUTION; MUTATIONS; POLYCOMB; EXOME	Recent exon-sequencing studies of human tumours have revealed that subunits of BAF (mammalian SWI/SNF) complexes are mutated in more than 20% of all human malignancies(1,2), but the mechanisms involved in tumour suppression are unclear. BAF chromatin-remodelling complexes are polymorphic assemblies that use energy provided by ATP hydrolysis to regulate transcription through the control of chromatin structure(3) and the placement of Polycomb repressive complex 2 (PRC2) across the genome(4,5). Several proteins dedicated to this multisubunit complex, including BRG1 (also known as SMARCA4) and BAF250a (also known as ARID1A), are mutated at frequencies similar to those of recognized tumour suppressors. In particular, the core ATPase BRG1 is mutated in 5-10% of childhood medulloblastomas(6-9) and more than 15% of Burkitt's lymphomas(10,11). Here we show a previously unknown function of BAF complexes in decatenating newly replicated sister chromatids, a requirement for proper chromosome segregation during mitosis. We find that deletion of Brg1 in mouse cells, as well as the expression of BRG1 point mutants identified in human tumours, leads to anaphase bridge formation (in which sister chromatids are linked by catenated strands of DNA) and a G2/M-phase block characteristic of the decatenation checkpoint. Endogenous BAF complexes interact directly with endogenous topoisomerase II alpha (TOP2A) through BAF250a and are required for the binding of TOP2A to approximately 12,000 sites across the genome. Our results demonstrate that TOP2A chromatin binding is dependent on the ATPase activity of BRG1, which is compromised in oncogenic BRG1 mutants. These studies indicate that the ability of TOP2A to prevent DNA entanglement at mitosis requires BAF complexes and suggest that this activity contributes to the role of BAF subunits as tumour suppressors.	[Dykhuizen, Emily C.; Hargreaves, Diana C.; Miller, Erik L.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Dykhuizen, Emily C.; Hargreaves, Diana C.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Miller, Erik L.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Cui, Kairong; Zhao, Keji] NIH, Bethesda, MD 20892 USA; [Korshunov, Andrey] German Canc Res Ctr, CCU Neuropathol, D-69120 Heidelberg, Germany; [Kool, Marcel; Pfister, Stefan] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Pfister, Stefan] Univ Heidelberg Hosp, Dept Pediat Oncol, D-69120 Heidelberg, Germany; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol & Neurosurg, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu	Pfister, Stefan M/F-6860-2013; Kool, Marcel/H-2541-2013	Pfister, Stefan M/0000-0002-5447-5322; Crabtree, Robert/0000-0002-6639-8707; Korshunov, Andrey/0000-0002-5257-3623; dykhuizen, emily/0000-0003-3072-1469	NIH; American Cancer Society; Helen Hay Whitney Foundation; NHLBI; NATIONAL CANCER INSTITUTE [R01CA163915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZICHL006058, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789, R37NS046789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032469] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Helen Hay Whitney Foundation; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to acknowledge the DNA Sequencing Core facility of the National Heart, Lung, and Blood Institute (NHLBI) for sequencing the ChIP-seq libraries. This work was supported by the NIH (G.R.C.), The American Cancer Society (E.C.D.), The Helen Hay Whitney Foundation (D.C.H.) and the Division of Intramural Research program of NHLBI (K.Z.). G.R.C. is an investigator at the Howard Hughes Medical Institute.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P4553, DOI 10.1093/nar/18.15.4553; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Johnson M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp480; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kadoch C., 2013, NATURE GENET; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramamoorthy M, 2012, NUCLEIC ACIDS RES, V40, P1621, DOI 10.1093/nar/gkr844; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; Sperling AS, 2011, P NATL ACAD SCI USA, V108, P12693, DOI 10.1073/pnas.1106834108; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	37	182	184	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					624	+		10.1038/nature12146	http://dx.doi.org/10.1038/nature12146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23698369	Green Accepted			2022-12-28	WOS:000319556100045
J	Church, TR; Black, WC; Aberle, DR; Berg, CD; Clingan, KL; Duan, FH; Fagerstrom, RM; Gareen, IF; Gierada, DS; Jones, GC; Mahon, I; Marcus, PM; Sicks, JD; Jain, A; Baum, S				Church, Timothy R.; Black, William C.; Aberle, Denise R.; Berg, Christine D.; Clingan, Kathy L.; Duan, Fenghai; Fagerstrom, Richard M.; Gareen, Ilana F.; Gierada, David S.; Jones, Gordon C.; Mahon, Irene; Marcus, Pamela M.; Sicks, JoRean D.; Jain, Amanda; Baum, Sarah		Natl Lung Screening Trial Res Team	Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPIRAL CT; MORTALITY; PROJECT; STATISTICS; PROSTATE; SMOKING; TRIAL	BACKGROUND Lung cancer is the largest contributor to mortality from cancer. The National Lung Screening Trial (NLST) showed that screening with low-dose helical computed tomography (CT) rather than with chest radiography reduced mortality from lung cancer. We describe the screening, diagnosis, and limited treatment results from the initial round of screening in the NLST to inform and improve lung-cancer-screening programs. METHODS At 33 U.S. centers, from August 2002 through April 2004, we enrolled asymptomatic participants, 55 to 74 years of age, with a history of at least 30 pack-years of smoking. The participants were randomly assigned to undergo annual screening, with the use of either low-dose CT or chest radiography, for 3 years. Nodules or other suspicious findings were classified as positive results. This article reports findings from the initial screening examination. RESULTS A total of 53,439 eligible participants were randomly assigned to a study group (26,715 to low-dose CT and 26,724 to chest radiography); 26,309 participants (98.5%) and 26,035 (97.4%), respectively, underwent screening. A total of 7191 participants (27.3%) in the low-dose CT group and 2387 (9.2%) in the radiography group had a positive screening result; in the respective groups, 6369 participants (90.4%) and 2176 (92.7%) had at least one follow-up diagnostic procedure, including imaging in 5717 (81.1%) and 2010 (85.6%) and surgery in 297 (4.2%) and 121 (5.2%). Lung cancer was diagnosed in 292 participants (1.1%) in the low-dose CT group versus 190 (0.7%) in the radiography group (stage 1 in 158 vs. 70 participants and stage IIB to IV in 120 vs. 112). Sensitivity and specificity were 93.8% and 73.4% for low-dose CT and 73.5% and 91.3% for chest radiography, respectively. CONCLUSIONS The NLST initial screening results are consistent with the existing literature on screening by means of low-dose CT and chest radiography, suggesting that a reduction in mortality from lung cancer is achievable at U. S. screening centers that have staff experienced in chest CT.	[Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA; [Black, William C.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Aberle, Denise R.] Univ Calif Los Angeles, Los Angeles, CA USA; [Berg, Christine D.; Fagerstrom, Richard M.; Marcus, Pamela M.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Clingan, Kathy L.] WESTAT Corp, Rockville, MD 20850 USA; [Duan, Fenghai; Gareen, Ilana F.; Sicks, JoRean D.; Jain, Amanda; Baum, Sarah] Brown Univ, ACRIN, Biostat Ctr, Providence, RI 02912 USA; [Gierada, David S.] Washington Univ, Sch Med, St Louis, MO USA; [Jones, Gordon C.] Informat Management Syst, Rockville, MD USA; [Mahon, Irene] ACRIN, Headquarters & Data Management Ctr, Philadelphia, PA USA	University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Westat; Brown University; Washington University (WUSTL)	Church, TR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, 200 Oak St SE,Suite 350, Minneapolis, MN 55455 USA.	trc@cccs.umn.edu	Duan, Fenghai/J-3709-2014; Aberle, Denise R./D-5699-2014; Berg, Christine/K-1047-2014; Gareen, Ilana/I-2816-2014; Church, Timothy/AAH-7017-2020	Duan, Fenghai/0000-0002-5084-0070; Aberle, Denise R./0000-0002-8858-3401; Gareen, Ilana/0000-0002-0457-5595; Church, Timothy/0000-0003-3292-5035; Edelman, Martin/0000-0002-3752-0726	National Cancer Institute; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025514, N01CN025518, N01CN075022, N01CN025512, N01CN025515, N01CN025522, N01CN025511, N01CN025513, N01CN025476, N01CN025516, N01CN025524] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [N01CA025522, N01CA025524, N01CA025514, N01CA025512, N01CA025518, N01CA025513, N01CA025516, N01CA075022, U01CA080098, U01CA079778, N01CA025515, U10CA080098, P30CA023108, N01CA025511] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute; NLST ClinicalTrials.gov number, NCT00047385.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American College of Radiology, 2002, STAND 2003 2004, P115; [Anonymous], 2009, MMWR-MORBID MORTAL W, V58, P1227; Cagnon CH, 2006, ACAD RADIOL, V13, P1431, DOI 10.1016/j.acra.2006.08.015; Church TR, 2003, ACAD RADIOL, V10, P713, DOI 10.1016/S1076-6332(03)80095-8; Efron B., 1993, CRC MONOGRAPHS STAT; Fontana RS, 2000, CANCER, V89, P2352, DOI 10.1002/1097-0142(20001201)89:11+<2352::AID-CNCR7>3.0.CO;2-5; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gierada DS, 2009, AM J ROENTGENOL, V193, P419, DOI 10.2214/AJR.08.1995; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Henschke CI, 2008, NEW ENGL J MED, V358, P1875; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Malarcher AM, 2000, AM J EPIDEMIOL, V152, P573, DOI 10.1093/aje/152.6.573; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; McMahon PM, 2011, J THORAC ONCOL, V6, P1841, DOI 10.1097/JTO.0b013e31822e59b3; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2002, CANC INCIDENCE 5 CON, VVIII; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Peto J, 2012, BRIT J CANCER, V107, P406, DOI 10.1038/bjc.2012.97; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sobin LH, 2002, TNM CLASSIFICATION M, V6th; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC	31	667	688	2	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1980	1991		10.1056/NEJMoa1209120	http://dx.doi.org/10.1056/NEJMoa1209120			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194KD	23697514	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000322630700008
J	Kawatani, Y; Hamilton, K				Kawatani, Yoshio; Hamilton, Kevin			Weakened stratospheric quasibiennial oscillation driven by increased tropical mean upwelling	NATURE			English	Article							BREWER-DOBSON CIRCULATION; CHANGING CLIMATE; QBO; PERIOD; MODEL; MODULATION; AIR; AGE	The zonal wind in the tropical stratosphere switches between prevailing easterlies and westerlies with a period of about 28 months(1). In the lowermost stratosphere, the vertical structure of this quasibiennial oscillation (QBO) is linked to the mean upwelling(2-4), which itself is a key factor in determining stratospheric composition. Evidence for changes in the QBO have until now been equivocal, raising questions as to the extent of stratospheric circulation changes in a global warming context. Here we report an analysis of near-equatorial radiosonde observations for 1953-2012, and reveal a long-term trend of weakening amplitude in the zonal wind QBO in the tropical lower stratosphere. The trend is particularly notable at the 70-hectopascal pressure level (an altitude of about 19 kilometres), where the QBO amplitudes dropped by roughly one-third over the period. This trend is also apparent in the global warming simulations of the four models in the Coupled Model Intercomparison Project Phase 5 (CMIP5) that realistically simulate the QBO. The weakening is most reasonably explained as resulting from a trend of increased mean tropical upwelling in the lower stratosphere. Almost all comprehensive climate models have projected an intensifying tropical upwelling in global warming scenarios(5-7), but attempts to estimate changes in the upwelling by using observational data have yielded ambiguous, inconclusive or contradictory results(8-10). Our discovery of a weakening trend in the lower-stratosphere QBO amplitude provides strong support for the existence of a long-term trend of enhanced upwelling near the tropical tropopause.	[Kawatani, Yoshio] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Hamilton, Kevin] Univ Hawaii Manoa, SOEST, Int Pacific Res Ctr, Honolulu, HI 96822 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Hawaii System; University of Hawaii Manoa	Kawatani, Y (corresponding author), Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Kanazawa Ku, 3173-25 Showamachi, Yokohama, Kanagawa 2360001, Japan.	yoskawatani@jamstec.go.jp	; Kawatani, Yoshio/B-1777-2013	Hamilton, Kevin/0000-0002-3560-8097; Kawatani, Yoshio/0000-0003-3260-8830	Japan Agency for Marine-Earth Science and Technology through International Pacific Research Center; Ministry of the Environment, Japan [A-1201]; JSPS KAKENHI [23740363, 24340113]; NASA [NNX07AG53G]; NOAA [NA11NMF4320128]; International Pacific Research Center; Data Integration and Analysis System (DIAS) Fund for National Key Technology from MEXT	Japan Agency for Marine-Earth Science and Technology through International Pacific Research Center; Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NASA(National Aeronautics & Space Administration (NASA)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); International Pacific Research Center; Data Integration and Analysis System (DIAS) Fund for National Key Technology from MEXT	This work was supported by the Japan Agency for Marine-Earth Science and Technology through its support of the International Pacific Research Center, by the Environment Research and Technology Development Fund (A-1201) of the Ministry of the Environment, Japan and by JSPS KAKENHI grant nos 23740363 and 24340113. This work was also supported by NASA (grant no. NNX07AG53G) and by NOAA (grant no. NA11NMF4320128), organisations that sponsor research at the International Pacific Research Center. We thank A. Noda, H. Tokinaga, M. Fujiwara, K. Miyazaki, M. Takahashi, T. Hirooka, K. Sato, H. Nakamura and Y. N. Takayabu for suggestions. We also thank O. Arakawa and N. Hirota for handling the CMIP5 data archive. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for making available their model output. For CMIP, the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We also acknowledge the Data Integration and Analysis System (DIAS) Fund for National Key Technology from MEXT.	Andrews D. G., 1987, MIDDLE ATMOSPHERE DY; Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; Butchart N, 2006, CLIM DYNAM, V27, P727, DOI 10.1007/s00382-006-0162-4; Butchart N, 2001, NATURE, V410, P799, DOI 10.1038/35071047; DUNKERTON TJ, 1985, J ATMOS SCI, V42, P376, DOI 10.1175/1520-0469(1985)042<0376:COTELS>2.0.CO;2; Engel A, 2009, NAT GEOSCI, V2, P28, DOI 10.1038/NGEO388; Garcia RR, 2008, J ATMOS SCI, V65, P2731, DOI 10.1175/2008JAS2712.1; Garfinkel CI, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008481; Geller MA, 1997, J ATMOS SCI, V54, P883, DOI 10.1175/1520-0469(1997)054<0883:COTSQB>2.0.CO;2; Hamilton K, 2004, J ATMOS SCI, V61, P383, DOI 10.1175/1520-0469; Hamilton K, 1999, J ATMOS SCI, V56, P3829, DOI 10.1175/1520-0469(1999)056<3829:MASWHV>2.0.CO;2; Hamilton K, 2002, J CLIMATE, V15, P2562, DOI 10.1175/1520-0442(2002)015<2562:OTQDMO>2.0.CO;2; KAROLY DJ, 1994, CLIM DYNAM, V10, P97, DOI 10.1007/s003820050038; Kawatani Y, 2011, J ATMOS SCI, V68, P265, DOI 10.1175/2010JAS3623.1; Kawatani Y, 2010, J ATMOS SCI, V67, P963, DOI 10.1175/2009JAS3222.1; LINDZEN RS, 1968, J ATMOS SCI, V25, P1095, DOI 10.1175/1520-0469(1968)025<1095:ATOTQB>2.0.CO;2; McLandress C, 2009, J CLIMATE, V22, P1516, DOI 10.1175/2008JCLI2679.1; NAUJOKAT B, 1986, J ATMOS SCI, V43, P1873, DOI 10.1175/1520-0469(1986)043<1873:AUOTOQ>2.0.CO;2; PLUMB RA, 1977, J ATMOS SCI, V34, P1847, DOI 10.1175/1520-0469(1977)034<1847:TIOTIW>2.0.CO;2; QUIROZ RS, 1981, MON WEATHER REV, V109, P665, DOI 10.1175/1520-0493(1981)109<0665:PMOTSQ>2.0.CO;2; Salby M, 2000, J CLIMATE, V13, P2652, DOI 10.1175/1520-0442(1999)012<2652:CBTSCA>2.0.CO;2; SARAVANAN R, 1990, J ATMOS SCI, V47, P2465, DOI 10.1175/1520-0469(1990)047<2465:AMMOTQ>2.0.CO;2; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Stiller GP, 2012, ATMOS CHEM PHYS, V12, P3311, DOI 10.5194/acp-12-3311-2012; Taguchi M, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014325; Takahashi M, 1996, GEOPHYS RES LETT, V23, P661, DOI 10.1029/95GL03413; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Watanabe S, 2012, J METEOROL SOC JPN, V90A, P351, DOI 10.2151/jmsj.2012-A20; Young PJ, 2012, J CLIMATE, V25, P1759, DOI 10.1175/2011JCLI4048.1	29	87	87	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					478	+		10.1038/nature12140	http://dx.doi.org/10.1038/nature12140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698448				2022-12-28	WOS:000319254000045
J	Chou, R				Chou, Roger			Review: Epidural corticosteroids reduce short- but not long-term leg pain and disability in sciatica	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.		Maher, Christopher/AAC-6267-2019; Pinto, Rafael Zambelli/I-2892-2012; Maher, Chris G/G-9682-2014	Maher, Christopher/0000-0002-1628-7857; Pinto, Rafael Zambelli/0000-0002-2775-860X; 				Moore A, 1997, PAIN, V69, P311, DOI 10.1016/S0304-3959(96)03306-4; Smith RM, 2012, NEW ENGL J MED; Vad VB, 2002, SPINE, V27, P11, DOI 10.1097/00007632-200201010-00005	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC7	10.7326/0003-4819-158-10-201305210-02007	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689786				2022-12-28	WOS:000319666200006
J	Arinaminpathy, N; Cordier-Lassalle, T; Vijay, A; Dye, C				Arinaminpathy, Nimalan; Cordier-Lassalle, Thierry; Vijay, Anant; Dye, Christopher			The Global Drug Facility and its role in the market for tuberculosis drugs	LANCET			English	Article							TB; PROCUREMENT; FUND; PLAN	Universal access to high-quality treatment is central to the Global Plan to Stop TB. The Global Drug Facility (GDF) was launched in 2001 to help to achieve this goal, through services including the supply of affordable, quality-assured drugs to countries in need. We assess the scale of GDF drug supplies worldwide and find that the GDF commands a substantial proportion of the market for drugs for first-line and second-line treatment regimens, having supplied, for example, first-line drugs for roughly 35% of cases reported worldwide in 2011. Significant potential remains for GDF expansion, especially in the provision of second-line drugs, which would be aided by future increases in case detection.	[Arinaminpathy, Nimalan] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Cordier-Lassalle, Thierry] WHO, Stop TB Global Drug Facil, CH-1211 Geneva, Switzerland; [Vijay, Anant] WHO, Stop TB Partnership Secretariat, CH-1211 Geneva, Switzerland; [Dye, Christopher] WHO, HIV AIDS TB Malaria & Neglected Trop Dis, CH-1211 Geneva, Switzerland	Princeton University; World Health Organization; World Health Organization; World Health Organization	Arinaminpathy, N (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	nimpathy@princeton.edu	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793; Arinaminpathy, Nimalan/0000-0001-9502-6876	Stop TB Partnership; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Stop TB Partnership; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NA was partly funded for this analysis by the Stop TB Partnership. TC-L is a staff member of the Stop TB Global Drug Facility and WHO. AV has been a member of the Stop TB Partnership. CD is a staff member of WHO. The authors alone are responsible for the views expressed in this publication, which do not necessarily represent the decisions, policy, or views of WHO.	Bate R, 2013, INT J TUBERC LUNG D, V17, P308, DOI 10.5588/ijtld.12.0355; Butler D, 2012, NATURE, V491, P508, DOI 10.1038/491508a; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; Global Drug Facility, ANN REP 2010; Global Drug Facility, 2010, QUAL ASS POL PROC; Hanif SNM, 2011, INT J TUBERC LUNG D, V15, P1274, DOI 10.5588/ijtld.11.0394; Kumaresan J, 2004, INT J TUBERC LUNG D, V8, P130; Matiru R, 2007, B WORLD HEALTH ORGAN, V85, P348, DOI 10.2471/BLT.06.035402; Maxmen A, 2012, NATURE, V490, P13, DOI 10.1038/490013a; Norval PY, 1999, INT J TUBERC LUNG D, V3, pS292; Portero JL, 2003, TROP MED INT HEALTH, V8, P329, DOI 10.1046/j.1365-3156.2003.01032.x; Raviglione MC, 2011, EUR RESPIR J, V37, P978, DOI 10.1183/09031936.00003111; Raviglione MC, 2006, INT J TUBERC LUNG D, V10, P238; Sabot O, 2012, LANCET, V379, pE25, DOI 10.1016/S0140-6736(11)61756-X; Stop TB Partnership, DOTS EXP WORK GROUP; Stop TB Partnership, 2001, GLOB PLAN STOP TB PH; Stop TB Partnership, 2011, FALL SHORT ENS ACC S; Styblo K, 1991, TUBERCULOSIS CAN BE, V2, P60; TB Stop partnership, 2011, GLOB PLAN STOP TB 20; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2003, TUBERCULOSIS, V83, P156, DOI 10.1016/S1472-9792(02)00073-2; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; Word Health Organization, GLOB TUB REP 2012; World Health Organization, 1998, GLOB TUB PROGR REP A; World Health Organization, 2006, ENG ALL HLTH CAR PRO; World Health Organization, 2011, SURV QUAL ANT MED CI; World Hlth Org, 2002, INT J TUBERC LUNG D, V6, P378	29	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1373	1379		10.1016/S0140-6736(13)60896-X	http://dx.doi.org/10.1016/S0140-6736(13)60896-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23726162				2022-12-28	WOS:000325975700027
J	Katz, J; Lee, ACC; Kozuki, N; Lawn, JE; Cousens, S; Blencowe, H; Ezzati, M; Bhutta, ZA; Marchant, T; Willey, BA; Adair, L; Barros, F; Baqui, AH; Christian, P; Fawzi, W; Gonzalez, R; Humphrey, J; Huybregts, L; Kolsteren, P; Mongkolchati, A; Mullany, LC; Ndyomugyenyi, R; Nien, JK; Osrin, D; Roberfroid, D; Sania, A; Schmiegelow, C; Silveira, MF; Tielsch, J; Vaidya, A; Velaphi, SC; Victora, CG; Watson-Jones, D; Black, RE				Katz, Joanne; Lee, Anne C. C.; Kozuki, Naoko; Lawn, Joy E.; Cousens, Simon; Blencowe, Hannah; Ezzati, Majid; Bhutta, Zulfiqar A.; Marchant, Tanya; Willey, Barbara A.; Adair, Linda; Barros, Fernando; Baqui, Abdullah H.; Christian, Parul; Fawzi, Wafaie; Gonzalez, Rogelio; Humphrey, Jean; Huybregts, Lieven; Kolsteren, Patrick; Mongkolchati, Aroonsri; Mullany, Luke C.; Ndyomugyenyi, Richard; Nien, Jyh Kae; Osrin, David; Roberfroid, Dominique; Sania, Ayesha; Schmiegelow, Christentze; Silveira, Mariangela F.; Tielsch, James; Vaidya, Anjana; Velaphi, Sithembiso C.; Victora, Cesar G.; Watson-Jones, Deborah; Black, Robert E.		CHERG Small-for-Gestational-Age-Pr	Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis	LANCET			English	Article							MULTIPLE MICRONUTRIENT SUPPLEMENTATION; INTRAUTERINE GROWTH-RETARDATION; PLACEBO-CONTROLLED TRIAL; LOW-BIRTH-WEIGHT; COHORT PROFILE; VITAMIN-A; NEONATAL-MORTALITY; RANDOMIZED-TRIAL; FETAL-GROWTH; DOUBLE-BLIND	Background Babies with low birthweight (<2500 g) are at increased risk of early mortality. However, low birthweight includes babies born preterm and with fetal growth restriction, and not all these infants have a birthweight less than 2500 g. We estimated the neonatal and infant mortality associated with these two characteristics in low-income and middle-income countries. Methods For this pooled analysis, we searched all available studies and identified 20 cohorts (providing data for 2 015 019 livebirths) from Asia, Africa, and Latin America that recorded data for birthweight, gestational age, and vital statistics through 28 days of life. Study dates ranged from 1982 through to 2010. We calculated relative risks (RR) and risk differences (RD) for mortality associated with preterm birth (<32 weeks, 32 weeks to <34 weeks, 34 weeks to <37 weeks), small-for-gestational-age (SGA; babies with birthweight in the lowest third percentile and between the third and tenth percentile of a US reference population), and preterm and SGA combinations. Findings Pooled overall RRs for preterm were 6.82 (95% CI 3.56-13.07) for neonatal mortality and 2.50 (1.48-4.22) for post-neonatal mortality. Pooled RRs for babies who were SGA (with birthweight in the lowest tenth percentile of the reference population) were 1.83 (95% CI 1.34-2.50) for neonatal mortality and 1.90 (1.32-2.73) for post-neonatal mortality. The neonatal mortality risk of babies who were both preterm and SGA was higher than that of babies with either characteristic alone (15.42; 9.11-26.12). Interpretation Many babies in low-income and middle-income countries are SGA. Preterm birth affects a smaller number of neonates than does SGA, but is associated with a higher mortality risk. The mortality risks associated with both characteristics extend beyond the neonatal period. Differentiation of the burden and risk of babies born preterm and SGA rather than with low birthweight could guide prevention and management strategies to speed progress towards Millennium Development Goal 4-the reduction of child mortality.	[Katz, Joanne; Lee, Anne C. C.; Kozuki, Naoko; Baqui, Abdullah H.; Christian, Parul; Humphrey, Jean; Mullany, Luke C.; Tielsch, James; Black, Robert E.] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Lee, Anne C. C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Lawn, Joy E.] Saving Newborn Lives & Save Children USA, Washington, DC USA; [Lawn, Joy E.; Marchant, Tanya; Willey, Barbara A.] London Sch Hyg & Trop Med, Maternal Reprod & Child Hlth Ctr, London WC1, England; [Cousens, Simon; Blencowe, Hannah; Willey, Barbara A.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan; [Marchant, Tanya] London Sch Hyg & Trop Med, Fac Infect Dis & Trop Dis, London WC1, England; [Marchant, Tanya; Willey, Barbara A.; Watson-Jones, Deborah] London Sch Hyg & Trop Med, Malaria Ctr, London WC1, England; [Adair, Linda] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Barros, Fernando; Silveira, Mariangela F.; Victora, Cesar G.] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, RS, Brazil; [Barros, Fernando] Univ Catolica Pelotas, Programa Posgrad Saude Comportamento, Pelotas, RS, Brazil; [Fawzi, Wafaie] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Fawzi, Wafaie; Sania, Ayesha] Harvard Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA 02115 USA; [Fawzi, Wafaie] Harvard Univ, Dept Global Hlth & Populat, Sch Publ Hlth, Boston, MA 02115 USA; [Gonzalez, Rogelio] Pontificia Univ Catolica Chile, Santiago, Chile; [Gonzalez, Rogelio] Clin Santa Maria, Santiago, Chile; [Humphrey, Jean] Borrowdale, Zvitambo, Harare, Zimbabwe; [Huybregts, Lieven; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, B-9000 Ghent, Belgium; [Huybregts, Lieven; Kolsteren, Patrick; Roberfroid, Dominique] Inst Trop Med, Woman & Child Hlth Res Ctr, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Mongkolchati, Aroonsri] Mahidol Univ, ASEAN Inst Hlth Dev, Nakhon Pathom, Thailand; [Ndyomugyenyi, Richard] Minist Hlth, Vector Control Div, Kampala, Uganda; [Nien, Jyh Kae] Clin Davila, Fetal Maternal Med Unit, Santiago, Chile; [Nien, Jyh Kae] Univ Los Andes, Fac Med, Santiago, Chile; [Osrin, David; Vaidya, Anjana] UCL Inst Child Hlth, Inst Global Hlth, London, England; [Tielsch, James] George Washington Univ, Dept Global Hlth, George Washington Sch Publ Hlth & Hlth Serv, Washington, DC USA; [Schmiegelow, Christentze] Univ Copenhagen, Ctr Med Parasitol, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Schmiegelow, Christentze] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Velaphi, Sithembiso C.] Univ Witwatersrand, Dept Paediat, Div Neonatol, Chris Hani Baragwaneth Hosp, Soweto, South Africa; [Watson-Jones, Deborah] Natl Inst Med Res, Mwanza Intervent Trial Unit, Mwanza, Tanzania	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Brigham & Women's Hospital; Save the Children; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Aga Khan University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Pontificia Universidad Catolica de Chile; Ghent University; Institute of Tropical Medicine (ITM); Mahidol University; Clinica Davila; Universidad de los Andes - Chile; University of London; University College London; George Washington University; University of Copenhagen; University of Copenhagen; University of Witwatersrand; National Institute of Medical Research	Katz, J (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,W5009, Baltimore, MD 21205 USA.	jkatz@jhsph.edu	Victora, Cesar Gomes/Y-2455-2019; Huybregts, Lieven/B-9578-2009; Victora, Cesar G/D-4476-2013; Lawn, Joy/ABE-6382-2020; Silveira, Mariangela F/L-6868-2013; Nien, Jyh Kae/AAT-2826-2020	Victora, Cesar Gomes/0000-0002-2465-2180; Huybregts, Lieven/0000-0002-3068-2853; Victora, Cesar G/0000-0002-2465-2180; Lawn, Joy/0000-0002-4573-1443; Silveira, Mariangela F/0000-0002-3551-9713; Nien, Jyh Kae/0000-0002-2572-9653; Blencowe, Hannah/0000-0003-1556-3159; Sania, Ayesha/0000-0002-6445-9481; Katz, Joanne/0000-0002-5997-7823; shmiegelow, christentze/0000-0002-9360-9741; Black, Robert/0000-0001-9926-7984; Marchant, Tanya/0000-0002-4228-4334; Tielsch, James/0000-0002-1151-060X	Bill & Melinda Gates Foundation; MRC [G0901756] Funding Source: UKRI; Medical Research Council [G0801056B, G0901756] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Bill & Melinda Gates Foundation.	ADAIR LS, 1989, PEDIATRICS, V84, P613; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Barfield WD, 2012, LATE PRETERM INFANTS; Bhutta ZA, 2013, LANCET; Bhutta ZA, 2009, FOOD NUTR BULL, V30, pS496, DOI 10.1177/15648265090304S404; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bott SJS, 2000, ADULTHOOD EXPLORING; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Clausson B, 1998, BRIT J OBSTET GYNAEC, V105, P1011, DOI 10.1111/j.1471-0528.1998.tb10266.x; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; Gonzalez R, 2006, PEDIATRICS, V117, pE949, DOI 10.1542/peds.2005-2354; Grisaru-Granovsky S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.08.025; Humphrey JH, 2006, AIDS, V20, P1437, DOI 10.1097/01.aids.0000233578.72091.09; Huybregts L, 2009, AM J CLIN NUTR, V90, P1593, DOI 10.3945/ajcn.2009.28253; Isaranurug Sirikul, 2007, Journal of the Medical Association of Thailand, V90, P2559; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Kristensen S, 2007, EARLY HUM DEV, V83, P99, DOI 10.1016/j.earlhumdev.2006.05.008; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Lee ACC, LANCET GLOB IN PRESS; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; March of Dimes, 2012, BORN TOO SOON GLOB A; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; Mehra Sunil, 2004, Indian Pediatr, V41, P137; Monden CWS, 2009, AM J HUM BIOL, V21, P305, DOI 10.1002/ajhb.20860; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Narchi H, 2010, J MATERN-FETAL NEO M, V23, P48, DOI 10.3109/14767050903067352; Ndyomugyenyi R, 2011, T ROY SOC TROP MED H, V105, P607, DOI 10.1016/j.trstmh.2011.07.012; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Osendarp SJM, 2000, AM J CLIN NUTR, V71, P114; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Pulver LS, 2009, PEDIATRICS, V123, pE1072, DOI 10.1542/peds.2008-3288; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; Regev RH, 2004, CLIN PERINATOL, V31, P453, DOI 10.1016/j.clp.2004.04.017; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Santos IS, 2011, INT J EPIDEMIOL, V40, P1461, DOI 10.1093/ije/dyq130; Schmiegelow C, 2012, ACTA OBSTET GYN SCAN, V91, P1061, DOI 10.1111/j.1600-0412.2012.01478.x; Tielsch JM, 2007, PEDIATRICS, V119, pE330, DOI 10.1542/peds.2006-1192; UNICEF, 2004, LOW BIRTHW COUNTR RE; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Wu LA, 2012, CHILD CARE HLTH DEV, V38, P332, DOI 10.1111/j.1365-2214.2011.01221.x	48	461	471	3	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					417	425		10.1016/S0140-6736(13)60993-9	http://dx.doi.org/10.1016/S0140-6736(13)60993-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MX	23746775	Green Accepted, Green Submitted			2022-12-28	WOS:000322638500034
J	Hondele, M; Stuwe, T; Hassler, M; Halbach, F; Bowman, A; Zhang, ET; Nijmeijer, B; Kotthoff, C; Rybin, V; Amlacher, S; Hurt, E; Ladurner, AG				Hondele, Maria; Stuwe, Tobias; Hassler, Markus; Halbach, Felix; Bowman, Andrew; Zhang, Elisa T.; Nijmeijer, Bianca; Kotthoff, Christiane; Rybin, Vladimir; Amlacher, Stefan; Hurt, Ed; Ladurner, Andreas G.			Structural basis of histone H2A-H2B recognition by the essential chaperone FACT	NATURE			English	Article							TRANSCRIPT ELONGATION; DNA; REVEALS; BINDING; DOMAIN; SPT16; HETERODIMER; REPLICATION; INITIATION; COMPLEX	Facilitates chromatin transcription (FACT) is a conserved histone chaperone that reorganizes nucleosomes and ensures chromatin integrity during DNA transcription, replication and repair(1-6). Key to the broad functions of FACT is its recognition of histones H2A-H2B (ref. 2). However, the structural basis for how histones H2A-H2B are recognized and how this integrates with the other functions of FACT, including the recognition of histones H3-H4 and other nuclear factors, is unknown. Here we reveal the crystal structure of the evolutionarily conserved FACT chaperone domain Spt16M from Chaetomium thermophilum, in complex with the H2A-H2B heterodimer. A novel 'U-turn' motif scaffolded onto a Rtt106-like module(7-10) embraces the alpha 1 helix of H2B. Biochemical and in vivo assays validate the structure and dissect the contribution of histone tails and H3-H4 towards Spt16M binding. Furthermore, we report the structure of the FACT heterodimerization domain that connects FACT to replicative polymerases. Our results show that Spt16M makes several interactions with histones, which we suggest allow the module to invade the nucleosome gradually and block the strongest interaction of H2B with DNA. FACT would thus enhance 'nucleosome breathing' by re-organizing the first 30 base pairs of nucleosomal histone-DNA contacts. Our snapshot of the engagement of the chaperone with H2A-H2B and the structures of all globular FACT domains enable the high-resolution analysis of the vital chaperoning functions of FACT, shedding light on how the complex promotes the activity of enzymes that require nucleosome reorganization.	[Hondele, Maria; Hassler, Markus; Bowman, Andrew; Kotthoff, Christiane; Ladurner, Andreas G.] Univ Munich, Butenandt Inst, Dept Physiol Chem, D-81377 Munich, Germany; [Hondele, Maria; Hassler, Markus; Bowman, Andrew; Kotthoff, Christiane; Ladurner, Andreas G.] Univ Munich, Fac Med, LMU Biomed Ctr, D-81377 Munich, Germany; [Hondele, Maria; Stuwe, Tobias; Hassler, Markus; Zhang, Elisa T.; Nijmeijer, Bianca; Rybin, Vladimir; Ladurner, Andreas G.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Hondele, Maria; Stuwe, Tobias; Hassler, Markus; Zhang, Elisa T.; Nijmeijer, Bianca; Rybin, Vladimir; Ladurner, Andreas G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Halbach, Felix] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Amlacher, Stefan; Hurt, Ed] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Ladurner, Andreas G.] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Ladurner, Andreas G.] Ctr Integrated Prot Sci Munich CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Max Planck Society; Ruprecht Karls University Heidelberg; University of Munich	Ladurner, AG (corresponding author), Univ Munich, Butenandt Inst, Dept Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	andreas.ladurner@med.lmu.de	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Hassler, Markus/0000-0001-9827-3477; Bowman, Andrew/0000-0002-5507-669X; Nijmeijer-Winter, Bianca/0000-0002-9429-8439; Ladurner, Andreas/0000-0003-3835-232X; Hondele, Maria/0000-0002-2733-2561	EMBL; LMU Munich; EC FP6 Marie Curie RTN Chromatin Plasticity; Boehringer Ingelheim Fonds	EMBL; LMU Munich; EC FP6 Marie Curie RTN Chromatin Plasticity; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank J. Basquin, E. Conti, the MPI for Biochemistry and staff at beamlines Swiss Light Source PXII and European Synchrotron Radiation Facility ID23 for crystallographic support, P. Becker, S. Hake, J. Muller and G. Schotta for H3 peptides, and F. Bonneau, P. Cramer, T. Gibson, D. Gilmour, J. Griesen beck, C. Haring, M. Hothorn, G. Jankevicius, D. Mokranjac, R. Russell, I. Schafer, K. Scheffzek, C. Schultz, F. Wieland, M. Winter and E. Wolf for discussion. EMBL, LMU Munich, EC FP6 Marie Curie RTN Chromatin Plasticity (to A. G. L.) and Boehringer Ingelheim Fonds (to M. Ho. and F. H.) funded this research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Capozzo C, 2000, YEAST, V16, P1089, DOI 10.1002/1097-0061(20000915)16:12<1089::AID-YEA600>3.3.CO;2-7; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; Hsieh F.-K., 2013, P NATL ACAD SCI US; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Killian JL, 2012, CURR OPIN STRUC BIOL, V22, P80, DOI 10.1016/j.sbi.2011.11.003; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; Kulaeva OI, 2009, NAT STRUCT MOL BIOL, V16, P1272, DOI 10.1038/nsmb.1689; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465; Zunder RM, 2012, P NATL ACAD SCI USA, V109, pE144, DOI 10.1073/pnas.1119095109	42	128	130	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					111	+		10.1038/nature12242	http://dx.doi.org/10.1038/nature12242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23698368				2022-12-28	WOS:000321285600044
J	Ablasser, A; Goldeck, M; Cavlar, T; Deimling, T; Witte, G; Rohl, I; Hopfner, KP; Ludwig, J; Hornung, V				Ablasser, Andrea; Goldeck, Marion; Cavlar, Taner; Deimling, Tobias; Witte, Gregor; Roehl, Ingo; Hopfner, Karl-Peter; Ludwig, Janos; Hornung, Veit			cGAS produces a 2 '-5 '-linked cyclic dinucleotide second messenger that activates STING	NATURE			English	Article							GMP-AMP SYNTHASE; C-DI-GMP; CYTOSOLIC DNA; RECOGNITION; ADAPTER; REVEALS; DISEASE; SIGNALS; BINDING; SENSOR	Detection of cytoplasmic DNA represents one of the most fundamental mechanisms of the innate immune system to sense the presence of microbial pathogens(1). Moreover, erroneous detection of endogenous DNA by the same sensing mechanisms has an important pathophysiological role in certain sterile inflammatory conditions(2,3). The endoplasmic-reticulum-resident protein STING is critically required for the initiation of type I interferon signalling upon detection of cytosolic DNA of both exogenous and endogenous origin(4-8). Next to its pivotal role in DNA sensing, STING also serves as a direct receptor for the detection of cyclic dinucleotides, which function as second messenger molecules in bacteria(9-13). DNA recognition, however, is triggered in an indirect fashion that depends on a recently characterized cytoplasmic nucleotidyl transferase, termed cGAMP synthase (cGAS), which upon interaction with DNA synthesizes a dinucleotide molecule that in turn binds to and activates STING(14,15). We here show in vivo and in vitro that the cGAS-catalysed reaction product is distinct from previously characterized cyclic dinucleotides. Using a combinatorial approach based on mass spectrometry, enzymatic digestion, NMR analysis and chemical synthesis we demonstrate that cGAS produces a cyclic GMP-AMP dinucleotide, which comprises a 2'-5' and a 3'-5' phosphodiester linkage. Gp(2'-5') Ap(3'-5')>. We found that the presence of this 2'-5' linkage was required to exert potent activation of human STING. Moreover, we show that cGAS first catalyses the synthesis of a linear 2'-5'-linked dinucleotide, which is then subject to cGAS-dependent cyclization in a second step through a 3'-5' phosphodiester linkage. This 13-membered ring structure defines a novel class of second messenger molecules, extending the family of 2'-5'-linked antiviral biomolecules.	[Ablasser, Andrea; Goldeck, Marion; Cavlar, Taner; Ludwig, Janos; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Deimling, Tobias; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Deimling, Tobias; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Roehl, Ingo] Axolabs GmbH, D-95326 Kulmbach, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Bonn; University of Munich; University of Munich; University of Munich	Ablasser, A (corresponding author), Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany.	andrea.ablasser@uni-bonn.de; veit.hornung@uni-bonn.de	Goldeck, Marion/AAX-5599-2020; Hopfner, Karl-Peter/B-6864-2014; Hornung, Veit/C-3565-2012; Witte, Gregor/B-4635-2011; Ludwig, Janos/I-3544-2013	Hopfner, Karl-Peter/0000-0002-4528-8357; Hornung, Veit/0000-0002-4150-194X; Witte, Gregor/0000-0003-0313-0962; Goldeck, Marion/0000-0003-1899-4763	National Institutes of Health [U19AI083025]; European Research Council [322869, ERC 243046]; Center for Integrated Protein Science Munich (CIPSM); German Research Foundation [SFB670]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Center for Integrated Protein Science Munich (CIPSM); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Pelegrin for providing us with LL171 cells. K.-P. H. is supported by the National Institutes of Health (U19AI083025), the European Research Council Advanced Grant 322869, and the Center for Integrated Protein Science Munich (CIPSM). A. A. and V. H. are members of the excellence cluster ImmunoSensation. V. H. is supported by grants from the German Research Foundation (SFB670) and the European Research Council (ERC 243046).	Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gaffney BL, 2010, ORG LETT, V12, P3269, DOI 10.1021/ol101236b; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	24	859	915	15	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					380	+		10.1038/nature12306	http://dx.doi.org/10.1038/nature12306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23722158	Green Accepted			2022-12-28	WOS:000320592900044
J	Saxena, S; Funk, M; Chisholm, D				Saxena, Shekhar; Funk, Michelle; Chisholm, Dan			World Health Assembly adopts Comprehensive Mental Health Action Plan 2013-2020	LANCET			English	Editorial Material							SCALE-UP; SERVICES		[Saxena, Shekhar; Funk, Michelle; Chisholm, Dan] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland	World Health Organization	Saxena, S (corresponding author), WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland.	saxenas@who.int						[Anonymous], 2013, DRAFT COMPREHENSIVE; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; IHP+Results, 2015, CONSTITUTION OF THE; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; World Health Organization, 2008, MHGAP MENTAL HEALTH	7	113	118	2	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 8	2013	381	9882					1970	1971		10.1016/S0140-6736(13)61139-3	http://dx.doi.org/10.1016/S0140-6736(13)61139-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171JY	23746771	Bronze			2022-12-28	WOS:000320924400010
J	Keller, M				Keller, Matthias			Interfacing Atoms and Light-The Smaller the Stronger	SCIENCE			English	Editorial Material							QUANTUM FACTORING ALGORITHM; STATE TRANSFER; SINGLE ATOMS; REALIZATION; NETWORK; CAVITY; PHOTON; CHIP; GATE		Univ Sussex, Dept Phys & Astron, Brighton, E Sussex, England	University of Sussex	Keller, M (corresponding author), Univ Sussex, Dept Phys & Astron, Brighton, E Sussex, England.	m.k.keller@sussex.ac.uk						Alton DJ, 2011, NAT PHYS, V7, P159, DOI [10.1038/nphys1837, 10.1038/NPHYS1837]; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Politi A, 2009, SCIENCE, V325, P1221, DOI 10.1126/science.1173731; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Schmidt-Kaler F, 2003, NATURE, V422, P408, DOI 10.1038/nature01494; Stute A, 2013, NAT PHOTONICS, V7, P219, DOI [10.1038/nphoton.2012.358, 10.1038/NPHOTON.2012.358]; Thompson JD, 2013, SCIENCE, V340, P1202, DOI 10.1126/science.1237125; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Ye J, 1999, PHYS REV LETT, V83, P4987, DOI 10.1103/PhysRevLett.83.4987	13	0	0	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1175	1176		10.1126/science.1239500	http://dx.doi.org/10.1126/science.1239500			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744932				2022-12-28	WOS:000319972800028
J	Conway, PH; Mostashari, F; Clancy, C				Conway, Patrick H.; Mostashari, Farzad; Clancy, Carolyn			The Future of Quality Measurement for Improvement and Accountability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Conway, Patrick H.; Mostashari, Farzad; Clancy, Carolyn] Dept Hlth & Human Serv, Washington, DC USA; [Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA; [Mostashari, Farzad] Off Natl Coordinator Hlth Informat Technol, Washington, DC USA; [Clancy, Carolyn] Agcy Healthcare Res & Qual, Rockville, MD USA	Centers for Medicare & Medicaid Services; Agency for Healthcare Research & Quality	Conway, PH (corresponding author), Ctr Medicare & Medicaid Serv, 7500 Secur Blvd,Mailstop S3-02-01, Baltimore, MD 21244 USA.	patrick.conway@cms.hhs.gov						Cimino JJ, 2013, JAMA-J AM MED ASSOC, V309, P991, DOI 10.1001/jama.2013.890; Conway PH, 2009, JAMA-J AM MED ASSOC, V301, P763, DOI 10.1001/jama.2009.103; Fleurant M, 2012, J AM MED INFORM ASSN, V19, P541, DOI 10.1136/amiajnl-2011-000689; Kern LM, 2013, ANN INTERN MED, V158, P77, DOI 10.7326/0003-4819-158-2-201301150-00001; US Department of Health and Human Services, 2012, ANN PROGR REP C NAT	5	72	72	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2215	2216		10.1001/jama.2013.4929	http://dx.doi.org/10.1001/jama.2013.4929			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736730				2022-12-28	WOS:000319859200022
J	Coomber, R; Cuffolo, G; Kalairajah, Y; Burtt, S; Bhumbra, R				Coomber, R.; Cuffolo, G.; Kalairajah, Y.; Burtt, S.; Bhumbra, R.			Forearm injury in a 5 year old boy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Coomber, R.; Cuffolo, G.; Kalairajah, Y.; Burtt, S.; Bhumbra, R.] Luton & Dunstable Hosp, Dept Orthopaed, Luton LU4 0DZ, Beds, England		Coomber, R (corresponding author), Luton & Dunstable Hosp, Dept Orthopaed, Luton LU4 0DZ, Beds, England.	Rosscoomber@hotmail.com		Cuffolo, Giulio/0000-0002-4553-5418				Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Monteggia GB, 1814, MILAN MASPERO, V5, P130; Ring D, 1998, J Am Acad Orthop Surg, V6, P215; Tan JW, 2008, INJURY, V39, P451, DOI 10.1016/j.injury.2007.07.010	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 5	2013	346								f3192	10.1136/bmj.f3192	http://dx.doi.org/10.1136/bmj.f3192			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YF	23739129				2022-12-28	WOS:000320229500002
J	Maier, RV				Maier, Ronald V.			Resuscitation Strategies in Trauma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MULTICENTER; INJURY		Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Maier, RV (corresponding author), Univ Washington, Harborview Med Ctr, Dept Surg, 325 9th Ave, Seattle, WA 98104 USA.	ronmaier@uw.edu						Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Inaba K, 2013, J AM COLL SURGEONS, V216, P290, DOI 10.1016/j.jamcollsurg.2012.10.017; Kian H, 2007, CHEST, V131, P1308, DOI 10.1378/chest.06-3048; Morrison JJ, 2013, JAMA SURG, V148, P218, DOI 10.1001/jamasurg.2013.764; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	10	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2270	2271		10.1001/jama.2013.5161	http://dx.doi.org/10.1001/jama.2013.5161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736736				2022-12-28	WOS:000319859200031
J	Willmann, G; Fischer, MD; Schatz, A; Schommer, K; Gekeler, F				Willmann, Gabriel; Fischer, M. Dominik; Schatz, Andreas; Schommer, Kai; Gekeler, Florian			Retinal Vessel Leakage at High Altitude	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Willmann, Gabriel; Fischer, M. Dominik; Schatz, Andreas; Gekeler, Florian] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Schommer, Kai] Heidelberg Univ, Med Clin, Dept Sports Med, Heidelberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Willmann, G (corresponding author), Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany.	gekeler@uni-tuebingen.de						Albert D.M., 2008, ALBERT JAKOBIECS PRI; FRAYSER R, 1971, ARCH INTERN MED, V127, P708, DOI 10.1001/archinte.127.4.708; FRAYSER R, 1970, NEW ENGL J MED, V282, P1183, DOI 10.1056/NEJM197005212822106; MCFADDEN DM, 1981, JAMA-J AM MED ASSOC, V245, P581, DOI 10.1001/jama.245.6.581; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402	6	20	21	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2210	2212		10.1001/jama.2013.5550	http://dx.doi.org/10.1001/jama.2013.5550			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736726	Bronze			2022-12-28	WOS:000319859200018
J	Gaston, K				Gaston, Kevin			A green light for efficiency	NATURE			English	Editorial Material									Univ Exeter, Environm & Sustainabil Inst, Penryn, England	University of Exeter	Gaston, K (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, England.	k.j.gaston@exeter.ac.uk		Gaston, Kevin J./0000-0002-7235-7928				Assum T, 1999, ACCIDENT ANAL PREV, V31, P545, DOI 10.1016/S0001-4575(99)00011-1; Beyer FR, 2010, COCHRANE DATABASE SY; Falchi F, 2011, J ENVIRON MANAGE, V92, P2714, DOI 10.1016/j.jenvman.2011.06.029; Gaston K. J., BIOL REV IN PRESS; Gaston KJ, 2012, J APPL ECOL, V49, P1256, DOI 10.1111/j.1365-2664.2012.02212.x; International Energy Agency, 2006, LIGHTS LAB LOS POL E; Marchant P., 2010, RADICAL STAT, V102, P32; Rich C., 2006, ECOLOGICAL CONSEQUEN; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178	9	22	22	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					560	561		10.1038/497560a	http://dx.doi.org/10.1038/497560a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	152UF	23719447	Bronze			2022-12-28	WOS:000319556100019
J	Philip, N; Waters, AP				Philip, Nisha; Waters, Andrew P.			Unveiling the Malaria Parasite's Cloak of Invisibility?	SCIENCE			English	Editorial Material							PLASMODIUM; PROTEIN		[Philip, Nisha; Waters, Andrew P.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow	Philip, N (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	andy.waters@glasgow.ac.uk		Philip, Nisha/0000-0001-9901-1997	Wellcome Trust [083811, 085349] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Dong YM, 2012, CELL HOST MICROBE, V12, P521, DOI 10.1016/j.chom.2012.09.004; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Thompson J, 2001, MOL BIOCHEM PARASIT, V118, P147, DOI 10.1016/S0166-6851(01)00377-2; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015	10	1	1	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					936	937		10.1126/science.1239146	http://dx.doi.org/10.1126/science.1239146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704563				2022-12-28	WOS:000319344100033
J	Bartlett, EC; Levison, WB; Munday, PE				Bartlett, Emily C.; Levison, Wendy B.; Munday, Pat E.			Pelvic inflammatory disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; COHORT; FERTILITY		[Bartlett, Emily C.] Kings Coll Hosp London, London SE5 9RS, England; [Levison, Wendy B.] Callowland Surg, Watford, England; [Munday, Pat E.] West Hertfordshire Hosp NHS Trust, Watford Gen Hosp, Watford, England	King's College Hospital NHS Foundation Trust; King's College Hospital; Watford General Hospital	Bartlett, EC (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	Emily.Bartlett@doctors.org.uk						BEVAN CD, 1995, BRIT J OBSTET GYNAEC, V102, P407, DOI 10.1111/j.1471-0528.1995.tb11294.x; Bignell C, 2012, UK NAT GUID GON TEST; British Association for Sexual Health and HIV. Clinical Effectiveness Group, 2011, UK NAT GUID MAN PELV; Doxanakis A, 2008, SEX TRANSM INFECT, V84, P518, DOI 10.1136/sti.2008.032318; French CE, 2011, SEX TRANSM DIS, V38, P158, DOI 10.1097/OLQ.0b013e3181f22f3e; Gaitan Hernando, 2002, Infect Dis Obstet Gynecol, V10, P171, DOI 10.1155/S1064744902000194; HILLIS SD, 1993, AM J OBSTET GYNECOL, V168, P1503, DOI 10.1016/S0002-9378(11)90790-X; MORCOS R, 1993, J REPROD MED, V38, P53; Munday PE, 2000, J INFECTION, V40, P31, DOI 10.1053/jinf.1999.0609; Ross J, 2008, CLIN EVID, V3, P1606; Royal College of Obstetricians and Gynaecologists, 2008, MAN AC PELV INFL DIS; SAFRIN S, 1992, AM J OBSTET GYNECOL, V166, P1300, DOI 10.1016/S0002-9378(11)90626-7; SELLORS J, 1991, AM J OBSTET GYNECOL, V164, P113, DOI 10.1016/0002-9378(91)90639-9; Simms I, 2003, SEX TRANSM INFECT, V79, P491, DOI 10.1136/sti.79.6.491; Taylor BD, 2011, SEX TRANSM DIS, V38, P434, DOI 10.1097/OLQ.0b013e3181ffa7c7; Walker CK, 2007, CLIN INFECT DIS, V44, pS111, DOI 10.1086/511424; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; Yeh JM, 2003, SEX TRANSM DIS, V30, P369, DOI 10.1097/00007435-200305000-00001	18	5	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2013	346								f3189	10.1136/bmj.f3189	http://dx.doi.org/10.1136/bmj.f3189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AW	23704128				2022-12-28	WOS:000319574500006
J	Eisenstein, M				Eisenstein, Michael			CHRONOBIOLOGY Stepping out of time	NATURE			English	Editorial Material																		Barger LK, 2012, SLEEP, V35, P1423, DOI 10.5665/sleep.2128; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Rajaratnam SMW, 2009, LANCET, V373, P482, DOI 10.1016/S0140-6736(08)61812-7; Revell VL, 2005, J BIOL RHYTHM, V20, P353, DOI 10.1177/0748730405277233; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030	8	17	19	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					S10	S12		10.1038/497S10a	http://dx.doi.org/10.1038/497S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698500	Bronze			2022-12-28	WOS:000319254000006
J	Eyink, G; Vishniac, E; Lalescu, C; Aluie, H; Kanov, K; Burger, K; Burns, R; Meneveau, C; Szalay, A				Eyink, Gregory; Vishniac, Ethan; Lalescu, Cristian; Aluie, Hussein; Kanov, Kalin; Buerger, Kai; Burns, Randal; Meneveau, Charles; Szalay, Alexander			Flux-freezing breakdown in high-conductivity magnetohydrodynamic turbulence	NATURE			English	Article							MAGNETIC RECONNECTION; DIFFUSION; LINES	The idea of 'frozen-in' magnetic field lines for ideal plasmas(1) is useful to explain diverse astrophysical phenomena(2), for example the shedding of excess angular momentum from protostars by twisting of field lines frozen into the interstellar medium. Frozen-in field lines, however, preclude the rapid changes in magnetic topology observed at high conductivities, as in solar flares(2,3). Microphysical plasma processes are a proposed explanation of the observed high rates(4-6), but it is an open question whether such processes can rapidly reconnect astrophysical flux structures much greater in extent than several thousand ion gyroradii. An alternative explanation(7,8) is that turbulent Richardson advection(9) brings field lines implosively together from distances far apart to separations of the order of gyroradii. Here we report an analysis of a simulation of magnetohydrodynamic turbulence at high conductivity that exhibits Richardson dispersion. This effect of advection in rough velocity fields, which appear non-differentiable in space, leads to line motions that are completely indeterministic or 'spontaneously stochastic', as predicted in analytical studies(10-13). The turbulent breakdown of standard flux freezing at scales greater than the ion gyroradius can explain fast reconnection of very large-scale flux structures, both observed (solar flares and coronal mass ejections) and predicted (the inner heliosheath, accretion disks, gamma-ray bursts and so on). For laminar plasma flows with smooth velocity fields or for low turbulence intensity, stochastic flux freezing reduces to the usual frozen-in condition. [GRAPHICS] .	[Eyink, Gregory; Lalescu, Cristian; Aluie, Hussein] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD 21218 USA; [Eyink, Gregory; Szalay, Alexander] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Eyink, Gregory; Meneveau, Charles] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Eyink, Gregory; Burns, Randal; Meneveau, Charles; Szalay, Alexander] Johns Hopkins Univ, Inst Data Intens Engn & Sci, Baltimore, MD 21218 USA; [Vishniac, Ethan] Univ Saskatchewan, Dept Phys & Engn Phys, Saskatoon, SK S7N 5E2, Canada; [Aluie, Hussein] Los Alamos Natl Lab, T Div, Los Alamos, NM 87545 USA; [Aluie, Hussein] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Kanov, Kalin; Burns, Randal] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Buerger, Kai] Tech Univ Munich, Fak Informat, D-85748 Garching, Germany	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Saskatchewan; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Johns Hopkins University; Technical University of Munich	Eyink, G (corresponding author), Johns Hopkins Univ, Dept Appl Math & Stat, 3400 North Charles St, Baltimore, MD 21218 USA.	eyink@jhu.edu	Meneveau, Charles/P-5120-2019; Meneveau, Charles/A-3319-2010; ALUIE, HUSSEIN/AAY-1147-2021	Meneveau, Charles/0000-0001-6947-3605; Meneveau, Charles/0000-0001-6947-3605; Vishniac, Ethan/0000-0002-2307-3857; Burns, Randal/0000-0002-2924-1997; Szalay, Alexander/0000-0002-4108-3282; Lalescu, Cristian C/0000-0003-0043-6632; Aluie, Hussein/0000-0003-3516-3697	US NSF [CDI-II: CMMI0941530, OCI-108849]; JHU's Institute for Data Intensive Engineering Science; National Science and Engineering Research Council of Canada; Directorate For Engineering [0941530] Funding Source: National Science Foundation; Office of Advanced Cyberinfrastructure (OAC) [1040114] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); JHU's Institute for Data Intensive Engineering Science; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The work of the group at the Johns Hopkins University was supported by the US NSF grant CDI-II: CMMI0941530, andthe database infrastructure was supported by US NSF grant OCI-108849 and JHU's Institute for Data Intensive Engineering & Science. The work of E. V. was supported by the National Science and Engineering Research Council of Canada. The authors thank R. Westermann for his contributions to the visualization tool and A. Lazarian for discussions of the science.	AlfvUn, 1942, ARK MAT ASTRON FYS, V29, P1, DOI DOI 10.1038/150405D0; [Anonymous], 2012, JHU TURB DAT CLUST; Beresnyak A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.075001; Bernard D, 1998, J STAT PHYS, V90, P519, DOI 10.1023/A:1023212600779; Boldyrev S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.115002; Busse A, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2818770; Chaves M, 2003, J STAT PHYS, V113, P643, DOI 10.1023/A:1027348316456; Che H, 2011, NATURE, V474, P184, DOI 10.1038/nature10091; Chepurnov A, 2010, ASTROPHYS J, V710, P853, DOI 10.1088/0004-637X/710/1/853; Ciaravella A, 2008, ASTROPHYS J, V686, P1372, DOI 10.1086/590655; Daughton W, 2011, NAT PHYS, V7, P539, DOI [10.1038/nphys1965, 10.1038/NPHYS1965]; E WN, 2000, P NATL ACAD SCI USA, V97, P8200, DOI 10.1073/pnas.97.15.8200; Eyink GL, 2007, PHYS LETT A, V368, P486, DOI 10.1016/j.physleta.2007.04.054; Eyink GL, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/51; Eyink GL, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056405; Eyink GL, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046314; Eyink GL, 2009, J MATH PHYS, V50, DOI 10.1063/1.3193681; Frisch U., 1995, TURBULENCE, P52; GOLDREICH P, 1995, ASTROPHYS J, V438, P763, DOI 10.1086/175121; Kowal G, 2009, ASTROPHYS J, V700, P63, DOI 10.1088/0004-637X/700/1/63; Kulsrud R. M., 2005, PLASMA PHYS ASTROPHY; Lazarian A, 1999, ASTROPHYS J, V517, P700, DOI 10.1086/307233; Leamon RJ, 1998, J GEOPHYS RES-SPACE, V103, P4775, DOI 10.1029/97JA03394; Li Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240802376389; Moser AL, 2012, NATURE, V482, P379, DOI 10.1038/nature10827; Priest E. R., 2000, MAGNETIC RECONNECTIO; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Sawford BL, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2946442; Schekochihin AA, 2009, ASTROPHYS J SUPPL S, V182, P310, DOI 10.1088/0067-0049/182/1/310	30	121	122	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					466	469		10.1038/nature12128	http://dx.doi.org/10.1038/nature12128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698445				2022-12-28	WOS:000319254000042
J	Xu, T; Agrawal, A; Abashin, M; Chau, KJ; Lezec, HJ				Xu, Ting; Agrawal, Amit; Abashin, Maxim; Chau, Kenneth J.; Lezec, Henri J.			All-angle negative refraction and active flat lensing of ultraviolet light	NATURE			English	Article							INDEX	Decades ago, Veselago(1) predicted that a material with simultaneously negative electric and magnetic polarization responses would yield a 'left-handed' medium in which light propagates with opposite phase and energy velocities-a condition described by a negative refractive index. He proposed that a flat slab of left-handed material possessing an isotropic refractive index of 21 could act like an imaging lens in free space. Left-handed materials do not occur naturally, and it has only recently become possible to achieve a left-handed response using metamaterials, that is, electromagnetic structures engineered on subwavelength scales to elicit tailored polarization responses. So far, left-handed responses have typically been implemented using resonant metamaterials composed of periodic arrays of unit cells containing inductive-capacitive resonators and conductive wires. Negative refractive indices that are isotropic in two(2) or three(3) dimensions at microwave frequencies have been achieved in resonant metamaterials with centimetre-scale features. Scaling the left-handed response to higher frequencies, such as infrared or visible, has been done by shrinking critical dimensions to submicrometre scales by means of top-down nanofabrication(4). This miniaturization has, however, so far been achieved at the cost of reduced unit-cell symmetry, yielding a refractive index that is negative along only one axis. Moreover, lithographic scaling limits have so far precluded the fabrication of resonant metamaterials with left-handed responses at frequencies beyond the visible(5). Here we report the experimental implementation of a bulk metamaterial with a left-handed response to ultraviolet light. The structure, based on stacked plasmonic waveguides(6), yields an omnidirectional left-handed response for transverse magnetic polarization characterized by a negative refractive index. By engineering the structure to have a refractive index close to -1 over a broad angular range, we achieve Veselago flat lensing, in free space, of arbitrarily shaped, two-dimensional objects beyond the near field. We further demonstrate active, all-optical modulation of the image transferred by the flat lens.	[Xu, Ting; Agrawal, Amit; Abashin, Maxim; Lezec, Henri J.] NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA; [Xu, Ting; Abashin, Maxim] Univ Maryland, Maryland Nano Ctr, College Pk, MD 20742 USA; [Agrawal, Amit] Syracuse Univ, Dept Elect Engn & Comp Sci, Syracuse, NY 13244 USA; [Chau, Kenneth J.] Univ British Columbia, Sch Engn, Kelowna, BC V1V 1V7, Canada	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Syracuse University; University of British Columbia	Lezec, HJ (corresponding author), NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA.	hlezec@nist.gov	Agrawal, Amit/C-3728-2009; Xu, Ting/D-3921-2013; Xu, Ting/E-7503-2018	Agrawal, Amit/0000-0001-8230-4603; Xu, Ting/0000-0002-2008-7049; Xu, Ting/0000-0002-0704-1089; Agrawal, Amit/0000-0002-9619-7623	University of Maryland [70NANB10H193]	University of Maryland	We thank A. Liddle, K. Srinivasan, R. McMichael, A. Nahata and S. Blair for discussions. We also thank the staff from CNST NanoFab for technical support. T. X. and M. A. acknowledge support under the Cooperative Research Agreement between the University of Maryland and the National Institute of Standards and Technology Center for Nanoscale Science and Technology, award number 70NANB10H193, through the University of Maryland.	Alu A, 2006, J OPT SOC AM B, V23, P571, DOI 10.1364/JOSAB.23.000571; Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Depine RA, 2004, MICROW OPT TECHN LET, V41, P315, DOI 10.1002/mop.20127; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Foteinopoulou S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.235107; Garcia N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207403; Grbic A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.117403; Hess O, 2012, NAT MATER, V11, P573, DOI [10.1038/nmat3356, 10.1038/NMAT3356]; Houck AA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.137401; Iyer AK, 2009, IEEE T ANTENN PROPAG, V57, P1720, DOI 10.1109/TAP.2009.2019890; Kao CK, 2011, J APPL PHYS, V109, DOI 10.1063/1.3567921; Lezec HJ, 2007, SCIENCE, V316, P430, DOI 10.1126/science.1139266; Loschialpo PF, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.025602; Menzel C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.195328; Nieto-Vesperinas M, 2004, J OPT SOC AM A, V21, P491, DOI 10.1364/JOSAA.21.000491; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Rao XS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.067601; Rudolph SM, 2012, IEEE T ANTENN PROPAG, V60, P3661, DOI 10.1109/TAP.2012.2201079; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shin H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.073907; Shvets G, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035109; Soukoulis CM, 2011, NAT PHOTONICS, V5, P523, DOI [10.1038/NPHOTON.2011.154, 10.1038/nphoton.2011.154]; Verhagen E, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.223901; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Xiao SM, 2009, OPT LETT, V34, P3478, DOI 10.1364/OL.34.003478; Yeh P., 1988, OPTICAL WAVES LAYERE, P118; Zhang XY, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2770995; Ziolkowski RW, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.056625	30	230	232	10	369	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					470	474		10.1038/nature12158	http://dx.doi.org/10.1038/nature12158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698446				2022-12-28	WOS:000319254000043
J	Cheifetz, AS				Cheifetz, Adam S.			Management of Active Crohn Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; PRACTICE GUIDELINES; RANDOMIZED-TRIAL; ACTIVITY INDEX; MAINTENANCE INFLIXIMAB; MONOCLONAL-ANTIBODY; HUMANIZED ANTIBODY; BIOLOGICAL THERAPY; AMERICAN-COLLEGE		[Cheifetz, Adam S.] Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, Boston, MA 02215 USA; [Cheifetz, Adam S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Cheifetz, AS (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, Div Gastroenterol, Rabb Rose 425,330 Brookline Ave, Boston, MA 02215 USA.	acheifet@bidmc.harvard.edu			Pfizer; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK092235-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092235, U01DK062422] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Cheifetz reports participation in advisory boards for UCB, Janssen (previously Centocor), Abbott, Warner-Chillcot (previously Procter & Gamble), Shire, Given Imaging, and Prometheus. He reports research support from Pfizer and the National Institute of Diabetes and Digestive and Kidney Diseases (grant 1R01DK092235-01A1).	Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P37, DOI [10.1002/ibd.22951, 10.1097/MIB.0b013e3182902ad9]; Baert F, 2010, GASTROENTEROLOGY, V138, P463, DOI 10.1053/j.gastro.2009.09.056; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Benchimol EI, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006792.pub2; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Biancone L, 2008, J CROHNS COLITIS, V2, P63, DOI 10.1016/j.crohns.2007.12.001; Bodger K, 2009, ALIMENT PHARM THER, V30, P265, DOI 10.1111/j.1365-2036.2009.04033.x; Canavan C, 2006, ALIMENT PHARM THER, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x; Cheifetz A, 2003, AM J GASTROENTEROL, V98, P1315, DOI 10.1016/S0002-9270(03)00231-4; Cheifetz AS, 2006, AM J GASTROENTEROL, V101, P2218, DOI 10.1111/j.1572-0241.2006.00761.x; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Colombel JF, 2006, GUT, V55, P1561, DOI 10.1136/gut.2005.084301; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Cullen G, 2011, ALIMENT PHARM THER, V34, P1318, DOI 10.1111/j.1365-2036.2011.04866.x; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Doherty GA, 2011, GASTROINTEST ENDOSC, V74, P167, DOI 10.1016/j.gie.2011.01.067; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.037, 10.1053/j.gastro.2009.12.035]; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; Feagan BG, 2008, CLIN GASTROENTEROL H, V6, P1370, DOI 10.1016/j.cgh.2008.06.007; Feuerstein JD, 2013, ALIMENT PHARM THER, V37, P937, DOI 10.1111/apt.12290; Gibbons RJ, 2003, CIRCULATION, V107, P2979, DOI 10.1161/01.CIR.0000063682.20730.A5; GREENBERG GR, 1994, NEW ENGL J MED, V331, P836, DOI 10.1056/NEJM199409293311303; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P379, DOI 10.1016/S1542-3565(04)00122-3; Heresbach D, 2005, GUT, V54, P215, DOI 10.1136/gut.2004.041715; Jess T, 2012, GASTROENTEROLOGY, V143, P375, DOI 10.1053/j.gastro.2012.04.016; Kornbluth A, 2004, AM J GASTROENTEROL, V99, P1371, DOI 10.1111/j.1572-0241.2004.40036.x; Korzenik JR, 2007, GUT, V56, P2, DOI 10.1136/gut.2006.095588; KURATA JH, 1992, GASTROENTEROLOGY, V102, P1940, DOI 10.1016/0016-5085(92)90317-R; Lahiff C, 2013, ALIMENT PHARM THER, V37, P786, DOI 10.1111/apt.12262; Lees CW, 2008, ALIMENT PHARM THER, V27, P220, DOI 10.1111/j.1365-2036.2007.03570.x; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Louis E, 2012, GASTROENTEROLOGY, V142, P63, DOI 10.1053/j.gastro.2011.09.034; MALCHOW H, 1984, GASTROENTEROLOGY, V86, P249; McLeod RS, 1997, GASTROENTEROLOGY, V113, P1823, DOI 10.1016/S0016-5085(97)70001-5; Moum B, 1997, SCAND J GASTROENTERO, V32, P1005, DOI 10.3109/00365529709011217; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; MUNKHOLM P, 1995, SCAND J GASTROENTERO, V30, P699, DOI 10.3109/00365529509096316; Odes S, 2008, WORLD J GASTROENTERO, V14, P6641, DOI 10.3748/wjg.14.6641; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000545.pub2; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Romberg-Camps MJL, 2009, AM J GASTROENTEROL, V104, P371, DOI 10.1038/ajg.2008.38; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956, DOI 10.1016/0016-5085(90)90613-6; Sandborn W., 2000, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000545; Sandborn WJ, 2007, GUT, V56, P1232, DOI 10.1136/gut.2006.106781; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Sands BE, 2006, ALIMENT PHARM THERAP, V23, P1127, DOI 10.1111/j.1365-2036.2006.02878.x; Sands BE, 2005, INFLAMM BOWEL DIS, V11, P133, DOI 10.1097/00054725-200502000-00006; Schnitzler F, 2009, INFLAMM BOWEL DIS, V15, P1295, DOI 10.1002/ibd.20927; Seow CH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000296.pub3; Siegel CA, 2009, CLIN GASTROENTEROL H, V7, P874, DOI 10.1016/j.cgh.2009.01.004; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; SILVERSTEIN MD, 1989, AM J GASTROENTEROL, V84, P31; Singh B, 2004, BRIT J SURG, V91, P801, DOI 10.1002/bjs.4613; Stappenbeck TS, 2011, AUTOPHAGY, V7, P355, DOI 10.4161/auto.7.2.13074; Thomsen OO, 1998, NEW ENGL J MED, V339, P370, DOI 10.1056/NEJM199808063390603; Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Treton X, 2009, CLIN GASTROENTEROL H, V7, P80, DOI 10.1016/j.cgh.2008.08.028; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Van Assche G, 2011, AM J GASTROENTEROL, V106, P1594, DOI 10.1038/ajg.2011.211; Vasiliauskas EA, 2000, GUT, V47, P487, DOI 10.1136/gut.47.4.487; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; Zimmermann EM, 2011, CURR OPIN GASTROEN, V27, P132, DOI 10.1097/MOG.0b013e3283438e5d	79	81	87	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2150	2158		10.1001/jama.2013.4466	http://dx.doi.org/10.1001/jama.2013.4466			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23695484	Green Accepted			2022-12-28	WOS:000319229600031
J	Kyithar, MP; Dinneen, SF				Kyithar, Ma P.; Dinneen, Sean F.			An intensive lifestyle intervention increased remission from type 2 diabetes in overweight adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kyithar, Ma P.; Dinneen, Sean F.] Galway Roscommon Univ Hosp Grp, Galway, Ireland		Kyithar, MP (corresponding author), Galway Roscommon Univ Hosp Grp, Galway, Ireland.							National Institutes of Health, 2012, WEIGHT LOSS DOES NOT	1	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC4	10.7326/0003-4819-158-10-201305210-02004	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689783				2022-12-28	WOS:000319666200003
J	Cheetham, SW; Brand, AH				Cheetham, Seth W.; Brand, Andrea H.			Insulin Finds Its Niche	SCIENCE			English	Editorial Material							ADULT HIPPOCAMPUS; STEM-CELLS; IGF-I; GROWTH; NEUROGENESIS; MECHANISMS; DROSOPHILA		[Cheetham, Seth W.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Cheetham, SW (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	a.brand@gurdon.cam.ac.uk	Cheetham, Seth/C-8842-2018; Brand, Andrea H/F-8220-2014	Cheetham, Seth/0000-0001-6428-3175; Brand, Andrea H/0000-0002-2089-6954	Wellcome Trust [092096] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aberg MAI, 2000, J NEUROSCI, V20, P2896; Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Britton JS, 1998, DEVELOPMENT, V125, P2149; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG1307, DOI 10.1152/ajpgi.2000.279.6.G1307; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Zygar CA, 2005, DEV BRAIN RES, V154, P91, DOI 10.1016/j.devbrainres.2004.10.009	16	9	9	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					817	818		10.1126/science.1238525	http://dx.doi.org/10.1126/science.1238525			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687033				2022-12-28	WOS:000318997400027
J	Griffin, MR				Griffin, Marie R.			High-dose non-steroidal anti-inflammatories: painful choices	LANCET			English	Editorial Material							DRUGS; RISK; COMPLICATIONS; ROFECOXIB; NAPROXEN; COX-2		[Griffin, Marie R.] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37212 USA; [Griffin, Marie R.] VA TN Valley Hlth Care Syst, Midsouth Geriatr Res Educ & Clin Ctr, Nashville, TN USA	Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Griffin, MR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37212 USA.	marie.griffin@vanderbilt.edu						Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; CHALMERS TC, 1988, ALIMENT PHARM THERAP, V2, P9; Coxib and traditional NSAID Trialists' (CNT) Collaboration, 2013, LANCET; Dowell D, 2013, JAMA-J AM MED ASSOC, V309, P2219, DOI 10.1001/jama.2013.5794; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; Rodriguez LAG, 2008, J AM COLL CARDIOL, V52, P1628, DOI 10.1016/j.jacc.2008.08.041; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Kuijpers T, 2011, EUR SPINE J, V20, P40, DOI 10.1007/s00586-010-1541-4; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Reid MC, 2011, PAIN MED, V12, P1336, DOI 10.1111/j.1526-4637.2011.01211.x; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109	16	8	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 31	2013	382	9894					746	748		10.1016/S0140-6736(13)61128-9	http://dx.doi.org/10.1016/S0140-6736(13)61128-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23726391				2022-12-28	WOS:000324239200005
J	Stevens, SM; Woller, SC				Stevens, Scott M.; Woller, Scott C.			Intermittent pneumatic compression in patients with stroke	LANCET			English	Editorial Material							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; RANDOMIZED-TRIAL; THIGH-LENGTH; PROPHYLAXIS; RISK; PREVENTION; STOCKINGS		[Stevens, Scott M.] Intermt Med Ctr, Thrombosis Clin, Murray, UT 84107 USA; Univ Utah, Dept Med, Salt Lake City, UT 84112 USA	Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah	Stevens, SM (corresponding author), Intermt Med Ctr, Thrombosis Clin, Murray, UT 84107 USA.	scott.stevensmd@imail.org	Woller, Scott C./AAV-6187-2021	Woller, Scott C./0000-0002-2522-2705				Bath PMW, 2000, STROKE, V31, P1770, DOI 10.1161/01.STR.31.7.1770; Bockheim HM, 2009, J CRIT CARE, V24, P192, DOI 10.1016/j.jcrc.2009.01.001; Bounameaux H, 2013, THROMB HAEMOSTASIS, V109, P585, DOI 10.1160/TH12-08-0627; CLOTS (Clots in Legs Or sTockings after Stroke) trials collaboration, 2013, LANCET; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Colwell CW, 2010, J BONE JOINT SURG AM, V92A, P527, DOI 10.2106/JBJS.I.00047; Dennis M, 2010, ANN INTERN MED, V153, P553, DOI 10.7326/0003-4819-153-9-201011020-00280; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Kahn SR, 2012, CHEST S, V141; Lederle FA, 2011, ANN INTERN MED, V155, P602, DOI 10.7326/0003-4819-155-9-201111010-00008; Wakefield TW, 2009, J VASC SURG, V49, P1620, DOI 10.1016/j.jvs.2009.01.058; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	13	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 10	2013	382	9891					484	486		10.1016/S0140-6736(13)61099-5	http://dx.doi.org/10.1016/S0140-6736(13)61099-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201SD	23731708	hybrid			2022-12-28	WOS:000323162400006
J	Black, RE; Victora, CG; Walker, SP; Bhutta, ZA; Christian, P; de Onis, M; Ezzati, M; Grantham-McGregor, S; Katz, J; Martorell, R; Uauy, R				Black, Robert E.; Victora, Cesar G.; Walker, Susan P.; Bhutta, Zulfiqar A.; Christian, Parul; de Onis, Mercedes; Ezzati, Majid; Grantham-McGregor, Sally; Katz, Joanne; Martorell, Reynaldo; Uauy, Ricardo		Maternal Child Nutr Study Grp	Maternal and child undernutrition and overweight in low-income and middle-income countries	LANCET			English	Article							VITAMIN-D DEFICIENCY; LOW-BIRTH-WEIGHT; BETA-CAROTENE SUPPLEMENTATION; PREVENTIVE ZINC SUPPLEMENTATION; PREGNANCY-RELATED MORTALITY; MULTIPLE MICRONUTRIENT SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; 1959-1961 CHINESE FAMINE; EARLY INFANT-MORTALITY; LONG-TERM HEALTH	Maternal and child malnutrition in low-income and middle-income countries encompasses both under nutrition and a growing problem with overweight and obesity. Low body-mass index, indicative of maternal undernutrition, has declined somewhat in the past two decades but continues to be prevalent in Asia and Africa. Prevalence of maternal overweight has had a steady increase since 1980 and exceeds that of underweight in all regions. Prevalence of stunting of linear growth of children younger than 5 years has decreased during the past two decades, but is higher in south Asia and sub-Saharan Africa than elsewhere and globally affected at least 165 million children in 2011; wasting affected at least 52 million children. Deficiencies of vitamin A and zinc result in deaths; deficiencies of iodine and iron, together with stunting, can contribute to children not reaching their developmental potential. Maternal undernutrition contributes to fetal growth restriction, which increases the risk of neonatal deaths and, for survivors, of stunting by 2 years of age. Suboptimum breastfeeding results in an increased risk for mortality in the first 2 years of life. We estimate that undernutrition in the aggregate-including fetal growth restriction, stunting, wasting, and deficiencies of vitamin A and zinc along with suboptimum breastfeeding-is a cause of 3.1 million child deaths annually or 45% of all child deaths in 2011. Maternal overweight and obesity result in increased maternal morbidity and infant mortality. Childhood overweight is becoming an increasingly important contributor to adult obesity, diabetes, and non-communicable diseases. The high present and future disease burden caused by mal nutrition in women of reproductive age, pregnancy, and children in the first 2 years of life should lead to interventions focused on these groups.	[Black, Robert E.; Christian, Parul; Katz, Joanne] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, RS, Brazil; [Walker, Susan P.] Univ W Indies, Trop Med Res Inst, Kingston 7, Jamaica; [Bhutta, Zulfiqar A.] Aga Khan Univ & Med Ctr, Dept Pediat, Karachi, Pakistan; [de Onis, Mercedes] WHO, Dept Nutr Hlth & Dev, CH-1211 Geneva, Switzerland; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, MRC HPA Ctr Environm & Hlth, London, England; [Grantham-McGregor, Sally] UCL, Inst Child Hlth, London, England; [Grantham-McGregor, Sally] Univ W Indies, Mona, Jamaica; [Martorell, Reynaldo] Emory Univ, Atlanta, GA 30322 USA; [Uauy, Ricardo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Pelotas; University West Indies Mona Jamaica; World Health Organization; Imperial College London; University of London; University College London; University West Indies Mona Jamaica; Emory University; University of London; London School of Hygiene & Tropical Medicine	Black, RE (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	rblack@jhsph.edu	Victora, Cesar Gomes/Y-2455-2019; Martorell, Reynaldo/I-2539-2012; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Katz, Joanne/0000-0002-5997-7823; Black, Robert/0000-0001-9926-7984	Bill AMP; Melinda Gates Foundation; Medical Research Council [G0801056B] Funding Source: researchfish	Bill AMP; Melinda Gates Foundation(CGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for the preparation of the Series was provided to the Johns Hopkins Bloomberg School of Public Health through a grant from the Bill & Melinda Gates Foundation. The sponsor had no role in the analysis and interpretation of the evidence or in writing the paper and the decision to submit for publication.	Aburto NJ, 2009, J NUTR, V139, P1751, DOI 10.3945/jn.108.100487; Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; ALFAHIM M, 1995, BRIT J NUTR, V73, P881, DOI 10.1079/BJN19950093; Allen LH, 2001, J NUTR, V131, p581S, DOI 10.1093/jn/131.2.581S; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; [Anonymous], LANCET GLOB IN PRESS; [Anonymous], 2007, ASS IOD DEF DIS MON; AUKETT MA, 1986, ARCH DIS CHILD, V61, P849, DOI 10.1136/adc.61.9.849; Aviram A, 2011, INT J GYNECOL OBSTET, V115, pS6, DOI 10.1016/S0020-7292(11)60004-0; Awasthi S, 2013, LANCET, V381, P1478, DOI 10.1016/S0140-6736(12)62126-6; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Beard JL, 2005, J NUTR, V135, P267, DOI 10.1093/jn/135.2.267; Beaton GH, 1993, 13 INT NUTR PROGR; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black MM, 2004, AM J CLIN NUTR, V80, P903, DOI 10.1093/ajcn/80.4.903; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLEICHRODT N, 1994, DAMAGED BRAIN OF IODINE DEFICIENCY, P195; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; BROOKE OG, 1980, BMJ-BRIT MED J, V280, P751, DOI 10.1136/bmj.280.6216.751; Brown KH, 2009, FOOD NUTR BULL, V30, pS12, DOI 10.1177/15648265090301S103; Brown KH, 2004, FOOD NUTR B S2, V25, pS99; Bruce KD, 2010, J NUTR, V140, P648, DOI 10.3945/jn.109.111179; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Bucher HC, 1996, JAMA-J AM MED ASSOC, V275, P1016, DOI 10.1001/jama.275.13.1016; Cappa C, 2012, LANCET, V379, P2324, DOI 10.1016/S0140-6736(12)60531-5; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Caulfield LE, 1999, J NUTR, V129, P1563, DOI 10.1093/jn/129.8.1563; Chan BCP, 2009, J OBSTET GYNAECOL RE, V35, P307, DOI 10.1111/j.1447-0756.2008.00939.x; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Chen A, 2009, EPIDEMIOLOGY, V20, P74, DOI 10.1097/EDE.0b013e3181878645; Chen YY, 2007, J HEALTH ECON, V26, P659, DOI 10.1016/j.jhealeco.2006.12.006; Cheung YB, 2010, ACTA PAEDIATR, V99, P1719, DOI 10.1111/j.1651-2227.2009.01593.x; Cheung YB, 2009, PAEDIATR PERINAT EP, V23, P463, DOI 10.1111/j.1365-3016.2009.01037.x; Child Trends, 2018, IMMIGRANT CHILDREN; Christian P, 1998, J NUTR, V128, P1458, DOI 10.1093/jn/128.9.1458; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Christian P, 2001, J NUTR, V131, P1510, DOI 10.1093/jn/131.5.1510; Christian P, INT J EPIDE IN PRESS; Christian P, 2008, PUBLIC HEALTH, V122, P161, DOI 10.1016/j.puhe.2007.06.003; Christian P, 2013, AM J CLIN NUTR, V97, P188, DOI 10.3945/ajcn.112.042275; Christian P, 2010, JAMA-J AM MED ASSOC, V304, P2716, DOI 10.1001/jama.2010.1861; Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813; Christian P, 2009, AM J EPIDEMIOL, V170, P1127, DOI 10.1093/aje/kwp253; Clausson B, 1998, BRIT J OBSTET GYNAEC, V105, P1011, DOI 10.1111/j.1471-0528.1998.tb10266.x; Cresswell JA, 2012, LANCET, V380, P1325, DOI 10.1016/S0140-6736(12)60869-1; Davis LM, 2010, J PEDIATR ADOL GYNEC, V23, P45, DOI 10.1016/j.jpag.2009.05.005; Dawodu A, 2007, ARCH DIS CHILD, V92, P737, DOI 10.1136/adc.2007.122689; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; De-Regil LM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009085.pub2; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Debes AK, BMC PUBLIC IN PRESS; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Dibley MJ, 2012, AM J CLIN NUTR, V95, P220, DOI 10.3945/ajcn.111.022699; Dror DK, 2011, CURR OPIN OBSTET GYN, V23, P422, DOI 10.1097/GCO.0b013e32834cb791; Dujardin B, 1996, TROP MED INT HEALTH, V1, P510, DOI 10.1046/j.1365-3156.1996.d01-83.x; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Edmond K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000658; Emond AM, 2006, ACTA PAEDIATR, V95, P1249, DOI 10.1080/08035250600615127; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Friel JK, 2003, J PEDIATR-US, V143, P582, DOI 10.1067/S0022-3476(03)00301-9; Frith AL, 2009, AM J CLIN NUTR, V90, P141, DOI 10.3945/ajcn.2008.26817; Galler JR, 2010, J CHILD PSYCHOL PSYC, V51, P789, DOI 10.1111/j.1469-7610.2010.02208.x; Galler JR, 2012, J NUTR, V142, P788, DOI 10.3945/jn.111.145441; Gandhi M, 2011, ACTA PAEDIATR, V100, P1113, DOI 10.1111/j.1651-2227.2011.02254.x; Gardner JMM, 1999, J CHILD PSYCHOL PSYC, V40, P819, DOI 10.1111/1469-7610.00497; Gewa CA, 2009, PUB HLTH NUTR, V13, P496; Gibbs CM, 2012, PAEDIATR PERINAT EP, V26, P259, DOI 10.1111/j.1365-3016.2012.01290.x; Gigante DP, 2005, J NUTR, V135, P74, DOI 10.1093/jn/135.1.74; Gilboa SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.005; Grantham-McGregor S., 2010, Annales Nestle, V68, P105, DOI 10.1159/000319670; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Griffiths LJ, 2010, INT J OBESITY, V34, P624, DOI 10.1038/ijo.2010.10; Grisaru-Granovsky S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.08.025; Gunatilake RP, 2011, AM J OBSTET GYNECOL, V204, P106, DOI 10.1016/j.ajog.2010.10.002; Haider BA, BMJ IN PRESS; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Haroon S, BMC PUBLIC IN PRESS; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Hofmeyr GJ, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001059.pub2, 10.1002/14651858.CD001059.pub4, 10.1002/14651858.CD001059.pub5]; Horta B.L., 2013, LONG TERM EFFECTS BR; Huang C, 2010, J DEV ORIG HLTH DIS, V1, P412, DOI 10.1017/S2040174410000504; Huang C, 2013, SOC SCI MED, V97, P259, DOI 10.1016/j.socscimed.2012.09.051; Huang C, 2010, J NUTR, V140, P1874, DOI 10.3945/jn.110.121293; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Hypponen E, 2010, BRIT J NUTR, V104, P309, DOI 10.1017/S0007114510002436; IDJRADINATA P, 1993, LANCET, V341, P1, DOI 10.1016/0140-6736(93)92477-B; IIPS Macro International, 2007, NATL FAMILY HLTH SUR, V1; Imdad Aamer, 2011, BMC Public Health, V11 Suppl 3, pS20, DOI 10.1186/1471-2458-11-S3-S20; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P138, DOI 10.1111/j.1365-3016.2012.01274.x; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P168, DOI 10.1111/j.1365-3016.2012.01312.x; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S22; Isaranurug Sirikul, 2007, Journal of the Medical Association of Thailand, V90, P2559; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Katz J, 2000, AM J CLIN NUTR, V71, P1570; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Katz J, 2010, J NUTR, V140, P1317, DOI 10.3945/jn.109.119925; Kazemi A, 2009, J WOMENS HEALTH, V18, P835, DOI 10.1089/jwh.2008.0954; King JC, 2000, AM J CLIN NUTR, V71, p1334S, DOI 10.1093/ajcn/71.5.1334s; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1848; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; Koplan JP, 2005, J AM DIET ASSOC, V105, P131, DOI 10.1016/j.jada.2004.11.023; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Kozuki N, BMC PUBLIC IN PRESS; Kristensen S, 2007, EARLY HUM DEV, V83, P99, DOI 10.1016/j.earlhumdev.2006.05.008; Kuklina EV, 2006, EARLY HUM DEV, V82, P425, DOI 10.1016/j.earlhumdev.2005.10.018; Kuzawa CW, 2012, AM J HUM BIOL, V24, P5, DOI 10.1002/ajhb.21227; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lamberti LM, BMC PUBLIC IN PRESS; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Li HJ, 2004, EARLY HUM DEV, V76, P1, DOI 10.1016/j.earlhumdev.2003.09.007; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lind T, 2003, AM J CLIN NUTR, V77, P883, DOI 10.1093/ajcn/77.4.883; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lumey LH, 2011, ANNU REV PUBL HEALTH, V32, P237, DOI 10.1146/annurev-publhealth-031210-101230; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Mackay-Sim A, 2004, INT REV NEUROBIOL, V59, P351; Madar AA, 2009, BRIT J NUTR, V101, P1052, DOI 10.1017/S0007114508055712; Maluccio JA, 2009, ECON J, V119, P734, DOI 10.1111/j.1468-0297.2009.02220.x; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Maternal and Child Nutrition Study Group, 2013, LANCET; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; Mazouni C, 2006, ACTA OBSTET GYN SCAN, V85, P567, DOI 10.1080/00016340600605044; McCormick DP, 2010, J PEDIATR-US, V157, P15, DOI 10.1016/j.jpeds.2010.01.028; McGuire W, 2010, SEMIN FETAL NEONAT M, V15, P108, DOI 10.1016/j.siny.2009.09.005; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Ministerio de Salud Publica y Asistencia Social Instituto Nacional de Estadistica Centros de Control y Prevencion de Enfermedades, 2010, ENSMI20082009 MIN SA; MOFFATT MEK, 1994, J PEDIATR-US, V125, P527, DOI 10.1016/S0022-3476(94)70003-6; Mori R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000230.pub4; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Murray-Kolb LE, 2011, J NUTR, V141, p747S, DOI 10.3945/jn.110.130658; Murray-Kolb LE, CHERG IRON REPORT MA; Narchi H, 2010, J MATERN-FETAL NEO M, V23, P48, DOI 10.3109/14767050903067352; Norman JE, 2011, P NUTR SOC, V70, P450, DOI 10.1017/S0029665111003077; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Olney DK, 2006, J NUTR, V136, P2427, DOI 10.1093/jn/136.9.2427; Olofin I, PLOS ONE IN PRESS; Ortega RM, 1999, ANN NUTR METAB, V43, P37, DOI 10.1159/000012765; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; OSULLIVAN JB, 1982, JAMA-J AM MED ASSOC, V248, P949, DOI 10.1001/jama.248.8.949; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Pena-Rosas Juan Pablo, 2015, Cochrane Database Syst Rev, pCD009997, DOI [10.1002/14651858.CD009997, 10.1002/14651858.CD009997.pub2]; Perez EM, 2005, J NUTR, V135, P850, DOI 10.1093/jn/135.4.850; PHAROAH POD, 1971, LANCET, V1, P308; Pongcharoen T, 2012, ARCH PEDIAT ADOL MED, V166, P411, DOI 10.1001/archpediatrics.2011.1413; Pongcharoen T, 2011, AM J CLIN NUTR, V93, P636, DOI 10.3945/ajcn.110.002220; PRENTICE A, 1994, AM J CLIN NUTR, V59, p477S, DOI 10.1093/ajcn/59.2.477S; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Pulver LS, 2009, PEDIATRICS, V123, pE1072, DOI 10.1542/peds.2008-3288; Qian M, 2005, ASIA PAC J CLIN NUTR, V14, P32; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; Rasmussen KM, 2003, AM J CLIN NUTR, V78, P673, DOI 10.1093/ajcn/78.4.673; Regev RH, 2004, CLIN PERINATOL, V31, P453, DOI 10.1016/j.clp.2004.04.017; Rice AL., 2004, COMP QUANTIFICATION, V1, P0211; Richter LM, 2012, INT J EPIDEMIOL, V41, P621, DOI 10.1093/ije/dyq251; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Ross A. C., 2010, Dietary reference intakes for calcium and vitamin D; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sabet F, 2009, INT J EPIDEMIOL, V38, P944, DOI 10.1093/ije/dyp204; Sachan A, 2005, AM J CLIN NUTR, V81, P1060; Sachdev HPS, 2005, PUBLIC HEALTH NUTR, V8, P117, DOI 10.1079/PHN2004677; Santos IS, 2011, INT J EPIDEMIOL, V40, P1461, DOI 10.1093/ije/dyq130; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Sheiner E, 2005, EUR J OBSTET GYN R B, V120, P175, DOI 10.1016/j.ejogrb.2004.09.013; Shenoy SD, 2005, ARCH DIS CHILD, V90, P437, DOI 10.1136/adc.2004.065268; Siegel EH, 2011, J HEALTH POPUL NUTR, V29, P593; SIMMER K, 1985, CLIN SCI, V68, P395, DOI 10.1042/cs0680395; Skeaff SA, 2011, NUTRIENTS, V3, P265, DOI 10.3390/nu3020265; Sohlberg S, 2012, AM J HYPERTENS, V25, P120, DOI 10.1038/ajh.2011.175; Song SG, 2009, SOC SCI MED, V68, P1315, DOI 10.1016/j.socscimed.2009.01.027; Srinivas SK, 2009, J PERINATOL, V29, P680, DOI 10.1038/jp.2009.83; Stein AD, 2006, AM J EPIDEMIOL, V164, P1160, DOI 10.1093/aje/kwj328; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Stoltzfus RJ, 2001, BRIT MED J, V323, P1389, DOI 10.1136/bmj.323.7326.1389; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Surkan PJ, 2013, NUTRITION, V29, P542, DOI 10.1016/j.nut.2012.09.003; Szajewska H, 2010, AM J CLIN NUTR, V91, P1684, DOI 10.3945/ajcn.2010.29191; Temple R, 2010, BEST PRACT RES CL EN, V24, P591, DOI 10.1016/j.beem.2010.05.011; Tielsch JM, 2008, J NUTR, V138, P787, DOI 10.1093/jn/138.4.787; Tofail F, 2012, EUR J CLIN NUTR, V66, P237, DOI 10.1038/ejcn.2011.165; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; Tsoi E, 2010, POSTGRAD MED J, V86, P617, DOI 10.1136/pgmj.2010.098186; UNICEF, 2011, LEV TRENDS CHILD MOR; UNICEF, 2008, PROGR CHILDR REP CAR; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; van Dijk CE, 2009, PEDIATRICS, V123, P102, DOI 10.1542/peds.2007-3382; Van Lieshout RJ, 2011, OBES REV, V12, pe548, DOI 10.1111/j.1467-789X.2010.00850.x; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; VILLAR J, 1983, INT J GYNECOL OBSTET, V21, P271, DOI 10.1016/0020-7292(83)90016-4; WALKER CLF, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0047908; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Walker SP, 2010, DEV MED CHILD NEUROL, V52, pe148, DOI 10.1111/j.1469-8749.2010.03637.x; Wang WL, 2008, J PEDIATR-US, V153, P333, DOI 10.1016/j.jpeds.2008.04.017; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; West KP, 2011, JAMA-J AM MED ASSOC, V305, P1986, DOI 10.1001/jama.2011.656; WHO, 2012, PROP GLOB TARG MAT I; Wong EM, 2011, FOOD NUTR BULL, V32, P206, DOI 10.1177/156482651103200304; World Health Organization, 2009, GLOB PREV VIT DEF PO; World Health Organization, 2011, WHO REC PREV TREATM; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23; Zeng LX, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2001; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zimmermann MB, 2012, NUTR REV, V70, P553, DOI 10.1111/j.1753-4887.2012.00528.x; Zimmermann MB, 2012, PAEDIATR PERINAT EP, V26, P108, DOI 10.1111/j.1365-3016.2012.01275.x	226	2735	2791	25	698	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					427	451		10.1016/S0140-6736(13)60937-X	http://dx.doi.org/10.1016/S0140-6736(13)60937-X			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23746772				2022-12-28	WOS:000322638500036
J	DeGennaro, M; McBride, CS; Seeholzer, L; Nakagawa, T; Dennis, EJ; Goldman, C; Jasinskiene, N; James, AA; Vosshall, LB				DeGennaro, Matthew; McBride, Carolyn S.; Seeholzer, Laura; Nakagawa, Takao; Dennis, Emily J.; Goldman, Chloe; Jasinskiene, Nijole; James, Anthony A.; Vosshall, Leslie B.			orco mutant mosquitoes lose strong preference for humans and are not repelled by volatile DEET	NATURE			English	Article							DROSOPHILA ODORANT RECEPTORS; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; CHANNELS; FEMALE	Female mosquitoes of some species are generalists and will blood-feed on a variety of vertebrate hosts, whereas others display marked host preference. Anopheles gambiae and Aedes aegypti have evolved a strong preference for humans, making them dangerously efficient vectors of malaria and Dengue haemorrhagic fever(1). Specific host odours probably drive this strong preference because other attractive cues, including body heat and exhaled carbon dioxide (CO2), are common to all warm-blooded hosts(2,3). Insects sense odours via several chemosensory receptor families, including the odorant receptors (ORs), membrane proteins that form heteromeric odour-gated ion channels(4,5) comprising a variable ligand-selective subunit and an obligate co-receptor called Orco (ref. 6). Here we use zinc-finger nucleases to generate targeted mutations in the orco gene of A. aegypti to examine the contribution of Orco and the odorant receptor pathway to mosquito host selection and sensitivity to the insect repellent DEET (N,N-diethyl-meta-toluamide). orco mutant olfactory sensory neurons have greatly reduced spontaneous activity and lack odour-evoked responses. Behaviourally, orco mutant mosquitoes have severely reduced attraction to honey, an odour cue related to floral nectar, and do not respond to human scent in the absence of CO2. However, in the presence of CO2, female orco mutant mosquitoes retain strong attraction to both human and animal hosts, but no longer strongly prefer humans. orco mutant females are attracted to human hosts even in the presence of DEET, but are repelled upon contact, indicating that olfactory- and contact-mediated effects of DEET are mechanistically distinct. We conclude that the odorant receptor pathway is crucial for an anthropophilic vector mosquito to discriminate human from non-human hosts and to be effectively repelled by volatile DEET.	[DeGennaro, Matthew; McBride, Carolyn S.; Seeholzer, Laura; Nakagawa, Takao; Dennis, Emily J.; Goldman, Chloe; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [DeGennaro, Matthew; Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Jasinskiene, Nijole; James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet & Mol Biol & Biochem, Irvine, CA 92697 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Irvine; University of California System; University of California Irvine	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.	Leslie.Vosshall@rockefeller.edu	; DeGennaro, Matthew/H-4975-2015	Dennis, Emily/0000-0002-9858-7190; James, Anthony/0000-0001-5577-3308; DeGennaro, Matthew/0000-0003-3837-4430; Vosshall, Leslie/0000-0002-6060-8099	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health [DC012069, AI29746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029746, R01AI029746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC012069, R00DC012069] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. J. Lee and members of the Vosshall lab for comments on the manuscript. F. Urnov of Sangamo BioSciences suggested the experiments in Supplementary Fig. 1. We thank C. McMeniman for initiating the A. aegypti GFP ZFN disruption project together with M. D. and for establishing mosquito microinjection at Genetic Services Inc. S. Dewell of the Rockefeller University Genomics Resource Center provided bioinformatic assistance. W. Takken and N. Verhulst suggested the use of nylon stockings in Figs 4 and 5. Roman Corfas provided advice on imaging in Fig. 5b. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative. This work was supported in part by grants from the National Institutes of Health to C. S. M. (DC012069) and N. J. and A. A. J. (AI29746). L. B. V. is an investigator of the Howard Hughes Medical Institute.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Foster WA, 2004, B ENTOMOL RES, V94, P145, DOI 10.1079/BER2003288; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Ghaninia M, 2007, EUR J NEUROSCI, V26, P1611, DOI 10.1111/j.1460-9568.2007.05786.x; GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680; Grant AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021785; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Remy S, 2010, TRANSGENIC RES, V19, P363, DOI 10.1007/s11248-009-9323-7; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; SKINNER WA, 1965, NATURE, V207, P661, DOI 10.1038/207661a0; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861	29	238	249	10	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					487	491		10.1038/nature12206	http://dx.doi.org/10.1038/nature12206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23719379	Green Accepted, Green Submitted			2022-12-28	WOS:000320929400053
J	Cooper, A; Garcia, M; Petrovas, C; Yamamoto, T; Koup, RA; Nabel, GJ				Cooper, Arik; Garcia, Mayra; Petrovas, Constantinos; Yamamoto, Takuya; Koup, Richard A.; Nabel, Gary J.			HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIOUS MOLECULAR CLONE; T-CELLS; IN-VIVO; RETROVIRAL INFECTION; QUANTITATIVE ASSAY; LYMPHOCYTES; INHIBITOR; DEPLETION; DYNAMICS	Human immunodeficiency virus-1 (HIV-1) has infected more than 60 million people and caused nearly 30 million deaths worldwide(1), ultimately the consequence of cytolytic infection of CD4(+) T cells. In humans and in macaque models, most of these cells contain viral DNA and are rapidly eliminated at the peak of viraemia(2-4), yet the mechanism by which HIV-1 induces helper T-cell death has not been defined. Here we show that virus-induced cell killing is triggered by viral integration. Infection by wild-type HIV-1, but not an integrase-deficient mutant, induced the death of activated primary CD4 lymphocytes. Similarly, raltegravir, a pharmacologic integrase inhibitor, abolished HIV-1-induced cell killing both in cell culture and in CD4(+) T cells from acutely infected subjects. The mechanism of killing during viral integration involved the activation of DNA-dependent protein kinase (DNA-PK), a central integrator of the DNA damage response, which caused phosphorylation of p53 and histone H2AX. Pharmacological inhibition of DNA-PK abolished cell death during HIV-1 infection in vitro, suggesting that processes which reduce DNA-PK activation in CD4 cells could facilitate the formation of latently infected cells that give rise to reservoirs in vivo. We propose that activation of DNA-PK during viral integration has a central role in CD4(+) T-cell depletion, raising the possibility that integrase inhibitors and interventions directed towards DNA-PK may improve T-cell survival and immune function in infected individuals.	[Cooper, Arik; Garcia, Mayra; Nabel, Gary J.] NIAID, Virol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Petrovas, Constantinos; Yamamoto, Takuya; Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Virol Lab, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,MSC 3005,40 Convent Dr, Bethesda, MD 20892 USA.	Gary.Nabel@sanofi.com	Yamamoto, Takuya/L-2642-2013	Yamamoto, Takuya/0000-0003-3753-1211	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005058, ZIAAI005014] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Ambrozak, R. Nguyen, and S. Perfetto for help with cell sorting, U. Olshevsky, J. Casazza, D. Bolton, A. Pegu and M. Louder for discussions and technical help, and A. Tislerics and B. Hartman for manuscript preparation. This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Ariumi Y, 2005, J VIROL, V79, P2973, DOI 10.1128/JVI.79.5.2973-2978.2005; Baekelandt V, 2000, J VIROL, V74, P11278, DOI 10.1128/JVI.74.23.11278-11285.2000; Bolton DL, 2007, J VIROL, V81, P8878, DOI 10.1128/JVI.00122-07; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; CHEN H, 1992, P NATL ACAD SCI USA, V89, P7678, DOI 10.1073/pnas.89.16.7678; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Daniel R, 2001, MOL CELL BIOL, V21, P1164, DOI 10.1128/MCB.21.4.1164-1172.2001; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Hill R, 2010, CELL CYCLE, V9, P3460, DOI 10.4161/cc.9.17.13043; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP FACT SHEET; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lau A, 2004, EMBO J, V23, P3421, DOI 10.1038/sj.emboj.7600348; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; LI YX, 1992, J VIROL, V66, P6587, DOI 10.1128/JVI.66.11.6587-6600.1992; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; MOROZOV VE, 1994, J BIOL CHEM, V269, P16684; Nagasawa M, 1997, CELL STRUCT FUNCT, V22, P585, DOI 10.1247/csf.22.585; Nilsson A, 1999, CELL PROLIFERAT, V32, P239, DOI 10.1046/j.1365-2184.1999.3240239.x; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279	39	158	162	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					376	+		10.1038/nature12274	http://dx.doi.org/10.1038/nature12274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23739328	Green Published			2022-12-28	WOS:000320592900043
J	Chou, SJ; Babot, Z; Leingartner, A; Studer, M; Nakagawa, Y; O'Leary, DDM				Chou, Shen-Ju; Babot, Zoila; Leingaertner, Axel; Studer, Michele; Nakagawa, Yasushi; O'Leary, Dennis D. M.			Geniculocortical Input Drives Genetic Distinctions Between Primary and Higher-Order Visual Areas	SCIENCE			English	Article							COUP-TFI; THALAMOCORTICAL CONNECTIONS; CEREBRAL-CORTEX; ROR-BETA; EXPRESSION; NEOCORTEX; FOREBRAIN; EMX2; SPECIFICATION; AXONS	Studies of area patterning of the neocortex have focused on primary areas, concluding that the primary visual area, V1, is specified by transcription factors (TFs) expressed by progenitors. Mechanisms that determine higher-order visual areas (V-HO) and distinguish them from V1 are unknown. We demonstrated a requirement for thalamocortical axon (TCA) input by genetically deleting geniculocortical TCAs and showed that they drive differentiation of patterned gene expression that distinguishes V1 and V-HO. Our findings suggest a multistage process for area patterning: TFs expressed by progenitors specify an occipital visual cortical field that differentiates into V1 and V-HO; this latter phase requires geniculocortical TCA input to the nascent V1 that determines genetic distinctions between V1 and V-HO for all layers and ultimately determines their area-specific functional properties.	[Chou, Shen-Ju; Babot, Zoila; Leingaertner, Axel; Nakagawa, Yasushi; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Studer, Michele] Fac Med Nice, INSERM, Inst Biol Valrose, F-06034 Nice, France	Salk Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	doleary@salk.edu	Studer, Michele/P-4580-2016	Studer, Michele/0000-0001-7105-2957; Babot, Zoila/0000-0003-4551-0189	NIH [NS31558, MH086147]; Vincent J. Coates Chair of Molecular Neurobiology; ANR, France [R09125AA]; Spanish Ministry of Education and Science; Generalitat de Catalunya (Spain); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558, R01NS031558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vincent J. Coates Chair of Molecular Neurobiology; ANR, France(French National Research Agency (ANR)); Spanish Ministry of Education and Science(Spanish Government); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the O'Leary lab for discussion, including S. May for developing Igfbp5 as a V1 marker using WMISH, and B. Higgins and H. Gutierrez for maintaining mice. We thank M. Goulding (Salk Institute) for the ROSA-GAP43-eGFP reporter line, K.-F. Lee (Salk Institute) for the IRES/Cre/FRT/neo/FRT construct, A. Nagy (Mount Sinai Hospital) for the R1 ES cells, J. Simon (Salk MultiMedia Relations) for help making Adobe Illustrator schematics, and C. Peto (Salk Institute Neuroscience Imaging Core) for help using ImageJ software. Support was provided by NIH R01 grants NS31558 and MH086147 and the Vincent J. Coates Chair of Molecular Neurobiology (D.D.M.O.). M. S. is supported by the ANR "2009 Chaires d'Excellence" Program, France, grant number R09125AA. Z.B. was a recipient of postdoctoral fellowships from the Spanish Ministry of Education and Science and from the Generalitat de Catalunya (Spain).	Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Dehay C, 1996, J COMP NEUROL, V367, P70, DOI 10.1002/(SICI)1096-9861(19960325)367:1<70::AID-CNE6>3.0.CO;2-G; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Jabaudon D, 2012, CEREB CORTEX, V22, P996, DOI 10.1093/cercor/bhr182; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Kashani AH, 2006, J NEUROSCI, V26, P8398, DOI 10.1523/JNEUROSCI.0618-06.2006; Leingartner A, 2003, CEREB CORTEX, V13, P648, DOI 10.1093/cercor/13.6.648; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; Van der Gucht E, 2007, CEREB CORTEX, V17, P2805, DOI 10.1093/cercor/bhm012; VANDERZEE EA, 1989, HISTOCHEMISTRY, V92, P475, DOI 10.1007/BF00524759; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	25	96	96	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1239	1242		10.1126/science.1232806	http://dx.doi.org/10.1126/science.1232806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744949	Green Accepted			2022-12-28	WOS:000319972800052
J	Downs, C; Linker, JA; Mikic, Z; Riley, P; Schrijver, CJ; Saint-Hilaire, P				Downs, Cooper; Linker, Jon A.; Mikic, Zoran; Riley, Pete; Schrijver, Carolus J.; Saint-Hilaire, Pascal			Probing the Solar Magnetic Field with a Sun-Grazing Comet	SCIENCE			English	Article							EMISSION; MODEL	On 15 and 16 December 2011, Sun-grazing comet C/2011 W3 (Lovejoy) passed deep within the solar corona, effectively probing a region that has never been visited by spacecraft. Imaged from multiple perspectives, extreme ultraviolet observations of Lovejoy's tail showed substantial changes in direction, intensity, magnitude, and persistence. To understand this unique signature, we combined a state-of-the-art magnetohydrodynamic model of the solar corona and a model for the motion of emitting cometary tail ions in an embedded plasma. The observed tail motions reveal the inhomogeneous magnetic field of the solar corona. We show how these motions constrain field and plasma properties along the trajectory, and how they can be used to meaningfully distinguish between two classes of magnetic field models.	[Downs, Cooper; Linker, Jon A.; Mikic, Zoran; Riley, Pete] Predict Sci Inc, San Diego, CA 92121 USA; [Schrijver, Carolus J.] Lockheed Martin Adv Technol Ctr, Palo Alto, CA 94304 USA; [Saint-Hilaire, Pascal] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA	Lockheed Martin; University of California System; University of California Berkeley	Downs, C (corresponding author), Predict Sci Inc, 9990 Mesa Rim Rd,Suite 170, San Diego, CA 92121 USA.	cdowns@predsci.com		Riley, Pete/0000-0002-1859-456X; Schrijver, Carolus/0000-0002-6010-8182	NASA SDO/AIA	NASA SDO/AIA	Supported by NASA SDO/AIA contracts. All observational data are freely available from the NASA/SDO, AIA, HMI, STEREO, and SECCHI science teams. Simulations were conducted using the NASA Pleiades and NSF Ranger supercomputers.	[Anonymous], 2008, NASATM2008214161; Aschwanden MJ, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/124; Bryans P, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/18; Burhonov O., 2012, MINOR PLANET ELECT C; Frazin RA, 2009, ASTROPHYS J, V701, P547, DOI 10.1088/0004-637X/701/1/547; Jia YD, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012175; Marsden BG, 2005, ANNU REV ASTRON ASTR, V43, P75, DOI 10.1146/annurev.astro.43.072103.150554; Riley P, 2006, ASTROPHYS J, V653, P1510, DOI 10.1086/508565; SCHATTEN KH, 1969, SOL PHYS, V6, P442, DOI 10.1007/BF00146478; Schrijver CJ, 2012, SCIENCE, V335, P324, DOI 10.1126/science.1211688; Sekanina Z, 2007, ASTROPHYS J, V663, P657, DOI 10.1086/517490; Sekanina Z, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/127	12	47	47	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1196	1199		10.1126/science.1236550	http://dx.doi.org/10.1126/science.1236550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744941				2022-12-28	WOS:000319972800039
J	Watts, C; Hossain, M; Zimmerman, C				Watts, Charlotte; Hossain, Mazeda; Zimmerman, Cathy			War and Sexual Violence - Mental Health Care for Survivors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONGO		[Watts, Charlotte; Hossain, Mazeda; Zimmerman, Cathy] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Watts, C (corresponding author), Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.		Hossain, Mazeda/AAL-3202-2020; Hossain, Mazeda/G-1953-2014	Hossain, Mazeda/0000-0002-1878-8145; 	Economic and Social Research Council [ES/J021032/1] Funding Source: researchfish; ESRC [ES/J021032/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2007, MEASURE DEM HLTH SUR; Duroch F, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-5; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Peterman A, 2011, AM J PUBLIC HEALTH, V101, P1060, DOI 10.2105/AJPH.2010.300070; United Nations High Commissioner on Refugees-Division of International Protection, 2011, ACT SEX GEND BAS VIO	5	8	8	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2152	2154		10.1056/NEJMp1304712	http://dx.doi.org/10.1056/NEJMp1304712			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DN	23738543	Bronze, Green Published			2022-12-28	WOS:000319948900002
J	Summerfield, D				Summerfield, Derek			"Global mental health" is an oxymoron and medical imperialism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Summerfield, Derek] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Summerfield, Derek] South London & Maudsley NHS Fdn Trust, London, England	University of London; King's College London; South London & Maudsley NHS Trust	Summerfield, D (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	derek.summerfield@slam.nhs.uk						[Anonymous], 2013, GLOB BURD DIS; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Summerfield D, 2008, BMJ-BRIT MED J, V336, P992, DOI 10.1136/bmj.39513.441030.AD; Summerfield D, 2012, TRANSCULT PSYCHIATRY, V49, P519, DOI 10.1177/1363461512454701	5	50	49	1	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2013	346								f3509	10.1136/bmj.f3509	http://dx.doi.org/10.1136/bmj.f3509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DQ	23729293				2022-12-28	WOS:000319949200004
J	Adler, JN; Colbert, JA				Adler, Jonathan N.; Colbert, James A.			Medicinal Use of Marijuana - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2013, N ENGL J MED, V368, P866	1	54	55	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					E30	E30		10.1056/NEJMclde1305159	http://dx.doi.org/10.1056/NEJMclde1305159			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AT	23718175				2022-12-28	WOS:000319574200015
J	Hoffmann, SS; McManus, JF; Curry, WB; Brown-Leger, LS				Hoffmann, Sharon S.; McManus, Jerry F.; Curry, William B.; Brown-Leger, L. Susan			Persistent export of Pa-231 from the deep central Arctic Ocean over the past 35,000 years	NATURE			English	Article							THERMOHALINE CIRCULATION; RAPID-DETERMINATION; LATE QUATERNARY; PARTICLE-FLUX; GLACIAL OCEAN; SEA-ICE; TH-230; PROFILES; BASIN; RATES	The Arctic Ocean has an important role in Earth's climate, both through surface processes(1) such as sea-ice formation and transport, and through the production and export of waters at depth that contribute to the global thermohaline circulation(2,3). Deciphering the deep Arctic Ocean's palaeo-oceanographic history is a crucial part of understanding its role in climatic change. Here we show that sedimentary ratios of the radionuclides thorium-230 (Th-230) and protactinium-231 (Pa-231), which are produced in sea water and removed by particle scavenging on timescales of decades to centuries, respectively(4), record consistent evidence for the export of 231Pa from the deep Arctic and may indicate continuous deep-water exchange between the Arctic and Atlantic oceans throughout the past 35,000 years. Seven well-dated box-core records provide a comprehensive overview of Pa-231 and Th-230 burial in Arctic sediments during glacial, deglacial and interglacial conditions. Sedimentary Pa-231/Th-230 ratios decrease nearly linearly with increasing water depth above the core sites, indicating efficient particle scavenging in the upper water column and greater influence of removal by lateral transport at depth. Although the measured Th-230 burial is in balance with its production in Arctic sea water, integrated depth profiles for all time intervals reveal a deficit in Pa-231 burial that can be balanced only by lateral export in the water column. Because no enhanced sink for Pa-231 has yet been found in the Arctic, our records suggest that deep-water exchange through the Fram strait may export Pa-231. Such export may have continued for the past 35,000 years, suggesting a century-scale replacement time for deep waters in the Arctic Ocean since the most recent glaciation and a persistent contribution of Arctic waters to the global ocean circulation.	[Hoffmann, Sharon S.; McManus, Jerry F.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Curry, William B.; Brown-Leger, L. Susan] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Curry, William B.] Bermuda Inst Ocean Sci, GE-01 St Georges, Bermuda	Columbia University; Woods Hole Oceanographic Institution; Bermuda Institute of Ocean Sciences	Hoffmann, SS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	ssh13@columbia.edu			Comer Science and Education Fund; US NSF [OCE-0402565, OCE-0550637, OCE-0902985, AGS-0936496, ARC-0520073]	Comer Science and Education Fund; US NSF(National Science Foundation (NSF))	We thank R. Poore for sharing radiocarbon dates for box cores 28 and 32. We thank O. Marchal, R. Newton, L. F. Robinson, D. McCorkle, E. Boyle, H. Oates and M. Jackson for discussions. The manuscript was improved by the comments of A. Thomas. This work was supported in part by the Comer Science and Education Fund and by US NSF grants OCE-0402565 (J.F.M.), OCE-0550637 (J.F.M.), OCE-0902985 (J.F.M.), AGS-0936496 (J.F.M.) and ARC-0520073 (W.B.C.).	AAGAARD K, 1985, J GEOPHYS RES-OCEANS, V90, P4833, DOI 10.1029/JC090iC03p04833; ANDERSON RF, 1983, EARTH PLANET SC LETT, V62, P7, DOI 10.1016/0012-821X(83)90067-5; BACON MP, 1989, EARTH PLANET SC LETT, V95, P15, DOI 10.1016/0012-821X(89)90164-7; Butzin M, 2005, EARTH PLANET SC LETT, V235, P45, DOI 10.1016/j.epsl.2005.03.003; Chase Z, 2002, EARTH PLANET SC LETT, V204, P215, DOI 10.1016/S0012-821X(02)00984-6; Choi MS, 2001, MAR CHEM, V76, P99, DOI 10.1016/S0304-4203(01)00050-0; Cochran JK, 1995, DEEP-SEA RES PT II, V42, P1495; Cronin TM, 2012, NAT GEOSCI, V5, P631, DOI [10.1038/NGEO1557, 10.1038/ngeo1557]; Darby DA, 1997, DEEP-SEA RES PT II, V44, P1745, DOI 10.1016/S0967-0645(97)00039-8; Edmonds HN, 2004, EARTH PLANET SC LETT, V227, P155, DOI 10.1016/j.epsl.2004.08.008; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Francois R, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000939; Gherardi JM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001696; Hanslik D, 2010, QUATERNARY SCI REV, V29, P3430, DOI 10.1016/j.quascirev.2010.06.011; Henderson GM, 2003, REV MINERAL GEOCHEM, V52, P493, DOI 10.2113/0520493; Hoffmann S, 2007, EARTH PLANET SC LETT, V258, P516, DOI 10.1016/j.epsl.2007.04.011; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Jakobsson M, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000302; KU TL, 1967, PROG OCEANOGR, V4, P95; LAO Y, 1992, EARTH PLANET SC LETT, V113, P173; Luo Y, 2010, OCEAN SCI, V6, P381, DOI 10.5194/os-6-381-2010; Marz C, 2011, GEOCHIM COSMOCHIM AC, V75, P7668, DOI 10.1016/j.gca.2011.09.046; MANGERUD J, 1975, QUATERNARY RES, V5, P263, DOI 10.1016/0033-5894(75)90028-9; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Moran SB, 2005, EARTH PLANET SC LETT, V234, P235, DOI 10.1016/j.epsl.2005.02.016; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Not C, 2010, QUATERNARY SCI REV, V29, P3665, DOI 10.1016/j.quascirev.2010.06.042; OSTLUND HG, 1987, J GEOPHYS RES-OCEANS, V92, P3769, DOI 10.1029/JC092iC04p03769; Poore R. Z., 1999, 9948 USGS; Poore RZ, 1999, GEOLOGY, V27, P759, DOI 10.1130/0091-7613(1999)027<0759:LPAHME>2.3.CO;2; Roy-Barman M, 2009, BIOGEOSCIENCES, V6, P3091, DOI 10.5194/bg-6-3091-2009; Rudels B, 1999, DEEP-SEA RES PT II, V46, P1023, DOI 10.1016/S0967-0645(99)00015-6; Rudels B., 2009, ENCY OCEAN SCI, P211, DOI DOI 10.1016/B978-012374473-9.00601-9; Schlosser P, 1997, NUCL INSTRUM METH B, V123, P431, DOI 10.1016/S0168-583X(96)00677-5; Scholten JC, 2008, EARTH PLANET SC LETT, V271, P159, DOI 10.1016/j.epsl.2008.03.060; Scholten JC, 1995, DEEP-SEA RES PT II, V42, P1519, DOI 10.1016/0967-0645(95)00052-6; Siddall M, 2005, EARTH PLANET SC LETT, V237, P135, DOI 10.1016/j.epsl.2005.05.031; Stuiver M., 2005, CALIB RADIOCARBON CA; Trimble SM, 2004, EARTH PLANET SC LETT, V222, P915, DOI 10.1016/j.epsl.2004.03.027; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0; Yu EF, 2001, EARTH PLANET SC LETT, V191, P219, DOI 10.1016/S0012-821X(01)00410-1	41	28	28	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					603	+		10.1038/nature12145	http://dx.doi.org/10.1038/nature12145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23719461	Green Published			2022-12-28	WOS:000319556100040
J	Parry, SW; Finch, T; Deary, V				Parry, Steve W.; Finch, Tracy; Deary, Vincent			How should we manage fear of falling in older adults living in the community?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACTIVITY AVOIDANCE; EXERCISE; PEOPLE; PROGRAM; BALANCE; RISK; INTERVENTIONS; PREVENTION; EFFICACY		[Parry, Steve W.] Royal Victoria Infirm, Falls & Syncope Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Parry, Steve W.] Royal Victoria Infirm, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Finch, Tracy] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Deary, Vincent] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Northumbria University	Parry, SW (corresponding author), Royal Victoria Infirm, Falls & Syncope Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	steve.parry@nuth.nhs.uk		Finch, Tracy/0000-0001-8647-735X; Deary, Vincent/0000-0001-6115-9259	National Institute for Health Research [09/70/04] Funding Source: researchfish; Department of Health [09/70/04, HTA/09/70/04] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Barnett A, 2003, AGE AGEING, V32, P407, DOI 10.1093/ageing/32.4.407; Carpenter MG, 2006, AGE AGEING, V35, P298, DOI 10.1093/ageing/afl002; Clemson L, 2004, J AM GERIATR SOC, V52, P1487, DOI 10.1111/j.1532-5415.2004.52411.x; Delbaere K, 2010, BMJ-BRIT MED J, V341, P4165, DOI DOI 10.1136/BMJ.C4165; Delbaere K, 2010, AGE AGEING, V39, P210, DOI 10.1093/ageing/afp225; Delbaere K, 2009, J GERONTOL A-BIOL, V64, P237, DOI 10.1093/gerona/gln014; Dorresteijn TAC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-228; Freiberger E, 2012, J AM GERIATR SOC, V60, P437, DOI 10.1111/j.1532-5415.2011.03859.x; Hadjistavropoulos T, 2011, J AGING HEALTH, V23, P3, DOI 10.1177/0898264310378039; Huang TT, 2011, J ADV NURS, V67, P961, DOI 10.1111/j.1365-2648.2010.05553.x; Kendrick D, 2012, COCHRANE DB SYST REV; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kwok BC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-155; Logghe IHJ, 2010, PREV MED, V51, P222, DOI 10.1016/j.ypmed.2010.06.003; National Institute for Health Research Health Technology Assessment Programme, STRAT INCREASE CONF; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Tennsledt S, 1998, J GERONTOL B-PSYCHOL, V53, pP384, DOI 10.1093/geronb/53B.6.P384; van Haastregt Jolanda C M, 2007, BMC Health Serv Res, V7, P156, DOI 10.1186/1472-6963-7-156; Vind AB, 2010, AGING CLIN EXP RES, V22, P249, DOI [10.1007/BF03324804, 10.3275/6628]; Zhang JG, 2006, ARCH GERONTOL GERIAT, V42, P107, DOI 10.1016/j.archger.2005.06.007; Zijlstra GAR, 2007, J AM GERIATR SOC, V55, P603, DOI 10.1111/j.1532-5415.2007.01148.x; Zijlstra GAR, 2009, J AM GERIATR SOC, V57, P2020, DOI 10.1111/j.1532-5415.2009.02489.x	23	16	16	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2013	346								f2933	10.1136/bmj.f2933	http://dx.doi.org/10.1136/bmj.f2933			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158CZ	23714190				2022-12-28	WOS:000319947500002
J	Miller-Jones, JCA; Sivakoff, GR; Knigge, C; Kording, EG; Templeton, M; Waagen, EO				Miller-Jones, J. C. A.; Sivakoff, G. R.; Knigge, C.; Kording, E. G.; Templeton, M.; Waagen, E. O.			An Accurate Geometric Distance to the Compact Binary SS Cygni Vindicates Accretion Disc Theory	SCIENCE			English	Article							3 DWARF NOVAE; INSTABILITY MODEL; ASTROMETRIC PARALLAXES; CALIBRATION; OUTBURSTS; AURIGAE; STARS	Dwarf novae are white dwarfs accreting matter from a nearby red dwarf companion. Their regular outbursts are explained by a thermal-viscous instability in the accretion disc, described by the disc instability model that has since been successfully extended to other accreting systems. However, the prototypical dwarf nova, SS Cygni, presents a major challenge to our understanding of accretion disc theory. At the distance of 159 +/- 12 parsecs measured by the Hubble Space Telescope, it is too luminous to be undergoing the observed regular outbursts. Using very long baseline interferometric radio observations, we report an accurate, model-independent distance to SS Cygni that places the source substantially closer at 114 +/- 2 parsecs. This reconciles the source behavior with our understanding of accretion disc theory in accreting compact objects.	[Miller-Jones, J. C. A.] Curtin Univ Technol, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Sivakoff, G. R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Sivakoff, G. R.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Knigge, C.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Kording, E. G.] Radboud Univ Nijmegen, Dept Astrophys IMAPP, NL-6500 GL Nijmegen, Netherlands; [Templeton, M.; Waagen, E. O.] Amer Assoc Variable Star Observers, Cambridge, MA 02138 USA	Curtin University; University of Alberta; University of Virginia; University of Southampton; Radboud University Nijmegen	Miller-Jones, JCA (corresponding author), Curtin Univ Technol, Int Ctr Radio Astron Res, GPO Box U1987, Perth, WA 6845, Australia.	james.miller-jones@curtin.edu.au	Miller-Jones, James C. A./B-2411-2013; Sivakoff, Gregory R/G-9602-2011	Miller-Jones, James C. A./0000-0003-3124-2814; Sivakoff, Gregory R/0000-0001-6682-916X; Templeton, Matthew/0000-0003-1918-0622	Australian Research Councils [DP120102393]; Natural Sciences and Engineering Research Council of Canada; UK Science and Technology Facilities Council; NWO; Netherlands Organisation for Scientific Research [016.123.356]; Science and Technology Facilities Council [ST/J001600/1] Funding Source: researchfish; STFC [ST/J001600/1] Funding Source: UKRI	Australian Research Councils(Australian Research Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the amateur astronomers of AAVSO, whose optical monitoring of SS Cygni was crucial for triggering our radio observations, and J. Thorstensen and A. Deller fur useful discussions. Supported by the Australian Research Councils Discovery Projects funding scheme (J.C.A.M.-J. and G.R.S.; project DP120102393), a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (G.R.S.), a Consolidated Grant from the UK Science and Technology Facilities Council to the Southampton Astronomy Group (C.K.), and a VIDI grant from NWO, the Netherlands Organisation for Scientific Research (E.G.K.; grant 016.123.356). The data reported in this paper arc tabulated in the supplementary materials. The National Radio Astronomy Observatory is a facility of NSF operated under cooperative agreement by Associated Universities Inc. The European VLBI Network is a joint facility of European, Chinese, South African, and other radio astronomy institutes funded by their national research councils. This work made use of the Swinburne University of Technology software correlator, developed as part of the Australian Major National Research Facilities Programme and operated under license.	Ak T, 2010, NEW ASTRON, V15, P491, DOI 10.1016/j.newast.2009.11.007; Bitner MA, 2007, ASTROPHYS J, V662, P564, DOI 10.1086/517496; CANNIZZO JK, 1992, ASTROPHYS J, V401, P642, DOI 10.1086/172092; Coriat M, 2012, MON NOT R ASTRON SOC, V424, P1991, DOI 10.1111/j.1365-2966.2012.21339.x; Dubus G, 2001, ASTRON ASTROPHYS, V373, P251, DOI 10.1051/0004-6361:20010632; Hameury JM, 2009, ASTRON ASTROPHYS, V496, P413, DOI 10.1051/0004-6361/200810928; Harrison TE, 2004, ASTRON J, V127, P460, DOI 10.1086/380228; Harrison TE, 1999, ASTROPHYS J, V515, pL93, DOI 10.1086/311982; Harrison TE, 2000, ASTRON J, V120, P2649, DOI 10.1086/316802; King AR, 1998, MON NOT R ASTRON SOC, V293, pL42, DOI 10.1046/j.1365-8711.1998.01295.x; KOEN C, 1992, MON NOT R ASTRON SOC, V256, P65, DOI 10.1093/mnras/256.1.65; Kording E, 2008, SCIENCE, V320, P1318, DOI 10.1126/science.1155492; Lasota J.-P., 2012, MEM SOC ASTRON ITAL, V83, P469; Lasota JP, 2008, NEW ASTRON REV, V51, P752, DOI 10.1016/j.newar.2008.03.003; Lasota JP, 2001, NEW ASTRON REV, V45, P449, DOI 10.1016/S1387-6473(01)00112-9; LIN DNC, 1986, ASTROPHYS J, V305, P28, DOI 10.1086/164225; LUTZ TE, 1973, PUBL ASTRON SOC PAC, V85, P573, DOI 10.1086/129506; North RC, 2002, MON NOT R ASTRON SOC, V337, P1215, DOI 10.1046/j.1365-8711.2002.05795.x; Patterson J, 2011, MON NOT R ASTRON SOC, V411, P2695, DOI 10.1111/j.1365-2966.2010.17881.x; Schreiber MR, 2007, ASTRON ASTROPHYS, V473, P897, DOI 10.1051/0004-6361:20078146; Schreiber MR, 2003, ASTRON ASTROPHYS, V410, P239, DOI 10.1051/0004-6361:20031221; Schreiber MR, 2002, ASTRON ASTROPHYS, V382, P124, DOI 10.1051/0004-6361:20011627; Smak J, 2010, ACTA ASTRONOM, V60, P83; vanParadijs J, 1996, ASTROPHYS J, V464, pL139, DOI 10.1086/310100; Zacharias N, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/2/44	25	41	41	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					950	952		10.1126/science.1237145	http://dx.doi.org/10.1126/science.1237145			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704566	Green Submitted			2022-12-28	WOS:000319344100039
J	Crow, JM				Crow, James Mitchell			INSOMNIA Chasing the dream	NATURE			English	Editorial Material							COGNITIVE-BEHAVIORAL THERAPY											Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Lin JS, 2011, J PHARMACOL EXP THER, V336, P17, DOI 10.1124/jpet.110.170134; Lopez-Munoz Francisco, 2005, Neuropsychiatr Dis Treat, V1, P329; Mets MAJ, 2011, SLEEP, V34, P1327, DOI 10.5665/SLEEP.1272; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Uslaner JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005213; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307	11	4	5	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					S16	S18		10.1038/497S16a	http://dx.doi.org/10.1038/497S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698503				2022-12-28	WOS:000319254000009
J	Heisenberg, CP; Bellaiche, Y				Heisenberg, Carl-Philipp; Bellaiche, Yohanns			Forces in Tissue Morphogenesis and Patterning	CELL			English	Review							PLANAR CELL POLARITY; LEFT-RIGHT ASYMMETRY; NEURAL-TUBE CLOSURE; LIGHT-SHEET MICROSCOPY; DORSAL CLOSURE; NODAL FLOW; E-CADHERIN; APICAL CONSTRICTION; ADHERENS JUNCTIONS; ACTOMYOSIN NETWORK	During development, mechanical forces cause changes in size, shape, number, position, and gene expression of cells. They are therefore integral to any morphogenetic processes. Force generation by actin-myosin networks and force transmission through adhesive complexes are two self-organizing phenomena driving tissue morphogenesis. Coordination and integration of forces by long-range force transmission and mechanosensing of cells within tissues produce large-scale tissue shape changes. Extrinsic mechanical forces also control tissue patterning by modulating cell fate specification and differentiation. Thus, the interplay between tissue mechanics and biochemical signaling orchestrates tissue morphogenesis and patterning in development.	[Heisenberg, Carl-Philipp] IST Austria, A-3400 Klosterneuburg, Austria; [Bellaiche, Yohanns] Inst Curie, CNRS UMR3215, INSERM U934, F-75248 Paris 05, France	Institute of Science & Technology - Austria; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Heisenberg, CP (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.	heisenberg@ist.ac.at; yohanns.bellaiche@curie.fr		bellaiche, yohanns/0000-0003-1686-2943; Heisenberg, Carl-Philipp/0000-0002-0912-4566	ANR-MorphoDro; ERC-CePoDro; CNRS; INSERM; Curie Institute; Institute of Science and Technology Austria; Deutsche Forschungsgemeinschaft (DFG); Fonds zur Forderung der wissenschaftlichen Forschung (FWF)	ANR-MorphoDro(French National Research Agency (ANR)); ERC-CePoDro; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Curie Institute; Institute of Science and Technology Austria; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF))	We apologize to all authors whose primary papers could not be cited because of space constraints. We thank D. Kiehart, G. Edwards, T. Lecuit, S. Noelli, A. Martin, B. Goldstein, and N. Ueno for kindly providing us with movies to illustrate some of the morphogenetic movements described in the review. Work in Y.B. lab is supported by the ANR-MorphoDro, ERC-CePoDro grants as well as funds by the CNRS, the INSERM, and the Curie Institute. C.-P.H. is supported by the Institute of Science and Technology Austria and grants from the Deutsche Forschungsgemeinschaft (DFG) and Fonds zur Forderung der wissenschaftlichen Forschung (FWF).	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; Almeida L, 2011, J THEOR BIOL, V268, P105, DOI 10.1016/j.jtbi.2010.09.029; Amack JD, 2012, SCIENCE, V338, P212, DOI 10.1126/science.1223953; Ambegaonkar AA, 2012, CURR BIOL, V22, P1302, DOI 10.1016/j.cub.2012.05.049; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Bardet PL, 2013, DEV CELL, V25, P534, DOI 10.1016/j.devcel.2013.04.020; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; Brittle A, 2012, CURR BIOL, V22, P907, DOI 10.1016/j.cub.2012.03.053; Brittle AL, 2010, CURR BIOL, V20, P803, DOI 10.1016/j.cub.2010.03.056; Brodland G. Wayne, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P121, DOI 10.1080/10255840601124704; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chiou KK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002512; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; Cui ML, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000538; David DJV, 2010, DEVELOPMENT, V137, P1645, DOI 10.1242/dev.044107; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Foty RA, 1996, DEVELOPMENT, V122, P1611; Founounou N, 2013, DEV CELL, V24, P242, DOI 10.1016/j.devcel.2013.01.008; Freund JB, 2012, DEVELOPMENT, V139, P1229, DOI 10.1242/dev.073593; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Gelbart MA, 2012, P NATL ACAD SCI USA, V109, P19298, DOI 10.1073/pnas.1205258109; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Gorfinkiel N, 2009, DEVELOPMENT, V136, P1889, DOI 10.1242/dev.030866; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Guillot C, 2013, DEV CELL, V24, P227, DOI 10.1016/j.devcel.2013.01.010; Haigo SL, 2011, SCIENCE, V331, P1071, DOI 10.1126/science.1199424; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hannezo E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.018101; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Herszterg S, 2013, DEV CELL, V24, P256, DOI 10.1016/j.devcel.2012.11.019; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hopyan S, 2011, DEV DYNAM, V240, P1054, DOI 10.1002/dvdy.22601; Howard J., 2001, MECH MOTOR PROTEINS; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Ishihara S, 2012, J THEOR BIOL, V313, P201, DOI 10.1016/j.jtbi.2012.08.017; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jones EAV, 2006, PHYSIOLOGY, V21, P388, DOI 10.1152/physiol.00020.2006; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013; Kee YS, 2008, CURR BIOL, V18, pR860, DOI 10.1016/j.cub.2008.07.071; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Keller R, 2012, SCIENCE, V338, P201, DOI 10.1126/science.1230718; Kennaway R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002071; Kiehart D.P., 2006, CELL BIOL LAB HDB, P87; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kobel S, 2011, CURR OPIN BIOTECH, V22, P690, DOI 10.1016/j.copbio.2011.07.001; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Kondo T, 2013, NATURE, V494, P125, DOI 10.1038/nature11792; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Kuchen EE, 2012, SCIENCE, V335, P1092, DOI 10.1126/science.1214678; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; le Noble F, 2005, CARDIOVASC RES, V65, P619, DOI 10.1016/j.cardiores.2004.09.018; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; Leptin M, 1995, ANNU REV CELL DEV BI, V11, P189; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Mammoto T, 2011, DEV CELL, V21, P758, DOI 10.1016/j.devcel.2011.07.006; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Morelli LG, 2012, SCIENCE, V336, P187, DOI 10.1126/science.1215478; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Okabe N, 2008, DEV DYNAM, V237, P3602, DOI 10.1002/dvdy.21730; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Ranft J, 2010, P NATL ACAD SCI USA, V107, P20863, DOI 10.1073/pnas.1011086107; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sagner A, 2012, CURR BIOL, V22, P1296, DOI 10.1016/j.cub.2012.04.066; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sawyer JK, 2011, MOL BIOL CELL, V22, P2491, DOI 10.1091/mbc.E11-05-0411; Schilling S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002025; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Simon MA, 2010, CURR BIOL, V20, P811, DOI 10.1016/j.cub.2010.04.016; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; Slough J, 2008, DEV DYNAM, V237, P2304, DOI 10.1002/dvdy.21669; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Suzanne M, 2010, CURR BIOL, V20, P1773, DOI 10.1016/j.cub.2010.08.056; Suzuki M, 2012, DEV GROWTH DIFFER, V54, P266, DOI 10.1111/j.1440-169X.2012.01346.x; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Warrington SJ, 2013, DEVELOPMENT, V140, P1045, DOI 10.1242/dev.088724; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765; Zhang HM, 2010, DEV DYNAM, V239, P1465, DOI 10.1002/dvdy.22255	162	655	664	12	274	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					948	962		10.1016/j.cell.2013.05.008	http://dx.doi.org/10.1016/j.cell.2013.05.008			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706734	Bronze			2022-12-28	WOS:000319456800005
J	Scully, T				Scully, Tony			SLEEP	NATURE			English	Editorial Material																			0	12	14	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S1	S1		10.1038/497S1a	http://dx.doi.org/10.1038/497S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698499	Bronze			2022-12-28	WOS:000319254000001
J	Strain, WD; Lukashevich, V; Kothny, W; Hoellinger, MJ; Paldanius, PM				Strain, W. David; Lukashevich, Valentina; Kothny, Wolfgang; Hoellinger, Marie-Jose; Paldanius, Paeivi Maria			Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study	LANCET			English	Article							OLDER-PEOPLE EDWPOP; GLUCOSE CONTROL; WORKING PARTY; MANAGEMENT; ASSOCIATION; STATEMENT; MELLITUS; HYPERGLYCEMIA; TOLERABILITY; MONOTHERAPY	Background Guidelines suggest setting individualised targets for glycaemic control in elderly patients with type 2 diabetes, despite no evidence. We aimed to assess the feasibility of setting and achieving individualised targets over 24 weeks along with conventional HbA(1c) reduction using vildagliptin versus placebo. Methods In this multinational, double-blind, 24 week study, we enrolled drug-naive or inadequately controlled (glycosylated haemoglobin A(1c) [HbA(1c)] >= 7.0% to <= 10.0%) patients with type 2 diabetes aged 70 years or older from 45 outpatient centres in Europe. Investigators set individualised treatment targets on the basis of age, baseline HbA(1c), comorbidities, and frailty status before a validated automated system randomly assigned patients (1: 1) to vildagliptin (50 mg once or twice daily as per label) or placebo. Coprimary efficacy endpoints were proportion of patients reaching their investigator-defined HbA(1c) target and HbA(1c) reduction from baseline to study end. The study is registered with ClinicalTrials.gov, number NCT01257451, and European Union Drug Regulating Authorities Clinical Trials database, number 2010-022658-18. Findings Between Dec 22, 2010, and March 14, 2012, we randomly assigned 139 patients each to the vildagliptin and placebo groups. 37 (27%) of 137 patients in the placebo group achieved their individualised targets by education and interactions with the study team alone and 72 (52.6%) of 137 patients achieved their target in the vildagliptin group (adjusted odds ratio 3.16, 96.2% CI 1.81-5.52; p<0.0001). This finding was accompanied by a clinically relevant 0.9% reduction in HbA(1c) from a baseline of 7.9% with vildagliptin and a between-group difference of -0.6% (98.8% CI -0.81 to -0.33; p<0.0001). The overall safety and tolerability was similar in the vildagliptin and placebo groups, with low incidence of hypoglycaemia and no emergence of new safety signals. Interpretation This study is the first to introduce and show the feasibility of using individualised HbA(1c) targets as an endpoint in any type 2 diabetes population. Individualised glycaemic target levels are achievable with vildagliptin without any tolerability issues in the elderly type 2 diabetes population.	[Strain, W. David] Univ Exeter, Sch Med, Diabet & Vasc Res Ctr, Exeter EX2 5AX, Devon, England; [Lukashevich, Valentina; Kothny, Wolfgang] Novartis Pharmaceut, E Hanover, NJ USA; [Hoellinger, Marie-Jose; Paldanius, Paeivi Maria] Novartis Pharma AG, Basel, Switzerland	University of Exeter; Novartis; Novartis	Strain, WD (corresponding author), Univ Exeter, Sch Med, Exeter EX2 5AX, Devon, England.	d.strain@exeter.ac.uk	Strain, William/Y-9858-2019; Paldanius, Päivi/AAR-6793-2020	Strain, William/0000-0002-6826-418X; Paldanius, Paivi Maria/0000-0001-5997-4879	Novartis Pharma AG	Novartis Pharma AG	Novartis Pharma AG.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Barzilai N, 2011, CURR MED RES OPIN, V27, P1049, DOI 10.1185/03007995.2011.568059; Bourdel-Marchasson Isabelle, 2011, Hosp Pract (1995), V39, P7, DOI 10.3810/hp.2011.02.369; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Chelliah A, 2004, DRUG AGING, V21, P511, DOI 10.2165/00002512-200421080-00003; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Kothny W, 2012, DIABETES OBES METAB, V14, P1032, DOI 10.1111/j.1463-1326.2012.01634.x; Ligueros-Saylan M, 2010, DIABETES OBES METAB, V12, P495, DOI 10.1111/j.1463-1326.2010.01214.x; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pratley RE, 2007, DIABETES CARE, V30, P3017, DOI 10.2337/dc07-1188; Pratley RE, 2012, POSTGRAD MED, V124, P133, DOI 10.3810/pgm.2012.01.2526; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Schweizer A, 2011, DIABETES OBES METAB, V13, P55, DOI 10.1111/j.1463-1326.2010.01325.x; Schweizer A, 2009, DIABETES OBES METAB, V11, P804, DOI 10.1111/j.1463-1326.2009.01051.x; Selvin E, 2006, DIABETES CARE, V29, P2415, DOI 10.2337/dc06-1058; Sinclair A, 2012, J AM MED DIR ASSOC, V13, P497, DOI 10.1016/j.jamda.2012.04.012; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4	24	100	102	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					409	416		10.1016/S0140-6736(13)60995-2	http://dx.doi.org/10.1016/S0140-6736(13)60995-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MX	23706759				2022-12-28	WOS:000322638500033
J	Jha, V; Garcia-Garcia, G; Iseki, K; Li, Z; Naicker, S; Plattner, B; Saran, R; Wang, AYM; Yang, CW				Jha, Vivekanand; Garcia-Garcia, Guillermo; Iseki, Kunitoshi; Li, Zuo; Naicker, Saraladevi; Plattner, Brett; Saran, Rajiv; Wang, Angela Yee-Moon; Yang, Chih-Wei			Chronic kidney disease: global dimension and perspectives	LANCET			English	Article							STAGE RENAL-DISEASE; ARISTOLOCHIC ACID NEPHROPATHY; GLOMERULAR-FILTRATION-RATE; SUB-SAHARAN-AFRICA; COST-EFFECTIVENESS; RISK-FACTORS; CARDIOVASCULAR EVENTS; SOCIOECONOMIC-STATUS; DEVELOPING-COUNTRIES; PRIMARY-CARE	Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated to be 8-16% worldwide. Complications include increased all-cause and cardiovascular mortality, kidney-disease progression, acute kidney injury, cognitive decline, anaemia, mineral and bone disorders, and fractures. Worldwide, diabetes mellitus is the most common cause of chronic kidney disease, but in some regions other causes, such as herbal and environmental toxins, are more common. The poorest populations are at the highest risk. Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced. Awareness of the disorder, however, remains low in many communities and among many physicians. Strategies to reduce burden and costs related to chronic kidney disease need to be included in national programmes for non-communicable diseases.	[Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Jha, Vivekanand] George Inst Global Hlth, 219-221 Splendor Forum, New Delhi, India; [Garcia-Garcia, Guillermo] Univ Guadalajara, Hlth Sci Ctr, Hosp Civil Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Iseki, Kunitoshi] Univ Hosp Ryukyus, Ryukyus, Okinawa, Japan; [Li, Zuo] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Naicker, Saraladevi] Univ Witwatersrand, Dept Internal Med, Johannesburg, South Africa; [Plattner, Brett; Saran, Rajiv] Univ Michigan, Ann Arbor, MI 48109 USA; [Saran, Rajiv] Univ Michigan, Kidney Epidemiol & Cost Ctr, Ann Arbor, MI 48109 USA; [Wang, Angela Yee-Moon] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Yang, Chih-Wei] Chang Gung Mem Hosp, Kidney Res Ctr, Linkou, Taiwan; [Yang, Chih-Wei] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Universidad de Guadalajara; University of the Ryukyus; Peking University; University of Witwatersrand; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Hong Kong; Chang Gung Memorial Hospital; Chang Gung University	Jha, V (corresponding author), George Inst Global Hlth, 219-221 Splendor Forum, New Delhi, India.	vjha@pginephro.org	Wang, Angela Y/B-9944-2008	Wang, Angela Yee-Moon/0000-0003-2508-7117; Garcia Garcia, Guillermo/0000-0003-0558-0035; Naicker, Saraladevi/0000-0002-7058-9725; Jha, Vivekanand/0000-0002-8015-9470	AbbVie; Baxter; Sanofi Renal	AbbVie(AbbVie); Baxter; Sanofi Renal	AY-M has received grants from AbbVie, Baxter, and Sanofi Renal, and speaker honoraria from Baxter, Fresinius Kabi, Roche Diagnostics, and Sanofi Renal. All other authors declare that they have no conflicts of interest.	Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Almaguer M, 2005, KIDNEY INT, V68, pS4, DOI 10.1111/j.1523-1755.2005.09701.x; Arogundade FA, 2008, AM J KIDNEY DIS, V51, P515, DOI 10.1053/j.ajkd.2007.12.006; Ashton Chris W, 2011, Healthc Q, V14, P42; Atkins RC, 2005, KIDNEY INT, V68, pS83, DOI 10.1111/j.1523-1755.2005.09815.x; Atthobari J, 2006, CLIN THER, V28, P432, DOI 10.1016/j.clinthera.2006.03.012; Ayodele OE, 2010, ADV CHRONIC KIDNEY D, V17, P215, DOI 10.1053/j.ackd.2010.02.001; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Barnes P. M., 2008, NATL HLTH STAT REPOR; Blickem C, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-28; Boulware LE, 2003, JAMA-J AM MED ASSOC, V290, P3101, DOI 10.1001/jama.290.23.3101; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chugh KS, 1999, TRANSPLANT P, V31, P3275, DOI 10.1016/S0041-1345(99)00722-8; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2010, KIDNEY INT, V78, P926, DOI 10.1038/ki.2010.259; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Cortes-Sanabria L, 2008, AM J KIDNEY DIS, V51, P777, DOI 10.1053/j.ajkd.2007.12.039; Cueto-Manzano AM, 2010, CLIN NEPHROL, V74, pS99; Dai SS, 2011, AM J KIDNEY DIS, V58, P496, DOI 10.1053/j.ajkd.2011.05.016; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Engelgau MM, 2011, DIR DEV, P15; Fabian J, 2009, ETHN DIS S1, V19, pS1; Feehally J, 2005, KIDNEY INT, V68, P414; Field M, 2008, NAT CLIN PRACT NEPHR, V4, P583, DOI 10.1038/ncpneph0951; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Frenk J, 1994, NOTAS POBLACION, V22, P79; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gonzalez-Martinez F, 2012, NEFROLOGIA SUPPL 3, V32, P171; Guh JY, 2007, AM J KIDNEY DIS, V49, P626, DOI 10.1053/j.ajkd.2007.02.259; Han TM, 2006, KIDNEY INT, V69, P2243, DOI 10.1038/sj.ki.5000339; Herman WH, 2003, DIABETES CARE, V26, P683, DOI 10.2337/diacare.26.3.683; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P463, DOI 10.1053/j.ajkd.2009.11.017; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Jha V, 2004, RENAL FAILURE, V26, P201, DOI 10.1081/JDI-120039516; Jha V, 2008, SEMIN NEPHROL, V28, P416, DOI 10.1016/j.semnephrol.2008.04.010; Jha V, 2013, NAT REV NEPHROL, V9, P278, DOI 10.1038/nrneph.2013.36; Jha V, 2012, NEPHROL DIAL TRANSPL, V27, P32, DOI 10.1093/ndt/gfs113; Jha V, 2009, SEMIN NEPHROL, V29, P487, DOI 10.1016/j.semnephrol.2009.06.005; Kanji Z, 2011, J AM SOC NEPHROL, V22, P2091, DOI 10.1681/ASN.2010121234; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; KHIN-MAUNG-U, 1987, Journal of Diarrhoeal Diseases Research, V5, P175; Kitiyakara C, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-1; Lafrance JP, 2010, NEPHROL DIAL TRANSPL, V25, P2203, DOI 10.1093/ndt/gfq011; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li PKT, 2011, NEPHROLOGY, V16, P633, DOI 10.1111/j.1440-1797.2011.01503.x; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047100; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu C, 2010, J HUAZHONG U SCI-MED, V30, P604, DOI 10.1007/s11596-010-0550-1; Ma YC, 2011, CLIN NEPHROL, V76, P296, DOI 10.5414/CN106912; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Manns B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5869; Martins D, 2006, AM J KIDNEY DIS, V47, P965, DOI 10.1053/j.ajkd.2006.02.179; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mazzuchi N, 2006, RENAL FAILURE, V28, P617, DOI 10.1080/08860220600925677; McDonald SP, 2003, NEPHROL DIAL TRANSPL, V18, P1555, DOI 10.1093/ndt/gfg199; Merkin SS, 2007, SOC SCI MED, V65, P809, DOI 10.1016/j.socscimed.2007.04.011; Ministerio de Salud, 2011, ESTRATEGIA NACIONAL; Minutolo R, 2008, AM J KIDNEY DIS, V52, P444, DOI 10.1053/j.ajkd.2008.03.002; Naaz I, 2010, Indian J Nephrol, V20, P211, DOI 10.4103/0971-4065.73451; Naicker S, 2010, CLIN NEPHROL, V74, pS129; Palmer AJ, 2008, NEPHROL DIAL TRANSPL, V23, P1216, DOI 10.1093/ndt/gfn082; Parameswaran S, 2011, NATL MED J INDIA, V24, P208; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Phisitkul S, 2010, KIDNEY INT, V77, P617, DOI 10.1038/ki.2009.519; Plantinga LC, 2008, ARCH INTERN MED, V168, P2268, DOI 10.1001/archinte.168.20.2268; Rajapurkar MM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-10; Rao C, 2012, EUR J PUBLIC HEALTH, V22, P280, DOI 10.1093/eurpub/ckq205; Ravera M, 2011, AM J KIDNEY DIS, V57, P71, DOI 10.1053/j.ajkd.2010.08.022; Rutkowski B., 2009, ETHN DIS S1, V19; Rutkowski B, 2006, ETHN DIS S2, V16, pS2; Schwedt E, 2010, NEPHRON CLIN PRACT, V114, pC47, DOI 10.1159/000245069; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stefanovic V, 2009, RENAL FAILURE, V31, P409, DOI 10.1080/08860220902839097; Subsecretaria de Innovacion y Calidad, 2010, RED ESTRATEGICA DE S; Tan-Torres Edejer T., 2004, MAKING CHOICES HLTH; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; Tiessen H, 1998, ADV GEOECOL, V31, P415; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; United States Renal Data System, 2012, USRDS 2012 ANNUAL DA; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Vassalotti JA, 2010, SEMIN NEPHROL, V30, P66, DOI 10.1016/j.semnephrol.2009.10.004; Vivante A, 2011, JAMA-J AM MED ASSOC, V306, P729, DOI 10.1001/jama.2011.1141; Wang AYM, 2006, KIDNEY INT, V69, P1726, DOI 10.1038/sj.ki.5000382; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wanigasuriya KP, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-32; Wei SY, 2010, NEPHROLOGY, V15, P108, DOI 10.1111/j.1440-1797.2009.01154.x; Whaley-Connell A, 2012, AM J MED, V125, P661, DOI 10.1016/j.amjmed.2011.11.026; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yang L, 2012, NEPHROL DIAL TRANSPL, V27, P292, DOI 10.1093/ndt/gfr291; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang LX, 2009, SEMIN NEPHROL, V29, P483, DOI 10.1016/j.semnephrol.2009.06.012	106	2418	2553	21	440	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					260	272		10.1016/S0140-6736(13)60687-X	http://dx.doi.org/10.1016/S0140-6736(13)60687-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FL	23727169				2022-12-28	WOS:000322543700036
J	Vilboux, T; Lev, A; Malicdan, MCV; Simon, AJ; Jarvinen, P; Racek, T; Puchalka, J; Sood, R; Carrington, B; Bishop, K; Mullikin, J; Huizing, M; Garty, BZ; Eyal, E; Wolach, B; Gavrieli, R; Toren, A; Soudack, M; Atawneh, OM; Babushkin, T; Schiby, G; Cullinane, A; Avivi, C; Polak-Charcon, S; Barshack, I; Amariglio, N; Rechavi, G; ten Bosch, JV; Anikster, Y; Klein, C; Gahl, WA; Somech, R				Vilboux, Thierry; Lev, Atar; Malicdan, May Christine V.; Simon, Amos J.; Jaervinen, Paeivi; Racek, Tomas; Puchalka, Jacek; Sood, Raman; Carrington, Blake; Bishop, Kevin; Mullikin, James; Huizing, Marjan; Garty, Ben Zion; Eyal, Eran; Wolach, Baruch; Gavrieli, Ronit; Toren, Amos; Soudack, Michalle; Atawneh, Osama M.; Babushkin, Tatiana; Schiby, Ginette; Cullinane, Andrew; Avivi, Camila; Polak-Charcon, Sylvie; Barshack, Iris; Amariglio, Ninette; Rechavi, Gideon; ten Bosch, Jutte van der Werff; Anikster, Yair; Klein, Christoph; Gahl, William A.; Somech, Raz			A Congenital Neutrophil Defect Syndrome Associated with Mutations in VPS45	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERMANSKY-PUDLAK-SYNDROME; OCULOCUTANEOUS ALBINISM; GENETIC-DEFECTS; PROTEIN; ZEBRAFISH; RABENOSYN-5; TRAFFICKING; DEFICIENCY; TRANSPORT; HOMOLOG	BACKGROUND Neutrophils are the predominant phagocytes that provide protection against bacterial and fungal infections. Genetically determined neutrophil disorders confer a predisposition to severe infections and reveal novel mechanisms that control vesicular trafficking, hematopoiesis, and innate immunity. METHODS We clinically evaluated seven children from five families who had neutropenia, neutrophil dysfunction, bone marrow fibrosis, and nephromegaly. To identify the causative gene, we performed homozygosity mapping using single-nucleotide polymorphism arrays, whole-exome sequencing, immunoblotting, immunofluorescence, electron microscopy, a real-time quantitative polymerase-chain-reaction assay, immunohistochemistry, flow cytometry, fibroblast motility assays, measurements of apoptosis, and zebrafish models. Correction experiments were performed by transfecting mutant fibroblasts with the nonmutated gene. RESULTS All seven affected children had homozygous mutations (Thr224Asn or Glu238Lys, depending on the child's ethnic origin) in VPS45, which encodes a protein that regulates membrane trafficking through the endosomal system. The level of VPS45 protein was reduced, as were the VPS45 binding partners rabenosyn-5 and syntaxin-16. The level of beta 1 integrin was reduced on the surface of VPS45-deficient neutrophils and fibroblasts. VPS45-deficient fibroblasts were characterized by impaired motility and increased apoptosis. A zebrafish model of vps45 deficiency showed a marked paucity of myeloperoxidase-positive cells (i.e., neutrophils). Transfection of patient cells with nonmutated VPS45 corrected the migration defect and decreased apoptosis. CONCLUSIONS Defective endosomal intracellular protein trafficking due to biallelic mutations in VPS45 underlies a new immunodeficiency syndrome involving impaired neutrophil function.	[Vilboux, Thierry; Malicdan, May Christine V.; Huizing, Marjan; Cullinane, Andrew; Gahl, William A.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Sood, Raman; Carrington, Blake; Bishop, Kevin] NHGRI, Zebrafish Core Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Mullikin, James] NHGRI, Comparat Genom Unit, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Lev, Atar; Simon, Amos J.; Somech, Raz] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Jeffrey Modell Fdn, Pediat Immunol Serv, Tel Hashomer, Israel; [Eyal, Eran; Amariglio, Ninette; Rechavi, Gideon] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Canc Res Ctr, Tel Hashomer, Israel; [Toren, Amos] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Hemato Oncol Unit, Tel Hashomer, Israel; [Soudack, Michalle] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Imaging Unit, Tel Hashomer, Israel; [Babushkin, Tatiana; Schiby, Ginette; Avivi, Camila; Polak-Charcon, Sylvie; Barshack, Iris] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Dept Pathol, Tel Hashomer, Israel; [Anikster, Yair] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Metab Dis Unit, Tel Hashomer, Israel; [Garty, Ben Zion; Wolach, Baruch; Gavrieli, Ronit; Toren, Amos; Soudack, Michalle; Babushkin, Tatiana; Schiby, Ginette; Avivi, Camila; Polak-Charcon, Sylvie; Barshack, Iris; Rechavi, Gideon; Anikster, Yair; Somech, Raz] Tel Aviv Univ, Sackler Fac Med, IL-52621 Tel Aviv, Israel; [Garty, Ben Zion] Schneider Childrens Med Ctr Israel, Dept Pediat B, Petah Tiqwa, Israel; [Garty, Ben Zion] Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Wolach, Baruch; Gavrieli, Ronit] Meir Med Ctr, Dept Pediat, Kefar Sava, Israel; [Wolach, Baruch; Gavrieli, Ronit] Meir Med Ctr, Lab Leukocyte Funct, Kefar Sava, Israel; [Atawneh, Osama M.] Palestine Red Crescent Soc Hosp, Hebron City, Germany; [Jaervinen, Paeivi; Racek, Tomas; Puchalka, Jacek; Klein, Christoph] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [ten Bosch, Jutte van der Werff] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Pediat, Brussels, Belgium	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; University of Munich; University Hospital Brussels; Vrije Universiteit Brussel	Somech, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Chaim Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, IL-52621 Tel Aviv, Israel.	raz.somech@sheba.health.gov.il	Huizing, Marjan/AAR-8860-2020; Malicdan, May Christine/AAK-7422-2021		National Human Genome Research Institute; Intramural Research Program of the National Human Genome Research Institute; European Research Council; Gottfried-Wilhelm-Leibniz Program of the Deutsche Forschungsgemeinschaft; Care-for-Rare Foundation; German Network on Primary Immunodeficiency Diseases; Jeffrey Modell Foundation; Israeli Science Foundation; Chief Scientist Office of the Israeli Ministry of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200322, ZIGHG200351, ZIAHG200330, ZIBHG000196, ZIAHG000215] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Research Council(European Research Council (ERC)European Commission); Gottfried-Wilhelm-Leibniz Program of the Deutsche Forschungsgemeinschaft; Care-for-Rare Foundation; German Network on Primary Immunodeficiency Diseases; Jeffrey Modell Foundation; Israeli Science Foundation(Israel Science Foundation); Chief Scientist Office of the Israeli Ministry of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funded by the National Human Genome Research Institute and others.; Supported by the Intramural Research Program of the National Human Genome Research Institute, an advanced grant (EXPLORE) from the European Research Council, the Gottfried-Wilhelm-Leibniz Program of the Deutsche Forschungsgemeinschaft, the Care-for-Rare Foundation, and the German Network on Primary Immunodeficiency Diseases. Dr. Somech is the recipient of grants from the Jeffrey Modell Foundation, the Israeli Science Foundation, and the Chief Scientist Office of the Israeli Ministry of Health.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bishop JB, 2004, TOXICOL SCI, V81, P512, DOI 10.1093/toxsci/kfh208; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Chen C, 2006, IMMUNITY, V25, P895, DOI 10.1016/j.immuni.2006.10.013; COWLES CR, 1994, J CELL SCI, V107, P3449; Cullinane AR, 2011, J INVEST DERMATOL, V131, P2017, DOI 10.1038/jid.2011.157; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Gissen P, 2006, HUM GENET, V120, P396, DOI 10.1007/s00439-006-0232-z; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Horn D, 2000, AM J MED GENET, V92, P285, DOI 10.1002/(SICI)1096-8628(20000605)92:4<285::AID-AJMG13>3.3.CO;2-4; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Klein C, 2013, HEMATOL ONCOL CLIN N, V27, pXI, DOI 10.1016/j.hoc.2012.11.005; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Morrison HA, 2008, MOL BIOL CELL, V19, P4167, DOI 10.1091/mbc.E08-07-0716; Nanua S, 2011, BLOOD, V117, P3539, DOI 10.1182/blood-2010-10-311704; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perskvist N, 2002, J CELL SCI, V115, P1321; Rahajeng J, 2010, EXP CELL RES, V316, P859, DOI 10.1016/j.yexcr.2009.11.007; Rajasekariah P, 1999, INT J BIOCHEM CELL B, V31, P683, DOI 10.1016/S1357-2725(99)00017-5; Rubio JP, 1997, AM J HUM GENET, V61, P899, DOI 10.1086/514876; Schaffer AA, 2007, CURR OPIN ALLERGY CL, V7, P481, DOI 10.1097/ACI.0b013e3282f1d690; Shanks SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049628; Sood Raman, 2012, Adv Hematol, V2012, P830703, DOI 10.1155/2012/830703; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tomita Y, 2004, AM J MED GENET C, V131C, P75, DOI 10.1002/ajmg.c.30036; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wider C, 2008, PARKINSONISM RELAT D, V14, P465, DOI 10.1016/j.parkreldis.2007.11.013; ZUCKERFRANKLIN D, 1977, BLOOD, V49, P425	43	87	91	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					54	65		10.1056/NEJMoa1301296	http://dx.doi.org/10.1056/NEJMoa1301296			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23738510	Green Accepted			2022-12-28	WOS:000321263500010
J	Goldberger, JJ; Buxton, AE				Goldberger, Jeffrey J.; Buxton, Alfred E.			Personalized Medicine vs Guideline-Based Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ACUTE MYOCARDIAL-INFARCTION; RISK STRATIFICATION		[Goldberger, Jeffrey J.] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Goldberger, Jeffrey J.] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Buxton, Alfred E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Beth Israel Deaconess Medical Center	Goldberger, JJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 251 E Huron St,Feinberg 8-503, Chicago, IL 60611 USA.	j-goldberger@northwestern.edu	Goldberger, Jeffrey J/AAB-3684-2020					[Anonymous], PRIOR PERS MED; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Goldberger JJ, 2011, CIRCULATION, V123, P2423, DOI 10.1161/CIRCULATIONAHA.110.959734; Goldberger JJ, 2009, J AM COLL CARDIOL, V54, P2001, DOI 10.1016/j.jacc.2009.08.018; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P288, DOI 10.1016/j.jacc.2007.08.058; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; VanderWeele TJ, 2011, ANN INTERN MED, V154, P680, DOI 10.7326/0003-4819-154-10-201105170-00008; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07	10	67	70	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2559	2560		10.1001/jama.2013.6629	http://dx.doi.org/10.1001/jama.2013.6629			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23712449				2022-12-28	WOS:000320848100024
J	Rietveld, CA; Medland, SE; Derringer, J; Yang, J; Esko, T; Martin, NW; Westra, HJ; Shakhbazov, K; Abdellaoui, A; Agrawal, A; Albrecht, E; Alizadeh, BZ; Amin, N; Bamard, J; Baumeister, SE; Benke, KS; Bielak, LF; Boatman, JA; Boyle, PA; Davies, G; De Leeuw, C; Eklund, N; Evans, DS; Ferhmann, R; Fischer, K; Gieger, C; Gjessing, HK; Hagg, S; Harris, JR; Hayward, C; Holzapfel, C; Ibrahim-Verbaas, CA; Ingelsson, E; Jacobsson, B; Joshi, PK; Jugessur, A; Kaakinen, M; Kanoni, S; Karjalainen, J; Kolcic, I; Kristiansson, K; Kutalik, Z; Lahti, J; Lee, SH; Lin, P; Lind, PA; Liu, YM; Lohman, K; Loitfelder, M; McMahon, G; Vidal, PM; Meirelles, O; Milani, L; Myhre, R; Nuotio, ML; Oldmeadow, CJ; Petrovic, KE; Peyrot, WJ; Polasek, O; Quaye, L; Reinmaa, E; Rice, JP; Rizzi, TS; Schmidt, H; Schmidt, R; Smith, AV; Smith, JA; Tanaka, T; Terracciano, A; van der Loos, MJHM; Vitart, V; Volzke, H; Wellmann, J; Yu, L; Zhao, W; Allik, J; Attia, JR; Bandinelli, S; Bastardot, F; Beauchamp, J; Bennett, DA; Berger, K; Bierut, LJ; Boomsma, DI; Bultmann, U; Campbell, H; Chabris, CF; Cherkas, L; Chung, MK; Cucca, F; de Andrade, M; De Jager, PL; De Neve, JE; Deary, IJ; Dedoussis, GV; Deloukas, P; Dimitriou, M; Eiriksdottir, G; Elderson, MF; Eriksson, JG; Evans, DM; Faul, JD; Ferrucci, L; Garcia, ME; Gronberg, H; Guonason, V; Hall, P; Harris, JM; Harris, TB; Hastie, ND; Heath, AC; Hernandez, DG; Hoffmann, W; Hofman, A; Holle, R; Holliday, EG; Hottenga, JJ; Iacono, WG; Illig, T; Jarvelin, MR; Kahonen, M; Kaprio, J; Kirkpatrick, RM; Kowgier, M; Latvala, A; Launer, LJ; Lawlor, DA; Lehtimaki, T; Li, JM; Lichtenstein, P; Lichtner, P; Liewald, DC; Madden, PA; Magnusson, PKE; Makinen, TE; Masala, M; McGue, M; Metspalu, A; Mielck, A; Miller, MB; Montgomery, GW; Mukherjee, S; Nyholt, DR; Oostra, BA; Palmer, LJ; Palotie, A; Penninx, BWJH; Perola, M; Peyser, PA; Preisig, M; Raikkonen, K; Raitakari, OT; Realo, A; Ring, SM; Ripatti, S; Rivadeneira, F; Rudan, I; Rustichini, A; Salomaa, V; Sarin, AP; Schlessinger, D; Scott, RJ; Snieder, H; St Pourcain, B; Starr, JM; Sul, JH; Surakka, I; Svento, R; Teumer, A; Tiemeier, H; van Rooij, FJA; Van Wagoner, DR; Vartiainen, E; Viikari, J; Vollenweider, P; Vonk, JM; Waeber, G; Weir, DR; Wichmann, HE; Widen, E; Willemsen, G; Wilson, JF; Wright, AF; Conley, D; Davey-Smith, G; Franke, L; Groenen, PJF; Hofman, A; Johannesson, M; Kardia, SLR; Krueger, RF; Laibson, D; Martin, NG; Meyer, MN; Posthuma, D; Thurik, AR; Timpson, NJ; Uitterlinden, AG; van Duijn, CM; Visscher, PM; Benjamin, DJ; Cesarini, D; Koellinger, PD				Rietveld, Cornelius A.; Medland, Sarah E.; Derringer, Jaime; Yang, Jian; Esko, Tonu; Martin, Nicolas W.; Westra, Harm-Jan; Shakhbazov, Konstantin; Abdellaoui, Abdel; Agrawal, Arpana; Albrecht, Eva; Alizadeh, Behrooz Z.; Amin, Najaf; Bamard, John; Baumeister, Sebastian E.; Benke, Kelly S.; Bielak, Lawrence F.; Boatman, Jeffrey A.; Boyle, Patricia A.; Davies, Gail; De Leeuw, Christiaan; Eklund, Niina; Evans, Daniel S.; Ferhmann, Rudolf; Fischer, Krista; Gieger, Christian; Gjessing, Hakon K.; Haegg, Sara; Harris, Jennifer R.; Hayward, Caroline; Holzapfel, Christina; Ibrahim-Verbaas, Carla A.; Ingelsson, Erik; Jacobsson, Bo; Joshi, Peter K.; Jugessur, Astanand; Kaakinen, Marika; Kanoni, Stavroula; Karjalainen, Juha; Kolcic, Ivana; Kristiansson, Kati; Kutalik, Zoltan; Lahti, Jari; Lee, Sang H.; Lin, Peng; Lind, Penelope A.; Liu, Yongmei; Lohman, Kurt; Loitfelder, Marisa; McMahon, George; Vidal, Pedro Marques; Meirelles, Osorio; Milani, Lili; Myhre, Ronny; Nuotio, Marja-Liisa; Oldmeadow, Christopher J.; Petrovic, Katja E.; Peyrot, Wouter J.; Polasek, Ozren; Quaye, Lydia; Reinmaa, Eva; Rice, John P.; Rizzi, Thais S.; Schmidt, Helena; Schmidt, Reinhold; Smith, Albert V.; Smith, Jennifer A.; Tanaka, Toshiko; Terracciano, Antonio; van der Loos, Matthijs J. H. M.; Vitart, Veronique; Voelzke, Henry; Wellmann, Juergen; Yu, Lei; Zhao, Wei; Allik, Jueri; Attia, John R.; Bandinelli, Stefania; Bastardot, Franois; Beauchamp, Jonathan; Bennett, David A.; Berger, Klaus; Bierut, Laura J.; Boomsma, Dorret I.; Bueltmann, Ute; Campbell, Harry; Chabris, Christopher F.; Cherkas, Lynn; Chung, Mina K.; Cucca, Francesco; de Andrade, Mariza; De Jager, Philip L.; De Neve, Jan-Emmanuel; Deary, Ian J.; Dedoussis, George V.; Deloukas, Panos; Dimitriou, Maria; Eiriksdottir, Guony; Elderson, Martin F.; Eriksson, Johan G.; Evans, David M.; Faul, Jessica D.; Ferrucci, Luigi; Garcia, Melissa E.; Groenberg, Henrik; Guonason, Vilmundur; Hall, Per; Harris, Juliette M.; Harris, Tamara B.; Hastie, Nicholas D.; Heath, Andrew C.; Hernandez, Dena G.; Hoffmann, Wolfgang; Hofman, Adriaan; Holle, Rolf; Holliday, Elizabeth G.; Hottenga, Jouke-Jan; Iacono, William G.; Illig, Thomas; Jaervelin, Marjo-Riitta; Kaehoenen, Mika; Kaprio, Jaakko; Kirkpatrick, Robert M.; Kowgier, Matthew; Latvala, Antti; Launer, Lenore J.; Lawlor, Debbie A.; Lehtimaeki, Terho; Li, Jingmei; Lichtenstein, Paul; Lichtner, Peter; Liewald, David C.; Madden, Pamela A.; Magnusson, Patrik K. E.; Maekinen, Tomi E.; Masala, Marco; McGue, Matt; Metspalu, Andres; Mielck, Andreas; Miller, Michael B.; Montgomery, Grant W.; Mukherjee, Sutapa; Nyholt, Dale R.; Oostra, Ben A.; Palmer, Lyle J.; Palotie, Aarno; Penninx, Brenda W. J. H.; Perola, Markus; Peyser, Patricia A.; Preisig, Martin; Raeikkoenen, Katri; Raitakari, Olli T.; Realo, Anu; Ring, Susan M.; Ripatti, Samuli; Rivadeneira, Fernando; Rudan, Igor; Rustichini, Aldo; Salomaa, Veikko; Sarin, Antti-Pekka; Schlessinger, David; Scott, Rodney J.; Snieder, Harold; St Pourcain, Beate; Starr, John M.; Sul, Jae Hoon; Surakka, Ida; Svento, Rauli; Teumer, Alexander; Tiemeier, Henning; van Rooij, Frank J. A.; Van Wagoner, David R.; Vartiainen, Erkki; Viikari, Jorma; Vollenweider, Peter; Vonk, Judith M.; Waeber, Gerard; Weir, David R.; Wichmann, H. -Erich; Widen, Elisabeth; Willemsen, Gonneke; Wilson, James F.; Wright, Alan F.; Conley, Dalton; Davey-Smith, George; Franke, Lude; Groenen, Patrick J. F.; Hofman, Albert; Johannesson, Magnus; Kardia, Sharon L. R.; Krueger, Robert F.; Laibson, David; Martin, Nicholas G.; Meyer, Michelle N.; Posthuma, Danielle; Thurik, A. Roy; Timpson, Nicholas J.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Visscher, Peter M.; Benjamin, Daniel J.; Cesarini, David; Koellinger, Philipp D.		LifeLines Cohort Study	GWAS of 126,559 Individuals Identifies Genetic Variants Associated with Educational Attainment	SCIENCE			English	Article							ENVIRONMENT; LOCI	A genome-wide association study (GWAS) of educational attainment was conducted in a discovery sample of 101,069 individuals and a replication sample of 25,490. Three independent single-nucleotide polymorphisms (SNPs) are genome-wide significant (rs9320913, rs11584700, rs4851266), and all three replicate. Estimated effects sizes are small (coefficient of determination R-2 approximate to 0.02%), approximately 1 month of schooling per allele. A linear polygenic score from all measured SNPs accounts for approximate to 2% of the variance in both educational attainment and cognitive function. Genes in the region of the loci have previously been associated with health, cognitive, and central nervous system phenotypes, and bioinformatics analyses suggest the involvement of the anterior caudate nucleus. These findings provide promising candidate SNPs for follow-up work, and our effect size estimates can anchor power analyses in social-science genetics.	[Rietveld, Cornelius A.; van der Loos, Matthijs J. H. M.; Thurik, A. Roy; Koellinger, Philipp D.] Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, NL-3000 DR Rotterdam, Netherlands; [Rietveld, Cornelius A.; van der Loos, Matthijs J. H. M.; Rivadeneira, Fernando; Tiemeier, Henning; van Rooij, Frank J. A.; Hofman, Albert; Uitterlinden, Andre G.; Koellinger, Philipp D.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Medland, Sarah E.; Martin, Nicolas W.; Lee, Sang H.; Lind, Penelope A.; Montgomery, Grant W.; Nyholt, Dale R.; Martin, Nicholas G.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Derringer, Jaime] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Yang, Jian; Shakhbazov, Konstantin; Visscher, Peter M.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Esko, Tonu; Fischer, Krista; Milani, Lili; Reinmaa, Eva; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Martin, Nicolas W.] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia; [Westra, Harm-Jan; Ferhmann, Rudolf; Karjalainen, Juha; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 GZ Groningen, Netherlands; [Shakhbazov, Konstantin; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Abdellaoui, Abdel; Boomsma, Dorret I.; Hottenga, Jouke-Jan; Willemsen, Gonneke] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Agrawal, Arpana; Lin, Peng; Rice, John P.; Bierut, Laura J.; Madden, Pamela A.] Washington Univ, Dept Psychiat, Sch Med, St Louis, MO 63110 USA; [Albrecht, Eva; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Alizadeh, Behrooz Z.; Snieder, Harold; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Amin, Najaf; Ibrahim-Verbaas, Carla A.; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, NL-3000 CA Rotterdam, Netherlands; [Bamard, John; Chung, Mina K.; Van Wagoner, David R.] Cleveland Clin, Heart & Vasc & Lerner Res Inst, Cleveland, OH 44195 USA; [Baumeister, Sebastian E.; Voelzke, Henry; Hoffmann, Wolfgang] Univ Med Greifswald, Inst Community Med, D-17489 Greifswald, Germany; [Benke, Kelly S.] Univ Toronto, Samuel Lunenfeld Res Inst, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Bielak, Lawrence F.; Smith, Jennifer A.; Zhao, Wei; Peyser, Patricia A.; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Boatman, Jeffrey A.] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA; [Boyle, Patricia A.; Yu, Lei; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Davies, Gail; Deary, Ian J.; Liewald, David C.; Starr, John M.] Univ Edinburgh, Ctr Cognit Aging & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [De Leeuw, Christiaan; Rizzi, Thais S.; Posthuma, Danielle] Vrije Univ Amsterdam, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [De Leeuw, Christiaan; Rizzi, Thais S.; Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, NL-1081 HV Amsterdam, Netherlands; Radboud Univ Nijmegen, Machine Learning Grp, Inst Comp & Informat Sci, Fac Sci, NL-6500 GL Nijmegen, Netherlands; [Eklund, Niina; Kristiansson, Kati; Nuotio, Marja-Liisa; Kaprio, Jaakko; Palotie, Aarno; Perola, Markus; Ripatti, Samuli; Sarin, Antti-Pekka; Surakka, Ida; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland; [Eklund, Niina; Kristiansson, Kati; Nuotio, Marja-Liisa; Perola, Markus; Ripatti, Samuli; Surakka, Ida] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Unit, Helsinki 00014, Finland; [Evans, Daniel S.; Perola, Markus] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Gjessing, Hakon K.; Harris, Jennifer R.; Jacobsson, Bo; Jugessur, Astanand; Myhre, Ronny] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, N-0403 Oslo, Norway; [Haegg, Sara; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Haegg, Sara; Ingelsson, Erik] Uppsala Univ, Sci Life Lab, S-75123 Uppsala, Sweden; [Haegg, Sara; Ingelsson, Erik; Groenberg, Henrik; Hall, Per; Lichtenstein, Paul; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Hayward, Caroline; Vitart, Veronique; Hastie, Nicholas D.; Wright, Alan F.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Holzapfel, Christina] Tech Univ Munich, Univ Hosp, Klinikum Rechts Isar, Else Kroener Fresenius Ctr Nutr Med, D-81675 Munich, Germany; [Holzapfel, Christina; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Ibrahim-Verbaas, Carla A.] Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Jacobsson, Bo] Sahgrenska Univ Hosp, Sahlgrenska Acad, Inst Publ Hlth, Dept Obstet & Gynecol, S-41345 Gothenburg, Sweden; [Joshi, Peter K.; Campbell, Harry; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Kaakinen, Marika; Jaervelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu 90014, Finland; [Kaakinen, Marika; Jaervelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Kanoni, Stavroula; Deloukas, Panos; Palotie, Aarno; Ripatti, Samuli] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Kolcic, Ivana; Polasek, Ozren] Univ Split, Fac Med, Split 21000, Croatia; [Kutalik, Zoltan] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Lahti, Jari; Raeikkoenen, Katri] Univ Helsinki, Inst Behav Sci, FIN-00014 Helsinki, Finland; [Liu, Yongmei] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Dept Epidemiol & Prevent, Winston Salem, NC 27157 USA; [Lohman, Kurt] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Loitfelder, Marisa; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Div Neurogeriatr, A-8036 Graz, Austria; [McMahon, George; Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PR, Avon, England; [Vidal, Pedro Marques] Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1005 Lausanne, Switzerland; [Meirelles, Osorio; Tanaka, Toshiko; Terracciano, Antonio; Ferrucci, Luigi; Garcia, Melissa E.; Harris, Tamara B.; Hernandez, Dena G.; Launer, Lenore J.; Schlessinger, David] NIA, NIH, Baltimore, MD 20892 USA; [Oldmeadow, Christopher J.; Attia, John R.; Holliday, Elizabeth G.; Scott, Rodney J.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2308, Australia; [Oldmeadow, Christopher J.; Attia, John R.; Holliday, Elizabeth G.; Scott, Rodney J.] Univ Newcastle, Fac Hlth, Newcastle, NSW 2308, Australia; [Petrovic, Katja E.] Gen Hosp, Div Gen Neurol, Dept Neurol, A-8036 Graz, Austria; [Petrovic, Katja E.] Med Univ Graz, A-8036 Graz, Austria; [Peyrot, Wouter J.; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, NL-1081 HL Amsterdam, Netherlands; [Quaye, Lydia; Cherkas, Lynn; Harris, Juliette M.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, A-8036 Graz, Austria; [Smith, Albert V.; Eiriksdottir, Guony; Guonason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert V.; Guonason, Vilmundur] Univ Iceland, Dept Med, IS-101 Reykjavik, Iceland; [Terracciano, Antonio] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; [Wellmann, Juergen; Berger, Klaus] Univ Munster, Inst Epidemiol & Social Med, D-48129 Munster, Germany; [Allik, Jueri; Realo, Anu] Univ Tartu, Dept Psychol, EE-50410 Tartu, Estonia; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, I-50125 Florence, Italy; [Bastardot, Franois; Preisig, Martin; Vollenweider, Peter; Waeber, Gerard] Univ Lausanne Hosp, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Beauchamp, Jonathan] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Bueltmann, Ute] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, NL-9700 AD Groningen, Netherlands; [Chabris, Christopher F.] Union Coll, Dept Psychol, Schenectady, NY 12308 USA; [Cucca, Francesco; Masala, Marco] Consejo Invest Nacl Italiano CNR, Ist Ric Genet & Biomed, I-09042 Cagliari, Italy; [Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Ss, Italy; [de Andrade, Mariza] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat Neuropsychiat Genom, Boston, MA 02115 USA; [De Neve, Jan-Emmanuel] UCL, Sch Publ Policy, London WC1H 9QU, England; [De Neve, Jan-Emmanuel] London Sch Econ, Ctr Econ Performance, London WC2A 2AE, England; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Dedoussis, George V.; Dimitriou, Maria] Harokopio Univ Athens, Dept Nutr & Dietet, Athens 17671, Greece; [Elderson, Martin F.; LifeLines Cohort Study] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, NL-9700 RB Groningen, Netherlands; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FIN-00014 Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki 00280, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki 00250, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa 65130, Finland; [Evans, David M.; Lawlor, Debbie A.; St Pourcain, Beate; Davey-Smith, George; Timpson, Nicholas J.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2PR, Avon, England; [Faul, Jessica D.; Weir, David R.] Univ Michigan, Survey Res Ctr, Inst Social Res, Ann Arbor, MI 48106 USA; [Heath, Andrew C.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Hofman, Adriaan] Univ Groningen, Fac Behav & Social Sci, NL-9747 AD Groningen, Netherlands; [Iacono, William G.; Kirkpatrick, Robert M.; McGue, Matt; Miller, Michael B.; Krueger, Robert F.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Holle, Rolf; Mielck, Andreas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, D-85764 Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Jaervelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Jaervelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu 90220, Finland; [Jaervelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu 90101, Finland; [Kaehoenen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33520, Finland; [Kaehoenen, Mika] Univ Tampere, Sch Med, Tampere 33520, Finland; [Kaprio, Jaakko; Latvala, Antti] Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; [Kaprio, Jaakko; Latvala, Antti] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki 00300, Finland; [Kowgier, Matthew; Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Lehtimaeki, Terho] Tampere Univ Hosp, Dept Clin Chem, Fimlab Labs, Tampere 33520, Finland; [Li, Jingmei] Genome Inst Singapore, Singapore 138672, Singapore; [Lichtner, Peter] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Maekinen, Tomi E.] Natl Inst Hlth & Welf, Dept Hlth Funct Capac & Welf, Helsinki 00271, Finland; [Mukherjee, Sutapa] Sir Charles Gairdner Hosp, Western Australia Sleep Disorders Res Inst, Perth, WA 6009, Australia; [Mukherjee, Sutapa] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Mukherjee, Sutapa] Univ Toronto, Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki 00014, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20520 Turku, Finland; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Rustichini, Aldo] Univ Minnesota, Dept Econ, Minneapolis, MN 55455 USA; [Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Chron Dis Epidemiol Unit, Helsinki 00271, Finland; [St Pourcain, Beate] Univ Bristol, Sch Oral & Dent Sci, Bristol BS1 2LY, Avon, England; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Sul, Jae Hoon] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; [Svento, Rauli] Univ Oulu, Oulu Business Sch, Dept Econ, Oulu 90014, Finland; [Teumer, Alexander] Univ Med Greifswald, Dept Funct Genom, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Tiemeier, Henning; Posthuma, Danielle] Erasmus MC, Dept Child & Adolescent Psychiat, NL-3000 CB Rotterdam, Netherlands; [Vartiainen, Erkki] Natl Inst Hlth & Welf, Div Welf & Hlth Promot, Helsinki 00271, Finland; [Viikari, Jorma] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, D-81377 Munich, Germany; [Wichmann, H. -Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Conley, Dalton] NYU, Dept Sociol, New York, NY 10012 USA; [Laibson, David] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Meyer, Michelle N.] Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Meyer, Michelle N.] SUNY Albany, Nelson A Rockefeller Inst Govt, Albany, NY 12203 USA; [Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; [Groenen, Patrick J. F.] Erasmus Univ, Econometr Inst, Erasmus Sch Econ, NL-3000 DR Rotterdam, Netherlands; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Thurik, A. Roy] Panteia, NL-2701 AA Zoetermeer, Netherlands; [Thurik, A. Roy] GSCM Montpellier Business Sch, F-34185 Montpellier, France; [van Duijn, Cornelia M.] Leiden Univ, Med Ctr, Ctr Med Syst Biol, NL-2300 RC Leiden, Netherlands; [Cesarini, David] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Cesarini, David] NYU, Ctr Expt Social Sci, Dept Econ, New York, NY 10012 USA; [Cesarini, David] New York Univ Abu Dhabi, Div Social Sci, Abu Dhabi, U Arab Emirates; [Cesarini, David] Res Inst Ind Econ, S-10215 Stockholm, Sweden	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; QIMR Berghofer Medical Research Institute; University of Colorado System; University of Colorado Boulder; University of Queensland; University of Tartu; University of Queensland; University of Groningen; University of Queensland; Vrije Universiteit Amsterdam; Washington University (WUSTL); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Cleveland Clinic Foundation; Greifswald Medical School; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; Rush University; University of Edinburgh; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; University of Helsinki; Finland National Institute for Health & Welfare; California Pacific Medical Center; California Pacific Medical Center Research Institute; Norwegian Institute of Public Health (NIPH); Uppsala University; Uppsala University; Karolinska Institutet; University of Edinburgh; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; University of Gothenburg; University of Edinburgh; University of Oulu; University of Oulu; Wellcome Trust Sanger Institute; University of Split; University of Lausanne; Swiss Institute of Bioinformatics; University of Helsinki; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Medical University of Graz; University of Bristol; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Medical University of Graz; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of London; King's College London; Medical University of Graz; Icelandic Heart Association; University of Iceland; State University System of Florida; Florida State University; University of Munster; University of Tartu; Azienda Sanitaria di Firenze; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; University of Groningen; Union College; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; Mayo Clinic; Harvard University; Brigham & Women's Hospital; University of London; University College London; University of London; London School Economics & Political Science; University of Edinburgh; Harokopio University Athens; University of Groningen; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; University of Bristol; University of Michigan System; University of Michigan; Washington University (WUSTL); University of Groningen; University of Minnesota System; University of Minnesota Twin Cities; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Imperial College London; University of Oulu; Finland National Institute for Health & Welfare; Tampere University; Tampere University Hospital; Tampere University; University of Helsinki; Finland National Institute for Health & Welfare; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Tampere University; Tampere University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Finland National Institute for Health & Welfare; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Helsinki; University of Turku; University of Turku; Erasmus University Rotterdam; Erasmus MC; University of Minnesota System; University of Minnesota Twin Cities; Finland National Institute for Health & Welfare; University of Bristol; University of Edinburgh; University of California System; University of California Los Angeles; University of Oulu; Greifswald Medical School; Erasmus University Rotterdam; Erasmus MC; Finland National Institute for Health & Welfare; University of Turku; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; New York University; Harvard University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Stockholm School of Economics; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Cornell University; New York University; Research Institute of Industrial Economics (IFN)	Benjamin, DJ (corresponding author), Cornell Univ, Dept Econ, Ithaca, NY 14853 USA.	visscher@uq.edu.au; db468@cornell.edu; dac12@nyu.edu; koellinger@ese.eur.nl	Polasek, Ozren/B-6002-2011; Van Wagoner, David R/C-6783-2008; Lind, Penelope A/B-2553-2009; Raitakari, Olli/AAQ-7389-2021; Latvala, Antti/AFK-1462-2022; Kaprio, Jaakko/A-1820-2008; Baumeister, Sebastian-Edgar/P-7894-2019; Deloukas, Panos/B-2922-2013; Wichmann, Heinz Erich/AAA-5695-2022; Kanoni, Stavroula/AAN-7161-2021; Colaus, PsyColaus/K-6607-2013; Vonk, Judith M/ABA-3009-2020; Penninx, Brenda WJH/S-7627-2017; Wilson, James F/A-5704-2009; Yang, Jian/A-5852-2010; Teumer, Alexander/S-7438-2019; Davey Smith, George/A-7407-2013; Timpson, Nicholas John/O-7548-2015; Lind, Penelope A/ABC-5341-2021; Rudan, Igor/I-1467-2012; Kolcic, Ivana/E-2713-2017; Kutalik, Zoltan/HHZ-5697-2022; Jacobsson, Bo/O-8007-2014; Lin, P/G-7702-2014; Johannesson, Magnus/E-9680-2011; Laibson, David/AAA-7362-2022; Bierut, Laura Jean/W-6806-2019; bandinelli, stefania/AAL-4570-2020; Yu, Lei/AAT-3685-2020; Palmer, Lyle John/N-1948-2019; Bastardot, François/P-7809-2019; Bastardot, Francois/J-4013-2017; Magnusson, Patrik KE/C-4458-2017; Karjalainen, Juha/P-8624-2016; St Pourcain, Beate/K-8004-2017; Lahti, Jari/P-7987-2018; Rivadeneira, Fernando/O-5385-2015; Nyholt, Dale Robert/J-3174-2017; Martin, Nicholas/R-9235-2019; Boomsma, Dorret I/AAX-4470-2020; Lehtimäki, Terho/AAD-1094-2022; Medland, Sarah/AAT-7595-2020; Schmidt, Reinhold/E-1137-2014; Montgomery, Grant W/B-7148-2008; Attia, John R/F-5376-2013; Li, Jingmei/I-2904-2012; Tiemeier, Henning/H-6534-2019; Mukherjee, Sutapa/U-7262-2017; Terracciano, Antonio/H-7403-2019; Thurik, Roy/A-9386-2012; Campbell, Harry/E-2959-2010; Milani, Lili/C-8759-2011; Fehrmann, Rudolf/E-2551-2011; Lee, Sang Hong/A-2569-2011; Allik, Jüri/N-3038-2019; Holle, Rolf/D-9333-2013; Milani, Lili/N-1097-2019; Holzapfel, Christina/AAO-5928-2020; Masala, Marco/Q-2748-2018; Palmer, Lyle John/K-3196-2014; Visscher, Peter/ABB-6151-2020; Dedoussis, George/AAN-7252-2021; Allik, Jüri/D-5609-2009; Lahti, Jari/P-2283-2019; Marques-Vidal, Pedro/C-9449-2009; Evans, David/H-6325-2013; Gudnason, Vilmundur/K-6885-2015; Hayward, Caroline/M-8818-2016; Scott, Rodney/B-2827-2013; Franke, Lude/P-7036-2016; Smith, Albert Vernon/K-5150-2015; Ziad Alizadeh, Behrooz/J-2921-2017	Polasek, Ozren/0000-0002-5765-1862; Van Wagoner, David R/0000-0001-8250-9828; Lind, Penelope A/0000-0002-3887-2598; Kaprio, Jaakko/0000-0002-3716-2455; Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Deloukas, Panos/0000-0001-9251-070X; Kanoni, Stavroula/0000-0002-1691-9615; Vonk, Judith M/0000-0001-7531-4547; Penninx, Brenda WJH/0000-0001-7779-9672; Wilson, James F/0000-0001-5751-9178; Yang, Jian/0000-0003-2001-2474; Teumer, Alexander/0000-0002-8309-094X; Davey Smith, George/0000-0002-1407-8314; Timpson, Nicholas John/0000-0002-7141-9189; Lind, Penelope A/0000-0002-3887-2598; Rudan, Igor/0000-0001-6993-6884; Kolcic, Ivana/0000-0001-7918-6052; Kutalik, Zoltan/0000-0001-8285-7523; Jacobsson, Bo/0000-0001-5079-2374; Johannesson, Magnus/0000-0001-8759-6393; Bierut, Laura Jean/0000-0002-9952-4810; Palmer, Lyle John/0000-0002-1628-3055; Bastardot, François/0000-0003-4060-0353; Bastardot, Francois/0000-0003-4060-0353; Magnusson, Patrik KE/0000-0002-7315-7899; St Pourcain, Beate/0000-0002-4680-3517; Lahti, Jari/0000-0002-4310-5297; Rivadeneira, Fernando/0000-0001-9435-9441; Nyholt, Dale Robert/0000-0001-7159-3040; Martin, Nicholas/0000-0003-4069-8020; Lehtimäki, Terho/0000-0002-2555-4427; Medland, Sarah/0000-0003-1382-380X; Montgomery, Grant W/0000-0002-4140-8139; Attia, John R/0000-0001-9800-1308; Li, Jingmei/0000-0001-8587-7511; Tiemeier, Henning/0000-0002-4395-1397; Mukherjee, Sutapa/0000-0001-5021-1648; Terracciano, Antonio/0000-0001-5799-8885; Thurik, Roy/0000-0002-0242-6908; Campbell, Harry/0000-0002-6169-6262; Milani, Lili/0000-0002-5323-3102; Fehrmann, Rudolf/0000-0002-7516-315X; Lee, Sang Hong/0000-0001-9701-2718; Allik, Jüri/0000-0002-8358-4747; Holle, Rolf/0000-0001-5395-2695; Milani, Lili/0000-0002-5323-3102; Holzapfel, Christina/0000-0002-0155-9338; Masala, Marco/0000-0001-5556-9964; Palmer, Lyle John/0000-0002-1628-3055; Visscher, Peter/0000-0002-2143-8760; Dedoussis, George/0000-0002-7798-6221; Allik, Jüri/0000-0002-8358-4747; Lahti, Jari/0000-0002-4310-5297; Marques-Vidal, Pedro/0000-0002-4548-8500; de Leeuw, Christiaan/0000-0003-1076-9828; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Groenen, Patrick/0000-0001-6683-8971; Latvala, Antti/0000-0001-5695-117X; Faul, Jessica/0000-0002-6969-6478; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Surakka, Ida/0000-0002-6669-5541; Lawlor, Debbie A/0000-0002-6793-2262; Evans, David/0000-0003-0663-4621; Esko, Tonu/0000-0003-1982-6569; Conley, Dalton/0000-0002-5174-7222; Gudnason, Vilmundur/0000-0001-5696-0084; Peyrot, Wouter/0000-0001-7954-8383; Van Duijn, Cornelia/0000-0002-2374-9204; CUCCA, Francesco/0000-0002-7414-1995; Cesarini, David/0000-0002-0043-009X; Posthuma, Danielle/0000-0001-7582-2365; s, hema/0000-0002-3440-9475; Hayward, Caroline/0000-0002-9405-9550; Smith, Jennifer Ann/0000-0002-3575-5468; Preisig, Martin/0000-0001-5689-4259; Hofman, Wiecher H.A./0000-0002-4716-3136; Gieger, Christian/0000-0001-6986-9554; Kahonen, Mika/0000-0002-4510-7341; Scott, Rodney/0000-0001-7724-3404; Willemsen, Gonneke/0000-0003-3755-0236; Eriksson, Johan/0000-0002-2516-2060; Kristiansson, Kati/0000-0003-4688-107X; Koellinger, Philipp/0000-0001-7413-0412; Maki-Opas, Tomi/0000-0002-0472-719X; Waeber, Gerard/0000-0003-4193-788X; Amin, Najaf/0000-0002-8944-1771; Nuotio, Marja-Liisa/0000-0002-6688-027X; Palotie, Aarno/0000-0002-2527-5874; Bultmann, Ute/0000-0001-9589-9220; Derringer, Jaime/0000-0002-7352-9859; Franke, Lude/0000-0002-5159-8802; Kaakinen, Marika/0000-0002-9228-0462; Hagg, Sara/0000-0002-2452-1500; Raikkonen, Katri/0000-0003-3124-3470; lichtenstein, paul/0000-0003-3037-5287; Smith, Albert Vernon/0000-0003-1942-5845; Oldmeadow, Christopher/0000-0001-6104-1322; Joshi, Peter/0000-0002-6361-5059; Ziad Alizadeh, Behrooz/0000-0002-1415-8007	Social Science Genetic Association Consortium (SSGAC); EAGER grant from the NSF; NIH Office of Behavioral and Social Sciences Research [SES-1064089]; Ragnar Soderberg Foundation [E9/11]; National Institute on Aging (NIA)/NIH [P01-AG005842, P01-AG005842-20S2, P30-AG012810, T32-AG000186-23]; BBSRC [BB/F019394/1] Funding Source: UKRI; ESRC [ES/H02123X/1] Funding Source: UKRI; MRC [G0700704, MC_UU_12013/1, MC_UU_12013/4, MC_PC_U127561128, G0600705, MC_UU_12013/5, MC_UU_12013/3] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090620, R01HL111314, R01HL105756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH016880, R01MH066140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000186, ZIAAG001050, U01AG009740, P30AG012810, P01AG005842, ZIAAG000965, ZIAAG007380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688, R37AA009367, R01AA011886, R01AA009367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005147, R01DA024417, F31DA029377, R01DA013240, U01DA024417, R37DA005147] Funding Source: NIH RePORTER; Divn Of Social and Economic Sciences [1064089] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Economic and Social Research Council [ES/H02123X/1] Funding Source: researchfish; Medical Research Council [MR/K026992/1, MC_PC_U127561128, MC_UU_12013/5, MC_PC_15018, MC_UU_12013/1, G9815508, MC_UU_12013/3, 1201677, G0600705, G0700704, G0801056B, MC_UU_12013/4] Funding Source: researchfish; Chief Scientist Office [CZB/4/710, ETM/55] Funding Source: researchfish	Social Science Genetic Association Consortium (SSGAC); EAGER grant from the NSF; NIH Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragnar Soderberg Foundation; National Institute on Aging (NIA)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This research was carried out under the auspices of the Social Science Genetic Association Consortium (SSGAC), a cooperative enterprise among medical researchers and social scientists that coordinates genetic-association studies for social-science variables. Data for our analyses come from many studies and organizations, some of which are subject to a materials transfer agreement (5). Results from the meta-analysis are available at the Web site of the consortium, www.ssgac.org. The formation of the SSGAC was made possible by an EAGER grant from the NSF and a supplemental grant from the NIH Office of Behavioral and Social Sciences Research (SES-1064089). This research was also funded in part by the Ragnar Soderberg Foundation (E9/11); the National Institute on Aging (NIA)/NIH through grants P01-AG005842, P01-AG005842-20S2, P30-AG012810, and T32-AG000186-23; and the Intramural Research Program of the NIA/NIH. For a full list of acknowledgments, see (5).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Beauchamp JP, 2011, J ECON PERSPECT, V25, P57, DOI 10.1257/jep.25.4.57; Benjamin DJ, 2012, ANNU REV ECON, V4, P627, DOI 10.1146/annurev-economics-080511-110939; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Benyamin B, 2013, MOL PSYCHIATR, DOI [10.1038/mp.2012.184, DOI 10.1038/MP.2012.184]; Carlstedt B, 2000, COGNITIVE ABILITIES; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; GOLDBERGER AS, 1979, ECONOMICA, V46, P327, DOI 10.2307/2553675; Heckman JJ, 2001, AM ECON REV, V91, P145, DOI 10.1257/aer.91.2.145; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JENCKS C, 1980, AM SOCIOL REV, V45, P723, DOI 10.2307/2094892; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Plomin R., 2013, BEHAV GENET; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; UNESCO Institute for Statistics, 2006, INTERNATIONAL STANDA; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39	21	486	490	3	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1467	1471		10.1126/science.1235488	http://dx.doi.org/10.1126/science.1235488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23722424	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000320647000046
J	Lammermann, T; Afonso, PV; Angermann, BR; Wang, JM; Kastenmuller, W; Parent, CA; Germain, RN				Laemmermann, Tim; Afonso, Philippe V.; Angermann, Bastian R.; Wang, Ji Ming; Kastenmueller, Wolfgang; Parent, Carole A.; Germain, Ronald N.			Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo	NATURE			English	Article							INNATE IMMUNE-RESPONSE; IMAGING REVEALS; HOST-DEFENSE; MICE LACKING; LYMPH-NODES; MIGRATION; RECRUITMENT; RECEPTOR; MOLECULE; LEUKOTRIENE-B4	Neutrophil recruitment from blood to extravascular sites of sterile or infectious tissue damage is a hallmark of early innate immune responses, and the molecular events leading to cell exit from the bloodstream have been well defined(1,2). Once outside the vessel, individual neutrophils often show extremely coordinated chemotaxis and cluster formation reminiscent of the swarming behaviour of insects(3-11). The molecular players that direct this response at the single-cell and population levels within the complexity of an inflamed tissue are unknown. Using two-photon intravital microscopy in mouse models of sterile injury and infection, we show a critical role for intercellular signal relay among neutrophils mediated by the lipid leukotriene B4, which acutely amplifies local cell death signals to enhance the radius of highly directed interstitial neutrophil recruitment. Integrin receptors are dispensable for long-distance migration(12), but have a previously unappreciated role in maintaining dense cellular clusters when congregating neutrophils rearrange the collagenous fibre network of the dermis to form a collagen-free zone at the wound centre. In this newly formed environment, integrins, in concert with neutrophil-derived leukotriene B4 and other chemoattractants, promote local neutrophil interaction while forming a tight wound seal. This wound seal has borders that cease to grow in kinetic concert with late recruitment of monocytes and macrophages at the edge of the displaced collagen fibres. Together, these data provide an initial molecular map of the factors that contribute to neutrophil swarming in the extravascular space of a damaged tissue. They reveal how local events are propagated over large-range distances, and how auto-signalling produces coordinated, self-organized neutrophil-swarming behaviour that isolates the wound or infectious site from surrounding viable tissue.	[Laemmermann, Tim; Angermann, Bastian R.; Kastenmueller, Wolfgang; Germain, Ronald N.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Afonso, Philippe V.; Parent, Carole A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wang, Ji Ming] NCI, Lab Mol Immunoregulat, Canc & Inflammat Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Kastenmueller, Wolfgang] Univ Bonn, Inst Mol Med, D-53105 Bonn, Germany; [Kastenmueller, Wolfgang] Univ Bonn, Inst Expt Immunol, D-53105 Bonn, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bonn; University of Bonn	Lammermann, T (corresponding author), NIAID, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	laemmermannt@niaid.nih.gov; rgermain@niaid.nih.gov	Germain, Ronald N./Z-1945-2019; Lämmermann, Tim/AAD-7453-2022; Germain, Ronald/ABE-7090-2020; Afonso, Philippe V/ABB-5692-2021; Afonso, Philippe/D-2234-2014	Afonso, Philippe V/0000-0002-4828-3797; Afonso, Philippe/0000-0002-4828-3797	Human Frontiers Science Program Long-Term Fellowship; Deutsche Forschungsgemeinschaft (DFG); National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011216, ZIABC010725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	Human Frontiers Science Program Long-Term Fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Birnbaumer, R. Fassler, E. Tuomanen, P. M. Murphy, S. Akira, S. Monkley, D. Critchley, R. Wedlich-Soldner and M. Sixt for providing mice for this study, J.G. Egen and J. Tang for assistance with imaging, M. Parsek for providing P. aeruginosa-GFP, J. H. Kehrl, P. M. Murphy, R. Varma and members of the Germain laboratory for discussions. This work was supported by the Intramural Research Program of National Institute of Allergy and Infectious Diseases and National Cancer Institute, National Institutes of Health. T. L. was supported by a Human Frontiers Science Program Long-Term Fellowship. W. K. is presently a member of the Deutsche Forschungsgemeinschaft (DFG)-funded excellence cluster ImmunoSensation, Bonn, Germany.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DIPERSIO JF, 1988, J IMMUNOL, V140, P4315; Faust N, 2000, BLOOD, V96, P719; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Gaiser MR, 2012, P NATL ACAD SCI USA, V109, pE889, DOI 10.1073/pnas.1117674109; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Guggenberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002434; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Liese J., 2012, CELL MICROBIOL; Malawista SE, 2008, P NATL ACAD SCI USA, V105, P17949, DOI 10.1073/pnas.0802572105; McDonald B, 2011, J MOL MED, V89, P1079, DOI 10.1007/s00109-011-0784-9; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Oh Hana, 2008, J Vis Exp, DOI 10.3791/745; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; PALMBLAD J, 1981, BLOOD, V58, P658; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sadik CD, 2012, P NATL ACAD SCI USA, V109, pE3177, DOI 10.1073/pnas.1213797109; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	49	569	576	4	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					371	+		10.1038/nature12175	http://dx.doi.org/10.1038/nature12175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23708969	Green Accepted, Green Published			2022-12-28	WOS:000320592900042
J	Andrey, G; Montavon, T; Mascrez, B; Gonzalez, F; Noordermeer, D; Leleu, M; Trono, D; Spitz, F; Duboule, D				Andrey, Guillaume; Montavon, Thomas; Mascrez, Benedicte; Gonzalez, Federico; Noordermeer, Daan; Leleu, Marion; Trono, Didier; Spitz, Francois; Duboule, Denis			A Switch Between Topological Domains Underlies HoxD Genes Collinearity in Mouse Limbs	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; EXPRESSION; MURINE; DROSOPHILA; POLYCOMB; GENOME; DIGITS; ORGANIZATION; MECHANISMS	Hox genes are major determinants of the animal body plan, where they organize structures along both the trunk and appendicular axes. During mouse limb development, Hoxd genes are transcribed in two waves: early on, when the arm and forearm are specified, and later, when digits form. The transition between early and late regulations involves a functional switch between two opposite topological domains. This switch is reflected by a subset of Hoxd genes mapping centrally into the cluster, which initially interact with the telomeric domain and subsequently swing toward the centromeric domain, where they establish new contacts. This transition between independent regulatory landscapes illustrates both the modularity of the limbs and the distinct evolutionary histories of its various pieces. It also allows the formation of an intermediate area of low HOX proteins content, which develops into the wrist, the transition between our arms and our hands. This regulatory strategy accounts for collinear Hox gene regulation in land vertebrate appendages.	[Andrey, Guillaume; Montavon, Thomas; Noordermeer, Daan; Leleu, Marion; Trono, Didier; Duboule, Denis] Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Mascrez, Benedicte; Gonzalez, Federico; Duboule, Denis] Univ Geneva, Dept Genet & Evolut, Natl Res Ctr Frontiers Genet, CH-1211 Geneva 4, Switzerland; [Spitz, Francois] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	University of Geneva; European Molecular Biology Laboratory (EMBL)	Duboule, D (corresponding author), Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland.	denis.duboule@unige.ch	Andrey, Guillaume/AAL-4397-2020; Noordermeer, Daan/F-3306-2011	Andrey, Guillaume/0000-0002-0911-4907; Noordermeer, Daan/0000-0002-9296-7002; Gonzalez Grassi, Federico/0000-0002-7147-2246; Spitz, Francois/0000-0002-1960-829X; duboule, denis/0000-0001-9961-2960; Montavon, Thomas/0000-0001-8247-1399	Ecole Polytechnique Federale de Lausanne; University of Geneva; National Center for Competence in Research Frontiers in Genetics; Boninchi Foundation; European Research Council grant SystemsHox.ch	Ecole Polytechnique Federale de Lausanne; University of Geneva; National Center for Competence in Research Frontiers in Genetics; Boninchi Foundation; European Research Council grant SystemsHox.ch	We thank I. Barde, S. Verp, and A. Quazzola, from the Ecole Polytechnique Federale de Lausanne transgenic platform, for their help; M. Docquier and P. Descombes, from the National Center in Genetics genomic platform; U. Gunthert and L. Thevenet for the CD44 and inv(attP-CD44) mice, respectively; B. Ren for permission to use and adapt data; and J.-P. Changeux for discussions. Computations were performed at the Vital-IT (www.vital-it.ch) computing center of the Swiss Institute of Bioinformatics using tools described in http://bbcf.epfl.ch. We also thank M. Friedli, N. Soshnikova, E. Joye, P. Schorderet, N. Lonfat, and other members of the Duboule laboratories for discussions and sharing reagents. This work was supported by the Ecole Polytechnique Federale de Lausanne, the University of Geneva, the National Center for Competence in Research Frontiers in Genetics, the Boninchi Foundation, and European Research Council grant SystemsHox.ch (to D. D.). The GEO accession number for the data is GSE45457. Authors' contributions: G. A., T. M., and D. D. designed the experiments; experiments were mostly performed by G. A., with some performed by T. M. F. G., B. M., and F. S. provided mutant mice. D. N. provided material and helped with 4C experiments. M. L. helped with data analysis, and D. T. collaborated on the transgenic screen. G. A. and D. D. wrote the manuscript with input from other coauthors.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruneau S, 2001, DEV BIOL, V237, P345, DOI 10.1006/dbio.2001.0382; Changeux JP, 2011, PROTEIN SCI, V20, P1119, DOI 10.1002/pro.658; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Herault Y, 1997, DEVELOPMENT, V124, P3493; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Tschopp P, 2011, DEV BIOL, V351, P288, DOI 10.1016/j.ydbio.2010.12.034; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Villavicencio-Lorini P, 2010, J CLIN INVEST, V120, P1994, DOI 10.1172/JCI41554; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0	41	292	300	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1195	+	1234167	10.1126/science.1234167	http://dx.doi.org/10.1126/science.1234167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744951				2022-12-28	WOS:000319972800038
J	Chang, RL; Andrews, K; Kim, D; Li, ZW; Godzik, A; Palsson, BO				Chang, Roger L.; Andrews, Kathleen; Kim, Donghyuk; Li, Zhanwen; Godzik, Adam; Palsson, Bernhard O.			Structural Systems Biology Evaluation of Metabolic Thermotolerance in Escherichia coli	SCIENCE			English	Article							RECONSTRUCTION; STABILITY; EVOLUTION; PROTEINS; ENZYMES; K-12	Genome-scale network reconstruction has enabled predictive modeling of metabolism for many systems. Traditionally, protein structural information has not been represented in such reconstructions. Expansion of a genome-scale model of Escherichia coli metabolism by including experimental and predicted protein structures enabled the analysis of protein thermostability in a network context. This analysis allowed the prediction of protein activities that limit network function at superoptimal temperatures and mechanistic interpretations of mutations found in strains adapted to heat. Predicted growth-limiting factors for thermotolerance were validated through nutrient supplementation experiments and defined metabolic sensitivities to heat stress, providing evidence that metabolic enzyme thermostability is rate-limiting at superoptimal temperatures. Inclusion of structural information expanded the content and predictive capability of genome-scale metabolic networks that enable structural systems biology of metabolism.	[Chang, Roger L.; Palsson, Bernhard O.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Andrews, Kathleen; Kim, Donghyuk; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Li, Zhanwen; Godzik, Adam] Sanford Burnham Med Res Inst, Bioinformat & Syst Biol Program, La Jolla, CA 92037 USA; [Li, Zhanwen; Godzik, Adam] JCSG, La Jolla, CA 92037 USA; [Palsson, Bernhard O.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Technical University of Denmark	Palsson, BO (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA.	palsson@ucsd.edu	Kim, Donghyuk/AAS-9141-2020; Godzik, Adam/AAW-1467-2020; Godzik, Adam/A-7279-2009	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Chang, Roger/0000-0003-1630-6584; Palsson, Bernhard/0000-0003-2357-6785	NSF [GK-12 742551]; U.S. Department of Energy [DE-SC0004917]; NIH [R01GM101457, R01 GM057089, U54GM094586]; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101457, R01GM057089, U54GM094586] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Nagarajan, A. M. Feist, P. Charusanti, P. E. Bourne, J. A. Lerman, E. T. O'Brien, D. Zielinski, Y. Zhang, and L. Jaroszewski for insightful discussion on this work and J. Orth for providing the iJO1366 network map. This work was supported by NSF grant GK-12 742551 to R. L. C.; U.S. Department of Energy grant DE-SC0004917 to R. L. C., K. A., D. K., and B.O.P.; NIH grants R01GM101457, R01 GM057089, and U54GM094586 to Z.L. and A. G.; and the Novo Nordisk Foundation to B.O.P. Data reported in this report are available in the supplementary materials and the National Center for Biotechnology Information Gene Expression Omnibus (GEO) database (GSE42675). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The University of California San Diego has filed a provisional patent for the method to predict proteins responsible for cellular thermosensitivity.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Beltrao P, 2007, CURR OPIN STRUC BIOL, V17, P378, DOI 10.1016/j.sbi.2007.05.005; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blaby IK, 2012, APPL ENVIRON MICROB, V78, P144, DOI 10.1128/AEM.05773-11; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Cheng TMK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002738; Cooper VS, 2001, EVOLUTION, V55, P889, DOI 10.1554/0014-3820(2001)055[0889:EOTDOG]2.0.CO;2; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Duplantis BN, 2010, P NATL ACAD SCI USA, V107, P13456, DOI 10.1073/pnas.1004119107; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Ku TH, 2009, COMPUT BIOL CHEM, V33, P445, DOI 10.1016/j.compbiolchem.2009.10.002; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; MURPHY KP, 1993, PURE APPL CHEM, V65, P1939, DOI 10.1351/pac199365091939; OOBATAKE M, 1993, PROG BIOPHYS MOL BIO, V59, P237, DOI 10.1016/0079-6107(93)90002-2; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Van Derlinden E, 2008, J APPL MICROBIOL, V104, P438, DOI 10.1111/j.1365-2672.2007.03592.x; Van Derlinden E, 2012, INT J FOOD MICROBIOL, V158, P73, DOI 10.1016/j.ijfoodmicro.2012.05.015; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	30	84	92	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1220	1223		10.1126/science.1234012	http://dx.doi.org/10.1126/science.1234012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744946	Green Accepted			2022-12-28	WOS:000319972800047
J	Purnell, BA				Purnell, Beverly A.			Getting into Shape INTRODUCTION	SCIENCE			English	Editorial Material																			0	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1183	1183		10.1126/science.340.6137.1183	http://dx.doi.org/10.1126/science.340.6137.1183			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744938				2022-12-28	WOS:000319972800034
J	Ham, C				Ham, Chris			Doctors must lead efforts to reduce waste and variation in practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London W1G 0AN, England		Ham, C (corresponding author), Kings Fund, London W1G 0AN, England.	C.Ham@kingsfund.org.uk						Appleby J., 2013, IS HLTH SOCIAL CARE; Appleby J, 2010, IMPROVING NHS PRODUC; Baker R, 2008, HIGH PERFORMING HEAL; Dickinson H., 2013, ARE WE THERE YET MOD; Iacobucci G, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3618; Wright O., 2013, INDEPENDENT	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 6	2013	346								f3668	10.1136/bmj.f3668	http://dx.doi.org/10.1136/bmj.f3668			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YI	23744651				2022-12-28	WOS:000320229900006
J	Kerlin, MP; Small, DS; Cooney, E; Fuchs, BD; Bellini, LM; Mikkelsen, ME; Schweickert, WD; Bakhru, RN; Gabler, NB; Harhay, MO; Hansen-Flaschen, J; Halpern, SD				Kerlin, Meeta Prasad; Small, Dylan S.; Cooney, Elizabeth; Fuchs, Barry D.; Bellini, Lisa M.; Mikkelsen, Mark E.; Schweickert, William D.; Bakhru, Rita N.; Gabler, Nicole B.; Harhay, Michael O.; Hansen-Flaschen, John; Halpern, Scott D.			A Randomized Trial of Nighttime Physician Staffing in an Intensive Care Unit	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CRITICALLY-ILL; MORTALITY; OUTCOMES; HOUSE; COVERAGE; DOCTORS; SAFETY	Background Increasing numbers of intensive care units (ICUs) are adopting the practice of nighttime intensivist staffing despite the lack of experimental evidence of its effectiveness. Methods We conducted a 1-year randomized trial in an academic medical ICU of the effects of nighttime staffing with in-hospital intensivists (intervention) as compared with nighttime coverage by daytime intensivists who were available for consultation by telephone (control). We randomly assigned blocks of 7 consecutive nights to the intervention or the control strategy. The primary outcome was patients' length of stay in the ICU. Secondary outcomes were patients' length of stay in the hospital, ICU and in-hospital mortality, discharge disposition, and rates of readmission to the ICU. For length-of-stay outcomes, we performed time-to-event analyses, with data censored at the time of a patient's death or transfer to another ICU. Results A total of 1598 patients were included in the analyses. The median Acute Physiology and Chronic Health Evaluation (APACHE) III score (in which scores range from 0 to 299, with higher scores indicating more severe illness) was 67 (interquartile range, 47 to 91), the median length of stay in the ICU was 52.7 hours (interquartile range, 29.0 to 113.4), and mortality in the ICU was 18%. Patients who were admitted on intervention days were exposed to nighttime intensivists on more nights than were patients admitted on control days (median, 100% of nights [interquartile range, 67 to 100] vs. median, 0% [interquartile range, 0 to 33]; P<0.001). Nonetheless, intensivist staffing on the night of admission did not have a significant effect on the length of stay in the ICU (rate ratio for the time to ICU discharge, 0.98; 95% confidence interval [CI], 0.88 to 1.09; P = 0.72), ICU mortality (relative risk, 1.07; 95% CI, 0.90 to 1.28), or any other end point. Analyses restricted to patients who were admitted at night showed similar results, as did sensitivity analyses that used different definitions of exposure and outcome. Conclusions In an academic medical ICU in the United States, nighttime in-hospital intensivist staffing did not improve patient outcomes.	[Kerlin, Meeta Prasad; Fuchs, Barry D.; Bellini, Lisa M.; Mikkelsen, Mark E.; Schweickert, William D.; Bakhru, Rita N.; Hansen-Flaschen, John; Halpern, Scott D.] Univ Penn, Perelman Sch Med, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Cooney, Elizabeth; Mikkelsen, Mark E.; Gabler, Nicole B.; Harhay, Michael O.; Halpern, Scott D.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Kerlin, Meeta Prasad; Small, Dylan S.; Halpern, Scott D.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Small, Dylan S.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Cooney, Elizabeth; Halpern, Scott D.] Univ Penn, Roybal Ctr Behav Econ & Hlth P30, Philadelphia, PA 19104 USA; [Cooney, Elizabeth; Mikkelsen, Mark E.; Gabler, Nicole B.; Harhay, Michael O.; Halpern, Scott D.] Univ Penn, FIELDS Program, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Perelman Sch Med, 719 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	shalpern@exchange.upenn.edu		Hansen-Flaschen, John/0000-0003-1989-7244; Harhay, Michael/0000-0002-0553-674X	University of Pennsylvania Health System; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER	University of Pennsylvania Health System; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by University of Pennsylvania Health System and others; ClinicalTrials.gov number, NCT01434823.	Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; [Anonymous], FACTSH ICU PHYS STAF; Blunt MC, 2000, LANCET, V356, P735, DOI 10.1016/S0140-6736(00)02634-9; Burnham EL, 2010, AM J RESP CRIT CARE, V181, P1159, DOI 10.1164/rccm.201004-0651ED; Candidate Critical Care Quality Indicators, 1995, SOC CRIT CAR MED QUA; Cartin-Ceba R, 2010, AM J RESP CRIT CARE, V181, P1279, DOI 10.1164/rccm.201004-0676ED; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Diaz-Guzman E, 2012, CHEST, V141, P959, DOI 10.1378/chest.11-2073; Epstein K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2488; Fields M, 1997, APPROACHING DEATH IM; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Gajic O, 2008, CRIT CARE MED, V36, P36, DOI 10.1097/01.CCM.0000297887.84347.85; Gajic O, 2009, CHEST, V135, P1038, DOI 10.1378/chest.08-1544; Garland A, 2012, AM J RESP CRIT CARE, V185, P738, DOI 10.1164/rccm.201109-1734OC; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hanson CW, 1999, CRIT CARE MED, V27, P270, DOI 10.1097/00003246-199902000-00030; Jones SF, 2010, AM J RESP CRIT CARE, V181, P1280, DOI 10.1164/rccm.201005-0681ED; Kahn JM, 2007, QUAL SAF HEALTH CARE, V16, P329, DOI 10.1136/qshc.2007.022376; Kahn JM, 2010, AM J RESP CRIT CARE, V181, P1160, DOI 10.1164/rccm.201004-0557ED; Kerlin MP, 2012, CHEST, V141, P1315, DOI 10.1378/chest.11-1459; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Korn EL, 2006, STAT SCI, V21, P310, DOI 10.1214/088342306000000286; Nguyen YL, 2010, AM J RESP CRIT CARE, V181, P1164, DOI 10.1164/rccm.200909-1441CP; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Rubenfeld GD, 2008, ANN INTERN MED, V148, P877, DOI 10.7326/0003-4819-148-11-200806030-00010; Therneau T.M., 2000, COX MODEL STAT BIOL, V20, P39; Vincent JL, 1997, INTENS CARE MED, V23, P1181, DOI 10.1007/s001340050479; Vincent JL, 2000, LANCET, V356, P695, DOI 10.1016/S0140-6736(00)02622-2; Wallace DJ, 2012, NEW ENGL J MED, V367, P881; Wallace DJ, 2012, NEW ENGL J MED, V366, P2093, DOI 10.1056/NEJMsa1201918; Young JQ, 2011, ANN INTERN MED, V155, P309, DOI 10.7326/0003-4819-155-5-201109060-00354	32	150	152	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2201	2209		10.1056/NEJMoa1302854	http://dx.doi.org/10.1056/NEJMoa1302854			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23688301	Green Accepted, Green Published			2022-12-28	WOS:000319948900008
J	Dowell, D; Kunins, HV; Farley, TA				Dowell, Deborah; Kunins, Hillary V.; Farley, Thomas A.			Opioid Analgesics-Risky Drugs, Not Risky Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC PAIN		[Dowell, Deborah; Kunins, Hillary V.; Farley, Thomas A.] New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Dowell, D (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St,8th Floor, Queens, NY 11101 USA.	ddowell1@health.nyc.gov						Alam A, 2012, ARCH INTERN MED, V172, P425, DOI 10.1001/archinternmed.2011.1827; American Academy of Pain Medicine the American Pain Society and the American Society of Addition Medicine, 2001, WMJ, V100, P28; Boscarino JA, 2011, J ADDICT DIS, V30, P185, DOI 10.1080/10550887.2011.581961; Centers for Disease Control and Prevention, PRIM CAR PUBL HLTH I; Haddox JD, 1997, CLIN J PAIN, V13, P6; Purdue Pharma LP, MED GUID OXYCONTIN T; Sehgal N, 2012, PAIN PHYSICIAN, V15, pES67; Stanos SP, 2012, APPROPRIATE USE OPIO; WEISSMAN DE, 1989, PAIN, V36, P363, DOI 10.1016/0304-3959(89)90097-3; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	10	48	48	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2219	2220		10.1001/jama.2013.5794	http://dx.doi.org/10.1001/jama.2013.5794			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	156YC	23700072				2022-12-28	WOS:000319859200024
J	Murad, MH; Montori, VM				Murad, M. Hassan; Montori, Victor M.			Synthesizing Evidence Shifting the Focus From Individual Studies to the Body of Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIALS		[Murad, M. Hassan; Montori, Victor M.] Mayo Clin, Coll Med, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Murad, MH (corresponding author), Mayo Clin, Div Prevent Occupat & Aerosp Med, 200 1st St SW, Rochester, MN 55905 USA.	murad.mohammad@mayo.edu	Murad, M. Hassan/AAW-4367-2020	Montori, Victor/0000-0003-0595-2898; Murad, Mohammad Hassan/0000-0001-5502-5975				Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Borm GF, 2009, J CLIN EPIDEMIOL, V62, P711, DOI 10.1016/j.jclinepi.2008.09.013; Clarke M, 2002, JAMA-J AM MED ASSOC, V287, P2799, DOI 10.1001/jama.287.21.2799; Guyatt GH, 2008, PLOS MED, V5, P3, DOI 10.1371/journal.pmed.0050004; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; IntHout J, 2016, STAT METHODS MED RES, V25, P538, DOI 10.1177/0962280212461098; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019	7	61	63	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2217	2218		10.1001/jama.2013.5616	http://dx.doi.org/10.1001/jama.2013.5616			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736731				2022-12-28	WOS:000319859200023
J	Zhou, CM; Zhang, TQ; Wang, X; Yu, S; Lan, H; Tang, HB; Feng, ZY; Zozomova-Lihova, J; Wang, JW				Zhou, Chuan-Miao; Zhang, Tian-Qi; Wang, Xi; Yu, Sha; Lan, Heng; Tang, Hongbo; Feng, Zheng-Yan; Zozomova-Lihova, Judita; Wang, Jia-Wei			Molecular Basis of Age-Dependent Vernalization in Cardamine flexuosa	SCIENCE			English	Article							FLOWERING-TIME; MIR156; TRANSITIONS; COMPETENCE; REPRESSOR; CONSTANS; MICRORNA; CONFERS; GENES; FLC	Plants flower in response to many varied cues, such as temperature, photoperiod, and age. The floral transition of Cardamine flexuosa, a herbaceous biennial-to-perennial plant, requires exposure to cold temperature, a treatment known as vernalization. C. flexuosa younger than 5 weeks old are not fully responsive to cold treatment. We demonstrate that the levels of two age-regulated microRNAs, miR156 and miR172, regulate the timing of sensitivity in response to vernalization. Age and vernalization pathways coordinately regulate flowering through modulating the expression of CfSOC1, a flower-promoting MADS-box gene. The related annual Arabidopsis thaliana, which has both vernalization and age pathways, does not possess an age-dependent vernalization response. Thus, the recruitment of age cue in response to environmental signals contributes to the evolution of life cycle in plants.	[Zhou, Chuan-Miao; Zhang, Tian-Qi; Yu, Sha; Lan, Heng; Tang, Hongbo; Feng, Zheng-Yan; Wang, Jia-Wei] Shanghai Inst Biol Sci SIBS, Inst Plant Physiol & Ecol SIPPE, Natl Key Lab Plant Mol Genet NKLPMG, Shanghai 200032, Peoples R China; [Zhang, Tian-Qi; Yu, Sha; Feng, Zheng-Yan] Univ Chinese Acad Sci CAS, Shanghai 200032, Peoples R China; [Wang, Xi; Wang, Jia-Wei] Max Planck Inst MPI Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Zozomova-Lihova, Judita] Slovak Acad Sci, Inst Bot, SK-84523 Bratislava, Slovakia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Slovak Academy of Sciences	Wang, JW (corresponding author), Shanghai Inst Biol Sci SIBS, Inst Plant Physiol & Ecol SIPPE, Natl Key Lab Plant Mol Genet NKLPMG, Shanghai 200032, Peoples R China.	jwwang@sibs.ac.cn	Zozomova-Lihova, Judita/P-3151-2019; Zozomova-Lihova, Judita/B-5011-2011	Zozomova-Lihova, Judita/0000-0002-8950-6643; Zozomova-Lihova, Judita/0000-0002-8950-6643; Wang, Jia-Wei/0000-0003-3885-6296; Zhang, Tian-Qi/0000-0001-8000-4770	National Natural Science Foundation of China [31222029, 912173023]; State Key Basic Research Program of China [2013CB127000]; Shanghai Pujiang Program [12PJ1409900]; Recruitment Program of Global Experts (China); NKLPMG (SIPPE, SIBS); Open Project Program of NKLPMG (SIPPE, SIBS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Program of China(National Basic Research Program of China); Shanghai Pujiang Program(Shanghai Pujiang Program); Recruitment Program of Global Experts (China); NKLPMG (SIPPE, SIBS); Open Project Program of NKLPMG (SIPPE, SIBS)	We thank I. R. Somoza and D. Weigel (MPI, Tubingen) for commenting on the manuscript, S. Bergonzi and G. Coupland (MPI, Koln) for exchanging unpublished results, and Y.-L. Guo (Institute of Botany, CAS, Beijing) for suggestion on phylogenetic analyses. The early phase of the work was conducted at the MM for Developmental Biology, where it was supported by Max Planck Society funds to D. Weigel. The majority of this work was conducted at SIPPE and supported by grants from National Natural Science Foundation of China (31222029 and 912173023), State Key Basic Research Program of China (2013CB127000), Shanghai Pujiang Program (12PJ1409900), Recruitment Program of Global Experts (China), and NKLPMG (SIPPE, SIBS) to J.-W.W., and Open Project Program of NKLPMG (SIPPE, SIBS) to X.W.	Albani MC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003130; Albani MC, 2010, CURR TOP DEV BIOL, V91, P323, DOI 10.1016/S0070-2153(10)91011-9; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Amasino R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-228; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bergonzi S, 2011, J EXP BOT, V62, P4415, DOI 10.1093/jxb/err192; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Lihova J, 2006, AM J BOT, V93, P1206, DOI 10.3732/ajb.93.8.1206; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Poethig RS, 2010, PLANT PHYSIOL, V154, P541, DOI 10.1104/pp.110.161620; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang RH, 2011, PLANT CELL, V23, P1307, DOI 10.1105/tpc.111.083451; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Yang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00260; Yu S, 2013, ELIFE, V2, DOI 10.7554/eLife.00269	30	104	120	5	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1097	1100		10.1126/science.1234340	http://dx.doi.org/10.1126/science.1234340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723237				2022-12-28	WOS:000319664500045
J	Baron, TH; Kamath, PS; McBane, RD				Baron, Todd H.; Kamath, Patrick S.; McBane, Robert D.			CURRENT CONCEPTS Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DUAL ANTIPLATELET THERAPY; COLLEGE-OF-CARDIOLOGY; AMERICAN-COLLEGE; VENOUS THROMBOEMBOLISM; ORAL ANTICOAGULANTS; EUROPEAN-SOCIETY; PERIOPERATIVE COAGULATION; BRIDGING ANTICOAGULATION; BLEEDING COMPLICATIONS; WARFARIN INTERRUPTION		[Baron, Todd H.; Kamath, Patrick S.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [McBane, Robert D.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [McBane, Robert D.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Baron, TH (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.	baron.todd@mayo.edu		McBane, Robert/0000-0001-8727-8029				Altenburg A, 2012, CARDIOVASC INTER RAD, V35, P30, DOI 10.1007/s00270-011-0204-0; Anderson MA, 2009, GASTROINTEST ENDOSC, V70, P1060, DOI 10.1016/j.gie.2009.09.040; Atwell TD, 2010, AM J ROENTGENOL, V194, P784, DOI 10.2214/AJR.08.2122; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Birnie DH, 2013, NEW ENGL J MED, V368, P2084, DOI 10.1056/NEJMoa1302946; Boustiere C, 2011, ENDOSCOPY, V43, P445, DOI 10.1055/s-0030-1256317; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; Carmignani L, 2011, TRANSFUS APHER SCI, V45, P275, DOI 10.1016/j.transci.2011.10.008; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Crowther MA, 2009, J THROMB HAEMOST, V7, P107, DOI 10.1111/j.1538-7836.2009.03429.x; de Jong PG, 2012, BRIT J HAEMATOL, V158, P433, DOI 10.1111/j.1365-2141.2012.09196.x; Desborough M, 2012, TRANSFUSION, V52, p20S, DOI 10.1111/j.1537-2995.2012.03691.x; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Douketis JD, 2012, THROMB HAEMOSTASIS, V108, P210, DOI 10.1160/TH12-04-0236; Douketis JD, 2012, CIRCULATION, V125, pE496, DOI 10.1161/CIRCULATIONAHA.111.084517; Douketis JD, 2012, CHEST, V141, pE326S, DOI 10.1378/chest.11-2298; Douketis JD, 2012, CHEST S, V141; Dzik W, 2012, TRANSFUSION, V52, p45S, DOI 10.1111/j.1537-2995.2012.03690.x; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Eikelboom JW, 2012, CHEST, V141, pE89S, DOI 10.1378/chest.11-2293; Eisen GM, 2002, GASTROINTEST ENDOSC, V55, P775, DOI 10.1016/S0016-5107(02)70402-1; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Geng DF, 2012, CARDIOLOGY, V122, P148, DOI 10.1159/000338812; Godfrey EM, 2011, CLIN RADIOL, V66, P693, DOI 10.1016/j.crad.2011.03.014; Gogarten W, 2010, EUR J ANAESTH, V27, P999, DOI 10.1097/EJA.0b013e32833f6f6f; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Guyatt GH, 2012, CHEST, V141, P1129; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hankey GJ, 2011, CIRCULATION, V123, P1436, DOI 10.1161/CIRCULATIONAHA.110.004424; Hart RG, 2012, NAT REV NEPHROL, V8, P569, DOI 10.1038/nrneph.2012.160; Healey JS, 2012, CIRCULATION, V126, P343, DOI 10.1161/CIRCULATIONAHA.111.090464; Hering D, 2005, CHEST, V127, P53, DOI 10.1378/chest.127.1.53; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Hussain N, 2007, ALIMENT PHARM THERAP, V25, P579, DOI 10.1111/j.1365-2036.2006.03225.x; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Kastrati A, 2011, JACC-CARDIOVASC INTE, V4, P1129, DOI 10.1016/j.jcin.2011.08.003; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Kleiman NS, 2012, CIRCULATION, V125, P1967, DOI 10.1161/CIRCULATIONAHA.112.102335; Korte W, 2011, THROMB HAEMOSTASIS, V105, P743, DOI 10.1160/TH10-04-0217; Kozek-Langenecker SA, 2010, BEST PRACT RES-CLIN, V24, P27, DOI 10.1016/j.bpa.2009.09.009; Landenhed M, 2010, SCAND CARDIOVASC J, V44, P100, DOI 10.3109/14017430903388334; Lansberg MG, 2012, CHEST, V141, pE601S, DOI 10.1378/chest.11-2302; Levine, 2012, CIRCULATION, V125, pE412, DOI 10.1161/CIR.0b013e31824da922; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lyman GH, 2010, THROMB RES, V125, pS120, DOI 10.1016/S0049-3848(10)70029-3; MacLean S, 2012, CHEST, V141, pE1S, DOI 10.1378/chest.11-2290; Malloy PC, 2009, J VASC INTERV RADIOL, V20, pS240, DOI 10.1016/j.jvir.2008.11.027; McBane RD, 2010, ARTERIOSCL THROM VAS, V30, P442, DOI 10.1161/ATVBAHA.109.199406; Nematullah A, 2009, J CAN DENT ASSOC, V75, P41; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Perry DJ, 2007, BRIT DENT J, V203, P389, DOI 10.1038/bdj.2007.892; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-15; Sie P, 2011, ARCH CARDIOVASC DIS, V104, P669, DOI 10.1016/j.acvd.2011.09.001; Siegal D, 2012, CIRCULATION, V126, P1630, DOI 10.1161/CIRCULATIONAHA.112.105221; Spyropoulos AC, 2012, THROMB HAEMOSTASIS, V108, P213, DOI 10.1160/TH12-04-0217; Tafur AJ, 2012, ANN ONCOL, V23, P1998, DOI 10.1093/annonc/mds058; Tafur AJ, 2012, J THROMB HAEMOST, V10, P261, DOI 10.1111/j.1538-7836.2011.04572.x; ten Cate H, 2012, THROMB HAEMOSTASIS, V107, P803, DOI 10.1160/TH12-03-0130; Usman MHU, 2009, AM J CARDIOL, V103, P1107, DOI 10.1016/j.amjcard.2009.01.003; Veitch AM, 2008, GUT, V57, P1322, DOI 10.1136/gut.2007.142497; Voils SA, 2012, THROMB RES, V130, P833, DOI 10.1016/j.thromres.2012.10.001; Wahidi MM, 2005, CHEST, V127, P961, DOI 10.1378/chest.127.3.961; Weitz JI, 2012, CHEST, V141, pE120S, DOI 10.1378/chest.11-2294; Woods K, 2007, J THROMB THROMBOLYS, V24, P93, DOI 10.1007/s11239-007-0022-z; Wysokinski WE, 2012, CIRCULATION, V126, P486, DOI 10.1161/CIRCULATIONAHA.112.092833	74	265	276	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2113	2124		10.1056/NEJMra1206531	http://dx.doi.org/10.1056/NEJMra1206531			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23718166				2022-12-28	WOS:000319574200009
J	Casanova-Acebes, M; Pitaval, C; Weiss, LA; Nombela-Arrieta, C; Chevre, R; A-Gonzalez, N; Kunisaki, Y; Zhang, DC; van Rooijen, N; Silberstein, LE; Weber, C; Nagasawa, T; Frenette, PS; Castrillo, A; Hidalgo, A				Casanova-Acebes, Maria; Pitaval, Christophe; Weiss, Linnea A.; Nombela-Arrieta, Cesar; Chevre, Raphael; A-Gonzalez, Noelia; Kunisaki, Yuya; Zhang, Dachuan; van Rooijen, Nico; Silberstein, Leslie E.; Weber, Christian; Nagasawa, Takashi; Frenette, Paul S.; Castrillo, Antonio; Hidalgo, Andres			Rhythmic Modulation of the Hematopoietic Niche through Neutrophil Clearance	CELL			English	Article							STEM-CELL NICHE; BONE-MARROW; G-CSF; PROGENITOR CELLS; P-SELECTIN; INFLAMMATION; CXCR4; MOBILIZATION; RELEASE; MICE	Unique among leukocytes, neutrophils follow daily cycles of release from and migration back into the bone marrow, where they are eliminated. Because removal of dying cells generates homeostatic signals, we explored whether neutrophil elimination triggers circadian events in the steady state. Here, we report that the homeostatic clearance of neutrophils provides cues that modulate the physiology of the bone marrow. We identify a population of CD62L(LO) CXCR4(HI) neutrophils that have "aged'' in the circulation and are eliminated at the end of the resting period in mice. Aged neutrophils infiltrate the bone marrow and promote reductions in the size and function of the hematopoietic niche. Modulation of the niche depends on macrophages and activation of cholesterol-sensing nuclear receptors and is essential for the rhythmic egress of hematopoietic progenitors into the circulation. Our results unveil a process that synchronizes immune and hematopoietic rhythms and expand the ascribed functions of neutrophils beyond inflammation.	[Casanova-Acebes, Maria; Pitaval, Christophe; Weiss, Linnea A.; Chevre, Raphael; A-Gonzalez, Noelia; Hidalgo, Andres] Fdn Ctr Nacl Invest Cardiovasc CNIC, Dept Epidemiol Atherothrombosis & Imaging, Madrid 28029, Spain; [Nombela-Arrieta, Cesar; Silberstein, Leslie E.] Childrens Hosp, Joint Program Transfus Med, Boston, MA 02115 USA; [Kunisaki, Yuya; Zhang, Dachuan; Frenette, Paul S.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Weber, Christian] Univ Munich, Inst Cardiovasc Prevent, D-80539 Munich, Germany; [Nagasawa, Takashi] Kyoto Univ, Core Res Evolut Sci & Technol CREST, Kyoto 6068507, Japan; [Nagasawa, Takashi] Kyoto Univ, Dept Immunobiol & Hematol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Nagasawa, Takashi] Japan Sci & Technol Agcy JST, Kyoto 6068507, Japan; [Castrillo, Antonio] UAM Madrid, CSIC, Inst Invest Biomed Alberto Sols, Las Palmas Gran Canaria 35016, Spain; [Castrillo, Antonio] Univ Las Palmas, CSIC, Unidad Asociada Biomed IIBM, Las Palmas Gran Canaria 35016, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Harvard University; Boston Children's Hospital; Yeshiva University; Albert Einstein College of Medicine; Vrije Universiteit Amsterdam; University of Munich; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Las Palmas de Gran Canaria	Hidalgo, A (corresponding author), Fdn Ctr Nacl Invest Cardiovasc CNIC, Dept Epidemiol Atherothrombosis & Imaging, Madrid 28029, Spain.	ahidalgo@cnic.es	Weber, Christian/AAW-2153-2020; Gonzalez, Noelia Alonso/H-4488-2015; Weiss, Linnea A/K-8062-2014; Frenette, Paul S/J-8272-2012; Van Rooijen, Nico/Z-1578-2019; Weiss, Linnea A/AFV-8680-2022; Zhang, Dachuan/GZA-8781-2022; Hidalgo, Andrés/L-5643-2014; Gonzalez, Noelia Alonso/ABC-7381-2021; Acebes, Maria Casanova/AAH-1929-2019	Weber, Christian/0000-0003-4610-8714; Gonzalez, Noelia Alonso/0000-0003-0533-5216; Frenette, Paul S/0000-0003-0862-9922; Hidalgo, Andrés/0000-0001-5513-555X; Gonzalez, Noelia Alonso/0000-0003-0533-5216; Acebes, Maria Casanova/0000-0002-5790-1163; , Linnea/0000-0002-7593-7821; Zhang, Dachuan/0000-0002-1746-275X; Nombela-Arrieta, Cesar/0000-0003-0415-259X; Nagasawa, Takashi/0000-0002-1085-0960	Deutsche Forschungsgemeinschaft (DFG) [WE1913/11-2, SFB914-B8, R01-DK056638, R01-HL69438, SAF2008-00057, SAF2011-29244]; Ramon y Cajal Fellowship [RYC-2007-00697]; MINECO [SAF2009-11037]; Comunidad de Madrid [S2010/BMD-2314]; FP7-People-IRG Program [246655]; Human Frontiers in Science Program long-term fellowship [00194/2008]; Spanish Ministry of Economy and Competitivity; Pro-CNIC Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116340, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ramon y Cajal Fellowship(Spanish Government); MINECO(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); FP7-People-IRG Program; Human Frontiers in Science Program long-term fellowship; Spanish Ministry of Economy and Competitivity(Spanish Government); Pro-CNIC Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Nacher, J. Ogonek, I. Ortega, V. Zorita, M. Leboeuf, J.M. Ligos, and the Cellomics, Microscopy, and Comparative Medicine Units at CNIC for technical support; J. Garaude, D. Lucas, and A. Ramiro for critically reviewing the manuscript; and S. Gonzalez and D. Sanz for reagents. This study was supported by Deutsche Forschungsgemeinschaft (DFG WE1913/11-2 and SFB914-B8) to C.W.; R01-DK056638 and R01-HL69438 to P.S.F.; grants SAF2008-00057 and SAF2011-29244 to A.C.; Ramon y Cajal Fellowship (RYC-2007-00697) and SAF2009-11037 from MINECO, S2010/BMD-2314 from Comunidad de Madrid, and FP7-People-IRG Program (246655) to A.H.; C.N-A. is funded by a Human Frontiers in Science Program long-term fellowship 00194/2008. M.C-A. is supported by a FPI fellowship from the Spanish Ministry of Economy and Competitivity. The Centro Nacional de Investigaciones Cardiovasculares is supported by the Spanish Ministry of Economy and Competitivity and the Pro-CNIC Foundation. M.C-A performed experiments and wrote the manuscript; L.A.W., C.P., and N.A-G performed experiments and edited the manuscript. C.N-A., R.C., Y.K., and D.Z. performed experiments; N.V.R., L.E.S., C.W., T.N., P.S.F., and A.C. contributed reagents, discussed experiments and helped in editing the manuscript; A.H. conceived the study, performed experiments and wrote the manuscript. C.P., L.A.W., and C.N-A. contributed equally to this study.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Van Eeden SF, 1997, AM J PHYSIOL-HEART C, V272, pH401, DOI 10.1152/ajpheart.1997.272.1.H401; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534	50	404	408	3	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1025	1035		10.1016/j.cell.2013.04.040	http://dx.doi.org/10.1016/j.cell.2013.04.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706740	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000319456800011
J	Hashem, Y; Georges, AD; Dhote, V; Langlois, R; Liao, HY; Grassucci, RA; Hellen, CUT; Pestova, TV; Frank, J				Hashem, Yaser; Georges, Amedee des; Dhote, Vidya; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Hellen, Christopher U. T.; Pestova, Tatyana V.; Frank, Joachim			Structure of the Mammalian Ribosomal 43S Preinitiation Complex Bound to the Scanning Factor DHX29	CELL			English	Article							EUKARYOTIC TRANSLATION INITIATION; CRYO-EM STRUCTURE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; TRANSFER-RNA; CRYOELECTRON MICROSCOPY; START CODON; ESCHERICHIA-COLI; 26S PROTEASOME; ALPHA-SUBUNIT	Eukaryotic translation initiation begins with assembly of a 43S preinitiation complex. First, methionylated initiator methionine transfer RNA (Met-tRNA(i)(Met)), eukaryotic initiation factor (eIF) 2, and guanosine triphosphate form a ternary complex (TC). The TC, eIF3, eIF1, and eIF1A cooperatively bind to the 40S subunit, yielding the 43S preinitiation complex, which is ready to attach to messenger RNA (mRNA) and start scanning to the initiation codon. Scanning on structured mRNAs additionally requires DHX29, a DExH-box protein that also binds directly to the 40S subunit. Here, we present a cryo-electron microscopy structure of the mammalian DHX29-bound 43S complex at 11.6 angstrom resolution. It reveals that eIF2 interacts with the 40S subunit via its a subunit and supports Met-tRNA(i)(Met) in an unexpected P/I orientation (eP/I). The structural core of eIF3 resides on the back of the 40S subunit, establishing two principal points of contact, whereas DHX29 binds around helix 16. The structure provides insights into eukaryote-specific aspects of translation, including the mechanism of action of DHX29.	[Dhote, Vidya; Hellen, Christopher U. T.; Pestova, Tatyana V.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Hashem, Yaser; Georges, Amedee des; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, HHMI, New York, NY 10032 USA; [Hashem, Yaser; Georges, Amedee des; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Frank, J (corresponding author), Columbia Univ, HHMI, New York, NY 10032 USA.	jf2192@columbia.edu	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781	HHMI; NIH [R01 GM29169, R01 GM59660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029169, R01GM059660] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Melissa Thomas for the assistance in preparation of figures and Assen Marintchev and Trevor Sweeney for critical reading of the manuscript. This work was supported by HHMI and NIH grant R01 GM29169 (to J.F.) and NIH grant R01 GM59660 (to T.V.P.).	Abaeva IS, 2011, EMBO J, V30, P115, DOI 10.1038/emboj.2010.302; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; CIGAN AM, 1989, P NATL ACAD SCI USA, V86, P2784, DOI 10.1073/pnas.86.8.2784; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Dhote V., 2012, P NATL ACAD SCI US, V109, pE3150; Dmitriev SE, 2011, J MOL BIOL, V413, P106, DOI 10.1016/j.jmb.2011.08.026; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gao HX, 2005, P NATL ACAD SCI USA, V102, P10206, DOI 10.1073/pnas.0500926102; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Julian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001095; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lumsden T, 2010, NUCLEIC ACIDS RES, V38, P1261, DOI 10.1093/nar/gkp1113; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Naveau M, 2013, NUCLEIC ACIDS RES, V41, P1047, DOI 10.1093/nar/gks1180; Nika J, 2001, J BIOL CHEM, V276, P1051, DOI 10.1074/jbc.M007398200; Parsyan A, 2009, P NATL ACAD SCI USA, V106, P22217, DOI 10.1073/pnas.0909773106; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmitt E, 2002, EMBO J, V21, P1821, DOI 10.1093/emboj/21.7.1821; Schmitt E, 2012, NAT STRUCT MOL BIOL, V19, P450, DOI 10.1038/nsmb.2259; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Stolboushkina E, 2008, J MOL BIOL, V382, P680, DOI 10.1016/j.jmb.2008.07.039; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Taylor KA, 2008, J STRUCT BIOL, V163, P214, DOI 10.1016/j.jsb.2008.06.004; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; WAGENKNECHT T, 1988, J MOL BIOL, V203, P753, DOI 10.1016/0022-2836(88)90207-0; Yatime L, 2006, STRUCTURE, V14, P119, DOI 10.1016/j.str.2005.09.020; Yatime L, 2007, P NATL ACAD SCI USA, V104, P18445, DOI 10.1073/pnas.0706784104; Yu YP, 2011, EMBO J, V30, P4423, DOI 10.1038/emboj.2011.306; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	72	142	145	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1108	1119		10.1016/j.cell.2013.04.036	http://dx.doi.org/10.1016/j.cell.2013.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706745	Green Accepted, Bronze			2022-12-28	WOS:000319456800017
J	Liao, YJ; Liu, TC				Liao, Yi-Ju; Liu, Tien-Chen			Mastoiditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liao, Yi-Ju; Liu, Tien-Chen] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Liao, YJ (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.	liuent@ntu.edu.tw							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					2014	2014		10.1056/NEJMicm1205007	http://dx.doi.org/10.1056/NEJMicm1205007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148TJ	23697516				2022-12-28	WOS:000319270200003
J	Fairfield, K				Fairfield, Kathleen			Review: Replacing dietary saturated fatty acids with n-6 polyunsaturated fatty acids does not reduce mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Maine Med Ctr, Portland, ME 04102 USA	Maine Medical Center	Fairfield, K (corresponding author), Maine Med Ctr, Portland, ME 04102 USA.			Zamora, Daisy/0000-0003-2114-5156				Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Stryjecki C, 2011, EUR J CLIN NUTR, V65, P285, DOI 10.1038/ejcn.2010.277	2	0	0	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC6	10.7326/0003-4819-158-10-201305210-02006	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689785				2022-12-28	WOS:000319666200005
J	Remuzzi, G; Ruggenenti, P				Remuzzi, Giuseppe; Ruggenenti, Piero			Prednisolone plus chlorambucil preserved renal function in membranous nephropathy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Remuzzi, Giuseppe; Ruggenenti, Piero] Ist Ric Farmacol Mario Negri IRCCS, Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Remuzzi, G (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Bergamo, Italy.		Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Perna A, 2004, AM J KIDNEY DIS, V44, P385, DOI 10.1053/j.ajkd.2004.05.020; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1416, DOI 10.1681/ASN.2012020181; Waldman M, 2012, J AM SOC NEPHROL, V23, P1617, DOI 10.1681/ASN.2012010058	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC9	10.7326/0003-4819-158-10-201305210-02009	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689788				2022-12-28	WOS:000319666200008
J	McIntyre, H				McIntyre, Hugh			Admission to hospital could be considered a disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							30-DAY READMISSIONS		Conquest Hosp, Hastings TN37 7RD, E Sussex, England		McIntyre, H (corresponding author), Conquest Hosp, Hastings TN37 7RD, E Sussex, England.	hugh.mcintyre@esht.nhs.uk						[Anonymous], MEDLINE PLUS MEDICAL; Billings J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001667; Centers for Medicare and Medicaid Services, 2013, READMISSIONS REDUCTI; Clarke A, 2012, J EPIDEMIOL COMMUN H, V66, pA45, DOI 10.1136/jech-2012-201753.117; Department of Health, 2011, PAYMENT BY RESULTS P; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; McHugh MD, 2013, MED CARE, V51, P52, DOI [10.1097/MLR.0b013e3182763284, 10.1097/01.NNA.0000435146.46961.d1]	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2013	346								f3242	10.1136/bmj.f3242	http://dx.doi.org/10.1136/bmj.f3242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AA	23690462				2022-12-28	WOS:000319572300004
J	Reynolds, SE				Reynolds, Stuart E.			Immunity and Invasive Success	SCIENCE			English	Editorial Material									Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Reynolds, SE (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	s.e.reynolds@bath.ac.uk	Reynolds, Stuart/AAI-6616-2021	Reynolds, Stuart/0000-0001-5043-0242				[Anonymous], 1997, GUNS GERMS STEEL; Dunn JC, 2009, BIOL INVASIONS, V11, P315, DOI 10.1007/s10530-008-9249-7; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Katsanis A, 2013, BIOCONTROL, V58, P73, DOI 10.1007/s10526-012-9470-2; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Sloggett JJ, 2012, ENTOMOL SCI, V15, P261, DOI 10.1111/j.1479-8298.2012.00519.x; Strauss A, 2012, FUNCT ECOL, V26, P1249, DOI 10.1111/1365-2435.12011; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032	9	8	8	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					816	817		10.1126/science.1238998	http://dx.doi.org/10.1126/science.1238998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687032				2022-12-28	WOS:000318997400026
J	Kocher, RP; Emanuel, EJ				Kocher, Robert P.; Emanuel, Ezekiel J.			The Transparency Imperative	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; LEARNING-CURVE		[Kocher, Robert P.] Venrock, Palo Alto, CA 94304 USA; Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Kocher, RP (corresponding author), Venrock, 3340 Hillview Ave, Palo Alto, CA 94304 USA.							Alemozaffar M, 2012, EUR UROL, V61, P1222, DOI 10.1016/j.eururo.2012.02.053; [Anonymous], 2011, FED REG, V76, P542; [Anonymous], 2013, TIME; Freire MP, 2010, UROL CLIN N AM, V37, P37, DOI 10.1016/j.ucl.2009.11.005; Robinson JC, 2012, HEALTH AFFAIR, V31, P2028, DOI 10.1377/hlthaff.2011.1313	5	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					296	+		10.7326/0003-4819-159-4-201308200-00666	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00666			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	23712392				2022-12-28	WOS:000323421700020
J	Nishizawa, T; Kita, S; Maturana, AD; Furuya, N; Hirata, K; Kasuya, G; Ogasawara, S; Dohmae, N; Iwamoto, T; Ishitani, R; Nureki, O				Nishizawa, Tomohiro; Kita, Satomi; Maturana, Andres D.; Furuya, Noritaka; Hirata, Kunio; Kasuya, Go; Ogasawara, Satoshi; Dohmae, Naoshi; Iwamoto, Takahiro; Ishitani, Ryuichiro; Nureki, Osamu			Structural Basis for the Counter-Transport Mechanism of a H+/Ca2+ Exchanger	SCIENCE			English	Article							SODIUM-CALCIUM EXCHANGE; HOMEOSTASIS; GENE	Ca2+/cation antiporters catalyze the exchange of Ca2+ with various cations across biological membranes to regulate cytosolic calcium levels. The recently reported structure of a prokaryotic Na+/Ca2+ exchanger (NCX_Mj) revealed its overall architecture in an outward-facing state. Here, we report the crystal structure of a H+/Ca2+ exchanger from Archaeoglobus fulgidus (CAX_Af) in the two representatives of the inward-facing conformation at 2.3 angstrom resolution. The structures suggested Ca2+ or H+ binds to the cation-binding site mutually exclusively. Structural comparison of CAX_Af with NCX_Mj revealed that the first and sixth transmembrane helices alternately create hydrophilic cavities on the intra-and extracellular sides. The structures and functional analyses provide insight into the mechanism of how the inward- to outward-facing state transition is triggered by the Ca2+ and H+ binding.	[Nishizawa, Tomohiro; Furuya, Noritaka; Kasuya, Go; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Nishizawa, Tomohiro; Dohmae, Naoshi; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Kita, Satomi; Iwamoto, Takahiro] Fukuoka Univ, Fac Med, Dept Pharmacol, Jonan Ku, Fukuoka 8140180, Japan; [Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hirata, Kunio] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Ogasawara, Satoshi] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Ogasawara, Satoshi] Kyoto Univ, Fac Med, Sakyo Ku, Kyoto 6068501, Japan	University of Tokyo; RIKEN; Fukuoka University; Nagoya University; RIKEN; Kyoto University; Kyoto University	Ishitani, R (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	ishitani@biochem.s.u-tokyo.ac.jp; nureki@biochem.s.u-tokyo.ac.jp	Furuya, Noritaka/AAG-5224-2019; NUREKI, OSAMU/G-4960-2014; Dohmae, Naoshi/C-2040-2011	Furuya, Noritaka/0000-0002-6815-479X; Dohmae, Naoshi/0000-0002-5242-9410; Kasuya, Go/0000-0003-1756-5764	Radioisotope Center, University of Tokyo; Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) Program "The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation" of Japan Science and Technology Agency (JST); MEXT; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23136517]; JSPS [23590319]; MEXT [24227004, 22687007]; Grants-in-Aid for Scientific Research [23590319] Funding Source: KAKEN	Radioisotope Center, University of Tokyo; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) Program "The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation" of Japan Science and Technology Agency (JST); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Nishimasu and M. Hattori for useful discussions and critical comments on the manuscript; T. Tsukazaki for sharing beamtime and useful discussion; A. Kurabayashi for technical assistance; the beam-line staffs at BL32XU and BL41XU of SPring-8 for assistance in data collection; and the RIKEN BioResource Center (Ibaraki, Japan) for providing the Archaeoglobus fulgidus genomic DNA. The diffraction experiments were performed at SPring-8 BL32XU and BL41XU (proposals 2012A1093, 2012A1201, and 2012A1087) and with the approval of RIKEN. Part of this work was performed with the support of the Radioisotope Center, University of Tokyo. This work was supported by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)" to O.N., by the Core Research for Evolutional Science and Technology (CREST) Program "The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation" of Japan Science and Technology Agency (JST) to O.N., by a grant for HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development by MEXT to R. I., by a Grant-in-Aid for Scientific Research on Innovative Areas (23136517) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) to S. K., by a Grant-in-Aid for Scientific Research (C) (23590319) from JSPS to T. I., and by a Grant-in-Aid for Scientific Research (S) (24227004) and a Grant-in-Aid for Young Scientists (A) (22687007) from the MEXT to O.N. and R. I., respectively. T.N. expressed and purified CAX_Af for crystallization, collected the diffraction data, solved the structures, and performed functional analyses in liposomes. N.F. screened CaCA genes and identified CAX_Af. S. K. and T. I. performed transport assays in E. coli cells. A. D. M. performed transport assays in E. coli spheloplasts. G. K. made mutants. K. H. assisted with data collection. S.O. supported crystallization. N.D. analyzed the purified protein by mass spectrometry. T.N., R. I., and O.N. wrote the manuscript. R. I. and O.N. directed and supervised all of the research. The coordinates and the structure factors have been deposited in the Protein Data Bank (PDB) under accession codes 4KPP.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Emery L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00001; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249	13	54	55	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					168	172		10.1126/science.1239002	http://dx.doi.org/10.1126/science.1239002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23704374				2022-12-28	WOS:000321965300041
J	Ludwig, DS				Ludwig, David S.			Examining the Health Effects of Fructose	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLYCEMIC INDEX; DISEASE; METAANALYSIS; CONSUMPTION; RISK		[Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ludwig, DS (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730, K24 DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; DUNNIGAN MG, 1970, CLIN SCI, V38, P1; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; HILL JO, 1995, AM J CLIN NUTR, V62, p264S, DOI 10.1093/ajcn/62.1.264S; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Lustig RH, 2013, ADV NUTR, V4, P226, DOI 10.3945/an.112.002998; MEYER B J, 1971, South African Medical Journal, V45, P253; Sievenpiper JL, 2012, J AM COLL NUTR, V31, P149, DOI 10.1080/07315724.2012.10720021; White JS, 2013, ADV NUTR, V4, P246, DOI 10.3945/an.112.003137	10	33	34	0	47	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					33	34		10.1001/jama.2013.6562	http://dx.doi.org/10.1001/jama.2013.6562			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23732692				2022-12-28	WOS:000321253000015
J	Li, WB; Notani, D; Ma, Q; Tanasa, B; Nunez, E; Chen, AY; Merkurjev, D; Zhang, J; Ohgi, K; Song, XY; Oh, S; Kim, HS; Glass, CK; Rosenfeld, MG				Li, Wenbo; Notani, Dimple; Ma, Qi; Tanasa, Bogdan; Nunez, Esperanza; Chen, Aaron Yun; Merkurjev, Daria; Zhang, Jie; Ohgi, Kenneth; Song, Xiaoyuan; Oh, Soohwan; Kim, Hong-Sook; Glass, Christopher K.; Rosenfeld, Michael G.			Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation	NATURE			English	Article							LONG NONCODING RNA; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; CHROMATIN; PRINCIPLES; ALPHA; INSIGHTS; MEDIATOR	The functional importance of gene enhancers in regulated gene expression is well established(1-3). In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells(4-6), bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs)(7-9). However, it has remained unclear whether these eRNAs are functional or merely a reflection of enhancer activation. Here we report that in human breast cancer cells 17 beta-oestradiol (E2)-bound oestrogen receptor alpha (ER-alpha) causes a global increase in eRNA transcription on enhancers adjacent to E2-upregulated coding genes. These induced eRNAs, as functional transcripts, seem to exert important roles for the observed ligand-dependent induction of target coding genes, increasing the strength of specific enhancer-promoter looping initiated by ER-alpha binding. Cohesin, present on many ER-alpha-regulated enhancers even before ligand treatment, apparently contributes to E2-dependent gene activation, at least in part by stabilizing E2/ER-alpha/eRNA-induced enhancer-promoter looping. Our data indicate that eRNAs are likely to have important functions in many regulated programs of gene transcription.	[Li, Wenbo; Notani, Dimple; Ma, Qi; Tanasa, Bogdan; Nunez, Esperanza; Chen, Aaron Yun; Merkurjev, Daria; Zhang, Jie; Ohgi, Kenneth; Song, Xiaoyuan; Oh, Soohwan; Kim, Hong-Sook; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Ma, Qi; Merkurjev, Daria] Univ Calif San Diego, Grad Program Bioinformat, La Jolla, CA 92093 USA; [Tanasa, Bogdan] Scripps Res Inst, Kellogg Sch Sci & Technol, Grad Program, La Jolla, CA 92037 USA; [Oh, Soohwan] Univ Calif San Diego, Grad Program Biol Sci, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Ma, Qi/C-9716-2015; li, wenbo/GZM-8930-2022; Glass, Christopher/AAI-3933-2021; , songxy/P-1094-2014	Glass, Christopher/0000-0003-4344-3592; , songxy/0000-0002-9011-5033; Notani, Dimple/0000-0002-9460-8070; Ma, Qi/0000-0002-8705-4460	UCSD Cancer Center [P30 CA23100]; Department of Defense (DoD) [BC110381, BC103858]; DoD;  [DK 039949];  [DK018477];  [NS034934];  [HL065445];  [CA173903]; NATIONAL CANCER INSTITUTE [T32CA009523, P30CA023100, R01CA173903, R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039949, R01DK039949, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	UCSD Cancer Center; Department of Defense (DoD)(United States Department of Defense); DoD(United States Department of Defense); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Hutt for help with statistical analyses; M. Ghassemian from the University of California, San Diego (UCSD) Biomolecular/Proteomics Mass Spectrometry Facility for assistance with mass spectrometry; C. Nelson for cell culture assistance; J. Hightower for assistance with figure and manuscript preparation. We thank H. Chang for providing the BoxB, lambda N-GAL4 constructs. We acknowledge the UCSD Cancer Center Specialized Support Grant P30 CA23100 for confocal microscopy. W. L. and D.N. are supported by Department of Defense (DoD) postdoctoral fellowships, BC110381 and BC103858, respectively. M. G. R. is an investigator with the Howard Hughes Medical Institute. This work was supported by grants DK 039949, DK018477, NS034934, HL065445, CA173903 to C. K. G., and from the DoD.	Abukhdeir AM, 2006, BREAST CANCER RES TR, V99, P23, DOI 10.1007/s10549-006-9177-0; Ahlenstiel CL, 2012, NUCLEIC ACIDS RES, V40, P1579, DOI 10.1093/nar/gkr891; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Newman JJ, 2010, COLD SH Q B, V75, P227, DOI 10.1101/sqb.2010.75.016; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Rueden CT, 2007, BIOTECHNIQUES, V43, P31, DOI 10.2144/000112511; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Servant N, 2012, BIOINFORMATICS, V28, P2843, DOI 10.1093/bioinformatics/bts521; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Zhong JF, 2008, LAB CHIP, V8, P68, DOI 10.1039/b712116d	40	652	670	4	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					516	+		10.1038/nature12210	http://dx.doi.org/10.1038/nature12210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23728302	Green Accepted			2022-12-28	WOS:000320929400059
J	Rivkin, E; Almeida, SM; Ceccarelli, DF; Juang, YC; MacLean, TA; Srikumar, T; Huang, H; Dunham, WH; Fukumura, R; Xie, G; Gondo, Y; Raught, B; Gingras, AC; Sicheri, F; Cordes, SP				Rivkin, Elena; Almeida, Stephanie M.; Ceccarelli, Derek F.; Juang, Yu-Chi; MacLean, Teresa A.; Srikumar, Tharan; Huang, Hao; Dunham, Wade H.; Fukumura, Ryutaro; Xie, Gang; Gondo, Yoichi; Raught, Brian; Gingras, Anne-Claude; Sicheri, Frank; Cordes, Sabine P.			The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis	NATURE			English	Article							KAPPA-B ACTIVATION; DU-CHAT-SYNDROME; POLYUBIQUITIN CHAINS; SIGNALING PATHWAY; MOUSE; INFLAMMATION; DERMATITIS; MUTATIONS; SHARPIN; COMPLEX	A complex interaction of signalling events, including the Wnt pathway, regulates sprouting of blood vessels from pre-existing vasculature during angiogenesis. Here we show that two distinct mutations in the (uro) chordate-specific gumby (also called Fam105b) gene cause an embryonic angiogenic phenotype in gumby mice. Gumby interacts with disheveled 2 (DVL2), is expressed in canonical Wnt-responsive endothelial cells and encodes an ovarian tumour domain class of deubiquitinase that specifically cleaves linear ubiquitin linkages. A crystal structure of gumby in complex with linear diubiquitin reveals how the identified mutations adversely affect substrate binding and catalytic function in line with the severity of their angiogenic phenotypes. Gumby interacts with HOIP (also called RNF31), a key component of the linear ubiquitin assemblycomplex, and decreases linear ubiquitination and activation of NF-kappa B-dependent transcription. This work provides support for the biological importance of linear (de) ubiquitination in angiogenesis, craniofacial and neural development and in modulating Wnt signalling.	[Rivkin, Elena; Almeida, Stephanie M.; Ceccarelli, Derek F.; Juang, Yu-Chi; MacLean, Teresa A.; Huang, Hao; Dunham, Wade H.; Xie, Gang; Gingras, Anne-Claude; Sicheri, Frank; Cordes, Sabine P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Rivkin, Elena; Almeida, Stephanie M.; MacLean, Teresa A.; Dunham, Wade H.; Gingras, Anne-Claude; Sicheri, Frank; Cordes, Sabine P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Srikumar, Tharan; Raught, Brian] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Srikumar, Tharan; Raught, Brian] Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Fukumura, Ryutaro; Gondo, Yoichi] RIKEN BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki 3050074, Japan	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; RIKEN	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@lunenfeld.ca; cordes@lunenfeld.ca	Sicheri, Frank/F-8856-2013; Srikumar, Tharan/Q-5642-2016; Gingras, Anne-Claude/ABA-8341-2020; Gondo, Yoichi/A-5375-2016; Cordes, Sabine P/A-5423-2012; Gingras, Anne-Claude/E-9982-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Gondo, Yoichi/0000-0003-2184-6489; Gingras, Anne-Claude/0000-0002-6090-4437; Ceccarelli, Derek/0000-0002-2674-9234	JSPS KAKENHI [15200032, 21240043]; Canadian Institutes for Health Research [MOP119289, MOP123433, MOP57795, MOP 97966, IHO 94384, MOP 111199]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank T. Saunders and the Michigan University Transgenic Core facility for generating gumby BAC transgenic mice; K. Iwai for HOIL and HOIP constructs; K. Nakajima for NF-kappa B and AP2 reporter constructs; B. Alman and C. C. Hui for TOPGAL reporter mice; J. Woodgett for TOPFLASH, FOPFLASH and PRL vectors; T. Pawson for WNT3A expressing L-cells; M. Barrios-Ramos for help with fluorometry; J. Culotti and C. C. Hui for critical feedback; and I. Kourinov and staff at NE-CAT for collecting diffraction data set. B. R. holds the Canada research chair in proteomics and molecular medicine. A.-C. G. holds the Canada research chair in Functional Proteomics. F. S. holds the Canada research chair in Structural Principles of Signal Transduction. S. M. A. and T. S. were supported by CIHR predoctoral student fellowships. This work was supported by operating funds from the JSPS KAKENHI (grant numbers 15200032 to Y.G. and 21240043 to Y.G. and R. F.), and Canadian Institutes for Health Research to B. R. (MOP119289), A.-C. G. (MOP123433), F. S. (MOP57795) and S. P. C. (MOP 97966, IHO 94384 and MOP 111199).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; AMBULOS NP, 1987, GENE, V51, P281, DOI 10.1016/0378-1119(87)90317-9; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Choi Hyungwon, 2012, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0815s39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Cirone P, 2008, ANGIOGENESIS, V11, P347, DOI 10.1007/s10456-008-9116-2; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dunham WH, 2011, PROTEOMICS, V11, P2603, DOI 10.1002/pmic.201000571; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gondo Y, 2008, NAT REV GENET, V9, P803, DOI 10.1038/nrg2431; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; HOGENESCH H, 1993, AM J PATHOL, V143, P972; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2011, CELL CYCLE, V10, P3095, DOI 10.4161/cc.10.18.17437; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Kim FA, 2005, MECH DEVELOP, V122, P1300, DOI 10.1016/j.mod.2005.08.001; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mainardi PC, 2006, EUR J MED GENET, V49, P363, DOI 10.1016/j.ejmg.2005.12.004; Mainardi PC, 2001, J MED GENET, V38, P151, DOI 10.1136/jmg.38.3.151; Mar L, 2005, J NEUROSCI, V25, P11787, DOI 10.1523/JNEUROSCI.3813-05.2005; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matsumoto ML, 2012, J MOL BIOL, V418, P134, DOI 10.1016/j.jmb.2011.12.053; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3; Zhang XX, 2005, AM J HUM GENET, V76, P312, DOI 10.1086/427762	49	193	206	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					318	+		10.1038/nature12296	http://dx.doi.org/10.1038/nature12296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23708998	Green Accepted			2022-12-28	WOS:000320592900031
J	Heilbron, J				Heilbron, John			The path to the quantum atom	NATURE			English	Editorial Material									Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heilbron, J (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	john@heilbron.eclipse.co.uk						Aaserud F, 2013, LOVE, LITERATURE, AND THE QUANTUM ATOM: NIELS BOHR'S 1913 TRILOGY REVISITED, P1; Bohr N, 1913, PHILOS MAG, V26, P1, DOI 10.1080/14786441308634955	2	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					27	30		10.1038/498027a	http://dx.doi.org/10.1038/498027a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158DC	23739408				2022-12-28	WOS:000319947800014
J	Lipkind, D; Marcus, GF; Bemis, DK; Sasahara, K; Jacoby, N; Takahasi, M; Suzuki, K; Feher, O; Ravbar, P; Okanoya, K; Tchernichovski, O				Lipkind, Dina; Marcus, Gary F.; Bemis, Douglas K.; Sasahara, Kazutoshi; Jacoby, Nori; Takahasi, Miki; Suzuki, Kenta; Feher, Olga; Ravbar, Primoz; Okanoya, Kazuo; Tchernichovski, Ofer			Stepwise acquisition of vocal combinatorial capacity in songbirds and human infants	NATURE			English	Article							SEQUENTIAL MOVEMENTS; SONG; MODEL	Human language, as well as birdsong, relies on the ability to arrange vocal elements in new sequences. However, little is known about the ontogenetic origin of this capacity. Here we track the development of vocal combinatorial capacity in three species of vocal learners, combining an experimental approach in zebra finches (Taeniopygia guttata) with an analysis of natural development of vocal transitions in Bengalese finches (Lonchura striata domestica) and pre-lingual human infants. We find a common, stepwise pattern of acquiring vocal transitions across species. In our first study, juvenile zebra finches were trained to perform one song and then the training target was altered, prompting the birds to swap syllable order, or insert a new syllable into a string. All birds solved these permutation tasks in a series of steps, gradually approximating the target sequence by acquiring new pairwise syllable transitions, sometimes too slowly to accomplish the task fully. Similarly, in the more complex songs of Bengalese finches, branching points and bidirectional transitions in song syntax were acquired in a stepwise fashion, starting from a more restrictive set of vocal transitions. The babbling of pre-lingual human infants showed a similar pattern: instead of a single developmental shift from reduplicated to variegated babbling (that is, from repetitive to diverse sequences), we observed multiple shifts, where each new syllable type slowly acquired a diversity of pairwise transitions, asynchronously over development. Collectively, these results point to a common generative process that is conserved across species, suggesting that the long-noted gap between perceptual versus motor combinatorial capabilities in human infants(1) may arise partly from the challenges in constructing new pairwise vocal transitions.	[Lipkind, Dina; Feher, Olga; Tchernichovski, Ofer] CUNY Hunter Coll, Dept Psychol, New York, NY 10065 USA; [Lipkind, Dina; Feher, Olga; Ravbar, Primoz; Tchernichovski, Ofer] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Marcus, Gary F.; Bemis, Douglas K.] NYU, Dept Psychol, New York, NY 10003 USA; [Sasahara, Kazutoshi; Takahasi, Miki; Suzuki, Kenta; Okanoya, Kazuo] RIKEN Brain Sci Inst, Lab Biolinguist, Wako, Saitama 3510198, Japan; [Jacoby, Nori] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; [Jacoby, Nori] Bar Ilan Univ, Dept Mus, IL-5290002 Ramat Gan, Israel; [Suzuki, Kenta; Okanoya, Kazuo] JST ERATO Okanoya Emot Informat Project, Wako, Saitama 3510198, Japan; [Feher, Olga; Ravbar, Primoz; Tchernichovski, Ofer] CUNY, Grad Ctr, New York, NY 10016 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); New York University; RIKEN; Hebrew University of Jerusalem; Bar Ilan University; City University of New York (CUNY) System	Lipkind, D (corresponding author), CUNY Hunter Coll, Dept Psychol, New York, NY 10065 USA.	dina.lipkind@gmail.com	Tchernichovski, Ofer/AAC-5678-2019	Tchernichovski, Ofer/0000-0001-6788-614X; Jacoby, Nori/0000-0003-2868-0100; Sasahara, Kazutoshi/0000-0003-2572-0648	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; US Public Health Service grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Benichov, J. Hyland Bruno, I. Ljubicic and C. Roeske for help with data analysis. We also thank A. Vouloumanos, M. Hauber, L. Parra and V. Valian for reading the manuscript. The study was supported by a US Public Health Service grant to O.T., by a Grant in Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to K.O., and by a Grant in Aid for Japan Society for the Promotion of Science Fellows to M.T.	Abe K, 2011, NAT NEUROSCI, V14, P1067, DOI 10.1038/nn.2869; Amador A, 2013, NATURE, V495, P59, DOI 10.1038/nature11967; Beckers GJL, 2012, NEUROREPORT, V23, P139, DOI 10.1097/WNR.0b013e32834f1765; Berwick RC, 2011, TRENDS COGN SCI, V15, P113, DOI 10.1016/j.tics.2011.01.002; DAVIS BL, 1995, J SPEECH HEAR RES, V38, P1199, DOI 10.1044/jshr.3806.1199; DEBOYSSONBARDIES B, 1991, LANGUAGE, V67, P297, DOI 10.2307/415108; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Edelman GM, 1987, NEURAL DARWINISM THE; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; GOLANI I, 1992, BEHAV BRAIN SCI, V15, P249, DOI 10.1017/S0140525X00068539; Hanuschkin A, 2011, J COMPUT NEUROSCI, V31, P509, DOI 10.1007/s10827-011-0318-z; HIKOSAKA O, 1995, J NEUROPHYSIOL, V74, P1652, DOI 10.1152/jn.1995.74.4.1652; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Jin DZ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051902; Katahira K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024516; MacWhinney B., 2000, CHILDES PROJECT TOOL; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; MITCHELL PR, 1990, J CHILD LANG, V17, P247, DOI 10.1017/S0305000900013751; Oller D. K., 1980, CHILD PHONOLOGY, V1, P93, DOI [10.1016/B978-0-12-770601-6.50011-5, DOI 10.1016/B978-0-12-770601-6.50011-5]; Plamondon SL, 2010, J COMP PSYCHOL, V124, P117, DOI 10.1037/a0017229; Rand MK, 2000, EXP BRAIN RES, V131, P293, DOI 10.1007/s002219900283; Rose GJ, 2004, NATURE, V432, P753, DOI 10.1038/nature02992; Smith B. L., 1989, FIRST LANG, V9, P175, DOI 10.1177/014272378900900605; Stark R. E., 1980, CHILD PHONOLOGY, V1, P73, DOI DOI 10.1016/B978-0-12-770601-6.50010-3; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; van Heijningen CAA, 2009, P NATL ACAD SCI USA, V106, P20538, DOI 10.1073/pnas.0908113106; VIHMAN MM, 1985, LANGUAGE, V61, P397, DOI 10.2307/414151; Yamashita Y, 2008, NEURAL NETWORKS, V21, P1224, DOI 10.1016/j.neunet.2008.03.003	30	128	129	1	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					104	+		10.1038/nature12173	http://dx.doi.org/10.1038/nature12173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158DC	23719373	Green Accepted, Green Submitted			2022-12-28	WOS:000319947800042
J	Gale, EAM				Gale, Edwin A. M.			Is type 2 diabetes a category error?	LANCET			English	Editorial Material									[Gale, Edwin A. M.] Univ Bristol, Bristol, Avon, England	University of Bristol	Gale, EAM (corresponding author), Southmead Hosp, Bristol BS10 5NB, Avon, England.	edwin.gale@bristol.ac.uk						Faber K, 1923, NOSOGRAPHY MODERN IN; Gale EAM, 2006, DIABETOLOGIA, V49, P1989, DOI 10.1007/s00125-006-0348-7; Gale EAM, 2001, DIABETES, V50, P217, DOI 10.2337/diabetes.50.2.217; Ryle G, CONCEPT MIND; Von Noorden C., 1907, METABOLISM PRACTICAL, P527	5	31	31	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1956	1957		10.1016/S0140-6736(12)62207-7	http://dx.doi.org/10.1016/S0140-6736(12)62207-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23725732				2022-12-28	WOS:000320319500036
J	Bergonzi, S; Albani, MC; van Themaat, EVL; Nordstrom, KJV; Wang, RH; Schneeberger, K; Moerland, PD; Coupland, G				Bergonzi, Sara; Albani, Maria C.; van Themaat, Emiel Ver Loren; Nordstroem, Karl J. V.; Wang, Renhou; Schneeberger, Korbinian; Moerland, Perry D.; Coupland, George			Mechanisms of Age-Dependent Response to Winter Temperature in Perennial Flowering of Arabis alpina	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; TARGET GENES; MICRORNA; APETALA2; INDUCTION; PATHWAYS; MUTANT; MIR172; SPL3	Perennial plants live for more than 1 year and flower only after an extended vegetative phase. We used Arabis alpina, a perennial relative of annual Arabidopsis thaliana, to study how increasing age and exposure to winter cold (vernalization) coordinate to establish competence to flower. We show that the APETALA2 transcription factor, a target of microRNA miR172, prevents flowering before vernalization. Additionally, miR156 levels decline as A. alpina ages, causing increased production of SPL (SQUAMOSA PROMOTER BINDING PROTEIN LIKE) transcription factors and ensuring that flowering occurs in response to cold. The age at which plants respond to vernalization can be altered by manipulating miR156 levels. Although miR156 and miR172 levels are uncoupled in A. alpina, miR156 abundance represents the timer controlling age-dependent flowering responses to cold.	[Bergonzi, Sara; Albani, Maria C.; van Themaat, Emiel Ver Loren; Nordstroem, Karl J. V.; Wang, Renhou; Schneeberger, Korbinian; Coupland, George] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [van Themaat, Emiel Ver Loren; Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1100 DE Amsterdam, Netherlands	Max Planck Society; University of Amsterdam; Academic Medical Center Amsterdam	Coupland, G (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany.	coupland@mpipz.mpg.de	Coupland, George/AAP-8609-2020; Schneeberger, Korbinian/U-6329-2019; Moerland, Perry/AAG-1425-2020	Coupland, George/0000-0001-6988-4172; Schneeberger, Korbinian/0000-0002-5512-0443; Moerland, Perry/0000-0002-2357-3659; Nordstrom, Karl/0000-0001-6231-4417; Albani, Maria/0000-0002-8215-020X	Deutsche Forschungsgemeinschaft [SPP1530]; Max Planck Genome Centre; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Genome Centre; Max Planck Society(Max Planck Society)	We thank E. Willing, G. Velikkakam, and the "A. alpina genome consortium" for access to genomic information and Y. Zeng for technical support. We thank members of CC's laboratory and P. Huijser for critical reading of the manuscript and D. Weigel for MIR156 constructs and comments on the manuscript. We acknowledge funding from Deutsche Forschungsgemeinschaft SPP1530 grants to G.C. and M.C.A., the Max Planck Genome Centre, and a core grant from the Max Planck Society. GenBank accession numbers are GSE40455 (microarray data), KC815948 to KC815963 (AaSPLs), KC831439 (PEP2), and KC848668 (Aapre-miR156a). Materials described here are available from G.C. subject to a Material Transfer Agreement with the Max Planck Institute for Plant Breeding Research.	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bergonzi S, 2011, J EXP BOT, V62, P4415, DOI 10.1093/jxb/err192; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; MOZLEY D, 1995, J EXP BOT, V46, P173, DOI 10.1093/jxb/46.2.173; Nordstrom KJV, 2013, NAT BIOTECHNOL, V31, P325, DOI 10.1038/nbt.2515; Poethig RS, 2010, PLANT PHYSIOL, V154, P541, DOI 10.1104/pp.110.161620; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang RH, 2011, PLANT CELL, V23, P1307, DOI 10.1105/tpc.111.083451; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Wollmann H, 2010, DEVELOPMENT, V137, P3633, DOI 10.1242/dev.036673; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606	26	141	156	1	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1094	1097		10.1126/science.1234116	http://dx.doi.org/10.1126/science.1234116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723236				2022-12-28	WOS:000319664500044
J	Nystedt, B; Street, NR; Wetterbom, A; Zuccolo, A; Lin, YC; Scofield, DG; Vezzi, F; Delhomme, N; Giacomello, S; Alexeyenko, A; Vicedomini, R; Sahlin, K; Sherwood, E; Elfstrand, M; Gramzow, L; Holmberg, K; Hallman, J; Keech, O; Klasson, L; Koriabine, M; Kucukoglu, M; Kaller, M; Luthman, J; Lysholm, F; Niittyla, T; Olson, A; Rilakovic, N; Ritland, C; Rossello, JA; Sena, J; Svensson, T; Talavera-Lopez, C; Theissen, G; Tuominen, H; Vanneste, K; Wu, ZQ; Zhang, B; Zerbe, P; Arvestad, L; Bhalerao, R; Bohlmann, J; Bousquet, J; Gil, RG; Hvidsten, TR; de Jong, P; MacKay, J; Morgante, M; Ritland, K; Sundberg, B; Thompson, SL; Van de Peer, Y; Andersson, B; Nilsson, O; Ingvarsson, PK; Lundeberg, J; Jansson, S				Nystedt, Bjorn; Street, Nathaniel R.; Wetterbom, Anna; Zuccolo, Andrea; Lin, Yao-Cheng; Scofield, Douglas G.; Vezzi, Francesco; Delhomme, Nicolas; Giacomello, Stefania; Alexeyenko, Andrey; Vicedomini, Riccardo; Sahlin, Kristoffer; Sherwood, Ellen; Elfstrand, Malin; Gramzow, Lydia; Holmberg, Kristina; Hallman, Jimmie; Keech, Olivier; Klasson, Lisa; Koriabine, Maxim; Kucukoglu, Melis; Kaller, Max; Luthman, Johannes; Lysholm, Fredrik; Niittyla, Totte; Olson, Ake; Rilakovic, Nemanja; Ritland, Carol; Rossello, Josep A.; Sena, Juliana; Svensson, Thomas; Talavera-Lopez, Carlos; Theissen, Guenter; Tuominen, Hannele; Vanneste, Kevin; Wu, Zhi-Qiang; Zhang, Bo; Zerbe, Philipp; Arvestad, Lars; Bhalerao, Rishikesh; Bohlmann, Joerg; Bousquet, Jean; Gil, Rosario Garcia; Hvidsten, Torgeir R.; de Jong, Pieter; MacKay, John; Morgante, Michele; Ritland, Kermit; Sundberg, Bjorn; Thompson, Stacey Lee; Van de Peer, Yves; Andersson, Bjorn; Nilsson, Ove; Ingvarsson, Par K.; Lundeberg, Joakim; Jansson, Stefan			The Norway spruce genome sequence and conifer genome evolution	NATURE			English	Article							LONG NONCODING RNAS; TRANSPOSABLE ELEMENTS; SIZE VARIATION; GENE FAMILY; RECOMBINATION; PLANTS; AMPLIFICATION; POLYPLOIDY; COMPLEXITY; SLOW	Conifers have dominated forests for more than 200 million years and are of huge ecological and economic importance. Here we present the draft assembly of the 20-gigabase genome of Norway spruce (Picea abies), the first available for any gymnosperm. The number of well-supported genes (28,354) is similar to the >100 times smaller genome of Arabidopsis thaliana, and there is no evidence of a recent whole-genome duplication in the gymnosperm lineage. Instead, the large genome size seems to result from the slow and steady accumulation of a diverse set of long-terminal repeat transposable elements, possibly owing to the lack of an efficient elimination mechanism. Comparative sequencing of Pinus sylvestris, Abies sibirica, Juniperus communis, Taxus baccata and Gnetum gnemon reveals that the transposable element diversity is shared among extant conifers. Expression of 24-nucleotide small RNAs, previously implicated in transposable element silencing, is tissue-specific and much lower than in other plants. We further identify numerous long (>10,000 base pairs) introns, gene-like fragments, uncharacterized long non-coding RNAs and short RNAs. This opens up new genomic avenues for conifer forestry and breeding.	[Nystedt, Bjorn; Sherwood, Ellen] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-17121 Solna, Sweden; [Street, Nathaniel R.; Scofield, Douglas G.; Delhomme, Nicolas; Keech, Olivier; Tuominen, Hannele; Zhang, Bo; Hvidsten, Torgeir R.; Jansson, Stefan] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Wetterbom, Anna; Luthman, Johannes; Lysholm, Fredrik; Talavera-Lopez, Carlos; Andersson, Bjorn] Karolinska Inst, Sci Life Lab, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Zuccolo, Andrea; Giacomello, Stefania; Vicedomini, Riccardo; Morgante, Michele] Ist Genom Applicata, I-33100 Udine, Italy; [Zuccolo, Andrea] Scuola Super Sant Anna, Inst Life Sci, I-56127 Pisa, Italy; [Lin, Yao-Cheng; Vanneste, Kevin; Van de Peer, Yves] Univ Ghent, Dept Plant Syst Biol VIB, B-9052 Ghent, Belgium; [Lin, Yao-Cheng; Vanneste, Kevin; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Scofield, Douglas G.; Wu, Zhi-Qiang; Thompson, Stacey Lee; Ingvarsson, Par K.] Umea Univ, Dept Ecol & Environm Sci, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Vezzi, Francesco; Sahlin, Kristoffer; Arvestad, Lars] KTH Royal Inst Technol, Sch Comp Sci & Commun, Sci Life Lab, S-17121 Solna, Sweden; [Giacomello, Stefania; Vicedomini, Riccardo; Morgante, Michele] Univ Udine, I-33100 Udine, Italy; [Alexeyenko, Andrey; Holmberg, Kristina; Hallman, Jimmie; Kaller, Max; Rilakovic, Nemanja; Lundeberg, Joakim] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, S-17121 Solna, Sweden; [Elfstrand, Malin; Olson, Ake] Swedish Univ Agr Sci, Uppsala Bioctr, Dept Forest Mycol & Plant Pathol, S-75007 Uppsala, Sweden; [Gramzow, Lydia; Theissen, Guenter] Univ Jena, Dept Genet, D-07743 Jena, Germany; [Klasson, Lisa] Uppsala Univ, Dept Cell & Mol Biol, S-75237 Uppsala, Sweden; [Koriabine, Maxim; de Jong, Pieter] Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA; [Kucukoglu, Melis; Niittyla, Totte; Bhalerao, Rishikesh; Gil, Rosario Garcia; Sundberg, Bjorn; Nilsson, Ove] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Ritland, Carol; Bohlmann, Joerg; Ritland, Kermit] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada; [Rossello, Josep A.] Univ Valencia, Jardi Bot, Valencia 46008, Spain; [Rossello, Josep A.] Carl Faust Fdn, Marimurtra Bot Garden, Blanes 17300, Spain; [Sena, Juliana; Bousquet, Jean; MacKay, John] Univ Laval, Canada Res Chair Forest & Environm Genom, Ctr Forest Res, Quebec City, PQ G1V 0A6, Canada; [Sena, Juliana; Bousquet, Jean; MacKay, John] Univ Laval, Inst Syst & Integrat Biol, Quebec City, PQ G1V 0A6, Canada; [Svensson, Thomas] Karolinska Inst, Sci Life Lab, Dept Biosci & Nutr, S-17121 Solna, Sweden; [Zerbe, Philipp; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Arvestad, Lars] Stockholm Univ, Swedish E Sci Res Ctr, Dept Numer Anal & Comp Sci, S-17121 Solna, Sweden; [Hvidsten, Torgeir R.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Stockholm University; Umea University; Karolinska Institutet; Scuola Superiore Sant'Anna; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Umea University; Royal Institute of Technology; University of Udine; Royal Institute of Technology; Swedish University of Agricultural Sciences; Friedrich Schiller University of Jena; Uppsala University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Swedish University of Agricultural Sciences; Umea University; University of British Columbia; University of Valencia; Laval University; Laval University; Karolinska Institutet; University of British Columbia; Stockholm University; Norwegian University of Life Sciences	Nilsson, O (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden.	ove.nilsson@slu.se; par.ingvarsson@emg.umu.se; joakim.lundeberg@scilifelab.se; stefan.jansson@umu.se	Zuccolo, Andrea/H-5636-2019; Zerbe, Philipp/H-8348-2015; MacKay, John/M-6978-2014; LIN, Yao-Cheng/B-4394-2008; , wuzhiqiang/C-7843-2017; Scofield, Douglas G/B-4246-2009; Alexeyenko, Andrey/F-1924-2016; Street, Nathaniel Robert/B-3920-2008; Sahlin, Kristoffer/H-4683-2019; Tuominen, Hannele/E-7263-2013; Ingvarsson, Pär/G-2748-2010; Delhomme, Nicolas/B-9187-2015; Hvidsten, Torgeir R./A-3409-2009; Vicedomini, Riccardo/AGE-3108-2022; Van de Peer, Yves/D-4388-2009; Jansson, Stefan/A-1119-2009; Wu, Zhiqiang/CAG-6688-2022; Van de Peer, Yves/AAE-7666-2019; Andersson, Bjorn/G-9832-2013; Tuominen, Hannele/D-9563-2014	Zuccolo, Andrea/0000-0001-7574-0714; Zerbe, Philipp/0000-0001-5163-9523; MacKay, John/0000-0002-4883-195X; LIN, Yao-Cheng/0000-0002-9390-795X; , wuzhiqiang/0000-0002-4238-7317; Scofield, Douglas G/0000-0001-5235-6461; Alexeyenko, Andrey/0000-0001-8812-6481; Street, Nathaniel Robert/0000-0001-6031-005X; Sahlin, Kristoffer/0000-0001-7378-2320; Tuominen, Hannele/0000-0002-4949-3702; Delhomme, Nicolas/0000-0002-3053-0796; Hvidsten, Torgeir R./0000-0001-6097-2539; Vicedomini, Riccardo/0000-0002-7706-0998; Van de Peer, Yves/0000-0003-4327-3730; Jansson, Stefan/0000-0002-7906-6891; Wu, Zhiqiang/0000-0002-4238-7317; Van de Peer, Yves/0000-0003-4327-3730; Andersson, Bjorn/0000-0002-4624-0259; Tuominen, Hannele/0000-0002-4949-3702; Klasson, Lisa/0000-0002-5874-7153; Nilsson, Ove/0000-0002-1033-1909; Talavera-Lopez, Carlos/0000-0001-8590-2393; Nystedt, Bjorn/0000-0001-7809-7664; Niittyla, Totte/0000-0001-8029-1503; Elfstrand, Malin/0000-0002-0214-5284; Arvestad, Lars/0000-0001-5341-1733; Giacomello, Stefania/0000-0003-0738-1574; Kucukoglu Topcu, Melis/0000-0002-2655-7398; Bhalerao, Rishikesh/0000-0003-4384-7036; Gramzow, Lydia/0000-0003-1919-6077; Ingvarsson, Par/0000-0001-9225-7521; Svensson, Thomas/0000-0002-9190-2979; MORGANTE, Michele/0000-0003-2591-2156	Knut and Alice Wallenberg Foundation; Swedish Research Council (VR); Swedish Governmental Agency for Innovation Systems (Vinnova); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Swedish foundation for Strategic Research (SSF); Government of Canada through Genome Canada; Genome British Columbia; Genome Quebec; Science for Life Laboratory; National Genomics Infrastructure (NGI), Sweden	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council (VR)(Swedish Research Council); Swedish Governmental Agency for Innovation Systems (Vinnova)(Vinnova); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Government of Canada through Genome Canada(Genome Canada); Genome British Columbia; Genome Quebec; Science for Life Laboratory; National Genomics Infrastructure (NGI), Sweden	The authors would like to acknowledge support from the Knut and Alice Wallenberg Foundation. Additional funding was provided in particular by the Swedish Research Council (VR), the Swedish Governmental Agency for Innovation Systems (Vinnova), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), the Swedish foundation for Strategic Research (SSF), the Government of Canada through Genome Canada, by Genome British Columbia, and by Genome Quebec, Science for Life Laboratory and the National Genomics Infrastructure (NGI), Sweden. We also acknowledge Skogforsk for the P. abies genetic material, UPPMAX for computational infrastructure, CLC Bio for assembly software development and Lucigen for fosmid-pool method development.	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Bennetzen JL, 2004, CURR OPIN PLANT BIOL, V7, P732, DOI 10.1016/j.pbi.2004.09.003; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Buschiazzo E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-8; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Flory W. S., 1936, J ARNOLD ARBORETUM, V17, P82; Garcia-Gil MR, 2008, J MOL EVOL, V67, P222, DOI 10.1007/s00239-008-9135-z; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jaramillo-Correa JP, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-22; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Klintenas M, 2012, NEW PHYTOL, V196, P1260, DOI 10.1111/j.1469-8137.2012.04332.x; Kovach A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-420; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Mackenzie S.A., 2007, PLANT MITOCHONDRIA, P36; Magbanua ZV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016214; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; Pavy N, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-84; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Raj M, 2005, SILVAE GENET, V54, P126, DOI 10.1515/sg-2005-0020; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-484; Sahlin K, 2012, BIOINFORMATICS, V28, P2215, DOI 10.1093/bioinformatics/bts441; Sanmiguel P, 1998, ANN BOT-LONDON, V82, P37, DOI 10.1006/anbo.1998.0746; SAVARD L, 1994, P NATL ACAD SCI USA, V91, P5163, DOI 10.1073/pnas.91.11.5163; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Stewart WN, 1993, PALEOBOTANY AND THE; Van de Peer Y, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-113; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031002; Vicedomini R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S6; Vicient CM, 1999, PLANT CELL, V11, P1769, DOI 10.1105/tpc.11.9.1769; Vitte C, 2003, MOL BIOL EVOL, V20, P528, DOI 10.1093/molbev/msg055; Wan LC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-146; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang JH, 2013, PLANTA, V237, P89, DOI 10.1007/s00425-012-1753-4	50	951	986	14	484	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					579	584		10.1038/nature12211	http://dx.doi.org/10.1038/nature12211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23698360	Green Published, hybrid			2022-12-28	WOS:000319556100035
J	Hansen, SG; Sacha, JB; Hughes, CM; Ford, JC; Burwitz, BJ; Scholz, I; Gilbride, RM; Lewis, MS; Gilliam, AN; Ventura, AB; Malouli, D; Xu, GW; Richards, R; Whizin, N; Reed, JS; Hammond, KB; Fischer, M; Turner, JM; Legasse, AW; Axthelm, MK; Edlefsen, PT; Nelson, JA; Lifson, JD; Fruh, K; Picker, LJ				Hansen, Scott G.; Sacha, Jonah B.; Hughes, Colette M.; Ford, Julia C.; Burwitz, Benjamin J.; Scholz, Isabel; Gilbride, Roxanne M.; Lewis, Matthew S.; Gilliam, Awbrey N.; Ventura, Abigail B.; Malouli, Daniel; Xu, Guangwu; Richards, Rebecca; Whizin, Nathan; Reed, Jason S.; Hammond, Katherine B.; Fischer, Miranda; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Edlefsen, Paul T.; Nelson, Joy A.; Lifson, Jeffrey D.; Frueh, Klaus; Picker, Louis J.			Cytomegalovirus Vectors Violate CD8(+) T Cell Epitope Recognition Paradigms	SCIENCE			English	Article							MHC-CLASS-I; COMPLEX CLASS-II; HLA CLASS-I; MAMU-B-ASTERISK-08-POSITIVE MACAQUES; ACCESSORY MOLECULES; VIRAL INTERFERENCE; RHESUS-MONKEYS; MEMORY; LYMPHOCYTES; AIDS	CD8(+) T cell responses focus on a small fraction of pathogen-or vaccine-encoded peptides, and for some pathogens, these restricted recognition hierarchies limit the effectiveness of antipathogen immunity. We found that simian immunodeficiency virus (SIV) protein-expressing rhesus cytomegalovirus (RhCMV) vectors elicit SIV-specific CD8(+) T cells that recognize unusual, diverse, and highly promiscuous epitopes, including dominant responses to epitopes restricted by class II major histocompatibility complex (MHC) molecules. Induction of canonical Sly epitope-specific CD8(+) T cell responses is suppressed by the RhCMV-encoded Rh189 gene (corresponding to human CMV US11), and the promiscuous MHC class I- and class II-restricted CD8(+) T cell responses occur only in the absence of the Rh157.5, Rh157.4, and Rh157.6 (human CMV U1128, U1130, and U1131) genes. Thus, CMV vectors can be genetically programmed to achieve distinct patterns of CD8(+) T cell epitope recognition.	[Hansen, Scott G.; Sacha, Jonah B.; Hughes, Colette M.; Ford, Julia C.; Burwitz, Benjamin J.; Scholz, Isabel; Gilbride, Roxanne M.; Lewis, Matthew S.; Gilliam, Awbrey N.; Ventura, Abigail B.; Malouli, Daniel; Xu, Guangwu; Richards, Rebecca; Whizin, Nathan; Reed, Jason S.; Hammond, Katherine B.; Fischer, Miranda; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Joy A.; Frueh, Klaus; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Hansen, Scott G.; Sacha, Jonah B.; Hughes, Colette M.; Ford, Julia C.; Burwitz, Benjamin J.; Scholz, Isabel; Gilbride, Roxanne M.; Lewis, Matthew S.; Gilliam, Awbrey N.; Ventura, Abigail B.; Malouli, Daniel; Xu, Guangwu; Richards, Rebecca; Whizin, Nathan; Reed, Jason S.; Hammond, Katherine B.; Fischer, Miranda; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Joy A.; Frueh, Klaus; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Populat Sci Program, Seattle, WA 98109 USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Computat Biol Program, Seattle, WA 98109 USA; [Lifson, Jeffrey D.] Frederick Natl Lab, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.	pickerl@ohsu.edu	Malouli, Daniel/AAX-1855-2021	Malouli, Daniel/0000-0003-1287-7283; Frueh, Klaus/0000-0001-8014-3877	NIH [P01 AI094417, RO1 AI060392, RO1 AI059457, P51 OD 011092, HHSN261200800001E]; Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery Program); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060392, R01AI059457, P01AI094417] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092, U24OD010850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery Program); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Morrow, A. Khan, K. Broderick, and D. Weiner for providing and administering the electroporated DNA/gag + IL-12 vaccines; G. Spies and B. Moss for the MVA/gag vector; M. Chiuchiulo and C. Parks for the Ad5/gag vector; P. Barry for the original GFP-expressing RhCMV 68-1 virus and the RhCMV 68-1 BAC; T. Shenk for providing the repaired RhCMV 68-1.2 BAC; D. Watkins for MHC-I typing; D. O'Connor and R. Wiseman for MHC-II typing; R. Geleziunas, J. Hesselgesser, and Gilead Science Inc. fur providing antiretruviral drugs; A. Townsend for help with the graphics; and J. Hines, A. Bhusari, R. Derrah, D. Dull, D. Morrow, E. McDonald, C. Kahl, S. Hagen, M. Jarvis, A. Sylwester, and L. Boshears for technical or administrative assistance. The data presented in this paper are tabulated in the main paper and the supplementary materials. Supported by NIH grants P01 AI094417, RO1 AI060392, RO1 AI059457, and P51 OD 011092 and contract HHSN261200800001E, the Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery Program), and the International AIDS Vaccine Initiative. L.J.P., K.F., and S.G.H. have applied for a patent entitled "CMV Glycoproteins and Recombinant Vectors" (PCT/US2011/029930) and have filed a provisional patent application entitled "Cytomegalovirus Vectors Enabling Control of T Cell Targeting" (application 61772962). Oregon Health & Science University (OHSU) and L.J.P., S.G.H., K.F., and J.A.N. have a significant financial interest in TomegaVax Inc., a company that may have a commercial interest in the results of this research and technology. The potential individual and institutional conflicts of interest have been reviewed and managed by OHSU. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services or NIH, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Busche A, 2013, J IMMUNOL, V190, P2767, DOI 10.4049/jimmunol.1200966; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Chelvanayagam G, 1997, HUM IMMUNOL, V58, P61, DOI 10.1016/S0198-8859(97)00185-7; Cline AN, 2005, J MED PRIMATOL, V34, P303; Corradin C, 1991, Int Rev Immunol, V7, P139; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Egan MA, 2005, AIDS RES HUM RETROV, V21, P629, DOI 10.1089/aid.2005.21.629; Gainey MD, 2012, P NATL ACAD SCI USA, V109, pE3260, DOI 10.1073/pnas.1217111109; Gao HH, 2013, ARCH VIROL, V158, P173, DOI 10.1007/s00705-012-1378-8; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hansen SG, 2003, J VIROL, V77, P6620, DOI 10.1128/JVI.77.12.6620-6636.2003; Heemskerk MHM, 2001, P NATL ACAD SCI USA, V98, P6806, DOI 10.1073/pnas.111162298; Hirosawa T, 2011, CANCER SCI, V102, P1281, DOI 10.1111/j.1349-7006.2011.01949.x; Hofstetter AR, 2011, CURR OPIN IMMUNOL, V23, P104, DOI 10.1016/j.coi.2010.09.009; Irvine Kari, 2006, Expert Rev Clin Immunol, V2, P135, DOI 10.1586/1744666X.2.1.135; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Laddy DJ, 2009, J VIROL, V83, P4624, DOI 10.1128/JVI.02335-08; Lilja AE, 2008, P NATL ACAD SCI USA, V105, P19950, DOI 10.1073/pnas.0811063106; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; LUSTGARTEN J, 1991, EUR J IMMUNOL, V21, P2507, DOI 10.1002/eji.1830211030; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MIZUOCHI T, 1988, J EXP MED, V168, P437, DOI 10.1084/jem.168.1.437; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Munks MW, 2007, J IMMUNOL, V178, P7235, DOI 10.4049/jimmunol.178.11.7235; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Oxford KL, 2008, VIROLOGY, V373, P181, DOI 10.1016/j.virol.2007.10.040; Pande NT, 2005, J VIROL, V79, P5786, DOI 10.1128/JVI.79.9.5786-5798.2005; Pearce EL, 2004, J IMMUNOL, V173, P2494, DOI 10.4049/jimmunol.173.4.2494; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; RIDDELL SR, 1991, J IMMUNOL, V146, P2795; Rist M, 2009, BLOOD, V114, P2244, DOI 10.1182/blood-2009-05-222596; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; Shimizu T, 1997, EUR J IMMUNOL, V27, P500, DOI 10.1002/eji.1830270222; Snyder CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009681; Southwood S, 1998, J IMMUNOL, V160, P3363; SUZUKI H, 1994, J IMMUNOL, V153, P4496; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Viola A, 1997, J EXP MED, V186, P1775, DOI 10.1084/jem.186.10.1775; VOSS G, 1992, J VIROL METHODS, V39, P185, DOI 10.1016/0166-0934(92)90137-3; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; Wolfe D. A., 1973, NONPARAMETRIC STAT M; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	69	320	342	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					940	+	1237874	10.1126/science.1237874	http://dx.doi.org/10.1126/science.1237874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704576	Green Accepted			2022-12-28	WOS:000319344100036
J	McKinstry, B; Hanley, J; Wild, S; Pagliari, C; Paterson, M; Lewis, S; Sheikh, A; Krishan, A; Stoddart, A; Padfield, P				McKinstry, Brian; Hanley, Janet; Wild, Sarah; Pagliari, Claudia; Paterson, Mary; Lewis, Steff; Sheikh, Aziz; Krishan, Ashma; Stoddart, Andrew; Padfield, Paul			Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOME BLOOD-PRESSURE; THERAPEUTIC INERTIA; SELF-MEASUREMENT; SOCIETY; METAANALYSIS; VALIDATION; GUIDELINES; EXERCISE; CARE; PAY	Objective To determine if an intervention consisting of telemonitoring and supervision by usual primary care clinicians of home self measured blood pressure and optional patient decision support leads to clinically important reductions in daytime systolic and diastolic ambulatory blood pressure in patients with uncontrolled blood pressure. Design Multicentre randomised controlled trial. Setting 20 primary care practices in south east Scotland. Participants 401 people aged 29-95 years with uncontrolled blood pressure (mean daytime ambulatory measurement >= 135/85 mm Hg but <= 210/135 mm Hg). Intervention Self measurement and transmission of blood pressure readings to a secure website for review by the attending nurse or doctor and participant, with optional automated patient decision support by text or email for six months. Main outcome measures Blinded assessment of mean daytime systolic ambulatory blood pressure six months after randomisation. Results 200 participants were randomised to the intervention and 201 to usual care; primary outcome data were available for 90% of participants (182 and 177, respectively). The mean difference in daytime systolic ambulatory blood pressure adjusted for baseline and minimisation factors between intervention and usual care was 4.3 mm Hg (95% confidence interval 2.0 to 6.5; P=0.0002) and for daytime diastolic ambulatory blood pressure was 2.3 mm Hg (0.9 to 3.6; P=0.001), with higher values in the usual care group. The intervention was associated with a mean increase of one general practitioner (95% confidence interval 0.5 to 1.6; P=0.0002) and 0.6 (0.1 to 1.0; P=0.01) practice nurse consultations during the course of the study. Conclusions Supported self monitoring by telemonitoring is an effective method for achieving clinically important reductions in blood pressure in patients with uncontrolled hypertension in primary care settings. However, it was associated with increase in use of National Health Service resources. Further research is required to determine if the reduction in blood pressure is maintained in the longer term and if the intervention is cost effective. Trial registration Current Controlled Trials ISRCTN72614272.	[McKinstry, Brian; Wild, Sarah; Pagliari, Claudia; Paterson, Mary; Lewis, Steff; Sheikh, Aziz] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Hanley, Janet] Edinburgh Napier Univ, Sch Nursing Midwifery & Social Care, Edinburgh, Midlothian, Scotland; [Krishan, Ashma; Stoddart, Andrew] Univ Edinburgh, Edinburgh Clin Trials Unit, Edinburgh EH8 9AG, Midlothian, Scotland; [Padfield, Paul] Scottish Govt, Edinburgh, Midlothian, Scotland	University of Edinburgh; Edinburgh Napier University; University of Edinburgh	McKinstry, B (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland.	brian.mckinstry@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Pagliari, Claudia C/P-6412-2018	Sheikh, Aziz/0000-0001-7022-3056; Pagliari, Claudia C/0000-0001-5791-7723; Stoddart, Andrew/0000-0002-1958-3897; Hanley, Janet/0000-0003-1728-0136; Lewis, Steff/0000-0003-1210-2314; McKinstry, Brian/0000-0001-9581-0468	BUPA Foundation [748/G24]; High Blood pressure Foundation; NHS Lothian; Scottish Chief Scientist Office; Edinburgh Health Services Research Unit; Chief Scientist Office [ARPG/07/03] Funding Source: researchfish	BUPA Foundation; High Blood pressure Foundation; NHS Lothian; Scottish Chief Scientist Office; Edinburgh Health Services Research Unit; Chief Scientist Office	This study was funded by the BUPA Foundation (grant No 748/G24) with additional support from the High Blood pressure Foundation and NHS Lothian. BMcK and JH were supported by the Scottish Chief Scientist Office and ASt by the Edinburgh Health Services Research Unit. The funders had no role in the analysis, writing up of the results, or decision to publish. The researchers were independent of the funders.	Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; Bosworth HB, 2011, ARCH INTERN MED, V171, P1173, DOI 10.1001/archinternmed.2011.276; Bray EP, 2010, ANN MED, V42, P371, DOI 10.3109/07853890.2010.489567; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Curtis L., 2010, UNIT COSTS HLTH SOCI; Department of Health, 2011, REF COSTS 2009 10; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Eldridge S, 2010, BMJ-BRIT MED J, V340, P26; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Hanley J, 2013, BMJOPEN IN PRESS; Haymarket Medical Media, 2011, MONTHL IND MED SPEC; Isaacs AJ, 2007, HEALTH TECHNOL ASSES, V11, P1; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Leonard K., 2004, ELECT HEALTHC, V2, P72; Lorig KR, 2001, EFF CLIN PRACT, V4, P256; Madsen LB, 2008, BLOOD PRESSURE, V17, P78, DOI 10.1080/08037050801915468; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Myers J, 2001, AM HEART J, V142, P1041, DOI 10.1067/mhj.2001.118740; National Institute for Health and Clinical Excellence, 2011, NICE GUID CG127 MAN; Neumann CL, 2011, J HUM HYPERTENS, V25, P732, DOI 10.1038/jhh.2010.119; NHS Prescriptions Services, 2011, DRUGS TAR; O'Brien E, 1991, J HYPERTENS       S5, V9, pS25; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Omboni S, 2011, AM J HYPERTENS, V24, P989, DOI 10.1038/ajh.2011.100; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Parati G, 2010, J HUM HYPERTENS, V24, P779, DOI 10.1038/jhh.2010.54; Parati G, 2009, J HYPERTENS, V27, P198, DOI 10.1097/HJH.0b013e3283163caf; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Rogers MAM, 2001, ANN INTERN MED, V134, P1024, DOI 10.7326/0003-4819-134-11-200106050-00008; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Serumaga Brian, 2011, BMJ, V342, pd108, DOI 10.1136/bmj.d108; Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Stoddart A, 2013, BMJOPEN IN PRESS; Strauss A., 1990, BASICS QUALITATIVE R; The Information Centre, 2007, 2006 07 UK GEN PRACT; The Scottish Government, 2012, SCOTT IND MULT DEPR; Verberk WJ, 2007, HYPERTENSION, V50, P1019, DOI 10.1161/HYPERTENSIONAHA.107.094193; Verberk WJ, 2011, BLOOD PRESS MONIT, V16, P149, DOI 10.1097/MBP.0b013e328346e092; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; Westhoff T, 2008, J HUM HYPERTENS, V22, P233, DOI 10.1038/sj.jhh.1002287; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; World Health Organization. Defined Daily Dose (DDD), 2012, DEF DAIL DOS DDD ACT; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	115	123	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2013	346								f3030	10.1136/bmj.f3030	http://dx.doi.org/10.1136/bmj.f3030			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155KE	23709583	Green Published, hybrid			2022-12-28	WOS:000319745800001
J	Costandi, M				Costandi, Moheb			NEURODEGENERATION Amyloid awakenings	NATURE			English	Editorial Material							SLEEP-WAKE CYCLE; DISEASE											Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Krishnan N, 2012, NEUROBIOL DIS, V45, P1129, DOI 10.1016/j.nbd.2011.12.034; Lim ASP, 2012, ANN NEUROL, V72, P324, DOI 10.1002/ana.23636; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115	7	12	12	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S19	S20		10.1038/497S19a	http://dx.doi.org/10.1038/497S19a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698504				2022-12-28	WOS:000319254000010
J	Houtkooper, RH; Mouchiroud, L; Ryu, D; Moullan, N; Katsyuba, E; Knott, G; Williams, RW; Auwerx, J				Houtkooper, Riekelt H.; Mouchiroud, Laurent; Ryu, Dongryeol; Moullan, Norman; Katsyuba, Elena; Knott, Graham; Williams, Robert W.; Auwerx, Johan			Mitonuclear protein imbalance as a conserved longevity mechanism	NATURE			English	Article							EXTENDS LIFE-SPAN; SYSTEMATIC RNAI SCREEN; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; GENE-EXPRESSION; C-ELEGANS; MITOCHONDRIAL-FUNCTION; CALORIC RESTRICTION; MICE; EXTENSION	Longevity is regulated by a network of closely linked metabolic systems. We used a combination of mouse population genetics and RNA interference in Caenorhabditis elegans to identify mitochondrial ribosomal protein S5 (Mrps5) and other mitochondrial ribosomal proteins as metabolic and longevity regulators. MRP knockdown triggers mitonuclear protein imbalance, reducing mitochondrial respiration and activating the mitochondrial unfolded protein response. Specific antibiotics targeting mitochondrial translation and ethidium bromide (which impairs mitochondrial DNA transcription) pharmacologically mimic mrp knockdown and extend worm lifespan by inducing mitonuclear protein imbalance, a stoichiometric imbalance between nuclear and mitochondrially encoded proteins. This mechanism was also conserved in mammalian cells. In addition, resveratrol and rapamycin, longevity compounds acting on different molecular targets, similarly induced mitonuclear protein imbalance, the mitochondrial unfolded protein response and lifespan extension in C. elegans. Collectively these data demonstrate that MRPs represent an evolutionarily conserved protein family that ties the mitochondrial ribosome and mitonuclear protein imbalance to the mitochondrial unfolded protein response, an overarching longevity pathway across many species.	[Houtkooper, Riekelt H.; Mouchiroud, Laurent; Ryu, Dongryeol; Moullan, Norman; Katsyuba, Elena; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Houtkooper, Riekelt H.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Knott, Graham] Ecole Polytech Fed Lausanne, BioEM Facil, CH-1015 Lausanne, Switzerland; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Williams, Robert W.] Ctr Integrat & Translat Genom, Memphis, TN 38163 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Tennessee System; University of Tennessee Health Science Center	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.	admin.auwerx@epfl.ch	Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019; Ryu, Dongryeol/AAQ-3642-2020; Auwerx, Johan/ABE-9307-2021; Williams, Robert W./H-8789-2016	Houtkooper, Riekelt H/0000-0001-9961-0842; Ryu, Dongryeol/0000-0001-5905-6760; Auwerx, Johan/0000-0002-5065-5393; Williams, Robert W./0000-0001-8924-4447; Knott, Graham W/0000-0002-2956-9052	NWO-Rubicon; AMC; FRM fellowship; EPFL; ERC [2008-AdG-23138]; Velux Stiftung; SNSF; National Institutes of Health (NIH) [P20-DA 21131, UO1AA13499, U01AA14425]; UT Center for Integrative and Translational Genomics; NIH [R01AG043930]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499, U01AA014425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	NWO-Rubicon(Netherlands Organization for Scientific Research (NWO)); AMC; FRM fellowship(Fondation pour la Recherche Medicale); EPFL; ERC(European Research Council (ERC)European Commission); Velux Stiftung; SNSF(Swiss National Science Foundation (SNSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Center for Integrative and Translational Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Gonczy and the Caenorhabditis Genetics Center for sharing or providing reagents. R. H. H. is supported by fellowships from NWO-Rubicon and AMC, and L.M. by an FRM fellowship. J.A. is the Nestle Chair in Energy Metabolism and supported by EPFL, ERC (2008-AdG-23138), Velux Stiftung and SNSF. R. W. W. and GeneNetwork are supported by the National Institutes of Health (NIH) (P20-DA 21131, UO1AA13499 and U01AA14425), and the UT Center for Integrative and Translational Genomics. R. W. W. and J.A. are supported by NIH grant R01AG043930.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Argmann CA, 2005, CELL METAB, V2, P349, DOI 10.1016/j.cmet.2005.11.002; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Geisert EE, 2009, MOL VIS, V15, P1730; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; WONG A, 1995, GENETICS, V139, P1247; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; ZYLBER E, 1969, J MOL BIOL, V44, P195, DOI 10.1016/0022-2836(69)90414-8	48	650	662	12	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					451	+		10.1038/nature12188	http://dx.doi.org/10.1038/nature12188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698443	Green Accepted			2022-12-28	WOS:000319254000039
J	Coiera, E				Coiera, Enrico			Social networks, social media, and social diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH MANAGEMENT-SYSTEM; BEHAVIOR; ADOPTION; QUALITY; SPREAD; COMMUNITIES; THERAPY; SUPPORT; RATINGS; OBESITY		Univ New S Wales, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW, Australia	University of New South Wales Sydney	Coiera, E (corresponding author), Univ New S Wales, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW, Australia.	e.coiera@unsw.edu.au		Coiera, Enrico/0000-0002-6444-6584				Aiello LM, 2012, ACM T WEB, V6, DOI 10.1145/2180861.2180866; Australian Medical Association, 2012, SOC MED MED PROF GUI; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Bardach NS, 2013, BMJ QUAL SAF, V22, P194, DOI 10.1136/bmjqs-2012-001360; Bargh JA, 2004, ANNU REV PSYCHOL, V55, P573, DOI 10.1146/annurev.psych.55.090902.141922; Beaudoin CE, 2008, NEW MEDIA SOC, V10, P321, DOI 10.1177/1461444807086477; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Brabham D.C., 2008, CONVERGENCE-US, V14, P75, DOI DOI 10.1177/1354856507084420; Broadhead RS, 1999, PUBLIC HEALTH, V113, P42; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chretien KC, 2011, JAMA-J AM MED ASSOC, V305, P566, DOI 10.1001/jama.2011.68; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Coiera E, 2004, BRIT MED J, V328, P1197, DOI 10.1136/bmj.328.7449.1197; Copello A, 2002, ADDICT BEHAV, V27, P345, DOI 10.1016/S0306-4603(01)00176-9; Creswick N, 2010, INT J MED INFORM, V79, pE116, DOI 10.1016/j.ijmedinf.2008.08.005; Cunningham FC, 2012, BMJ QUAL SAF, V21, P239, DOI 10.1136/bmjqs-2011-000187; Dunn AG, 2012, SCI TRANSL MED, V4, P132; Eysenbach G, 2003, CA-CANCER J CLIN, V53, P356, DOI 10.3322/canjclin.53.6.356; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338; GALANTER M, 1993, PSYCHOTHER, V30, P251, DOI 10.1037/0033-3204.30.2.251; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Greaves F, 2013, BMJ QUAL SAF, V22, P251, DOI 10.1136/bmjqs-2012-001527; Greaves F, 2012, ARCH INTERN MED, V172, P435, DOI 10.1001/archinternmed.2011.1675; Haythornthwaite C., 2005, Information Communication & Society, V8, P125, DOI 10.1080/13691180500146185; Iaconesi S, MY OPEN SOURCE CURE; Iaconesi S, CURE; Iedema R, 2012, BMJ QUAL SAF, V21, P198, DOI 10.1136/bmjqs-2011-000100; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kawrykow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031362; Lau Annie Y. S., 2012, Journal of the American Medical Informatics Association, V19, P719, DOI 10.1136/amiajnl-2011-000433; Lau AYS, 2008, J MED INTERNET RES, V10, DOI [10.2196/jmir.963, 10.2196/jmr.963]; Lau AYS, 2012, ELECTRON J HEALTH IN, V7; Lau AYS, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2414; Litt MD, 2009, J CONSULT CLIN PSYCH, V77, P229, DOI 10.1037/a0015252; Long JC, 2013, BMC HEALTH SERV RES, V13, DOI [10.1186/1472-6963-13-338, 10.1186/1472-6963-13-158]; Mascia D, 2011, SOC SCI MED, V72, P798, DOI 10.1016/j.socscimed.2010.12.011; McLaughlin M, 2012, COMPUT HUM BEHAV, V28, P631, DOI 10.1016/j.chb.2011.11.009; McLuhan M., 1994, UNDERSTANDING MEDIA; Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591; Neiger BL, 2012, HEALTH PROMOT PRACT, V13, P159, DOI 10.1177/1524839911433467; Ranmuthugala G, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-273; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Sugawara Yuya, 2012, BMC Res Notes, V5, P699, DOI 10.1186/1756-0500-5-699; Sutton JN, 2012, P 9 INT C INF SYST C, P208; Swan M, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1988; Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242; Thomson R, 2012, P 9 INT C INF SYST C, P112; Tichy N. M., 1979, ACAD MANAGE REV, V4, P507, DOI [10.5465/AMR.1979.4498309, DOI 10.5465/AMR.1979.4498309]; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; van Mierlo T, 2012, J MED INTERNET RES, V14, P45, DOI 10.2196/jmir.1854; von Muhlen M, 2012, J AM MED INFORM ASSN, V19, P777, DOI 10.1136/amiajnl-2012-000990; Weitzman ER, 2011, J AM MED INFORM ASSN, V18, P292, DOI [10.1136/jamia.2010.009712, 10.1136/amiajnl-2010.009712]; West H, 2012, J THORAC ONCOL, V7, P482, DOI 10.1097/JTO.0b013e3182432646; WILLIAMSON PM, 1975, SOC SCI MED, V9, P233, DOI 10.1016/0037-7856(75)90027-X; Yates D, 2011, INT J INFORM MANAGE, V31, P6, DOI 10.1016/j.ijinfomgt.2010.10.001	62	54	55	0	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2013	346								f3007	10.1136/bmj.f3007	http://dx.doi.org/10.1136/bmj.f3007			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AV	23697672				2022-12-28	WOS:000319574400010
J	Hankey, GJ				Hankey, Graeme J.			An optimum blood pressure target after lacunar stroke?	LANCET			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; RISK; PREVENTION		Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia.	graeme.hankey@uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Arima H, 2010, J HYPERTENS, V28, P395, DOI 10.1097/HJH.0b013e328333b009; Chapman N, 2004, STROKE, V35, P116, DOI 10.1161/01.STR.0000106480.76217.6F; Delcourt C, 2010, INT J STROKE, V5, P110, DOI 10.1111/j.1747-4949.2010.00415.x; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hackshaw A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3340; HANKEY GJ, 1987, MED J AUSTRALIA, V146, P412, DOI 10.5694/j.1326-5377.1987.tb120332.x; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Rothwell PM, 2011, LANCET, V377, P1681, DOI 10.1016/S0140-6736(11)60516-3; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Rothwell PM, 2003, STROKE, V34, P2583, DOI 10.1161/01.STR.0000094424.38761.56; The SPS3 Study Group, 2013, LANCET; Thomas D, 2006, INT J STROKE, V1, P245, DOI 10.1111/j.1747-4949.2006.00059.x; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8	15	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2013	382	9891					482	484		10.1016/S0140-6736(13)60940-X	http://dx.doi.org/10.1016/S0140-6736(13)60940-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201SD	23726160				2022-12-28	WOS:000323162400005
J	Pavia, AT				Pavia, Andrew T.			Influenza A(H7N9): From Anxiety to Preparedness	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRANSMISSION; FERRETS; VIRUS		Univ Utah, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Pavia, AT (corresponding author), Univ Utah, 295 Chipeta Way, Salt Lake City, UT 84108 USA.	andy.pavia@hsc.utah.edu						[Anonymous], 2013, HUM INF INFL A H7N9; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050830; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Infectious Diseases Society of America, 2012, PAND SEAS INFL PRINC; Ison MG, 2012, J INFECT DIS, V206, P1806, DOI 10.1093/infdis/jis623; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0	9	4	5	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					219	+		10.7326/0003-4819-159-3-201308060-00653	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-00653			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201RD	23697995				2022-12-28	WOS:000323159800008
J	Ibrahim, MX; Sayin, VI; Akula, MK; Liu, M; Fong, LG; Young, SG; Bergo, MO				Ibrahim, Mohamed X.; Sayin, Volkan I.; Akula, Murali K.; Liu, Meng; Fong, Loren G.; Young, Stephen G.; Bergo, Martin O.			Targeting Isoprenylcysteine Methylation Ameliorates Disease in a Mouse Model of Progeria	SCIENCE			English	Article							HUTCHINSON-GILFORD PROGERIA; PRELAMIN-A; SYNDROME MUTATION; CELL BIOLOGY; MICE; ZMPSTE24; RAS; FIBROBLASTS; DEFICIENCY; PHENOTYPES	Several progeroid disorders, including Hutchinson-Gilford progeria syndrome (HGPS) and restrictive dermopathy (ZMPSTE24 deficiency), arise when a farnesylated and methylated form of prelamin A accumulates at the nuclear envelope. Here, we found that a hypomorphic allele of isoprenylcysteine carboxyl methyltransferase (ICMT) increased body weight, normalized grip strength, and prevented bone fractures and death in Zmpste24-deficient mice. The reduced ICMT activity caused prelamin A mislocalization within the nucleus and triggered prelamin A-dependent activation of AKT-mammalian target of rapamycin (mTOR) signaling, which abolished the premature senescence of Zmpste24-deficient fibroblasts. ICMT inhibition increased AKT-mTOR signaling and proliferation and delayed senescence in human HGPS fibroblasts but did not reduce the levels of misshapen nuclei in mouse and human cells. Thus, targeting ICMT might be useful for treating prelamin A-associated progeroid disorders.	[Ibrahim, Mohamed X.; Sayin, Volkan I.; Akula, Murali K.; Liu, Meng; Bergo, Martin O.] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Canc Ctr, Inst Med,Sahlgrenska Acad, S-41390 Gothenburg, Sweden; [Liu, Meng] Univ Gothenburg, Dept Clin Chem & Transfus Med, Inst Biomed, Sahlgrenska Acad, S-41345 Gothenburg, Sweden; [Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of Gothenburg; University of Gothenburg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bergo, MO (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Canc Ctr, Inst Med,Sahlgrenska Acad, S-41390 Gothenburg, Sweden.	martin.bergo@gu.se	Ibrahim, Mohamed x./T-5479-2019	Ibrahim, Mohamed x./0000-0002-7762-1580; Young, Stephen/0000-0001-7270-3176; akula, naga venkata muralikrishna/0000-0002-6418-8300; Liu, Viktor/0000-0003-2865-034X	European Research Council; Swedish Cancer Society; Swedish Research Council; Swedish Children's Cancer Fund; Vastra Gotalandsregionen; Ingabritt and Arne Lundberg's Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, R01HL086683, R01HL089781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035626] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children's Cancer Fund; Vastra Gotalandsregionen; Ingabritt and Arne Lundberg's Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Proteomics and Imaging Core Facilities at the Sahlgrenska Academy; M. Dalin, P. Lindahl, and J. Nilsson for comments; C. Karlsson and P. Iranmanesh for technical assistance; and S. Ordway for editing the manuscript. This study was supported by a Starting Investigator Grant from the European Research Council; and by grants from the Swedish Cancer Society, the Swedish Research Council, the Swedish Children's Cancer Fund, Vastra Gotalandsregionen, and the Ingabritt and Arne Lundberg's Research Foundation (to M.O.B). Data are available in the supplementary materials.	Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Couzin-Frankel J, 2012, SCIENCE, V337, P1594, DOI 10.1126/science.337.6102.1594; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Gordon LB, 2012, J CELL BIOL, V199, P9, DOI 10.1083/jcb.201207072; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Svensson AW, 2006, METHOD ENZYMOL, V407, P144, DOI 10.1016/S0076-6879(05)07013-8; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, BBA-MOL CELL BIOL L, V1781, P36, DOI 10.1016/j.bbalip.2007.11.003; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	22	79	81	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1330	1333		10.1126/science.1238880	http://dx.doi.org/10.1126/science.1238880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23686339	Green Accepted			2022-12-28	WOS:000320320200045
J	Gao, HN; Lu, HZ; Cao, B; Du, B; Shang, H; Gan, JH; Lu, SH; Yang, YD; Fang, Q; Shen, YZ; Xi, XM; Gu, Q; Zhou, XM; Qu, HP; Yan, Z; Li, FM; Zhao, W; Gao, ZC; Wang, GF; Ruan, LX; Wang, WH; Ye, J; Cao, HF; Li, XW; Zhang, WH; Fang, XC; He, J; Liang, WF; Xie, J; Zeng, M; Wu, XZ; Li, J; Xia, Q; Jin, ZC; Chen, Q; Tang, C; Zhang, ZY; Hou, BM; Feng, ZX; Sheng, JF; Zhong, NS; Li, LJ				Gao, Hai-Nv; Lu, Hong-Zhou; Cao, Bin; Du, Bin; Shang, Hong; Gan, Jian-He; Lu, Shui-Hua; Yang, Yi-Da; Fang, Qiang; Shen, Yin-Zhong; Xi, Xiu-Ming; Gu, Qin; Zhou, Xian-Mei; Qu, Hong-Ping; Yan, Zheng; Li, Fang-Ming; Zhao, Wei; Gao, Zhan-Cheng; Wang, Guang-Fa; Ruan, Ling-Xiang; Wang, Wei-Hong; Ye, Jun; Cao, Hui-Fang; Li, Xing-Wang; Zhang, Wen-Hong; Fang, Xu-Chen; He, Jian; Liang, Wei-Feng; Xie, Juan; Zeng, Mei; Wu, Xian-Zheng; Li, Jun; Xia, Qi; Jin, Zhao-Chen; Chen, Qi; Tang, Chao; Zhang, Zhi-Yong; Hou, Bao-Min; Feng, Zhi-Xian; Sheng, Ji-Fang; Zhong, Nan-Shan; Li, Lan-Juan			Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							H5N1; THAILAND; HUMANS; CHINA	BACKGROUND During the spring of 2013, a novel avian-origin influenza A (H7N9) virus emerged and spread among humans in China. Data were lacking on the clinical characteristics of the infections caused by this virus. METHODS Using medical charts, we collected data on 111 patients with laboratory-confirmed avian-origin influenza A (H7N9) infection through May 10, 2013. RESULTS Of the 111 patients we studied, 76.6% were admitted to an intensive care unit (ICU), and 27.0% died. The median age was 61 years, and 42.3% were 65 years of age or older; 31.5% were female. A total of 61.3% of the patients had at least one underlying medical condition. Fever and cough were the most common presenting symptoms. On admission, 108 patients (97.3%) had findings consistent with pneumonia. Bilateral ground-glass opacities and consolidation were the typical radiologic findings. Lymphocytopenia was observed in 88.3% of patients, and thrombo-cytopenia in 73.0%. Treatment with antiviral drugs was initiated in 108 patients (97.3%) at a median of 7 days after the onset of illness. The median times from the onset of illness and from the initiation of antiviral therapy to a negative viral test result on real-time reverse-transcriptase-polymerase-chain-reaction assay were 11 days (interquartile range, 9 to 16) and 6 days (interquartile range, 4 to 7), respectively. Multivariate analysis revealed that the presence of a coexisting medical condition was the only independent risk factor for the acute respiratory distress syndrome (ARDS) (odds ratio, 3.42; 95% confidence interval, 1.21 to 9.70; P = 0.02). CONCLUSIONS During the evaluation period, the novel H7N9 virus caused severe illness, including pneumonia and ARDS, with high rates of ICU admission and death. (Funded by the National Natural Science Foundation of China and others.)	[Gao, Hai-Nv; Yang, Yi-Da; Fang, Qiang; Ruan, Ling-Xiang; Liang, Wei-Feng; Xia, Qi; Feng, Zhi-Xian; Sheng, Ji-Fang; Li, Lan-Juan] Zhejiang Univ, Affiliated Coll Med 1, Dept Infect Dis, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Wei-Hong] Huzhou Cent Hosp, Huzhou, Peoples R China; [Lu, Hong-Zhou; Lu, Shui-Hua; Shen, Yin-Zhong; Zhang, Zhi-Yong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Qu, Hong-Ping] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China; [Li, Fang-Ming; Xie, Juan] Fifth Hosp Shanghai, Shanghai, Peoples R China; [Ye, Jun] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Shanghai, Peoples R China; [Cao, Hui-Fang] Jingan Dist Cent Hosp, Shanghai, Peoples R China; [Zhang, Wen-Hong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Fang, Xu-Chen] Yangpu Dist Shidong Hosp Shanghai, Shanghai, Peoples R China; [He, Jian] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China; [Zeng, Mei] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Wu, Xian-Zheng] Tongji Univ, Tongji Hosp, Shanghai 200092, Peoples R China; [Cao, Bin] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China; [Du, Bin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med Intens Care Unit, Beijing 100730, Peoples R China; [Xi, Xiu-Ming] Capital Med Univ, Fuxing Hosp, Beijing, Peoples R China; [Gao, Zhan-Cheng] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Wang, Guang-Fa] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Li, Xing-Wang] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing, Peoples R China; [Shang, Hong] China Med Univ, Hosp 1, Shenyang, Peoples R China; [Gan, Jian-He] Soochow Univ, Coll Med, Affiliated Hosp 1, Suzhou, Peoples R China; [Gu, Qin] Nanjing Univ, Sch Med, Affiliated Hosp, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Xian-Mei] Jiangsu Prov Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Zhao, Wei] Southeast Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Li, Jun] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Yan, Zheng] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Wuxi, Peoples R China; [Jin, Zhao-Chen] First Hosp Zhenjiang, Zhenjiang, Peoples R China; [Chen, Qi] First Hosp Yancheng, Yancheng, Peoples R China; [Tang, Chao] Peoples Hosp Bozhou, Bozhou, Peoples R China; [Hou, Bao-Min] Zhoukou Infect Dis Hosp, Zhoukou, Peoples R China; [Zhong, Nan-Shan] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Huzhou University; Fudan University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; Fudan University; Naval Medical University; Fudan University; Tongji University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; Peking University; Peking University; Capital Medical University; China Medical University; Soochow University - China; Nanjing University; Nanjing University of Chinese Medicine; Southeast University - China; Nanjing Medical University; Nanjing Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Li, LJ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	nanshan@vip.163.com; ljli@zju.edu.cn	gao, hainv/H-3868-2013	gao, hainv/0000-0003-4590-9181; LI, Lanjuan/0000-0001-6945-0593	National Natural Science Foundation of China [81070005/H0104, 81030032/H19]; National Program for the Prevention and Control of Human Infections by Avian-Origin H7N9 Influenza A Virus [KJYJ-2013-01]; National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China [2012ZX10004-206, 2012ZX10004-210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for the Prevention and Control of Human Infections by Avian-Origin H7N9 Influenza A Virus; National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China	Supported by grants from the National Natural Science Foundation of China (81070005/H0104 and 81030032/H19), the National Program for the Prevention and Control of Human Infections by Avian-Origin H7N9 Influenza A Virus (KJYJ-2013-01), and the National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China (2012ZX10004-206 and 2012ZX10004-210).	Bai L, 2011, CHEST, V139, P1156, DOI 10.1378/chest.10-1036; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chen Y, 2013, LANCET; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; D'Silva D, 2009, PEDIATR INFECT DIS J, V28, P1138, DOI 10.1097/INF.0b013e3181c03cf2; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; World Health Organization, 2013, NUMB CONF HUM CAS AV; World Health Organization, 2009, CLIN MAN HUM INF PAN; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029652, 10.1371/journal.pone.0035836]; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985	19	494	590	7	336	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2277	2285		10.1056/NEJMoa1305584	http://dx.doi.org/10.1056/NEJMoa1305584			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23697469				2022-12-28	WOS:000320230500003
J	Burguiere, E; Monteiro, P; Feng, GP; Graybiel, AM				Burguiere, Eric; Monteiro, Patricia; Feng, Guoping; Graybiel, Ann M.			Optogenetic Stimulation of Lateral Orbitofronto-Striatal Pathway Suppresses Compulsive Behaviors	SCIENCE			English	Article							DISORDER; INTERNEURONS; INHIBITION; ACTIVATION; CHOICE; OCD; RAT	Dysfunctions in frontostriatal brain circuits have been implicated in neuropsychiatric disorders, including those characterized by the presence of repetitive behaviors. We developed an optogenetic approach to block repetitive, compulsive behavior in a mouse model in which deletion of the synaptic scaffolding gene, Sapap3, results in excessive grooming. With a delay-conditioning task, we identified in the mutants a selective deficit in behavioral response inhibition and found this to be associated with defective down-regulation of striatal projection neuron activity. Focused optogenetic stimulation of the lateral orbitofrontal cortex and its terminals in the striatum restored the behavioral response inhibition, restored the defective down-regulation, and compensated for impaired fast-spiking neuron striatal microcircuits. These findings raise promising potential for the design of targeted therapy for disorders involving excessive repetitive behavior.	[Burguiere, Eric; Monteiro, Patricia; Feng, Guoping; Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Burguiere, Eric; Monteiro, Patricia; Feng, Guoping; Graybiel, Ann M.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Graybiel, AM (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	graybiel@mit.edu	Burguière, Eric/G-1114-2015; Burguière, Eric/K-9925-2019; Feng, Guoping/Y-2827-2019; Monteiro, Patricia/Q-7646-2017	Burguière, Eric/0000-0002-9690-5909; Monteiro, Patricia/0000-0003-3288-4560; Graybiel, Ann/0000-0002-4326-7720	Simons Initiative on Autism; Brain at MIT; National Institute of Child Health and Development, NIH [R37 HD028341]; Defense Advanced Research Projects Agency [W911NF1010059]; National Institute on Mental Health, NIH [R01 MH081201]; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081201, R01MH097104] Funding Source: NIH RePORTER	Simons Initiative on Autism; Brain at MIT; National Institute of Child Health and Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institute on Mental Health, NIH; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank D. Hu, H. F. Hall, C. Keller-McGandy, J. Lee, Y. Kubota, R. MacRae, and D. J. Gibson for their generous help. Funded by the Simons Initiative on Autism and the Brain at MIT (A. M. G. and E. B.); National Institute of Child Health and Development, NIH, R37 HD028341 and Defense Advanced Research Projects Agency, W911NF1010059 (A. M. G.); and National Institute on Mental Health, NIH, R01 MH081201 and Simons Foundation Autism Research Initiative (G. F.). E. B. and A. M. G. designed the experiments, performed data analysis, and wrote the manuscript; E. B. conducted the experiments; P. M. conducted the cell counts; G. F. provided the Sapap3 mutant mouse model and read the manuscript. The authors declare no competing financial interest. Correspondence and requests for materials should be addressed to A. M. G. (graybiel@mit.edu).	Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Chen M, 2011, J NEUROSCI, V31, P9563, DOI 10.1523/JNEUROSCI.1701-11.2011; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Eagle DM, 2011, J NEUROSCI, V31, P7349, DOI 10.1523/JNEUROSCI.6182-10.2011; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Franklin ME, 2011, ANNU REV CLIN PSYCHO, V7, P229, DOI 10.1146/annurev-clinpsy-032210-104533; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gittis AH, 2012, TRENDS NEUROSCI, V35, P557, DOI 10.1016/j.tins.2012.06.008; Goodman Wayne K, 2007, J Clin Psychiatry, V68, pe30; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Mar AC, 2011, J NEUROSCI, V31, P6398, DOI 10.1523/JNEUROSCI.6620-10.2011; Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; Morein-Zamir S, 2010, PSYCHOL MED, V40, P263, DOI 10.1017/S003329170999033X; Otte Christian, 2011, Dialogues Clin Neurosci, V13, P413; RIDLEY RM, 1994, PROG NEUROBIOL, V44, P221, DOI 10.1016/0301-0082(94)90039-6; Saka E, 2004, J NEUROSCI, V24, P7557, DOI 10.1523/JNEUROSCI.1072-04.2004; Steinmetz JE, 2001, INTEGR PHYS BEH SCI, V36, P220, DOI 10.1007/BF02734095; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zuchner S, 2009, MOL PSYCHIATR, V14, P6, DOI 10.1038/mp.2008.83	24	270	276	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1243	1246		10.1126/science.1232380	http://dx.doi.org/10.1126/science.1232380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744950	Green Submitted, Green Accepted			2022-12-28	WOS:000319972800053
J	Fang, LH; Choi, SH; Baek, JS; Liu, C; Almazan, F; Ulrich, F; Wiesner, P; Taleb, A; Deer, E; Pattison, J; Torres-Vazquez, J; Li, AC; Miller, YI				Fang, Longhou; Choi, Soo-Ho; Baek, Ji Sun; Liu, Chao; Almazan, Felicidad; Ulrich, Florian; Wiesner, Philipp; Taleb, Adam; Deer, Elena; Pattison, Jennifer; Torres-Vazquez, Jesus; Li, Andrew C.; Miller, Yury I.			Control of angiogenesis by AIBP-mediated cholesterol efflux	NATURE			English	Article							EMBRYONIC VASCULAR DEVELOPMENT; CASSETTE TRANSPORTER 1; I BINDING-PROTEIN; ENDOTHELIAL-CELLS; TANGIER-DISEASE; ZEBRAFISH; EXPRESSION; ABCG1; GENE; ACTIVATION	Cholesterol is a structural component of the cell and is indispensable for normal cellular function, although its excess often leads to abnormal proliferation, migration, inflammatory responses and/or cell death. To prevent cholesterol overload, ATP-binding cassette (ABC) transporters mediate cholesterol efflux from the cells to apolipoprotein A-I (apoA-I) and the apoA-I-containing high-density lipoprotein (HDL)(1-3). Maintaining efficient cholesterol efflux is essential for normal cellular function(4-6). However, the role of cholesterol efflux in angiogenesis and the identity of its local regulators are poorly understood. Here we show that apoA-I binding protein (AIBP) accelerates cholesterol efflux from endothelial cells to HDL and thereby regulates angiogenesis. AIBP- and HDL-mediated cholesterol depletion reduces lipid rafts, interferes with VEGFR2 (also known as KDR) dimerization and signalling and inhibits vascular endothelial growth factor-induced angiogenesis in vitro and mouse aortic neovascularization ex vivo. Notably, Aibp, a zebrafish homologue of human AIBP, regulates the membrane lipid order in embryonic zebrafish vasculature and functions as a non-cell-autonomous regulator of angiogenesis. aibp knockdown results in dysregulated sprouting/branching angiogenesis, whereas forced Aibp expression inhibits angiogenesis. Dysregulated angiogenesis is phenocopied in Abca1 (also known as Abca1a) Abcg1-deficient embryos, and cholesterol levels are increased in Aibp-deficient and Abca1Abcg1-deficient embryos. Our findings demonstrate that secreted AIBP positively regulates cholesterol efflux from endothelial cells and that effective cholesterol efflux is critical for proper angiogenesis.	[Fang, Longhou; Choi, Soo-Ho; Baek, Ji Sun; Liu, Chao; Almazan, Felicidad; Wiesner, Philipp; Taleb, Adam; Deer, Elena; Pattison, Jennifer; Li, Andrew C.; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ulrich, Florian; Torres-Vazquez, Jesus] NYU, Langone Med Ctr, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA	University of California System; University of California San Diego; New York University; NYU Langone Medical Center	Miller, YI (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yumiller@ucsd.edu	Fang, Longhou/G-6582-2013	Fang, Longhou/0000-0003-1653-5221; Torres-Vazquez, Jesus/0000-0002-3808-3978	NIH [HL093767, HL055798, HL114734]; UC Tobacco-Related Disease Program [18FT-0137]; UCSD [P30NS047101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL114734, R01HL093767, R00HL114734, P01HL088093, P01HL055798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Tobacco-Related Disease Program; UCSD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Traver, N. Chi, J. Witztum, R. Klemke, D. Yelon, T. Handel, K. Stoletov, W. Clements, C. Pouget, Z. Garavito-Aguilar, A. Ablooglu, R. Zhang, X. Yang, M. Angert, K. Pestonjamasp and J. Santini (University of California, San Diego), C. Hedrick, K. Ley, D. Sag, P. Sundd and A. Wu (La Jolla Institute for Allergy and Immunology), S. Trzaska (New York University), S. J. Du (University of Maryland), B. Schmid and C. Haass (Ludwig-Maximilians-University Munchen), D. Owen and A. Magenau (University of New South Wales), A. Siekmann (Max Planck Institute for Molecular Biomedicine) and C. Binder (Medical University of Vienna) for discussions, technical assistance and/or for providing reagents and access to equipment for this study. The project was supported by the NIH grants HL093767 (Y.I.M.), HL055798 (Y.I.M.) and HL114734 (L. F.), and the fellowship 18FT-0137 from the UC Tobacco-Related Disease Program (L. F.), as well as the UCSD Neuroscience Microscopy Facility Grant P30NS047101. The authors declare no conflicts of interests.	Archer A, 2008, DEV DYNAM, V237, P1090, DOI 10.1002/dvdy.21476; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Avraham-Davidi I, 2012, NAT MED, V18, P967, DOI 10.1038/nm.2759; Bellacen Keren, 2009, J Vis Exp, DOI 10.3791/1564; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Fang LH, 2010, J BIOL CHEM, V285, P32343, DOI 10.1074/jbc.M110.137257; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Gao F, 2011, INTEGR BIOL-UK, V3, P479, DOI 10.1039/c0ib00147c; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liao WX, 2009, MOL ENDOCRINOL, V23, P1428, DOI 10.1210/me.2008-0475; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Noghero A, 2012, ARTERIOSCL THROM VAS, V32, P2280, DOI 10.1161/ATVBAHA.112.250621; O'Connell BJ, 2004, CIRCULATION, V110, P2881, DOI 10.1161/01.CIR.0000146333.20727.2B; Oshikawa J, 2012, AM J PHYSIOL-HEART C, V302, pH724, DOI 10.1152/ajpheart.00739.2011; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Ritter M, 2002, GENOMICS, V79, P693, DOI 10.1006/geno.2002.6761; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schwend T, 2011, J LIPID RES, V52, P1328, DOI 10.1194/jlr.M012377; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	42	132	138	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					118	+		10.1038/nature12166	http://dx.doi.org/10.1038/nature12166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23719382	Green Accepted			2022-12-28	WOS:000319947800045
J	Hepworth, MR; Monticelli, LA; Fung, TC; Ziegler, CGK; Grunberg, S; Sinha, R; Mantegazza, AR; Ma, HL; Crawford, A; Angelosanto, JM; Wherry, EJ; Koni, PA; Bushman, FD; Elson, CO; Eberl, G; Artis, D; Sonnenberg, GF				Hepworth, Matthew R.; Monticelli, Laurel A.; Fung, Thomas C.; Ziegler, Carly G. K.; Grunberg, Stephanie; Sinha, Rohini; Mantegazza, Adriana R.; Ma, Hak-Ling; Crawford, Alison; Angelosanto, Jill M.; Wherry, E. John; Koni, Pandelakis A.; Bushman, Frederic D.; Elson, Charles O.; Eberl, Gerard; Artis, David; Sonnenberg, Gregory F.			Innate lymphoid cells regulate CD4(+) T-cell responses to intestinal commensal bacteria	NATURE			English	Article							TISSUE HOMEOSTASIS; ACTIVATION; IDENTITY; FATE	Innate lymphoid cells (ILCs) are a recently characterized family of immune cells that have critical roles in cytokine-mediated regulation of intestinal epithelial cell barrier integrity(1-10). Alterations in ILC responses are associated with multiple chronic human diseases, including inflammatory bowel disease, implicating a role for ILCs in disease pathogenesis(3,8,11-13). Owing to an inability to target ILCs selectively, experimental studies assessing ILC function have predominantly used mice lacking adaptive immune cells(1-10). However, in lymphocyte-sufficient hosts ILCs are vastly outnumbered by CD4(+) T cells, which express similar profiles of effector cytokines. Therefore, the function of ILCs in the presence of adaptive immunity and their potential to influence adaptive immune cell responses remain unknown. To test this, we used genetic or antibody-mediated depletion strategies to target murine ILCs in the presence of an adaptive immune system. We show that loss of retinoic-acid-receptor-related orphan receptor-gamma t-positive (ROR gamma t(+)) ILCs was associated with dysregulated adaptive immune cell responses against commensal bacteria and low-grade systemic inflammation. Remarkably, ILC-mediated regulation of adaptive immune cells occurred independently of interleukin (IL)-17A, IL-22 or IL-23. Genome-wide transcriptional profiling and functional analyses revealed that ROR gamma t(+) ILCs express major histocompatibility complex class II (MHCII) and can process and present antigen. However, rather than inducing T-cell proliferation, ILCs acted to limit commensal bacteria-specific CD4(+) T-cell responses. Consistent with this, selective deletion of MHCII in murine ROR gamma t(+) ILCs resulted in dysregulated commensal bacteria-dependent CD4(+) T-cell responses that promoted spontaneous intestinal inflammation. These data identify that ILCs maintain intestinal homeostasis through MHCII-dependent interactions with CD4(+) T cells that limit pathological adaptive immune cell responses to commensal bacteria.	[Hepworth, Matthew R.; Fung, Thomas C.; Sonnenberg, Gregory F.] Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Hepworth, Matthew R.; Monticelli, Laurel A.; Fung, Thomas C.; Crawford, Alison; Angelosanto, Jill M.; Wherry, E. John; Artis, David; Sonnenberg, Gregory F.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Monticelli, Laurel A.; Fung, Thomas C.; Grunberg, Stephanie; Sinha, Rohini; Crawford, Alison; Angelosanto, Jill M.; Wherry, E. John; Bushman, Frederic D.; Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Ziegler, Carly G. K.] Mem Sloan Kettering Canc Ctr, ImmunoDynam Grp, Program Computat Biol, New York, NY 10065 USA; [Ziegler, Carly G. K.] Mem Sloan Kettering Canc Ctr, ImmunoDynam Grp, Program Immunol, New York, NY 10065 USA; [Mantegazza, Adriana R.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mantegazza, Adriana R.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Ma, Hak-Ling] Pfizer Worldwide R&D, Biotherapeut Res & Dev, Inflammat & Immunol Res Unit, Cambridge, MA 02140 USA; [Koni, Pandelakis A.] Georgia Hlth Sci Univ, Ctr Canc, Canc Immunol Inflammat & Tolerance Program, Augusta, GA 30912 USA; [Elson, Charles O.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France; [Eberl, Gerard] CNRS, URA 1961, F-75724 Paris, France; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pfizer; University System of Georgia; Augusta University; University of Alabama System; University of Alabama Birmingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Pennsylvania	Sonnenberg, GF (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	gfield@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; crawford, alison/AAS-3155-2020; Eberl, Gerard/A-1160-2013; Crawford, Alison/N-3234-2014	Ziegler, Carly/0000-0002-8279-7150; Koni, Pandelakis/0000-0002-0892-4764; Hepworth, Matthew/0000-0002-9613-7858; Bushman, Frederic/0000-0003-4740-4056; Mantegazza, Adriana/0000-0002-7583-0231; Eberl, Gerard/0000-0002-1119-5638; Crawford, Alison/0000-0002-4591-6341; Artis, David/0000-0002-1753-4100	National Institutes of Health [AI061570, AI087990, AI074878, AI095776, AI102942, AI095466, AI095608, AI097333, T32-AI055428, DK071176, DP5OD012116]; Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund; NCI Comprehensive Cancer Center [2-P30 CA016520]; National Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095776, R01AI061570, R01AI097333, R21AI087990, R21AI083480, U01AI095608, R01AI102942, R01AI074878, T32AI055428, R01AI095466, T32AI007532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, P01DK071176] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NCI Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Sonnenberg and Artis laboratories for discussions and critical reading of the manuscript. We also thank H. L. Ma, L. A. Fouser, S. Olland, R. Zollner, K. Lam and A. Root at Pfizer for critical discussions, valuable advice and the preparation of IL-22 antibodies; M. M. Elloso at Janssen Research and Development for critical discussions, valuable advice and the preparation of IL-17 and IL-23 antibodies; and M. S. Marks for providing the E-alpha protein and Y-Ae antibody. The research is supported by the National Institutes of Health (AI061570, AI087990, AI074878, AI095776, AI102942, AI095466, AI095608 and AI097333 to D. A.; T32-AI055428 to L. A. M.; DK071176 to C.O.E.; and DP5OD012116 to G. F. S.), the Crohn's and Colitis Foundation of America (to D. A.) and the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (to D. A.). We also thank the Matthew J. Ryan Veterinary Hospital Pathology Lab, the National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core (P30DK50306), the Penn Microarray Facility and the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory (partially supported by NCI Comprehensive Cancer Center Support Grant (2-P30 CA016520)) for technical advice and support. Human tissue samples were provided by the Cooperative Human Tissue Network, which is funded by the National Cancer Institute.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Ciccia F, 2012, ARTHRITIS RHEUM-US, V64, P1869, DOI 10.1002/art.34355; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	32	491	516	2	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					113	+		10.1038/nature12240	http://dx.doi.org/10.1038/nature12240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23698371	Green Accepted			2022-12-28	WOS:000319947800044
J	Milde, P; Kohler, D; Seidel, J; Eng, LM; Bauer, A; Chacon, A; Kindervater, J; Muhlbauer, S; Pfleiderer, C; Buhrandt, S; Schutte, C; Rosch, A				Milde, P.; Koehler, D.; Seidel, J.; Eng, L. M.; Bauer, A.; Chacon, A.; Kindervater, J.; Muehlbauer, S.; Pfleiderer, C.; Buhrandt, S.; Schuette, C.; Rosch, A.			Unwinding of a Skyrmion Lattice by Magnetic Monopoles	SCIENCE			English	Article							NON-FERMI-LIQUID; REAL-SPACE OBSERVATION; CHIRAL MAGNET; SPIN ICE; MNSI; FERROMAGNETS	Skyrmion crystals are regular arrangements of magnetic whirls that exist in a wide range of chiral magnets. Because of their topology, they cannot be created or destroyed by smooth rearrangements of the direction of the local magnetization. Using magnetic force microscopy, we tracked the destruction of the skyrmion lattice on the surface of a bulk crystal of Fe1-xCoxSi (x = 0.5). Our study revealed that skyrmions vanish by a coalescence, forming elongated structures. Numerical simulations showed that changes of topology are controlled by singular magnetic point defects. They can be viewed as quantized magnetic monopoles and antimonopoles, which provide sources and sinks of one flux quantum of emergent magnetic flux, respectively.	[Milde, P.; Koehler, D.; Eng, L. M.] Tech Univ Dresden, Inst Angew Photophys, D-01069 Dresden, Germany; [Seidel, J.] Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia; [Bauer, A.; Chacon, A.; Kindervater, J.; Pfleiderer, C.] Tech Univ Munich, Phys Dept E21, D-85748 Garching, Germany; [Muehlbauer, S.] Tech Univ Munich, Forsch Neutronenquelle Heinz Maier Leibnitz, D-85747 Garching, Germany; [Buhrandt, S.; Schuette, C.; Rosch, A.] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany	Technische Universitat Dresden; University of New South Wales Sydney; Technical University of Munich; Technical University of Munich; University of Cologne	Milde, P (corresponding author), Tech Univ Dresden, Inst Angew Photophys, D-01069 Dresden, Germany.	peter.milde@iapp.de	Pfleiderer, Christian/P-3575-2014; Milde, Peter/AAT-5370-2020; Seidel, Jan/AAD-9920-2020; Rosch, Achim/AAY-7730-2020; Rosch, Achim/A-2962-2009	Pfleiderer, Christian/0000-0001-7749-7965; Milde, Peter/0000-0002-6844-0905; Seidel, Jan/0000-0003-2814-3241; Rosch, Achim/0000-0002-6586-5721; Rosch, Achim/0000-0002-6586-5721; Bauer, Andreas/0000-0002-1070-9748	European Research Council [AdG 291079]; Deutsche Forschungsgemeinschaft (DFG) [SFB 608, SFB TR 12, SFB TR 80]; TUM Graduate School; Bonn-Cologne Graduate School of Physics and Astronomy (BCGS); DFG [RIG 1401/2]; Australian Research Council [FT110100523]; Emmy-Noether group (DFG)	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); TUM Graduate School; Bonn-Cologne Graduate School of Physics and Astronomy (BCGS); DFG(German Research Foundation (DFG)); Australian Research Council(Australian Research Council); Emmy-Noether group (DFG)(German Research Foundation (DFG))	We. thank R. Bamler, P. Boni, K. Everschor, L Fritz, M. Garst, R. Georgii, S. Mayr, and the team of FRM II, and, especially, D. Meier. We are grateful to B. Pedersen for checking the orientation of our sample on the diffractometer HEIDI at FRM II. Financial support through European Research Council AdG 291079 (TOPFIT) and through SFB 608, SFB TR 12, and SFB TR 80 of the Deutsche Forschungsgemeinschaft (DFG) is gratefully acknowledged. A.B. A.C., and J.K. acknowledge support through the TUM Graduate School, S.B. and C.S. through the Bonn-Cologne Graduate School of Physics and Astronomy (BCGS), D.K. through RIG 1401/2 (DFG), J.S. by the Australian Research Council through a Future Fellowship (FT110100523), and S.B. through the Emmy-Noether group (DFG) of L. Fritz.	Adams T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237204; [Anonymous], 2007, PRINCIPLES CONDENSED; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Dirac PAM, 1931, P R SOC LOND A-CONTA, V133, P60, DOI 10.1098/rspa.1931.0130; Jonietz F, 2010, SCIENCE, V330, P1648, DOI 10.1126/science.1195709; Manton N.S., 2004, TOPOLOGICAL SOLITONS; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Munzer W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041203; Neubauer A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186602; Pfleiderer C, 2004, NATURE, V427, P227, DOI 10.1038/nature02232; Pfleiderer C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/16/164207; Pfleiderer C, 2001, NATURE, V414, P427, DOI 10.1038/35106527; Ritz R, 2013, NATURE, V497, P231, DOI 10.1038/nature12023; Schulz T, 2012, NAT PHYS, V8, P301, DOI [10.1038/NPHYS2231, 10.1038/nphys2231]; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; Tonomura A, 2012, NANO LETT, V12, P1673, DOI 10.1021/nl300073m; VOLOVIK GE, 1987, J PHYS C SOLID STATE, V20, pL83, DOI 10.1088/0022-3719/20/7/003; Yu XZ, 2011, NAT MATER, V10, P106, DOI 10.1038/nmat2916; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; Yu XZ, 2012, P NATL ACAD SCI USA, V109, P8856, DOI 10.1073/pnas.1118496109; Zang JD, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.136804; Zhang SF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086601	23	393	394	15	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1076	1080		10.1126/science.1234657	http://dx.doi.org/10.1126/science.1234657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723232				2022-12-28	WOS:000319664500039
J	Sharon, M				Sharon, Michal			Structural MS Pulls Its Weight	SCIENCE			English	Editorial Material							IONIZATION-MASS-SPECTROMETRY; PROTEIN COMPLEXES; ARCHITECTURE		Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Sharon, M (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	michal.sharon@weizmann.ac.il		Sharon, Michal/0000-0003-3933-0595				Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Ben-Nissan G, 2011, CHEM SOC REV, V40, P3627, DOI 10.1039/c1cs15052a; Dyachenko A, 2013, P NATL ACAD SCI USA, V110, P7235, DOI 10.1073/pnas.1302395110; Ferguson CN, 2011, ANAL CHEM, V83, P6468, DOI 10.1021/ac201390w; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Mellors JS, 2010, ANAL CHEM, V82, P967, DOI 10.1021/ac902218y; Rosati S, 2012, ANGEW CHEM INT EDIT, V51, P12992, DOI 10.1002/anie.201206745; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/NMETH.2208, 10.1038/nmeth.2208]; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; Urban PL, 2011, ANAL CHEM, V83, P1843, DOI 10.1021/ac102702m; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148	15	50	50	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1059	1060		10.1126/science.1236303	http://dx.doi.org/10.1126/science.1236303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723227				2022-12-28	WOS:000319664500032
J	Goodnough, LT				Goodnough, Lawrence T.			Blood management: transfusion medicine comes of age	LANCET			English	Editorial Material							ANEMIA		[Goodnough, Lawrence T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Goodnough, Lawrence T.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Goodnough, LT (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	ltgoodno@stanford.edu						[Anonymous], 2012, NY TIMES; Despotis GJ, 1997, CLIN CHEM, V43, P1684; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Goodnough LT, 2013, ANESTH ANALG, V116, P15, DOI 10.1213/ANE.0b013e318273f4ae; Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3; Goodnough LT, 2011, BLOOD, V117, P6091, DOI 10.1182/blood-2010-11-316075; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; McCullough J, 2010, TRANSFUSION, V50, P2542, DOI 10.1111/j.1537-2995.2010.02787.x; Murphy WG, 2012, TRANSFUSION, V52, P2278, DOI 10.1111/j.1537-2995.2012.03931.x; Pattakos G, 2012, ARCH INTERN MED, V172, P1154, DOI 10.1001/archinternmed.2012.2449; Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x; Salisbury AC, 2011, ARCH INTERN MED, V171, P1646, DOI 10.1001/archinternmed.2011.361; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; The Joplin Globe, DECL NEED BLOOD LEAD; US Food and Drug Administration, FAT REP FDA FOLL BLO; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; World Health Organization (WHO), 63 WORLD HLTH ASS AV; ZUCK TF, 1990, ARCH PATHOL LAB MED, V114, P309	18	53	55	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1791	1792		10.1016/S0140-6736(13)60673-X	http://dx.doi.org/10.1016/S0140-6736(13)60673-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151EO	23706789	Green Published, Bronze			2022-12-28	WOS:000319443700004
J	Shapiro, L; Losick, R				Shapiro, Lucy; Losick, Richard			Francois Jacob (1920-2013)	SCIENCE			English	Biographical-Item									[Shapiro, Lucy] Stanford Univ, Stanford, CA 94305 USA; [Losick, Richard] Harvard Univ, Biol Labs, Cambridge, MA 02138 USA	Stanford University; Harvard University	Shapiro, L (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	shapiro@stanford.edu; losick@mcb.harvard.edu						JACOB F, PUBLICATION LIST	1	1	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					939	939		10.1126/science.1239975	http://dx.doi.org/10.1126/science.1239975			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704565				2022-12-28	WOS:000319344100035
J	Bender, SL; Sherry, NA; Masia, R				Bender, Suzanne L.; Sherry, Nicole A.; Masia, Ricard			Case 16-2013: A 12-Year-Old Girl with Irritability, Hypersomnia, and Somatic Symptoms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; SSRI-RESISTANT DEPRESSION; SUBJECTIVE HEALTH-STATUS; CELIAC-DISEASE; DEHYDROEPIANDROSTERONE REPLACEMENT; ADRENAL INSUFFICIENCY; ADDISONS-DISEASE; MENTAL-DISORDERS; ITALIAN PATIENTS; ADOLESCENTS		[Bender, Suzanne L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sherry, Nicole A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Masia, Ricard] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bender, Suzanne L.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Sherry, Nicole A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Masia, Ricard] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bender, SL (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.				MacroGenics; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK065522] Funding Source: NIH RePORTER	MacroGenics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Sherry reports receiving consulting fees and grant support through her institution from MacroGenics. No other potential conflict of interest relevant to this article was reported.	AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114; Alkatib AA, 2009, J CLIN ENDOCR METAB, V94, P3676, DOI 10.1210/jc.2009-0672; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2011, ANT MED CHILDR AD IN; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; BARRICKMAN LL, 1995, J AM ACAD CHILD PSY, V34, P649, DOI 10.1097/00004583-199505000-00017; Benazzi F, 2009, PROG NEURO-PSYCHOPH, V33, P86, DOI 10.1016/j.pnpbp.2008.10.007; Betterle C, 2006, EUR J ENDOCRINOL, V154, P275, DOI 10.1530/eje.1.02089; Biagi F, 2006, SCAND J GASTROENTERO, V41, P302, DOI 10.1080/00365520500206517; Birmaher B, 2007, J AM ACAD CHILD PSY, V46, P1503, DOI 10.1097/chi.0b013e318145ae1c; Bleicken B, 2010, AM J MED SCI, V339, P525, DOI 10.1097/MAJ.0b013e3181db6b7a; Braaten E, 2004, STRAIGHT TALK PSYCHO, P151; Brent D, 2008, JAMA-J AM MED ASSOC, V299, P901, DOI 10.1001/jama.299.8.901; Brent DA, 2009, AM J PSYCHIAT, V166, P418, DOI 10.1176/appi.ajp.2008.08070976; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Campo JV, 2007, ARCH PEDIAT ADOL MED, V161, P131, DOI 10.1001/archpedi.161.2.131; Campo JV, 1999, J AM ACAD CHILD PSY, V38, P1093, DOI 10.1097/00004583-199909000-00012; Choe CJ, 2012, CHILD ADOL PSYCH CL, V21, P807, DOI 10.1016/j.chc.2012.07.002; Drossman DA, 1999, GUT, V45, P1; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; Elsenbruch S, 2011, BRAIN BEHAV IMMUN, V25, P386, DOI 10.1016/j.bbi.2010.11.010; Forty L, 2008, BRIT J PSYCHIAT, V192, P388, DOI 10.1192/bjp.bp.107.045294; Garcia-Manzanares A, 2011, NUTR CLIN PRACT, V26, P163, DOI 10.1177/0884533611399773; GELLER B, 1994, J AM ACAD CHILD PSY, V33, P461, DOI 10.1097/00004583-199405000-00003; Geringer ES, 2012, IRWIN RIPPES INTENSI, P2087; Gurnell EM, 2008, J CLIN ENDOCR METAB, V93, P400, DOI 10.1210/jc.2007-1134; Hahner S, 2007, J CLIN ENDOCR METAB, V92, P3912, DOI 10.1210/jc.2007-0685; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; Hughes CW, 2007, J AM ACAD CHILD PSY, V46, P667, DOI 10.1097/chi.0b013e31804a859b; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; Koloski NA, 2012, GUT, V61, P1284, DOI 10.1136/gutjnl-2011-300474; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; Lovas K, 2002, CLIN ENDOCRINOL, V56, P581, DOI 10.1046/j.1365-2265.2002.01466.x; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; March JS, 2008, ARCH GEN PSYCHIAT, V65, P723, DOI 10.1001/archpsyc.65.6.723-b; March JS, 2007, ARCH GEN PSYCHIAT, V64, P1132; Myhre AG, 2003, SCAND J GASTROENTERO, V38, P511, DOI 10.1080/00365520310002544; O'Leary C, 2002, QJM-INT J MED, V95, P79, DOI 10.1093/qjmed/95.2.79; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Palermo TM, 2010, PAIN, V148, P387, DOI 10.1016/j.pain.2009.10.004; Pynnonen PA, 2004, PSYCHOSOMATICS, V45, P325, DOI 10.1176/appi.psy.45.4.325; ROHDE P, 1991, J ABNORM PSYCHOL, V100, P214, DOI 10.1037/0021-843X.100.2.214; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Vitiello B, 2011, J CLIN PSYCHIAT, V72, P388, DOI 10.4088/JCp.09m05885blu; WASSERMAN AL, 1988, J AM ACAD CHILD PSY, V27, P179, DOI 10.1097/00004583-198803000-00008; Weissman MM, 2005, ARCH GEN PSYCHIAT, V62, P29, DOI 10.1001/archpsyc.62.1.29; Weisz JR, 2006, PSYCHOL BULL, V132, P132, DOI 10.1037/0033-2909.132.1.132	48	5	5	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					2015	2024		10.1056/NEJMcpc1208145	http://dx.doi.org/10.1056/NEJMcpc1208145			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148TJ	23697517	Green Accepted			2022-12-28	WOS:000319270200005
J	Saunders, A; Ashe, HL				Saunders, Abbie; Ashe, Hilary L.			Taking a Pause to Reflect on Morphogenesis	CELL			English	Editorial Material							DROSOPHILA; PROMOTERS; ROLES		[Saunders, Abbie; Ashe, Hilary L.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Ashe, HL (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	hilary.ashe@manchester.ac.uk						Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Ghosh SKB, 2011, MOL CELL BIOL, V31, P4232, DOI 10.1128/MCB.05930-11; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lagha M, 2013, CELL, V153, P976, DOI 10.1016/j.cell.2013.04.045; Lis J., 1998, S QUANT BIOL, V63, P347; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Saunders A, 2013, GENE DEV, V27, P1146, DOI 10.1101/gad.215459.113	10	3	3	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					941	943		10.1016/j.cell.2013.05.009	http://dx.doi.org/10.1016/j.cell.2013.05.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706731	Bronze			2022-12-28	WOS:000319456800002
J	Baggett, TP				Baggett, Travis P.			The Proud Paratrooper	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Baggett, Travis P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med,Dept Med, Boston, MA 02114 USA; [Baggett, Travis P.] Boston Hlth Care Homeless Program, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Baggett, TP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med,Dept Med, Boston, MA 02114 USA.	tbaggett@partners.org							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2109	2110		10.1001/jama.2013.3044	http://dx.doi.org/10.1001/jama.2013.3044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23695481				2022-12-28	WOS:000319229600026
J	Doig, GS; Simpson, F; Sweetman, EA; Finfer, SR; Cooper, DJ; Heighes, PT; Davies, AR; O'Leary, M; Solano, T; Peake, S				Doig, Gordon S.; Simpson, Fiona; Sweetman, Elizabeth A.; Finfer, Simon R.; Cooper, D. Jamie; Heighes, Philippa T.; Davies, Andrew R.; O'Leary, Michael; Solano, Tom; Peake, Sandra		Early PN Investigators ANZICS Clin	Early Parenteral Nutrition in Critically Ill Patients With Short-term Relative Contraindications to Early Enteral Nutrition A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIALS; GUIDELINES; MORTALITY; THERAPY; QUALITY; HUMANS; ADULTS; DISUSE	Importance Systematic reviews suggest adult patients in intensive care units (ICUs) with relative contraindications to early enteral nutrition (EN) may benefit from parenteral nutrition (PN) provided within 24 hours of ICU admission. Objective To determine whether providing early PN to critically ill adults with relative contraindications to early EN alters outcomes. Design, Setting, and Participants Multicenter, randomized, single-blind clinical trial conducted between October 2006 and June 2011 in ICUs of 31 community and tertiary hospitals in Australia and New Zealand. Participants were critically ill adults with relative contraindications to early EN who were expected to remain in the ICU longer than 2 days. Interventions Random allocation to pragmatic standard care or early PN. Main Outcomes and Measures Day-60 mortality; quality of life, infections, and body composition. Results A total of 1372 patients were randomized (686 to standard care, 686 to early PN). Of 682 patients receiving standard care, 199 patients (29.2%) initially commenced EN, 186 patients (27.3%) initially commenced PN, and 278 patients (40.8%) remained unfed. Time to EN or PN in patients receiving standard care was 2.8 days (95% CI, 2.3 to 3.4). Patients receiving early PN commenced PN a mean of 44 minutes after enrollment (95% CI, 36 to 55). Day-60 mortality did not differ significantly (22.8% for standard care vs 21.5% for early PN; risk difference, -1.26%; 95% CI, -6.6 to 4.1; P=.60). Early PN patients rated day-60 quality of life (RAND-36 General Health Status) statistically, but not clinically meaningfully, higher (45.5 for standard care vs 49.8 for early PN; mean difference, 4.3; 95% CI, 0.95 to 7.58; P=.01). Early PN patients required fewer days of invasive ventilation (7.73 vs 7.26 days per 10 patient x ICU days, risk difference, -0.47; 95% CI, -0.82 to -0.11; P=.01) and, based on Subjective Global Assessment, experienced less muscle wasting (0.43 vs 0.27 score increase per week; mean difference, -0.16; 95% CI, -0.28 to -0.038; P=.01) and fat loss (0.44 vs 0.31 score increase per week; mean difference, -0.13; 95% CI, -0.25 to -0.01; P=.04). Conclusions and Relevance The provision of early PN to critically ill adults with relative contraindications to early EN, compared with standard care, did not result in a difference in day-60 mortality. The early PN strategy resulted in significantly fewer days of invasive ventilation but not significantly shorter ICU or hospital stays.	[Doig, Gordon S.; Simpson, Fiona; Sweetman, Elizabeth A.; Heighes, Philippa T.] Univ Sydney, Northern Clin Sch, Intens Care Res Unit, Sydney, NSW 2006, Australia; [Finfer, Simon R.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Cooper, D. Jamie; Davies, Andrew R.] Alfred Hosp, Melbourne, Vic, Australia; [O'Leary, Michael] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Solano, Tom] Westmead Hosp, Sydney, NSW, Australia; [Peake, Sandra] Queen Elizabeth Hosp, Adelaide, SA, Australia	University of Sydney; George Institute for Global Health; University of Sydney; Florey Institute of Neuroscience & Mental Health; University of Sydney; University of Sydney	Doig, GS (corresponding author), Royal N Shore Hosp, Intens Care Unit, Pacific Hwy, St Leonards, NSW 2065, Australia.	gdoig@med.usyd.edu.au	O'Leary, Michael/S-8980-2019; Cooper, D. James/G-7961-2013	Cooper, D. James/0000-0002-5872-9051; Hammond, Naomi/0000-0002-6559-7747; /0000-0002-4157-5148; Finfer, Simon/0000-0002-2785-5864; SHEHABI, Yahya/0000-0003-4707-7462; Knowles, Serena/0000-0002-5028-3825; Doig, Gordon/0000-0003-2141-7000; Rye, Peter/0000-0002-9085-2092; Simpson, Fiona/0000-0002-4598-2488; Micallef, Sharon/0000-0002-8496-2324	Fresenius Kabi Deutschland; Baxter Healthcare; Nestle Nutrition; Pfizer; Astra; Fresenius Kabi Australia; Esai; Eli Lilly; Australian National Health and Medical Research Council (NHMRC)	Fresenius Kabi Deutschland; Baxter Healthcare; Nestle Nutrition(Nestle SA); Pfizer(Pfizer); Astra; Fresenius Kabi Australia; Esai; Eli Lilly(Eli Lilly); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Doig reported receiving academic research grants from Fresenius Kabi Deutschland and Baxter Healthcare; consulting fees from Nestle Nutrition, Fresenius Kabi Deutschland, and Baxter Healthcare; speakers' honoraria from Nestle Nutrition, Baxter Healthcare, and Fresenius Kabi Deutschland; and travel support from Fresenius Kabi Deutschland, Baxter Healthcare, and Nestle Nutrition. Ms Simpson reported receiving academic research grants from Fresenius Kabi Deutschland and Baxter Healthcare, speakers' honoraria from Fresenius Kabi, and travel support from Fresenius Kabi Deutschland and Baxter Healthcare. Dr Solano reported receiving consulting fees from Pfizer and Astra and conference attendance support from Pfizer. Dr Finfer reported receiving academic research grants from Fresenius Kabi Deutschland and Fresenius Kabi Australia and consultancy fees from Esai and Eli Lilly. Ms Heighes reported receiving academic research grants and travel support from Fresenius Kabi Deutschland and Baxter Healthcare. Dr O'Leary reported receiving speakers' honoraria from Baxter Healthcare. Ms Sweetman reported receiving academic research grants from Fresenius Kabi Deutschland and Baxter Healthcare. No other disclosures were reported.; This work was supported by a peer-reviewed academic grant from the Australian National Health and Medical Research Council (NH&MRC) and unrestricted academic grants from Fresenius Kabi Deutschland and Baxter Healthcare. Fresenius Kabi Australia supplied the study parenteral nutrition.	[Anonymous], EARL PN TRIAL HARR B; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bender R, 2010, CONTEMP CLIN TRIALS, V31, P498, DOI 10.1016/j.cct.2010.07.005; Bernard GR, 1995, AM J RESP CRIT CARE, V151, pA323; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Casaer MP, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-21; Cohen J, 2004, CRIT CARE MED, V32, P1510, DOI [10.1097/01.CCM.0000129973.13104.2D, 10.1097/01.CCM.0000145917.89975.F5]; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Doig GS, 2008, JAMA-J AM MED ASSOC, V300, P2731, DOI 10.1001/jama.2008.826; Doig GS, STAT ANAL PLAN MULTI; DUDRICK SJ, 1968, SURGERY, V64, P134; Dudrick SJ, 2003, JPEN-PARENTER ENTER, V27, P291, DOI 10.1177/0148607103027004291; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Heyland DK, 2008, JPEN-PARENTER ENTER, V32, P486, DOI 10.1177/0148607108320659; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Jaber S, 2011, CRIT CARE, V15, DOI 10.1186/cc10023; Kelsey JL, 1986, METHODS OBSERVATIONA, P254; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Marik PE, 2011, CRIT CARE MED, V39, P1536, DOI 10.1097/CCM.0b013e318218542c; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Meijer Alfred J., 2008, V445, P89, DOI 10.1007/978-1-59745-157-4_5; Monk DN, 1996, ANN SURG, V223, P395, DOI 10.1097/00000658-199604000-00008; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; PINGLETON S K, 1987, Journal of the American Medical Association, V257, P3094, DOI 10.1001/jama.257.22.3094; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Simpson F, ANTHROPOMETRIC PROCE; Simpson F, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-17; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; van Nieuwenhoven CA, 2001, JAMA-J AM MED ASSOC, V286, P335, DOI 10.1001/jama.286.3.335; Walters SJ, 2009, PHARM STAT, V8, P163, DOI 10.1002/pst.334; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zubrod C.G., 1960, J CHRON DIS, V11, P7	38	329	359	3	58	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2130	2138		10.1001/jama.2013.5124	http://dx.doi.org/10.1001/jama.2013.5124			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23689848	Bronze			2022-12-28	WOS:000319229600029
J	Hankey, GJ				Hankey, Graeme J.			Adding endovascular therapy to t-PA did not improve 90-day survival or functional independence after stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE ISCHEMIC-STROKE; TRIAL		Univ Western Australia, Perth, WA 6009, Australia	University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Perth, WA 6009, Australia.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC12	10.7326/0003-4819-158-10-201305210-02012	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689779				2022-12-28	WOS:000319666200011
J	Noorduin, WL; Grinthal, A; Mahadevan, L; Aizenberg, J				Noorduin, Wim L.; Grinthal, Alison; Mahadevan, L.; Aizenberg, Joanna			Rationally Designed Complex, Hierarchical Microarchitectures	SCIENCE			English	Article							SILICA; CARBONATE; CRYSTALS; REDUCTION; CHEMISTRY; ARAGONITE; SURFACES; KINETICS; GROWTH	The emergence of complex nano- and microstructures is of fundamental interest, and the ability to program their form has practical ramifications in fields such as optics, catalysis, and electronics. We developed carbonate-silica microstructures in a dynamic reaction-diffusion system that allow us to rationally devise schemes for precisely sculpting a great variety of elementary shapes by diffusion of carbon dioxide (CO2) in a solution of barium chloride and sodium metasilicate. We identify two distinct growth modes and show how continuous and discrete modulations in CO2 concentration, pH, and temperature can be used to deterministically switch between different regimes and create a bouquet of hierarchically assembled multiscale microstructures with unprecedented levels of complexity and precision. These results outline a nanotechnology strategy for "collaborating" with self-assembly processes in real time to build arbitrary tectonic architectures.	[Noorduin, Wim L.; Grinthal, Alison; Mahadevan, L.; Aizenberg, Joanna] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Mahadevan, L.; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Mahadevan, L.; Aizenberg, Joanna] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Aizenberg, Joanna] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Harvard University	Noorduin, WL (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	wnoord@seas.harvard.edu; jaiz@seas.harvard.edu			NSF Materials Research Science and Engineering Centers [DMR-0820484]; Netherlands Organization for Scientific Research; NSF [ECS-0335765]	NSF Materials Research Science and Engineering Centers(National Science Foundation (NSF)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NSF(National Science Foundation (NSF))	We thank J. C. Weaver for advice with the SEM imaging, S. K. Y. Tang and R. Sadza for the microfluidic experiments, L. Hendriks for growing the structures in Fig. 5F, and A. J. Aizenberg for help with the manuscript. This work was supported by the NSF Materials Research Science and Engineering Centers under award no. DMR-0820484. W.L.N. thanks the Netherlands Organization for Scientific Research for financial support. EM was performed at Harvard's Center for Nanoscale Systems, supported by the NSF under award no. ECS-0335765.	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Ball P, 1999, SELF MADE TAPESTRY P; Bao ZH, 2007, NATURE, V446, P172, DOI 10.1038/nature05570; Berg H C, 2003, E COLI MOTION; Brinker C.J., 1990, SOL GEL SCI, DOI [10.1016/B978-0-08-057103-4.50013-1, DOI 10.1016/C2009-0-22386-5]; Cartwright JHE, 2002, J COLLOID INTERF SCI, V256, P351, DOI 10.1006/jcis.2002.8620; Chu KH, 2010, NAT MATER, V9, P413, DOI [10.1038/nmat2726, 10.1038/NMAT2726]; ERTL G, 1991, SCIENCE, V254, P1750, DOI 10.1126/science.254.5039.1750; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Garcia-Ruiz JM, 2009, SCIENCE, V323, P362, DOI 10.1126/science.1165349; GARCIARUIZ JM, 1981, J CRYST GROWTH, V55, P379, DOI 10.1016/0022-0248(81)90038-5; Ge J, 2012, NAT NANOTECHNOL, V7, P428, DOI [10.1038/NNANO.2012.80, 10.1038/nnano.2012.80]; Gower LA, 1998, J CRYST GROWTH, V191, P153, DOI 10.1016/S0022-0248(98)00002-5; Grzybowski BA, 2009, CHEM MOTION; Harting P., 1872, Q J MICROSC SCI, V1872, P118; Kellermeier M, 2012, CHEM-EUR J, V18, P2272, DOI 10.1002/chem.201102407; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; LENGYEL I, 1991, SCIENCE, V251, P650, DOI 10.1126/science.251.4994.650; Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Lowenstam HA, 1989, BIOMINERALIZATION; Madou M., 2002, FUNDAMENTALS MICROFA; MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; MARSHALL WL, 1980, GEOCHIM COSMOCHIM AC, V44, P915, DOI 10.1016/0016-7037(80)90281-1; Pagano JL, 2008, ANGEW CHEM INT EDIT, V47, P9900, DOI 10.1002/anie.200803203; Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c; Ritchie C, 2009, NAT CHEM, V1, P47, DOI [10.1038/NCHEM.113, 10.1038/nchem.113]; SIMS SD, 1995, J CHEM SOC CHEM COMM, P1031, DOI 10.1039/c39950001031; Terada T, 2003, J CRYST GROWTH, V253, P435, DOI 10.1016/S0022-0248(03)01008-X; Thompson D.W, 1917, GROWTH FORM; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Whitesides GM, 1999, SCIENCE, V284, P89, DOI 10.1126/science.284.5411.89; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Yu SH, 2005, NAT MATER, V4, P51, DOI 10.1038/nmat1263	38	264	265	11	680	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					832	837		10.1126/science.1234621	http://dx.doi.org/10.1126/science.1234621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687041	Green Submitted			2022-12-28	WOS:000318997400036
J	Vlieg, E				Vlieg, Elias			Complexity from Simplicity	SCIENCE			English	Editorial Material							CARBONATE; SILICA		Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands	Radboud University Nijmegen	Vlieg, E (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	e.vlieg@science.ru.nl	Vlieg, Elias/G-3386-2012	Vlieg, Elias/0000-0002-1343-4102				Algra RE, 2008, NATURE, V456, P369, DOI 10.1038/nature07570; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; Elemans JAAW, 2006, ADV MATER, V18, P1251, DOI 10.1002/adma.200502498; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Garcia-Ruiz JM, 2009, SCIENCE, V323, P362, DOI 10.1126/science.1165349; Ge J, 2012, NAT NANOTECHNOL, V7, P428, DOI [10.1038/NNANO.2012.80, 10.1038/nnano.2012.80]; Lehn JM, 2013, ANGEW CHEM INT EDIT, V52, P2836, DOI 10.1002/anie.201208397; Noorduin WL, 2013, SCIENCE, V340, P832, DOI 10.1126/science.1234621; Soukoulis CM, 2011, NAT PHOTONICS, V5, P523, DOI [10.1038/NPHOTON.2011.154, 10.1038/nphoton.2011.154]; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j	10	6	6	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					822	823		10.1126/science.1238619	http://dx.doi.org/10.1126/science.1238619			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687037				2022-12-28	WOS:000318997400031
J	Bhutta, ZA; Das, JK; Rizvi, A; Gaffey, MF; Walker, N; Horton, S; Webb, P; Lartey, A; Black, RE				Bhutta, Zulfiqar A.; Das, Jai K.; Rizvi, Arjumand; Gaffey, Michelle F.; Walker, Neff; Horton, Susan; Webb, Patrick; Lartey, Anna; Black, Robert E.		Lancet Nutr Interventions Review G; Maternal Child Nutr Study Grp	Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?	LANCET			English	Article							SEVERELY MALNOURISHED CHILDREN; FATTY-ACID SUPPLEMENTATION; MULTIPLE MICRONUTRIENT SUPPLEMENTATION; PREVENTIVE ZINC SUPPLEMENTATION; INDOOR AIR-POLLUTION; LOW-INCOME COUNTRIES; SOLID-FUEL USE; INTEGRATED MANAGEMENT; DOUBLE-BLIND; SYSTEMATIC ANALYSIS	Maternal undernutrition contributes to 800 000 neonatal deaths annually through small for gestational age births; stunting, wasting, and micronutrient deficiencies are estimated to underlie nearly 3.1 million child deaths annually. Progress has been made with many interventions implemented at scale and the evidence for effectiveness of nutrition interventions and delivery strategies has grown since The Lancet Series on Maternal and Child Undernutrition in 2008. We did a comprehensive update of interventions to address undernutrition and micronutrient deficiencies in women and children and used standard methods to assess emerging new evidence for delivery platforms. We modelled the effect on lives saved and cost of these interventions in the 34 countries that have 90% of the world's children with stunted growth. We also examined the effect of various delivery platforms and delivery options using community health workers to engage poor populations and promote behaviour change, access and uptake of interventions. Our analysis suggests the current total of deaths in children younger than 5 years can be reduced by 15% if populations can access ten evidence-based nutrition interventions at 90% coverage. Additionally, access to and uptake of iodised salt can alleviate iodine deficiency and improve health outcomes. Accelerated gains are possible and about a fifth of the existing burden of stunting can be averted using these approaches, if access is improved in this way. The estimated total additional annual cost involved for scaling up access to these ten direct nutrition interventions in the 34 focus countries is Int$9.6 billion per year. Continued investments in nutrition-specific interventions to avert maternal and child undernutrition and micronutrient deficiencies through community engagement and delivery strategies that can reach poor segments of the population at greatest risk can make a great difference. If this improved access is linked to nutrition-sensitive approaches-ie, women's empowerment, agriculture, food systems, education, employment, social protection, and safety nets-they can greatly accelerate progress in countries with the highest burden of maternal and child undernutrition and mortality.	[Bhutta, Zulfiqar A.; Das, Jai K.; Rizvi, Arjumand] Aga Khan Univ, Karachi 74800, Pakistan; [Gaffey, Michelle F.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Walker, Neff; Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Horton, Susan] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Webb, Patrick] Tufts Univ, Medford, MA 02155 USA; [Lartey, Anna] Univ Ghana, Accra, Ghana	Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Waterloo; Tufts University; University of Ghana	Bhutta, ZA (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu	Webb, Patrick/P-3420-2017	Webb, Patrick/0000-0002-9857-3354; Black, Robert/0000-0001-9926-7984; Das, Jai/0000-0002-2966-7162; Horton, Susan/0000-0002-9243-4767	Bill & Melinda Gates Foundation; Aga Khan University, Karachi, Pakistan; Program for Program for Global Pediatric Research, Global Child Health, Hospital for Sick Children (Toronto, ON, Canada)	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Aga Khan University, Karachi, Pakistan; Program for Program for Global Pediatric Research, Global Child Health, Hospital for Sick Children (Toronto, ON, Canada)	Funding for the preparation of the Series was provided to the Johns Hopkins Bloomberg School of Public Health through a grant from the Bill & Melinda Gates Foundation. The sponsor had no role in the analysis and interpretation of the evidence or in writing the paper and the decision to submit for publication. We thank the Aga Khan University, Karachi, Pakistan and the Program for Program for Global Pediatric Research, Global Child Health, Hospital for Sick Children (Toronto, ON, Canada) for support to ZAB during the course of this work.	Abdulwadud O. A., 2012, COCHRANE DB SYST REV, V3; Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Adu-Afarwuah S, 2008, AM J CLIN NUTR, V87, P929, DOI 10.1093/ajcn/87.4.929; Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; Ahmed HM, 2010, HEALTH POLICY, V96, P128, DOI 10.1016/j.healthpol.2010.01.013; Alderman H, HUNGER MALNUTRITION; Allen LH, 2009, J NUTR, V139, P1022, DOI 10.3945/jn.107.086199; Amorin Adegboye AR, 2012, COCHRANE DB SYST REV, V2; Amouzou A, 2010, INT J EPIDEMIOL, V39, P186, DOI 10.1093/ije/dyq034; [Anonymous], COCHRANE DATABASE SY; [Anonymous], 2012, GUID DAIL IR FOL AC; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Austin MP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005124.pub2; Awasthi S, 2013, LANCET, V381, P1469, DOI 10.1016/S0140-6736(12)62125-4; Bailey S., 2012, IMPACT CASH TRANSFER; Balogun Olukunmi O, 2016, Cochrane Database Syst Rev, V11, pCD001688; Basnet S, 2012, PEDIATRICS, V129, P701, DOI 10.1542/peds.2010-3091; Bhatnagar S, 2012, LANCET, V379, P2072, DOI 10.1016/S0140-6736(12)60477-2; Bhutta ZA, BMC PUBLIC IN PRESS; Bhutta ZA, BMC PUBLIC IN PRESS; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2013, LANCET, V381, P2207, DOI 10.1016/S0140-6736(12)61999-0; Bhutta ZA, 2012, LANCET, V380, P1125, DOI 10.1016/S0140-6736(12)61382-8; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown KH, 2009, FOOD NUTR BULL, V30, pS12, DOI 10.1177/15648265090301S103; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Carolan M, 2003, JOGNN-J OBST GYN NEO, V32, P19, DOI 10.1177/0884217502239797; Chinkhumba J, 2008, T ROY SOC TROP MED H, V102, P639, DOI 10.1016/j.trstmh.2008.04.028; Clar C, 2006, COCHRANE DB SYST REV, V3; Collins S, 2004, COMMUNITY BASED THER; Collins S, 2006, FOOD NUTR BULL, V27, pS49, DOI 10.1177/15648265060273S304; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Conde-Agudelo A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub2; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Cumming O, 2011, COCHRANE DB SYST REV, V3; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Dary O, 2012, PUBLIC HEALTH NUTR, V1, P1; Das J, BMC PUBLIC IN PRESS; Das RR, 2012, PAEDIATR RESPIR REV, V13, P184, DOI 10.1016/j.prrv.2012.01.004; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; De-Regil LM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009085.pub2; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Diaz-Gomez NM, 2003, PEDIATRICS, V111, P1002, DOI 10.1542/peds.111.5.1002; Diego MA, 2007, ACTA PAEDIATR, V96, P1588, DOI 10.1111/j.1651-2227.2007.00476.x; Doherty T, 2010, TROP MED INT HEALTH, V15, P296, DOI 10.1111/j.1365-3156.2009.02454.x; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Dziechciarz P, 2010, J AM COLL NUTR, V29, P443, DOI 10.1080/07315724.2010.10719881; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Eichler K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-506; Eilander A, 2010, AM J CLIN NUTR, V91, P115, DOI 10.3945/ajcn.2009.28376; Fergusson P, 2009, ARCH DIS CHILD, V94, P512, DOI 10.1136/adc.2008.142646; Fernandez-Gaxiola AC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009218.pub2; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Friberg I, BMC PUBLIC IN PRESS; Furber CM, 2013, COCHRANE DB SYST REV, V1; Futures Institute, UN INT COST TOOL; Gaffey MF, BMC PUBLIC IN PRESS; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; Gera T, 2012, AM J CLIN NUTR, V96, P309, DOI 10.3945/ajcn.111.031500; GHWA, 2010, GLOB EXP COMM HLTH W; Gillespie S, 2013, LANCET; Global Nutrition Cluster of the Inter Agency Standing Committee, 2008, TOOLK ADDR NUTR EM S; Gogia S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007991.pub2; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Graham PJ, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000501.PUB2; Grijalva-Eternod CS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001320; Gulmezoglu AM, 2009, COCHRANE DB SYST REV, V4; Haider BA, 2012, COCHRANE DB SYST REV, V2; Haider BA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub3; Haider BA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006980.pub2; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Haldre K, 2007, EUR J OBSTET GYN R B, V131, P45, DOI 10.1016/j.ejogrb.2006.05.002; Hall A., 2011, IMPACT EFFECTIVENESS; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Haroon S, BMC PUBLIC IN PRESS; Hofmeyr GJ, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001059.pub2, 10.1002/14651858.CD001059.pub4, 10.1002/14651858.CD001059.pub5]; Hossain MM, 2009, INDIAN PEDIATR, V46, P213; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; IFRC, 2011, FOC HUNG MALN; IHME, 2012, FIN GLOB HLTH 2012 E; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S24; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P138, DOI 10.1111/j.1365-3016.2012.01274.x; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P178, DOI 10.1111/j.1365-3016.2012.01308.x; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S22; Imdad A, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008524.pub2, 10.1002/14651858.CD008524.pub4]; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khanum S, 1998, AM J CLIN NUTR, V67, P940, DOI 10.1093/ajcn/67.5.940; Klemens CM, 2011, BJOG-INT J OBSTET GY, V118, P916, DOI 10.1111/j.1471-0528.2010.02846.x; Kramer MS, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000032; Kulier R, 1998, INT J GYNECOL OBSTET, V63, P231, DOI 10.1016/S0020-7292(98)00163-5; Langendorf C, 2012, EVALUATION DIFFERENT; Lassi ZS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006896.pub2; Lassi ZS, 2010, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD007754.PUB2; Lassi ZS, BMC PUBLIC IN PRESS; Lassi ZS, 2011, COCHRANE DB SYST REV, V10; Lerch C, 2007, Cochrane Database Syst Rev, pCD006164; Lewin S, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004015.PUB3; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mahal A, 2009, SCALING UP NUTR WHAT; Mannar M. G. Venkatesh, 2003, Food and Nutrition Bulletin, V24, pS151; Marriott BP, 2012, MATERN CHILD NUTR, V8, P354, DOI 10.1111/j.1740-8709.2011.00380.x; Martin RM, 2013, JAMA-J AM MED ASSOC, V309, P1005, DOI 10.1001/jama.2013.167; Mayer JE, 2008, CURR OPIN PLANT BIOL, V11, P166, DOI 10.1016/j.pbi.2008.01.007; McDonald S. J, 2009, COCHRANE DB SYST REV, V2; Mehra Sunil, 2004, Indian Pediatr, V41, P137; Mehta K, 2013, INDIAN PEDIATR, V50, P390, DOI 10.1007/s13312-013-0120-2; Menozzi C, 2013, LANCET; Meremikwu MM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003756.pub4; Michaelsen KF, 2011, MATERN CHILD NUTR, V7, P124, DOI 10.1111/j.1740-8709.2011.00302.x; Moore ER, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub3; Mori R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000230.pub4; Muhlhausler BS, 2010, AM J CLIN NUTR, V92, P857, DOI 10.3945/ajcn.2010.29495; Mullany LC, BMC PUBLIC HLT UNPUB; Mullany LC, 2008, J NUTR, V138, P599, DOI 10.1093/jn/138.3.599; National Institute of Population Studies, 2012, PAK DEM HLTH SURV 20; Natri AM, 2006, J NUTR, V136, P123, DOI 10.1093/jn/136.1.123; Neufeld LM, 2011, J NUTR, V141, P2064, DOI 10.3945/jn.110.135061; Nutrition Service of the World Food Program, 2006, Food Nutr Bull, V27, P57; Ohlsson A, 2009, COCHRANE DB SYST REV, V2; Olsen SF, 2007, COCHRANE DB SYST REV, V3; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Paranjothy S, 2009, ARCH DIS CHILD, V94, P239, DOI 10.1136/adc.2007.115915; Pena-Rosas Juan Pablo, 2015, Cochrane Database Syst Rev, pCD009997, DOI [10.1002/14651858.CD009997, 10.1002/14651858.CD009997.pub2]; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Peto R, 2013, LANCET; Petticrew M, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD00467.PUB2; Phuka JC, 2008, ARCH PEDIAT ADOL MED, V162, P619, DOI 10.1001/archpedi.162.7.619; Phuka JC, 2009, AM J CLIN NUTR, V89, P382, DOI 10.3945/ajcn.2008.26483; Plagemann Andreas, 2005, Metabolic Syndrome and Related Disorders, V3, P222, DOI 10.1089/met.2005.3.222; Pope DP, 2010, EPIDEMIOL REV, V32, P70, DOI 10.1093/epirev/mxq005; Prentice AM, 2011, MATERN CHILD NUTR, V7, P89, DOI 10.1111/j.1740-8709.2011.00313.x; Puckett R. M., 2010, COCHRANE DB SYST REV, V4; Puoane T, 2008, HEALTH POLICY PLANN, V23, P428, DOI 10.1093/heapol/czn036; Rabe H, 2011, COCHRANE DB SYST REV, V8; Rahman A, 2008, TROP MED INT HEALTH, V13, P579, DOI 10.1111/j.1365-3156.2008.02036.x; Rodriguez G, 2012, BRIT J NUTR, V107, pS117, DOI 10.1017/S0007114512001511; Ronnenberg AG, 2004, J NUTR, V134, P2586, DOI 10.1093/jn/134.10.2586; Ronsmans C, 2009, FOOD NUTR BULL, V30, pS547, DOI 10.1177/15648265090304S409; Rosenthal AN, 1998, BRIT J OBSTET GYNAEC, V105, P1064, DOI 10.1111/j.1471-0528.1998.tb09937.x; Ruel MT, 2002, J NUTR, V132, P1180, DOI 10.1093/jn/132.6.1180; Ryan AS, 2010, PROSTAG LEUKOTR ESS, V82, P305, DOI 10.1016/j.plefa.2010.02.007; Sachdev HPS, 2005, PUBLIC HEALTH NUTR, V8, P117, DOI 10.1079/PHN2004677; Salvig JD, 2011, ACTA OBSTET GYN SCAN, V90, P825, DOI 10.1111/j.1600-0412.2011.01171.x; Satyanarayana Veena A, 2011, Indian J Psychiatry, V53, P351, DOI 10.4103/0019-5545.91911; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Schofield C, 1996, B WORLD HEALTH ORGAN, V74, P223; Shah GS, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-36; Shamim AA, 2013, FASEB J, V27, P5225; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; Spears D., 63512013 WPS WORLD B; Srinivas SK, 2009, J PERINATOL, V29, P680, DOI 10.1038/jp.2009.83; Srinivasan MG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-14; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Szajewska H, 2006, AM J CLIN NUTR, V83, P1337, DOI 10.1093/ajcn/83.6.1337; Taylor-Robinson D, 2012, COCHRANE DB SYST REV, V4; ter Kuile FO, 2009, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003755; The Johns Hopkins University's Bloomberg School of Public Health and International Committee of the Red Cross, 2008, PUBL HLTH GUID EM; The Sphere Project, 2011, SPHER HDB; Thompson LM, 2011, ENVIRON HEALTH PERSP, V119, P1489, DOI 10.1289/ehp.1002928; Tobias JH, 2013, LANCET; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; UNFPA, 2012, MARR TOO YOUNG END C; UNICEF, 2011, CHILD HLTH DAYS 1999; UNICEF, 2013, IMPR CHILD NUTR INCR; United Nations High Commissioner for Refugees World Food Programme, 2011, GUID SEL FEED MAN MA; Vaidya A, 2008, LANCET, V371, P492, DOI 10.1016/S0140-6736(08)60172-5; van den Broek N, 2011, BMC PUBLIC HLTH S3, V11, pS22; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; Walker N, 2010, INT J EPIDEMIOL S1, V39, pi1; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; Webb P, BMC PUBLIC IN PRESS; Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849; WHO, HLTH SYST INF; WHO, 2011, LIF EXP BIRTH LOW IN; WHO, 2006, GUIDELINES FOOD FORT; WHO, 2009, M TECHN CONS VIT NEW; WHO, 2013, GUID UPD TECHN ASP M; WHO, 2012, M M DEV GLOB CONS PR; WHO, 2011, GUID INT IR SUPPL PR; WHO, 2002, M INF M REV DEV IND; WHO The Partnership for Maternal Newborn and Child Health, 2012, REACH CHILD BRID; WINKVIST A, 1992, AM J PUBLIC HEALTH, V82, P691, DOI 10.2105/AJPH.82.5.691; World Health Organization , 2007, COMM BAS MAN SEV AC; World Health Organization (WHO), 2007, ADOLESCENT PREGNANCY; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23; Young H, 2004, LANCET, V364, P1899, DOI 10.1016/S0140-6736(04)17447-3; Zimmermann MB, 2012, PAEDIATR PERINAT EP, V26, P108, DOI 10.1111/j.1365-3016.2012.01275.x	202	1510	1527	13	351	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					452	477		10.1016/S0140-6736(13)60996-4	http://dx.doi.org/10.1016/S0140-6736(13)60996-4			26	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23746776				2022-12-28	WOS:000322638500037
J	Osterholm, MT; Ballering, KS; Kelley, NS				Osterholm, Michael T.; Ballering, Katie S.; Kelley, Nicholas S.			Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS-VACCINE; TRIAL		[Osterholm, Michael T.; Ballering, Katie S.; Kelley, Nicholas S.] Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA; [Osterholm, Michael T.; Kelley, Nicholas S.] Univ Minnesota, Minnesota Ctr Excellence Influenza Res & Surveill, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Univ Minnesota, Ctr Infect Dis Res & Policy, 420 Delaware St,SE MMC263, Minneapolis, MN 55455 USA.	mto@umn.edu			PHS HHS [HHSN266200700007C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], MMWR; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Osterholm MT, 2012, CIDRAP           OCT; Partridge J, 2013, VACCINE, V31, P728, DOI 10.1016/j.vaccine.2012.10.111; Schnirring L., 2013, CIDRAP NEWS     0508; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; US Food and Drug Administration, 2007, GUID IND CLIN DAT NE; World Health Organization, 2013, VACC RESP AV INFL H7	9	28	32	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2557	2558		10.1001/jama.2013.6589	http://dx.doi.org/10.1001/jama.2013.6589			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23700117				2022-12-28	WOS:000320848100023
J	Awad, MM; Katayama, R; McTigue, M; Liu, W; Deng, YL; Brooun, A; Friboulet, L; Huang, DH; Falk, MD; Timofeevski, S; Wilner, KD; Lockerman, EL; Khan, TM; Mahmood, S; Gainor, JF; Digumarthy, SR; Stone, JR; Mino-Kenudson, M; Christensen, JG; Iafrate, AJ; Engelman, JA; Shaw, AT				Awad, Mark M.; Katayama, Ryohei; McTigue, Michele; Liu, Wei; Deng, Ya-Li; Brooun, Alexei; Friboulet, Luc; Huang, Donghui; Falk, Matthew D.; Timofeevski, Sergei; Wilner, Keith D.; Lockerman, Elizabeth L.; Khan, Tahsin M.; Mahmood, Sidra; Gainor, Justin F.; Digumarthy, Subba R.; Stone, James R.; Mino-Kenudson, Mari; Christensen, James G.; Iafrate, A. John; Engelman, Jeffrey A.; Shaw, Alice T.			Acquired Resistance to Crizotinib from a Mutation in CD74-ROS1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL LUNG-CANCER; GEFITINIB; EML4-ALK; SAFETY; GENE; INHIBITOR; EFFICACY; THERAPY; KINASE	Crizotinib, an inhibitor of anaplastic lymphoma kinase (ALK), has also recently shown efficacy in the treatment of lung cancers with ROS1 translocations. Resistance to crizotinib developed in a patient with metastatic lung adenocarcinoma harboring a CD74-ROS1 rearrangement who had initially shown a dramatic response to treatment. We performed a biopsy of a resistant tumor and identified an acquired mutation leading to a glycine-to-arginine substitution at codon 2032 in the ROS1 kinase domain. Although this mutation does not lie at the gatekeeper residue, it confers resistance to ROS1 kinase inhibition through steric interference with drug binding. The same resistance mutation was observed at all the metastatic sites that were examined at autopsy, suggesting that this mutation was an early event in the clonal evolution of resistance.	[Awad, Mark M.; Katayama, Ryohei; Friboulet, Luc; Lockerman, Elizabeth L.; Khan, Tahsin M.; Mahmood, Sidra; Gainor, Justin F.; Engelman, Jeffrey A.; Shaw, Alice T.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA; [Digumarthy, Subba R.] Massachusetts Gen Hosp, Ctr Canc, Dept Radiol, Boston, MA 02114 USA; [Stone, James R.; Mino-Kenudson, Mari; Iafrate, A. John] Massachusetts Gen Hosp, Ctr Canc, Dept Pathol, Boston, MA 02114 USA; [McTigue, Michele; Liu, Wei; Deng, Ya-Li; Brooun, Alexei; Huang, Donghui; Falk, Matthew D.; Timofeevski, Sergei; Wilner, Keith D.; Christensen, James G.] Pfizer Worldwide Res & Dev, La Jolla, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Pfizer	Engelman, JA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 55 Fruit St, Boston, MA 02114 USA.	jengelman@partners.org; ashaw1@partners.org	Gainor, Justin/T-5411-2019; Katayama, Ryohei/K-8537-2014; friboulet, luc/N-7276-2015	Katayama, Ryohei/0000-0001-7394-895X; friboulet, luc/0000-0002-1129-4978; Gerlinger, Marco/0000-0003-2719-299X; Swanton, Charles/0000-0002-4299-3018	Pfizer; National Cancer Institute [5R01CA164273-02, R01CA137008, Lung SPORE P50CA090578, a1R21CA161590-01]; V Foundation Translational Research Grant; Be a Piece of the Solution; Evan Spirito Memorial Foundation; NATIONAL CANCER INSTITUTE [P50CA090578, R01CA137008, R01CA164273, R21CA161590] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation Translational Research Grant; Be a Piece of the Solution; Evan Spirito Memorial Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Pfizer, by grants from the National Cancer Institute (5R01CA164273-02, to Drs. Shaw and Engelman; R01CA137008 and Lung SPORE P50CA090578, to Dr. Engelman; and a1R21CA161590-01, to Dr. Iafrate), by a V Foundation Translational Research Grant (to Drs. Shaw and Engelman), by Be a Piece of the Solution, and by the Evan Spirito Memorial Foundation.	Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shaw AT, 2012, ANN M AM SOC CLIN ON; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945	25	286	310	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2395	2401		10.1056/NEJMoa1215530	http://dx.doi.org/10.1056/NEJMoa1215530			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23724914	Green Accepted			2022-12-28	WOS:000320601700009
J	Godefroit, P; Cau, A; Hu, DY; Escuillie, F; Wu, WH; Dyke, G				Godefroit, Pascal; Cau, Andrea; Hu Dong-Yu; Escuillie, Franois; Wu Wenhao; Dyke, Gareth			A Jurassic avialan dinosaur from China resolves the early phylogenetic history of birds	NATURE			English	Article							LONG FEATHERS; THEROPOD; ARCHAEOPTERYX; MANIRAPTORAN; EVOLUTION	The recent discovery of small paravian theropod dinosaurs with well-preserved feathers in the Middle-Late Jurassic Tiaojishan Formation of Liaoning Province (northeastern China)(1-4) has challenged the pivotal position of Archaeopteryx(3,4), regarded from its discovery to be the most basal bird. Removing Archaeopteryx from the base of Avialae to nest within Deinonychosauria implies that typical bird flight, powered by the forelimbs only, either evolved at least twice, or was subsequently lost or modified in some deinonychosaurians(3,5). Here we describe the complete skeleton of a new paravian from the Tiaojishan Formation of Liaoning Province, China. Including this new taxon in a comprehensive phylogenetic analysis for basal Paraves does the following: (1) it recovers it as the basal-most avialan; (2) it confirms the avialan status of Archaeopteryx; (3) it places Troodontidae as the sister-group to Avialae; (4) it supports a single origin of powered flight within Paraves; and (5) it implies that the early diversification of Paraves and Avialae took place in the Middle-Late Jurassic period.	[Godefroit, Pascal] Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, B-1000 Brussels, Belgium; [Cau, Andrea] Museo Geol Giovanni Capellini, I-40127 Bologna, Italy; [Hu Dong-Yu] Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China; [Hu Dong-Yu] NE Normal Univ, Minist Educ, Key Lab Vegetat Ecol, Changchun 130024, Peoples R China; [Escuillie, Franois] Eldonia, F-3800 Gannat, France; [Wu Wenhao] Jilin Univ, Res Ctr Paleontol & Stratig, Changchun 130021, Peoples R China; [Dyke, Gareth] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Royal Belgian Institute of Natural Sciences; Shenyang Normal University; Northeast Normal University - China; Jilin University; NERC National Oceanography Centre; University of Southampton	Godefroit, P (corresponding author), Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, Rue Vautier 29, B-1000 Brussels, Belgium.	Pascal.Godefroit@naturalsciences.be	Dyke, Gareth/AAJ-9320-2020; Cau, Andrea/S-8546-2016; Wu, Wenhao/AAU-4325-2020; Cau, Andrea/ABB-7972-2021	Dyke, Gareth/0000-0002-8390-7817; Cau, Andrea/0000-0001-8761-3720	SPP Politique scientifique (Belgium) [BL/36/62]; Key Laboratory of Evolutionary Systematics of Vertebrates [CAS2011LESV011]; National Natural Science Foundation of China [41172026]	SPP Politique scientifique (Belgium); Key Laboratory of Evolutionary Systematics of Vertebrates; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank B. Pohl for making fossils available for study, S. Ge for help and comments on the manuscript and T. Hubin for photographs. This study was supported by a grant (BL/36/62) to P. G. from the SPP Politique scientifique (Belgium). D. H. was supported by the Key Laboratory of Evolutionary Systematics of Vertebrates (CAS2011LESV011) and by the National Natural Science Foundation of China (41172026).	Chiappe LM, 1999, B AM MUS NAT HIST, P3; Currie PJ, 2001, CAN J EARTH SCI, V38, P1753, DOI 10.1139/e01-065; Elzanowski A, 1996, J VERTEBR PALEONTOL, V16, P81, DOI 10.1080/02724634.1996.10011286; EVANS SE, 1994, IN THE SHADOW OF THE DINOSAURS, P303; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; Godefroit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2389; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 2003, AM MUS NOVIT, P1; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; van der Lubbe T, 2009, ACTA PALAEONTOL POL, V54, P401, DOI 10.4202/app.2008.0007; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753; Zheng XT, 2010, P ROY SOC B-BIOL SCI, V277, P211, DOI 10.1098/rspb.2009.1178; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179	28	120	127	1	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					359	362		10.1038/nature12168	http://dx.doi.org/10.1038/nature12168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23719374				2022-12-28	WOS:000320592900039
J	Shaked, Y; Rose, A				Shaked, Yeala; Rose, Andrew			Seas of Superoxide	SCIENCE			English	Editorial Material							GENERATED SUPEROXIDE; DECAY		[Shaked, Yeala] InterUniv Inst Marine Sci, IL-88103 Elat, Israel; [Shaked, Yeala] Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel; [Rose, Andrew] So Cross Univ, Lismore, NSW 2480, Australia	Hebrew University of Jerusalem; Southern Cross University	Shaked, Y (corresponding author), InterUniv Inst Marine Sci, IL-88103 Elat, Israel.	yeala.shaked@mail.huji.ac.il	Shaked, Yeala/AAH-7956-2021; Rose, Andrew/B-9557-2012	Rose, Andrew/0000-0003-1063-3832; Shaked, Yeala/0000-0002-7831-8313				BAXTER RM, 1983, NATURE, V306, P575, DOI 10.1038/306575a0; Diaz JM, 2013, SCIENCE, V340, P1223, DOI 10.1126/science.1237331; Hansard SP, 2011, ENVIRON SCI TECHNOL, V45, P2811, DOI 10.1021/es104014s; Hansard SP, 2010, DEEP-SEA RES PT I, V57, P1111, DOI 10.1016/j.dsr.2010.05.007; Kustka AB, 2005, LIMNOL OCEANOGR, V50, P1172, DOI 10.4319/lo.2005.50.4.1172; Learman DR, 2011, NAT GEOSCI, V4, P95, DOI [10.1038/ngeo1055, 10.1038/NGEO1055]; Marshall JA, 2005, MAR BIOL, V147, P533, DOI 10.1007/s00227-005-1596-7; MICINSKI E, 1993, J GEOPHYS RES-OCEANS, V98, P2299, DOI 10.1029/92JC02766; Rose AL, 2008, ENVIRON SCI TECHNOL, V42, P2387, DOI 10.1021/es7024609; Rose AL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00124; Rose AL, 2010, LIMNOL OCEANOGR, V55, P1521, DOI 10.4319/lo.2010.55.4.1521; Rusak SA, 2011, MAR CHEM, V127, P155, DOI 10.1016/j.marchem.2011.08.005; Saragosti E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012508; Shaked Y, 2010, ENVIRON SCI TECHNOL, V44, P3238, DOI 10.1021/es902343y	14	16	17	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1176	1177		10.1126/science.1240195	http://dx.doi.org/10.1126/science.1240195			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744933				2022-12-28	WOS:000319972800029
J	Hunninghake, GM; Hatabu, H; Okajima, Y; Gao, W; Dupuis, J; Latourelle, JC; Nishino, M; Araki, T; Zazueta, OE; Kurugol, S; Ross, JC; Estepar, RS; Murphy, E; Steele, MP; Loyd, JE; Schwarz, MI; Fingerlin, TE; Rosas, IO; Washko, GR; O'Connor, GT; Schwartz, DA				Hunninghake, Gary M.; Hatabu, Hiroto; Okajima, Yuka; Gao, Wei; Dupuis, Josee; Latourelle, Jeanne C.; Nishino, Mizuki; Araki, Tetsuro; Zazueta, Oscar E.; Kurugol, Sila; Ross, James C.; Estepar, Raul San Jose; Murphy, Elissa; Steele, Mark P.; Loyd, James E.; Schwarz, Marvin I.; Fingerlin, Tasha E.; Rosas, Ivan O.; Washko, George R.; O'Connor, George T.; Schwartz, David A.			MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; PATHOLOGICAL FEATURES; REFERENCE VALUES; CLINICAL-COURSE; POPULATION; PREVALENCE; CAPACITY; SMOKING; DISEASE; SAMPLE	Background A common promoter polymorphism (rs35705950) in MUC5B, the gene encoding mucin 5B, is associated with idiopathic pulmonary fibrosis. It is not known whether this polymorphism is associated with interstitial lung disease in the general population. Methods We performed a blinded assessment of interstitial lung abnormalities detected in 2633 participants in the Framingham Heart Study by means of volumetric chest computed tomography (CT). We evaluated the relationship between the abnormalities and the genotype at the rs35705950 locus. Results Of the 2633 chest CT scans that were evaluated, interstitial lung abnormalities were present in 177 (7%). Participants with such abnormalities were more likely to have shortness of breath and chronic cough and reduced measures of total lung and diffusion capacity, as compared with participants without such abnormalities. After adjustment for covariates, for each copy of the minor rs35705950 allele, the odds of interstitial lung abnormalities were 2.8 times greater (95% confidence interval [CI], 2.0 to 3.9; P<0.001), and the odds of definite CT evidence of pulmonary fibrosis were 6.3 times greater (95% CI, 3.1 to 12.7; P<0.001). Although the evidence of an association between the MUC5B genotype and interstitial lung abnormalities was greater among participants who were older than 50 years of age, a history of cigarette smoking did not appear to influence the association. Conclusions The MUC5B promoter polymorphism was found to be associated with interstitial lung disease in the general population. Although this association was more apparent in older persons, it did not appear to be influenced by cigarette smoking.	[Hunninghake, Gary M.; Zazueta, Oscar E.; Rosas, Ivan O.; Washko, George R.] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Hatabu, Hiroto; Okajima, Yuka; Nishino, Mizuki; Araki, Tetsuro] Brigham & Womens Hosp, Ctr Pulm Funct Imaging, Boston, MA 02115 USA; [Hatabu, Hiroto; Okajima, Yuka; Nishino, Mizuki; Araki, Tetsuro; Estepar, Raul San Jose] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Kurugol, Sila; Ross, James C.; Estepar, Raul San Jose] Brigham & Womens Hosp, Dept Radiol, Surg Planning Lab, Boston, MA 02115 USA; [Ross, James C.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Hunninghake, Gary M.; Zazueta, Oscar E.; Rosas, Ivan O.; Washko, George R.] Harvard Univ, Sch Med, Boston, MA USA; [Gao, Wei; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Latourelle, Jeanne C.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Latourelle, Jeanne C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Gao, Wei; Dupuis, Josee; O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Murphy, Elissa; Schwarz, Marvin I.; Schwartz, David A.] Univ Colorado, Dept Med, Ctr Pulm, Denver, CO USA; [Fingerlin, Tasha E.] Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA; [Steele, Mark P.; Loyd, James E.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Boston University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Vanderbilt University	Hunninghake, GM (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, 75 Francis St, Boston, MA 02115 USA.	ghunninghake@partners.org; david.schwartz@ucdenver.edu	Zazueta, Oscar/GQQ-7506-2022; San Jose Estepar, Raul/AAQ-5657-2020	San Jose Estepar, Raul/0000-0002-3677-1996; Kurugol, Sila/0000-0002-5081-4569; Latourelle, Jeanne/0000-0002-4218-9572; Loyd, James/0000-0002-5042-7390; O'Connor, George/0000-0002-6476-3926; Dupuis, Josee/0000-0003-2871-3603; Zazueta, Oscar E/0000-0001-5374-3906	National Institutes of Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K23CA157631, R21CA116271] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL092222, R01HL097163, K25HL104085, RC2HL101715, R01HL116473, P01HL092870, R01HL095393, R01HL111024, R01HL107246, K23HL089353] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Funded by the National Institutes of Health and others; ClinicalTrials.gov number NCT00005121.	BITTERMAN PB, 1986, NEW ENGL J MED, V314, P1343, DOI 10.1056/NEJM198605223142103; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; de Leon AD, 2011, CHEST, V140, P753, DOI 10.1378/chest.10-2865; Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P756, DOI 10.1164/rccm.201109-1618OC; El-Chemaly S, 2011, CHEST, V139, P1203, DOI 10.1378/chest.10-2048; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; FERRIS BG, 1978, B EUR PHYSIOPATH RES, V14, P145; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HOURIHANE DO, 1966, BMJ-BRIT MED J, V1, P1069, DOI 10.1136/bmj.1.5495.1069; IWAI K, 1994, AM J RESP CRIT CARE, V150, P670, DOI 10.1164/ajrccm.150.3.8087336; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; Lee HY, 2012, CHEST, V142, P1577, DOI 10.1378/chest.11-2812; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ross JC, 2009, LECT NOTES COMPUT SC, V5762, P690, DOI 10.1007/978-3-642-04271-3_84; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Uh Hae-Won, 2009, BMC Proc, V3 Suppl 7, pS123; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Xu JF, 2012, AM J RESP CRIT CARE, V185, P547, DOI 10.1164/rccm.201108-1574OC	25	264	265	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2192	2200		10.1056/NEJMoa1216076	http://dx.doi.org/10.1056/NEJMoa1216076			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23692170	Green Accepted			2022-12-28	WOS:000319948900007
J	Piot, P; Quinn, TC				Piot, Peter; Quinn, Thomas C.			Response to the AIDS Pandemic - A Global Health Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; MALE CIRCUMCISION; HIV PREVENTION; ANTIRETROVIRAL THERAPY; PREEXPOSURE PROPHYLAXIS; INCOME COUNTRIES; FOLLOW-UP; INFECTION; RISK; MEN		[Piot, Peter] Univ London London Sch Hyg & Trop Med, London SW6 6RE, England; [Quinn, Thomas C.] NIAID, NIH, Bethesda, MD 20892 USA	University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Piot, P (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London SW6 6RE, England.	director@lshtm.ac.uk			Intramural NIH HHS [ZIA AI000361-30] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abebe Y, 2003, ETHIOPIAN MED J, V41, P25; *AIDS2031 CONS, 2010, AIDS TAK LONG TERM V; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], 2012, EUR GUID TREATM HIV; [Anonymous], 2012, GLOB REP UNAIDS REP; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; BEASLEY R, 2010, REDUCING HARM BRIEF; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; El-Sadr WM, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000298105.79484.62; Gallo RC, 2003, NEW ENGL J MED, V349, P2283, DOI 10.1056/NEJMp038194; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gouws E, 2011, SEX TRANSM INFECT, V87, P8, DOI 10.1136/sti.2010.044933corr1; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028691; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Harries AD, 2009, JAIDS-J ACQ IMM DEF, V52, pS14, DOI 10.1097/QAI.0b013e3181bbc99e; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jan S, 2011, HEALTH POLICY PLANN, V26, P366, DOI 10.1093/heapol/czq071; Karim QA, 2011, SCIENCE, V333, P524; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lamptey P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001086; MacPherson EE, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17364; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Pandey A, 2008, AIDS, V22, pS81, DOI 10.1097/01.aids.0000343766.00573.15; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; PIOT P, 1984, LANCET, V2, P65; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; QUINN T, 2010, PREPARING FUTURE HIV; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; Rasschaert Freya, 2011, J Int AIDS Soc, V14 Suppl 1, pS3, DOI 10.1186/1758-2652-14-S1-S3; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; *S AFR NAT DEP HLT, 2011, 2010 NAT ANT HIV SYP; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Stoneburner RL, 2004, SCIENCE, V306, P1477; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; UNAIDS, 2012, AIDSINFO EP STAT; UNAIDS, 2000, EV 100 COND PROGR TH; *UNAIDS, 2012, GUID COUPL HIV TEST; UNAIDS, 2011, WORLD AIDS DAY REP 2; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; WHO, ANT THER HIV INF AD; 2011, MMWR MORB MORTAL WKL, V60, P852; 1981, MMWR MORB MORTAL WKL, V30, P250; 2011, MMWR MORTAL WKLY REP, V60, P1618; 2010, SEX TRANSM INFECT S2, V86, P72; 1981, MMWR MORB MORTAL WKL, V30, P305	65	101	104	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2210	+		10.1056/NEJMra1201533	http://dx.doi.org/10.1056/NEJMra1201533			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23738546	Green Accepted			2022-12-28	WOS:000319948900009
J	Jones, BRT; Renowden, SA; Lowis, SP; Kurian, KM				Jones, Benjamin R. T.; Renowden, Shelley A.; Lowis, Stephen P.; Kurian, Kathreena M.			Early morning headache with vomiting in a 5 year old boy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TUMORS		[Jones, Benjamin R. T.] Univ Bristol, Sch Med, Bristol BS8 1TH, Avon, England; [Renowden, Shelley A.] Frenchay Hosp, Dept Neuroradiol, Bristol BS16 1LE, Avon, England; [Lowis, Stephen P.] Bristol Royal Hosp Children, Dept Paediat Haematol, Bristol, Avon, England; [Lowis, Stephen P.] Bristol Royal Hosp Children, BMT, Bristol, Avon, England; [Kurian, Kathreena M.] Frenchay Hosp, Dept Neuropathol, Brain Tumour Res Grp, Bristol BS16 1LE, Avon, England	University of Bristol; Bristol Royal Hospital For Children; Bristol Royal Hospital For Children	Jones, BRT (corresponding author), Univ Bristol, Sch Med, Bristol BS8 1TH, Avon, England.	bjones7392@gmail.com		Kurian, Kathreena/0000-0003-0303-3716				Catsman-Berrevoets CE, 2010, CORTEX, V46, P933, DOI 10.1016/j.cortex.2009.10.007; Gandola L, 2009, J CLIN ONCOL, V27, P566, DOI 10.1200/JCO.2008.18.4176; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Lannering B, 2012, J CLIN ONCOL, V30, P3187, DOI 10.1200/JCO.2011.39.8719; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Souweidane MM, 2010, J NEUROSURG-PEDIATR, V5, P325, DOI 10.3171/2009.11.PEDS09369; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3	9	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3315	10.1136/bmj.f3315	http://dx.doi.org/10.1136/bmj.f3315			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DG	23719641				2022-12-28	WOS:000319948200009
J	Kirby, T				Kirby, Tony			Glenn Marshall: lynchpin for research in paediatric cancer	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1807	1807		10.1016/S0140-6736(13)61109-5	http://dx.doi.org/10.1016/S0140-6736(13)61109-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23706791				2022-12-28	WOS:000319443700013
J	Herm, ZR; Wiers, BM; Mason, JA; van Baten, JM; Hudson, MR; Zajdel, P; Brown, CM; Masciocchi, N; Krishna, R; Long, JR				Herm, Zoey R.; Wiers, Brian M.; Mason, Jarad A.; van Baten, Jasper M.; Hudson, Matthew R.; Zajdel, Pawel; Brown, Craig M.; Masciocchi, Norberto; Krishna, Rajamani; Long, Jeffrey R.			Separation of Hexane Isomers in a Metal-Organic Framework with Triangular Channels	SCIENCE			English	Article							BRANCHED ALKANES; ADSORPTION; METHANE; HYDROGEN; SORPTION; SELECTIVITY; PARAFFINS; STORAGE	Metal-organic frameworks can offer pore geometries that are not available in zeolites or other porous media, facilitating distinct types of shape-based molecular separations. Here, we report Fe-2(BDP)(3) (BDP2- = 1,4-benzenedipyrazotate), a highly stable framework with triangular channels that effect the separation of hexane isomers according to the degree of branching. Consistent with the varying abilities of the isomers to wedge along the triangular corners of the structure, adsorption isotherms and calculated isosteric heats indicate an adsorption selectivity order of n-hexane > 2-methytpentane > 3-methytpentane > 2,3-dimethytbutane approximate to 2,2-dimethytbutane. A breakthrough experiment performed at 160 degrees C with an eguimotar mixture of all five molecules confirms that the dibranched isomers elute first from a bed packed with Fe-2(BDP)(3), followed by the monobranched isomers and finally linear n-hexane. Configurational-bias Monte Carlo simulations confirm the origins of the molecular separation.	[Herm, Zoey R.; Wiers, Brian M.; Mason, Jarad A.; Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [van Baten, Jasper M.; Krishna, Rajamani] Univ Amsterdam, Vant Hoff Inst Mol Sci, NL-1098 XH Amsterdam, Netherlands; [Hudson, Matthew R.; Brown, Craig M.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Zajdel, Pawel] Silesian Univ, Inst Phys, PL-40007 Katowice, Poland; [Brown, Craig M.] Univ Delaware, Newark, DE 19716 USA; [Masciocchi, Norberto] Univ Insubria, Dipartimento Sci & Alta Tecnol, I-22100 Como, Italy	University of California System; University of California Berkeley; University of Amsterdam; National Institute of Standards & Technology (NIST) - USA; University of Silesia in Katowice; University of Delaware; University of Insubria	Krishna, R (corresponding author), Univ Amsterdam, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	r.krishna@uva.nl; jrlong@berkeley.edu	Krishna, Rajamani/A-1098-2012; EFRC, CGS/I-6680-2012; Stangl, Kristin/D-1502-2015; Brown, Craig M/B-5430-2009; Enrique, Colacio/L-6020-2014; van Baten, Jasper/AAS-7177-2021; Masciocchi, Norberto/K-4400-2015; Zajdel, Pawel/B-7574-2013	Krishna, Rajamani/0000-0002-4784-8530; Brown, Craig M/0000-0002-9637-9355; Enrique, Colacio/0000-0002-6745-9241; van Baten, Jasper/0000-0002-6643-7593; Masciocchi, Norberto/0000-0001-9921-2350; Zajdel, Pawel/0000-0003-1220-5866	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001015]; National Institute of Standards and Technology National Research Council Postdoctoral Associateship program; Cariplo Foundation [2011-0289]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institute of Standards and Technology National Research Council Postdoctoral Associateship program; Cariplo Foundation(Fondazione Cariplo)	This research was supported through the Center for Gas Separations Relevant to Clean Energy Technologies, an I Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001015. We thank G. Chita (Institute of Crystallography National Research Council, Bari, Italy) for assistance during x-ray powder diffraction data collection. M.R.H. acknowledges the support of the National Institute of Standards and Technology National Research Council Postdoctoral Associateship program. N.M. thanks the Cariplo Foundation (2011-0289) for partial funding. Z.R.H. thanks P. J. Fischer for meaningful discussions and E. D. Bloch for experimental assistance. Additional data described in this paper are presented in the supplementary materials. Metrical data for the solid-state structure of Fe<INF>2</INF>(BDP)<INF>3</INF> is available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC 915106. The authors and the University of California, Berkeley have filed a patent on some of the results presented herein.	Bae YS, 2012, ANGEW CHEM INT EDIT, V51, P1857, DOI 10.1002/anie.201107534; Bao ZB, 2011, LANGMUIR, V27, P13554, DOI 10.1021/la2030473; Barcia PS, 2007, AICHE J, V53, P1970, DOI 10.1002/aic.11233; Barcia PS, 2006, IND ENG CHEM RES, V45, P4316, DOI 10.1021/ie0513954; Barcia PS, 2011, MICROPOR MESOPOR MAT, V139, P67, DOI 10.1016/j.micromeso.2010.10.019; Barcia PS, 2005, MICROPOR MESOPOR MAT, V79, P145, DOI 10.1016/j.micromeso.2004.10.037; Bhide SY, 2004, MOL PHYS, V102, P1057, DOI 10.1080/00268970410001734305; Bloch ED, 2012, SCIENCE, V335, P1606, DOI 10.1126/science.1217544; Chang N, 2010, J AM CHEM SOC, V132, P13645, DOI 10.1021/ja1058229; Choi HJ, 2008, J AM CHEM SOC, V130, P7848, DOI 10.1021/ja8024092; Clavier R., 2007, WILEY CRITICAL CONTE; Czaja AU, 2009, CHEM SOC REV, V38, P1284, DOI 10.1039/b804680h; DESTY DH, 1961, J PHYS CHEM-US, V65, P766, DOI 10.1021/j100823a015; Dubbeldam D, 2012, ANGEW CHEM INT EDIT, V51, P11867, DOI 10.1002/anie.201205040; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b; Ferreira AFP, 2008, MICROPOR MESOPOR MAT, V111, P171, DOI 10.1016/j.micromeso.2007.07.043; Finsy V, 2009, PHYS CHEM CHEM PHYS, V11, P3515, DOI 10.1039/b822247a; Guillerm V, 2012, ANGEW CHEM INT EDIT, V51, P9267, DOI 10.1002/anie.201204806; JASRA RV, 1988, SEPAR SCI TECHNOL, V23, P945, DOI 10.1080/01496398808058436; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Krishna R, 2002, CHEM SOC REV, V31, P185, DOI 10.1039/b101267n; Li JR, 2012, CHEM REV, V112, P869, DOI 10.1021/cr200190s; Li KH, 2008, CHEM COMMUN, P6123, DOI 10.1039/b814498b; Lin XA, 2010, TOP CURR CHEM, V293, P35, DOI 10.1007/128_2009_21; Liu DM, 2012, CHEM SCI, V3, P3032, DOI 10.1039/c2sc20601c; Lobo R. F., 2003, HDB ZEOLITE SCI TECH; Makal TA, 2012, CHEM SOC REV, V41, P7761, DOI 10.1039/c2cs35251f; Miller SR, 2005, CHEM COMMUN, P3850, DOI 10.1039/b506677h; Myers R. A., 2004, HDB PETROLEUM REFINI; Nadim F, 2001, ENERG POLICY, V29, P1, DOI 10.1016/S0301-4215(00)00099-9; Peralta D, 2012, IND ENG CHEM RES, V51, P4692, DOI 10.1021/ie202995g; Silva JAC, 1999, IND ENG CHEM RES, V38, P2434, DOI 10.1021/ie980696t; Silvestre-Albero A, 2009, LANGMUIR, V25, P939, DOI 10.1021/la802692z; SMIT B, 1995, NATURE, V374, P42, DOI 10.1038/374042a0; Suh MP, 2012, CHEM REV, V112, P782, DOI 10.1021/cr200274s; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Vlugt TJH, 1999, J PHYS CHEM B, V103, P1102, DOI 10.1021/jp982736c	38	489	501	29	615	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					960	964		10.1126/science.1234071	http://dx.doi.org/10.1126/science.1234071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704568				2022-12-28	WOS:000319344100042
J	Flinter, F				Flinter, Frances			Should we sequence everyone's genome? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDERS		Guys & St Thomas NHS Fdn Trust, Dept Clin Genet, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Flinter, F (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Clin Genet, London SE1 9RT, England.	frances.flinter@gstt.nhs.uk						Biesecker LG, 2012, NAT REV GENET, V13, P818, DOI 10.1038/nrg3357; Groisman IJ, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-36; Gullapalli Rama R, 2012, J Pathol Inform, V3, P40, DOI 10.4103/2153-3539.103013; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hawkes N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8413; PHG Foundation, STRAT LIF SCI IMPL P; PHG Foundation, MAN INC PERT FIND W; Rabbani B, 2012, J HUM GENET, V57, P621, DOI 10.1038/jhg.2012.91; Wright C., 2011, NEXT STEPS SEQUENCE; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	10	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3132	10.1136/bmj.f3132	http://dx.doi.org/10.1136/bmj.f3132			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23694690				2022-12-28	WOS:000319573300007
J	Hamilton, W; Coleman, MG; Rubin, G				Hamilton, William; Coleman, Mark G.; Rubin, Greg			Colorectal cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; MISSED OPPORTUNITIES; DIAGNOSIS; ANEMIA; SYMPTOMS; RECORDS; COHORT; RISK		[Hamilton, William] Univ Exeter, Exeter EX2 4SG, Devon, England; [Coleman, Mark G.] Derriford Hosp, Lapco Natl Training Programme Laparoscop Colorect, Plymouth PL6 8DH, Devon, England; [Rubin, Greg] Univ Durham, Wolfson Res Inst, Stockton On Tees, England	University of Exeter; Derriford Hospital; Durham University	Hamilton, W (corresponding author), Univ Exeter, Veysey Bldg, Exeter EX2 4SG, Devon, England.	w.hamilton@exeter.ac.uk		Hamilton, William/0000-0003-1611-1373	Medical Research Council [MR/K02325X/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Astin Margaret, 2011, Br J Gen Pract, V61, pe231, DOI 10.3399/bjgp11X572427; Atkin W, 2013, LANCET; Cancer Research UK, 2012, CANCERSTATS KEY FACT; Damery S, 2011, COLORECTAL DIS, V13, pE53, DOI 10.1111/j.1463-1318.2010.02488.x; Dominguez-Ayala M, 2012, REV ESP ENFERM DIG, V104, P343, DOI 10.4321/s1130-01082012000700002; Ellis BG, 2005, BRIT J GEN PRACT, V55, P949; Elliss-Brookes L, BR J CANC, V107, P1220; Halligan S, 2013, LANCET; Hamilton W, 2008, BRIT J CANCER, V98, P323, DOI 10.1038/sj.bjc.6604165; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; Hamilton W, 2010, BRIT J GEN PRACT, V60, P121, DOI 10.3399/bjgp10X483175; Hamilton W, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-17; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Masson S, 2007, COLORECTAL DIS, V9, P736, DOI 10.1111/j.1463-1318.2006.01200.x; National Institute for Health and Clinical Excellence, 2011, CG131 NICE; NHS Scotland, 2021, SCOTT REF GUID SUSP; Rodriguez LAG, 2000, SCAND J GASTROENTERO, V35, P306; Sawhney MS, 2007, AM J GASTROENTEROL, V102, P82, DOI 10.1111/j.1572-0241.2006.00908.x; Singh H, 2009, AM J GASTROENTEROL, V104, P2543, DOI 10.1038/ajg.2009.324; Stapley S, 2006, BRIT J CANCER, V95, P1321, DOI 10.1038/sj.bjc.6603439; Thompson MR, 2007, BRIT J SURG, V94, P1260, DOI 10.1002/bjs.5826; Thompson MR, 2011, COLORECTAL DIS, V13, P6, DOI 10.1111/j.1463-1318.2009.01986.x; Torring ML, 2011, BRIT J CANCER, V104, P934, DOI 10.1038/bjc.2011.60	23	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3172	10.1136/bmj.f3172	http://dx.doi.org/10.1136/bmj.f3172			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23693056	Green Submitted, Green Accepted			2022-12-28	WOS:000319573300009
J	Khazanie, P; Newby, LK				Khazanie, Prateeti; Newby, L. Kristin			Review: In patients with heart failure, beta-blockers reduce mortality but do not differ from each other	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Khazanie, Prateeti; Newby, L. Kristin] Duke Univ, Sch Med, Durham, NC 27706 USA	Duke University	Khazanie, P (corresponding author), Duke Univ, Sch Med, Durham, NC 27706 USA.							Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10							JC2	10.7326/0003-4819-158-10-201305210-02002	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-02002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689781				2022-12-28	WOS:000319666200001
J	Gardner, AS; Moholdt, G; Cogley, JG; Wouters, B; Arendt, AA; Wahr, J; Berthier, E; Hock, R; Pfeffer, WT; Kaser, G; Ligtenberg, SRM; Bolch, T; Sharp, MJ; Hagen, JO; van den Broeke, MR; Paul, F				Gardner, Alex S.; Moholdt, Geir; Cogley, J. Graham; Wouters, Bert; Arendt, Anthony A.; Wahr, John; Berthier, Etienne; Hock, Regine; Pfeffer, W. Tad; Kaser, Georg; Ligtenberg, Stefan R. M.; Bolch, Tobias; Sharp, Martin J.; Hagen, Jon Ove; van den Broeke, Michiel R.; Paul, Frank			A Reconciled Estimate of Glacier Contributions to Sea Level Rise: 2003 to 2009	SCIENCE			English	Article							ICESAT LASER ALTIMETRY; MASS-BALANCE; CAPS; GREENLAND; AMERICA	Glaciers distinct from the Greenland and Antarctic Ice Sheets are losing large amounts of water to the world's oceans. However, estimates of their contribution to sea level rise disagree. We provide a consensus estimate by standardizing existing, and creating new, mass-budget estimates from satellite gravimetry and altimetry and from local glaciological records. In many regions, local measurements are more negative than satellite-based estimates. All regions lost mass during 2003-2009, with the largest losses from Arctic Canada, Alaska, coastal Greenland, the southern Andes, and high-mountain Asia, but there was little loss from glaciers in Antarctica. Over this period, the global mass budget was -259 +/- 28 gigatons per year, equivalent to the combined loss from both ice sheets and accounting for 29 +/- 13% of the observed sea level rise.	[Gardner, Alex S.] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Gardner, Alex S.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Moholdt, Geir] Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Cogley, J. Graham] Trent Univ, Dept Geog, Peterborough, ON K9J 7B8, Canada; [Wouters, Bert; Wahr, John] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Wouters, Bert] Bristol Glaciol Ctr, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Arendt, Anthony A.; Hock, Regine] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Wahr, John] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Berthier, Etienne] Univ Toulouse, LEGOS, CNRS, F-31400 Toulouse, France; [Hock, Regine] Uppsala Univ, Dept Earth Sci, SE-75105 Uppsala, Sweden; [Pfeffer, W. Tad] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Kaser, Georg] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; [Ligtenberg, Stefan R. M.; van den Broeke, Michiel R.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3508 TA Utrecht, Netherlands; [Bolch, Tobias; Paul, Frank] Univ Zurich, Dept Geog, CH-8057 Zurich, Switzerland; [Bolch, Tobias] Tech Univ Dresden, Inst Kartog, D-01062 Dresden, Germany; [Sharp, Martin J.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Hagen, Jon Ove] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway	Clark University; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Scripps Institution of Oceanography; Trent University; University of Colorado System; University of Colorado Boulder; University of Bristol; University of Alaska System; University of Alaska Fairbanks; University of Colorado System; University of Colorado Boulder; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Uppsala University; University of Colorado System; University of Colorado Boulder; University of Innsbruck; Utrecht University; University of Zurich; Technische Universitat Dresden; University of Alberta; University of Oslo	Gardner, AS (corresponding author), Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA.	agardner@clarku.edu	Wouters, Bert/A-5301-2017; Ligtenberg, Stefan/AAF-8290-2020; Van den Broeke, Michiel R./F-7867-2011; Hock, Regine/C-6179-2013; Berthier, Etienne/B-8900-2009; Bolch, Tobias/ABE-6635-2020; Wouters, Bert/AAA-4254-2019; Bolch, Tobias/A-1935-2008	Wouters, Bert/0000-0002-1086-2435; Van den Broeke, Michiel R./0000-0003-4662-7565; Berthier, Etienne/0000-0001-5978-9155; Bolch, Tobias/0000-0002-8201-5059; Wouters, Bert/0000-0002-1086-2435; Bolch, Tobias/0000-0002-8201-5059; Gardner, Alex/0000-0002-8394-8889; Hock, Regine/0000-0001-8336-9441	Natural Sciences and Engineering Research Council of Canada; NASA [NNX09AE52G, NNX11AF41G, NNX11A023G]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [FP7-PEOPLE-2011-IOF-301260]; TOSCA program of the French Space Agency (CNES); NSF [ANT-1043649]; Austrian Science Fund (FWF) [P25362-N26]; Deutsche Forschungsgemeinschaft (DFG) [BO 3199/2-1]; European Space Agency project Glaciers_cci [4000101778/10/I-AM]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NASA(National Aeronautics & Space Administration (NASA)); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; TOSCA program of the French Space Agency (CNES); NSF(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Space Agency project Glaciers_cci	We thank K. Matsuo, M. Huss, T. Jacob, A. Kaab, S. Luthcke, A. Willsman, M. Willis, and I. Sasgen for updated or early access to regional estimates of glacier mass change; M. Flanner, T. Jacob, and S. Swenson for helping with analysis of the hydrologic models; A. Bliss, N. Molg, C. Nuth, P. Rastner, M. Willis, and G. Wolken for providing regional areas of ocean-terminating glacier basins; J. Lenaerts and J. van Angelen for providing RACMO2 output for Greenland and Antarctica; J. Box and C. Chen for making available Greenland Ice Sheet snowline estimates; G. A, R. Riva, and P. Stocchi for providing glacial isostatic adjustment models; and C. Starr and the NASA/Goddard Space Flight Center Scientific Visualization Studio for help with Fig. 1. This work was supported by funding to A. S. G. and M. J. S. from the Natural Sciences and Engineering Research Council of Canada, G. M. from NASA award NNX09AE52G, B. W. from a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (FP7-PEOPLE-2011-IOF-301260), E. B. from the TOSCA program of the French Space Agency (CNES), R. H. from NASA grants NNX11AF41G and NNX11A023G and NSF grant ANT-1043649, G. K. from Austrian Science Fund (FWF) grant P25362-N26, T. B. from the Deutsche Forschungsgemeinschaft (DFG, BO 3199/2-1), and F. P. from European Space Agency project Glaciers_cci (4000101778/10/I-AM).	Arendt A., 2012, RANDOLPH GLACIER INV; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Bliss A, 2013, ANN GLACIOL, V54, P191, DOI 10.3189/2013AoG63A377; Bolch T, 2013, GEOPHYS RES LETT, V40, P875, DOI 10.1002/grl.50270; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Cogley JG, 2009, ANN GLACIOL, V50, P96, DOI 10.3189/172756409787769744; Cogley JG, 1998, J GLACIOL, V44, P315, DOI 10.3189/S0022143000002641; Dyurgerov M., 2005, 55 U COL I ARCT AL S; Dyurgerov MB, 1997, ARCTIC ALPINE RES, V29, P379, DOI 10.2307/1551986; Gardelle J, 2012, NAT GEOSCI, V5, P322, DOI [10.1038/ngeo1450, 10.1038/NGEO1450]; Gardner A, 2012, CRYOSPHERE, V6, P1103, DOI 10.5194/tc-6-1103-2012; Gardner AS, 2011, NATURE, V473, P357, DOI 10.1038/nature10089; Hock R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037020; Ivins ER, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007607; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Kaser G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027511; Ligtenberg SRM, 2011, CRYOSPHERE, V5, P809, DOI 10.5194/tc-5-809-2011; Luthcke SB, 2008, J GLACIOL, V54, P767, DOI 10.3189/002214308787779933; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Melkonian A. K., 2012, CRYOSPHERE DISCUSS, V6, P3503; Moholdt G, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051466; Moholdt G, 2010, REMOTE SENS ENVIRON, V114, P2756, DOI 10.1016/j.rse.2010.06.008; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rastner P, 2012, CRYOSPHERE, V6, P1483, DOI 10.5194/tc-6-1483-2012; Rignot E, 2003, SCIENCE, V302, P434, DOI 10.1126/science.1087393; Rinne EJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF001972; Sasgen I, 2012, J GEODYN, V59-60, P49, DOI 10.1016/j.jog.2012.03.004; Schiefer E, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030780; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Willis MJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053136; Willis MJ, 2012, REMOTE SENS ENVIRON, V117, P184, DOI 10.1016/j.rse.2011.09.017; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zemp M, 2009, ANN GLACIOL, V50, P101, DOI 10.3189/172756409787769591	35	872	926	21	431	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					852	857		10.1126/science.1234532	http://dx.doi.org/10.1126/science.1234532			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687045	Green Accepted			2022-12-28	WOS:000318997400041
J	Stratta, P; Rossi, A				Stratta, Paolo; Rossi, Alessandro			Misreporting of suicide after the L'Aquila earthquake	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AFTERMATH; DISASTERS		[Stratta, Paolo] ASL 1, Dept Mental Hlth, I-67100 Laquila, Italy; [Stratta, Paolo] Univ Pisa, Dept Clin & Expt Med, PhD Programme, I-56100 Pisa, Italy; [Rossi, Alessandro] Univ Aquila, Dept Appl Clin Sci & Biotechnol, I-67100 Laquila, Italy	University of Pisa; University of L'Aquila	Stratta, P (corresponding author), ASL 1, Dept Mental Hlth, Via Bellisari, I-67100 Laquila, Italy.	psystr@tin.it		ROSSI, Alessandro/0000-0001-8723-7622; Stratta, Paolo/0000-0002-3337-1225				[Anonymous], AQ DIM; [Anonymous], MAL VIV AQ AUM NUM S; [Anonymous], ANS ABB OR SISM SCUO; Dell'Osso L, 2011, J AFFECT DISORDERS, V131, P79, DOI 10.1016/j.jad.2010.11.023; Istat.it, SUIC TENT SUIC; Kolves K, 2013, J AFFECT DISORDERS, V146, P1, DOI 10.1016/j.jad.2012.07.037; Stratta P, 2013, CRISIS, V34, P142, DOI 10.1027/0227-5910/a000166; Stratta P, 2012, ANN I SUPER SANITA, V48, P132, DOI 10.4415/ANN_12_02_05; Vasterman P, 2005, EPIDEMIOL REV, V27, P107, DOI 10.1093/epirev/mxi002; World Health Organization, 2000, PREV SUIC RES MED PR	10	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2013	346								f3179	10.1136/bmj.f3179	http://dx.doi.org/10.1136/bmj.f3179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OK	23687102				2022-12-28	WOS:000319254600001
J	Benavente, OR; Coffey, CS; Conwit, R; Hart, RG; McClure, LA; Pearce, LA; Pergola, PE; Szychowski, JM; Benavente, OR; Hart, RG; Pergola, PE; Palacio, S; Castro, I; Farias, A; Roldan, A; Kase, C; Gavras, I; Lau, H; Ogrodnik, M; Allen, N; Meissner, I; Graves, J; Herzig, D; Covalt, J; Meyer, B; Jackson, C; Gamble, P; Kelly, N; Warner, J; Bell, J; Demaerschalk, B; Hogan, M; Wochos, D; Wieser, J; Cleary, B; Wood, L; Hanna, J; Zipp, T; Bailey, S; Cook, D; Liskay, A; Simcox, D; Kappler, J; Anderson, D; Grimm, R; Brauer, D; Pettigrew, C; Vaishnov, A; Sawaya, P; Fowler, A; Hughes, N; Rice, J; Vanderpool, K; Cruz-Flores, S; Walden, HD; Holzemer, E; Santhakumar, S; Van Stavern, R; Chatuverdi, S; Flack, J; Mada, F; Wiseman, D; Berlow, E; Klinker, J; Chiu, D; Taylor, A; Katz, L; Coull, B; Howard, L; Malekniazi, M; VanSkiver, M; Bruck, D; Redman, S; Logan, W; Carpenter, D; Schroer, S; Katramados, A; Silver, B; Yee, J; Aiello, K; Wilson, K; McCarthy, S; Dandapani, B; Spies, CP; Vasile, C; Anthony, B; Ferguson, J; Krubel, S; Synman, A; Andrews, N; Kirshner, H; Sussman, C; Brown, D; Elkind, M; Crew, RJ; Radhakrishan, J; Corporan, TE; Diaz, J; Aragon, R; Slivka, A; Spetie, D; Agriesti, J; Notstein, P; Naritoku, D; Zweifler, R; Culpepper, M; Parnell, M; Yunker, R; Boots, K; Drinkard, R; Backlin, R; Benesch, C; Bisognano, J; Leonhardt, A; Zentner, J; Hildreth, M; Johnson, M; Liu, Y; Goldsteen, R; Blair, A; Wright, G; Gathua, N; Book, D; Eapen, S; Grimm, C; Blaney, B; Rozman, S; Gaertner, L; Bradenburg, E; Loomis, L; Monarch-Cotton, J; Ravavelli-Meyer, J; Golembieski, A; Burgin, SW; Hollander, J; Polashenski, W; Wallace, P; Weber, C; Lutsep, H; Girard, D; Seisler, K; Cingel, M; Ross, M; Stone, R; Larsen, D; Doherty, A; David, L; Levy, P; Buchheimer, N; Vaughn, S; Smith, E; Satterfield, J; Tirschwell, D; Logar, C; Ryan, M; Schubert, G; Tanzai, P; Mirsen, T; McAllister, S; Bastien, A; Niblack, P; Frey, J; Darbonne, C; Karanjia, P; Murali, N; Dart, R; Mancl, K; Atkinson, R; Lieberman, R; Carter, T; Zrelak, P; Kenney, N; Jacoby, M; Jones, D; DeFrancisco, J; Hamm, T; Romano, J; Ortiz, G; Lichtenberger, MD; Linas, R; Kravet, S; Alt, J; Sundararajan, S; Rahman, M; Horvath, T; Korosec, D; Murphy, C; Greenberg, J; Lennihan, L; King, M; Tenteromano, L; Frankel, M; Doyle, J; Braimah, J; Pereira, L; Ching, M; Sawyer, R; Parkes, K; Conover, C; Albakri, E; Ramirez, G; Segal, S; Taylor, K; Jackson, J; Helgason, K; Hillmann, M; Ringel, R; Fleming, N; Mckown, B; Cohen, S; Jenders, R; Singh, R; La, MT; Trinh, K; Weinberger, J; Wright, L; Burch, D; Horowitz, R; Atlas, S; Augustine, S; Van Stavern, R; Brown, A; Serna, J; Newgent, J; Naylor, J; Carpenter, L; Warwick, T; Stoltz, S; Garcia, R; Scheck, M; Chadwick, L; Fleck, J; Weinberger, M; Sears, A; Fanale, C; Neeper, L; Fisk, P; Cohen, S; Sabry, D; Phoenix, R; Tong, D; Garcia, M; Mackey, A; Morin, J; Hache, A; Lessard, C; Cote, R; Green, L; Wadup, L; Fontaine, AM; Gubitz, G; Rebello, R; Dean, T; Reidy, Y; Sharma, M; Stotts, G; Clark, H; Mortensen, M; Sauve, J; Sharma, D; Savage, M; Minuk, J; Trudeau, L; Schanz, C; Berger, L; Brunet, S; Pontbriand, J; Mainville, M; Racicot, D; Hill, M; Fischer, K; Cole-Kaskayne, A; Keeney, C; Shuab, A; Khan, K; Dean, N; Herbert, F; Kastelic, K; Pretell, EJ; Valdivia, J; Pretell, M; del Brutto, O; Santibanez, R; Lara, J; Zambrano, M; Arauz, A; Cervantes, GA; Leyva, A; Camacho, I; Sandoval, JLR; Vasquez, ES; Ruiz, C; Brito, CC; Fernandez, M; Gongora-Rivera, JF; Escamilla, JM; Moxica, J; Arciniega, G; Gonzalez, WJ; Matamala, G; Goecke, H; Parra, M; Pozo, J; Tapia, J; Godoy, IE; Valdes, M; Estol, C; Peralta, C; Ellenberg, A; Chezzio, D; Pardal, MMF; Trimachi, H; Bonardo, P; Mazziotti, J; Rey, RC; Caruso, G; Melamud, L; Lepera, S; Stilman, AP; Ameriso, S; Sanchez, R; Bruera, G; Moschini, J; Ramirez, MJ; Bueri, JA; Sevilla, S; de Ambrosi, B; Marinsalta, G; Rubio, F; Krupinski, Y; Carvajal, A; Roquer, J; Serrano, AO; Conde, JJ; Rodriguez, A; Romeral, G; Arboix, A; Pelegri, A; Blanco, L; Verge, DC; Herrero, JE; Gomez, A; Blanco, L; Leal, JS; Castellanos, M; Cruz, V; Cepeda, M; Gomis, M; Arenillas, J; Davalos, A; Sunol, A; Reverte, S; Lluis, J; Sergio, MV; Marin, MR; Sanchez, JC; Blanco, M; Rodriguez, GM; Jimenez, I; Rodriguez, J; Tejedor, ED; Martinez, P; Fuentes, B; Singla, LS; Balaguer, E; Izquierdo, J; Soler, C; Armenteros, M; Benavente, OR; Hart, RG; Pergola, PE; Shepherd, A; Roldan, A; Benavente, MF; White, C; Robu, C; Kelly, C; Talbert, R; Martinez, E; Bazan, C; Pergola, G; Pearce, LA; Costello, R; Jacova, C; Camelia, L; Mendoza, C; Pratt, B; Kin, B; Holliday, S; McClure, LA; Coffey, C; Szychowski, M; Howard, G; Katholi, C; Zhang, Y; Peri, K; Allcorn, C; Mailhot, R; Irby, L; Guyton, F; Sewell, MJ; Ringer, R; Raisch, D; Hunt, D; Rubio, F; Rosso, CM; Martin, A; Sanllorente, M; Arabetti, C; Fernandez, JL; Cremona, MJ; Capece, A; Benavente, OR; Hart, RG; Benavente, MF; Coffey, C; Conwit, R; McClure, LA; Pergola, PE; Roldan, A; Szychowski, JM; Talbert, R; Benavente, OR; Anderson, D; Arauz, A; Benavente, MF; Coffey, C; Conwit, R; Cote, R; Demaerschalk, B; del Brutto, O; Elkind, M; Hart, RG; Kase, C; McClure, LA; Moy, C; Pergola, PE; Roldan, A; Sharma, M; Szychowski, JM; Talbert, R; White, C; White, C; Benavente, OR; Benesch, C; Coffey, C; Conwit, R; Graves, J; Grimm, R; Gubitz, G; Holliday, S; Lau, H; Moy, C; Pearce, LA; Szychowski, JM; Aguilar, M; Sherman, D; Nasco, E; Blackshear, J; Chung, M; Fayad, P; Gage, B; Johnston, C; Kernan, W; Leira, E; Merino, J; Roman, G; Sila, C; Sung, G; van Walraven, C; Zweifler, R; Stern, B; Conwit, R; Moy, C; Welch, KM; Clarke, W; Cutler, J; Furie, K; Johnston, K; Mayo, M				Benavente, O. R.; Coffey, C. S.; Conwit, R.; Hart, R. G.; McClure, L. A.; Pearce, L. A.; Pergola, P. E.; Szychowski, J. M.; Benavente, O. R.; Hart, R. G.; Pergola, P. E.; Palacio, S.; Castro, I.; Farias, A.; Roldan, A.; Kase, C.; Gavras, I.; Lau, H.; Ogrodnik, M.; Allen, N.; Meissner, I.; Graves, J.; Herzig, D.; Covalt, J.; Meyer, B.; Jackson, C.; Gamble, P.; Kelly, N.; Warner, J.; Bell, J.; Demaerschalk, B.; Hogan, M.; Wochos, D.; Wieser, J.; Cleary, B.; Wood, L.; Hanna, J.; Zipp, T.; Bailey, S.; Cook, D.; Liskay, A.; Simcox, D.; Kappler, J.; Anderson, D.; Grimm, R.; Brauer, D.; Pettigrew, C.; Vaishnov, A.; Sawaya, P.; Fowler, A.; Hughes, N.; Rice, J.; Vanderpool, K.; Cruz-Flores, S.; Walden, H. D.; Holzemer, E.; Santhakumar, S.; Van Stavern, R.; Chatuverdi, S.; Flack, J.; Mada, F.; Wiseman, D.; Berlow, E.; Klinker, J.; Chiu, D.; Taylor, A.; Katz, L.; Coull, B.; Howard, L.; Malekniazi, M.; VanSkiver, M.; Bruck, D.; Redman, S.; Logan, W.; Carpenter, D.; Schroer, S.; Katramados, A.; Silver, B.; Yee, J.; Aiello, K.; Wilson, K.; McCarthy, S.; Dandapani, B.; Spies, C. P.; Vasile, C.; Anthony, B.; Ferguson, J.; Krubel, S.; Synman, A.; Andrews, N.; Kirshner, H.; Sussman, C.; Brown, D.; Elkind, M.; Crew, R. J.; Radhakrishan, J.; Corporan, T. E.; Diaz, J.; Aragon, R.; Slivka, A.; Spetie, Dan; Agriesti, J.; Notstein, P.; Naritoku, D.; Zweifler, R.; Culpepper, M.; Parnell, M.; Yunker, R.; Boots, K.; Drinkard, R.; Backlin, R.; Benesch, C.; Bisognano, J.; Leonhardt, A.; Zentner, J.; Hildreth, M.; Johnson, M.; Liu, Y.; Goldsteen, R.; Blair, A.; Wright, G.; Gathua, N.; Book, D.; Eapen, S.; Grimm, C.; Blaney, B.; Rozman, S.; Gaertner, L.; Bradenburg, E.; Loomis, L.; Monarch-Cotton, J.; Ravavelli-Meyer, J.; Golembieski, A.; Burgin, S. W.; Hollander, J.; Polashenski, W.; Wallace, P.; Weber, C.; Lutsep, H.; Girard, D.; Seisler, K.; Cingel, M.; Ross, M.; Stone, R.; Larsen, D.; Doherty, A.; David, L.; Levy, P.; Buchheimer, N.; Vaughn, S.; Smith, E.; Satterfield, J.; Tirschwell, D.; Logar, C.; Ryan, M.; Schubert, G.; Tanzai, P.; Mirsen, T.; McAllister, S.; Bastien, A.; Niblack, P.; Frey, J.; Darbonne, C.; Karanjia, P.; Murali, N.; Dart, R.; Mancl, K.; Atkinson, R.; Lieberman, R.; Carter, T.; Zrelak, P.; Kenney, N.; Jacoby, M.; Jones, D.; DeFrancisco, J.; Hamm, T.; Romano, J.; Ortiz, G.; Lichtenberger, M. del Carmen; Linas, R.; Kravet, S.; Alt, J.; Sundararajan, S.; Rahman, M.; Horvath, T.; Korosec, D.; Murphy, C.; Greenberg, J.; Lennihan, L.; King, M.; Tenteromano, L.; Frankel, M.; Doyle, J.; Braimah, J.; Pereira, L.; Ching, M.; Sawyer, R.; Parkes, K.; Conover, C.; Albakri, E.; Ramirez, G.; Segal, S.; Taylor, K.; Jackson, J.; Helgason, K.; Hillmann, M.; Ringel, R.; Fleming, N.; Mckown, B.; Cohen, S.; Jenders, R.; Singh, R.; La, M-T; Trinh, K.; Weinberger, J.; Wright, L.; Burch, D.; Horowitz, R.; Atlas, S.; Augustine, S.; Van Stavern, R.; Brown, A.; Serna, J.; Newgent, J.; Naylor, J.; Carpenter, L.; Warwick, T.; Stoltz, S.; Garcia, R.; Scheck, M.; Chadwick, L.; Fleck, J.; Weinberger, M.; Sears, A.; Fanale, C.; Neeper, L.; Fisk, P.; Cohen, S.; Sabry, D.; Phoenix, R.; Tong, D.; Garcia, M.; Mackey, A.; Morin, J.; Hache, A.; Lessard, C.; Cote, R.; Green, L.; Wadup, L.; Fontaine, A-M; Gubitz, G.; Rebello, R.; Dean, T.; Reidy, Y.; Sharma, M.; Stotts, G.; Clark, H.; Mortensen, M.; Sauve, J.; Sharma, D.; Savage, M.; Minuk, J.; Trudeau, L.; Schanz, C.; Berger, L.; Brunet, S.; Pontbriand, J.; Mainville, M.; Racicot, D.; Hill, M.; Fischer, K.; Cole-Kaskayne, A.; Keeney, C.; Shuab, A.; Khan, K.; Dean, N.; Herbert, F.; Kastelic, K.; Pretell, E. J.; Valdivia, J.; Pretell, M.; del Brutto, O.; Santibanez, R.; Lara, J.; Zambrano, M.; Arauz, A.; Cervantes, G. A.; Leyva, A.; Camacho, I.; Sandoval, J. L. Ruiz; Vasquez, E. Salcido; Ruiz, C.; Brito, C. Cantu; Fernandez, M.; Gongora-Rivera, J. F.; Escamilla, J. M.; Moxica, J.; Arciniega, G.; Gonzalez, W. J.; Matamala, G.; Goecke, H.; Parra, M.; Pozo, J.; Tapia, J.; Godoy, I. E.; Valdes, M.; Estol, C.; Peralta, C.; Ellenberg, A.; Chezzio, D.; Pardal, M. M. Fernandez; Trimachi, H.; Bonardo, P.; Mazziotti, J.; Rey, R. C.; Caruso, G.; Melamud, L.; Lepera, S.; Stilman, A. P.; Ameriso, S.; Sanchez, R.; Bruera, G.; Moschini, J.; Ramirez, M. J.; Bueri, J. A.; Sevilla, S.; de Ambrosi, B.; Marinsalta, G.; Rubio, F.; Krupinski, Y.; Carvajal, A.; Roquer, J.; Serrano, A. Oliveras; Conde, J. Jimenez; Rodriguez, A.; Romeral, G.; Arboix, A.; Pelegri, A.; Blanco, L.; Verge, D. Canovas; Herrero, J. Estela; Gomez, A.; Blanco, L.; Leal, J. S.; Castellanos, M.; Cruz, V.; Cepeda, M.; Gomis, M.; Arenillas, J.; Davalos, A.; Sunol, A.; Reverte, S.; Lluis, J.; Sergio, M. V.; Marin, M. R.; Sanchez, J. Castillo; Blanco, M.; Rodriguez, G. Manuel; Jimenez, I.; Rodriguez, J.; Tejedor, E. Diez; Martinez, P.; Fuentes, B.; Singla, L. Soler; Balaguer, E.; Izquierdo, J.; Soler, C.; Armenteros, M.; Benavente, O. R.; Hart, R. G.; Pergola, P. E.; Shepherd, A.; Roldan, A.; Benavente, M-F; White, C.; Robu, C.; Kelly, C.; Talbert, R.; Martinez, E.; Bazan, C.; Pergola, G.; Pearce, L. A.; Costello, R.; Jacova, C.; Camelia, L.; Mendoza, C.; Pratt, B.; Kin, B.; Holliday, S.; McClure, L. A.; Coffey, C.; Szychowski, M.; Howard, G.; Katholi, C.; Zhang, Yu; Peri, K.; Allcorn, C.; Mailhot, R.; Irby, L.; Guyton, F.; Sewell, M. J.; Ringer, R.; Raisch, D.; Hunt, D.; Rubio, F.; Rosso, C. M.; Martin, A.; Sanllorente, M.; Arabetti, C.; Fernandez, J. Luis; Cremona, M. J.; Capece, A.; Benavente, O. R.; Hart, R. G.; Benavente, M-F; Coffey, C.; Conwit, R.; McClure, L. A.; Pergola, P. E.; Roldan, A.; Szychowski, J. M.; Talbert, R.; Benavente, O. R.; Anderson, D.; Arauz, A.; Benavente, M-F; Coffey, C.; Conwit, R.; Cote, R.; Demaerschalk, B.; del Brutto, O.; Elkind, M.; Hart, R. G.; Kase, C.; McClure, L. A.; Moy, C.; Pergola, P. E.; Roldan, A.; Sharma, M.; Szychowski, J. M.; Talbert, R.; White, C.; White, C.; Benavente, O. R.; Benesch, C.; Coffey, C.; Conwit, R.; Graves, J.; Grimm, R.; Gubitz, G.; Holliday, S.; Lau, H.; Moy, C.; Pearce, L. A.; Szychowski, J. M.; Aguilar, M.; Sherman, D.; Nasco, E.; Blackshear, J.; Chung, M.; Fayad, P.; Gage, B.; Johnston, C.; Kernan, W.; Leira, E.; Merino, J.; Roman, G.; Sila, C.; Sung, G.; van Walraven, C.; Zweifler, R.; Stern, B.; Conwit, R.; Moy, C.; Welch, K. M.; Clarke, W.; Cutler, J.; Furie, K.; Johnston, K.; Mayo, M.			Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial	LANCET			English	Article							SECONDARY PREVENTION; RECURRENT STROKE; ASPIRIN; EVENTS; CLOPIDOGREL; RISK	Background Lowering of blood pressure prevents stroke but optimum target levels to prevent recurrent stroke are unknown. We investigated the effects of different blood-pressure targets on the rate of recurrent stroke in patients with recent lacunar stroke. Methods In this randomised open-label trial, eligible patients lived in North America, Latin America, and Spain and had recent, MRI-defined symptomatic lacunar infarctions. Patients were recruited between March, 2003, and April, 2011, and randomly assigned, according to a two-by-two multifactorial design, to a systolic-blood-pressure target of 130-149 mm Hg or less than 130 mm Hg. The primary endpoint was reduction in all stroke (including ischaemic strokes and intracranial haemorrhages). Analysis was done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT 00059306. Findings 3020 enrolled patients, 1519 in the higher-target group and 1501 in the lower-target group, were followed up for a mean of 3.7 (SD 2.0) years. Mean age was 63 (SD 11) years. After 1 year, mean systolic blood pressure was 138 mm Hg (95% CI 137-139) in the higher-target group and 127 mm Hg (95% CI 126-128) in the lower-target group. Non-significant rate reductions were seen for all stroke (hazard ratio 0.81, 95% CI 0.64-1.03, p=0.08), disabling or fatal stroke (0.81, 0.53-1.23, p=0.32), and the composite outcome of myocardial infarction or vascular death (0.84, 0.68-1.04, p=0.32) with the lower target. The rate of intracerebral haemorrhage was reduced significantly (0.37, 0.15-0.95, p=0.03). Treatment-related serious adverse events were infrequent. Interpretation Although the reduction in stroke was not significant, our results support that in patients with recent lacunar stroke, the use of a systolic-blood-pressure target of less than 130 mm Hg is likely to be beneficial.	[Benavente, O. R.] Univ British Columbia, Dept Med, Div Neurol, S169-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada; [Benavente, O. R.; Hart, R. G.; Pergola, P. E.; Palacio, S.; Castro, I.; Farias, A.; Roldan, A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Kase, C.; Gavras, I.; Lau, H.; Ogrodnik, M.; Allen, N.] Boston Univ, Boston, MA 02215 USA; [Meissner, I.; Graves, J.; Herzig, D.; Covalt, J.] Mayo Clin Rochester, Stroke Ctr, Rochester, MN USA; [Meyer, B.; Jackson, C.; Gamble, P.; Kelly, N.; Warner, J.; Bell, J.] Univ Calif San Diego, San Diego, CA 92103 USA; [Demaerschalk, B.; Hogan, M.; Wochos, D.; Wieser, J.; Cleary, B.; Wood, L.] Mayo Clin Scottsdale, Scottsdale, AZ USA; [Hanna, J.; Zipp, T.; Bailey, S.; Cook, D.; Liskay, A.; Simcox, D.; Kappler, J.] Metrohealth Med Ctr, Cleveland, OH USA; [Anderson, D.; Grimm, R.; Brauer, D.] Berman Ctr Clin Res, Minneapolis, MN USA; [Pettigrew, C.; Vaishnov, A.; Sawaya, P.; Fowler, A.; Hughes, N.; Rice, J.; Vanderpool, K.] Univ Kentucky, Lexington, KY USA; [Cruz-Flores, S.; Walden, H. D.; Holzemer, E.] St Louis Univ, St Louis, MO 63103 USA; [Santhakumar, S.; Van Stavern, R.; Chatuverdi, S.; Flack, J.; Mada, F.; Wiseman, D.; Berlow, E.; Klinker, J.] Wayne State Univ, Sch Med, Detroit, MI USA; [Chiu, D.; Taylor, A.; Katz, L.] Methodist Hosp, Houston, TX 77030 USA; [Coull, B.; Howard, L.; Malekniazi, M.; VanSkiver, M.; Bruck, D.; Redman, S.] Univ Arizona, Tucson, AZ USA; [Logan, W.; Carpenter, D.; Schroer, S.] St Johns Mercy Med Ctr, St Louis, MO 63141 USA; [Katramados, A.; Silver, B.; Yee, J.; Aiello, K.; Wilson, K.; McCarthy, S.] Henry Ford Hosp, Detroit, MI 48202 USA; [Dandapani, B.; Spies, C. P.; Vasile, C.; Anthony, B.; Ferguson, J.; Krubel, S.; Synman, A.] MIMA, Melbourne, FL USA; [Kirshner, H.; Sussman, C.; Brown, D.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Elkind, M.; Crew, R. J.; Radhakrishan, J.; Corporan, T. E.; Diaz, J.; Aragon, R.] Columbia Univ, Med Ctr, New York, NY USA; [Slivka, A.; Spetie, Dan; Agriesti, J.; Notstein, P.] Ohio State Univ, Columbus, OH 43210 USA; [Naritoku, D.; Zweifler, R.; Culpepper, M.; Parnell, M.; Yunker, R.; Boots, K.; Drinkard, R.; Backlin, R.] Univ S Alabama, Mobile, AL 36688 USA; [Benesch, C.; Bisognano, J.; Leonhardt, A.; Zentner, J.; Hildreth, M.] Univ Rochester, Rochester, NY USA; [Johnson, M.; Liu, Y.; Goldsteen, R.] Univ Texas Southwestern, Dallas, TX USA; [Book, D.; Eapen, S.; Grimm, C.; Blaney, B.; Rozman, S.; Gaertner, L.; Bradenburg, E.; Loomis, L.; Monarch-Cotton, J.; Ravavelli-Meyer, J.; Golembieski, A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Burgin, S. W.; Hollander, J.; Polashenski, W.; Wallace, P.; Weber, C.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Lutsep, H.; Girard, D.; Seisler, K.; Cingel, M.; Ross, M.; Stone, R.; Larsen, D.; Doherty, A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [David, L.; Levy, P.; Buchheimer, N.; Vaughn, S.; Smith, E.; Satterfield, J.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Tirschwell, D.; Logar, C.; Ryan, M.; Schubert, G.; Tanzai, P.] Univ Washington, Seattle, WA 98195 USA; [Mirsen, T.; McAllister, S.; Bastien, A.; Niblack, P.] Cooper Hlth Syst Dept Med, Camden, NJ USA; [Frey, J.; Darbonne, C.] St Josephs Hosp, Med Ctr, Phoenix, AZ USA; [Karanjia, P.; Murali, N.; Dart, R.; Mancl, K.] Marshfield Clin Dept Neurol, Marshfield, WI USA; [Atkinson, R.; Lieberman, R.; Carter, T.; Zrelak, P.; Kenney, N.] Sutter Neurosci Inst, Sacramento, CA USA; [Jacoby, M.; Jones, D.; DeFrancisco, J.; Hamm, T.] Ruan Neurol Clin & Res Ctr, Des Moines, IA USA; [Romano, J.; Ortiz, G.; Lichtenberger, M. del Carmen] Univ Miami, Miller Sch, Miami, FL USA; [Linas, R.; Kravet, S.; Alt, J.] Johns Hopkins Bayview, Baltimore, MD USA; [Sundararajan, S.; Rahman, M.; Horvath, T.; Korosec, D.; Murphy, C.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Greenberg, J.; Lennihan, L.; King, M.; Tenteromano, L.] Helen Hayes Hosp, W Haverstraw, NY USA; [Frankel, M.; Doyle, J.; Braimah, J.] Emory Univ, Atlanta, GA 30322 USA; [Pereira, L.; Ching, M.; Sawyer, R.; Parkes, K.; Conover, C.] SUNY Buffalo, Res Fdn, Buffalo, NY USA; [Albakri, E.; Ramirez, G.; Segal, S.; Taylor, K.; Jackson, J.] Florida Neurovasc Inst, Tampa, FL USA; [Helgason, K.; Hillmann, M.] Univ Illinois, Chicago, IL USA; [Ringel, R.; Fleming, N.; Mckown, B.] Spartanburg Reg Med Ctr, Spartanburg, SC USA; [Cohen, S.; Jenders, R.; Singh, R.; La, M-T] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Weinberger, J.; Wright, L.; Burch, D.] North Gen Hosp, New York, NY USA; [Horowitz, R.; Atlas, S.; Augustine, S.] Mt Sinai Sch Med, New York, NY USA; [Van Stavern, R.; Brown, A.; Serna, J.; Newgent, J.; Naylor, J.; Carpenter, L.] Washington Univ, St Louis, MO USA; [Warwick, T.; Stoltz, S.; Garcia, R.] Univ Calif San Francisco, Fresno, CA USA; [Scheck, M.; Chadwick, L.] Loyola Univ, Maywood, IL 60153 USA; [Fleck, J.; Weinberger, M.; Sears, A.] Indiana Univ, Indianapolis, IN 46204 USA; [Fanale, C.; Neeper, L.; Fisk, P.] Colorado Neurol Inst, Denver, CO USA; [Cohen, S.; Sabry, D.; Phoenix, R.] Nevada Neurosci Inst Sunrise, Las Vegas, NV USA; [Tong, D.; Garcia, M.] Stanford Univ, Stanford, CA 94305 USA; [Mackey, A.; Morin, J.; Hache, A.; Lessard, C.] Hopital Enfant Jesus CHA, Quebec City, PQ, Canada; [Cote, R.; Green, L.; Wadup, L.; Fontaine, A-M] McGill Univ Montreal Gen, Montreal, PQ, Canada; [Gubitz, G.; Rebello, R.; Dean, T.; Reidy, Y.] Clin Res Ctr, Halifax, NS, Canada; [Sharma, M.; Stotts, G.; Clark, H.; Mortensen, M.; Sauve, J.; Sharma, D.; Savage, M.] Ottawa Civic Hosp, Ottawa, ON K1Y 4E9, Canada; [Minuk, J.; Trudeau, L.; Schanz, C.] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Hill, M.; Fischer, K.; Cole-Kaskayne, A.; Keeney, C.] Univ Calgary, Calgary, AB, Canada; [Shuab, A.; Khan, K.; Dean, N.; Herbert, F.; Kastelic, K.] Univ Alberta Stroke Res NACTRC, Edmonton, AB, Canada; [Pretell, E. J.; Valdivia, J.; Pretell, M.] Hosp Clin Kennedy, Guayaquil, Ecuador; [Arauz, A.; Cervantes, G. A.; Leyva, A.; Camacho, I.] Inst Nacl Neurol & Neurocirug, Mexico City, DF, Mexico; [Sandoval, J. L. Ruiz; Vasquez, E. Salcido; Ruiz, C.] Hosp Civil Mexico, Guadalajara, Jalisco, Mexico; [Brito, C. Cantu; Fernandez, M.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Matamala, G.; Goecke, H.; Parra, M.; Pozo, J.] Catholic Univ, Hosp Naval, Santiago, Spain; [Tapia, J.; Godoy, I. E.; Valdes, M.] Catholic Univ Chile, Hosp Clin, Santiago, Chile; [Estol, C.; Peralta, C.; Ellenberg, A.; Chezzio, D.] Ctr Neurol, Buenos Aires, DF, Argentina; [Pardal, M. M. Fernandez; Trimachi, H.; Bonardo, P.; Mazziotti, J.] Hosp Britan, Buenos Aires, DF, Argentina; [Rey, R. C.; Caruso, G.; Melamud, L.; Lepera, S.; Stilman, A. P.] Hosp Ramos Mejia, Buenos Aires, DF, Argentina; [Ameriso, S.; Sanchez, R.; Bruera, G.; Moschini, J.; de Ambrosi, B.; Marinsalta, G.] Inst FLENI, Buenos Aires, DF, Argentina; [Bueri, J. A.; Sevilla, S.; de Ambrosi, B.; Marinsalta, G.] Hosp Univ Austral, Buenos Aires, DF, Argentina; [Rubio, F.; Krupinski, Y.; Carvajal, A.] Bellvitge Hosp, Barcelona, Spain; [Roquer, J.; Serrano, A. Oliveras; Conde, J. Jimenez; Rodriguez, A.; Romeral, G.] Hosp Mar, Barcelona, Spain; [Arboix, A.; Pelegri, A.; Blanco, L.] Hosp Sagrat Cor, Barcelona, Spain; [Blanco, L.; Verge, D. Canovas; Herrero, J. Estela; Gomez, A.] Hosp Parc Tauli, Barcelona, Spain; [Gomis, M.; Arenillas, J.; Davalos, A.; Sunol, A.; Reverte, S.] Hosp Univ German Trias Pujol, Barcelona, Spain; [Lluis, J.; Sergio, M. V.; Marin, M. R.] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Sanchez, J. Castillo; Blanco, M.; Rodriguez, G. Manuel; Jimenez, I.; Rodriguez, J.] Univ Santiago Compostela, Hosp Clin, Santiago De Compostela, Spain; [Tejedor, E. Diez; Martinez, P.; Fuentes, B.] Hosp La Paz, Madrid, Spain; [Singla, L. Soler; Balaguer, E.; Izquierdo, J.; Soler, C.; Armenteros, M.] Hosp Gen Cataluna, Barcelona, Spain	University of British Columbia; University of Texas System; University of Texas Health San Antonio; Boston University; Mayo Clinic; University of California System; University of California San Diego; Mayo Clinic; Mayo Clinic Phoenix; MetroHealth System; University of Kentucky; Saint Louis University; Wayne State University; The Methodist Hospital System; The Methodist Hospital - Houston; University of Arizona; Saint Johns Mercy Medical Center; Henry Ford Health System; Henry Ford Hospital; Vanderbilt University; Columbia University; University System of Ohio; Ohio State University; University of South Alabama; University of Rochester; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical College of Wisconsin; University of Rochester; Oregon Health & Science University; Wake Forest University; University of Washington; University of Washington Seattle; St. Joseph's Hospital and Medical Center; University of Miami; Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University; Case Western Reserve University Hospital; Emory University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cedars Sinai Medical Center; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); University of California System; University of California San Francisco; University of California San Francisco at Fresno; Loyola University Chicago; Indiana University System; Indiana University-Purdue University Indianapolis; Stanford University; Dalhousie University; University of Ottawa; Ottawa Hospital Research Institute; McGill University; University of Calgary; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Catolica de Valencia San Vicente Martir; Pontificia Universidad Catolica de Chile; Hospital Britanico de Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Austral University; Hospital Universitario Austral; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Germans Trias i Pujol; Hospital of Santa Creu i Sant Pau; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Hospital Universitario La Paz	Benavente, OR (corresponding author), Univ British Columbia, Dept Med, Div Neurol, S169-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	scar.benavente@ubc.ca; oscar.benavente@ubc.ca	ameriso, sebastian/AAV-2296-2020; Reverté Villarroya, Silvia/AAX-7360-2020; Fuentes, Blanca/I-2114-2019; Hill, Michael D/C-9073-2012; Sánchez, Patricia Martínez/O-5687-2016; Cruz-Flores, Salvador/AAR-1233-2020; Zweifler, Richard/K-1314-2015; Arenillas, Juan F./AAE-1142-2020; McClure, Leslie/P-2929-2015; Scheck, Marcus/M-2839-2018; CCRN, Patricia Zrelak PhD NEA-bc SCRN/ABD-8527-2021; JIMENEZ-CONDE, JORDI/C-1941-2012; Roquer, Jaume/G-8919-2017; Arboix, Adrià/E-2067-2018	Reverté Villarroya, Silvia/0000-0002-2052-9978; Fuentes, Blanca/0000-0002-0363-862X; Hill, Michael D/0000-0002-6269-1543; Sánchez, Patricia Martínez/0000-0003-1945-4435; Cruz-Flores, Salvador/0000-0003-4998-1471; Scheck, Marcus/0000-0002-9624-3909; Roquer, Jaume/0000-0001-5992-2606; Arboix, Adrià/0000-0002-8512-7881; Spies, Claudia/0000-0002-1062-0495; Tirschwell, David/0000-0002-8059-2901; Castellanos, Maria del Mar/0000-0003-3116-1352; Pearce, Lesly/0000-0002-0838-1739	National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS038529] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS)	[Anonymous], 1974, JAMA-J AM MED ASSOC, V229, P409; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Benavente OR, 2011, INT J STROKE, V6, P164, DOI 10.1111/j.1747-4949.2010.00573.x; Bousser MG, 2011, LANCET, V377, P2013, DOI 10.1016/S0140-6736(11)60600-4; Chapman N, 2004, STROKE, V35, P116, DOI 10.1161/01.STR.0000106480.76217.6F; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; ERIKSSON S, 1995, CEREBROVASC DIS, V5, P21, DOI 10.1159/000107813; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gueyffier F, 1997, STROKE, V28, P2557, DOI 10.1161/01.STR.28.12.2557; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hansson L, 1994, Blood Press, V3, P322, DOI 10.3109/08037059409102281; Hong KS, 2011, CIRCULATION, V123, P2111, DOI 10.1161/CIRCULATIONAHA.109.934786; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; LIU LS, 1995, CHINESE MED J-PEKING, V108, P710; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; McClure LA, 2012, CONTEMP CLIN TRIALS, V33, P1088, DOI 10.1016/j.cct.2012.06.007; Pergola PE, 2007, BLOOD PRESS MONIT, V12, P1; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Sacco S, 2006, NEUROLOGY, V66, P1335, DOI 10.1212/01.wnl.0000210457.89798.0e; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; White CL, 2013, J STROKE CEREBROVASC, V22, P764, DOI 10.1016/j.jstrokecerebrovasdis.2012.03.002; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, N ENGL J MED, V364, P928; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593	25	417	432	1	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2013	382	9891					507	515		10.1016/S0140-6736(13)60852-1	http://dx.doi.org/10.1016/S0140-6736(13)60852-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201SD	23726159	Green Accepted			2022-12-28	WOS:000323162400029
J	Wolchok, JD; Kluger, H; Callahan, MK; Postow, MA; Rizvi, NA; Lesokhin, AM; Segal, NH; Ariyan, CE; Gordon, RA; Reed, K; Burke, MM; Caldwell, A; Kronenberg, SA; Agunwamba, BU; Zhang, XL; Lowy, I; Inzunza, HD; Feely, W; Horak, CE; Hong, Q; Korman, AJ; Wigginton, JM; Gupta, A; Sznol, M				Wolchok, Jedd D.; Kluger, Harriet; Callahan, Margaret K.; Postow, Michael A.; Rizvi, Naiyer A.; Lesokhin, Alexander M.; Segal, Neil H.; Ariyan, Charlotte E.; Gordon, Ruth-Ann; Reed, Kathleen; Burke, Matthew M.; Caldwell, Anne; Kronenberg, Stephanie A.; Agunwamba, Blessing U.; Zhang, Xiaoling; Lowy, Israel; Inzunza, Hector David; Feely, William; Horak, Christine E.; Hong, Quan; Korman, Alan J.; Wigginton, Jon M.; Gupta, Ashok; Sznol, Mario			Nivolumab plus Ipilimumab in Advanced Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY; SAFETY; THERAPY; CTLA-4; PD-1	BACKGROUND In patients with melanoma, ipilimumab (an antibody against cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4]) prolongs overall survival, and nivolumab (an antibody against the programmed death 1 [PD-1] receptor) produced durable tumor regression in a phase 1 trial. On the basis of their distinct immunologic mechanisms of action and supportive preclinical data, we conducted a phase 1 trial of nivolumab combined with ipilimumab in patients with advanced melanoma. METHODS We administered intravenous doses of nivolumab and ipilimumab in patients every 3 weeks for 4 doses, followed by nivolumab alone every 3 weeks for 4 doses (concurrent regimen). The combined treatment was subsequently administered every 12 weeks for up to 8 doses. In a sequenced regimen, patients previously treated with ipilimumab received nivolumab every 2 weeks for up to 48 doses. RESULTS A total of 53 patients received concurrent therapy with nivolumab and ipilimumab, and 33 received sequenced treatment. The objective-response rate (according to modified World Health Organization criteria) for all patients in the concurrent-regimen group was 40%. Evidence of clinical activity (conventional, unconfirmed, or immune-related response or stable disease for >= 24 weeks) was observed in 65% of patients. At the maximum doses that were associated with an acceptable level of adverse events (nivolumab at a dose of 1 mg per kilogram of body weight and ipilimumab at a dose of 3 mg per kilogram), 53% of patients had an objective response, all with tumor reduction of 80% or more. Grade 3 or 4 adverse events related to therapy occurred in 53% of patients in the concurrent-regimen group but were qualitatively similar to previous experience with monotherapy and were generally reversible. Among patients in the sequenced-regimen group, 18% had grade 3 or 4 adverse events related to therapy and the objective-response rate was 20%. CONCLUSIONS Concurrent therapy with nivolumab and ipilimumab had a manageable safety profile and provided clinical activity that appears to be distinct from that in published data on monotherapy, with rapid and deep tumor regression in a substantial proportion of patients.	[Wolchok, Jedd D.; Callahan, Margaret K.; Postow, Michael A.; Rizvi, Naiyer A.; Lesokhin, Alexander M.; Segal, Neil H.; Ariyan, Charlotte E.; Gordon, Ruth-Ann; Kronenberg, Stephanie A.; Agunwamba, Blessing U.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Kluger, Harriet; Reed, Kathleen; Burke, Matthew M.; Caldwell, Anne; Sznol, Mario] Yale Univ, Sch Med, New Haven, CT USA; [Kluger, Harriet; Reed, Kathleen; Burke, Matthew M.; Caldwell, Anne; Sznol, Mario] Yale New Haven Med Ctr, Smilow Canc Ctr, New Haven, CT 06504 USA; [Zhang, Xiaoling] Dako North Amer, Carpinteria, CA USA; [Korman, Alan J.] Bristol Myers Squibb, Redwood City, CA USA; [Lowy, Israel; Inzunza, Hector David; Feely, William; Horak, Christine E.; Hong, Quan; Wigginton, Jon M.; Gupta, Ashok] Bristol Myers Squibb Co, Princeton, NJ USA	Memorial Sloan Kettering Cancer Center; Yale University; Yale University; Bristol-Myers Squibb; Bristol-Myers Squibb	Wolchok, JD (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	wolchokj@mskcc.org		Ariyan, Charlotte/0000-0003-0818-3895; Sznol, Mario/0000-0002-4359-8749	Bristol-Myers Squibb; Ono Pharmaceutical; Ziopharm Oncology; Polynoma; Merck; GlaxoSmithKline; MedImmune; Genesis Biopharma; Nektar; Anaeropharma Science; BeiGene; Genzyme; Johnson Johnson; Prometheus Medical; Institute for Medical Education and Research; TRM Oncology; DAVA Oncology; Center for Biomedical Continuing Education; NATIONAL CANCER INSTITUTE [P30CA008748, K24CA172123] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Ono Pharmaceutical; Ziopharm Oncology; Polynoma; Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); MedImmune(AstraZenecaMedimmune); Genesis Biopharma; Nektar; Anaeropharma Science; BeiGene; Genzyme(Sanofi-AventisGenzyme Corporation); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Prometheus Medical; Institute for Medical Education and Research; TRM Oncology; DAVA Oncology; Center for Biomedical Continuing Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Bristol-Myers Squibb and Ono Pharmaceutical.; Dr. Wolchok reports receiving consulting fees from Bristol-Myers Squibb, Ziopharm Oncology, Polynoma, and Merck and grant support from Bristol-Myers Squibb, GlaxoSmithKline, and MedImmune on behalf of his institution. Dr. Postow reports receiving grant support from Bristol-Myers Squibb on behalf of his institution and serving as an unpaid consultant for and receiving reimbursement for travel expenses from Bristol-Myers Squibb. Dr. Lesokhin reports receiving consulting fees from Bristol-Myers Squibb and grant support from Bristol-Myers Squibb on behalf of his institution. Dr. Segal reports receiving grant support from Bristol-Myers Squibb on behalf of his institution. Dr. Ariyan reports receiving consulting fees from Bristol-Myers Squibb. Ms. Gordon reports receiving consulting fees from Bristol-Myers Squibb. Mr. Burke reports receiving lecture fees from Bristol-Myers Squibb. Dr. Lowy reports being a former employee of and holding stock in Bristol-Myers Squibb. U. S. patents on human monoclonal antibodies against Bacillus anthracis protective antigen and antibodies against Clostridium difficile toxins and a surrogate therapeutic end point for anti-CLTA-4-based immunotherapy of disease have been issued; Dr. Lowy is listed as an inventor on the patents, which are owned by Bristol-Myers Squibb. Dr. Inzunza reports being an employee of Bristol-Myers Squibb. Mr. Feely and Drs. Horak, Hong, Wigginton, and Gupta report being employees of and holding stock or stock options in Bristol-Myers Squibb. Dr. Korman reports being an employee of, holding stock or stock options in, and receiving reimbursement for travel expenses from Bristol-Myers Squibb. Dr. Sznol reports receiving consulting fees from Bristol-Myers Squibb, Genesis Biopharma, Nektar, Anaeropharma Science, Genzyme, BeiGene, Johnson & Johnson, and Prometheus Medical and lecture fees from the Institute for Medical Education and Research, TRM Oncology, DAVA Oncology, and the Center for Biomedical Continuing Education. No other potential conflict of interest relevant to this article was reported.	Berman DM, 2009, J CLIN ONCOL S, V27, p15s; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; *CTEP COMM TERM, 2006, CANC THER EV PROGR C; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; DELYON J, 2013, ANN ONCOL; Fong L, 2008, J CLIN ONCOL, V26, P5275, DOI 10.1200/JCO.2008.17.8954; GORDON MS, 2013, ANN M AM ASS CANC RE; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ku GY, 2010, CANCER-AM CANCER SOC, V116, P1767, DOI 10.1002/cncr.24951; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; ODAYSJ, 2007, CANCER, V110, P2614; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Postow MA, 2012, J CLIN ONCOL S, V30; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Robert C, 2009, ONCOLOGIST, V14, P848, DOI 10.1634/theoncologist.2009-0028; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; SELBY M, 2013, J CLIN ONCOL S, V31; SZNOL M, 2013, J CLIN ONCOL S, P31; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; WOLCHOK JD, 2013, ANN ONCOL; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; 2012, YERV	27	3062	3277	7	361	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					122	133		10.1056/NEJMoa1302369	http://dx.doi.org/10.1056/NEJMoa1302369			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23724867	Green Accepted, Bronze			2022-12-28	WOS:000321567300008
J	Weiskopf, K; Ring, AM; Ho, CCM; Volkmer, JP; Levin, AM; Volkmer, AK; Ozkan, E; Fernhoff, NB; van de Rijn, M; Weissman, IL; Garcia, KC				Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Levin, Aron M.; Volkmer, Anne Kathrin; Oezkan, Engin; Fernhoff, Nathaniel B.; van de Rijn, Matt; Weissman, Irving L.; Garcia, K. Christopher			Engineered SIRP alpha Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies	SCIENCE			English	Article							SIGNAL-REGULATORY-PROTEIN; STEM-CELLS; CD47; RECEPTOR; THERAPY; CLEARANCE; RITUXIMAB; EFFICACY; TARGET; SAFETY	CD47 is an antiphagocytic signal that cancer cells employ to inhibit macrophage-mediated destruction. Here, we modified the binding domain of human SIRP alpha, the receptor for CD47, for use as a CD47 antagonist. We engineered high-affinity SIRP alpha variants with about a 50,000-fold increased affinity for human CD47 relative to wild-type SIRP alpha. As high-affinity SIRP alpha monomers, they potently antagonized CD47 on cancer cells but did not induce macrophage phagocytosis on their own. Instead, they exhibited remarkable synergy with all tumor-specific monoclonal antibodies tested by increasing phagocytosis in vitro and enhancing antitumor responses in vivo. This "one-two punch" directs immune responses against tumor cells while lowering the threshold for macrophage activation, thereby providing a universal method for augmenting the efficacy of therapeutic anticancer antibodies.	[Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Volkmer, Anne Kathrin; Fernhoff, Nathaniel B.; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Volkmer, Anne Kathrin; Fernhoff, Nathaniel B.; Weissman, Irving L.; Garcia, K. Christopher] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA; [Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Volkmer, Anne Kathrin; Fernhoff, Nathaniel B.; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Ring, Aaron M.; Ho, Chia Chi M.; Levin, Aron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ring, Aaron M.; Ho, Chia Chi M.; Levin, Aron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Ring, Aaron M.; Ho, Chia Chi M.; Levin, Aron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Volkmer, Anne Kathrin] Univ Dusseldorf, Dept Obstet & Gynaecol, Dusseldorf, Germany; [van de Rijn, Matt; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Heinrich Heine University Dusseldorf; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Ring, Aaron/0000-0003-3699-2446; van de Rijn, Matt/0000-0002-1909-9739; Ozkan, Engin/0000-0002-0263-6729	National Cancer Institute [F30CA168059, CA139490]; National Institute of Diabetes and Digestive and Kidney Diseases [F30DK094541]; Stanford Medical Scientist Training Program [NIH-GM07365]; Stanford University SPARK Program; Deutsche Forschungsgemeinschaft [VO 1976/1]; Joseph and Laurie Lacob Gynecologic/Ovarian Cancer Fund; Virginia and D. K. Ludwig Fund for Cancer Research; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA139490, F30CA168059, R01CA177684, R01CA112270, R01CA086017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanford Medical Scientist Training Program; Stanford University SPARK Program(Stanford University); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Joseph and Laurie Lacob Gynecologic/Ovarian Cancer Fund; Virginia and D. K. Ludwig Fund for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank members of the Weissman and Garcia laboratories for helpful advice and discussions. The authors thank R. Majeti, J. Liu, and the CD47 Disease Team for discussions and for providing antibodies to CD47. The authors thank T. Storm, L. Jerabek, H. Contreras-Trujillo, A. McCarty, S. Jaiswal, B. di Robilant, S. Varma, T. Naik, S. Willingham, H. Kohrt, N. Goriatcheva, D. Waghray, and S. Fischer for technical assistance, discussions, and reagents. The data presented in this paper are tabulated in the main paper and the supplementary materials. Atomic coordinates and structure factors of the FD6:CD47 complex (PDB code 4KJY) have been deposited in the Protein Data Bank. Research reported in this publication was supported by the National Cancer Institute (F30CA168059 to K. W. and CA139490 to I. L. W.), the National Institute of Diabetes and Digestive and Kidney Diseases (F30DK094541 to A. M. R.), the Stanford Medical Scientist Training Program (NIH-GM07365 to K. W. and A. M. R.), the Stanford University SPARK Program (to K. W. and A. M. R.), the Deutsche Forschungsgemeinschaft (VO 1976/1 to A. K. V.), the Joseph and Laurie Lacob Gynecologic/Ovarian Cancer Fund (to I. L. W), the Virginia and D. K. Ludwig Fund for Cancer Research (to I. L. W.), and the Howard Hughes Medical Institute (to K. C. G.). The content of this manuscript is solely the responsibility of the authors. K. W., A. M. R., A. M. L., I. L. W., and K. C. G. have filed a patent describing the high-affinity SIRP alpha reagents.	Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Beckman RA, 2007, CANCER-AM CANCER SOC, V109, P170, DOI 10.1002/cncr.22402; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Lapalombella R, 2008, CLIN CANCER RES, V14, P569, DOI 10.1158/1078-0432.CCR-07-1006; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Maloney DG, 1997, BLOOD, V90, P2188; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Reichert JM, 2012, DRUG DISCOV TODAY, V17, P954, DOI 10.1016/j.drudis.2012.04.006; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; STANCOVSKI I, 1991, P NATL ACAD SCI USA, V88, P8691, DOI 10.1073/pnas.88.19.8691; Tabrizi MA, 2007, DRUG DISCOV TODAY, V12, P540, DOI 10.1016/j.drudis.2007.05.010; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Theocharides APA, 2012, J EXP MED, V209, P1883, DOI 10.1084/jem.20120502; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yamauchi T, 2013, BLOOD, V121, P1316, DOI 10.1182/blood-2012-06-440354; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	30	293	353	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					88	91		10.1126/science.1238856	http://dx.doi.org/10.1126/science.1238856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23722425	Green Accepted			2022-12-28	WOS:000321291700055
J	Melosh, HJ; Freed, AM; Johnson, BC; Blair, DM; Andrews-Hanna, JC; Neumann, GA; Phillips, RJ; Smith, DE; Solomon, SC; Wieczorek, MA; Zuber, MT				Melosh, H. J.; Freed, Andrew M.; Johnson, Brandon C.; Blair, David M.; Andrews-Hanna, Jeffrey C.; Neumann, Gregory A.; Phillips, Roger J.; Smith, David E.; Solomon, Sean C.; Wieczorek, Mark A.; Zuber, Maria T.			The Origin of Lunar Mascon Basins	SCIENCE			English	Article							INTERNAL STRUCTURE; GRAVITY-FIELD; MOON; IMPACTS; SIMULATIONS; MISSION; MERCURY; GRAIL; CRUST; MODEL	High-resolution gravity data from the Gravity Recovery and Interior Laboratory spacecraft have clarified the origin of lunar mass concentrations (mascons). Free-air gravity anomalies over lunar impact basins display bull's-eye patterns consisting of a central positive (mascon) anomaly, a surrounding negative collar, and a positive outer annulus. We show that this pattern results from impact basin excavation and collapse followed by isostatic adjustment and cooling and contraction of a voluminous melt pool. We used a hydrocode to simulate the impact and a self-consistent finite-element model to simulate the subsequent viscoelastic relaxation and cooling. The primary parameters controlling the modeled gravity signatures of mascon basins are the impactor energy, the lunar thermal gradient at the time of impact, the crustal thickness, and the extent of volcanic fill.	[Melosh, H. J.; Freed, Andrew M.; Blair, David M.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Melosh, H. J.; Johnson, Brandon C.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Andrews-Hanna, Jeffrey C.] Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA; [Neumann, Gregory A.] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA; [Smith, David E.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Wieczorek, Mark A.] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, F-75205 Paris 13, France	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Colorado School of Mines; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT); Carnegie Institution for Science; Columbia University; UDICE-French Research Universities; Universite Paris Cite	Melosh, HJ (corresponding author), Purdue Univ, Dept Earth Atmospher & Planetary Sci, 550 Stadium Mall Dr, W Lafayette, IN 47907 USA.	jmelosh@purdue.edu	Neumann, Gregory A/I-5591-2013; Wieczorek, Mark A/G-6427-2010	Neumann, Gregory A/0000-0003-0644-9944; Wieczorek, Mark A/0000-0001-7007-4222; Johnson, Brandon/0000-0002-4267-093X	NASA	NASA(National Aeronautics & Space Administration (NASA))	The GRAIL mission is supported by NASA's Discovery Program and is performed under contract to the Massachusetts Institute of Technology and the Jet Propulsion Laboratory. The Lunar Reconnaissance Orbiter LOLA investigation is supported by the NASA Science Mission Directorate under contract to the NASA Goddard Space Flight Center and Massachusetts Institute of Technology. Data from the GRAIL and LOLA missions have been deposited in the Geosciences Node of NASA's Planetary Data System.	Amsden A. A., 1980, LA8095 LANL; Andrews-Hanna J. C., 2012, LUNAR PLANET SCI, V43, P2804; Collins GS, 2004, METEORIT PLANET SCI, V39, P217, DOI 10.1111/j.1945-5100.2004.tb00337.x; Freed AM, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004119; Freed AM, 2009, EARTH PLANET SC LETT, V285, P320, DOI 10.1016/j.epsl.2009.02.038; Ivanov BA, 2010, GEOL SOC AM SPEC PAP, V465, P29, DOI 10.1130/2010.2465(03); Le Feuvre M, 2011, ICARUS, V214, P1, DOI 10.1016/j.icarus.2011.03.010; Melosh H. J., 2012, LUNAR PLANET SCI, V43, P2596; MULLER PM, 1968, SCIENCE, V161, P680, DOI 10.1126/science.161.3842.680; Neumann GA, 1996, J GEOPHYS RES-PLANET, V101, P16841, DOI 10.1029/96JE01246; Pierazzo E, 2000, ICARUS, V145, P252, DOI 10.1006/icar.1999.6332; Schubert G, 2001, MANTLE CONVECTION EA; Sjogren W. L., 1974, Moon, V9, P115, DOI 10.1007/BF00565398; Smith DE, 2012, SCIENCE, V336, P214, DOI 10.1126/science.1218809; Smith DE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043751; SMITH DE, 1993, J GEOPHYS RES-PLANET, V98, P20871, DOI 10.1029/93JE01839; Taylor S. R., 1982, PLANETARY SCI LUNAR; Wieczorek MA, 1999, ICARUS, V139, P246, DOI 10.1006/icar.1999.6102; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Wunnemann K, 2006, ICARUS, V180, P514, DOI 10.1016/j.icarus.2005.10.013; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839	22	115	119	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1552	1555		10.1126/science.1235768	http://dx.doi.org/10.1126/science.1235768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23722426				2022-12-28	WOS:000321007000036
J	Huang, SS; Septimus, E; Kleinman, K; Moody, J; Hickok, J; Avery, TR; Lankiewicz, J; Gombosev, A; Terpstra, L; Hartford, F; Hayden, MK; Jernigan, JA; Weinstein, RA; Fraser, VJ; Haffenreffer, K; Cui, E; Kaganov, RE; Lolans, K; Perlin, JB; Platt, R				Huang, Susan S.; Septimus, Edward; Kleinman, Ken; Moody, Julia; Hickok, Jason; Avery, Taliser R.; Lankiewicz, Julie; Gombosev, Adrijana; Terpstra, Leah; Hartford, Fallon; Hayden, Mary K.; Jernigan, John A.; Weinstein, Robert A.; Fraser, Victoria J.; Haffenreffer, Katherine; Cui, Eric; Kaganov, Rebecca E.; Lolans, Karen; Perlin, Jonathan B.; Platt, Richard		CDC Prevention Epictr Program; AHRQ DECIDE Network; Healthcare-Associated Infections P	Targeted versus Universal Decolonization to Prevent ICU Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; INTRANASAL MUPIROCIN; CHLORHEXIDINE; REDUCE; COLONIZATION; SURVEILLANCE; PRECAUTIONS; STRATEGIES	BACKGROUND Both targeted decolonization and universal decolonization of patients in intensive care units (ICUs) are candidate strategies to prevent health care-associated infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). METHODS We conducted a pragmatic, cluster-randomized trial. Hospitals were randomly assigned to one of three strategies, with all adult ICUs in a given hospital assigned to the same strategy. Group 1 implemented MRSA screening and isolation; group 2, targeted decolonization (i.e., screening, isolation, and decolonization of MRSA carriers); and group 3, universal decolonization (i.e., no screening, and decolonization of all patients). Proportional-hazards models were used to assess differences in infection reductions across the study groups, with clustering according to hospital. RESULTS A total of 43 hospitals (including 74 ICUs and 74,256 patients during the intervention period) underwent randomization. In the intervention period versus the baseline period, modeled hazard ratios for MRSA clinical isolates were 0.92 for screening and isolation (crude rate, 3.2 vs. 3.4 isolates per 1000 days), 0.75 for targeted decolonization (3.2 vs. 4.3 isolates per 1000 days), and 0.63 for universal decolonization (2.1 vs. 3.4 isolates per 1000 days) (P = 0.01 for test of all groups being equal). In the intervention versus baseline periods, hazard ratios for bloodstream infection with any pathogen in the three groups were 0.99 (crude rate, 4.1 vs. 4.2 infections per 1000 days), 0.78 (3.7 vs. 4.8 infections per 1000 days), and 0.56 (3.6 vs. 6.1 infections per 1000 days), respectively (P<0.001 for test of all groups being equal). Universal decolonization resulted in a significantly greater reduction in the rate of all bloodstream infections than either targeted decolonization or screening and isolation. One bloodstream infection was prevented per 54 patients who underwent decolonization. The reductions in rates of MRSA bloodstream infection were similar to those of all bloodstream infections, but the difference was not significant. Adverse events, which occurred in 7 patients, were mild and related to chlorhexidine. CONCLUSIONS In routine ICU practice, universal decolonization was more effective than targeted decolonization or screening and isolation in reducing rates of MRSA clinical isolates and bloodstream infection from any pathogen. (Funded by the Agency for Healthcare Research and the Centers for Disease Control and Prevention; REDUCE MRSA ClinicalTrials.gov number, NCT00980980.)	[Huang, Susan S.; Gombosev, Adrijana; Terpstra, Leah; Cui, Eric] Univ Calif Irvine, Sch Med, Orange, CA 92868 USA; [Septimus, Edward] Hosp Corp Amer, Houston, TX USA; [Moody, Julia; Hickok, Jason; Perlin, Jonathan B.] Hosp Corp Amer, Nashville, TN USA; [Septimus, Edward] Texas A&M Hlth Sci Ctr, Houston, TX USA; [Kleinman, Ken; Avery, Taliser R.; Lankiewicz, Julie; Hartford, Fallon; Haffenreffer, Katherine; Kaganov, Rebecca E.; Platt, Richard] Harvard Univ, Sch Med, Boston, MA USA; [Kleinman, Ken; Avery, Taliser R.; Lankiewicz, Julie; Hartford, Fallon; Haffenreffer, Katherine; Kaganov, Rebecca E.; Platt, Richard] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Hayden, Mary K.; Lolans, Karen] Rush Med Coll, Chicago, IL 60612 USA; [Weinstein, Robert A.] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA; [Jernigan, John A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Fraser, Victoria J.] Washington Univ, St Louis, MO 63130 USA	University of California System; University of California Irvine; Hospital Corporation of America; Hospital Corporation of America; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Rush University; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centers for Disease Control & Prevention - USA; Washington University (WUSTL)	Huang, SS (corresponding author), Univ Calif Irvine, Sch Med, Div Infect Dis, 101 City Dr,City Tower Suite 400,ZC 4081, Orange, CA 92868 USA.	sshuang@uci.edu	Emery, Sean/O-9122-2019; Phillips, Andrew N/B-4427-2008; Emery, Sean/J-3825-2017	Emery, Sean/0000-0001-6072-8309; Phillips, Andrew N/0000-0003-2384-4807; Emery, Sean/0000-0001-6072-8309; Kleinman, Ken/0000-0002-5600-5834; Fraser, Victoria/0000-0001-6251-0733; Lolans, Karen/0000-0003-1903-756X; Jernigan, John/0000-0001-8163-925X; Hayden, Mary/0000-0002-4603-8501	Agency for Healthcare Research; Centers for Disease Control and Prevention; AHRQ Healthcare-Associated Infections Program [HHSA290201000008I]; CDC Prevention Epicenters Program [1U01 CI000344]; 3M; Sage Products; MRC [G1000803] Funding Source: UKRI; Medical Research Council [G1000803] Funding Source: researchfish; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000344] Funding Source: NIH RePORTER	Agency for Healthcare Research; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); AHRQ Healthcare-Associated Infections Program; CDC Prevention Epicenters Program(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); 3M(3M); Sage Products(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by the Agency for Healthcare Research and the Centers for Disease Control and Prevention; REDUCE MRSA ClinicalTrials.gov number, NCT00980980.; Supported by a contract with the AHRQ Healthcare-Associated Infections Program (HHSA290201000008I) and by a grant from the CDC Prevention Epicenters Program (1U01 CI000344, to Dr. Platt).; Dr. Septimus reports receiving consulting fees from 3M and lecture fees from Sage Products; Dr. Hayden, conducting research involving a contributed product from Sage Products; Dr. Weinstein, serving as an unpaid consultant for Sage Products; and Dr. Fraser, owning stock in Express Scripts. No other potential conflict of interest relevant to this article was reported.	Batra R, 2010, CLIN INFECT DIS, V50, P210, DOI 10.1086/648717; Bleasdale SC, 2007, ARCH INTERN MED, V167, P2073, DOI 10.1001/archinte.167.19.2073; Centers for Disease Control and Prevention, HEALTHC INF CONTR PR; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; Ellis MW, 2007, ANTIMICROB AGENTS CH, V51, P3591, DOI 10.1128/AAC.01086-06; Fritz SA, 2013, ANTIMICROB AGENTS CH, V57, P559, DOI 10.1128/AAC.01633-12; Harbarth S, 1999, ANTIMICROB AGENTS CH, V43, P1412, DOI 10.1128/AAC.43.6.1412; Harbarth S, 2000, CLIN INFECT DIS, V31, P1380, DOI 10.1086/317484; HAYES RH, 2009, CLUSTER RANDOMIZED T, P207; Huang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024340; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jarvis WR, 2012, AM J INFECT CONTROL, V40, P194, DOI 10.1016/j.ajic.2012.02.001; Jones JC, 2007, CLIN INFECT DIS, V45, P541, DOI 10.1086/520663; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; McNeil JC, 2013, PEDIATR INFECT DIS J, V32, P124, DOI 10.1097/INF.0b013e318271c4e0; Moody J, 2013, AM J INFECT CONTROL, V41, P126, DOI 10.1016/j.ajic.2012.02.017; Morgan DJ, 2009, AM J INFECT CONTROL, V37, P85, DOI 10.1016/j.ajic.2008.04.257; *NAT HEALTHC SAF N, PAT SAF COMP MAN; Nijssen S, 2005, CLIN INFECT DIS, V40, P405, DOI 10.1086/427281; Perlin JB, 2013, J HEALTHC QUAL, V35, P57, DOI 10.1111/jhq.12008; Platt R, 2010, MED CARE, V48, pS52, DOI 10.1097/MLR.0b013e3181dbebcf; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P959, DOI 10.1086/605925; Ridenour G, 2007, INFECT CONT HOSP EP, V28, P1155, DOI 10.1086/520102; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; Robicsek A, 2009, INFECT CONT HOSP EP, V30, P623, DOI 10.1086/597550; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; SIGNS V, 2011, MMWR-MORBID MORTAL W, V60, P243; Simor AE, 2007, ANTIMICROB AGENTS CH, V51, P3880, DOI 10.1128/AAC.00846-07; Solomon MZ, 2013, HASTINGS CENT REP, V43, pS2, DOI 10.1002/hast.132; Stickler DJ, 2002, J APPL MICROBIOL, V92, p163S, DOI 10.1046/j.1365-2672.92.5s1.6.x; Upton A, 2003, J ANTIMICROB CHEMOTH, V51, P613, DOI 10.1093/jac/dkg127; Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306; Weber SG, 2007, INFECT CONT HOSP EP, V28, P249, DOI 10.1086/512261; Wenzel RP, 2010, INT J INFECT DIS, V14, pS3, DOI 10.1016/j.ijid.2010.05.002; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060	38	503	513	0	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2255	2265		10.1056/NEJMoa1207290	http://dx.doi.org/10.1056/NEJMoa1207290			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23718152	Green Published			2022-12-28	WOS:000320230500001
J	Armitage, PJ				Armitage, Philip J.			A Trap for Planet Formation	SCIENCE			English	Editorial Material							SOLAR; DISK; PLANETESIMALS; GAP; AU		[Armitage, Philip J.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Armitage, Philip J.] NIST, Boulder, CO 80309 USA; [Armitage, Philip J.] Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Armitage, PJ (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	pja@jilau1.colorado.edu						Armitage P.J., 2010, ASTROPHYSICS PLANET; BARGE P, 1995, ASTRON ASTROPHYS, V295, pL1; Brown JM, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/116; Calvet N, 2002, ASTROPHYS J, V568, P1008, DOI 10.1086/339061; Chiang E, 2010, ANNU REV EARTH PL SC, V38, P493, DOI 10.1146/annurev-earth-040809-152513; Geers VC, 2007, ASTRON ASTROPHYS, V469, pL35, DOI 10.1051/0004-6361:20077524; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Howard AW, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/15; Kretke KA, 2007, ASTROPHYS J, V664, pL55, DOI 10.1086/520718; Lovelace RVE, 1999, ASTROPHYS J, V513, P805, DOI 10.1086/306900; Rice WKM, 2003, MON NOT R ASTRON SOC, V342, P79, DOI 10.1046/j.1365-8711.2003.06515.x; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525	15	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1179	1180		10.1126/science.1239404	http://dx.doi.org/10.1126/science.1239404			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744935				2022-12-28	WOS:000319972800031
J	Keller, PJ				Keller, Philipp J.			Imaging Morphogenesis: Technological Advances and Biological Insights	SCIENCE			English	Review							LIGHT-SHEET MICROSCOPY; PLANE ILLUMINATION MICROSCOPY; COLLECTIVE CELL-MIGRATION; STRUCTURED-ILLUMINATION; GENE-EXPRESSION; LIVING CELLS; FLUORESCENCE MICROSCOPY; CAENORHABDITIS-ELEGANS; ADAPTIVE OPTICS; RESOLUTION	Morphogenesis, the development of the shape of an organism, is a dynamic process on a multitude of scales, from fast subcellular rearrangements and cell movements to slow structural changes at the whole-organism level. Live-imaging approaches based on light microscopy reveal the intricate dynamics of this process and are thus indispensable for investigating the underlying mechanisms. This Review discusses emerging imaging techniques that can record morphogenesis at temporal scales from seconds to days and at spatial scales from hundreds of nanometers to several millimeters. To unlock their full potential, these methods need to be matched with new computational approaches and physical models that help convert highly complex image data sets into biological insights.	Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Keller, PJ (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	kellerp@janelia.hhmi.org		Keller, Philipp/0000-0003-2896-4920	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	I thank K. Branson for helpful discussions and help with preparing the figures; Y. Wan and W. Lemon for help with recording the zebrafish SiMView data set; and F. Amat, Y. Bellaiche, E. Betzig, M. Handberg-Thorsager, B. Hoeckendorf, K. Khairy, M. Knop, W. Lemon, J. Liu, K. McDole, S. Srinivas, D. Stern and Y. Wan for helpful comments on the manuscript. This work was supported by the Howard Hughes Medical Institute.	Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Booth MJ, 2007, PHILOS T R SOC A, V365, P2829, DOI 10.1098/rsta.2007.0013; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Fahrbach FO, 2010, NAT PHOTONICS, V4, P780, DOI [10.1038/nphoton.2010.204, 10.1038/NPHOTON.2010.204]; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Khairy K, 2011, GENESIS, V49, P488, DOI 10.1002/dvg.20698; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Mahou P, 2012, NAT METHODS, V9, P815, DOI [10.1038/NMETH.2098, 10.1038/nmeth.2098]; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Nowotschin S, 2010, CURR OPIN GENET DEV, V20, P420, DOI 10.1016/j.gde.2010.05.008; Oates AC, 2009, NAT REV GENET, V10, P517, DOI 10.1038/nrg2548; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Piliszek A, 2011, METHODS MOL BIOL, V770, P243, DOI 10.1007/978-1-61779-210-6_9; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Reeves GT, 2012, DEV CELL, V22, P544, DOI 10.1016/j.devcel.2011.12.007; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Si K, 2012, NAT PHOTONICS, V6, P657, DOI [10.1038/nphoton.2012.205, 10.1038/NPHOTON.2012.205]; Siedentopf H., 1902, ANN PHYS, V315, P1, DOI [DOI 10.1002/ANDP.19023150102, 10.1002/andp.19023150102]; Supatto W, 2009, NAT PROTOC, V4, P1397, DOI 10.1038/nprot.2009.130; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Trichas G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001256; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wang YC, 2012, NATURE, V484, P390, DOI 10.1038/nature10938; Wu B, 2011, CURR OPIN CELL BIOL, V23, P310, DOI 10.1016/j.ceb.2010.12.004; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108; Xu XA, 2011, NAT PHOTONICS, V5, P154, DOI 10.1038/NPHOTON.2010.306	49	133	139	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1184	+	1234168	10.1126/science.1234168	http://dx.doi.org/10.1126/science.1234168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744952				2022-12-28	WOS:000319972800035
J	Guerin, C; Reignier, J; Richard, JC; Beuret, P; Gacouin, A; Boulain, T; Mercier, E; Badet, M; Mercat, A; Baudin, O; Clavel, M; Chatellier, D; Jaber, S; Rosselli, S; Mancebo, J; Sirodot, M; Hilbert, G; Bengler, C; Richecoeur, J; Gainnier, M; Bayle, F; Bourdin, G; Leray, V; Girard, R; Baboi, L; Ayzac, L				Guerin, Claude; Reignier, Jean; Richard, Jean-Christophe; Beuret, Pascal; Gacouin, Arnaud; Boulain, Thierry; Mercier, Emmanuelle; Badet, Michel; Mercat, Alain; Baudin, Olivier; Clavel, Marc; Chatellier, Delphine; Jaber, Samir; Rosselli, Sylvene; Mancebo, Jordi; Sirodot, Michel; Hilbert, Gilles; Bengler, Christian; Richecoeur, Jack; Gainnier, Marc; Bayle, Frederique; Bourdin, Gael; Leray, Veronique; Girard, Raphaele; Baboi, Loredana; Ayzac, Louis		PROSEVA Study Grp	Prone Positioning in Severe Acute Respiratory Distress Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LUNG INJURY; RANDOMIZED CONTROLLED-TRIAL; VENTILATION; FAILURE; METAANALYSIS; RECRUITMENT; MULTICENTER; DEFINITION; PHYSIOLOGY; SURVIVAL	Background Previous trials involving patients with the acute respiratory distress syndrome (ARDS) have failed to show a beneficial effect of prone positioning during mechanical ventilatory support on outcomes. We evaluated the effect of early application of prone positioning on outcomes in patients with severe ARDS. Methods In this multicenter, prospective, randomized, controlled trial, we randomly assigned 466 patients with severe ARDS to undergo prone-positioning sessions of at least 16 hours or to be left in the supine position. Severe ARDS was defined as a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (Fio(2)) of less than 150 mm Hg, with an Fio(2) of at least 0.6, a positive end-expiratory pressure of at least 5 cm of water, and a tidal volume close to 6 ml per kilogram of predicted body weight. The primary outcome was the proportion of patients who died from any cause within 28 days after inclusion. Results A total of 237 patients were assigned to the prone group, and 229 patients were assigned to the supine group. The 28-day mortality was 16.0% in the prone group and 32.8% in the supine group (P<0.001). The hazard ratio for death with prone positioning was 0.39 (95% confidence interval [CI], 0.25 to 0.63). Unadjusted 90-day mortality was 23.6% in the prone group versus 41.0% in the supine group (P<0.001), with a hazard ratio of 0.44 (95% CI, 0.29 to 0.67). The incidence of complications did not differ significantly between the groups, except for the incidence of cardiac arrests, which was higher in the supine group. Conclusions In patients with severe ARDS, early application of prolonged prone-positioning sessions significantly decreased 28-day and 90-day mortality.	[Guerin, Claude; Richard, Jean-Christophe; Bayle, Frederique; Bourdin, Gael; Leray, Veronique; Baboi, Loredana] Hop Croix Rousse, Serv Reanimat Med, F-69004 Lyon, France; [Guerin, Claude; Richard, Jean-Christophe; Bayle, Frederique; Leray, Veronique; Baboi, Loredana] Univ Lyon, Lyon, France; [Guerin, Claude; Richard, Jean-Christophe; Bayle, Frederique; Bourdin, Gael; Leray, Veronique; Baboi, Loredana] Creatis INSERM 1044, Lyon, France; [Reignier, Jean] CRICS Grp, La Roche Sur Yon, France; [Gacouin, Arnaud] Hop Pontchaillou, Rennes, France; [Boulain, Thierry] Hop Orleans, CRICS Grp, Orleans, France; [Mercier, Emmanuelle] Hop Bretonneau, Tours, France; [Mercier, Emmanuelle] Univ Tours, Tours, France; [Badet, Michel] Hop Chambery, Chambery, France; [Mercat, Alain] Univ Angers, CHU Angers, Univ Nantes Angers Le Mans, Angers, France; [Baudin, Olivier] Hop Angouleme, CRICS Grp, Angouleme, France; [Clavel, Marc] Hop Limoges, Reanimat Polyvalente Ctr, Invest Clin 0801, Limoges, France; [Clavel, Marc] Hosp Civils Lyon, CRICS Grp, Lyon, France; [Chatellier, Delphine] Hop Poitiers, Poitiers, France; [Chatellier, Delphine] CRICS Grp, Poitiers, France; [Chatellier, Delphine] Univ Poitiers, Poitiers, France; [Jaber, Samir] Hop St Eloi, INSERM, U1046, Montpellier, France; [Jaber, Samir] Univ Montpellier, F-34059 Montpellier, France; [Rosselli, Sylvene] Hop St Joseph & St Luc, Lyon, France; [Sirodot, Michel] Hop Annecy, Annecy, France; [Hilbert, Gilles] Hop Pellegrin, F-33076 Bordeaux, France; [Hilbert, Gilles] Univ Bordeaux, Bordeaux, France; [Bengler, Christian] Hop Nimes, Nimes, France; [Bengler, Christian] Univ Nimes Montpellier, Nimes, France; [Richecoeur, Jack] Hop Cergy Pontoise, Cergy Pontoise, France; [Gainnier, Marc] Hop La Timone, Marseille, France; [Gainnier, Marc] Univ Aix Marseille 2, Marseille, France; [Girard, Raphaele] Hosp Civils Lyon, Grp Hosp Lyon Sud, Serv Hyg Hosp, Pierre Benite, France; [Baboi, Loredana] Hop Henri Gabrielle, Ctr Coordinat & Lutte Contre Infect Nosocomiales, St Genis Laval, France; [Mancebo, Jordi] Hosp Santa Creu & Sant Pau, Serv Med Intens, Barcelona, Spain	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Centre Hospitalier Regional d'Orleans; CHU Tours; Universite de Tours; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Limoges; CHU Lyon; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Centre Hospitalier Annecy Genevois; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universite de Montpellier; CHU de Nimes; Centre Hospitalier Rene Dubos, Pontoise; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; CHU Lyon; Hospital of Santa Creu i Sant Pau	Guerin, C (corresponding author), Hop Croix Rousse, Serv Reanimat Med, 103 Grande Rue Croix Rousse, F-69004 Lyon, France.	claude.guerin@chu-lyon.fr	Mercat, Alain/AFU-4426-2022; RICHARD, Jean-Christophe/A-4097-2009; Boulain, Thierry/M-3309-2019; guerin, claude/H-5692-2014; Chiche, Jean-Daniel/P-5220-2017	RICHARD, Jean-Christophe/0000-0003-1503-3035; Boulain, Thierry/0000-0003-4664-3661; guerin, claude/0000-0003-4700-6672; Chiche, Jean-Daniel/0000-0002-6433-6254; Johnston, Andrew McDonald/0000-0002-0220-0589; GAINNIER, Marc/0000-0002-5353-9275; BISBAL, MAGALI/0000-0001-6571-0861; wallet, florent/0000-0003-3174-6246; Aguirre-Bermeo, Hernan/0000-0001-7205-7020	French Ministry of Health	French Ministry of Health	Funded by the Programme Hospitalier de Recherche Clinique National 2006 and 2010 of the French Ministry of Health; PROSEVA ClinicalTrials.gov number, NCT00527813.)	Abroug F, 2008, INTENS CARE MED, V34, P1002, DOI 10.1007/s00134-008-1062-3; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Broccard A, 2000, CRIT CARE MED, V28, P295, DOI 10.1097/00003246-200002000-00001; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Charron C, 2011, INTENS CARE MED, V37, P785, DOI 10.1007/s00134-011-2180-x; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Galiatsou E, 2006, AM J RESP CRIT CARE, V174, P187, DOI 10.1164/rccm.200506-899OC; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Gattinoni L, 2010, MINERVA ANESTESIOL, V76, P448; Guerin C, 2004, JAMA-J AM MED ASSOC, V292, P2379, DOI 10.1001/jama.292.19.2379; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V271, P1321; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Mancebo J, 2006, AM J RESP CRIT CARE, V173, P1233, DOI 10.1164/rccm.200503-353OC; MCCABE WR, 1983, AM J MED, V75, P7, DOI 10.1016/0002-9343(83)90067-0; Mentzelopoulos SD, 2005, EUR RESPIR J, V25, P534, DOI 10.1183/09031936.05.00105804; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; MURRAY JF, 1989, AM REV RESPIR DIS, V139, P1065; MUTOH T, 1992, AM REV RESPIR DIS, V146, P300, DOI 10.1164/ajrccm/146.2.300; Papazian L, 2005, CRIT CARE MED, V33, P2162, DOI 10.1097/01.CCM.0000181298.05474.2B; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Sud S, 2010, INTENS CARE MED, V36, P585, DOI 10.1007/s00134-009-1748-1; Taccone P, 2009, JAMA-J AM MED ASSOC, V302, P1977, DOI 10.1001/jama.2009.1614; Villar J, 2007, AM J RESP CRIT CARE, V176, P795, DOI 10.1164/rccm.200610-1534OC; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	26	1987	2130	6	143	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2159	2168		10.1056/NEJMoa1214103	http://dx.doi.org/10.1056/NEJMoa1214103			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23688302				2022-12-28	WOS:000319948900004
J	Roehr, B				Roehr, Bob			American Psychiatric Association explains DSM-5	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com							0	65	68	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 6	2013	346								f3591	10.1136/bmj.f3591	http://dx.doi.org/10.1136/bmj.f3591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YI	23744600				2022-12-28	WOS:000320229900002
J	Boseley, S				Boseley, Sarah			Alex Coutinho: transforming HIV care in Africa	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1895	1895		10.1016/S0140-6736(13)61148-4	http://dx.doi.org/10.1016/S0140-6736(13)61148-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23725719	Bronze			2022-12-28	WOS:000320319500015
J	Lee, GH; Cooper, RC; An, SJ; Lee, S; van der Zande, A; Petrone, N; Hammerherg, AG; Lee, C; Crawford, B; Oliver, W; Kysar, JW; Hone, J				Lee, Gwan-Hyoung; Cooper, Ryan C.; An, Sung Joo; Lee, Sunwoo; van der Zande, Arend; Petrone, Nicholas; Hammerherg, Alexandra G.; Lee, Changgu; Crawford, Bryan; Oliver, Warren; Kysar, Jeffrey W.; Hone, James			High-Strength Chemical-Vapor Deposited Graphene and Grain Boundaries	SCIENCE			English	Article							MEMBRANES	Pristine graphene is the strongest material ever measured. However, large-area graphene films produced by means of chemical vapor deposition (CVD) are polycrystalline and thus contain grain boundaries that can potentially weaken the material. We combined structural characterization by means of transmission electron microscopy with nanoindentation in order to study the mechanical properties of CVD-graphene films with different grain sizes. We show that the elastic stiffness of CVD-graphene is identical to that of pristine graphene if postprocessing steps avoid damage or rippling. Its strength is only slightly reduced despite the existence of grain boundaries. Indentation tests directly on grain boundaries confirm that they are almost as strong as pristine. Graphene films consisting entirely of well-stitched grain boundaries can retain ultrahigh strength, which is critical for a large variety of applications, such as flexible electronics and strengthening components.	[Lee, Gwan-Hyoung; Cooper, Ryan C.; An, Sung Joo; van der Zande, Arend; Petrone, Nicholas; Hammerherg, Alexandra G.; Kysar, Jeffrey W.; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Lee, Gwan-Hyoung] Samsung Sungkyunkwan Univ SKKU Graphene Ctr SSGC, Suwon 440746, South Korea; [Lee, Sunwoo] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [van der Zande, Arend] Columbia Univ, Energy Frontier Res Ctr, New York, NY 10027 USA; [Lee, Changgu] SKKU, Sch Mech Engn, Suwon 440746, Gyeonggi, South Korea; [Lee, Changgu] SKKU, SKKU Adv Inst Nanotechnol SAINT, Suwon 440746, Gyeonggi, South Korea; [Crawford, Bryan; Oliver, Warren] Nanomechanics, Oak Ridge, TN 37830 USA	Columbia University; Sungkyunkwan University (SKKU); Columbia University; Columbia University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Kysar, JW (corresponding author), Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.	jk2079@columbia.edu; jh2228@columbia.edu	van der Zande, Arend M/C-1989-2016; Hone, James C/E-1879-2011	van der Zande, Arend M/0000-0001-5104-9646; Hone, James C/0000-0002-8084-3301; Petrone, Nicholas/0000-0003-1995-4077; Lee, Gwan-Hyoung/0000-0002-3028-867X; Cooper, Ryan/0000-0003-0879-4434	Air Force Office of Scientific Research [FA9550-09-1-0048, FA9550-09-1-0705]; NSF [CMMI-0927891]; Basic Science Research Program [2011-0014209]; Global Frontier Research Center for Advanced Soft Electronics through the National Research Foundation [2011-0031629]; Korean government Ministry of Education, Science, and Technology	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); Basic Science Research Program; Global Frontier Research Center for Advanced Soft Electronics through the National Research Foundation; Korean government Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	We acknowledge support from Air Force Office of Scientific Research grants FA9550-09-1-0048 and FA9550-09-1-0705 and NSF grant CMMI-0927891. C.L. was supported by Basic Science Research Program (2011-0014209) and the Global Frontier Research Center for Advanced Soft Electronics (2011-0031629) through the National Research Foundation funded by the Korean government Ministry of Education, Science, and Technology. We thank P. Y. Huang and D. Muller (Cornell University) for help in TEM imaging.	Ernst F, 1996, Z METALLKD, V87, P911; Grantab R, 2010, SCIENCE, V330, P946, DOI 10.1126/science.1196893; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Kim K, 2012, NANO LETT, V12, P293, DOI 10.1021/nl203547z; Kim K, 2011, ACS NANO, V5, P2142, DOI 10.1021/nn1033423; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li XS, 2011, J AM CHEM SOC, V133, P2816, DOI 10.1021/ja109793s; Meyers MA, 2009, MECHANICAL BEHAVIOR OF MATERIALS, 2ND EDITION, P1; Petrone N, 2012, NANO LETT, V12, P2751, DOI 10.1021/nl204481s; Poot M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857472; Ruiz-Vargas CS, 2011, NANO LETT, V11, P2259, DOI 10.1021/nl200429f; Tsen AW, 2012, SCIENCE, V336, P1143, DOI 10.1126/science.1218948; Wei XD, 2012, INT J SOLIDS STRUCT, V49, P3201, DOI 10.1016/j.ijsolstr.2012.06.019; Wei XD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205407; Wei YJ, 2012, NAT MATER, V11, P759, DOI [10.1038/NMAT3370, 10.1038/nmat3370]; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/NMAT3010, 10.1038/nmat3010]	16	670	683	35	820	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1073	1076		10.1126/science.1235126	http://dx.doi.org/10.1126/science.1235126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723231				2022-12-28	WOS:000319664500038
J	Janson, C; Larsson, K; Lisspers, KH; Stallberg, B; Stratelis, G; Goike, H; Jorgensen, L; Johansson, G				Janson, Christer; Larsson, Kjell; Lisspers, Karin H.; Stallberg, Bjorn; Stratelis, Georgios; Goike, Helena; Jorgensen, Leif; Johansson, Gunnar			Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting beta(2) agonist: observational matched cohort study (PATHOS)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; SALMETEROL/FLUTICASONE PROPIONATE; HEALTHY-SUBJECTS; RISK; BUDESONIDE/FORMOTEROL; EXACERBATIONS; FLUTICASONE; BUDESONIDE; SALMETEROL	Objective To investigate the occurrence of pneumonia and pneumonia related events in patients with chronic obstructive pulmonary disease (COPD) treated with two different fixed combinations of inhaled corticosteroid/long acting beta(2) agonist. Design Observational retrospective pairwise cohort study matched (1:1) for propensity score. Setting Primary care medical records data linked to Swedish hospital, drug, and cause of death registry data for years 1999-2009. Participants Patients with COPD diagnosed by a physician and prescriptions of either budesonide/formoterol or fluticasone/salmeterol. Main outcome measures Yearly pneumonia event rates, admission to hospital related to pneumonia, and mortality. Results 9893 patients were eligible for matching (2738 in the fluticasone/salmeterol group; 7155 in the budesonide/formoterol group), yielding two matched cohorts of 2734 patients each. In these patients, 2115 (39%) had at least one recorded episode of pneumonia during the study period, with 2746 episodes recorded during 19 170 patient years of follow up. Compared with budesonide/formoterol, rate of pneumonia and admission to hospital were higher in patients treated with fluticasone/salmeterol:rate ratio 1.73 (95% confidence interval 1.57 to 1.90; P<0.001) and 1.74 (1.56 to 1.94; P<0.001), respectively. The pneumonia event rate per 100 patient years for fluticasone/salmeterol versus budesonide/formoterol was 11.0 (10.4 to 11.8) versus 6.4 (6.0 to 6.9) and the rate of admission to hospital was 7.4 (6.9 to 8.0) versus 4.3 (3.9 to 4.6). The mean duration of admissions related to pneumonia was similar for both groups, but mortality related to pneumonia was higher in the fluticasone/salmeterol group (97 deaths) than in the budesonide/formoterol group (52 deaths) (hazard ratio 1.76, 1.22 to 2.53; P=0.003). All cause mortality did not differ between the treatments (1.08, 0.93 to 1.14; P=0.59). Conclusions There is an intra-class difference between fixed combinations of inhaled corticosteroid/long acting beta(2) agonist with regard to the risk of pneumonia and pneumonia related events in the treatment of patients with COPD. Trial registration Clinical Trials.gov NCT01146392.	[Janson, Christer] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Larsson, Kjell] Karolinska Inst, Natl Inst Environm Med, Unit Lung & Allergy Res, Stockholm, Sweden; [Lisspers, Karin H.; Stallberg, Bjorn] Uppsala Univ, Dept Publ Hlth & Caring Sci Family Med & Clin Epi, Uppsala, Sweden; [Stratelis, Georgios; Goike, Helena; Jorgensen, Leif] AstraZeneca Nord, Sodertalje, Sweden; [Johansson, Gunnar] Uppsala Univ, Dept Publ Hlth & Caring Sci Family Med & Prevent, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Uppsala University; AstraZeneca; Uppsala University	Janson, C (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	christer.janson@medsci.uu.se			AstraZeneca	AstraZeneca(AstraZeneca)	This study was funded by AstraZeneca. AstraZeneca was a member of the study steering committee that carried overall responsibility for the study concept and design. Project management was provided by AstraZeneca. Data collection was performed by Pygargus AB, Uppsala, Sweden, and funded by AstraZeneca. The statistical analysis plan was agreed on by the study steering committee, and data analysis was performed by the study database owner in collaboration with AstraZeneca. As member of the study steering committee AstraZeneca took part in the interpretation of the data and the drafting of the manuscript.	Cabello H, 1997, EUR RESPIR J, V10, P1137, DOI 10.1183/09031936.97.10051137; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Dalby C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-104; de Molina RM, 2010, EUR RESPIR J, V36, P751, DOI 10.1183/09031936.00077509; Ek A, 1999, ALLERGY, V54, P691, DOI 10.1034/j.1398-9995.1999.00087.x; Eklind-Cervenka M, 2011, JAMA-J AM MED ASSOC, V305, P175, DOI 10.1001/jama.2010.1949; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Ferguson GT, 2008, RESP MED, V102, P1099, DOI 10.1016/j.rmed.2008.04.019; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Halpin DMG, 2011, INT J CLIN PRACT, V65, P764, DOI 10.1111/j.1742-1241.2011.02685.x; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; Holguin F, 2005, CHEST, V128, P2005, DOI 10.1378/chest.128.4.2005; Nannini LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829.pub2; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Larsson K, 2013, J INTERN MED, V273, P584, DOI 10.1111/joim.12067; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martinell M, 2012, UPSALA J MED SCI, V117, P52, DOI 10.3109/03009734.2011.653015; Miller-Larsson A, 2000, AM J RESP CRIT CARE, V162, P1455, DOI 10.1164/ajrccm.162.4.9806112; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Parsons, 2001, P 26 ANN SAS US GROU; Perkins SM, 2000, PHARMACOEPIDEM DR S, V9, P93, DOI 10.1002/(SICI)1099-1557(200003/04)9:2<93::AID-PDS474>3.0.CO;2-I; Russell D, 2011, J CLIN HYPERTENS, V13, P189, DOI 10.1111/j.1751-7176.2010.00410.x; Sin DD, 2009, LANCET, V374, P712, DOI 10.1016/S0140-6736(09)61250-2; Spindler C, 2012, SCAND J INFECT DIS, V44, P885, DOI 10.3109/00365548.2012.700120; Suissa S, 2004, AM J RESP CRIT CARE, V169, P83, DOI 10.1164/rccm.200305-640OC; Suissa Samy, 2007, Proc Am Thorac Soc, V4, P535, DOI 10.1513/pats.200701-024FM; Suissa S, 2013, THORAX, V68, P540, DOI 10.1136/thoraxjnl-2012-202709; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Vestbo J, 2011, CLIN RESPIR J, V5, P44, DOI 10.1111/j.1752-699X.2010.00198.x; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC	35	128	132	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3306	10.1136/bmj.f3306	http://dx.doi.org/10.1136/bmj.f3306			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DG	23719639	Green Published, hybrid			2022-12-28	WOS:000319948200008
J	Herrett, E; Shah, AD; Boggon, R; Denaxas, S; Smeeth, L; van Staa, T; Timmis, A; Hemingway, H				Herrett, Emily; Shah, Anoop Dinesh; Boggon, Rachael; Denaxas, Spiros; Smeeth, Liam; van Staa, Tjeerd; Timmis, Adam; Hemingway, Harry			Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; CARDIOVASCULAR-DISEASE; DISCHARGE DATA; DEATH; RISK; STATISTICS; VALIDATION; LINKAGE; STROKE; CANCER	Objective To determine the completeness and diagnostic validity of myocardial infarction recording across four national health record sources in primary care, hospital care, a disease registry, and mortality register. Design Cohort study. Participants 21 482 patients with acute myocardial infarction in England between January 2003 and March 2009, identified in four prospectively collected, linked electronic health record sources: Clinical Practice Research Datalink (primary care data), Hospital Episode Statistics (hospital admissions), the disease registry MINAP (Myocardial Ischaemia National Audit Project), and the Office for National Statistics mortality register (cause specific mortality data). Setting One country (England) with one health system (the National Health Service). Main outcome measures Recording of acute myocardial infarction, incidence, all cause mortality within one year of acute myocardial infarction, and diagnostic validity of acute myocardial infarction compared with electrocardiographic and troponin findings in the disease registry (gold standard). Results Risk factors and non-cardiovascular coexisting conditions were similar across patients identified in primary care, hospital admission, and registry sources. Immediate all cause mortality was highest among patients with acute myocardial infarction recorded in primary care, which (unlike hospital admission and disease registry sources) included patients who did not reach hospital, but at one year mortality rates in cohorts from each source were similar. 5561 (31.0%) patients with non-fatal acute myocardial infarction were recorded in all three sources and 11 482 (63.9%) in at least two sources. The crude incidence of acute myocardial infarction was underestimated by 25-50% using one source compared with using all three sources. Compared with acute myocardial infarction defined in the disease registry, the positive predictive value of acute myocardial infarction recorded in primary care was 92.2% (95% confidence interval 91.6% to 92.8%) and in hospital admissions was 91.5% (90.8% to 92.1%). Conclusion Each data source missed a substantial proportion (25-50%) of myocardial infarction events. Failure to use linked electronic health records from primary care, hospital care, disease registry, and death certificates may lead to biased estimates of the incidence and outcome of myocardial infarction.	[Herrett, Emily; Smeeth, Liam; van Staa, Tjeerd] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Shah, Anoop Dinesh; Denaxas, Spiros; Hemingway, Harry] UCL, Clin Epidemiol Grp, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Boggon, Rachael; van Staa, Tjeerd] Med & Healthcare Prod Regulatory Agcy, Clin Practice Res Datalink Grp, London, England; [Boggon, Rachael; van Staa, Tjeerd] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Timmis, Adam] Barts & London Queen Marys Sch Med & Dent, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; The Medicines & Healthcare Products Regulatory Agency; Utrecht University; University of London; Queen Mary University London	Herrett, E (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	emily.herrett@lshtm.ac.uk	Shah, Anoop Dinesh/D-4396-2014; Greiver, Michelle/N-8764-2015; Hemingway, Harry/C-1219-2009; Smeeth, Liam/X-5862-2018	Shah, Anoop Dinesh/0000-0002-8907-5724; Greiver, Michelle/0000-0001-8957-0285; van Staa, Tjeerd/0000-0001-9363-742X; Denaxas, Spiros/0000-0001-9612-7791; Hemingway, Harry/0000-0003-2279-0624; Smeeth, Liam/0000-0002-9168-6022	UK National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z, 098504, 0938/30/Z/10/Z]; UK Biobank; Medical Research Council; Healthcare products Regulatory Agency; National Institute for Health Research health technology assessment programme; Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU; GlaxoSmithKline; Novo Nordisk; Dutch Medicines Evaluation Board; Dutch Ministry of Health; Economic and Social Research Council [ES/L007517/1] Funding Source: researchfish; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090, RP-PG-0407-10314] Funding Source: researchfish; ESRC [ES/L007517/1] Funding Source: UKRI	UK National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Biobank; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Healthcare products Regulatory Agency; National Institute for Health Research health technology assessment programme(National Institute for Health Research (NIHR)); Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU(European Commission); GlaxoSmithKline(GlaxoSmithKline); Novo Nordisk(Novo Nordisk); Dutch Medicines Evaluation Board; Dutch Ministry of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by grants from the UK National Institute for Health Research (grant No RP-PG-0407-10314), the Wellcome Trust (086091/Z/08/Z), and UK Biobank. LS is supported by a senior clinical fellowship from the Wellcome Trust (098504). EH is supported by a Medical Research Council studentship. AS is supported by a clinical research training fellowship from the Wellcome Trust (0938/30/Z/10/Z). Clinical Practice Research Datalink is owned by the UK Department of Health and operates within the Medicines and Healthcare products Regulatory Agency. Clinical Practice Research Datalink has received funding from the Healthcare products Regulatory Agency, Wellcome Trust, Medical Research Council, National Institute for Health Research health technology assessment programme, Innovative Medicine Initiative, UK Department of Health, Technology Strategy Board, Seventh Framework Programme EU, various universities, contract research organisations, and pharmaceutical companies. The department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, the private-public funded Top Institute Pharma (www.tipharma.nl, includes co-funding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health. The funding sources had no role in the design and conduct of the study, analysis, interpretation, preparation, review, and approval of the manuscript; or the decision to submit the paper for publication. The views expressed in this paper are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	Almqvist C, 2011, EUR J EPIDEMIOL, V26, P67, DOI 10.1007/s10654-010-9521-x; [Anonymous], 1995, J Clin Epidemiol, V48, P1441; [Anonymous], 2013, MILLION VETERAN PROG; [Anonymous], 2007, UK BIOB PROT; [Anonymous], 2012, MAND GOV NHS COMM BO; [Anonymous], 2013, READ COD; [Anonymous], 2012, DEATH CERT REF ENGL; [Anonymous], 2013, ENV HLTH; Barchielli A, 2012, J EPIDEMIOL COMMUN H, V66, P462, DOI 10.1136/jech.2010.110908; Bhattarai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029776; Boggon R, 2013, PHARMACOEPIDEM DR S, V22, P168, DOI 10.1002/pds.3374; BOYLE CA, 1995, AUST NZ J MED, V25, P316, DOI 10.1111/j.1445-5994.1995.tb01896.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Delaney Joseph A C, 2007, BMC Cardiovasc Disord, V7, P38, DOI 10.1186/1471-2261-7-38; Denaxas Spiros C, 2012, Int J Epidemiol, V41, P1625, DOI 10.1093/ije/dys188; Department of Health, 2013, HOSP EP STAT; Department of Health, 2013, CARD DIS OUTC STRAT; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Goldacre MJ, 2004, EUR J PUBLIC HEALTH, V14, P338, DOI 10.1093/eurpub/14.4.338; Gulliford MC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-115; Gulliford MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007168; Hall GC, 2004, NEUROLOGY, V62, P563, DOI 10.1212/01.WNL.0000110312.36809.7F; Hammad TA, 2008, PHARMACOEPIDEM DR S, V17, P315, DOI 10.1002/pds.1560; Hammad TA, 2008, PHARMACOEPIDEM DR S, V17, P1197, DOI 10.1002/pds.1672; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Jick H, 1996, LANCET, V347, P627, DOI 10.1016/S0140-6736(96)91334-3; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Johansson S, 2003, ALIMENT PHARM THER, V18, P973, DOI 10.1046/j.1365-2036.2003.01798.x; Lewsey J D, 2000, Health Technol Assess, V4, P1; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; McLennan D, 2011, ENGLISH INDICES DEPR; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; Nieminen P, 2005, INT J CANCER, V115, P307, DOI 10.1002/ijc.20902; Office for Life Sciences, 2013, STRAT UK LIF SCI; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Payne RA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000723; R Core Team, 2012, R LANG ENV STAT COMP; Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; Sekhri N, 2007, HEART, V93, P458, DOI 10.1136/hrt.2006.090894; Silver LE, 2009, HEART, V95, pA5; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; van Staa TP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e55; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; World Health Organization, 2010, INT STAT CLASS DIS H, V2; Wright FL, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-161	56	157	160	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f2350	10.1136/bmj.f2350	http://dx.doi.org/10.1136/bmj.f2350			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AK	23692896	hybrid, Green Published			2022-12-28	WOS:000319573300001
J	Dennis, M				Dennis, Martin		CLOTS Trials Collaboration	Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial	LANCET			English	Article							VENOUS THROMBOEMBOLISM PROPHYLAXIS; MOLECULAR-WEIGHT HEPARIN; ACUTE ISCHEMIC-STROKE; AMERICAN-COLLEGE	Background Venous thromboembolism is a common, potentially avoidable cause of death and morbidity in patients in hospital, including those with stroke. In surgical patients, intermittent pneumatic compression (IPC) reduces the risk of deep vein thrombosis (DVT), but no reliable evidence exists about its effectiveness in patients who have had a stroke. We assessed the effectiveness of IPC to reduce the risk of DVT in patients who have had a stroke. Methods The CLOTS 3 trial is a multicentre parallel group randomised trial assessing IPC in immobile patients (ie, who cannot walk to the toilet without the help of another person) with acute stroke. We enrolled patients from day 0 to day 3 of admission and allocated them via a central randomisation system (ratio 1: 1) to receive either IPC or no IPC. A technician who was masked to treatment allocation did a compression duplex ultrasound (CDU) of both legs at 7-10 days and, wherever practical, at 25-30 days after enrolment. Caregivers and patients were not masked to treatment assignment. Patients were followed up for 6 months to determine survival and later symptomatic venous thromboembolism. The primary outcome was a DVT in the proximal veins detected on a screening CDU or any symptomatic DVT in the proximal veins, confirmed on imaging, within 30 days of randomisation. Patients were analysed according to their treatment allocation. Trial registration: ISRCTN93529999. Findings Between Dec 8, 2008, and Sept 6, 2012, 2876 patients were enrolled in 94 centres in the UK. The included patients were broadly representative of immobile stroke patients admitted to hospital and had a median age of 76 years (IQR 67-84). The primary outcome occurred in 122 (8.5%) of 1438 patients allocated IPC and 174 (12.1%) of 1438 patients allocated no IPC; an absolute reduction in risk of 3.6% (95% CI 1.4-5.8). Excluding the 323 patients who died before any primary outcome and 41 without any screening CDU, the adjusted OR for the comparison of 122 of 1267 patients vs 174 of 1245 patients was 0.65 (95% CI 0.51-0.84; p=0.001). Deaths in the treatment period occurred in 156 (11%) patients allocated IPC and 189 (13%) patients allocated no IPC died within the 30 days of treatment period (p=0.057); skin breaks on the legs were reported in 44 (3%) patients allocated IPC and in 20 (1%) patients allocated no IPC (p=0.002); falls with injury were reported in 33 (2%) patients in the IPC group and in 24 (2%) patients in the no-IPC group (p=0.221). Interpretation IPC is an effective method of reducing the risk of DVT and possibly improving survival in a wide variety of patients who are immobile after stroke.	[Dennis, Martin] Univ Edinburgh, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dennis, M (corresponding author), Univ Edinburgh, Western Gen Hosp, Bramwell Dott Bldg,Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	martin.dennis@ed.ac.uk	Piechowski-Jozwiak, Bartlomiej/HCI-4426-2022; Durkan, Colm/F-1950-2011; Forbes, John F/L-2558-2013; Culmsee, Carsten/ABC-3120-2021; Macleod, Malcolm Robert/B-2052-2010; Wardlaw, Joanna M/Y-3456-2019	Forbes, John F/0000-0002-8255-3762; Culmsee, Carsten/0000-0002-5121-5015; Macleod, Malcolm Robert/0000-0001-9187-9839; Wardlaw, Joanna M/0000-0002-9812-6642; dennis, martin/0000-0003-1148-8972; Cranswick, Gina/0000-0002-4479-6034; PIECHOWSKI-JOZWIAK, BARTLOMIEJ/0000-0002-1886-9949; Murray, Gordon/0000-0001-9866-4734; Piechowski-Jozwiak, Bartlomiej/0000-0001-7814-0028; Kwan, Joseph/0000-0003-4635-3322; Tyrrell, Pippa/0000-0001-9609-1231	National Institute of Health Research (NIHR) Health Technology Assessment (HTA) programme, UK; Chief Scientist Office of Scottish Government; Covidien (MA, USA); MRC [G0800803] Funding Source: UKRI; Medical Research Council [G0800803] Funding Source: researchfish; National Institute for Health Research [08/14/03] Funding Source: researchfish; Chief Scientist Office [CZH/4/417, CZG/2/378] Funding Source: researchfish	National Institute of Health Research (NIHR) Health Technology Assessment (HTA) programme, UK; Chief Scientist Office of Scottish Government; Covidien (MA, USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	National Institute of Health Research (NIHR) Health Technology Assessment (HTA) programme, UK; Chief Scientist Office of Scottish Government; Covidien (MA, USA).	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; [Anonymous], 2010, NICE CLIN GUID; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Dennis M, 2010, ANN INTERN MED, V153, P553, DOI 10.7326/0003-4819-153-9-201011020-00280; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Dennis M, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-66; Dennis M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-26; Dennis M, 2011, J NEUROL NEUROSUR PS, V82, P1067, DOI 10.1136/jnnp.2010.235945; Galanaud JP, 2009, THROMB HAEMOSTASIS, V102, P493, DOI 10.1160/TH09-01-0053; House of Commons Health Committee, 2005, PREV VEN THROMB HOSP; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kakkar AK, 2011, NEW ENGL J MED, V365, P2463, DOI 10.1056/NEJMoa1111288; Kelly J, 2004, STROKE, V35, P2320, DOI 10.1161/01.STR.0000140741.13279.4f; Kelly J, 2002, AGE AGEING, V31, P235, DOI 10.1093/ageing/31.4.235; Kohro S, 2005, ACTA ANAESTH SCAND, V49, P660, DOI 10.1111/j.1399-6576.2005.00661.x; Lederle FA, 2011, ANN INTERN MED, V155, P602, DOI 10.7326/0003-4819-155-9-201111010-00008; Naccarato M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001922.pub3; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Roderick P, 2005, HEALTH TECHNOL ASSES, V9, P1; Whiteley WN, 2013, LANCET NEUROL, V12, P539, DOI 10.1016/S1474-4422(13)70079-6	20	183	193	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2013	382	9891					516	524		10.1016/S0140-6736(13)61050-8	http://dx.doi.org/10.1016/S0140-6736(13)61050-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201SD	23727163	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000323162400030
J	Roychoudhuri, R; Hirahara, K; Mousavi, K; Clever, D; Klebanoff, CA; Bonelli, M; Sciume, G; Zare, H; Vahedi, G; Dema, B; Yu, ZY; Liu, H; Takahashi, H; Rao, M; Muranski, P; Crompton, JG; Punkosdy, G; Bedognetti, D; Wang, E; Hoffmann, V; Rivera, J; Marincola, FM; Nakamura, A; Sartorelli, V; Kanno, Y; Gattinoni, L; Muto, A; Igarashi, K; O'Shea, JJ; Restifo, NP				Roychoudhuri, Rahul; Hirahara, Kiyoshi; Mousavi, Kambiz; Clever, David; Klebanoff, Christopher A.; Bonelli, Michael; Sciume, Giuseppe; Zare, Hossein; Vahedi, Golnaz; Dema, Barbara; Yu, Zhiya; Liu, Hui; Takahashi, Hayato; Rao, Mahadev; Muranski, Pawel; Crompton, Joseph G.; Punkosdy, George; Bedognetti, Davide; Wang, Ena; Hoffmann, Victoria; Rivera, Juan; Marincola, Francesco M.; Nakamura, Atsushi; Sartorelli, Vittorio; Kanno, Yuka; Gattinoni, Luca; Muto, Akihiko; Igarashi, Kazuhiko; O'Shea, John J.; Restifo, Nicholas P.			BACH2 represses effector programs to stabilize T-reg-mediated immune homeostasis	NATURE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; CELL-DIFFERENTIATION; SUSCEPTIBILITY LOCI; RISK LOCI; B-CELLS; TRANSCRIPTION; DISEASE; INTERLEUKIN-4; METAANALYSIS	Through their functional diversification, distinct lineages of CD4(+) T cells can act to either drive or constrain immune-mediated pathology. Transcription factors are critical in the generation of cellular diversity, and negative regulators antagonistic to alternate fates often act in conjunction with positive regulators to stabilize lineage commitment(1). Genetic polymorphisms within a single locus encoding the transcription factor BACH2 are associated with numerous autoimmune and allergic diseases including asthma(2), Crohn's disease(3,4), coeliac disease(5), vitiligo(6), multiple sclerosis(7) and type 1 diabetes(8). Although these associations point to a shared mechanism underlying susceptibility to diverse immune-mediated diseases, a function for BACH2 in the maintenance of immune homeostasis has not been established. Here, by studying mice in which the Bach2 gene is disrupted, we define BACH2 as a broad regulator of immune activation that stabilizes immunoregulatory capacity while repressing the differentiation programs of multiple effector lineages in CD4(+) T cells. BACH2 was required for efficient formation of regulatory (T-reg) cells and consequently for suppression of lethal inflammation in a manner that was T-reg-cell-dependent. Assessment of the genome-wide function of BACH2, however, revealed that it represses genes associated with effector cell differentiation. Consequently, its absence during T-reg polarization resulted in inappropriate diversion to effector lineages. In addition, BACH2 constrained full effector differentiation within T(H)1, T(H)2 and T(H)17 cell lineages. These findings identify BACH2 as a key regulator of CD4(+) T-cell differentiation that prevents inflammatory disease by controlling the balance between tolerance and immunity.	[Roychoudhuri, Rahul; Clever, David; Klebanoff, Christopher A.; Yu, Zhiya; Rao, Mahadev; Muranski, Pawel; Crompton, Joseph G.; Gattinoni, Luca; Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hirahara, Kiyoshi; Bonelli, Michael; Sciume, Giuseppe; Vahedi, Golnaz; Takahashi, Hayato; Kanno, Yuka; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Mousavi, Kambiz; Zare, Hossein; Sartorelli, Vittorio] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Dema, Barbara; Rivera, Juan] NIAMS, Lab Mol Immunogenet, NIH, Bethesda, MD 20892 USA; [Liu, Hui; Bedognetti, Davide; Wang, Ena; Marincola, Francesco M.] NIH, Dept Transfus Med, Bethesda, MD 20892 USA; [Punkosdy, George] NIAID, NIH, Bethesda, MD 20892 USA; [Hoffmann, Victoria] NIH, Div Vet Resources, Bethesda, MD 20892 USA; [Marincola, Francesco M.] Sidra Med & Res Ctr, Doha, Qatar; [Nakamura, Atsushi; Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; [Muto, Akihiko; Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi 9808575, Japan; [Restifo, Nicholas P.] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; Sidra Medical & Research Center; Tohoku University; Japan Science & Technology Agency (JST); National Institutes of Health (NIH) - USA	Roychoudhuri, R (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	roychoudhuri@mail.nih.gov; osheajo@mail.nih.gov; restifo@nih.gov	Hirahara, Kiyoshi/E-2460-2017; Roychoudhuri, Rahul/A-7442-2010; Sciume, Giuseppe/K-8985-2016; Kanno, Yuka/B-5802-2013; Gattinoni, Luca/A-2281-2008; Bedognetti, Davide/GLQ-9410-2022; Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas Phillip/Z-1614-2019; Dema, Barbara/AAM-2354-2020; Takahashi, Hayato/AAV-7707-2021; zare, hossein/ABB-5871-2021; Bedognetti, Davide/ADI-1011-2022	Hirahara, Kiyoshi/0000-0002-9128-9449; Roychoudhuri, Rahul/0000-0002-5392-1853; Sciume, Giuseppe/0000-0003-0131-512X; Kanno, Yuka/0000-0001-5668-9319; Gattinoni, Luca/0000-0003-2239-3282; Takahashi, Hayato/0000-0001-6768-8821; Igarashi, Kazuhiko/0000-0002-2470-2475; Crompton, Joseph/0000-0001-9325-2909; Restifo, Nicholas P./0000-0003-4229-4580; Bonelli, Michael/0000-0002-6122-7482; Bedognetti, Davide/0000-0002-5857-773X; Clever, David/0000-0002-9137-8177; Klebanoff, Christopher/0000-0001-9645-3896; Sartorelli, Vittorio/0000-0002-9284-3675	Intramural Research Programs of the National Cancer Institute (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases; NIH Center for Regenerative Medicine; JSPS Research Fellowship for Japanese Biomedical and Behavioural Researchers at NIH; NATIONAL CANCER INSTITUTE [Z01BC011037] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041165, ZIAAR041164, ZIAAR041159] Funding Source: NIH RePORTER	Intramural Research Programs of the National Cancer Institute (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH Center for Regenerative Medicine; JSPS Research Fellowship for Japanese Biomedical and Behavioural Researchers at NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the Intramural Research Programs of the National Cancer Institute (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the NIH Center for Regenerative Medicine and the JSPS Research Fellowship for Japanese Biomedical and Behavioural Researchers at NIH. We thank D. N. Roychoudhuri, D. C. Macallan, G. E. Griffin, S. A. Rosenberg, M. S. Rao, Y. Ji, D. Palmer, M. Sukumar, G. Fabozzi, K. Hanada, E. Lugli, J. H. Pan and N. Van Panhuys for discussions, A. Mixon and S. Farid for cell sorting, G. McMullen for mouse handling and Y. Luo, Y. Wakabayashi, J. Zhu, G. Gutierrez-Cruz and H. W. Sun for help with sequencing and analysis.	Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Christodoulou K., 2012, GUT; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	35	264	275	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					506	+		10.1038/nature12199	http://dx.doi.org/10.1038/nature12199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23728300	Green Accepted			2022-12-28	WOS:000320929400057
J	Shaw, AT; Kim, DW; Nakagawa, K; Seto, T; Crino, L; Ahn, MJ; De Pas, T; Besse, B; Solomon, BJ; Blackhall, F; Wu, YL; Thomas, M; O'Byrne, KJ; Moro-Sibilot, D; Camidge, DR; Mok, T; Hirsh, V; Riely, GJ; Iyer, S; Tassell, V; Polli, A; Wilner, KD; Janne, PA				Shaw, Alice T.; Kim, Dong-Wan; Nakagawa, Kazuhiko; Seto, Takashi; Crino, Lucio; Ahn, Myung-Ju; De Pas, Tommaso; Besse, Benjamin; Solomon, Benjamin J.; Blackhall, Fiona; Wu, Yi-Long; Thomas, Michael; O'Byrne, Kenneth J.; Moro-Sibilot, Denis; Camidge, D. Ross; Mok, Tony; Hirsh, Vera; Riely, Gregory J.; Iyer, Shrividya; Tassell, Vanessa; Polli, Anna; Wilner, Keith D.; Jaenne, Pasi A.			Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EML4-ALK FUSION GENE; CLINICAL-TRIALS; OPEN-LABEL; PHASE-III; LYMPHOMA; ONCOLOGY; EGFR; REARRANGEMENT; GEFITINIB; DOCETAXEL	Background In single-group studies, chromosomal rearrangements of the anaplastic lymphoma kinase gene (ALK) have been associated with marked clinical responses to crizotinib, an oral tyrosine kinase inhibitor targeting ALK. Whether crizotinib is superior to standard chemotherapy with respect to efficacy is unknown. Methods We conducted a phase 3, open-label trial comparing crizotinib with chemotherapy in 347 patients with locally advanced or metastatic ALK-positive lung cancer who had received one prior platinum-based regimen. Patients were randomly assigned to receive oral treatment with crizotinib (250 mg) twice daily or intravenous chemotherapy with either pemetrexed (500 mg per square meter of body-surface area) or docetaxel (75 mg per square meter) every 3 weeks. Patients in the chemotherapy group who had disease progression were permitted to cross over to crizotinib as part of a separate study. The primary end point was progression-free survival. Results The median progression-free survival was 7.7 months in the crizotinib group and 3.0 months in the chemotherapy group (hazard ratio for progression or death with crizotinib, 0.49; 95% confidence interval [CI], 0.37 to 0.64; P<0.001). The response rates were 65% (95% CI, 58 to 72) with crizotinib, as compared with 20% (95% CI, 14 to 26) with chemotherapy (P<0.001). An interim analysis of overall survival showed no significant improvement with crizotinib as compared with chemotherapy (hazard ratio for death in the crizotinib group, 1.02; 95% CI, 0.68 to 1.54; P = 0.54). Common adverse events associated with crizotinib were visual disorder, gastrointestinal side effects, and elevated liver aminotransferase levels, whereas common adverse events with chemotherapy were fatigue, alopecia, and dyspnea. Patients reported greater reductions in symptoms of lung cancer and greater improvement in global quality of life with crizotinib than with chemotherapy. Conclusions Crizotinib is superior to standard chemotherapy in patients with previously treated, advanced non-small-cell lung cancer with ALK rearrangement.	[Shaw, Alice T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Jaenne, Pasi A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Kim, Dong-Wan] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Osakasayama City, Osaka, Japan; [Seto, Takashi] Kyushu Natl Canc Ctr, Fukuoka, Japan; [Crino, Lucio] Azienda Osped Perugia, Perugia, Italy; [De Pas, Tommaso] European Inst Oncol, Milan, Italy; [Polli, Anna] Pfizer Italia, Milan, Italy; [Besse, Benjamin] Inst Gustave Roussy, Villejuif, France; [Moro-Sibilot, Denis] CHU Grenoble, Thorac Oncol Unit, F-38043 Grenoble, France; [Solomon, Benjamin J.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Blackhall, Fiona] Christie Natl Hlth Serv Fdn Trust, Manchester, Lancs, England; [Wu, Yi-Long] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Thomas, Michael] Univ Klinikum Heidelberg, Thoraxklinik, Heidelberg, Germany; [Thomas, Michael] Translat Lung Res Ctr Heidelberg, Heidelberg, Germany; [O'Byrne, Kenneth J.] St James Hosp, Dublin, Ireland; [Camidge, D. Ross] Univ Colorado, Aurora, CO USA; [Mok, Tony] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Hirsh, Vera] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Riely, Gregory J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Iyer, Shrividya] Pfizer Oncol, New York, NY USA; [Tassell, Vanessa; Wilner, Keith D.] Pfizer Oncol, La Jolla, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Kindai University (Kinki University); University of Perugia; Azienda Ospedaliera di Perugia; IRCCS European Institute of Oncology (IEO); Pfizer; UNICANCER; Gustave Roussy; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Peter Maccallum Cancer Center; Christie NHS Foundation Trust; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Ruprecht Karls University Heidelberg; Trinity College Dublin; University of Colorado System; University of Colorado Anschutz Medical Campus; Chinese University of Hong Kong; McGill University; Memorial Sloan Kettering Cancer Center; Pfizer; Pfizer	Shaw, AT (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Yawkey 7B,32 Fruit St, Boston, MA 02114 USA.	ashaw1@partners.org	De Pas, tommaso/K-4879-2018; Blackhall, Fiona H/N-2186-2015; Wu, Yi-Long/GRJ-9238-2022; Wu, Yi-Long/AAW-9832-2020; Wu, Yi-Long/AAB-9137-2022; Riely, Gregory/AAF-4300-2019; Wu, Yi-Long/C-3396-2008; Mok, Tony Shu Kam/B-2310-2019; MORO-SIBILOT, denis L/N-6493-2013; Besse, Benjamin/V-1523-2019; Kim, Dong-Wan/J-5391-2012; Camidge, David Ross/AAG-9144-2019	Blackhall, Fiona H/0000-0001-8716-3395; Wu, Yi-Long/0000-0002-3611-0258; Wu, Yi-Long/0000-0002-3611-0258; Mok, Tony Shu Kam/0000-0002-8251-0551; Besse, Benjamin/0000-0001-5090-8189; Iyer, shrividya/0000-0002-1770-2311; Solomon, Benjamin/0000-0003-3059-5730; MORO-SIBILOT, Denis/0000-0001-6776-8610; O'Byrne, Kenneth/0000-0002-6754-5633	Pfizer	Pfizer(Pfizer)	Funded by Pfizer; ClinicalTrials.gov number, NCT00932893.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; BERGMAN B, 1994, EUR J CANCER, V30A, P635, DOI 10.1016/0959-8049(94)90535-5; Blackhall F, 2012, ANN ONCOL, V23, P73; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Kim DW, 2012, ANN M AM SOC CLIN ON; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mosse YP, 2012, ANN M AM SOC CLIN ON; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ou SHI, 2011, J THORAC ONCOL, V6, P942, DOI 10.1097/JTO.0b013e31821528d3; Peerzada Maajid Mumtaz, 2011, Clin Adv Hematol Oncol, V9, P824; Reuben A, 2004, HEPATOLOGY, V39, P574, DOI 10.1002/hep.20081; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181	30	2556	2684	11	282	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2385	2394		10.1056/NEJMoa1214886	http://dx.doi.org/10.1056/NEJMoa1214886			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23724913	Green Published			2022-12-28	WOS:000320601700008
J	Beeler, MC; Williams, RA; Jimenez-Garcia, K; LeBlanc, LJ; Perry, AR; Spielman, IB				Beeler, M. C.; Williams, R. A.; Jimenez-Garcia, K.; LeBlanc, L. J.; Perry, A. R.; Spielman, I. B.			The spin Hall effect in a quantum gas	NATURE			English	Article							NEUTRAL ATOMS	Electronic properties such as current flow are generally independent of the electron's spin angular momentum, an internal degree of freedom possessed by quantum particles. The spin Hall effect, first proposed 40 years ago(1), is an unusual class of phenomena in which flowing particles experience orthogonally directed, spin-dependent forces-analogous to the conventional Lorentz force that gives the Hall effect, but opposite in sign for two spin states. Spin Hall effects have been observed for electrons flowing in spin-orbit-coupled materials such as GaAs and InGaAs (refs 2, 3) and for laser light traversing dielectric junctions(4). Here we observe the spin Hall effect in a quantum-degenerate Bose gas, and use the resulting spin-dependent Lorentz forces to realize a cold-atom spin transistor. By engineering a spatially inhomogeneous spin-orbit coupling field for our quantum gas, we explicitly introduce and measure the requisite spin-dependent Lorentz forces, finding them to be in excellent agreement with our calculations. This 'atomtronic' transistor behaves as a type of velocity-insensitive adiabatic spin selector, with potential application in devices such as magnetic(5) or inertial(6) sensors. In addition, such techniques for creating and measuring the spin Hall effect are clear prerequisites for engineering topological insulators(7,8) and detecting their associated quantized spin Hall effects in quantum gases. As implemented, our system realizes a laser-actuated analogue to the archetypal semiconductor spintronic device, the Datta-Das spin transistor(9,10).	[Beeler, M. C.; Williams, R. A.; Jimenez-Garcia, K.; LeBlanc, L. J.; Perry, A. R.; Spielman, I. B.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Beeler, M. C.; Williams, R. A.; Jimenez-Garcia, K.; LeBlanc, L. J.; Perry, A. R.; Spielman, I. B.] Univ Maryland, Gaithersburg, MD 20899 USA; [Jimenez-Garcia, K.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis, Mexico City 07360, DF, Mexico	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Spielman, IB (corresponding author), NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	ian.spielman@nist.gov	LeBlanc, Lindsay/ABA-8511-2020	Williams, Ross/0000-0001-9347-0922	DARPA OLE programme; ARO atomtronics MURI; NIST; US NSF through the PFC at the JQI; NSERC; Division Of Physics [0822671] Funding Source: National Science Foundation	DARPA OLE programme; ARO atomtronics MURI(MURI); NIST(National Institute of Standards & Technology (NIST) - USA); US NSF through the PFC at the JQI; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by the DARPA OLE programme; the ARO atomtronics MURI, NIST, and the US NSF through the PFC at the JQI. M. C. B. acknowledges NIST-ARRA, L.J.L. acknowledges support from NSERC and K.J.-G. acknowledges CONACYT.	Anderson BM, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.031602; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Cheuk LW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095302; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; DYAKONOV MI, 1971, JETP LETT-USSR, V13, P467; Estienne B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/045012; Gaunt AL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00721; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Ho TL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.150403; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Jungwirth T, 2012, NAT MATER, V11, P382, DOI [10.1038/NMAT3279, 10.1038/nmat3279]; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kitching J, 2011, IEEE SENS J, V11, P1749, DOI 10.1109/JSEN.2011.2157679; LeBlanc LJ, 2012, P NATL ACAD SCI USA, V109, P10811, DOI 10.1073/pnas.1202579109; Lee JG, 2013, SCI REP-UK, V3, DOI [10.1038/srep01034, 10.1038/srep02197]; Lin YJ, 2011, NATURE, V471, P83, DOI 10.1038/nature09887; Lin YJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.130401; Lin YJ, 2011, NAT PHYS, V7, P531, DOI [10.1038/nphys1954, 10.1038/NPHYS1954]; Liu XJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026602; Lyanda-Geller Y, 1998, PHYS REV LETT, V80, P4273, DOI 10.1103/PhysRevLett.80.4273; Palima D, 2007, OPT EXPRESS, V15, P11971, DOI 10.1364/OE.15.011971; Pasienski M, 2008, OPT EXPRESS, V16, P2176, DOI 10.1364/OE.16.002176; Peskin M. E., 1995, INTRO QUANTUM FIELD, P481; Ruseckas J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010404; Sakurai J. J., 1994, MODERN QUANTUM MECH, P130; Schliemann J, 2006, INT J MOD PHYS B, V20, P1015, DOI 10.1142/S021797920603370X; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Stanescu TD, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053639; Vaishnav JY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.265302; Wang PJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095301; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; YANG CN, 1954, PHYS REV, V96, P191, DOI 10.1103/PhysRev.96.191; Zhang JY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.115301; Zhang YP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.035302; Zhu SL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.240401	40	152	154	2	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					201	+		10.1038/nature12185	http://dx.doi.org/10.1038/nature12185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23739329	Green Accepted			2022-12-28	WOS:000320283400041
J	Callen, E; Di Virgilio, M; Kruhlak, MJ; Nieto-Soler, M; Wong, N; Chen, HT; Faryabi, RB; Polato, F; Santos, M; Starnes, LM; Wesemann, DR; Lee, JE; Tubbs, A; Sleckman, BP; Daniel, JA; Ge, K; Alt, FW; Fernandez-Capetillo, O; Nussenzweig, MC; Nussenzweig, A				Callen, Elsa; Di Virgilio, Michela; Kruhlak, Michael J.; Nieto-Soler, Maria; Wong, Nancy; Chen, Hua-Tang; Faryabi, Robert B.; Polato, Federica; Santos, Margarida; Starnes, Linda M.; Wesemann, Duane R.; Lee, Ji-Eun; Tubbs, Anthony; Sleckman, Barry P.; Daniel, Jeremy A.; Ge, Kai; Alt, Frederick W.; Fernandez-Capetillo, Oscar; Nussenzweig, Michel C.; Nussenzweig, Andre			53BP1 Mediates Productive and Mutagenic DNA Repair through Distinct Phosphoprotein Interactions	CELL			English	Article							CLASS SWITCH RECOMBINATION; LYSINE-4 METHYLTRANSFERASE COMPLEX; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; END RESECTION; BRCT-DOMAIN; DYSFUNCTIONAL TELOMERES; B-CELLS; PTIP; RIF1	The DNA damage response (DDR) protein 53BP1 protects DNA ends from excessive resection in G1, and thereby favors repair by nonhomologous end-joining (NHEJ) as opposed to homologous recombination (HR). During S phase, BRCA1 antagonizes 53BP1 to promote HR. The pro-NHEJ and antirecombinase functions of 53BP1 are mediated in part by RIF1, the only known factor that requires 53BP1 phosphorylation for its recruitment to double-strand breaks (DSBs). Here, we show that a 53BP1 phosphomutant, 53BP1(8A), comprising alanine substitutions of the eight most N-terminal S/TQ phosphorylation sites, mimics 53BP1 deficiency by restoring genome stability in BRCA1-deficient cells yet behaves like wild-type 53BP1 with respect to immunoglobulin class switch recombination (CSR). 53BP1(8A) recruits RIF1 but fails to recruit the DDR protein PTIP to DSBs, and disruption of PTIP phenocopies 53BP1(8A). We conclude that 53BP1 promotes productive CSR and suppresses mutagenic DNA repair through distinct phosphodependent interactions with RIF1 and PTIP.	[Callen, Elsa; Wong, Nancy; Chen, Hua-Tang; Faryabi, Robert B.; Polato, Federica; Santos, Margarida; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Di Virgilio, Michela; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Di Virgilio, Michela; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Nieto-Soler, Maria; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Gen Instabil Grp, Madrid 28029, Spain; [Santos, Margarida; Daniel, Jeremy A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Wesemann, Duane R.; Alt, Frederick W.] Childrens Hosp, Program Cellular & Mol Med, Immune Dis Inst, Boston, MA 02115 USA; [Wesemann, Duane R.; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lee, Ji-Eun; Ge, Kai] NIDDKD, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Tubbs, Anthony; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Copenhagen; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Washington University (WUSTL)	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Faryabi, Robert/AAN-5512-2020; Fernandez-Capetillo, Oscar/H-3508-2015; Nussenzweig, Michel/AAE-7292-2019; Faryabi, Robert B/H-3544-2015; Santos, Margarida/GWR-2285-2022; Polato, Federica/Q-1803-2018; Lee, Ji-Eun/F-7891-2011; Ge, Kai/H-2810-2019; Daniel, Jeremy/S-4729-2016; Di Virgilio, Michela/AAE-9298-2022	Faryabi, Robert/0000-0002-7931-2175; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Faryabi, Robert B/0000-0002-7931-2175; Lee, Ji-Eun/0000-0002-3768-7016; Ge, Kai/0000-0002-7442-5138; Daniel, Jeremy/0000-0002-1981-5571; Tubbs, Anthony/0000-0002-5605-8231; Nieto-Soler, Maria/0000-0002-4334-6533; Wesemann, Duane/0000-0002-6690-944X; Starnes, Linda/0000-0002-7322-9928; Di Virgilio, Michela/0000-0001-5189-0793	NIH [AI89972]; American Association of Allergy Asthma and Immunology and CSL Behring; Career Award for Medical Scientists (Burroughs Wellcome Fund); Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; Department of Defense grant [BC102335]; NATIONAL CANCER INSTITUTE [ZICBC010915, ZICBC009255, Z01BC010959, ZIABC010283, Z01BC010283, ZIABC010959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074953, R01AI047829, K08AI089972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075017, ZIADK047055, ZIADK075003] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Allergy Asthma and Immunology and CSL Behring; Career Award for Medical Scientists (Burroughs Wellcome Fund); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the A. Nussenzweig lab and Davide Robbiani for discussions; Titia de Lange for RIF1f/f mice; Susan Sharrow for flow cytometry; and Sandy Chang for the TRF2 shRNA construct. M.C.N., F.W.A and O.F.-C. are HHMI investigators. D.R.W. was supported by NIH grants AI89972, the American Association of Allergy Asthma and Immunology and CSL Behring, and a Career Award for Medical Scientists (Burroughs Wellcome Fund). This work was supported by the Intramural Research Program of the NIH, the National Cancer Institute, and the Center for Cancer Research, and by a Department of Defense grant to A.N. (BC102335).	Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bowman-Colin C, 2013, P NATL ACAD SCI USA, V110, P8632, DOI 10.1073/pnas.1305362110; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Callen E, 2012, IMMUNITY, V37, P971, DOI 10.1016/j.immuni.2012.10.007; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Lottersberger F., 2013, P NATL ACAD SCI US; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wang X, 2010, GENES CELLS, V15, P243, DOI 10.1111/j.1365-2443.2009.01379.x; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wesemann DR, 2011, J EXP MED, V208, P2733, DOI 10.1084/jem.20111155; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	53	246	249	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1266	1280		10.1016/j.cell.2013.05.023	http://dx.doi.org/10.1016/j.cell.2013.05.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23727112	Green Accepted, Bronze			2022-12-28	WOS:000319979200012
J	Lock, M				Lock, Margaret			The lure of the epigenome	LANCET			English	Editorial Material									McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada	McGill University	Lock, M (corresponding author), McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada.	margaret.lock@mcgill.ca						[Anonymous], 2010, MIRAGE SPACE NATURE; Labonte B, 2012, ARCH GEN PSYCHIAT, V69, P722, DOI 10.1001/archgenpsychiatry.2011.2287; Lock M, 2010, ANTHR BIOMEDICINE; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Moshe S., 2011, EPIGENETICS, V6, P1; Nada B., 2012, INT J EPIDEMIOL, V41, P6; Rich-Edwards J, 2001, PAEDIATR PERINAT EP, V15, P124, DOI 10.1046/j.1365-3016.2001.00013.x; Tester FJ, 2004, SOC SCI MED, V58, P2625, DOI 10.1016/j.socscimed.2003.09.021	8	28	28	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1896	1897		10.1016/S0140-6736(13)61149-6	http://dx.doi.org/10.1016/S0140-6736(13)61149-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23734394	Bronze			2022-12-28	WOS:000320319500016
J	Kay, M				Kay, Meera			Unsafe abortion: why restricting abortive drugs only makes a bad situation worse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INDIA					meerakay@ymail.com						Banerjee S, 2009, EXPLORING PATHWAYS U; Duggal R, 2004, REPROD HEALTH MATTER, V12, P122, DOI 10.1016/S0968-8080(04)24009-5; Ganatra B, 2005, REPROD HEALTH MATTER, V13, P65, DOI 10.1016/S0968-8080(05)26215-8; Indian Council of Medical Research, 1989, ILL AB RUR AR TASK F; International Consortium for Medical Abortion, COUNTR AB PROF IND; International Pregnancy Advisory Services (Ipas) India, DIS MED AB DRUGS FAC; Jain A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1957; Ministry of Health and Family Welfare, 2011, FAM WELF STAT IND; World Health Organization, 2013, UNS AB GLOB REG EST	9	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2013	346								f3159	10.1136/bmj.f3159	http://dx.doi.org/10.1136/bmj.f3159			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DQ	23729428				2022-12-28	WOS:000319949200002
J	Rosenthal, MB; Mello, MM				Rosenthal, Meredith B.; Mello, Michelle M.			Sunlight as Disinfectant - New Rules on Disclosure of Industry Payments to Physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNINTENDED CONSEQUENCES		[Rosenthal, Meredith B.; Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Mello, Michelle/0000-0003-2877-4270; Rosenthal, Meredith/0000-0003-3410-0184				Centers for Medicare & Medicaid Services (CMS) HHS, 2013, Fed Regist, V78, P9457; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P669, DOI 10.1001/jama.2012.154; Pham-Kanter G, 2012, ARCH INTERN MED, V172, P819, DOI 10.1001/archinternmed.2012.1210; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239	4	45	46	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2052	2054		10.1056/NEJMp1305090	http://dx.doi.org/10.1056/NEJMp1305090			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AT	23718162	Green Published			2022-12-28	WOS:000319574200002
J	Kouzine, F; Wojtowicz, D; Yamane, A; Resch, W; Kieffer-Kwon, KR; Bandle, R; Nelson, S; Nakahashi, H; Awasthi, P; Feigenbaum, L; Menoni, H; Hoeijmakers, J; Vermeulen, W; Ge, H; Przytycka, TM; Levens, D; Casellas, R				Kouzine, Fedor; Wojtowicz, Damian; Yamane, Arito; Resch, Wolfgang; Kieffer-Kwon, Kyong-Rim; Bandle, Russell; Nelson, Steevenson; Nakahashi, Hirotaka; Awasthi, Parirokh; Feigenbaum, Lionel; Menoni, Herve; Hoeijmakers, Jan; Vermeulen, Wim; Ge, Hui; Przytycka, Teresa M.; Levens, David; Casellas, Rafael			Global Regulation of Promoter Melting in Naive Lymphocytes	CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS IIE; IN-VIVO; C-MYC; BASAL TRANSCRIPTION; HUMAN GENOME; QUADRUPLEX STRUCTURES; HISTONE ACETYLATION; ACTIVE PROMOTERS	Lymphocyte activation is initiated by a global increase in messenger RNA synthesis. However, the mechanisms driving transcriptome amplification during the immune response are unknown. By monitoring single-stranded DNA genome wide, we show that the genome of naive cells is poised for rapid activation. In G(0), similar to 90% of promoters from genes to be expressed in cycling lymphocytes are polymerase loaded but unmelted and support only basal transcription. Furthermore, the transition from abortive to productive elongation is kinetically limiting, causing polymerases to accumulate nearer to transcription start sites. Resting lymphocytes also limit the expression of the transcription factor IIH complex, including XPB and XPD helicases involved in promoter melting and open complex extension. To date, two rate-limiting steps have been shown to control global gene expression in eukaryotes: preinitiation complex assembly and polymerase pausing. Our studies identify promoter melting as a third key regulatory step and propose that this mechanism ensures a prompt lymphocyte response to invading pathogens.	[Kouzine, Fedor; Bandle, Russell; Levens, David] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wojtowicz, Damian; Przytycka, Teresa M.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Yamane, Arito; Resch, Wolfgang; Kieffer-Kwon, Kyong-Rim; Nelson, Steevenson; Nakahashi, Hirotaka; Casellas, Rafael] NIAMS, NIH, Bethesda, MD 20892 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Awasthi, Parirokh; Feigenbaum, Lionel] NCI, Sci Applicat Int Corp, NIH, Bethesda, MD 20892 USA; [Wojtowicz, Damian] Univ Warsaw, Inst Informat, PL-02098 Warsaw, Poland; [Menoni, Herve; Hoeijmakers, Jan; Vermeulen, Wim] Erasmus MC, Dept Genet, NL-3015 GE Rotterdam, Netherlands; [Ge, Hui] Ascentgene Inc, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Warsaw; Erasmus University Rotterdam; Erasmus MC	Levens, D (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	levens@helix.nih.gov; casellar@mail.nih.gov	Hoeijmakers, Jan/AAX-6972-2021; Levens, David/C-9216-2009; Vermeulen, Wim/W-8708-2019; Wojtowicz, Damian/AAF-2007-2022; Wojtowicz, Damian/AFG-8518-2022; Yamane, Arito/A-2959-2013	Levens, David/0000-0002-7616-922X; Vermeulen, Wim/0000-0003-3616-734X; Wojtowicz, Damian/0000-0002-4274-6383; Wojtowicz, Damian/0000-0002-4274-6383; Przytycka, Teresa/0000-0002-6261-277X; Menoni, Herve/0000-0002-5302-4933; Resch, Wolfgang/0000-0001-7594-5963	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS); National Cancer Institute (Center for Cancer Research); National Library of Medicine of the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041186, ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200887] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS); National Cancer Institute (Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine of the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank G. Gutierrez for technical assistance with the genome analyzer; J. Simone and J. Lay for bone marrow sorts; J. Qian and K. Zaal for the B cell confocal micrographs; and C. Benham for SIDD mapping. We thank the Casellas and Levens lab members for critically reading the manuscript. We also thank A. Hoofring from the National Institutes of Health (NIH) Medical Arts for designing the pictures shown in Figure 6D. This work was supported in part by the Intramural Research Program of National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS), the National Cancer Institute (Center for Cancer Research), and the National Library of Medicine of the NIH. This study utilized the high-performance computational capabilities of the Helix Systems at the NIH (http://helix.nih.gov). All animal experiments were performed according to the NIH guidelines for laboratory animals and were approved by the Scientific Committee of the NIAMS Animal Facilities. For questions regarding computational analysis, please contact T.M.P. (przytyck@ncbi.nlm.nih.gov).	Assfalg R, 2012, NUCLEIC ACIDS RES, V40, P650, DOI 10.1093/nar/gkr746; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Benham CJ, 2004, J COMPUT BIOL, V11, P519, DOI 10.1089/cmb.2004.11.519; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Calvo KR, 2008, BLOOD, V112, P3818, DOI 10.1182/blood-2008-02-138933; Cer RZ, 2011, NUCLEIC ACIDS RES, V39, pD383, DOI 10.1093/nar/gkq1170; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; Di Virgilio M., 2013, SCIENCE; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Giglia-Mari G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000220; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guzman E, 1999, MOL CELL BIOL, V19, P5652; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; JAEHNING JA, 1975, CELL, V4, P51, DOI 10.1016/0092-8674(75)90133-6; Jenne A, 1999, BIOTECHNIQUES, V26, P249, DOI 10.2144/99262bm15; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; Khil PP, 2012, GENOME RES, V22, P957, DOI 10.1101/gr.130583.111; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; Kouzine F, 2004, NAT STRUCT MOL BIOL, V11, P1092, DOI 10.1038/nsmb848; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lutz R, 2001, NUCLEIC ACIDS RES, V29, P3873, DOI 10.1093/nar/29.18.3873; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; MELCHERS F, 1984, CELL, V37, P715, DOI 10.1016/0092-8674(84)90407-0; MIRKOVITCH J, 1992, MOL BIOL CELL, V3, P1085, DOI 10.1091/mbc.3.10.1085; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; POGO BGT, 1967, J CELL BIOL, V35, P477, DOI 10.1083/jcb.35.2.477; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Raghavan SC, 2006, BIOESSAYS, V28, P480, DOI 10.1002/bies.20353; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; SAWAI M, 1990, EXP CELL RES, V187, P4, DOI 10.1016/0014-4827(90)90108-M; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shklover J, 2010, NUCLEIC ACIDS RES, V38, P2369, DOI 10.1093/nar/gkp1208; SPRENT J, 1993, CURR OPIN IMMUNOL, V5, P433, DOI 10.1016/0952-7915(93)90065-Z; STERNER DE, 1995, MOL CELL BIOL, V15, P5716; TU CPD, 1980, GENE, V10, P177, DOI 10.1016/0378-1119(80)90135-3; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yafe A, 2008, NUCLEIC ACIDS RES, V36, P3916, DOI 10.1093/nar/gkn340; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhou ZX, 2013, GENOME RES, V23, P705, DOI 10.1101/gr.146357.112	75	110	110	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					988	999		10.1016/j.cell.2013.04.033	http://dx.doi.org/10.1016/j.cell.2013.04.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706737	Green Accepted, Bronze			2022-12-28	WOS:000319456800008
J	Smith, K				Smith, Kerri			NEUROSCIENCE Off to night school	NATURE			English	Editorial Material							SLEEP; COHERENCE; REPLAY; MEMORY											Aton SJ, 2013, P NATL ACAD SCI USA, V110, P3101, DOI 10.1073/pnas.1208093110; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Mander BA, 2013, NAT NEUROSCI, V16, P357, DOI 10.1038/nn.3324; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Wamsley EJ, 2012, BIOL PSYCHIAT, V71, P154, DOI 10.1016/j.biopsych.2011.08.008; Wilhelm I, 2013, NAT NEUROSCI, V16, P391, DOI 10.1038/nn.3343	9	5	5	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S4	S5		10.1038/497S4a	http://dx.doi.org/10.1038/497S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698506				2022-12-28	WOS:000319254000003
J	Greenough, PG				Greenough, P. Gregg			The Kumbh Mela stampede: disaster preparedness must bridge jurisdictions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Greenough, P. Gregg] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Greenough, P. Gregg] Harvard Univ, FXB Ctr Hlth & Human Rights, Cambridge, MA 02138 USA	Harvard University; Harvard University	Greenough, PG (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.							Bhatti A., 2003, DISASTER RISK REDUCT, P61; BIGNELL V, 1978, CATASTROPHIC FAILURE; US Department of Homeland Security, 2010, GAP ASS EM RESP COMM; Zhang J., 2012, FORSCHUNGSZENTRUM JU, V14, P103	4	9	9	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2013	346								f3254	10.1136/bmj.f3254	http://dx.doi.org/10.1136/bmj.f3254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AA	23690498				2022-12-28	WOS:000319572300005
J	Rottingen, JA; Regmi, S; Eide, M; Young, AJ; Viergever, RF; Ardal, C; Guzman, J; Edwards, D; Matlin, SA; Terry, RF				Rottingen, John-Arne; Regmi, Sadie; Eide, Mari; Young, Alison J.; Viergever, Roderik F.; Ardal, Christine; Guzman, Javier; Edwards, Danny; Matlin, Stephen A.; Terry, Robert F.			Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?	LANCET			English	Article							COVERAGE	The need to align investments in health research and development (R&D) with public health demands is one of the most pressing global public health challenges. We aim to provide a comprehensive description of available data sources, propose a set of indicators for monitoring the global landscape of health R&D, and present a sample of country indicators on research inputs (investments), processes (clinical trials), and outputs (publications), based on data from international databases. Total global investments in health R&D (both public and private sector) in 2009 reached US$240 billion. Of the US$214 billion invested in high-income countries, 60% of health R&D investments came from the business sector, 30% from the public sector, and about 10% from other sources (including private non-profit organisations). Only about 1% of all health R&D investments were allocated to neglected diseases in 2010. Diseases of relevance to high-income countries were investigated in clinical trials seven-to-eight-times more often than were diseases whose burden lies mainly in low-income and middle-income countries. This report confirms that substantial gaps in the global landscape of health R&D remain, especially for and in low-income and middle-income countries. Too few investments are targeted towards the health needs of these countries. Better data are needed to improve priority setting and coordination for health R&D, ultimately to ensure that resources are allocated to diseases and regions where they are needed the most. The establishment of a global observatory on health R&D, which is being discussed at WHO, could address the absence of a comprehensive and sustainable mechanism for regular global monitoring of health R&D.	[Rottingen, John-Arne; Ardal, Christine] Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, N-0316 Oslo, Norway; [Rottingen, John-Arne] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Rottingen, John-Arne] Harvard Univ, Harvard Global Hlth Inst, Cambridge, MA 02138 USA; [Regmi, Sadie] Univ Manchester, Inst Sci Eth & Innovat, Manchester, Lancs, England; [Regmi, Sadie] Univ Manchester, Sch Med, Manchester, Lancs, England; [Eide, Mari] Norwegian Univ Sci & Technol, Fac Med, Trondheim, Norway; [Viergever, Roderik F.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Viergever, Roderik F.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England; [Ardal, Christine] Norwegian Knowledge Ctr Hlth Serv, Hamar, Norway; [Guzman, Javier] Policy Cures, London, England; [Edwards, Danny] Council Hlth Res Dev, Geneva, Switzerland; [Matlin, Stephen A.] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London, England; [Terry, Robert F.] WHO, Publ Hlth Innovat & Intellectual Property, CH-1211 Geneva, Switzerland	University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Manchester; University of Manchester; Norwegian University of Science & Technology (NTNU); Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine; Norwegian Knowledge Centre for Health Services; Imperial College London; World Health Organization	Rottingen, JA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	jrotting@hsph.harvard.edu	Viergever, Roderik F./I-4847-2019; Terry, Robert F/AAF-8569-2020	Viergever, Roderik F./0000-0001-5328-2580; Terry, Robert F/0000-0003-3849-7705; Regmi, Sadie/0000-0002-7743-0119; Guzman, Javier/0000-0002-3013-0602	Norwegian Research Council; WHO	Norwegian Research Council(Research Council of NorwayEuropean Commission); WHO(World Health Organization)	J-AR and CA were partly funded by the Norwegian Research Council. Analysis undertaken by RFV and Thomson Reuters (Evidence) were funded by WHO. Authors undertook the research under the auspices of their respective organisations. We thank Sloan Sanford (WHO intern) and Ai Koba (WHO) for help with identification of data sources, Colin Mathers (WHO) for assistance with table 2 and global burden of disease data, and Thomson Reuters (Evidence) for providing data and analysis on research publications.	[Anonymous], 2009, GLOBAL HLTH GOVERNAN; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], MONITORING FINANCIAL; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], RES DEV COORD FIN; [Anonymous], B WHO IN PRESS; [Anonymous], CHANG MINDS STRAT HL; [Anonymous], MONITORING FINANCIAL; [Anonymous], RESOURCES HLTH RES D; [Anonymous], INV HLTH RES DEV; [Anonymous], 1999, WORLD HLTH REPORT 19; [Anonymous], FRASC MAN 2002 PROP; [Anonymous], MON FIN FLOWS HLTH R; [Anonymous], MONITORING FINANCIAL; [Anonymous], 13221 EB WHO CONS EX; [Anonymous], DEF DIS TYP 1 2 3; [Anonymous], G FINDER 2011 NEGLEC; [Anonymous], OP END M FOLL UP CON; [Anonymous], INT C HLTH RES DEV B; [Anonymous], MONITORING FINANCIAL; [Anonymous], NEPAD AG BUS PLAN 20; Consultative Expert Working Group on Research and Development Financing and Coordination, 2012, RES DEV MEET HLTH NE; Evans DB, 2012, LANCET, V380, P864, DOI 10.1016/S0140-6736(12)61483-4; Frenk J, 2012, LANCET, V380, P862, DOI 10.1016/S0140-6736(12)61341-5; Hoffman SJ, 2012, B WORLD HEALTH ORGAN, V90, P854, DOI 10.2471/BLT.12.109827; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Ijsselmuiden C, 2012, DEV WORLD BIOETH, V12, P74, DOI 10.1111/j.1471-8847.2012.00325.x; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; Latko B, 2011, LANCET, V377, P2161, DOI 10.1016/S0140-6736(10)62006-5; Moon S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001218; MURRAY CJL, 1990, J TROP MED HYG, V93, P229; Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078; Rottingen JA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001219; Rottingen JA, 2012, B WORLD HEALTH ORGAN, V90, P398, DOI 10.2471/BLT.12.105460; Terry RF, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-28; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2006, PUBL HLTH INN INT PR; World Health Organization, 2008, The global burden of disease: 2004 update	39	187	187	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1286	1307		10.1016/S0140-6736(13)61046-6	http://dx.doi.org/10.1016/S0140-6736(13)61046-6			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	23697824				2022-12-28	WOS:000325756400032
J	Strom, BL; Anderson, CAM; Ix, JH				Strom, Brian L.; Anderson, Cheryl A. M.; Ix, Joachim H.			Sodium Reduction in Populations Insights From the Institute of Medicine Committee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Strom, Brian L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Anderson, Cheryl A. M.; Ix, Joachim H.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA	University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Strom, BL (corresponding author), Univ Penn, Perelman Sch Med, 237 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	bstrom@mail.med.upenn.edu			NHLBI NIH HHS [K01 HL092595] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL092595] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aliti GB, 2013, JAMA INTERN MED, V173, P1058, DOI 10.1001/jamainternmed.2013.552; Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Institute of Medicine, 2010, STRATEGIES TO REDUCE; Institute of Medicine, 2013, SODIUM INTAKE IN POP; [U.S. Department of Agriculture U.S. Department of Health and Human Services], 2010, DIETARY GUIDELINES F; [USDA USDHHS], 2010, REPORT OF THE DIETAR; World Health Organization, 2012, GUIDELINE SODIUM INT	9	53	53	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					31	32		10.1001/jama.2013.7687	http://dx.doi.org/10.1001/jama.2013.7687			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23743860				2022-12-28	WOS:000321253000014
J	Floyd, SR; Pacold, ME; Huang, QY; Clarke, SM; Lam, FC; Cannell, IG; Bryson, BD; Rameseder, J; Lee, MJ; Blake, EJ; Fydrych, A; Ho, R; Greenberger, BA; Chen, GC; Maffa, A; Del Rosario, AM; Root, DE; Carpenter, AE; Hahn, WC; Sabatini, DM; Chen, CC; White, FM; Bradner, JE; Yaffe, MB				Floyd, Scott R.; Pacold, Michael E.; Huang, Qiuying; Clarke, Scott M.; Lam, Fred C.; Cannell, Ian G.; Bryson, Bryan D.; Rameseder, Jonathan; Lee, Michael J.; Blake, Emily J.; Fydrych, Anna; Ho, Richard; Greenberger, Benjamin A.; Chen, Grace C.; Maffa, Amanda; Del Rosario, Amanda M.; Root, David E.; Carpenter, Anne E.; Hahn, William C.; Sabatini, David M.; Chen, Clark C.; White, Forest M.; Bradner, James E.; Yaffe, Michael B.			The bromodomain protein Brd4 insulates chromatin from DNA damage signalling	NATURE			English	Article							P-TEFB; GAMMA-H2AX; ACTIVATION; TRANSCRIPTION; REPAIR; BREAKS	DNA damage activates a signalling network that blocks cell-cycle progression, recruits DNA repair factors and/or triggers senescence or programmed cell death(1). Alterations in chromatin structure are implicated in the initiation and propagation of the DNA damage response(2). Here we further investigate the role of chromatin structure in the DNA damage response by monitoring ionizing-radiation-induced signalling and response events with a high-content multiplex RNA-mediated interference screen of chromatin-modifying and -interacting genes. We discover that an isoform of Brd4, a bromodomain and extra-terminal (BET) family member, functions as an endogenous inhibitor of DNA damage response signalling by recruiting the condensin II chromatin remodelling complex to acetylated histones through bromodomain interactions. Loss of this isoform results in relaxed chromatin structure, rapid cell-cycle checkpoint recovery and enhanced survival after irradiation, whereas functional gain of this isoform compacted chromatin, attenuated DNA damage response signalling and enhanced radiation-induced lethality. These data implicate Brd4, previously known for its role in transcriptional control, as an insulator of chromatin that can modulate the signalling response to DNA damage.	[Floyd, Scott R.; Pacold, Michael E.; Huang, Qiuying; Clarke, Scott M.; Lam, Fred C.; Cannell, Ian G.; Bryson, Bryan D.; Rameseder, Jonathan; Lee, Michael J.; Blake, Emily J.; Fydrych, Anna; Ho, Richard; Greenberger, Benjamin A.; Chen, Grace C.; Maffa, Amanda; Del Rosario, Amanda M.; White, Forest M.; Yaffe, Michael B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Floyd, Scott R.] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA; [Pacold, Michael E.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Pacold, Michael E.; Sabatini, David M.] Whitehead Inst, Cambridge, MA 02139 USA; [Root, David E.; Carpenter, Anne E.; Hahn, William C.; Sabatini, David M.; Bradner, James E.; Yaffe, Michael B.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Hahn, William C.; Chen, Clark C.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Chen, Clark C.; Yaffe, Michael B.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [White, Forest M.; Yaffe, Michael B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Yaffe, Michael B.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yaffe, MB (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu	Cannell, Ian/AAL-7852-2020; Carpenter, Anne/C-4982-2008; Chen, Clark C/C-8714-2013	Cannell, Ian/0000-0001-5832-9210; Carpenter, Anne/0000-0003-1555-8261; Chen, Clark C/0000-0001-6258-9277; /0000-0002-1446-7256; floyd, scott/0000-0002-8067-2426; Greenberger, Benjamin/0000-0002-2262-5867; White, Forest/0000-0002-1545-1651; Lee, Michael/0000-0003-3378-6196	Koch Institute; Center for Environmental Health Sciences National Institutes of Health [P30-CA14051, ES-002109]; SPARC; Holman Pathway Research Resident Seed Grant; American Society for Radiation Oncology Junior Faculty Career Research Training Award; Burroughs Wellcome Career Award for Medical Scientists;  [R01-ES15339];  [1-U54-CA112967-04];  [R21-NS063917]; NATIONAL CANCER INSTITUTE [U54CA112967, P30CA014051, K08CA158149, R21CA109661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109, R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063917] Funding Source: NIH RePORTER	Koch Institute; Center for Environmental Health Sciences National Institutes of Health; SPARC; Holman Pathway Research Resident Seed Grant; American Society for Radiation Oncology Junior Faculty Career Research Training Award; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Le, T. R. Jones and M. Vokes for assistance with screening and image analysis. We thank C. Whittaker, S. Hoersch and M. Moran for computing and data analysis assistance; C. Reinhardt, C. Ellson and A. Gardino for manuscript editing; and P. Filippakopoulos and S. Knapp for discussions. This work was partially supported by the Koch Institute and Center for Environmental Health Sciences National Institutes of Health Core Grants P30-CA14051 and ES-002109; and by grants R01-ES15339, 1-U54-CA112967-04 and R21-NS063917; a SPARC grant to M.B.Y.; and a Holman Pathway Research Resident Seed Grant, American Society for Radiation Oncology Junior Faculty Career Research Training Award, Klarman Scholar, Koch Institute Clinical Investigator Award, and Burroughs Wellcome Career Award for Medical Scientists to S.R.F.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Carey M., 2007, CSH PROTOC, V2007; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	22	212	239	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					246	+		10.1038/nature12147	http://dx.doi.org/10.1038/nature12147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23728299	Green Accepted, Green Submitted			2022-12-28	WOS:000320283400052
J	Rauch, SL; Carlezon, WA				Rauch, Scott L.; Carlezon, William A., Jr.			Illuminating the Neural Circuitry of Compulsive Behaviors	SCIENCE			English	Editorial Material							STIMULATION		[Rauch, Scott L.; Carlezon, William A., Jr.] Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA	Harvard University; McLean Hospital	Rauch, SL (corresponding author), Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA.	srauch@partners.org		/0000-0002-4162-3947	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097860, R01MH063266, R56MH097860] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH097860, MH097860, R01 MH063266, MH063266] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; George MS, 2003, NEUROSURG CLIN N AM, V14, P283, DOI 10.1016/S1042-3680(02)00120-1; Goodman Wayne K, 2007, J Clin Psychiatry, V68, pe30; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kopell BH, 2008, NEUROSCI BIOBEHAV R, V32, P408, DOI 10.1016/j.neubiorev.2007.07.004; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009; Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; Morris Sarah E, 2012, Dialogues Clin Neurosci, V14, P29; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Saxena S, 2000, PSYCHIAT CLIN N AM, V23, P563, DOI 10.1016/S0193-953X(05)70181-7; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171	15	7	7	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1174	1175		10.1126/science.1239652	http://dx.doi.org/10.1126/science.1239652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744931	Green Accepted			2022-12-28	WOS:000319972800027
J	Karlsson, FH; Tremaroli, V; Nookaew, I; Bergstrom, G; Behre, CJ; Fagerberg, B; Nielsen, J; Backhed, F				Karlsson, Fredrik H.; Tremaroli, Valentina; Nookaew, Intawat; Bergstrom, Goran; Behre, Carl Johan; Fagerberg, Bjorn; Nielsen, Jens; Backhed, Fredrik			Gut metagenome in European women with normal, impaired and diabetic glucose control	NATURE			English	Article							INTESTINAL MICROBIOTA; INSULIN SENSITIVITY; RISK; CLASSIFICATION; DISCOVERY; PROGRAM; OBESITY; GENDER; AGE	Type 2 diabetes (T2D) is a result of complex gene-environment interactions, and several risk factors have been identified, including age, family history, diet, sedentary lifestyle and obesity. Statistical models that combine known risk factors for T2D can partly identify individuals at high risk of developing the disease. However, these studies have so far indicated that human genetics contributes little to the models, whereas socio-demographic and environmental factors have greater influence(1). Recent evidence suggests the importance of the gut microbiota as an environmental factor, and an altered gut microbiota has been linked to metabolic diseases including obesity(2,3), diabetes(4) and cardiovascular disease(5). Here we use shotgun sequencing to characterize the faecal metagenome of 145 European women with normal, impaired or diabetic glucose control. We observe compositional and functional alterations in the metagenomes of women with T2D, and develop a mathematical model based on metagenomic profiles that identified T2D with high accuracy. We applied this model to women with impaired glucose tolerance, and show that it can identify women who have a diabetes-like metabolism. Furthermore, glucose control and medication were unlikely to have major confounding effects. We also applied our model to a recently described Chinese cohort(4) and show that the discriminant metagenomicmarkers for T2D differ between the European and Chinese cohorts. Therefore, metagenomic predictive tools for T2D should be specific for the age and geographical location of the populations studied.	[Karlsson, Fredrik H.; Nookaew, Intawat; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden; [Tremaroli, Valentina; Bergstrom, Goran; Behre, Carl Johan; Fagerberg, Bjorn; Backhed, Fredrik] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, SE-41345 Gothenburg, Sweden; [Tremaroli, Valentina; Bergstrom, Goran; Behre, Carl Johan; Fagerberg, Bjorn; Backhed, Fredrik] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Ctr Cardiovasc & Metab Res, SE-41345 Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Receptol & Enteroendocrinol, DK-2200 Copenhagen, Denmark	Chalmers University of Technology; University of Gothenburg; University of Gothenburg; Novo Nordisk Foundation; University of Copenhagen	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.	nielsenj@chalmers.se; fredrik.backhed@wlab.gu.se	Tremaroli, Valentina/AAE-8001-2019; Backhed, Fredrik/ABE-6613-2020; Nielsen, Jens/Q-1347-2017	Tremaroli, Valentina/0000-0002-9150-4233; Backhed, Fredrik/0000-0002-4871-8818; Karlsson, Fredrik/0000-0003-4377-6514; Nielsen, Jens/0000-0002-9955-6003; Bergstrom, Goran/0000-0003-4289-5722	Swedish Research Council; NovoNordisk foundation; Torsten Soderberg's foundation; Ragnar Soderberg's foundation; Swedish Diabetes foundation; Swedish Heart Lung Foundation; IngaBritt och Arne Lundbergs foundation; Chalmers foundation; Bioinformatics Infrastructure for Life Sciences (BILS); Knut and Alice Wallenberg foundation; Swedish Foundation for Strategic Research; AstraZeneca R&D Molndal, Sweden; Region Vastra Gotaland; Sahlgrenska University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk foundation(Novo Nordisk Foundation); Torsten Soderberg's foundation; Ragnar Soderberg's foundation; Swedish Diabetes foundation; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); IngaBritt och Arne Lundbergs foundation; Chalmers foundation; Bioinformatics Infrastructure for Life Sciences (BILS); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); AstraZeneca R&D Molndal, Sweden(AstraZeneca); Region Vastra Gotaland; Sahlgrenska University Hospital	We would like to acknowledge R. Perkins for editing the manuscript and M.-L. Ekholm, B. Jannemark, G. Ostergren-Lunden, H. Kling Backhed, C. Schmidt and U. Prahl for technical assistance. This study was supported by the Swedish Research Council, the NovoNordisk foundation, Torsten Soderberg's foundation, Ragnar Soderberg's foundation, Swedish Diabetes foundation, Swedish Heart Lung Foundation, IngaBritt och Arne Lundbergs foundation, Chalmers foundation, Bioinformatics Infrastructure for Life Sciences (BILS), Knut and Alice Wallenberg foundation, the Swedish Foundation for Strategic Research, AstraZeneca R&D Molndal, Sweden and the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital. The computations were performed on Chalmers C3SE computing resources.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Brohall G, 2006, DIABETES CARE, V29, P363, DOI 10.2337/diacare.29.02.06.dc05-1229; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dongen SV, 2000, THESIS U UTRECHT; Fagerberg B, 2011, J INTERN MED, V269, P636, DOI 10.1111/j.1365-2796.2010.02336.x; Finegold SM, 2005, EUR J CLIN MICROBIOL, V24, P319, DOI 10.1007/s10096-005-1334-6; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gaetti-Jardim E, 2009, J MED MICROBIOL, V58, P1568, DOI 10.1099/jmm.0.013383-0; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Karjalainen Kaisa M., 1996, Pediatric Dentistry, V18, P306; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Lundberg V, 1997, J INTERN MED, V241, P485; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Development Core Team, 2012, R LANG ENV STAT COMP; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vendrame F, 2004, ENDOCRIN METAB CLIN, V33, P75, DOI 10.1016/j.ecl.2003.12.006; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	37	1674	1822	15	466	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					99	+		10.1038/nature12198	http://dx.doi.org/10.1038/nature12198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23719380				2022-12-28	WOS:000319947800041
J	Chou, R; Wasson, N				Chou, Roger; Wasson, Ngoc			Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							PLATELET RATIO INDEX; CHRONIC VIRAL-HEPATITIS; SERUM HYALURONIC-ACID; STEPWISE COMBINATION ALGORITHMS; ALANINE AMINOTRANSFERASE RATIO; PREDICTS ADVANCED FIBROSIS; STANDARD LABORATORY TESTS; SIMPLE NONINVASIVE INDEX; LIVER FIBROSIS; BIOCHEMICAL MARKERS	Background: Many blood tests have been proposed as alternatives to liver biopsy for identifying fibrosis or cirrhosis. Purpose: To evaluate the diagnostic accuracy of blood tests to identify fibrosis or cirrhosis in patients with hepatitis C virus (HCV) infection. Data Sources: MEDLINE (1947 to January 2013), the Cochrane Library, and reference lists. Study Selection: Studies that compared the diagnostic accuracy of blood tests with that of liver biopsy. Data Extraction: Investigators abstracted and checked study details and quality by using predefined criteria. Data Synthesis: 172 studies evaluated diagnostic accuracy. For identifying clinically significant fibrosis, the platelet count, age-platelet index, aspartate aminotransferase-platelet ratio index (APRI), FibroIndex, FibroTest, and Forns index had median positive likelihood ratios of 5 to 10 at commonly used cutoffs and areas under the receiver-operating characteristic curve (AUROCs) of 0.70 or greater (range, 0.71 to 0.86). For identifying cirrhosis, the plate-let count, age-platelet index, APRI, and Hepascore had median positive likelihood ratios of 5 to 10 and AUROCs of 0.80 or greater (range, 0.80 to 0.91). The Goteborg University Cirrhosis Index and the Lok index had slightly lower positive likelihood ratios (4.8 and 4.4, respectively). In direct comparisons, the APRI was associated with a slightly lower AUROC than the FibroTest for identifying fibrosis and a substantially higher AUROC than the aspartate aminotransferase-alanine aminotransferase ratio for identifying fibrosis or cirrhosis. Limitation: Only English-language articles were included, and most studies had methodological limitations, including failure to describe blinded interpretation of liver biopsy specimens and inadequate description of enrollment methods. Conclusion: Many blood tests are moderately useful for identifying clinically significant fibrosis or cirrhosis in HCV-infected patients.	[Chou, Roger; Wasson, Ngoc] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Mail Code BICC, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610	AHRQ, Rockville, Maryland [290-2007-10057-I]; Agency for Healthcare Research and Quality	AHRQ, Rockville, Maryland; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.; By AHRQ (contract 290-2007-10057-I, task order 8), Rockville, Maryland.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Adler M, 2008, HEPATOLOGY, V47, P762, DOI 10.1002/hep.22085; *AG HLTH RES QUAL, 2012, AHRQ PUBL, V10; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Alsatie M, 2007, J CLIN GASTROENTEROL, V41, P416, DOI 10.1097/01.mcg.0000225593.93577.64; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; Anderson FH, 2000, HEPATOL RES, V18, P63, DOI 10.1016/S1386-6346(99)00085-6; Andriulli A, 2004, J VIRAL HEPATITIS, V11, P536, DOI 10.1111/j.1365-2893.2004.00519.x; [Anonymous], 1997, HEPATOLOGY, V26, pS2; Arabul M, 2012, TURK J GASTROENTEROL, V23, P538, DOI 10.4318/tjg.2012.0358; Arain SA, 2011, SAUDI MED J, V32, P1241; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P331, DOI 10.1080/15321810701603476; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P155, DOI 10.1080/15321810701212088; Attallah AM, 2013, ANN HEPATOL, V12, P44, DOI 10.1016/S1665-2681(19)31384-5; Attallah Abdelfattah M, 2011, Egypt J Immunol, V18, P33; Attallah AM, 2012, CLIN CHIM ACTA, V413, P1725, DOI 10.1016/j.cca.2012.06.031; Attallah AM, 2011, HEPATOL RES, V41, P1075, DOI 10.1111/j.1872-034X.2011.00862.x; Attallah AM, 2006, CLIN CHIM ACTA, V369, P66, DOI 10.1016/j.cca.2006.01.004; Attallah AM, 2006, HEPATOL RES, V34, P163, DOI 10.1016/j.hepres.2005.12.004; Bain VG, 2004, J VIRAL HEPATITIS, V11, P375, DOI 10.1111/j.1365-2893.2004.00520.x; Becker L, 2009, CLIN GASTROENTEROL H, V7, P696, DOI 10.1016/j.cgh.2009.01.010; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bejarano G, 2009, REV ESP ENFERM DIG, V101, P325, DOI 10.4321/s1130-01082009000500004; Ben Jazia E, 2009, INFECT DIS CLIN PRAC, V17, P385; Berg T, 2004, HEPATOLOGY, V39, P1456, DOI 10.1002/hep.20226; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302; Borroni G, 2006, ALIMENT PHARM THER, V24, P797, DOI 10.1111/j.1365-2036.2006.03034.x; Bota S, 2011, HEPAT MON, V11, P548; Bourliere M, 2008, ALIMENT PHARM THER, V28, P458, DOI 10.1111/j.1365-2036.2008.03742.x; Bourliere M, 2006, J VIRAL HEPATITIS, V13, P659, DOI 10.1111/j.1365-2893.2006.00736.x; Boursier J, 2012, HEPATOLOGY, V55, P58, DOI 10.1002/hep.24654; Boursier J, 2011, AM J GASTROENTEROL, V106, P1255, DOI 10.1038/ajg.2011.100; Boursier J, 2009, EUR J GASTROEN HEPAT, V21, P28, DOI 10.1097/MEG.0b013e32830cebd7; Burton MJ, 2011, SOUTH MED J, V104, P309, DOI 10.1097/SMJ.0b013e318213cf52; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Cales P, 2008, LIVER INT, V28, P1352, DOI 10.1111/j.1478-3231.2008.01789.x; Cales P, 2010, CLIN BIOCHEM, V43, P1315, DOI 10.1016/j.clinbiochem.2010.08.010; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Castera L, 2010, J HEPATOL, V52, P191, DOI 10.1016/j.jhep.2009.11.008; Castera L, 2009, J VIRAL HEPATITIS, V16, P300, DOI 10.1111/j.1365-2893.2009.01087.x; Cheong JY, 2011, DIGEST DIS SCI, V56, P555, DOI 10.1007/s10620-010-1305-3; Cheung KJ, 2011, EUR J GASTROEN HEPAT, V23, P701, DOI 10.1097/MEG.0b013e3283471b74; Cheung RC, 2008, J CLIN GASTROENTEROL, V42, P827, DOI 10.1097/MCG.0b013e318046ea9a; CHOU R, 2012, COMP EFFECTIVENESS R; Christensen C, 2006, J VIRAL HEPATITIS, V13, P652, DOI 10.1111/j.1365-2893.2006.00743.x; Chrysanthos NV, 2006, EUR J GASTROEN HEPAT, V18, P389, DOI 10.1097/00042737-200604000-00012; Cobbold JFL, 2010, J VIRAL HEPATITIS, V17, P537, DOI 10.1111/j.1365-2893.2009.01209.x; Colletta C, 2005, HEPATOLOGY, V42, P838, DOI 10.1002/hep.20814; Colli A, 2005, WORLD J GASTROENTERO, V11, P7318, DOI 10.3748/wjg.v11.i46.7318; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Crisan D, 2012, HEPAT MON, V12, P177, DOI 10.5812/hepatmon.853; Cross TJS, 2010, J VIRAL HEPATITIS, V17, P546, DOI 10.1111/j.1365-2893.2009.01210.x; Cross TJS, 2009, EUR J GASTROEN HEPAT, V21, P730, DOI 10.1097/MEG.0b013e32830dfcb3; da Silva RG, 2008, BRAZ J INFECT DIS, V12, P15, DOI 10.1590/S1413-86702008000100005; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Deghady A, 2012, GENET TEST MOL BIOMA, V16, P531, DOI 10.1089/gtmb.2011.0098; Dinesen L, 2008, DIGEST LIVER DIS, V40, P743, DOI 10.1016/j.dld.2008.01.013; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Ehsan N, 2008, ARAB J GASTROENTEROL, V9, P7; El-Gindy Iman, 2003, Egypt J Immunol, V10, P27; El-Mezayen HA, 2013, EUR J GASTROEN HEPAT, V25, P69, DOI 10.1097/MEG.0b013e3283594924; El-Sayed Rokaya, 2011, Trop Gastroenterol, V32, P267; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; el-Shorbagy Eman, 2004, J Egypt Soc Parasitol, V34, P459; Fabris C, 2008, CLIN CHEM LAB MED, V46, P253, DOI 10.1515/CCLM.2008.051; Amorim TGF, 2012, ANN HEPATOL, V11, P855; Ferraioli G, 2012, AM J ROENTGENOL, V199, P19, DOI 10.2214/AJR.11.7517; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Fontanges T, 2008, GASTROEN CLIN BIOL, V32, P858, DOI 10.1016/j.gcb.2008.05.019; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Fouad SA, 2012, WORLD J GASTROENTERO, V18, P2988, DOI 10.3748/wjg.v18.i23.2988; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Gabrielli GB, 1997, CLIN CHIM ACTA, V265, P21, DOI 10.1016/S0009-8981(97)00103-4; Gara N, 2013, CLIN GASTROENTEROL H, V11, P303, DOI 10.1016/j.cgh.2012.10.044; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giannini E, 2003, ARCH INTERN MED, V163, P218, DOI 10.1001/archinte.163.2.218; Giannini E, 2003, HEPATOLOGY, V38, P1312, DOI 10.1053/jhep.2003.50500; Giannini EG, 2006, J CLIN GASTROENTEROL, V40, P521, DOI 10.1097/00004836-200607000-00011; Gordon A, 2005, J GASTROEN HEPATOL, V20, P825, DOI 10.1111/j.1440-1746.2005.03828.x; Grigorescu M, 2007, J GASTROINTEST LIVER, V16, P31; Guechot J, 1996, CLIN CHEM, V42, P558; GUECHOT J, 1994, J HEPATOL, V20, P388, DOI 10.1016/S0168-8278(94)80013-8; Guechot J, 2012, CLIN CHEM LAB MED, V50, P693, DOI 10.1515/cclm-2011-0858; Guechot J, 2010, CLIN CHIM ACTA, V411, P86, DOI 10.1016/j.cca.2009.10.011; Guzelbulut F, 2011, TURK J GASTROENTEROL, V22, P279, DOI 10.4318/tjg.2011.0213; Halfon P, 2006, AM J GASTROENTEROL, V101, P547, DOI 10.1111/j.1572-0241.2006.00411.x; Halfon P, 2007, HEPATOLOGY, V46, P280, DOI 10.1002/hep.21717; Halfon P, 2007, J HEPATOL, V46, P395, DOI 10.1016/j.jhep.2006.09.020; Halfon Philippe, 2005, Comp Hepatol, V4, P6, DOI 10.1186/1476-5926-4-6; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hsieh YY, 2012, WORLD J GASTROENTERO, V18, P746, DOI 10.3748/wjg.v18.i8.746; Hsieh Yung-Yu, 2009, Chang Gung Med J, V32, P614; Iacobellis A, 2005, ALIMENT PHARM THER, V22, P769, DOI 10.1111/j.1365-2036.2005.02633.x; Iacobellis A, 2005, AM J GASTROENTEROL, V100, P868, DOI 10.1111/j.1572-0241.2005.40881.x; Ichino N, 2010, WORLD J GASTROENTERO, V16, P4809, DOI 10.3748/wjg.v16.i38.4809; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Imperiale TF, 2000, AM J GASTROENTEROL, V95, P2328, DOI 10.1111/j.1572-0241.2000.02322.x; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Islam S, 2005, SCAND J GASTROENTERO, V40, P867, DOI 10.1080/00365520510015674; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jeffers Lennox J, 2007, Gastroenterol Hepatol (N Y), V3, P367; Kalantari H, 2011, HEPAT RES TREAT, V2011, DOI DOI 10.1155/2011/972759]; Kaul V, 2002, AM J GASTROENTEROL, V97, P2623, DOI 10.1111/j.1572-0241.2002.06040.x; Khairy M, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6718; Khan Dilshad Ahmad, 2008, J Ayub Med Coll Abbottabad, V20, P122; Khokhar N, 2003, J Pak Med Assoc, V53, P101; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Lackner C, 2006, HEPATOLOGY, V43, P378, DOI 10.1002/hep.21037; Lackner C, 2005, HEPATOLOGY, V41, P1376, DOI 10.1002/hep.20717; Lambert J, 2008, CLIN CHEM, V54, P1372, DOI 10.1373/clinchem.2007.097923; Le Calvez S, 2004, HEPATOLOGY, V39, P862, DOI 10.1002/hep.20099; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Leroy V, 2008, CLIN BIOCHEM, V41, P1368, DOI 10.1016/j.clinbiochem.2008.06.020; Leroy V, 2007, J HEPATOL, V46, P775, DOI 10.1016/j.jhep.2006.12.013; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Liu CH, 2006, LIVER INT, V26, P1087, DOI 10.1111/j.1478-3231.2006.01355.x; Lo Iacono O, 1998, ALIMENT PHARM THERAP, V12, P1091; Loaeza-del-Castillo A, 2008, ANN HEPATOL, V7, P350, DOI 10.1016/S1665-2681(19)31836-8; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Lu SN, 2006, CANCER-AM CANCER SOC, V107, P2212, DOI 10.1002/cncr.22242; Luo JC, 2002, HEPATO-GASTROENTEROL, V49, P478; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; McHutchison JG, 2000, J GASTROEN HEPATOL, V15, P945, DOI 10.1046/j.1440-1746.2000.02233.x; Metwally MA, 2007, DIGEST DIS SCI, V52, P582, DOI 10.1007/s10620-006-9366-z; Morali G, 2007, ISR MED ASSOC J, V9, P588; Morra R, 2007, ALIMENT PHARM THER, V26, P847, DOI 10.1111/j.1365-2036.2007.03427.x; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Mossong Joel, 2011, Bull Soc Sci Med Grand Duche Luxemb, P19; Murawaki Y, 2001, J GASTROEN HEPATOL, V16, P777, DOI 10.1046/j.1440-1746.2001.02515.x; Murawaki Y, 2001, J GASTROENTEROL, V36, P399, DOI 10.1007/s005350170084; Myers RP, 2003, DIGEST DIS SCI, V48, P146, DOI 10.1023/A:1021702902681; Myers RP, 2002, AM J GASTROENTEROL, V97, P2419, DOI 10.1111/j.1572-0241.2002.05997.x; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Obrador BD, 2006, EUR J GASTROEN HEPAT, V18, P57, DOI 10.1097/00042737-200601000-00010; Obuchowski NA, 2005, ACAD RADIOL, V12, P1198, DOI 10.1016/j.acra.2005.05.013; Ohta T, 2006, ACTA MED OKAYAMA, V60, P77; Omran Mohamed M, 2011, Arab J Gastroenterol, V12, P74, DOI 10.1016/j.ajg.2011.04.006; Paggi S, 2008, J HEPATOL, V49, P564, DOI 10.1016/j.jhep.2008.07.007; Parise ER, 2006, LIVER INT, V26, P1095, DOI 10.1111/j.1478-3231.2006.01356.x; Park G, 2005, AM J GASTROENTEROL, V100, P1623, DOI 10.1111/j.1572-0241.2005.50006_6.x; Park GJH, 2000, J GASTROEN HEPATOL, V15, P386, DOI 10.1046/j.1440-1746.2000.02172.x; Park JJ, 2011, HEPATO-GASTROENTEROL, V58, P1321, DOI 10.5754/hge11041; Park Joong-Won, 2005, Korean J Gastroenterol, V45, P217; Park SH, 2011, CLIN BIOCHEM, V44, P1396, DOI 10.1016/j.clinbiochem.2011.08.1151; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Patel K, 2009, J VIRAL HEPATITIS, V16, P178, DOI 10.1111/j.1365-2893.2008.01062.x; Patel K, 2004, J HEPATOL, V41, P935, DOI 10.1016/j.jhep.2004.08.008; Pham B, 2005, J CLIN EPIDEMIOL, V58, P769, DOI 10.1016/j.jclinepi.2004.08.021; Plevris JN, 2000, EUR J GASTROEN HEPAT, V12, P1121, DOI 10.1097/00042737-200012100-00009; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Poynard T, 2003, HEPATOLOGY, V38, P481, DOI 10.1053/jhep.2003.50319; Poynard T, 2002, J VIRAL HEPATITIS, V9, P128, DOI 10.1046/j.1365-2893.2002.00341.x; Poynard T, 1997, J VIRAL HEPATITIS, V4, P199, DOI 10.1046/j.1365-2893.1997.00141.x; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Poynard T, 2010, ANTIVIR THER, V15, P617, DOI 10.3851/IMP1570; Pradat P, 2002, HEPATOLOGY, V36, P973, DOI 10.1053/jhep.2002.35530; Reedy DW, 1998, DIGEST DIS SCI, V43, P2156, DOI 10.1023/A:1018888021118; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Renou C, 2001, AM J GASTROENTEROL, V96, P1657, DOI 10.1111/j.1572-0241.2001.03830.x; Romagnuolo J, 2001, AM J GASTROENTEROL, V96, P3165, DOI 10.1111/j.1572-0241.2001.05275.x; Romera M, 2006, REV ESP ENFERM DIG, V98, P161, DOI 10.4321/s1130-01082006000300002; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Rossi E, 2003, CLIN CHEM, V49, P450, DOI 10.1373/49.3.450; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; Said Yosra, 2010, Tunis Med, V88, P573; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P476, DOI 10.3748/wjg.v11.i4.476; Schiano TD, 2005, CLIN GASTROENTEROL H, V3, P930, DOI 10.1016/S1542-3565(05)00541-0; Schneider ARJ, 2006, CLIN EXP PHARMACOL P, V33, P300, DOI 10.1111/j.1440-1681.2006.04365.x; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Sebastiani G, 2012, ALIMENT PHARM THER, V35, P92, DOI 10.1111/j.1365-2036.2011.04897.x; Sebastiani G, 2011, ALIMENT PHARM THER, V34, P1202, DOI 10.1111/j.1365-2036.2011.04861.x; Sebastiani G, 2009, HEPATOLOGY, V49, P1821, DOI 10.1002/hep.22859; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Shlomai A, 2013, J VIRAL HEPATITIS, V20, P95, DOI 10.1111/j.1365-2893.2012.01628.x; Silva ISS, 2004, J GASTROEN HEPATOL, V19, P314, DOI 10.1111/j.1440-1746.2003.03256.x; Sirli R, 2010, HEPAT MON, V10, P88; Snyder N, 2007, CLIN CHIM ACTA, V381, P119, DOI 10.1016/j.cca.2007.02.046; Snyder N, 2006, J CLIN GASTROENTEROL, V40, P535, DOI 10.1097/00004836-200607000-00013; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Stibbe KJM, 2011, SCAND J GASTROENTERO, V46, P962, DOI 10.3109/00365521.2011.574725; Sud A, 2004, HEPATOLOGY, V39, P1239, DOI 10.1002/hep.20207; Testa R, 2006, J INTERN MED, V260, P142, DOI 10.1111/j.1365-2796.2006.01673.x; Thabut D, 2003, HEPATOLOGY, V37, P1220, DOI 10.1053/jhep.2003.50109; Trocme C, 2006, J VIRAL HEPATITIS, V13, P643, DOI 10.1111/j.1365-2893.2006.00730.x; Usluer G, 2012, EUR J CLIN MICROBIOL, V31, P1873, DOI 10.1007/s10096-011-1513-6; Uyar C, 2010, INDIAN J PATHOL MICR, V53, P470, DOI 10.4103/0377-4929.68281; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Viana MSVB, 2009, ANN HEPATOL, V8, P26, DOI 10.1016/S1665-2681(19)31807-1; Verbaan H, 1997, SCAND J GASTROENTERO, V32, P494, DOI 10.3109/00365529709025088; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Walsh KM, 2000, J HEPATOL, V32, P325, DOI 10.1016/S0168-8278(00)80079-3; Walsh KM, 1999, DIGEST DIS SCI, V44, P624, DOI 10.1023/A:1026630129025; Walsh KM, 1999, EUR J GASTROEN HEPAT, V11, P827, DOI 10.1097/00042737-199908000-00003; West J, 2010, GASTROENTEROLOGY, V139, P1230, DOI 10.1053/j.gastro.2010.06.015; Westin J, 2008, SCAND J GASTROENTERO, V43, P73, DOI 10.1080/00365520701514461; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2; Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091; Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x; Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1002/hep.510230607; Yilmaz Y, 2011, HEPAT MON, V11, P103; Zaman A, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.06.044; Zarski JP, 2012, J HEPATOL, V56, P55, DOI 10.1016/j.jhep.2011.05.024; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960; ZWEIG MH, 1993, CLIN CHEM, V39, P561	215	240	245	2	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					807	+		10.7326/0003-4819-158-11-201306040-00005	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00005			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23732714				2022-12-28	WOS:000320379800004
J	Hamano, K; Abe, Y; Genda, H				Hamano, Keiko; Abe, Yutaka; Genda, Hidenori			Emergence of two types of terrestrial planet on solidification of magma ocean	NATURE			English	Article							HYDRODYNAMIC ESCAPE; VENUS; EARTH; EVOLUTION; ATMOSPHERE; WATER; TECTONICS; DYNAMICS; RUNAWAY; MODEL	Understanding the origins of the diversity in terrestrial planets is a fundamental goal in Earth and planetary sciences. In the Solar System, Venus has a similar size and bulk composition to those of Earth, but it lacks water(1-3). Because a richer variety of exoplanets is expected to be discovered, prediction of their atmospheres and surface environments requires a general framework for planetary evolution. Here we show that terrestrial planets can be divided into two distinct types on the basis of their evolutionary history during solidification from the initially hot molten state expected from the standard formation model(4,5). Even if, apart from their orbits, they were identical just after formation, the solidified planets can have different characteristics. A type I planet, which is formed beyond a certain critical distance from the host star, solidifies within several million years. If the planet acquires water during formation, most of this water is retained and forms the earliest oceans. In contrast, on a type II planet, which is formed inside the critical distance, a magma ocean can be sustained for longer, even with a larger initial amount of water. Its duration could be as long as 100 million years if the planet is formed together with a mass of water comparable to the total inventory of the modern Earth. Hydrodynamic escape desiccates type II planets during the slow solidification process. Although Earth is categorized as type I, it is not clear which type Venus is because its orbital distance is close to the critical distance. However, because the dryness of the surface and mantle predicted for type II planets is consistent with the characteristics of Venus, it may be representative of type II planets. Also, future observations may have a chance to detect not only terrestrial exoplanets covered with water ocean but also those covered with magma ocean around a young star.	[Hamano, Keiko; Abe, Yutaka; Genda, Hidenori] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Genda, Hidenori] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528551, Japan	University of Tokyo; Tokyo Institute of Technology	Hamano, K (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	keiko@eps.s.u-tokyo.ac.jp	Abe, Yutaka/I-1933-2012; Genda, Hidenori/A-7858-2014		Ministry of Education, Culture, Sports, Science and Technology [23103003]; Japan Society for the Promotion of Science [23340168, 22740291]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank J.F. Kasting for constructive comments on the manuscript. We appreciate proofreading and editing assistance from the GCOE programme. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (23103003) and from Japan Society for the Promotion of Science (23340168 and 22740291). This study is a part of the PhD thesis of K. H. submitted to the University of Tokyo.	Abe Y, 1997, PHYS EARTH PLANET IN, V100, P27, DOI 10.1016/S0031-9201(96)03229-3; ABE Y, 1988, J ATMOS SCI, V45, P3081, DOI 10.1175/1520-0469(1988)045<3081:EOAIGH>2.0.CO;2; [Anonymous], 2012, EXTRASOLAR PLANETS E; Batalha NM, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/2/24; Canil D, 1996, J PETROL, V37, P609, DOI 10.1093/petrology/37.3.609; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Caro G, 2011, ANNU REV EARTH PL SC, V39, P31, DOI 10.1146/annurev-earth-040610-133400; Cavosie AJ, 2005, EARTH PLANET SC LETT, V235, P663, DOI 10.1016/j.epsl.2005.04.028; Chassefiere E, 1996, ICARUS, V124, P537, DOI 10.1006/icar.1996.0229; Elkins-Tanton LT, 2008, EARTH PLANET SC LETT, V271, P181, DOI 10.1016/j.epsl.2008.03.062; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; JOHNSON KTM, 1992, J GEOPHYS RES-SOL EA, V97, P9219, DOI 10.1029/92JB00701; KASTING JF, 1983, ICARUS, V53, P479, DOI 10.1016/0019-1035(83)90212-9; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; KIEFER WS, 1986, GEOPHYS RES LETT, V13, P14, DOI 10.1029/GL013i001p00014; Lewis J. S., 1970, Earth and Planetary Science Letters, V10, P73, DOI 10.1016/0012-821X(70)90066-X; LEWIS JS, 1990, SCIENCE, V249, P1273, DOI 10.1126/science.249.4974.1273; Mackwell SJ, 1998, J GEOPHYS RES-SOL EA, V103, P975, DOI 10.1029/97JB02671; MATSUI T, 1986, NATURE, V319, P303, DOI 10.1038/319303a0; Moresi L, 1998, GEOPHYS J INT, V133, P669, DOI 10.1046/j.1365-246X.1998.00521.x; NAKAJIMA S, 1992, J ATMOS SCI, V49, P2256, DOI 10.1175/1520-0469(1992)049<2256:ASOTGE>2.0.CO;2; Nimmo F, 1998, ANNU REV EARTH PL SC, V26, P23, DOI 10.1146/annurev.earth.26.1.23; Papale P, 1997, CONTRIB MINERAL PETR, V126, P237, DOI 10.1007/s004100050247; Presnall D. C., 1987, GEOCHEM SOC SPEC PUB, V1, P75; Ribas I, 2005, ASTROPHYS J, V622, P680, DOI 10.1086/427977; Schaefer L, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/41; Solomatov V. S., 2007, TREATISE GEOPHYS, V9, P91, DOI DOI 10.1016/B978-044452748-6.00141-3); Trail D, 2011, NATURE, V480, P79, DOI 10.1038/nature10655; WATSON AJ, 1981, ICARUS, V48, P150, DOI 10.1016/0019-1035(81)90101-9; ZAHNLE KJ, 1988, ICARUS, V74, P62, DOI 10.1016/0019-1035(88)90031-0	34	203	206	6	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					607	+		10.1038/nature12163	http://dx.doi.org/10.1038/nature12163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23719462				2022-12-28	WOS:000319556100041
J	Ashby, M				Ashby, Michael			Caring for dying patients is not about prolonging life at all costs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Ashby, Michael] Univ Tasmania, Royal Hobart Hosp, Southern Tasmania Area Hlth Serv, Hobart, Tas 7001, Australia; [Ashby, Michael] Univ Tasmania, Fac Hlth Sci, Hobart, Tas 7001, Australia	Royal Hobart Hospital; University of Tasmania; University of Tasmania	Ashby, M (corresponding author), Univ Tasmania, Royal Hobart Hosp, Southern Tasmania Area Hlth Serv, Hobart, Tas 7001, Australia.	michael.ashby@dhhs.tas.gov.au						[Anonymous], 1996, HASTINGS CTR REPOR S, V26, pS1; Ashby MA, 2013, MED J AUSTRALIA, V198, P188, DOI 10.5694/mja12.10498; Ashby MA, 2011, J BIOETHIC INQ, V8, P151, DOI 10.1007/s11673-011-9291-5; Breen E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1837; Economist Intelligence Unit, 2010, QUAL DEATH RANK END; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; Hanson MJ, 1999, GOALS MED FORGOTTEN; Hastings Center, J LYNN CALLS REF END; Kellehear A, 1999, HLTH PROMOTING PALLI	9	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2013	346								f3027	10.1136/bmj.f3027	http://dx.doi.org/10.1136/bmj.f3027			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158CZ	23714191				2022-12-28	WOS:000319947500004
J	Wang, XF; Ha, T				Wang, Xuefeng; Ha, Taekjip			Defining Single Molecular Forces Required to Activate Integrin and Notch Signaling	SCIENCE			English	Article							LIGAND ENDOCYTOSIS; MECHANICAL FORCE; TRACTION FORCE; CELL; TENSION; MECHANOTRANSDUCTION; DNA	Cell-cell and cell-matrix mechanical interactions through membrane receptors direct a wide range of cellular functions and orchestrate the development of mutticeltular organisms. To define the single molecular forces required to activate signaling through a ligand-receptor bond, we developed the tension gauge tether (TGT) approach in which the ligand is immobilized to a surface through a rupturable tether before receptor engagement. TGT serves as an autonomous gauge to restrict the receptor-ligand tension. Using a range of tethers with tunable tension tolerances, we show that cells apply a universal peak tension of about 40 piconewtons (pN) to single integrin-ligand bonds during initial adhesion. We find that less than 12 pN is required to activate Notch receptors. TGT can also provide a defined molecular mechanical cue to regulate cellular functions.	[Wang, Xuefeng; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA; [Wang, Xuefeng; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009; Wang, Xuefeng/G-1663-2011	Ha, Taekjip/0000-0003-2195-6258; Wang, Xuefeng/0000-0002-3301-3196	National Science Foundation through the Physics Frontiers Center Program [0822613]	National Science Foundation through the Physics Frontiers Center Program	We thank I. D. Bernstein for the generous gift of DLL1. We also appreciate the genetically modified CHO-K1 cull line for Notch study provided by M. B. Elowitz. We thank Q. Xu, N. Wang, and Y. Wang for carefully reading the manuscript. Funding was provided by the National Science Foundation through the Physics Frontiers Center Program (0822613). T.H. is an investigator with the Howard Hughes Medical Institute.	Albrecht C, 2003, SCIENCE, V301, P367, DOI 10.1126/science.1084713; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hatch K, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011920; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li Z, 2009, NANO LETT, V9, P3575, DOI 10.1021/nl901774m; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parks AL, 2000, DEVELOPMENT, V127, P1373; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Shergill B, 2012, DEV CELL, V22, P1313, DOI 10.1016/j.devcel.2012.04.007; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stabley DR, 2012, NAT METHODS, V9, P64, DOI [10.1038/NMETH.1747, 10.1038/nmeth.1747]; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	31	319	327	15	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					991	994		10.1126/science.1231041	http://dx.doi.org/10.1126/science.1231041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704575	Green Accepted			2022-12-28	WOS:000319344100051
J	Leprivier, G; Remke, M; Rotblat, B; Dubuc, A; Mateo, ARF; Kool, M; Agnihotri, S; El-Naggar, A; Yu, B; Somasekharan, SP; Faubert, B; Bridon, G; Tognon, CE; Mathers, J; Thomas, R; Li, A; Barokas, A; Kwok, B; Bowden, M; Smith, S; Wu, XC; Korshunov, A; Hielscher, T; Northcott, PA; Galpin, JD; Ahern, CA; Wang, Y; McCabe, MG; Collins, VP; Jones, RG; Pollak, M; Delattre, O; Gleave, ME; Jan, E; Pfister, SM; Proud, CG; Derry, WB; Taylor, MD; Sorensen, PH				Leprivier, Gabriel; Remke, Marc; Rotblat, Barak; Dubuc, Adrian; Mateo, Abigail-Rachele F.; Kool, Marcel; Agnihotri, Sameer; El-Naggar, Amal; Yu, Bin; Somasekharan, Syam Prakash; Faubert, Brandon; Bridon, Gaelle; Tognon, Cristina E.; Mathers, Joan; Thomas, Ryan; Li, Amy; Barokas, Adi; Kwok, Brian; Bowden, Mary; Smith, Stephanie; Wu, Xiaochong; Korshunov, Andrey; Hielscher, Thomas; Northcott, Paul A.; Galpin, Jason D.; Ahern, Christopher A.; Wang, Ye; McCabe, Martin G.; Collins, V. Peter; Jones, Russell G.; Pollak, Michael; Delattre, Olivier; Gleave, Martin E.; Jan, Eric; Pfister, Stefan M.; Proud, Christopher G.; Derry, W. Brent; Taylor, Michael D.; Sorensen, Poul H.			The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation	CELL			English	Article							ETV6-NTRK3 GENE FUSION; TUMOR-CELL SURVIVAL; MESSENGER-RNA; PATHWAY; GROWTH; INHIBITION; PHOSPHORYLATION; PROLIFERATION; HOMEOSTASIS; METABOLISM	Metabolic adaptation is essential for cell survival during nutrient deprivation. We report that eukaryotic elongation factor 2 kinase (eEF2K), which is activated by AMP-kinase (AMPK), confers cell survival under acute nutrient depletion by blocking translation elongation. Tumor cells exploit this pathway to adapt to nutrient deprivation by reactivating the AMPK-eEF2K axis. Adaptation of transformed cells to nutrient withdrawal is severely compromised in cells lacking eEF2K. Moreover, eEF2K knockdown restored sensitivity to acute nutrient deprivation in highly resistant human tumor cell lines. In vivo, overexpression of eEF2K rendered murine tumors remarkably resistant to caloric restriction. Expression of eEF2K strongly correlated with overall survival in human medulloblastoma and glioblastoma multiforme. Finally, C. elegans strains deficient in efk-1, the eEF2K ortholog, were severely compromised in their response to nutrient depletion. Our data highlight a conserved role for eEF2K in protecting cells from nutrient deprivation and in conferring tumor cell adaptation to metabolic stress.	[Leprivier, Gabriel; Rotblat, Barak; El-Naggar, Amal; Somasekharan, Syam Prakash; Tognon, Cristina E.; Mathers, Joan; Thomas, Ryan; Li, Amy; Barokas, Adi; Kwok, Brian; Sorensen, Poul H.] Univ British Columbia, British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L4, Canada; [Leprivier, Gabriel; Rotblat, Barak; El-Naggar, Amal; Somasekharan, Syam Prakash; Tognon, Cristina E.; Mathers, Joan; Thomas, Ryan; Li, Amy; Barokas, Adi; Kwok, Brian; Sorensen, Poul H.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1L4, Canada; [Remke, Marc; Dubuc, Adrian; Agnihotri, Sameer; Wu, Xiaochong; Northcott, Paul A.; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1L7, Canada; [Remke, Marc; Dubuc, Adrian; Agnihotri, Sameer; Wu, Xiaochong; Northcott, Paul A.; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1L7, Canada; [Remke, Marc; Dubuc, Adrian; Mateo, Abigail-Rachele F.; Wu, Xiaochong; Derry, W. Brent; Taylor, Michael D.] Univ Toronto, HSC, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Remke, Marc; Kool, Marcel; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Hielscher, Thomas] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany; [Mateo, Abigail-Rachele F.; Yu, Bin; Taylor, Michael D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 2M9, Canada; [Faubert, Brandon; Jones, Russell G.] McGill Univ, Dept Physiol, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Bridon, Gaelle] McGill Univ, Goodman Canc Res Ctr, Metabol Core Facil, Montreal, PQ H3A 1A3, Canada; [Bowden, Mary; Smith, Stephanie; Gleave, Martin E.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Bowden, Mary; Smith, Stephanie; Gleave, Martin E.] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Korshunov, Andrey] Heidelberg Univ, DKFZ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Galpin, Jason D.; Ahern, Christopher A.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Wang, Ye; Pollak, Michael] Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada; [Wang, Ye; Pollak, Michael] McGill Univ, Montreal, PQ H3T 1E2, Canada; [McCabe, Martin G.] Univ Manchester, Sch Canc & Enabling Sci, Manchester M20 4BX, Lancs, England; [McCabe, Martin G.; Collins, V. Peter] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Delattre, Olivier] Inst Curie, INSERM, U830, Lab Genet & Biol Canc, F-75248 Paris, France; [Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Proud, Christopher G.] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; McGill University; McGill University; University of British Columbia; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Iowa; McGill University; McGill University; University of Manchester; University of Cambridge; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of British Columbia; Ruprecht Karls University Heidelberg; University of Southampton	Sorensen, PH (corresponding author), Univ British Columbia, British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L4, Canada.	psor@mail.ubc.ca	Derry, Brent/CAF-4503-2022; Jones, Russell/AAC-2861-2022; McCabe, Martin/P-5896-2015; Jones, Russell Graham/ABD-5261-2021; Rotblat, Barak/H-5970-2019; AGNIHOTRI, SAMEER/HHS-2255-2022; Northcott, Paul A/N-4022-2018; Kool, Marcel/H-2541-2013; Pfister, Stefan M/F-6860-2013; Jan, Eric/O-1923-2019; EL-Naggar, Amal/AAE-5565-2022	McCabe, Martin/0000-0002-5138-0707; Jones, Russell Graham/0000-0003-2250-4675; Rotblat, Barak/0000-0003-2985-7115; AGNIHOTRI, SAMEER/0000-0001-6584-3795; Northcott, Paul A/0000-0002-1220-5252; Pfister, Stefan M/0000-0002-5447-5322; Gleave, Martin/0000-0003-4235-0167; Korshunov, Andrey/0000-0002-5257-3623; delattre, olivier/0000-0002-8730-2276; Somasekharan, Syam/0000-0002-9006-8206; EL-Naggar, Amal/0000-0002-3202-6171; Derry, Brent/0000-0002-1977-8475; Pollak, Michael/0000-0003-3047-0604; Ahern, Christopher/0000-0002-7975-2744; Remke, Marc/0000-0002-9404-9993; Proud, Christopher/0000-0003-0704-6442; Faubert, Brandon/0000-0002-2886-886X; Taylor, Michael/0000-0001-7009-3466; Galpin, Jason/0000-0003-1923-5312	Canadian Cancer Society Research Institute; British Columbia Cancer Foundation; National Institutes of Health [CA159859]; Terry Fox Research Institute; Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA159859] Funding Source: NIH RePORTER; The Brain Tumour Charity [10/106] Funding Source: researchfish	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); British Columbia Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry Fox Research Institute; Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Brain Tumour Charity	We thank T. Tang, M. Robertson, and C. Chow for technical assistance and B. Fonseca (McGill University), S. Aparicio, S. Mullaly, T. Ng (UBC), J.A. Pospisilik, and R. Teperino (Max Planck Institute, Freiburg) for helpful discussions. This work was supported by the Canadian Cancer Society Research Institute and the British Columbia Cancer Foundation (to P.H.S.) through generous donations from Team Finn and other riders in the Ride to Conquer Cancer and by the National Institutes of Health (CA159859), the Terry Fox Research Institute, and the Pediatric Brain Tumor Foundation (to M.D.T.).	Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; BRENNER S, 1974, GENETICS, V77, P71; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Caro-Maldonado A., 2011, OPEN CELL SIGNAL J, V3, P42, DOI DOI 10.2174/1876390101103010042; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Sakagami H, 2002, NEUROSCI LETT, V330, P41, DOI 10.1016/S0304-3940(02)00715-2; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Somasekharan Syam Prakash, 2012, J Proteomics, V77, pe1, DOI 10.1016/j.jprot.2012.08.019; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	276	289	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1064	1079		10.1016/j.cell.2013.04.055	http://dx.doi.org/10.1016/j.cell.2013.04.055			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706743	Green Accepted, Bronze			2022-12-28	WOS:000319456800014
J	Guery, B; Poissy, J; el Mansouf, L; Sejourne, C; Ettahar, N; Lemaire, X; Vuotto, F; Goffard, A; Behillil, S; Enouf, V; Caro, V; Mailles, A; Che, D; Manuguerra, JC; Mathieu, D; Fontanet, A; van der Werf, S				Guery, Benoit; Poissy, Julien; el Mansouf, Loubna; Sejourne, Caroline; Ettahar, Nicolas; Lemaire, Xavier; Vuotto, Fanny; Goffard, Anne; Behillil, Sylvie; Enouf, Vincent; Caro, Valerie; Mailles, Alexandra; Che, Didier; Manuguerra, Jean-Claude; Mathieu, Daniel; Fontanet, Arnaud; van der Werf, Sylvie		MERS-CoV Study Grp	Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission	LANCET			English	Article							SARS; PNEUMONIA	Background Human infection with a novel coronavirus named Middle East Respiratory Syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia and the Middle East in September, 2012, with 44 laboratory-confirmed cases as of May 23, 2013. We report detailed clinical and virological data for two related cases of MERS-CoV disease, after nosocomial transmission of the virus from one patient to another in a French hospital. Methods Patient 1 visited Dubai in April, 2013; patient 2 lives in France and did not travel abroad. Both patients had underlying immunosuppressive disorders. We tested specimens from the upper (nasopharyngeal swabs) or the lower (bronchoalveolar lavage, sputum) respiratory tract and whole blood, plasma, and serum specimens for MERS-CoV by real-time RT-PCR targeting the upE and Orf1A genes of MERS-CoV. Findings Initial clinical presentation included fever, chills, and myalgia in both patients, and for patient 1, diarrhoea. Respiratory symptoms rapidly became predominant with acute respiratory failure leading to mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Both patients developed acute renal failure. MERS-CoV was detected in lower respiratory tract specimens with high viral load (eg, cycle threshold [Ct] values of 22.9 for upE and 24 for Orf1a for a bronchoalveolar lavage sample from patient 1; Ct values of 22.5 for upE and 23.9 for Orf1a for an induced sputum sample from patient 2), whereas nasopharyngeal specimens were weakly positive or inconclusive. The two patients shared the same room for 3 days. The incubation period was estimated at 9-12 days for the second case. No secondary transmission was documented in hospital staff despite the absence of specific protective measures before the diagnosis of MERS-CoV was suspected. Patient 1 died on May 28, due to refractory multiple organ failure. Interpretation Patients with respiratory symptoms returning from the Middle East or exposed to a confirmed case should be isolated and investigated for MERS-CoV with lower respiratory tract sample analysis and an assumed incubation period of 12 days. Immunosuppression should also be taken into account as a risk factor.	[Guery, Benoit; Vuotto, Fanny] Univ Lille 2, Ctr Hosp Reg & Univ Lille, Hop Huriez, Serv Gest Risque Infect Vigilances & Infectiol, Lille, France; [Poissy, Julien; Mathieu, Daniel] Univ Lille 2, Ctr Hosp Reg & Univ Lille, Hop Roger Salengro, Pole Reanimat, Lille, France; [el Mansouf, Loubna; Lemaire, Xavier] Ctr Hosp Douai, Serv Malad Infect, Douai, France; [Sejourne, Caroline] Ctr Hosp Douai, Serv Reanimat, Douai, France; [Ettahar, Nicolas] Ctr Hosp Valenciennes, Unite Malad Infect, Valenciennes, France; [Goffard, Anne] Univ Lille 2, Ctr Hosp Reg & Univ Lille, Ctr Biol Pathol, Virol Lab, Lille, France; [Behillil, Sylvie; Enouf, Vincent; van der Werf, Sylvie] Inst Pasteur, Natl Reference Ctr Influenza Viruses, F-75015 Paris, France; [Behillil, Sylvie; Enouf, Vincent; van der Werf, Sylvie] Inst Pasteur, Unit Mol Genet RNA Viruses, F-75015 Paris, France; [Behillil, Sylvie; Enouf, Vincent; van der Werf, Sylvie] Univ Paris Diderot, Sorbonne Paris Cite, Unit Mol Genet RNA Viruses, Paris, France; [Behillil, Sylvie; Enouf, Vincent; van der Werf, Sylvie] CNRS, UMR3569, Paris, France; [Caro, Valerie; Manuguerra, Jean-Claude] Inst Pasteur, F-75015 Paris, France; [Mailles, Alexandra; Che, Didier] Inst Veille Sanit, St Maurice, France; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France; [Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, F-75015 Paris, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; CH de Valenciennes; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institute of Public Health Surveillance; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	van der Werf, S (corresponding author), Inst Pasteur, Natl Reference Ctr Influenza Viruses, F-75015 Paris, France.	bguery@invivo.edu; sylvie.van-der-werf@pasteur.fr	Guery, Benoit/AAP-2046-2021; Goffard, Anne/G-5488-2016; Guery, Benoit/D-8089-2017; Behillil, sylvie/H-6496-2017; ENOUF, Vincent/H-6494-2017	Goffard, Anne/0000-0002-6521-9711; Guery, Benoit/0000-0002-6526-0714; Vincentelli, Andre/0000-0003-4081-786X; , julien/0000-0001-6017-5353; , arnaud/0000-0002-5239-6110; Parmentier-Decrucq, Erika/0000-0002-5836-5956; van der WERF, Sylvie/0000-0002-1148-4456; Faure, Karine/0000-0002-2608-9790; rousse, natacha/0000-0003-2837-4285; Mailles, Alexandra/0000-0002-8739-1168; Behillil, sylvie/0000-0002-1520-5020; ENOUF, Vincent/0000-0001-7609-4742	French Institute for Public Health Surveillance (Institut de veille sanitaire, InVS); ANR grant Labex Integrative Biology of Emerging Infectious Diseases (IBEID) from the French Government's Investissement d'Avenir programme [ANR-10-LABX-62-IBEID]; European Community [223498, 278433]	French Institute for Public Health Surveillance (Institut de veille sanitaire, InVS); ANR grant Labex Integrative Biology of Emerging Infectious Diseases (IBEID) from the French Government's Investissement d'Avenir programme(French National Research Agency (ANR)); European Community(European Commission)	The National Reference Center for Influenza Viruses and the CIBU are supported in part by funds from the French Institute for Public Health Surveillance (Institut de veille sanitaire, InVS). Work related to collection of data, implementation of the assays, and sequencing was done with funds from ANR grant Labex Integrative Biology of Emerging Infectious Diseases (IBEID, grant number ANR-10-LABX-62-IBEID from the French Government's Investissement d'Avenir programme) and from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project EMPERIE (European Community grant agreement number 223498) and under the project PREDEMICS (grant agreement number 278433). We thank the nurses and all health-care workers from the hospitals in Valenciennes, Douai, and Lille who, in this crisis situation, took care of the patients and controlled the spread of this disease. We thank P Despres, S Paulous, and M P Frenkiel (Unit of Flavivirus-Host Molecular Interactions, Institut Pasteur) for preliminary serological analyses. We thank Eric Kipnis for editing of the report.	Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Buchholz U, 2013, EUROSURVEILLANCE, V18, P6; Cheng PKC, 2004, LANCET, V363, P1699, DOI 10.1016/S0140-6736(04)16255-7; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Gomersall CD, 2004, INTENS CARE MED, V30, P381, DOI 10.1007/s00134-003-2143-y; Gulland A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3114; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; McCloskey B, 2013, LANCET INFECT DIS, V13, P384, DOI 10.1016/S1473-3099(13)70082-3; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Tahir M, 2013, EUROSURVEILLANCE, V18, P4; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van der Hoek L, 2007, ANTIVIR THER, V12, P651; WHO, 2013, NOV COR INF UPD MAY; World Health Organization, NOV COR SUMM LIT UPD; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	23	295	309	0	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2265	2272		10.1016/S0140-6736(13)60982-4	http://dx.doi.org/10.1016/S0140-6736(13)60982-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173SU	23727167	Green Published, Bronze			2022-12-28	WOS:000321100300030
J	Memish, ZA; Zumla, AI; Al-Hakeem, RF; Al-Rabeeah, AA; Stephens, GM				Memish, Ziad A.; Zumla, Alimuddin I.; Al-Hakeem, Rafat F.; Al-Rabeeah, Abdullah A.; Stephens, Gwen M.			Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PNEUMONIA	A human coronavirus, called the Middle East respiratory syndrome coronavirus (MERS-CoV), was first identified in September 2012 in samples obtained from a Saudi Arabian businessman who died from acute respiratory failure. Since then, 49 cases of infections caused by MERS-CoV (previously called a novel coronavirus) with 26 deaths have been reported to date. In this report, we describe a family case cluster of MERS-CoV infection, including the clinical presentation, treatment outcomes, and household relationships of three young men who became ill with MERS-CoV infection after the hospitalization of an elderly male relative, who died of the disease. Twenty-four other family members living in the same household and 124 attending staff members at the hospitals did not become ill. MERS-CoV infection may cause a spectrum of clinical illness. Although an animal reservoir is suspected, none has been discovered. Meanwhile, global concern rests on the ability of MERS-CoV to cause major illness in close contacts of patients.	[Memish, Ziad A.; Zumla, Alimuddin I.; Al-Hakeem, Rafat F.; Al-Rabeeah, Abdullah A.; Stephens, Gwen M.] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 11176, Saudi Arabia; [Memish, Ziad A.] Al Faisal Univ, Riyadh, Saudi Arabia; [Zumla, Alimuddin I.] UCL, Div Infect & Immun, London WC1E 6BT, England; [Zumla, Alimuddin I.] UCL Hosp NHS Fdn Trust, Dept Med Microbiol, London, England	Alfaisal University; University of London; University College London; University of London; University College London	Memish, ZA (corresponding author), Minist Hlth, WHO Collaborating Ctr Mass Gathering Med, Riyadh 11176, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022; ZUMLA, Alimuddin/ABA-8208-2020	Memish, Ziad Ahmed/0000-0002-5099-0714; ZUMLA, Alimuddin/0000-0002-5111-5735				AlBarrak AM, 2012, SAUDI MED J, V33, P1265; Corman VM, 2012, EUROSURVEILLANCE, V17; Health Protection Agency, 2012, GEN SEQ INF SCI NOV; Hoffman C, 2003, SARS REFERENCE 10 20; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; World Health Organization, 2003, WHO FIN SUMM SARS; World Health Organization, 2013, INT SURV REC HUM INF; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zumla A, 2013, LANCET RESP MED 0520	10	315	327	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2487	2494		10.1056/NEJMoa1303729	http://dx.doi.org/10.1056/NEJMoa1303729			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23718156	Bronze			2022-12-28	WOS:000320926900009
J	Marmot, MG				Marmot, Michael G.			Sorting Through the Arguments on Breast Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER		UCL, Inst Hlth Equ, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England	University of London; University College London	Marmot, MG (corresponding author), UCL, Inst Hlth Equ, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 7HB, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0601647, G0902037, G1000616, G0701830] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0902037, G19/35, G0701830, G0100222, G8802774, G0601647, G1000616] Funding Source: Medline	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Independent UK Panel on Breast Cancer Screening, 2013, Lancet, V381, P803, DOI 10.1016/S0140-6736(13)60628-5; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Ransohoff DF, 2013, JAMA-J AM MED ASSOC, V309, P139, DOI 10.1001/jama.2012.156703	6	24	24	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2553	2554		10.1001/jama.2013.6822	http://dx.doi.org/10.1001/jama.2013.6822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23722915				2022-12-28	WOS:000320848100021
J	Kanamori, T; Kanai, MI; Dairyo, Y; Yasunaga, K; Morikawa, RK; Emoto, K				Kanamori, Takahiro; Kanai, Makoto I.; Dairyo, Yusuke; Yasunaga, Kei-ichiro; Morikawa, Rei K.; Emoto, Kazuo			Compartmentalized Calcium Transients Trigger Dendrite Pruning in Drosophila Sensory Neurons	SCIENCE			English	Article							INDICATORS; MECHANISMS; CELLS	Dendrite pruning is critical for sculpting the final connectivity of neural circuits as it removes inappropriate projections, yet how neurons can selectively eliminate unnecessary dendritic branches remains elusive. Here, we show that calcium transients that are compartmentalized in specific dendritic branches act as temporal and spatial cues to trigger pruning in Drosophila sensory neurons. Calcium transients occurred in local dendrites at similar to 3 hours before branch elimination. In dendritic branches, intrinsic excitability increased locally to activate calcium influx via the voltage-gated calcium channels (VGCCs), and blockade of the VGCC activities impaired pruning. Further genetic analyses suggest that the calcium-activated protease calpain functions downstream of the calcium transients. Our findings reveal the importance of the compartmentalized subdendritic calcium signaling in spatiotemporally selective elimination of dendritic branches.	[Kanamori, Takahiro; Kanai, Makoto I.; Dairyo, Yusuke; Yasunaga, Kei-ichiro; Morikawa, Rei K.; Emoto, Kazuo] Osaka Biosci Inst, Dept Cell Biol, Suita, Osaka 5650872, Japan; [Emoto, Kazuo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Dairyo, Yusuke] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	University of Tokyo; Nara Institute of Science & Technology	Emoto, K (corresponding author), Osaka Biosci Inst, Dept Cell Biol, 6-2-4 Furuedai, Suita, Osaka 5650872, Japan.	emoto@biol.s.u-tokyo.ac.jp	EMOTO, KAZUO/G-4992-2014		Japanese Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Strategic Research Program for Brain Science, CREST; Takeda Science Foundation	Japanese Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Program for Brain Science, CREST; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Y. N. Jan, C. Montel, M. Miura, L. L Looger, K. Deisseroth, Bloomington Stock Center, and Kyoto Stock Center for reagents; Riken BSI-Olympus collaboration center for measuring the blue-light intensity; W. Sugano and A. Kawasaki for technical assistance; S. Nakanishi and J. Z. Parrish for helpful comments on the manuscript. This work was supported by grants-in-aid for Science and Technology from the Japanese Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Strategic Research Program for Brain Science, CREST, and Takeda Science Foundation.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Emoto K, 2012, CURR OPIN NEUROBIOL, V22, P805, DOI 10.1016/j.conb.2012.04.005; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	17	81	82	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1475	1478		10.1126/science.1234879	http://dx.doi.org/10.1126/science.1234879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23722427				2022-12-28	WOS:000320647000048
J	McLean, PF; Cooley, L				McLean, Peter F.; Cooley, Lynn			Protein Equilibration Through Somatic Ring Canals in Drosophila	SCIENCE			English	Article							INTERCELLULAR BRIDGES; OVARIAN-FOLLICLE; CELLS; MELANOGASTER; DIFFERENTIATION; ORGANIZATION; SPERMATIDS; LEG	Although intercellular bridges resulting from incomplete cytokinesis were discovered in somatic Drosophila tissues decades ago, the impact of these structures on intercellular communication and tissue biology is largely unknown. In this work, we demonstrate that the similar to 250-nanometer-diameter somatic ring canals permit diffusion of cytoplasmic contents between connected cells and across mitotic clone boundaries and enable the equilibration of protein between transcriptionally mosaic follicle cells in the Drosophila ovary. We obtained similar, although more restricted, results in the larval imaginal discs. Our work illustrates the lack of cytoplasmic autonomy in these tissues and suggests a role for somatic ring canals in promoting homogeneous protein expression within the tissue.	[McLean, Peter F.; Cooley, Lynn] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Cooley, Lynn] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Cooley, Lynn] Yale Univ, Dept Mol Cellular & Dev Biol MCDB, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Cooley, L (corresponding author), Yale Univ, Dept Genet, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	lynn.cooley@yale.edu	McLean, Peter F/G-5751-2012	McLean, Peter/0000-0001-7938-5713	NIH from the National Center for Research Resources [P41 GM103313]; NIH [T32 GM007499, GM091791, GM043301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499, P41GM103313, R01GM043301, RC1GM091791] Funding Source: NIH RePORTER	NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Zimmerman, N. Peters, and C. Berg (Genome Sciences, University of Washington) for their assistance in troubleshooting the FISH protocol; N. Woodward and J. Carlson (MCDB, Yale University) for providing reagents and support for the FISH experiments; C. Tsai (Neuroscience and Cell Biology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School) for the SMRTER reagents; T. Xu (Genetics, Yale University) for the use of the upright Zeiss LSM510 META microscope; and the Bloomington Drosophila Stock Center for flies. For their support in the development of the VCell models, we thank A. Cowan and B. Slepchenko; the described VCell models are available at www.vcell.org under the shared username peterfoster. The Virtual Cell is supported by NIH grant P41 GM103313 from the National Center for Research Resources. We also thank the Center for Cellular and Molecular Imaging core facility (Yale University) for the use of their microscopes and for assistance with EM acquisition. P.F.M. received support from NIH Genetics training grant T32 GM007499. This work was supported by grants to L.C. from NIH (GM091791 and GM043301).	Airoldi SJ, 2011, J CELL SCI, V124, P4077, DOI 10.1242/jcs.090456; BRAND AH, 1993, DEVELOPMENT, V118, P401; DYM M, 1971, BIOL REPROD, V4, P195, DOI 10.1093/biolreprod/4.2.195; GIORGI F, 1978, CELL TISSUE RES, V186, P413; GONDOS B, 1973, Differentiation, V1, P177, DOI 10.1111/j.1432-0436.1973.tb00112.x; Greenbaum MP, 2009, BIOL REPROD, V80, P449, DOI 10.1095/biolreprod.108.070649; Haglund K, 2010, CURR BIOL, V20, P944, DOI 10.1016/j.cub.2010.03.068; Kramerova IA, 1999, DEV DYNAM, V216, P349, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<349::AID-DVDY4>3.0.CO;2-X; LARSEN EW, 1989, T AM MICROSC SOC, V108, P159, DOI 10.2307/3226372; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Minestrini G, 2002, J CELL SCI, V115, P725; Nystul T, 2010, GENETICS, V184, P503, DOI 10.1534/genetics.109.109538; Pepling ME, 1998, DEVELOPMENT, V125, P3323; POODRY CA, 1970, ROUX ARCH DEV BIOL, V166, P1, DOI 10.1007/BF00576805; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Skora AD, 2010, P NATL ACAD SCI USA, V107, P7389, DOI 10.1073/pnas.1003180107; Thakar R, 2005, J CELL SCI, V118, P951, DOI 10.1242/jcs.01684; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Woodruff RI, 1998, DEV BIOL, V200, P82, DOI 10.1006/dbio.1998.8948	21	32	32	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1445	1447		10.1126/science.1234887	http://dx.doi.org/10.1126/science.1234887			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23704373	Green Accepted			2022-12-28	WOS:000320647000040
J	Zhang, R; Zhang, Y; Dong, ZC; Jiang, S; Zhang, C; Chen, LG; Zhang, L; Liao, Y; Aizpurua, J; Luo, Y; Yang, JL; Hou, JG				Zhang, R.; Zhang, Y.; Dong, Z. C.; Jiang, S.; Zhang, C.; Chen, L. G.; Zhang, L.; Liao, Y.; Aizpurua, J.; Luo, Y.; Yang, J. L.; Hou, J. G.			Chemical mapping of a single molecule by plasmon-enhanced Raman scattering	NATURE			English	Article							SPECTROSCOPY; MICROSCOPY; RESOLUTION	Visualizing individual molecules with chemical recognition is a longstanding target in catalysis, molecular nanotechnology and biotechnology. Molecular vibrations provide a valuable 'finger-print' for such identification. Vibrational spectroscopy based on tip-enhanced Raman scattering allows us to access the spectral signals of molecular species very efficiently via the strong localized plasmonic fields produced at the tip apex(1-11). However, the best spatial resolution of the tip-enhanced Raman scattering imaging is still limited to 3-15 nanometres(5,12-16), which is not adequate for resolving a single molecule chemically. Here we demonstrate Raman spectral imaging with spatial resolution below one nanometre, resolving the inner structure and surface configuration of a single molecule. This is achieved by spectrally matching the resonance of the nanocavity plasmon to the molecular vibronic transitions, particularly the downward transition responsible for the emission of Raman photons. This matching is made possible by the extremely precise tuning capability provided by scanning tunnelling microscopy. Experimental evidence suggests that the highly confined and broadband nature of the nanocavity plasmon field in the tunnelling gap is essential for ultrahigh-resolution imaging through the generation of an efficient double-resonance enhancement for both Raman excitation and Raman emission. Our technique not only allows for chemical imaging at the single-molecule level, but also offers a new way to study the optical processes and photochemistry of a single molecule.	[Zhang, R.; Zhang, Y.; Dong, Z. C.; Jiang, S.; Zhang, C.; Chen, L. G.; Zhang, L.; Liao, Y.; Luo, Y.; Yang, J. L.; Hou, J. G.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Aizpurua, J.] Mat Phys Ctr CSIC UPV EHU, Donostia San Sebastian 20018, Spain; [Aizpurua, J.] Donostia Int Phys Ctr DIPC, Donostia San Sebastian 20018, Spain; [Luo, Y.] Royal Inst Technol, Sch Biotechnol, S-10691 Stockholm, Sweden	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; Royal Institute of Technology	Dong, ZC (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zcdong@ustc.edu.cn; jghou@ustc.edu.cn	Yang, Jinlong/D-3465-2009; Aizpurua, Javier/E-6889-2014; Luo, Yi/B-1449-2009; Jiang, Song/AAI-6839-2021; Dong, Z. C./HGD-0338-2022; Liao, Yuan/H-3525-2013	Aizpurua, Javier/0000-0002-1444-7589; Luo, Yi/0000-0003-0007-0394; Liao, Yuan/0000-0001-5658-8948; Zhang, Yao/0000-0002-6524-0289; Jiang, Song/0000-0002-2223-8517	National Basic Research Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences; Natural Science Foundation of China; Basque Government Project of Excellence (ETORTEK)	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basque Government Project of Excellence (ETORTEK)(Basque Government)	We thank B. Wang, B. Ren, H. X. Xu, Z. Liu, and X. M. Yang for discussions and Unisoku Company for technical assistance. This work is supported by the National Basic Research Program of China, the Strategic Priority Research Program of the Chinese Academy of Sciences, the Natural Science Foundation of China and the Basque Government Project of Excellence (ETORTEK).	Aizpurua J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.156803; Alonso-Gonzalez P, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1674; Anderson MS, 2000, APPL PHYS LETT, V76, P3130, DOI 10.1063/1.126546; Anderson N, 2005, J AM CHEM SOC, V127, P2533, DOI 10.1021/ja045190i; Berweger S, 2010, ANAL BIOANAL CHEM, V396, P115, DOI 10.1007/s00216-009-3085-1; Berweger S, 2009, NAT NANOTECHNOL, V4, P496, DOI [10.1038/NNANO.2009.190, 10.1038/nnano.2009.190]; Dong ZC, 2010, NAT PHOTONICS, V4, P50, DOI 10.1038/NPHOTON.2009.257; Dong ZC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.086801; Hayazawa N, 2000, OPT COMMUN, V183, P333, DOI 10.1016/S0030-4018(00)00894-4; Ichimura T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186101; Itoh T, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2177662; Jiang N, 2012, NANO LETT, V12, P5061, DOI 10.1021/nl2039925; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Liu Z, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1310; Neacsu CC, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.193406; Pettinger B, 2000, ELECTROCHEMISTRY, V68, P942, DOI 10.5796/electrochemistry.68.942; Pettinger B, 2012, ANNU REV PHYS CHEM, V63, P379, DOI 10.1146/annurev-physchem-032511-143807; Pettinger B, 2009, SURF SCI, V603, P1335, DOI 10.1016/j.susc.2008.08.033; Sonntag MD, 2012, J PHYS CHEM C, V116, P478, DOI 10.1021/jp209982h; Stadler J, 2010, NANO LETT, V10, P4514, DOI 10.1021/nl102423m; Steidtner J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236101; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Stockle RM, 2000, CHEM PHYS LETT, V318, P131, DOI 10.1016/S0009-2614(99)01451-7; Treffer R, 2011, BEILSTEIN J NANOTECH, V2, P628, DOI 10.3762/bjnano.2.66; van Schrojenstein Lantman EM, 2012, NAT NANOTECHNOL, V7, P583, DOI [10.1038/nnano.2012.131, 10.1038/NNANO.2012.131]; Wang X, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2776860; Xu HX, 2000, PHYS REV E, V62, P4318, DOI 10.1103/PhysRevE.62.4318; Yano T, 2009, NAT PHOTONICS, V3, P473, DOI 10.1038/NPHOTON.2009.74; Yorulmaz M, 2012, NANO LETT, V12, P4385, DOI 10.1021/nl302196a; Zhang C, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3617456	30	1205	1229	69	1668	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					82	86		10.1038/nature12151	http://dx.doi.org/10.1038/nature12151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23739426				2022-12-28	WOS:000319947800037
J	Ikramuddin, S; Korner, J; Lee, WJ; Connett, JE; Inabnet, WB; Billington, CJ; Thomas, AJ; Leslie, DB; Chong, K; Jeffery, RW; Ahmed, L; Vella, A; Chuang, LM; Bessler, M; Sarr, MG; Swain, JM; Laqua, P; Jensen, MD; Bantle, JP				Ikramuddin, Sayeed; Korner, Judith; Lee, Wei-Jei; Connett, John E.; Inabnet, William B., III; Billington, Charles J.; Thomas, Avis J.; Leslie, Daniel B.; Chong, Keong; Jeffery, Robert W.; Ahmed, Leaque; Vella, Adrian; Chuang, Lee-Ming; Bessler, Marc; Sarr, Michael G.; Swain, James M.; Laqua, Patricia; Jensen, Michael D.; Bantle, John P.			Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia The Diabetes Surgery Study Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR RISK-FACTORS; BARIATRIC SURGERY; LIFE-STYLE; THERAPY; ADULTS	Importance Controlling glycemia, blood pressure, and cholesterol is important for patients with diabetes. How best to achieve this goal is unknown. Objective To compare Roux-en-Y gastric bypass with lifestyle and intensive medical management to achieve control of comorbid risk factors. Design, Setting, and Participants A 12-month, 2-group unblinded randomized trial at 4 teaching hospitals in the United States and Taiwan involving 120 participants who had a hemoglobin A(1c) (HbA(1c)) level of 8.0% or higher, body mass index (BMI) between 30.0 and 39.9, C peptide level of more than 1.0 ng/mL, and type 2 diabetes for at least 6 months. The study began in April 2008. Interventions Lifestyle-intensive medical management intervention and Roux-en-Y gastric bypass surgery. Medications for hyperglycemia, hypertension, and dyslipidemia were prescribed according to protocol and surgical techniques that were standardized. Main Outcomes and Measures Composite goal of HbA1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg. Results All 120 patients received the intensive lifestyle-medical management protocol and 60 were randomly assigned to undergo Roux-en-Y gastric bypass. After 12-months, 28 participants (49%; 95% CI, 36%-63%) in the gastric bypass group and 11 (19%; 95% CI, 10%-32%) in the lifestyle-medical management group achieved the primary end points (odds ratio [OR], 4.8; 95% CI, 1.9-11.7). Participants in the gastric bypass group required 3.0 fewer medications (mean, 1.7 vs 4.8; 95% CI for the difference, 2.3-3.6) and lost 26.1% vs 7.9% of their initial body weigh compared with the lifestyle-medical management group (difference, 17.5%; 95% CI, 14.2%-20.7%). Regression analyses indicated that achieving the composite end point was primarily attributable to weight loss. There were 22 serious adverse events in the gastric bypass group, including 1 cardiovascular event, and 15 in the lifestyle-medical management group. There were 4 perioperative complications and 6 late postoperative complications. The gastric bypass group experienced more nutritional deficiency than the lifestyle-medical management group. Conclusions and Relevance In mild to moderately obese patients with type 2 diabetes, adding gastric bypass surgery to lifestyle and medical management was associated with a greater likelihood of achieving the composite goal. Potential benefits of adding gastric bypass surgery to the best lifestyle and medical management strategies of diabetes must be weighed against the risk of serious adverse events.	[Ikramuddin, Sayeed; Leslie, Daniel B.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Connett, John E.; Thomas, Avis J.] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA; [Jeffery, Robert W.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Billington, Charles J.; Bantle, John P.] Univ Minnesota, Sch Publ Hlth, Dept Med, Div Endocrinol & Diabet, Minneapolis, MN 55455 USA; [Laqua, Patricia] Univ Minnesota, Berman Ctr Clin Res, Minneapolis, MN 55455 USA; [Korner, Judith] Columbia Univ, Med Ctr, Dept Med, Div Endocrinol, New York, NY USA; [Ahmed, Leaque; Bessler, Marc] Columbia Univ, Med Ctr, Dept Surg, New York, NY USA; [Lee, Wei-Jei] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Div Metab & Endocrinol, Taipei 100, Taiwan; [Inabnet, William B., III] Mt Sinai Med Ctr, Dept Surg, New York, NY 10029 USA; [Chong, Keong] Min Sheng Gen Hosp, Dept Endocrinol, Tao Yuan, Taiwan; [Vella, Adrian; Jensen, Michael D.] Mayo Clin, Dept Med, Div Endocrinol & Diabet, Rochester, MN USA; [Sarr, Michael G.] Mayo Clin, Dept Gastroenterol & Gen Surg, Rochester, MN USA; [Swain, James M.] Scottsdale Healthcare Bariatr Ctr, Scottsdale, AZ USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Columbia University; Columbia University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Icahn School of Medicine at Mount Sinai; Mayo Clinic; Mayo Clinic	Ikramuddin, S (corresponding author), Univ Minnesota, Dept Surg, 420 Delaware St SE,MMC290, Minneapolis, MN 55455 USA.	ikram001@umn.edu	Chuang, Lee-Ming/AAF-3324-2019	CHUANG, LEE-MING/0000-0003-0978-2662	National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040, UL1 RR024156]; Covidien; Covidien, Mansfield, Massachusetts; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082396] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Covidien; Covidien, Mansfield, Massachusetts; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Diabetes Surgery Study was supported by Covidien, Mansfield, Massachusetts. Covidien provided funds for these 5 clinical locations: University of Minnesota, Minneapolis; Mayo Clinic, Rochester, Minnesota; Columbia University, New York, New York; National Taiwan University Hospital, Taipei, Taiwan; Min-Sheng General Hospital, Taoyuan, Taiwan. This publication was supported in part by grant UL1 TR000040 and grant UL1 RR024156 to Columbia University both from the National Center for Advancing Translational Sciences, National Institutes of Health, formerly the National Center for Research Resources.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Bertoni AG, 2008, J DIABETES COMPLICAT, V22, P1, DOI 10.1016/j.jdiacomp.2006.10.003; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; DeMaria J, 2002, ANN SURG, V235, P640, DOI 10.1097/00000658-200205000-00005; DiGiorgi M, 2010, SURG OBES RELAT DIS, V6, P249, DOI 10.1016/j.soard.2009.09.019; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Espeland M, 2007, DIABETES CARE, V30, P1374; Hutter MM, 2011, ANN SURG, V254, P410, DOI 10.1097/SLA.0b013e31822c9dac; Ikramuddin S, 2007, J GASTROINTEST SURG, V11, P217, DOI 10.1007/s11605-006-0028-4; Ludwig DS, 2012, JAMA-J AM MED ASSOC, V308, P981, DOI 10.1001/2012.jama.10156; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Ryan DH, 2012, DIABETES CARE, V35, P1399, DOI 10.2337/dc12-0729; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Wong KL, 2012, J DIABETES COMPLICAT, V26, P169, DOI 10.1016/j.jdiacomp.2012.03.006	25	516	539	0	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2240	2249		10.1001/jama.2013.5835	http://dx.doi.org/10.1001/jama.2013.5835			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736733	Green Submitted, Green Accepted			2022-12-28	WOS:000319859200028
J	Stevens, B; Bony, S				Stevens, Bjorn; Bony, Sandrine			What Are Climate Models Missing?	SCIENCE			English	Editorial Material							EARTH SYSTEM MODELS; SENSITIVITY		[Stevens, Bjorn] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Bony, Sandrine] Univ Paris 06, CNRS, Meteorol Dynam Lab, Inst Pierre Simon Laplace, Paris, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Stevens, B (corresponding author), Max Planck Inst Meteorol, Bundesstr 53, D-20146 Hamburg, Germany.	bjorn.stevens@mpimet.mpg.de	Stevens, Bjorn/A-1757-2013; Bony, Sandrine/AAG-5804-2019	Stevens, Bjorn/0000-0003-3795-0475; Bony, Sandrine/0000-0002-4791-4438				Bony S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023851; Bony S, 2013, CLIMATE SCI SERVING; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Dufresne JL, 2008, J CLIMATE, V21, P5135, DOI 10.1175/2008JCLI2239.1; Eliassen A., 1949, TELLUS, V1, P38, DOI [DOI 10.3402/TELLUSA.V1I2.8500, 10.3402/tellusa.v1i2.8500]; Flato GM, 2011, WIRES CLIM CHANGE, V2, P783, DOI 10.1002/wcc.148; Good P, 2013, J CLIMATE, V26, P495, DOI 10.1175/JCLI-D-11-00366.1; Medeiros B, 2008, J CLIMATE, V21, P4974, DOI 10.1175/2008JCLI1995.1; Min QL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032398; Ocko IB, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018019; Oueslati B, 2013, J CLIMATE, V26, P2931, DOI 10.1175/JCLI-D-12-00314.1; Popke D, 2013, J ADV MODEL EARTH SY, V5, P1, DOI 10.1029/2012MS000191; Simmons AJ, 2002, Q J ROY METEOR SOC, V128, P647, DOI 10.1256/003590002321042135; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)0912.3.CO;2, 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, 10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2]	14	262	266	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1053	1054		10.1126/science.1237554	http://dx.doi.org/10.1126/science.1237554			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23723223				2022-12-28	WOS:000319664500028
J	Shu, J; Wu, C; Wu, YT; Li, ZY; Shao, SD; Zhao, WH; Tang, X; Yang, H; Shen, LJ; Zuo, XH; Yang, WF; Shi, Y; Chi, XC; Zhang, HQ; Gao, G; Shu, YM; Yuan, KH; He, WW; Tang, C; Zhao, Y; Deng, HK				Shu, Jian; Wu, Chen; Wu, Yetao; Li, Zhiyuan; Shao, Sida; Zhao, Wenhui; Tang, Xing; Yang, Huan; Shen, Lijun; Zuo, Xiaohan; Yang, Weifeng; Shi, Yan; Chi, Xiaochun; Zhang, Hongquan; Gao, Ge; Shu, Youmin; Yuan, Kehu; He, Weiwu; Tang, Chao; Zhao, Yang; Deng, Hongkui			Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers	CELL			English	Article							EMBRYONIC STEM-CELLS; PRIMITIVE ENDODERM; DIRECT CONVERSION; HUMAN FIBROBLASTS; DIFFERENTIATION; OCT4; EXPRESSION; GENERATION; GENE; DEDIFFERENTIATION	The reprogramming factors that induce pluripotency have been identified primarily from embryonic stem cell (ESC)-enriched, pluripotency-associated factors. Here, we report that, during mouse somatic cell reprogramming, pluripotency can be induced with lineage specifiers that are pluripotency rivals to suppress ESC identity, most of which are not enriched in ESCs. We found that OCT4 and SOX2, the core regulators of pluripotency, can be replaced by lineage specifiers that are involved in mesendo-dermal (ME) specification and in ectodermal (ECT) specification, respectively. OCT4 and its substitutes attenuated the elevated expression of a group of ECT genes, whereas SOX2 and its substitutes curtailed a group of ME genes during reprogramming. Surprisingly, the two counteracting lineage specifiers can synergistically induce pluripotency in the absence of both OCT4 and SOX2. Our study suggests a "seesaw model'' in which a balance that is established using pluripotency factors and/or counteracting lineage specifiers can facilitate reprogramming.	[Shu, Jian; Shao, Sida; Zhao, Wenhui; Shen, Lijun; Yang, Weifeng; Zhao, Yang; Deng, Hongkui] Peking Univ, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Li, Zhiyuan; Tang, Chao] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Shu, Jian; Wu, Chen; Wu, Yetao; Zhao, Wenhui; Yang, Huan; Zuo, Xiaohan; Tang, Chao; Zhao, Yang; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Tang, Xing; Gao, Ge] Peking Univ, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China; [Chi, Xiaochun; Zhang, Hongquan] Peking Univ, Sch Basic Med Sci, Lab Stem Cells Dev & Reprod Med, Beijing 100191, Peoples R China; [Wu, Chen; Wu, Yetao; Yang, Huan; Zuo, Xiaohan; Shi, Yan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Li, Zhiyuan] Univ Calif San Francisco, Biophys Grad Program, San Francisco, CA 94158 USA; [Shu, Youmin; Yuan, Kehu; He, Weiwu] OriGene Technol, Rockville, MD 20850 USA	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; University Town of Shenzhen; University of California System; University of California San Francisco	Tang, C (corresponding author), Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China.	tangc@pku.edu.cn; hongkui_deng@pku.edu.cn	Gao, Ge/F-3615-2012; Zhang, Xiaoming/L-2904-2013; li, zhiyuan/M-8378-2013	li, zhiyuan/0000-0001-6662-2636; Tang, Chao/0000-0003-1474-3705; Yang, Huan/0000-0001-8345-9957	National Basic Research Program of China (973 program) [2012CB966401, 2009CB941101, 2010CB945204, 2009CB918500]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; National Natural Science Foundation of China [90919031, 11021463]; 111 project; NSF [CMMI-0941355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER	National Basic Research Program of China (973 program)(National Basic Research Program of China); Key New Drug Creation and Manufacturing Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chengyan Wang and Xiaolei Yin for helpful discussions. We also thank Haisong Liu, Jiancheng Wang, Zhiyuan Hou, Ren Li, Fangfang Zhu, Dongyi Xu, and Xing Zhang for technical assistance. J.S., C.W., and Y.W. conducted most of the experiments in this study. Z.L. performed the computer analysis and mathematical model analysis. H.D., Y.Z., and C.T. conceived of and supervised the study. This work was supported by grants from the National Basic Research Program of China (973 program grant numbers 2012CB966401, 2009CB941101, 2010CB945204, and 2009CB918500), the Key New Drug Creation and Manufacturing Program (grant numbers 2011ZX09102-010-03), the National Natural Science Foundation of China (grant numbers 90919031 and 11021463), the 111 project, and NSF (CMMI-0941355).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cao Q, 2012, DEVELOPMENT, V139, P3950, DOI 10.1242/dev.082024; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tontsch S, 2001, MECH DEVELOP, V108, P165, DOI 10.1016/S0925-4773(01)00477-4; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	52	206	225	10	215	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					963	975		10.1016/j.cell.2013.05.001	http://dx.doi.org/10.1016/j.cell.2013.05.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706735	Green Accepted, Bronze			2022-12-28	WOS:000319456800006
J	Jiang, W; Velazquez, EJ; Kuchibhatla, M; Samad, Z; Boyle, SH; Kuhn, C; Becker, RC; Ortel, TL; Williams, RB; Rogers, JG; O'Connor, C				Jiang, Wei; Velazquez, Eric J.; Kuchibhatla, Maragatha; Samad, Zainab; Boyle, Stephen H.; Kuhn, Cynthia; Becker, Richard C.; Ortel, Thomas L.; Williams, Redford B., Jr.; Rogers, Joseph G.; O'Connor, Christopher			Effect of Escitalopram on Mental Stress-Induced Myocardial Ischemia Results of the REMIT Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CORONARY-ARTERY-DISEASE; DEPENDENT DIABETES-MELLITUS; HEART-DISEASE; PSYCHOLOGICAL STRESS; OBESE-PATIENTS; FLUOXETINE; DEPRESSION; INFARCTION; SERTRALINE	Importance Mental stress can induce myocardial ischemia and also has been implicated in triggering cardiac events. However, pharmacological interventions aimed at reducing mental stress-induced myocardial ischemia (MSIMI) have not been well studied. Objective To examine the effects of 6 weeks of escitalopram treatment vs placebo on MSIMI and other psychological stress-related biophysiological and emotional parameters. Design, Setting, and Participants The REMIT (Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment) study, a randomized, double-blind, placebo-controlled trial of patients with clinically stable coronary heart disease and laboratory-diagnosed MSIMI. Enrollment occurred from July 24, 2007, through August 24, 2011, at a tertiary medical center. Interventions Eligible participants were randomized 1: 1 to receive escitalopram (dose began at 5 mg/d, with titration to 20 mg/d in 3 weeks) or placebo over 6 weeks. Main Outcomes and Measures Occurrence of MSIMI, defined as development or worsening of regional wall motion abnormality; left ventricular ejection fraction reduction of 8% or more; and/or horizontal or down-sloping ST-segment depression of 1 mm or more in 2 or more leads, lasting for 3 or more consecutive beats, during 1 or more of 3 mental stressor tasks. Results Of 127 participants randomized to receive escitalopram (n=64) or placebo (n=63), 112 (88.2%) completed end point assessments (n=56 in each group). At the end of 6 weeks, more patients taking escitalopram (34.2% [95% CI, 25.4%-43.0%]) had absence of MSIMI during the 3 mental stressor tasks compared with patients taking placebo (17.5% [95% CI, 10.4%-24.5%]), based on the unadjusted multiple imputation model for intention-to-treat analysis. A significant difference favoring escitalopram was observed (odds ratio, 2.62 [95% CI, 1.06-6.44]). Rates of exercise-induced ischemia were slightly lower at 6 weeks in the escitalopram group (45.8% [95% CI, 36.6%-55.0%]) than in patients receiving placebo (52.5% [95% CI, 43.3%-61.8%]), but this difference was not statistically significant (adjusted odds ratio; 1.24 [95% CI, 0.60-2.58]; P=.56). Conclusions and Relevance Among patients with stable coronary heart disease and baseline MSIMI, 6 weeks of escitalopram, compared with placebo, resulted in a lower rate of MSIMI. There was no statistically significant difference in exercise-induced ischemia. Replication of these results in multicenter settings and investigations of other medications for reducing MSIMI are needed.	[Jiang, Wei; Velazquez, Eric J.; Samad, Zainab; Becker, Richard C.; Ortel, Thomas L.; Rogers, Joseph G.; O'Connor, Christopher] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Jiang, Wei; Boyle, Stephen H.; Kuhn, Cynthia; Williams, Redford B., Jr.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Kuchibhatla, Maragatha] Duke Univ, Med Ctr, Ctr Aging, Durham, NC 27710 USA; [Jiang, Wei; Boyle, Stephen H.; O'Connor, Christopher] Duke Univ, Med Ctr, Duke Heart Mind Ctr, Durham, NC 27710 USA; [Jiang, Wei; Velazquez, Eric J.; Becker, Richard C.; Rogers, Joseph G.; O'Connor, Christopher] Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Jiang, W (corresponding author), Duke Univ, Med Ctr, Dept Med, DUMCBox 3366, Durham, NC 27710 USA.	jiang001@mc.duke.edu			National Heart, Lung, and Blood Institute (NHLBI); Abbott Laboratories; Evalve; Ikaria; Boehringer Ingelheim; Gilead; Novartis; American Society of Echocardiography; Baxter; Bristol-Myers Squibb; Johnson Johnson; Regado Biosciences; Bayer; Daiichi Sankyo; Merck; sanofi-aventis; GlaxoSmithKline; Eisai; Pfizer; Instrumentation Laboratory; Stago; Boston Scientific Corporation; HeartWare; Thoratec Corporation; Actelion Pharmaceuticals Ltd; Amgen Inc; Biscardia LLC; Faculty Connection; GE Healthcare; Novella Clinical Inc; Pfizer Inc; Pozen; Roche Diagnostics; NHLBI, Bethesda, Maryland [R01 HL085704]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118077, R01HL085704, P01HL036587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Abbott Laboratories(Abbott Laboratories); Evalve; Ikaria; Boehringer Ingelheim(Boehringer Ingelheim); Gilead(Gilead Sciences); Novartis(Novartis); American Society of Echocardiography; Baxter; Bristol-Myers Squibb(Bristol-Myers Squibb); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Regado Biosciences; Bayer(Bayer AG); Daiichi Sankyo(Daiichi Sankyo Company Limited); Merck(Merck & Company); sanofi-aventis(Sanofi-Aventis); GlaxoSmithKline(GlaxoSmithKline); Eisai(Eisai Co Ltd); Pfizer(Pfizer); Instrumentation Laboratory; Stago; Boston Scientific Corporation(Boston Scientific); HeartWare; Thoratec Corporation; Actelion Pharmaceuticals Ltd; Amgen Inc(Amgen); Biscardia LLC; Faculty Connection; GE Healthcare(General ElectricGE Healthcare); Novella Clinical Inc; Pfizer Inc(Pfizer); Pozen; Roche Diagnostics; NHLBI, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. All authors reported receiving salary support through a National Heart, Lung, and Blood Institute (NHLBI) research grant. Dr Jiang reported that she is named on a patent application to Duke University related to selective serotonin reuptake inhibitor (SSRI) treatment for mental stress-induced myocardial ischemia (MSIMI). Dr Velazquez reported receiving research grants from Abbott Laboratories, Evalve, and Ikaria; receiving consulting fees from Boehringer Ingelheim, Gilead, and Novartis; and that he is named on a patent application to Duke University related to SSRI treatment for MSIMI. Dr Samad reported receiving a grant or grant pending from the American Society of Echocardiography. Dr Becker reported receiving research grant support from Baxter, Bristol-Myers Squibb, Johnson & Johnson, and Regado Biosciences; receiving consulting/lecture fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Johnson & Johnson, Merck, Regado Biosciences, and sanofi-aventis. Dr Ortel reported serving as a consultant for Instrumentation Laboratory, Boehringer Ingelheim, and Bayer and receiving grants or grants pending from GlaxoSmithKline, Eisai, Pfizer, Daiichi Sankyo, Instrumentation Laboratory, and Stago. Dr Williams reported holding a US patent on the 5HTTLPR L allele for use as a marker of increased cardiovascular risk in stressed persons and that he is a founder and major stockholder of Williams LifeSkills Inc. Dr Rogers reported receiving funding from Boston Scientific Corporation, HeartWare, and Thoratec Corporation. Dr O'Connor reported receiving funding from Actelion Pharmaceuticals Ltd, Amgen Inc, Biscardia LLC, Faculty Connection, GE Healthcare, Ikaria, Novella Clinical Inc, Pfizer Inc, Pozen, and Roche Diagnostics; serving as a consultant for Novartis, Heartware, ResMed, Johnson & Johnson, Gilead, Critical Diagnostics, BG Medicine, Otsuka, Astellas, Cytokinetics, and Capricor; holding stock or stock options in Neurotronik/Interventional Autonomics Corporation; that he is named on a patent application to Duke University related to SSRI treatment for MSIMI; and serving as a journal editor for the American College of Cardiology. No other authors reported disclosures.; The REMIT study was funded by the NHLBI (R01 HL085704), Bethesda, Maryland. Escitalopram and matched placebo were supplied by Forest Research Institute Inc, Germantown, Maryland.	Akinboboye O, 2005, AM J CARDIOL, V95, P322, DOI 10.1016/j.amjcard.2004.09.027; Andrews TC, 1998, J AM COLL CARDIOL, V32, P1680, DOI 10.1016/S0735-1097(98)00445-8; Aoki T, 2012, EUR HEART J, V33, P2796, DOI 10.1093/eurheartj/ehs288; BAIREY CN, 1991, J AM COLL CARDIOL, V17, P1388, DOI 10.1016/S0735-1097(10)80152-4; Barefoot JC, 2011, ARCH INTERN MED, V171, P929, DOI 10.1001/archinternmed.2011.41; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Breum L, 1995, METABOLISM, V44, P1570, DOI 10.1016/0026-0495(95)90077-2; Brydon L, 2006, BRAIN BEHAV IMMUN, V20, P113, DOI 10.1016/j.bbi.2005.08.002; Camacho A, 2000, PSYCHOSOM MED, V62, P326, DOI 10.1097/00006842-200005000-00006; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; Daubresse JC, 1996, OBES RES, V4, P391, DOI 10.1002/j.1550-8528.1996.tb00247.x; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Douglas PS, 2009, J AM SOC ECHOCARDIOG, V22, P755, DOI 10.1016/j.echo.2009.05.020; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Golding M, 2005, PSYCHOPHARMACOLOGY, V182, P321, DOI 10.1007/s00213-005-0075-7; GRAY DS, 1992, INT J OBESITY, V16, P193; JAIN D, 1995, AM J CARDIOL, V76, P31, DOI 10.1016/S0002-9149(99)80796-6; Jiang W, 1996, JAMA-J AM MED ASSOC, V275, P1651, DOI 10.1001/jama.275.21.1651; Jiang W, 2013, J AM COLL CARDIOL, V61, P714, DOI 10.1016/j.jacc.2012.11.037; Jiang W, 2012, AM HEART J, V163, P20, DOI 10.1016/j.ahj.2011.09.018; Jiao Z, 2012, AM J CARDIOL, V109, P502, DOI 10.1016/j.amjcard.2011.09.045; Kamarck TW, 2011, PSYCHONEUROENDOCRINO, V36, P1070, DOI 10.1016/j.psyneuen.2011.01.005; Kamarck TW, 2009, J CONSULT CLIN PSYCH, V77, P174, DOI 10.1037/a0014394; Maheux P, 1997, INT J OBESITY, V21, P97, DOI 10.1038/sj.ijo.0800372; McCloskey DJ, 2008, TRANSL RES, V151, P168, DOI 10.1016/j.trsl.2007.10.004; McGregor M, 1986, CANAD J CARD SA, p53A; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; OKANE M, 1994, DIABETIC MED, V11, P105, DOI 10.1111/j.1464-5491.1994.tb00238.x; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; ROZANSKI A, 1988, NEW ENGL J MED, V318, P1005, DOI 10.1056/NEJM198804213181601; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Strike PC, 2003, EUR HEART J, V24, P690, DOI 10.1016/S0195-668X(02)00615-2; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; TRICHOPOULOS D, 1983, LANCET, V1, P441; VANLOON BJP, 1992, INT J OBESITY, V16, P79	38	60	67	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2139	2149		10.1001/jama.2013.5566	http://dx.doi.org/10.1001/jama.2013.5566			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23695483	Green Accepted, Bronze			2022-12-28	WOS:000319229600030
J	Psaty, BM; Goodman, SN; Breckenridge, A				Psaty, Bruce M.; Goodman, Steven N.; Breckenridge, Alasdair			Advances in Regulatory Science at the Food and Drug Administration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98121 USA; [Goodman, Steven N.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Breckenridge, Alasdair] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Stanford University; University of Liverpool	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu		Goodman, Steven/0000-0002-3872-5723	NHLBI NIH HHS [HL087652, HL103612, HL078888, HL105756, HL080295, R01 HL078888, R01 HL103612, HL085251] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, R01HL085251, R01HL087652, R01HL078888, R01HL080295, U01HL080295, R01HL103612] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], BEN RISK METH PROJ; Baciu A, 2006, FUT DRUG SAF PROM PR; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Levinson DR, 2013, OEI041100510 OFF INS; Lumpkin MM, 2012, CLIN PHARMACOL THER, V92, P486, DOI 10.1038/clpt.2012.146; Psaty BM, 2013, JAMA-J AM MED ASSOC, V309, P1895, DOI 10.1001/jama.2013.3445; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; US Food and Drug Administration Department of Health and Human Services, 2012, FED REG, V77, P13339; US Food and Drug Administration (FDA), 2013, STRUCT APPR IN PRESS	9	8	8	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2103	2104		10.1001/jama.2013.4503	http://dx.doi.org/10.1001/jama.2013.4503			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23695478				2022-12-28	WOS:000319229600023
J	Young, D; Harrison, DA; Cuthbertson, BH; Rowan, K				Young, Duncan; Harrison, David A.; Cuthbertson, Brian H.; Rowan, Kathy		TracMan Collaborators	Effect of Early vs Late Tracheostomy Placement on Survival in Patients Receiving Mechanical Ventilation The TracMan Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROLONGED TRANSLARYNGEAL INTUBATION; INTENSIVE-CARE; CLINICAL-TRIALS; UNITED-KINGDOM; ICU PATIENTS; TRACHEOTOMY; PREDICTORS; DURATION; OUTCOMES; DISEASE	Importance Tracheostomy is a widely used intervention in adult critical care units. There is little evidence to guide clinicians regarding the optimal timing for this procedure. Objective To test whether early vs late tracheostomy would be associated with lower mortality in adult patients requiring mechanical ventilation in critical care units. Design and Setting An open multicentered randomized clinical trial conducted between 2004 and 2011 involving 70 adult general and 2 cardiothoracic critical care units in 13 university and 59 nonuniversity hospitals in the United Kingdom. Participants Of 1032 eligible patients, 909 adult patients breathing with the aid of mechanical ventilation for less than 4 days and identified by the treating physician as likely to require at least 7 more days of mechanical ventilation. Interventions Patients were randomized 1: 1 to early tracheostomy (within 4 days) or late tracheostomy (after 10 days if still indicated). Main Outcomes and Measures The primary outcome measure was 30-day mortality and the analysis was by intention to treat. Results Of the 455 patients assigned to early tracheostomy, 91.9% (95% CI, 89.0%-94.1%) received a tracheostomy and of 454 assigned to late tracheostomy, 44.9% (95% CI, 40.4%-49.5%) received a tracheostomy. All-cause mortality 30 days after randomization was 30.8% (95% CI, 26.7%-35.2%) in the early and 31.5% (95% CI, 27.3%-35.9%) in the late group (absolute risk reduction for early vs late, 0.7%; 95% CI, -5.4% to 6.7%). Two-year mortality was 51.0% (95% CI, 46.4%-55.6%) in the early and 53.7% (95% CI, 49.1%-58.3%) in the late group (P=.74). Median critical care unit length of stay in survivors was 13.0 days in the early and 13.1 days in the late group (P=.74). Tracheostomy-related complications were reported for 6.3% (95% CI, 4.6%-8.5%) of patients (5.5% in the early group, 7.8% in the late group). Conclusions and Relevance For patients breathing with the aid of mechanical ventilation treated in adult critical care units in the United Kingdom, tracheostomy within 4 days of critical care admission was not associated with an improvement in 30-day mortality or other important secondary outcomes. The ability of clinicians to predict which patients required extended ventilatory support was limited.	[Young, Duncan] John Radcliffe Hosp, Adult Intens Care Unit, Oxford OX3 9DU, England; [Harrison, David A.; Rowan, Kathy] ICNARC, London, England; [Cuthbertson, Brian H.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Cuthbertson, Brian H.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada	University of Oxford; Intensive Care National Audit & Research Centre; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Young, D (corresponding author), John Radcliffe Hosp, Adult Intens Care Unit, Headley Way, Oxford OX3 9DU, England.	duncan.young@nda.ox.ac.uk	Harrison, David A/O-4355-2018; Young, John D/M-9756-2016; Auzinger, Georg/E-8426-2015	Harrison, David A/0000-0002-9002-9098; Auzinger, Georg/0000-0003-3231-1332; Woodcock, Thomas/0000-0001-5878-4379; Young, John Duncan/0000-0002-6838-4835; Rowan, Kathryn/0000-0001-8217-5602	UK Intensive Care Society; Medical Research Council; University of Oxford; MRC [G0500970] Funding Source: UKRI; Medical Research Council [G0500970] Funding Source: researchfish	UK Intensive Care Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Intensive Care Society funded the research prioritization work that led to this study. The study was funded by the UK Intensive Care Society and the Medical Research Council.; The University of Oxford acted as the sponsor. The funders and sponsor had no influence on the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. The randomization service was provided by the Health Services Research Unit in the University of Aberdeen.	Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; CIAGLIA P, 1985, CHEST, V87, P715, DOI 10.1378/chest.87.6.715; Clec'h C, 2007, CRIT CARE MED, V35, P132, DOI 10.1097/01.CCM.0000251134.96055.A6; Combes A, 2007, CRIT CARE MED, V35, P802, DOI 10.1097/01.CCM.0000256721.60517.B1; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Freeman BD, 2012, CRIT CARE MED, V40, P2890, DOI 10.1097/CCM.0b013e31825bc948; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Harvey S, 2006, HEALTH TECHNOL ASSES, V10, P1; HEFFNER JE, 1990, CHEST, V97, P447, DOI 10.1378/chest.97.2.447; Howie JC, 2002, SCOTTISH INTENSIVE C; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koch T, 2012, LANGENBECK ARCH SURG, V397, P1001, DOI 10.1007/s00423-011-0873-9; Kollef MH, 1999, CRIT CARE MED, V27, P1714, DOI 10.1097/00003246-199909000-00003; Krishnan K, 2005, ANAESTHESIA, V60, P360, DOI 10.1111/j.1365-2044.2004.04106.x; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Scales DC, 2008, INTENS CARE MED, V34, P1743, DOI 10.1007/s00134-008-1194-5; Scales DC, 2008, CRIT CARE MED, V36, P2547, DOI 10.1097/CCM.0b013e31818444a5; Seneff MG, 1996, CHEST, V110, P469, DOI 10.1378/chest.110.2.469; Taves DR, 2010, CONTEMP CLIN TRIALS, V31, P180, DOI 10.1016/j.cct.2009.12.005; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Troche G, 1997, CHEST, V112, P745, DOI 10.1378/chest.112.3.745; Veenith Tonny, 2008, Int Arch Med, V1, P21, DOI 10.1186/1755-7682-1-21; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC; Zheng Y, 2012, CHINESE MED J-PEKING, V125, P1925, DOI 10.3760/cma.j.issn.0366-6999.2012.11.016	27	344	362	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2121	2129		10.1001/jama.2013.5154	http://dx.doi.org/10.1001/jama.2013.5154			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23695482				2022-12-28	WOS:000319229600028
J	Mendelow, AD; Gregson, BA; Rowan, EN; Murray, GD; Gholkar, A; Mitchell, PM				Mendelow, A. David; Gregson, Barbara A.; Rowan, Elise N.; Murray, Gordon D.; Gholkar, Anil; Mitchell, Patrick M.		STICH II Investigators	Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial	LANCET			English	Article							EARLY SURGICAL-TREATMENT; HEMORRHAGE STICH; INTRAVENTRICULAR HEMORRHAGE; PLASMINOGEN-ACTIVATOR; PUTAMINAL HEMORRHAGE; MECHANISMS; SPINE	Background The balance of risk and benefit from early neurosurgical intervention for conscious patients with superficial lobar intracerebral haemorrhage of 10-100 mL and no intraventricular haemorrhage admitted within 48 h of ictus is unclear. We therefore tested the hypothesis that early surgery compared with initial conservative treatment could improve outcome in these patients. Methods In this international, parallel-group trial undertaken in 78 centres in 27 countries, we compared early surgical haematoma evacuation within 12 h of randomisation plus medical treatment with initial medical treatment alone (later evacuation was allowed if judged necessary). An automatic telephone and internet-based randomisation service was used to assign patients to surgery and initial conservative treatment in a 1: 1 ratio. The trial was not masked. The primary outcome was a prognosis-based dichotomised (favourable or unfavourable) outcome of the 8 point Extended Glasgow Outcome Scale (GOSE) obtained by questionnaires posted to patients at 6 months. Analysis was by intention to treat. This trial is registered, number ISRCTN22153967. Findings 307 of 601 patients were randomly assigned to early surgery and 294 to initial conservative treatment; 298 and 291 were followed up at 6 months, respectively; and 297 and 286 were included in the analysis, respectively. 174 (59%) of 297 patients in the early surgery group had an unfavourable outcome versus 178 (62%) of 286 patients in the initial conservative treatment group (absolute difference 3.7% [95% CI -4.3 to 11.6], odds ratio 0.86 [0.62 to 1.20]; p=0.367). Interpretation The STICH II results confirm that early surgery does not increase the rate of death or disability at 6 months and might have a small but clinically relevant survival advantage for patients with spontaneous superficial intracerebral haemorrhage without intraventricular haemorrhage.	[Mendelow, A. David; Gregson, Barbara A.; Rowan, Elise N.; Mitchell, Patrick M.] Newcastle Univ, Neurosurg Trials Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Murray, Gordon D.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Gholkar, Anil] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; University of Edinburgh; Newcastle University - UK	Gregson, BA (corresponding author), Neurosurg Trials Unit, 3-4 Claremont Terrace, Newcastle Upon Tyne NE2 4AE, Tyne & Wear, England.	barbara.gregson@ncl.ac.uk	Mendelow, Alexander/AAW-2878-2021; Juráň, Vilém/ABD-9854-2020; Teo, Kejia/U-5524-2017; Neugebauer, Hermann/AAD-8309-2019; Florian, Ioan Stefan I/D-5934-2016; Smrčka, Martin/AAM-8872-2021; Osama Abdelaziz, MBChB/K-4428-2019; Hamann, Gerhard F./J-6300-2014; Roka, Yam Bahadur/AHC-6818-2022; Abdullah, J/C-2828-2011; Kleindienst, Andrea/F-1674-2014; Agrawal, Amit/C-1511-2011; Szczygielski, Jacek/AAV-4791-2021; Benes, Vladimir/M-4755-2017; Bradac, Ondrej/M-4882-2017; Mohapl, Milan/O-5822-2017; Belli, Antonio/I-3799-2015	Juráň, Vilém/0000-0003-1080-3520; Teo, Kejia/0000-0003-4586-1683; Neugebauer, Hermann/0000-0003-3759-356X; Florian, Ioan Stefan I/0000-0001-7127-0946; Smrčka, Martin/0000-0002-9191-8700; Osama Abdelaziz, MBChB/0000-0002-4767-4286; Roka, Yam Bahadur/0000-0003-1458-3705; Abdullah, J/0000-0002-0258-7410; Kleindienst, Andrea/0000-0003-4758-0324; Agrawal, Amit/0000-0002-3287-5448; Szczygielski, Jacek/0000-0002-3157-2824; Chilton, Lucy/0000-0002-3559-5644; Benes, Vladimir/0000-0002-6889-857X; Buchvald, Pavel/0000-0001-7071-4381; Kitchener, Nabil/0000-0002-8084-2173; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Tyrrell, Pippa/0000-0001-9609-1231; Ford, Gary A/0000-0001-8719-4968; Mariak, Zenon/0000-0003-4132-9278; Pomposo Gaztelu, Inigo/0000-0002-3095-2649; Munoz-Narbona, Lucia/0000-0002-0884-3024; Qureshi, Adnan/0000-0003-4962-540X; RAMANA, P V/0000-0003-4654-0590; Gregson, Barbara/0000-0003-4868-9137; Murray, Gordon/0000-0001-9866-4734; Menon, Girish/0000-0002-1849-0453; Bradac, Ondrej/0000-0003-4364-5522; Mohapl, Milan/0000-0002-5202-3242; Krivoshapkin, Alexey/0000-0003-0789-8039; Belli, Antonio/0000-0002-3211-9933; Martin-Laez, Ruben/0000-0003-4675-6818; Hanley, Daniel/0000-0002-9536-4258; Kaye, Andrew Henry/0000-0001-5049-8861	UK Medical Research Council; Medical Research Council [G0501444, G0800803] Funding Source: researchfish; MRC [G0501444, G0800803] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Medical Research Council.	AUER LM, 1989, J NEUROSURG, V70, P530, DOI 10.3171/jns.1989.70.4.0530; BATJER HH, 1990, ARCH NEUROL-CHICAGO, V47, P1103, DOI 10.1001/archneur.1990.00530100071015; Bhattathiri PS, 2006, ACTA NEUROCHIR SUPPL, V96, P65; BRODERICK JP, 1994, STROKE, V25, P1081, DOI 10.1161/str.25.5.1081b; CHEN X, 1992, ACTA ACAD MED SHANGH, V19, P237; Chen X-C, 2001, CHIN J CLIN NEUROSCI, V4, P365; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; Gregson BA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-222; Gregson BA, 2012, STROKE, V43, P1496, DOI 10.1161/STROKEAHA.111.640284; Hanley DF, 2013, MISTIE 3 MINIMALLY I; Hanley DF, 2013, CLEAR 3 CLOT LYSIS E; Hattori N, 2004, J NEUROSURG, V101, P417, DOI 10.3171/jns.2004.101.3.0417; HOSSEINI H, 2003, CEREBROVASC DIS, V16, P57; JUVELA S, 1989, J NEUROSURG, V70, P755, DOI 10.3171/jns.1989.70.5.0755; Keep RF, 2005, STROKE, V36, P1594, DOI 10.1161/01.STR.0000170701.41507.e1; MCKISSOCK W, 1961, LANCET, V2, P221; Mendelow A D, 1984, Neurol Res, V6, P189; Mendelow AD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-124; Mendelow AD, 2005, LANCET, V365, P387; MENDELOW AD, 1993, STROKE, V24, pI115; Mendelow AD, 2011, STROKE PATHOPHYSIOLO; Morgenstern LB, 1998, NEUROLOGY, V51, P1359, DOI 10.1212/WNL.51.5.1359; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Naff N, 2011, STROKE, V42, P3009, DOI 10.1161/STROKEAHA.110.610949; NEHLS DG, 1990, NEUROSURGERY, V27, P674, DOI 10.1227/00006123-199011000-00002; Pantazis G, 2006, SURG NEUROL, V66, P492, DOI 10.1016/j.surneu.2006.05.054; Prasad K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub3; Siddique MS, 2000, ACT NEUR S, V76, P517; Teernstra OPM, 2003, STROKE, V34, P968, DOI 10.1161/01.STR.0000063367.52044.40; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang WZ, 2009, INT J STROKE, V4, P11, DOI 10.1111/j.1747-4949.2009.00239.x; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; Zuccarello M, 1999, STROKE, V30, P1833, DOI 10.1161/01.STR.30.9.1833	38	679	717	1	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					397	408		10.1016/S0140-6736(13)60986-1	http://dx.doi.org/10.1016/S0140-6736(13)60986-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MX	23726393	hybrid, Green Published			2022-12-28	WOS:000322638500032
J	Roy, X; Lee, CH; Crowther, AC; Schenck, CL; Besara, T; Lalancette, RA; Siegrist, T; Stephens, PW; Brus, LE; Kim, P; Steigerwald, ML; Nuckolls, C				Roy, Xavier; Lee, Chul-Ho; Crowther, Andrew C.; Schenck, Christine L.; Besara, Tiglet; Lalancette, Roger A.; Siegrist, Theo; Stephens, Peter W.; Brus, Louis E.; Kim, Philip; Steigerwald, Michael L.; Nuckolls, Colin			Nanoscale Atoms in Solid-State Chemistry	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PEROVSKITES; FULLERIDES; SALTS	We describe a solid-state material formed from binary assembly of atomically precise molecular clusters. [Co6Se8(PEt3)(6)][C-60](2) and [Cr6Te8(PEt3)(6)][C-60](2) assembled into a superatomic relative of the cadmium iodide (CdI2) structure type. These solid-state materials showed activated electronic transport with activation energies of 100 to 150 millielectron volts. The more reducing cluster Ni9Te6(PEt3)(8) transferred more charge to the fullerene and formed a rock-salt-related structure. In this material, the constituent clusters are able to interact electronically to produce a magnetically ordered phase at low temperature, akin to atoms in a solid-state compound.	[Roy, Xavier; Lee, Chul-Ho; Schenck, Christine L.; Brus, Louis E.; Steigerwald, Michael L.; Nuckolls, Colin] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Lee, Chul-Ho; Kim, Philip] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Crowther, Andrew C.] Columbia Univ Barnard Coll, Dept Chem, New York, NY 10027 USA; [Besara, Tiglet; Siegrist, Theo] Florida State Univ, NHMFL, Tallahassee, FL 32310 USA; [Siegrist, Theo] Florida A&M Univ FSU Coll Engn, Dept Chem & Biomed Engn, Tallahassee, FL 32310 USA; [Lalancette, Roger A.] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Stephens, Peter W.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA	Columbia University; Columbia University; Columbia University; State University System of Florida; Florida State University; Rutgers State University Newark; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Steigerwald, ML (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	mls2064@columbia.edu; cn37@columbia.edu	Besara, Tiglet/M-7969-2014; Siegrist, Theo/R-3855-2019; Lee, Chul-Ho/AAI-6876-2020; Kim, Philip/N-1886-2013	Besara, Tiglet/0000-0002-2143-2254; Siegrist, Theo/0000-0001-5368-1442; Lee, Chul-Ho/0000-0003-1570-8688; Kim, Philip/0000-0002-8255-0086	Center for Re-Defining Photovoltaic Efficiency Through Molecular-Scale Control, an Energy Frontier Research Center (EFRC); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001085]; Natural Sciences and Engineering Research Council of Canada; National Research Foundation of Korea [357-2011-1-C00035]; National Science Foundation [DGE-1144155, DMR-1157490]; State of Florida; U.S. Department of Energy; Florida State University; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-98CH10886]; U.S. Department of Energy, Office of Basic Sciences [DE-SC0008832]	Center for Re-Defining Photovoltaic Efficiency Through Molecular-Scale Control, an Energy Frontier Research Center (EFRC); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Foundation of Korea(National Research Foundation of Korea); National Science Foundation(National Science Foundation (NSF)); State of Florida; U.S. Department of Energy(United States Department of Energy (DOE)); Florida State University; U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Basic Sciences(United States Department of Energy (DOE))	This work was supported primarily through the Center for Re-Defining Photovoltaic Efficiency Through Molecular-Scale Control, an Energy Frontier Research Center (EFRC) funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001085. X. R. thanks the Natural Sciences and Engineering Research Council of Canada for a postdoctoral fellowship. C.-H. L. is partially supported by the Basic Science Research Program through the National Research Foundation of Korea (357-2011-1-C00035). C. L. S. is supported by the National Science Foundation Graduate Research Fellowship under award DGE-1144155. We thank Y. Uemura for the SQUID magnetometer. NHMFL was supported in part by the National Science Foundation Cooperative Agreement DMR-1157490, the State of Florida, the U.S. Department of Energy, and Florida State University. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Basic Energy Sciences under contract DE-AC02-98CH10886. Structural analysis work done by T. B. and T. S. is supported by the U.S. Department of Energy, Office of Basic Sciences under contract DE-SC0008832, the State of Florida, and Florida State University. The crystallographic data presented in this work are available through the Cambridge Crystallographic Data Center referencing deposition nos. 940469 to 940472. We gratefully acknowledge R. J. Cava for very helpful conversations.	Auyeung E, 2012, NAT NANOTECHNOL, V7, P24, DOI [10.1038/nnano.2011.222, 10.1038/NNANO.2011.222]; BATAIL P, 1991, ANGEW CHEM INT EDIT, V30, P1498, DOI 10.1002/anie.199114981; Baudron SA, 2005, J AM CHEM SOC, V127, P11785, DOI 10.1021/ja0523385; Bozorth RM, 1922, J AM CHEM SOC, V44, P2232, DOI 10.1021/ja01431a019; BRENNAN JG, 1989, J AM CHEM SOC, V111, P9240, DOI 10.1021/ja00208a023; Claridge SA, 2009, ACS NANO, V3, P244, DOI 10.1021/nn800820e; COULON C, 1993, J PHYS I, V3, P1153, DOI 10.1051/jp1:1993262; DAVID WIF, 1991, NATURE, V353, P147, DOI 10.1038/353147a0; Degroot M. W., 2003, COMPREHENSIVE COORDI, P57; Dong AG, 2010, NATURE, V466, P474, DOI 10.1038/nature09188; HESSEN B, 1993, INORG CHEM, V32, P5165, DOI 10.1021/ic00075a037; Kovalenko MV, 2009, SCIENCE, V324, P1417, DOI 10.1126/science.1170524; KUZMANY H, 1994, ADV MATER, V6, P731, DOI 10.1002/adma.19940061004; Long DL, 2007, CHEM SOC REV, V36, P105, DOI 10.1039/b502666k; Mitzi DB, 1999, PROG INORG CHEM, V48, P1, DOI 10.1002/9780470166499.ch1; PENICAUD A, 1990, CHEM MATER, V2, P123, DOI 10.1021/cm00008a011; Reed CA, 2000, CHEM REV, V100, P1075, DOI 10.1021/cr980017o; Roy X, 2012, ANGEW CHEM INT EDIT, V51, P12473, DOI 10.1002/anie.201206301; Wells A.F., 1984, STRUCTURAL INORGANIC; XIE QS, 1992, J AM CHEM SOC, V114, P3978, DOI 10.1021/ja00036a056	20	170	173	4	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					157	160		10.1126/science.1236259	http://dx.doi.org/10.1126/science.1236259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23744780	Bronze			2022-12-28	WOS:000321965300038
J	Hu, YW; Lu, SH; Song, ZG; Wang, W; Hao, P; Li, JH; Zhang, XN; Yen, HL; Shi, BS; Li, T; Guan, WC; Xu, L; Liu, Y; Wang, S; Zhang, XL; Tian, D; Zhu, ZQ; He, J; Huang, K; Chen, HJ; Zheng, LL; Li, X; Ping, J; Kang, B; Xi, XH; Zha, LJ; Li, YX; Zhang, ZY; Peiris, M; Yuan, ZH				Hu, Yunwen; Lu, Shuihua; Song, Zhigang; Wang, Wei; Hao, Pei; Li, Jianhua; Zhang, Xiaonan; Yen, Hui-Ling; Shi, Bisheng; Li, Tao; Guan, Wencai; Xu, Lei; Liu, Yi; Wang, Sen; Zhang, Xiaoling; Tian, Di; Zhu, Zhaoqin; He, Jing; Huang, Kai; Chen, Huijie; Zheng, Lulu; Li, Xuan; Ping, Jie; Kang, Bin; Xi, Xiuhong; Zha, Lijun; Li, Yixue; Zhang, Zhiyong; Peiris, Malik; Yuan, Zhenghong			Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance	LANCET			English	Article							MUTATIONS	Background On March 30, a novel influenza A subtype H7N9 virus (A/H7N9) was detected in patients with severe respiratory disease in eastern China. Virological factors associated with a poor clinical outcome for this virus remain unclear. We quantified the viral load and analysed antiviral resistance mutations in specimens from patients with A/H7N9. Methods We studied 14 patients with A/H7N9 disease admitted to the Shanghai Public Health Clinical Centre (SPHCC), China, between April 4, and April 20, 2013, who were given antiviral treatment (oseltamivir or peramivir) for less than 2 days before admission. We investigated the viral load in throat, stool, serum, and urine specimens obtained sequentially from these patients. We also sequenced viral RNA from these specimens to study the mutations associated with resistance to neuraminidase inhibitors and their association with disease outcome. Findings All patients developed pneumonia, seven of them required mechanical ventilation, and three of them further deteriorated to become dependent on extracorporeal membrane oxygenation (ECMO), two of whom died. Antiviral treatment was associated with a reduction of viral load in throat swab specimens in 11 surviving patients. Three patients with persistently high viral load in the throat in spite of antiviral therapy became ECMO dependent. An Arg292Lys mutation in the virus neuraminidase (NA) gene known to confer resistance to both zanamivir and oseltamivir was identified in two of these patients, both also received corticosteroid treatment. In one of them, wild-type sequence Arg292 was noted 2 days after start of antiviral treatment, and the resistant mutant Lys292 dominated 9 days after start of treatment. Interpretation Reduction of viral load following antiviral treatment correlated with improved outcome. Emergence of NA Arg292Lys mutation in two patients who also received corticosteroid treatment led to treatment failure and a poor clinical outcome. The emergence of antiviral resistance in A/H7N9 viruses, especially in patients receiving corticosteroid therapy, is concerning, needs to be closely monitored, and considered in pandemic preparedness planning.	[Hu, Yunwen; Song, Zhigang; Wang, Wei; Zhang, Xiaonan; Shi, Bisheng; Guan, Wencai; Xu, Lei; Liu, Yi; Zhang, Xiaoling; Tian, Di; Zhu, Zhaoqin; He, Jing; Kang, Bin; Zhang, Zhiyong] Fudan Univ, Shanghai Med Coll, Dept Pathogen Diag & Biosafety, Shanghai Publ Hlth Clin Ctr,Key Lab Med Mol Virol, Shanghai 200030, Peoples R China; [Wang, Sen; Li, Yixue; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, Shanghai 200030, Peoples R China; [Lu, Shuihua; Li, Tao; Xi, Xiuhong; Zha, Lijun] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200030, Peoples R China; [Hao, Pei; Ping, Jie] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai, Peoples R China; [Huang, Kai; Chen, Huijie; Zheng, Lulu; Li, Xuan; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Yen, Hui-Ling; Peiris, Malik] Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Hong Kong	Yuan, ZH (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, 138 Yi Xue Yuan Rd, Shanghai 200030, Peoples R China.	malik@hkucc.hku.hk; zhyuan@shaphc.org	Yen, Hui-Ling/GNH-5083-2022; Yen, Hui-Ling/C-4501-2009; zheng, lu/GXH-7035-2022; Peiris, Joseph Sriyal Malik/C-4380-2009	Yen, Hui-Ling/0000-0003-2493-3609; Hao, Pei/0000-0002-1498-7059; Zhang, Xiaonan/0000-0002-1286-7280; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Li, Jianhua/0000-0001-7329-5688	National Megaprojects of China for Infectious Diseases [2012ZX10004211]; National Natural Science Foundation of China [81341004]; Ministry of Science and Technology [KJYJ-2013-01-01]; Shanghai Municipal Health and Family Planning Commission; National Key Basic Research Program of China [2012CB519000]; Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06]; Hong Kong SAR Government; National Institutes of Health (NIAID) [HHSN266200700005C]	National Megaprojects of China for Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Municipal Health and Family Planning Commission; National Key Basic Research Program of China(National Basic Research Program of China); Area of Excellence Scheme of the University Grants Committee; Hong Kong SAR Government; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Yumei Wen (Shanghai Medical College of Fudan University) and Guoping Zhao (Shanghai Institutes for Biological Sciences, CAS) for their valuable suggestions and useful discussion. We thank B J Cowling for help with statistical analysis for supplementary figure S2 (appendix). This research was supported by the National Megaprojects of China for Infectious Diseases (2012ZX10004211), National Natural Science Foundation of China (81341004), Ministry of Science and Technology (KJYJ-2013-01-01), Shanghai Municipal Health and Family Planning Commission, and the National Key Basic Research Program of China (2012CB519000). H-LY and MP are supported by Funding from the Area of Excellence Scheme of the University Grants Committee (AoE/M-12/06), Hong Kong SAR Government and National Institutes of Health (NIAID contract HHSN266200700005C).	Chan MCW, 2011, EMERG INFECT DIS, V17, P2038, DOI 10.3201/eid1711.110205; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321	15	253	290	3	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2273	2279		10.1016/S0140-6736(13)61125-3	http://dx.doi.org/10.1016/S0140-6736(13)61125-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173SU	23726392				2022-12-28	WOS:000321100300031
J	Carolin, SA; Cobb, KM; Adkins, JF; Clark, B; Conroy, JL; Lejau, S; Malang, J; Tuen, AA				Carolin, Stacy A.; Cobb, Kim M.; Adkins, Jess F.; Clark, Brian; Conroy, Jessica L.; Lejau, Syria; Malang, Jenny; Tuen, Andrew A.			Varied Response of Western Pacific Hydrology to Climate Forcings over the Last Glacial Period	SCIENCE			English	Article							EAST-ASIAN MONSOON; PAST 130,000 YEARS; SOUTH CHINA SEA; U-TH AGES; MILLENNIAL-SCALE; INTERGLACIAL PERIOD; TEMPERATURE-CHANGE; LATE PLEISTOCENE; NORTHERN BORNEO; WARM POOL	Atmospheric deep convection in the west Pacific plays a key role in the global heat and moisture budgets, yet its response to orbital and abrupt climate change events is poorly resolved. Here, we present four absolutely dated, overlapping stalagmite oxygen isotopic records from northern Borneo that span most of the last glacial cycle. The records suggest that northern Borneo's hydroclimate shifted in phase with precessional forcing but was only weakly affected by glacial-interglacial changes in global climate boundary conditions. Regional convection likely decreased during Heinrich events, but other Northern Hemisphere abrupt climate change events are notably absent. The new records suggest that the deep tropical Pacific hydroclimate variability may have played an important role in shaping the global response to the largest abrupt climate change events.	[Carolin, Stacy A.; Cobb, Kim M.; Conroy, Jessica L.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Adkins, Jess F.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Clark, Brian; Lejau, Syria; Malang, Jenny] Gunung Mulu Natl Pk, Sarawak, Malaysia; [Tuen, Andrew A.] Univ Malaysia Sarawak, Inst Biodivers & Environm Conservat, Sarawak, Malaysia	University System of Georgia; Georgia Institute of Technology; California Institute of Technology; University of Malaysia Sarawak	Carolin, SA (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	stacy.carolin@gatech.edu	Adkins, Jess/GYI-8778-2022	Cobb, Kim/0000-0002-2125-9164; Carolin, Stacy Anne/0000-0001-7181-2370	NSF PECASE [0645291]; NSF AGS [0903099]; NSF	NSF PECASE(National Science Foundation (NSF)); NSF AGS; NSF(National Science Foundation (NSF))	We thank N. Meckler, J. Partin, and S. Clark (Gunung Mulu National Park) for field assistance; J. Partin for assistance in sample analysis; G. Paris, M. Raven, S. Hines, and A. Subhas for assistance in U-Th dating; and J. Lynch-Stieglitz for providing comments on early versions of the manuscript. S. A. C, K. M. C., and J. F. A. were involved in the writing and design of this study; A. A. T. and B. C. facilitated the fieldwork for this study; S. A. C, K. M. C., S. L., and J. M. collected samples; and S. A. C. analyzed the samples. The research was funded by NSF PECASE Award no. 0645291 to K. M. C., NSF AGS award no. 0903099 to J. F. A., and a NSF Graduate Research Fellowship to S. A. C. Permits for this work were granted by the Malaysian Economic Planning Unit, the Sarawak State Planning Unit, and the Sarawak Forestry Department. All data reported in this paper are archived at the National Climatic Data Center (ftp://ftp.ncdc.noaa.gov/pub/data/paleo/speleothem/pacific/borneo2013.txt).	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Bush ABG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003027; Cane M, 1999, GEOPH MONOG SERIES, V112, P373; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Cobb KM, 2007, EARTH PLANET SC LETT, V263, P207, DOI 10.1016/j.epsl.2007.08.024; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; Dannenmann S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000390; DANSGAARD W, 1964, TELLUS, V16, P436; De Deckker P, 2003, GLOBAL PLANET CHANGE, V35, P25, DOI 10.1016/S0921-8181(02)00089-9; DiNezio PN, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002083; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Kanner LC, 2012, SCIENCE, V335, P570, DOI 10.1126/science.1213397; MADDEN RA, 1972, J ATMOS SCI, V29, P1109, DOI 10.1175/1520-0469(1972)029<1109:DOGSCC>2.0.CO;2; Meckler AN, 2012, SCIENCE, V336, P1301, DOI 10.1126/science.1218340; Moerman JW, 2013, EARTH PLANET SC LETT, V369, P108, DOI 10.1016/j.epsl.2013.03.014; Oppo DW, 2005, GEOLOGY, V33, P785, DOI 10.1130/G21867.1; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Rashid H, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000913; ROZANSKI K, 1992, SCIENCE, V258, P981, DOI 10.1126/science.258.5084.981; Scholz D, 2011, QUAT GEOCHRONOL, V6, P369, DOI 10.1016/j.quageo.2011.02.002; Storey M, 2012, P NATL ACAD SCI USA, V109, P18684, DOI 10.1073/pnas.1208178109; Tierney JE, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018060; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1; Zhao MX, 2006, PALAEOGEOGR PALAEOCL, V236, P39, DOI 10.1016/j.palaeo.2005.11.033	33	107	113	4	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1564	1566		10.1126/science.1233797	http://dx.doi.org/10.1126/science.1233797			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23744779				2022-12-28	WOS:000321007000039
J	Vickers, J; Safai, B				Vickers, Jennifer; Safai, Bijan			Scombroid Poisoning	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vickers, Jennifer; Safai, Bijan] New York Med Coll, New York, NY USA	New York Medical College	Vickers, J (corresponding author), New York Med Coll, New York, NY USA.	safai@aol.com							0	6	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					E31	E31		10.1056/NEJMicm1300169	http://dx.doi.org/10.1056/NEJMicm1300169			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23738567				2022-12-28	WOS:000319948900010
J	Mesmin, B; Antonny, B				Mesmin, Bruno; Antonny, Bruno			Vitamin Currency in a Lipid Exchange Market	SCIENCE			English	Editorial Material							ALPHA-TOCOPHEROL; BINDING		[Mesmin, Bruno] Univ Nice, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; CNRS, F-06560 Valbonne, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Mesmin, B (corresponding author), Univ Nice, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Antonny, Bruno/ABH-7434-2020; Mesmin, Bruno/N-9246-2017	Antonny, Bruno/0000-0002-9166-8668; Mesmin, Bruno/0000-0002-5437-3246				Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Di Donato I, 2010, NEUROL SCI, V31, P511, DOI 10.1007/s10072-010-0261-1; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Morley S, 2006, BIOCHEMISTRY-US, V45, P1075, DOI 10.1021/bi052271y; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Traber MG, 2007, ANNU REV NUTR, V27, P347, DOI 10.1146/annurev.nutr.27.061406.093819	11	6	6	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1051	1052		10.1126/science.1239800	http://dx.doi.org/10.1126/science.1239800			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723221				2022-12-28	WOS:000319664500026
J	Shaw, RJ				Shaw, Reuben J.			GATORs Take a Bite Out of mTOR	SCIENCE			English	Editorial Material							RAG GTPASES; COMPLEX; AUTOPHAGY; MUTATIONS		Salk Inst Biol Studies, Howard Hughes Med Inst, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Mol & Cell Biol Lab, La Jolla, CA 92037 USA.	shaw@salk.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Dibbens LM, 2013, NAT GENET, V45, P546, DOI 10.1038/ng.2599; Dokudovskaya S, 2011, AUTOPHAGY, V7, P1392, DOI 10.4161/auto.7.11.17347; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Ishida S, 2013, NAT GENET, V45, P552, DOI 10.1038/ng.2601; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li F, 2004, CANCER RES, V64, P6438, DOI 10.1158/0008-5472.CAN-03-3869; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Seng TJ, 2005, GENE CHROMOSOME CANC, V43, P181, DOI 10.1002/gcc.20181; van Eeghen AM, 2012, EUR J HUM GENET, V20, P510, DOI 10.1038/ejhg.2011.241; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525	15	9	9	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1056	1057		10.1126/science.1240315	http://dx.doi.org/10.1126/science.1240315			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723225				2022-12-28	WOS:000319664500030
J	Boland, B				Boland, Billy			Integration of health and social care would better safeguard adults from harm	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK		Hertfordshire Partnership NHS Fdn Trust, St Albans AL3 5TL, England		Boland, B (corresponding author), Hertfordshire Partnership NHS Fdn Trust, St Albans AL3 5TL, England.	billyboland@doctors.org.uk						Boland B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2716; Care Quality Commission, HLTH CAR NEEDS PEOPL; Department for Work and Pensions, STAT FITN WORK FIT N; Dyer C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3482; Flynn M., WINT VIEW HOSP SER C; Francis R, 2013, REP MID STAFF NHS FD; Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3152; National Voices, PRINC INT CAR; NHS Information Centre, 2012, AB VULN AD ENGL 2010; Williams D., 2012, HLTH SERVICE J  0802; Williams D., 2013, HLTH SERVICE J	11	0	0	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3266	10.1136/bmj.f3266	http://dx.doi.org/10.1136/bmj.f3266			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23693058				2022-12-28	WOS:000319573300011
J	Delamothe, T				Delamothe, Tony			Slip an extra locust on the barbie?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						Dicke Marcel, 2010, WHY NOT EAT INSECTS; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445	2	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2013	346								f3293	10.1136/bmj.f3293	http://dx.doi.org/10.1136/bmj.f3293			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AA	23690504				2022-12-28	WOS:000319572300012
J	Morgan, MA; Shilatifard, A				Morgan, Marc Alard; Shilatifard, Ali			(Poly)Combing the Pediatric Cancer Genome for Answers	SCIENCE			English	Editorial Material							HISTONE; PRC2		[Morgan, Marc Alard; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Morgan, MA (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	ash@stowers.org						Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Herz HM, 2010, MOL CELL BIOL, V30, P2485, DOI 10.1128/MCB.01633-09; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Venneti S, 2013, BRAIN PATHOL, V23, P558, DOI 10.1111/bpa.12042; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102	15	9	10	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					823	824		10.1126/science.1239223	http://dx.doi.org/10.1126/science.1239223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687038				2022-12-28	WOS:000318997400032
J	Ledford, H				Ledford, Heidi			'Master protocol' aims to revamp cancer trials	NATURE			English	News Item																		2010, NATURE, V464, P1258	1	21	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					146	147		10.1038/498146a	http://dx.doi.org/10.1038/498146a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23745189	Bronze			2022-12-28	WOS:000320283400009
